<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6002110\results\search\disease\results.xml">
   <result pre="(YFV) (family Flaviviridae, genus Flavivirus) is the etiologic agent of" exact="yellow fever" post="(YF). In Brazil, the urban cycle has not occured"/>
   <result pre="the urban cycle has not occured since 1942, but sylvatic" exact="yellow fever" post="(SYF) occurs in the Amazon Basin (S1A Fig) in"/>
   <result pre="and adjacent regions. Supporting information S1 Fig Historical data of" exact="yellow fever" post="in Brazil. (A) Geopolitical map of Brazil and the"/>
   <result pre="Brazil and the Amazon Basin. The Amazon Basin, where sylvatic" exact="yellow fever" post="is endemic, is highlighted. Brazilian geopolitical regions are colored"/>
   <result pre="and MinistÃ©rio do Meio Ambiente [35]. (B) Number of sylvatic" exact="yellow fever" post="human cases, from 2001 to February 2018, according to"/>
   <result pre="The Brazilian regions and the bars representing the numbers of" exact="yellow fever" post="human cases are colored accordingly. *data from May 2016"/>
   <result pre="2017 to February 2018 [36]. Data regarding the number of" exact="yellow fever" post="cases were obtained from Sistema de InformaÃ§Ã£o de Agravos"/>
   <result pre="South American Genotypes are shown in green, and the Brazilian" exact="yellow fever" post="virus from outbreaks 2016â€&quot;2018 are collapsed in a triangle."/>
   <result pre="circles drawn in scale in the nodes. Clades containing Brazilian" exact="yellow fever" post="virus from outbreaks 2000â€&quot;01, 2008â€&quot;09 and the current (2016â€&quot;2018)"/>
   <result pre="de, SantosMP, RibeiroIP, et al.Genomic and structural features of the" exact="yellow fever" post="virus from the 2016â€&quot;2017 Brazilian outbreak. J Gen Virol."/>
   <result pre="dos SantosCN. Isolation and characterization of a Brazilian strain of" exact="yellow fever" post="virus from an epizootic outbreak in 2009. Acta Trop."/>
   <result pre="BradyOJ, KraemerMUG, et al.Existing and potential infection risk zones of" exact="yellow fever" post="worldwide: a modelling analysis. Lancet Glob Heal. 2018;6: e270â€&quot;e278."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6050668\results\search\disease\results.xml">
   <result pre="to the data of NHPs vaccinated with a recombinant vesicular" exact="stomatitis" post="virus vaccine (rVSV-EBOV) [44]. This vaccine had shown a"/>
   <result pre="R0 Basic reproduction number Re Effective reproduction number VSV Vesicular" exact="stomatitis" post="virus WHO World health organization Electronic supplementary material The"/>
   <result pre="Sci USA20141115118095610.1073/pnas.142155111125502594 4WillemLVerelstFBilckeJHensNBeutelsPLessons from a decade of individual-based models for" exact="infectious disease" post="transmission: a systematic review (2006-2015)BMC Infect Dis201717161210.1186/s12879-017-2699-828893198 5AndersonRMMayRMInfectious Diseases"/>
   <result pre="5AndersonRMMayRMInfectious Diseases of Humans: Dynamics and Control1992OxfordOUP Oxford 6HeesterbeekHAndersonRMAndreasenVBansalSDe AngelisDDyeCEamesKTDEdmundsWJFrostSDWFunkSHollingsworthTDHouseTIshamVKlepacPLesslerJLloyd-SmithJOMetcalfCJEMollisonDPellisLPulliamJRCRobertsMGViboudCModeling" exact="infectious disease" post="dynamics in the complex landscape of global healthScience201534762274339910.1126/science.aaa4339 7BrittonTStochastic"/>
   <result pre="Ring VaccinationPLoS Negl Trop Dis20161011000509310.1371/journal.pntd.0005093 11LukensSDePasseJRosenfeldRGhedinEMochanEBrownSTGrefenstetteJBurkeDSSwigonDClermontGA large-scale immuno-epidemiological simulation of" exact="influenza" post="A epidemicsBMC Public Health201414101910.1186/1471-2458-14-101925266818 12World Health Organization. Outbreak communication:"/>
   <result pre="Technical report. 13Nguyen VK, Parra-Rojas C, Hernandez-Vargas EA. The 2017" exact="plague" post="outbreak in Madagascar: data descriptions and epidemic modelling. Epidemics."/>
   <result pre="kinetics and exhaled droplet size affect indoor transmission dynamics of" exact="influenza" post="infectionIndoor Air20091954011310.1111/j.1600-0668.2009.00603.x19659895 19FarberDLYudaninNARestifoNPHuman memory T cells: generation, compartmentalization and"/>
   <result pre="generation, compartmentalization and homeostasisNat Rev Immunol2014141243510.1038/nri356724336101 20Hernandez-VargasEAWilkECaniniLToapantaFRBinderSCUvarovskiiARossTMGuzmanCAPerelsonASMeyer-HermannMEffects of aging on" exact="influenza" post="virus infection dynamicsJ. Virol.201488841233110.1128/JVI.03644-1324478442 21RozhnovaGMetcalfCJEGrenfellBTCharacterizing the dynamics of rubella"/>
   <result pre="on influenza virus infection dynamicsJ. Virol.201488841233110.1128/JVI.03644-1324478442 21RozhnovaGMetcalfCJEGrenfellBTCharacterizing the dynamics of" exact="rubella" post="relative to measles: the role of stochasticityJ R Soc"/>
   <result pre="Interface20131088201306432013064310.1098/rsif.2013.064324026472 22CaudronQMahmudASMetcalfCJEGottfrethssonMViboudCCliffADGrenfellBTPredictability in a highly stochastic system: final size of" exact="measles" post="epidemics in small populationsJ R Soc Interface2014121022014112510.1098/rsif.2014.1125 23FinkenstadtBFA stochastic"/>
   <result pre="for extinction and recurrence of epidemics: estimation and inference for" exact="measles" post="outbreaksBiostatistics20023449351010.1093/biostatistics/3.4.49312933594 24MurilloLNMurilloMSPerelsonASTowards multiscale modeling of influenza infectionJ Theor Biol20133322679010.1016/j.jtbi.2013.03.02423608630"/>
   <result pre="estimation and inference for measles outbreaksBiostatistics20023449351010.1093/biostatistics/3.4.49312933594 24MurilloLNMurilloMSPerelsonASTowards multiscale modeling of" exact="influenza" post="infectionJ Theor Biol20133322679010.1016/j.jtbi.2013.03.02423608630 25DayTAlizonSMideoNBridging scales in the evolution of"/>
   <result pre="influenza infectionJ Theor Biol20133322679010.1016/j.jtbi.2013.03.02423608630 25DayTAlizonSMideoNBridging scales in the evolution of" exact="infectious disease" post="life histories: theoryEvolution2011651234486110.1111/j.1558-5646.2011.01394.x22133217 26LonginiIMNizamAXuSUngchusakKHanshaoworakulWCummingsDAHalloranMEContaining pandemic influenza at the sourceScience200530957371083710.1126/science.111571716079251"/>
   <result pre="the evolution of infectious disease life histories: theoryEvolution2011651234486110.1111/j.1558-5646.2011.01394.x22133217 26LonginiIMNizamAXuSUngchusakKHanshaoworakulWCummingsDAHalloranMEContaining pandemic" exact="influenza" post="at the sourceScience200530957371083710.1126/science.111571716079251 27CenXFengZZhaoYEmerging disease dynamics in a model"/>
   <result pre="networksPhys Rev Let2001863200310.1103/PhysRevLett.86.320011290142 32BrownSTTaiJHBaileyRRCooleyPCWheatonWDPotterMAVoorheesRELeJeuneMGrefenstetteJJBurkeDSMcGloneSMLeeBYWould school closure for the 2009 H1N1" exact="influenza" post="epidemic have been worth the cost?: a computational simulation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6083217\results\search\disease\results.xml">
   <result pre="similarities to other flaviviruses, such as West Nile virus, Japanese" exact="encephalitis" post="virus (JEV) and dengue virus. ZIKV has an approximately"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6091172\results\search\disease\results.xml">
   <result pre="D. Hepatitis A immunisation in persons not previously exposed to" exact="hepatitis" post="A. Cochrane Database Syst Rev. 2012;(Issue 7):Art No.:CD009051. 16.FrancisDPHadlerSCThompsonSEMaynardJEOrstrowDGet"/>
   <result pre="Database Syst Rev. 2012;(Issue 7):Art No.:CD009051. 16.FrancisDPHadlerSCThompsonSEMaynardJEOrstrowDGet al.The prevention of" exact="hepatitis" post="B with vaccineAnn Intern Med19829736236610.7326/0003-4819-97-3-3626810736 17.GuptaRWarrenTWaldAGenital HerpesLancet20073702127213710.1016/S0140-6736(07)61908-418156035 18.Moreno R,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6109282\results\search\disease\results.xml">
   <result pre="effective vector control and immunization programs for nearly a century," exact="yellow fever" post="epidemics reemerged in many Latin American countries, particularly Brazil."/>
   <result pre="to constrain yellow fever: vector control and immunization. In contrast," exact="yellow fever" post="is absent from Asia and the Pacific despite the"/>
   <result pre="virus. Based on a review of the global history of" exact="yellow fever" post="and its epidemiology, the authors deliver some recommendations for"/>
   <result pre="Brazil Latin America Africa Background Brazil has experienced an exceptional" exact="yellow fever" post="(YF) outbreak since December 2016 (TableÂ 1). After the"/>
   <result pre="2016 to 8 May 2018, in 2050 confirmed cases of" exact="yellow fever" post="including 681 deaths, indicating a case fatality rate of"/>
   <result pre="of the virus at this stage [2]. Table 1 Confirmed" exact="yellow fever" post="cases and deaths in Brazil from December, 2016 to"/>
   <result pre="Federal 1 1 Total 2050 681 Fig. 1 Confirmed human" exact="yellow fever" post="cases in Brazil between 1980 and 2017 (from Sinan;"/>
   <result pre="2017 (from Sinan; GT-Arbo/UVTV/CGDT/DEVIT/SVS/MS [2]) Fig. 2 Number of confirmed" exact="yellow fever" post="cases by epidemiological week (EW) based on date of"/>
   <result pre="in major Brazilian cities and improve preventive measures. History of" exact="yellow fever" post="and origin of the virus YF probably impacted the"/>
   <result pre="virus: â€œIt is more than likely that the germs of" exact="yellow fever," post="as well as those of small pox, measles, hydrophobia,"/>
   <result pre="discontinued because of its adverse effects [53, 54]. Epidemiology of" exact="yellow fever" post="in Africa YF has been known in Africa since"/>
   <result pre="by its stability and administration by scarification associated with the" exact="smallpox" post="vaccine, mass immunization led to remarkably effective control of"/>
   <result pre="introducing routine YF vaccination in 9-month-old children together with the" exact="measles" post="immunization supported by GAVI (Global Alliance for Vaccines and"/>
   <result pre="by GAVI (Global Alliance for Vaccines and Immunization). Epidemiology of" exact="yellow fever" post="in the Americas In South America, YF was mentioned"/>
   <result pre="century when it was revealed as an urban vector of" exact="dengue fever" post="[114]. Phylogenetic data suggest that the Asian strain originates"/>
   <result pre="Oceania. In addition, the abundant circulation of other arboviruses, dengue," exact="chikungunya" post="and Zika, the latter two coming from Africa like"/>
   <result pre="expense of YF and d) cross-reactivity with other Flavoviridae, including" exact="dengue fever," post="in humans and other animals [121, 122]. Recent modeling"/>
   <result pre="the probability of YF expansion in Asia (â€œAsian hypothesisâ€�) and" exact="dengue fever" post="in Africa (â€œAfrican hypothesisâ€�) [123]. The first was based"/>
   <result pre="have not yet been elucidated. Rooting out and controlling of" exact="yellow fever" post="in Brazil Since its introduction in the seventeenth century,"/>
   <result pre="of vector development is high. The recent epidemics of dengue," exact="chikungunya" post="and Zika in Brazil demonstrated the limits of this"/>
   <result pre="incidence of serious adverse events (SAE). In addition to vaccine" exact="hypersensitivity" post="and anaphylactic shock, SAEs were categorized into two groups:"/>
   <result pre="6.BryantJEHolmesECBarrettADTOut of Africa: a molecular perspective on the introduction of" exact="yellow fever" post="virus into the AmericasPLoS Pathog200735e7510.1371/journal.ppat.003007517511518 7.MutebiJPRijnbrandRCWangHRymanKDWangEFulopLDet al.Genetic relationships and"/>
   <result pre="AmericasPLoS Pathog200735e7510.1371/journal.ppat.003007517511518 7.MutebiJPRijnbrandRCWangHRymanKDWangEFulopLDet al.Genetic relationships and evolution of genotypes of" exact="yellow fever" post="virus and other members of the yellow fever virus"/>
   <result pre="genotypes of yellow fever virus and other members of the" exact="yellow fever" post="virus group within the Flavivirus genus based on the"/>
   <result pre="based on the 3â€² noncoding regionJ Virol200478189652966510.1128/JVI.78.18.9652-9665.200415331698 8.LiYYangZAdaptive diversification between" exact="yellow fever" post="virus west African and south American lineages: a genome-wide"/>
   <result pre="York: Oxford University Press; 2009. pp. 102â€&quot;4. 11.MarrJSCatheyJTThe 1802 saint-Domingue" exact="yellow fever" post="epidemic and the Louisiana purchaseJ Public Health Manag Pract2013191778210.1097/PHH.0b013e318252eea823169407"/>
   <result pre="Louisiana purchaseJ Public Health Manag Pract2013191778210.1097/PHH.0b013e318252eea823169407 12.Augustin G. History of" exact="yellow fever." post="Searcy &amp;amp; Pfaff ltd, New Orleans, USA; 1909. 13.EltonNWYellow"/>
   <result pre="20.BeauperthuyLDRecherches sur la cause du cholÃ©ra asiatique, sur celle du" exact="typhus" post="ictÃ©rode et de fiÃ¨vres de marÃ©cagesC R Acad Sci18561413692693"/>
   <result pre="Habana188118147169 23.ReedWRecent researches concerning the etiology, propagation, and prevention of" exact="yellow fever," post="by the United States Army CommissionJ Hyg (Lond)19022210111910.1017/S002217240000185620474139 24.ReedWCarrolJAgramonteAThe"/>
   <result pre="the United States Army CommissionJ Hyg (Lond)19022210111910.1017/S002217240000185620474139 24.ReedWCarrolJAgramonteAThe etiology of" exact="yellow fever" post="- an additional noteJAMA19013643144010.1001/jama.1901.52470070017001f 25.ReedWCarrollJAgramonteALazearJWThe etiology of yellow fever-a"/>
   <result pre="thÃ©orique et clinique de la fiÃ¨vre jaune1891ParisDoin 28.DeubelVDigoutteJPMonathTPGirardMGenetic heterogeneity of" exact="yellow fever" post="virus strains from Africa and the AmericasJ Gen Virol.198667Pt"/>
   <result pre="the AmericasJ Gen Virol.198667Pt 120921310.1099/0022-1317-67-1-2093944583 29.LepiniecLDalgarnoLHuongVTMonathTPDigoutteJPDeubelVGeographic distribution and evolution of" exact="yellow fever" post="viruses based on direct sequencing of genomic cDNA fragmentsJ"/>
   <result pre="cDNA fragmentsJ Gen Virol199475Pt 241742310.1099/0022-1317-75-2-4178113765 30.MutebiJPWangHLiLBryantJEBarrettADPhylogenetic and evolutionary relationships among" exact="yellow fever" post="virus isolates in AfricaJ Virol200175156999700810.1128/JVI.75.15.6999-7008.200111435580 31.von LindernJJAronerSBarrettNDWickerJADavisCTBarrettADGenome analysis and"/>
   <result pre="phylogenetic relationships between east, central and west African isolates of" exact="yellow fever" post="virusJ Gen Virol.200687Pt 489590710.1099/vir.0.81236-016528039 32.Beaty BJ, Aitken THG. In"/>
   <result pre="Virol.200687Pt 489590710.1099/vir.0.81236-016528039 32.Beaty BJ, Aitken THG. In vitro transmission of" exact="yellow fever" post="virus by geographic strains of Aedes aegypti. Mosq News."/>
   <result pre="strains of Aedes aegypti. Mosq News. 1979;39(2):232â€&quot;8. 33.EllisBRBarrettADThe enigma of" exact="yellow fever" post="in East AfricaRev Med Virol200818533134610.1002/rmv.58418615782 34.MonathTCetronMSTeuwenDEPlotkinSAOrensteinWAOffitPAYellow fever vaccineVaccines20085PhiladelphiaSaunders Elsevier9591055"/>
   <result pre="caseRev Inst Med Trop Sao Paulo199537433734110.1590/S0036-466519950004000098599063 38.ChristophersSRAedes aegypti (L.) the" exact="yellow fever" post="mosquitoIts life history, bionomics and structure1960Cambridge, Great BritainCambridge University"/>
   <result pre="mÃ©moireAnn Inst Pasteur1906251640 41.FontenilleDDialloMMondoMNdiayeMThonnonJFirst evidence of natural vertical transmission of" exact="yellow fever" post="virus in Aedes aegypti, its epidemic vectorTrans R Soc"/>
   <result pre="Yellow Fever. Med News. 1898;73:326â€&quot;331 and 360â€&quot;9. 48.StokesABauerJHHudsonNPExperimental transmission of" exact="yellow fever" post="to laboratory animalsAm J Trop Med1928810316410.4269/ajtmh.1928.s1-8.103 49.TheilerMSmithHHThe use of"/>
   <result pre="fever to laboratory animalsAm J Trop Med1928810316410.4269/ajtmh.1928.s1-8.103 49.TheilerMSmithHHThe use of" exact="yellow fever" post="modified by in vitro cultivation for human immunizationJ Exp"/>
   <result pre="Histoires Â», Paris2004201205 71.TaylorRMFonseca da CunhaJAn epidemiological study of jungle" exact="yellow fever" post="in an endemic area in Brazil; epidemiology of human"/>
   <result pre="Trop Med Hyg.1946266 Suppl 26920279501 72.LaemmertHWJrFerreiraLCTaylorRMAn epidemiological study of jungle" exact="yellow fever" post="in an endemic area in Brazil. Investigation of vertebrate"/>
   <result pre="al. Evidence for multiple sylvatic transmission cycles during the 2016-2017" exact="yellow fever" post="virus outbreak, Brazil. Clin Microbiol Infect. 2018; 74.KummHWLaemmertHWJrThe geographical"/>
   <result pre="Clin Microbiol Infect. 2018; 74.KummHWLaemmertHWJrThe geographical distribution of immunity to" exact="yellow fever" post="among the primates of BrazilAm J Trop Med Hyg.195030573374810.4269/ajtmh.1950.s1-30.73314771397"/>
   <result pre="to Brazilian monkeys preliminary observationsJ Exp Med1929501818510.1084/jem.50.1.8119869607 76.FernandesNCCACunhaMSGuerraJMRÃ©ssioRACirqueiraCDSIgleziasSDet al.Outbreak of" exact="yellow fever" post="among nonhuman primates, Espirito Santo, Brazil, 2017Emerg Infect Dis201723122038204110.3201/eid2312.17068529148378"/>
   <result pre="Pathol Exot19918443863971687266 79.MondetBVasconcelosPFTravassos da RosaAPTravassos da RosaESRodriguesSGTravassos RosaJFet al.Isolation of" exact="yellow fever" post="virus from nulliparous Haemagogus (Haemagogus) janthinomys in eastern AmazoniaVector"/>
   <result pre="serratus mosquitoes, southern Brazil, 2008Emerg Infect Dis201016121918192410.3201/eid1612.10060821122222 81.AlencarJMelloCFBarbosaLSGil-SantanaHRMaiaDAMarcondesCBet al.Diversity of" exact="yellow fever" post="mosquito vectors in the Atlantic Forest of Rio de"/>
   <result pre="mosquitoes (Diptera: Culicidae) in an area of sylvatic transmission of" exact="yellow fever" post="in the state of SÃ£o Paulo, BrazilJ Venom Anim"/>
   <result pre="83.MucciLFMedeiros-SousaARCeretti-JÃºniorWFernandesACamargoAAEvangelistaEet al.Haemagogus leucocelaenus and other mosquitoes potentially associated with sylvatic" exact="yellow fever" post="in Cantareira State Park in the SÃ£o Paulo metropolitan"/>
   <result pre="Assoc201632432933210.2987/16-6587.128206862 84.Couto-LimaDMadecYBersotMICamposSSMottaMASantosFBDet al.Potential risk of re-emergence of urban transmission of" exact="yellow fever" post="virus in Brazil facilitated by competent Aedes populationsSci Rep201771484810.1038/s41598-017-05186-328687779"/>
   <result pre="competent Aedes populationsSci Rep201771484810.1038/s41598-017-05186-328687779 85.VasconcelosPFCBryantJEda RosaAPATTeshRBRodriguesSGBarrettADTGenetic divergence and dispersal of" exact="yellow fever" post="virus, BrazilEmerg Infect Dis20041091578158410.3201/eid1009.04019715498159 86.NunesMRPalaciosGCardosoJFMartinsLCSousaECJrde LimaCPet al.Genomic and phylogenetic"/>
   <result pre="Infect Dis20041091578158410.3201/eid1009.04019715498159 86.NunesMRPalaciosGCardosoJFMartinsLCSousaECJrde LimaCPet al.Genomic and phylogenetic characterization of Brazilian" exact="yellow fever" post="virus strainsJ Virol20128624132631327110.1128/JVI.00565-1223015713 87.CarringtonCVAugusteAJEvolutionary and ecological factors underlying the"/>
   <result pre="87.CarringtonCVAugusteAJEvolutionary and ecological factors underlying the tempo and distribution of" exact="yellow fever" post="virus activityInfect Genet Evol20131319821010.1016/j.meegid.2012.08.01522981999 88.de SouzaRPFosterPGSallumMACoimbraTLMaedaAYSilveiraVRet al.Detection of a"/>
   <result pre="virus activityInfect Genet Evol20131319821010.1016/j.meegid.2012.08.01522981999 88.de SouzaRPFosterPGSallumMACoimbraTLMaedaAYSilveiraVRet al.Detection of a new" exact="yellow fever" post="virus lineage within the south American genotype I in"/>
   <result pre="south American genotype I in BrazilJ Med Virol201082117518510.1002/jmv.2160619950229 89.MirDDelatorreEBonaldoMLourenÃ§o-de-OliveiraRVicenteACBelloGPhylodynamics of" exact="yellow fever" post="virus in the Americas: new insights into the origin"/>
   <result pre="Brazilian outbreakSci Rep201771738510.1038/s41598-017-07873-728785067 90.VasconcelosPFRodriguesSGDegallierNMoraesMAda RosaJFda RosaESet al.An epidemic of sylvatic" exact="yellow fever" post="in the southeast region of Maranhao state, Brazil, 1993-1994:"/>
   <result pre="Aedes aegypti to Brazil, the major vector of the dengue," exact="chikungunya" post="and Zika virusesPLoS Negl Trop Dis2017117e000565310.1371/journal.pntd.000565328742801 93.ReiterPAedes albopictus and"/>
   <result pre="to come?J Am Mosq Control Assoc199814183949599329 94.DialloMThonnonJFontenilleDVertical transmission of the" exact="yellow fever" post="virus by Aedes aegypti (Diptera, Culicidae): dynamics of infection"/>
   <result pre="Negl Trop Dis201374e217510.1371/journal.pntd.000217523638196 105.TabachnickWJWallisGPAitkenTHMillerBRAmatoGDLorenzLet al.Oral infection of Aedes aegypti with" exact="yellow fever" post="virus: geographic variation and genetic considerationsAm J Trop Med"/>
   <result pre="historical and recent evolution in Aedes aegypti, the dengue and" exact="yellow fever" post="mosquitoEvolution201468251452510.1111/evo.1228124111703 111.PowellJRTabachnickWJHistory of domestication and spread of Aedes aegypti"/>
   <result pre="populations of this major disease vectorBMC Biol20171511610.1186/s12915-017-0351-028241828 113.MutebiJPBarrettADThe epidemiology of" exact="yellow fever" post="in AfricaMicrobes Infect20024141459146810.1016/S1286-4579(02)00028-X12475636 114.SmithCEThe history of dengue in tropical"/>
   <result pre="115.WallisGPTabachnickWJPowellJRMacrogeographic genetic variation in a human commensal: Aedes aegypti, the" exact="yellow fever" post="mosquitoGenet Res198341324125810.1017/S00166723000213156884770 116.ScarpassaVMCardozaTBCardoso JuniorRPPopulation genetics and phylogeography of Aedes"/>
   <result pre="al.Flavivirus susceptibility in Aedes aegyptiArch Med Res200233437938810.1016/S0188-4409(02)00373-912234528 119.CuiSPanYLyuYLiangZLiJSunYet al.Detection of" exact="yellow fever" post="virus genomes from four imported cases in ChinaInt J"/>
   <result pre="J Infect Dis2016489810310.1016/j.ijid.2016.04.02527156836 121.TheilerMAndersonCRThe relative resistance of dengue-immune monkeys to" exact="yellow fever" post="virusAm J Trop Med Hyg.197524111511710.4269/ajtmh.1975.24.1151111351 122.XiaoSYGuzmanHda RosaAPZhuHBTeshRBAlteration of clinical"/>
   <result pre="Med Hyg.197524111511710.4269/ajtmh.1975.24.1151111351 122.XiaoSYGuzmanHda RosaAPZhuHBTeshRBAlteration of clinical outcome and histopathology of" exact="yellow fever" post="virus infection in a hamster model by previous infection"/>
   <result pre="with heterologous flavivirusesAm J Trop Med Hyg.200368669570312887029 123.AmakuMCoutinhoFAMassadEWhy dengue and" exact="yellow fever" post="coexist in some areas of the world and not"/>
   <result pre="R Soc Trop Med Hyg2014108525225710.1093/trstmh/tru04324743951 125.TuboiSHCostaZGVasconcelosPFHatchDClinical and epidemiological characteristics of" exact="yellow fever" post="in Brazil: analysis of reported cases 1998-2002Trans R Soc"/>
   <result pre="used in Aedes aegypti control in the successful campaign for" exact="yellow fever" post="prophylaxis in Rio de Janeiro, Brazil, in 1928 and"/>
   <result pre="2008-2009PLoS Negl Trop Dis201483e274010.1371/journal.pntd.000274024625634 130.Camargo-NevesVLFPolettoDWRodasLACPachioliMLCardosoRPScandarSASet al.Entomological investigation of a sylvatic" exact="yellow fever" post="area in SÃ£o Paulo state, BrazilCad Saude Publica.20052141278128610.1590/S0102-311X200500040003116021266 131.CavalcanteKRLJTauilPLEpidemiological"/>
   <result pre="in SÃ£o Paulo state, BrazilCad Saude Publica.20052141278128610.1590/S0102-311X200500040003116021266 131.CavalcanteKRLJTauilPLEpidemiological characteristics of" exact="yellow fever" post="in Brazil, 2000-2012Epidemiol Serv Saude2016251112027861674 132.FortalezaCMCBRochaRAragÃ£oVDNAlmeidaRAMBâ€œSyndromic surveillanceâ€� and the"/>
   <result pre="Brazil, 2000-2012Epidemiol Serv Saude2016251112027861674 132.FortalezaCMCBRochaRAragÃ£oVDNAlmeidaRAMBâ€œSyndromic surveillanceâ€� and the reemergence of" exact="yellow fever" post="in SÃ£o Paulo state, Brazil, 2009J Venom Anim Toxins"/>
   <result pre="age of a dengue vaccinePLoS Negl Trop Dis2017118e000578510.1371/journal.pntd.000578528806786 136.ShearerFMMoyesCLPigottDMBradyOJMarinhoFDeshpandeAet al.Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
   <result pre="analysisLancet Infect Dis201717111209121710.1016/S1473-3099(17)30419-X28822780 137.Martins RdeMPavÃ£oALde OliveiraPMdos SantosPRCarvalhoSMMohrdieckRet al.Adverse events following" exact="yellow fever" post="immunization: report and analysis of 67 neurological cases in"/>
   <result pre="BrazilVaccine201432496676668210.1016/j.vaccine.2014.05.00324837504 138.MonathTPWoodallJPGublerDJYuillTMMackenzieJSMartinsRMet al.Yellow fever vaccine supply: a possible solutionLancet2016387100281599160010.1016/S0140-6736(16)30195-727116054 139.BarrettADMonathTPBarbanVNiedrigMTeuwenDE17D" exact="yellow fever" post="vaccines: new insights. A report of a workshop held"/>
   <result pre="tropics, Marseille, France, Monday 12 September 2005Vaccine200725152758276510.1016/j.vaccine.2006.12.01517368349 140.MartinsRMMaia MdeLFariasRHCamachoLAFreireMSGallerRet al.17DD" exact="yellow fever" post="vaccine: a double blind, randomized clinical trial of immunogenicity"/>
   <result pre="safety on a dose-response studyHum Vaccin Immunother20139487988810.4161/hv.2298223364472 141.WuJTPeakCMLeungGMLipsitchMFractional dosing of" exact="yellow fever" post="vaccine to extend supply: a modelling studyLancet2016388100622904291110.1016/S0140-6736(16)31838-427837923 142.VisserLGRoukensAHModelling a"/>
   <result pre="142.VisserLGRoukensAHModelling a way out of yellow feverLancet2016388100622847284810.1016/S0140-6736(16)31330-727837922 143.ThomasRELorenzettiDLSpraginsWJacksonDWilliamsonTThe safety of" exact="yellow fever" post="vaccine 17D or 17DD in children, pregnant women, HIV+"/>
   <result pre="systematic reviewAm J Trop Med Hyg.201286235937210.4269/ajtmh.2012.11-052522302874 144.SeligmanSJCohenJEItanYCasanovaJLPezzulloJCDefining risk groups to" exact="yellow fever" post="vaccine-associated viscerotropic disease in the absence of denominator dataAm"/>
   <result pre="dataAm J Trop Med Hyg.201490226727110.4269/ajtmh.13-054224394480 145.ThomasRELorenzettiDLSpraginsWJacksonDWilliamsonTActive and passive surveillance of" exact="yellow fever" post="vaccine 17D or 17DD-associated serious adverse events: systematic reviewVaccine201129284544455510.1016/j.vaccine.2011.04.05521549787"/>
   <result pre="vaccine-associated adverse events following extensive immunization in ArgentinaVaccine201432111266127210.1016/j.vaccine.2014.01.01524456625 147.collab: WHOEliminate" exact="yellow fever" post="epidemics (EYE): a global strategy, 2017-2026Wkly Epidemiol Rec2017921619320428429585 148.ReiterPGlobal"/>
   <result pre="http://www.who.int/csr/don/09-march-2018-yellow-fever-brazil/en/ (accessed 17 Apr 2018). 150.AlmeidaMABCardosoJCdos SantosEda FonsecaDFCruzLLFaracoFJCet al.Surveillance for" exact="yellow fever" post="virus in non-human primates in southern Brazil, 2001-2011: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6137132\results\search\disease\results.xml">
   <result pre="to cause yearly seasonal epidemics worldwide and periodically pandemics. Although" exact="influenza" post="virus infection and its epidemiology have been extensively studied,"/>
   <result pre="studied, a new pandemic is likely. One of the reasons" exact="influenza" post="virus causes epidemics is its ability to constantly antigenically"/>
   <result pre="In this mini-review, we describe the evolutionary procedures related with" exact="influenza" post="viruses and their hosts, under the prism of a"/>
   <result pre="under the prism of a predator-prey relationship. adaptation antagonistic evolution" exact="influenza" post="virus bottleneck immune system antigen genetics mutation fig-count: table-count:"/>
   <result pre="table-count: equation-count: ref-count: page-count: word-count: Introduction Health disasters caused by" exact="influenza" post="viruses are abundant in human history (1â€&quot;3). The Spanish"/>
   <result pre="and 2 million deaths each. In 2009, a novel H1N1" exact="influenza" post="virus spread rapidly from Mexico to the rest of"/>
   <result pre="mutagenesis or due to transmission in other species. Pandemics of" exact="influenza" post="are due to these random and sudden viral mutations"/>
   <result pre="transmissions. Under this perspective, in this paper, we discuss about" exact="influenza" post="viruses and the coevolution with the human genomes. Influenza"/>
   <result pre="antigenically distinct HA subtypes and 11 distinct NA subtypes of" exact="influenza" post="A virus strains infecting humans and animals have so"/>
   <result pre="of such receptors, making zoonotic transmission difficult. For example, human" exact="influenza" post="strains have a predilection for SA Î±-2,6 galactose receptors,"/>
   <result pre="respiratory epithelium of the upper airways in humans, while animal" exact="influenza" post="A viruses bind to SA Î±-2,3 galactose, which is"/>
   <result pre="of 1â€&quot;2 days. Systemic symptoms are characteristic and help differentiate" exact="influenza" post="from other upper respiratory tract viral illnesses. These include"/>
   <result pre="throat, hoarseness, nasal congestion, and discharge (18). Different subtypes of" exact="influenza" post="have different ability to infect airway epithelial cells of"/>
   <result pre="result in severe lung injury (21â€&quot;23). Host immune response to" exact="influenza" post="virus infection Cells of the innate immune response are"/>
   <result pre="innate immune response are the first and fast responders upon" exact="influenza" post="virus infection, recruited by chemokines released by airway epithelial"/>
   <result pre="pyrin domain containing 3 (NALP3) inflammasome is also activated upon" exact="influenza" post="virus infection promoting IL-1Î² and IL-18 secretion, and pulmonary"/>
   <result pre="activity. NK cells have cytotoxic activity on cells infected with" exact="influenza" post="virus, macrophages phagocytose infected cells and regulate adaptive immune"/>
   <result pre="B cells are essential in the adaptive immune response to" exact="influenza" post="virus infection. Naive CD8+ T cells, upon activation by"/>
   <result pre="to cytotoxic T lymphocytes (CTLs). CTLs are able to kill" exact="influenza" post="virus-infected cells and also restrict viral replication via production"/>
   <result pre="cell specific responses (32). Comprising an essential defense mechanism against" exact="influenza" post="virus infection, B cells generate neutralizing (hemagglutinin-inhibiting antibodies) as"/>
   <result pre="cell-mediated cytotoxicity, play an important role in cross-protection against different" exact="influenza" post="subtypes (31, 33). There is increased interest in the"/>
   <result pre="could elicit â€œuniversalâ€� immunity against different or novel strains of" exact="influenza" post="viruses. Viral evolution Predator and prey. antagonistic evolution Predator-prey"/>
   <result pre="this being a highly effective immunological shield. Genetic diversification of" exact="influenza" post="viruses Influenza viruses exhibit vast genetic variability sourced from"/>
   <result pre="of different viral strains. The eight RNA fragments of the" exact="influenza" post="virus can re-assort between different strains, producing new subtypes."/>
   <result pre="people live in proximity with animals (38). Antigenic shifts caused" exact="influenza" post="pandemics in the past. On the other hand, mutations,"/>
   <result pre="proteins, this being the cause of the appearance of new" exact="influenza" post="strains each year (39). Antigenic drifts are very important"/>
   <result pre="production. The major cause of the high evolutionary rate of" exact="influenza" post="viruses is the lack of proofreading (correction) function of"/>
   <result pre="innate immune recognition, something that is not so vital for" exact="influenza" post="B evolution (42, 43). Additionally, it has been shown"/>
   <result pre="has been shown that antigenic drifts are more frequent to" exact="influenza" post="A viruses than influenza B viruses (44). Even though"/>
   <result pre="antigenic drifts are more frequent to influenza A viruses than" exact="influenza" post="B viruses (44). Even though antigenic drifts are usually"/>
   <result pre="be excluded. One of the most interesting recent findings regarding" exact="influenza" post="virus' genetic variability and evolution is that when people"/>
   <result pre="Further understanding of the mutational and evolutionary procedures related to" exact="influenza" post="viruses can help us develop prediction models. Prediction models"/>
   <result pre="surface protein hemagglutinin (49). Hemagglutinin DNA sequences for thousands of" exact="influenza" post="A strains, isolated over the last 40 years, are"/>
   <result pre="reviews (51) and (52). A predatorâ€&quot;prey relationship between human and" exact="influenza" post="virus The relationship between viruses and eukaryotic cells has"/>
   <result pre="this long lasting ancient interaction (53, 54). Antibody-mediated immunity to" exact="influenza" post="viruses is well-understood. Vaccines success is based on this"/>
   <result pre="T8 cells epitopes may have shaped the long-term evolution of" exact="influenza" post="A virus (55, 56). On the other hand, influenza"/>
   <result pre="of influenza A virus (55, 56). On the other hand," exact="influenza" post="viruses seem to respond to this evolutionary pressure by"/>
   <result pre="membrane lipid layers. IFITM3 seems to be more specific for" exact="influenza" post="viruses (61). Gene polymorphisms in IFITM3 gene can increase"/>
   <result pre="polymorphisms in IFITM3 gene can increase or reduce susceptibility to" exact="influenza" post="infections, underlining the evolutionary significance of these proteins (62,"/>
   <result pre="(67). Experimental studies in ferret and guinea pig showed that" exact="influenza" post="infections coming from limited dose of aerosol exposure had"/>
   <result pre="the past and will continue to co-evolve. Our understanding of" exact="influenza" post="virus pathogenesis and evolution has increased, however, we are"/>
   <result pre="1.RamiroDGarciaSCasadoYCilekLChowellG. Age-specific excess mortality patterns and transmissibility during the 1889-1890" exact="influenza" post="pandemic in Madrid, Spain. Ann Epidemiol. (2018) 28:267â€&quot;72. 10.1016/j.annepidem.2017.12.00929336941"/>
   <result pre="10.1016/j.bbi.2008.05.01019618626 4.ChowellGSullivanPRothenbergR. Introduction to symposium: a century after the 1918" exact="influenza" post="pandemic. Ann Epidemiol. (2018) 28:265â€&quot;6. 10.1016/j.annepidem.2018.03.01029622467 5.JohnsonNPASMuellerJ. Updating the"/>
   <result pre="5.JohnsonNPASMuellerJ. Updating the accounts: global mortality of the 1918-1920 â€œSpanishâ€�" exact="influenza" post="pandemic. Bull Hist Med. (2002) 76:105â€&quot;15. 10.1353/bhm.2002.002211875246 6.CockburnWCDelonPJFerreiraW. Origin"/>
   <result pre="10.1353/bhm.2002.002211875246 6.CockburnWCDelonPJFerreiraW. Origin and progress of the 1968-69 Hong Kong" exact="influenza" post="epidemic. Bull World Health Organ. (1969) 41:345â€&quot;8. 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;25309437 7.SimonsenLSpreeuwenbergPLustigRTaylorRJFlemingDMKronemanMet"/>
   <result pre="41:345â€&quot;8. 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;25309437 7.SimonsenLSpreeuwenbergPLustigRTaylorRJFlemingDMKronemanMet al.. Global mortality estimates for the 2009" exact="influenza" post="pandemic from the GLaMOR project: a modeling study. PLoS"/>
   <result pre="Dis. (2017) 23:1392â€&quot;6. 10.3201/eid2308.17005928726609 11.MatsuzakiYAbikoCMizutaKSugawaraKTakashitaEMurakiYet al.. A nationwide epidemic of" exact="influenza" post="C virus infection in Japan in 2004. J Clin"/>
   <result pre="PLoS Pathog. (2015) 11:e1004819. 10.1371/journal.ppat.100481926042416 14.LinYPGregoryVBennettMHayA. Recent changes among human" exact="influenza" post="viruses. Virus Res. (2004) 103:47â€&quot;52. 10.1016/j.virusres.2004.02.01115163487 15.ShawMWXuXLiYNormandSUekiRTKunimotoGYet al.. Reappearance"/>
   <result pre="10.1016/j.virusres.2004.02.01115163487 15.ShawMWXuXLiYNormandSUekiRTKunimotoGYet al.. Reappearance and global spread of variants of" exact="influenza" post="B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons."/>
   <result pre="and 2001-2002 seasons. Virology (2002) 303:1â€&quot;8. 10.1006/viro.2002.171912482653 16.IkonenNPyhÃ¤lÃ¤RAxelinTKleemolaMKorpelaH. Reappearance of" exact="influenza" post="B/Victoria/2/87-lineage viruses: Epidemic activity, genetic diversity and vaccination efficacy"/>
   <result pre="Defence Forces. Epidemiol Infect. (2005) 133:263â€&quot;71. 10.1017/S095026880400346215816151 17.SunXWhittakerGR. Entry of" exact="influenza" post="virus. Adv Exp Med Biol. (2013) 790:72â€&quot;82. 10.1007/978-1-4614-7651-1_423884586 18.MandellGBennettJDolinRMandell,"/>
   <result pre="Sciences (2015). 19.de GraafMFouchierRAM. Role of receptor binding specificity in" exact="influenza" post="A virus transmission and pathogenesis. EMBO J. (2014) 33:823â€&quot;41."/>
   <result pre="33:823â€&quot;41. 10.1002/embj.20138744224668228 20.Byrd-LeotisLCummingsRDSteinhauerDA. The interplay between the host receptor and" exact="influenza" post="virus hemagglutinin and neuraminidase. Int J Mol Sci. (2017)"/>
   <result pre="Sci. (2017) 18:e18071541. 10.3390/ijms1807154128714909 21.Van RielDMunsterVJDe WitERimmelzwaanGFFouchierRAMOsterhausADMEet al.. Human and" exact="avian influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="(2017) 18:e18071541. 10.3390/ijms1807154128714909 21.Van RielDMunsterVJDe WitERimmelzwaanGFFouchierRAMOsterhausADMEet al.. Human and avian" exact="influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="mammals. Am J Pathol. (2007) 171:1215â€&quot;23. 10.2353/ajpath.2007.07024817717141 22.KuikenTRiteauBFouchierRAMRimmelzwaanGF. Pathogenesis of" exact="influenza" post="virus infections: The good, the bad and the ugly."/>
   <result pre="Curr Opin Virol. (2012) 2:276â€&quot;86. 10.1016/j.coviro.2012.02.01322709515 23.NichollsJMChanMCWChanWYWongHKCheungCYKwongDLWet al.. Tropism of" exact="avian influenza" post="A (H5N1) in the upper and lower respiratory tract."/>
   <result pre="Opin Virol. (2012) 2:276â€&quot;86. 10.1016/j.coviro.2012.02.01322709515 23.NichollsJMChanMCWChanWYWongHKCheungCYKwongDLWet al.. Tropism of avian" exact="influenza" post="A (H5N1) in the upper and lower respiratory tract."/>
   <result pre="Nat Med. (2007) 13:147â€&quot;9. 10.1038/nm152917206149 24.Le GofficRPothlichetJVitourDFujitaTMeursEChignardMet al.. Cutting edge:" exact="influenza" post="A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses"/>
   <result pre="59-diphosphates. Nature (2014) 514:372â€&quot;5. 10.1038/nature1359025119032 26.ChenXLiuSGorayaMUMaaroufMHuangSChenJ-L. Host immune response to" exact="influenza" post="A virus infection. Front Immunol. (2018) 9:1â€&quot;13. 10.3389/fimmu.2018.0032029403488 27.OngJDHMansellATateMD."/>
   <result pre="9:1â€&quot;13. 10.3389/fimmu.2018.0032029403488 27.OngJDHMansellATateMD. Hero turned villain: NLRP3 inflammasome-induced inflammation during" exact="influenza" post="A virus infection. J Leukoc Biol. (2017) 101:863â€&quot;74. 10.1189/jlb.4MR0616-288R27707881"/>
   <result pre="it hurts. Rev Med Virol. (2011) 21:301â€&quot;14. 10.1002/rmv.69721714121 29.GrantEJQuiÃ±ones-ParraSMClemensEBKedzierskaK. Human" exact="influenza" post="viruses and CD8 + T cell responses. Curr Opin"/>
   <result pre="Curr Opin Virol. (2016) 16:132â€&quot;42. 10.1016/j.coviro.2016.01.01626974887 30.LiangSMozdzanowskaKPalladinoGGerhardW. Heterosubtypic immunity to" exact="influenza" post="type A virus in mice. effector mechanisms and their"/>
   <result pre="J Immunol. (1994) 152:1653â€&quot;61. 10.4049/jimmunol.178.2.10308120375 31.SridharS. Heterosubtypic T-cell immunity to" exact="influenza" post="in humans: Challenges for universal T-cell influenza vaccines. Front"/>
   <result pre="T-cell immunity to influenza in humans: Challenges for universal T-cell" exact="influenza" post="vaccines. Front Immunol. (2016) 7:e00195. 10.3389/fimmu.2016.0019527242800 32.La GrutaNLTurnerSJ. T"/>
   <result pre="DunandCJWilsonPC. Heads, stalks and everything else: how can antibodies eradicate" exact="influenza" post="as a human disease?Curr Opin Immunol. (2016) 42:48â€&quot;55. 10.1016/j.coi.2016.05.01227268395"/>
   <result pre="Soc B Biol Sci. (1998) 265:1177â€&quot;83. 10.1098/rspb.1998.04169699311 37.ShaoWLiXGorayaMUWangSChenJL. Evolution of" exact="influenza" post="a virus by mutation and re-assortment. Int J Mol"/>
   <result pre="(2017) 18:e18081650. 10.3390/ijms1808165028783091 38.MaWKahnRERichtJAThe pig as a mixing vessel for" exact="influenza" post="viruses: human and veterinary implications. J Mol Genet Med."/>
   <result pre="03:158â€&quot;66. 10.4172/1747-0862.1000028 39.JohnsonKEESongTGreenbaumBGhedinE. Getting the flu: 5 key facts about" exact="influenza" post="virus evolution. PLoS Pathog. (2017) 13:1â€&quot;6. 10.1371/journal.ppat.100645028837690 40.AhlquistP. RNA-dependent"/>
   <result pre="viruses, and RNA silencing. Science (2002) 296:1270â€&quot;3. 10.1126/science.106913212016304 41.ChenRHolmesEC. Avian" exact="influenza" post="virus exhibits rapid evolutionary dynamics. Mol Biol Evol. (2006)"/>
   <result pre="42.Jimenez-BarandaSGreenbaumBManchesOHandlerJRabadanRLevineAet al.. Oligonucleotide motifs that disappear during the evolution of" exact="influenza" post="virus in humans increase alpha interferon secretion by plasmacytoid"/>
   <result pre="Proc Natl Acad Sci USA. (2014) 111:5054â€&quot;9. 10.1073/pnas.140228511124639520 44.BedfordTSuchardMALemeyPDudasGGregoryVHayAJet al.Integrating" exact="influenza" post="antigenic dynamics with molecular evolution. Elife (2014) 2014:e0191410.7554/eLife.01914 45.PoonLLMSongTRosenfeldRLinXRogersMBZhouBet"/>
   <result pre="dynamics with molecular evolution. Elife (2014) 2014:e0191410.7554/eLife.01914 45.PoonLLMSongTRosenfeldRLinXRogersMBZhouBet al.. Quantifying" exact="influenza" post="virus diversity and transmission in humans. Nat Genet. (2016)"/>
   <result pre="al.Deep sequencing reveals potential antigenic variants at low frequencies in" exact="influenza" post="A virus-infected humans. J Virol. (2016) 90:3355â€&quot;65. 10.1128/JVI.03248-1526739054 47.Å�ukszaMLÃ¤ssigM."/>
   <result pre="The effects of a deleterious mutation load on patterns of" exact="influenza" post="A/H3N2's antigenic evolution in humans. Elife (2015) 4: e07361."/>
   <result pre="Elife (2015) 4: e07361. 10.7554/eLife.0736126371556 49.MorrisDHGosticKMPompeiSBedfordTÅ�ukszaMNeherRAet al.. Predictive modeling of" exact="influenza" post="shows the promise of applied evolutionary biology. Trends Microbiol."/>
   <result pre="(2017) 26:102â€&quot;18. 10.1016/j.tim.2017.09.00429097090 50.ShuYMcCauleyJ. GISAID: Global initiative on sharing all" exact="influenza" post="data â€&quot; from vision to reality. Eurosurveillance (2017) 22:30494."/>
   <result pre="(2017) 22:30494. 10.2807/1560-7917.ES.2017.22.13.3049428382917 51.AgorJKÃ–zaltinOY. Models for predicting the evolution of" exact="influenza" post="to inform vaccine strain selection. Hum Vaccin Immunother. (2018)"/>
   <result pre="14:678â€&quot;83. 10.1080/21645515.2017.142315229337643 52.KlingenTRReimeringSGuzmÃ¡nCAMcHardyAC. In silico vaccine strain prediction for human" exact="influenza" post="viruses. Trends Microbiol. (2017) 26:119â€&quot;31. 10.1016/j.tim.2017.09.00129032900 53.LanderESLintonLMBirrenBNusbaumCZodyMCBaldwinJet al.. Initial"/>
   <result pre="6:1001191. 10.1371/journal.pgen.100119121124940 55.WoolthuisRGVan DorpCHKeÅŸmirCDe BoerRJVan BovenM. Long-term adaptation of the" exact="influenza" post="A virus by escaping cytotoxic T-cell recognition. Sci Rep."/>
   <result pre="10.1038/srep3333427629812 56.FanKJiaYWangSLiHWuDWangGet al.Role of Itk signaling in the interaction between" exact="influenza" post="A virus and T cells. J Gen Virol. (2012)"/>
   <result pre="A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human" exact="influenza" post="A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol."/>
   <result pre="78:5216â€&quot;22. 10.1128/JVI.78.10.5216-5222.200415113903 58.BerkhoffEGMGeelhoed-MierasMMFouchierRAMOsterhausADMERimmelzwaanGF. Assessment of the extent of variation in" exact="influenza" post="A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+"/>
   <result pre="Sequence variation in a newly identified HLA-B35-restricted epitope in the" exact="influenza" post="A virus nucleoprotein associated with escape from cytotoxic T"/>
   <result pre="Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe" exact="influenza" post="in Chinese individuals. Nat Commun. (2013) 4:1418. 10.1038/ncomms243323361009 64.ZwartMPElenaSF."/>
   <result pre="Virol. (2012) 2:546â€&quot;55. 10.1016/j.coviro.2012.08.00122921636 66.StackJCMurciaPRGrenfellBTWoodJLNHolmesEC. Inferring the inter-host transmission of" exact="influenza" post="A virus using patterns of intra-host genetic variation. Proc"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6142641\results\search\disease\results.xml">
   <result pre="virus, SARS, MERS, Dengue, Chicken Guinea, West Nile and Japanese" exact="encephalitis" post="have created panic owing to their severe life-threatening consequences,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6196792\results\search\disease\results.xml">
   <result pre="work is properly cited. Abstract The rapid worldwide spread of" exact="chikungunya" post="(CHIKV), dengue (DENV), and Zika (ZIKV) viruses have raised"/>
   <result pre="TecnolÃ³gico300700/2016-4 Medical Research CouncilMC_UU_12014MR/N017552/1 1. Introduction Mosquito-borne viruses such as" exact="chikungunya" post="(CHIKV), dengue (DENV), and Zika (ZIKV) viruses have rapidly"/>
   <result pre="the Flaviviridae family, which also includes other species such as" exact="yellow fever" post="virus (YFV), Japanese encephalitis virus (JEV), Spondweni virus (SPOV),"/>
   <result pre="includes other species such as yellow fever virus (YFV), Japanese" exact="encephalitis" post="virus (JEV), Spondweni virus (SPOV), and West Nile virus"/>
   <result pre="on this neglected virus because of the dramatic increase of" exact="microcephaly" post="in newborns [17, 18]. There is by now compelling"/>
   <result pre="Ae. albopictuseLife2015410.7554/eLife.08347 6BeltrÃ¡n-SilvaS. L.ChacÃ³n-HernÃ¡ndezS. S.Moreno-PalaciosE.Pereyra-MolinaJ. Ã�.Clinical and differential diagnosis: dengue," exact="chikungunya" post="and ZikaRevista MÃ©dica del Hospital General de MÃ©xico201881314615310.1016/j.hgmx.2016.09.011 7CareyD."/>
   <result pre="T.FariaN. R.de VasconcelosJ. M.et al.Emergence and potential for spread of" exact="chikungunya" post="virus in BrazilBMC Medicine2015131p. 10210.1186/s12916-015-0348-x25976325 10BhattS.GethingP. W.BradyO. J.et al.The"/>
   <result pre="using a graphic matroid approachBMC Bioinformatics2009101p. 15210.1186/1471-2105-10-15219450271 48GuzmanM. G.KouriG.Dengue and" exact="dengue hemorrhagic fever" post="in the Americas: lessons and challengesJournal of Clinical Virology200327111310.1016/S1386-6532(03)00010-612727523"/>
   <result pre="indicated by solid colors. The sequences in bold indicate ZIKV-associated" exact="microcephaly" post="and those in italics indicate that ZIKV was imported"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6197989\results\search\disease\results.xml">
   <result pre="University S2319-4170(18)30297-X doi: 10.1016/j.bj.2018.08.002 : Special Edition Centennial review of" exact="influenza" post="in Taiwan GongYu-Nonga1KuoRei-Linabc1ChenGuang-Wugwchen@mail.cgu.edu.twadeâˆ—âˆ—ShihShin-Rusrshih@mail.cgu.edu.twabefâˆ—[a], [b], [c], [d], [e], [f], âˆ—Corresponding"/>
   <result pre="under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract The history of" exact="influenza" post="in Taiwan can be traced up to the 1918"/>
   <result pre="1968 H3N2, and the 2009 new H1N1. A couple of" exact="avian influenza" post="viruses of H5N1 and H7N9 also posed threats to"/>
   <result pre="H3N2, and the 2009 new H1N1. A couple of avian" exact="influenza" post="viruses of H5N1 and H7N9 also posed threats to"/>
   <result pre="in Taiwan in the two recent decades. Nevertheless, two seasonal" exact="influenza" post="A viruses and two lineages of influenza B viruses"/>
   <result pre="Nevertheless, two seasonal influenza A viruses and two lineages of" exact="influenza" post="B viruses continue causing annual endemics one after the"/>
   <result pre="Keywords Influenza Pandemic Genome evolution Surveillance Brief history of global" exact="influenza" post="virus outbreaks There are four types of influenza viruses:"/>
   <result pre="of global influenza virus outbreaks There are four types of" exact="influenza" post="viruses: types A, B, C, and D. Influenza A,"/>
   <result pre="on human health globally. Influenza B causes seasonal epidemics while" exact="influenza" post="C causes mild human infections with minimal public health"/>
   <result pre="pandemic known as the â€œAsian fluâ€� caused by an H2N2" exact="influenza" post="A virus resulted in another million deaths. In 1968"/>
   <result pre="virus acquired a novel haemagglutinin and PB2 gene segment from" exact="avian influenza" post="virus origin to cause another pandemic that was first"/>
   <result pre="acquired a novel haemagglutinin and PB2 gene segment from avian" exact="influenza" post="virus origin to cause another pandemic that was first"/>
   <result pre="and led to epidemics worldwide. Since that time, the two" exact="influenza" post="A viruses, H1N1 and H3N2, have circulated worldwide as"/>
   <result pre="H1N1 and H3N2, have circulated worldwide as the major human" exact="influenza" post="A seasonal flu viruses resulting in annual epidemics or"/>
   <result pre="history. This new H1N1 virus was initially called a â€œswine-originâ€�" exact="influenza" post="virus because its gene segments are derived from swine"/>
   <result pre="influenza virus because its gene segments are derived from swine" exact="influenza" post="viruses. The 2009 pandemic virus replaced the previous seasonal"/>
   <result pre="to 2008 and since then has co-circulated in humans with" exact="influenza" post="A H3N2 and influenza B viruses. Pandemics and epidemics"/>
   <result pre="then has co-circulated in humans with influenza A H3N2 and" exact="influenza" post="B viruses. Pandemics and epidemics in Taiwan 1918 H1N1"/>
   <result pre="the western Pacific Ocean, is relatively isolated from other countries," exact="influenza" post="pandemics have still affected its inhabitants. During the 1918"/>
   <result pre="pandemics have still affected its inhabitants. During the 1918 H1N1" exact="influenza" post="pandemic, Taiwan was governed by Japan. Previous studies have"/>
   <result pre="[1], [2]. Similar to the transmission route of the 1918" exact="influenza" post="virus in the United States, this H1N1 virus may"/>
   <result pre="Megumi in 1918â€&quot;19 [Fig.Â 1], the earliest cases of the" exact="influenza" post="infection may have originated in Keelung Harbor in northern"/>
   <result pre="population during 1918â€&quot;20 in Taiwan and concluded that the 1918" exact="influenza" post="pandemic caused significant mortality in Taiwan [4]. Wilson Smith"/>
   <result pre="[4]. Wilson Smith (1933) isolated the causative agent of human" exact="influenza" post="in 1933. Fig.Â 1 Part of the original manuscript"/>
   <result pre="Part of the original manuscript (in Japanese) describing the 1918" exact="influenza" post="pandemic in Taiwan reported by a Japanese medical officer,"/>
   <result pre="caused the 1957 Asian flu pandemic was recognized as an" exact="influenza" post="A virus [5] of different A subtype designated as"/>
   <result pre="haemagglutinin (HA), neuraminidase (NA) and PB1 gene segments from an" exact="avian influenza" post="virus [7]. Several strains of the influenza A virus"/>
   <result pre="(HA), neuraminidase (NA) and PB1 gene segments from an avian" exact="influenza" post="virus [7]. Several strains of the influenza A virus"/>
   <result pre="from an avian influenza virus [7]. Several strains of the" exact="influenza" post="A virus related to the pandemic were isolated in"/>
   <result pre="1968, a new worldwide pandemic was caused by an H3N2" exact="influenza" post="A virus. Because the virus was first isolated in"/>
   <result pre="H2N2 virus acquiring HA and PB1 gene segments from an" exact="avian influenza" post="A virus [13], [14]. During 1968â€&quot;71, the number of"/>
   <result pre="virus acquiring HA and PB1 gene segments from an avian" exact="influenza" post="A virus [13], [14]. During 1968â€&quot;71, the number of"/>
   <result pre="[13], [14]. During 1968â€&quot;71, the number of deaths related to" exact="influenza" post="infection in Taiwan increased, which may indicate the burden"/>
   <result pre="the first indication of reverse zoonosis, with pigs acquiring human" exact="influenza" post="viruses [15]. Several influenza A viruses closely related to"/>
   <result pre="reverse zoonosis, with pigs acquiring human influenza viruses [15]. Several" exact="influenza" post="A viruses closely related to human A/Hong Kong/68 (H3N2)"/>
   <result pre="H3N2 virus has continuously circulated among humans as a seasonal" exact="influenza" post="virus. Antigenic drift of this H3N2 has occurred. Reappearance"/>
   <result pre="strain of H3N2 adapted to humans and became a seasonal" exact="influenza" post="virus, an H1N1 virus reappeared and caused epidemics in"/>
   <result pre="its emergence in 1977, the H1N1 virus became a seasonal" exact="influenza" post="virus that co-circulated with H3N2 viruses worldwide, including in"/>
   <result pre="California were identified to be infected with a novel H1N1" exact="influenza" post="A virus that was genetically similar to the swine-origin"/>
   <result pre="North American avian, human H3N2, classic swine, and Eurasian swine" exact="influenza" post="A viruses [22], [23], [24]. In Taiwan, the first"/>
   <result pre="with less number of viruses being isolated. Interestingly, the severe" exact="influenza" post="and pneumonia/influenza related death from this virus seemed to"/>
   <result pre="the A (H1N1)pdm09 virus now being recognized as a seasonal" exact="influenza" post="virus. At the time of writing this review, the"/>
   <result pre="1977 up to 2009 in Taiwan [30]. Threats related to" exact="avian influenza" post="viruses H5N1 and H7N9 In 1997, cases of human"/>
   <result pre="up to 2009 in Taiwan [30]. Threats related to avian" exact="influenza" post="viruses H5N1 and H7N9 In 1997, cases of human"/>
   <result pre="In 1997, cases of human infection with a highly pathogenic" exact="avian influenza" post="A virus (H5N1) were reported in Hong Kong [31]."/>
   <result pre="1997, cases of human infection with a highly pathogenic avian" exact="influenza" post="A virus (H5N1) were reported in Hong Kong [31]."/>
   <result pre="in Taiwan at the time of writing this review, this" exact="avian influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="Taiwan at the time of writing this review, this avian" exact="influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="to public health. Several imported cases of infection with another" exact="avian influenza" post="A virus (H7N9) in humans have been reported in"/>
   <result pre="public health. Several imported cases of infection with another avian" exact="influenza" post="A virus (H7N9) in humans have been reported in"/>
   <result pre="established surveillance systems and early diagnostic technology to monitor the" exact="avian influenza" post="viruses throughout Taiwan. Epidemics of seasonal influenza viruses in"/>
   <result pre="surveillance systems and early diagnostic technology to monitor the avian" exact="influenza" post="viruses throughout Taiwan. Epidemics of seasonal influenza viruses in"/>
   <result pre="monitor the avian influenza viruses throughout Taiwan. Epidemics of seasonal" exact="influenza" post="viruses in Taiwan Seasonal influenza A and B viruses"/>
   <result pre="throughout Taiwan. Epidemics of seasonal influenza viruses in Taiwan Seasonal" exact="influenza" post="A and B viruses circulate worldwide, infecting 5â€&quot;10% of"/>
   <result pre="and this network has substantially contributed to the control of" exact="influenza" post="virus infections [37]. Influenza epidemic waves from 2000 to"/>
   <result pre="the time of writing this review, the major lineages of" exact="influenza" post="viruses responsible for influenza epidemics in Taiwan are the"/>
   <result pre="this review, the major lineages of influenza viruses responsible for" exact="influenza" post="epidemics in Taiwan are the H3N2 and H1N1 subtypes"/>
   <result pre="epidemics in Taiwan are the H3N2 and H1N1 subtypes of" exact="influenza" post="A viruses and the Victoria and Yamagata lineages of"/>
   <result pre="influenza A viruses and the Victoria and Yamagata lineages of" exact="influenza" post="B viruses. The peak circulation of these viruses is"/>
   <result pre="dominant lineages in the 2000â€&quot;01 and 2001â€&quot;02 seasons were the" exact="influenza" post="B and H1N1 viruses, respectively, those in 2002â€&quot;03 and"/>
   <result pre="2003â€&quot;04 were H3N2 [37], and in 2004â€&quot;05 H3N2 co-circulated with" exact="influenza" post="B viruses [38], [39]. In the subsequent period from"/>
   <result pre="H1N1 subtype prevailed (except for the co-circulation of H3N2 and" exact="influenza" post="B viruses in 2006â€&quot;07) [38], [39]. The 2009 pandemic"/>
   <result pre="A (H1N1)pdm09 virus, which was generated by reassortment of several" exact="influenza" post="viruses. This new H1N1 virus continued to be the"/>
   <result pre="viruses. This new H1N1 virus continued to be the dominant" exact="influenza" post="virus in the two subsequent winters [40] and replaced"/>
   <result pre="H1N1 virus to become the new seasonal H1N1 virus. Although" exact="influenza" post="B viruses circulated in 2011â€&quot;12, a summer epidemic of"/>
   <result pre="epidemics in 2005, 2007, and 2012 followed the circulation of" exact="influenza" post="B viruses during the winters of 2004â€&quot;05, 2006â€&quot;07, and"/>
   <result pre="prediction of their global migrations In addition to Taiwan, summer" exact="influenza" post="outbreaks have been reported in Okinawa (Japan), Hong Kong,"/>
   <result pre="computational analytics may improve understanding of the global spread of" exact="influenza" post="viruses. 2015â€&quot;16 H1N1 epidemic In Taiwan, a most recent"/>
   <result pre="in 2015â€&quot;16, causing 163 deaths and 1663 severe infections (including" exact="influenza" post="infection cases with pulmonary complications, neurologic complications, myocarditis, invasive"/>
   <result pre="with pulmonary complications, neurologic complications, myocarditis, invasive bacterial infections, or" exact="pericarditis" post="that required intensive care or resulting in death) from"/>
   <result pre="federal districts of Russia, the rate of morbidity due to" exact="influenza" post="and acute respiratory infection rapidly increased in the 2015â€&quot;16"/>
   <result pre="(A/Michigan/45/2015) in the following 2017 southern and 2017â€&quot;18 northern hemisphere" exact="influenza" post="seasons [54], [55]. This suggests that selection of strains"/>
   <result pre="This suggests that selection of strains for vaccines against seasonal" exact="influenza" post="viruses must be improved. Establishing a real-time monitoring system"/>
   <result pre="enable more effective selection of vaccine strains. Circulating H3N2 and" exact="influenza" post="B viruses from 2016 to 2018 The H3N2 virus"/>
   <result pre="climatic changes were possible contributors [58]. After this summer epidemic," exact="influenza" post="B viruses were the dominant viruses in the 2017â€&quot;18"/>
   <result pre="October 2017 to March 2018 [59]. Notably, an unusually early" exact="influenza" post="epidemic caused by the H3N2 virus co-circulating with the"/>
   <result pre="by the H3N2 virus co-circulating with the Yamagata lineage of" exact="influenza" post="B viruses occurred during this period in Canada [60]."/>
   <result pre="still prevailed, and thus further research is necessary to improve" exact="influenza" post="vaccines. In conclusion, although the timing of influenza epidemics"/>
   <result pre="to improve influenza vaccines. In conclusion, although the timing of" exact="influenza" post="epidemics and the evolutionary pattern of influenza viruses remain"/>
   <result pre="the timing of influenza epidemics and the evolutionary pattern of" exact="influenza" post="viruses remain unpredictable, recent computational techniques and sequencing platforms"/>
   <result pre="and highly effective method for analyzing the rapid evolution of" exact="influenza" post="viruses. Improving our understanding of and capacity to predict"/>
   <result pre="our understanding of and capacity to predict the evolution of" exact="influenza" post="viruses could lead to the development of superior techniques"/>
   <result pre="superior techniques for public health surveillance and effective recommendations for" exact="influenza" post="vaccine strains in future seasons. Discussion and future perspectives"/>
   <result pre="the establishment of an island-wide laboratory-based surveillance network has facilitated" exact="influenza" post="epidemiology monitoring in Taiwan since 2000. The seamless collaboration"/>
   <result pre="H5N1 disease in humans had been reported in Taiwan, this" exact="avian influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="disease in humans had been reported in Taiwan, this avian" exact="influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="public health. Several imported cases of human infection with an" exact="avian influenza" post="A virus (H7N9) have been reported in Taiwan since"/>
   <result pre="health. Several imported cases of human infection with an avian" exact="influenza" post="A virus (H7N9) have been reported in Taiwan since"/>
   <result pre="and early diagnostic technology to monitor both human seasonal and" exact="avian influenza" post="virus throughout Taiwan. In particular, advances in cell culture,"/>
   <result pre="early diagnostic technology to monitor both human seasonal and avian" exact="influenza" post="virus throughout Taiwan. In particular, advances in cell culture,"/>
   <result pre="modeling should all contribute to help in our understanding of" exact="influenza" post="epidemics. Conflicts of interest The authors declare no conflicts"/>
   <result pre="declare no conflicts of interest. References References 1ChanC.H.Gene analysis of" exact="influenza" post="A and B Isolates1999Institute of Microbiology and Immunology. Ph.D.:"/>
   <result pre="Immunology. Ph.D.: National Yang-Ming University 2NHRISpecial report for the 1918" exact="influenza" post="pandemic in Taiwan. H5N1 influenza2008The National Health Research InstituteTaiwan"/>
   <result pre="influenza2008The National Health Research InstituteTaiwan 3HsiehY.H.ChanC.H.Excess healthcare burden during 1918-1920" exact="influenza" post="pandemic in Taiwan: implications for post-pandemic preparednessBMC Publ Health11201141"/>
   <result pre="post-pandemic preparednessBMC Publ Health11201141 4HsiehY.H.Excess deaths and immunoprotection during 1918-1920" exact="influenza" post="pandemic, TaiwanEmerg Infect Dis1520091617161919861055 5KilbourneE.D.Studies on influenza in the"/>
   <result pre="immunoprotection during 1918-1920 influenza pandemic, TaiwanEmerg Infect Dis1520091617161919861055 5KilbourneE.D.Studies on" exact="influenza" post="in the pandemic of 1957-1958. III. Isolation of influenza"/>
   <result pre="on influenza in the pandemic of 1957-1958. III. Isolation of" exact="influenza" post="A (Asian strain) viruses from influenza patients with pulmonary"/>
   <result pre="1957-1958. III. Isolation of influenza A (Asian strain) viruses from" exact="influenza" post="patients with pulmonary complications; details of virus isolation and"/>
   <result pre="isolates, with quantitative comparison of isolation methodsJ Clin Invest38195926627413620785 6DunnF.L.Pandemic" exact="influenza" post="in 1957; review of international spread of new Asian"/>
   <result pre="strainJ Am Med Assoc16619581140114813513331 7SchaferJ.R.KawaokaY.BeanW.J.SussJ.SenneD.WebsterR.G.Origin of the pandemic 1957 H2" exact="influenza" post="A virus and the persistence of its possible progenitors"/>
   <result pre="8WangS.P.LinT.Y.Laboratory studies on some biological properties of the far east" exact="influenza" post="virusJ Infect Dis103195817818213588070 9GreenI.J.RasmussenA.F.HsuS.H.HsiehW.C.HungS.C.Antigenic characteristics of Asian influenza viruses"/>
   <result pre="far east influenza virusJ Infect Dis103195817818213588070 9GreenI.J.RasmussenA.F.HsuS.H.HsiehW.C.HungS.C.Antigenic characteristics of Asian" exact="influenza" post="viruses isolated on Taiwan in 1961Taiwan Yi Xue Hui"/>
   <result pre="Xue Hui Za Zhi61196210510913901411 10ChangS.S.ChenC.Y.Studies on complement fixation antigens of" exact="influenza" post="virus. I. Type-specific and strainspecific complement fixation tests as"/>
   <result pre="as compared with hemagglutination-inhibition testJ Formos Med Assoc60196110101025 11PaleseP.WangT.T.Why do" exact="influenza" post="virus subtypes die out? A hypothesisMBio22011pii=e00150-11 12JonesJ.C.BaranovichT.MaratheB.M.DannerA.F.SeilerJ.P.FranksJ.Risk assessment of"/>
   <result pre="virus subtypes die out? A hypothesisMBio22011pii=e00150-11 12JonesJ.C.BaranovichT.MaratheB.M.DannerA.F.SeilerJ.P.FranksJ.Risk assessment of H2N2" exact="influenza" post="viruses from the avian reservoirJ Virol8820141175118824227848 13KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission of"/>
   <result pre="avian reservoirJ Virol8820141175118824227848 13KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission of the PB1 gene of" exact="influenza" post="A viruses in the 1957 and 1968 pandemicsJ Virol631989460346082795713"/>
   <result pre="1968 pandemicsJ Virol631989460346082795713 14ScholtissekC.RohdeW.Von HoyningenV.RottR.On the origin of the human" exact="influenza" post="virus subtypes H2N2 and H3N2Virology8719781320664248 15KundinW.D.Hong Kong A-2 influenza"/>
   <result pre="human influenza virus subtypes H2N2 and H3N2Virology8719781320664248 15KundinW.D.Hong Kong A-2" exact="influenza" post="virus infection among swine during a human epidemic in"/>
   <result pre="of influenzavirus A subtype H1N1Bull World Health Organ561978919922310733 18NakajimaK.DesselbergerU.PaleseP.Recent human" exact="influenza" post="A (H1N1) viruses are closely related genetically to strains"/>
   <result pre="related genetically to strains isolated in 1950Nature2741978334339672956 19KendalA.P.NobleG.R.SkehelJ.J.DowdleW.R.Antigenic similarity of" exact="influenza" post="A (H1N1) viruses from epidemics in 1977-1978 to &quot;Scandinavian&quot;"/>
   <result pre="strain and the gain-of-function debatemBio62015e01013e0101526286690 21Centers for Disease C, PreventionSwine" exact="influenza" post="A (H1N1) infection in two children--Southern California, March-April 2009MMWR"/>
   <result pre="2009MMWR Morb Mortal Wkly Rep58200940040219390508 22DawoodF.S.JainS.FinelliL.ShawM.W.LindstromS.GartenR.J.Emergence of a novel swine-origin" exact="influenza" post="A (H1N1) virus in humansN Engl J Med36020092605261519423869 23GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.Antigenic"/>
   <result pre="J Med36020092605261519423869 23GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.Antigenic and genetic characteristics of swine-origin 2009 A(H1N1)" exact="influenza" post="viruses circulating in humansScience325200919720119465683 24SmithG.J.VijaykrishnaD.BahlJ.LycettS.J.WorobeyM.PybusO.G.Origins and evolutionary genomics of"/>
   <result pre="humansScience325200919720119465683 24SmithG.J.VijaykrishnaD.BahlJ.LycettS.J.WorobeyM.PybusO.G.Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemicNature45920091122112519516283 25HoT.S.WangS.M.LiuC.C.Historical review of pandemic influenza A in"/>
   <result pre="2009 swine-origin H1N1 influenza A epidemicNature45920091122112519516283 25HoT.S.WangS.M.LiuC.C.Historical review of pandemic" exact="influenza" post="A in Taiwan, 2009Pediatr Neonatol512010838820417458 26YenM.Y.ChiuA.W.SchwartzJ.KingC.C.LinY.E.ChangS.C.From SARS in 2003"/>
   <result pre="green I and modified probe real-time reverse transcription-PCR assays identify" exact="influenza" post="H1N1 viruses and distinguish between pandemic and seasonal strainsJ"/>
   <result pre="29WuU.I.WangJ.T.ChangS.C.ChuangY.C.LinW.R.LuM.C.Impacts of a mass vaccination campaign against pandemic H1N1 2009" exact="influenza" post="in Taiwan: a time-series regression analysisInt J Infect Dis232014828924721165"/>
   <result pre="a time-series regression analysisInt J Infect Dis232014828924721165 30ChuangJ.H.HuangA.S.HuangW.T.LiuM.T.ChouJ.H.ChangF.Y.Nationwide surveillance of" exact="influenza" post="during the pandemic (2009-10) and post-pandemic (2010-11) periods in"/>
   <result pre="and post-pandemic (2010-11) periods in TaiwanPLoS One72012e3612022545158 31ClaasE.C.OsterhausA.D.van BeekR.De JongJ.C.RimmelzwaanG.F.SenneD.A.Human" exact="influenza" post="A H5N1 virus related to a highly pathogenic avian"/>
   <result pre="JongJ.C.RimmelzwaanG.F.SenneD.A.Human influenza A H5N1 virus related to a highly pathogenic" exact="avian influenza" post="virusLancet35119984724779482438 32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9 influenza in TaiwanLancet38120131621"/>
   <result pre="influenza A H5N1 virus related to a highly pathogenic avian" exact="influenza" post="virusLancet35119984724779482438 32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9 influenza in TaiwanLancet38120131621"/>
   <result pre="highly pathogenic avian influenza virusLancet35119984724779482438 32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9" exact="influenza" post="in TaiwanLancet38120131621 33YangJ.R.KuoC.Y.HuangH.Y.WuF.T.HuangY.L.ChengC.Y.Characterization of influenza A (H7N9) viruses isolated"/>
   <result pre="32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9 influenza in TaiwanLancet38120131621 33YangJ.R.KuoC.Y.HuangH.Y.WuF.T.HuangY.L.ChengC.Y.Characterization of" exact="influenza" post="A (H7N9) viruses isolated from human cases imported into"/>
   <result pre="imported into TaiwanPLoS One102015e011979225748033 34GaoR.CaoB.HuY.FengZ.WangD.HuW.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN Engl J Med36820131888189723577628 35LiQ.ZhouL.ZhouM.ChenZ.LiF.WuH.Epidemiology of human"/>
   <result pre="(H7N9) virusN Engl J Med36820131888189723577628 35LiQ.ZhouL.ZhouM.ChenZ.LiF.WuH.Epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in ChinaN Engl J Med370201452053223614499 36World Health"/>
   <result pre="virusN Engl J Med36820131888189723577628 35LiQ.ZhouL.ZhouM.ChenZ.LiF.WuH.Epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in ChinaN Engl J Med370201452053223614499 36World Health"/>
   <result pre="36World Health OrganizationSeasonal influenza2018http://www.who.int/ith/diseases/influenza_seasonal/en/ 37ShihS.R.ChenG.W.YangC.C.YangW.Z.LiuD.P.LinJ.H.Laboratory-based surveillance and molecular epidemiology of" exact="influenza" post="virus in TaiwanJ Clin Microbiol4320051651166115814980 38LinJ.H.ChiuS.C.ChengJ.C.ChangH.W.HsiaoK.L.LinY.C.Molecular epidemiology and antigenic"/>
   <result pre="in TaiwanJ Clin Microbiol4320051651166115814980 38LinJ.H.ChiuS.C.ChengJ.C.ChangH.W.HsiaoK.L.LinY.C.Molecular epidemiology and antigenic analyses of" exact="influenza" post="A viruses H3N2 in TaiwanClin Microbiol Infect17201121422220370800 39LinJ.H.ChiuS.C.LinY.C.ChengJ.C.WuH.S.SalemiM.Exploring the"/>
   <result pre="Microbiol Infect17201121422220370800 39LinJ.H.ChiuS.C.LinY.C.ChengJ.C.WuH.S.SalemiM.Exploring the molecular epidemiology and evolutionary dynamics of" exact="influenza" post="A virus in TaiwanPLoS One82013e6195723613982 40ChenG.W.TsaoK.C.HuangC.G.GongY.N.ChangS.C.LiuY.C.Amino acids transitioning of"/>
   <result pre="2011PLoS One72012e4594623029335 41YangJ.R.TengH.J.LiuM.T.LiS.Y.Taiwan's public health national laboratory system: success in" exact="influenza" post="diagnosis and surveillanceHealth Secur15201715416428418742 42SunagawaS.IhaY.TairaK.OkanoS.KinjoT.HigaF.An epidemiological analysis of summer"/>
   <result pre="influenza diagnosis and surveillanceHealth Secur15201715416428418742 42SunagawaS.IhaY.TairaK.OkanoS.KinjoT.HigaF.An epidemiological analysis of summer" exact="influenza" post="epidemics in OkinawaIntern Med5520163579358427980256 43BaeleG.SuchardM.A.RambautA.LemeyP.Emerging concepts of data integration"/>
   <result pre="Biol52009e100050519855824 46BedfordT.CobeyS.BeerliP.PascualM.Global migration dynamics underlie evolution and persistence of human" exact="influenza" post="A (H3N2)PLoS Pathog62010e100091820523898 47BahlJ.NelsonM.I.ChanK.H.ChenR.VijaykrishnaD.HalpinR.A.Temporally structured metapopulation dynamics and persistence"/>
   <result pre="A (H3N2)PLoS Pathog62010e100091820523898 47BahlJ.NelsonM.I.ChanK.H.ChenR.VijaykrishnaD.HalpinR.A.Temporally structured metapopulation dynamics and persistence of" exact="influenza" post="A H3N2 virus in humansProc Natl Acad Sci U"/>
   <result pre="S A1082011193591936422084096 48LemeyP.SuchardM.RambautA.Reconstructing the initial global spread of a human" exact="influenza" post="pandemic: a Bayesian spatial-temporal model for the global spread"/>
   <result pre="global spread of H1N1pdmPLoS Curr12009RRN103120029613 49GongY.N.TsaoK.C.ChenG.W.Inferring the global phylodynamics of" exact="influenza" post="A/H3N2 viruses in TaiwanJ Formos Med Assoc2018[Epub ahead of"/>
   <result pre="their molecular determinantsPLoS Pathog62010e100088420463813 51Taiwan Centers for Disease Control. Taiwan" exact="influenza" post="express (2016/03/06-2016/03/12), https://www.cdc.gov.tw/info.aspx?treeid=1F07E8862BA550CF&amp;amp;nowtreeid=204B424A955D572F&amp;amp;tid=C363651DDC5981F3; [accessed 6 July 2018]. 52CousinsS.Death toll"/>
   <result pre="from swine flu in India exceeds 2500BMJ3512015h496626384378 53KomissarovA.FadeevA.SergeevaM.PetrovS.SintsovaK.EgorovaA.Rapid spread of" exact="influenza" post="A(H1N1)pdm09 viruses with a new set of specific mutations"/>
   <result pre="(Russian Federation)Influenza Other Respir Viruses10201624725326992820 54World Health OrganizationRecommended composition of" exact="influenza" post="virus vaccines for use in the 2017 southern hemisphere"/>
   <result pre="influenza virus vaccines for use in the 2017 southern hemisphere" exact="influenza" post="season2016http://www.who.int/influenza/vaccines/virus/recommendations/201609_recommendation.pdf?ua=1 55World Health OrganizationRecommended composition of influenza virus vaccines"/>
   <result pre="2017 southern hemisphere influenza season2016http://www.who.int/influenza/vaccines/virus/recommendations/201609_recommendation.pdf?ua=1 55World Health OrganizationRecommended composition of" exact="influenza" post="virus vaccines for use in the 2017-2018 northern hemisphere"/>
   <result pre="influenza virus vaccines for use in the 2017-2018 northern hemisphere" exact="influenza" post="season2017http://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 56NeherR.A.BedfordT.nextflu: real-time tracking of seasonal influenza virus evolution"/>
   <result pre="2017-2018 northern hemisphere influenza season2017http://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 56NeherR.A.BedfordT.nextflu: real-time tracking of seasonal" exact="influenza" post="virus evolution in humansBioinformatics3120153546354826115986 57TsouT.P.SuC.P.HuangW.T.YangJ.R.LiuM.T.Influenza A(H3N2) virus variants and"/>
   <result pre="57TsouT.P.SuC.P.HuangW.T.YangJ.R.LiuM.T.Influenza A(H3N2) virus variants and patient characteristics during a summer" exact="influenza" post="epidemic in Taiwan, 2017Euro Surveill222017pii=17-00767 58YangJ.R.HsuS.Z.KuoC.Y.HuangH.Y.HuangT.Y.WangH.C.An epidemic surge of"/>
   <result pre="influenza epidemic in Taiwan, 2017Euro Surveill222017pii=17-00767 58YangJ.R.HsuS.Z.KuoC.Y.HuangH.Y.HuangT.Y.WangH.C.An epidemic surge of" exact="influenza" post="A(H3N2) virus at the end of the 2016-2017 season"/>
   <result pre="genetic heterogeneityJ Clin Virol99â€&quot;10020181521 59Taiwan Centers for Disease Control. Taiwan" exact="influenza" post="express (2018/03/04-2018/03/10), https://www.cdc.gov.tw/info.aspx?treeid=1F07E8862BA550CF&amp;amp;nowtreeid=CB122F160E7AC2B9&amp;amp;tid=3D8AA6E7A9B58EDA; [accessed 6 JulyÂ 2018]. 60SkowronskiD.M.ChambersC.De SerresG.DickinsonJ.A.WinterA.L.HickmanR.Early"/>
   <result pre="https://www.cdc.gov.tw/info.aspx?treeid=1F07E8862BA550CF&amp;amp;nowtreeid=CB122F160E7AC2B9&amp;amp;tid=3D8AA6E7A9B58EDA; [accessed 6 JulyÂ 2018]. 60SkowronskiD.M.ChambersC.De SerresG.DickinsonJ.A.WinterA.L.HickmanR.Early season co-circulation of" exact="influenza" post="A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness,"/>
   <result pre="of 2017/18 vaccine effectiveness, Canada, January 2018Euro Surveill23201818-00035 61SullivanS.G.ChilverM.B.CarvilleK.S.DengY.M.GrantK.A.HigginsG.Low interim" exact="influenza" post="vaccine effectiveness, Australia, 1 May to 24 September 2017Euro"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6197992\results\search\disease\results.xml">
   <result pre="University S2319-4170(18)30382-2 doi: 10.1016/j.bj.2018.08.006 : Special Edition Legacy of the" exact="influenza" post="pandemic 1918: Introduction GordonSiamonsiamon.gordon@mail.cgu.edu.twâˆ—[], [], âˆ—Corresponding author. Graduate Institute"/>
   <result pre="and secretory responses to a range of pathogens, including flaviviruses," exact="influenza" post="and HIV.He is interested in the history of immunology,"/>
   <result pre="first group of reviews to mark the centennial of the" exact="influenza" post="pandemic which swept the world in 1918, continuing into"/>
   <result pre="social and economic disruption, reminiscent of previous epidemics of smallpox," exact="plague" post="and cholera. It coincided with the termination of the"/>
   <result pre="of infection, yet its role in the onset of the" exact="influenza" post="pandemic is not entirely clear. The pandemic initiated a"/>
   <result pre="respiratory epithelium which underlie the pathobiology of infection by the" exact="influenza" post="virus; Yu-Nong Gong, Rei-Lin Kuo, Guang-Wu Chen, and Shin-Ru"/>
   <result pre="Shih trace the viral evolution associated with the epidemiology of" exact="influenza" post="outbreaks in Taiwan, and Andrew McMichael outlines milestones in"/>
   <result pre="the initial response to infection and vaccines. Our understanding of" exact="influenza" post="virusâ€&quot;host interactions has catalyzed research into other emerging virus"/>
   <result pre="HIV and Ebola, as well as vaccination strategies for polio," exact="measles" post="and flaviviruses such as yellow fever and dengue. Yet,"/>
   <result pre="as vaccination strategies for polio, measles and flaviviruses such as" exact="yellow fever" post="and dengue. Yet, the development of effective antiviral treatment"/>
   <result pre="by the three corresponding authors. Ling-Pei Ho: Respiratory epithelium during" exact="influenza" post="virus infection The specific role of respiratory epithelium in"/>
   <result pre="specific role of respiratory epithelium in the host defence against" exact="influenza" post="has been less studied compared to the immune system"/>
   <result pre="as the first point in the innate immune machinery against" exact="influenza" post="virus infection. Prof Ho and her team were originally"/>
   <result pre="T cell (NKT) regulated lung immune responses [1]. They used" exact="influenza" post="as a model to understand lung immune responses [2],"/>
   <result pre="found that myeloid cells are key to immunepathology during murine" exact="influenza" post="virus infections [5], [6]. During the recent pandemic, Prof"/>
   <result pre="that again implicated the monocyte-macrophage pathway in lung immunepathology during" exact="influenza" post="infection [7]. Her team also contributed to studies which"/>
   <result pre="3ZhaoY.H.ZhangL.DenneyL.YoungD.PowellT.PengY.C.High levels of virus-specific CD4+ T cells predict severe pandemic" exact="influenza" post="a virus infectionAm J Respir Crit Care Med18620121292129723087026 4HoL.P.DenneyL.LuhnK.TeohD.ClellandC.McMichaelA.J.Activation"/>
   <result pre="the innate immune response and improves the disease course in" exact="influenza" post="A virus infectionEur J Immunol3820081913192218521958 5KokW.L.DenneyL.BenamK.ClellandC.McMichaelA.J.HoL.P.Invariant NKT cells decrease"/>
   <result pre="infectionEur J Immunol3820081913192218521958 5KokW.L.DenneyL.BenamK.ClellandC.McMichaelA.J.HoL.P.Invariant NKT cells decrease immunepathology in lethal" exact="influenza" post="A virus infection by reducing accumulation of inflammatory monocytes"/>
   <result pre="9ZhangY.H.ZhaoY.LiN.PengY.C.GiannoulatouE.JinR.H.IFITM3 rs12252-C is associated with disease severity in acute, pandemic" exact="influenza" post="A H1N1/09 infected Chinese individualsNat Commun42013141823361009 Shin-Ru Shih: Centennial"/>
   <result pre="H1N1/09 infected Chinese individualsNat Commun42013141823361009 Shin-Ru Shih: Centennial review of" exact="influenza" post="in Taiwan Shin-Ru Shih obtained her bachelor degree in"/>
   <result pre="Gung University in 2009 as centre director. Dr. Shih began" exact="influenza" post="virus research from her Ph.D. study under the supervision"/>
   <result pre="of Professor Robert M. Krug [1], [2]. Her papers regarding" exact="influenza" post="virus surveillance have been widely discussed in influenza control"/>
   <result pre="papers regarding influenza virus surveillance have been widely discussed in" exact="influenza" post="control and surveillance [3], [4]. Her team identified several"/>
   <result pre="References References 1ShihS.R.NemeroffM.E.KrugR.M.The choice of alternative 5 splice sites in" exact="influenza" post="virus M1 mRNA is regulated by the viral polymerase"/>
   <result pre="Acad Sci USA921995632463287541537 2ShihS.R.KrugR.M.Novel exploitation of a nuclear function by" exact="influenza" post="virus : the cellular SF2/ASF splicing factor controls the"/>
   <result pre="protein in infected cellsEMBO J151996541554278895585 3ChenG.W.ChangS.C.MokC.K.LoY.L.WangJ.Y.ChiangC.Genomic signatures of human versus" exact="avian influenza" post="a virusesEmerg Infect Dis1220061353136017073083 4ChenG.W.ShihS.R.Genomic signatures of pandemic (H1N1)"/>
   <result pre="in infected cellsEMBO J151996541554278895585 3ChenG.W.ChangS.C.MokC.K.LoY.L.WangJ.Y.ChiangC.Genomic signatures of human versus avian" exact="influenza" post="a virusesEmerg Infect Dis1220061353136017073083 4ChenG.W.ShihS.R.Genomic signatures of pandemic (H1N1)"/>
   <result pre="a virusesEmerg Infect Dis1220061353136017073083 4ChenG.W.ShihS.R.Genomic signatures of pandemic (H1N1) 2009" exact="influenza" post="virusEmerg Infect Dis1520091897190319998748 5ChenM.F.WengK.F.HuangS.Y.LiuY.C.TsengS.N.DavidM.Pretreatment with a heat-killed probiotic modulates"/>
   <result pre="probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of" exact="influenza" post="and enterovirus 71 infectionsMucosal Immunol10201721522727072606 6KuoS.M.ChenC.J.ChangS.C.LiuT.J.ChenY.S.HuangS.Y.Inhibition of avian influenza"/>
   <result pre="pathogenicity of influenza and enterovirus 71 infectionsMucosal Immunol10201721522727072606 6KuoS.M.ChenC.J.ChangS.C.LiuT.J.ChenY.S.HuangS.Y.Inhibition of" exact="avian influenza" post="A virus replication in human cells by host restriction"/>
   <result pre="of influenza and enterovirus 71 infectionsMucosal Immunol10201721522727072606 6KuoS.M.ChenC.J.ChangS.C.LiuT.J.ChenY.S.HuangS.Y.Inhibition of avian" exact="influenza" post="A virus replication in human cells by host restriction"/>
   <result pre="is correlated with autophagyMBio82017e00481-1728611246 Andrew J McMichael: Legacy of the" exact="influenza" post="pandemic 1918: The host T cell response The wealth"/>
   <result pre="T cell response The wealth of knowledge gained on the" exact="influenza" post="virus, stimulated by the 1918 pandemic and subsequent discovery"/>
   <result pre="revealed twelve years later when Townsend etÂ al. showed that" exact="influenza" post="specific T cells recognized peptides bound to class I"/>
   <result pre="References References 1ZinkernagelR.M.DohertyP.C.Restriction of in vitro T cell-mediated cytotoxicity in" exact="lymphocytic choriomeningitis" post="within a syngeneic or semiallogeneic systemNature24819747017024133807 2TownsendA.R.RothbardJ.GotchF.M.BahadurG.WraithD.McMichaelA.J.The epitopes of"/>
   <result pre="choriomeningitis within a syngeneic or semiallogeneic systemNature24819747017024133807 2TownsendA.R.RothbardJ.GotchF.M.BahadurG.WraithD.McMichaelA.J.The epitopes of" exact="influenza" post="nucleoprotein recognized by cytotoxic T lymphocytes can be defined"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6199244\results\search\disease\results.xml">
   <result pre="a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract Seasonal H3N2" exact="influenza" post="viruses are recognized as major epidemic viruses, exhibiting complex"/>
   <result pre="we performed a genome-wide analysis of samples collected from 62" exact="influenza" post="A/H3N2-infected patients in Shanghai during 2016â€&quot;2017. Phylogenetic analysis of"/>
   <result pre="during 2016â€&quot;2017. Phylogenetic analysis of all eight segments of the" exact="influenza" post="A virus revealed that there were two epidemic influenza"/>
   <result pre="the influenza A virus revealed that there were two epidemic" exact="influenza" post="virus strains circulating in the 2016â€&quot;2017 winter season (2016â€&quot;2017win)"/>
   <result pre="in viral adaptation and persistence in subsequent seasons. Introduction Seasonal" exact="influenza" post="is responsible for an average of approximately 1 billion"/>
   <result pre="to 500,000 deaths annually. Increasing evidence has suggested that seasonal" exact="influenza" post="patterns are highly diverse in different zones, especially in"/>
   <result pre="into the following three regions according to the seasonality of" exact="influenza" post="viruses: the northern provinces experience epidemics during winter, the"/>
   <result pre="belongs to the category of provinces at intermediate latitudes, and" exact="influenza" post="A epidemics, particularly seasonal A/H3N2 and A/H1N1 viruses, usually"/>
   <result pre="A/H1N1 viruses, usually appear between autumn and spring, with the" exact="influenza" post="activity peaking after October2,3. Between 2014 and 2016, only"/>
   <result pre="activity peaking after October2,3. Between 2014 and 2016, only sporadic" exact="influenza" post="infections were reported during summer in Shanghai. However, in"/>
   <result pre="September among inpatients at Ruijin Hospital. To further examine the" exact="influenza" post="epidemics during the summer of 2017 in Shanghai, we"/>
   <result pre="of the mutations in the internal gene segments of the" exact="influenza" post="A virus during 2017. The influenza A virus contains"/>
   <result pre="gene segments of the influenza A virus during 2017. The" exact="influenza" post="A virus contains eight gene segments, namely, basic polymerase"/>
   <result pre="was to compare the complete genome sequences of two sequential" exact="influenza" post="epidemic viruses and to investigate whether the genetic differences"/>
   <result pre="confer temperature sensitivity and attenuate the polymerase activity of the" exact="influenza" post="virus, changing the seasonality and adaptation of the virus."/>
   <result pre="virus. Results Clinical characterization of patients infected with the H3N2" exact="influenza" post="virus during 2016â€&quot;2017 Sixty-two patients were diagnosed with a"/>
   <result pre="virus during 2016â€&quot;2017 Sixty-two patients were diagnosed with a H3N2" exact="influenza" post="virus infection from Nov. 2016 to Sep. 2017: 28"/>
   <result pre="were observed in all patients who were subsequently diagnosed with" exact="influenza" post="A by real-time RT-PCR. No significant differences were observed"/>
   <result pre="1 Demographic characteristics and clinical features of 62 inpatients with" exact="influenza" post="infection from 2016â€&quot;2017 Characteristics Inpatients during Nov. 2016â€&quot; Mar."/>
   <result pre="mutations in several segments The gene sequences of all eight" exact="influenza" post="virus gene segments were analyzed. Genetic analysis of the"/>
   <result pre="subunit. Compared with the WHO-recommended vaccine strains for the 2016â€&quot;2018" exact="influenza" post="seasons (A/Hong Kong/4801/ 2014), the 2017sum and 2016â€&quot;2017win virus"/>
   <result pre="using a minireplicon assay. The pPolI-NP-luciferase plasmid produces a modified" exact="influenza" post="virus NP viral RNA in which the NP-coding sequences"/>
   <result pre="lead to reduced polymerase activity at high temperatures. Discussion Seasonal" exact="influenza" post="epidemics are known to result in substantial morbidity and"/>
   <result pre="in regions with temperate climates, and the mechanism of seasonal" exact="influenza" post="activity and transmission has not been elucidated. Influenza seasons"/>
   <result pre="been elucidated. Influenza seasons are determined by climate regions. Worldwide," exact="influenza" post="epidemics always follow low seasonal temperatures, suggesting that low"/>
   <result pre="host susceptibility14,15. Moreover, humidity may be a critical driver of" exact="influenza" post="outbreaks. Absolute humidity has a regulatory effect on airborne"/>
   <result pre="influenza outbreaks. Absolute humidity has a regulatory effect on airborne" exact="influenza" post="transmission, and this effect can be modulated by temperature16."/>
   <result pre="Generally, the northern and southern regions in China experience different" exact="influenza" post="seasonality and evolutionary dynamics. Usually, the northern region experiences"/>
   <result pre="seasonality and evolutionary dynamics. Usually, the northern region experiences an" exact="influenza" post="season during the winter months (with a median peak"/>
   <result pre="ranging from Dec. to Jan.), while the southern region experiences" exact="influenza" post="during the summer months (with a median peak from"/>
   <result pre="subtropical climate but is located in the intermediate-latitude region, the" exact="influenza" post="seasonality in Shanghai is atypical3,17. Between 2006 and 2016,"/>
   <result pre="and 2016, the annual seasonality in Shanghai was irregular. Two" exact="influenza" post="peaks were observed in 2008 and 2010, and only"/>
   <result pre="during the other years. However, in 2017, the following two" exact="influenza" post="epidemics occurred in Shanghai: one epidemic between Nov. 2016"/>
   <result pre="2017 and Sep. 2017. These epidemics were consistent with the" exact="influenza" post="epidemics observed in Hong Kong and Guangdong in 2017."/>
   <result pre="epidemics observed in Hong Kong and Guangdong in 2017. Although" exact="influenza" post="epidemics occur frequently during summer in the southern region,"/>
   <result pre="during summer in the southern region, the mechanism underlying summer" exact="influenza" post="epidemics has not been elucidated18. In this study, we"/>
   <result pre="2017 in an attempt to investigate the evolution of the" exact="influenza" post="virus during 2017 in Shanghai and the effects of"/>
   <result pre="segments of the 2017sum virus strains were already present in" exact="influenza" post="viruses circulating in 2016. This tendency was consistent with"/>
   <result pre="was consistent with the phylogenetic analysis of other segments. The" exact="influenza" post="virus polymerase consists of three subunits, encoded by the"/>
   <result pre="To further investigate the effects of these mutations on the" exact="influenza" post="polymerase in the 2016â€&quot;2017win and 2017sum virus strains, we"/>
   <result pre="the polymerase complex in determining the temperature range over which" exact="influenza" post="viruses can replicate5. Bradel Tretheway et al.21 showed that"/>
   <result pre="the 2016â€&quot;2017win viruses was conferred by a mutation in the" exact="influenza" post="polymerase PA subunit. Introducing a single substitution at residue"/>
   <result pre="the PKR-binding site of the NS1 protein (position 123â€&quot;127)26. The" exact="influenza" post="virus NS1 protein plays a key role in blocking"/>
   <result pre="a key role in blocking the activation of PKR during" exact="influenza" post="infection and interacts with the viral polymerase to mediate"/>
   <result pre="result in the deregulation of vRNA synthesis, resulting in attenuated" exact="influenza" post="virus replication27. There has been no report regarding mutations"/>
   <result pre="of vRNA at the early infection stage. In summary, the" exact="influenza" post="A (H3N2) virus strains circulating in the 2016â€&quot;2017 winter"/>
   <result pre="may be the result of the natural evolution of the" exact="influenza" post="virus and could explain the second epidemic that occurred"/>
   <result pre="Shanghai. These data further enhance our understanding of the summer" exact="influenza" post="epidemic in Shanghai and subtropical Asia and thus provide"/>
   <result pre="insights for the prediction of the next epidemic strain of" exact="influenza" post="A (H3N2). Our research provides information on the temperature-sensitive"/>
   <result pre="temperature-sensitive signature and further insight into the function of the" exact="influenza" post="A polymerase. Future studies investigating the functional properties of"/>
   <result pre="should be performed to fully understand the evolution of the" exact="influenza" post="virus and pave the way for the prevention of"/>
   <result pre="and pave the way for the prevention of new severe" exact="influenza" post="pandemics. Materials and methods Ethics statement The Research Laboratory"/>
   <result pre="Hospital. Nasopharyngeal specimens from the 2016â€&quot;2017 winter and 2017 summer" exact="influenza" post="outbreaks were collected from influenza-infected inpatients before the administration"/>
   <result pre="Research Database under GenBank accession numbers MG984093 to MG984541. The" exact="influenza" post="A viruses were isolated from MDCK cells as previously"/>
   <result pre="than 99.9% identity in all eight segments. We used an" exact="influenza" post="A (H3N2) viral strain isolated in 2014 as our"/>
   <result pre="Contaminant DNA was eliminated using DNase. Amplification of all eight" exact="influenza" post="genome segments (PB2, PB1, PA, HA, NP, NA, M,"/>
   <result pre="The amino acids in epitopes A to E of the" exact="influenza" post="A (H3N2) HA protein referenced in this study have"/>
   <result pre="of an additional 18 to 20 nucleotides unrelated to the" exact="influenza" post="virus were added to distinguish the three types of"/>
   <result pre="influenza virus were added to distinguish the three types of" exact="influenza" post="RNAs (vRNA, cRNA, and mRNA). The resulting cDNA was"/>
   <result pre="of interest. References References 1.BedfordTet al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 2.SahaSChadhaMShuYDivergent seasonal patterns of"/>
   <result pre="influenza viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 2.SahaSChadhaMShuYDivergent seasonal patterns of" exact="influenza" post="types A and B across latitude gradient in Tropical"/>
   <result pre="in Tropical AsiaInfluenza Other Respir. Virus.20161017618410.1111/irv.12372 3.YuHet al.Characterization of regional" exact="influenza" post="seasonality patterns in China and implications for vaccination strategies:"/>
   <result pre="5.JinHet al.Multiple amino acid residues confer temperature sensitivity to human" exact="influenza" post="virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793"/>
   <result pre="from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793 6.ChanWZhouHKembleGJinHThe cold adapted and temperature sensitive" exact="influenza" post="A/Ann Arbor/6/60 virus, the master donor virus for live"/>
   <result pre="A/Ann Arbor/6/60 virus, the master donor virus for live attenuated" exact="influenza" post="vaccines, has multiple defects in replication at the restrictive"/>
   <result pre="7.JinHZhouHLuBKembleGImparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34" exact="influenza" post="virus by transferring the genetic signature for temperature sensitivity"/>
   <result pre="sensitivity from cold-adapted A/Ann Arbor/6/60J. Virol.20047899599810.1128/JVI.78.2.995-998.200414694130 8.NotonSLet al.Studies of an" exact="influenza" post="A virus temperature-sensitive mutant identify a late role for"/>
   <result pre="NP in the formation of infectious virionsJ. Virol.20098356257110.1128/JVI.01424-0818987140 9.FengLet al.Seasonal" exact="influenza" post="vaccine supply and target vaccinated population in China, 2004-2009Vaccine2010286778678210.1016/j.vaccine.2010.07.06420688038"/>
   <result pre="supply and target vaccinated population in China, 2004-2009Vaccine2010286778678210.1016/j.vaccine.2010.07.06420688038 10.ZhouLet al.Seasonal" exact="influenza" post="vaccination coverage rate of target groups in selected cities"/>
   <result pre="in China by season (2009/10 to 2011/12)PLoS ONE20138e7372410.1371/journal.pone.007372424040041 11.CarrSet al.Oseltamivir-resistant" exact="influenza" post="A and B viruses pre- and postantiviral therapy in"/>
   <result pre="young adults with cancerPediatr. Infect. Dis. J.20113028428810.1097/INF.0b013e3181ff863b21048522 12.MoncorgeOet al.Investigation of" exact="influenza" post="virus polymerase activity in pig cellsJ. Virol.20138738439410.1128/JVI.01633-1223077313 13.ReganJFLiangYParslowTGDefective assembly"/>
   <result pre="virus polymerase activity in pig cellsJ. Virol.20138738439410.1128/JVI.01633-1223077313 13.ReganJFLiangYParslowTGDefective assembly of" exact="influenza" post="A virus due to a mutation in the polymerase"/>
   <result pre="PAJ. Virol.20068025226110.1128/JVI.80.1.252-261.200616352550 14.Azziz BaumgartnerEet al.Seasonality, timing, and climate drivers of" exact="influenza" post="activity worldwideJ. Infect. Dis.201220683884610.1093/infdis/jis46722829641 15.YaariRKatrielGHuppertAAxelsenJBStoneLModelling seasonal influenza: the role"/>
   <result pre="AsiaBull. World Health Organ20149231833010.2471/BLT.13.12441224839321 18.ParkAWGlassKDynamic patterns of avian and human" exact="influenza" post="in east and southeast AsiaLancet Infect. Dis.2007754354810.1016/S1473-3099(07)70186-X17646027 19.HayashiTWillsSBusseyKATakimotoTIdentification of"/>
   <result pre="influenza in east and southeast AsiaLancet Infect. Dis.2007754354810.1016/S1473-3099(07)70186-X17646027 19.HayashiTWillsSBusseyKATakimotoTIdentification of" exact="influenza" post="A virus PB2 residues involved in enhanced polymerase activity"/>
   <result pre="low temperaturesJ. Virol.2015898042804910.1128/JVI.00901-1526018156 20.WangLet al.FunctionalJ. Virol.2015902938294710.1128/JVI.02400-1526719244 21.Bradel-TrethewayBGet al.The human H5N1" exact="influenza" post="A virus polymerase complex is active in vitro over"/>
   <result pre="coat protein of phage P22Genetics19941364274388150274 23.KawaguchiANagataKDe novo replication of the" exact="influenza" post="virus RNA genome is regulated by DNA replicative helicase,"/>
   <result pre="24.ObayashiEet al.The structural basis for an essential subunit interaction in" exact="influenza" post="virus RNA polymeraseNature20084541127113110.1038/nature0722518660801 25.GhanemAet al.Peptide-mediated interference with influenza A"/>
   <result pre="interaction in influenza virus RNA polymeraseNature20084541127113110.1038/nature0722518660801 25.GhanemAet al.Peptide-mediated interference with" exact="influenza" post="A virus polymeraseJ. Virol.2007817801780410.1128/JVI.00724-0717494067 26.minJYLiSSenGCKrugRMA site on the influenza"/>
   <result pre="with influenza A virus polymeraseJ. Virol.2007817801780410.1128/JVI.00724-0717494067 26.minJYLiSSenGCKrugRMA site on the" exact="influenza" post="A virus NS1 protein mediates both inhibition of PKR"/>
   <result pre="RNA synthesisVirology200736323624310.1016/j.virol.2007.01.03817320139 27.LiFet al.Robust expression of vault RNAs induced by" exact="influenza" post="A virus plays a critical role in suppression of"/>
   <result pre="induced by influenza A virus plays a critical role in" exact="suppression" post="of PKR-mediated innate immunityNucleic Acids Res.201543103211033726490959 28.BalishALKatzJMKlimovAIInfluenza: propagation, quantification,"/>
   <result pre="of Gymnophthalmid lizardsSyst. Biol.20045344846910.1080/1063515049044579715503673 31.Da CostaBet al.Temperature-sensitive mutants in the" exact="influenza" post="A virus RNA polymerase: alterations in the PA linker"/>
   <result pre="protein expressionJ. Virol. Methods200512819219710.1016/j.jviromet.2005.05.00515955576 33.KawakamiEet al.Strand-specific real-time RT-PCR for distinguishing" exact="influenza" post="vRNA, cRNA, and mRNAJ. Virol. Methods20111731610.1016/j.jviromet.2010.12.01421185869 34.WangSet al.Transport of"/>
   <result pre="influenza vRNA, cRNA, and mRNAJ. Virol. Methods20111731610.1016/j.jviromet.2010.12.01421185869 34.WangSet al.Transport of" exact="influenza" post="virus neuraminidase (NA) to host cell surface is regulated"/>
   <result pre="proteinsJ. Biol. Chem.20122879804981610.1074/jbc.M111.31295922318733 35.AlymovaIVet al.Immunopathogenic and antibacterial effects of H3N2" exact="influenza" post="A virus PB1-F2 map to amino acid residues 62,"/>
   <result pre="79, and 82J. Virol.201185123241233310.1128/JVI.05872-1121937639 36.GambaryanASet al.Receptor-binding profiles of H7 subtype" exact="influenza" post="viruses in different host speciesJ. Virol.2012864370437910.1128/JVI.06959-1122345462"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6200010\results\search\disease\results.xml">
   <result pre="2014 (4), and the reported dissemination of dengue (9) and" exact="chikungunya" post="(10) viruses from French Caribbean territories into French Polynesia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6223252\results\search\disease\results.xml">
   <result pre="Tropical pmid: 3042740500402 doi: 10.1590/S1678-9946201860070 : Review Hand, foot and" exact="mouth disease" post="and herpangina caused by enterovirus A71 infections: a review"/>
   <result pre="doi: 10.1590/S1678-9946201860070 : Review Hand, foot and mouth disease and" exact="herpangina" post="caused by enterovirus A71 infections: a review of enterovirus"/>
   <result pre="(EV-A71) infections are one of the main etiological agents of" exact="hand, foot and mouth disease" post="(HFMD) and herpangina worldwide. EV-A71 infection is a life-threatening"/>
   <result pre="one of the main etiological agents of hand, foot and" exact="mouth disease" post="(HFMD) and herpangina worldwide. EV-A71 infection is a life-threatening"/>
   <result pre="etiological agents of hand, foot and mouth disease (HFMD) and" exact="herpangina" post="worldwide. EV-A71 infection is a life-threatening communicable disease and"/>
   <result pre="for the development of an EV-A71 vaccine. Hand, foot and" exact="mouth disease" post="Herpangina Enterovirus A71 Vaccine fig-count: table-count: equation-count: ref-count: INTRODUCTION"/>
   <result pre="ref-count: INTRODUCTION Enterovirus A71 (EV-A71) is an important cause of" exact="hand, foot and mouth disease" post="(HFMD) and herpangina 1 . EV-A71 infects infants and"/>
   <result pre="A71 (EV-A71) is an important cause of hand, foot and" exact="mouth disease" post="(HFMD) and herpangina 1 . EV-A71 infects infants and"/>
   <result pre="important cause of hand, foot and mouth disease (HFMD) and" exact="herpangina" post="1 . EV-A71 infects infants and young children and"/>
   <result pre="is characterized by a febrile illness accompanied by a maculopapular" exact="rash" post="or blisters on the hands, soles of feet and"/>
   <result pre="In 1969, EV-A71 was first isolated from a child with" exact="encephalitis" post="in the USA 14 . Subsequently, several EV-A71 epidemics"/>
   <result pre="38 , a total of 46 children with EV-A71-related brainstem" exact="encephalitis" post="(EBE) were enrolled and subsequently underwent 1.5 Tesla magnetic"/>
   <result pre="infection can lead to severe or fatal disease due to" exact="pulmonary edema." post="The mechanism of pulmonary edema among patients with severe"/>
   <result pre="or fatal disease due to pulmonary edema. The mechanism of" exact="pulmonary edema" post="among patients with severe EV-A71 infection is currently unclear."/>
   <result pre="EV-A71 infection may be an important etiological mechanism of neurogenic" exact="pulmonary edema." post="Virus-host interactions significantly influence viral replication, virulence and pathogenicity"/>
   <result pre="vaccines can prevent more than 90% of EV-A71-associated HFMD or" exact="herpangina" post="and 80% of other EV-A71-associated disease symptoms. It has"/>
   <result pre="vaccinesClin Exp Vaccine Res2017641428168168 2ChenKTChangHLWangSTChengYTYangJYEpidemiologic features of hand-foot-mouth disease and" exact="herpangina" post="caused by enterovirus 71 in Taiwan, 1998-2005Pediatrics2007120e244e25217671037 3ChanKPGohKTChongCYTeoESLauGLingAEEpidemic hand,"/>
   <result pre="and herpangina caused by enterovirus 71 in Taiwan, 1998-2005Pediatrics2007120e244e25217671037 3ChanKPGohKTChongCYTeoESLauGLingAEEpidemic" exact="hand, foot and mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis20039788512533285 4BessaudMRazafindratsimandresyRNougairÃ¨deAJoffretMLDeshpandeJMDubot-PÃ©rÃ¨sAet"/>
   <result pre="by enterovirus 71 in Taiwan, 1998-2005Pediatrics2007120e244e25217671037 3ChanKPGohKTChongCYTeoESLauGLingAEEpidemic hand, foot and" exact="mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis20039788512533285 4BessaudMRazafindratsimandresyRNougairÃ¨deAJoffretMLDeshpandeJMDubot-PÃ©rÃ¨sAet"/>
   <result pre="diversityPLoS One20149e9062424598878 5ChanLGParasharUDLyeMSOngFGZakiSRAlexanderJPet al.Deaths of children during an outbreak of" exact="hand, foot, and mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="al.Deaths of children during an outbreak of hand, foot, and" exact="mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="of enterovirus 71 infection in children during an outbreak of" exact="hand, foot, and mouth disease" post="in Western AustraliaClin Infect Dis20013223624211170913 7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and"/>
   <result pre="infection in children during an outbreak of hand, foot, and" exact="mouth disease" post="in Western AustraliaClin Infect Dis20013223624211170913 7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and"/>
   <result pre="AustraliaClin Infect Dis20013223624211170913 7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and virologic investigation of" exact="hand, foot, and mouth disease," post="southern Vietnam, 2005Emerg Infect Dis2007131733174118217559 8KomatsuHShimizuYTakeuchiYIshikoHTakadaHOutbreak of severe neurologic"/>
   <result pre="7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and virologic investigation of hand, foot, and" exact="mouth disease," post="southern Vietnam, 2005Emerg Infect Dis2007131733174118217559 8KomatsuHShimizuYTakeuchiYIshikoHTakadaHOutbreak of severe neurologic"/>
   <result pre="enterovirus 71 infections and meteorological parameters in TaiwanPLoS One20127e4684523071650 11MaELamTWongCChuangSKIs" exact="hand, foot and mouth disease" post="associated with meteorological parameters?Epidemiol Infect20101381779178820875200 12DowellSFSeasonal variation in host"/>
   <result pre="and meteorological parameters in TaiwanPLoS One20127e4684523071650 11MaELamTWongCChuangSKIs hand, foot and" exact="mouth disease" post="associated with meteorological parameters?Epidemiol Infect20101381779178820875200 12DowellSFSeasonal variation in host"/>
   <result pre="Infect Dis19741293043094361245 15HosoyaMKawasakiYSatoMHonzumiKKatoAHiroshimaTet al.Genetic diversity of enterovirus 71 associated with" exact="hand, foot and mouth disease" post="epidemics in Japan from 1983 to 2003Pediatr Infect Dis"/>
   <result pre="al.Genetic diversity of enterovirus 71 associated with hand, foot and" exact="mouth disease" post="epidemics in Japan from 1983 to 2003Pediatr Infect Dis"/>
   <result pre="Plain of ChinaPLoS One20116e2789522125635 20GeogheganJLTan leVKÃ¼hnertDHalpinRALinXSimenauerAet al.Phylodynamics of enterovirus A71-associated" exact="hand, foot, and mouth disease" post="in Viet NamJ Virol2015898871887926085170 21ChumakovMVoroshilovaMShindarovLLavrovaIGrachevaLKorolevaGet al.Enterovirus 71 isolated from"/>
   <result pre="One20116e2789522125635 20GeogheganJLTan leVKÃ¼hnertDHalpinRALinXSimenauerAet al.Phylodynamics of enterovirus A71-associated hand, foot, and" exact="mouth disease" post="in Viet NamJ Virol2015898871887926085170 21ChumakovMVoroshilovaMShindarovLLavrovaIGrachevaLKorolevaGet al.Enterovirus 71 isolated from"/>
   <result pre="53OngKCDeviSCardosaMJWongKTFormaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71" exact="encephalomyelitis" post="against diseaseJ Virol20108466166519864378 54LiuLZhangYWangJZhaoHJiangLCheYet al.Study of the integrated immune"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6251852\results\search\disease\results.xml">
   <result pre="Abstract Chikungunya (CHIK) is an arboviral infection caused by the" exact="chikungunya" post="virus. An unusual feature of CHIK is its long"/>
   <result pre="range from a mild self-limiting febrile illness with arthralgia and" exact="rash" post="to crippling acute and lingering debilitating arthritis. In about"/>
   <result pre="of CHIK across the globe. Keywords Arboviral infection Chikungunya Inflammatory" exact="arthritis" post="Introduction Chikungunya (CHIK) is an arboviral infection caused by"/>
   <result pre="Introduction Chikungunya (CHIK) is an arboviral infection caused by the" exact="chikungunya" post="virus (CHIKV), belonging to the family Togaviridae and genus"/>
   <result pre="Manifestations of CHIK range from a mild self-limiting fever with" exact="rash" post="and arthralgia to severe crippling acute debilitating arthritis. Musculoskeletal"/>
   <result pre="before apparently disappearing for several years to decades. Also, unlike" exact="dengue fever," post="with CHIK the dearth of asymptomatic infections leads to"/>
   <result pre="switching and has been speculated to be associated with persistent" exact="arthritis" post="in CHIKV [26]. Clinical Features Clinical manifestations of CHIK"/>
   <result pre="the large joints, such as the knee and shoulder. CHIK" exact="arthritis" post="has also a predilection to affect both early and"/>
   <result pre="are extremely tender to touch in many patients [30]. The" exact="arthritis" post="persists for varying periods of time. In the pervious"/>
   <result pre="time. In the pervious study conducted by the authors, the" exact="arthritis" post="resolved within 1 week in 25% of patients and"/>
   <result pre="with or without tenderness is a common feature of CHIK" exact="arthritis" post="and close to 90% patients in the authorsâ€™ study"/>
   <result pre="authorsâ€™ previous study, the most common joints affected with chronic" exact="arthritis" post="were the ankle (63%), followed by the knee (55%)"/>
   <result pre="arthritis. Apart from chronic arthritis, CHIK can evolve or precipitate" exact="rheumatoid arthritis," post="as was noted by the authors in 5% of"/>
   <result pre="manifestations are a prominent feature of CHIK fever. Transient maculopapular" exact="rash" post="may be seen in approximately 50% patients [27]. Nasal"/>
   <result pre="centrofacial hyperpigmentation, lichenoid eruptions, hyperpigmentation in photodistributed areas and exfoliative" exact="dermatitis" post="are other dermatological manifestations observed [27]. In the authorsâ€™"/>
   <result pre="other dermatological manifestations observed [27]. In the authorsâ€™ previous study," exact="rash" post="was present in 68% patients, which was erythematous (45%),"/>
   <result pre="(42%) and papular in pattern (20%) [28]. An unusual centrofacial" exact="rash" post="was observed in 21% patients, which began as an"/>
   <result pre="was observed in 21% patients, which began as an erythematous" exact="rash" post="at the tip of the nose and malar eminences"/>
   <result pre="and malar eminences and later became hyperpigmented, resembling the malar" exact="rash" post="of systemic lupus erythematosus. Desquamation of ear lobules, palms"/>
   <result pre="eminences and later became hyperpigmented, resembling the malar rash of" exact="systemic lupus erythematosus." post="Desquamation of ear lobules, palms and soles was observed"/>
   <result pre="and later became hyperpigmented, resembling the malar rash of systemic" exact="lupus erythematosus." post="Desquamation of ear lobules, palms and soles was observed"/>
   <result pre="observed in 26% of patients, and pruritus with or without" exact="rash" post="was seen in 29% [28]. Mucosal lesions in the"/>
   <result pre="lesions in the form of aphthous ulcers, lip ulcers and" exact="glossitis" post="were also observed [28]. Other systemic manifestations of CHIK"/>
   <result pre="systemic manifestations of CHIK include headache, asthenia, myalgia, vomiting and" exact="lymphadenopathy" post="[28, 31]. Although alphaviruses are notorious in causing neurological"/>
   <result pre="usually mild in these cases, with fever, irritability and bullous" exact="dermatitis" post="[7, 27]. Diagnosis Laboratory Diagnosis As there is considerable"/>
   <result pre="common Retro-orbital pain Less common More common Characteristic pattern of" exact="rash" post="Centrofacial hyperpigmentation Erythematous maculo-papular â€œWhite Islands in Red Seaâ€�"/>
   <result pre="reveal lymphopenia consistent with that of a viral fever. However," exact="thrombocytopenia" post="is not a prominent finding and its presence would"/>
   <result pre="finding and its presence would help to differentiate CHIK from" exact="dengue fever" post="[27]. Also, the erythrocyte sedimentation rate and acute phase"/>
   <result pre="onset of fever and severe arthralgia/arthritis with or without skin" exact="rash" post="and residence in an epidemic area or having been"/>
   <result pre="Chloroquine phosphate (CQ) has been used effectively to manage CHIKV" exact="arthritis" post="[36]. In a previous study, the authors used hydroxychloroquine"/>
   <result pre="compared to sulfasalazine alone in patients with chronic persistent CHIK" exact="arthritis" post="not responding to NSAIDs and HCQ for 3 months"/>
   <result pre="initial therapy [40]. The role of DMARDs in acute CHIK" exact="arthritis" post="is uncertain. HCQ takes weeks to produce its effect,"/>
   <result pre="takes weeks to produce its effect, by which time the" exact="arthritis" post="has resolved in the majority of patients. Also, the"/>
   <result pre="effects if used early in the disease course before the" exact="arthritis" post="self-remits [7]. In one study, ribavarin 200Â mg twice"/>
   <result pre="the viral persistence and progression of the disease into disabling" exact="arthritis" post="is a realistic goal. Newer research avenues with the"/>
   <result pre="Health Organization; 2013. http://www.who.int/mediacentre/factsheets/fs32. 4.SudeepABParasharDChikungunya: an overviewJ Biosci20083344344910.1007/s12038-008-0063-219208970 5.LahariyaCPradhanSKEmergence of" exact="chikungunya" post="infection in India after 32Â years: a reviewJ Vect"/>
   <result pre="of dengue and chikungunyaIndian J Med Res200612447548017213513 19.McIntoshBMJuppPGAttempts to transmit" exact="chikungunya" post="virus with six species of mosquitoJ Med Ent1970761561810.1093/jmedent/7.5.615 20.PradeepKJosephRKamarajTJambulingamPA226V"/>
   <result pre="of mosquitoJ Med Ent1970761561810.1093/jmedent/7.5.615 20.PradeepKJosephRKamarajTJambulingamPA226V mutation in virus during 2007" exact="chikungunya" post="outbreak in Kerala, IndiaJ Gen Virol2008891945194810.1099/vir.0.83628-018632966 21.GÃ©rardinPBarauGMichaultAet al.Multidisciplinary prospective"/>
   <result pre="Kerala, IndiaJ Gen Virol2008891945194810.1099/vir.0.83628-018632966 21.GÃ©rardinPBarauGMichaultAet al.Multidisciplinary prospective study of mother-to-child" exact="chikungunya" post="virus infections on the island of La RÃ©unionPLoS Med.20085e6010.1371/journal.pmed.005006018351797"/>
   <result pre="virus infectionAm J Trop Med200879113313910.4269/ajtmh.2008.79.133 24.SchilteCCoudercTChretienFet al.Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cellsJ Exp Med2010207242944210.1084/jem.2009085120123960"/>
   <result pre="reunion: epidemiology and surveillanceEuro Surveill200611210.2807/esm.11.12.00665-en 31.CeciliaDCurrent status of dengue and" exact="chikungunya" post="in IndiaWHO South-East Asia J Public Health.2014312210.4103/2224-3151.20687928607250 32.SebastianMLodhaRKabraSChikungunya infection"/>
   <result pre="cytokine response in patients with early persistent musculoskeletal pain and" exact="arthritis" post="following chikungunya virus infectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 38.RavindranVinodAliasGeorgeEfficacy of combination DMARD"/>
   <result pre="in patients with early persistent musculoskeletal pain and arthritis following" exact="chikungunya" post="virus infectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 38.RavindranVinodAliasGeorgeEfficacy of combination DMARD therapy vs."/>
   <result pre="of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent" exact="chikungunya" post="arthritis: a 24-week randomized controlled open label studyClinical Rheumatology20163661335134010.1007/s10067-016-3429-027699657"/>
   <result pre="upJ Assoc Phys India2011598386 40.SimonFJavelleECabieAet al.French guidelines for management of" exact="chikungunya" post="(acute and persistent presentations), November 2014Med Mal Infect.20154524326310.1016/j.medmal.2015.05.00726119684 41.RavichandranRManianMRibavirin"/>
   <result pre="41.RavichandranRManianMRibavirin therapy for Chikungunya arthritisJ Infect Dev Ctries.2008214014210.3855/T2.2.14019738340 42.RulliNERolphMSSrikiatkhachornAAnantapreechaSGuglielmottiAMahalingamSProtection from" exact="arthritis" post="and myositis in a mouse model of acute chikungunya"/>
   <result pre="for Chikungunya arthritisJ Infect Dev Ctries.2008214014210.3855/T2.2.14019738340 42.RulliNERolphMSSrikiatkhachornAAnantapreechaSGuglielmottiAMahalingamSProtection from arthritis and" exact="myositis" post="in a mouse model of acute chikungunya virus disease"/>
   <result pre="from arthritis and myositis in a mouse model of acute" exact="chikungunya" post="virus disease by bindarit, an inhibitor of monocyte chemotactic"/>
   <result pre="autophagy-inducing peptideNature201349420120610.1038/nature1186623364696 45.WangYLuJLinCet al.Antiviral activities of niclosamide and nitazoxanide against" exact="chikungunya" post="virus entry and transmissionAntiviral Res2016135819010.1016/j.antiviral.2016.10.00327742486 46.HoYWangYLuJet al.Suramin inhibits chikungunya"/>
   <result pre="against chikungunya virus entry and transmissionAntiviral Res2016135819010.1016/j.antiviral.2016.10.00327742486 46.HoYWangYLuJet al.Suramin inhibits" exact="chikungunya" post="virus entry and transmissionPLoS One2015107e013351110.1371/journal.pone.013351126208101 47.LounibosLPKramerLDInvasiveness of Aedes aegypti"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6254586\results\search\disease\results.xml">
   <result pre="doi: 10.2147/IDR.S179517idr-11-2411 : Original Research Epidemiological and molecular analysis of" exact="avian influenza" post="A(H7N9) virus in Shanghai, China, 2013â€&quot;2017 WangSeong Jin123LiuXue Wei1ShenXiaojuan12HuaXiu"/>
   <result pre="10.2147/IDR.S179517idr-11-2411 : Original Research Epidemiological and molecular analysis of avian" exact="influenza" post="A(H7N9) virus in Shanghai, China, 2013â€&quot;2017 WangSeong Jin123LiuXue Wei1ShenXiaojuan12HuaXiu"/>
   <result pre="is properly attributed. Abstract Background Human infections with a novel" exact="avian influenza" post="A virus (H7N9) were reported in Shanghai municipality, China,"/>
   <result pre="properly attributed. Abstract Background Human infections with a novel avian" exact="influenza" post="A virus (H7N9) were reported in Shanghai municipality, China,"/>
   <result pre="in Shanghai municipality, China, at the beginning of 2013. High-pathogenic" exact="avian influenza" post="(HPAI) H7N9 virus emerged in late February 2017 along"/>
   <result pre="Shanghai municipality, China, at the beginning of 2013. High-pathogenic avian" exact="influenza" post="(HPAI) H7N9 virus emerged in late February 2017 along"/>
   <result pre="virus emerged in late February 2017 along with existing low-pathogenic" exact="avian influenza" post="(LPAI) H7N9 virus, and this has the potential to"/>
   <result pre="emerged in late February 2017 along with existing low-pathogenic avian" exact="influenza" post="(LPAI) H7N9 virus, and this has the potential to"/>
   <result pre="to human-type receptors, with the characteristics of high-virulence and low-pathogenic" exact="influenza" post="viruses. Furthermore, our findings suggest that the Shanghai chicken"/>
   <result pre="of the outbreak of human infection caused by a novel" exact="avian influenza" post="A H7N9 virus [A(H7N9) virus] in Shanghai, China, in"/>
   <result pre="the outbreak of human infection caused by a novel avian" exact="influenza" post="A H7N9 virus [A(H7N9) virus] in Shanghai, China, in"/>
   <result pre="circulating among poultry in China had been categorized as low-pathogenic" exact="avian influenza" post="(LPAI), and the infected poultry showed no symptoms.3 Since"/>
   <result pre="among poultry in China had been categorized as low-pathogenic avian" exact="influenza" post="(LPAI), and the infected poultry showed no symptoms.3 Since"/>
   <result pre="2017, in the fifth epidemic, the appearance of a high-pathogenic" exact="avian influenza" post="(HPAI) A(H7N9) virus infection in humans was first reported"/>
   <result pre="in the fifth epidemic, the appearance of a high-pathogenic avian" exact="influenza" post="(HPAI) A(H7N9) virus infection in humans was first reported"/>
   <result pre="A(H7N9) viruses because migratory shorebirds are a natural reservoir for" exact="avian influenza" post="virus.11â€&quot;13 Several coastal wetland areas, which are significant congregation"/>
   <result pre="viruses because migratory shorebirds are a natural reservoir for avian" exact="influenza" post="virus.11â€&quot;13 Several coastal wetland areas, which are significant congregation"/>
   <result pre="in Shanghai, increasing the risk of the emergence of novel" exact="influenza" post="viruses.14 It should be noted that the first case"/>
   <result pre="(SHMCHFP) from 1 January 2013 to 31 December 2017. Avian" exact="influenza" post="reports published by the Department of Health, Government of"/>
   <result pre="PA, are regarded as essential for mammalian adaptation of the" exact="avian influenza" post="virus.19â€&quot;21 E627K mutations in the PB2 protein occurred in"/>
   <result pre="are regarded as essential for mammalian adaptation of the avian" exact="influenza" post="virus.19â€&quot;21 E627K mutations in the PB2 protein occurred in"/>
   <result pre="surface receptor, which is believed to play important roles in" exact="influenza" post="infection. It is noteworthy that a single amino acid"/>
   <result pre="prevention could be more effective than nationwide policies in controlling" exact="infectious disease." post="WHO and Chinese experts assessed that quarantine measures conducted"/>
   <result pre="A(H7N9) viruses circulating within Shanghai belong to high-virulence and low-pathogenic" exact="influenza" post="viruses, considering their NA deletion (positions 69â€&quot;73) and the"/>
   <result pre="H7N9 Avian Viruses in Mainland ChinaJ Virol20179123 3WangXJiangHWuPet al.Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="Avian Viruses in Mainland ChinaJ Virol20179123 3WangXJiangHWuPet al.Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="Dis201717882283228583578 4PeirisJSCowlingBJWuJTet al.Interventions to reduce zoonotic and pandemic risks from" exact="avian influenza" post="in AsiaLancet Infect Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging"/>
   <result pre="4PeirisJSCowlingBJWuJTet al.Interventions to reduce zoonotic and pandemic risks from avian" exact="influenza" post="in AsiaLancet Infect Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging"/>
   <result pre="Infect Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging highly pathogenic H7N9" exact="avian influenza" post="virus in ChinaJ Infect2017751717528390707 6QuanCShiWYangYet al.New Threats from H7N9"/>
   <result pre="Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging highly pathogenic H7N9 avian" exact="influenza" post="virus in ChinaJ Infect2017751717528390707 6QuanCShiWYangYet al.New Threats from H7N9"/>
   <result pre="Epidemic - China, October 2016-February 2017MMWR201766925425528278147 9ZhuYQiXCuiLZhouMWangHHuman co-infection with novel" exact="avian influenza" post="A H7N9 and influenza A H3N2 viruses in Jiangsu"/>
   <result pre="- China, October 2016-February 2017MMWR201766925425528278147 9ZhuYQiXCuiLZhouMWangHHuman co-infection with novel avian" exact="influenza" post="A H7N9 and influenza A H3N2 viruses in Jiangsu"/>
   <result pre="2017MMWR201766925425528278147 9ZhuYQiXCuiLZhouMWangHHuman co-infection with novel avian influenza A H7N9 and" exact="influenza" post="A H3N2 viruses in Jiangsu province, ChinaLancet20133819883213423769236 10KileJCRenRLiuLet al.Update:"/>
   <result pre="2016â€&quot;August 7, 2017MMWR2017663592893228880856 11GaoRCaoBHuYet al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN Engl J Med2013368201888189723577628 12CapuaIAlexanderDJAvian influenza: recent"/>
   <result pre="influenza: recent developmentsAvian Pathol200433439340415370036 13AlvarezPMattielloRRivaillerPet al.First isolation of an H1N1" exact="avian influenza" post="virus from wild terrestrial non-migratory birds in ArgentinaVirology20103961768419896684 14BaiQChenJChenZZengQIdentification"/>
   <result pre="recent developmentsAvian Pathol200433439340415370036 13AlvarezPMattielloRRivaillerPet al.First isolation of an H1N1 avian" exact="influenza" post="virus from wild terrestrial non-migratory birds in ArgentinaVirology20103961768419896684 14BaiQChenJChenZZengQIdentification"/>
   <result pre="Bigger DatasetsMol Biol Evol20163371870187427004904 17XiongXMartinSRHaireLFet al.Receptor binding by an H7N9" exact="influenza" post="virus from humansNature2013499745949649923787694 18MunierSLarcherTCormier-AlineFet al.A genetically engineered waterfowl influenza"/>
   <result pre="H7N9 influenza virus from humansNature2013499745949649923787694 18MunierSLarcherTCormier-AlineFet al.A genetically engineered waterfowl" exact="influenza" post="virus with a deletion in the stalk of the"/>
   <result pre="Respiratory TractScience2006312577239916556800 20LiZChenHJiaoPet al.Molecular basis of replication of duck H5N1" exact="influenza" post="viruses in a mammalian mouse modelJ Virol20057918120581206416140781 21RenLYuXZhaoBet al.Infection"/>
   <result pre="mammalian mouse modelJ Virol20057918120581206416140781 21RenLYuXZhaoBet al.Infection with possible precursor of" exact="avian influenza" post="A(H7N9) virus in a child, China, 2013Emerg Infect Dis20142081362136525061975"/>
   <result pre="mouse modelJ Virol20057918120581206416140781 21RenLYuXZhaoBet al.Infection with possible precursor of avian" exact="influenza" post="A(H7N9) virus in a child, China, 2013Emerg Infect Dis20142081362136525061975"/>
   <result pre="child, China, 2013Emerg Infect Dis20142081362136525061975 22RogersGNPaulsonJCDanielsRSSkehelJJWilsonIAWileyDCSingle amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificityNature1983304592176786191220 23ImaiMWatanabeTHattaMet al.Experimental adaptation of"/>
   <result pre="haemagglutinin change receptor binding specificityNature1983304592176786191220 23ImaiMWatanabeTHattaMet al.Experimental adaptation of an" exact="influenza" post="H5 haemagglutinin (HA) confers respiratory droplet transmission to a"/>
   <result pre="HA/H1N1 virus in ferretsNature2012486740342042822722205 24WangDYangLGaoRet al.Genetic tuning of the novel" exact="avian influenza" post="A(H7N9) virus during interspecies transmission, China, 2013Euro Surveill20141925 25LamTTHonCCTangJWUse"/>
   <result pre="virus in ferretsNature2012486740342042822722205 24WangDYangLGaoRet al.Genetic tuning of the novel avian" exact="influenza" post="A(H7N9) virus during interspecies transmission, China, 2013Euro Surveill20141925 25LamTTHonCCTangJWUse"/>
   <result pre="viral infectionsCrit Rev Clin Lab Sci201047154920367503 26WebsterRGBeanWJGormanOTChambersTMKawaokaYEvolution and ecology of" exact="influenza" post="A virusesMicrobiol Rev19925611521791579108 27SchrauwenEJHerfstSLeijtenLMet al.The multibasic cleavage site in"/>
   <result pre="in ferretsJ Virol20128673975398422278228 28ShinyaKMakinoAHattaMet al.Subclinical brain injury caused by H5N1" exact="influenza" post="virus infectionJ Virol201185105202520721389133 29ShinyaKMakinoATanakaHet al.Systemic dissemination of H5N1 influenza"/>
   <result pre="H5N1 influenza virus infectionJ Virol201185105202520721389133 29ShinyaKMakinoATanakaHet al.Systemic dissemination of H5N1" exact="influenza" post="A viruses in ferrets and hamsters after direct intragastric"/>
   <result pre="for a correlation of hemagglutinin cleavability and virulence of an" exact="avian influenza" post="A virusJ Virol1994685312031288151777 31McKimm-BreschkinJTrivediTHampsonAet al.Neuraminidase sequence analysis and susceptibilities"/>
   <result pre="a correlation of hemagglutinin cleavability and virulence of an avian" exact="influenza" post="A virusJ Virol1994685312031288151777 31McKimm-BreschkinJTrivediTHampsonAet al.Neuraminidase sequence analysis and susceptibilities"/>
   <result pre="A virusJ Virol1994685312031288151777 31McKimm-BreschkinJTrivediTHampsonAet al.Neuraminidase sequence analysis and susceptibilities of" exact="influenza" post="virus clinical isolates to zanamivir and oseltamivirAntimicrob Agents Chemother20034772264227212821478"/>
   <result pre="and virology of mild, severe and fatal human infections with" exact="avian influenza" post="A (H7N9) virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human"/>
   <result pre="virology of mild, severe and fatal human infections with avian" exact="influenza" post="A (H7N9) virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human"/>
   <result pre="(H7N9) virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human infection with" exact="avian influenza" post="A(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human infection with avian" exact="influenza" post="A(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="Pac Surveill Response J201781614 34LiQZhouLZhouMet al.Epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in ChinaN Engl J Med2014370652053223614499 35SuSGuMLiuDet al.Epidemiology,"/>
   <result pre="Surveill Response J201781614 34LiQZhouLZhouMet al.Epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in ChinaN Engl J Med2014370652053223614499 35SuSGuMLiuDet al.Epidemiology,"/>
   <result pre="in ChinaTrends Microbiol201725971372828734617 36ShenYLuHQiTet al.Fatal cases of human infection with" exact="avian influenza" post="A (H7N9) virus in Shanghai, China in 2013Biosci Trends201591737825787912"/>
   <result pre="ChinaTrends Microbiol201725971372828734617 36ShenYLuHQiTet al.Fatal cases of human infection with avian" exact="influenza" post="A (H7N9) virus in Shanghai, China in 2013Biosci Trends201591737825787912"/>
   <result pre="Family PlanningPrevention and control measures of Human infection with H7N9" exact="influenza" post="virus in Shanghai municipalityAvailable from: http://www.wsjsw.gov.cn/xwfb/20180525/35470.htmlAccessed November 13, 2018Chinese"/>
   <result pre="Care Med201637450151127486732 39HeYLiuPTangSet al.Live poultry market closure and control of" exact="avian influenza" post="A(H7N9), Shanghai, ChinaEmerg Infect Dis20142091565156625148432 40collab: Shanghai Municipal Agricultural"/>
   <result pre="Med201637450151127486732 39HeYLiuPTangSet al.Live poultry market closure and control of avian" exact="influenza" post="A(H7N9), Shanghai, ChinaEmerg Infect Dis20142091565156625148432 40collab: Shanghai Municipal Agricultural"/>
   <result pre="from: http://www.gov.cn/jrzg/2013-04/23/content_2386475.htmAccessed November 13, 2018Chinese Figure 1 Confirmed cases of" exact="avian influenza" post="A(H7N9) virus infections in humans, birds, and the environment"/>
   <result pre="http://www.gov.cn/jrzg/2013-04/23/content_2386475.htmAccessed November 13, 2018Chinese Figure 1 Confirmed cases of avian" exact="influenza" post="A(H7N9) virus infections in humans, birds, and the environment"/>
   <result pre="Publicly released infections in the Disease Outbreak News (http://www.who.int/csr/don/en/) or" exact="avian influenza" post="report issued by the Department of Health, Government of"/>
   <result pre="released infections in the Disease Outbreak News (http://www.who.int/csr/don/en/) or avian" exact="influenza" post="report issued by the Department of Health, Government of"/>
   <result pre="2 Age, gender, and death distributions of confirmed cases of" exact="avian influenza" post="A(H7N9) virus infection during the five epidemics in Shanghai,"/>
   <result pre="Age, gender, and death distributions of confirmed cases of avian" exact="influenza" post="A(H7N9) virus infection during the five epidemics in Shanghai,"/>
   <result pre="circle. Abbreviation: NA, neuraminidase. Table 1 Confirmed human cases of" exact="avian influenza" post="A(H7N9) virus in Shanghai as of 31 December 2017"/>
   <result pre="Abbreviation: NA, neuraminidase. Table 1 Confirmed human cases of avian" exact="influenza" post="A(H7N9) virus in Shanghai as of 31 December 2017"/>
   <result pre="2 Amino acid homology (%) of the eight genes of" exact="avian influenza" post="A(H7N9) virus strains in Shanghai, China, 2013â€&quot;2017 HA NA"/>
   <result pre="Amino acid homology (%) of the eight genes of avian" exact="influenza" post="A(H7N9) virus strains in Shanghai, China, 2013â€&quot;2017 HA NA"/>
   <result pre="(%) of the surface HA and NA proteins between the" exact="avian influenza" post="A(H7N9) Shanghai strains and WHO-recommended vaccine candidates A/Anhui/1/2013 A/Shanghai/02/2013"/>
   <result pre="of the surface HA and NA proteins between the avian" exact="influenza" post="A(H7N9) Shanghai strains and WHO-recommended vaccine candidates A/Anhui/1/2013 A/Shanghai/02/2013"/>
   <result pre="NA, neuraminidase. Table 4 Characterization of key molecular markers of" exact="avian influenza" post="A(H7N9) viruses in Shanghai, 2013â€&quot;2017 Gene Function Mutation Amino"/>
   <result pre="neuraminidase. Table 4 Characterization of key molecular markers of avian" exact="influenza" post="A(H7N9) viruses in Shanghai, 2013â€&quot;2017 Gene Function Mutation Amino"/>
   <result pre="Amino acid Human Non-human Total HA* Increased binding to human-type" exact="influenza" post="receptor G186V G 3 2 5 V 25 25"/>
   <result pre="â†&quot;, cleavage site. Table 5 Signature amino acid mutations of" exact="avian influenza" post="A(H7N9) viruses in Shanghai with WHO-recommended vaccine candidates, 2013â€&quot;2017"/>
   <result pre="cleavage site. Table 5 Signature amino acid mutations of avian" exact="influenza" post="A(H7N9) viruses in Shanghai with WHO-recommended vaccine candidates, 2013â€&quot;2017"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6256408\results\search\disease\results.xml">
   <result pre="historical and current data regarding the reemergence of St. Louis" exact="encephalitis" post="virus (SLEV; genus Flavivirus) in the Americas. Historically, SLEV"/>
   <result pre="virus (SLEV; genus Flavivirus) in the Americas. Historically, SLEV caused" exact="encephalitis" post="outbreaks in the United States; however, it was not"/>
   <result pre="is related to the epidemic strains isolated during a human" exact="encephalitis" post="outbreak in CÃ³rdoba, Argentina, in 2005. Ecoepidemiologic studies suggest"/>
   <result pre="populations of the eared dove (amplifying host). Keywords: St. Louis" exact="encephalitis" post="virus emerging infectious disease phylogeography arbovirus viruses United States"/>
   <result pre="eared dove (amplifying host). Keywords: St. Louis encephalitis virus emerging" exact="infectious disease" post="phylogeography arbovirus viruses United States Americas South America The"/>
   <result pre="States Americas South America The disease known as St. Louis" exact="encephalitis" post="(SLE) is caused by St. Louis encephalitis virus (SLEV),"/>
   <result pre="as St. Louis encephalitis (SLE) is caused by St. Louis" exact="encephalitis" post="virus (SLEV), identified as the causative agent of a"/>
   <result pre="(Figure 1). Figure 1 Geographic distribution of historical St. Louis" exact="encephalitis" post="human cases reported in the Americas through November 2017."/>
   <result pre="a febrile human suspected to have Argentinean hemorrhagic fever. Human" exact="encephalitis" post="cases were reported sporadically until 2005, when an unprecedented"/>
   <result pre="was detected (Spearman coefficientÂ =Â 0.74) (22). The frequency of" exact="encephalomyelitis" post="varied from 80% of the cases in patients &amp;lt;20"/>
   <result pre="expansion (29). Figure 2 Phylogeny and spread of St. Louis" exact="encephalitis" post="virus (SLEV) in the Americas. A) Multiple sequence alignment"/>
   <result pre="fluid. All SLEV-infected patients (6) had an initial diagnosis of" exact="dengue fever" post="or viral encephalitis; 3 cases were diagnosed as viral"/>
   <result pre="viral meningoencephalitis, and the other 3 patients had signs of" exact="hemorrhagic disease" post="(32). This finding was the first reported link of"/>
   <result pre="was the first reported link of SLE infection and human" exact="hemorrhagic disease" post="(32). A blastn analysis (https://blast.ncbi.nlm.nih.gov/Blast.cgi) comparing genomes of different"/>
   <result pre="in Kern County during a 1952 outbreak of Western equine" exact="encephalitis" post="virus (33). SLEV caused periodic epidemics in humans and"/>
   <result pre="by metagenomic next-generation sequencing to diagnose a fatal case of" exact="meningoencephalitis" post="from SLEV in a patient from Kern County, California,"/>
   <result pre="viruses, including dengue (emerged in 1990), WNV (emerged in 1999)," exact="chikungunya" post="(2013), and Zika viruses (2015), have emerged as public"/>
   <result pre="Coffey LL, Burkett-Cadena N, Day JF. Reemergence of St. Louis" exact="encephalitis" post="virus in the Americas. Emerg Infect Dis. 2018 Dec"/>
   <result pre="and viruses. References References 1. ReisenWK. Epidemiology of St. Louis" exact="encephalitis" post="virus.Adv Virus Res. 2003;61:139â€&quot;83. 10.1016/S0065-3527(03)61004-314714432 2. RodriguesSG, NunesMR, CassebSM,"/>
   <result pre="CassebSM, PrazeresAS, RodriguesDS, SilvaMO, et al.Molecular epidemiology of Saint Louis" exact="encephalitis" post="virus in the Brazilian Amazon: genetic divergence and dispersal.J"/>
   <result pre="1997. p. 1133â€&quot;86. 5. DayJF, StarkLM. Frequency of Saint Louis" exact="encephalitis" post="virus in humans from Florida, USA: 1990-1999.J Med Entomol."/>
   <result pre="and oviposition before, during and after a widespread St. Louis" exact="encephalitis" post="epidemic in Florida.J Med Entomol. 1999;36:176â€&quot;81. 10.1093/jmedent/36.2.17610083754 7. DayJF."/>
   <result pre="Florida.J Med Entomol. 1999;36:176â€&quot;81. 10.1093/jmedent/36.2.17610083754 7. DayJF. Predicting St. Louis" exact="encephalitis" post="virus epidemics: lessons from recent, and not so recent,"/>
   <result pre="10.1146/annurev.ento.46.1.11111112165 8. ShamanJ, DayJF, StieglitzM. Drought-induced amplification of Saint Louis" exact="encephalitis" post="virus, Florida.Emerg Infect Dis. 2002;8:575â€&quot;80. 10.3201/eid0806.01041712023912 9. EpsteinPR, DefilippoC."/>
   <result pre="FangY, ReisenWK. Previous infection with West Nile or St. Louis" exact="encephalitis" post="viruses provides cross protection during reinfection in house finches.Am"/>
   <result pre="West Nile virus on the natural history of St. Louis" exact="encephalitis" post="virus in Florida [dissertation]. Tampa (FL): University of South"/>
   <result pre="https://scholarcommons.usf.edu/cgi/viewcontent.cgi?referer=https://www.google.com/&amp;amp;httpsredir=1&amp;amp;article=1437&amp;amp;context=etd 14. DayJF, StarkLM. Avian serology in a St. Louis" exact="encephalitis" post="epicenter before, during, and after a widespread epidemic in"/>
   <result pre="FangY, GreenEN. Experimental infection of California birds with western equine" exact="encephalomyelitis" post="and St. Louis encephalitis viruses.J Med Entomol. 2003;40:968â€&quot;82. 10.1603/0022-2585-40.6.96814765678"/>
   <result pre="of California birds with western equine encephalomyelitis and St. Louis" exact="encephalitis" post="viruses.J Med Entomol. 2003;40:968â€&quot;82. 10.1603/0022-2585-40.6.96814765678 17. ReisenWK, LothropHD, WheelerSS,"/>
   <result pre="West Nile virus transmission and the apparent displacement St. Louis" exact="encephalitis" post="virus in southeastern California, 2003-2006.J Med Entomol. 2008;45:494â€&quot;508.18533445 18."/>
   <result pre="19. collab: Centers for Disease Control and Prevention. Saint Louis" exact="encephalitis" post="virus: epidemiology and geographic distribution; 2017 [cited 2018 Jul"/>
   <result pre="Med Argent. 1968;82:267â€&quot;9. 21. MettlerNE, CasalsJ. Isolation of St. Louis" exact="encephalitis" post="virus from man in Argentina.Acta Virol. 1971;15:148â€&quot;54.4396413 22. SpinsantiLI,"/>
   <result pre="GlatsteinN, ArselÃ¡nS, MoralesMA, FarÃ­asAA, et al.Human outbreak of St. Louis" exact="encephalitis" post="detected in Argentina, 2005.J Clin Virol. 2008;42:27â€&quot;33. 10.1016/j.jcv.2007.11.02218249032 23."/>
   <result pre="RÃ©V, AlmirÃ³nWR, FarÃ­asA, VÃ¡zquezA, Sanchez-SecoMP, et al.Genotype III Saint Louis" exact="encephalitis" post="virus outbreak, Argentina, 2005.Emerg Infect Dis. 2006;12:1752â€&quot;4. 10.3201/eid1211.06048617283629 24."/>
   <result pre="Albrieu LlinÃ¡sG, VÃ¡zquezA, TenorioA, ContigianiMS. Silent circulation of St. Louis" exact="encephalitis" post="virus prior to an encephalitis outbreak in Cordoba, Argentina"/>
   <result pre="Silent circulation of St. Louis encephalitis virus prior to an" exact="encephalitis" post="outbreak in Cordoba, Argentina (2005).PLoS Negl Trop Dis. 2012;6:e1489."/>
   <result pre="10.1371/journal.pntd.000148922303490 25. DiazLA, NemethNM, BowenRA, AlmironWR, ContigianiMS. Comparison of argentinean" exact="saint louis encephalitis" post="virus non-epidemic and epidemic strain infections in an avian"/>
   <result pre="DiazLA, NemethNM, BowenRA, AlmironWR, ContigianiMS. Comparison of argentinean saint louis" exact="encephalitis" post="virus non-epidemic and epidemic strain infections in an avian"/>
   <result pre="Virulence variation among epidemic and non-epidemic strains of Saint Louis" exact="encephalitis" post="virus circulating in Argentina.Mem Inst Oswaldo Cruz. 2014;109:197â€&quot;201. 10.1590/0074-027613047524810175"/>
   <result pre="KonigheimBS, BorisAS, AguilarJJ, KomarN, et al.Activity patterns of St. Louis" exact="encephalitis" post="and West Nile viruses in free ranging birds during"/>
   <result pre="West Nile viruses in free ranging birds during a human" exact="encephalitis" post="outbreak in Argentina.PLoS One. 2016;11:e0161871. 10.1371/journal.pone.016187127564679 28. DÃ­azA, FloresFS,"/>
   <result pre="of Argentinean bird species as amplifying hosts for St. Louis" exact="encephalitis" post="virus (Flavivirus, Flaviviridae).Am J Trop Med Hyg. 2018;99:216â€&quot;21. 10.4269/ajtmh.17-085629761767"/>
   <result pre="BarreroPR, ViegasM, Alvarez LÃ³pezMC, MistchenkoAS. Molecular evidence of St. Louis" exact="encephalitis" post="virus infection in patients in Buenos Aires, Argentina.J Clin"/>
   <result pre="SantosCL, SallumMA, FrancoHM, OshiroFM, RoccoIM. Genetic characterization of St. Louis" exact="encephalitis" post="virus isolated from human in SÃ£o Paulo, Brazil.Mem Inst"/>
   <result pre="32. MondiniA, CardealIL, LÃ¡zaroE, NunesSH, MoreiraCC, RahalP, et al.Saint Louis" exact="encephalitis" post="virus, Brazil.Emerg Infect Dis. 2007;13:176â€&quot;8. 10.3201/eid1301.06090517370543 33. ReevesWC, HammonWM,"/>
   <result pre="PeckBA, MoraSJ, et al.Epidemiological aspects of the 1984 St Louis" exact="encephalitis" post="epidemic in southern California.Proc Calif Mosq Vector Control Assoc."/>
   <result pre="et al.Ecological observations on the 1989 outbreak of St. Louis" exact="encephalitis" post="virus in the southern San Joaquin Valley of California.J"/>
   <result pre="36. TuellerJE. An outbreak of illness due to St. Louis" exact="encephalitis" post="virus in the southern San Joaquin Valley, California, 1989.Proc"/>
   <result pre="CamposEG, GruwellJ, FrancyDB, WomeldorfD, et al.Antibody prevalence of St. Louis" exact="encephalitis" post="virus in avian hosts in Los Angeles, California, 1986.J"/>
   <result pre="Los Angeles area for their ability to vector St. Louis" exact="encephalitis" post="virus.Proc Calif Mosq Vector Control Assoc.1986;54:9â€&quot;10. 39. ReisenWK, MilbyMM,"/>
   <result pre="ReisenWK, MilbyMM, PresserSB, HardyJL. Ecology of mosquitoes and St. Louis" exact="encephalitis" post="virus in the Los Angeles Basin of California, 1987â€&quot;1990.J"/>
   <result pre="CusackR, GreenEG, FangY, et al.Persistence and amplification of St. Louis" exact="encephalitis" post="virus in the Coachella Valley of California, 2000â€&quot;2001.J Med"/>
   <result pre="HardyJL, JacksonAO. Genotypic and phenotypic variation of selected Saint Louis" exact="encephalitis" post="viral strains isolated in California.Am J Trop Med Hyg."/>
   <result pre="FeiszliT, PadgettK, SimpsonJ, BarkerCM, FangY, SalasM, et al.Surveillance for mosquito-borne" exact="encephalitis" post="virus activity in California, 2015.Proc Papers Mosq Vector Control"/>
   <result pre="FeiszliT, PadgettK, SimpsonJ, BarkerCM, FangY, SalasM, et al.Surveillance for mosquito-borne" exact="encephalitis" post="virus activity in California, 2016.Proc Papers Mosq Vector Control"/>
   <result pre="2016.Proc Papers Mosq Vector Control Assoc Calif.2017;85:9â€&quot;14. 45. Saint Louis" exact="encephalitis" post="virus (SLEV) in California counties 2017 YTD; updated Jan"/>
   <result pre="WilsonMR, et al.Diagnosis of fatal human case of St. Louis" exact="encephalitis" post="virus infection by metagenomic sequencing, California, 2016.Emerg Infect Dis."/>
   <result pre="HennesseyM, JonesJ, AdamsL, FischerM, et al.Concurrent outbreaks of St. Louis" exact="encephalitis" post="virus and West Nile virus diseaseâ€&quot;Arizona, 2015.MMWR Morb Mortal"/>
   <result pre="SymmesK, SunP, FangY, GarciaS, SteinerC, et al.Reemergence of St. Louis" exact="encephalitis" post="virus, California, 2015.Emerg Infect Dis. 2016;22:2185â€&quot;8. 10.3201/eid2212.16080527869600"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6264817\results\search\disease\results.xml">
   <result pre="Infectious Disease Surveillance A scoping review of published literature on" exact="chikungunya" post="virus A scoping review of published literature on chikungunya"/>
   <result pre="on chikungunya virus A scoping review of published literature on" exact="chikungunya" post="virus http://orcid.org/0000-0002-5947-6690MascarenhasMariolaConceptualizationData curationFormal analysisInvestigationMethodologyProject administrationSupervisionValidationWriting â€&quot; original draftWriting â€&quot;"/>
   <result pre="are accessible at https://doi.org/10.5061/dryad.qd65020. Introduction Chikungunya disease is caused by" exact="chikungunya" post="virus (CHIKV), a mosquito-borne alphavirus belonging to the family"/>
   <result pre="over in painâ€� [2], describing the stooped posture of many" exact="chikungunya" post="afflicted patients due to severe joint pains and arthralgias,"/>
   <result pre="forming an Indian Ocean sub-lineage within ECSA [17â€&quot;20]. The large" exact="chikungunya" post="epidemic in Brazil that started in late 2013 was"/>
   <result pre="as the scientific community, and facilitate decision-making on mitigation of" exact="chikungunya" post="and/or CHIKV competent vectors. Methods A ScR protocol was"/>
   <result pre="questions: â€œWhat is the current state of research knowledge on" exact="chikungunya" post="virus (CHIKV), including its pathogenesis, attributes of clinical infection"/>
   <result pre="literature. The final search algorithm included two parts, one encompassing" exact="chikungunya" post="research and the other to capture additional research on"/>
   <result pre="Central and South America due to the recent emergence of" exact="chikungunya" post="in those regions. To verify that our search algorithm"/>
   <result pre="aspects of the review question: i.e., information on CHIKV and" exact="chikungunya" post="disease, competence parameters of CHIKV vectors, or control of"/>
   <result pre="environmental factors associated with CHIKV transmission, 6) economic burden of" exact="chikungunya" post="disease, or 7) modeling studies on chikungunya or CHIKV"/>
   <result pre="economic burden of chikungunya disease, or 7) modeling studies on" exact="chikungunya" post="or CHIKV vectors. Articles that did not meet the"/>
   <result pre="Checklist. The focus area researched most extensively was epidemiology of" exact="chikungunya" post="related to hosts and vectors, with a total of"/>
   <result pre="signs, symptoms and diagnosis of CHIKV in humans. Treatment for" exact="chikungunya" post="in humans was reported in 283/2326 (12%) studies, and"/>
   <result pre="103/2326 (4%), social impact examining knowledge, attitudes and perceptions of" exact="chikungunya" post="in various target human populations in 46/2326 (2%) studies,"/>
   <result pre="in tracking the quantity of research underpinning different areas of" exact="chikungunya" post="research. This ScR focuses on the detailed characteristics of"/>
   <result pre="mitigation practices 33 âˆ’ âˆ’ âˆ’ âˆ’ âˆ’ Knowledge on" exact="chikungunya" post="disease 29 âˆ’ âˆ’ âˆ’ âˆ’ âˆ’ Knowledge on"/>
   <result pre="experimental or trial stages. The efficacy of drugs to treat" exact="chikungunya" post="symptoms was assessed in 3/17 (18%) controlled trial studies"/>
   <result pre="systematic and purposeful programs mainly focussed on collecting numbers of" exact="chikungunya" post="patients without a rigid action plan. Passive surveillance, mainly"/>
   <result pre="epidemics was reported in 14/126 (11%) articles where data on" exact="chikungunya" post="patients were collected in a hospital or other healthcare"/>
   <result pre="of possible sequential CHIKV infection [112]. Risk factors for developing" exact="chikungunya" post="infection in humans were investigated in 345 studies. Landscape"/>
   <result pre="in the 0â€&quot;14 age group [113]. Other risk factors for" exact="chikungunya" post="were pre-existing chronic conditions such as Type 2 diabetes,"/>
   <result pre="chikungunya were pre-existing chronic conditions such as Type 2 diabetes," exact="cardiovascular disease" post="[114â€&quot;117] and obesity [118â€&quot;119]. CHIKV epidemics Over 70 chikungunya"/>
   <result pre="conditions such as Type 2 diabetes, cardiovascular disease [114â€&quot;117] and" exact="obesity" post="[118â€&quot;119]. CHIKV epidemics Over 70 chikungunya epidemics have occurred"/>
   <result pre="cardiovascular disease [114â€&quot;117] and obesity [118â€&quot;119]. CHIKV epidemics Over 70" exact="chikungunya" post="epidemics have occurred in several countries across many continents"/>
   <result pre="2014 [21], [249] Central America/South America/Caribbean Suriname 2015 [250] Travel-related" exact="chikungunya" post="There were 215/1159 (19%) articles reporting travel-related CHIKV infections;"/>
   <result pre="symptoms days after returning to their home countries from a" exact="chikungunya" post="endemic country where they were exposed to the virus."/>
   <result pre="virus. Of the travel-related studies, 29/215 (13%) studied prevalence of" exact="chikungunya" post="infection among travelers. Clinical manifestation of acute phase CHIKV"/>
   <result pre="of 764/2326 (33%) articles reported clinical signs and symptoms of" exact="chikungunya" post="infection, of which 269/764 (35%) were case or case"/>
   <result pre="accepted triad of CHIKV symptoms is fever (539/764, 71%), itchy" exact="rash" post="(410/764, 54%) and joint pain (506/764, 66%), however, the"/>
   <result pre="including: headache (291/764, 38%), myalgia or muscle ache (246/764, 32%)," exact="conjunctivitis" post="(82/764, 11%), gastrointestinal symptoms such as nausea, vomiting, diarrhea"/>
   <result pre="32%), conjunctivitis (82/764, 11%), gastrointestinal symptoms such as nausea, vomiting," exact="diarrhea" post="or abdominal pain (218/764, 29%), and fatigue, malaise or"/>
   <result pre="disorders and 95/764 (12%) articles described neurological symptoms associated with" exact="chikungunya" post="disease. These results do not represent the frequency of"/>
   <result pre="articles. Atypical signs and symptoms Atypical signs and symptoms of" exact="chikungunya" post="infection were described in 121/764 (16%) articles, all with"/>
   <result pre="sequelae associated with CHIKV; Table 1. Persistent post-infection morbidities included" exact="tendinitis" post="(5/239; 2%), synovitis (14/239; 6%), balance disorders (1/239; 0.4%),"/>
   <result pre="CHIKV; Table 1. Persistent post-infection morbidities included tendinitis (5/239; 2%)," exact="synovitis" post="(14/239; 6%), balance disorders (1/239; 0.4%), and tunnel syndromes"/>
   <result pre="9/239 (4%) articles that reported Guillaine-BarrÃ© Syndrome (GBS) associated with" exact="chikungunya" post="infection. Other long term complications reported were chronic arthritis"/>
   <result pre="with chikungunya infection. Other long term complications reported were chronic" exact="arthritis" post="(163/239; 68%), neurological disorders such as encephalopathies (18/239; 8%),"/>
   <result pre="arthritis (163/239; 68%), neurological disorders such as encephalopathies (18/239; 8%)," exact="acute disseminated encephalomyelitis" post="(ADEM) (5/239; 2%), and ocular disorders (17/239; 7%). These"/>
   <result pre="68%), neurological disorders such as encephalopathies (18/239; 8%), acute disseminated" exact="encephalomyelitis" post="(ADEM) (5/239; 2%), and ocular disorders (17/239; 7%). These"/>
   <result pre="suggests that hyperferritinemia may be a potential marker of chronic" exact="chikungunya" post="disease [257]. Co-infections with CHIKV in humans Chikungunya co-infections"/>
   <result pre="109/1159 (9%) articles reporting co-infections with chikungunya: dengue (77/109; 71%)," exact="malaria" post="(13/109, 12%) and zika (9/109; 8%); Table 1. There"/>
   <result pre="reported with CHIKV is compiled in S5 Table. Treatment for" exact="chikungunya" post="infections in humans Chikungunya disease is generally managed through"/>
   <result pre="(25%) studies; Table 1. Antibiotics were prescribed as treatment for" exact="chikungunya" post="in 30/283 (11%) studies. There were 7/283 (2%) studies"/>
   <result pre="(2%) studies that described the use of antiviral drugs for" exact="chikungunya" post="treatment and 29/283 (10%) studies described using an anti-malarial"/>
   <result pre="described using an anti-malarial agent such as hydroxychloroquine to treat" exact="chikungunya" post="symptoms. A randomized controlled trial examining the effectiveness of"/>
   <result pre="randomized controlled trial examining the effectiveness of chloroquine to treat" exact="chikungunya" post="concluded that there is no justification for its use"/>
   <result pre="(5%) studies described the use of traditional medicine for treating" exact="chikungunya" post="and its symptoms. The efficacy of plant-based drugs (19"/>
   <result pre="medicines (8 studies) for treating acute and chronic symptoms of" exact="chikungunya" post="was assessed in experimental studies. CHIKV transmission in humans"/>
   <result pre="and intravascular coagulation [265]. Public knowledge, attitudes and perceptions of" exact="chikungunya" post="disease and CHIKV vectors Knowledge, attitudes and perceptions about"/>
   <result pre="cross-sectional articles; Table 1. Articles on attitudes and perceptions to" exact="chikungunya" post="disease focused on concerns about toxic or environmental effects"/>
   <result pre="(3/46; 7%), perception about the severity and risks associated with" exact="chikungunya" post="disease (16/46; 35%), and perception on the efficacy of"/>
   <result pre="various protective measures (13/46; 28%). Several studies evaluated knowledge on" exact="chikungunya" post="disease (29/46; 63%), CHIKV vectors (27/46; 59%) and behavioral"/>
   <result pre="CHIKV, of which 19/23 (83%%) studied the economic burden of" exact="chikungunya" post="disease in humans, 3/23 (13%) examined the cost-benefit of"/>
   <result pre="1. There was no validated and approved ready-to-use vaccine against" exact="chikungunya" post="for humans identified from our data analyses. However, there"/>
   <result pre="103/2326 (4%) modeling studies including quantitative risk assessment articles on" exact="chikungunya" post="disease or competent CHIKV vectors. Exposure to CHIKV, illness,"/>
   <result pre="CHIKV vectors. Exposure to CHIKV, illness, or costs attributed to" exact="chikungunya" post="disease in humans was the outcome modeled in 58/103"/>
   <result pre="the other twin was severely ill due to congenitally acquired" exact="chikungunya" post="[267]. Another study examining outcomes of CHIKV infection to"/>
   <result pre="is important to keep in mind that vertical transmission of" exact="chikungunya" post="in an asymptomatic infected mother or neonate can also"/>
   <result pre="mothers and neonates in maternity units. A single case of" exact="microcephaly" post="in a neonate born to a mother with gestational"/>
   <result pre="microcephaly in a neonate born to a mother with gestational" exact="chikungunya" post="infection has been described [290]. Microcephaly is believed to"/>
   <result pre="that this could be a coincidental finding, but CHIKV associated" exact="microcephaly" post="certainly warrants future research given that CHIKV and ZIKV"/>
   <result pre="for public health authorities and physicians to be aware of" exact="chikungunya" post="disease and the possible epidemic risks associated with the"/>
   <result pre="semen [74]. Pre-existing risk factors for developing chronic sequelae Although" exact="chikungunya" post="is a self-limiting disease, it can result in long"/>
   <result pre="that pre-existing morbidities can predispose an individual to more severe" exact="chikungunya" post="disease and chronic sequelae post-CHIKV infection [110] and that"/>
   <result pre="clinical manifestation of CHIKV illness can predict progression to chronic" exact="arthritis" post="[294]. The list of pre-existing morbidities in CHIKV patients"/>
   <result pre="and confidence in any potential association that might exist. Atypical" exact="chikungunya" post="disease Several studies described atypical and severe forms of"/>
   <result pre="chikungunya disease Several studies described atypical and severe forms of" exact="chikungunya" post="disease during both acute and convalescent phases, as well"/>
   <result pre="unexpected nasal skin necrosis in a few patients with severe" exact="chikungunya" post="disease [298]. It remains unclear whether this atypical sign"/>
   <result pre="ocular disease associated with chikungunya, ranging from varied forms of" exact="uveitis" post="and other manifestations, to complete blindness [299â€&quot;300]. Five studies"/>
   <result pre="and other manifestations, to complete blindness [299â€&quot;300]. Five studies described" exact="acute disseminated encephalomyelitis" post="(ADEM) in CHIKV patients from India [256, 301â€&quot;304]. It"/>
   <result pre="manifestations, to complete blindness [299â€&quot;300]. Five studies described acute disseminated" exact="encephalomyelitis" post="(ADEM) in CHIKV patients from India [256, 301â€&quot;304]. It"/>
   <result pre="these outcomes. Other neurological complications were infrequently observed across early" exact="chikungunya" post="outbreaks, however, Guillain BarrÃ© Syndrome (GBS) is a relatively"/>
   <result pre="of CHIKV [27, 156, 247, 305â€&quot;306]. A study on a" exact="chikungunya" post="epidemic in French Polynesia reported an increase in the"/>
   <result pre="reported to be associated with GBS [307]. Treatment Management of" exact="chikungunya" post="illness is predominantly supportive, with analgesics, steroids and NSAIDs"/>
   <result pre="contributed significantly to the global expansion of risk areas for" exact="chikungunya" post="and also highlights the plasticity of CHIKV and its"/>
   <result pre="the literature and are compiled in this ScR. Burden of" exact="chikungunya" post="disease One of the challenges of estimating the true"/>
   <result pre="other analyses that use surveillance data as inputs. Misclassification of" exact="chikungunya" post="as dengue or zika infections could also occur as"/>
   <result pre="SugunanAP, RaiSK, VijayachariP, ShriramAN, SharmaS, et al.Short report: Outbreak of" exact="chikungunya" post="fever, Dakshina Kannada District, South India, 2008. Am J"/>
   <result pre="BoumahniB, GerardinP, MichaultA, FourmaintrauxA, SchuffeneckerI, et al.Vertical maternal-fetal transmission of" exact="chikungunya" post="virus: ten cases on Reunion among 84 pregnant women."/>
   <result pre="DuranS, SandovalI, CastellanosJE. Easy and inexpensive molecular detection of dengue," exact="chikungunya" post="and zika viruses in febrile patients. Acta Trop201611;163:32â€&quot;37. 10.1016/j.actatropica.2016.07.02127477452"/>
   <result pre="burden of disease caused by co-circulation and co-infection of dengue," exact="chikungunya" post="and Zika in the Americas. Travel Med Infect Dis2016May-Jun;14(3):177â€&quot;179."/>
   <result pre="14Villamil-GomezWE, Rodriguez-MoralesAJ, Uribe-GarciaAM, Gonzalez-ArismendyE, CastellanosJE, CalvoEP, et al.Zika, dengue, and" exact="chikungunya" post="co-infection in a pregnant woman from Colombia. Int J"/>
   <result pre="15KhanAH, MoritaK, ParquetMdC, HasebeF, MathengeEGM, IgarashiA. Complete nucleotide sequence of" exact="chikungunya" post="virus and evidence for an internal polyadenylation site. J"/>
   <result pre="SuarezLAC, LabayoHKM, LilesVR, SalvozaNC, KlinzingDC, et al.Complete genome sequence of" exact="chikungunya" post="virus isolated in the Philippines. Genome Announcements2014;2(3):e00336â€&quot;14. 9 ref."/>
   <result pre="Virol2010;84(13):6497â€&quot;6504. 63 ref. 10.1128/JVI.01603-0920410280 18PowersAM, BraultAC, TeshRB, WeaverSC. Re-emergence of" exact="chikungunya" post="and oâ€™nyong-nyong viruses: evidence for distinct geographical lineages and"/>
   <result pre="19SchuffeneckerI, ItemanI, MichaultA, MurriS, FrangeulL, VaneyMC, et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak. PLoS Medicine2006;3(7):e263 44"/>
   <result pre="PLoS Medicine2006;3(7):e263 44 ref. 10.1371/journal.pmed.003026316700631 20PowersAM, LogueCH. Changing patterns of" exact="chikungunya" post="virus: re-emergence of a zoonotic arbovirus. Journal of General"/>
   <result pre="27SuryawanshiSD, DubeAH, KhadseRK, JalgaonkarSV, SathePS, ZawarSD, et al.Clinical profile of" exact="chikungunya" post="fever in patients in a tertiary care centre in"/>
   <result pre="29YoosufAA, ShihamI, MohamedAJ, AliG, LunaJM, PandavR, et al.First report of" exact="chikungunya" post="from the Maldives. Trans R Soc Trop Med Hyg2009;103(2):192â€&quot;196."/>
   <result pre="et al.Importance of case definition to monitor ongoing outbreak of" exact="chikungunya" post="virus on a background of actively circulating dengue virus,"/>
   <result pre="Eurosurveillance2014;19(13). 32LedransM, CassadouS, BoucauS, HucAnaisP, LeparcGoffartI, PratC, et al.Emergence of" exact="chikungunya" post="in the French overseas territories of the Americas: organization"/>
   <result pre="Eurosurveillance; 2014 0759;19(13):2; 81 ref. 34YamanishiH, SawayamaT, MatsumuraT. Multiplication of" exact="chikungunya" post="virus in male Culex pipiens molestus. Jap J Sanit"/>
   <result pre="ref. 35ViennetE, KnopeK, FaddyHM, WilliamsCR, HarleyD. Assessing the threat of" exact="chikungunya" post="virus emergence in Australia. Commun Dis Intell Q Rep2013630;37(2):E136â€&quot;43."/>
   <result pre="65 ref.19476608 37TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog200712;3(12):e20110.1371/journal.ppat.003020118069894"/>
   <result pre="Infect Dis2011115;203(2):141â€&quot;143. 10.1093/infdis/jiq02621288810 48HiggsS, ZieglerSA. A nonhuman primate model of" exact="chikungunya" post="disease. J Clin Invest20103;120(3):657â€&quot;660. 10.1172/JCI4239220179348 49OgdenNH, LindsayLR, CoulthartM. Is"/>
   <result pre="Invest20103;120(3):657â€&quot;660. 10.1172/JCI4239220179348 49OgdenNH, LindsayLR, CoulthartM. Is there a risk of" exact="chikungunya" post="transmission in Canada? (Special Issue: Chikungunya virus.). Canada Communicable"/>
   <result pre="53KarPK, NagpalBN, DuaVK, GhoshSK, RaghavendraK, BhattRM, et al.Molecular characterization of" exact="chikungunya" post="virus from Andhra Pradesh, India. Indian J Med Res20093;129(3):335â€&quot;7;"/>
   <result pre="337. 19491431 54CassadouS, BoucauS, PetitSinturelM, HucP, LeparcGoffartI, LedransM. Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin Island,"/>
   <result pre="ref. 57GouldEA, GallianP, De LamballerieX, CharrelRN. First cases of autochthonous" exact="dengue fever" post="and chikungunya fever in France: from bad dream to"/>
   <result pre="De LamballerieX, CharrelRN. First cases of autochthonous dengue fever and" exact="chikungunya" post="fever in France: from bad dream to reality!Clin Microbiol"/>
   <result pre="reality!Clin Microbiol Infect201012;16(12):1702â€&quot;1704. 10.1111/j.1469-0691.2010.03386.x21040155 58McCarthyM. First case of locally acquired" exact="chikungunya" post="is reported in US. BMJ2014;349. 59YactayoS, StaplesJE, MillotV, CibrelusL,"/>
   <result pre="ChenRB, YunRM, RossiSL, PlanteKS, GuerboisM, et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="and Humans. PLoS One2015108;10(10):e013948110.1371/journal.pone.013948126447467 68BandeiraAC, CamposGS, SardiSI, RochaVF, RochaGC. Neonatal" exact="encephalitis" post="due to Chikungunya vertical transmission: First report in Brazil."/>
   <result pre="10.1016/j.idcr.2016.07.00827500084 69MussoD, TeissierA, RouaultE, TeururaiS, de PinaJJ, NhanTX. Detection of" exact="chikungunya" post="virus in saliva and urine. Virol J2016616;13:102-016-0556-9. 70KeeACL, YangS,"/>
   <result pre="Hyg1996;90(1):31â€&quot;33. 5 ref. 8730305 81DialloM, ThonnonJ, TraoreLamizanaM, FontenilleD. Vectors of" exact="chikungunya" post="virus in Senegal: current data and transmission cycles. Am"/>
   <result pre="ref.24393488 85NakgoiK, NitatpattanaN, WajjwalkuW, PongsopawijitP, KaewchotS, YoksanS, et al.Dengue, Japanese" exact="encephalitis" post="and Chikungunya virus antibody prevalence among captive monkey (Macaca"/>
   <result pre="94JuppPG, McIntoshBM. Aedes furcifer and other mosquitoes as vectors of" exact="chikungunya" post="virus at Mica, northeastern Transvaal, South Africa. J Am"/>
   <result pre="Assoc1990;6(3):415â€&quot;420. 13 ref. 1977875 95NakaoE, HottaS. Immunogenicity of purified, inactivated" exact="chikungunya" post="virus in monkeys. Bull World Health Organ19735;48(5):559â€&quot;562. 4204490 96BinnLN,"/>
   <result pre="of viremia and antibody observed in rhesus monkeys inoculated with" exact="chikungunya" post="and other serologically related group A arboviruses. Am J"/>
   <result pre="Hyg1968;62(2):269â€&quot;277. 4384491 98McIntoshBM, SweetnamJ, McGillivrayGM, De SousaJ. Laboratory transmission of" exact="chikungunya" post="virus by Mansonia (Mansonioides) africana (Theobald). Ann Trop Med"/>
   <result pre="vector studies on six mosquito and one tick species with" exact="chikungunya" post="virus. Trans R Soc Trop Med Hyg1981;75(1):15â€&quot;19. 12 ref."/>
   <result pre="Med Hyg1981;75(1):15â€&quot;19. 12 ref. 6115488 104SempalaSDK, KiryaBG. Laboratory transmission of" exact="chikungunya" post="virus by Aedes (Stegomyia) apicoargenteus Theobald (Diptera, Culicidae). Am"/>
   <result pre="Journal of Hygiene1956;54(2):17713346078 106JainRuchi, AcharyaAS, JyotiKhandekar, JaisManoj. Entomo-epidemiological investigations of" exact="chikungunya" post="outbreak in Delhi, India. Annals of Tropical Medicine and"/>
   <result pre="Public Health2013;6(3):297â€&quot;300. 18 ref. 107PuwarTapasvi, ShethJK, KohliVijay, YadavRajpal. Prevalence of" exact="chikungunya" post="in the city of Ahmedabad, India, during the 2006"/>
   <result pre="community-based study. (Special Issue: Cost and burden of dengue and" exact="chikungunya" post="from the Americas to Asia.). Dengue Bulletin; 201034:40â€&quot;45 14"/>
   <result pre="108KannanM, RajendranR, SunishIP, BalasubramaniamR, ArunachalamN, ParamsivanR, et al.A study on" exact="chikungunya" post="outbreak during 2007 in Kerala, south India. Indian J"/>
   <result pre="de MastQ, WidjajaS, SudjanaP, AntonjayaU, Maâ€™roefC, et al.Evidence for endemic" exact="chikungunya" post="virus infections in Bandung, Indonesia. PLoS Negl Trop Dis20131024;7(10):e248310.1371/journal.pntd.000248324205417"/>
   <result pre="Dis201654;10(5):e000463010.1371/journal.pntd.000463027144588 116BorgheriniG, PoubeauP, StaikowskyF, LoryM, MoullecNl, BecquartJP, et al.Outbreak of" exact="chikungunya" post="on Reunion Island: early clinical and laboratory features in"/>
   <result pre="18 ref. 10.1016/j.jcv.2009.06.02719640780 118PadmakumarB, JayanJB, MenonRejeesh, KottaratharaAJ. Clinical profile of" exact="chikungunya" post="sequelae, association with obesity and rest during acute phase."/>
   <result pre="JayanJB, MenonRejeesh, KottaratharaAJ. Clinical profile of chikungunya sequelae, association with" exact="obesity" post="and rest during acute phase. Southeast Asian J Trop"/>
   <result pre="context. Population2008;63(3):491â€&quot;518. 121LarrieuS, BalleydierE, RenaultP, BavilleM, FilleulL. Epidemiological surveillance du" exact="chikungunya" post="on Reunion Island from 2005 to 2011. (Special chikungunya.)"/>
   <result pre="BoissonV, LamballerieXd, FavierF, FontenilleD, et al.An interdisciplinary approach to controlling" exact="chikungunya" post="outbreaks on French islands in the south-west Indian Ocean."/>
   <result pre="in five districts of Kerala affected by the epidemic of" exact="chikungunya" post="fever in 2007. Natl Med J India2010Mar-Apr;23(2):82â€&quot;84. 20925203 126BletteryM,"/>
   <result pre="Rhodesia. Cent Afr J Med19639;43:351â€&quot;359. 130HalsteadSB, UdomsakdiS, SingharajP, NisalakA. Dengue" exact="chikungunya" post="virus infection in man in Thailand, 1962â€&quot;1964. 3. Clinical,"/>
   <result pre="Hyg1967;61(5):725â€&quot;735. 4383288 132ThiruvengadamKV, KalyanasundaramV, RajgopalJ. Clinical and pathological studies on" exact="chikungunya" post="fever in Madras city. Indian J Med Res1965;53(8):729â€&quot;744. 5830407"/>
   <result pre="Med Res1967;55(1):1â€&quot;12. 6036047 134CareyDE, MyersRM, DeranitzCM, JadhavM, ReubenR. The 1964" exact="chikungunya" post="epidemic at vellore, South India, including observations on concurrent"/>
   <result pre="Med Res19747;62(7):1005â€&quot;1010. 4435911 137GhoshSN, SheikhBH. Investigations on the outbreak of" exact="dengue fever" post="in Ajmer City, Rajasthan in 1969. Part II: Result"/>
   <result pre="Indian J Med Res1974;62(4):523â€&quot;533. 4435862 138PadbidriVS, GnaneswarTT. Epidemiological investigations of" exact="chikungunya" post="epidemic at Barsi, Maharashtra state, India. J Hyg Epidemiol"/>
   <result pre="Epidemiol Microbiol Immunol1979;23(4):445â€&quot;451. 575900 139FourieED, MorrisonJG. Rheumatoid arthritic syndrome after" exact="chikungunya" post="fever. South African Medical Journal1979;56(4):130â€&quot;132. 494034 140SaluzzoJF, CornetM, DigoutteJP."/>
   <result pre="LarasatiRP, BangsMJ, KosimR, Djauzi, et al.Tracking the re-emergence of epidemic" exact="chikungunya" post="virus in Indonesia. Trans R Soc Trop Med Hyg2005;99(2):128â€&quot;141."/>
   <result pre="Surveill200622;11(2):E060202.1. 148PaquetC, QuatresousI, SoletJL, SissokoD, RenaultP, PierreV, et al.Epidemiology of" exact="chikungunya" post="virus infection on the Island of Reunion: situation on"/>
   <result pre="2006(hors serie):2â€&quot;3. 5 ref. 149LedransM, QuatresousI, RenaultP, PierreV. Outbreak of" exact="chikungunya" post="in the French Territories, 2006: lessons learned. Euro surveillance:"/>
   <result pre="SoletJL, SissokoD, BalleydierE, LarrieuS, FilleulL, et al.A major epidemic of" exact="chikungunya" post="virus infection on Reunion Island, France, 2005â€&quot;2006. Am J"/>
   <result pre="the Reunion Island population in the context of the 2005â€&quot;2006" exact="chikungunya" post="outbreak. (Special issueâ€&quot;What did we learn from the chikungunya"/>
   <result pre="2005â€&quot;2006 chikungunya outbreak. (Special issueâ€&quot;What did we learn from the" exact="chikungunya" post="outbreak in the Indian Ocean in 2005â€&quot;2006?) [French]. Bulletin"/>
   <result pre="153DominguezM, EconomopoulouA, SissokoD, BoissonV, GauzereBA, PierreV, et al.Atypical forms of" exact="chikungunya" post="in epidemic period, Reunion Island, France, 2005â€&quot;2006. (Special issueâ€&quot;What"/>
   <result pre="Island, France, 2005â€&quot;2006. (Special issueâ€&quot;What did we learn from the" exact="chikungunya" post="outbreak in the Indian Ocean in 2005â€&quot;2006?) [French]. Bulletin"/>
   <result pre="ref. 154BrottetE, RenaultP, GlorieuxMonturyS, FrancoJM, TurquetM, BalleydierE, et al.Epidemic of" exact="chikungunya" post="virus infection on the Reunion Island, France, 2005â€&quot;2006: description"/>
   <result pre="a surveillance network. (Special issueâ€&quot;What did we learn from the" exact="chikungunya" post="outbreak in the Indian Ocean in 2005â€&quot;2006?) [French]. Bulletin"/>
   <result pre="TalarminF, GrivardP, SouabA, SchuffeneckerI, Le RouxK, et al.Prospective study of" exact="chikungunya" post="virus acute infection in the Island of La RÃ©union"/>
   <result pre="Mohammed BasheeruddinD, ChowdharyT, MadhuB. Cutaneous manifestations in patients suspected of" exact="chikungunya" post="disease. Indian J Dermatol2009;54(2):128â€&quot;131. 10.4103/0019-5154.5318620101307 160JainS, KadriS, VenkateshS, LalS,"/>
   <result pre="KadriS, VenkateshS, LalS, KatyalR. Epidemiological investigation of an outbreak of" exact="chikungunya" post="in hyderabad and nalgonda districts of andhra pradesh, India."/>
   <result pre="HarisoaJ, RatovonjatoJ, BiacabeS, ReynesJM, ZellerH, et al.Outbreak of dengue and" exact="chikungunya" post="fevers, Toamasina, Madagascar, 2006. Emerging Infectious Diseases2008;14(7):1135â€&quot;1137. 8 ref."/>
   <result pre="6 ref. 18338714 165JainSK, KumarKaushal, BhattacharyaD, VenkateshS, JainDC, ShivLal. Chikungunya" exact="viral disease" post="in district Bhilwara (Rajasthan) India. J Commun Dis2007;39(1):25â€&quot;31. 11"/>
   <result pre="ReguK, MohananMK, BoraD, DhariwalAC, et al.Study on the eco-epidemiology of" exact="chikungunya" post="in U.T of Lakshadweep. J Commun Dis2009;41(2):81â€&quot;92. 22010495 167SamuelPP,"/>
   <result pre="Commun Dis2009;41(2):81â€&quot;92. 22010495 167SamuelPP, KrishnamoorthiR, HamzakoyaKK, AggarwalCS. Entomo-epidemiological investigations on" exact="chikungunya" post="outbreak in the Lakshadweep islands, Indian Ocean. Indian J"/>
   <result pre="of different systems of medicines and the present scenario of" exact="chikungunya" post="in Kerala. Asian Pacific Journal of Tropical Medicine2010;3(6):443â€&quot;447. 15"/>
   <result pre="40 ref. 10.1089/vbz.2008.019019874187 170DokePP, DakhureDS, PatilAV. A clinico-epidemiological study of" exact="chikungunya" post="outbreak in Maharashtra state, India. Indian J Public Health2011;55(4):313â€&quot;316."/>
   <result pre="171DwibediB, SabatJ, MahapatraN, KarSK, KerkettaAS, HazraRK, et al.Rapid spread of" exact="chikungunya" post="virus infection in Orissa: India. Indian J Med Res2011;133(3):316â€&quot;321."/>
   <result pre="Med Res2011;133(3):316â€&quot;321. 21 ref.21441687 172SeylerT, SakdapolrakP, Sanjeevi PrasadS, DhanrajR. A" exact="chikungunya" post="outbreak in the metropolis of Chennai, India, 2006. J"/>
   <result pre="cohort study. Journal of Tropical Medicine2012. 174RazmyAM. Clinical features of" exact="chikungunya" post="infection in Sri Lanka. Asian Pacific Journal of Tropical"/>
   <result pre="AliMK, DhillonGPS. Epidemiological and entomological aspects of an outbreak of" exact="chikungunya" post="in Lakshadweep Islands, India, during 2007. Dengue Bulletin2008;32:178â€&quot;185. 177SanthoshSR,"/>
   <result pre="180AngeliniR, FinarelliAC, AngeliniP, PoC, PetropulacosK, MaciniP, et al.An outbreak of" exact="chikungunya" post="fever in the province of Ravenna, Italy. Euro Surveill200796;12(9):E070906.1."/>
   <result pre="Surveill200796;12(9):E070906.1. 181RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliAC, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="Transfus200810;6(4):199â€&quot;210. 10.2450/2008.0016-0819112735 183SeylerT, RizzoC, FinarelliAC, PoC, AlessioP, SambriV, et al.Autochthonous" exact="chikungunya" post="virus transmission may have occurred in Bologna, Italy, during"/>
   <result pre="Euro Surveill2008117;13(3):801518445394 184MoroML, GrilliE, CorvettaA, SilviG, AngeliniR, MascellaF, et al.Long-term" exact="chikungunya" post="infection clinical manifestations after an outbreak in Italy: a"/>
   <result pre="27 ref. 186LeroyEM, NkogheD, OllomoB, NzeNkogueC, BecquartP, GrardG, et al.Concurrent" exact="chikungunya" post="and dengue virus infections during simultaneous outbreaks, Gabon, 2007."/>
   <result pre="187ManimundaSP, VijayachariPaluru, UppoorRaghuraj, SugunanAP, SinghSS, RaiSK, et al.Clinical progression of" exact="chikungunya" post="fever during acute and chronic arthritic stages and the"/>
   <result pre="AngLiWei, TanBoonHian, TangChoonSiang, OoiPengLim, JamesL, et al.Epidemiology and control of" exact="chikungunya" post="fever in Singapore. J Infect2011;62(4):263â€&quot;270. 10.1016/j.jinf.2011.02.00121315108 194SamIChing, ChanYokeFun, ChanShieYien,"/>
   <result pre="10.1016/j.jcv.2009.07.01619683467 195ThavaraU, TawatsinA, PengsakulT, BhakdeenuanP, ChanamaS, AnantapreechaS, et al.Outbreak of" exact="chikungunya" post="fever in Thailand and virus detection in field population"/>
   <result pre="ref. 198NakkharaP, ChongsuvivatwongV, ThammapaloS. Risk factors for symptomatic and asymptomatic" exact="chikungunya" post="infection. Trans R Soc Trop Med Hyg2013;107(12):789â€&quot;796. 30 ref."/>
   <result pre="39 ref. 22662594 202PaupyC, Kassa KassaF, CaronM, NkogheD, LeroyEM. A" exact="chikungunya" post="outbreak associated with the vector Aedes albopictus in remote"/>
   <result pre="LarrieuS, RenaultP, BavilleM, FilleulL. How to explain the re-emergence of" exact="chikungunya" post="infection in Reunion Island in 2010?Acta Trop2012;123(2):85â€&quot;90. 25 ref."/>
   <result pre="209GuravYK, GopalkrishnaV, ShahPS, PatilDR, MishraM, PaingankarMS, et al.An outbreak of" exact="chikungunya" post="in Jamshedpur, Jharkhand in 2011. Indian J Med Res2012;136(5):886â€&quot;889."/>
   <result pre="10.3201/eid1909.13045123968609 215MoyenN, ThibervilleS-, PastorinoB, NougairedeA, ThirionL, MombouliJ-, et al.First reported" exact="chikungunya" post="fever outbreak in the republic of Congo, 2011. PLoS"/>
   <result pre="10.3201/eid2205.15126827088593 218HorwoodP, BandeG, DaginaR, GuillaumotL, AaskovJ, PavlinB. The threat of" exact="chikungunya" post="in Oceania. Western Pac Surveill Response J201364;4(2):8â€&quot;10. 10.5365/WPSAR.2013.4.2.00324015365 219HorwoodPF,"/>
   <result pre="ConanA, DuongV, LyS, NganC, BuchyP, et al.A model for a" exact="chikungunya" post="outbreak in a rural Cambodian setting: implications for disease"/>
   <result pre="Penserga EG. A three-month follow up of musculoskeletal manifestions in" exact="chikungunya" post="fever. 2014. 224BalleraJE, ZapantaMJ, de los ReyesVC, SucalditoMN, TayagE."/>
   <result pre="2014. 224BalleraJE, ZapantaMJ, de los ReyesVC, SucalditoMN, TayagE. Investigation of" exact="chikungunya" post="fever outbreak in Laguna, Philippines, 2012. Western Pac Surveill"/>
   <result pre="space, and behaviors shape the spread of infectious diseases using" exact="chikungunya" post="as a case study. Proc Natl Acad Sci U"/>
   <result pre="ShimonoT, LamaningaoP, DarcyAW, MishimaN, et al.Co-circulation of the dengue with" exact="chikungunya" post="virus during the 2013 outbreak in the southern part"/>
   <result pre="Dominica. PLoS Negl Trop Dis2015814;9(8):e000397710.1371/journal.pntd.000397726274813 228KendrickK, StanekD, BlackmoreC. Transmission of" exact="chikungunya" post="virus in the continental United Statesâ€&quot;Florida, 2014. Morbidity and"/>
   <result pre="Giron S, Delisle E, Chappert JL, et al. Monitoring of" exact="chikungunya" post="and dengue in metropolitan France, 2014. 2015;. Accessed 13."/>
   <result pre="et al. Increase in cases of guillain-barre syndrome during a" exact="chikungunya" post="outbreak, French Polynesia, 2014 to 2015. 2015;. Accessed 48,"/>
   <result pre="Mondragon-CardonaAE, Rodriguez-MoralesAJ. From imported to an endemic disease: impact of" exact="chikungunya" post="virus disease in the hospital epidemiology, Tolima, Colombia, 2014â€&quot;2015."/>
   <result pre="RomeroSE, Mercado ReyesM, Campo CareyA, Alarcon CruzA. Autochthonous transmission of" exact="chikungunya" post="in Colombia, October 2014. Informe Quincenalâ€&quot;Epidemiologico Nacional2014;19(20):312â€&quot;340. 13 ref."/>
   <result pre="247CrosbyL, PerreauC, MadeuxB, CossicJ, ArmandC, Herrmann-StorkeC, et al.Severe manifestations of" exact="chikungunya" post="virus in critically ill patients during the 2013â€&quot;2014 Caribbean"/>
   <result pre="252BabuK, KiniR, PhilipsM, SubbakrishnaDK. Clinical profile of isolated viral anterior" exact="uveitis" post="in a South Indian patient population. Ocul Immunol Inflamm201410;22(5):356â€&quot;359."/>
   <result pre="10.3109/09273948.2013.84148224111839 253BabuK, AdigaM, GovekarSR, KumarBR, MurthyKR. Associations of Fuchs heterochromic" exact="iridocyclitis" post="in a South Indian patient population. J Ophthalmic Inflamm"/>
   <result pre="patients. Neuroimmunomodulation2014;21(6):338â€&quot;346. 10.1159/00035824024776821 256DasSuman, SarkarNirmalya, MajumderJayitri, ChatterjeeKaushani, BholanathA. Acute disseminated" exact="encephalomyelitis" post="in a child with chikungunya virus infection. Journal of"/>
   <result pre="MajumderJayitri, ChatterjeeKaushani, BholanathA. Acute disseminated encephalomyelitis in a child with" exact="chikungunya" post="virus infection. Journal of Pediatric Infectious Diseases2014;9(1):37â€&quot;41. 15 ref."/>
   <result pre="10.1093/cid/ciw58927578819 260d LamballerieX, BoissonV, ReynierJC, EnaultS, CharrelRN, FlahaultA, et al.On" exact="chikungunya" post="acute infection and chloroquine treatment. Vector Borne and Zoonotic"/>
   <result pre="Diseases2008;8(6):837â€&quot;840. 10 ref. 10.1089/vbz.2008.004918620511 261PatersonHE, McIntoshBM. Further studies on the" exact="chikungunya" post="outbreak in southern Rhodesia in 1962. II. Transmission experiments"/>
   <result pre="Ann Trop Med Parasitol1964;58:52â€&quot;55. 14147665 262ShahKV, BaronS. Laboratory infection with" exact="chikungunya" post="virus: a case report. Indian J Med Res1965;53(7):610â€&quot;613. 5827506"/>
   <result pre="Res1965;53(7):610â€&quot;613. 5827506 263ParolaP, LamballerieXd, JourdanJ, RoveryC, VaillantV, MinodierP, et al.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islands."/>
   <result pre="Falleiros-ArlantLH, DuenasL, Pleitez-NavarreteJ, SalgadoDM, CastilloJB. Congenital and perinatal complications of" exact="chikungunya" post="fever: a Latin American experience. Int J Infect Dis201610;51:85â€&quot;88."/>
   <result pre="MichaultA, BintnerM, RandrianaivoH, ChokerG, et al.Multidisciplinary prospective study of mother-to-child" exact="chikungunya" post="virus infections on the Island of La Reunion. PLoS"/>
   <result pre="Hyg19808;83(4):165â€&quot;171. 7411679 273ErasmusJH, AugusteAJ, KaelberJT, LuoH, RossiSL, FentonK, et al.A" exact="chikungunya" post="fever vaccine utilizing an insect-specific virus platform. Nat Med20161219."/>
   <result pre="PerryJG, MangiaficoJA. Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218. Am J Trop Med Hyg2000;62(6):681â€&quot;685. 30"/>
   <result pre="Med Hyg2000;62(6):681â€&quot;685. 30 ref. 11304054 275JenyoshikawaM, TangCS, NishibuchiM. Incidence of" exact="chikungunya" post="fever in Singapore: Implications of public health measures and"/>
   <result pre="Wkly Rep2016513;65(18):479â€&quot;480. doi: 10.15585/mmwr.mm6518e327171600 277MoulayD, Aziz-AlaouiMA, KwonH-. Optimal control of" exact="chikungunya" post="disease: Larvae reduction, treatment and prevention. Mathematical Biosciences and"/>
   <result pre="efficacy of two poeciliid fish in indoor cement tanks against" exact="chikungunya" post="vector Aedes aegypti in villages in Karnataka, India. BMC"/>
   <result pre="Travel Medicine1999;6(2):137â€&quot;139. 15 ref. 10381967 287Lourenco-de-OliveiraR, FaillouxA. High risk for" exact="chikungunya" post="virus to initiate an enzootic sylvatic cycle in the"/>
   <result pre="Pediatr201510;61(5):386â€&quot;392. 10.1093/tropej/fmv05126246086 289SenanayakeMP, SenanayakeSM, VidanageKK, GunasenaS, LamabadusuriyaSP. Vertical transmission in" exact="chikungunya" post="infection. Ceylon Med J20096;54(2):47â€&quot;50. 19670548 290PeterR, KrishnanL, AnandrajV, KuruvilaS."/>
   <result pre="ReceveurMC, SissokoD, et al.Factors associated with persistence of arthralgia among" exact="chikungunya" post="virus-infected travellers: report of 42 French cases. Journal of"/>
   <result pre="SUPPL.):12â€&quot;19. 302TaraphdarD, RoyBK, ChatterjeeS. Chikungunya virus infection amongst the acute" exact="encephalitis" post="syndrome cases in West Bengal, India. Indian Journal of"/>
   <result pre="ref. 10.1097/CCM.0b013e318183f2d218679124 306LebrunG, ChaddaK, RebouxAH, MartinetO, GauzereBA. Guillain-Barre syndrome after" exact="chikungunya" post="infection. Emerging Infectious Diseases2009;15(3):495â€&quot;496. 8 ref. 10.3201/eid1503.07148219239775 307BenoÃ®tRozÃ©, FatihaNajioullah,"/>
   <result pre="ref. 312ChemYK, ZainahS, BerendamSJ, RogayahTengku, KhairulAH, ChuaKB. Molecular epidemiology of" exact="chikungunya" post="virus in Malaysia since its first emergence in 1998."/>
   <result pre="313NyariN, MaanHS, SharmaS, PandeySN, DholeTN. Identification and genetic characterization of" exact="chikungunya" post="virus from Aedes mosquito vector collected in the Lucknow"/>
   <result pre="314ContevilleLC, ZanellaL, MarinMA, FilippisAM, NogueiraRM, VicenteAC, et al.Phylogenetic analyses of" exact="chikungunya" post="virus among travelers in Rio de Janeiro, Brazil, 2014â€&quot;2015."/>
   <result pre="GreigJ, YoungI, HierlihyC, MascarenhasM. Risk perceptions, attitudes, and knowledge of" exact="chikungunya" post="among the public and health professionals: a systematic review."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6293476\results\search\disease\results.xml">
   <result pre="developed that target Rev-erbÎ±/Î² to improve metabolic dysfunction of diet-induced" exact="obesity" post="in mice and inhibit inflammatory response in immune cells"/>
   <result pre="were infected with Oâ€™nyongâ€™nyong virus (ONNV; MOI 5), GFP-expressing vesicular" exact="stomatitis" post="virus (VSV-GFP; MOI 0.5), or Zika virus (ZIKV; MOI"/>
   <result pre="TNFÎ±, CCL2, and MMP9) (Figure 2B), which are involved in" exact="rheumatoid arthritis" post="[14] and implicated in alphavirus-induced joint pathology [15]. Additional"/>
   <result pre="CCL2, and MMP9) (Figure 2B), which are involved in rheumatoid" exact="arthritis" post="[14] and implicated in alphavirus-induced joint pathology [15]. Additional"/>
   <result pre="overview. Nat Rev Rheumatol2012; 8:420â€&quot;9.22565316 2.SchwartzO, AlbertMLBiology and pathogenesis of" exact="chikungunya" post="virus. Nat Rev Microbiol2010; 8:491â€&quot;500.20551973 3.BurtFJ, ChenW, MinerJJ, et"/>
   <result pre="Infect Dis2017; 17:e107â€&quot;17.28159534 4.RezzaG, ChenR, WeaverSCOâ€™nyong-nyong fever: a neglected mosquito-borne" exact="viral disease." post="Pathog Glob Health2017; 111(6):271â€&quot;5.28829253 5.EverettLJ, LazarMANuclear receptor Rev-erbÎ±: up,"/>
   <result pre="4:247â€&quot;61.28831712 15.ChenW, FooSS, SimsNA, et al.Arthritogenic alphaviruses: new insights into" exact="arthritis" post="and bone pathology. Trends Microbiol2015; 23:35â€&quot;43.25449049"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6298241\results\search\disease\results.xml">
   <result pre="KD including fever, rash, mucosal changes, conjunctival erythema, and cervical" exact="lymphadenopathy" post="are all compatible with an infectious illness, and many"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6303045\results\search\disease\results.xml">
   <result pre=": Information Theory: Information Entropy Predicting antigenic variants of H1N1" exact="influenza" post="virus based on epidemics and pandemics using a stacking"/>
   <result pre="are credited.pone.0207777.pdf Abstract H1N1 is the earliest emerging subtype of" exact="influenza" post="A viruses with available genomic sequences, has caused several"/>
   <result pre="variation patterns across periods, which would help assess a new" exact="influenza" post="strainâ€™s antigenicity. Three different feature extraction methods, i.e. residue-based,"/>
   <result pre="It would also facilitate rapid determination of antigenic variants and" exact="influenza" post="surveillance. Funding This study is supported by Ministry of"/>
   <result pre="paper and its Supporting Information files. Introduction Influenza is an" exact="infectious disease" post="that poses significant threat to public health worldwide, especially"/>
   <result pre="poses significant threat to public health worldwide, especially H1N1 of" exact="influenza" post="A virus, which caused several pandemics in history, e.g."/>
   <result pre="and neuraminidase (NA) are the most important proteins that characterize" exact="influenza" post="A viruses [3]. HA is responsible for binding the"/>
   <result pre="assay is the primary method to determine the antigenicity of" exact="influenza" post="viruses and quantitative antibody titers for vaccine selection [7]."/>
   <result pre="constructed an antigenic map to determine the antigenic evolution of" exact="influenza" post="A H3N2 virus from 1968 to 2003 [8]. Lorusso"/>
   <result pre="antigenically divergent [9]. The antigenic patterns and evolution of human" exact="influenza" post="A (H1N1) viruses were investigated by Liu et al.,"/>
   <result pre="[11, 12]. These previous works depicted the evolutionary paths of" exact="influenza" post="and provided the foundation for computational models of antigenicity"/>
   <result pre="identify antigenicity-associated sites in the hemagglutinin protein of A/H1N1 seasonal" exact="influenza" post="virus [14]. Yin et al. detected the potential critical"/>
   <result pre="one of the most crucial factors for the success of" exact="influenza" post="vaccination is the timely determination of emerging influenza virus"/>
   <result pre="success of influenza vaccination is the timely determination of emerging" exact="influenza" post="virus antigenic variants. Sun et al. provided a novel,"/>
   <result pre="al. provided a novel, experimentally validated, computational method for determining" exact="influenza" post="virus antigenicity based on HA sequences [16]. Yao et"/>
   <result pre="et al. proposed a joint random forest method for predicting" exact="influenza" post="H3N2 antigenicity from hemagglutinin sequence data [17]. Qiu et"/>
   <result pre="structural context of HA protein to calculate the antigenicity for" exact="influenza" post="virus A/H3N2 with an accuracy of 0.875 [18]. By"/>
   <result pre="By building a universal model for all HA subtypes of" exact="influenza" post="A viruses based on conserved antigenic structures, Peng et"/>
   <result pre="achieved an accuracy of 0.77 for predicting antigenic variants of" exact="avian influenza" post="H9N2 viruses [19]. Furthermore, Richard Neher et al. showed"/>
   <result pre="an accuracy of 0.77 for predicting antigenic variants of avian" exact="influenza" post="H9N2 viruses [19]. Furthermore, Richard Neher et al. showed"/>
   <result pre="of the viral population, which maps the adaptive history of" exact="influenza" post="A and suggests guidance for vaccine selection [21]. Despite"/>
   <result pre="variants for influenza, most of the models were built for" exact="influenza" post="A/H3N2. There is still insufficient knowledge on the influenza"/>
   <result pre="for influenza A/H3N2. There is still insufficient knowledge on the" exact="influenza" post="H1N1 that caused numerous epidemics all over the world."/>
   <result pre="this study, we built a stacking model to include all" exact="influenza" post="periods of H1N1 based on epidemics and pandemics for"/>
   <result pre="inferring the antigenic relation between H1N1 virus strains. We categorized" exact="influenza" post="strains into two types, pandemic-based and epidemic-based, denoted as"/>
   <result pre="way, we not only classified the antigenic relation of two" exact="influenza" post="strains within a certain period, but also compared antigenic"/>
   <result pre="residue position of HA1 protein for strains, we demonstrated that" exact="influenza" post="H1N1 went through different variations across the periods. Pearson"/>
   <result pre="help facilitate rough determination of antigenic variants, the surveillance of" exact="influenza" post="and as a reference to the selection of vaccine"/>
   <result pre="HI assay data of HA1 viral strains were obtained for" exact="influenza" post="H1N1. As for the sequence dataset of HA1, it"/>
   <result pre="five epitope regions. Model construction As we know that the" exact="influenza" post="strains in different periods may lead to various levels"/>
   <result pre="sites on HA1, which could reflect the variant patterns of" exact="influenza" post="virus antigens. Then, Pearson Correlation Coefficient (PCC) analysis was"/>
   <result pre="two different strains as a pair. Since the evolution of" exact="influenza" post="viruses is in a forward path [32], the strains"/>
   <result pre="evolve within one period to another period chronologically. For example," exact="influenza" post="strains in period 2 could only evolve directly or"/>
   <result pre="a universal model for the prediction of antigenic variants of" exact="influenza" post="H1N1 that can be applied to all types, so"/>
   <result pre="Results The HA1 viral protein, as the main antigen of" exact="influenza" post="viruses, is the immunodominant part of HA segment [36]."/>
   <result pre="in distinct variation patterns could lead to different extent of" exact="influenza" post="outbreaks through years. Fig 2 Position-dependent entropy. Moving average"/>
   <result pre="with a window size of 11 for HA1 protein if" exact="influenza" post="A virus in each period, that is period 2"/>
   <result pre="only attaining 0.05 and 0.03 respectively. It may infer the" exact="influenza" post="H1N1 strains appeared in 1977 Russia flu yielded drastic"/>
   <result pre="the results above suggested the diversity of mutation patterns of" exact="influenza" post="H1N1 in terms of pandemic and epidemic events, and"/>
   <result pre="0.36 0.36 1.00 Our analysis suggested that HA1 proteins of" exact="influenza" post="H1N1 in different periods probably experienced distinct variation patterns."/>
   <result pre="built to predict the antigenic variants of HA1 proteins of" exact="influenza" post="H1N1 for all circumstances. Logistic regression, neural network and"/>
   <result pre="curve of the stacking model predicting the antigenic variants of" exact="influenza" post="A H1N1 virus. Discussion Since the occurrence of 1918"/>
   <result pre="virus. Discussion Since the occurrence of 1918 Spanish pandemic, the" exact="influenza" post="H1N1 has been evolving and circulating up to now."/>
   <result pre="up to now. The rapid mutations of the antigenicity of" exact="influenza" post="A virus are unceasingly causing other epidemics or pandemics"/>
   <result pre="in different periods, which is in accordance with update of" exact="influenza" post="vaccines every year [39â€&quot;41]. Besides, the value of moving"/>
   <result pre="variants. Meanwhile, the mutation pattern analyses demonstrated the diversity of" exact="influenza" post="virus antigens in different periods. Single model was built"/>
   <result pre="that integrated all the situations of antigenic variants prediction of" exact="influenza" post="H1N1 HA1 proteins in different types using all the"/>
   <result pre="obtain good performance on the prediction results based on different" exact="influenza" post="epidemics and pandemics, there are still some space on"/>
   <result pre="and reliability on the prediction of antigenic variants of H1N1" exact="influenza" post="A virus. The analysis also raises the perspective of"/>
   <result pre="select a proper model when predicting the antigenic variants for" exact="influenza" post="viruses in different types with few antigenic data available."/>
   <result pre="can distinguish the formation of epidemics and pandemics caused by" exact="influenza" post="H1N1 viruses. Conclusion In conclusion, we divide the influenza"/>
   <result pre="by influenza H1N1 viruses. Conclusion In conclusion, we divide the" exact="influenza" post="strains of H1N1 epidemic and pandemic events into different"/>
   <result pre="into different periods chronologically. Mutation pattern analysis of HA1 of" exact="influenza" post="A H1N1 proves that the amino acid changes and"/>
   <result pre="construction of the stacking model of prediction antigenic variants of" exact="influenza" post="H1N1 overcomes the challenge of diverse mutation variations, combining"/>
   <result pre="a path on the study of distinct antigenic evolution of" exact="influenza" post="H1N1 virus, but also gives insight on the potential"/>
   <result pre="each type for calculating the antigenic relation between strains of" exact="influenza" post="H1N1 HA proteins. (CSV) LINK Click here for additional"/>
   <result pre="MuellerJ. Updating the accounts: global mortality of the 1918-1920 â€œSpanishâ€�" exact="influenza" post="pandemic. Bulletin of the History of Medicine. 2002;76(1):105â€&quot;115. 10.1353/bhm.2002.002211875246"/>
   <result pre="10.1016/j.jcv.2007.10.01718340670 4RussellRJ, KerryPS, StevensDJ, SteinhauerDA, MartinSR, GamblinSJ, et al.Structure of" exact="influenza" post="hemagglutinin in complex with an inhibitor of membrane fusion."/>
   <result pre="Codon bias and frequency-dependent selection on the hemagglutinin epitopes of" exact="influenza" post="A virus. Proceedings of the National Academy of Sciences."/>
   <result pre="7De JongJ, PalacheA, BeyerW, RimmelzwaanG, BoonA, OsterhausA. Haemagglutination-inhibiting antibody to" exact="influenza" post="virus. Developments in biologicals. 2003;115:63â€&quot;73. 15088777 8SmithDJ, LapedesAS, de"/>
   <result pre="RimmelzwaanGF, OsterhausAD, et al.Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. science. 2004;305(5682):371â€&quot;376. 10.1126/science.109721115218094 9LorussoA, VincentAL, HarlandML, AltD, BaylesDO,"/>
   <result pre="AltD, BaylesDO, SwensonSL, et al.Genetic and antigenic characterization of H1" exact="influenza" post="viruses from United States swine from 2008. Journal of"/>
   <result pre="BarrIG, BroorS, ChadhaM, CoxNJ, et al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic drift. Nature. 2015;523(7559):217â€&quot;220. 10.1038/nature1446026053121 12DuX,"/>
   <result pre="12DuX, DongL, LanY, PengY, WuA, ZhangY, et al.Mapping of H3N2" exact="influenza" post="antigenic evolution in China reveals a strategy for vaccine"/>
   <result pre="of antigenicity-associated sites in the hemagglutinin protein of a/h1n1 seasonal" exact="influenza" post="virus. PloS one. 2015;10(5):e012674210.1371/journal.pone.012674225978416 15Yin R, Zhou X, Ivan"/>
   <result pre="YangG, et al.Using sequence data to infer the antigenicity of" exact="influenza" post="virus. MBio. 2013;4(4):e00230â€&quot;13. 10.1128/mBio.00230-1323820391 17YaoY, LiX, LiaoB, HuangL, HeP,"/>
   <result pre="2013;4(4):e00230â€&quot;13. 10.1128/mBio.00230-1323820391 17YaoY, LiX, LiaoB, HuangL, HeP, WangF, et al.Predicting" exact="influenza" post="antigenicity from Hemagglutintin sequence data based on a joint"/>
   <result pre="structure context of HA protein to improve antigenicity calculation for" exact="influenza" post="virus A/H3N2. Scientific reports. 2016;6:3115610.1038/srep3115627498613 19PengY, WangD, WangJ, LiK,"/>
   <result pre="et al.A universal computational model for predicting antigenic variants of" exact="influenza" post="A virus based on conserved antigenic structures. Scientific Reports."/>
   <result pre="ShraimanBI. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal" exact="influenza" post="viruses. Proceedings of the National Academy of Sciences. 2016;113(12):E1701â€&quot;E1709."/>
   <result pre="2012;40(D1):D13â€&quot;D25. 10.1093/nar/gkr118422140104 24ShuY, McCauleyJ. GISAID: Global initiative on sharing all" exact="influenza" post="dataâ€&quot;from vision to reality. Eurosurveillance. 2017;22(13). 10.2807/1560-7917.ES.2017.22.13.30494 25HirstGK. The"/>
   <result pre="to reality. Eurosurveillance. 2017;22(13). 10.2807/1560-7917.ES.2017.22.13.30494 25HirstGK. The quantitative determination of" exact="influenza" post="virus and antibodies by means of red cell agglutination."/>
   <result pre="10.1084/jem.75.1.4919871167 26NdifonW, DushoffJ, LevinSA. On the use of hemagglutination-inhibition for" exact="influenza" post="surveillance: surveillance data are predictive of influenza vaccine effectiveness."/>
   <result pre="of hemagglutination-inhibition for influenza surveillance: surveillance data are predictive of" exact="influenza" post="vaccine effectiveness. Vaccine. 2009;27(18):2447â€&quot;2452. 10.1016/j.vaccine.2009.02.04719368786 27LiaoYC, LeeMS, KoCY, HsiungCA."/>
   <result pre="LeeMS, KoCY, HsiungCA. Bioinformatics models for predicting antigenic variants of" exact="influenza" post="A/H3N2 virus. Bioinformatics. 2008;24(4):505â€&quot;512. 10.1093/bioinformatics/btm63818187440 28ZacourM, WardBJ, BrewerA, TangP,"/>
   <result pre="A computational analysis of the antigenic properties of haemagglutinin in" exact="influenza" post="A H3N2. Bioinformatics. 2010;26(11):1403â€&quot;1408. 10.1093/bioinformatics/btq16020388627 31DeemMW, PanK. The epitope"/>
   <result pre="Bioinformatics. 2010;26(11):1403â€&quot;1408. 10.1093/bioinformatics/btq16020388627 31DeemMW, PanK. The epitope regions of H1-subtype" exact="influenza" post="A, with application to vaccine efficacy. Protein Engineering, Design"/>
   <result pre="al.Different evolutionary trajectories of European avian-like and classical swine H1N1" exact="influenza" post="A viruses. Journal of virology. 2009;83(11):5485â€&quot;5494. 10.1128/JVI.02565-0819297491 33PolikarR. Ensemble"/>
   <result pre="36RussellR, GamblinS, HaireL, StevensD, XiaoB, HaY, et al.H1 and H7" exact="influenza" post="haemagglutinin structures extend a structural classification of haemagglutinin subtypes."/>
   <result pre="Virology. 2004;325(2):287â€&quot;296. 10.1016/j.virol.2004.04.04015246268 37BurkeDF, SmithDJ. A recommended numbering scheme for" exact="influenza" post="A HA subtypes. PloS one. 2014;9(11):e11230210.1371/journal.pone.011230225391151 38BushRM, BenderCA, SubbaraoK,"/>
   <result pre="38BushRM, BenderCA, SubbaraoK, CoxNJ, FitchWM. Predicting the evolution of human" exact="influenza" post="A. Science. 1999;286(5446):1921â€&quot;1925. 10.1126/science.286.5446.192110583948 39collab: Centers for Disease Control"/>
   <result pre="10.1126/science.286.5446.192110583948 39collab: Centers for Disease Control and Prevention. Updated interim" exact="influenza" post="vaccination recommendationsâ€&quot;2004-05 influenza season. MMWR Morbidity and mortality weekly"/>
   <result pre="for Disease Control and Prevention. Updated interim influenza vaccination recommendationsâ€&quot;2004-05" exact="influenza" post="season. MMWR Morbidity and mortality weekly report. 2004;53(50):118315614237 40FioreAE,"/>
   <result pre="Centers for Disease Control and Prevention. Prevention and control of" exact="influenza" post="with vaccines: recommendations of the Advisory Committee on Immunization"/>
   <result pre="of the Advisory Committee on Immunization Practices (ACIP)â€&quot;United States, 2012-13" exact="influenza" post="season. MMWR Morbidity and mortality weekly report. 2012;61(32):61322895385 42WilsonIA,"/>
   <result pre="report. 2012;61(32):61322895385 42WilsonIA, CoxNJ. Structural basis of immune recognition of" exact="influenza" post="virus hemagglutinin. Annual review of immunology. 1990;8(1):737â€&quot;787. 10.1146/annurev.iy.08.040190.0035132188678 43BlackburneBP,"/>
   <result pre="HayAJ, GoldsteinRA. Changing selective pressure during antigenic changes in human" exact="influenza" post="H3. PLoS pathogens. 2008;4(5):e100005810.1371/journal.ppat.100005818451985 44GÃ¼neÅŸ F, Wolfinger R, Tan"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6318360\results\search\disease\results.xml">
   <result pre="Ihekweazu C, Bock C-T. 2019. Complete genome sequence of a" exact="hepatitis" post="E virus genotype 1e strain from an outbreak in"/>
   <result pre="virus (HEV) is the most common causative agent of acute" exact="viral hepatitis." post="Eight HEV genotypes (HEV-1 to HEV-8) have been described,"/>
   <result pre="views of the funders. References REFERENCES 1.NanY, WuC, ZhaoQ, ZhouEM2017Zoonotic" exact="hepatitis" post="E virus: an ignored risk for public health. Front"/>
   <result pre="doi:10.3389/fmicb.2017.02396.29255453 2.van CuyckH, JugeF, RoquesP2003Phylogenetic analysis of the first complete" exact="hepatitis" post="E virus (HEV) genome from Africa. FEMS Immunol Med"/>
   <result pre="LutgehetmannM, PischkeS, WedermeyerH, HofmannJ, BockCT2018Comprehensive molecular approach for characterization of" exact="hepatitis" post="E virus genotype 3 variants. J Clin Microbiol56:e01686-17. doi:10.1128/JCM.01686-17.29514938"/>
   <result pre="doi:10.1128/JCM.01686-17.29514938 4.WangB, HarmsD, HofmannJ, CiardoD, KneubuhlA, BockCT2017Identification of a novel" exact="hepatitis" post="E virus genotype 3 strain isolated from a chronic"/>
   <result pre="hepatitis E virus genotype 3 strain isolated from a chronic" exact="hepatitis" post="E virus infection in a kidney transplant recipient in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6331147\results\search\disease\results.xml">
   <result pre="Flaviviruses: West Nile virus Molecular characterization of viruses associated with" exact="encephalitis" post="in SÃ£o Paulo, Brazil Molecular characterization of a viral"/>
   <result pre="SÃ£o Paulo, Brazil Molecular characterization of a viral etiology of" exact="encephalitis" post="http://orcid.org/0000-0002-9729-9154FerreiraJerenice E.ConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject administrationResourcesSoftwareSupervisionValidationVisualizationWriting â€&quot; original draftWriting"/>
   <result pre="of this study was to characterize the prevalence of viral" exact="encephalitis" post="due to arbovirus infection of the Togaviridae and Flaviviridae"/>
   <result pre="2012 and January 2013, from patients with symptoms of acute" exact="encephalitis" post="were analyzed. Findings suggestive of viral encephalitisâ€&quot;elevations in cell"/>
   <result pre="tested for Flaviviruses (dengue virus 1, 2, 3 and 4," exact="yellow fever" post="virus and West Nile virus), Alphavirus (NS5 region) and"/>
   <result pre="cases, dengue viruses (DENV) in 2 CSFs and St. Louis" exact="encephalitis" post="virus (SLEV) in one case. In Group 2 there"/>
   <result pre="patients suffer from severe memory disorder, which presents as clinical" exact="dementia" post="[1]. In addition to the personal, family and social"/>
   <result pre="survive, they rarely become productive again [1,2]. The incidence of" exact="encephalitis" post="ranges from 1.5 to 8/100,000 inhabitants, being higher in"/>
   <result pre="under one year of age [3,4]. Viruses known to cause" exact="encephalitis" post="worldwide are herpesviruses, arboviruses and enteroviruses [1]. Arboviruses are"/>
   <result pre="arboviruses and enteroviruses [1]. Arboviruses are the leading cause of" exact="encephalitis" post="worldwide [2]. In developed countries, herpes simplex virus type"/>
   <result pre="the leading cause of encephalitis worldwide [2]. In developed countries," exact="herpes simplex" post="virus type 1 (HSV-1) is the leading cause of"/>
   <result pre="virus type 1 (HSV-1) is the leading cause of sporadic" exact="encephalitis" post="in adults, while Varicella zoster virus (VZV) is responsible"/>
   <result pre="for up to 22% of pediatric cases [1]. Overall, Japanese" exact="encephalitis" post="virus (JEV) is the most prevalent arbovirus associated with"/>
   <result pre="Nile virus (WNV) is the most frequent agent of arbovirus" exact="encephalitis" post="and can be found in parts of Europe, Russia,"/>
   <result pre="Similar to other countries, the most frequent cause of viral" exact="encephalitis" post="in Brazil appears to be HSV- 1, followed by"/>
   <result pre="1â€&quot;4, Rocio virus (ROCV), Iguape virus (IGUV), IlhÃ©us virus (ILHV)," exact="yellow fever" post="virus (YFV) and Saint Louis encephalitis virus (SLEV) have"/>
   <result pre="IlhÃ©us virus (ILHV), yellow fever virus (YFV) and Saint Louis" exact="encephalitis" post="virus (SLEV) have also been reported at low frequency"/>
   <result pre="study was to assess the prevalence of sporadic, non-seasonal viral" exact="encephalitis" post="associated with arbovirus infection of the Togaviridae and Flaviviridae"/>
   <result pre="genders and any age group) with clinical suspicion of acute" exact="encephalitis" post="(at least two of the following symptoms: fever, altered"/>
   <result pre="thousand and one hundred beds [15, 16]. The distribution of" exact="encephalitis" post="cases were from the metropolitan region, coastal and inland"/>
   <result pre="al., for DENV serotype 2 [20]; Mantel et al., for" exact="yellow fever" post="virus- YFV [21]; and Briese et al., for WNV"/>
   <result pre="France) kit was used to identify eight human herpesviruses: HSV-1," exact="herpes simplex" post="virus type 2 (HSV-2), VZV, cytomegalovirus (CMV), Epstein- Barr"/>
   <result pre="Group 2. Identification of a possible viral etiologic agent of" exact="encephalitis" post="was accomplished in only 18 (8.0%) CSF samples from"/>
   <result pre="dengue virus (D-RT-PCR and Real Time PCR); SLEV: Saint Louis" exact="encephalitis" post="virus (D-RT-PCR); HSV-1: Herpes Simplex virus type 1 (CLART-Entherpex);"/>
   <result pre="â€&quot; â€&quot; â€&quot; â€&quot; â€&quot; â€&quot; â€&quot; SLEV: Saint Louis" exact="encephalitis" post="virus. The prevalence of arbovirus-related encephalitis in subjects in"/>
   <result pre="â€&quot; SLEV: Saint Louis encephalitis virus. The prevalence of arbovirus-related" exact="encephalitis" post="in subjects in our study was 2.4%, including 4"/>
   <result pre="prevalence of HSV and a 5.1% prevalence of VZV in" exact="encephalitis" post="patients [25]. In the present study HHV-6 and EBV"/>
   <result pre="and one from SÃ£o Paulo had clinical symptoms consistent with" exact="dengue fever" post="[27â€&quot;29]. Non-human SLEV infections have also been found in"/>
   <result pre="suggest that this virus is not yet a cause of" exact="encephalitis" post="in SÃ£o Paulo. Epidemics of DENV and ZIKV have"/>
   <result pre="suspected cases of encephalitis. Worldwide, &amp;gt;70% of cases of presumptive" exact="encephalitis" post="cases are not associated with any known infectious agent."/>
   <result pre="exposures, remains an additional possibility. This outbreak of 500 presumed" exact="encephalitis" post="cases within a six month period was not registered"/>
   <result pre="we found only a low prevalence of arboviruses in this" exact="encephalitis" post="population, there remains a need to employ molecular tests"/>
   <result pre="in Brazil. Continuous monitoring of arbovirus as a cause of" exact="encephalitis" post="is essential for the adequate treatment of these patients"/>
   <result pre="different viruses in the central nervous system of patients with" exact="meningitis" post="or encephalitis highlights the importance of maintaining a diagnostic"/>
   <result pre="in the central nervous system of patients with meningitis or" exact="encephalitis" post="highlights the importance of maintaining a diagnostic laboratory capable"/>
   <result pre="ColombaniS, MosteC, et al.Standardized quantitative RT-PCR assays for quantitation of" exact="yellow fever" post="and chimeric yellow fever-dengue vaccines. J Virol Methods. 2008;"/>
   <result pre="27SantosCLS, SallumMAM, FrancoHM, OshiroFM, RoccoIM. Genetic characterization of St Louis" exact="encephalitis" post="virus isolated from human in SÃ£o Paulo, Brasil. Mem"/>
   <result pre="LopesO, de Abreu SachettaL, CoimbraTL, PereiraLE. Isolation of St. Louis" exact="encephalitis" post="virus in south Brazil. Am J Trop Med Hyg."/>
   <result pre="208â€&quot;25. 31RosaR, CostaEA, MarquesRE, OliveiraTS, FurtiniR, BomfimMR, et al.Isolation of" exact="saint louis encephalitis" post="virus from a horse with neurological disease in Brazil."/>
   <result pre="CostaEA, MarquesRE, OliveiraTS, FurtiniR, BomfimMR, et al.Isolation of saint louis" exact="encephalitis" post="virus from a horse with neurological disease in Brazil."/>
   <result pre="35HeinenLB, ZuchiN, SerraOP, CardosoBF, GondimBH, Dos SantosMA, et al.Saint Louis" exact="encephalitis" post="virus in Mato Grosso, central-western Brazil. Inst Med Trop"/>
   <result pre="10.1016/j.jcv.2007.06.00717658293 37RoccoIM, SantosCLS, BisordiI, PetrellaSMCN, PereiraLE, SouzaRP, et al.St. Louis" exact="encephalitis" post="virus: first isolation from a human in SÃ£o Paulo"/>
   <result pre="46LeVT, PhanTQ, DoQH, NguyenBH, LamQB, BachV, et al.Viral etiology of" exact="encephalitis" post="in children in southern Vietnam: results of a one-"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6336248\results\search\disease\results.xml">
   <result pre="source are credited.pntd.0006919.pdf Abstract Chikungunya fever (CHIKF) is an emerging" exact="infectious disease" post="caused by an alphavirus transmitted by Aedes spp. mosquitoes."/>
   <result pre="mosquitoes. Infection with CHIKV typically causes a self-limiting febrile illness," exact="chikungunya" post="fever (CHIKF), characterized by chronic, severe joint pain, and"/>
   <result pre="Health Organization (http://www.who.int/emergencies/diseases/chikungunya/en/) and Pan American Health Organization (https://www.paho.org/hq/index.php?option=com_topics&amp;amp;view=article&amp;amp;id=343&amp;amp;Itemid=40931&amp;amp;lang=en). CHIKV," exact="chikungunya" post="virus. Secondly, although the caseâ€&quot;fatality rate of CHIKF is"/>
   <result pre="alphaviruses are not considered neurotropic sensu strictu [18], cases of" exact="meningoencephalitis" post="have been documented, especially during Indian outbreaks [1], and"/>
   <result pre="have been documented, especially during Indian outbreaks [1], and fatal" exact="encephalitis" post="has been reported with CHIKV infection both in Italy"/>
   <result pre="Unlike other mosquito-borne viruses such as dengue, Zika, and even" exact="yellow fever," post="CHIKV typically causes symptomatic infection, and consequently outbreaks are"/>
   <result pre="previously vaccinated with other live-attenuated alphavirus vaccines (i.e., Venezuelan equine" exact="encephalitis" post="virus), suggesting immunological interference [35]. Ultimately, development of this"/>
   <result pre="[49, 50] MV-CHIK Inst. Pasteur, Themis Bioscience Recombinant live- attenuated" exact="measles" post="vaccine expressing CHIKV virus-like particles derived from the structural"/>
   <result pre="preclinical (immunogenicity and efficacy in mice, NHPs) [48] Abbreviations: CHIKF," exact="chikungunya" post="fever; CHIKV, chikungunya virus; EILV, Eilat virus; NHP, nonhuman"/>
   <result pre="efficacy in mice, NHPs) [48] Abbreviations: CHIKF, chikungunya fever; CHIKV," exact="chikungunya" post="virus; EILV, Eilat virus; NHP, nonhuman primate; nsP3, nonstructural"/>
   <result pre="vaccine in advanced stages of clinical development employs an attenuated" exact="measles" post="virus strain as a vector to express the CHIKV"/>
   <result pre="with adequate incidence of CHIKF to demonstrate efficacy. Bottlenecks for" exact="chikungunya" post="vaccine development: Which obstacles should be removed? CHIKF outbreak"/>
   <result pre="long-term protection in endemic locations. Viral-vectored platforms such as vesicular" exact="stomatitis" post="or measles can also be rapidly adapted for new"/>
   <result pre="in endemic locations. Viral-vectored platforms such as vesicular stomatitis or" exact="measles" post="can also be rapidly adapted for new viral targets"/>
   <result pre="endemic for CHIKF, but the typical misdiagnosis of CHIKF as" exact="dengue fever" post="[56] will need to be overcome with improved surveillance"/>
   <result pre="efficacy to human protection. Further work to model arthralgia and" exact="arthritis" post="in NHPs could greatly enhance the value of preclinical"/>
   <result pre="ME, Riccardo F, Severini F, et al. Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017. Euro"/>
   <result pre="et al. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. The"/>
   <result pre="Sitar S, Plummer SH, et al. Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: a phase 1"/>
   <result pre="2014;20(8):1351â€&quot;4. 10.3201/eid2008.13161525061762 7CassadouS, BoucauS, Petit-SinturelM, HucP, Leparc-GoffartI, LedransM. Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin island,"/>
   <result pre=".24721536 8RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliAC, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="Di LucaM, FortunaC, RemoliME, RiccardoF, SeveriniF, et al.Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017. Euro"/>
   <result pre="Vaccine. 2017;35(37):4851â€&quot;8. 10.1016/j.vaccine.2017.07.065 .28760614 14TsetsarkinKA, ChenR, WeaverSC. Interspecies transmission and" exact="chikungunya" post="virus emergence. Curr Opin Virol. 2016;16:143â€&quot;50. 10.1016/j.coviro.2016.02.00726986235 15TsetsarkinKA, ChenR,"/>
   <result pre="ChenR, YunR, RossiSL, PlanteKS, GuerboisM, et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="MakhanM, MoheeputK. Excess mortality as an epidemic intelligence tool in" exact="chikungunya" post="mapping. Euro Surveill. 2008;13(7). Epub 2008/05/01. .18445418 18ArpinoC, CuratoloP,"/>
   <result pre=".26690898 21QueyriauxB, SimonF, GrandadamM, MichelR, TolouH, BoutinJP. Clinical burden of" exact="chikungunya" post="virus infection. Lancet Infect Dis. 2008;8(1):2â€&quot;3. 10.1016/S1473-3099(07)70294-3 .18156079 22SissokoD,"/>
   <result pre="and rheumatoid-like polyarthritis more than 2 years after infection with" exact="chikungunya" post="virus. Postgraduate Med J. 2013;89(1054):440â€&quot;7. 10.1136/postgradmedj-2012-131477 .23645664 24MoroML, GrilliE,"/>
   <result pre="10.1136/postgradmedj-2012-131477 .23645664 24MoroML, GrilliE, CorvettaA, SilviG, AngeliniR, MascellaF, et al.Long-term" exact="chikungunya" post="infection clinical manifestations after an outbreak in Italy: a"/>
   <result pre="2011/06/23. 10.1371/journal.pntd.000119721695162 26Shepard DS. Cost and burden of dengue and" exact="chikungunya" post="from the Americas to Asia. Dengue Bulletin 2010; 34."/>
   <result pre="for South-East Asia, 2010. 27BlochD. The cost and burden of" exact="chikungunya" post="in the Americas. New Haven EliScholar, USA: Yale University;"/>
   <result pre="of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against" exact="chikungunya" post="virus. Vaccine. 2012;30(43):6142â€&quot;9. 10.1016/j.vaccine.2012.07.072 .22884660 32LevittNH, RamsburgHH, HastySE, RepikPM,"/>
   <result pre="HastySE, RepikPM, ColeFE, LuptonHW. Development of an attenuated strain of" exact="chikungunya" post="virus for use in vaccine production. Vaccine. 1986;4(3):157â€&quot;62. 3020820"/>
   <result pre="PerryJG, MangiaficoJA. Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62(6):681â€&quot;5."/>
   <result pre="2014/01/10. 10.1093/infdis/jiu01424403555 41PlanteK, WangE, PartidosCD, WegerJ, GorchakovR, TsetsarkinK, et al.Novel" exact="chikungunya" post="vaccine candidate with an IRES-based attenuation and host range"/>
   <result pre="ThomasSJ, et al.Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet"/>
   <result pre="Dis. 2015;9(10):e000411910.1371/journal.pntd.000411926492074 48ErasmusJH, AugusteAJ, KaelberJT, LuoH, RossiSL, FentonK, et al.A" exact="chikungunya" post="fever vaccine utilizing an insect-specific virus platform. Nat Med."/>
   <result pre="DowdKA, MendozaFH, SaundersJG, SitarS, PlummerSH, et al.Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: a phase 1"/>
   <result pre="CoudercT, NgLF, HallengardD, PowersA, LecuitM, et al.Therapeutics and vaccines against" exact="chikungunya" post="virus. Vector Borne Zoonotic Dis. 2015;15(4):250â€&quot;7. 10.1089/vbz.2014.1681 .25897811 53SinghP,"/>
   <result pre="et al.Current research and clinical trials for a vaccine against" exact="chikungunya" post="virus. Vaccine Development and Therapy. 2013;3:35â€&quot;46. 54WhiteheadSS, SubbaraoK. Which"/>
   <result pre="ShedlockDJ, BaoH, KawalekarOU, FagoneP, RamanathanAA, et al.A DNA vaccine against" exact="chikungunya" post="virus is protective in mice and induces neutralizing antibodies"/>
   <result pre=".29194012 63BrandlerS, RuffieC, CombredetC, BraultJB, NajburgV, PrevostMC, et al.A recombinant" exact="measles" post="vaccine expressing chikungunya virus-like particles is strongly immunogenic and"/>
   <result pre="CombredetC, BraultJB, NajburgV, PrevostMC, et al.A recombinant measles vaccine expressing" exact="chikungunya" post="virus-like particles is strongly immunogenic and protects mice from"/>
   <result pre="is strongly immunogenic and protects mice from lethal challenge with" exact="chikungunya" post="virus. Vaccine. 2013;31(36):3718â€&quot;25. Epub 2013/06/08. 10.1016/j.vaccine.2013.05.086 .23742993 64HallengardD, LumFM,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6346436\results\search\disease\results.xml">
   <result pre="hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and" exact="yellow fever" post="virus by real-time reverse transcription-PCR.J Clin Microbiol. 2002;40:2323â€&quot;30. 10.1128/JCM.40.7.2323-2330.200212089242"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6346475\results\search\disease\results.xml">
   <result pre="infection of urban and peri-urban nonhuman primates with Zika and" exact="chikungunya" post="viruses in Brazil. mSphere. 2018;3:e00523â€&quot;17. 10.1128/mSphere.00523-1729404420 10. CollinsMH, McGowanE,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6360178\results\search\disease\results.xml">
   <result pre="with these terms. Abstract Several mosquito-borne Flaviviruses such as Japanese" exact="encephalitis" post="virus (JEV), West Nile virus (WNV), Dengue Virus (DENV),"/>
   <result pre="unknown (Simmonds et al., 2017). Some Flaviviruses such as Japanese" exact="encephalitis" post="virus (JEV) infect a broad range of vertebrate hosts"/>
   <result pre="and 2) viruses. Virology485, 189â€&quot;198. 10.1016/j.virol.2015.07.01526280469 CaoS.LiY.YeJ.YangX.ChenL.LiuX.et al.. (2011). Japanese" exact="encephalitis" post="Virus wild strain infection suppresses dendritic cells maturation and"/>
   <result pre="CoetzerJ. A.BarnardB. J. (1977). Hydrops amnii in sheep associated with" exact="hydranencephaly" post="and arthrogryposis with wesselsbron disease and rift valley fever"/>
   <result pre="sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and" exact="rift valley fever" post="viruses as aetiological agents. Onderstepoort J. Vet. Res.44, 119â€&quot;126."/>
   <result pre="reservoirs for flaviviruses (yellow fever, dengue 2 and St Louis" exact="encephalitis" post="viruses) in French Guiana. Trans. R. Soc. Trop. Med."/>
   <result pre="365â€&quot;369. 10.1016/j.vetmic.2015.02.00525724332 Espada-MuraoL. A.MoritaK. (2011). Delayed cytosolic exposure of Japanese" exact="encephalitis" post="virus double-stranded RNA impedes interferon activation and enhances viral"/>
   <result pre="Res.179, 204â€&quot;211. 10.1016/j.virusres.2013.08.00924220223 Garcia-NicolasO.RicklinM. E.LinigerM.VielleN. J.PythonS.SouqueP.et al.. (2017). A Japanese" exact="encephalitis" post="virus vaccine inducing antibodies strongly enhancing in vitro infection"/>
   <result pre="Italy. Clin. Microbiol. Infect.23, 33â€&quot;37. 10.1016/j.cmi.2016.09.01927677699 GuptaN.HegdeP.LecerfM.NainM.KaurM.KaliaM.et al.. (2014). Japanese" exact="encephalitis" post="virus expands regulatory T cells by increasing the expression"/>
   <result pre="of domestic pigs to West Nile virus followed by Japanese" exact="encephalitis" post="virus infection and vice versa. Acta Virol.38, 157â€&quot;161. 7817897"/>
   <result pre="is critical for infection by the virulent strain of Japanese" exact="encephalitis" post="virus. Cell. Microbiol.13, 1358â€&quot;1370. 10.1111/j.1462-5822.2011.01624.x21707907 ManokaranG.FinolE.WangC.GunaratneJ.BahlJ.OngE. Z.et al.. (2015)."/>
   <result pre="Science350, 217â€&quot;221. 10.1126/science.aab336926138103 MansfieldK. L.Hernandez-TrianaL. M.BanyardA. C.FooksA. R.JohnsonN. (2017). Japanese" exact="encephalitis" post="virus infection, diagnosis and control in domestic animals. Vet."/>
   <result pre="RicklinM. E.Garcia-NicolasO.BrechbuhlD.PythonS.ZumkehrB.NougairedeA.et al.. (2016). Vector-free transmission and persistence of Japanese" exact="encephalitis" post="virus in pigs. Nat. Commun.7:10832. 10.1038/ncomms1083226902924 SantiniM.Vilibic-CavlekT.BarsicB.BarbicL.SavicV.StevanovicV.et al.. (2015)."/>
   <result pre="ShimojimaM.TakenouchiA.ShimodaH.KimuraN.MaedaK. (2014). Distinct usage of three C-type lectins by Japanese" exact="encephalitis" post="virus: DC-SIGN, DC-SIGNR, and LSECtin. Arch. Virol.159, 2023â€&quot;2031. 10.1007/s00705-014-2042-224623090"/>
   <result pre="SooryanarainH.SapkalG. N.GoreM. M. (2012). Pathogenic and vaccine strains of Japanese" exact="encephalitis" post="virus elicit different levels of human macrophage effector functions."/>
   <result pre="(2001). Highly sulfated forms of heparin sulfate are involved in" exact="japanese encephalitis" post="virus infection. Virology286, 206â€&quot;215. 10.1006/viro.2001.098611448173 SummerfieldA.HornM. P.LozanoG.CarrascoC. P.AtzeK.McCulloughK. (2003)."/>
   <result pre="Highly sulfated forms of heparin sulfate are involved in japanese" exact="encephalitis" post="virus infection. Virology286, 206â€&quot;215. 10.1006/viro.2001.098611448173 SummerfieldA.HornM. P.LozanoG.CarrascoC. P.AtzeK.McCulloughK. (2003)."/>
   <result pre="Virol.150, 1249â€&quot;1256. 10.1007/s00705-004-0478-515770358 ThongtanT.WikanN.WintachaiP.RattanarungsanC.SrisomsapC.CheepsunthornP.et al.. (2012). Characterization of putative Japanese" exact="encephalitis" post="virus receptor molecules on microglial cells. J. Med. Virol.84,"/>
   <result pre="microglial cells. J. Med. Virol.84, 615â€&quot;623. 10.1002/jmv.2324822337301 TurtleL.SolomonT. (2018). Japanese" exact="encephalitis" post="- the prospects for new treatments. Nat. Rev. Neurol.14,"/>
   <result pre="WangP.HuK.LuoS.ZhangM.DengX.LiC.et al.. (2016). DC-SIGN as an attachment factor mediates Japanese" exact="encephalitis" post="virus infection of human dendritic cells via interaction with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6366427\results\search\disease\results.xml">
   <result pre="from unknown fever were used for screening of six arboviruses," exact="hepatitis" post="E virus and malarial using molecular techniques and serology.Â"/>
   <result pre="was 61.3% (73/119). The highest positivity rate was 73.1% (52/73)" exact="chikungunya" post="virus; 29 males and 20 females patients were chikungunya"/>
   <result pre="(52/73) chikungunya virus; 29 males and 20 females patients were" exact="chikungunya" post="positive. OtherÂ arbovirusesÂ were circulating in low rate 20.5%"/>
   <result pre="low rate 20.5% (15/73), and 6.8% (5/73) for sindbis and" exact="rift valley fever" post="viruses respectively. Hepatitis E virus was negative in all"/>
   <result pre="respectively. Hepatitis E virus was negative in all cases and" exact="malaria" post="positivity rate 13.4% (16/119). The prevalence of arboviruses among"/>
   <result pre="of eastern region in Sudan is significantly high (61.3%). The" exact="chikungunya" post="virus is the predominant causative agent of arboviruses. Molecular"/>
   <result pre="diagnosis of this viral outbreak. KEYWORDS Arthropod-transmitted viruses mosquito-borne viruses" exact="chikungunya" post="virus Sindbis virus molecular techniques Funding Research Centre of"/>
   <result pre="socioeconomic consequences [2â€&quot;5]. Mosquito-borne viruses affecting humans, these viruses include:" exact="chikungunya" post="(CHIKV), dengue fever (DFV), yellow fever (YFV), Rift Valley"/>
   <result pre="[2â€&quot;5]. Mosquito-borne viruses affecting humans, these viruses include: chikungunya (CHIKV)," exact="dengue fever" post="(DFV), yellow fever (YFV), Rift Valley fever virus (RVFV),"/>
   <result pre="affecting humans, these viruses include: chikungunya (CHIKV), dengue fever (DFV)," exact="yellow fever" post="(YFV), Rift Valley fever virus (RVFV), Sindbis virus (SINV),"/>
   <result pre="virus (RVFV), Sindbis virus (SINV), and alkhurma viruses [2,6â€&quot;9]. Dengue," exact="yellow fever," post="chikungunya, Rift Valley fever, alkhurma haemorrhagic fever, and Sindbis"/>
   <result pre="be interfere with other parasitic or non-parasitic infections such as" exact="malaria" post="or bacterial meningitis. Most of arbovirus infections could be"/>
   <result pre="with other parasitic or non-parasitic infections such as malaria or" exact="bacterial meningitis." post="Most of arbovirus infections could be seriously severe, resulting"/>
   <result pre="its enzootic hosts by mosquitoes, and causes polyarthritis, fever, and" exact="rash" post="[23,24] Hantaviruses have almost entirely been associated with human"/>
   <result pre="period from November 2010 to March 2011 an outbreak of" exact="hepatitis" post="E virus (HEV) among pregnant women presented at Port"/>
   <result pre="hypothesized that some of febrile patients who frequently diagnosed as" exact="malaria" post="patients may harbour one or more of the viral"/>
   <result pre="was divided into: 1.5 mL anticoagulant EDTA containers for performing" exact="malaria" post="rapid diagnostic test and the rest whole blood sample"/>
   <result pre="RVFV, CHIKV, and SINV infections. Most samples were positive for" exact="chikungunya" post="and Sindbis (73.1% and 19.4%, respectively). Out of the"/>
   <result pre="Out of the 73 arboviruses-positive samples, 49 were positive for" exact="chikungunya" post="(29 males and 20 females). In contrast to this,"/>
   <result pre="as RVFV (7.4%). Results also revealed that both SINV and" exact="malaria" post="parasite shared the same positive proportions among the detected"/>
   <result pre="by SINV 10.92% cases and RVFV (P Ë‚Â 0.05). However," exact="malaria" post="was more dominant than RVFV, representing 10.92% cases (Figure"/>
   <result pre="10.92% cases (Figure 1). The distribution of arboviruses, HEV, and" exact="malaria" post="infection for all patients presented to the hospital with"/>
   <result pre="been summarized in Table 1. 10.1080/19932820.2018.1564511-T0001Table 1. Distribution of arboviruses," exact="hepatitis" post="E virus and malaria for all the patients with"/>
   <result pre="1. 10.1080/19932820.2018.1564511-T0001Table 1. Distribution of arboviruses, hepatitis E virus and" exact="malaria" post="for all the patients with unknown fever. Infection Children"/>
   <result pre="73.1% (52/73) CHIKV; 29 male and 20 female patients were" exact="chikungunya" post="positive. CHIKV, SINV, and RVFV in using qRT-PCR, whereas"/>
   <result pre="CHIKV, and SINV infections, previous studies shown that infection with" exact="chikungunya" post="and Sindbis viruses characterize by specific symptoms such as"/>
   <result pre="show high rates of malarial parasite infection. High prevalence of" exact="malaria" post="is usually observed in children [49]; however, in this"/>
   <result pre="usually observed in children [49]; however, in this study, most" exact="malaria" post="patients were adults (10 patients); however, only three children"/>
   <result pre="patients were adults (10 patients); however, only three children had" exact="malaria" post="positive. The African continent has witnessed a long-term decline"/>
   <result pre="witnessed a long-term decline in the prevalence of Plasmodium falciparum," exact="malaria" post="burden in the six endemic countries (Afghanistan, Djibouti, Pakistan,"/>
   <result pre="Virol J. 2016;13:144.27565893 [8]AhmedSS, SoghaierMA, MohammedS, et alConcomitant outbreaks of" exact="yellow fever" post="and hepatitis E virus in Darfur States, Sudan, 2012."/>
   <result pre="[8]AhmedSS, SoghaierMA, MohammedS, et alConcomitant outbreaks of yellow fever and" exact="hepatitis" post="E virus in Darfur States, Sudan, 2012. J Infect"/>
   <result pre="to 2011. Vector Borne Zoonotic Dis. 2015;15(8):502â€&quot;511.26273812 [15]QuichaudJThe epidemiology of" exact="yellow fever" post="in Africa. Sem Med Prof Med Soc. 1955;31(38):1179â€&quot;1181.13290801 [16]MahaffyAFThe"/>
   <result pre="Africa. Sem Med Prof Med Soc. 1955;31(38):1179â€&quot;1181.13290801 [16]MahaffyAFThe epidemiology of" exact="yellow fever" post="in Central Africa. Trans R Soc Trop Med Hyg."/>
   <result pre="Zoonotic Dis. 2016;16(4):290â€&quot;291.26974266 [22]GouldLH, OsmanMS, FarnonEC, et alAn outbreak of" exact="yellow fever" post="with concurrent chikungunya virus transmission in South Kordofan, Sudan,"/>
   <result pre="OsmanMS, FarnonEC, et alAn outbreak of yellow fever with concurrent" exact="chikungunya" post="virus transmission in South Kordofan, Sudan, 2005. Trans R"/>
   <result pre="Epidemiol Rec2007, 82(48):417â€&quot;418. [32]RayisDA, JumaaAM, GasimGI, et alAn outbreak of" exact="hepatitis" post="E and high maternal mortality at Port Sudan, Eastern"/>
   <result pre="Sudan, Eastern Sudan. Pathog Glob Health. 2013;107(2):66â€&quot;68.23683332 [33]EldumaAH, OsmanWMDengue and" exact="hepatitis" post="E virus infection in pregnant women in Eastern Sudan,"/>
   <result pre="Clin Virol. 2013;56(4):280â€&quot;285.23290388 [35]GyarmatiP, MohammedN, NorderH, et alUniversal detection of" exact="hepatitis" post="E virus by two real-time PCR assays: taqMan and"/>
   <result pre="alFour dengue virus serotypes found circulating during an outbreak of" exact="dengue fever" post="and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004."/>
   <result pre="Front Public Health. 2014;2:169.25340047 [43]EldigailMH, AdamGK, BabikerRA, et alPrevalence of" exact="dengue fever" post="virus antibodies and associated risk factors among residents of"/>
   <result pre="2016. Virusdisease. 2018;29(3):303â€&quot;307.30159364 [49]KayentaoK, FloreyLS, MihigoJ, et alImpact evaluation of" exact="malaria" post="control interventions on morbidity and all-cause child mortality in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6369168\results\search\disease\results.xml">
   <result pre="In September 1998, there was an outbreak of severe febrile" exact="encephalitis" post="among pig farmers in the state of Perak, Malaysia,"/>
   <result pre="These deaths were initially thought to be due to Japanese" exact="encephalitis" post="(JE), an endemic disease in Malaysia. However, with most"/>
   <result pre="following month, there were 11 cases of respiratory illness and" exact="encephalitis" post="amongst Singapore abattoir workers who had handled pigs imported"/>
   <result pre="respiratory and neurological syndromeâ€� (also known as â€œporcine respiratory and" exact="encephalitis" post="syndromeâ€�), or, in peninsular Malaysia, â€œbarking pig syndromeâ€� (28)."/>
   <result pre="The experimental viral vectored vaccine candidates for NiV include vesicular" exact="stomatitis" post="virus, rabies virus, canarypox virus (ALVAC strain), adeno-associated virus"/>
   <result pre="viral vectored vaccine candidates for NiV include vesicular stomatitis virus," exact="rabies" post="virus, canarypox virus (ALVAC strain), adeno-associated virus (AAV), measles"/>
   <result pre="virus, rabies virus, canarypox virus (ALVAC strain), adeno-associated virus (AAV)," exact="measles" post="virus, Newcastle disease virus (NDV) and Venezuelan equine encephalitis"/>
   <result pre="(AAV), measles virus, Newcastle disease virus (NDV) and Venezuelan equine" exact="encephalitis" post="virus (40). ALVAC expressing NiV G or F (ALVAC-G"/>
   <result pre="Fund manages vaccine banks and the delivery of vaccines for" exact="avian influenza," post="rabies, foot-and-mouth disease, and peste de petit ruminants (46)."/>
   <result pre="play a major component in an emergency response against emerging" exact="infectious disease," post="with the main aim to reduce virus spread between"/>
   <result pre="the development of new human vaccines to prevent and contain" exact="infectious disease" post="epidemics. CEPI selected NiV, Lassa virus and Middle East"/>
   <result pre="cell-mediated responses (53). In 2015, a vaccine to protect against" exact="anthrax" post="was the first to be approved through the â€œanimal"/>
   <result pre="growing appreciation that pigs provide a superior animal model for" exact="influenza" post="A virus infection and immunity and should play a"/>
   <result pre="play a more prominent role as a model for human" exact="influenza" post="vaccine development (65). The success of the pig as"/>
   <result pre="at: https://www.cdc.gov/vhf/nipah/outbreaks/distribution-map.html (Accessed August 21, 2018). 10.HsuVPHossainMJParasharUDAliMMKsiazekTGKuzminIet al.. Nipah virus" exact="encephalitis" post="reemergence, Bangladesh. Emerging Infect Dis. (2004) 10:2082â€&quot;7. 10.3201/eid1012.04070115663842 11.DonaldsonHLuceyD."/>
   <result pre="zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe" exact="encephalitis" post="in Malaysia. J Infect Dis. (2000) 181:1755â€&quot;9. 10.1086/31545710823779 18.HuynhTTAarninkAJDruckerAVerstegenMWPig"/>
   <result pre="emergent deadly Paramyxovirus. Science (2000) 288:1432â€&quot;5. 10.1126/science.288.5470.143210827955 20.LamSKChuaKB. Nipah virus" exact="encephalitis" post="outbreak in Malaysia. Clin Infect Dis. (2002) 34(Suppl. 2):S48â€&quot;51."/>
   <result pre="Virol. (2006) 80:7929â€&quot;38. 10.1128/jvi.00263-0616873250 42.KongDWenZSuHGeJChenWWangXet al.. Newcastle disease virus-vectored Nipah" exact="encephalitis" post="vaccines induce B and T cell responses in mice"/>
   <result pre="pneumonia. Eur Respir J. (2009) 33:182â€&quot;8. 10.1183/09031936.0004630819118229 62.KhatriMDwivediVKrakowkaSManickamCAliAWangLFet al.. Swine" exact="influenza" post="H1N1 virus induces acute inflammatory immune responses in pig"/>
   <result pre="in pig lungs: a potential animal model for human H1N1" exact="influenza" post="virus. J Virol. (2010) 84:11210â€&quot;8. 10.1128/jvi.01211-1020719941 63.MeurensFSummerfieldANauwynckHSaifLGerdtsV. The pig:"/>
   <result pre="J. (2009) 181:211â€&quot;20. 10.1016/j.tvjl.2008.10.01619084436 65.RajaoDSVincentAL. Swine as a model for" exact="influenza" post="A virus infection and immunity. ILAR J. (2015) 56:44â€&quot;52."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6370227\results\search\disease\results.xml">
   <result pre="original author and source are credited.pbio.3000124.pdf Abstract The eradication of" exact="smallpox" post="is one of the greatest medical successes in history."/>
   <result pre="death and disease in the modern world. The eradication of" exact="smallpox" post="was one of the greatest medical successes in history."/>
   <result pre="ever exist. With a devastating 20% to 60% mortality rate," exact="smallpox" post="killed an estimated 300 million people in the 20th"/>
   <result pre="commonly recognised at the time that milkmaids, who would catch" exact="cowpox" post="from their cattle, never died of smallpox. The English"/>
   <result pre="nonlethal yet close relative of variola virus and showed that" exact="cowpox" post="infection protected a person from smallpox. However, it took"/>
   <result pre="of the devastating killer [1,2]. Health officials subsequently stopped routine" exact="smallpox" post="vaccinations because the risk of using a live virus"/>
   <result pre="me from smallpox. In fact, for most people alive today," exact="vaccinia virus" post="is simply the vaccine once used to protect people"/>
   <result pre="established a research project to study the fundamental biology of" exact="vaccinia virus." post="I was excited to study vaccinia because, independent of"/>
   <result pre="VRKs are implicated in several cancers including liver, lung, and" exact="breast cancer" post="[4â€&quot;6]. As a result, this kinase family serves as"/>
   <result pre="are implicated in several cancers including liver, lung, and breast" exact="cancer" post="[4â€&quot;6]. As a result, this kinase family serves as"/>
   <result pre="result, this kinase family serves as potential targets for developing" exact="cancer" post="therapeutics, with comparative studies of vaccinia B1 still guiding"/>
   <result pre="dimensions of 350 nm Ã— 250 nm Ã— 250 nm," exact="vaccinia virus" post="is large (for a virus!) and can be easily"/>
   <result pre="known to be employed by 20 clinically relevant viruses, including" exact="chikungunya" post="virus, dengue virus, hepatitis A virus, Lassa virus, Marburg"/>
   <result pre="by 20 clinically relevant viruses, including chikungunya virus, dengue virus," exact="hepatitis" post="A virus, Lassa virus, Marburg virus, and Ebola virus"/>
   <result pre="limit of the microscope. Fig 1 An electron micrograph of" exact="vaccinia virus." post="The three subviral structures, core (C), lateral bodies (L),"/>
   <result pre="will be able to see and understand. The eradication of" exact="smallpox" post="was undeniably a world-changing accomplishment, but vaccinia virus is"/>
   <result pre="The eradication of smallpox was undeniably a world-changing accomplishment, but" exact="vaccinia virus" post="is more than simply the vaccine that enabled this"/>
   <result pre="Vaccinia has a lot more biology to teach us. With" exact="vaccinia virus" post="as a tool, poxvirologists all over the world are"/>
   <result pre="vaccinia-related kinase References References 1RiedelS.Edward Jenner and the history of" exact="smallpox" post="and vaccination. Proc (Bayl Univ Med Cent)2005, 18, 21â€&quot;25.16200144"/>
   <result pre="putative serine/threonine kinases, vrk1 and vrk2, with structural similarity to" exact="vaccinia virus" post="b1r kinase. Genomics1997, 45, 327â€&quot;331. 9344656 4KimS.H.; RyuH.G.; LeeJ.;"/>
   <result pre="anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in" exact="lung cancer" post="cells. Sci Rep2015, 5, 1457010.1038/srep1457026412148 5SalzanoM.; Vazquez-CedeiraM.; Sanz-GarciaM.; ValbuenaA.;"/>
   <result pre="activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung" exact="cancer" post="cells. Sci Rep2015, 5, 1457010.1038/srep1457026412148 5SalzanoM.; Vazquez-CedeiraM.; Sanz-GarciaM.; ValbuenaA.;"/>
   <result pre="kinase 1 (vrk1) confers resistance to DNA-damaging agents in human" exact="breast cancer" post="by affecting DNA damage response. Oncotarget2014, 5, 1770â€&quot;1778. 10.18632/oncotarget.167824731990"/>
   <result pre="1 (vrk1) confers resistance to DNA-damaging agents in human breast" exact="cancer" post="by affecting DNA damage response. Oncotarget2014, 5, 1770â€&quot;1778. 10.18632/oncotarget.167824731990"/>
   <result pre="al.High vrk1 expression contributes to cell proliferation and survival in" exact="hepatocellular carcinoma." post="Pathol Res Pract2016, 212, 171â€&quot;178. 10.1016/j.prp.2015.11.01526706601 7OlsonA.T.; RicoA.B.; WangZ.;"/>
   <result pre="212, 171â€&quot;178. 10.1016/j.prp.2015.11.01526706601 7OlsonA.T.; RicoA.B.; WangZ.; DelhonG.; WiebeM.S.Deletion of the" exact="vaccinia virus" post="b1 kinase reveals essential functions of this enzyme complemented"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6370234\results\search\disease\results.xml">
   <result pre="outbreak of exanthematous febrile illness complicated by Guillain-Barre syndrome (GBS)," exact="microcephaly" post="and other birth defects [1]. ZIKV was first discovered"/>
   <result pre="flavivirus naÃ¯ve, as determined by seronegativity to DENV, ZIKV, Japanese" exact="encephalitis" post="virus (JEV), West Nile Virus (WNV) and yellow fever"/>
   <result pre="ZIKV, Japanese encephalitis virus (JEV), West Nile Virus (WNV) and" exact="yellow fever" post="virus (YFV)[30]. In the DENV-exposed group, DENV exposure occurred"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6373151\results\search\disease\results.xml">
   <result pre="Case Report A case report of a teenager with severe" exact="hand, foot, and mouth disease" post="with brainstem encephalitis caused by enterovirus 71 ChenYing-FuHuLan+86-15823308699kldhl629@126.comXuFengxufeng9899@163.comLiuCheng-junliucwd@163.comLiJinglijingwangyi@126.com[], 0000"/>
   <result pre="case report of a teenager with severe hand, foot, and" exact="mouth disease" post="with brainstem encephalitis caused by enterovirus 71 ChenYing-FuHuLan+86-15823308699kldhl629@126.comXuFengxufeng9899@163.comLiuCheng-junliucwd@163.comLiJinglijingwangyi@126.com[], 0000"/>
   <result pre="teenager with severe hand, foot, and mouth disease with brainstem" exact="encephalitis" post="caused by enterovirus 71 ChenYing-FuHuLan+86-15823308699kldhl629@126.comXuFengxufeng9899@163.comLiuCheng-junliucwd@163.comLiJinglijingwangyi@126.com[], 0000 0000 8653 0555grid.203458.8Intensive"/>
   <result pre="this article, unless otherwise stated. Abstract Background Hand, foot, and" exact="mouth disease" post="(HFMD) is an acute viral infection occurring mostly in"/>
   <result pre="be life-saving in these patients. Keywords HFMD Enterovirus 71 Brainstem" exact="encephalitis" post="Teenager patient Background Hand, foot, and mouth disease (HFMD)"/>
   <result pre="Enterovirus 71 Brainstem encephalitis Teenager patient Background Hand, foot, and" exact="mouth disease" post="(HFMD) is an acute viral infection occurring mostly in"/>
   <result pre="associated with severe and sometimes fatal neurological complications such as" exact="aseptic meningitis," post="acute flaccid paralysis, encephalitis, and neurogenic pulmonary edema. There"/>
   <result pre="such as aseptic meningitis, acute flaccid paralysis, encephalitis, and neurogenic" exact="pulmonary edema." post="There are very limited reports of neurological manifestations in"/>
   <result pre="on June 30, 2014 with a history of fever, skin" exact="rash" post="over hand and feet, headache, and weakness in lower"/>
   <result pre="IgM antibodies against Enterovirus, Herpes simplex virus, Cossack virus, and" exact="measles" post="virus. EV71 RNA, but not CVA16, was detected in"/>
   <result pre="clinical symptoms, a diagnosis of severe HFMD with brain stem" exact="encephalitis" post="was established by specialists in the Department of Neurology"/>
   <result pre="performed on day 3. The results were indicative of diffuse" exact="encephalopathy" post="with mixed delta and theta wave activity in the"/>
   <result pre="movement, and intelligence). Discussion and conclusions HFMD is an acute" exact="infectious disease" post="caused by a group of enteroviruses, among which EV71"/>
   <result pre="to develop severe complications such as meningitis, encephalitis, encephalomyelitis, neurogenic" exact="pulmonary edema," post="and circulatory failure [3]. Since the first report in"/>
   <result pre="severe, potentially life-threatening complications in children, such as brainstem encephalitis," exact="aseptic meningitis," post="encephalitis, flaccid paralysis, heart failure, and lung failure [11]."/>
   <result pre="neurological complications [3, 8]. Brainstem encephalitis, a distinctive form of" exact="encephalitis" post="with typical neuropathological characteristics, has been the hallmark of"/>
   <result pre="and sluggish pupillary light reflex. The diagnosis of brain stem" exact="encephalitis" post="was established based on the above clinical symptoms by"/>
   <result pre="Enterovirus 71 HEVA Human Enterovirus A HFMD Hand, foot, and" exact="mouth disease" post="PICU Paediatric intensive care unit RT-PCR Reverse-transcriptase-polymerase chain reaction"/>
   <result pre="maps and institutional affiliations. References References 1.DowningCRamirez-FortMKDoanHQet al.Coxsackievirus A6 associated" exact="hand, foot and mouth disease" post="in adults: clinical presentation and review of the literatureJ"/>
   <result pre="affiliations. References References 1.DowningCRamirez-FortMKDoanHQet al.Coxsackievirus A6 associated hand, foot and" exact="mouth disease" post="in adults: clinical presentation and review of the literatureJ"/>
   <result pre="2.NguyenNTPhamHVHoangCQet al.Epidemiological and clinical characteristics of children who died from" exact="hand, foot and mouth disease" post="in Vietnam, 2011BMC Infect Dis2014181434110.1186/1471-2334-14-341 3.OoiMHWongSCMohanAet al.Identification and validation"/>
   <result pre="clinical characteristics of children who died from hand, foot and" exact="mouth disease" post="in Vietnam, 2011BMC Infect Dis2014181434110.1186/1471-2334-14-341 3.OoiMHWongSCMohanAet al.Identification and validation"/>
   <result pre="predictors for the risk of neurological involvement in children with" exact="hand, foot, and mouth disease" post="in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic hand, foot and"/>
   <result pre="risk of neurological involvement in children with hand, foot, and" exact="mouth disease" post="in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic hand, foot and"/>
   <result pre="foot, and mouth disease in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic" exact="hand, foot and mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis200391788510.3201/eid1301.02011212533285 5.JeeYMCheonDSKimKet"/>
   <result pre="disease in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic hand, foot and" exact="mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis200391788510.3201/eid1301.02011212533285 5.JeeYMCheonDSKimKet"/>
   <result pre="2000Arch Virol200314891735174610.1007/s00705-003-0133-614505086 6.ChanLGParasharUDLyeMSet al.Deaths of children during an outbreak of" exact="hand, foot, and mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="al.Deaths of children during an outbreak of hand, foot, and" exact="mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="for the outbreak study groupClin Infect Dis200031367868310.1086/31403211017815 7.FujimotoTChikahiraMYoshidaSet al.Outbreak of" exact="central nervous system disease" post="associated with hand, foot, and mouth disease in Japan"/>
   <result pre="the outbreak study groupClin Infect Dis200031367868310.1086/31403211017815 7.FujimotoTChikahiraMYoshidaSet al.Outbreak of central" exact="nervous system disease" post="associated with hand, foot, and mouth disease in Japan"/>
   <result pre="Dis200031367868310.1086/31403211017815 7.FujimotoTChikahiraMYoshidaSet al.Outbreak of central nervous system disease associated with" exact="hand, foot, and mouth disease" post="in Japan during the summer of 2000: detection and"/>
   <result pre="of central nervous system disease associated with hand, foot, and" exact="mouth disease" post="in Japan during the summer of 2000: detection and"/>
   <result pre="of enterovirus 71Microbiol Immunol200246962162710.1111/j.1348-0421.2002.tb02743.x12437029 8.TuPVThaoNTPereraDet al.Epidemiologic and virologic investigation of" exact="hand, foot, and mouth disease," post="southern Vietnam, 2005Emerg Infect Dis200713111733174110.3201/eid1311.07063218217559 9.LiuCCTsengHWWangSMet al.An outbreak of"/>
   <result pre="Immunol200246962162710.1111/j.1348-0421.2002.tb02743.x12437029 8.TuPVThaoNTPereraDet al.Epidemiologic and virologic investigation of hand, foot, and" exact="mouth disease," post="southern Vietnam, 2005Emerg Infect Dis200713111733174110.3201/eid1311.07063218217559 9.LiuCCTsengHWWangSMet al.An outbreak of"/>
   <result pre="characterization of enterovirus infections among pediatric patients with hand foot" exact="mouth disease," post="herpangina and influenza like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237"/>
   <result pre="enterovirus infections among pediatric patients with hand foot mouth disease," exact="herpangina" post="and influenza like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237 12.XingWLiaoQViboudCet"/>
   <result pre="among pediatric patients with hand foot mouth disease, herpangina and" exact="influenza" post="like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237 12.XingWLiaoQViboudCet al.Hand, foot,"/>
   <result pre="like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237 12.XingWLiaoQViboudCet al.Hand, foot, and" exact="mouth disease" post="in China, 2008â€&quot;12:an epidemiological studyLancet Infect Dis201414430831810.1016/S1473-3099(13)70342-624485991 13.AngLWKohBKChanKPet al.Epidemiology"/>
   <result pre="2008â€&quot;12:an epidemiological studyLancet Infect Dis201414430831810.1016/S1473-3099(13)70342-624485991 13.AngLWKohBKChanKPet al.Epidemiology and control of" exact="hand, foot and mouth disease" post="in Singapore, 2001-2007Ann Acad Med Singap200938210611219271036 14.WangYZouGXiaAet al.Enterovirus 71"/>
   <result pre="Infect Dis201414430831810.1016/S1473-3099(13)70342-624485991 13.AngLWKohBKChanKPet al.Epidemiology and control of hand, foot and" exact="mouth disease" post="in Singapore, 2001-2007Ann Acad Med Singap200938210611219271036 14.WangYZouGXiaAet al.Enterovirus 71"/>
   <result pre="Acad Med Singap200938210611219271036 14.WangYZouGXiaAet al.Enterovirus 71 infection in children with" exact="hand, foot, and mouth disease" post="in Shanghai, China: epidemiology, clinical feature and diagnosisVirol J2015128310.1186/s12985-015-0308-226036928"/>
   <result pre="14.WangYZouGXiaAet al.Enterovirus 71 infection in children with hand, foot, and" exact="mouth disease" post="in Shanghai, China: epidemiology, clinical feature and diagnosisVirol J2015128310.1186/s12985-015-0308-226036928"/>
   <result pre="anti-enterovirus 71 IgM in children with severe hand, food and" exact="mouth disease" post="induced by enterovirus 71 infection and its clinical significanceZhonghua"/>
   <result pre="its clinical significanceZhonghua Er Ke Za Zhi201553535535926080665 16.KhanhTHSabanathanSThanhTTet al.Enterovirus 71-associated" exact="hand, foot, and mouth disease," post="southern Vietnam, 2011Emerg Infect Dis201218122002200510.3201/eid1812.12092923194699 17.KaminskaKMartinettiGLucchiniRet al.Coxsackievirus A6 and"/>
   <result pre="Er Ke Za Zhi201553535535926080665 16.KhanhTHSabanathanSThanhTTet al.Enterovirus 71-associated hand, foot, and" exact="mouth disease," post="southern Vietnam, 2011Emerg Infect Dis201218122002200510.3201/eid1812.12092923194699 17.KaminskaKMartinettiGLucchiniRet al.Coxsackievirus A6 and"/>
   <result pre="stem encephalitisFront Pharmacol201678227065870 21.ChiCYKhanhTHle PKTet al.Milrinone therapy for enterovirus 71-induced" exact="pulmonary edema" post="and/or neurogenic shock in children: a randomized controlled trialCrit"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6373929\results\search\disease\results.xml">
   <result pre="asymptomatic to several symptomatic forms ranging in severity from classical" exact="dengue fever," post="to Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome"/>
   <result pre="weekly intervals. After the final immunization, mice were inoculated with" exact="sarcoma" post="180 cells, and the resulting immune ascitic fluids were"/>
   <result pre="al. (2016) The first acute febrile illness investigation associated with" exact="dengue fever" post="in Ethiopia, 2013: A descriptive analysis. Ethiop J Health"/>
   <result pre="Act6. 18LeroyEM, NkogheD, OllomoB, Nze-NkogueC, BecquartP, et al. (2009) Concurrent" exact="chikungunya" post="and dengue virus infections during simultaneous outbreaks, Gabon, 2007."/>
   <result pre="Comparative analysis of the genome sequences and replication profiles of" exact="chikungunya" post="virus isolates within the East, Central and South African"/>
   <result pre="(2013) Oral receptivity of Aedes aegypti from Cape Verde for" exact="yellow fever," post="dengue, and chikungunya viruses. Vect Born Zoo Dis13: 37â€&quot;40."/>
   <result pre="Aedes aegypti from Cape Verde for yellow fever, dengue, and" exact="chikungunya" post="viruses. Vect Born Zoo Dis13: 37â€&quot;40. 42MillerB, MonathT, TabachnickW,"/>
   <result pre="Born Zoo Dis13: 37â€&quot;40. 42MillerB, MonathT, TabachnickW, EzikeV (1989) Epidemic" exact="yellow fever" post="caused by an incompetent mosquito vector. Trop Med Parasitol:"/>
   <result pre="Zusammenarbeit (GTZ)40: 396â€&quot;399. 43Garrett-JonesC (1964) The human blood index of" exact="malaria" post="vectors in relation to epidemiological assessment. Bull World Health"/>
   <result pre="Mechanical College. 47MoncayoAC, EdmanJD, TurellMJ (2000) Effect of eastern equine" exact="encephalomyelitis" post="virus on the survival of Aedes albopictus, Anopheles quadrimaculatus,"/>
   <result pre="Entomol37: 701â€&quot;706. 11004781 48MahmoodF, ReisenWK, ChilesRE, FangY (2004) Western equine" exact="encephalomyelitis" post="virus infection affects the life table characteristics of Culex"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6375641\results\search\disease\results.xml">
   <result pre="purifying selection in vertebrate hosts [19]. Studies with Venezuelan equine" exact="encephalitis" post="virus (VEEV), for example, have shown that epizootic strains"/>
   <result pre="tested for the presence of antibodies against WNV, St. Louis" exact="encephalitis" post="(SLEV) and western equine encephalitis virus (WEEV) [26]. Seronegative"/>
   <result pre="presence of antibodies against WNV, St. Louis encephalitis (SLEV) and" exact="western equine encephalitis" post="virus (WEEV) [26]. Seronegative birds were transported to UC"/>
   <result pre="antibodies against WNV, St. Louis encephalitis (SLEV) and western equine" exact="encephalitis" post="virus (WEEV) [26]. Seronegative birds were transported to UC"/>
   <result pre="West Nile virus transmission and the apparent displacement St. Louis" exact="encephalitis" post="virus in southeastern California, 2003â€&quot;2006. J Med Entomol. 2008;45(3):494â€&quot;508."/>
   <result pre="competence determine the efficiency of West Nile and St. Louis" exact="encephalitis" post="virus transmission. J Med Entomol. 2005;42(3):367â€&quot;75. 15962789 11FossL, PadgettK,"/>
   <result pre="the e2 envelope glycoprotein are associated with the emergence of" exact="venezuelan equine encephalitis" post="virus. J Virol. 2002;76(4):1718â€&quot;30. 10.1128/JVI.76.4.1718-1730.200211799167 21WorwaG, HuttonAA, FreyM, DuggalNK,"/>
   <result pre="envelope glycoprotein are associated with the emergence of venezuelan equine" exact="encephalitis" post="virus. J Virol. 2002;76(4):1718â€&quot;30. 10.1128/JVI.76.4.1718-1730.200211799167 21WorwaG, HuttonAA, FreyM, DuggalNK,"/>
   <result pre="30FangY, ReisenWK. Previous infection with West Nile or St. Louis" exact="encephalitis" post="viruses provides cross protection during reinfection in house finches."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6379635\results\search\disease\results.xml">
   <result pre="work is properly cited.file:IRV-13-148.pdf Abstract Background Epidemiological analysis of past" exact="influenza" post="epidemics remains essential to understand the evolution of the"/>
   <result pre="system over the last three decades to study trends in" exact="influenza" post="epidemics and describe epidemic profiles according to circulating influenza"/>
   <result pre="in influenza epidemics and describe epidemic profiles according to circulating" exact="influenza" post="viruses. Methods Influenzaâ€�like illness (ILI) weekly incidences were estimated"/>
   <result pre="applying a periodic regression to this time series. Epidemic (coâ€�)dominant" exact="influenza" post="virus (sub)types were determined using French virology data. Results"/>
   <result pre="607 ILI cases were reported allowing the detection of 33" exact="influenza" post="epidemics. On average, seasonal epidemics lasted 9Â weeks and"/>
   <result pre="and older age of cases. Conclusions The declining trend in" exact="influenza" post="epidemic size and height over the last 33Â years"/>
   <result pre="factors like increased vaccine coverage, hygiene improvements or changing in" exact="influenza" post="viruses. However, further researches are needed to assess the"/>
   <result pre="to assess the impact of potential contributing factors to adapt" exact="influenza" post="plans. epidemics influenza influenzaâ€�like illness primary care surveillance fig-count:"/>
   <result pre="impact of potential contributing factors to adapt influenza plans. epidemics" exact="influenza" post="influenzaâ€�like illness primary care surveillance fig-count: table-count: page-count: word-count:"/>
   <result pre="Viruses. 2019;13:148â€�157. 10.1111/irv.12620 1 INTRODUCTION Influenza is a common respiratory" exact="infectious disease," post="manifested typically by influenzaâ€�like illness (ILI) usually defined by"/>
   <result pre="myalgia and respiratory signs.1 Although morbidity and mortality attributed to" exact="influenza" post="epidemics vary depending on circulating strains,2 influenza epidemics cause"/>
   <result pre="mortality attributed to influenza epidemics vary depending on circulating strains,2" exact="influenza" post="epidemics cause each year between 3 and 5 million"/>
   <result pre="the 2012â€�2017 period.4, 5 The excess respiratory deaths due to" exact="influenza" post="seasonal epidemics were estimated to 2.9 per 100Â 000"/>
   <result pre="spent for medical care.8 The health and socioâ€�economic impact of" exact="influenza" post="epidemics, along with the need to assess the impact"/>
   <result pre="epidemics, along with the need to assess the impact of" exact="influenza" post="vaccine in the field, justify its surveillance. Realâ€�time monitoring"/>
   <result pre="vaccine in the field, justify its surveillance. Realâ€�time monitoring of" exact="influenza" post="epidemics is used by authorities and healthcare professionals to"/>
   <result pre="professionals to implement or adjust interventions. However, retrospective analysis of" exact="influenza" post="epidemics over a long period of time seems essential"/>
   <result pre="The French primary care surveillance networkâ€&quot;calledÂ Sentinelles, participate in monitoring" exact="influenza" post="epidemics since 1984 through a sample of general practitioners"/>
   <result pre="consultation.10 ILI definition used had a high predictive value for" exact="influenza" post="although other respiratory viruses could cause ILI.11 This definition"/>
   <result pre="allowing study of trends in ILI. There were no steady" exact="influenza" post="virological database available in primary care since 1984, as"/>
   <result pre="presented here aims to study evolution of the dynamics of" exact="influenza" post="epidemics observed in primary care in France between winters"/>
   <result pre="and 2016/17 and to describe epidemic profiles according to circulating" exact="influenza" post="viruses. 2 METHODS 2.1 Study population: influenzaâ€�like illness cases"/>
   <result pre="questions linked to public health issues. They concern: age, sex," exact="influenza" post="seasonal vaccination status (since September 1986) and whether the"/>
   <result pre="September 2014), hospitalization request (since September 1997), risk factors for" exact="influenza" post="complications except age (since September 2009), antiviral prescription (since"/>
   <result pre="in a recent study.20 Each epidemic was named by its" exact="influenza" post="season (ie, 2011/12 epidemic, refers to the epidemic period"/>
   <result pre="classified into three groups according to the time of the" exact="influenza" post="season startedâ€&quot;called â€œstart period.â€� Breaks were defined using the"/>
   <result pre="France, there was no shared and steady database about circulating" exact="influenza" post="viruses in primary care. To obtain quantitative data on"/>
   <result pre="influenza viruses in primary care. To obtain quantitative data on" exact="influenza" post="viruses circulating in primary care during past epidemics in"/>
   <result pre="season are detailed in TableÂ 1. Table 1 Characteristics of" exact="influenza" post="epidemics in primary care detected by the Sentinelles network,"/>
   <result pre="source used for determination of virological dominance and coâ€�dominance by" exact="influenza" post="epidemic in France: aFrench national public health agency. bMorbidity"/>
   <result pre="Ltd, Using these collected data, virological dominance and coâ€�dominance by" exact="influenza" post="epidemic was established using the following decision rule adapted"/>
   <result pre="collected by the Sentinelles network allowed the detection of 32" exact="influenza" post="seasonal epidemics and one pandemic during the 33 monitored"/>
   <result pre="circulating Influenza virus dominance and coâ€�dominance established for the 33" exact="influenza" post="epidemics were reported in TableÂ 1. For 22 epidemics"/>
   <result pre="(12%) viruses A and B were coâ€�dominant. Lastly, one pandemic" exact="influenza" post="was observed in 2009/10, dominated by A(H1N1)pdm09. Epidemics dominated"/>
   <result pre="P valueÂ =Â 2.10âˆ’3) (FigureÂ 3). Figure 3 Characteristics of" exact="influenza" post="epidemics grouped by viral dominant or coâ€�dominant (sub)types; (A)"/>
   <result pre="RIRs were decreasing with age. Figure 4 Age distribution of" exact="influenza" post="epidemics grouped by viral dominant or coâ€�dominant (sub)types; (A)"/>
   <result pre="Since 1984, the primary care Sentinelles surveillance network has monitored" exact="influenza" post="epidemics in France. Its seniority, the stability of the"/>
   <result pre="and ILI definition used allowed the comparison of 32 seasonal" exact="influenza" post="epidemics and a pandemic, observed between winters 1984/85 and"/>
   <result pre="epidemic duration, which may suggest a reduction of transmissibility of" exact="influenza" post="viruses. At first sight, this can be related to"/>
   <result pre="viruses. At first sight, this can be related to the" exact="influenza" post="vaccination programme developed in France from the beginning of"/>
   <result pre="had still not been achieved. Unlike to some others countries,33" exact="influenza" post="vaccination is not recommended for children in France, although"/>
   <result pre="contributing to a larger transmissibility and risk of infection.35 Although" exact="influenza" post="vaccination might contribute to the declining trend in influenza"/>
   <result pre="Although influenza vaccination might contribute to the declining trend in" exact="influenza" post="epidemic size and height, its impact could be limited"/>
   <result pre="impact could be limited in France. Secondly, observed decrease in" exact="influenza" post="incidence rates may also be related to behaviour changes"/>
   <result pre="improvements; which might have contributed to reduce the transmissibility of" exact="influenza" post="viruses.27 Recently, the 2009 pandemic could have impacted hygiene"/>
   <result pre="that time.36 Thirdly, changes in the biological properties of circulating" exact="influenza" post="viruses may have occurred, particularly for A(H3N2) subtype 37â€&quot;the"/>
   <result pre="This could be explained by acquired immunity against subtypes of" exact="influenza" post="A(H1N1) in adults and elderly encountered through past exposure"/>
   <result pre="respectively).12 Our study has some limitations. We implemented a single" exact="influenza" post="epidemic detection method among the various used worldwide.45 Based"/>
   <result pre="and we included ILI cases only during the epidemic periodâ€&quot;where" exact="influenza" post="positivity rates of cases were the highest, allows to"/>
   <result pre="ILI consultations with a febrile ILI definition could underestimate true" exact="influenza" post="burden in the community, especially among elderly who usually"/>
   <result pre="have worse health than those consulting in primary care. Conversely," exact="influenza" post="burden in children could be overestimated relatively to adultsâ€™"/>
   <result pre="electronic data collection protocol. This stability is needed to compare" exact="influenza" post="activity and epidemiology over several decades in the community:"/>
   <result pre="understanding of past patterns, monitoring change in trends and estimating" exact="influenza" post="vaccine effectiveness.14, 18 Longâ€�standing surveillance systems constitute an important"/>
   <result pre="the pressure on health services and to adapt and develop" exact="influenza" post="control strategies in the coming years. In conclusion, data"/>
   <result pre="since 1984 allowed us to highlight a declining trend in" exact="influenza" post="epidemic size and height. This decrease could be related"/>
   <result pre="including increased vaccine coverage, hygiene improvements and diminished fitness of" exact="influenza" post="viruses. Future researches combining epidemiological and virological issues should"/>
   <result pre="etÂ al. Heterogeneous case definitions used for the surveillance of" exact="influenza" post="in Europe. Eur J Epidemiol. 2003;18(8):751â€�754.12974549 2ThompsonWW, ShayDK, WeintraubE,"/>
   <result pre="Epidemiol. 2003;18(8):751â€�754.12974549 2ThompsonWW, ShayDK, WeintraubE, etÂ al. Mortality associated with" exact="influenza" post="and respiratory syncytial virus in the United States. JAMA."/>
   <result pre="The potential value of crowdsourced surveillance systems in supplementing sentinel" exact="influenza" post="networks: the case of France. Euro Surveill. 2018;23(25): pii:"/>
   <result pre="ReyG, MillerM, SimonsenL, ViboudC. Mortality burden of the 2009 A/H1N1" exact="influenza" post="pandemic in France: comparison to seasonal influenza and the"/>
   <result pre="the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal" exact="influenza" post="and the A/H3N2 pandemic. PLoS ONE. 2012;7(9):e45051.23028756 7CarratF, SahlerC,"/>
   <result pre="France. Arch Intern Med. 2002;162(16):1842â€�1848.12196082 8LevyE. French economic evaluations of" exact="influenza" post="and influenza vaccination. Pharmacoeconomics. 1996;9(Suppl 3):62â€�66.10160489 9collab: Ã‰quipes de"/>
   <result pre="Intern Med. 2002;162(16):1842â€�1848.12196082 8LevyE. French economic evaluations of influenza and" exact="influenza" post="vaccination. Pharmacoeconomics. 1996;9(Suppl 3):62â€�66.10160489 9collab: Ã‰quipes de surveillance de"/>
   <result pre="Clin Infect Dis. 1999;28(2):283â€�290.10064245 12MosnierA, CainiS, DaviaudI, etÂ al. Ten" exact="influenza" post="seasons in France: distribution and timing of influenza A"/>
   <result pre="al. Ten influenza seasons in France: distribution and timing of" exact="influenza" post="A and B circulation, 2003â€&quot;2013. BMC Infect Dis. 2015;15:357.26289794"/>
   <result pre="Dis. 2015;15:357.26289794 13VilcuAM, SoutyC, EnoufV, etÂ al. Estimation of seasonal" exact="influenza" post="vaccine effectiveness using data collected in primary care in"/>
   <result pre="14SoutyC, VilcuAM, CapaiL, etÂ al. Early estimates of 2016/17 seasonal" exact="influenza" post="vaccine effectiveness in primary care in France. J Clin"/>
   <result pre="25, 2017. 18TurbelinC, SoutyC, PelatC, etÂ al. Age distribution of" exact="influenza" post="like illness cases during postâ€�pandemic A(H3N2): comparison with the"/>
   <result pre="al. Performances of statistical methods for the detection of seasonal" exact="influenza" post="epidemics using a consensusâ€�based gold standard. Epidemiol Infect. 2018;146(2):168â€�176.29208062"/>
   <result pre="standard. Epidemiol Infect. 2018;146(2):168â€�176.29208062 21LemaitreM, CarratF. Comparative age distribution of" exact="influenza" post="morbidity and mortality during seasonal influenza epidemics and the"/>
   <result pre="Comparative age distribution of influenza morbidity and mortality during seasonal" exact="influenza" post="epidemics and the 2009 H1N1 pandemic. BMC Infect Dis."/>
   <result pre="KoelleK, FerrariMJ, BhartiN, GrenfellBT. Global patterns in seasonal activity of" exact="influenza" post="A/H3N2, A/H1N1, and B from 1997 to 2005: viral"/>
   <result pre="BrownCS, MeuwissenLE, van der VeldenJ. Epidemiological and virological assessment of" exact="influenza" post="activity in Europe, during the 2004â€�2005 winter. Euro Surveill."/>
   <result pre="Disease Control and Prevention . Prevention and control of seasonal" exact="influenza" post="with vaccines. Recommendations of the Advisory Committee on Immunization"/>
   <result pre="al. The contribution of social behaviour to the transmission of" exact="influenza" post="a in a human population. PLoS Pathog. 2014;10(6):e1004206.24968312 36Van"/>
   <result pre="etÂ al. Evolution of the receptor binding properties of the" exact="influenza" post="A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A."/>
   <result pre="ViboudC, TaubenbergerJK, HolmesEC. The genomic and epidemiological dynamics of human" exact="influenza" post="A virus. Nature. 2008;453(7195):615â€�619.18418375 40LeeBE, MukhiSN, DrewsSJ. Association between"/>
   <result pre="Nature. 2008;453(7195):615â€�619.18418375 40LeeBE, MukhiSN, DrewsSJ. Association between patient age and" exact="influenza" post="A subtype during influenza outbreaks. Infect Control Hosp Epidemiol."/>
   <result pre="DrewsSJ. Association between patient age and influenza A subtype during" exact="influenza" post="outbreaks. Infect Control Hosp Epidemiol. 2010;31(5):535â€�537.20334548 41SimonsenL, ClarkeMJ, WilliamsonGD,"/>
   <result pre="2010;31(5):535â€�537.20334548 41SimonsenL, ClarkeMJ, WilliamsonGD, StroupDF, ArdenNH, SchonbergerLB. The impact of" exact="influenza" post="epidemics on mortality: introducing a severity index. Am J"/>
   <result pre="FarrellGM, St GeorgeK, RabadanR. Differences in patient age distribution between" exact="influenza" post="A subtypes. PLoS ONE. 2009;4(8):e6832.19718262 43FergusonNM, GalvaniAP, BushRM. Ecological"/>
   <result pre="ONE. 2009;4(8):e6832.19718262 43FergusonNM, GalvaniAP, BushRM. Ecological and immunological determinants of" exact="influenza" post="evolution. Nature. 2003;422(6930):428â€�433.12660783 44FlemingDM, ZambonM, BarteldsAIM, de JongJC. The"/>
   <result pre="44FlemingDM, ZambonM, BarteldsAIM, de JongJC. The duration and magnitude of" exact="influenza" post="epidemics: a study of surveillance data from sentinel general"/>
   <result pre="Epidemiol. 1999;15(5):467â€�473.10442473 45CowlingBJ, WongIO, HoLM, RileyS, LeungGM. Methods for monitoring" exact="influenza" post="surveillance data. Int J Epidemiol. 2006;35(5):1314â€�1321.16926216 46ValleronAJ, BouvetE, GarnerinP,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6383869\results\search\disease\results.xml">
   <result pre="can cause hantavirus pulmonary syndrome (HPS) in the Americas and" exact="hemorrhagic fever with renal syndrome" post="(HFRS) in Eurasia. In recent decades, repeated outbreaks of"/>
   <result pre="some outbreaks resulting in case fatality rates of 12% (for" exact="hemorrhagic fever with renal syndrome" post="[HFRS] in Europe and Asia) and up to 40%"/>
   <result pre="(ESRI, Redlands, CA, USA) based on World Countries (http://www.arcgis.com/home/item.html?id=d974d9c6bc924ae0a2ffea0a46d71e3d). HFRS," exact="hemorrhagic fever with renal syndrome;" post="HPS, hantavirus pulmonary syndrome; NE, nephropathia epidemica; PUUV, Puumala"/>
   <result pre="hemorrhagic fever with renal syndrome; HPS, hantavirus pulmonary syndrome; NE," exact="nephropathia epidemica;" post="PUUV, Puumala virus; SEOV, Seoul virus; THAIV, Thailand virus."/>
   <result pre="linked to rodent populations in deciduous forests [30,49]. Outbreaks of" exact="nephropathia epidemica" post="(NE; a mild form of HFRS caused by PUUV"/>
   <result pre="with hantavirus infections Abbreviations: ENSO, El NiÃ±o Southern Oscillation; HFRS," exact="hemorrhagic fever with renal syndrome;" post="HPS, hantavrius pulmonary syndrome; NDVI, normalized difference vegetation index;"/>
   <result pre="HPS, hantavrius pulmonary syndrome; NDVI, normalized difference vegetation index; NE," exact="nephropathia epidemica;" post="(Y 0), during the same year; Y-n, n years"/>
   <result pre="increasingly more apparent that climatic variations have profound impacts on" exact="infectious disease" post="dynamics [75,76], especially for climate-sensitive infectious diseases; e.g., human"/>
   <result pre="2016 with permission of the publisher [127]). Dim, dimension; HFRS," exact="hemorrhagic fever with renal syndrome;" post="NDVI, normalized difference vegetation index. However, precipitation can also"/>
   <result pre="effect of immigration remained constant. Source: Adapted from [114]. HFRS," exact="hemorrhagic fever with renal syndrome." post="Vaccination programs against HFRS have been in practice for"/>
   <result pre="Feng D, et al. (2007) Landscape elements and Hantaan virus-related" exact="hemorrhagic fever with renal syndrome," post="People's Republic of China. Emerging Infectious Diseases 13(9): 1301â€&quot;1306."/>
   <result pre="Epidemiol Infect143: 405â€&quot;411. 10.1017/S095026881400100924787374 14JohnsonPT, de RoodeJC, FentonA (2015) Why" exact="infectious disease" post="research needs community ecology. Science349: 125950410.1126/science.125950426339035 15SmithMJ, TelferS, KallioER,"/>
   <result pre="Animal reservoir, natural and socioeconomic variations and the transmission of" exact="hemorrhagic fever with renal syndrome" post="in Chenzhou, China, 2006â€&quot;2010. PLoS Negl Trop Dis8: e261510.1371/journal.pntd.000261524421910"/>
   <result pre="(2017) Anthropogenically driven environmental changes shift the ecological dynamics of" exact="hemorrhagic fever with renal syndrome." post="PLoS Pathog13: e100619810.1371/journal.ppat.100619828141833 46TianH, YuP, CazellesB, XuL, TanH, et"/>
   <result pre="available and climatic variables on the animal host density of" exact="hemorrhagic fever with renal syndrome" post="in Changsha, China. PLoS ONE8: e6153610.1371/journal.pone.006153623637849 48GuanP, HuangD, HeM,"/>
   <result pre="effects of climatic variables and reservoir on the incidence of" exact="hemorrhagic fever with renal syndrome" post="in Huludao City, China: a 17-year data analysis based"/>
   <result pre="VerstraetenWW, ClementJ, et al. (2011) A dynamic data-based model describing" exact="nephropathia epidemica" post="in Belgium. Biosyst Eng109: 77â€&quot;89. 52TersagoK, VerhagenR, ServaisA, al"/>
   <result pre="McKenzieFE, RealLA, SmithDL, et al. (2005) Ecological theory to enhance" exact="infectious disease" post="control and public health policy. Front Ecol Environ3: 29â€&quot;37."/>
   <result pre="Landscape and rodent community composition are associated with risk of" exact="hemorrhagic fever with renal syndrome" post="in two cities in China, 2006â€&quot;2013. BMC Infect Dis18:"/>
   <result pre="Animal reservoir, natural and socioeconomic variations and the transmission of" exact="hemorrhagic fever with renal syndrome" post="in Chenzhou, China, 2006â€&quot;2010. PLoS Negl Trop Dis8: e261510.1371/journal.pntd.000261524421910"/>
   <result pre="TongSL, et al. (2013) Atmospheric moisture variability and transmission of" exact="hemorrhagic fever with renal syndrome" post="in Changsha City, Mainland China, 1991â€&quot;2010. PLoS Negl Trop"/>
   <result pre="348â€&quot;360. 10.7589/0090-3558-48.2.34822493110 84BiP, PartonKA (2003) El NiÃ±o and incidence of" exact="hemorrhagic fever with renal syndrome" post="in China. JAMA289: 176â€&quot;177. 85BiP, TongS, DonaldK, PartonK, NiJ"/>
   <result pre="ZhangF, PartonKA, TongS (1998) Seasonal rainfall variability, the incidence of" exact="hemorrhagic fever with renal syndrome," post="and prediction of the disease in low-lying areas of"/>
   <result pre="GuoWD, FangLQ, LiCP, BiP, et al. (2010) Climate variability and" exact="hemorrhagic fever with renal syndrome" post="transmission in Northeastern China. Environ Health Perspect118: 915â€&quot;920. 10.1289/ehp.090150420142167"/>
   <result pre="SongS, et al. (2010) Spatiotemporal trends and climatic factors of" exact="hemorrhagic fever with renal syndrome" post="epidemic in Shandong Province, China. PLoS Negl Trop Dis4:"/>
   <result pre="(2015) Changes in rodent abundance and weather conditions potentially drive" exact="hemorrhagic fever with renal syndrome" post="outbreaks in Xi'an, China, 2005â€&quot;2012. PLoS Negl Trop Dis9:"/>
   <result pre="(2004) Unhealthy landscapes: Policy recommendations on land use change and" exact="infectious disease" post="emergence. Environ Health Perspect112: 1092â€&quot;1098. 10.1289/ehp.687715238283 102LambinEF, TranA, VanwambekeSO,"/>
   <result pre="ZhangLQ, FengD, et al. (2007) Landscape elements and Hantaan virusâ€&quot;related" exact="hemorrhagic fever with renal syndrome," post="Peopleâ€™s Republic of China. Emerg Infect Dis13: 1301â€&quot;1306. 10.3201/eid1309.06148118252099"/>
   <result pre="LiangS, de VlasS, FengD, et al. (2006) Spatial analysis of" exact="hemorrhagic fever with renal syndrome" post="in China. BMC Infect Dis6: 7710.1186/1471-2334-6-7716638156 117KlempaB, Fichet-CalvetE, LecompteE,"/>
   <result pre="(2016) Effects of humidity variation on the hantavirus infection and" exact="hemorrhagic fever with renal syndrome" post="occurrence in subtropical China. Am J Trop Med Hyg94:"/>
   <result pre="129LiC, CuiZ, LiS, MagalhaesRJS, WangB, et al. (2013) Association between" exact="hemorrhagic fever with renal syndrome" post="epidemic and climate factors in Heilongjiang Province, China. Am"/>
   <result pre="10.4269/ajtmh.12-047324019443 130HanSS, KimS, ChoiY, KimS, KimYS (2013) Air pollution and" exact="hemorrhagic fever with renal syndrome" post="in South Korea: an ecological correlation study. BMC Public"/>
   <result pre="ZhangZ, LuL, LiX, LiuQ (2014) Meteorological factors are associated with" exact="hemorrhagic fever with renal syndrome" post="in Jiaonan County, China, 2006â€&quot;2011. Int J Biometeorol58: 1031â€&quot;1037."/>
   <result pre="de VlasSJ, ZhangWY, LiangS, et al. (2009) Spatiotemporal dynamics of" exact="hemorrhagic fever with renal syndrome," post="Beijing, Peopleâ€™s Republic of China. Emerg Infect Dis15: 2043â€&quot;2045."/>
   <result pre="der GroenG, BarriosJM, et al. (2010) Beechnuts and outbreaks of" exact="nephropathia epidemica" post="(NE): of mast, mice and men. Nephrol Dial Transplant25:"/>
   <result pre="HuangH, ZhangW, WangJ, RenY, et al. (2009) The relationship between" exact="hemorrhagic fever with renal syndrome" post="cases and time series of NDVI in Dayangshu District."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6384943\results\search\disease\results.xml">
   <result pre="10.1038/s41598-019-39057-w : Article Estimation of the effective reproduction number of" exact="influenza" post="based on weekly reports in Miyazaki Prefecture YamauchiTakenoriyamauchi-t@med.showa-u.ac.jp1TakeuchiShouhei2YamanoYuko1KurodaYoshiki3NakadateToshio1[1], 0000"/>
   <result pre="of surveillance for seasonal influenza, the number of patients per" exact="influenza" post="sentinel site is counted on a weekly basis. Currently,"/>
   <result pre="reference values are set for the weekly reported number of" exact="influenza" post="cases per sentinel, and pre-epidemic and epidemic warnings are"/>
   <result pre="the validity of the reference value was also high for" exact="influenza" post="transmission. However, our results indicated the presence of secondary"/>
   <result pre="the surrounding jurisdictions for more detailed epidemic predictions. Introduction Seasonal" exact="influenza" post="is a respiratory infectious disease caused by the influenza"/>
   <result pre="more detailed epidemic predictions. Introduction Seasonal influenza is a respiratory" exact="infectious disease" post="caused by the influenza virus, and it occurs annually"/>
   <result pre="Seasonal influenza is a respiratory infectious disease caused by the" exact="influenza" post="virus, and it occurs annually during winter months. In"/>
   <result pre="virus, and it occurs annually during winter months. In Japan," exact="influenza" post="is designated as a Category V infectious disease by"/>
   <result pre="months. In Japan, influenza is designated as a Category V" exact="infectious disease" post="by the Act on the Prevention of Infectious Diseases"/>
   <result pre="Control Law) executed in 1999. Based on this law, seasonal" exact="influenza" post="is listed as a target illness of the National"/>
   <result pre="of Infectious Diseases (NESID)1, and specific medical facilities such as" exact="influenza" post="sentinel sites are expected to report the number of"/>
   <result pre="up in increments of PHC. The number of patients per" exact="influenza" post="sentinel site under the jurisdiction of each PHC is"/>
   <result pre="Public Health Institute websites. Data on the reporting criteria of" exact="influenza" post="are also provided. The administrators of influenza sentinel sites"/>
   <result pre="reporting criteria of influenza are also provided. The administrators of" exact="influenza" post="sentinel sites are expected to notify cases every Monday"/>
   <result pre="signs and symptoms, if a patient is suspected to have" exact="influenza" post="or if a patient exhibits all symptoms (i.e. sudden"/>
   <result pre="swab. Reporting criteria for sentinel hospitals are separately stipulated2. Seasonal" exact="influenza" post="is a threat to public health, and issuing of"/>
   <result pre="Pre-epidemic warnings are issued when the weekly reported number of" exact="influenza" post="cases per sentinel (Weekly CPS) in a jurisdiction of"/>
   <result pre="based on Weekly CPS, without considering the characteristic of the" exact="infectious disease." post="One of our aims was to confirm the consistency"/>
   <result pre="(i.e. the Rt based evaluation considering factors associated with the" exact="influenza" post="epidemic such as human movement, and the evaluation based"/>
   <result pre="Descriptive epidemiological data of each PHC jurisdiction During the 2010â€&quot;2011" exact="influenza" post="season in Miyazaki Prefecture, the first case was reported"/>
   <result pre="type A and type B cases were prevalent during the" exact="influenza" post="season from 2010 to 2011. The number of virus"/>
   <result pre="A(H3)Hong Kong. Type B virus was sporadically detected throughout the" exact="influenza" post="season from 2010 to 2011, but the association between"/>
   <result pre="model were used to compare the weekly reported number of" exact="influenza" post="cases per sentinel, as shown in Fig.Â 1. When"/>
   <result pre="study, the Rt was estimated using Weekly CPS of the" exact="influenza" post="epidemic from 2010 to 2011 in Miyazaki Prefecture. Despite"/>
   <result pre="warning is probably reasonable even when the features associated with" exact="influenza" post="epidemic such as human movement and serial interval were"/>
   <result pre="lowest among the nine jurisdictions, and the estimated number of" exact="influenza" post="patients was also the lowest. At the 3rd week"/>
   <result pre="the secondary epidemic. However, the items to be notified at" exact="influenza" post="sentinel sites are surveillance period, name of medical facility,"/>
   <result pre="medical facility, sex, and age10. Because the serotype of the" exact="influenza" post="virus is not included, it is not clarified in"/>
   <result pre="problems even if they were not modified21. However, in the" exact="influenza" post="epidemic in Miyazaki Prefecture from 2010 to 2011, the"/>
   <result pre="Murakami et al. who suggested the possibility that the local" exact="influenza" post="epidemic would expand22, it is also possible that the"/>
   <result pre="would expand22, it is also possible that the distribution of" exact="influenza" post="sentinel sites or patients did not have the representative"/>
   <result pre="the number of weekly reported cases by the number of" exact="influenza" post="sentinel sites, with no coefficient reflecting the types of"/>
   <result pre="influenza sentinel sites, with no coefficient reflecting the types of" exact="influenza" post="sentinel sites. For our aim, although bias could not"/>
   <result pre="very large. In conclusion, pre-epidemic warnings based on the current" exact="influenza" post="surveillance system effectively functioned at least in the Miyazaki"/>
   <result pre="the epidemic situation considering all the available information on the" exact="infectious disease," post="such as viral serotype, viral strain, and the epidemic"/>
   <result pre="the end of the epidemic in future studies. Methods As" exact="influenza" post="epidemic data, we used Weekly CPS at a PHC"/>
   <result pre="the number of weekly reported cases by the number of" exact="influenza" post="sentinel sites. There are nine PHCs (i.e. Miyazaki city,"/>
   <result pre="45, 61, 10 and 35. Then, the number of weekly" exact="influenza" post="patients at each PHC jurisdiction was estimated by the"/>
   <result pre="was estimated by equation (1). Finally, the number of daily" exact="influenza" post="cases at each PHC jurisdiction ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym}"/>
   <result pre="parameters suitable for influenza, to investigate the spatial distribution of" exact="influenza" post="infection among ten regions. Publisherâ€™s note: Springer Nature remains"/>
   <result pre="authors declare no competing interests. References References 1.TaniguchiKet al.Overview of" exact="infectious disease" post="surveillance system in Japan, 1999-2005J. Epidemiol.200717Suppl, S31310.2188/jea.17.S318239339 2.Ministry of"/>
   <result pre="Epidemiol. 151, 1039â€&quot;1048, discussion 1049â€&quot;1052 (2000). 5.WallingaJTeunisPDifferent epidemic curves for" exact="severe acute respiratory syndrome" post="reveal similar impacts of control measuresAm. J. Epidemiol.200416050951610.1093/aje/kwh25515353409 6.Miyazaki"/>
   <result pre="6.Miyazaki prefectural institute for public health and environment. Miyazaki prefecture" exact="infectious disease" post="weekly report back issue (2010) https://www.pref.miyazaki.lg.jp/contents/org/fukushi/eikanken/center/infectious/2010/index.html (2010). 7.Miyazaki prefectural"/>
   <result pre="7.Miyazaki prefectural institute for public health and environment. Miyazaki prefecture" exact="infectious disease" post="weekly report back issue (2011) https://www.pref.miyazaki.lg.jp/contents/org/fukushi/eikanken/center/infectious/2011/index.html (2011). 8.FavierCet al.Early"/>
   <result pre="Int. Health20061133234010.1111/j.1365-3156.2006.01560.x16553913 9.ChowellGNishiuraHBettencourtLMComparative estimation of the reproduction number for pandemic" exact="influenza" post="from daily case notification dataJ. R. Soc. Interface2007415516610.1098/rsif.2006.016117254982 10.Ministry"/>
   <result pre="courseJ. R. Soc. Interface2010729730710.1098/rsif.2009.015319570792 12.FergusonNMet al.Strategies for containing an emerging" exact="influenza" post="pandemic in Southeast AsiaNature200543720921410.1038/nature0401716079797 13.CowlingBJFangVJRileySMalik PeirisJSLeungGMEstimation of the serial"/>
   <result pre="of influenzaEpidemiology20092034434710.1097/EDE.0b013e31819d109219279492 14.LevyJWet al.The serial intervals of seasonal and pandemic" exact="influenza" post="viruses in households in Bangkok, ThailandAm. J. Epidemiol.20131771443145110.1093/aje/kws40223629874 15.WhiteLFPaganoMTransmissibility"/>
   <result pre="in households in Bangkok, ThailandAm. J. Epidemiol.20131771443145110.1093/aje/kws40223629874 15.WhiteLFPaganoMTransmissibility of the" exact="influenza" post="virus in the 1918 pandemicPLoS One20083e149810.1371/journal.pone.000149818231585 16.CauchemezSet al.Household transmission"/>
   <result pre="the 1918 pandemicPLoS One20083e149810.1371/journal.pone.000149818231585 16.CauchemezSet al.Household transmission of 2009 pandemic" exact="influenza" post="A (H1N1) virus in the United StatesN. Engl. J."/>
   <result pre="United StatesN. Engl. J. Med.20093612619262710.1056/NEJMoa090549820042753 17.LesslerJet al.Outbreak of 2009 pandemic" exact="influenza" post="A (H1N1) at a New York City schoolN. Engl."/>
   <result pre="Engl. J. Med.20093612628263610.1056/NEJMoa090608920042754 18.YangYet al.The transmissibility and control of pandemic" exact="influenza" post="A (H1N1) virusScience200932672973310.1126/science.117737319745114 19.Nishiura, H. &amp;amp; Chowell, G. Early"/>
   <result pre="geographical variation in epidemics determined from the results of an" exact="infectious disease" post="surveillance system in Japan description of epidemic patterns by"/>
   <result pre="changing critical values of the early epidemic detection system for" exact="infectious disease" post="surveillance in JapanNihon Koshu Eisei Zasshi20075416817717461028 22.MurakamiYet al.Wide-area epidemics"/>
   <result pre="surveillance in JapanNihon Koshu Eisei Zasshi20075416817717461028 22.MurakamiYet al.Wide-area epidemics of" exact="influenza" post="and pediatric diseases from infectious disease surveillance in Japan,"/>
   <result pre="Zasshi20075416817717461028 22.MurakamiYet al.Wide-area epidemics of influenza and pediatric diseases from" exact="infectious disease" post="surveillance in Japan, 1999-2005J. Epidemiol.200717SupplS233110.2188/jea.17.S2318239338 23.MurakamiYet al.Evaluation of a"/>
   <result pre="during epidemicsAm. J. Epidemiol.20131781505151210.1093/aje/kwt13324043437 26.BoellePYAnsartSCoriAValleronAJTransmission parameters of the A/H1N1 (2009)" exact="influenza" post="virus pandemic: a reviewInfluenza Other Respir Viruses2011530631610.1111/j.1750-2659.2011.00234.x21668690"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6400443\results\search\disease\results.xml">
   <result pre="transmitted by Aedes aegypti and Aedes albopictus mosquitoes. DENV causes" exact="dengue fever," post="which may progress to severe dengue. Hospital-based surveillance was"/>
   <result pre="accompanied by at least one clinical sign or symptom of" exact="dengue fever" post="such as headache, rash, arthralgia, retro-orbital pain, malaise, signs"/>
   <result pre="such as headache, rash, arthralgia, retro-orbital pain, malaise, signs of" exact="dengue hemorrhagic fever" post="or dengue shock syndrome were enrolled. A case of"/>
   <result pre="in this virus. Discussion Dengue fever is an acute, emerging" exact="infectious disease" post="caused by DENV, which is transmitted by Aedes aegypti"/>
   <result pre="host genetic background. In terms of the clinical manifestations of" exact="dengue fever" post="in the study participants, some clinical signs and symptoms"/>
   <result pre="response diversity may play roles in the pathogenesis of severe" exact="dengue fever" post="during a primary infection [39]. In conclusion, during the"/>
   <result pre="serotypes in human populations. Therefore, elucidating the immune responses to" exact="dengue fever" post="and the pathogenic mechanisms used by DENV are important"/>
   <result pre="Province and in Southeast Asian countries, indicating the possibility of" exact="dengue fever" post="becoming endemic in China, although most research has attributed"/>
   <result pre="in China, although most research has attributed the presence of" exact="dengue fever" post="in China to imported cases [12,40]. However, dengue infection"/>
   <result pre="LiL JL. A big challenge for prevention and control of" exact="dengue fever" post="in China. South Chin J Prev Med. 2007;33: 1â€&quot;3."/>
   <result pre="Prev Med. 2007;33: 1â€&quot;3. 18YiBT ZZ. Epidemic and control of" exact="dengue fever" post="in China. Chin Public Heal. 2002;18: 1128â€&quot;1130. 19B K."/>
   <result pre="2002;18: 1128â€&quot;1130. 19B K. Proposition for prevalence and monitor of" exact="dengue fever" post="in China. Chin J Vector Bio Control. 1997;8: 152â€&quot;156."/>
   <result pre="e8559610.1371/journal.pone.008559624465613 25LiangWJ, HeJF, LuoHM, ZhouHQ, Yang FZK. Epidemiological analysis of" exact="dengue fever" post="in Guangdong province, 2001â€&quot;2006. South Chin J Prev Med."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6406440\results\search\disease\results.xml">
   <result pre="identified in pigs with influenza-like illness was classified as the" exact="influenza" post="D virus (IDV) which is distantly related to the"/>
   <result pre="(IDV) which is distantly related to the previously characterized human" exact="influenza" post="C virus. Several other back-to-back studies soon suggested cattle"/>
   <result pre="natural reservoir and possible involvement of IDV in the bovine" exact="respiratory disease" post="complex was established. Not much is known about its"/>
   <result pre="Here, we review the evolution, epidemiology, virology and pathobiology of" exact="influenza" post="D virus and the possibility of transmission among various"/>
   <result pre="transmission among various hosts and potential to cause human disease." exact="influenza" post="influenza A virus (IAV) influenza B virus (IBV) influenza"/>
   <result pre="among various hosts and potential to cause human disease. influenza" exact="influenza" post="A virus (IAV) influenza B virus (IBV) influenza C"/>
   <result pre="potential to cause human disease. influenza influenza A virus (IAV)" exact="influenza" post="B virus (IBV) influenza C virus (ICV) influenza D"/>
   <result pre="disease. influenza influenza A virus (IAV) influenza B virus (IBV)" exact="influenza" post="C virus (ICV) influenza D virus (IDV) emerging pathogen"/>
   <result pre="virus (IAV) influenza B virus (IBV) influenza C virus (ICV)" exact="influenza" post="D virus (IDV) emerging pathogen epidemic pandemic respiratory illness"/>
   <result pre="acute respiratory illness and of the four known types, the" exact="influenza" post="A virus is a significant public health concern with"/>
   <result pre="antibody binding sites, this event is responsible for (i) frequent" exact="influenza" post="epidemics and (ii) the requirement of annual influenza vaccine"/>
   <result pre="(i) frequent influenza epidemics and (ii) the requirement of annual" exact="influenza" post="vaccine formulations. Genetic shift is the result of genetic"/>
   <result pre="between the genes of two or more different strains of" exact="influenza" post="virus infecting the same cell in a host. This"/>
   <result pre="avian and human IAVs [12,13,14]. Genetic shift has created novel" exact="influenza" post="virus strains with the ability to sustain efficient human-to-human"/>
   <result pre="to sustain efficient human-to-human transmission, and thus accountable for several" exact="influenza" post="pandemics in the past [4,11]. A total of 18"/>
   <result pre="have been reported to cause sustained, human-to-human transmission leading to" exact="influenza" post="epidemics [19]. Apart from the human influenza strains, there"/>
   <result pre="transmission leading to influenza epidemics [19]. Apart from the human" exact="influenza" post="strains, there are several low pathogenic avian influenza viruses"/>
   <result pre="from the human influenza strains, there are several low pathogenic" exact="avian influenza" post="viruses (LPAI) and highly pathogenic avian influenza viruses (HPAI)"/>
   <result pre="the human influenza strains, there are several low pathogenic avian" exact="influenza" post="viruses (LPAI) and highly pathogenic avian influenza viruses (HPAI)"/>
   <result pre="several low pathogenic avian influenza viruses (LPAI) and highly pathogenic" exact="avian influenza" post="viruses (HPAI) that have been in circulation in wild"/>
   <result pre="low pathogenic avian influenza viruses (LPAI) and highly pathogenic avian" exact="influenza" post="viruses (HPAI) that have been in circulation in wild"/>
   <result pre="thus are a significant cause of concern worldwide [20]. The" exact="influenza" post="B virus was first identified in the year 1940"/>
   <result pre="virus was first identified in the year 1940 [21]. Unlike" exact="influenza" post="A viruses that have a wide range of host,"/>
   <result pre="viruses that have been circulating worldwide since 1983 [26]. The" exact="influenza" post="B viruses also cause annual epidemics, but due to"/>
   <result pre="and similar to IBV, is known to cause relatively mild" exact="respiratory disease" post="in humans [28]. ICV is widely distributed throughout the"/>
   <result pre="discouraged its inclusion in the routine virological screenings. A novel" exact="influenza" post="virus, recently classified as the influenza D virus, has"/>
   <result pre="virological screenings. A novel influenza virus, recently classified as the" exact="influenza" post="D virus, has been identified in several animals, such"/>
   <result pre="the epidemiology, pathology, evolution and molecular biology of the novel" exact="influenza" post="D virus that represents a potential threat to public"/>
   <result pre="[35]. Of the approximately 3â€&quot;5 million people who develop severe" exact="influenza" post="infection, almost one million die annually [35]. Both influenza"/>
   <result pre="severe influenza infection, almost one million die annually [35]. Both" exact="influenza" post="A and B viruses are known to cause annual"/>
   <result pre="ICVs and human ICVs [37]. In the year 2011, an" exact="influenza" post="C-like virus was isolated from pigs having a influenza-like"/>
   <result pre="having a influenza-like illness in the USA. The newly identified" exact="influenza" post="D virus shared approximately 50% homology with ICV and"/>
   <result pre="detected in goats and pigs [43]. The study showed that" exact="influenza" post="viremia, as an indicator of disease severity, was observed"/>
   <result pre="The authors observed that the Dromedary camels in Kenya harbored" exact="influenza" post="C or D virus antibodies suggesting a new host"/>
   <result pre="respiratory viruses along with IDV to collectively cause the bovine" exact="respiratory disease" post="(BRD) [38]. The cattle industry in the US and"/>
   <result pre="the morbidity in the USA [38]. The IDV causes mild" exact="respiratory disease" post="in experimentally infected cattle. Several studies have already been"/>
   <result pre="nasal swabs with no clinical symptoms and lesions typical of" exact="influenza" post="viruses. The study also revealed that IDV could be"/>
   <result pre="revealed that the most commonly detected viruses were the bovine" exact="rhinitis" post="A and B virus, and bovine coronavirus along with"/>
   <result pre="maximum-likelihood phylogenetic tree generated from the sequence of PB1 from" exact="influenza" post="type A, B, C and D viruses [57]. Another"/>
   <result pre="have revealed crucial functions performed by the individual genes of" exact="influenza" post="A and B viruses [58], however very little of"/>
   <result pre="little of such studies have been performed in case of" exact="influenza" post="C and D viruses. A scanning transmission electron microscopic"/>
   <result pre="of IDV is still in infancy and is unclear. The" exact="influenza" post="viruses that cause zoonotic infections in humans have been"/>
   <result pre="be transmitted among ferrets, which are the model for human" exact="influenza" post="virus infection, and guinea pigs [72]. These studies highlight"/>
   <result pre="with more number of relevant studies; however, the ability of" exact="influenza" post="viruses to acquire frequent mutations makes IDV a potential"/>
   <result pre="Infection and Management of Future Threat Since the discovery of" exact="influenza" post="viruses, annual epidemics and several pandemics have been recorded"/>
   <result pre="have been recorded to claim numerous lives. With time, the" exact="influenza" post="viruses have also shown remarkable evolutionary changes and their"/>
   <result pre="remarkable changes in the public health infrastructure. Surveillance activities against" exact="influenza" post="viruses have been implemented worldwide to timely diagnose and"/>
   <result pre="detect a wide range of respiratory viruses in the bovine" exact="respiratory disease" post="complex [76]. In a most recent study, Henritzi et"/>
   <result pre="et al. developed a tetraplex real-time RT-PCR assay for screening" exact="influenza" post="virus types A, B, C and D simultaneously [77]."/>
   <result pre="of low cost and less invasive sampling to detect novel" exact="influenza" post="viruses [79]. Aerosol surveillance for respiratory viruses at an"/>
   <result pre="[80]. Developments in the antiviral strategies and vaccine technology against" exact="influenza" post="viruses have been in action to tackle disease outbreaks."/>
   <result pre="infections [82]. Another report highlights the development of an inactivated" exact="influenza" post="D virus vaccine that was found to be immunogenic"/>
   <result pre="also leads to socio-economic loss. Among the four genera, the" exact="influenza" post="A viruses have been reported to be of significant"/>
   <result pre="105 different species of birds have been reported to harbor" exact="influenza" post="A viruses [88,89]. Most of these carriers are almost"/>
   <result pre="fly longer distances while on migration [92,93]. Until recently, the" exact="influenza" post="C viruses were known to exist as a single"/>
   <result pre="drastic antigenic change over the years, yet the unpredictability of" exact="influenza" post="viruses make this type a potential health threat. IDV"/>
   <result pre="can sustain human-to-human transmission. Advancements in several approaches to managing" exact="influenza" post="infections have led to quick and efficient control measures"/>
   <result pre="also been in action against several respiratory viruses, including human" exact="influenza" post="viruses [94,95,96,97,98,99,100,101]. It would be interesting to have such"/>
   <result pre="the disease in cattle and other potential hosts. As the" exact="influenza" post="viruses continue to evolve, there is a need of"/>
   <result pre="policy makers across the world to closely monitor the circulating" exact="influenza" post="viruses and prevent any future outbreaks. Author Contributions Conceptualization,"/>
   <result pre="References 1.Familyâ€&quot;OrthomyxoviridaeVirus TaxonomyKingA.M.Q.AdamsM.J.CarstensE.B.LefkowitzE.J.ElsevierSan Diego, CA, USA2012749761 2.HauseB.M.CollinE.A.LiuR.HuangB.ShengZ.LuW.WangD.NelsonE.A.LiF.Characterization of a novel" exact="influenza" post="virus in cattle and Swine: Proposal for a new"/>
   <result pre="Virology of the Influenza VirusesInfluenzaSpringer USBoston, MA, USA19872532 4.KumarB.AshaK.KhannaM.RonsardL.MesekoC.A.SanicasM.The emerging" exact="influenza" post="virus threat: Status and new prospects for its therapy"/>
   <result pre="comparative accountFuture Virol.2013833534210.2217/fvl.13.18 7.MesekoC.KumarB.SanicasM.Preventing Zoonotic InfluenzaInfluenza-Therapeutics and ChallengesSaxenaS.K.IntechOpenLondon, UK20183355 8.KhannaM.KumarP.ChoudharyK.KumarB.VijayanV.K.Emerging" exact="influenza" post="virus: A global threatJ. Biosci.20083347548210.1007/s12038-008-0066-z19208973 9.KhannaM.KumarB.GuptaA.KumarP.Pandemic Influenza A H1N1"/>
   <result pre="Past and Implications for the FutureIndian J. Virol.201223121710.1007/s13337-012-0066-323729996 10.KhannaM.KumarB.GuptaN.KumarP.GuptaA.VijayanV.K.KaurH.Pandemic swine" exact="influenza" post="virus (H1N1): A threatening evolutionIndian J. Microbiol.20094936536910.1007/s12088-009-0064-323100799 11.TreanorJ.Influenza Vaccineâ€&quot;Outmaneuvering"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="virusesNature201552612212510.1038/nature1537926416728 13.ChotheS.K.BhushanG.NisslyR.H.YehY.T.BrownJ.TurnerG.FisherJ.SewallB.J.ReederD.M.TerronesM.et al.Avian and human influenza virus compatible sialic"/>
   <result pre="of adaptation for transmissible influenza virusesNature201552612212510.1038/nature1537926416728 13.ChotheS.K.BhushanG.NisslyR.H.YehY.T.BrownJ.TurnerG.FisherJ.SewallB.J.ReederD.M.TerronesM.et al.Avian and human" exact="influenza" post="virus compatible sialic acid receptors in little brown batsSci."/>
   <result pre="a potential mixing vessel for the generation of new reassortant" exact="influenza" post="A virusesVet. Microbiol.201216030531310.1016/j.vetmic.2012.05.04322763173 15.YoonS.W.WebbyR.J.WebsterR.G.Evolution and ecology of influenza A"/>
   <result pre="new reassortant influenza A virusesVet. Microbiol.201216030531310.1016/j.vetmic.2012.05.04322763173 15.YoonS.W.WebbyR.J.WebsterR.G.Evolution and ecology of" exact="influenza" post="A virusesCurr. Top. Microbiol. Immunol.201438535937510.1007/82_2014_39624990620 16.OlsenB.MunsterV.J.WallenstenA.WaldenstromJ.OsterhausA.D.FouchierR.A.Global patterns of influenza"/>
   <result pre="of influenza A virusesCurr. Top. Microbiol. Immunol.201438535937510.1007/82_2014_39624990620 16.OlsenB.MunsterV.J.WallenstenA.WaldenstromJ.OsterhausA.D.FouchierR.A.Global patterns of" exact="influenza" post="a virus in wild birdsScience200631238438810.1126/science.112243816627734 17.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats"/>
   <result pre="virus in wild birdsScience200631238438810.1126/science.112243816627734 17.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats harbor diverse" exact="influenza" post="A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 18.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of influenza"/>
   <result pre="diverse influenza A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 18.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of" exact="influenza" post="A virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 19.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic"/>
   <result pre="virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 19.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of" exact="avian influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 20.SuS.BiY.WongG.GrayG.C.GaoG.F.LiS.Epidemiology, Evolution, and Recent Outbreaks"/>
   <result pre="from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 19.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of avian" exact="influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 20.SuS.BiY.WongG.GrayG.C.GaoG.F.LiS.Epidemiology, Evolution, and Recent Outbreaks"/>
   <result pre="B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 23.KawanoJ.OntaT.KidaH.YanagawaR.Distribution of antibodies in animals against" exact="influenza" post="B and C virusesJpn. J. Vet. Res.1978267480739713 24.ChangC.P.NewA.E.TaylorJ.F.ChiangH.S.Influenza virus"/>
   <result pre="B VirusesJ. Virol.2015894818482610.1128/JVI.00059-1525673727 26.RotaP.A.WallisT.R.HarmonM.W.RotaJ.S.KendalA.P.NeromeK.Cocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983Virology1990175596810.1016/0042-6822(90)90186-U2309452 27.TaylorR.M.Studies on survival of"/>
   <result pre="influenza type B virus since 1983Virology1990175596810.1016/0042-6822(90)90186-U2309452 27.TaylorR.M.Studies on survival of" exact="influenza" post="virus between epidemics and antigenic variants of the virusAm."/>
   <result pre="Nations Health19493917117810.2105/AJPH.39.2.17118111593 28.Crescenzo-ChaigneB.BarbezangeC.van der WerfS.Non coding extremities of the seven" exact="influenza" post="virus type C vRNA segments: Effect on transcription and"/>
   <result pre="to Type C Influenza VirusMicrobiol. Immunol.19822663964210.1111/mim.1982.26.7.6397132793 30.ManuguerraJ.C.HannounC.Saenz MdelC.VillarE.CabezasJ.A.Sero-epidemiological survey of" exact="influenza" post="C virus infection in SpainEur. J. Epidemiol.199410919410.1007/BF017174597957798 31.YuanjiG.FengenJ.PingW.MinW.JimingZ.Isolation of"/>
   <result pre="Camelids, Africa, 1991â€&quot;2015Emerg. Infect. Dis. J.201723155610.3201/eid2309.170342 34.BaileyE.S.ChoiJ.Y.FieldhouseJ.K.BorkenhagenL.K.ZemkeJ.ZhangD.GrayG.C.The continual threat of" exact="influenza" post="virus infections at the humanâ€&quot;animal interfaceWhat is new from"/>
   <result pre="from a one health perspective?Evol. Med. Public Health2018201819219810.1093/emph/eoy01330210800 35.Vaccines against" exact="influenza" post="WHO position paperâ€&quot;November 2012Wkly. Epidemiol. Rec.20128746147623210147 36.HauseB.M.DucatezM.CollinE.A.RanZ.LiuR.ShengZ.ArmienA.KaplanB.ChakravartyS.HoppeA.D.et al.Isolation of"/>
   <result pre="Gen. Virol.1984651857187210.1099/0022-1317-65-11-18576502138 38.MitraN.CernicchiaroN.TorresS.LiF.HauseB.M.Metagenomic characterization of the virome associated with bovine" exact="respiratory disease" post="in feedlot cattle identified novel viruses and suggests an"/>
   <result pre="cattle identified novel viruses and suggests an etiologic role for" exact="influenza" post="D virusJ. Gen. Virol.2016971771178410.1099/jgv.0.00049227154756 39.FergusonL.EckardL.EppersonW.B.LongL.-P.SmithD.HustonC.GenovaS.WebbyR.WanX.-F.Influenza D virus infection in"/>
   <result pre="Mississippi beef cattleVirology2015486283410.1016/j.virol.2015.08.03026386554 40.QuastM.SreenivasanC.SextonG.NedlandH.SingreyA.FawcettL.MillerG.LauerD.VossS.PollockS.et al.Serological evidence for the presence of" exact="influenza" post="D virus in small ruminantsVet. Microbiol.201518028128510.1016/j.vetmic.2015.09.00526414999 41.LuoJ.FergusonL.SmithD.R.WoolumsA.R.EppersonW.B.WanX.-F.Serological evidence for"/>
   <result pre="United States, 2003â€&quot;2004Virology2017501889110.1016/j.virol.2016.11.00427888742 42.JiangW.-M.WangS.-C.PengC.YuJ.-M.ZhuangQ.-Y.HouG.-Y.LiuS.LiJ.-P.ChenJ.-M.Identification of a potential novel type of" exact="influenza" post="virus in Bovine in ChinaVirus Genes20144949349610.1007/s11262-014-1107-325142163 43.Shao-LunZ.HeZ.Sheng-NanC.XiaZ.TaoL.RunxiaL.Dian-HongL.Xiao-HuiW.Wen-KangW.DanW.et al.Influenza D"/>
   <result pre="49.NedlandH.WollmanJ.SreenivasanC.QuastM.SingreyA.FawcettL.Christopher-HenningsJ.NelsonE.KaushikR.S.WangD.et al.Serological evidence for the co-circulation of two lineages of" exact="influenza" post="D viruses in equine populations of the Midwest United"/>
   <result pre="CattleJ. Virol.2015891036104210.1128/JVI.02718-1425355894 56.MekataH.YamamotoM.HamabeS.TanakaH.OmatsuT.MizutaniT.HauseB.M.OkabayashiT.Molecular epidemiological survey and phylogenetic analysis of bovine" exact="influenza" post="D virus in JapanTransbound. Emerg. Dis.201865e355e36010.1111/tbed.1276529143492 57.SuS.FuX.LiG.KerlinF.VeitM.Novel Influenza D"/>
   <result pre="Thermal and Acid Stability of Influenza D VirusmSphere20172e002540021710.1128/mSphere.00254-1728808690 62.NodaT.KawaokaY.Structure of" exact="influenza" post="virus ribonucleoprotein complexes and their packaging into virionsRev. Med."/>
   <result pre="virionsRev. Med. Virol.20102038039110.1002/rmv.66620853340 63.KumarB.KhannaM.KumarP.SoodV.VyasR.BanerjeaA.C.Nucleic acid-mediated cleavage of M1 gene of" exact="influenza" post="A virus is significantly augmented by antisense molecules targeted"/>
   <result pre="cleavage siteMol. Biotechnol.201251273610.1007/s12033-011-9437-z21744034 64.KumarB.KumarP.RajputR.SaxenaL.DagaM.KhannaM.Sequence-specific cleavage of BM2 gene transcript of" exact="influenza" post="B virus by 10-23 catalytic motif containing DNA enzymes"/>
   <result pre="ModelJ. Virol.2007816890689810.1128/JVI.00170-0717459930 70.MainesT.R.ChenL.-M.MatsuokaY.ChenH.RoweT.OrtinJ.FalcÃ³nA.HienN.T.MaiL.Q.SedyaningsihE.R.et al.Lack of transmission of H5N1 avianâ€&quot;human reassortant" exact="influenza" post="viruses in a ferret modelProc. Natl. Acad. Sci. USA2006103121211212610.1073/pnas.060513410316880383"/>
   <result pre="D Virus in a Guinea Pig ModelJ. Virol.201589119901200110.1128/JVI.01630-1526378161 73.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of" exact="influenza" post="C virus but not influenza D virus in Scottish"/>
   <result pre="Pig ModelJ. Virol.201589119901200110.1128/JVI.01630-1526378161 73.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of influenza C virus but not" exact="influenza" post="D virus in Scottish respiratory samplesJ. Clin. Virol.201674505310.1016/j.jcv.2015.11.03626655269 74.WhiteS.K.MaW.McDanielC.J.GrayG.C.LednickyJ.A.Serologic"/>
   <result pre="Scottish respiratory samplesJ. Clin. Virol.201674505310.1016/j.jcv.2015.11.03626655269 74.WhiteS.K.MaW.McDanielC.J.GrayG.C.LednickyJ.A.Serologic evidence of exposure to" exact="influenza" post="D virus among persons with occupational contact with cattleJ."/>
   <result pre="of a new Real-Time RT-PCR assay for detection of proposed" exact="influenza" post="D virusJ. Virol. Methods2017243313410.1016/j.jviromet.2017.01.01928153610 76.KishimotoM.TsuchiakaS.RahpayaS.S.HasebeA.OtsuK.SugimuraS.KobayashiS.KomatsuN.NagaiM.OmatsuT.et al.Development of a one-run"/>
   <result pre="one-run real-time PCR detection system for pathogens associated with bovine" exact="respiratory disease" post="complexJ. Vet. Med. Sci.20177951752310.1292/jvms.16-048928070089 77.HenritziD.HoffmannB.WacheckS.PeschS.HerrlerG.BeerM.HarderT.C.A newly developed tetraplex real-time"/>
   <result pre="77.HenritziD.HoffmannB.WacheckS.PeschS.HerrlerG.BeerM.HarderT.C.A newly developed tetraplex real-time RT-PCR for simultaneous screening of" exact="influenza" post="virus types A, B, C and DInflu. Other Respir."/>
   <result pre="Viruses201913718210.1111/irv.1261330264926 78.MorenoA.LelliD.LavazzaA.SozziE.ZanniI.ChiapponiC.FoniE.CapucciL.BrocchiE.MAb-based competitive ELISA for the detection of antibodies against" exact="influenza" post="D virusTransbound. Emerg. Dis.20196626827610.1111/tbed.1301230179314 79.AndersonB.D.MaM.XiaY.WangT.ShuB.LednickyJ.A.MaM.-J.LuJ.GrayG.C.Bioaerosol Sampling in Modern Agriculture:"/>
   <result pre="81.KumarP.KhannaM.KumarB.RajputR.BanerjeaA.C.A conserved matrix epitope based DNA vaccine protects mice against" exact="influenza" post="A virus challengeAntiviral Res.201293788510.1016/j.antiviral.2011.10.02122086129 82.WanY.KangG.SreenivasanC.DaharshL.ZhangJ.FanW.WangD.MoriyamaH.LiF.LiQ.A DNA Vaccine Expressing Consensus"/>
   <result pre="by Two Lineages of Influenza D VirusJ. Virol.20189210.1128/JVI.00110-18 83.HauseB.M.HuntimerL.FalkenbergS.HenningsonJ.LechtenbergK.HalburT.An inactivated" exact="influenza" post="D virus vaccine partially protects cattle from respiratory disease"/>
   <result pre="83.HauseB.M.HuntimerL.FalkenbergS.HenningsonJ.LechtenbergK.HalburT.An inactivated influenza D virus vaccine partially protects cattle from" exact="respiratory disease" post="caused by homologous challengeVet. Microbiol.2017199475310.1016/j.vetmic.2016.12.02428110784 84.EasterdayB.C.TrainerD.O.TÅ®MovÃ�B.PereiraH.G.Evidence of Infection with"/>
   <result pre="in North AmericaVector-Borne Zoonotic Dis.2004417718910.1089/vbz.2004.4.17715631061 87.SpackmanE.StallknechtD.E.SlemonsR.D.WinkerK.SuarezD.L.ScottM.SwayneD.E.Phylogenetic analyses of type A" exact="influenza" post="genes in natural reservoir species in North America reveals"/>
   <result pre="Res.20051148910010.1016/j.virusres.2005.05.01316039745 88.MunsterV.J.BaasC.LexmondP.WaldenstromJ.WallenstenA.FranssonT.RimmelzwaanG.F.BeyerW.E.SchuttenM.OlsenB.et al.Spatial, temporal, and species variation in prevalence of" exact="influenza" post="A viruses in wild migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 89.StallknechtD.E.ShaneS.M.Host range"/>
   <result pre="A viruses in wild migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 89.StallknechtD.E.ShaneS.M.Host range of" exact="avian influenza" post="virus in free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with"/>
   <result pre="viruses in wild migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 89.StallknechtD.E.ShaneS.M.Host range of avian" exact="influenza" post="virus in free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with"/>
   <result pre="in free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with highly pathogenic" exact="avian influenza" post="H5N1 in wild birds: How sound is the evidence?Virol."/>
   <result pre="free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with highly pathogenic avian" exact="influenza" post="H5N1 in wild birds: How sound is the evidence?Virol."/>
   <result pre="InfectionsJ. Clin. Med.20188610.3390/jcm801000630577479 95.KhannaM.SaxenaL.RajputR.KumarB.PrasadR.Gene silencing: A therapeutic approach to combat" exact="influenza" post="virus infectionsFuture Microbiol.20151013114010.2217/fmb.14.9425598342 96.KumarB.AshaK.ChauhanS.DNAzyme mediated post-transcriptional gene silencing: A"/>
   <result pre="of antisense oligonucleotide developed against the common 3â€² NCR of" exact="influenza" post="A virus genomeMol. Biotechnol.20135520321110.1007/s12033-013-9670-823729285 98.RajputR.KhannaM.KumarP.KumarB.SharmaS.GuptaN.SaxenaL.Small interfering RNA targeting the"/>
   <result pre="98.RajputR.KhannaM.KumarP.KumarB.SharmaS.GuptaN.SaxenaL.Small interfering RNA targeting the nonstructural gene 1 transcript inhibits" exact="influenza" post="A virus replication in experimental miceNucleic Acid Ther.20122241442210.1089/nat.2012.035923062009 99.MotardJ.RouxelR.PaunA.von"/>
   <result pre="experimental miceNucleic Acid Ther.20122241442210.1089/nat.2012.035923062009 99.MotardJ.RouxelR.PaunA.von MesslingV.BisaillonM.PerreaultJ.P.A novel ribozyme-based prophylaxis inhibits" exact="influenza" post="A virus replication and protects from severe diseasePLoS ONE20116e2732710.1371/journal.pone.002732722110627"/>
   <result pre="ONE20116e2732710.1371/journal.pone.002732722110627 100.ZhangZ.ZhangS.WangS.DNAzymes Dz13 target the c-jun possess antiviral activity against" exact="influenza" post="A virusesMicrob. Pathog.201710315516110.1016/j.micpath.2016.12.02428039102 101.TangX.B.HobomG.LuoD.Ribozyme mediated destruction of influenza A"/>
   <result pre="activity against influenza A virusesMicrob. Pathog.201710315516110.1016/j.micpath.2016.12.02428039102 101.TangX.B.HobomG.LuoD.Ribozyme mediated destruction of" exact="influenza" post="A virus in vitro and in vivoJ. Med. Virol.19944238539510.1002/jmv.18904204118046429"/>
   <result pre="Virol.19944238539510.1002/jmv.18904204118046429 Figure 1 Summary of the wide host range of" exact="influenza" post="viruses. Few host species are susceptible to infection by"/>
   <result pre="species are susceptible to infection by all the four known" exact="influenza" post="viruses (influenza A virusâ€&quot;IAV, influenza B virusâ€&quot;IBV, influenza C"/>
   <result pre="by all the four known influenza viruses (influenza A virusâ€&quot;IAV," exact="influenza" post="B virusâ€&quot;IBV, influenza C virusâ€&quot;ICV and influenza D virusâ€&quot;IDV),"/>
   <result pre="four known influenza viruses (influenza A virusâ€&quot;IAV, influenza B virusâ€&quot;IBV," exact="influenza" post="C virusâ€&quot;ICV and influenza D virusâ€&quot;IDV), while others are"/>
   <result pre="(influenza A virusâ€&quot;IAV, influenza B virusâ€&quot;IBV, influenza C virusâ€&quot;ICV and" exact="influenza" post="D virusâ€&quot;IDV), while others are known to be infected"/>
   <result pre="while others are known to be infected by only specific" exact="influenza" post="viruses. Cattles are the major known reservoir of influenza"/>
   <result pre="specific influenza viruses. Cattles are the major known reservoir of" exact="influenza" post="D virus; however, other small ruminants and humans have"/>
   <result pre="IDV infections in different conditions. Figure 2 Schematic representation of" exact="influenza" post="D virus. IDV is an enveloped virus with seven"/>
   <result pre="as the ion channel. jcm-08-00192-t001_Table 1Table 1 Revised classification of" exact="influenza" post="viruses in the family Orthomyxovirideae by International Committee on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410043\results\search\disease\results.xml">
   <result pre="(CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The recent explosive pandemic of" exact="chikungunya" post="virus (CHIKV) followed by Zika (ZIKV) virus infections occurring"/>
   <result pre="(i) the Flaviviridae (genus flavivirus) which includes West Nile (WNV)," exact="yellow fever" post="(YFV), dengue (DENV) and Zika (ZIKV) viruses and (ii)"/>
   <result pre="arthralgia with CIKV infection, haemorrhagic fever with DENV infection and" exact="microcephaly" post="and other neurological manifestations with ZIKV infection [1,6,16]. It"/>
   <result pre="region of related flaviviruses, including DENGV, ZIKV, YFV and Japanese" exact="encephalitis" post="viruses, to KIR2DS2. The other activating NK receptors are:"/>
   <result pre="This was shown in a 3-month-old girl with a Tâˆ’B+NK+" exact="severe combined immunodeficiency" post="phenotype who recovered from cytomegalovirus (CMV) infection without antiviral"/>
   <result pre="made in the context of CHIKV [45], Hantavirus [52] and" exact="viral hepatitis" post="B and C [53,54]. Until now, the presence and"/>
   <result pre="in the context of CHIKV [45], Hantavirus [52] and viral" exact="hepatitis" post="B and C [53,54]. Until now, the presence and"/>
   <result pre="consistent with those obtained in degenerative joint disease associated with" exact="osteoarthritis" post="in which synovial tissue-infiltrating NK cells displayed impaired IFN-Î³"/>
   <result pre="as a major pathogen following an outbreak of fever and" exact="encephalitis" post="in New York, USA in 1999, where deaths in"/>
   <result pre="to Guillain-BarrÃ© syndrome in adults and multiple neurodevelopmental defects, including" exact="microcephaly" post="in infants born of mothers infected during the first"/>
   <result pre="Of note, in other flavivirus infections, such as WNV and" exact="tick-borne encephalitis" post="(TBEV), another flavivirus transmitted to humans by ticks, specific"/>
   <result pre="note, in other flavivirus infections, such as WNV and tick-borne" exact="encephalitis" post="(TBEV), another flavivirus transmitted to humans by ticks, specific"/>
   <result pre="dengue virus transmissionPLoS Negl. Trop. Dis.20104e64610.1371/journal.pntd.000064620520794 6.PetitdemangeC.WauquierN.VieillardV.Control of immunopathology during" exact="chikungunya" post="virus infectionJ. Allergy Clin. Immunol.201513584685510.1016/j.jaci.2015.01.03925843597 7.ShepardD.S.UndurragaE.A.HalasaY.A.StanawayJ.D.The global economic burden"/>
   <result pre="host interferon response in zebrafishPLoS Pathog.20139e100361910.1371/journal.ppat.100361924039582 11.SchwartzO.AlbertM.L.Biology and pathogenesis of" exact="chikungunya" post="virusNat. Rev. Microbiol.2010849150010.1038/nrmicro236820551973 12.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et al.Novel chikungunya vaccine candidate with"/>
   <result pre="11.SchwartzO.AlbertM.L.Biology and pathogenesis of chikungunya virusNat. Rev. Microbiol.2010849150010.1038/nrmicro236820551973 12.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et al.Novel" exact="chikungunya" post="vaccine candidate with an IRES-based attenuation and host range"/>
   <result pre="threat?Emerg. Microbes Infect.2018716310.1038/s41426-018-0163-530254258 45.PetitdemangeC.BecquartP.WauquierN.BÃ©ziatV.DebrÃ©P.LeroyE.M.VieillardV.Unconventional repertoire profile is imprinted during acute" exact="chikungunya" post="infection for natural killer cells polarization toward cytotoxicityPLoS Pathog.20117e100226810.1371/journal.ppat.100226821966274"/>
   <result pre="of NK and NKT-like populations during the early stages of" exact="chikungunya" post="infectionFront. Microbiol.2015689510.3389/fmicb.2015.0089526388848 48.FoxJ.M.DiamondM.S.Immune-Mediated Protection and Pathogenesis of Chikungunya VirusJ."/>
   <result pre="Exp. Med.2011208132110.1084/jem.2010076221173105 53.OlivieroB.VarchettaS.PaudiceE.MicheloneG.ZaramellaM.MavilioD.De FilippiF.BrunoS.MondelliM.U.Natural killer cell functional dichotomy in chronic" exact="hepatitis" post="B and chronic hepatitis C virus infectionsGastroenterology20091371151116010.1053/j.gastro.2009.05.04719470388 54.BÃ©ziatV.DalgardO.AsselahT.HalfonP.BedossaP.BoudifaA.HervierB.TheodorouI.MartinotM.DebrÃ©P.et al.CMV"/>
   <result pre="killer cell functional dichotomy in chronic hepatitis B and chronic" exact="hepatitis" post="C virus infectionsGastroenterology20091371151116010.1053/j.gastro.2009.05.04719470388 54.BÃ©ziatV.DalgardO.AsselahT.HalfonP.BedossaP.BoudifaA.HervierB.TheodorouI.MartinotM.DebrÃ©P.et al.CMV drives clonal expansion of"/>
   <result pre="expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic" exact="hepatitis" post="patientsEur. J. Immunol.20124244745710.1002/eji.20114182622105371 55.RÃ¶lleA.BrodinP.Immune Adaptation to Environmental Influence: The"/>
   <result pre="Acute Joint PathologyJ. Virol.2015897955796910.1128/JVI.00909-1525995257 62.HussR.S.HuddlestonJ.I.GoodmanS.B.ButcherE.C.ZabelB.A.Synovial tissue-infiltrating natural killer cells in" exact="osteoarthritis" post="and periprosthetic inflammationArthritis Rheum.2010623799380510.1002/art.2775120848566 63.JaimeP.GarcÃ­a-GuerreroN.EstellaR.PardoJ.GarcÃ­a-Ã�lvarezF.Martinez-LostaoL.CD56+/CD16âˆ’ Natural Killer cells expressing"/>
   <result pre="NY, USA1951 65.JiaX.Y.BrieseT.JordanI.RambautA.ChiH.C.MackenzieJ.S.HallR.A.ScherretJ.LipkinW.I.Genetic analysis of West Nile New York 1999" exact="encephalitis" post="virusLancet19993541971197210.1016/S0140-6736(99)05384-210622305 66.NgonoA.E.ShrestaS.Immune Response to Dengue and ZikaAnnu. Rev. Immunol.20183627930810.1146/annurev-immunol-042617-05314229345964"/>
   <result pre="PatientsFront. Immunol.2015650710.3389/fimmu.2015.0050726500647 77.NevesP.C.MatosD.C.MarcovistzR.GallerR.TLR expression and NK cell activation after human" exact="yellow fever" post="vaccinationVaccine2009275543554910.1016/j.vaccine.2009.07.02819647065 78.MarquardtN.IvarssonM.A.BlomK.GonzalezV.D.BraunM.FalconerK.GustafssonR.Fogdell-HahnA.SandbergJ.K.MichaÃ«lssonJ.The Human NK Cell Response to Yellow Fever"/>
   <result pre="virus (BOUV), Dengue virus (DENV), Israel Turkey meningoencephalomyelitis (ITV), Japanese" exact="encephalitis" post="virus (JEV), Jugra virus (JUGV), Kokobera virus (KOKV), Lamni"/>
   <result pre="virus (JUGV), Kokobera virus (KOKV), Lamni virus (LAMV), Murray Valley" exact="encephalitis" post="virus (MVEV), NouanamÃ© virus (NOUV), Rabensburg virus (RABV), Saint"/>
   <result pre="virus (MVEV), NouanamÃ© virus (NOUV), Rabensburg virus (RABV), Saint Louis" exact="encephalitis" post="virus (SLEV), Spondweni virus (SPOV), Tembusu virus (TMUV), Tâ€™Ho"/>
   <result pre="Usutu virus (USUV), Wesselsbron virus (WESSV), West Nile virus (WNV)," exact="yellow fever" post="virus (YFV) and Zika virus (ZIKV). Alphaviruses: Barmah forest"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410066\results\search\disease\results.xml">
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The" exact="influenza" post="virus-host interaction is a classic arms race. The recurrent"/>
   <result pre="classic arms race. The recurrent and evolving nature of the" exact="influenza" post="virus family allows a single host to be infected"/>
   <result pre="host to be infected several times. Locked in co-evolution, recurrent" exact="influenza" post="virus infection elicits continual refinement of the host immune"/>
   <result pre="host immune system. Here we give historical context of circulating" exact="influenza" post="viruses to understand how the individual immune history is"/>
   <result pre="the individual immune history is mirrored by the history of" exact="influenza" post="virus circulation. Original Antigenic Sin was first proposed as"/>
   <result pre="first proposed as the negative influence of the hostâ€™s first" exact="influenza" post="virus infection on the next and Imprinting modernizes Antigenic"/>
   <result pre="the continual refinement of the host immune system with each" exact="influenza" post="virus infection. We discuss imprinting and the interplay of"/>
   <result pre="influenza virus infection. We discuss imprinting and the interplay of" exact="influenza" post="virus homology, vaccination, and host age establishing preimmunity. We"/>
   <result pre="for future investigation. Understanding the effects of antigenic variable recurrent" exact="influenza" post="virus infection on immune refinement will advance vaccination strategies,"/>
   <result pre="as pandemic preparedness. immune response original antigenic sin imprinting preimmunity" exact="influenza" post="virus antigenic drift antigenic shift orthomyxoviridae Spanish influenza pandemic"/>
   <result pre="imprinting preimmunity influenza virus antigenic drift antigenic shift orthomyxoviridae Spanish" exact="influenza" post="pandemic 1. Introduction: Influenza Viruses are the Archetype Emerging"/>
   <result pre="the ability to infect the vulnerable human population [4]. Yearly," exact="influenza" post="viruses infect between 5% and 15% of the population"/>
   <result pre="that every person will be infected or exposed to the" exact="influenza" post="virus by the time they are four years old."/>
   <result pre="time they are four years old. Furthermore, considering prominent government-supported" exact="influenza" post="vaccination programs, the age of first influenza virus exposure"/>
   <result pre="considering prominent government-supported influenza vaccination programs, the age of first" exact="influenza" post="virus exposure is most likely lower. Since influenza viruses"/>
   <result pre="of first influenza virus exposure is most likely lower. Since" exact="influenza" post="viruses cycle yearly in the human population and the"/>
   <result pre="previous infection is not life-long [6], people are exposed to" exact="influenza" post="viruses recurrently. This means that everyone, with the exception"/>
   <result pre="that everyone, with the exception of newborn infants, has an" exact="influenza" post="immune history. Humans build a complex immune history due"/>
   <result pre="a complex immune history due to repeated exposures with new" exact="influenza" post="strains from infection and seasonal vaccinations. The influence of"/>
   <result pre="1960s. Dr. Thomas Francis Jr. suggested that a personâ€™s first" exact="influenza" post="virus infection would be deleterious to the clinical outcome"/>
   <result pre="Immune history is not simply composed of the hostâ€™s first" exact="influenza" post="virus infection. Rather, the interaction between the immune system"/>
   <result pre="virus infection. Rather, the interaction between the immune system and" exact="influenza" post="viruses is dynamic with each exposure. Each host-pathogen interaction"/>
   <result pre="stalk [15]. The constant circulation of a heterogeneous pool of" exact="influenza" post="viruses allows for many possible permutations for viral infection"/>
   <result pre="Heterotypic sequential infections (Table 1). The influence of a previous" exact="influenza" post="virus exposure on the outcome of a subsequent infection"/>
   <result pre="infection may be both beneficial and deleterious. A personâ€™s first" exact="influenza" post="infection is a significant event, the imprinting event, which"/>
   <result pre="memory cells [16]. Subsequent infections lead to cumulative effects of" exact="influenza" post="viruses on the immune background which shape future responses"/>
   <result pre="responses [17]. We propose that a personâ€™s immune history of" exact="influenza" post="virus infections should be known as preimmunity. The schematic"/>
   <result pre="an individualâ€™s immune landscape may evolve during seasonal exposures to" exact="influenza" post="viruses and vaccinations (Figure 1). The imprinting event that"/>
   <result pre="target surface and internal viral epitopes specific to this first" exact="influenza" post="virus which remain prominent throughout life [18]. Most antibodies"/>
   <result pre="to antibody specificity and B cell longevity. Following a new" exact="influenza" post="virus infection, the resulting immune constellation is dependent on"/>
   <result pre="the pre-existing immune specificity and the characteristics of the next" exact="influenza" post="virus infection (virus strain, subtype, lineage, or type). Below"/>
   <result pre="subtype, lineage, or type). Below we review the literature surrounding" exact="influenza" post="virus immune imprinting and preimmunity. We first outline the"/>
   <result pre="preimmunity. We first outline the development of preimmunity by discussing" exact="influenza" post="virology, influenza history, and primary immune responses. This sets"/>
   <result pre="first outline the development of preimmunity by discussing influenza virology," exact="influenza" post="history, and primary immune responses. This sets the stage"/>
   <result pre="of host preimmunity will contribute to the next generation of" exact="influenza" post="vaccines. 2. Influenza Virus Biology Enables Frequent Antigenic Change"/>
   <result pre="Enables Frequent Antigenic Change The segmented RNA genome of the" exact="influenza" post="virus family (Orthomyxoviridae) facilitates antigenic variability [20]. The family"/>
   <result pre="types: A, B, C (Figure 2), and D [21,22]. Briefly," exact="influenza" post="C and D viruses are not regarded as health"/>
   <result pre="D viruses are not regarded as health threats. In humans," exact="influenza" post="C virus causes mild illness while type D virus"/>
   <result pre="virus is incapable of human infection [23]. The surface of" exact="influenza" post="C virus is defined by a single spike protein"/>
   <result pre="capabilities, and enzymatic activity for egress [23]. Although antibodies to" exact="influenza" post="C virus are detected early in life [23], little"/>
   <result pre="NA [25] surface proteins are the immunodominant proteins of the" exact="influenza" post="virus which is why they have been the focus"/>
   <result pre="the rearrangement of genomic RNA segments between two or more" exact="influenza" post="viruses [41]. Antigenic Drift leads to seasonal influenza epidemics"/>
   <result pre="or more influenza viruses [41]. Antigenic Drift leads to seasonal" exact="influenza" post="epidemics while shift is the cause of pandemic influenza"/>
   <result pre="seasonal influenza epidemics while shift is the cause of pandemic" exact="influenza" post="virus outbreaks [41]. Both avenues lead to antigenically divergent"/>
   <result pre="Using experimental studies, the early stages of a hostâ€™s first" exact="influenza" post="virus infection have been defined by the antiviral response"/>
   <result pre="By summarizing the knowledge of the immune responses to primary" exact="influenza" post="virus infection we create a reference point for the"/>
   <result pre="dissemination, and recruiting effector cells for viral clearance [42]. Since" exact="influenza" post="viruses are transmitted through the respiratory route, the initial"/>
   <result pre="through the respiratory route, the initial site of infection for" exact="influenza" post="viruses is the respiratory epithelium [40,43,44,45]. Specifically, ciliated pseudostratified"/>
   <result pre="immune cells for viral clearance [40]. NK cells aid in" exact="influenza" post="viral clearance by recognizing and lysing influenza virus-infected cells"/>
   <result pre="cells aid in influenza viral clearance by recognizing and lysing" exact="influenza" post="virus-infected cells [46]. Alveolar macrophages phagocytose virus infected cells"/>
   <result pre="bridging innate immunity to the targeted adaptive immune responses during" exact="influenza" post="virus infection [50]. Conventional DCs sit under the epithelium"/>
   <result pre="survey the airway environment with their dendrites [34]. Detection of" exact="influenza" post="virus initiates DC up-regulation of the chemokine receptor CCR7"/>
   <result pre="to kill virus infected cells. Global gene expression analysis of" exact="influenza" post="infection in ferrets has shown that the host immune"/>
   <result pre="this review will concentrate on the humoral immune response during" exact="influenza" post="virus infection in the preimmune host. With this in"/>
   <result pre="migrate to the lymph node transporting with them the acquired" exact="influenza" post="virus antigen. In the lymph node, naÃ¯ve CD8+ T"/>
   <result pre="T cells have greater potential for cross-reactivity between antigenically divergent" exact="influenza" post="virus strains since these cells can target internal conserved"/>
   <result pre="T cell specific clones can increase the recovery time of" exact="influenza" post="virus secondary infections. The primary humoral response to infection"/>
   <result pre="plasma cells producing antibodies targeted at viral epitopes. During primary" exact="influenza" post="virus infection, a large and diverse pool of antibodies"/>
   <result pre="of antibodies are produced and circulated [17]. Animal modeling of" exact="influenza" post="virus infection in naÃ¯ve hosts has shown that most"/>
   <result pre="memory B cells are lifelong since antibodies specific to historical" exact="influenza" post="viruses have been detected in humans decades after initial"/>
   <result pre="Immunological Memory Infection-reinfection or sequential infection experiments attempt to recapitulate" exact="influenza" post="seasonality using animal models. The host is primed with"/>
   <result pre="using animal models. The host is primed with an initial" exact="influenza" post="virus before a challenge with a secondary infection following"/>
   <result pre="[13]. Above we defined the exposure permutations in terms of" exact="influenza" post="virus antigenicity as monosubtypic homologous, monosubtypic heterologous, heterosubtypic, and"/>
   <result pre="contraction phase of the primary adaptive immune response. For the" exact="influenza" post="virus-host interaction, the interval of time between a primary"/>
   <result pre="Virus Circulation Mirrors the Human Influenza Background The history of" exact="influenza" post="virus circulation is encompassed within the individual. In each"/>
   <result pre="will briefly review the modern history (past ~150 years) of" exact="influenza" post="virus circulation to understand the epidemiological and immunological outcomes"/>
   <result pre="virus circulation to understand the epidemiological and immunological outcomes of" exact="influenza" post="virus infection and vaccination. The influenza A virus was"/>
   <result pre="and immunological outcomes of influenza virus infection and vaccination. The" exact="influenza" post="A virus was first identified as the etiological agent"/>
   <result pre="virus was first identified as the etiological agent of human" exact="influenza" post="in 1933 shortly after the advent of electron microscopy"/>
   <result pre="the agent responsible for influenza-like epidemics/pandemics such as the 1918" exact="influenza" post="pandemic were not readily determined [74]. The constructed timeline"/>
   <result pre="timeline (Figure 3) starting in 1889 shows the history of" exact="influenza" post="A and B virus circulation in the human population."/>
   <result pre="human population. There have been six presumptive pandemics caused by" exact="influenza" post="A viruses since 1889 that have defined the immunological"/>
   <result pre="the 1918 pandemic occurred prior to the discovery of the" exact="influenza" post="virus [1,6]. The etiology of these disease outbreaks was"/>
   <result pre="The H2N2 virus was usurped by the introduction of the" exact="influenza" post="A virus subtype H3N2 of swine origin which emerged"/>
   <result pre="be the populationâ€™s previous immunity to sub-immunodominant domains on the" exact="influenza" post="virus, i.e., the HA stalk and the neuraminidase [28]."/>
   <result pre="stalk and the neuraminidase [28]. H3N2 circulated as the only" exact="influenza" post="A virus for nine years, until H1N1 resurfaced in"/>
   <result pre="emergence of an antigenically novel H1N1 â€œlineageâ€� caused the sixth" exact="influenza" post="virus pandemic [80]. The virus, which was a reassortment"/>
   <result pre="The virus, which was a reassortment of human, swine, and" exact="avian influenza" post="viruses, replaced the former seasonal H1N1 virus â€œlineageâ€� which"/>
   <result pre="virus, which was a reassortment of human, swine, and avian" exact="influenza" post="viruses, replaced the former seasonal H1N1 virus â€œlineageâ€� which"/>
   <result pre="and imprinting [81]. Human infections of zoonotic strains of other" exact="influenza" post="A virus subtypes such as H5N1, H6N2, H7N1, H7N7,"/>
   <result pre="hundreds of human infections [81,83]. During 1891 to present day," exact="influenza" post="B viruses have been co-circulating, creating a complex immune"/>
   <result pre="Influenza B was identified in 1942 and added to the" exact="influenza" post="vaccine to create a bivalent vaccine [73] (Figure 3)."/>
   <result pre="a bivalent vaccine [73] (Figure 3). The WHO initiated circulating" exact="influenza" post="virus surveillance in 1973, which led to the discovery"/>
   <result pre="in the late 1980s [73]. By viewing the history of" exact="influenza" post="virus circulation through the lens of imprinting, researchers can"/>
   <result pre="make assumptions about individual host imprinting and immune history. The" exact="influenza" post="virus strain that an individual imprinted upon can be"/>
   <result pre="of H1N1 viruses since it was the only subtype of" exact="influenza" post="A circulating in those years [16]. Those born between"/>
   <result pre="Since there was a sequential emergence and replacement of the" exact="influenza" post="A virus subtypes (H1N1, H2N2, and H3N2) the current"/>
   <result pre="much variability for imprinted immunity. Moreover, the sequential nature of" exact="influenza" post="virus circulation has led to heterosubtypic infection-reinfections throughout history."/>
   <result pre="(sH1N1) imprinting with a 2009 H1N1 reinfection (sH1N1-&amp;gt;2009 H1N1). Since," exact="influenza" post="B viruses have co-circulated during A virus flux, there"/>
   <result pre="during A virus flux, there is further complexity to human" exact="influenza" post="virus preimmunity. Studies are only beginning to uncover the"/>
   <result pre="of Preimmunity We know that extrapolating results from naÃ¯ve animal" exact="influenza" post="virus studies to human disease is limited due the"/>
   <result pre="to human disease is limited due the existence of human" exact="influenza" post="preimmunity [87]. Below we review the recent literature of"/>
   <result pre="preimmunity [87]. Below we review the recent literature of sequential" exact="influenza" post="virus infection using laboratory-controlled experiments with animal models of"/>
   <result pre="influenza virus infection using laboratory-controlled experiments with animal models of" exact="influenza" post="preimmunity. The conclusions are then synthesized with findings from"/>
   <result pre="preimmune host is re-exposed to the same or slightly drifted" exact="influenza" post="virus strain. To investigate the nuanced humoral antibody changes"/>
   <result pre="of age) and adults (28â€&quot;74 years of age) following seasonal" exact="influenza" post="virus vaccination. The samples were subjected to HAI and"/>
   <result pre="hypothesize that the generation of this antibody occurred following sequential" exact="influenza" post="infections which occurred during the donorâ€™s lifetime which encompassed"/>
   <result pre="exposures to sequential MsHe viruses in the course of historical" exact="influenza" post="pandemics: H2N2 -&amp;gt; H3N2 -&amp;gt; H1N1. Relatedly, other researchers"/>
   <result pre="stalk reactive antibodies, a wider breadth of protection against evolving" exact="influenza" post="viruses may be achieved [31,99]. Specifically, one strategy has"/>
   <result pre="chimeric HA molecule containing the stalk region from the original" exact="influenza" post="HA protein but an HA head containing little a.a."/>
   <result pre="far more complex than that of experimental animal models, personal" exact="influenza" post="virus exposure history can be deduced. As discussed previously,"/>
   <result pre="previously, cross-referencing a personâ€™s birth year against the history of" exact="influenza" post="A and B virus circulation we can surmise a"/>
   <result pre="The data suggested that antibodies previously generated from past seasonal" exact="influenza" post="virus infections (MsHe infection) had a negative impact on"/>
   <result pre="virus in sequence. Each year, H1N1, H3N2, B-Yamagata, and B-Victoria" exact="influenza" post="virus strains circulate in the human population. Despite the"/>
   <result pre="population. Despite the continuing circulation of both A and B" exact="influenza" post="viruses, there is a paucity of information regarding heterotypic"/>
   <result pre="interseasonal as well as intraseasonal. In the northern hemisphere, the" exact="influenza" post="season begins in October lasting until April and peaks"/>
   <result pre="until April and peaks early January. Typically, in each season" exact="influenza" post="A cases are prominent in the first half to"/>
   <result pre="first half to three quarters of the season [101,102]. As" exact="influenza" post="A human cases begin to decline, there is an"/>
   <result pre="to decline, there is an increase in the prominence of" exact="influenza" post="B viruses [101,102] suggesting viral interference or the opportunistic"/>
   <result pre="viruses [101,102] suggesting viral interference or the opportunistic infection of" exact="influenza" post="B viruses in immunosuppressed hosts. One human study documented"/>
   <result pre="medical intervention were documented to have been infected with an" exact="influenza" post="A strain and then reinfected with an influenza B"/>
   <result pre="with an influenza A strain and then reinfected with an" exact="influenza" post="B virus during the same season [103]. All children"/>
   <result pre="without cross-protection. Moreover, other studies have showed prominent co-infections of" exact="influenza" post="A and influenza B viruses [104]. Further study is"/>
   <result pre="other studies have showed prominent co-infections of influenza A and" exact="influenza" post="B viruses [104]. Further study is needed to understand"/>
   <result pre="is needed to understand the mechanisms of immune activation or" exact="suppression" post="during sequential heterotypic and co-infections of two influenza virus"/>
   <result pre="activation or suppression during sequential heterotypic and co-infections of two" exact="influenza" post="virus types. 7. Vaccination Preimmunity May Influence Future Vaccination"/>
   <result pre="Vaccination Preimmunity May Influence Future Vaccination Outcome Despite immune history," exact="influenza" post="viruses are a recurrent and as yet unsolved public"/>
   <result pre="estimated at 500,000 people worldwide by the WHO [79,102,105]. Yearly" exact="influenza" post="vaccination is recommended by the National Advisory Committee on"/>
   <result pre="Health Organization (WHO) as the most effective strategy for reducing" exact="influenza" post="burden [22,106,107]. The low effectiveness of the seasonal influenza"/>
   <result pre="reducing influenza burden [22,106,107]. The low effectiveness of the seasonal" exact="influenza" post="vaccine has been attributed to the frequent mutations in"/>
   <result pre="has previously been linked by some researchers to repeated seasonal" exact="influenza" post="vaccination in specific antigenically-defined influenza seasons [11]. These effects"/>
   <result pre="some researchers to repeated seasonal influenza vaccination in specific antigenically-defined" exact="influenza" post="seasons [11]. These effects of repeated vaccination was first"/>
   <result pre="statistically determined protective advantage compared to unvaccinated children during seasonal" exact="influenza" post="virus circulation [9,109]. Loss of protection due to repeated"/>
   <result pre="to a greater percentage of vaccinated people testing positive for" exact="influenza" post="virus infections [11]. The evidence supporting the antigen distance"/>
   <result pre="distance hypothesis as a mechanism of reduced effectiveness for specific" exact="influenza" post="seasons remains a hypothesis and is not presented here"/>
   <result pre="hypothesis and is not presented here as leverage for skipping" exact="influenza" post="virus vaccinations. More studies of vaccination effectiveness in other"/>
   <result pre="Furthermore, there are numerous publications supporting the regular use of" exact="influenza" post="vaccinations in children, adults, and pregnant women following rigorous"/>
   <result pre="these analyses support vaccine induced protection against severe disease following" exact="influenza" post="virus infection, as well as improved neonatal outcomes when"/>
   <result pre="of subsequent infections. Previous studies investigating the immune re-encounter with" exact="influenza" post="viral antigens or live virus infection are frequently designed"/>
   <result pre="This design would more accurately reflect the seasonal exposures of" exact="influenza" post="viruses in humans. Longer recovery times for animal experiments"/>
   <result pre="the adaptive immune memory phase will uncover immune mechanisms relating" exact="influenza" post="pathogenesis. Furthermore, since most studies are focused on the"/>
   <result pre="and functions. The standard methodology for assessing immune activation following" exact="influenza" post="virus infection is the HAI (hemagglutinin inhibition) assay which"/>
   <result pre="known that children and infants have different clinical outcomes to" exact="influenza" post="virus infection and vaccination compared to adults [120,121,122]. Infants"/>
   <result pre="Infants and young children are high-risk groups for developing severe" exact="respiratory disease" post="leading to hospitalization following influenza virus infection [102,107], which"/>
   <result pre="groups for developing severe respiratory disease leading to hospitalization following" exact="influenza" post="virus infection [102,107], which may be due to the"/>
   <result pre="Associated Lymphoid Tissue) in the lungs of young animals following" exact="influenza" post="virus infection [125,126]. Despite this evidence, we are unaware"/>
   <result pre="[125,126]. Despite this evidence, we are unaware of any sequential" exact="influenza" post="animal models that imprint during infancy and reinfect during"/>
   <result pre="postpartum [127], it is essential that animal models of recurrent" exact="influenza" post="infection take age into account. Having a more complete"/>
   <result pre="take age into account. Having a more complete understanding of" exact="influenza" post="infection during youth and the immunity gained will guide"/>
   <result pre="immune memory for antigenically variable and dynamic pathogens such as" exact="influenza" post="viruses is limited. The human studies from Andrews and"/>
   <result pre="Concluding Statement The host pathogen interaction of antigenically-evolving and variable" exact="influenza" post="viruses leads to a complex host immune background. Preimmunity"/>
   <result pre="immune background. Preimmunity blends age, immune function, and sequence of" exact="influenza" post="virus infections. By analyzing consecutive influenza virus exposures as"/>
   <result pre="function, and sequence of influenza virus infections. By analyzing consecutive" exact="influenza" post="virus exposures as monosubtypic homologous, monosubtypic heterologous, heterosubtypic, or"/>
   <result pre="future vaccine design and offer insight into an effective universal" exact="influenza" post="vaccine. Although this has been the strategy of universal"/>
   <result pre="influenza vaccine. Although this has been the strategy of universal" exact="influenza" post="vaccine development targeting the HA stalk domain [61], there"/>
   <result pre="memory B cell mechanisms. Findings from animal models of sequential" exact="influenza" post="virus infection may be extrapolated to the knowledge gaps"/>
   <result pre="studies. Understanding how the human immune response changes over sequential" exact="influenza" post="infections and vaccinations will inform the rational development of"/>
   <result pre="Understanding Patterns of Emergence and TransmissionPathogens201656610.3390/pathogens504006627929449 3.BarberisI.MylesP.AultS.K.BragazziN.L.MartiniM.History and evolution of" exact="influenza" post="control through vaccination: From the first monovalent vaccine to"/>
   <result pre="4.NeuK.E.Henry DunandC.J.WilsonP.C.Heads, stalks and everything else: How can antibodies eradicate" exact="influenza" post="as a human disease?Curr. Opin. Immunol.201642485510.1016/j.coi.2016.05.01227268395 5.collab: WHOBiologicals: InfluenzaAvailable"/>
   <result pre="InfluenzaAvailable online: https://www.who.int/biologicals/vaccines/influenza/en/(accessed on December 2018) 6.HayA.J.GregoryV.DouglasA.R.LinY.P.The evolution of human" exact="influenza" post="virusesPhilos. Trans. R. Soc. Lond. B Biol. Sci.20013561861187010.1098/rstb.2001.099911779385 7.FrancisT.J.On"/>
   <result pre="Original Antigenic SinProc. Am. Philos. Soc.1960104572578 8.FonvilleJ.M.WilksS.H.JamesS.L.FoxA.VentrescaM.AbanM.XueL.JonesT.C.LeN.M.H.PhamQ.T.et al.Antibody landscapes after" exact="influenza" post="virus infection or vaccinationScience2014346996100010.1126/science.125642725414313 9.MontoA.S.MaloshR.E.PetrieJ.G.MartinE.T.The Doctrine of Original Antigenic"/>
   <result pre="Good From EvilJ. Infect. Dis.20172151782178810.1093/infdis/jix17328398521 10.LesslerJ.RileyS.ReadJ.M.WangS.ZhuH.SmithG.J.GuanY.JiangC.Q.CummingsD.A.Evidence for antigenic seniority in" exact="influenza" post="A (H3N2) antibody responses in southern ChinaPLoS Pathog.20128e100280210.1371/journal.ppat.100280222829765 11.SkowronskiD.M.ChambersC.De"/>
   <result pre="2010â€&quot;2011 to 2014â€&quot;2015J. Infect. Dis.20172151059109910.1093/infdis/jix07428180277 12.MillerM.S.GardnerT.J.KrammerF.AguadoL.C.TortorellaD.BaslerC.F.PaleseP.Neutralizing antibodies against previously encountered" exact="influenza" post="virus strains increase over time: A longitudinal analysisSci. Transl."/>
   <result pre="over time: A longitudinal analysisSci. Transl. Med.20135198ra10710.1126/scitranslmed.300663723946196 13.FangY.BannerD.KelvinA.A.HuangS.S.PaigeC.J.CorfeS.A.KaneK.P.BleackleyR.C.RoweT.LeonA.J.et al.Seasonal H1N1" exact="influenza" post="virus infection induces cross-protective pandemic H1N1 virus immunity through"/>
   <result pre="responses to influenzaSci. Transl. Med.20157316ra19210.1126/scitranslmed.aad052226631631 15.KrammerF.PaleseP.Advances in the development of" exact="influenza" post="virus vaccinesNat. Rev. Drug Discov.20151416718210.1038/nrd452925722244 16.GosticK.M.AmbroseM.WorobeyM.Lloyd-SmithJ.O.Potent protection against H5N1"/>
   <result pre="vaccinesNat. Rev. Drug Discov.20151416718210.1038/nrd452925722244 16.GosticK.M.AmbroseM.WorobeyM.Lloyd-SmithJ.O.Potent protection against H5N1 and H7N9" exact="influenza" post="via childhood hemagglutinin imprintingScience201635472272610.1126/science.aag132227846599 17.HenryC.PalmA.E.KrammerF.WilsonP.C.From Original Antigenic Sin to"/>
   <result pre="Immunol.201839707910.1016/j.it.2017.08.00328867526 18.HancockK.VeguillaV.LuX.ZhongW.ButlerE.N.SunH.LiuF.DongL.DeVosJ.R.GargiulloP.M.et al.Cross-reactive antibody responses to the 2009 pandemic H1N1" exact="influenza" post="virusN. Engl. J. Med.20093611945195210.1056/NEJMoa090645319745214 19.CobeyS.HensleyS.E.Immune history and influenza virus"/>
   <result pre="pandemic H1N1 influenza virusN. Engl. J. Med.20093611945195210.1056/NEJMoa090645319745214 19.CobeyS.HensleyS.E.Immune history and" exact="influenza" post="virus susceptibilityCurr. Opin. Virol.20172210511110.1016/j.coviro.2016.12.00428088686 20.LewnardJ.A.CobeyS.Immune History and Influenza Vaccine"/>
   <result pre="December 2018) 23.HerrlerG.KlenkH.D.Structure and function of the HEF glycoprotein of" exact="influenza" post="C virusAdv. Virus Res.1991402132341957719 24.LofgrenE.FeffermanN.H.NaumovY.N.GorskiJ.NaumovaE.N.Influenza seasonality: Underlying causes and"/>
   <result pre="seasonality: Underlying causes and modeling theoriesJ. Virol.2007815429543610.1128/JVI.01680-0617182688 25.BouvierN.M.PaleseP.The biology of" exact="influenza" post="virusesVaccine200826D49D5310.1016/j.vaccine.2008.07.03919230160 26.TumpeyT.M.BaslerC.F.AguilarP.V.ZengH.SolorzanoA.SwayneD.E.CoxN.J.KatzJ.M.TaubenbergerJ.K.PaleseP.et al.Characterization of the reconstructed 1918 Spanish influenza"/>
   <result pre="of influenza virusesVaccine200826D49D5310.1016/j.vaccine.2008.07.03919230160 26.TumpeyT.M.BaslerC.F.AguilarP.V.ZengH.SolorzanoA.SwayneD.E.CoxN.J.KatzJ.M.TaubenbergerJ.K.PaleseP.et al.Characterization of the reconstructed 1918 Spanish" exact="influenza" post="pandemic virusScience2005310778010.1126/science.111939216210530 27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918 influenza virus polymerase"/>
   <result pre="reconstructed 1918 Spanish influenza pandemic virusScience2005310778010.1126/science.111939216210530 27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918" exact="influenza" post="virus polymerase genesNature200543788989310.1038/nature0423016208372 28.PaleseP.WangT.T.Why do influenza virus subtypes die"/>
   <result pre="27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918 influenza virus polymerase genesNature200543788989310.1038/nature0423016208372 28.PaleseP.WangT.T.Why do" exact="influenza" post="virus subtypes die out? A hypothesisMBio20112e00150-1110.1128/mBio.00150-1121878571 29.KrammerF.PicaN.HaiR.TanG.S.PaleseP.Hemagglutinin Stalk-Reactive Antibodies"/>
   <result pre="Virol.201286103021030710.1128/JVI.01336-1222787225 30.PicaN.HaiR.KrammerF.WangT.T.MaamaryJ.EgginkD.TanG.S.KrauseJ.C.MoranT.SteinC.R.et al.Hemagglutinin stalk antibodies elicited by the 2009 pandemic" exact="influenza" post="virus as a mechanism for the extinction of seasonal"/>
   <result pre="AntibodiesJ. Virol.2015901116112810.1128/JVI.02372-1526559834 32.PaquetteS.G.HuangS.S.BannerD.XuL.LeomicronnA.KelvinA.A.KelvinD.J.Impaired heterologous immunity in aged ferrets during sequential" exact="influenza" post="A H1N1 infectionVirology2014464â€&quot;46517718310.1016/j.virol.2014.07.013 33.GamblinS.J.SkehelJ.J.Influenza hemagglutinin and neuraminidase membrane glycoproteinsJ."/>
   <result pre="34.ChenX.LiuS.GorayaM.U.MaaroufM.HuangS.ChenJ.L.Host Immune Response to Influenza A Virus InfectionFront. Immunol.2018932010.3389/fimmu.2018.0032029556226 35.HuangS.S.BannerD.PaquetteS.G.LeonA.J.KelvinA.A.KelvinD.J.Pathogenic" exact="influenza" post="B virus in the ferret model establishes lower respiratory"/>
   <result pre="respiratory tract infectionJ. Gen. Virol.2014952127213910.1099/vir.0.064352-024989173 36.BodewesR.MorickD.de MutsertG.OsingaN.BestebroerT.van der VlietS.SmitsS.L.KuikenT.RimmelzwaanG.F.FouchierR.A.et al.Recurring" exact="influenza" post="B virus infections in sealsEmerg. Infect. Dis.20131951151210.3201/eid1903.12096523750359 37.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern"/>
   <result pre="sealsEmerg. Infect. Dis.20131951151210.3201/eid1903.12096523750359 37.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern of the hemagglutinin gene of" exact="influenza" post="B viruses isolated in Japan: Cocirculating lineages in the"/>
   <result pre="monoclonal antibody that targets the fusion domain of group 2" exact="influenza" post="A virus hemagglutininJ. Virol.201488135801359210.1128/JVI.02289-1425210195 40.IwasakiA.PillaiP.S.Innate immunity to influenza virus"/>
   <result pre="group 2 influenza A virus hemagglutininJ. Virol.201488135801359210.1128/JVI.02289-1425210195 40.IwasakiA.PillaiP.S.Innate immunity to" exact="influenza" post="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 41.ChenJ.DengY.M.Influenza virus antigenic variation, host"/>
   <result pre="&amp;amp; adaptive immunityFuture Virol.2011695196221909336 43.ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virusProc."/>
   <result pre="autopsy cases with 2009 H1N1 virus infectionMod. Pathol.20122511310.1038/modpathol.2011.12521874012 45.PanW.DongZ.LiF.MengW.FengL.NiuX.LiC.LuoQ.LiZ.SunC.et al.Visualizing" exact="influenza" post="virus infection in living miceNat. Commun.20134236910.1038/ncomms336924022374 46.PulendranB.MaddurM.S.Innate immune sensing"/>
   <result pre="respond to different microbial antigensJ. Exp. Med.200119486386910.1084/jem.194.6.86311561001 49.IchinoheT.LeeH.K.OguraY.FlavellR.IwasakiA.Inflammasome recognition of" exact="influenza" post="virus is essential for adaptive immune responsesJ. Exp. Med.2009206798710.1084/jem.2008166719139171"/>
   <result pre="essential for adaptive immune responsesJ. Exp. Med.2009206798710.1084/jem.2008166719139171 50.WaithmanJ.MinternJ.D.Dendritic cells and" exact="influenza" post="A virus infectionVirulence2012360360810.4161/viru.2186423076333 51.LeonA.J.BannerD.XuL.RanL.PengZ.YiK.ChenC.XuF.HuangJ.ZhaoZ.et al.Sequencing, annotation, and characterization of"/>
   <result pre="A virus infectionVirulence2012360360810.4161/viru.2186423076333 51.LeonA.J.BannerD.XuL.RanL.PengZ.YiK.ChenC.XuF.HuangJ.ZhaoZ.et al.Sequencing, annotation, and characterization of the" exact="influenza" post="ferret infectomeJ. Virol.2013871957196610.1128/JVI.02476-1223236062 52.RoweT.LeonA.J.CrevarC.J.CarterD.M.XuL.RanL.FangY.CameronC.M.CameronM.J.BannerD.et al.Modeling host responses in ferrets"/>
   <result pre="infectomeJ. Virol.2013871957196610.1128/JVI.02476-1223236062 52.RoweT.LeonA.J.CrevarC.J.CarterD.M.XuL.RanL.FangY.CameronC.M.CameronM.J.BannerD.et al.Modeling host responses in ferrets during A/California/07/2009" exact="influenza" post="infectionVirology201040125726510.1016/j.virol.2010.02.02020334888 53.SunJ.BracialeT.J.Role of T cell immunity in recovery from"/>
   <result pre="influenza infectionVirology201040125726510.1016/j.virol.2010.02.02020334888 53.SunJ.BracialeT.J.Role of T cell immunity in recovery from" exact="influenza" post="virus infectionCurr. Opin. Virol.2013342542910.1016/j.coviro.2013.05.00123721865 54.GrantE.J.Quinones-ParraS.M.ClemensE.B.KedzierskaK.Human influenza viruses and CD8(+)"/>
   <result pre="immunity in recovery from influenza virus infectionCurr. Opin. Virol.2013342542910.1016/j.coviro.2013.05.00123721865 54.GrantE.J.Quinones-ParraS.M.ClemensE.B.KedzierskaK.Human" exact="influenza" post="viruses and CD8(+) T cell responsesCurr. Opin. Virol.20161613214210.1016/j.coviro.2016.01.01626974887 55.HuffordM.M.KimT.S.SunJ.BracialeT.J.Antiviral"/>
   <result pre="vivoJ. Immunol.20111864599460810.4049/jimmunol.100197221389258 57.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation during acute" exact="influenza" post="virus infection by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 58.McKinstryK.K.StruttT.M.BuckA.CurtisJ.D.DibbleJ.P.HustonG.TigheM.HamadaH.SellS.DuttonR.W.et al.IL-10 deficiency"/>
   <result pre="and vaccinesCurr. Opin. Virol.2013352153010.1016/j.coviro.2013.07.00723978327 62.BuiH.H.PetersB.AssarssonE.MbawuikeI.SetteA.Ab and T cell epitopes of" exact="influenza" post="A virus, knowledge and opportunitiesProc. Natl. Acad. Sci. USA200710424625110.1073/pnas.060933010417200302"/>
   <result pre="knowledge and opportunitiesProc. Natl. Acad. Sci. USA200710424625110.1073/pnas.060933010417200302 63.EllebedyA.H.WebbyR.J.Influenza vaccinesVaccine200927D65D6810.1016/j.vaccine.2009.08.03819837290 64.MontoA.S.Seasonal" exact="influenza" post="and vaccination coverageVaccine201028D33D4410.1016/j.vaccine.2010.08.02720713259 65.TangyeS.G.TarlintonD.M.Memory B cells: Effectors of long-lived"/>
   <result pre="longevity of natural killer cellsImmunol. Rev.2010236839410.1111/j.1600-065X.2010.00900.x20636810 69.ChiuC.EllebedyA.H.WrammertJ.AhmedR.B cell responses to" exact="influenza" post="infection and vaccinationCurr. Top. Microbiol. Immunol.201538638139825193634 70.LipsitchM.ViboudC.Influenza seasonality: Lifting"/>
   <result pre="the fogProc. Natl. Acad. Sci. USA20091063645364610.1073/pnas.090093310619276125 71.SmithW.AndrewesC.H.LaidlawP.A virus isolated from" exact="influenza" post="patientsLancet1933225666810.1016/S0140-6736(00)78541-2 72.YangJ.R.HuangY.P.ChangF.Y.HsuL.C.LinY.C.HuangH.Y.WuF.T.WuH.S.LiuM.T.Phylogenetic and evolutionary history of influenza B viruses,"/>
   <result pre="virus isolated from influenza patientsLancet1933225666810.1016/S0140-6736(00)78541-2 72.YangJ.R.HuangY.P.ChangF.Y.HsuL.C.LinY.C.HuangH.Y.WuF.T.WuH.S.LiuM.T.Phylogenetic and evolutionary history of" exact="influenza" post="B viruses, which caused a large epidemic in 2011â€&quot;2012,"/>
   <result pre="large epidemic in 2011â€&quot;2012, TaiwanPLoS ONE20127e4717910.1371/journal.pone.004717923071751 73.HannounC.The evolving history of" exact="influenza" post="viruses and influenza vaccinesExpert Rev. Vacc.2013121085109410.1586/14760584.2013.82470924024871 74.TaubenbergerJ.K.ReidA.H.JanczewskiT.A.FanningT.G.Integrating historical, clinical"/>
   <result pre="2011â€&quot;2012, TaiwanPLoS ONE20127e4717910.1371/journal.pone.004717923071751 73.HannounC.The evolving history of influenza viruses and" exact="influenza" post="vaccinesExpert Rev. Vacc.2013121085109410.1586/14760584.2013.82470924024871 74.TaubenbergerJ.K.ReidA.H.JanczewskiT.A.FanningT.G.Integrating historical, clinical and molecular genetic"/>
   <result pre="to explain the origin and virulence of the 1918 Spanish" exact="influenza" post="virusPhilos. Trans. R Soc. Lond. B Biol. Sci.20013561829183910.1098/rstb.2001.102011779381 75.WorobeyM.HanG.Z.RambautA.Genesis"/>
   <result pre="Biol. Sci.20013561829183910.1098/rstb.2001.102011779381 75.WorobeyM.HanG.Z.RambautA.Genesis and pathogenesis of the 1918 pandemic H1N1" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA20141118107811210.1073/pnas.132419711124778238 76.TaubenbergerJ.K.ReidA.H.KrafftA.E.BijwaardK.E.FanningT.G.Initial genetic characterization"/>
   <result pre="Acad. Sci. USA20141118107811210.1073/pnas.132419711124778238 76.TaubenbergerJ.K.ReidA.H.KrafftA.E.BijwaardK.E.FanningT.G.Initial genetic characterization of the 1918 &quot;Spanish&quot;" exact="influenza" post="virusScience19972751793179610.1126/science.275.5307.17939065404 77.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic influenza virusesProc. Natl."/>
   <result pre="the 1918 &quot;Spanish&quot; influenza virusScience19972751793179610.1126/science.275.5307.17939065404 77.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic" exact="influenza" post="virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 78.WertheimJ.O.The re-emergence of H1N1"/>
   <result pre="influenza virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 78.WertheimJ.O.The re-emergence of H1N1" exact="influenza" post="virus in 1977: A cautionary tale for estimating divergence"/>
   <result pre="United StatesAvailable online: https://www.cdc.gov/flu/about/disease/burden-averted-vaccination.htm.(accessed on December 2018) 80.ShindeV.BridgesC.B.UyekiT.M.ShuB.BalishA.XuX.LindstromS.GubarevaL.V.DeydeV.GartenR.J.et al.Triple-reassortant swine" exact="influenza" post="A (H1) in humans in the United States, 2005â€&quot;2009N."/>
   <result pre="United States, 2005â€&quot;2009N. Engl. J. Med.20093602616262510.1056/NEJMoa090381219423871 81.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of" exact="avian influenza" post="A H5N1 virus infection in humans, 1997â€&quot;2015: A systematic"/>
   <result pre="States, 2005â€&quot;2009N. Engl. J. Med.20093602616262510.1056/NEJMoa090381219423871 81.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of avian" exact="influenza" post="A H5N1 virus infection in humans, 1997â€&quot;2015: A systematic"/>
   <result pre="of individual case dataLancet Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 82.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an" exact="avian influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="individual case dataLancet Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 82.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an avian" exact="influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="Influenza Virus: Evidence for Anti-PA-X AntibodiesJ. Virol.2016909383939310.1128/JVI.01408-1627512055 84.PeirisM.YuenK.Y.LeungC.W.ChanK.H.IpP.L.LaiR.W.OrrW.K.ShortridgeK.F.Human infection with" exact="influenza" post="H9N2Lancet199935491691710.1016/S0140-6736(99)03311-510489954 85.collab: CDCHuman Infection with Highly Pathogenic A(H7N7) Avian"/>
   <result pre="Secondary Immune Responses to Influenza VirusesPLoS Pathog.201612e100580610.1371/journal.ppat.100580627537358 89.DuttaA.HuangC.T.LinC.Y.ChenT.C.LinY.C.ChangC.S.HeY.C.Sterilizing immunity to" exact="influenza" post="virus infection requires local antigen-specific T cell response in"/>
   <result pre="in the lungsSci. Rep.201663297310.1038/srep3297327596047 90.EllebedyA.H.AhmedR.Re-engaging cross-reactive memory B cells: The" exact="influenza" post="puzzleFront. Immunol.201235310.3389/fimmu.2012.0005322566934 91.Oâ€™NeillE.KraussS.L.RiberdyJ.M.WebsterR.G.WoodlandD.L.Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza"/>
   <result pre="The influenza puzzleFront. Immunol.201235310.3389/fimmu.2012.0005322566934 91.Oâ€™NeillE.KraussS.L.RiberdyJ.M.WebsterR.G.WoodlandD.L.Heterologous protection against lethal A/HongKong/156/97 (H5N1)" exact="influenza" post="virus infection in C57BL/6 miceJ. Gen. Virol.2000812689269610.1099/0022-1317-81-11-268911038381 92.LaMereM.W.LamH.T.MoquinA.HaynesL.LundF.E.RandallT.D.KaminskiD.A.Contributions of"/>
   <result pre="Gen. Virol.2000812689269610.1099/0022-1317-81-11-268911038381 92.LaMereM.W.LamH.T.MoquinA.HaynesL.LundF.E.RandallT.D.KaminskiD.A.Contributions of antinucleoprotein IgG to heterosubtypic immunity against" exact="influenza" post="virusJ. Immunol.20111864331433910.4049/jimmunol.100305721357542 93.LaurieK.L.CarolanL.A.MiddletonD.LowtherS.KelsoA.BarrI.G.Multiple infections with seasonal influenza A virus"/>
   <result pre="heterosubtypic immunity against influenza virusJ. Immunol.20111864331433910.4049/jimmunol.100305721357542 93.LaurieK.L.CarolanL.A.MiddletonD.LowtherS.KelsoA.BarrI.G.Multiple infections with seasonal" exact="influenza" post="A virus induce cross-protective immunity against A(H1N1) pandemic influenza"/>
   <result pre="seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic" exact="influenza" post="virus in a ferret modelJ. Infect. Dis.20102021011102010.1086/65618820715930 94.LiY.MyersJ.L.BostickD.L.SullivanC.B.MadaraJ.LindermanS.L.LiuQ.CarterD.M.WrammertJ.EspositoS.et al.Immune"/>
   <result pre="Infect. Dis.20102021011102010.1086/65618820715930 94.LiY.MyersJ.L.BostickD.L.SullivanC.B.MadaraJ.LindermanS.L.LiuQ.CarterD.M.WrammertJ.EspositoS.et al.Immune history shapes specificity of pandemic H1N1" exact="influenza" post="antibody responsesJ. Exp. Med.20132101493150010.1084/jem.2013021223857983 95.KosikovaM.LiL.RadvakP.YeZ.WanX.F.XieH.Imprinting of Repeated Influenza A/H3"/>
   <result pre="and Transmission in FerretsJ. Virol.2015903268327310.1128/JVI.02481-1526719251 100.MonsalvoA.C.BatalleJ.P.LopezM.F.KrauseJ.C.KlemencJ.HernandezJ.Z.MaskinB.BugnaJ.RubinsteinC.AguilarL.et al.Severe pandemic 2009 H1N1" exact="influenza" post="disease due to pathogenic immune complexesNat. Med.20111719519910.1038/nm.226221131958 101.collab: PHACFluwatch,"/>
   <result pre="mediocre?Science20173571222122310.1126/science.357.6357.122228935783 109.HoskinsT.W.DaviesJ.R.SmithA.J.MillerC.L.AllchinA.Assessment of inactivated influenza-A vaccine after three outbreaks of" exact="influenza" post="A at Christâ€™s HospitalLancet19791333510.1016/S0140-6736(79)90468-983475 110.SkowronskiD.M.ChambersC.De SerresG.SabaiducS.WinterA.L.DickinsonJ.A.GubbayJ.B.DrewsS.J.FonsecaK.CharestH.et al.Vaccine effectiveness against"/>
   <result pre="HospitalLancet19791333510.1016/S0140-6736(79)90468-983475 110.SkowronskiD.M.ChambersC.De SerresG.SabaiducS.WinterA.L.DickinsonJ.A.GubbayJ.B.DrewsS.J.FonsecaK.CharestH.et al.Vaccine effectiveness against lineage matched and mismatched" exact="influenza" post="B viruses across 8 seasons in Canada, 2010â€&quot;2011 to"/>
   <result pre="of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal" exact="influenza" post="virus vaccineJ. Infect. Dis.20001811133113710.1086/31532310720541 112.LeggeA.DoddsL.MacDonaldN.E.ScottJ.McNeilS.Rates and determinants of seasonal"/>
   <result pre="influenza virus vaccineJ. Infect. Dis.20001811133113710.1086/31532310720541 112.LeggeA.DoddsL.MacDonaldN.E.ScottJ.McNeilS.Rates and determinants of seasonal" exact="influenza" post="vaccination in pregnancy and association with neonatal outcomesCMAJ2014186E157E16410.1503/cmaj.13049924396098 113.ThompsonM.G.KwongJ.C.ReganA.K.KatzM.A.DrewsS.J.Azziz-BaumgartnerE.KleinN.P.ChungH.EfflerP.V.FeldmanB.S.et"/>
   <result pre="Design Study, 2010â€&quot;2016Clin. Infec.t Dis.201810.1093/cid/ciy73730307490 114.NicholK.L.MendelmanP.M.MallonK.P.JacksonL.A.GorseG.J.BelsheR.B.GlezenW.P.WittesJ.Effectiveness of live, attenuated intranasal" exact="influenza" post="virus vaccine in healthy, working adults: A randomized controlled"/>
   <result pre="system, co-administered or sequentially administered with an inactivated trivalent seasonal" exact="influenza" post="vaccineBMC Infect. Dis.20121227910.1186/1471-2334-12-27923110320 122.LangleyJ.M.WangL.AggarwalN.BuesoA.ChandrasekaranV.CousinL.HalperinS.A.LiP.LiuA.McNeilS.et al.Immunogenicity and Reactogenicity of an"/>
   <result pre="Multicenter, Multicountry, Clinical TrialJ. Pediatr. Infect. Dis. Soc.2015424225110.1093/jpids/piu09826336604 123.CollieM.H.RushtonD.I.SweetC.SmithH.Studies of" exact="influenza" post="virus infection in newborn ferretsJ. Med. Microbiol.19801356157110.1099/00222615-13-4-5617431374 124.PaquetteS.G.BannerD.HuangS.S.AlmansaR.LeonA.XuL.BartoszkoJ.KelvinD.J.KelvinA.A.Influenza Transmission"/>
   <result pre="infections and vaccinations. The schematic illustrates possible immune fluctuations following" exact="influenza" post="virus infection or vaccination. Immune fluctuations and potential protection"/>
   <result pre="genetic and antigenic relatedness. Immune specificity that is gained during" exact="influenza" post="virus immune imprinting during infancy or childhood leading to"/>
   <result pre="basic 2 (PB2). Figure 3 Timeline of the history of" exact="influenza" post="virus circulation in humans since 1890s. The timeline shows"/>
   <result pre="in humans since 1890s. The timeline shows the history of" exact="influenza" post="virus type A and B circulation since 1890. There"/>
   <result pre="pandemic of ~1891 occurred prior to the discovery of the" exact="influenza" post="virus and is known only by historical medical records."/>
   <result pre="circulation from the 1977 lineage. In addition to circulating seasonal" exact="influenza" post="viruses, avian virus spillover events also lead to human"/>
   <result pre="virus spillover events occurred in 1997 and 2013 for the" exact="influenza" post="A viruses H5N1 and H7N9, respectively. During this time"/>
   <result pre="A viruses H5N1 and H7N9, respectively. During this time period," exact="influenza" post="B viruses have also co-circulated in humans. *Image credit"/>
   <result pre="humans. *Image credit CDC for the 1918 pandemic and the" exact="influenza" post="virion [79]. Figure 4 Influenza immune imprinting and the"/>
   <result pre="Figure 4 Influenza immune imprinting and the history of circulating" exact="influenza" post="viruses. The timeline illustrates the relationship between virus circulation"/>
   <result pre="viruses. The timeline illustrates the relationship between virus circulation and" exact="influenza" post="virus immune imprinting at infancy. Several published studies have"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410127\results\search\disease\results.xml">
   <result pre="Rift Valley fever (RVF) is an emerging transboundary, mosquito-borne, zoonotic" exact="viral disease" post="caused high morbidity and mortality in both human and"/>
   <result pre="1. Introduction Rift Valley Fever (RVF) is an acute, arthropod-borne" exact="viral disease" post="of sheep, goats, cattle, camels, and humans caused by"/>
   <result pre="coma encephalitis, and visual hallucination [46], (2) ocular complications including" exact="retinitis" post="and vision loss [47], and (3) hemorrhagic fever with"/>
   <result pre="(4) RVFV disease notification, (5) daily reporting of RVF and" exact="encephalitis" post="cases in humans, (6) surveillance and regular visits to"/>
   <result pre="Crimean-Congo hemorrhagic fever virus, and preM and E genes of" exact="tick-borne encephalitis" post="virus [107]. The DNA vaccine combination produced protective antibodies"/>
   <result pre="hemorrhagic fever virus, and preM and E genes of tick-borne" exact="encephalitis" post="virus [107]. The DNA vaccine combination produced protective antibodies"/>
   <result pre="and One Health Approach RVFV is a highly fatal endemic" exact="viral disease" post="in Egypt and was included by the OIE in"/>
   <result pre="2.MoutaillerS.RocheB.ThibergeJ.-M.CaroV.RougeonF.FaillouxA.-B.Host alternation is necessary to maintain the genome stability of" exact="rift valley fever" post="virusPLoS Negl. Trop. Dis.20115e115610.1371/journal.pntd.000115621629727 3.GerrardS.R.NicholS.T.Synthesis, proteolytic processing and complex"/>
   <result pre="and complex formation of N-terminally nested precursor proteins of the" exact="rift valley fever" post="virus glycoproteinsVirology200735712413310.1016/j.virol.2006.08.00216963099 4.IkegamiT.MakinoS.The pathogenesis of rift valley feverViruses2011349351910.3390/v305049321666766 5.MullerR.PochO.DelarueM.BishopD.H.BouloyM.Rift"/>
   <result pre="regions conserved in RNA-dependent polymerasesJ. Gen. Virol.1994751345135210.1099/0022-1317-75-6-13457515937 6.BillecocqA.SpiegelM.VialatP.KohlA.WeberF.BouloyM.HallerO.Nss protein of" exact="rift valley fever" post="virus blocks interferon production by inhibiting host gene transcriptionJ."/>
   <result pre="8.SuzichJ.KakachL.CollettM.Expression strategy of a phlebovirus: biogenesis of proteins from the" exact="rift valley fever" post="virus M segmentJ. Virol.199064154915552319645 9.IkegamiT.Molecular biology and genetic diversity"/>
   <result pre="virus M segmentJ. Virol.199064154915552319645 9.IkegamiT.Molecular biology and genetic diversity of" exact="rift valley fever" post="virusAntivi. Res.20129529331010.1016/j.antiviral.2012.06.001 10.DaubneyR.HudsonJ.GarnhamP.Enzootic hepatitis or rift valley fever. An"/>
   <result pre="and genetic diversity of rift valley fever virusAntivi. Res.20129529331010.1016/j.antiviral.2012.06.001 10.DaubneyR.HudsonJ.GarnhamP.Enzootic" exact="hepatitis" post="or rift valley fever. An undescribed virus disease of"/>
   <result pre="diversity of rift valley fever virusAntivi. Res.20129529331010.1016/j.antiviral.2012.06.001 10.DaubneyR.HudsonJ.GarnhamP.Enzootic hepatitis or" exact="rift valley fever." post="An undescribed virus disease of sheep cattle and man"/>
   <result pre="of the regional and national socio-economic impacts of the 2007" exact="rift valley fever" post="outbreak in KenyaAm. J. Trop. Med. Hyg.201083525710.4269/ajtmh.2010.09-029120682906 13.Al-AfaleqA.HusseinM.The status"/>
   <result pre="outbreak in KenyaAm. J. Trop. Med. Hyg.201083525710.4269/ajtmh.2010.09-029120682906 13.Al-AfaleqA.HusseinM.The status of" exact="rift valley fever" post="in animals in Saudi Arabia: A mini reviewVector Borne"/>
   <result pre="as biological weapons: Medical and public health managementJAMA20022872391240510.1001/jama.287.18.239111988060 17.BaudinM.JumaaA.M.JommaH.J.E.KarsanyM.S.BuchtG.NaslundJ.AhlmC.EvanderM.MohamedN.Association of" exact="rift valley fever" post="virus infection with miscarriage in Sudanese women: A cross-sectional"/>
   <result pre="and practices that affect community involvement in the control of" exact="rift valley fever" post="outbreaksPLoS Negl. Trop. Dis.201711e000538310.1371/journal.pntd.000538328207905 19.DrakeJ.M.HassanA.N.BeierJ.C.A statistical model of rift"/>
   <result pre="valley fever outbreaksPLoS Negl. Trop. Dis.201711e000538310.1371/journal.pntd.000538328207905 19.DrakeJ.M.HassanA.N.BeierJ.C.A statistical model of" exact="rift valley fever" post="activity in EgyptJ. Soc. Vector Ecol.20133825125910.1111/j.1948-7134.2013.12038.x 20.McElroyA.AlbariÃ±oC.G.NicholS.T.Development of a"/>
   <result pre="and coding strategies of the S RNAs of Toscana and" exact="rift valley fever" post="viruses compared to those of Punta Toro, Sicilian Sandfly"/>
   <result pre="25.BrennanB.WelchS.ElliottR.The consequences of reconfiguring the Ambisense S genome segment of" exact="rift valley fever" post="virus on viral replication in mammalian and mosquito cells"/>
   <result pre="trade of cattle and camels and the derived risk of" exact="rift valley fever" post="introduction into and transmission within EgyptPLoS Negl. Trop. Dis.201812e000614310.1371/journal.pntd.000614329351273"/>
   <result pre="transmission within EgyptPLoS Negl. Trop. Dis.201812e000614310.1371/journal.pntd.000614329351273 27.CorwinA.HabibM.WattsD.OlsonJ.DarwishM.HibbsR.KilpatrickM.Prevalence of antibody to" exact="rift valley fever" post="virus in the Nile river delta of Egypt, 13"/>
   <result pre="Hyg. (Lond.)19859424124410.1017/S00221724000614413989285 34.LabudaM.NuttallP.Tick-borne virusesParasitology2004129S221S24510.1017/S003118200400522015938513 35.DialloD.BaY.DiaI.LassanaK.DialloM.Use of insecticide-treated cattle to control" exact="rift valley fever" post="and west Nile virus vectors in SenegalBull. Soc. Pathol."/>
   <result pre="governorate, EgyptJ. Med. Entomol.19953257357710.1093/jmedent/32.5.5737473609 38.TurellM.J.PresleyS.M.GadA.M.CopeS.E.DohmD.J.MorrillJ.C.ArthurR.R.Vector competence of Egyptian mosquitoes for" exact="rift valley fever" post="virusAm. J. Trop. Med. Hyg.19965413613910.4269/ajtmh.1996.54.1368619436 39.KenawyM.A.BeierJ.C.ZimmermanJ.H.el SaidS.AbbassyM.M.Host-feeding patterns of"/>
   <result pre="feeding of mosquitoes (diptera: Culicidae) associated with the recurrence of" exact="rift valley fever" post="in EgyptJ. Med. Entomol.19993670971410593070 41.HanafiH.A.FryauffD.J.SaadM.D.SolimanA.K.MoharebE.W.MedhatI.EarhartK.C.Virus isolations and high population"/>
   <result pre="implicate culex antennatus (becker) (diptera: Culicidae) as a vector of" exact="rift valley fever" post="virus during an outbreak in the Nile delta of"/>
   <result pre="ValB.P.RivasR.IglesiasJ.RodriguezF.SolanesD.et al.Experimental infection of young adult European breed sheep with" exact="rift valley fever" post="virus field isolatesVector Borne Zoonotic Dis.20101068969610.1089/vbz.2009.020520854022 44.ArcherB.N.ThomasJ.WeyerJ.CengimboA.LandohD.E.JacobsC.NtuliS.ModiseM.MathonsiM.MashishiM.S.et al.Epidemiologic investigations"/>
   <result pre="isolatesVector Borne Zoonotic Dis.20101068969610.1089/vbz.2009.020520854022 44.ArcherB.N.ThomasJ.WeyerJ.CengimboA.LandohD.E.JacobsC.NtuliS.ModiseM.MathonsiM.MashishiM.S.et al.Epidemiologic investigations into outbreaks of" exact="rift valley fever" post="in humans, South Africa, 2008â€&quot;2011Emerg. Infect. Dis201319191810.3201/eid1912.12152729360021 45.LaBeaudA.MuchiriE.NdzovuM.MwanjeM.MuiruriS.PetersC.KingC.H.Interepidemic rift"/>
   <result pre="valley fever in humans, South Africa, 2008â€&quot;2011Emerg. Infect. Dis201319191810.3201/eid1912.12152729360021 45.LaBeaudA.MuchiriE.NdzovuM.MwanjeM.MuiruriS.PetersC.KingC.H.Interepidemic" exact="rift valley fever" post="virus seropositivity, northeastern KenyaEmer. Infect. Dis.2008141240124610.3201/eid1408.08008218680647 46.SeufiA.GalalF.Role of culex"/>
   <result pre="of culex and anopheles mosquito species as potential vectors of" exact="rift valley fever" post="virus in Sudan outbreak, 2007BMC Infect. Dis.2010106510.1186/1471-2334-10-6520222979 47.YoserS.L.ForsterD.J.RaoN.A.Systemic viral"/>
   <result pre="infections and their retinal and choroidal manifestationsSurv. Ophthalmol.19933731335210.1016/0039-6257(93)90064-E8387231 48.MuiruriS.PetersC.J.Clinton WhiteA.LeDucJ.KingC.H.NjengaM.K.MuchiriE.M.Severe" exact="rift valley fever" post="may present with a characteristic clinical syndromeAmer. J. Trop."/>
   <result pre="J. Trop. Med. Hyg.20108237137520207858 49.KortekaasJ.OreshkovaN.van KeulenL.KantJ.BoschB.J.BouloyM.MoulinV.GoovaertsD.MoormannR.J.Comparative efficacy of two next-generation" exact="rift valley fever" post="vaccinesVaccine2014324901490810.1016/j.vaccine.2014.07.03725050973 50.El-MekkiA.A.Female gender: A risk factor for acquiring rift"/>
   <result pre="valley fever vaccinesVaccine2014324901490810.1016/j.vaccine.2014.07.03725050973 50.El-MekkiA.A.Female gender: A risk factor for acquiring" exact="rift valley fever" post="virus infection in Jazan region, southwestern Saudi ArabiaMed. J."/>
   <result pre="Cairo Uni.201482201205 51.NyakarahukaL.de St MauriceA.PurpuraL.ErvinE.BalinandiS.TumusiimeA.KyondoJ.MuleiS.TusiimeP.LutwamaJ.et al.Prevalence and risk factors of" exact="rift valley fever" post="in humans and animals from kabale district in southwestern"/>
   <result pre="district in southwestern Uganda, 2016PLoS Negl. Trop. Dis.201812e000641210.1371/journal.pntd.000641229723189 52.KamalS.A.Observations on" exact="rift valley fever" post="virus and vaccines in EgyptVirol. J.2011853210.1186/1743-422X-8-53222152149 53.MeeganJ.M.The rift valley"/>
   <result pre="rift valley fever virus and vaccines in EgyptVirol. J.2011853210.1186/1743-422X-8-53222152149 53.MeeganJ.M.The" exact="rift valley fever" post="epizootic in Egypt 1977â€&quot;1978. Description of the epizzotic and"/>
   <result pre="Soc. Trop Med. Hyg.19797361862310.1016/0035-9203(79)90004-X 54.KamalS.A.Pathological studies on postvaccinal reactions of" exact="rift valley fever" post="in goatsVirol. J.200969410.1186/1743-422X-6-9419580675 55.SamyA.M.PetersonA.T.HallM.Phylogeography of rift valley fever virus"/>
   <result pre="reactions of rift valley fever in goatsVirol. J.200969410.1186/1743-422X-6-9419580675 55.SamyA.M.PetersonA.T.HallM.Phylogeography of" exact="rift valley fever" post="virus in Africa and the Arabian peninsulaPLoS Negl. Trop."/>
   <result pre="Egypt. Octoberâ€&quot;December 1977J. Egypt Public Health Assoc.197853123128572393 59.GrobbelaarA.A.WeyerJ.LemanP.A.KempA.PaweskaJ.T.SwanepoelR.Molecular epidemiology of" exact="rift valley fever" post="virusEmerg. Infect. Dis.2011172270227610.3201/eid1712.11103522172568 60.ArthurR.R.el-SharkawyM.S.CopeS.E.BotrosB.A.OunS.MorrillJ.C.ShopeR.E.HibbsR.G.DarwishM.A.ImamI.Z.Recurrence of rift valley fever in"/>
   <result pre="epidemiology of rift valley fever virusEmerg. Infect. Dis.2011172270227610.3201/eid1712.11103522172568 60.ArthurR.R.el-SharkawyM.S.CopeS.E.BotrosB.A.OunS.MorrillJ.C.ShopeR.E.HibbsR.G.DarwishM.A.ImamI.Z.Recurrence of" exact="rift valley fever" post="in EgyptLancet19933421149115010.1016/0140-6736(93)92128-G7901480 61.TahaM.ElianK.MarcossT.MS EmanA.L.Monitoring of rift valley fever virus"/>
   <result pre="60.ArthurR.R.el-SharkawyM.S.CopeS.E.BotrosB.A.OunS.MorrillJ.C.ShopeR.E.HibbsR.G.DarwishM.A.ImamI.Z.Recurrence of rift valley fever in EgyptLancet19933421149115010.1016/0140-6736(93)92128-G7901480 61.TahaM.ElianK.MarcossT.MS EmanA.L.Monitoring of" exact="rift valley fever" post="virus in Egypt during year 2000 using Elisa for"/>
   <result pre="Egypt2018Available online: https://www.who.int/news-room/fact-sheets/detail/rift-valley-fever(accessed on 19 February 2018) 64.MarawanM.A.EbiedM.H.GalilaE.M.YoussefA.I.HassanK.Z.Epidemiological studies on" exact="rift valley fever" post="disease in EgyptBenha Vet. Med. J.201223171184 65.MrozC.GwidaM.El-AshkerM.El-DiastyM.El-BeskawyM.ZieglerU.EidenM.GroschupM.H.Seroprevalence of rift"/>
   <result pre="valley fever disease in EgyptBenha Vet. Med. J.201223171184 65.MrozC.GwidaM.El-AshkerM.El-DiastyM.El-BeskawyM.ZieglerU.EidenM.GroschupM.H.Seroprevalence of" exact="rift valley fever" post="virus in livestock during inter-epidemic period in Egypt, 2014/15BMC"/>
   <result pre="insights into pathogenesis and preventionJ. Virol.2011856098610510.1128/JVI.02641-1021450816 67.JostC.C.NzietchuengS.KihuS.BettB.NjoguG.SwaiE.S.MarinerJ.C.Epidemiological assessment of the" exact="rift valley fever" post="outbreak in Kenya and Tanzania in 2006 and 2007Am."/>
   <result pre="via livestock vaccinationCurr. Opin. Virol.2012231532310.1016/j.coviro.2012.02.01722463980 70.NiklassonB.S.MeadorsG.F.PetersC.J.Active and passive immunization against" exact="rift valley fever" post="virus infection in Syrian hamstersActa. Pathol. Microbiol. Immunol. Scand."/>
   <result pre="71.IkegamiT.MakinoS.Rift valley fever vaccinesVaccine200927Suppl. 4D69D7210.1016/j.vaccine.2009.07.04619837291 72.RandallR.GibbsC.J.Jr.AulisioC.G.BinnL.N.HarrisonV.R.The development of a formalin-killed" exact="rift valley fever" post="virus vaccine for use in manJ. Immunol.19628966067113990748 73.FaburayB.LaBeaudA.D.McVeyD.S.WilsonW.C.RichtJ.A.Current status"/>
   <result pre="virus vaccine for use in manJ. Immunol.19628966067113990748 73.FaburayB.LaBeaudA.D.McVeyD.S.WilsonW.C.RichtJ.A.Current status of" exact="rift valley fever" post="vaccine developmentVaccines (Basel)20175859110.3390/vaccines5030029 74.NiklassonB.PetersC.J.BengtssonE.NorrbyE.Rift valley fever virus vaccine trial:"/>
   <result pre="of neutralizing antibody response in humansVaccine1985312312710.1016/0264-410X(85)90061-14036271 75.PittmanP.R.LiuC.T.CannonT.L.MakuchR.S.MangiaficoJ.A.GibbsP.H.PetersC.J.Immunogenicity of an inactivated" exact="rift valley fever" post="vaccine in humans: A 12-year experienceVaccine19991818118910.1016/S0264-410X(99)00218-210501248 76.BotrosB.OmarA.ElianK.MohamedG.SolimanA.SalibA.SalmanD.SaadM.EarhartK.Adverse response of"/>
   <result pre="of non-indigenous cattle of European breeds to live attenuated Smithburn" exact="rift valley fever" post="vaccineJ. Med. Virol.20067878779110.1002/jmv.2062416628582 77.CaplenH.PetersC.J.BishopD.H.Mutagen-directed attenuation of rift valley fever"/>
   <result pre="Smithburn rift valley fever vaccineJ. Med. Virol.20067878779110.1002/jmv.2062416628582 77.CaplenH.PetersC.J.BishopD.H.Mutagen-directed attenuation of" exact="rift valley fever" post="virus as a method for vaccine developmentJ. Gen. Virol.1985662271227710.1099/0022-1317-66-10-22714045430"/>
   <result pre="reassortant viruses to map attenuating and temperature-sensitive mutations of the" exact="rift valley fever" post="virus mp-12 vaccineVaccine1990836937510.1016/0264-410X(90)90096-52396475 79.MorrillJ.C.MebusC.A.PetersC.J.Safety and efficacy of a mutagen-attenuated"/>
   <result pre="fever virus mp-12 vaccineVaccine1990836937510.1016/0264-410X(90)90096-52396475 79.MorrillJ.C.MebusC.A.PetersC.J.Safety and efficacy of a mutagen-attenuated" exact="rift valley fever" post="virus vaccine in cattleAm. J. Vet. Res.199758110411099328662 80.MorrillJ.C.PetersC.J.Protection of"/>
   <result pre="mp-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent" exact="rift valley fever" post="virusJ. Infect. Dis.201120422923610.1093/infdis/jir24921673033 81.MansfieldK.L.BanyardA.C.McElhinneyL.JohnsonN.HortonD.L.Hernandez-TrianaL.M.FooksA.R.Rift valley fever virus: A review"/>
   <result pre="and implications for emergence in europeVaccine2015335520553110.1016/j.vaccine.2015.08.02026296499 82.KortekaasJ.OreshkovaN.Cobos-JimenezV.VloetR.P.PotgieterC.A.MoormannR.J.Creation of a nonspreading" exact="rift valley fever" post="virusJ. Virol.201185126221263010.1128/JVI.00841-1121957302 83.MullerR.SaluzzoJ.F.LopezN.DreierT.TurellM.SmithJ.BouloyM.Characterization of clone 13, a naturally attenuated"/>
   <result pre="83.MullerR.SaluzzoJ.F.LopezN.DreierT.TurellM.SmithJ.BouloyM.Characterization of clone 13, a naturally attenuated avirulent isolate of" exact="rift valley fever" post="virus, which is altered in the small segmentAm. J."/>
   <result pre="Hyg.19955340541110.4269/ajtmh.1995.53.4057485695 84.DunguB.LouwI.LubisiA.HunterP.von TeichmanB.F.BouloyM.Evaluation of the efficacy and safety of the" exact="rift valley fever" post="clone 13 vaccine in sheepVaccine2010284581458710.1016/j.vaccine.2010.04.08520470792 85.von TeichmanB.EngelbrechtA.ZuluG.DunguB.PardiniA.BouloyM.Safety and efficacy"/>
   <result pre="clone 13 vaccine in sheepVaccine2010284581458710.1016/j.vaccine.2010.04.08520470792 85.von TeichmanB.EngelbrechtA.ZuluG.DunguB.PardiniA.BouloyM.Safety and efficacy of" exact="rift valley fever" post="smithburn and clone 13 vaccines in calvesVaccine2011295771577710.1016/j.vaccine.2011.05.05521664400 86.NjengaM.K.NjagiL.ThumbiS.M.KahaririS.GithinjiJ.OmondiE.BadenA.MurithiM.PaweskaJ.IthondekaP.M.et al.Randomized"/>
   <result pre="controlled field trial to assess the immunogenicity and safety of" exact="rift valley fever" post="clone 13 vaccine in livestockPLoS Negl. Trop. Dis.20159e000355010.1371/journal.pntd.000355025756501 87.DoddK.A.McElroyA.K.JonesT.L.ZakiS.R.NicholS.T.SpiropoulouC.F.Rift"/>
   <result pre="vaccine in livestockPLoS Negl. Trop. Dis.20159e000355010.1371/journal.pntd.000355025756501 87.DoddK.A.McElroyA.K.JonesT.L.ZakiS.R.NicholS.T.SpiropoulouC.F.Rift valley fever virus" exact="encephalitis" post="is associated with an ineffective systemic immune response and"/>
   <result pre="immunocompetent mouse modelPLoS Negl. Trop. Dis.20148e287410.1371/journal.pntd.000287424922480 88.VialatP.BillecocqA.KohlA.BouloyM.The s segment of" exact="rift valley fever" post="phlebovirus (bunyaviridae) carries determinants for attenuation and virulence in"/>
   <result pre="and stillbirthsPLoS Negl. Trop. Dis.201610e000455010.1371/journal.pntd.000455027031621 90.DaouamS.FakriF.EnnajiM.El arkamA.TadlaouiK.OuraC.ElharrakM.Heat stability of the" exact="rift valley fever" post="virus clone 13 live vaccinesTrials Vaccinol.20143616410.1016/j.trivac.2014.03.001 91.DaouamS.GhzalF.ArkamA.E.NaouliY.JazouliM.EnnajiM.M.TadlaouiK.O.OuraC.El HarrakM.Evaluation of"/>
   <result pre="of the safety and efficacy of a live attenuated thermostable" exact="rift valley fever" post="vaccine in sheep, goats and cattleJ. Vaccines Vaccin.20156295 92.PapinJ.F.VerardiP.H.JonesL.A.Monge-NavarroF.BraultA.C.HolbrookM.R.WorthyM.N.FreibergA.N.YilmaT.D.Recombinant"/>
   <result pre="fever vaccine in sheep, goats and cattleJ. Vaccines Vaccin.20156295 92.PapinJ.F.VerardiP.H.JonesL.A.Monge-NavarroF.BraultA.C.HolbrookM.R.WorthyM.N.FreibergA.N.YilmaT.D.Recombinant" exact="rift valley fever" post="vaccines induce protective levels of antibody in baboons and"/>
   <result pre="in miceProc. Natl. Acad. Sci. USA2011108149261493110.1073/pnas.111214910821873194 93.SoiR.K.RurangirwaF.R.McGuireT.C.RwamboP.M.DeMartiniJ.C.CrawfordT.B.Protection of sheep against" exact="rift valley fever" post="virus and sheep poxvirus with a recombinant capripoxvirus vaccineClin."/>
   <result pre="feverSci. Rep.201662061710.1038/srep2061726847478 96.WarimweG.M.LorenzoG.Lopez-GilE.Reyes-SandovalA.CottinghamM.G.SpencerA.J.CollinsK.A.DicksM.D.MilicicA.LallA.et al.Immunogenicity and efficacy of a chimpanzee adenovirus-vectored" exact="rift valley fever" post="vaccine in miceVirol. J.20131034910.1186/1743-422X-10-34924304565 97.Lopez-GilE.LorenzoG.HeviaE.BorregoB.EidenM.GroschupM.GilbertS.C.BrunA.A single immunization with MVA"/>
   <result pre="RVFV infectionPLoS Negl. Trop. Dis.20137e230910.1371/journal.pntd.000230923875044 98.KortekaasJ.AntonisA.F.KantJ.VloetR.P.VogelA.OreshkovaN.de BoerS.M.BoschB.J.MoormannR.J.Efficacy of three candidate" exact="rift valley fever" post="vaccines in sheepVaccine2012303423342910.1016/j.vaccine.2012.03.02722449427 99.KortekaasJ.DekkerA.de BoerS.M.WeerdmeesterK.VloetR.P.de WitA.A.PeetersB.P.MoormannR.J.Intramuscular inoculation of calves"/>
   <result pre="experimental newcastle disease virus-based vector vaccine elicits neutralizing antibodies against" exact="rift valley fever" post="virusVaccine2010282271227610.1016/j.vaccine.2010.01.00120079874 100.HeiseM.T.WhitmoreA.ThompsonJ.ParsonsM.GrobbelaarA.A.KempA.PaweskaJ.T.MadricK.WhiteL.J.SwanepoelR.et al.An alphavirus replicon-derived candidate vaccine against rift"/>
   <result pre="valley fever virusVaccine2010282271227610.1016/j.vaccine.2010.01.00120079874 100.HeiseM.T.WhitmoreA.ThompsonJ.ParsonsM.GrobbelaarA.A.KempA.PaweskaJ.T.MadricK.WhiteL.J.SwanepoelR.et al.An alphavirus replicon-derived candidate vaccine against" exact="rift valley fever" post="virusEpidemiol. Infect.20091371309131810.1017/S095026880800169619171081 101.SaidA.ElmanzalawyM.MaG.DamianiA.M.OsterriederN.An equine herpesvirus type 1 (EHV-1) vector"/>
   <result pre="virusEpidemiol. Infect.20091371309131810.1017/S095026880800169619171081 101.SaidA.ElmanzalawyM.MaG.DamianiA.M.OsterriederN.An equine herpesvirus type 1 (EHV-1) vector expressing" exact="rift valley fever" post="virus (RVFV) GN and GC induces neutralizing antibodies in"/>
   <result pre="future?Arch. Immunol. Ther. Exp.20075538739810.1007/s00005-007-0044-418060369 107.SpikK.ShurtleffA.McElroyA.K.GuttieriM.C.HooperJ.W.SchmalJohnC.Immunogenicity of combination DNA vaccines for" exact="rift valley fever" post="virus, tick-borne encephalitis virus, hantaan virus, and crimean congo"/>
   <result pre="107.SpikK.ShurtleffA.McElroyA.K.GuttieriM.C.HooperJ.W.SchmalJohnC.Immunogenicity of combination DNA vaccines for rift valley fever virus," exact="tick-borne encephalitis" post="virus, hantaan virus, and crimean congo hemorrhagic fever virusVaccine2006244657466610.1016/j.vaccine.2005.08.03416174542"/>
   <result pre="of combination DNA vaccines for rift valley fever virus, tick-borne" exact="encephalitis" post="virus, hantaan virus, and crimean congo hemorrhagic fever virusVaccine2006244657466610.1016/j.vaccine.2005.08.03416174542"/>
   <result pre="immune responses and protective efficacy in mice after immunisation with" exact="rift valley fever" post="virus cDNA constructsVirol. J.20096610.1186/1743-422X-6-619149901 109.LorenzoG.Martin-FolgarR.HeviaE.BoshraH.BrunA.Protection against lethal rift valley"/>
   <result pre="rift valley fever virus cDNA constructsVirol. J.20096610.1186/1743-422X-6-619149901 109.LorenzoG.Martin-FolgarR.HeviaE.BoshraH.BrunA.Protection against lethal" exact="rift valley fever" post="virus (RVFV) infection in transgenic ifnar(-/-) mice induced by"/>
   <result pre="110.HabjanM.PenskiN.SpiegelM.WeberF.T7 RNA polymerase-dependent and -independent systems for cdna-based rescue of" exact="rift valley fever" post="virusJ. Gen. Virol.2008892157216610.1099/vir.0.2008/002097-018753225 111.LiuL.CelmaC.C.RoyP.Rift valley fever virus structural proteins:"/>
   <result pre="particles expressing the nucleocapsid gene as an efficient vaccine against" exact="rift valley fever" post="virusVector Borne Zoonotic Dis.20101070170310.1089/vbz.2009.024820854024 113.BeyerT.HerrmannM.ReiserC.BertlingW.HessJ.Bacterial carriers and virus-like-particles as"/>
   <result pre="Targ. Infect. Disord.2001128730210.2174/1568005014605973 114.MandellR.B.KoukuntlaR.MoglerL.J.CarzoliA.K.HolbrookM.R.MartinB.K.VahanianN.LinkC.J.FlickR.Novel suspension cell-based vaccine production systems for" exact="rift valley fever" post="virus-like particlesJ. Virol. Methods201016925926810.1016/j.jviromet.2010.07.01520655330 115.NaslundJ.LagerqvistN.HabjanM.LundkvistA.EvanderM.AhlmC.WeberF.BuchtG.Vaccination with virus-like particles protects"/>
   <result pre="115.NaslundJ.LagerqvistN.HabjanM.LundkvistA.EvanderM.AhlmC.WeberF.BuchtG.Vaccination with virus-like particles protects mice from lethal infection of" exact="rift valley fever" post="virusVirology200938540941510.1016/j.virol.2008.12.01219157482 116.FaburayB.WilsonW.C.GaudreaultN.N.DavisA.S.ShivannaV.BawaB.SunwooS.Y.MaW.DroletB.S.MorozovI.et al.A recombinant rift valley fever virus glycoprotein"/>
   <result pre="lethal infection of rift valley fever virusVirology200938540941510.1016/j.virol.2008.12.01219157482 116.FaburayB.WilsonW.C.GaudreaultN.N.DavisA.S.ShivannaV.BawaB.SunwooS.Y.MaW.DroletB.S.MorozovI.et al.A recombinant" exact="rift valley fever" post="virus glycoprotein subunit vaccine confers full protection against rift"/>
   <result pre="valley fever virus glycoprotein subunit vaccine confers full protection against" exact="rift valley fever" post="challenge in sheepSci. Rep.201662771910.1038/srep2771927296136 117.FaburayB.LebedevM.McVeyD.S.WilsonW.MorozovI.YoungA.RichtJ.A.A glycoprotein subunit vaccine elicits"/>
   <result pre="in sheepSci. Rep.201662771910.1038/srep2771927296136 117.FaburayB.LebedevM.McVeyD.S.WilsonW.MorozovI.YoungA.RichtJ.A.A glycoprotein subunit vaccine elicits a strong" exact="rift valley fever" post="virus neutralizing antibody response in sheepVector Borne Zoonotic Dis.20141474675610.1089/vbz.2014.165025325319"/>
   <result pre="119.StobartC.C.MooreM.L.RNA virus reverse genetics and vaccine designViruses201462531255010.3390/v607253124967693 120.Wichgers SchreurP.J.OreshkovaN.MoormannR.J.KortekaasJ.Creation of" exact="rift valley fever" post="viruses with four-segmented genomes reveals flexibility in bunyavirus genome"/>
   <result pre="packagingJ. Virol.201488108831089310.1128/JVI.00961-1425008937 121.ChenH.AngelM.LiW.FinchC.GonzalezA.S.SuttonT.SantosJ.PerezD.R.All-in-one bacmids: An efficient reverse genetics strategy for" exact="influenza" post="a virus vaccinesJ. Virol.201488100131002510.1128/JVI.01468-1424942589 122.HuB.JiangJ.ZhanJ.LiG.JiangY.GuanX.ChenY.FangZ.Development of a reverse genetics"/>
   <result pre="viral RNA for the rescue of infectious virulent and avirulent" exact="rift valley fever" post="virusesVirology200837837738410.1016/j.virol.2008.05.03318614193 124.IkegamiT.WonS.PetersC.J.MakinoS.Rescue of infectious rift valley fever virus entirely"/>
   <result pre="virulent and avirulent rift valley fever virusesVirology200837837738410.1016/j.virol.2008.05.03318614193 124.IkegamiT.WonS.PetersC.J.MakinoS.Rescue of infectious" exact="rift valley fever" post="virus entirely from cDNA, analysis of virus lacking the"/>
   <result pre="in adult and pregnant sheepJ. Virol.201185129011290910.1128/JVI.06046-1121976656 126.MorrillJ.C.LaughlinR.C.LokugamageN.WuJ.PughR.KananiP.AdamsL.G.MakinoS.PetersC.J.Immunogenicity of a recombinant" exact="rift valley fever" post="mp-12-nsm deletion vaccine candidate in calvesVaccine2013314988499410.1016/j.vaccine.2013.08.00323994375 127.WeingartlH.M.NfonC.K.ZhangS.MarszalP.WilsonW.C.MorrillJ.C.BettingerG.E.PetersC.J.Efficacy of a"/>
   <result pre="mp-12-nsm deletion vaccine candidate in calvesVaccine2013314988499410.1016/j.vaccine.2013.08.00323994375 127.WeingartlH.M.NfonC.K.ZhangS.MarszalP.WilsonW.C.MorrillJ.C.BettingerG.E.PetersC.J.Efficacy of a recombinant" exact="rift valley fever" post="virus mp-12 with nsm deletion as a vaccine candidate"/>
   <result pre="vaccine candidate in sheepVaccine2014322345234910.1016/j.vaccine.2013.12.06424462482 128.SmithD.R.JohnstonS.C.PiperA.BottoM.DonnellyG.ShamblinJ.AlbarinoC.G.HensleyL.E.SchmaljohnC.NicholS.T.et al.Attenuation and efficacy of live-attenuated" exact="rift valley fever" post="virus vaccine candidates in non-human primatesPLoS Negl. Trop. Dis.201812e000647410.1371/journal.pntd.000647429742102"/>
   <result pre="Dis.201812e000647410.1371/journal.pntd.000647429742102 129.YoussefB.Study the immune response for sheep and cattle with" exact="rift valley fever" post="inactivated and attenuated vaccineAlex J. Med. Sci.2004208597 Figure 1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410217\results\search\disease\results.xml">
   <result pre="of effective therapeutic strategies, vector control measures, and eradication actions." exact="chikungunya" post="virus viral tropism arthropod vectors animal hosts pathogenesis vertical"/>
   <result pre="the midgut to secondary organs, as follows: (i) newly formed" exact="chikungunya" post="virions accumulate at the level of the midgut basal"/>
   <result pre="important for the efficient infection of alphaviruses (i.e., Eastern equine" exact="encephalitis" post="virus (EEEV) and Venezuelan equine encephalitis virus (VEEV)), have"/>
   <result pre="alphaviruses (i.e., Eastern equine encephalitis virus (EEEV) and Venezuelan equine" exact="encephalitis" post="virus (VEEV)), have been implicated in CHIKV attachment (reviewed"/>
   <result pre="for clinicians, nowadays, is to differentiate the clinical signs of" exact="chikungunya" post="from those of Zika and dengue fever, especially when"/>
   <result pre="the clinical signs of chikungunya from those of Zika and" exact="dengue fever," post="especially when these viruses are co-circulating. Unlike ZIKV and"/>
   <result pre="the bite of Aedes spp. mosquito vectors, and causes the" exact="chikungunya" post="virus disease (CHIKD), characterized, in the acute phase, by"/>
   <result pre="can occur, and range from photophobia to retro-orbital pain and" exact="conjunctivitis" post="[95]. Chikungunya chronic disease is characterized by the persistence"/>
   <result pre="may present for several weeks to months, and may mimic" exact="rheumatoid arthritis." post="Rodriguez-Morales and coworkers systematically reviewed the data on post-chikungunya"/>
   <result pre="systematically reviewed the data on post-chikungunya infection with chronic inflammatory" exact="arthritis" post="in reports published from 2007 to 2015, and calculated"/>
   <result pre="to the occurrence of severe manifestations [100,101,102]. Unusual manifestations of" exact="chikungunya" post="infection comprise cardiovascular, renal, cutaneous, ocular, hepatic, and respiratory"/>
   <result pre="(approximately 0.1% of CHIKV infection develops neurological disorders), most commonly" exact="encephalitis" post="and encephalopathy, prompted the investigation of CHIKV tropism for"/>
   <result pre="the central nervous system (CNS) [107]. Acute flaccid paralysis and" exact="meningoencephalitis" post="have also been described [99,108,109]. Moreover, Guillainâ€&quot;BarrÃ© syndrome (GBS),"/>
   <result pre="described [99,108,109]. Moreover, Guillainâ€&quot;BarrÃ© syndrome (GBS), an acute inflammatory demyelinating" exact="polyneuropathy" post="that usually occurs after infection by a variety of"/>
   <result pre="Importantly, the inhibition of monocytes/macrophages recruitment or macrophages depletion attenuated" exact="arthritis" post="and joint swelling in mouse models [165,167], but resulted"/>
   <result pre="in vitro infection of human cells demonstrated the susceptibility of" exact="neuroblastoma" post="cells (neural crest derived cells) [172,173], and of glial"/>
   <result pre="cells [176,177] to CHIKV. The apoptosis observed in CHIKV infected" exact="neuroblastoma" post="cells and astrocytes suggests a direct implication of viral"/>
   <result pre="CHIKV patients. Ocular diseases present mainly as retro-orbital pain or" exact="conjunctivitis" post="at the time of CHIKV systemic illness, and predominantly"/>
   <result pre="of CHIKV systemic illness, and predominantly as uveitis, retinitis, or" exact="optic neuritis" post="in later phases and recurrences [107,183,184,185,186]. The presence of"/>
   <result pre="organs targeted by CHIKV may explain the rare consequences of" exact="chikungunya" post="infection, and the clinical manifestations observed in patients (i.e.,"/>
   <result pre="use recombinant replication-deficient viruses as antigen delivery vectors (i.e., the" exact="measles" post="virus (MV-CHIV) and adenovirus derived from a chimpanzee (ChAdOx))"/>
   <result pre="the Entebbe peninsulaTrans. R. Soc. Trop. Med. Hyg.19585225825913556870 3.PowersA.M.BraultA.C.TeshR.B.WeaverS.C.Re-emergence of" exact="chikungunya" post="and oâ€™nyong-nyong viruses: Evidence for distinct geographical lineages and"/>
   <result pre="Viruses Causing the Indian Ocean OutbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 6.RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA.PanningM.CordioliP.FortunaC.BorosS.MaguranoF.et al.Infection with" exact="chikungunya" post="virus in Italy: An outbreak in a temperate regionLancet20073701840184610.1016/S0140-6736(07)61779-618061059"/>
   <result pre="goegraphic strains of Aedes albopictus in susceptibility to infection with" exact="chikungunya" post="virusAm. J. Trop. Med. Hyg.19762532633510.4269/ajtmh.1976.25.3261259092 16.TsetsarkinK.A.ChenR.ShermanM.B.WeaverS.C.Chikungunya virus: Evolution and"/>
   <result pre="genetic determinants of emergenceCurr. Opin. Virol.2011131031710.1016/j.coviro.2011.07.00421966353 17.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 18.ThibervilleS.-D.MoyenN.Dupuis-MaguiragaL.NougairedeA.GouldE.A.RoquesP.de"/>
   <result pre="FranceEmerg. Infect. Dis.20111791091310.3201/eid1705.10187321529410 21.BordiL.CarlettiF.LalleE.ColavitaF.MeschiS.Di CaroA.NicastriE.ScognamiglioP.VairoF.Di LalloD.et al.Molecular characterization of autochthonous" exact="chikungunya" post="cluster in latium region, ItalyEmerg. Infect. Dis.20182417818010.3201/eid2401.171605 22.TsetsarkinK.A.WeaverS.C.Sequential Adaptive"/>
   <result pre="and Its Epidemic EmergencePLoS Pathog.20117e100241210.1371/journal.ppat.100241222174678 23.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="LevelPLoS ONE20138e5754810.1371/journal.pone.005754823437397 25.JuppP.G.McIntoshB.M.Aedes furcifer and other mosquitoes as vectors of" exact="chikungunya" post="virus at Mica, northeastern Transvaal, South AfricaJ. Am. Mosq."/>
   <result pre="vector studies on six mosquito and one tick species with" exact="chikungunya" post="virusTrans. R. Soc. Trop. Med. Hyg.198175151910.1016/0035-9203(81)90005-56115488 27.DialloM.ThonnonJ.Traore-lamizanaM.FontenilleD.Vectors of Chikungunya"/>
   <result pre="transmission cyclesAm. J. Trop. Med. Hyg.19996028128610.4269/ajtmh.1999.60.28110072152 28.McIntoshB.M.PatersonH.E.McGillivrayG.DesousaJ.Further studies on the" exact="chikungunya" post="outbreak in Rhodesia. I. Mosquitoes, wild primates and birds"/>
   <result pre="Aedes bromeliae and Aedes vitattus mosquito populations from Kenya for" exact="chikungunya" post="virusPLoS Negl. Trop. Dis.201812e000674610.1371/journal.pntd.000674630321181 35.RichardV.PaoaafaiteT.Cao-LormeauV.-M.Vector Competence of Aedes aegypti"/>
   <result pre="of arboviruses in citiesPLoS Negl. Trop. Dis.20171111710.1371/journal.pntd.000566728650959 37.LourenÃ§o-de-OliveiraR.FaillouxA.B.High risk for" exact="chikungunya" post="virus to initiate an enzootic sylvatic cycle in the"/>
   <result pre="new European invader Aedes (Finlaya) koreicus: A potential vector of" exact="chikungunya" post="virusPathog. Glob. Health201811210711410.1080/20477724.2018.146478029737236 41.FrosJ.J.GeertsemaC.ZouacheK.BaggenJ.DomeradzkaN.Van LeeuwenD.M.FlipseJ.VlakJ.M.FaillouxA.B.PijlmanG.P.Mosquito Rasputin interacts with chikungunya"/>
   <result pre="of chikungunya virusPathog. Glob. Health201811210711410.1080/20477724.2018.146478029737236 41.FrosJ.J.GeertsemaC.ZouacheK.BaggenJ.DomeradzkaN.Van LeeuwenD.M.FlipseJ.VlakJ.M.FaillouxA.B.PijlmanG.P.Mosquito Rasputin interacts with" exact="chikungunya" post="virus nsP3 and determines the infection rate in Aedes"/>
   <result pre="method on susceptibility of Aedes aegypti and Aedes albopictus to" exact="chikungunya" post="virusJ. Med. Entomol.20094639539910.1603/033.046.022819351094 43.LeeR.C.H.HapuarachchiH.C.ChenK.C.HussainK.M.ChenH.LowS.L.NgL.C.LinR.NgM.M.L.ChuJ.J.H.Mosquito Cellular Factors and Functions in"/>
   <result pre="digestionPLoS Negl. Trop. Dis.20171112610.1371/journal.pntd.000597628961239 45.DongS.KantorA.M.LinJ.PassarelliA.L.ClemR.J.FranzA.W.E.Infection pattern and transmission potential of" exact="chikungunya" post="virus in two New World laboratory-adapted Aedes aegypti strainsSci."/>
   <result pre="New World laboratory-adapted Aedes aegypti strainsSci. Rep.201662472910.1038/srep2472927102548 46.KantorA.M.GrantD.G.BalaramanV.WhiteT.A.FranzA.W.E.Ultrastructural analysis of" exact="chikungunya" post="virus dissemination from the midgut of the yellow fever"/>
   <result pre="analysis of chikungunya virus dissemination from the midgut of the" exact="yellow fever" post="mosquito, aedes aegyptiViruses20181057110.3390/v1010057130340365 47.BowersD.F.ColemanC.G.BrownD.T.Sindbis virus-associated pathology in Aedes albopictus"/>
   <result pre="in salivary glands of the mosquito aedes albopictusViruses201575902590710.3390/v711291726593936 52.Tchankouo-NguetcheuS.BourguetE.LenormandP.RousselleJ.-C.NamaneA.ChoumetV.Infection by" exact="chikungunya" post="virus modulates the expression of several proteins in Aedes"/>
   <result pre="Aedes aegypti salivary glandsParasit. Vectors2012526410.1186/1756-3305-5-26423153178 53.Le CoupanecA.Tchankouo-NguetcheuS.RouxP.KhunH.HuerreM.Morales-VargasR.EnguehardM.LavilletteD.MissÃ©D.ChoumetV.Co-infection of mosquitoes with" exact="chikungunya" post="and dengue viruses reveals modulation of the replication of"/>
   <result pre="Reveals Impact on Egg-Laying PathwaysJ. Med. Entomol.2018551580158710.1093/jme/tjy09729931258 58.ThavaraU.TawatsinA.PengsakulT.BhakdeenuanP.ChanamaS.AnantapreechaS.MolitoC.ChompoosriJ.ThammapaloS.SawanpanyalertP.et al.Outbreak of" exact="chikungunya" post="fever in Thailand and virus detection in field population"/>
   <result pre="Trop. Med. Public Health20094095196219842379 59.JainJ.KushwahR.B.S.SinghS.S.SharmaA.AdakT.SinghO.P.BhatnagarR.K.SubbaraoS.K.SunilS.Evidence for natural vertical transmission of" exact="chikungunya" post="viruses in field populations of Aedes aegypti in Delhi"/>
   <result pre="preliminary reportActa Trop.2016162465510.1016/j.actatropica.2016.06.00427282096 60.ChompoosriJ.ThavaraU.TawatsinA.BoonsermR.PhumeeA.SangkitpornS.SiriyasatienP.Vertical transmission of Indian Ocean Lineage of" exact="chikungunya" post="virus in Aedes aegypti and Aedes albopictus mosquitoesParasit. Vectors2016922710.1186/s13071-016-1505-627108077"/>
   <result pre="Virus in Aedes aegyptiPLoS Negl. Trop. Dis.20148e299010.1371/journal.pntd.000299025080107 62.WongH.V.VythilingamI.SulaimanW.Y.W.LullaA.MeritsA.ChanY.F.SamI.C.Detection of persistent" exact="chikungunya" post="virus RNA but not infectious virus in experimental vertical"/>
   <result pre="arbovirusesAnnu. Rev. Entomol.19832822926210.1146/annurev.en.28.010183.0013056131642 65.MascarenhasM.GarasiaS.BerthiaumeP.CorrinT.GreigJ.NgV.YoungI.WaddellL.A scoping review of published literature on" exact="chikungunya" post="virusPLoS ONE201813e020755410.1371/journal.pone.020755430496207 66.AlthouseB.M.GuerboisM.CummingsD.A.T.DiopO.M.FayeO.FayeA.DialloD.SadioB.D.SowA.FayeO.et al.Role of monkeys in the sylvatic"/>
   <result pre="ONE201813e020755410.1371/journal.pone.020755430496207 66.AlthouseB.M.GuerboisM.CummingsD.A.T.DiopO.M.FayeO.FayeA.DialloD.SadioB.D.SowA.FayeO.et al.Role of monkeys in the sylvatic cycle of" exact="chikungunya" post="virus in SenegalNat. Commun.2018911010.1038/s41467-018-03332-729317637 67.EastwoodG.SangR.C.GuerboisM.TarachaE.L.N.WeaverS.C.Enzootic circulation of chikungunya virus"/>
   <result pre="cycle of chikungunya virus in SenegalNat. Commun.2018911010.1038/s41467-018-03332-729317637 67.EastwoodG.SangR.C.GuerboisM.TarachaE.L.N.WeaverS.C.Enzootic circulation of" exact="chikungunya" post="virus in East Africa: Serological evidence in non-human Kenyan"/>
   <result pre="Kenyan primatesAm. J. Trop. Med. Hyg.2017971399140410.4269/ajtmh.17-012629016323 68.OsterriethP.RatheE.Deleplanque-LiegeoisP.[Simultaneous isolation of the" exact="yellow fever" post="and Chikungunya viruses at Bili (Haut-Uele, Belgian Congo)]Ann. la"/>
   <result pre="Transplant.20016431031610.4269/ajtmh.2001.64.310 74.SamI.C.ChuaC.L.Rovie-RyanJ.J.FuJ.Y.L.TongC.SitamF.T.ChanY.F.Chikungunya virus in macaques, MalaysiaEmerg. Infect. Dis.2015211683168510.3201/eid2109.15043926291585 75.NakgoiK.NitatpattanaN.WajjwalkuW.PongsopawijitP.KaewchotS.YoksanS.SiripolwatV.SourisM.GonzalezJ.P.Dengue, Japanese" exact="encephalitis" post="and Chikungunya virus antibody prevalence among captive monkey (Macaca"/>
   <result pre="monkeys in the Philippines.pdfJ. Med. Primatol.200332899410.1034/j.1600-0684.2003.00015.x12823631 78.ApandiY.NazniW.A.AzleenZ.A.N.VythilingamI.NoorazianM.Y.AzahariA.H.ZainahS.LeeH.L.The first isolation of" exact="chikungunya" post="virus from non-human primates in MalaysiaJ. Gen. Mol. Virol.200913539"/>
   <result pre="in BrazilmSphere20183e00523-1710.1128/mSphere.00523-1729404420 80.Bosco-LauthA.M.HartwigA.E.BowenR.A.Reptiles and amphibians as potential reservoir hosts of" exact="chikungunya" post="virusAm. J. Trop. Med. Hyg.20189884184410.4269/ajtmh.17-073029313469 81.Bosco-LauthA.M.NemethN.M.KohlerD.J.BowenR.A.Viremia in North American"/>
   <result pre="in North American mammals and birds after experimental infection with" exact="chikungunya" post="virusesAm. J. Trop. Med. Hyg.20169450450610.4269/ajtmh.15-069626666699 82.McIntoshB.M.Antibody against Chikungunya virus"/>
   <result pre="Southern AfricaS. Afr. J. Med. Sci.19703565744398581 83.van Duijl-RichterM.K.S.HoornwegT.E.Rodenhuis-ZybertI.A.SmitJ.M.Early events in" exact="chikungunya" post="virus infectionâ€&quot;From virus cell binding to membrane fusionViruses201573647367410.3390/v707279226198242 84.WintachaiP.WikanN.KuadkitkanA.JaimipukT.UbolS.PulmanausahakulR.AuewarakulP.KasinrerkW.WengW.Y.PanyasrivanitM.et"/>
   <result pre="virus receptor proteinJ. Med. Virol.2012841757177010.1002/jmv.2340322997079 85.WintachaiP.ThuaudF.BasmadjianC.RoytrakulS.UbolS.DÃ©saubryL.SmithD.R.Assessment of flavaglines as potential" exact="chikungunya" post="virus entry inhibitorsMicrobiol. Immunol.20155912914110.1111/1348-0421.1223025643977 86.ZhangR.KimA.S.FoxJ.M.NairS.BasoreK.KlimstraW.B.RimkunasR.FongR.H.LinH.PoddarS.et al.Mxra8 is a receptor"/>
   <result pre="Mosquito Cell LineIntervirology20186024726210.1159/000489308 88.FongsaranC.JirakanwisalK.KuadkitkanA.WikanN.WintachaiP.ThepparitC.UbolS.PhaonakropN.RoytrakulS.SmithD.R.Involvement of ATP synthase Î² subunit in" exact="chikungunya" post="virus entry into insect cellsArch. Virol.20141593353336410.1007/s00705-014-2210-425168043 89.HabyM.M.PinartM.EliasV.ReveizL.Prevalence of asymptomatic"/>
   <result pre="and the eyeInt. J. Retin. Vitr.20173410.1186/s40942-016-0057-428163928 96.FourieE.D.MorrisonJ.G.Rheumatoid arthritic syndrome after" exact="chikungunya" post="feverS. Afr. Med. J.197956130132494034 97.AalstV.NelenC.M.GoorhuisA.StijnisC.GrobuschM.P.Long-term sequelae of chikungunya virus"/>
   <result pre="syndrome after chikungunya feverS. Afr. Med. J.197956130132494034 97.AalstV.NelenC.M.GoorhuisA.StijnisC.GrobuschM.P.Long-term sequelae of" exact="chikungunya" post="virus disease: A systematic reviewTravel Med. Infect. Dis.20171582210.1016/j.tmaid.2017.01.00428163198 98.RodrÃ­guez-MoralesA.J.Cardona-OspinaJ.A.Fernanda"/>
   <result pre="the 2017 Italian OutbreakOpen Forum Infect. Dis.20185ofy27610.1093/ofid/ofy27630539034 101.LemantJ.BoissonV.WinerA.ThibaultL.AndrÃ©H.TixierF.LemercierM.AntokE.CrestaM.P.GrivardP.et al.Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the reunion island"/>
   <result pre="the reunion island outbreak in 2005â€&quot;2006Crit. Care Med.2008362536254110.1097/CCM.0b013e318183f2d218679124 102.RenaultP.BalleydierE.Dâ€™OrtenzioE.BÃ¢villeM.FilleulL.Epidemiology of" exact="chikungunya" post="infection on Reunion Island, Mayotte, and neighboring countriesMÃ©decine Mal."/>
   <result pre="Island, Mayotte, and neighboring countriesMÃ©decine Mal. Infect.2012429310110.1016/j.medmal.2011.12.002 103.RajapakseS.RodrigoC.RajapakseA.Atypical manifestations of" exact="chikungunya" post="infectionTrans. R. Soc. Trop. Med. Hyg.2010104899610.1016/j.trstmh.2009.07.03119716149 104.MercadoM.Acosta-ReyesJ.ParraE.GuzmÃ¡nL.BeltrÃ¡nM.GasqueP.MejÃ­a-GarcÃ­aC.ViasusD.Renal involvement in"/>
   <result pre="Soc. Trop. Med. Hyg.2010104899610.1016/j.trstmh.2009.07.03119716149 104.MercadoM.Acosta-ReyesJ.ParraE.GuzmÃ¡nL.BeltrÃ¡nM.GasqueP.MejÃ­a-GarcÃ­aC.ViasusD.Renal involvement in fatal cases of" exact="chikungunya" post="virus infectionJ. Clin. Virol.2018103161810.1016/j.jcv.2018.03.00929604514 105.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and toxic epidermal"/>
   <result pre="Virol.2018103161810.1016/j.jcv.2018.03.00929604514 105.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of" exact="chikungunya" post="fever: A case seriesPediatr. Dermatol.20183539239610.1111/pde.1345029573443 106.DuttaP.SharmaA.A case of atypical"/>
   <result pre="ophthalmoplegia after Chikungunya feverInt. Ophthalmol.20183883783910.1007/s10792-017-0529-z28397145 107.MehtaR.GerardinP.de BritoC.A.A.SoaresC.N.FerreiraM.L.B.SolomonT.The neurological complications of" exact="chikungunya" post="virus: A systematic reviewRev. Med. Virol.201828e197810.1002/rmv.197829671914 108.ShardaM.MeenaH.Neurological complications in"/>
   <result pre="Phys. India200755765769 109.SinghS.S.ManimundaS.P.SugunanA.P.VijayachariP.Four cases of acute flaccid paralysis associated with" exact="chikungunya" post="virus infectionEpidemiol. Infect.20081361277128010.1017/S095026880700973918634716 110.WielanekA.C.MonredonJ.D.AmraniM.E.RogerJ.C.ServeauxJ.P.Guillain-BarrÃ© syndrome complicating a chikungunya virus"/>
   <result pre="associated with chikungunya virus infectionEpidemiol. Infect.20081361277128010.1017/S095026880700973918634716 110.WielanekA.C.MonredonJ.D.AmraniM.E.RogerJ.C.ServeauxJ.P.Guillain-BarrÃ© syndrome complicating a" exact="chikungunya" post="virus infectionNeurology2007692105210710.1212/01.wnl.0000277267.07220.8818040016 111.AcevedoN.WaggonerJ.RodriguezM.RiveraL.LandivarJ.PinskyB.ZambranoH.Zika virus, chikungunya virus, and dengue virus"/>
   <result pre="Infect.20081361277128010.1017/S095026880700973918634716 110.WielanekA.C.MonredonJ.D.AmraniM.E.RogerJ.C.ServeauxJ.P.Guillain-BarrÃ© syndrome complicating a chikungunya virus infectionNeurology2007692105210710.1212/01.wnl.0000277267.07220.8818040016 111.AcevedoN.WaggonerJ.RodriguezM.RiveraL.LandivarJ.PinskyB.ZambranoH.Zika virus," exact="chikungunya" post="virus, and dengue virus in cerebrospinal fluid from adults"/>
   <result pre="SilvaM.T.T.Rosala-HallasA.JardimM.R.BurnsideG.PamplonaL.BhojakM.et al.The spectrum of neurological disease associated with Zika and" exact="chikungunya" post="viruses in adults in Rio de Janeiro, Brazil: A"/>
   <result pre="for Viral InfectionCell. Physiol. Biochem.2018512377239610.1159/00049589730537741 115.SchilteC.CoudercT.ChretienF.SourisseauM.GangneuxN.Guivel-BenhassineF.KraxnerA.TschoppJ.HiggsS.MichaultA.et al.Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cellsJ. Exp. Med.201020742944210.1084/jem.2009085120123960"/>
   <result pre="Inhibits Type I/II Interferon-Stimulated JAK-STAT SignalingJ. Virol.201084108771088710.1128/JVI.00949-1020686047 118.JonesP.H.MaricM.MadisonM.N.MauryW.RollerR.J.OkeomaC.M.BST-2/tetherin-mediated restriction of" exact="chikungunya" post="(CHIKV) VLP budding is counteracted by CHIKV non-structural protein"/>
   <result pre="SeverityPLoS Negl. Trop. Dis.20115e127910.1371/journal.pntd.000127921858242 124.MichlmayrD.PakT.R.RahmanA.H.AmirE.D.KimE.Kim-SchulzeS.SuprunM.StewartM.G.ThomasG.P.BalmasedaA.et al.Comprehensive innate immune profiling of" exact="chikungunya" post="virus infection in pediatric casesMol. Syst. Biol.201814e786210.15252/msb.2017786230150281 125.PooY.S.RuddP.A.GardnerJ.WilsonJ.A.C.LarcherT.ColleM.A.LeT.T.NakayaH.I.WarrilowD.AllcockR.et al.Multiple"/>
   <result pre="in Southeastern SenegalAm. J. Primatol.201076466 133.LumF.-M.NgL.F.P.Cellular and molecular mechanisms of" exact="chikungunya" post="pathogenesisAntiviral Res.201512016517410.1016/j.antiviral.2015.06.00926092642 134.HawmanD.W.StoermerK.A.MontgomeryS.A.PalP.OkoL.DiamondM.S.MorrisonT.E.Chronic Joint Disease Caused by Persistent Chikungunya"/>
   <result pre="Immunol.201319025926910.4049/jimmunol.120217723209328 136.PartidosC.D.WegerJ.BrewooJ.SeymourR.BorlandE.M.LedermannJ.P.PowersA.M.WeaverS.C.StinchcombD.T.OsorioJ.E.Probing the attenuation and protective efficacy of a candidate" exact="chikungunya" post="virus vaccine in mice with compromised interferon (IFN) signalingVaccine2011293067307310.1016/j.vaccine.2011.01.07621300099"/>
   <result pre="human dermal fibroblastsInfect. Genet. Evol.20153240140810.1016/j.meegid.2015.03.02525847693 140.SourisseauM.SchilteC.CasartelliN.TrouilletC.Guivel-BenhassineF.RudnickaD.Sol-FoulonN.Le RouxK.PrevostM.C.FsihiH.et al.Characterization of reemerging" exact="chikungunya" post="virusPLoS Pathog.200730804081710.1371/journal.ppat.003008917604450 141.WichitS.DiopF.HamelR.TalignaniL.FerrarisP.CornelieS.LiegeoisF.ThomasF.YsselH.MissÃ©D.Aedes Aegypti saliva enhances chikungunya virus replication"/>
   <result pre="al.Characterization of reemerging chikungunya virusPLoS Pathog.200730804081710.1371/journal.ppat.003008917604450 141.WichitS.DiopF.HamelR.TalignaniL.FerrarisP.CornelieS.LiegeoisF.ThomasF.YsselH.MissÃ©D.Aedes Aegypti saliva enhances" exact="chikungunya" post="virus replication in human skin fibroblasts via inhibition of"/>
   <result pre="are risk factors for severe diseasePLoS Pathog.20084e2910.1371/journal.ppat.004002918282093 143.PuipromO.Morales VargasR.E.PotiwatR.ChaichanaP.IkutaK.RamasootaP.OkabayashiT.Characterization of" exact="chikungunya" post="virus infection of a human keratinocyte cell line: Role"/>
   <result pre="suppressing the host immune responseInfect. Genet. Evol.20131721021510.1016/j.meegid.2013.04.00523583544 144.BernardE.HamelR.NeyretA.EkchariyawatP.MolÃ¨sJ.P.SimmonsG.ChazalN.DesprÃ¨sP.MissÃ©D.BriantL.Human keratinocytes restrict" exact="chikungunya" post="virus replication at a post-fusion stepVirology201547611010.1016/j.virol.2014.11.01325496825 145.RuddP.A.WilsonJ.GardnerJ.LarcherT.BabaritC.LeT.T.AnrakuI.KumagaiY.LooY.-M.GaleM.et al.Interferon Response"/>
   <result pre="responses of human melanocytes in infectious diseasesJ. Infect.20157141342110.1016/j.jinf.2015.06.00626092350 149.ParolaP.de LamballerieX.JourdanJ.RoveryC.VaillantV.MinodierP.BrouquiP.FlahaultA.RaoultD.CharrelR.N.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islandsEmerg."/>
   <result pre="151.Ruiz SilvaM.Van Der Ende-MetselaarH.MulderH.L.SmitJ.M.Rodenhuis-ZybertI.A.Mechanism and role of MCP-1 upregulation upon" exact="chikungunya" post="virus infection in human peripheral blood mononuclear cellsSci. Rep.201661910.1038/srep3228828442746"/>
   <result pre="blood mononuclear cellsSci. Rep.201661910.1038/srep3228828442746 152.Ruiz SilvaM.Aguilar BriseÃ±oJ.A.UpasaniV.van der Ende-MetselaarH.SmitJ.M.Rodenhuis-ZybertI.A.Suppression of" exact="chikungunya" post="virus replication and differential innate responses of human peripheral"/>
   <result pre="during co-infection with dengue virusPLoS Negl. Trop. Dis.201711e000571210.1371/journal.pntd.000571228644900 153.LaughhunnA.HuangY.-J.S.VanlandinghamD.L.LanteriM.C.StassinopoulosA.Inactivation of" exact="chikungunya" post="virus in blood components treated with amotosalen/ultraviolet A light"/>
   <result pre="and monocytes/macrophages in CHIKV-induced arthralgia/arthritisVirus Res.201317717918810.1016/j.virusres.2013.08.01124012515 160.LokireddyS.VemulaS.VaddeR.Connective tissue metabolism in" exact="chikungunya" post="patientsVirol. J.200853110.1186/1743-422X-5-3118302795 161.HerreroL.J.FooS.-S.ShengK.-C.ChenW.ForwoodM.R.BucalaR.MahalingamS.Pentosan Polysulfate: A Novel Glycosaminoglycan-Like Molecule for"/>
   <result pre="Alphavirus-Induced Cartilage Destruction and Inflammatory DiseaseJ. Virol.2015898063807610.1128/JVI.00224-1526018160 162.KuoS.C.WangY.M.HoY.J.ChangT.Y.LaiZ.Z.TsuiP.Y.WuT.Y.LinC.C.Suramin treatment reduces" exact="chikungunya" post="pathogenesis in miceAntiviral Res.2016134899610.1016/j.antiviral.2016.07.02527577529 163.NoretM.HerreroL.RulliN.RolphM.SmithP.N.LiR.W.RoquesP.GrasG.MahalingamS.Interleukin 6, RANKL, and osteoprotegerin"/>
   <result pre="in miceAntiviral Res.2016134899610.1016/j.antiviral.2016.07.02527577529 163.NoretM.HerreroL.RulliN.RolphM.SmithP.N.LiR.W.RoquesP.GrasG.MahalingamS.Interleukin 6, RANKL, and osteoprotegerin expression by" exact="chikungunya" post="virus-infected human osteoblastsJ. Infect. Dis.201220645545710.1093/infdis/jis36822634878 164.GoupilB.A.McNultyM.A.MartinM.J.McCrackenM.K.ChristoffersonR.C.MoresC.N.Novel Lesions of Bones"/>
   <result pre="do not knowRev. Med. Virol.20091912112910.1002/rmv.60619274635 170.ThiruvengadamK.V.KalyanasundaramV.RajgopalJ.Clinical and pathological studies on" exact="chikungunya" post="fever in Madras cityIndian J. Med. Res.1965537297445830407 171.GanesanK.DiwanA.ShankarS.K.DesaiS.B.SainaniG.S.KatrakS.M.Chikungunya encephalomyeloradiculitis:"/>
   <result pre="findingsAm. J. Neuroradiol.2008291636163710.3174/ajnr.A113318566010 172.DhanwaniR.KhanM.BhaskarA.S.B.SinghR.PatroI.K.RaoP.V.L.ParidaM.M.Characterization of Chikungunya virus infection in human" exact="neuroblastoma" post="SH-SY5Y cells: Role of apoptosis in neuronal cell deathVirus"/>
   <result pre="Cells Restricts Chikungunya Virus ReplicationJ. Proteome Res.2017164144415510.1021/acs.jproteome.7b0051328959884 176.AbereB.WikanN.UbolS.AuewarakulP.PaemaneeA.KittisenachaiS.RoytrakulS.SmithD.R.Proteomic analysis of" exact="chikungunya" post="virus infected microgial cellsPLoS ONE20127e3480010.1371/journal.pone.003480022514668 177.WikanN.SakoonwatanyooP.UbolS.YoksanS.SmithD.R.Chikungunya virus infection of"/>
   <result pre="east, central and south African lineagePLoS ONE20127e3110210.1371/journal.pone.003110222299053 178.ChiamC.W.ChanY.F.OngK.C.WongK.T.SamI.C.Neurovirulence comparison of" exact="chikungunya" post="virus isolates of the Asian and East/Central/South African genotypes"/>
   <result pre="of viral neuroinvasion in the zebrafish reveals that Sindbis and" exact="chikungunya" post="viruses favour different entry routesDis. Model. Mech.20171084785710.1242/dmm.02923128483796 183.MahendradasP.AvadhaniK.ShettyR.Chikungunya and"/>
   <result pre="184.LinJ.ChenR.W.S.HazanA.WeissM.Chikungunya Virus Infection Manifesting as Intermediate UveitisOcul. Immunol. Inflamm.20182668068210.1080/09273948.2016.126334028010143 185.SalceanuS.O.RamanV.Recurrent" exact="chikungunya" post="retinitisBMJ Case Rep.2018201810.1136/bcr-2017-22286430150331 186.Ulloa-PadillaJ.P.DavilaP.J.IzquierdoN.J.Garcia-RodriguezO.JimenezI.Z.Ocular Symptoms and Signs of Chikungunya"/>
   <result pre="Fever in Puerto RicoP. R. Health Sci. J.201837838729905918 187.MahendradasP.ShettyR.MalathiJ.MadhavanH.N.Chikungunya virus" exact="iridocyclitis" post="in Fuchsâ€™ heterochromic iridocyclitisIndian J. Ophthalmol.20105854554710.4103/0301-4738.7170720952847 188.BabuK.MurthyG.Chikungunya virus iridocyclitis"/>
   <result pre="virus iridocyclitis in Fuchsâ€™ heterochromic iridocyclitisIndian J. Ophthalmol.20105854554710.4103/0301-4738.7170720952847 188.BabuK.MurthyG.Chikungunya virus" exact="iridocyclitis" post="in Fuchsâ€² heterochromic iridocyclitisIndian J. Ophthalmol.2012607310.4103/0301-4738.9049522218256 189.CoudercT.GangneuxN.ChrÃ©tienF.CaroV.Le LuongT.DuclouxB.TolouH.LecuitM.GrandadamM.Chikungunya virus"/>
   <result pre="and Not Purified in MosquitoesJ. Virol.2014888213822610.1128/JVI.01032-1424829346 191.ChuaH.H.RashidK.A.LawW.C.HamizahA.ChemY.K.KhairulA.H.ChuaK.B.A fatal case of" exact="chikungunya" post="virus infection with liver involvementMed. J. Malaysia201065838421265260 192.DavisJ.L.HodgeH.M.CampbellW.E.Growth of"/>
   <result pre="chikungunya virus infection with liver involvementMed. J. Malaysia201065838421265260 192.DavisJ.L.HodgeH.M.CampbellW.E.Growth of" exact="chikungunya" post="virus in baby hamster kidney cell (BHK-21-clone 13) suspension"/>
   <result pre="hamster kidney cell (BHK-21-clone 13) suspension culturesAppl. Microbiol.1971213383415549705 193.GardnerJ.RuddP.A.ProwN.A.BelarbiE.RoquesP.LarcherT.GreshL.BalmasedaA.HarrisE.SchroderW.A.et al.Infectious" exact="chikungunya" post="virus in the saliva of mice, monkeys and humansPLoS"/>
   <result pre="the diagnosis of emerging virusesBMC Infect. Dis.20181870710.1186/s12879-018-3611-x30594124 195.MussoD.TeissierA.RouaultE.TeururaiS.de PinaJ.-J.NhanT.-X.Detection of" exact="chikungunya" post="virus in saliva and urineVirol. J.20161310210.1186/s12985-016-0556-927306056 196.Contopoulos-IoannidisD.Newman-LindsayS.ChowC.LaBeaudA.D.Mother-to-child transmission of"/>
   <result pre="Chemother.201863e01389-1810.1128/AAC.01389-1830455237 210.FrancoE.J.RodriquezJ.L.PomeroyJ.J.HanrahanK.C.BrownA.N.The effectiveness of antiviral agents with broad-spectrum activity against" exact="chikungunya" post="virus varies between host cell linesAntivir. Chem. Chemother.20182620402066188075810.1177/204020661880758030354193 211.ChopraA.SalujaM.VenugopalanA.Effectiveness"/>
   <result pre="Arthritis Following Chikungunya Virus InfectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 212.de LamballerieX.NinoveL.CharrelR.N.Antiviral treatment of" exact="chikungunya" post="virus infectionInfect. Disord. Drug Targets2009910110410.2174/18715260978784771219275698 213.KhanM.SanthoshS.R.TiwariM.Lakshmana RaoP.V.ParidaM.Assessment of in"/>
   <result pre="of in vitro prophylactic and therapeutic efficacy of chloroquine against" exact="chikungunya" post="virus in vero cellsJ. Med. Virol.20108281782410.1002/jmv.2166320336760 214.RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de LamballerieX.et al.Paradoxical"/>
   <result pre="Virol.20108281782410.1002/jmv.2166320336760 214.RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de LamballerieX.et al.Paradoxical effect of chloroquine treatment in enhancing" exact="chikungunya" post="virus infectionViruses20181026810.3390/v10050268 215.SmithS.A.SilvaL.A.FoxJ.M.FlyakA.I.KoseN.SapparapuG.KhomandiakS.AshbrookA.W.KahleK.M.FongR.H.et al.Isolation and Characterization of Broad and"/>
   <result pre="mosquito-borne arbovirus controlPLoS Negl. Trop. Dis.201913e000682210.1371/journal.pntd.000682230605475 Figure 1 Sites of" exact="chikungunya" post="virus replication in the Aedes mosquito vector. Figure 2"/>
   <result pre="vector. Figure 2 Examples of tissue and cell tropism of" exact="chikungunya" post="virus. Chikungunya virus (CHIKV) infected cells in skin (A);"/>
   <result pre="viruses-11-00175-t001_Table 1Table 1 Reported natural vertebrate animal hosts of the" exact="chikungunya" post="virus. NHPsâ€&quot;non-human primates. World Region Species Common Name Method"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410223\results\search\disease\results.xml">
   <result pre="causing more than 700,000 deaths annually. Mosquito-transmitted viruses, such as" exact="yellow fever," post="dengue, West Nile, chikungunya, and Zika viruses, have re-emerged"/>
   <result pre="Humans have known about arboviruses since the 15th century when" exact="yellow fever" post="was first described as devastating the human populations in"/>
   <result pre="arboviruses that have caused recent epidemics are the flaviviruses, including" exact="yellow fever," post="dengue, West Nile, and Zika, and the Toga viruses,"/>
   <result pre="Control and Prevention (CDC) of the United States estimates that" exact="yellow fever" post="virus (YFV) causes 200,000 cases and 30,000 deaths globally"/>
   <result pre="Americas by 2014. Over half a million autochthonous and 3700" exact="microcephaly" post="cases had been reported by January 2018 according to"/>
   <result pre="as the enhanced likelihood of developing fever, joint pains, and" exact="rash" post="in those infected with CHIKV [25]. The SNP in"/>
   <result pre="Non-integrin (DC-SIGN)) promoter region could contribute to the pathogenesis of" exact="dengue hemorrhagic fever" post="(DHF) in Thai and Taiwanese populations [29,30]. The SNP"/>
   <result pre="in neural progenitor cells and promote apoptosis, possibly producing the" exact="microcephaly" post="and other pathologies seen in pregnant women during the"/>
   <result pre="of a number of flaviviruses including YFV, WNV, Japanese encephalitis," exact="tick-borne encephalitis," post="DENV, and ZIKV is secreted out of host cells"/>
   <result pre="1.BryantJ.E.HolmesE.C.BarrettA.D.Out of Africa: A molecular perspective on the introduction of" exact="yellow fever" post="virus into the AmericasPLoS Pathog.20073e7510.1371/journal.ppat.003007517511518 2.GublerD.J.Resurgent vector-borne diseases as"/>
   <result pre="February 2019) 4.BrentS.E.WattsA.CetronM.GermanM.KraemerM.U.BogochI.I.BradyO.J.HayS.I.CreatoreM.I.KhanK.International travel between global urban centres vulnerable to" exact="yellow fever" post="transmissionBull. World Health Organ.201896343354B10.2471/BLT.17.20565829875519 5.BhattS.GethingP.W.BradyO.J.MessinaJ.P.FarlowA.W.MoyesC.L.DrakeJ.M.BrownsteinJ.S.HoenA.G.SankohO.et al.The global distribution and"/>
   <result pre="Infect. Dis.20152122011202010.1093/infdis/jiv32126063222 25.DuttaS.K.TripathiA.Association of toll-like receptor polymorphisms with susceptibility to" exact="chikungunya" post="virus infectionVirology201751120721310.1016/j.virol.2017.08.00928888110 26.Xavier-CarvalhoC.GibsonG.BrasilP.FerreiraR.X.de Souza SantosR.Goncalves CruzO.de OliveiraS.A.de Sa CarvalhoM.PachecoA.G.KubelkaC.F.et"/>
   <result pre="Genet.20053750751310.1038/ng155015838506 30.WangL.ChenR.F.LiuJ.W.LeeI.K.LeeC.P.KuoH.C.HuangS.K.YangK.D.DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with" exact="dengue hemorrhagic fever" post="and correlated to DC-SIGN expression and immune augmentationPLoS Negl."/>
   <result pre="HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection," exact="dengue hemorrhagic fever" post="and dengue shock syndromePLoS Negl. Trop. Dis.20082e30418827882 40.LokeH.BethellD.B.PhuongC.X.DungM.SchneiderJ.WhiteN.J.DayN.P.FarrarJ.HillA.V.Strong HLA"/>
   <result pre="allele, a possible severity risk factor of hemorrhagic manifestation in" exact="dengue fever" post="patientsTissue Antigens20046446947210.1111/j.1399-0039.2004.00304.x15361124 49.SantosA.C.de MouraE.L.FerreiraJ.M.SantosB.R.AlvesV.M.de FariasK.F.de Souza FigueiredoE.V.Meta-Analysis of the"/>
   <result pre="nonstructural protein NS1 is a dimerVirology198816218719610.1016/0042-6822(88)90408-42827377 73.PostP.R.CarvalhoR.GallerR.Glycosylation and secretion of" exact="yellow fever" post="virus nonstructural protein NS1Virus Res.19911829130210.1016/0168-1702(91)90025-Q1828321 74.FanW.F.MasonP.W.Membrane association and secretion"/>
   <result pre="protein NS1Virus Res.19911829130210.1016/0168-1702(91)90025-Q1828321 74.FanW.F.MasonP.W.Membrane association and secretion of the Japanese" exact="encephalitis" post="virus NS1 protein from cells expressing NS1 cDNAVirology199017747047610.1016/0042-6822(90)90511-O2142554 75.CrooksA.J.LeeJ.M.EasterbrookL.M.TimofeevA.V.StephensonJ.R.The"/>
   <result pre="protein from cells expressing NS1 cDNAVirology199017747047610.1016/0042-6822(90)90511-O2142554 75.CrooksA.J.LeeJ.M.EasterbrookL.M.TimofeevA.V.StephensonJ.R.The NS1 protein of" exact="tick-borne encephalitis" post="virus forms multimeric species upon secretion from the host"/>
   <result pre="from cells expressing NS1 cDNAVirology199017747047610.1016/0042-6822(90)90511-O2142554 75.CrooksA.J.LeeJ.M.EasterbrookL.M.TimofeevA.V.StephensonJ.R.The NS1 protein of tick-borne" exact="encephalitis" post="virus forms multimeric species upon secretion from the host"/>
   <result pre="in Rio de Janeiro, BrazilPLoS Curr.2017910.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727 82.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.C.LavenirR.PardigonN.ReynesJ.M.PettinelliF.et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 83.NiyasK.P.AbrahamR.UnnikrishnanR.N.MathewT.NairS.ManakkadanA.IssacA.SreekumarE.Molecular characterization"/>
   <result pre="larvae from Kerala, South IndiaVirol. J.2010718910.1186/1743-422X-7-18920704755 84.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 85.BraultA.C.HuangC.Y.LangevinS.A.KinneyR.M.BowenR.A.RameyW.N.PanellaN.A.HolmesE.C.PowersA.M.MillerB.R.A"/>
   <result pre="DSS [51] Phospholipase PLCE1 Increased risk for DSS [52,53] DHF:" exact="dengue hemorrhagic fever," post="DSS: dengue shock syndrome, UTR: untranslated region, *: Locus"/>
   <result pre="[71] NS1/A188V Enhanced NS1 secretability in the host blood, immune" exact="suppression" post="in mosquitoes [78] CHIKV E1/K211T Increased fitness in Ae."/>
   <result pre="in Culex spp. mosquitoes [86,87] sfRNA: subgenomic flaviviral RNA, DHF:" exact="dengue hemorrhagic fever," post="E: envelope, NS: nonstructural, UTR: untranslated genomic region."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6430813\results\search\disease\results.xml">
   <result pre="Several neurological complications, such as Guillain-BarrÃ© syndrome in adults4, and" exact="microcephaly" post="in neonates5, are associated with ZIKV infection. As a"/>
   <result pre="to ZIKV, the RNA of other flaviviruses, such as DENV26,42," exact="yellow fever" post="virus43, and West Nile viruses (WNV)44 have also been"/>
   <result pre="Zika virus in the cerebrospinal fluid of 30 neonates with" exact="microcephaly" post="in BrazilLancet20163871811181210.1016/S0140-6736(16)30253-7 6.BuenoMGMartinezNAbdallaLDuarteDSCChameMAnimals in the Zika virus life cycle:"/>
   <result pre="cultured in SIRC cells from a patient suspected of having" exact="rubella" post="virusRev. Inst. Med. Trop. Sao Paulo201860e1529557985 18.FonsecaKet al.First case"/>
   <result pre="Nov 2018. 31.HeinzFXet al.Structural changes and functional control of the" exact="tick-borne encephalitis" post="virus glycoprotein E by the heterodimeric association with protein"/>
   <result pre="2018. 31.HeinzFXet al.Structural changes and functional control of the tick-borne" exact="encephalitis" post="virus glycoprotein E by the heterodimeric association with protein"/>
   <result pre="in plasmaTrans. R. Soc. Trop. Med. Hyg.200710173873910.1016/j.trstmh.2007.02.00717418320 43.DomingoCet al.Detection of" exact="yellow fever" post="17D genome in urineJ. Clin. Microbiol.20114976076210.1128/JCM.01775-1021106799 44.TonryJHet al.West Nile"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6443840\results\search\disease\results.xml">
   <result pre="Host-Pathogen Interactions During Arboviral Infections West Nile virus dengue virus" exact="chikungunya" post="virus tick-borne encephalitis virus Japanese encephalitis virus Zika virus"/>
   <result pre="During Arboviral Infections West Nile virus dengue virus chikungunya virus" exact="tick-borne encephalitis" post="virus Japanese encephalitis virus Zika virus systems biology immunity"/>
   <result pre="Arboviral Infections West Nile virus dengue virus chikungunya virus tick-borne" exact="encephalitis" post="virus Japanese encephalitis virus Zika virus systems biology immunity"/>
   <result pre="Nile virus dengue virus chikungunya virus tick-borne encephalitis virus Japanese" exact="encephalitis" post="virus Zika virus systems biology immunity fig-count: table-count: equation-count:"/>
   <result pre="(e.g., Bluetongue virus), Orthomyxoviridae (e.g., Bourbon virus), Rhabdoviridae (e.g., vesicular" exact="stomatitis" post="virus), Togaviridae (e.g., equine encephalitis and chikungunya viruses), or"/>
   <result pre="Bourbon virus), Rhabdoviridae (e.g., vesicular stomatitis virus), Togaviridae (e.g., equine" exact="encephalitis" post="and chikungunya viruses), or Flaviviridae (e.g., tick-borne encephalitis, dengue,"/>
   <result pre="Rhabdoviridae (e.g., vesicular stomatitis virus), Togaviridae (e.g., equine encephalitis and" exact="chikungunya" post="viruses), or Flaviviridae (e.g., tick-borne encephalitis, dengue, Japanese encephalitis,"/>
   <result pre="Togaviridae (e.g., equine encephalitis and chikungunya viruses), or Flaviviridae (e.g.," exact="tick-borne encephalitis," post="dengue, Japanese encephalitis, West Nile, Zika, and yellow fever"/>
   <result pre="(e.g., tick-borne encephalitis, dengue, Japanese encephalitis, West Nile, Zika, and" exact="yellow fever" post="viruses) (Hanley and Weaver, 2008). Flaviviruses pose a major"/>
   <result pre="for any flavivirus and no approved vaccines other than for" exact="yellow fever" post="and Japanese encephalitis viruses, indicating an unmet need in"/>
   <result pre="no approved vaccines other than for yellow fever and Japanese" exact="encephalitis" post="viruses, indicating an unmet need in medicine. Moreover, diabetic"/>
   <result pre="humans are often neurotropic and can cause acute neuroinflammation or" exact="tick-borne encephalitis" post="(TBE) disease. Cases of TBE are highest in the"/>
   <result pre="are often neurotropic and can cause acute neuroinflammation or tick-borne" exact="encephalitis" post="(TBE) disease. Cases of TBE are highest in the"/>
   <result pre="(CHK2), which regulates the cell cycle, is activated during Japanese" exact="encephalitis" post="virus (JEV) infection to aid in its replication. As"/>
   <result pre="including new vaccines and monoclonal antibodies, to diagnose and combat" exact="viral disease." post="With regard to cellular markers and tropism of flaviviral"/>
   <result pre="other flaviviral infections, particularly DENV, with which ZIKV co-circulates, or" exact="yellow fever" post="virus, for which there is a vaccine, could facilitate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6445942\results\search\disease\results.xml">
   <result pre="Creative Commons Attribution 4.0 International license.mBio.00521-19.pdf Since 2014, acute flaccid" exact="myelitis" post="(AFM), a long-recognized condition associated with polioviruses, nonpolio enteroviruses,"/>
   <result pre="aspect of AFM reemergence. Abstract ABSTRACT Since 2014, acute flaccid" exact="myelitis" post="(AFM), a long-recognized condition associated with polioviruses, nonpolio enteroviruses,"/>
   <result pre="that the AFM epidemic offers important clues to mechanisms of" exact="viral disease" post="emergence. KEYWORDS acute flaccid myelitis emerging diseases enterovirus neurology"/>
   <result pre="clues to mechanisms of viral disease emergence. KEYWORDS acute flaccid" exact="myelitis" post="emerging diseases enterovirus neurology fig-count: table-count: equation-count: ref-count: page-count:"/>
   <result pre="In recent decades, new human infectious diseases such as HIV/AIDS," exact="severe acute respiratory syndrome" post="(SARS), and Nipah virus infection, among others have emerged."/>
   <result pre="and natural disasters (e.g., cholera), and viral evolution (e.g., poultry-adapted" exact="influenza" post="A H5N1 and H7N9) (1). Joining this list is"/>
   <result pre="and H7N9) (1). Joining this list is epidemic acute flaccid" exact="myelitis" post="(AFM), characterized by sudden denervation-associated muscle paralysis of healthy"/>
   <result pre="(and occasionally adults) in one or more limbs that mimics" exact="poliomyelitis" post="but which is not caused by polioviruses (2). AFM"/>
   <result pre="of acute flaccid paralysis (AFP) (9, 10), in which cord" exact="myelitis" post="is documented, typically by magnetic resonance imaging (MRI) visualization"/>
   <result pre="endemically and epidemically every late summer/fall, causing localized outbreaks of" exact="aseptic meningitis" post="and other conditions. Although immunity to NPEVs is near-universal"/>
   <result pre="and epidemically every late summer/fall, causing localized outbreaks of aseptic" exact="meningitis" post="and other conditions. Although immunity to NPEVs is near-universal"/>
   <result pre="can sufficiently dilute it. Such patterns were well described for" exact="measles" post="and other childhood diseases in the prevaccine era. NPEVs,"/>
   <result pre="that had been reemerging globally since 2008 to cause pandemic" exact="respiratory disease" post="(16, 21). The reemergence of EV-D68 was itself unprecedented."/>
   <result pre="The reemergence of EV-D68 was itself unprecedented. Although acute hemorrhagic" exact="conjunctivitis" post="associated with EVA24v and with EV-D70 had caused global"/>
   <result pre="associated with cases of cranial nerve paralysis, bulbar paralysis, and" exact="meningoencephalitis" post="(3, 20). Once viral damage to gray matter has"/>
   <result pre="LanciottiR, NixWA, SakthivelSK, SchmidDS, SewardJF, TongS, ObersteMS, PallanschM, FeikinD2016Acute flaccid" exact="myelitis" post="in the United States, August-December 2014: results of nationwide"/>
   <result pre="SamI-C, RampalS, WanNorAmalinaW, NurAtifahG, VerasahibK, OngCC, MohdAdibM, ChanYF2016Cyclical patterns of" exact="hand, foot and mouth disease" post="caused by enterovirus A71 in Malaysia. PLoS Negl Trop"/>
   <result pre="NurAtifahG, VerasahibK, OngCC, MohdAdibM, ChanYF2016Cyclical patterns of hand, foot and" exact="mouth disease" post="caused by enterovirus A71 in Malaysia. PLoS Negl Trop"/>
   <result pre="PadillaT, StroberJB, AldrovandiG, WadfordDA, ChiuCY, XiaD, HarrimanK, WattJP, GlaserCA2015Acute flaccid" exact="myelitis" post="of unknown etiology in California, 2012-2015. JAMA314:2663â€&quot;2671. doi:10.1001/jama.2015.17275.26720027 20.GreningerAL,"/>
   <result pre="ChiuCY2015A novel outbreak enterovirus D68 strain associated with acute flaccid" exact="myelitis" post="cases in the USA (2012â€&quot;14): a retrospective cohort study."/>
   <result pre="40.EvansWJ, HurstBL, PetersonCJ, van WettereAJ, DayCW, SmeeDF, TarbetEB2019Development of a" exact="respiratory disease" post="model for enterovirus D68 in 4-week old mice for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6456646\results\search\disease\results.xml">
   <result pre="comply with these terms. Abstract Human immunodeficiency virus (HIV)-1 and" exact="hepatitis" post="C virus (HCV) are major contributors to the global"/>
   <result pre="recombinant DNA represents a feasible therapeutic intervention to even cure" exact="cervical cancer," post="highlighting the potential of using DNA for human vaccinations."/>
   <result pre="of an efficacious vaccine against these viral infections. DNA vaccine" exact="hepatitis" post="C human immunodeficiency virus HIV/AIDS HCV tissue-resident memory T"/>
   <result pre="equation-count: ref-count: page-count: word-count: Introduction Human immunodeficiency virus (HIV)-1 and" exact="hepatitis" post="C virus (HCV) are significant contributors to the global"/>
   <result pre="virus that primarily infects and replicates in hepatocytes. In primary" exact="hepatitis" post="C infection, ~25% of patients naturally clear the virus"/>
   <result pre="vaccine has been tested for therapeutic vaccination against HCV. 12" exact="hepatitis" post="C patients suffering from chronic disease received three doses"/>
   <result pre="the future given the success of using DAA to cure" exact="hepatitis" post="C patients. DNA vaccines against HIV-1 have been tested"/>
   <result pre="I and II clinical trials especially in the context of" exact="cancer" post="(Kim et al., 2014; Trimble et al., 2015). However,"/>
   <result pre="10.1371/journal.ppat.100531526745376 BaileyJ. R.BarnesE.CoxA. L. (2019). Approaches, progress, and challenges to" exact="hepatitis" post="C vaccine development. Gastroenterology156, 418â€&quot;4430. 10.1053/j.gastro.2018.08.06030268785 BaileyJ. R.FlyakA. I.CohenV."/>
   <result pre="al.. (2017). Broadly neutralizing antibodies with few somatic mutations and" exact="hepatitis" post="C virus clearance. JCI Insight2:e92872. 10.1172/jci.insight.9287228469084 BakariM.AboudS.NilssonC.FrancisJ.BumaD.MoshiroC.et al.. (2011)."/>
   <result pre="Lancet392, 232â€&quot;243. 10.1016/S0140-6736(18)31364-330047376 BaumertT. F.FauvelleC.ChenD. Y.LauerG. M. (2014). A prophylactic" exact="hepatitis" post="C virus vaccine: a distant peak still worth climbing."/>
   <result pre="M.HedskogC.ParhyB.HylandR. H.StammL. M.BrainardD. M.et al.. (2018). Identification of a novel" exact="hepatitis" post="C virus genotype from Punjab, India: expanding classification of"/>
   <result pre="hepatitis C virus genotype from Punjab, India: expanding classification of" exact="hepatitis" post="C virus into 8 genotypes. J. Infect. Dis.218, 1722â€&quot;1729."/>
   <result pre="al.. (2011). Sequential bottlenecks drive viral evolution in early acute" exact="hepatitis" post="C virus infection. PLoS Pathog.7:e1002243. 10.1371/journal.ppat.100224321912520 BurtonD. R.HangartnerL. (2016)."/>
   <result pre="1467â€&quot;1479. 10.1002/ijc.3116629159802 CuburuN.WangK.GoodmanK. N.PangY. Y.ThompsonC. D.LowyD. R.et al.. (2015). Topical" exact="herpes simplex" post="virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing"/>
   <result pre="EpsteinJ. E.TewariK.LykeK. E.SimB. K.BillingsleyP. F.LaurensM. B.et al.. (2011). Live attenuated" exact="malaria" post="vaccine designed to protect through hepatic CD8(+) T cell"/>
   <result pre="Liver-resident memory CD8(+) T cells form a front-line defense against" exact="malaria" post="liver-stage infection. Immunity45, 889â€&quot;902. 10.1016/j.immuni.2016.08.01127692609 FerraroB.MorrowM. P.HutnickN. A.ShinT. H.LuckeC."/>
   <result pre="nonlymphoid tissue that provide enhanced local immunity during infection with" exact="herpes simplex" post="virus. Nat. Immunol.10, 524â€&quot;530. 10.1038/ni.171819305395 collab: German Advisory Committee"/>
   <result pre="M.et al.. (2018). Prime and target immunization protects against liver-stage" exact="malaria" post="in mice. Sci. Transl. Med.10:eaap9128. 10.1126/scitranslmed.aap912830257955 GrebelyJ.PrinsM.HellardM.CoxA. L.OsburnW. O.LauerG.et"/>
   <result pre="J.et al.. (2015). A multiantigenic DNA vaccine that induces broad" exact="hepatitis" post="C virus-specific T-cell responses in mice. J. Virol.89, 7991â€&quot;8002."/>
   <result pre="region vaccines vectored by plasmid DNA, simian adenovirus and modified" exact="vaccinia virus" post="ankara administered to human immunodeficiency virus type 1-uninfected adults"/>
   <result pre="HoughtonM. (2011). Prospects for prophylactic and therapeutic vaccines against the" exact="hepatitis" post="C viruses. Immunol. Rev.239, 99â€&quot;108. 10.1111/j.1600-065X.2010.00977.x21198667 IshizukaA. S.LykeK. E.DeZureA.BerryA."/>
   <result pre="IshizukaA. S.LykeK. E.DeZureA.BerryA. A.RichieT. L.MendozaF. H.et al. (2016). Protection against" exact="malaria" post="at 1 year and immune correlates following PfSPZ vaccination."/>
   <result pre="antigen-specific immunity. Vaccine15, 1049â€&quot;1056.9269046 OlsenT. M.StoneB. C.ChuenchobV.MurphyS. C. (2018). Prime-and-Trap" exact="malaria" post="vaccination to generate protective CD8(+) liver-resident memory T cells."/>
   <result pre="OsburnW. O.SniderA. E.WellsB. L.LatanichR.BaileyJ. R.ThomasD. L.et al.. (2014). Clearance of" exact="hepatitis" post="C infection is associated with the early appearance of"/>
   <result pre="A.KlarquistJ.PalmerB. E.PawlotskyJ. M.Golden-MasonL.et al.. (2008). Spontaneous recovery in acute human" exact="hepatitis" post="C virus infection: functional T-cell thresholds and relative importance"/>
   <result pre="10.1128/jvi.01581-0718045940 StoneJ.MartinN. K.HickmanM.HellardM.ScottN.McBrydeE.et al.. (2016). The potential impact of a" exact="hepatitis" post="C vaccine for people who inject drugs: is a"/>
   <result pre="standard of care therapy in patients with genotype 1 chronic" exact="hepatitis" post="C. Mol. Ther.21, 1796â€&quot;1805. 10.1038/mt.2013.11923752314 collab: WHO (2017). Global"/>
   <result pre="2018). WijesundaraD. K.GummowJ.LiY.YuW.QuahB. J.RanasingheC.et al.. (2018). Induction of genotype cross-reactive," exact="hepatitis" post="C virus-specific, cell-mediated immunity in DNA-vaccinated mice. J. Virol.92:e02133-17."/>
   <result pre="(2014). A novel challenge model to evaluate the efficacy of" exact="hepatitis" post="C virus vaccines in mice. Vaccine32, 3409â€&quot;3416. 10.1016/j.vaccine.2014.04.01424742491 ZhangX."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6463034\results\search\disease\results.xml">
   <result pre="in 2015 in Brazil mainly due to its association with" exact="microcephaly" post="in newborns. Although most infections in adults are asymptomatic"/>
   <result pre="persist in the male genital tract, which could lead to" exact="infertility" post="[4]. After its explosion in Brazil, the virus rapidly"/>
   <result pre="combining clinical findings, animal, organoid, and cell culture results, ZIKV-induced" exact="microcephaly" post="was found to be the result of the marked"/>
   <result pre="thus reducing brain size. In addition to this â€œdirect effectâ€�," exact="placental insufficiency" post="and inflammatory responses during the infection would also contribute"/>
   <result pre="with vaccination for the control of other flaviviral diseases like" exact="yellow fever," post="Japanese encephalitis, or tick-borne-encephalitis invite optimism. However, the experience"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6465516\results\search\disease\results.xml">
   <result pre="and North America. In Brazil, during ZIKV outbreak thousands of" exact="microcephaly" post="cases occurred that caused a state of urgency among"/>
   <result pre="The evidences supporting the association of ZIKV infection with congenital" exact="microcephaly" post="and fetal brain tissue damage is rapidly increasing, and"/>
   <result pre="mechanism of ZIKV infection causing microcephaly. Zika virus emerging infection" exact="microcephaly" post="neurological disorders public health fig-count: table-count: equation-count: ref-count: page-count:"/>
   <result pre="a mosquito-borne, single-stranded RNA, flavivirus that is closely related to" exact="yellow fever" post="virus (YFV), Japanese encephalitis virus (JEV) and dengue virus"/>
   <result pre="that is closely related to yellow fever virus (YFV), Japanese" exact="encephalitis" post="virus (JEV) and dengue virus (DENV). It can adapt"/>
   <result pre="ambiguities in previously reported data (9), the ZIKV association with" exact="microcephaly" post="was considered ambiguous. However, the World Health Organization situation"/>
   <result pre="genuine facts that ZIKV infection is the cause of congenital" exact="microcephaly" post="(11). Figure 1 Zika virus infection is transmitted to"/>
   <result pre="emerged as a profoundly important public health concern when congenital" exact="microcephaly" post="and other fetal/neonatal abnormalities were recorded in infected pregnant"/>
   <result pre="fetal/neonatal abnormalities were recorded in infected pregnant women (12). Congenital" exact="microcephaly" post="is a rarely occurring neurological birth defect, characterized by"/>
   <result pre="there is no universally accepted and uniform diagnostic standard of" exact="microcephaly" post="(15). The possible etiologies may include environmental or genetic"/>
   <result pre="other prenatal viral infections e.g., cytomegalovirus, syphilis, rubella, herpesvirus, and" exact="toxoplasmosis" post="(TORCHES) (7). Intriguingly, it was not included in the"/>
   <result pre="microorganisms until 2015 (7, 16). The number of suspected congenital" exact="microcephaly" post="cases associated with ZIKV in Brazil had increased to"/>
   <result pre="of International Concern (PHEIC) on February 2016, when recorded congenital" exact="microcephaly" post="cases soared up in the geographically widespread ZIKV epidemic"/>
   <result pre="and Puerto Rico. In USA, the first ZIKV associated congenital" exact="microcephaly" post="case was reported in Hawaii, in 2016 (21). Due"/>
   <result pre="as happened in the Yap Island. Its potential association with" exact="microcephaly" post="has been reported in the French Polynesia, Brazil, America,"/>
   <result pre="From 2014-15, Brazil reported multiple cases of illness and skin" exact="rash" post="to the World Health Organization (WHO), occurring in the"/>
   <result pre="In these states (February to April 2015), around 7,000 skin" exact="rash" post="cases were reported but no identification tests were performed"/>
   <result pre="and November 2015. It caused a 20-fold increase in the" exact="microcephaly" post="cases in Brazil, whereas, around 1,248 new suspected cases"/>
   <result pre="(11). In the Brazilian state, Bahia, multiple cases of acute" exact="rash" post="were followed by increased number of microcephalic fetuses (13),"/>
   <result pre="average of 163 (5.6 per 100,000 live birth) cases of" exact="microcephaly" post="occurred annually before 2015 ZIKA epidemic in Brazil, while"/>
   <result pre="while 3,530 (121.7 per 100,000 live births) suspected cases of" exact="microcephaly" post="were reported in 2015, including 46 death cases (16)."/>
   <result pre="damage to cerebral tissue (12). Here we discussed ZIKV related" exact="microcephaly" post="clinical manifestations to better understand the outcomes of this"/>
   <result pre="reported that 8 out of 19 identified cases had severe" exact="microcephaly" post="with major brain lesions, five had visible malformations and"/>
   <result pre="placental barrier (27). Cauchemez et al. calculated the risk of" exact="microcephaly" post="during ZIKV outbreak in French Polynesian outbreak (Sept, 2013,"/>
   <result pre="by authors (28). While another report presented 22% risk of" exact="microcephaly" post="during first trimester. Similarly, a more recent cohort study"/>
   <result pre="case report, HC declined from 47th to 24th percentile without" exact="microcephaly" post="and intracranial calcifications (15). The infant's cerebrospinal fluid sample"/>
   <result pre="to understand and explain the cellular and molecular basis of" exact="microcephaly" post="development, level of selective neurotropism (25), spectrum of changes"/>
   <result pre="fetal brain. Dang et al. (41) investigated the ZIKV and" exact="microcephaly" post="relationship by using cerebral organoids derived human embryonic stem"/>
   <result pre="disrupt neurogenetic pathways, affects apoptosis, and plays crucial role in" exact="microcephaly" post="(41). Garcez et al. (42) used human-induced pluripotent stem"/>
   <result pre="model derived from human-induced pluripotent stem cells, which resulted in" exact="microcephaly" post="like symptoms, such as increased cell death, decline in"/>
   <result pre="ZIKV Related Studies Despite the evidences supporting ZIKV association with" exact="microcephaly" post="and neonatal/fetal brain congenital abnormalities, scientists from different backgrounds"/>
   <result pre="abnormalities, scientists from different backgrounds suggest that clinical symptoms of" exact="microcephaly" post="are shared by various other congenital infections (e.g., cytomegalovirus),"/>
   <result pre="congenital infections (e.g., cytomegalovirus), and arboviruses that can potentially cause" exact="microcephaly" post="(31, 46). Furthermore, approximately 80% of ZIKV infected patients"/>
   <result pre="this hypothesis is considered true the ratio of ZIKV related" exact="microcephaly" post="cases are still ambiguous (1). An American reported case"/>
   <result pre="pregnancy has the highest risk of laboratory-confirmed ZIKV transmission and" exact="microcephaly" post="as compared to 2nd and 3rd trimesters that have"/>
   <result pre="study conducted by Cauchemez et al. estimated 1% risk of" exact="microcephaly" post="to the fetuses/neonates, as discussed earlier, has provided crucial"/>
   <result pre="status directly that may add to a false diagnosis of" exact="microcephaly" post="as malnutrition and can negatively impact fetal growth and"/>
   <result pre="circumference (1, 5, 48). In Brazil, the diagnostic standard of" exact="microcephaly" post="after December 2015 illustrating results with more specificity and"/>
   <result pre="specificity and sensitivity, pondered a question about the prevalence of" exact="microcephaly" post="during 2015 (about 20 cases/10,000 births) as compared to"/>
   <result pre="and post-diagnosis follow-up is cautious and necessary for correctly diagnosing" exact="microcephaly" post="ascribed to ZIKV because incorrect diagnosis may exaggerate, limit"/>
   <result pre="out other viral infections to confirm the ZIKV link with" exact="microcephaly" post="is quite important (32), as during previous ZIKV epidemic"/>
   <result pre="diseases (11, 47), for instance, West Nile virus (WNV), Japanese" exact="encephalitis" post="viruses, Dengue virus (DENV) and the yellow fever virus"/>
   <result pre="virus (WNV), Japanese encephalitis viruses, Dengue virus (DENV) and the" exact="yellow fever" post="virus (46) that are genetically similar to ZIKV. ZIKV"/>
   <result pre="can only be used in predicting the course of a" exact="microcephaly" post="outbreak (46). ZIKV epidemic in Cape Verde (2015â€&quot;2016), probably"/>
   <result pre="mosquitoes, resulted in thousands of infection cases without causing any" exact="neurological disorder" post="(20). Calvet et al. report on ZIKV genomic RNA"/>
   <result pre="broad range of time interval (average, 13 weeks) since fetal" exact="microcephaly" post="was first diagnosed, and maternal clinical symptoms appeared. In"/>
   <result pre="ZIKV epidemic could predict profound increase in the number of" exact="microcephaly" post="cases, almost 5â€&quot;10 months later. During this time maternal"/>
   <result pre="it is inappropriate to predict the total expected number of" exact="microcephaly" post="cases in Brazil and in the rest of the"/>
   <result pre="control group of these limited number of samples had a" exact="rash" post="like symptoms during pregnancy, but the cause of rash"/>
   <result pre="a rash like symptoms during pregnancy, but the cause of" exact="rash" post="was not analyzed or diagnosed clearly (39). Moreover, it"/>
   <result pre="both mouse and human neural progenitor cells (NPCs), resulting in" exact="microcephaly" post="in the mouse fetus, and higher mortality in neonatal"/>
   <result pre="more infectious to human NPCs, by contributing to the increased" exact="microcephaly" post="rate in recent ZIKV epidemics (53). Is it possible"/>
   <result pre="reason of neurotropism. Although evidences are supporting ZIKV relationship with" exact="microcephaly" post="and other brain injuries, yet information about its epidemiology,"/>
   <result pre="than dengue neutralizing antibody can be a useful approach. Other" exact="arthritis" post="causing infections causing such as, CHIKV, DENV, malaria, Rubella,"/>
   <result pre="and go through follow-up cohorts and calculate potential risk of" exact="microcephaly" post="throughout women pregnancy, along with proper investigation of materno-fetal"/>
   <result pre="surface groups that can be potentially used against sexually transmitted" exact="herpes simplex" post="virus (HSV), human immunodeficiency virus (HIV), and human papillomavirus"/>
   <result pre="and virosomal (liposome) vaccine is used for the treatment of" exact="influenza" post="and hepatitis A virus (HAV) (69â€&quot;71). Similarly, another therapeutic"/>
   <result pre="(liposome) vaccine is used for the treatment of influenza and" exact="hepatitis" post="A virus (HAV) (69â€&quot;71). Similarly, another therapeutic vaccine for"/>
   <result pre="(72). Another example is use of wet lipid nanoparticles against" exact="hepatitis" post="B virus (HBV) that target 3 sites on the"/>
   <result pre="ZIKV. Conclusions Apart West Nile virus (78), thousands of congenital" exact="microcephaly" post="cases, fetal brain tissue damage and neurological syndromes have"/>
   <result pre="a relative stable virus is on a rise. Although congenital" exact="microcephaly" post="is a rare disorder however, due to lack of"/>
   <result pre="XimenesRAde Barros Miranda-FilhoDMontarroyosURde MeloAPLet al.Association between Zika virus infection and" exact="microcephaly" post="in Brazil, January to May, 2016: preliminary report of"/>
   <result pre="(2016) 16:2576â€&quot;92. 10.1016/j.celrep.2016.08.03827568284 CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.. Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013â€&quot;15: a retrospective study. Lancet. (2016)"/>
   <result pre="47:6â€&quot;7. 10.1002/uog.1583126731034 AshwalSMichelsonDPlawnerLDobynsWB. Practice parameter: evaluation of the child with" exact="microcephaly" post="(an evidence-based review) report of the quality standards Subcommittee"/>
   <result pre="Zika virus infection is neurotropic in fetuses and infants with" exact="microcephaly" post="following transplacental transmission. Arch Pathol Lab Med. (2016) 141:68â€&quot;72."/>
   <result pre="Cavalcanti Souza CruzDTenorioMvan der LindenAPenaLJet al.. Computed tomographic findings in" exact="microcephaly" post="associated with Zika virus. N Engl J Med. (2016)"/>
   <result pre="Zika virus infection and stillbirths: a case of hydrops fetalis," exact="hydranencephaly" post="and fetal demise. PLoS Negl Trop Dis. (2016) 10:e0004517."/>
   <result pre="LiCXuDYeQHongSJiangYLiuXet al.Zika virus disrupts neural progenitor development and leads to" exact="microcephaly" post="in mice. Cell Stem Cell. (2016) 19:120â€&quot;6. 10.1016/j.stem.2016.04.01727179424 TangHHammackCOgdenSCWenZQianXLiYet"/>
   <result pre="113:14408â€&quot;14413. 10.1073/pnas.161802911327911847 TeixeiraMGCosta MdaCde OliveiraWKNunesMLRodriguesLC. The epidemic of Zika virusâ€&quot;related" exact="microcephaly" post="in Brazil: detection, control, etiology, and future scenarios. Am"/>
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: a case study. Lancet Infect Dis. (2016)"/>
   <result pre="Variation of the specificity of the human antibody responses after" exact="tick-borne encephalitis" post="virus infection and vaccination. J Virol. (2014) 88:13845â€&quot;57. 10.1128/JVI.02086-1425253341"/>
   <result pre="of the specificity of the human antibody responses after tick-borne" exact="encephalitis" post="virus infection and vaccination. J Virol. (2014) 88:13845â€&quot;57. 10.1128/JVI.02086-1425253341"/>
   <result pre="(2016) 2016:2405954. 10.1155/2016/240595428053975 KimKY. Nanotechnology platforms and physiological challenges for" exact="cancer" post="therapeutics. Nanomedicine. (2007) 3:103â€&quot;10. 10.1016/j.nano.2006.12.00217442621 IslanGADurÃ¡nMCacicedoMLNakazatoGKobayashiRKTMartinezDSTet al.. Nanopharmaceuticals as"/>
   <result pre="Release. (2017) 252:28â€&quot;49. 10.1016/j.jconrel.2017.03.00828279798 BovierPAEpaxalÂ®: a virosomal vaccine to prevent" exact="hepatitis" post="A infection. Expert Rev Vaccines. (2008) 7:1141â€&quot;50. 10.1586/14760584.7.8.114118844588 HerzogEByrneHJDavorenMCaseyADuschlAOostinghGJ."/>
   <result pre="SetoW-KHuiAJWongVW-SWongGL-HLiuKS-HLaiC-Let al.. Treatment cessation of entecavir in Asian patients with" exact="hepatitis" post="B e antigen negative chronic hepatitis B: a multicentre"/>
   <result pre="in Asian patients with hepatitis B e antigen negative chronic" exact="hepatitis" post="B: a multicentre prospective study. Gut. (2015) 64:667â€&quot;72. 10.1136/gutjnl-2014-30723724833635"/>
   <result pre="multicentre prospective study. Gut. (2015) 64:667â€&quot;72. 10.1136/gutjnl-2014-30723724833635 SetoW-KWongD-HChanT-YHwangY-YFungJLiuKS-Het al.Association of" exact="hepatitis" post="B core-related antigen with hepatitis B virus reactivation in"/>
   <result pre="64:667â€&quot;72. 10.1136/gutjnl-2014-30723724833635 SetoW-KWongD-HChanT-YHwangY-YFungJLiuKS-Het al.Association of hepatitis B core-related antigen with" exact="hepatitis" post="B virus reactivation in occult viral carriers undergoing high-risk"/>
   <result pre="Changes of HBsAg and HBV DNA levels in Chinese chronic" exact="hepatitis" post="B patients after 5 years of entecavir treatment. J"/>
   <result pre="active-controlled trial. Lancet. (2011) 378:238â€&quot;46. 10.1016/S0140-6736(11)60936-721763936 SavastaSRovidaFFoiadelliTCampanaAMPercivalleEMarsegliaGLet al.. West-Nile virus" exact="encephalitis" post="in an immunocompetent pediatric patient: successful recovery. Ital J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466003\results\search\disease\results.xml">
   <result pre="is important to understand the role of meteorological factors in" exact="influenza" post="virus (IV) epidemics. In this study, we investigated the"/>
   <result pre="surveillance and promote development of accurate predictive models for future" exact="influenza" post="outbreaks in the region. influenza epidemics weather temperature UV"/>
   <result pre="accurate predictive models for future influenza outbreaks in the region." exact="influenza" post="epidemics weather temperature UV 1. Introduction Influenza A (H1N1"/>
   <result pre="also been suggested to have an influence on the seasonal" exact="influenza" post="epidemics in temperate climates [12,13]. In fact, temperature, humidity,"/>
   <result pre="(genetic and social) may be valuable indicators to include in" exact="influenza" post="surveillance for accurate prediction of future influenza outbreaks in"/>
   <result pre="to include in influenza surveillance for accurate prediction of future" exact="influenza" post="outbreaks in different climate zones. In this study, we"/>
   <result pre="highlighted an important role of temperature and UV index in" exact="influenza" post="epidemics in Northern Europe. 2. Materials and Methods 2.1."/>
   <result pre="2.1. The â€œNorthernFluâ€� Consortium To better understand the etiology of" exact="influenza" post="epidemics in Norway, Sweden, Finland, Estonia, Latvia and Lithuania"/>
   <result pre="Data Collection Weekly statistics of the specimensâ€™ number positive for" exact="influenza" post="across six analyzed countries were collected from the World"/>
   <result pre="Global Influenza Surveillance and Response System (GISRS) and other national" exact="influenza" post="reference laboratories collaborating actively with GISRS, or were uploaded"/>
   <result pre="The FluNet database provided weekly statistics of specimens positive for" exact="influenza" post="viruses, whereas meteorological factor data were measured daily. Therefore,"/>
   <result pre="order to investigate the potential relationship between meteorological factors and" exact="influenza" post="activity (number of IV positive specimens) in all analyzed"/>
   <result pre="The Pearson correlation coefficient (r) between each meteorological factor and" exact="influenza" post="activity was calculated using the â€œstatsâ€� R package with"/>
   <result pre="was optimized to find the most predictive meteorological factors of" exact="influenza" post="activity. More specifically, for each country, the time-series measurements"/>
   <result pre="media was replaced with fresh GM-CSF free macrophage media. GFP-expressing" exact="influenza" post="A/PR8-NS116-GFP strain (PR8-GFP) was purified by centrifugation in sucrose"/>
   <result pre="specimens in six countries, only 11% were classified: 3744 were" exact="influenza" post="A viruses (71% of A/H3 and 29% of A/H1)"/>
   <result pre="(71% of A/H3 and 29% of A/H1) and 2866 were" exact="influenza" post="B viruses (97% of B/Yamagata and 3% of B/Victoria)."/>
   <result pre="14th weeks of 2018 (Figure 1), while the peak of" exact="influenza" post="occurred between 29 January, 2018 and 11 March, 2018"/>
   <result pre="weeks). The only exception was Latvia, where the peak of" exact="influenza" post="activity occurred between the 9th and 12th weeks (Figure"/>
   <result pre="revealed that temperature was the most predictive meteorological factor of" exact="influenza" post="activity in all six Northern European countries (Figure 2)."/>
   <result pre="and UV indexes, we performed in vitro experiments. Purified GFP-encoding" exact="influenza" post="A/Puerto Rico/1934 virus (PR8-GFP) was incubated at different temperatures"/>
   <result pre="cells (Figure 4B,C). We performed similar experiment using clinical A/H1N1(pdm09)" exact="influenza" post="isolate and human PBMC-derived macrophages. Viruses exposed to high"/>
   <result pre="onset. It was proposed that fewer people were infected with" exact="influenza" post="during warm winters, thereby leaving an unnaturally large fraction"/>
   <result pre="It was shown that low winter temperatures correlated with both" exact="influenza" post="incidence and global mortality, which mainly affected those aged"/>
   <result pre="the world, and help to develop accurate predictive models of" exact="influenza" post="epidemics. Moreover, the combination of epidemiological, meteorological and genetic"/>
   <result pre="epidemiological, meteorological and genetic studies could unravel the evolution of" exact="influenza" post="viruses and, consequently, improve early intervention and long-term control"/>
   <result pre="consequently, improve early intervention and long-term control strategies of future" exact="influenza" post="outbreaks. Acknowledgments We gratefully acknowledge WHO, NICs, GISRS, NWS,"/>
   <result pre="The following are available online at https://www.mdpi.com/1999-4915/11/3/207/s1. Figure S1: Weekly" exact="influenza" post="virus activity and daily temperatures across six Northern European"/>
   <result pre="1 September 2017 and 31 August 2018. Figure S2: Weekly" exact="influenza" post="virus activity and daily UV indices across six Northern"/>
   <result pre="S4: Effect of temperature and UV radiation on infectivity of" exact="influenza" post="A/Puerto Rico/8/1934 (PR8-GFP) and A/Helsinki/P18/2009(pdm09) strains. LINK Click here"/>
   <result pre="Interest The authors declare no conflicts of interest. Abbreviations IV" exact="influenza" post="virus IAV influenza A virus UV ultraviolet GFP green"/>
   <result pre="declare no conflicts of interest. Abbreviations IV influenza virus IAV" exact="influenza" post="A virus UV ultraviolet GFP green fluorescent protein RPE"/>
   <result pre="4.KashJ.C.TaubenbergerJ.K.The role of viral, host, and secondary bacterial factors in" exact="influenza" post="pathogenesisAm. J. Pathol.20151851528153610.1016/j.ajpath.2014.08.03025747532 5.SooryanarainH.ElankumaranS.Environmental role in influenza virus outbreaksAnnu."/>
   <result pre="bacterial factors in influenza pathogenesisAm. J. Pathol.20151851528153610.1016/j.ajpath.2014.08.03025747532 5.SooryanarainH.ElankumaranS.Environmental role in" exact="influenza" post="virus outbreaksAnnu. Rev. Anim. Biosci.2015334737310.1146/annurev-animal-022114-11101725422855 6.Gomez-BarrosoD.Leon-GomezI.Delgado-SanzC.LarrauriA.Climatic Factors and Influenza"/>
   <result pre="Israeli DistrictsPLoS ONE201510e013470110.1371/journal.pone.013470126309214 10.LowenA.C.SteelJ.Roles of humidity and temperature in shaping" exact="influenza" post="seasonalityJ. Virol.2014887692769510.1128/JVI.03544-1324789791 11.PeciA.WinterA.L.LiL.GnaneshanS.LiuJ.MubarekaS.GubbayJ.B.Effect of absolute and relative humidity, temperature"/>
   <result pre="of absolute and relative humidity, temperature and wind speed on" exact="influenza" post="activity in Toronto, CanadaAppl. Environ. Microbiol.201910.1128/AEM.02426-1830610079 12.CharlandK.M.BuckeridgeD.L.SturtevantJ.L.MeltonF.ReisB.Y.MandlK.D.BrownsteinJ.S.Effect of environmental"/>
   <result pre="Microbiol.201910.1128/AEM.02426-1830610079 12.CharlandK.M.BuckeridgeD.L.SturtevantJ.L.MeltonF.ReisB.Y.MandlK.D.BrownsteinJ.S.Effect of environmental factors on the spatio-temporal patterns of" exact="influenza" post="spreadEpidemiol. Infect.20091371377138710.1017/S095026880900228319296868 13.SagripantiJ.L.LytleC.D.Inactivation of influenza virus by solar radiationPhotochem."/>
   <result pre="on the spatio-temporal patterns of influenza spreadEpidemiol. Infect.20091371377138710.1017/S095026880900228319296868 13.SagripantiJ.L.LytleC.D.Inactivation of" exact="influenza" post="virus by solar radiationPhotochem. Photobiol.2007831278128210.1111/j.1751-1097.2007.00177.x17880524 14.FluNetAvailable online: http://www.who.int/influenza/gisrs_laboratory/flunet/en/(accessed on"/>
   <result pre="on 10 October 2018) 15.DenisovaO.V.KakkolaL.FengL.StenmanJ.NagarajA.LampeJ.YadavB.AittokallioT.KaukinenP.AholaT.et al.Obatoclax, saliphenylhalamide, and gemcitabine inhibit" exact="influenza" post="a virus infectionJ. Biol. Chem.2012287353243533210.1074/jbc.M112.39214222910914 16.PirhonenJ.SarenevaT.KurimotoM.JulkunenI.MatikainenS.Virus infection activates IL-1"/>
   <result pre="a caspase-1-dependent pathwayJ. Immunol.19991627322732910358182 17.ReimerC.B.BakerR.S.van FrankR.M.NewlinT.E.ClineG.B.AndersonN.G.Purification of large quantities of" exact="influenza" post="virus by density gradient centrifugationJ. Virol.19671120712165621490 18.KittelC.SereinigS.FerkoB.StasakovaJ.RomanovaJ.WolkerstorferA.KatingerH.EgorovA.Rescue of influenza"/>
   <result pre="of influenza virus by density gradient centrifugationJ. Virol.19671120712165621490 18.KittelC.SereinigS.FerkoB.StasakovaJ.RomanovaJ.WolkerstorferA.KatingerH.EgorovA.Rescue of" exact="influenza" post="virus expressing GFP from the NS1 reading frameVirology2004324677310.1016/j.virol.2004.03.03515183054 19.LakspereT.TynellJ.KaloinenM.VanledeM.ParsonsA.IkonenN.Kallio-KokkoH.KanteleA.MattilaP.AlmusaH.et"/>
   <result pre="Patients from 2009 to 2013Genome Announc.20142e01004-1310.1128/genomeA.01004-1324435855 20.TameriusJ.D.ShamanJ.AlonsoW.J.Bloom-FeshbachK.UejioC.K.ComrieA.ViboudC.Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climatesPLoS Pathog.20139e100319410.1371/annotation/df689228-603f-4a40-bfbf-a38b13f8814723505366 21.BallesterJ.RodÃ³X.RobineJ.M.HerrmannF.R.European seasonal"/>
   <result pre="across temperate and tropical climatesPLoS Pathog.20139e100319410.1371/annotation/df689228-603f-4a40-bfbf-a38b13f8814723505366 21.BallesterJ.RodÃ³X.RobineJ.M.HerrmannF.R.European seasonal mortality and" exact="influenza" post="incidence due to winter temperature variabilityNat. Clim. Chang.2016692793010.1038/nclimate3070 22.TowersS.ChowellG.HameedR.JastrebskiM.KhanM.MeeksJ.MubayiA.HarrisG.Climate"/>
   <result pre="22.TowersS.ChowellG.HameedR.JastrebskiM.KhanM.MeeksJ.MubayiA.HarrisG.Climate change and influenza: The likelihood of early and severe" exact="influenza" post="seasons following warmer than average wintersPLoS Curr.2013510.1371/currents.flu.3679b56a3a5313dc7c043fb944c6f13824045424 23.GeierD.A.KernJ.K.GeierM.R.A longitudinal"/>
   <result pre="than average wintersPLoS Curr.2013510.1371/currents.flu.3679b56a3a5313dc7c043fb944c6f13824045424 23.GeierD.A.KernJ.K.GeierM.R.A longitudinal ecological study of seasonal" exact="influenza" post="deaths in relation to climate conditions in the United"/>
   <result pre="10 October 2018) Figure 1 Weekly number of detections of" exact="influenza" post="viruses in six Northern European countries, 2017â€&quot;2018. (A). Map"/>
   <result pre="(temperature, UV index, humidity, wind speed, precipitation, and pressure) and" exact="influenza" post="activity in six Northern Europe countries (Norway, Sweden, Finland,"/>
   <result pre="of a machine learning Random Forest model trained to predict" exact="influenza" post="activity. The contribution is measured as percentage mean decrease"/>
   <result pre="more important the factor). (B) Correlation between meteorological factors and" exact="influenza" post="activity. Absolute values of Pearson correlation coefficient (95% confidence"/>
   <result pre="(temperature, UV index, humidity, wind speed, precipitation, and pressure) and" exact="influenza" post="activity in six Northern Europe countries averaged for the"/>
   <result pre="34 of 2017. (Left) Correlation analysis between meteorological factors and" exact="influenza" post="activity. (Right) Contribution of each meteorological factor to predictive"/>
   <result pre="performance of machine-learning Random Forest models trained to predict the" exact="influenza" post="virus (IV) activity in six Northern European countries. Contribution"/>
   <result pre="Effect of temperature and UV radiation on infectivity of GFP-encoding" exact="influenza" post="A virus (PR8-GFP). (A) PR8-GFP was incubated at indicated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6467424\results\search\disease\results.xml">
   <result pre="recent epidemics have seen more severe disease manifestations, such as" exact="microcephaly" post="and central nervous malformations in neonates [17, 18], and"/>
   <result pre="MercierA, LepersC, HoyD, DuituturagaS, BenyonE, et al.Concurrent outbreaks of dengue," exact="chikungunya" post="and Zika virus infectionsâ€&quot;an unprecedented epidemic wave of mosquito-borne"/>
   <result pre="BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al.Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013â€&quot;15: a retrospective study. Lancet. 2016;387:2125â€&quot;2132."/>
   <result pre="TidedM, MachiengP, et al.Aedes hensilli as a potential vector of" exact="chikungunya" post="and Zika viruses. PloS Negl Trop Dis. 2014;8: e318810.1371/journal.pntd.000318825299181"/>
   <result pre="albopictus and Aedes aegypti in the emergence of dengue and" exact="chikungunya" post="in Central Africa. Vector Borne Zoonotic Dis. 2010;10: 259â€&quot;266."/>
   <result pre="259â€&quot;266. 10.1089/vbz.2009.000519725769 42TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog."/>
   <result pre="FrentiuFD, McElroyK, DayA, et al.Impact of Wolbachia on infection with" exact="chikungunya" post="and yellow fever viruses in the mosquito vector Aedes"/>
   <result pre="DayA, et al.Impact of Wolbachia on infection with chikungunya and" exact="yellow fever" post="viruses in the mosquito vector Aedes aegypti. PloS Negl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6468063\results\search\disease\results.xml">
   <result pre="al.): The causes of longâ€�term trends in the epidemiology of" exact="influenza" post="LETTER TO THE EDITOR CainiSaveriohttps://orcid.org/0000-0002-2262-1102s.caini@nivel.nl1PagetJohnhttps://orcid.org/0000-0002-1503-24811[1], Netherlands Institute for Health"/>
   <result pre="read Souty et al's1 paper on the declining size of" exact="influenza" post="epidemics in France during 1984â€�2017 with interest. The authors"/>
   <result pre="Sprujit et al2 failed to find a convincing association between" exact="influenza" post="vaccination coverage and influenzaâ€�like illness in fourteen European countries."/>
   <result pre="epidemiological evidence that supports the notion that the occurrence of" exact="influenza" post="epidemics is driven by climatic parameters, in particular absolute"/>
   <result pre="and host susceptibility are enhanced, thus favoring the transmission of" exact="influenza" post="viruses and the onset of epidemics.5 Researchers have long"/>
   <result pre="are often hypothesized as possible drivers of longâ€�term trends in" exact="influenza" post="incidence (eg, hygienic standards, social contact patterns, household size,"/>
   <result pre="de LangeMM, DijkstraF, DonkerGA, van der HoekW. Longâ€�term correlation between" exact="influenza" post="vaccination coverage and incidence of influenzaâ€�like illness in 14"/>
   <result pre="2019. 4TameriusJD, ShamanJ, AlonsoWJ, et al. Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climates. PLoS Pathog. 2013;9(3):e1003194.23505366"/>
   <result pre="ViboudC, GrenfellBT, LipsitchM. Absolute humidity and the seasonal onset of" exact="influenza" post="in the continental United States. PLoS Biol. 2010;8(2)e1000316.20186267 6TowersS,"/>
   <result pre="Climate change and influenza: the likelihood of early and severe" exact="influenza" post="seasons following warmer than average winters. PLoS Curr. 2013;5."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6468813\results\search\disease\results.xml">
   <result pre="Here, we discuss the current knowledge on the interactions between" exact="influenza" post="A virus (IAV), the causative agent for most of"/>
   <result pre="in the endoplasmic reticulum that are affected by this virus." exact="influenza" post="A virus (IAV) virusâ€&quot;host interaction proteostasis protein quality control"/>
   <result pre="machinery, with focus on proteostasis imbalance, throughout the course of" exact="influenza" post="A virus (IAV) life-cycle and explore its significance for"/>
   <result pre="significance for infection efficiency. Although information on the interplay between" exact="influenza" post="B virus (IBV) and host-cell proteostasis is scarce, we"/>
   <result pre="epidemics in humans as well as the for the major" exact="influenza" post="pandemics in the last century, associated with high morbidity"/>
   <result pre="responses and the proteostasis maintenance. Currently, the permanent risk of" exact="influenza" post="epidemics and pandemics is due to the continuous viral"/>
   <result pre="synthesis [39]. This process was suggested to be distinct among" exact="influenza" post="viruses, since IBV polymerase possesses a distinct cap recognition"/>
   <result pre="of infection, essentially to identify unanticipated cellular factors required for" exact="influenza" post="replication and pathogenicity, or related to host antiviral responses,"/>
   <result pre="as a consequence of the reassortment of avian and human" exact="influenza" post="virusâ€™s gene segments, which requires an adaptation of the"/>
   <result pre="that RNA-directed RNA polymerase catalytic subunit (PB1) protein from the" exact="avian influenza" post="pandemic virus H3N2 (1698) evolved in humans to reduce"/>
   <result pre="RNA-directed RNA polymerase catalytic subunit (PB1) protein from the avian" exact="influenza" post="pandemic virus H3N2 (1698) evolved in humans to reduce"/>
   <result pre="to be involved in the assembly and nuclear transport of" exact="influenza" post="RNA polymerase subunits [64] and stimulates its RNA synthesis"/>
   <result pre="3). A functional UPS is important for the replication of" exact="influenza" post="viruses, in order to maintain proper function and the"/>
   <result pre="using specific inhibitors can lead to the sequestration of incoming" exact="influenza" post="particles in cytoplasmic endosomes, directly affecting the early stages"/>
   <result pre="ubiquitination process as necessary for IAV entry and replication. However," exact="influenza" post="proteins can be targeted for ubiquitin-mediated degradation as an"/>
   <result pre="such an extent that TRIM41 deficiency increases host susceptibility to" exact="influenza" post="[79] (Figure 3). On the other hand, IAV has"/>
   <result pre="efficiently replicate, in particular to allow the nuclear import of" exact="influenza" post="particles and to permit its genome replication. When the"/>
   <result pre="Yet, chemical genomics identified PERK as a cellular target for" exact="influenza" post="virus inhibition, as, according to the authors [121], IAV"/>
   <result pre="and Exploiting Proteome Organization during Viral InfectionJ. Virol.201791e00268-1710.1128/JVI.00268-1728679763 9.HeatonN.S.MoshkinaN.FenouilR.GardnerT.J.AguirreS.ShahP.S.ZhaoN.ManganaroL.HultquistJ.NoelJ.et al.Limiting" exact="influenza" post="virus, HIV and dengue virus infection by targeting viral"/>
   <result pre="overall benefits still hotly debated?J. Prev. Med. Hyg.201556E37E4310.15167/2421-4248/jpmh2015.56.1.47426789831 19.ShaoW.LiX.GorayaM.U.WangS.ChenJ.L.Evolution of" exact="influenza" post="a virus by mutation and re-assortmentInt. J. Mol. Sci.201718165010.3390/ijms18081650"/>
   <result pre="the cellular 3â€™-end processing machineryEMBO J.1999182273228310.1093/emboj/18.8.227310205180 26.Bercovich-KinoriA.TaiJ.GelbartI.A.ShitritA.Ben-MosheS.DroriY.ItzkovitzS.MandelboimM.Stern-GinossarN.A systematic view on" exact="influenza" post="induced host shutoffElife2016512010.7554/eLife.18311 27.WangW.KrugR.M.The RNA-Binding and Effector Domains of"/>
   <result pre="a Translational Activator of Influenza VirusMol. Cell. Biol.2000206259626810.1128/MCB.20.17.6259-6268.200010938102 30.SalvatoreM.BaslerC.F.ParisienJ.-P.HorvathC.M.BourmakinaS.ZhengH.MusterT.PaleseP.GarcÃ­a-SastreA.Effects of" exact="influenza" post="A virus NS1 protein on protein expression: The NS1"/>
   <result pre="the RNA-Dependent Protein Kinase PKRJ. Virol.20179110.1128/JVI.00198-1728250123 34.MinJ.-Y.LiS.SenG.C.KrugR.M.A site on the" exact="influenza" post="A virus NS1 protein mediates both inhibition of PKR"/>
   <result pre="ActivityJ. Virol.2000748781878410.1128/JVI.74.18.8781-8784.200010954584 37.MinJ.-Y.KrugR.M.The primary function of RNA binding by the" exact="influenza" post="A virus NS1 protein in infected cells: Inhibiting the"/>
   <result pre="Viral InfectionsCell Host Microbe20151746647710.1016/j.chom.2015.02.01025816776 39.KoppsteinD.AshourJ.BartelD.P.Sequencing the cap-snatching repertoire of H1N1" exact="influenza" post="provides insight into the mechanism of viral transcription initiationNucleic"/>
   <result pre="host shutoffElife20165e2075510.7554/eLife.2075527644108 45.VesterD.RappE.GadeD.GenzelY.ReichlU.Quantitative analysis of cellular proteome alterations in human" exact="influenza" post="A virus-infected mammalian cell linesProteomics200993316332710.1002/pmic.20080089319504497 46.KroekerA.L.EzzatiP.CoombsK.M.HalaykoA.J.Influenza A infection of"/>
   <result pre="Primary MacrophagesPLoS Pathog.2011710.1371/journal.ppat.1001340 49.AlbersS.CzechA.Exploiting tRNAs to Boost VirulenceLife20166410.3390/life6010004 50.Pavon-EternodM.DavidA.DittmarK.BerglundP.PanT.BenninkJ.R.YewdellJ.W.Vaccinia and" exact="influenza" post="A viruses select rather than adjust tRNAs to optimize"/>
   <result pre="Codon Usage toward Interferon-Altered tRNA PoolsMBio20189e01222-1810.1128/mBio.01222-1829970470 52.WangR.ZhangY.-Y.LuJ.-S.XiaB.-H.YangZ.-X.ZhuX.-D.ZhouX.-W.HuangP.-T.The highly pathogenic H5N1" exact="influenza" post="A virus down-regulated several cellular MicroRNAs which target viral"/>
   <result pre="and OAS2Mol. Ther. Nucleic Acids20191450951910.1016/j.omtn.2018.12.01430753994 56.KeshavarzM.Dianat-MoghadamH.SofianiV.H.KarimzadehM.ZargarM.MoghoofeiM.BiglariH.GhorbaniS.NahandJ.S.MirzaeiH.MiRNA-based strategy for modulation of" exact="influenza" post="A virus infectionEpigenomics20181082984410.2217/epi-2017-017029888954 57.HartlF.U.BracherA.Hayer-hartlM.Molecular chaperones in protein folding and"/>
   <result pre="vitroNucleic Acids Res.2008363389340010.1093/nar/gkn17718442994 59.BatraJ.TripathiS.KumarA.KatzJ.M.CoxN.J.LalR.B.SambharaS.LalS.K.Human Heat shock protein 40 (Hsp40/DnaJB1) promotes" exact="influenza" post="A virus replication by assisting nuclear import of viral"/>
   <result pre="ActivityJ. Virol.201488140781408910.1128/JVI.02475-1425253355 61.LiG.ZhangJ.TongX.LiuW.YeX.Heat shock protein 70 inhibits the activity of" exact="influenza" post="a virus ribonucleoprotein and blocks the replication of virus"/>
   <result pre="Vitro and In VivoPLoS ONE2011610.1371/journal.pone.0016546 62.ManzoorR.KurodaK.YoshidaR.TsudaY.FujikuraD.MiyamotoH.KajiharaM.KidaH.TakadaA.Heat shock protein 70 modulates" exact="influenza" post="A virus polymerase activityJ. Biol. Chem.20142897599761410.1074/jbc.M113.50779824474693 63.ShimizuK.IguchiA.GomyouR.OnoY.Influenza Virus Inhibits"/>
   <result pre="65.MomoseF.NaitoT.YanoK.SugimotoS.MorikawaY.NagataK.Identification of Hsp90 as a stimulatory host factor involved in" exact="influenza" post="virus RNA synthesisJ. Biol. Chem.2002277453064531410.1074/jbc.M20682220012226087 66.ChaseG.DengT.FodorE.LeungB.W.MayerD.SchwemmleM.BrownleeG.Hsp90 inhibitors reduce influenza"/>
   <result pre="in influenza virus RNA synthesisJ. Biol. Chem.2002277453064531410.1074/jbc.M20682220012226087 66.ChaseG.DengT.FodorE.LeungB.W.MayerD.SchwemmleM.BrownleeG.Hsp90 inhibitors reduce" exact="influenza" post="virus replication in cell cultureVirology200837743143910.1016/j.virol.2008.04.04018570972 67.GuanZ.LiuD.MiS.ZhangJ.YeQ.WangM.GaoG.F.YanJ.Interaction of Hsp40 with"/>
   <result pre="influenza virus replication in cell cultureVirology200837743143910.1016/j.virol.2008.04.04018570972 67.GuanZ.LiuD.MiS.ZhangJ.YeQ.WangM.GaoG.F.YanJ.Interaction of Hsp40 with" exact="influenza" post="virus M2 protein: Implications for PKR signaling pathwayProtein Cell2010194495510.1007/s13238-010-0115-x21204021"/>
   <result pre="through a PKR-Mediated MechanismJ. Virol.2007812221223010.1128/JVI.02151-0617166899 70.WatanabeK.FuseT.AsanoI.TsukaharaF.MaruY.NagataK.KitazatoK.KobayashiN.Identification of Hsc70 as an" exact="influenza" post="virus matrix protein (M1) binding factor involved in the"/>
   <result pre="in the virus life cycleFEBS Lett.20065805785579010.1016/j.febslet.2006.09.04017022977 71.HalderU.C.BagchiP.ChattopadhyayS.DuttaD.Chawla-SarkarM.Cell death regulation during" exact="influenza" post="A virus infection by matrix (M1) protein: A model"/>
   <result pre="the cellular survival pathwayCell Death Dis.20112e19710.1038/cddis.2011.7521881599 72.ZhangC.YangY.ZhouX.YangZ.LiuX.CaoZ.SongH.HeY.HuangP.The NS1 protein of" exact="influenza" post="a virus interacts with heat shock protein Hsp90 in"/>
   <result pre="system: Molecular mechanism of viral pathogenesisCurr. Opin. Virol.20161711010.1016/j.coviro.2015.09.00526426962 74.RudnickaA.YamauchiY.Ubiquitin in" exact="influenza" post="virus entry and innate immunityViruses2016829310.3390/v810029327783058 75.WidjajaI.de VriesE.TscherneD.M.Garcia-SastreA.RottierP.J.M.de HaanC.A.M.Inhibition of"/>
   <result pre="ubiquitin-vacuolar protein sorting system is selectively required during entry of" exact="influenza" post="virus into host cellsTraffic2003485786810.1046/j.1398-9219.2003.0140.x14617349 77.FuB.WangL.DingH.SchwambornJ.C.LiS.DorfM.E.TRIM32 Senses and Restricts Influenza"/>
   <result pre="Host Microbe2009543944910.1016/j.chom.2009.04.00619454348 81.KoliopoulosM.G.LethierM.Van Der VeenA.G.HaubrichK.HennigJ.KowalinskiE.StevensR.V.MartinS.R.Reis E SousaC.CusackS.et al.Molecular mechanism of" exact="influenza" post="A NS1-mediated TRIM25 recognition and inhibitionNat. Commun.2018910.1038/s41467-018-04214-8 82.RajsbaumR.AlbrechtR.A.WangM.K.MaharajN.P.VersteegG.A.Nistal-VillÃ¡nE.GarcÃ­a-SastreA.GackM.U.Species-Specific Inhibition"/>
   <result pre="Viral RNA ReplicationMBio20178e00597-1710.1128/mBio.00597-1728536288 87.LiaoT.L.WuC.Y.SuW.C.JengK.S.LaiM.M.C.Ubiquitination and deubiquitination of NP protein regulates" exact="influenza" post="A virus RNA replicationEMBO J.2010293879389010.1038/emboj.2010.25020924359 88.KoÅ¡Ã­kI.PrÃ¡znovskÃ¡M.KoÅ¡Ã­kovÃ¡M.BobiÅ¡ovÃ¡Z.HollÃ½J.VareÄ�kovÃ¡E.KostolanskÃ½F.RussG.The ubiquitination of the"/>
   <result pre="influenza A virus RNA replicationEMBO J.2010293879389010.1038/emboj.2010.25020924359 88.KoÅ¡Ã­kI.PrÃ¡znovskÃ¡M.KoÅ¡Ã­kovÃ¡M.BobiÅ¡ovÃ¡Z.HollÃ½J.VareÄ�kovÃ¡E.KostolanskÃ½F.RussG.The ubiquitination of the" exact="influenza" post="a virus PB1-F2 protein is crucial for its biological"/>
   <result pre="for its biological functionPLoS ONE201510e011847710.1371/journal.pone.011847725866881 89.LiuG.ZhongM.GuoC.KomatsuM.XuJ.WangY.KitazatoK.Autophagy is involved in regulating" exact="influenza" post="A virus RNA and protein synthesis associated with both"/>
   <result pre="signaling pathwayInt. J. Biochem. Cell Biol.20167210010810.1016/j.biocel.2016.01.01226794463 90.ZhouZ.JiangX.LiuD.FanZ.HuX.YanJ.WangM.GaoG.F.Autophagy is involved in" exact="influenza" post="A virus replicationAutophagy2009532132810.4161/auto.5.3.740619066474 91.YeganehB.GhavamiS.RahimM.N.KlonischT.HalaykoA.J.CoombsK.M.Autophagy activation is required for influenza"/>
   <result pre="in influenza A virus replicationAutophagy2009532132810.4161/auto.5.3.740619066474 91.YeganehB.GhavamiS.RahimM.N.KlonischT.HalaykoA.J.CoombsK.M.Autophagy activation is required for" exact="influenza" post="A virus-induced apoptosis and replicationBiochim. Biophys. Acta Mol. Cell"/>
   <result pre="replicationBiochim. Biophys. Acta Mol. Cell Res.2018186536437810.1016/j.bbamcr.2017.10.01429108912 92.FeiziN.MehrbodP.RomaniB.SoleimanjahiH.BamdadT.FeiziA.JazaeriE.O.TarghiH.S.SalehM.JamaliA.et al.Autophagy induction regulates" exact="influenza" post="virus replication in a time-dependent mannerJ. Med. Microbiol.20176653654110.1099/jmm.0.00045528463668 93.WangR.ZhuY.ZhaoJ.RenC.LiP.ChenH.JinM.ZhouH.Autophagy"/>
   <result pre="In VitroJ. Virol.201993e01984-1810.1128/JVI.01984-1830541828 94.PerotB.P.BoussierJ.YatimN.RossmanJ.S.IngersollM.A.AlbertM.L.Autophagy diminishes the early interferon-Î² response to" exact="influenza" post="A virus resulting in differential expression of interferon-stimulated genesCell"/>
   <result pre="in Influenza Virus-Infected Dendritic CellsJ. Immunol.200517589189810.4049/jimmunol.175.2.89116002687 99.VidicJ.RichardC.A.PÃ©chouxC.Da CostaB.BerthoN.MazeratS.DelmasB.ChevalierC.Amyloid assemblies of" exact="influenza" post="a virus PB1-F2 protein damage membrane and induce cytotoxicityJ."/>
   <result pre="Innate Immune Response Mediated by MDA5 and MAVSJ. Virol.2012868245825810.1128/JVI.00215-1222623778 103.NingY.J.WangM.DengM.ShenS.LiuW.CaoW.C.DengF.WangY.Y.HuZ.WangH.Viral" exact="suppression" post="of innate immunity via spatial isolation of TBK1/IKKÎµ from"/>
   <result pre="of viral glycoproteins in the ER impacts the production of" exact="influenza" post="A virusVirus Res.2008136919710.1016/j.virusres.2008.04.02818550190 115.DanielsR.KurowskiB.JohnsonA.E.HebertD.N.N-Linked Glycans Direct the Cotranslational Folding"/>
   <result pre="Viruses by an ER Stress PathwayCell Rep.2015111591160310.1016/j.celrep.2015.05.01226051937 118.FrabuttD.A.WangB.RiazS.SchwartzR.C.ZhengY.-H.Innate sensing of" exact="influenza" post="A virus hemagglutinin glycoproteins by the host endoplasmic reticulum"/>
   <result pre="the transcription and translation machinery in (a) uninfected and (b)" exact="influenza" post="A virus (IAV)-infected cells. (a) After being transcribed and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6472721\results\search\disease\results.xml">
   <result pre=": Viral Pathogens : Flaviviruses: Zika Virus Epidemiological trend of" exact="chikungunya" post="outbreak in Pakistan: 2016â€&quot;2018 BadarNazish12SalmanMuhammad1AnsariJamil1IkramAamer1QaziJavaria2AlamMuhammad Masroor1*[1], Department of Virology,"/>
   <result pre="last three decades, despite a recent trend of increasingly frequent" exact="chikungunya" post="cases, first detected in December 2016. Chikungunya infection is"/>
   <result pre="total 1,549 samples tested through July 31, 2018, we found" exact="chikungunya" post="and dengue infection in 776 (50%) and 109 (7%)"/>
   <result pre="diseases in the coming years. Fig 1 Epidemiological curve of" exact="chikungunya" post="cases reported at NIH, Islamabad. Red bars indicate the"/>
   <result pre="bars indicate the number of patients who tested positive for" exact="chikungunya" post="RNA using real-time reverse transcriptase PCR, green squares indicate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6473099\results\search\disease\results.xml">
   <result pre="significant morbidity and mortality, our arsenal of options to treat" exact="influenza" post="A virus (IAV) infections remains limited and is challenged"/>
   <result pre="classes to modulate the immune response induced after IAV infections." exact="influenza" post="treatment response modifiers antiviral immune response immunomodulators Funding Alexander"/>
   <result pre="with ~500,000 annual deaths worldwide. IVs can cause severe acute" exact="respiratory disease" post="especially in high-risk populations like children, the elderly and"/>
   <result pre="populations like children, the elderly and the immunocompromised. While both" exact="influenza" post="A and B viruses (IAV and IBV, respectively) cause"/>
   <result pre="significant damage or destruction of the respiratory epithelium leading to" exact="acute respiratory distress syndrome" post="(ARDS) (7, 8). Clinical treatment options for severe influenza"/>
   <result pre="distress syndrome (ARDS) (7, 8). Clinical treatment options for severe" exact="influenza" post="virus infections remain limited and relying heavily on the"/>
   <result pre="36). ANGPTL4 was significantly elevated in lung biopsies from IAV-induced" exact="pneumonia" post="patients (16). In mouse studies, neutralizing anti-ANGPTL4 Abs reduced"/>
   <result pre="IAV infections (37). Neutrophil extracellular traps (NETs) released during IAV-induced" exact="pneumonia" post="into the alveolar space caused alveolar damage (38). The"/>
   <result pre="inhibitor zanamivir that is used for the treatment of human" exact="influenza" post="patients (21). Both cellular and viral FADD-like IL-1Î²-converting enzyme-inhibitory"/>
   <result pre="10 amino acids from the Î±2 helix of the Kaposi's" exact="sarcoma" post="herpes virus (KSHV) death effector domain 1 protein. A"/>
   <result pre="of SphK1 was shown to decrease IAV RNA synthesis via" exact="suppression" post="of NFkB activation (69). Treatment of mice with specific"/>
   <result pre="Netherlands, UK and USA reported an association of reduced IAV-related" exact="pneumonia" post="and lower case fatality due to lower respiratory tract"/>
   <result pre="of the immune status spectrum and underlying conditions of high-risk" exact="influenza" post="patients (young, immunocompromised, non-naive, obese, pregnant, or aged). Using"/>
   <result pre="to space limitations. References References 1.van de SandtCEKreijtzJHRimmelzwaanGF. Evasion of" exact="influenza" post="A viruses from innate and adaptive immune responses. Viruses."/>
   <result pre="responses. Viruses. (2012) 4:1438â€&quot;76. 10.3390/v409143823170167 2.ChenXLiuSGorayaMUMaaroufMHuangSChenJL. Host immune response to" exact="influenza" post="A virus infection. Front Immunol. (2018) 9:320. 10.3389/fimmu.2018.0032029556226 3.TakeuchiOAkiraS."/>
   <result pre="(2010) 32:305â€&quot;15. 10.1016/j.immuni.2010.03.01220346772 5.PangIKIwasakiA. Inflammasomes as mediators of immunity against" exact="influenza" post="virus. Trends Immunol. (2011) 32:34â€&quot;41. 10.1016/j.it.2010.11.00421147034 6.SandersCJDohertyPCThomasPG. Respiratory epithelial"/>
   <result pre="32:34â€&quot;41. 10.1016/j.it.2010.11.00421147034 6.SandersCJDohertyPCThomasPG. Respiratory epithelial cells in innate immunity to" exact="influenza" post="virus infection. Cell Tissue Res. (2011) 343:13â€&quot;21. 10.1007/s00441-010-1043-z20848130 7.KuikenTRiteauBFouchierRARimmelzwaanGF."/>
   <result pre="infection. Cell Tissue Res. (2011) 343:13â€&quot;21. 10.1007/s00441-010-1043-z20848130 7.KuikenTRiteauBFouchierRARimmelzwaanGF. Pathogenesis of" exact="influenza" post="virus infections: the good, the bad and the ugly."/>
   <result pre="Curr Opin Virol. (2012) 2:276â€&quot;86. 10.1016/j.coviro.2012.02.01322709515 8.ShortKRKroezeEFouchierRAMKuikenT. Pathogenesis of influenza-induced" exact="acute respiratory distress syndrome." post="Lancet Infect Dis. (2014) 14:57â€&quot;69. 10.1016/S1473-3099(13)70286-X24239327 9.ZambonM. Developments in"/>
   <result pre="10.de JongMDThanhTTKhanhTHHienVMSmithGJDChauNVet al.Brief report - Oseltamivir resistance during treatment of" exact="influenza" post="A (H5N1) infection. N Engl J Med. (2005) 353:2667â€&quot;72."/>
   <result pre="(2005) 353:2667â€&quot;72. 10.1056/NEJMoa05451216371632 11.ChanPKLeeNZamanMAdisasmitoWCokerRHanshaoworakulWet al.. Determinants of antiviral effectiveness in" exact="influenza" post="virus A subtype H5N1. J Infect Dis. (2012) 206:1359â€&quot;66."/>
   <result pre="between adverse clinical outcome in human disease caused by novel" exact="influenza" post="A H7N9 virus and sustained viral shedding and emergence"/>
   <result pre="support treatment and prophylaxis based on population modeling of seasonal" exact="influenza" post="A outbreaks. EBioMedicine. (2016) 5:147â€&quot;55. 10.1016/j.ebiom.2016.02.02127077121 14.AliOTakasTNyborgACJensenKMDubovskyFMalloryRA phase 2a"/>
   <result pre="of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human" exact="influenza" post="A virus challenge model. Antimicrob Agents Chemother. (2017) 61:e01154-17."/>
   <result pre="al.. Angiopoietin-like 4 increases pulmonary tissue leakiness and damage during" exact="influenza" post="pneumonia. Cell Rep. (2015) 10:654â€&quot;63. 10.1016/j.celrep.2015.01.01125660016 17.SunSZhaoGLiuCFanWZhouXZengLet al.. Treatment"/>
   <result pre="60:586â€&quot;95. 10.1093/cid/ciu88725433014 18.BrincksELKatewaAKucabaTAGriffithTSLeggeKL. CD8 T cells utilize TRAIL to control" exact="influenza" post="virus infection. J Immunol. (2008) 181:4918â€&quot;25. 10.4049/jimmunol.181.7.491818802095 19.HeroldSSteinmuellerMvon WulffenWCakarovaLPintoRPleschkaSet"/>
   <result pre="(2008) 181:4918â€&quot;25. 10.4049/jimmunol.181.7.491818802095 19.HeroldSSteinmuellerMvon WulffenWCakarovaLPintoRPleschkaSet al.. Lung epithelial apoptosis in" exact="influenza" post="virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand."/>
   <result pre="10.1002/1521-4141(200109)31:9&amp;lt;2566::AID-IMMU2566&amp;gt;3.0.CO;2-L11536154 21.BarlowPGSvobodaPMackellarANashAAYorkIAPohlJet al.. Antiviral activity and increased host defense against" exact="influenza" post="infection elicited by the human cathelicidin LL-37. PLoS ONE."/>
   <result pre="ONE. (2011) 6:e25333. 10.1371/journal.pone.002533322031815 22.MoonHJNikapitiyaCLeeHCParkMEKimJHKimTHet al.. Inhibition of highly pathogenic" exact="avian influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="(2011) 6:e25333. 10.1371/journal.pone.002533322031815 22.MoonHJNikapitiyaCLeeHCParkMEKimJHKimTHet al.. Inhibition of highly pathogenic avian" exact="influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="possess antiviral activity against highly pathogenic avian and human pandemic" exact="influenza" post="A viruses. Biol Chem. (2012) 393:525â€&quot;34. 10.1515/hsz-2011-027022628315 24.XieJZhangSHuYLiDCuiJXueJet al.."/>
   <result pre="393:525â€&quot;34. 10.1515/hsz-2011-027022628315 24.XieJZhangSHuYLiDCuiJXueJet al.. Regulatory roles of c-jun in H5N1" exact="influenza" post="virus replication and host inflammation. Biochim Biophys Acta. (2014)."/>
   <result pre="A):2479â€&quot;88. 10.1016/j.bbadis.2014.04.01724780373 25.BorgelingYSchmolkeMViemannDNordhoffCRothJLudwigS. Inhibition of p38 mitogen-activated protein kinase impairs" exact="influenza" post="virus-induced primary and secondary host gene responses and protects"/>
   <result pre="al.. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic" exact="avian influenza" post="A virus. Antiviral Res. (2013) 99:336â€&quot;44. 10.1016/j.antiviral.2013.06.00823811282 28.YanguezEHunzikerADobayMPYildizSSchadingSElshinaEet al.."/>
   <result pre="The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian" exact="influenza" post="A virus. Antiviral Res. (2013) 99:336â€&quot;44. 10.1016/j.antiviral.2013.06.00823811282 28.YanguezEHunzikerADobayMPYildizSSchadingSElshinaEet al.."/>
   <result pre="(2013) 99:336â€&quot;44. 10.1016/j.antiviral.2013.06.00823811282 28.YanguezEHunzikerADobayMPYildizSSchadingSElshinaEet al.. Phosphoproteomic-based kinase profiling early in" exact="influenza" post="virus infection identifies GRK2 as antiviral drug target. Nat"/>
   <result pre="10.1038/s41467-018-06119-y30206219 29.XiaCSeoYJStudstillCJVijayanMWolfJJHahmB. Transient inhibition of sphingosine kinases confers protection to" exact="influenza" post="A virus infected mice. Antiviral Res. (2018) 158:171â€&quot;7. 10.1016/j.antiviral.2018.08.01030125617"/>
   <result pre="Antiviral Res. (2018) 158:171â€&quot;7. 10.1016/j.antiviral.2018.08.01030125617 30.KhoufacheKBerriFNackenWVogelABDelenneMCamererEet al.. PAR1 contributes to" exact="influenza" post="A virus pathogenicity in mice. J Clin Invest. (2013)"/>
   <result pre="al.. TNF/iNOS-producing dendritic cells are the necessary evil of lethal" exact="influenza" post="virus infection.Proc Natl Acad Sci USA. (2009) 106:5306â€&quot;11. 10.1073/pnas.090065510619279209"/>
   <result pre="proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal" exact="influenza" post="virus challenge in mice. Influenza Other Respir Viruses. (2010)"/>
   <result pre="mice. Influenza Other Respir Viruses. (2010) 4:307â€&quot;11. 10.1111/j.1750-2659.2010.00155.x20716159 34.DavidsonS. Treating" exact="influenza" post="infection, from now and into the future. Front Immunol."/>
   <result pre="Inflamm Res. (2014) 63:13â€&quot;22. 10.1007/s00011-013-0678-024173241 37.PerroneLAPlowdenJKGarcia-SastreAKatzJMTumpeyTM. H5N1 and 1918 pandemic" exact="influenza" post="virus infection results in early and excessive infiltration of"/>
   <result pre="and neutrophil extracellular traps contribute to acute lung injury of" exact="influenza" post="pneumonitis. Am J Pathol. (2011) 179:199â€&quot;210. 10.1016/j.ajpath.2011.03.01321703402 39.YousefiSMihalacheCKozlowskiESchmidISimonHU. Viable"/>
   <result pre="Cell Death Differ. (2009) 16:1438â€&quot;44. 10.1038/cdd.2009.9619609275 40.JulkunenISarenevaTPirhonenJRonniTMelenKMatikainenS. Molecular pathogenesis of" exact="influenza" post="A virus infection and virus-induced regulation of cytokine gene"/>
   <result pre="10.1016/S1359-6101(00)00026-511325600 41.IwaiAShiozakiTMiyazakiT. Relevance of signaling molecules for apoptosis induction on" exact="influenza" post="A virus replication. Biochem Biophys Res Commun. (2013) 441:531â€&quot;7."/>
   <result pre="of host cytokine responses in the pathogenesis of avian H5N1" exact="influenza" post="viruses in mice. J Virol. (2007) 81:2736â€&quot;44. 10.1128/JVI.02336-0617182684 43.PeirisJSCheungCYLeungCYNichollsJMInnate"/>
   <result pre="mice. J Virol. (2007) 81:2736â€&quot;44. 10.1128/JVI.02336-0617182684 43.PeirisJSCheungCYLeungCYNichollsJMInnate immune responses to" exact="influenza" post="A H5N1: friend or foe?Trends Immunol. (2009) 30:574â€&quot;84. 10.1016/j.it.2009.09.00419864182"/>
   <result pre="Immunol. (2009) 30:574â€&quot;84. 10.1016/j.it.2009.09.00419864182 44.GuoXJThomasPG. New fronts emerge in the" exact="influenza" post="cytokine storm. Semin Immunopathol. (2017) 39:541â€&quot;50. 10.1007/s00281-017-0636-y28555383 45.HsiehINHartshornKL. The"/>
   <result pre="(2017) 39:541â€&quot;50. 10.1007/s00281-017-0636-y28555383 45.HsiehINHartshornKL. The role of antimicrobial peptides in" exact="influenza" post="virus infection and their potential as antiviral and immunomodulatory"/>
   <result pre="32:4650â€&quot;8. 10.1021/bi00068a0247683492 50.SieczkarskiSBBrownHAWhittakerGR. Role of protein kinase C betaII in" exact="influenza" post="virus entry via late endosomes. J Virol. (2003) 77:460â€&quot;9."/>
   <result pre="of focal adhesion kinase in cytoplasmic entry and replication of" exact="influenza" post="A viruses. J Virol. (2014) 88:6714â€&quot;28. 10.1128/JVI.00530-1424696469 55.ChoiMSHeoJYiCMBanJLeeNJLeeNRet al.."/>
   <result pre="protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and" exact="influenza" post="A virus replication by inhibiting virus-induced p38 MAPK activation."/>
   <result pre="56.ElbaheshHBergmannSRussellCJ. Focal adhesion kinase (FAK) regulates polymerase activity of multiple" exact="influenza" post="A virus subtypes. Virology. (2016) 499:369â€&quot;74. 10.1016/j.virol.2016.10.00227743963 57.ZhangJRuanTShengTWangJSunJWangJet al.."/>
   <result pre="57.ZhangJRuanTShengTWangJSunJWangJet al.. Role of c-Jun terminal kinase (JNK) activation in" exact="influenza" post="A virus-induced autophagy and replication. Virology. (2018) 526:1â€&quot;12. 10.1016/j.virol.2018.09.02030316042"/>
   <result pre="of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic" exact="avian influenza" post="virus in vitro and in vivo. Antiviral Res. (2011)"/>
   <result pre="the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian" exact="influenza" post="virus in vitro and in vivo. Antiviral Res. (2011)"/>
   <result pre="MEK inhibitors and oseltamivir leads to synergistic antiviral effects after" exact="influenza" post="A virus infection in vitro. Antiviral Res. (2013) 98:319â€&quot;24."/>
   <result pre="17:5858â€&quot;62. 10.1016/j.bmcl.2007.08.02217869512 65.EhrhardtCRuckleAHrinciusERHaasbachEAnhlanDAhmannKet al.. The NF-kappaB inhibitor SC75741 efficiently blocks" exact="influenza" post="virus propagation and confers a high barrier for development"/>
   <result pre="RNA synthesis and nuclear export of viral ribonucleoprotein complex upon" exact="influenza" post="virus infection. PLoS ONE. (2013) 8:e75005. 10.1371/journal.pone.007500524137500 70.CoughlinSRCamererE. PARticipation"/>
   <result pre="expression and in vivo lung function of protease-activated receptors during" exact="influenza" post="A virus infection in mice. Am J Physiol Lung"/>
   <result pre="and prophylaxis. Clin Infect Dis. (2006) 43:199â€&quot;205. 10.1086/50511616779747 73.FedsonDS. Treating" exact="influenza" post="with statins and other immunomodulatory agents. Antiviral Res. (2013)"/>
   <result pre="[Experience in the management of the severe form of human" exact="influenza" post="A H1N1 pneumonia in an intensive care unit]. Cir"/>
   <result pre="management of the severe form of human influenza A H1N1" exact="pneumonia" post="in an intensive care unit]. Cir Cir. (2011) 79:409â€&quot;16.22385760"/>
   <result pre="use of statins and mortality among patients hospitalized with laboratory-confirmed" exact="influenza" post="virus infections: a multistate study. J Infect Dis. (2012)"/>
   <result pre="80.HaoLSakuraiAWatanabeTSorensenENidomCANewtonMAet al.. Drosophila RNAi screen identifies host genes important for" exact="influenza" post="virus replication. Nature. (2008) 454:890â€&quot;3. 10.1038/nature0715118615016 81.BrassALHuangICBenitaYJohnSPKrishnanMNFeeleyEMet al.. The"/>
   <result pre="10.1038/nature0715118615016 81.BrassALHuangICBenitaYJohnSPKrishnanMNFeeleyEMet al.. The IFITM proteins mediate cellular resistance to" exact="influenza" post="A H1N1 virus, West Nile virus, and dengue virus."/>
   <result pre="al.. Genome-wide RNAi screen identifies human host factors crucial for" exact="influenza" post="virus replication. Nature. (2010) 463:818â€&quot;22. 10.1038/nature0876020081832 85.KonigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human"/>
   <result pre="(2010) 463:818â€&quot;22. 10.1038/nature0876020081832 85.KonigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human host factors required for" exact="influenza" post="virus replication. Nature. (2010) 463:813â€&quot;7. 10.1038/nature0869920027183 86.TrippRAMark TompkinsS. Antiviral"/>
   <result pre="88.HanJPerezJTChenCLiYBenitezAKandasamyMet al.. Genome-wide CRISPR/Cas9 screen identifies host factors essential for" exact="influenza" post="virus replication. Cell Rep. (2018) 23:596â€&quot;607. 10.1016/j.celrep.2018.03.04529642015 89.LiCCWangXJWangHR. Repurposing"/>
   <result pre="23:596â€&quot;607. 10.1016/j.celrep.2018.03.04529642015 89.LiCCWangXJWangHR. Repurposing host-based therapeutics to control coronavirus and" exact="influenza" post="virus. Drug Discov Today. (2019) 24:726â€&quot;36. 10.1016/j.drudis.2019.01.01830711575 90.PizzornoATerrierONicolas de"/>
   <result pre="10.1016/j.drudis.2019.01.01830711575 90.PizzornoATerrierONicolas de LamballerieCJulienTPadeyBTraversierAet al.. Repurposing of drugs as novel" exact="influenza" post="inhibitors from clinical gene expression infection signatures. Front Immunol."/>
   <result pre="infection signatures. Front Immunol. (2019) 10:60. 10.3389/fimmu.2019.0006030761132 91.WangLFuBLiWPatilGLiuLDorfMEet al.. Comparative" exact="influenza" post="protein interactomes identify the role of plakophilin 2 in"/>
   <result pre="Nat Commun. (2017) 8:13876. 10.1038/ncomms1387628169297 92.AckermanEEKawakamiEKatohMWatanabeTWatanabeSTomitaYet al.. Network-guided discovery of" exact="influenza" post="virus replication host factors. MBio. (2018) 9:e02002-18. 10.1128/mBio.02002-1830563907 93.WatanabeTWatanabeSKawaokaY."/>
   <result pre="MBio. (2018) 9:e02002-18. 10.1128/mBio.02002-1830563907 93.WatanabeTWatanabeSKawaokaY. Cellular networks involved in the" exact="influenza" post="virus life cycle. Cell Host Microbe. (2010) 7:427â€&quot;39. 10.1016/j.chom.2010.05.00820542247"/>
   <result pre="7:427â€&quot;39. 10.1016/j.chom.2010.05.00820542247 94.de ChasseyBMeyniel-SchicklinLAublin-GexAAndrePLotteauV. Genetic screens for the control of" exact="influenza" post="virus replication: from meta-analysis to drug discovery. Mol Biosyst."/>
   <result pre="(2012) 8:1297â€&quot;303. 10.1039/c2mb05416g22307679 95.TripathiSPohlMOZhouYRodriguez-FrandsenAWangGSteinDAet al.. Meta- and orthogonal integration of" exact="influenza" post="â€œOMICsâ€� data defines a role for UBR4 in virus"/>
   <result pre="the T cell response to a clinically significant dose of" exact="influenza" post="virus is regulated by TRAIL.J Immunol. (2011) 187:4581â€&quot;8. 10.4049/jimmunol.100224121940678"/>
   <result pre="187:4581â€&quot;8. 10.4049/jimmunol.100224121940678 97.DavidsonSCrottaSMcCabeTMWackA. Pathogenic potential of interferon alphabeta in acute" exact="influenza" post="infection. Nat Commun. (2014) 5:3864. 10.1038/ncomms486424844667 98.KakkolaLDenisovaOVTynellJViiliainenJYsenbaertTMatosRCet al.. Anticancer"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6473713\results\search\disease\results.xml">
   <result pre="out of the five Darfur states. We reported the first" exact="dengue fever" post="outbreak in the Darfur region. Our results highlight the"/>
   <result pre="Darfur Sudan 1. Introduction Dengue fever (DF) is a mosquito-borne" exact="viral disease" post="caused by one of four closely-related dengue virus serotypes"/>
   <result pre="a self-limiting flu-like illness to the fatal severe form of" exact="dengue hemorrhagic fever" post="or dengue shock syndrome [1,3]. Dengue is a rapidly"/>
   <result pre="the area has recently suffered from one of the worst" exact="yellow fever" post="epidemics worldwide [25,26,27]. The outbreak of yellow fever was"/>
   <result pre="the worst yellow fever epidemics worldwide [25,26,27]. The outbreak of" exact="yellow fever" post="was influenced by the living condition in a humanitarian"/>
   <result pre="this communication, we report the first outbreak of dengue and" exact="dengue hemorrhagic fever" post="along with West Nile virus and Crimeanâ€&quot;Congo hemorhagic fever"/>
   <result pre="case and tested for the major arboviral infectious agents of" exact="dengue fever" post="(DF), yellow fever (YF), Rift Valley fever (RVF), Crimeanâ€&quot;Congo"/>
   <result pre="for the major arboviral infectious agents of dengue fever (DF)," exact="yellow fever" post="(YF), Rift Valley fever (RVF), Crimeanâ€&quot;Congo Hemorrhagic Fever (CCHF),"/>
   <result pre="fever (RVF), Crimeanâ€&quot;Congo Hemorrhagic Fever (CCHF), West Nile virus (WNV)," exact="chikungunya" post="virus (CHIKV), and Zika virus (ZIKV). Arboviral-specific enzyme-linked immunosorbent"/>
   <result pre="samples (Table 1). Molecular analysis confirmed 32 positive cases of" exact="dengue fever" post="out of the 204 (15.7%) from 11 localities in"/>
   <result pre="East Darfur (Table 1). No cases of Zika virus (ZIKV)," exact="yellow fever" post="(YF), chikungunya virus (CHIKV), or Rift Valley fever (RVF)"/>
   <result pre="1). No cases of Zika virus (ZIKV), yellow fever (YF)," exact="chikungunya" post="virus (CHIKV), or Rift Valley fever (RVF) were detected"/>
   <result pre="Discussion In this communication, we investigated the first outbreak of" exact="dengue fever" post="in the Darfur area and we confirmed the presence"/>
   <result pre="of Darfur, except East Darfur. We believe the prevalence of" exact="dengue fever" post="cases might be higher than reported here because of"/>
   <result pre="detected DENV infections presented with bleeding, suggesting the involvement of" exact="dengue hemorrhagic fever," post="one of the severe forms of the disease according"/>
   <result pre="the early 1900s [19,23,27]. Darfur has a recent history of" exact="yellow fever" post="epidemics [25,29], but DENV has only been detected in"/>
   <result pre="North Darfur, for the first time in 2014. Compared to" exact="dengue fever," post="similarly high infections of yellow fever among children and"/>
   <result pre="in 2014. Compared to dengue fever, similarly high infections of" exact="yellow fever" post="among children and young adults have recently been reported"/>
   <result pre="between infection and gender [29]. The severe clinical presentations of" exact="dengue fever" post="cases during this outbreak seems to suggest a lack"/>
   <result pre="DENV infection. Most of these cases were treated as severe" exact="malaria" post="cases, which is a common confusion in resource-limited settings"/>
   <result pre="of the population to the risk of infectious diseases, including" exact="dengue fever" post="and other arboviral infections, and made the health system"/>
   <result pre="the area, as some of those troops are coming from" exact="dengue fever" post="endemic areas [18,27]. Another possible scenario for introducing DENV"/>
   <result pre="the area is through immigrants from neighboring countries with endemic" exact="dengue fever," post="who came to work in the local gold mines"/>
   <result pre="This situation has most likely contributed to the epidemic of" exact="yellow fever" post="in the same area in 2012 [8,29,31]. One of"/>
   <result pre="of the risk factors influencing the emergence and outbreaks of" exact="dengue fever" post="in the area. Furthermore, we highlight the need to"/>
   <result pre="continuing global threatNat. Rev. Microbiol.20108S7S1610.1038/nrmicro246021079655 7.Van KleefE.BambrickH.HalesS.The geographic distribution of" exact="dengue fever" post="and the potential influence of global climate changeAvailable online:"/>
   <result pre="the Conflict in DarfurWorld Bank Econ. Rev.20102438641110.1093/wber/lhq019 29.AhmedS.S.SoghaierM.A.MohammedS.KhogaliH.S.OsmanM.M.AbdallaA.M.Concomitant outbreaks of" exact="yellow fever" post="and hepatitis E virus in Darfur States, Sudan, 2012J."/>
   <result pre="DarfurWorld Bank Econ. Rev.20102438641110.1093/wber/lhq019 29.AhmedS.S.SoghaierM.A.MohammedS.KhogaliH.S.OsmanM.M.AbdallaA.M.Concomitant outbreaks of yellow fever and" exact="hepatitis" post="E virus in Darfur States, Sudan, 2012J. Infect. Dev."/>
   <result pre="area of Greater Darfur (in the light blue color, and" exact="dengue fever" post="endemic areas in Sudan (the darker blue). Figure 2"/>
   <result pre="(the darker blue). Figure 2 Epidemic curve of the first" exact="dengue fever" post="outbreak in Greater Darfur showing the development of the"/>
   <result pre="boxes. Figure 3 Clinical presentations of the confirmed cases of" exact="dengue fever." post="tropicalmed-04-00043-t001_Table 1Table 1 Number of hemorrhagic fever suspected cases,"/>
   <result pre="1 0 0 1:0 Total 32 6 3 - DF:" exact="dengue fever;" post="WNV: West Nile virus; CCHFV: Crimeanâ€&quot;Congo hemorrhagic fever. F:M"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6474636\results\search\disease\results.xml">
   <result pre="1 This essay focuses on the most extreme bottleneck in" exact="viral disease" post="emergence: The replication of animal viruses in their first"/>
   <result pre="human versions of the cellular receptors used by poliovirus and" exact="hepatitis" post="C viruses leads to enhanced viral infection because these"/>
   <result pre="human CD81, OCLN receptors, and lack STAT1 [38] Epsteinâ€&quot;Barr virus/Kaposi" exact="sarcoma" post="herpesvirus Mouse Highly species specific in pathogenicity and disease"/>
   <result pre="family member A (ANP32A) is a key cofactor required for" exact="influenza" post="virus replication [55,56]. Avian influenza viruses require a mutation"/>
   <result pre="a key cofactor required for influenza virus replication [55,56]. Avian" exact="influenza" post="viruses require a mutation in their PB2 polymerase subunit"/>
   <result pre="mutation, this human transcriptional activator provides a potent block to" exact="avian influenza" post="virus replication in humans. As another example, RanBP2 is"/>
   <result pre="this human transcriptional activator provides a potent block to avian" exact="influenza" post="virus replication in humans. As another example, RanBP2 is"/>
   <result pre="Replication in Human Cells Viral Mutations that Overcome Barriera Avian" exact="influenza" post="viruses Î±-2,6â€&quot;linked sialic acidreceptor Mutations in receptor binding site"/>
   <result pre="from bats) NPC1breceptor Mutation in viral surface glycoprotein [69â€&quot;71]b Feline" exact="leukemia" post="virus APOBEC3restriction factor Not yet zoonotic (escape path not"/>
   <result pre="mosquitos or ticks Alkhumra virusBanzi virusBussuquara virusEdge Hill virusIlheus virusJapanese" exact="encephalitis" post="virusKokobera virusKoutango virusKyasanur forest disease virusLangat virusLouping-ill virusMurray Valley"/>
   <result pre="encephalitis virusKokobera virusKoutango virusKyasanur forest disease virusLangat virusLouping-ill virusMurray Valley" exact="encephalitis" post="virus Omsk hemorrhagic fever virusPowassan virusRocio virusSepik virusSpondweni virusSt."/>
   <result pre="virus Omsk hemorrhagic fever virusPowassan virusRocio virusSepik virusSpondweni virusSt. Louis" exact="encephalitis" post="virusSylvatic dengue virusTick-borne encephalitis virusUsutu virusWesselsbron virusWest Nile virusYellow"/>
   <result pre="virusPowassan virusRocio virusSepik virusSpondweni virusSt. Louis encephalitis virusSylvatic dengue virusTick-borne" exact="encephalitis" post="virusUsutu virusWesselsbron virusWest Nile virusYellow fever virusZika virus Dengue"/>
   <result pre="1â€&quot;4Hepatitis C virus Orthomyxoviridaezoonotic orthomyxoviruses typically associated with birds Avian" exact="influenza" post="A viruses (multiple)Dhori virus Quaranfil virusThogoto virus Influenza A,"/>
   <result pre="HTLV, human T-lymphotropic virus; MERS, Middle East respiratory syndrome; SARS," exact="severe acute respiratory syndrome;" post="SIV, simian immunodeficiency virus; SIVcpz, SIV of chimpanzees; SIVgor,"/>
   <result pre="replication in a multiple-drugâ€&quot;treated host. Alarmingly, some of the H5N1" exact="influenza" post="viruses that are currently circulating in the avian reservoir"/>
   <result pre="NPC intracellular cholesterol transporter 1; PDB, Protein Data Bank; SARS," exact="severe acute respiratory syndrome;" post="TfR1, transferrin receptor 1. Box 3. Lessons in zoonosis"/>
   <result pre="spread in the new host. For instance, a less pathogenic" exact="influenza" post="virus variant that causes lower levels of inflammation and"/>
   <result pre="and increased nasal secretions, which serve as major routes for" exact="influenza" post="virus transmission. However, factors external to the virus are"/>
   <result pre="integral to transmission. If a poorly spreading virus, like the" exact="influenza" post="variant just mentioned, emerged in a densely populated megacity,"/>
   <result pre="further refinement in humans. On the other hand, if an" exact="influenza" post="virus variant arises with characteristics that make it excellent"/>
   <result pre="Ebola is that it spreads through loveâ€� [114]. The 1918" exact="influenza" post="virus emerged during World War I and spread well"/>
   <result pre="the soldiers shown are very likely infected with the 1918" exact="influenza" post="virus at the time the photo was taken. The"/>
   <result pre="2 NPC1 NPC intracellular cholesterol transporter 1 OCLN occludin PB2" exact="influenza" post="virus polymerase PB2 PDB Protein Data Bank PVR PVR"/>
   <result pre="SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 SARS" exact="severe acute respiratory syndrome" post="SHIV SIVmac/HIV chimeric virus SIV simian immunodeficiency virus SIVcpz"/>
   <result pre="10.1093/acprof:oso/9780199207466.003.0016 2HeesterbeekH, AndersonRM, AndreasenV, BansalS, De AngelisD, DyeC, et al.Modeling" exact="infectious disease" post="dynamics in the complex landscape of global health. Science."/>
   <result pre="HorwitzJA, DonovanBM, LabittRN, BudellWC, FrilingT, et al.Completion of the entire" exact="hepatitis" post="C virus life cycle in genetically humanized mice. Nature."/>
   <result pre="MoncorgÃ©O, FriseR, MistryB, JamesJ, et al.Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature. 2016;529: 101â€&quot;104. 10.1038/nature1647426738596"/>
   <result pre="vitro assessment of attachment pattern and replication efficiency of H5N1" exact="influenza" post="A viruses with altered receptor specificity. J Virol. 2010;84:"/>
   <result pre="62LipsitchM, BarclayW, RamanR, RussellCJ, BelserJA, CobeyS, et al.Viral factors in" exact="influenza" post="pandemic risk assessment. eLife. 2016;5: 316ra19210.7554/eLife.1849127834632 63LongJS, MistryB, HaslamSM,"/>
   <result pre="316ra19210.7554/eLife.1849127834632 63LongJS, MistryB, HaslamSM, BarclayWS. Host and viral determinants of" exact="influenza" post="A virus species specificity.Nat Rev Micro. 2019;17: 67â€&quot;81. 10.1038/s41579-018-0115-z30487536"/>
   <result pre="effect of the PB2 mutation 627K on highly pathogenic H5N1" exact="avian influenza" post="virus is dependent on the virus lineage. J Virol."/>
   <result pre="of the PB2 mutation 627K on highly pathogenic H5N1 avian" exact="influenza" post="virus is dependent on the virus lineage. J Virol."/>
   <result pre="66SheahanT, RockxB, DonaldsonE, SimsA, PicklesR, CortiD, et al.Mechanisms of zoonotic" exact="severe acute respiratory syndrome" post="coronavirus host range expansion in human airway epithelium. J"/>
   <result pre="SimmonsCP, ThanhTT, HienVM, SmithGJD, ChauTNB, et al.Fatal outcome of human" exact="influenza" post="A (H5N1) is associated with high viral load and"/>
   <result pre="96DemoginesA, FarzanM, SawyerSL. Evidence for ACE2-utilizing coronaviruses (CoVs) related to" exact="severe acute respiratory syndrome" post="CoV in bats. J Virol. 2012;86: 6350â€&quot;6353. 10.1128/JVI.00311-1222438550 97KaelberJT,"/>
   <result pre="2008;451: 990â€&quot;993. 10.1038/nature0653618288193 116HanBA, DrakeJM. Future directions in analytics for" exact="infectious disease" post="intelligence: Toward an integrated warning system for emerging pathogens."/>
   <result pre="292â€&quot;294. 10.2471/BLT.17.20500529695886 118BarryJM. The site of origin of the 1918" exact="influenza" post="pandemic and its public health implications. J Transl Med."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6476501\results\search\disease\results.xml">
   <result pre="doi: 10.1371/journal.pone.0215514PONE-D-18-35451 : Research Article Unreliable usage of a single" exact="influenza" post="virus IgM antibody assay in influenza-like illness: A retrospective"/>
   <result pre="flu epidemic A retrospective study of usage of a single" exact="influenza" post="virus IgM antibody assay in 2016-2018 flu epidemic YaoYaoConceptualizationData"/>
   <result pre="credited.pone.0215514.pdf Abstract We retrospectively analyzed serum IgM antibodies (Abs) to" exact="influenza" post="viruses from two tertiary hospitals in Beijing from December"/>
   <result pre="IgM Abs were less effective in the diagnosis of acute" exact="influenza" post="virus infection, and the use of this assay for"/>
   <result pre="available from the Fighare datebase, https://figshare.com/s/a8342851717c2acfdd00. Introduction The epidemic of" exact="influenza" post="is an important public health problem in worldwide [1]."/>
   <result pre="B (Flu B) infections account for a vast majority of" exact="influenza" post="cases in humans [2]. Most of these infections are"/>
   <result pre="symptoms, presenting as influenza-like illnesses (ILI). However, some patients with" exact="influenza" post="exhibit severe symptoms, leading to hospitalization or even death,"/>
   <result pre="the elderly, and those with underlying chronic conditions [3]. Seasonal" exact="influenza" post="results in approximately 250,000â€&quot;500,000 deaths worldwide in each year"/>
   <result pre="seasonal A (H3N2) (sH3N2), as well as the type B" exact="influenza" post="virus Victoria lineage (B/Victoria) [10]. However, low immunization coverage"/>
   <result pre="[10]. However, low immunization coverage and lack of type B" exact="influenza" post="viruses of the Yamagata lineage (B/Yamagata) in the current"/>
   <result pre="viruses of the Yamagata lineage (B/Yamagata) in the current trivalent" exact="influenza" post="vaccine in China would promote its prevalence [11]. Indeed,"/>
   <result pre="during the 2017â€&quot;2018 winter season, China experienced a national wide" exact="influenza" post="epidemic. Reported influenza cases throughout the entire nation in"/>
   <result pre="winter season, China experienced a national wide influenza epidemic. Reported" exact="influenza" post="cases throughout the entire nation in winter of 2017"/>
   <result pre="for simpler and rapider assays to facilitate the diagnosis of" exact="influenza" post="infections and differentiate the subtypes/lineages of the viruses. Reverse"/>
   <result pre="subtypes/lineages of the viruses. Reverse transcription-polymerase chain reaction (PCR)-based tests," exact="influenza" post="rapid diagnostic test (IRDT), and serological detection of specific"/>
   <result pre="IgG Abs) targeting the viruses were recommended to assist with" exact="influenza" post="diagnosis from ILI cases in the clinical setting [14]."/>
   <result pre="tests, providing insights into the use of IgM Abs for" exact="influenza" post="diagnosis. Materials and methods Ethics statement Data were analyzed"/>
   <result pre="(DIAGNOSTIC HYBRIDS, USA) was used at Beijing Childrenâ€™s Hospital for" exact="influenza" post="antigen detection. This kit uses viral antigen-specific murine monoclonal"/>
   <result pre="Influenza A&amp;amp;B was used at Beijing Tsinghua Changgung Hospital for" exact="influenza" post="antigen tests. This kit is a product of Alear"/>
   <result pre="indicate the epidemic intensities of certain pathogens, we compared the" exact="influenza" post="antigen and IgM Abs results during the 2016 and"/>
   <result pre="were 923 hospitalized pediatric patients with ILI simultaneously analyzed for" exact="influenza" post="antigen and IgM Abs (519 in the 2016 and"/>
   <result pre="reliable pathogens screening is important for diagnosis and prevention of" exact="influenza" post="virus infection. Common detecting methods include IRDT for Flu"/>
   <result pre="for viral RNA, and serum-specific IgM or IgG Abs to" exact="influenza" post="virus [21,22]. To date, many reports have described the"/>
   <result pre="ELISA to detect IgM, IgG, and IgA Abs responses to" exact="influenza" post="p(H1N1) hemagglutinin in infected persons during the 2009 pandemic"/>
   <result pre="of IgM Abs to Flu A and Flu B with" exact="influenza" post="antigen detection. Beijing Childrenâ€™s Hospital and Beijing Tsinghua Changgung"/>
   <result pre="environment and keep neutralizing antibodies from their mothers, thereby avoiding" exact="influenza" post="virus infection. On other hand, children ages 4â€&quot;5 years"/>
   <result pre="active to public facilities and therefore have more exposure to" exact="influenza" post="viruses [26]. The incidence of IgM Abs to Flu"/>
   <result pre="limitations of the present study. To determine the presence of" exact="influenza" post="infection, the standard method should be virus culture combined"/>
   <result pre="on IgM Abs detection. According to a survey, the general" exact="influenza" post="vaccination rate in China is less than 3%, but"/>
   <result pre="IgM Abs were less effective for the diagnosis of acute" exact="influenza" post="virus infection owing to lack of detection of IgM"/>
   <result pre="further studies are needed to develop new broad spectrum of" exact="influenza" post="diagnostic assays based on serum. Supporting information S1 Table"/>
   <result pre="BarrIG, BroorS, ChadhaM, CoxNJ, et al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic drift. Nature. 2015;523(7559): 217â€&quot;220. 10.1038/nature1446026053121"/>
   <result pre="Yousey-HindesK, et al.Comparing clinical characteristics between hospitalized adults with lAbsoratory-confirmed" exact="influenza" post="A and B virus infection. Clin Infect Dis. 2014;59(2):"/>
   <result pre="WatsonSJ, ChoyK-T, SiaSF, WongDDY, PoonLLM, et al.Generation and characterization of" exact="influenza" post="A viruses with altered polymerase fidelity. Nat Commun. 2014;5:"/>
   <result pre="van BeekR, SpronkenMIJ, et al.Genetic evolution of the neuraminidase of" exact="influenza" post="A (H3N2) viruses from 1968 to 2009 and its"/>
   <result pre="9): 1996â€&quot;2007. 10.1099/vir.0.043059-022718569 7ChenR, HolmesEC. The evolutionary dynamics of human" exact="influenza" post="B virus. J Mol Evol. 2008;66(6): 655â€&quot;663. 10.1007/s00239-008-9119-z18504518 8JianJ-W,"/>
   <result pre="ChenP-J, et al.Genetic analysis and evaluation of the reassortment of" exact="influenza" post="B viruses isolated in Taiwan during the 2004â€&quot;2005 and"/>
   <result pre="et al.Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemic. Nature. 2009;459: 112210.1038/nature0818219516283 10CainiS, SpreeuwenbergP, KusznierzGF, RudiJM,"/>
   <result pre="112210.1038/nature0818219516283 10CainiS, SpreeuwenbergP, KusznierzGF, RudiJM, OwenR, PenningtonK, et al.Distribution of" exact="influenza" post="virus types by age using case-based global surveillance data"/>
   <result pre="of 10 years of clinical experience with Chinese domestic trivalent" exact="influenza" post="vaccine Anflu(Â®). Human Vaccines Immunother. 2014;10(1): 73â€&quot;82. 12(CNIC) CNIC."/>
   <result pre="14collab: Commission NHaFP. Chinese guidelines for diagnosis and treatment of" exact="influenza" post="(2018 version). Chin J Viral Dis. 2018;81â€&quot;85. 15DÃ¶llerG, DÃ¶llerPC,"/>
   <result pre="J Viral Dis. 2018;81â€&quot;85. 15DÃ¶llerG, DÃ¶llerPC, GerthHJ. Diagnostic significance of" exact="influenza" post="subtype-specific IgG, IgA, and IgM antibodies. J Biol Standard."/>
   <result pre="LiR, et al. (2019) Detection and characterization of type B" exact="influenza" post="virus from influenza-like illness cases during the 2017â€&quot;2018 winter"/>
   <result pre="influenza virus from influenza-like illness cases during the 2017â€&quot;2018 winter" exact="influenza" post="season in Beijing, China. Archives of virology. 19IpDKM, LauLLH,"/>
   <result pre="et al.A sandwich ELISA for the detection of neuraminidase of" exact="avian influenza" post="A(H7N9) virus. J Virol Methods. 2017;247: 58â€&quot;60. 10.1016/j.jviromet.2017.05.01428551451 22LinZ-F,"/>
   <result pre="al.A sandwich ELISA for the detection of neuraminidase of avian" exact="influenza" post="A(H7N9) virus. J Virol Methods. 2017;247: 58â€&quot;60. 10.1016/j.jviromet.2017.05.01428551451 22LinZ-F,"/>
   <result pre="LAbs. 2015;61(8): 917â€&quot;924. 23UrquhartGE. Serum IgM and IgA responses in" exact="influenza" post="A infections. J Clin Pathol. 1974;3(27). 24LiZ-N, LinS-C, CarneyPJ,"/>
   <result pre="LiuF, LuX, et al.IgM, IgG, and IgA antibody responses to" exact="influenza" post="A(H1N1)pdm09 hemagglutinin in infected persons during the first wave"/>
   <result pre="HoleK, BerhaneY. Production and diagnostic application of monoclonal antibodies against" exact="influenza" post="virus H5. J Virol Methods. 2009;162(1): 194â€&quot;202.19699764 26GartenR, BlantonL,"/>
   <result pre="2009;162(1): 194â€&quot;202.19699764 26GartenR, BlantonL, ElalAIA, AlAbsiN, BarnesJ, BiggerstaffM, et al.Update:" exact="influenza" post="activity in the United States during the 2017â€&quot;18 season"/>
   <result pre="States during the 2017â€&quot;18 season and composition of the 2018â€&quot;19" exact="influenza" post="vaccine. Morbid Mortal Weekly Rep. 2018;67(22): 634â€&quot;642. 27JenningsL, HuangQS,"/>
   <result pre="LeePI, KimWJ, BuchyP, et al.Literature review of the epidemiology of" exact="influenza" post="B disease in 15 countries in the Asiaâ€�Pacific region."/>
   <result pre="2018;12(3): 383â€&quot;411. 10.1111/irv.1252229127742 28WeiM, YanZq, WangC, LiuW, CaoW. Eightâ€�hospital based" exact="influenza" post="like illness surveillance from April, 2009 to March, 2011"/>
   <result pre="10.1111/irv.1206423216804 29TranD, VaudryW, MooreD, BettingerJA, HalperinSA, ScheifeleDW, et al.Hospitalization for" exact="influenza" post="A versus B. Pediatrics. 2016;138(3). 30HenricksonKJ, HooverS, KehlKS, HuaWM."/>
   <result pre="of a risk score for predicting hospitalization in children with" exact="influenza" post="virus infection. Ped Emerg Care. 2009;25(6): 369â€&quot;375. 32RojoJC, Ruiz-ContrerasJ,"/>
   <result pre="33LiuX-X, LiY, ZhuY, ZhangJ, LiX, ZhangJ, et al.Seasonal pattern of" exact="influenza" post="activity in a subtropical city, China, 2010â€&quot;2015. Sci Rep."/>
   <result pre="Performance of rapid-test kits for the detection of the pandemic" exact="influenza" post="A/H1N1 virus. J Virol Methods. 2011;173(2): 387â€&quot;389. 10.1016/j.jviromet.2011.02.00921333688 35LevineMZ,"/>
   <result pre="JeffersonS, ColeKS, ArchibaldCA, et al.Neutralizing antibody responses to antigenically drifted" exact="influenza" post="A(H3N2) viruses among children and adolescents following 2014â€&quot;2015 inactivated"/>
   <result pre="among children and adolescents following 2014â€&quot;2015 inactivated and live attenuated" exact="influenza" post="vaccination. Clin Vaccine Immunol. 2016;23(10): 831â€&quot;839. 10.1128/CVI.00297-1627558294 36GuthmillerJJ, WilsonPC."/>
   <result pre="2016;23(10): 831â€&quot;839. 10.1128/CVI.00297-1627558294 36GuthmillerJJ, WilsonPC. Harnessing immune history to combat" exact="influenza" post="viruses. Curr Opin Immunol. 2018;53: 187â€&quot;195. 10.1016/j.coi.2018.05.01029890370"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6480969\results\search\disease\results.xml">
   <result pre="Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The 2009 pandemic" exact="influenza" post="virus caused the majority of the influenza A virus"/>
   <result pre="The 2009 pandemic influenza virus caused the majority of the" exact="influenza" post="A virus infections in China in 2009. It arrived"/>
   <result pre="to humans by direct body contact or respiratory droplets. The" exact="infectious disease" post="can spread widely as people carrying pathogens travel and"/>
   <result pre="people who travel daily along the interstate highways during the" exact="influenza" post="season is larger than 3.8 million, which is over"/>
   <result pre="and Foshan city in China [5]. For the highly pathogenic" exact="avian influenza," post="national highways were one of the most important predictive"/>
   <result pre="[16]. In the United States, the genetic distances between seasonal" exact="influenza" post="A (H1N1) viruses were found to correlate with the"/>
   <result pre="kilometers, and the role of this road-based travel in facilitating" exact="influenza" post="transmission should not be neglected [6]. Research on the"/>
   <result pre="be neglected [6]. Research on the spread of the 2009" exact="influenza" post="A (H1N1) virus in the Republic of Korea showed"/>
   <result pre="has been reported to partially affect the transmission of seasonal" exact="influenza" post="in U.S. cities [21]. Other socioeconomic factors like population"/>
   <result pre="unemployment were significantly associated with the mortality from the 1918" exact="influenza" post="pandemic in Chicago [19]. As for the 2009 influenza"/>
   <result pre="1918 influenza pandemic in Chicago [19]. As for the 2009" exact="influenza" post="pandemic in China, it has been suggested that the"/>
   <result pre="network and socioeconomic factors on the diffusion of the 2009" exact="influenza" post="pandemic. 2. Materials and Methods 2.1. Data The suspected"/>
   <result pre="and Methods 2.1. Data The suspected and laboratory-confirmed cases of" exact="influenza" post="A (H1N1) used in this study were obtained from"/>
   <result pre="transportation and the spatial distance to the spread of the" exact="influenza" post="virus, we used spatial autoregressive models [33] performed in"/>
   <result pre="nearly all Chinese cities had been exposed to the emerging" exact="influenza" post="virus. 3.2. Characteristics of the National Highway Network The"/>
   <result pre="traffic and other socioeconomic factors on the nationwide spread of" exact="influenza" post="A (H1N1) across China in 2009. We constructed a"/>
   <result pre="week and Multicenter Distance, we understand the transmission process of" exact="influenza" post="A (H1N1) as follows: At the very beginning, internationally"/>
   <result pre="traffic, as well as socioeconomic factors and the spread of" exact="influenza" post="A (H1N1), we conducted spatial regression analyses. When the"/>
   <result pre="significantly associated with the arrival time of the first confirmed" exact="influenza" post="A (H1N1) case in each Chinese county in 2009"/>
   <result pre="between 5â€&quot;24 years old were most affected by the 2009" exact="influenza" post="A (H1N1) in China. Therefore, our positive association between"/>
   <result pre="would tend to conduct stronger intervention measures to control the" exact="infectious disease," post="reducing the cumulative incidence. When the onset week was"/>
   <result pre="be the true first person who was infected by the" exact="influenza" post="virus in a given city. It is possible that"/>
   <result pre="taken place. As the reservoir of the 2009 pandemic H1N1" exact="influenza" post="virus, pigs can carry this virus, can transmit it"/>
   <result pre="reported that school students were more susceptible to the 2009" exact="influenza" post="A (H1N1) than other age groups in China [37]"/>
   <result pre="in China [37] and that schools were high-risk areas for" exact="influenza" post="outbreaks and should be the focus for prevention [22,40]."/>
   <result pre="of road transportation in the spatial diffusion of the 2009" exact="influenza" post="A (H1N1) virus in mainland China. It has been"/>
   <result pre="is a significant factor in the global spread of the" exact="influenza" post="virus, short-range daily travel on the ground is more"/>
   <result pre="than air travel for the spatial transmission of the 2009" exact="influenza" post="A (H1N1) virus in China. Unlike some countries in"/>
   <result pre="in Europe and America which experienced two infection peaks of" exact="influenza" post="during 2009, China had only one autumn-winter wave in"/>
   <result pre="it is much more difficult to restrict the diffusion of" exact="influenza" post="virus by road travel. In this respect, the role"/>
   <result pre="not only have direct impacts on the development of an" exact="influenza" post="pandemic but also indirectly exert an influence by stimulating"/>
   <result pre="and socioeconomic factors in the face of a newly emerging" exact="influenza" post="pandemic, especially in the early stages. For instance, although"/>
   <result pre="of the percentage of respiratory specimens tested positive for the" exact="influenza" post="virus, the number of reported cases was much less"/>
   <result pre="of infected individuals [34]. It was observed globally in many" exact="influenza" post="outbreaksthat not all cases were reported to the medical"/>
   <result pre="be constructed to investigate the diffusion process of the 2009" exact="influenza" post="A (H1N1) under the effects of socioeconomic factors. 5."/>
   <result pre="factors had significant impacts on the diffusion of the 2009" exact="influenza" post="A (H1N1) virus at the city level in mainland"/>
   <result pre="should be candidates for the prevention and control of future" exact="influenza" post="pandemics. Acknowledgments We would like to thank Jun Cai,"/>
   <result pre="Rev. E Stat. Nonlinear Soft Matter Phys.20097901611110.1103/PhysRevE.79.016111 5.LiQ.CaoW.RenH.JiZ.JiangH.Spatiotemporal responses of" exact="dengue fever" post="transmission to the road network in an urban areaActa"/>
   <result pre="Transp. Eng.20055120123 9.WengW.NiS.Evaluation of containment and mitigation strategies for an" exact="influenza" post="A pandemic in ChinaSimulation20159140741610.1177/0037549715581637 10.FangL.Q.WangL.P.de VlasS.J.LiangS.TongS.L.LiY.L.LiY.P.QianQ.YangH.ZhouM.G.et al.Distribution and risk"/>
   <result pre="ChinaSimulation20159140741610.1177/0037549715581637 10.FangL.Q.WangL.P.de VlasS.J.LiangS.TongS.L.LiY.L.LiY.P.QianQ.YangH.ZhouM.G.et al.Distribution and risk factors of 2009 pandemic" exact="influenza" post="A (H1N1) in mainland ChinaAm. J. Epidemiol.201217589089710.1093/aje/kwr41122491083 11.FangL.Q.de VlasS.J.LiangS.LoomanC.W.GongP.XuB.YanL.YangH.RichardusJ.H.CaoW.C.Environmental"/>
   <result pre="Epidemiol.201217589089710.1093/aje/kwr41122491083 11.FangL.Q.de VlasS.J.LiangS.LoomanC.W.GongP.XuB.YanL.YangH.RichardusJ.H.CaoW.C.Environmental factors contributing to the spread of H5N1" exact="avian influenza" post="in mainland ChinaPLoS ONE20083e226810.1371/journal.pone.000226818509468 12.MeiS.ChenB.ZhuY.LeesM.H.BoukhanovskyA.V.SlootP.M.A.Simulating city-level airborne infectious diseasesComput."/>
   <result pre="11.FangL.Q.de VlasS.J.LiangS.LoomanC.W.GongP.XuB.YanL.YangH.RichardusJ.H.CaoW.C.Environmental factors contributing to the spread of H5N1 avian" exact="influenza" post="in mainland ChinaPLoS ONE20083e226810.1371/journal.pone.000226818509468 12.MeiS.ChenB.ZhuY.LeesM.H.BoukhanovskyA.V.SlootP.M.A.Simulating city-level airborne infectious diseasesComput."/>
   <result pre="Int. Health200914Suppl. 1142010.1111/j.1365-3156.2008.02189.x19508436 14.TeurlaiM.HuyR.CazellesB.DubozR.BaehrC.VongS.Can human movements explain heterogeneous propagation of" exact="dengue fever" post="in Cambodia?PLoS Negl. Trop. Dis.20126e195710.1371/journal.pntd.000195723236536 15.CaoC.XuM.ChangC.XueY.ZhongS.FangL.CaoW.ZhangH.GaoM.HeQ.et al.Risk analysis for"/>
   <result pre="Negl. Trop. Dis.20126e195710.1371/journal.pntd.000195723236536 15.CaoC.XuM.ChangC.XueY.ZhongS.FangL.CaoW.ZhangH.GaoM.HeQ.et al.Risk analysis for the highly pathogenic" exact="avian influenza" post="in Mainland China using meta-modelingChin. Sci. Bull.2010554168417810.1007/s11434-010-4225-x 16.YupianaY.de VlasS.J.AdnanN.M.RichardusJ.H.Risk"/>
   <result pre="Trop. Dis.20126e195710.1371/journal.pntd.000195723236536 15.CaoC.XuM.ChangC.XueY.ZhongS.FangL.CaoW.ZhangH.GaoM.HeQ.et al.Risk analysis for the highly pathogenic avian" exact="influenza" post="in Mainland China using meta-modelingChin. Sci. Bull.2010554168417810.1007/s11434-010-4225-x 16.YupianaY.de VlasS.J.AdnanN.M.RichardusJ.H.Risk"/>
   <result pre="VlasS.J.AdnanN.M.RichardusJ.H.Risk factors of poultry outbreaks and human cases of H5N1" exact="avian influenza" post="virus infection in West Java Province, IndonesiaInt. J. Infect."/>
   <result pre="factors of poultry outbreaks and human cases of H5N1 avian" exact="influenza" post="virus infection in West Java Province, IndonesiaInt. J. Infect."/>
   <result pre="using commuting flow for national spread of the 2009 H1N1" exact="influenza" post="virus in the Republic of KoreaJ. Biol.201845432032910.1016/j.jtbi.2018.06.01629940195 18.TianH.HuS.CazellesB.ChowellG.GaoL.LaineM.LiY.YangH.LiY.YangQ.et al.Urbanization"/>
   <result pre="hantavirus epidemics in citiesProc. Natl. Acad. Sci. USA20181154707471210.1073/pnas.171276711529666240 19.GrantzK.H.RaneM.S.SaljeH.GlassG.E.SchachterleS.E.CummingsD.A.Disparities in" exact="influenza" post="mortality and transmission related to sociodemographic factors within Chicago"/>
   <result pre="of 1918Proc. Natl. Acad. Sci. USA2016113138391384410.1073/pnas.161283811327872284 20.WangL.WangJ.XuC.LiuT.Modelling input-output flows of" exact="severe acute respiratory syndrome" post="in mainland ChinaBMC Public Health20161619110.1186/s12889-016-2867-626924026 21.DalzielB.D.KisslerS.GogJ.R.ViboudC.BjÃ¸rnstadO.N.MetcalfC.J.E.GrenfellB.T.Urbanization and humidity shape"/>
   <result pre="ChinaBMC Public Health20161619110.1186/s12889-016-2867-626924026 21.DalzielB.D.KisslerS.GogJ.R.ViboudC.BjÃ¸rnstadO.N.MetcalfC.J.E.GrenfellB.T.Urbanization and humidity shape the intensity of" exact="influenza" post="epidemics in U.S. citiesScience2018362757910.1126/science.aat603030287659 22.XiaoH.LinX.ChowellG.HuangC.GaoL.ChenB.WangZ.ZhouL.HeX.LiuH.Urban structure and the risk"/>
   <result pre="epidemics in U.S. citiesScience2018362757910.1126/science.aat603030287659 22.XiaoH.LinX.ChowellG.HuangC.GaoL.ChenB.WangZ.ZhouL.HeX.LiuH.Urban structure and the risk of" exact="influenza" post="A(H1N1) outbreaks in municipal districtsSci. Bull.20145955456210.1007/s11434-013-0084-6 23.MATLAB and Statistics"/>
   <result pre="flowsJ. Reg. Sci.20104894196710.1111/j.1467-9787.2008.00573.x 34.Cui-LingX.U.SunS.H.ZhangY.P.ShiJ.H.XiangN.J.WangL.J.YuanF.ChenM.ChenT.YangJ.Epidemiological characteristics of confirmed cases of pandemic" exact="influenza" post="A(H1N1) 2009 in mainland China, 2009-2010Dis. Surveill.201126780784 35.LeeS.S.WongN.S.The clustering"/>
   <result pre="China, 2009-2010Dis. Surveill.201126780784 35.LeeS.S.WongN.S.The clustering and transmission dynamics of pandemic" exact="influenza" post="A (H1N1) 2009 cases in Hong KongJ. Infect.20116327428010.1016/j.jinf.2011.03.01121601284 36.TellierR.Aerosol"/>
   <result pre="(H1N1) 2009 cases in Hong KongJ. Infect.20116327428010.1016/j.jinf.2011.03.01121601284 36.TellierR.Aerosol transmission of" exact="influenza" post="A virus: A review of new studiesJ. R. Soc."/>
   <result pre="dynamics, border entry screening, and school holidays during the 2009" exact="influenza" post="A (H1N1) pandemic, ChinaEmerg. Infect. Dis.20121875876610.3201/eid1805.11035622515989 38.HolmesE.C.GrenfellB.T.Discovering the phylodynamics"/>
   <result pre="Biol.20095e100050510.1371/journal.pcbi.100050519855824 39.BootsmaM.C.J.FergusonN.M.The effect of public health measures on the 1918" exact="influenza" post="pandemic in U.S. citiesProc. Natl. Acad. Sci. USA20071047588759310.1073/pnas.061107110417416677 40.CauchemezS.FergusonN.M.WachtelC.TegnellA.SaourG.DuncanB.NicollA.Closure"/>
   <result pre="citiesProc. Natl. Acad. Sci. USA20071047588759310.1073/pnas.061107110417416677 40.CauchemezS.FergusonN.M.WachtelC.TegnellA.SaourG.DuncanB.NicollA.Closure of schools during an" exact="influenza" post="pandemicLancet Infect. Dis.2009947348110.1016/S1473-3099(09)70176-819628172 41.CaiJ.XuB.ChanK.K.Y.ZhangX.ZhangB.ChenZ.XuB.Roles of Different Transport Modes in"/>
   <result pre="labeled with their names. Figure 2 The development of the" exact="influenza" post="pandemic in mainland China in 2009: (a) The weekly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6489371\results\search\disease\results.xml">
   <result pre="Oswaldo Cruz201811310e18027830427974 2NunesMRTPalaciosGCardosoJFMartinsLCSousaECde LimaCPSet al.Genomic and phylogenetic characterization of Brazilian" exact="yellow fever" post="virus strainsJ Virol132201986241326313271http://www.ncbi.nlm.nih.gov/pubmed/23015713 3MirDDelatorreEBonaldoMLourenÃ§o-de-OliveiraRVicenteACBelloGPhylodynamics of Yellow Fever virus in"/>
   <result pre="Dis2017119127 44MondetBVasconcelosPFCTravassos da RosaAPATravassos da RosaESRodriguesSGTravassos da RosaJFSet al.Isolation of" exact="yellow fever" post="virus from Nulliparous Haemagogus (Haemagogus) janthinomys in Eastern Amazonia0922019214750http://www.ncbi.nlm.nih.gov/pubmed/12656130"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6504036\results\search\disease\results.xml">
   <result pre="accuracy of a rapid RT-PCR assay for point-of-care detection of" exact="influenza" post="A/B virus at emergency department admission: A prospective evaluation"/>
   <result pre="at emergency department admission: A prospective evaluation during the 2017/2018" exact="influenza" post="season Rapid RT-PCR assay to detect influenza A/B in"/>
   <result pre="during the 2017/2018 influenza season Rapid RT-PCR assay to detect" exact="influenza" post="A/B in the emergency department http://orcid.org/0000-0002-4301-4213MaignanMaximeConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject"/>
   <result pre="this study and are currently working outside the field of" exact="influenza" post="diagnosis or treatment. MM and DV received a grant"/>
   <result pre="investigate the performance of a rapid RT-PCR assay to detect" exact="influenza" post="A/B at emergency department admission. Methods This single-center prospective"/>
   <result pre="Rapid RT-PCR assay performed by nurses at triage to detect" exact="influenza" post="A/B is feasible and highly accurate. Funding Roche Diagnosticshttp://orcid.org/0000-0002-4301-4213MaignanMaxime"/>
   <result pre="department stay lengths, bed use and premature patient departures during" exact="influenza" post="epidemics.[3â€&quot;5] During influenza epidemics, the management of patients attending"/>
   <result pre="bed use and premature patient departures during influenza epidemics.[3â€&quot;5] During" exact="influenza" post="epidemics, the management of patients attending the emergency department"/>
   <result pre="assess the diagnostic accuracy of a rapid RT-PCR assay for" exact="influenza" post="A/B by nurses at a triage point of care."/>
   <result pre="The study took place in January 2018, when the 2017/2018" exact="influenza" post="season was at its peak. All patients were screened"/>
   <result pre="results from the triage assay. At triage, the Roche cobas" exact="influenza" post="A/B Nucleic Acid test, a Clinical Laboratory Improvement Amendments"/>
   <result pre="RT-PCR assay (cobas Liat system) performed at triage to detect" exact="influenza" post="A/B, therefore RSV detection was not evaluated. The primary"/>
   <result pre="the diagnostic accuracy of the rapid RT-PCR assay to detect" exact="influenza" post="A/B, including sensitivity, specificity and the negative and positive"/>
   <result pre="RT-PCR performed in the department of virology using the Human" exact="influenza" post="A/B PCR kitâ€&quot;R-DiaFlu (Diagenode Diagnostics, OugrÃ©e, Belgium) was considered"/>
   <result pre="a sample was also sent for analysis to the national" exact="influenza" post="virus reference center (Centre National de RÃ©fÃ©rence du Virus"/>
   <result pre="the estimation that 45% of samples would be positive to" exact="influenza" post="A or B, a sample size of 173 patients"/>
   <result pre="(52%) patients: 28 (15%) patients had a positive result for" exact="influenza" post="A, 44 (24%) patients had a positive result for"/>
   <result pre="influenza A, 44 (24%) patients had a positive result for" exact="influenza" post="B and 25 (13%) patients had a positive result"/>
   <result pre="laboratory assay results. Of these three, two positive results for" exact="influenza" post="A at triage were found to be negative in"/>
   <result pre="national reference center. The third result discrepancy was a negative" exact="influenza" post="B triage result that was found to be positive"/>
   <result pre="rapid RT-PCR assay at triage had a global sensitivity for" exact="influenza" post="A/B of 0.98 (95% CI: 0.91â€&quot;1.00) and a specificity"/>
   <result pre="(IQR: 35â€&quot;42). Discussion This study demonstrated that the detection of" exact="influenza" post="A/B virus using rapid RT-PCR assay at triage performed"/>
   <result pre="specificity of the cobas Liat system for the detection of" exact="influenza" post="A/B was higher than 0.98, even when performed by"/>
   <result pre="Direct comparison of rapid molecular tests for the detection of" exact="influenza" post="was carried out under laboratory conditions using samples from"/>
   <result pre="further studies are necessary to assess the clinical impact of" exact="influenza" post="RT-PCR assay at triage in order to evaluate its"/>
   <result pre="[36,38] and antiviral treatment [37], especially for patients with an" exact="influenza" post="negative diagnosis, highlighting the importance of tests that have"/>
   <result pre="had several limitations. First, the percentage of positive results for" exact="influenza" post="was lower than that anticipated in the sample size"/>
   <result pre="be noted that the results may differ slightly depending on" exact="influenza" post="strains and epidemics. Third, this study was conducted in"/>
   <result pre="department were not included. Not all patients who actually have" exact="influenza" post="have fever, particularly older people, which may have led"/>
   <result pre="has the potential to dramatically improve patient care during seasonal" exact="influenza" post="epidemics. This study demonstrated the feasibility and the high"/>
   <result pre="and the high accuracy of rapid RT-PCR assay to detect" exact="influenza" post="A/B when performed by trained nurses at triage. Further"/>
   <result pre="Australas. 2018;30(1):77â€&quot;80. 10.1111/1742-6723.1280828544364 4SchanzerDL, SchwartzB. Impact of seasonal and pandemic" exact="influenza" post="on emergency department visits, 2003â€&quot;2010, Ontario, Canada. Acad Emerg"/>
   <result pre="10.1111/acem.1211123701347 5BeysardN, YersinB, MeylanP, HugliO, CarronP-N. Impact of the 2014â€&quot;2015" exact="influenza" post="season on the activity of an academic emergency department."/>
   <result pre="J Emerg Med. 2016;50(3):536â€&quot;42. 10.1016/j.jemermed.2015.10.01326763858 7Esteve-EsteveM, Bautista-RenteroD, ZanÃ³n-ViguerV. Risk of" exact="influenza" post="transmission in a hospital emergency department during the week"/>
   <result pre="8ChuHY, EnglundJA, HuangD, ScottE, ChanJD, JainR, et al.Impact of rapid" exact="influenza" post="PCR testing on hospitalization and antiviral use: A retrospective"/>
   <result pre="NEAR isothermal nucleic acid amplification assay for the detection of" exact="influenza" post="using adult nasopharyngeal specimens. J Clin Virol. 2017;94:86â€&quot;90. 10.1016/j.jcv.2017.07.01228772170"/>
   <result pre="17MelchersWJG, KuijpersJ, SicklerJJ, Rahamat-LangendoenJ. Lab-in-a-tube: Real-time molecular point-of-care diagnostics for" exact="influenza" post="A and B using the cobas Liat system. J"/>
   <result pre="Flu PCR test and the OSOM immunochromatographic rapid test for" exact="influenza" post="A and B virus among adult patients in the"/>
   <result pre="&amp;amp; B point of care test for the diagnosis of" exact="influenza" post="in an ED. Am J Emerg Med. 2018;36(6):916â€&quot;21. 10.1016/j.ajem.2017.10.04629137903"/>
   <result pre="ChoiSH, LimCS. The use of saliva specimens for detection of" exact="influenza" post="A and B viruses by rapid influenza diagnostic tests."/>
   <result pre="for detection of influenza A and B viruses by rapid" exact="influenza" post="diagnostic tests. J Virol Methods. 2017;243:15â€&quot;19. 10.1016/j.jviromet.2017.01.01328111058 30ValentinT, KieslingerP,"/>
   <result pre="et al.Prospective evaluation of three rapid molecular tests for seasonal" exact="influenza" post="in patients presenting at an emergency unit. J Clin"/>
   <result pre="PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of" exact="influenza" post="virus infection. Clin Microbiol Infect. 2018. 33YoungsJ, IqbalY, GlassS,"/>
   <result pre="GlassS, RileyP, PopeC, PlancheT, et al.Implementation of the cobas Liat" exact="influenza" post="point-of-care test into an emergency department during a high-incidence"/>
   <result pre="HarterK. An intervention to improve compliance with transmission precautions for" exact="influenza" post="in the emergency department: successes and challenges. J Emerg"/>
   <result pre="201914 37YoungsJ, MarshallB, FarragherM, WhitneyL, GlassS, PopeC, et al.Implementation of" exact="influenza" post="point-of-care testing and patient cohorting during a high-incidence season:"/>
   <result pre="RashidH, BooyR. Emergence of oseltamivir resistance: control and management of" exact="influenza" post="before, during and after the pandemic. Infect Disord Drug"/>
   <result pre="2013;13(1):34â€&quot;45. 23675925 41HussainM, GalvinHD, HawTY, NutsfordAN, HusainM. Drug resistance in" exact="influenza" post="A virus: the epidemiology and management. Infect Drug Resist."/>
   <result pre="42MontoAS, GravensteinS, ElliottM, ColopyM, SchweinleJ. Clinical signs and symptoms predicting" exact="influenza" post="infection. Arch Intern Med. 2000;160(21):3243â€&quot;7. 11088084"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6518542\results\search\disease\results.xml">
   <result pre="Original Paper Association of meteorological factors with seasonal activity of" exact="influenza" post="A subtypes and B lineages in subtropical western China"/>
   <result pre="the original work is properly cited.S0950268818003485a.pdf The seasonality of individual" exact="influenza" post="subtypes/lineages and the association of influenza epidemics with meteorological"/>
   <result pre="The seasonality of individual influenza subtypes/lineages and the association of" exact="influenza" post="epidemics with meteorological factors in the tropics/subtropics have not"/>
   <result pre="of the 2009 H1N1 pandemic on the prevalence of seasonal" exact="influenza" post="virus remains to be explored. Using wavelet analysis, the"/>
   <result pre="the upper reaches of the Yangtze River. The relationship between" exact="influenza" post="epidemics and local climatic variables was examined based on"/>
   <result pre="was examined based on regression models. The temporal distribution of" exact="influenza" post="subtypes/lineages during the pre-pandemic (2006â€&quot;2009), pandemic (2009) and post-pandemic"/>
   <result pre="A total of 6892 respiratory specimens were collected and 737" exact="influenza" post="viruses were isolated. A/H3N2 showed an annual cycle with"/>
   <result pre="lower absolute humidity. The role of weather conditions in regulating" exact="influenza" post="epidemics could be complicated since the diverse viral transmission"/>
   <result pre="Differences in seasonality and different associations with meteorological factors by" exact="influenza" post="subtypes/lineages should be considered in epidemiological studies in the"/>
   <result pre="and control measures is of significant importance. Key words Humidity" exact="influenza" post="A subtypes influenza B lineages meteorological factors pandemic seasonality"/>
   <result pre="is of significant importance. Key words Humidity influenza A subtypes" exact="influenza" post="B lineages meteorological factors pandemic seasonality subtropical western China"/>
   <result pre="China fig-count: table-count: ref-count: page-count: Introduction Type A and B" exact="influenza" post="viruses have caused significant morbidity, mortality and economic burden"/>
   <result pre="winter in temperate regions [3, 4]. However, seasonal activity of" exact="influenza" post="virus in the tropics/subtropics has not been well characterised."/>
   <result pre="low levels of absolute humidity (AH) are strongly associated with" exact="influenza" post="epidemics in temperate regions [6â€&quot;8]. In the tropics/subtropics, however,"/>
   <result pre="regions [6â€&quot;8]. In the tropics/subtropics, however, the climatic drivers of" exact="influenza" post="epidemics are inconsistent. Increased seasonal activity of influenza virus"/>
   <result pre="drivers of influenza epidemics are inconsistent. Increased seasonal activity of" exact="influenza" post="virus was reported to be associated with higher humidity"/>
   <result pre="or contradictory effects were observed in other locales [9â€&quot;11]. Currently," exact="influenza" post="A virus subtype H3N2 (A/H3N2) and the 2009 pandemic"/>
   <result pre="influenza A virus subtype H3N2 (A/H3N2) and the 2009 pandemic" exact="influenza" post="A virus subtype H1N1 (A/H1N1pdm09), as well as two"/>
   <result pre="influenza A virus subtype H1N1 (A/H1N1pdm09), as well as two" exact="influenza" post="B lineages, B/Victoria/2/1987-like (Victoria) and B/Yamagata/16/1988-like (Yamagata), co-circulate in"/>
   <result pre="H1N1 pandemic. After the pandemic, A/H1N1pdm09 replaced the pre-existing seasonal" exact="influenza" post="A virus subtype H1N1 (seasonal A/H1N1) [12â€&quot;15]. The epidemic"/>
   <result pre="virus subtype H1N1 (seasonal A/H1N1) [12â€&quot;15]. The epidemic peaks of" exact="influenza" post="type A and B have been reported to coincide"/>
   <result pre="[16, 17]. However, epidemiological studies on the seasonality of individual" exact="influenza" post="A subtypes and B lineages are limited; and the"/>
   <result pre="of the pandemic on the seasonal activity of the resident" exact="influenza" post="subtypes/lineages remain to be explored. The objectives of this"/>
   <result pre="study were to characterise and compare the temporal distribution of" exact="influenza" post="subtypes/lineages during the pre-pandemic, pandemic and post-pandemic years, as"/>
   <result pre="post-pandemic years, as well as to examine the relationships between" exact="influenza" post="epidemics and meteorological factors in a subtropical city in"/>
   <result pre="subtropical city in detail. Since the diverse seasonal patterns of" exact="influenza" post="virus in the tropics/subtropics, analysing surveillance data with greater"/>
   <result pre="Yamagata were characterised; and the relationship between seasonal activity of" exact="influenza" post="virus and climate variables was assessed. We also calculated"/>
   <result pre="climate variables was assessed. We also calculated the frequency of" exact="influenza" post="B vaccination mismatches. Materials and methods Influenza surveillance data"/>
   <result pre="Influenza surveillance was conducted year-round based on a sentinel hospital-based" exact="influenza" post="surveillance system, including two Grade III level A hospitals"/>
   <result pre="to inoculate clinical specimens. The types, subtypes and lineages of" exact="influenza" post="isolates were identified by haemagglutination inhibition (HI) test and/or"/>
   <result pre="test were used to identify types, subtypes and lineages of" exact="influenza" post="isolates. From 2009 to 2015, both virus culture and"/>
   <result pre="subtyped using virus culture and HI test. ILI consultation and" exact="influenza" post="virologic surveillance were carried out based on the guideline"/>
   <result pre="surveillance were carried out based on the guideline for national" exact="influenza" post="surveillance [19]. The primers and probes used for rRT-PCR"/>
   <result pre="China. Data were collected based on the guideline for national" exact="influenza" post="surveillance [19] coordinated and supported by the Chinese Center"/>
   <result pre="six post-pandemic years (2010â€&quot;2015) were included in the analyses. Unsubtyped" exact="influenza" post="A virus-positive isolates were allocated to A/H3N2, seasonal A/H1N1"/>
   <result pre="each lineage, excluding 2010 when 24 out of 33 (72.3%)" exact="influenza" post="B virus-positive specimens were not determined. Because the A/H1N1pdm09"/>
   <result pre="which were calculated as monthly numbers of positive specimens (all" exact="influenza" post="viruses, or each A subtype, or each B lineage)"/>
   <result pre="a P value satisfying PÂ Correlations of seasonal activity of" exact="influenza" post="subtypes/lineages with monthly mean temperature, VP and RH, as"/>
   <result pre="(SPSS Inc., Chicago, IL, USA). Results Seasonality and periodicity of" exact="influenza" post="epidemics in Panzhihua A total of 6892 respiratory specimens"/>
   <result pre="Panzhihua A total of 6892 respiratory specimens were collected and" exact="influenza" post="viruses were isolated from 737 (10.69%) specimens during 2006â€&quot;2015"/>
   <result pre="from 737 (10.69%) specimens during 2006â€&quot;2015 (Table 1). The composite" exact="influenza" post="virus activity including all laboratory-confirmed influenza viruses exhibited non-stationary"/>
   <result pre="(Table 1). The composite influenza virus activity including all laboratory-confirmed" exact="influenza" post="viruses exhibited non-stationary periodicity (Fig. 1). Semi-annual cycles (PÂ"/>
   <result pre="non-stationary periodicity (Fig. 1). Semi-annual cycles (PÂ Fig. 1. Composite" exact="influenza" post="virus activity in Panzhihua during 2006â€&quot;2015. (a) The monthly"/>
   <result pre="Panzhihua during 2006â€&quot;2015. (a) The monthly positive rate of all" exact="influenza" post="viruses combined and the monthly positive numbers of laboratory-confirmed"/>
   <result pre="(b) Wavelet power spectrum of the monthly activity of all" exact="influenza" post="viruses combined. Black lines highlight periodicities that reach statistical"/>
   <result pre="square-root transformed. Table 1. Number, positive rates and proportions of" exact="influenza" post="virus by season in Panzhihua, 2006â€&quot;2015 No. (frequencya) of"/>
   <result pre="influenza virus by season in Panzhihua, 2006â€&quot;2015 No. (frequencya) of" exact="influenza" post="A subtypes and B lineages Proportionb of influenza A"/>
   <result pre="(frequencya) of influenza A subtypes and B lineages Proportionb of" exact="influenza" post="A subtypes and B lineages Year Specimens, No. Positive"/>
   <result pre="(2.70%) 59.43% 24.97% 5.43% 29.04% 40.30% 11.80% 25.24% Differences of" exact="influenza" post="virus-positive rates between the years before, during and after"/>
   <result pre="to be statistically significant (PÂ aThe positive rate of laboratory-confirmed" exact="influenza" post="cases among all specimens collected. bThe proportion of subtype-"/>
   <result pre="bThe proportion of subtype- or lineage-positive cases among all laboratory-confirmed" exact="influenza" post="cases. cA total of two isolates were of mixed"/>
   <result pre="two isolates were of mixed infections. dA total of 24" exact="influenza" post="B isolates in 2010 were not characterised into lineages."/>
   <result pre="each subtype/lineage in Panzhihua, 184, 40, 214, 87 and 186" exact="influenza" post="cases of A/H3N2, seasonal A/H1N1, A/H1N1pdm09, Victoria and Yamagata"/>
   <result pre="years (Fig. 2b and Fig. S1). Fig. 2. Monthly average" exact="influenza" post="virus activity and climatic parameters in Panzhihua during 2006â€&quot;2015."/>
   <result pre="2006â€&quot;2015. (a) The monthly average positive rates (square-root transformed) of" exact="influenza" post="A subtypes. Error bars show standard errors based on"/>
   <result pre="variation between years. (b) The same as A, but for" exact="influenza" post="B lineages. (c) Temperature, vapour pressure, and relative humidity."/>
   <result pre="and relative humidity. (d) Precipitation and sunshine hours. Association of" exact="influenza" post="epidemics with climatic parameters The monthly statistics for the"/>
   <result pre="h. The relationship between climate variables and the activity of" exact="influenza" post="subtypes/lineages was evaluated on a monthly basis. Table 2"/>
   <result pre="2 shows the Spearman's rank correlation coefficients between the monthly" exact="influenza" post="virus prevalence data and meteorological factors. A/H3N2 activity was"/>
   <result pre="0.044). Table 2. Spearman's rank correlation between meteorological factors and" exact="influenza" post="activity in Panzhihua, 2006â€&quot;2015 Spearman's rank correlation Temperature (Â°C)"/>
   <result pre="prevalence pattern of A/H1N1pdm09 during inter-pandemic years. Subtype/lineage distributions of" exact="influenza" post="epidemics Overall, 59.4% and 40.3% of influenza-positive cases during"/>
   <result pre="were significantly higher than in the pre-pandemic period. The predominant" exact="influenza" post="subtypes/lineages observed in Panzhihua are shown in Figure 1a"/>
   <result pre="were at least two subtypes/lineages co-circulating each year. One of" exact="influenza" post="A subtypes or one of B lineages predominated in"/>
   <result pre="in most years, except in 2012 and 2013 when an" exact="influenza" post="A subtype and a B lineage were codominant. Influenza"/>
   <result pre="and 2010 and A/H1N1pdm09 were not detected in 2015. Two" exact="influenza" post="B lineages co-circulated in many years, except in 2013â€&quot;2015"/>
   <result pre="when Yamagata were not detected. So far, only trivalent inactivated" exact="influenza" post="vaccine (TIV) have been available in the market in"/>
   <result pre="in the market in China. It was shown that the" exact="influenza" post="B strain included in TIV did not match the"/>
   <result pre="nine vaccination years studied (Fig. 3). Fig. 3. Proportion of" exact="influenza" post="B lineages in Panzhihua by vaccination year (September 2006â€&quot;August"/>
   <result pre="represent Victoria, white boxes represent Yamagata and grey boxes represent" exact="influenza" post="B isolates that were not determined. Horizontal bars on"/>
   <result pre="not determined. Horizontal bars on the top show the WHO-recommended" exact="influenza" post="B vaccine lineage. Discussion Ten-year surveillance demonstrated non-stationary seasonality"/>
   <result pre="vaccine lineage. Discussion Ten-year surveillance demonstrated non-stationary seasonality of composite" exact="influenza" post="virus activity in Panzhihua. Although well-defined seasonal patterns, such"/>
   <result pre="also reported [4, 5, 30]. However, the seasonality of individual" exact="influenza" post="subtypes/lineages and the seasonal drivers remain to be investigated."/>
   <result pre="be investigated. Our study found that the seasonal patterns among" exact="influenza" post="subtypes/lineages were not the same and the associations with"/>
   <result pre="southern China, which found that RH was positively correlated with" exact="influenza" post="A activity [10, 21, 32]. However, lower RH was"/>
   <result pre="lower RH was also found to be associated with higher" exact="influenza" post="A activity in subtropical Japan [11]. The periodicity of"/>
   <result pre="showed an annual cycle, respectively, as previous studies of both" exact="influenza" post="B lineages combined [30]. Our study found that the"/>
   <result pre="activity was negatively associated with AH. The inverse association between" exact="influenza" post="B activity and humidity was different from previous studies"/>
   <result pre="Kong and Okinawa, which showed that the epidemics of all" exact="influenza" post="B viruses combined could be promoted by higher RH/AH"/>
   <result pre="RH/AH [10, 11]. Animal experiments demonstrated that transmission of both" exact="influenza" post="B lineages could be enhanced at colder temperature [34]."/>
   <result pre="at colder temperature [34]. But the impact of humidity on" exact="influenza" post="B transmission remains to be examined. Differences in seasonality"/>
   <result pre="findings suggested that the different effects of weather conditions on" exact="influenza" post="subtypes/lineages might be related to the regional heterogeneity of"/>
   <result pre="influenza subtypes/lineages might be related to the regional heterogeneity of" exact="influenza" post="seasonality. Animal experiments showed that aerosol transmission of type"/>
   <result pre="experiments showed that aerosol transmission of type A and B" exact="influenza" post="strains was highly effective at low temperature (5Â Â°C)"/>
   <result pre="spring and early summer. Therefore, the association of temperature with" exact="influenza" post="epidemics might not be significant. Our analyses showed that"/>
   <result pre="significant. Our analyses showed that the associations between humidity and" exact="influenza" post="activity varied by subtype/lineage in Panzhihua. This might indicate"/>
   <result pre="indicate that at the context of a subtropical city, each" exact="influenza" post="subtype/lineage could have a most suitable humidity with different"/>
   <result pre="humidity with different temperature condition. RH might perform effects on" exact="influenza" post="virus transmission at different level [35, 36]. Aerosol transmission"/>
   <result pre="virus transmission at different level [35, 36]. Aerosol transmission of" exact="influenza" post="A could be maximal at low RH (20% and"/>
   <result pre="(80%). Notably, effective transmission (75% or 100%) of type A" exact="influenza" post="virus was also observed at 20Â Â°C and 65%"/>
   <result pre="and Suzhou, showed that higher RH was correlated with higher" exact="influenza" post="A activity [10, 21, 32]. However, these studies did"/>
   <result pre="activity [10, 21, 32]. However, these studies did not analyze" exact="influenza" post="A subtypes or influenza B lineages separately. In addition,"/>
   <result pre="However, these studies did not analyze influenza A subtypes or" exact="influenza" post="B lineages separately. In addition, RH is a measure"/>
   <result pre="of a gas. It is suggested that aerosol transmission of" exact="influenza" post="virus shows a direct dependence on AH, rather than"/>
   <result pre="humidity (either RH or AH) and temperature affect transmission of" exact="influenza" post="subtypes/lineages by more than one mechanism. It is suggested"/>
   <result pre="and post-pandemic years. However, periodicity changes were not detected for" exact="influenza" post="virus in Panzhihua, which was identified in Chengdu in"/>
   <result pre="The interaction between the novel pandemic strain and other resident" exact="influenza" post="viruses, virus virulence variation and host susceptibility might be"/>
   <result pre="might be related to the changes in positive rates of" exact="influenza" post="subtypes/lineages. Understanding the seasonal pattern and the climatic drivers"/>
   <result pre="subtypes/lineages. Understanding the seasonal pattern and the climatic drivers of" exact="influenza" post="virus is of significant importance for predicting epidemic timing"/>
   <result pre="in seasonality by subtype/lineage indicated that except for the winter" exact="influenza" post="epidemics, the summerâ€&quot;autumn peak of A/H3N2 should also be"/>
   <result pre="be considered in vaccination campaign in Panzhihua. Moreover, since the" exact="influenza" post="B strain included in TIV did not match the"/>
   <result pre="the nine vaccination years, it is suggested to use quadrivalent" exact="influenza" post="vaccine (QIV) to provide broad protection against all circulating"/>
   <result pre="for individual subtypes/lineages since the 2009 H1N1 pandemic. Therefore, year-round" exact="influenza" post="surveillance is needed to be strengthened to monitor on-going"/>
   <result pre="be more appropriate. Second, the relationship between seasonal activity of" exact="influenza" post="virus and some other seasonal drivers, such as virus"/>
   <result pre="virus culture and rRT-PCR assay might have different sensitivity of" exact="influenza" post="virus detection [40]. However, the subtype/lineage distribution and seasonality"/>
   <result pre="[41]. Our wavelet analysis results showed that the periodicity of" exact="influenza" post="subtypes/lineages were consistent during 2006â€&quot;2015 in Panzhihua, except for"/>
   <result pre="study expands our knowledge regarding the epidemiological characteristics of individual" exact="influenza" post="subtypes/lineages as well as the association with meteorological factors"/>
   <result pre="be related to the diverse transmission modes and mechanism of" exact="influenza" post="virus. Studies of influenza seasonality and its relationship with"/>
   <result pre="diverse transmission modes and mechanism of influenza virus. Studies of" exact="influenza" post="seasonality and its relationship with climatic drivers should therefore"/>
   <result pre="for individual subtypes/lineages. Moreover, it is necessary to increase year-round" exact="influenza" post="surveillance and develop subtype/lineage-specific prevention and control measures. In"/>
   <result pre="In addition, QIV is recommended to provide protection against both" exact="influenza" post="B lineages. Acknowledgements We thank all the clinicians, and"/>
   <result pre="laboratory, research and administrative staff who took part in the" exact="influenza" post="surveillance. Conflict of interest None. Supplementary material For supplementary"/>
   <result pre="the manuscript. References References 1.SimonsenL (1999) The global impact of" exact="influenza" post="on morbidity and mortality. Vaccine17, S3â€&quot;S10.10471173 2.LipsitchMet al. (2009)"/>
   <result pre="2.LipsitchMet al. (2009) Managing and reducing uncertainty in an emerging" exact="influenza" post="pandemic. New England Journal of Medicine361, 112â€&quot;115.19474417 3.ViboudCet al."/>
   <result pre="of Sciences of the USA106, 3645â€&quot;3646.19276125 5.TameriusJet al. (2011) Global" exact="influenza" post="seasonality: reconciling patterns across temperate and tropical. Environmental Health"/>
   <result pre="6.ShamanJet al. (2010) Absolute humidity and the seasonal onset of" exact="influenza" post="in the continental United States. PLoS Biology8, e1000316.20186267 7.ShamanJ,"/>
   <result pre="of Epidemiology173, 127â€&quot;135.21081646 8.ShamanJ and KohnM (2009) Absolute humidity modulates" exact="influenza" post="survival, transmission, and seasonality. Proceedings of the National Academy"/>
   <result pre="the USA106, 3243â€&quot;3248.19204283 9.TameriusJet al. (2013) Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climates. PLoS Pathogens9, e1003194.23505366"/>
   <result pre="and tropical climates. PLoS Pathogens9, e1003194.23505366 10.ChanPKet al. (2009) Seasonal" exact="influenza" post="activity in Hong Kong and its association with meteorological"/>
   <result pre="of Medical Virology81, 1797â€&quot;1806.19697414 11.IhaYet al. (2016) Comparative epidemiology of" exact="influenza" post="A and B viral infection in a subtropical region:"/>
   <result pre="of the spring and fall waves of the H1N1/2009 pandemic" exact="influenza" post="virus in the United States. Journal of Virology85, 828â€&quot;834.21068250"/>
   <result pre="828â€&quot;834.21068250 13.BaillieGJet al. (2012) Evolutionary dynamics of local pandemic H1N1/2009" exact="influenza" post="virus lineages revealed by whole-genome analysis. Journal of Virology86,"/>
   <result pre="11â€&quot;18.22013031 14.FraserCet al. (2009) Pandemic potential of a strain of" exact="influenza" post="A (H1N1): early findings. Science324, 1557â€&quot;1561.19433588 15.GartenRJet al. (2009)"/>
   <result pre="al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1)" exact="influenza" post="viruses circulating in humans. Science325, 197â€&quot;201.19465683 16.CainiSet al. (2016)"/>
   <result pre="in humans. Science325, 197â€&quot;201.19465683 16.CainiSet al. (2016) Temporal patterns of" exact="influenza" post="A and B in tropical and temperate countries-what are"/>
   <result pre="B in tropical and temperate countries-what are the lessons for" exact="influenza" post="vaccination. PLoS ONE11, e0152310.27031105 17.CainiSet al. (2016) Divergent seasonal"/>
   <result pre="PLoS ONE11, e0152310.27031105 17.CainiSet al. (2016) Divergent seasonal patterns of" exact="influenza" post="types A and B across latitude gradient in tropical"/>
   <result pre="for Disease Control and Prevention (2010) The guideline for national" exact="influenza" post="surveillance. Beijing. 20.collab: National Meteorological Information Center, CMA, Beijing."/>
   <result pre="(Accessed 7 August 2018). 21.WangXLet al. (2017) Different responses of" exact="influenza" post="epidemic to weather factors among Shanghai, Hong Kong, and"/>
   <result pre="spread of influenza. Science312, 447â€&quot;451.16574822 23.AlonsoWJet al. (2007) Seasonality of" exact="influenza" post="in Brazil: a traveling wave from the Amazon to"/>
   <result pre="E75, 016707. 26.ChengXet al. (2013) Epidemiological dynamics and phylogeography of" exact="influenza" post="virus in southern China. The Journal of Infectious Disease207,"/>
   <result pre="Beijing: China Statistics Press. 30.YuHet al. (2013) Characterization of regional" exact="influenza" post="seasonality patterns in China and implications for vaccination strategies:"/>
   <result pre="PLoS Medicine10, e1001552.24348203 31.YangLet al. (2015) Age-specific epidemic waves of" exact="influenza" post="and respiratory syncytial virus in a subtropical city. Scientific"/>
   <result pre="Virology159, 631â€&quot;639.24114148 33.ZhaoXet al. (2016) Meteorological influence on the 2009" exact="influenza" post="a (H1N1) pandemic in mainland China. Environmental Earth Sciences75,"/>
   <result pre="China. Environmental Earth Sciences75, 1â€&quot;9. 34.PicaNet al. (2012) Transmission of" exact="influenza" post="B viruses in the guinea pig. Journal of Virology86,"/>
   <result pre="36.SteelJ, PaleseP and LowenAC (2011) Transmission of a 2009 pandemic" exact="influenza" post="virus shows a sensitivity to temperature and humidity similar"/>
   <result pre="transcription-PCR, virus isolation, and enzyme-linked immunosorbent assay for diagnosis of" exact="influenza" post="A virus infection in different age groups. Journal of"/>
   <result pre="Microbiology40, 2051â€&quot;2056.12037063 41.ChiarellaFCet al. (2017) Characterization and circulation of seasonal" exact="influenza" post="viruses in Madrid, 2010â€&quot;2016. Journal of Medical Virology89, 1726â€&quot;1733.28504416"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6519843\results\search\disease\results.xml">
   <result pre="periods. Author summary Rift Valley fever (RVF) is a mosquito-transmitted" exact="viral disease" post="that may cause large epidemics in domestic livestock and"/>
   <result pre="but in severe cases can result in encephalopathy, haemorrhagic signs," exact="retinopathy" post="and even death. The disease in ruminants may be"/>
   <result pre="death. The disease in ruminants may be characterized by necrotic" exact="hepatitis" post="but may also be inapparent or mild, and in"/>
   <result pre="RVF in humans in the area; however, the fact that" exact="malaria" post="is common there may result in other causes of"/>
   <result pre="that region and that most RVF cases are misdiagnosed as" exact="malaria" post="[61]. Therefore, the current status and potential impact of"/>
   <result pre="Oxford University Press; 2004 p. 1037â€&quot;70. 3DaubneyR, HudsonJR, GarnhamPC. Enzootic" exact="hepatitis" post="or Rift Valley fever. An undescribed virus disease of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6527025\results\search\disease\results.xml">
   <result pre="roles of apoptosis, autophagy and unfolded protein response in arbovirus," exact="influenza" post="virus, and HIV infections P. MEHRBOD ET AL. VIRULENCE"/>
   <result pre="Beclin-1. In this review article we first briefly discuss arboviruses," exact="influenza" post="virus, and HIV and then describe the concepts of"/>
   <result pre="are involved in the regulation of cellular responses to arboviruses," exact="influenza" post="virus and HIV infections. Abbreviation: AIDS: Acquired Immunodeficiency Syndrome;"/>
   <result pre="thus, it is being explored as a potential tool for" exact="cancer" post="treatment [6]. Vaccines are a common defense against virus"/>
   <result pre="derived from whole or subunits of viruses. For example, the" exact="hepatitis" post="B vaccine was developed from the viral surface antigens"/>
   <result pre="pollution. Example of viruses The following three virus groups (arboviruses," exact="influenza" post="virus, and human immunodeficiency virus â€&quot; HIV) will be"/>
   <result pre="[12]. In 2015, Zika virus (ZIKV) was reported to cause" exact="microcephaly" post="and microencephaly in infants born to infected mothers [13]."/>
   <result pre="additional genera [16]. However, most human outbreaks are caused by" exact="influenza" post="type A virus (IAV). IAV has several subtypes which"/>
   <result pre="(CMV â€&quot; a herpesvirus) and Flaviviruses (DENV, ZIKV and Japanese" exact="encephalitis" post="virus (JEV)) induce the host UPR response, which promotes"/>
   <result pre="protein folding and successful viral replication, while other viruses like" exact="herpes simplex" post="virus type 1 (HSV-1) work to downregulate the IRE1/XBP-1"/>
   <result pre="the manifestation of virus-induced effects like ZIKV-induced development of microcephaly," exact="influenza" post="virus-induced inflammatory damage, and reactivation of HSV-1 in previously"/>
   <result pre="oxidative stress, are also used by viruses like ZIKV and" exact="influenza" post="virus to promote viral replication and increase virally induced"/>
   <result pre="are involved in the regulation of viral infection in arboviruses," exact="influenza" post="virus, and HIV. Apoptosis The term apoptosis was introduced"/>
   <result pre="autophagy influences outcomes in disorders such as neurodegeneration, immunity, and" exact="cancer" post="[59,64â€&quot;69]. Historically, research in the autophagy field was initiated"/>
   <result pre="are degraded in the lysosomes. CMA has been implicated in" exact="cancer" post="[115]. Autophagy and viral infection Autophagy has harmonized with"/>
   <result pre="[156]. Regarding WNV, which is a neurotropic flavivirus responsible for" exact="meningitis" post="and encephalitis, its replication is autophagy independent; however, it"/>
   <result pre="Chikungunya virus (CHIKV)-infected HEK293 (human embryonic kidney) cells [148]. Epizootic" exact="hemorrhagic disease" post="virus (EHDV) induces autophagy, apoptosis, activates c-Jun N-terminal kinase"/>
   <result pre="in processes such as autophagy [169]. A study on vesicular" exact="stomatitis" post="virus (VSV), showed that the interaction of PRR-PAMP with"/>
   <result pre="[131]] . DENV: Dengue virus; ZIKV: Zika virus; JEV: Japanese" exact="encephalitis" post="virus; CHIKV: Chikungunya virus; TBEV: tick-borne encephalitis virus; VSV:"/>
   <result pre="Zika virus; JEV: Japanese encephalitis virus; CHIKV: Chikungunya virus; TBEV:" exact="tick-borne encephalitis" post="virus; VSV: vesicular stomatitis virus. Several studies were conducted"/>
   <result pre="virus; JEV: Japanese encephalitis virus; CHIKV: Chikungunya virus; TBEV: tick-borne" exact="encephalitis" post="virus; VSV: vesicular stomatitis virus. Several studies were conducted"/>
   <result pre="virus; CHIKV: Chikungunya virus; TBEV: tick-borne encephalitis virus; VSV: vesicular" exact="stomatitis" post="virus. Several studies were conducted on ZIKV. The results"/>
   <result pre="was demonstrated that Brazilian ZIKV crosses the placenta and causes" exact="microcephaly" post="by targeting cortical progenitor cells, inducing cell death by"/>
   <result pre="restrict ZIKV infection and to control neuronal infection [175]. Tick-borne" exact="encephalitis" post="virus (TBEV), which is an important travel-associated arbovirus, replicates"/>
   <result pre="was demonstrated that Brazilian ZIKV crosses the placenta and causes" exact="microcephaly" post="[175] Studied Drosophila brain system Suggested an essential role"/>
   <result pre="autophagosome formation CHIKV: Chikungunya virus; DENV: Dengue virus; EHDV: Epizootic" exact="hemorrhagic disease" post="virus; JEV: Japanese encephalitis virus; RVFV: Rift Valley fever"/>
   <result pre="DENV: Dengue virus; EHDV: Epizootic hemorrhagic disease virus; JEV: Japanese" exact="encephalitis" post="virus; RVFV: Rift Valley fever virus; TBEV: Tick-borne encephalitis"/>
   <result pre="Japanese encephalitis virus; RVFV: Rift Valley fever virus; TBEV: Tick-borne" exact="encephalitis" post="virus; VSV: Vesicular stomatitis virus; WNV: West Nile virus;"/>
   <result pre="Rift Valley fever virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular" exact="stomatitis" post="virus; WNV: West Nile virus; ZIKV: Zika virus. Arboviruses"/>
   <result pre="virus; ZIKV: Zika virus; WNV: West Nile virus; JEV: Japanese" exact="encephalitis" post="virus; CHIKV: Chikungunya virus; CCHFV: Crimean Congo hemorrhagic fever"/>
   <result pre="has anti-apoptotic functions which can block or delay apoptosis by" exact="suppression" post="of the PI3-kinase-dependent process at the early stage of"/>
   <result pre="initiation of apoptosis (Figure 2) [202]. In another experiment, mouse" exact="neuroblastoma" post="cell line N18 was infected with UV-inactivated JEV (UV-JEV)."/>
   <result pre="death through a ROS-dependent and NF-kB-mediated pathway [203]. The initial" exact="suppression" post="of UV-JEV-induced cell death, followed by co-infection with active"/>
   <result pre="demonstrated that JEV may trigger cell survival signaling in mouse" exact="neuroblastoma" post="N18 and human neuronal NT-2 cells to modify cellular"/>
   <result pre="including hepatocytes, monocytes, endothelial cells, dendritic cells, mast cells, and" exact="neuroblastoma" post="cells. However, the mechanisms are not yet fully understood."/>
   <result pre="neuronal cells to infection by this virus [222]. Saint Louis" exact="encephalitis" post="virus (SLEV) is a neglected flavivirus. Its epidemic strain,"/>
   <result pre="EGFR-co-amplified and overexpressed protein (ECOP) [203] Studied JEV in mouse" exact="neuroblastoma" post="cell line N18 N18 was infected with UV-inactivated JEV"/>
   <result pre="ROS-dependent and NF-kB-mediated pathway [203] Studied JEV replication The initial" exact="suppression" post="of UV-JEV-induced cell death, followed by co-infection with active"/>
   <result pre="fever virus; CHIKV: Chikungunya virus; DENV: Dengue virus; EHDV: Epizootic" exact="hemorrhagic disease" post="virus; JEV: Japanese encephalitis virus; RVFV: Rift Valley fever"/>
   <result pre="DENV: Dengue virus; EHDV: Epizootic hemorrhagic disease virus; JEV: Japanese" exact="encephalitis" post="virus; RVFV: Rift Valley fever virus; SINV: Sindbis virus;"/>
   <result pre="Rift Valley fever virus; SINV: Sindbis virus; SLEV: Saint Louis" exact="encephalitis" post="virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular stomatitis virus;"/>
   <result pre="SINV: Sindbis virus; SLEV: Saint Louis encephalitis virus; TBEV: Tick-borne" exact="encephalitis" post="virus; VSV: Vesicular stomatitis virus; WNV: West Nile virus;"/>
   <result pre="Saint Louis encephalitis virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular" exact="stomatitis" post="virus; WNV: West Nile virus; ZIKV: Zika virus. Arboviruses"/>
   <result pre="viruses. Another study showed the activation of XBP1 pathway when" exact="neuroblastoma" post="N18 cells were infected with the arboviruses JEV and"/>
   <result pre="and BHK-21 cells, respectively [233,234]. Another study showed that A547" exact="ovarian cancer" post="cells infected with DENV elicited the UPR signaling response"/>
   <result pre="BHK-21 cells, respectively [233,234]. Another study showed that A547 ovarian" exact="cancer" post="cells infected with DENV elicited the UPR signaling response"/>
   <result pre="[235] Studied UPR involvement in DENV infection Showed that A547" exact="ovarian cancer" post="cells infected with DENV elicited the UPR signaling responseDifferent"/>
   <result pre="Studied UPR involvement in DENV infection Showed that A547 ovarian" exact="cancer" post="cells infected with DENV elicited the UPR signaling responseDifferent"/>
   <result pre="dependent manner. CHIKV: Chikungunya virus; DENV: Dengue virus; JEV: Japanese" exact="encephalitis" post="virus; RVFV: Rift Valley fever virus; SINV: Sindbis virus;"/>
   <result pre="RVFV: Rift Valley fever virus; SINV: Sindbis virus; TBEV: Tick-borne" exact="encephalitis" post="virus; VEEV: Venezuelan equine encephalitis virus; WNV: West Nile"/>
   <result pre="SINV: Sindbis virus; TBEV: Tick-borne encephalitis virus; VEEV: Venezuelan equine" exact="encephalitis" post="virus; WNV: West Nile viruss. Influenza virus and autophagy"/>
   <result pre="autophagy [259]. It has been proposed that the highly pathogenic" exact="avian influenza" post="virus, H5N1, induces autophagy in MEF cells by suppressing"/>
   <result pre="[259]. It has been proposed that the highly pathogenic avian" exact="influenza" post="virus, H5N1, induces autophagy in MEF cells by suppressing"/>
   <result pre="also contains an LC3-interacting region (LIR) which is required for" exact="influenza" post="virus subversion of autophagy; this leads to LC3 redistribution"/>
   <result pre="illustrated in Figure 4 and a summary of autophagy and" exact="influenza" post="virus infection is summarized in Table 4. 10.1080/21505594.2019.1605803-T0004Table 4."/>
   <result pre="infection is summarized in Table 4. 10.1080/21505594.2019.1605803-T0004Table 4. Summary of" exact="influenza" post="virus infection and autophagy pathway. Reference Summary of the"/>
   <result pre="cells and molecular mechanism underlying the reduction of SOD1 during" exact="influenza" post="infection Supported the critical role of autophagy in the"/>
   <result pre="(NY55), A/Puerto Rico/8/1934 (H1N1) (PR8), and 2009 pandemic swine origin" exact="influenza" post="virus (SOIV) (A/California/07/2009) [278]. Apoptosis and autophagy in IAV"/>
   <result pre="Bax was activated at 24 hpi. Lack of Bax prevented" exact="influenza" post="A virus-induced apoptosis and caused diminished viral replication [280]."/>
   <result pre="for this induction [286]. It has been suggested that the" exact="influenza" post="virus could facilitate the progress of its pathogenesis and"/>
   <result pre="apoptosis pathway (Figure 5) [301]. The polymerase acidic protein of" exact="influenza" post="virus (PA)-X, encoded by the PA mRNA as an"/>
   <result pre="immune response to H5N1. This was mediated by AvIFIT binding" exact="influenza" post="NP protein, which increased the expression of IRF1, IRF7,"/>
   <result pre="pro-inflammatory responses against IAV infection [307]. High antibody response to" exact="influenza" post="vaccine showed decrease in post-vaccination tumor necrosis factor-like weak"/>
   <result pre="epithelial cells with IAV along with antioxidant treatment could decrease" exact="influenza" post="virus replication and apoptosis induction [309]. To screen some"/>
   <result pre="other) proteins. Additional studies examined the role of P53 in" exact="influenza" post="infection, and apoptosis induction via attenuation of host ubiquitin"/>
   <result pre="promising antiviral targets against H1N1 IAV [317]. The interaction of" exact="influenza" post="A virus with the host apoptosis pathway is illustrated"/>
   <result pre="illustrated in Figure 5 and a summary of apoptosis and" exact="influenza" post="virus infection is summarized in Table 5. 10.1080/21505594.2019.1605803-T0005Table 5."/>
   <result pre="infection is summarized in Table 5. 10.1080/21505594.2019.1605803-T0005Table 5. Summary of" exact="influenza" post="virus infection and apoptosis pathway. Reference Summary of the"/>
   <result pre="Induction of apoptosis in neutrophils and NK cells [289][290][284][292]â€&quot;294[295] -Studied" exact="influenza" post="virus NS1 protein -Caspase-1 activation, fast apoptosis and release"/>
   <result pre="apoptosis-Siva-1 involvement for IAV replication through caspase activation [296] Studied" exact="influenza" post="virus (A/California/2009(H1N1) strain) NP protein in A549 cells Apoptosis"/>
   <result pre="AvIFIT protein, similar to human IFIT2 induces apoptosis by binding" exact="influenza" post="NP protein and enhancing the IFN signaling-Attenuation of host"/>
   <result pre="which may act synergistically with UPR-mediated transcriptional activation to help" exact="influenza" post="virus escape from both PKR- and PERK-mediated translational repression"/>
   <result pre="which is independent of PERK [321,322]. Recently, scientists showed that" exact="influenza" post="virus HA glycoprotein induced a strong innate antiviral response"/>
   <result pre="IAV infection through the IRE1 pathway [318]. The interaction of" exact="influenza" post="A virus with the host UPR pathway is illustrated"/>
   <result pre="illustrated in Figure 6 and a summary of UPR and" exact="influenza" post="virus infection is summarized in Table 6. 10.1080/21505594.2019.1605803-T0006Table 6."/>
   <result pre="infection is summarized in Table 6. 10.1080/21505594.2019.1605803-T0006Table 6. Summary of" exact="influenza" post="virus infection and UPR pathway. Reference Summary of the"/>
   <result pre="ATG7, and LC3II in post-mortem brains of HIV patients with" exact="encephalitis" post="[324]. HIV and apoptosis Patients infected with HIV experience"/>
   <result pre="with CXCR4 can also cause MMP (mitochondrial membrane permeabilization) through" exact="pertussis" post="toxin-sensitive G protein (Gia) P38 MPAK pathway and/or through"/>
   <result pre="inhibition can successfully affect symptoms of viral infection in a" exact="hepatitis" post="c drug irresponsive population [335]. Therefore, there could be"/>
   <result pre="2018. [6]GongJ, SachdevE, MitaAC, et alClinical development of reovirus for" exact="cancer" post="therapy: an oncolytic virus with immune-mediated antitumor activity. World"/>
   <result pre="p. 1647â€&quot;1689. [17]TongSX, LiY, RivaillerP, et alA distinct lineage of" exact="influenza" post="A virus from bats. Proceedings of the National Academy"/>
   <result pre="National Academy of Sciences109 (2012) 4269â€&quot;4274 [18]collab: Prevention CfDCaTypes of" exact="influenza" post="viruses. 20162016 617]; Available from: http://www.cdc.gov/flu/about/viruses/types.htm. [19]SellersSA, HaganRS, HaydenFG,"/>
   <result pre="burden of influenza: A review of the extra-pulmonary complications of" exact="influenza" post="infection. Influenza Other Respir Viruses. 2017;11:372â€&quot;393.28745014 [20]KwongJC, SchwartzKL, CampitelliMAAcute"/>
   <result pre="Respir Viruses. 2017;11:372â€&quot;393.28745014 [20]KwongJC, SchwartzKL, CampitelliMAAcute myocardial infarction after laboratory-confirmed" exact="influenza" post="infection REPLY. N Engl J Med. 2018;378:2540â€&quot;2541. [21]BreseeJ, FitznerJ,"/>
   <result pre="influenza. Emerg Infect Dis. 2018;24:1173â€&quot;1177.29912681 [22]SauttoGA, KirchenbaumGA, RossTMTowards a universal" exact="influenza" post="vaccine: different approaches for one goal. Virol J. 2018;15:17."/>
   <result pre="[31]LiuMM, ChenFZ, LiuT, et alThe role of oxidative stress in" exact="influenza" post="virus infection. Microbes Infect. 2017;19:580â€&quot;586.28918004 [32]OngHK, SooBPC, ChuKL, et"/>
   <result pre="2018;21:63-+. [34]PrestonCM, NichollMJInduction of cellular stress overcomes the requirement of" exact="herpes simplex" post="virus type 1 for immediate-early protein ICP0 and reactivates"/>
   <result pre="2016;5:2804.27990281 [44]SarosiekKA, LetaiADirectly targeting the mitochondrial pathway of apoptosis for" exact="cancer" post="therapy using BH3 mimetics - recent successes, current challenges"/>
   <result pre="[50]KaczanowskiSApoptosis: its origin, history, maintenance and the medical implications for" exact="cancer" post="and aging. Phys Biol. 2016;13:031001.27172135 [51]FadeelB, OrreniusS, ZhivotovskyBApoptosis in"/>
   <result pre="beta 1 induced epithelial to mesenchymal transition in non-small cell" exact="lung cancer" post="cells. Biochim Biophys Acta, Mol Cell Res. 2018;1865:749â€&quot;768.29481833 [60]Hombach-KlonischS,"/>
   <result pre="1 induced epithelial to mesenchymal transition in non-small cell lung" exact="cancer" post="cells. Biochim Biophys Acta, Mol Cell Res. 2018;1865:749â€&quot;768.29481833 [60]Hombach-KlonischS,"/>
   <result pre="autophagy and epithelial to mesenchymal transition in the non-small cell" exact="lung cancer" post="cells. Methods Mol Biol. 2019;1854:87â€&quot;103.29101677 [70]NovikoffAB, BeaufayH, De DuveCElectron"/>
   <result pre="and epithelial to mesenchymal transition in the non-small cell lung" exact="cancer" post="cells. Methods Mol Biol. 2019;1854:87â€&quot;103.29101677 [70]NovikoffAB, BeaufayH, De DuveCElectron"/>
   <result pre="J Gastroenterol. 2015;21:13225â€&quot;13239.26715805 [79]AlavianSM, AndeSR, CoombsKM, et alVirus-triggered autophagy in" exact="viral hepatitis" post="- possible novel strategies for drug development. J Viral"/>
   <result pre="Gastroenterol. 2015;21:13225â€&quot;13239.26715805 [79]AlavianSM, AndeSR, CoombsKM, et alVirus-triggered autophagy in viral" exact="hepatitis" post="- possible novel strategies for drug development. J Viral"/>
   <result pre="regulation of different types of autophagy and their participation in" exact="cancer" post="pathogenesis. Oncotarget. 2018;9:34413â€&quot;34428.30344951 [91]WhiteE, MehnertJM, ChanCSAutophagy, Metabolism, and Cancer."/>
   <result pre="self-digestion. Nature. 2008;451:1069â€&quot;1075.18305538 [111]McAlindenKD, DeshpandeDA, GhavamiS, et alAutophagy activation in" exact="asthma" post="airways remodeling. Am J Respir Cell Mol Biol. 2018."/>
   <result pre="Microbe. 2010;7:115â€&quot;127.20159618 [124]GannagÃ©M, DormannD, AlbrechtR, et alMatrix protein 2 of" exact="influenza" post="A virus blocks autophagosome fusion with lysosomes. Cell Host"/>
   <result pre="2013;12:703â€&quot;719.23989796 [134]McGrathEP, LogueSE, MnichK, et alThe unfolded protein response in" exact="breast cancer." post="Cancers (Basel). 2018;10:10. [135]DejeansN, BarrosoK, Fernandez-ZapicoME, et alNovel roles"/>
   <result pre="viral replication. Virol J. 2011;8:432.21902836 [149]ShaiB, SchmuklerE, YanivR, et alEpizootic" exact="hemorrhagic disease" post="virus induces and benefits from cell stress, autophagy, and"/>
   <result pre="amphisomes. J Gen Virol. 2009;90:448â€&quot;456.19141455 [153]SharmaM, BhattacharyyaS, NainM, et alJapanese" exact="encephalitis" post="virus replication is negatively regulated by autophagy and occurs"/>
   <result pre="protein response. Front Microbiol. 2015;5. [161]SharmaM, BhattacharyyaS, SharmaKB, et alJapanese" exact="encephalitis" post="virus activates autophagy through XBP1 and ATF6 ER stress"/>
   <result pre="West Nile virus encephalitis. J Virol. 2007;81:2614â€&quot;2623.17192305 [180]SunJ, YuY, DeubelVJapanese" exact="encephalitis" post="virus NS1â€² protein depends on pseudoknot secondary structure and"/>
   <result pre="alNucleophosmin (NPM1)/B23 in the proteome of human astrocytic cells restricts" exact="chikungunya" post="virus replication. J Proteome Res. 2017;16:4144â€&quot;4155.28959884 [194]ChiamCW, ChanYF, OngKC,"/>
   <result pre="antiapoptotic factors. J Virol. 2012;86:5278â€&quot;5287.22345437 [202]YangT-C, Lai-C-C, ShiuS-L, et alJapanese" exact="encephalitis" post="virus down-regulates thioredoxin and induces ROS-mediated ASK1-ERK/p38 MAPK activation"/>
   <result pre="cells. Microbes Infect. 2010;12:643â€&quot;651.20430109 [203]LinR-J, LiaoC-L, LinY-LReplication-incompetent virions of Japanese" exact="encephalitis" post="virus trigger neuronal cell death by oxidative stress in"/>
   <result pre="[204]MelianEB, HinzmanE, NagasakiT, et alNS1â€² of flaviviruses in the Japanese" exact="encephalitis" post="virus serogroup is a product of ribosomal frameshifting and"/>
   <result pre="not antiviral function of Human bcl-2 assists establishment of Japanese" exact="encephalitis" post="virus persistence in cultured cells. J Virol. 1998;72:9844â€&quot;9854.9811720 [206]Al-ObaidiMMJ,"/>
   <result pre="cultured cells. J Virol. 1998;72:9844â€&quot;9854.9811720 [206]Al-ObaidiMMJ, BahadoranA, HarLS, et alJapanese" exact="encephalitis" post="virus disrupts blood-brain barrier and modulates apoptosis proteins in"/>
   <result pre="Med Virol. 2009;81:1069â€&quot;1081.19382257 [211]AustinD, BaerA, LundbergL, et alp53 activation following" exact="rift valley fever" post="virus infection contributes to cell death and viral production."/>
   <result pre="PLoS ONE. 2012;7:e36327.22574148 [212]WonS, IkegamiT, PetersC, et alNSm protein of" exact="rift valley fever" post="virus suppresses virus-induced apoptosis. J Virol. 2007;81:13335â€&quot;13345.17913816 [213]IkegamiT, NarayananK,"/>
   <result pre="in mice induced by an epidemic strain of Saint Louis" exact="encephalitis" post="virus isolated in Argentina. Front Microbiol. 2018;9. [224]WangH, GortT,"/>
   <result pre="[236]AlbornozA, CarlettiT, CorazzaG, et alThe stress granule component TIA-1 binds" exact="tick-borne encephalitis" post="virus RNA and is recruited to perinuclear sites of"/>
   <result pre="CarlettiT, CorazzaG, et alThe stress granule component TIA-1 binds tick-borne" exact="encephalitis" post="virus RNA and is recruited to perinuclear sites of"/>
   <result pre="to inhibit viral translation. J Virol. 2014;88:6611â€&quot;6622.24696465 [237]YuCY, AchaziK, NiedrigMTick-borne" exact="encephalitis" post="virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor"/>
   <result pre="Virol. 2016;90:3558â€&quot;3572.26792742 [239]ZhouZ, JiangX, LiuD, et alAutophagy is involved in" exact="influenza" post="A virus replication. Autophagy. 2009;5:321â€&quot;328.19066474 [240]YeganehB, GhavamiS, KroekerAL, et"/>
   <result pre="virus replication. Autophagy. 2009;5:321â€&quot;328.19066474 [240]YeganehB, GhavamiS, KroekerAL, et alSuppression of" exact="influenza" post="a virus replication in human lung epithelial cells by"/>
   <result pre="Liver Physiol. 2015;308:L270â€&quot;L286. [241]LawAH-Y, LeeDC-W, YuenK-Y, et alCellular response to" exact="influenza" post="virus infection: a potential role for autophagy in CXCL10"/>
   <result pre="developmental biology. Elsevier; 2010;21: 699â€&quot;711.20403453 [247]RossmanJS, LambRAAutophagy, apoptosis, and the" exact="influenza" post="virus M2 protein. Cell Host Microbe. 2009;6:367â€&quot;380.19837376 [248]SchmidDAutophagy delivers"/>
   <result pre="specific inhibitor of vacuolar-type proton pump, on the growth of" exact="influenza" post="A and B viruses in MDCK cells. Antiviral Res."/>
   <result pre="1995;27:425â€&quot;430.8540761 [250]MehrbodP, Hair-BejoM, IbrahimTAT, et alSimvastatin modulates cellular components in" exact="influenza" post="A virus-infected cells. Int J Mol Med. 2014;34:61â€&quot;73.24788303 [251]ComberJD,"/>
   <result pre="Med. 2014;34:61â€&quot;73.24788303 [251]ComberJD, RobinsonTM, SicilianoNA, et alFunctional macroautophagy induction by" exact="influenza" post="A virus without a contribution to major histocompatibility complex"/>
   <result pre="2011;85:6453â€&quot;6463.21525345 [252]ZhuH-Y, HanL, ShiX-L, et alBaicalin inhibits autophagy induced by" exact="influenza" post="A virus H3N2. Antiviral Res. 2015;113:62â€&quot;70.25446340 [253]HaleBG, JacksonD, ChenYH,"/>
   <result pre="(2006) 14194â€&quot;14199 [254]RenY, LiC, FengL, et alProton channel activity of" exact="influenza" post="A virus matrix protein 2 contributes to autophagy arrest."/>
   <result pre="[256]SuWC, YuWY, HuangSH, et alUbiquitination of the cytoplasmic domain of" exact="influenza" post="A virus M2 protein is crucial for production of"/>
   <result pre="2011;7:645â€&quot;646.21460623 [258]LiuG, ZhongM, GuoC, et alAutophagy is involved in regulating" exact="influenza" post="A virus RNA and protein synthesis associated with both"/>
   <result pre="of cellular degradation. Science. 2000;290:1717â€&quot;1721.11099404 [260]MaJ, SunQ, MiR, et alAvian" exact="influenza" post="A virus H5N1 causes autophagy-mediated cell death through suppression"/>
   <result pre="alAvian influenza A virus H5N1 causes autophagy-mediated cell death through" exact="suppression" post="of mTOR signaling. J Genet Genome. 2011;38:533â€&quot;537. [261]SunY, LiC,"/>
   <result pre="et alInhibition of autophagy ameliorates acute lung injury caused by" exact="avian influenza" post="A H5N1 infection. Sci Signal. 2012;5:1r16. [262]EhrhardtC, MarjukiH, WolffT,"/>
   <result pre="alInhibition of autophagy ameliorates acute lung injury caused by avian" exact="influenza" post="A H5N1 infection. Sci Signal. 2012;5:1r16. [262]EhrhardtC, MarjukiH, WolffT,"/>
   <result pre="MarjukiH, WolffT, et alBivalent role of the phosphatidylinositol-3-kinase (PI3K) during" exact="influenza" post="virus infection and host cell defence. Cell Microbiol. 2006;8:1336â€&quot;1348.16882036"/>
   <result pre="signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during" exact="influenza" post="A infection. Virology. 2014;452â€&quot;453:175â€&quot;190. [264]PulestonDJ, ZhangH, PowellTJ, et alAutophagy"/>
   <result pre="by Vici Syndrome Gene Epg5 and additional autophagy genes promotes" exact="influenza" post="pathogenesis. Cell Host Microbe. 2016;19:102â€&quot;113.26764600 [266]ZhaoH, ZhaoYG, WangX, et"/>
   <result pre="BoussierJ, YatimN, et alAutophagy diminishes the early interferon-Î² response to" exact="influenza" post="A virus resulting in differential expression of interferon-stimulated genes."/>
   <result pre="Nat Immunol. 2013;14:480â€&quot;488.23525089 [271]FeiziN, MehrbodP, RomaniB, et alAutophagy induction regulates" exact="influenza" post="virus replication in a time-dependent manner. J Med Microbiol."/>
   <result pre="Microbiol. 2017;2:1543â€&quot;1557.28871090 [273]MoonHJ, NikapitiyaC, LeeH-C, et alInhibition of highly pathogenic" exact="avian influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="2017;2:1543â€&quot;1557.28871090 [273]MoonHJ, NikapitiyaC, LeeH-C, et alInhibition of highly pathogenic avian" exact="influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="[275]WuQM, LiuSL, ChenG, et alUncovering the Rab5-independent autophagic trafficking of" exact="influenza" post="A virus by quantum-dot-based single-virus tracking. Small. 2018;14:e1702841.29409147 [276]MoriI,"/>
   <result pre="[276]MoriI, KomatsuT, TakeuchiK, et alIn vivo induction of apoptosis by" exact="influenza" post="virus. J Gen Virol. 1995;76:2869â€&quot;2873.7595397 [277]YangN, HongX, YangP, et"/>
   <result pre="2013;87:1049â€&quot;1060.23135712 [279]YeganehB, GhavamiS, RahimMN, et alAutophagy activation is required for" exact="influenza" post="A virus-induced apoptosis and replication. Biochim Biophys Acta, Mol"/>
   <result pre="Res. 2018;1865:364â€&quot;378.29108912 [280]McLeanJE, DatanE, MatassovD, et alLack of Bax prevents" exact="influenza" post="A virus-induced apoptosis and causes diminished viral replication. J"/>
   <result pre="OlsenCW, Dybdahl-SissokoN, et alApoptosis: a mechanism of cell killing by" exact="influenza" post="A and B viruses. J Virol. 1994;68:3667â€&quot;3673.8189504 [282]OlsenCW, KehrenJC,"/>
   <result pre="viruses. J Virol. 1994;68:3667â€&quot;3673.8189504 [282]OlsenCW, KehrenJC, Dybdahl-SissokoNR, et albcl-2 alters" exact="influenza" post="virus yield, spread, and hemagglutinin glycosylation. J Virol. 1996;70:663â€&quot;666.8523590"/>
   <result pre="[283]GuanZ, ShiN, SongY, et alInduction of the cellular microRNA-29c by" exact="influenza" post="virus contributes to virus-mediated apoptosis through repression of antiapoptotic"/>
   <result pre="Biochem Biophys Res Commun. 2012;425:662â€&quot;667.22850539 [284]LudwigS, WangX, EhrhardtC, et alThe" exact="influenza" post="A virus NS1 protein inhibits activation of Jun N-Terminal"/>
   <result pre="Virol. 2002;76:11166â€&quot;11171.12368362 [285]LuX, MasicA, LiY, et alThe PI3K/Akt pathway inhibits" exact="influenza" post="A virus-induced Bax-mediated apoptosis by negatively regulating the JNK"/>
   <result pre="a transcriptome-driven network at the early stage of infection with" exact="influenza" post="A H1N1 in human lung alveolar epithelial cells. Biomol"/>
   <result pre="infections. Open Virol J. 2009;3:52â€&quot;59.19572056 [288]MaoH, LiuY, SiaSF, et alAvian" exact="influenza" post="virus directly infects human natural killer cells and inhibits"/>
   <result pre="DengJ, LiC, et alCharacterization of the 2009 pandemic A/Beijing/501/2009 H1N1" exact="influenza" post="strain in human airway epithelial cells and ferrets. PLoS"/>
   <result pre="ferrets. PLoS ONE. 2012;7:e46184.23049974 [293]ZhangC, YangY, ZhouX, et alHighly pathogenic" exact="avian influenza" post="A virus H5N1 NS1 protein induces caspase-dependent apoptosis in"/>
   <result pre="PLoS ONE. 2012;7:e46184.23049974 [293]ZhangC, YangY, ZhouX, et alHighly pathogenic avian" exact="influenza" post="A virus H5N1 NS1 protein induces caspase-dependent apoptosis in"/>
   <result pre="[295]ShiozakiT, IwaiA, KawaokaY, et alRequirement for Siva-1 for replication of" exact="influenza" post="A virus through apoptosis induction. J Gen Virol. 2011;92:315â€&quot;325.21048035"/>
   <result pre="FEBS Lett. 2009;583:2517â€&quot;2520.19596000 [298]TinocoR, CarretteF, HenriquezML, et alFucosyltransferase induction during" exact="influenza" post="virus infection is required for the generation of functional"/>
   <result pre="YanoM, et alPrion protein protects mice from lethal infection with" exact="influenza" post="A viruses. PLoS Pathog. 2018;14:e1007049.29723291 [300]YangW, QuS, LiuQ, et"/>
   <result pre="A viruses. PLoS Pathog. 2018;14:e1007049.29723291 [300]YangW, QuS, LiuQ, et alAvian" exact="influenza" post="virus A/chicken/Hubei/489/2004 (H5N1) induces caspase-dependent apoptosis in a cell-specific"/>
   <result pre="the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1" exact="avian influenza" post="viruses. Sci Rep. 2015;5:8262.25652161 [303]GaoZ, HuJ, WangX, et alThe"/>
   <result pre="virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian" exact="influenza" post="viruses. Sci Rep. 2015;5:8262.25652161 [303]GaoZ, HuJ, WangX, et alThe"/>
   <result pre="nucleolin acts as an antiviral factor during highly pathogenic H5N1" exact="avian influenza" post="virus infection. Arch Virol. 2018;163:2775â€&quot;2786.. [304]StawowczykM, Van ScoyS, KumarKP,"/>
   <result pre="acts as an antiviral factor during highly pathogenic H5N1 avian" exact="influenza" post="virus infection. Arch Virol. 2018;163:2775â€&quot;2786.. [304]StawowczykM, Van ScoyS, KumarKP,"/>
   <result pre="Immunol. 2018;84:71â€&quot;81.29428489 [306]WeinAN, DunbarPR, McMasterSR, et alIL-36Î³ protects against severe" exact="influenza" post="infection by promoting lung alveolar macrophage survival and limiting"/>
   <result pre="manner. J Virol. 2018;92:e00396â€&quot;18.29743359 [308]Keshtkar-JahromiM, OuyangM, KeshtkarjahromiM, et alEffect of" exact="influenza" post="vaccine on tumor necrosis factor-like Weak inducer of apoptosis"/>
   <result pre="pro-inflammatory mediators in alveolar type II epithelial cells infected with" exact="influenza" post="virus A and B and with respiratory syncytial virus"/>
   <result pre="Microbiol. 2018;213:5â€&quot;14.29292004 [311]CoombsKM, BerardA, XuW, et alQuantitative proteomic analyses of" exact="influenza" post="virus-infected cultured human lung cells. J Virol. 2010;84:10888â€&quot;10906.20702633 [312]SimonPF,"/>
   <result pre="J Virol. 2010;84:10888â€&quot;10906.20702633 [312]SimonPF, de La VegaMA, ParadisE, et alAvian" exact="influenza" post="viruses that cause highly virulent infections in humans exhibit"/>
   <result pre="signaling pathways are temporally high-jacked by the highly pathogenic 1918" exact="influenza" post="virus. EBioMedicine. 2018;32:142â€&quot;163.29866590 [314]KroekerAL, EzzatiP, HalaykoAJ, et alResponse of"/>
   <result pre="HalaykoAJ, et alResponse of primary human airway epithelial cells to" exact="influenza" post="infection: a quantitative proteomic study. J Proteome Res. 2012;11:4132â€&quot;4146.22694362"/>
   <result pre="Proteome Res. 2013;12:3139â€&quot;3151.23750822 [316]NailwalH, SharmaS, MayankAK, et alThe nucleoprotein of" exact="influenza" post="A virus induces p53 signaling and apoptosis via attenuation"/>
   <result pre="Death Dis. 2015;6:e1768.25996295 [317]LiY, LinZ, GuoM, et alInhibition of H1N1" exact="influenza" post="virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through"/>
   <result pre="15920â€&quot;15925 [322]GoodmanAG, SmithJA, BalachandranS, et alThe cellular protein P58IPK regulates" exact="influenza" post="virus mRNA translation and replication through a PKR-mediated mechanism."/>
   <result pre="J Virol. 2007;81:2221â€&quot;2230.17166899 [323]FrabuttDA, WangB, RiazS, et alInnate sensing of" exact="influenza" post="A virus hemagglutinin glycoproteins by the host endoplasmic reticulum"/>
   <result pre="chloroquine on some clinical and biochemical parameters in non-response chronic" exact="hepatitis" post="C virus infection patients: pilot clinical trial. Acta Biomed."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6527078\results\search\disease\results.xml">
   <result pre="an immunoglobulin Y-alkaline phosphatase bioconjugate as a diagnostic tool for" exact="influenza" post="A virus B. OZKAN ET AL. BIOENGINEERED OzkanBusraaBudama-KilincYaseminaCakir-KocRabiaaMeseSevimbBadurSelimc[a], Department"/>
   <result pre="original work is properly cited.kbie-10-01-1586054.pdf Abstract ABSTRACT The diagnosis of" exact="influenza" post="A virus is essential since it can be confused"/>
   <result pre="A virus is essential since it can be confused with" exact="influenza" post="A like illness and lead to inaccurate drug prescription."/>
   <result pre="all virus subtypes, was used as a diagnostic marker of" exact="influenza" post="A. For the first time, M2e-specific IgY antibody was"/>
   <result pre="as Influenza A via the RT-PCR method. KEYWORDS Immunoglobulin Y" exact="influenza" post="A alkaline phosphatase ELISA methods diagnosis Funding The Scientific"/>
   <result pre="on an M2e peptide-specific IgY antibody for the diagnosis of" exact="influenza" post="A infectionâ€™ (Project No: 115S132); The Scientific and Technological"/>
   <result pre="in the winter season [1,2] The annual epidemics caused by" exact="influenza" post="A can be attributed to major mutations in the"/>
   <result pre="HA and NA, the M protein on the surface of" exact="influenza" post="A virus is the most conserved structural protein and"/>
   <result pre="is the most conserved structural protein and is similar among" exact="influenza" post="A virus species [6]. The M gene of influenza"/>
   <result pre="among influenza A virus species [6]. The M gene of" exact="influenza" post="A virus encodes M1 (a capsid protein) and M2"/>
   <result pre="composed of 24 amino acids, is highly conserved among human" exact="influenza" post="A viruses [2,8,12,15â€&quot;18]. In particular, the N-terminal epitope of"/>
   <result pre="M2e, SLLTEVET (residues 2â€&quot;9), is conserved among all subtypes of" exact="influenza" post="A viruses [2]. Furthermore, M2e is highly expressed on"/>
   <result pre="considered to be an excellent tool for the diagnosis of" exact="influenza" post="A virus [6]. The diagnosis of influenza A virus"/>
   <result pre="the diagnosis of influenza A virus [6]. The diagnosis of" exact="influenza" post="A virus is required for preventing outbreaks at health"/>
   <result pre="(ILIs) [20] . Various methods have been used to diagnose" exact="influenza" post="A, such as serologic tests, molecular methods, viral culture,"/>
   <result pre="is commonly used for the rapid and specific detection of" exact="influenza" post="A antigens particularly in clinical applications [22â€&quot;24]. Monoclonal antibodies"/>
   <result pre="IgY antibody to ALP using glutaraldehyde for the detection of" exact="influenza" post="A. The novel structure was characterized by fluorescence and"/>
   <result pre="M2e-specific IgY-ALP conjugation and validate nasopharyngeal specimens tested positive for" exact="influenza" post="A by real-time reverse transcriptase PCR (rRT-PCR). Results The"/>
   <result pre="M2e-specific IgY-ALP bioconjugate in samples tested positive or negative for" exact="influenza" post="A. The cut-off value of the data was around"/>
   <result pre="is 0.257. Discussion Among the various methods used to identify" exact="influenza" post="A virus [35], ELISA is an attractive choice in"/>
   <result pre="[36]. In this study, IgY antibody, which is specific for" exact="influenza" post="A M2e peptide antigen, was conjugated with ALP enzyme"/>
   <result pre="the M2e peptide sequence is a common region among most" exact="influenza" post="subtypes including H1N1 and H3N2. In some cases, despite"/>
   <result pre="the value of M2e peptide for the diagnosis of the" exact="influenza" post="virus [39] and our present study also showed the"/>
   <result pre="as a diagnostic marker that can detect different types of" exact="influenza" post="A viruses. This study aims to demonstrate that the"/>
   <result pre="viruses. This study aims to demonstrate that the production of" exact="influenza" post="A virus M2e peptide sequence-specific IgY antibody, which was"/>
   <result pre="the conjugate of this IgY antibody and ALP enzyme, for" exact="influenza" post="A diagnosis in ELISA. Thus, a novel diagnostic method"/>
   <result pre="use of the anti-M2e-specific IgY antibody for the detection of" exact="influenza" post="A virus was developed. The results obtained suggest that"/>
   <result pre="and treatment group. In total, 15 hens were immunized with" exact="influenza" post="A virus, and five hens were used as the"/>
   <result pre="EZ1 Advanced XL device following the manufacturerâ€™s instructions. Influenza A," exact="influenza" post="AH3, influenza AH1, influenza AH1pdm, RNase P forward primer"/>
   <result pre="XL device following the manufacturerâ€™s instructions. Influenza A, influenza AH3," exact="influenza" post="AH1, influenza AH1pdm, RNase P forward primer and reverse"/>
   <result pre="following the manufacturerâ€™s instructions. Influenza A, influenza AH3, influenza AH1," exact="influenza" post="AH1pdm, RNase P forward primer and reverse primer, and"/>
   <result pre="was selected as the target region for the detection of" exact="influenza" post="A. The hemaglutinin gene region was selected for sub-typing."/>
   <result pre="rRT-PCR. References References [1]PoonLL, LeungCS, ChanKH, et alDetection of human" exact="influenza" post="A viruses by loop-mediated isothermal amplification. J Clin Microbiol."/>
   <result pre="J Clin Microbiol. 2005;43:427â€&quot;430.15635005 [2]De FiletteM, MartensW, RooseK, et alAn" exact="influenza" post="A vaccine based on tetrameric ectodomain of matrix protein"/>
   <result pre="Trends in infectious diseases. India: InTech; 2014. [5]AmanoY, ChengQ.Detection of" exact="influenza" post="virus: traditional approaches and development of biosensors. Anal Bioanal"/>
   <result pre="2005;381:156â€&quot;164.15592819 [6]BucherD, MikhailA, PoppleS, et alRapid detection of type A" exact="influenza" post="viruses with monoclonal antibodies to the M protein (M1)"/>
   <result pre="peptide vaccine protects mice from lethal challenge with divergent H5N1" exact="influenza" post="viruses. Virol J. 2010;7:9.20082709 [9]YongCY, YeapSK, HoKL, et alPotential"/>
   <result pre="J. 2010;7:9.20082709 [9]YongCY, YeapSK, HoKL, et alPotential recombinant vaccine against" exact="influenza" post="A virus based on M2e displayed on nodaviral capsid"/>
   <result pre="antibody response to native form of matrix protein 2 of" exact="influenza" post="A viruses. J Immunol Methods. 2011;369:115â€&quot;124.21570401 [11]HemmatzadehF, SumarningsihS, TariganS,"/>
   <result pre="M2e protein-based ELISA: A novel and inexpensive approach for differentiating" exact="avian influenza" post="infected chickens from vaccinated ones. PloS one. 2013;8:e56801.23437243 [12]De"/>
   <result pre="protein-based ELISA: A novel and inexpensive approach for differentiating avian" exact="influenza" post="infected chickens from vaccinated ones. PloS one. 2013;8:e56801.23437243 [12]De"/>
   <result pre="ones. PloS one. 2013;8:e56801.23437243 [12]De FiletteM, JouWM, BirkettA, et alUniversal" exact="influenza" post="A vaccine: optimization of M2-based constructs. Virology. 2005;337:149â€&quot;161.15914228 [13]ZebedeeSL,"/>
   <result pre="alA lipopeptide based on the M2 and HA proteins of" exact="influenza" post="A viruses induces protective antibody. Immunol Cell Biol. 2010;88:605â€&quot;611.20177411"/>
   <result pre="Biol. 2010;88:605â€&quot;611.20177411 [15]LeeY-N, KimM-C, LeeY-T, et alMechanisms of cross-protection by" exact="influenza" post="virus M2-based vaccines. Immune Netw. 2015;15:213â€&quot;221.26557805 [16]ZengW, TanACL, HorrocksK,"/>
   <result pre="HorrocksK, et alA lipidated form of the extracellular domain of" exact="influenza" post="M2 protein as a self-adjuvanting vaccine candidate. Vaccine. 2015;33:3526â€&quot;3532.26049002"/>
   <result pre="effects of an M2-specific monoclonal antibody on different strains of" exact="influenza" post="A virus. Jpn J Vet Res. 2012;60:71â€&quot;83.23094582 [18]MardanovaES, KotlyarovRY,"/>
   <result pre="[18]MardanovaES, KotlyarovRY, KuprianovVV, et alRapid high-yield expression of a candidate" exact="influenza" post="vaccine based on the ectodomain of M2 protein linked"/>
   <result pre="flagellin in plants using viral vectors. BMC Biotechnol. 2015;15:42.26022390 [19]SaelensXThe" exact="influenza" post="matrix protein 2 as a vaccine target. Future Medicine"/>
   <result pre="167-178. [20]BoivinG, HardyI, KressAEvaluation of a rapid optical immunoassay for" exact="influenza" post="viruses (FLU OIA test) in comparison with cell culture"/>
   <result pre="on emerging diagnostic assay for viral detection: the case of" exact="avian influenza" post="virus. Mol Biol Rep. 2015;42:187â€&quot;199.25245956 [22]SoemaPC, KompierR, AmorijJ-P, et"/>
   <result pre="emerging diagnostic assay for viral detection: the case of avian" exact="influenza" post="virus. Mol Biol Rep. 2015;42:187â€&quot;199.25245956 [22]SoemaPC, KompierR, AmorijJ-P, et"/>
   <result pre="Rep. 2015;42:187â€&quot;199.25245956 [22]SoemaPC, KompierR, AmorijJ-P, et alCurrent and next generation" exact="influenza" post="vaccines: formulation and production strategies. Eur J Pharm Biopharm."/>
   <result pre="production strategies. Eur J Pharm Biopharm. 2015;94:251â€&quot;263.26047796 [23]KumarS, HenricksonKJUpdate on" exact="influenza" post="diagnostics: lessons from the novel H1N1 influenza A pandemic."/>
   <result pre="[23]KumarS, HenricksonKJUpdate on influenza diagnostics: lessons from the novel H1N1" exact="influenza" post="A pandemic. Clin Microbiol Rev. 2012;25:344â€&quot;361.22491775 [24]CoughlanL, LambeTMeasuring cellular"/>
   <result pre="a universally conserved m2e and hemagglutinin peptide-based elisa method against" exact="influenza" post="a. J Clin Anal Med. 2017;8:320â€&quot;323. [36]EngvallE, PerlmannPEnzyme-linked immunosorbent"/>
   <result pre="alSynthesis and immunogenicity assessment of elastin-like polypeptide-M2e construct as an" exact="influenza" post="antigen. Nano Life. 2014;4:1450004.25825595 [38]KhuranaS, SasonoP, FoxA, et alH5N1-SeroDetect"/>
   <result pre="PLoS One. 2012;7:e40391.22808150 [44]collab: WHOCDC protocol of realtime RTPCR for" exact="influenza" post="A(H1N1). USA: WHO; 2009. [45]collab: WHOWHO information for molecular"/>
   <result pre="USA: WHO; 2009. [45]collab: WHOWHO information for molecular diagnosis of" exact="influenza" post="virus â€&quot; update. China: WHO; 2018. [46]HeQ, VelumaniS, DuQ,"/>
   <result pre="China: WHO; 2018. [46]HeQ, VelumaniS, DuQ, et alDetection of H5" exact="avian influenza" post="viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal"/>
   <result pre="WHO; 2018. [46]HeQ, VelumaniS, DuQ, et alDetection of H5 avian" exact="influenza" post="viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6530251\results\search\disease\results.xml">
   <result pre="signal the start of an epidemic. For influenza, another viral" exact="respiratory disease," post="another approach, the moving epidemic method (MEM), is widely"/>
   <result pre="definitions (Supplementary Text S1). The swabs are screened for enterovirus," exact="influenza" post="virus, rhinovirus and RSV at the National Institute for"/>
   <result pre="and the Environment (RIVM), Bilthoven, which is the centre for" exact="infectious disease" post="control in the country. The population of the 40"/>
   <result pre="or co-dominance was established using the 60/40 rule used in" exact="influenza" post="surveillance [31]. The coincidence between RSV-type distribution and seasonality"/>
   <result pre="for RSV, which is so far only widely used in" exact="influenza" post="research [19,20]. As compared with two commonly used other"/>
   <result pre="in elderly patients, with hospitalisation and mortality rates similar to" exact="influenza" post="virus infection [34] and outbreaks in nursing homes with"/>
   <result pre="HoekWet al.Mortality attributable to 9 common infections: significant effect of" exact="influenza" post="A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza"/>
   <result pre="common infections: significant effect of influenza A, respiratory syncytial virus," exact="influenza" post="B, norovirus, and parainfluenza in elderly persons.J Infect Dis."/>
   <result pre="cohort study.BMC Infect Dis. 2014;14(1):665. 10.1186/s12879-014-0665-225494918 11KyeyagalireRTempiaSCohenALSmithADMcAnerneyJMDermaux-MsimangVet al.Hospitalizations associated with" exact="influenza" post="and respiratory syncytial virus among patients attending a network"/>
   <result pre="2009;14(40):1-5. 19822120 13PagetWJBalderstonCCasasIDonkerGEdelmanLFlemingDet al.collab: EPIA collaboratorsAssessing the burden of paediatric" exact="influenza" post="in Europe: the European Paediatric Influenza Analysis (EPIA) project.Eur"/>
   <result pre="2009;28(10):860-6. 10.1097/INF.0b013e3181a3e94920118684 16van AstenLBijkerkPFanoyEvan GinkelASuijkerbuijkAvan der HoekWet al.Early occurrence of" exact="influenza" post="A epidemics coincided with changes in occurrence of other"/>
   <result pre="Viruses. 2016;10(1):14-26. 10.1111/irv.1234826369646 17Bloom-FeshbachKAlonsoWJCharuVTameriusJSimonsenLMillerMAet al.Latitudinal variations in seasonal activity of" exact="influenza" post="and respiratory syncytial virus (RSV): a global comparative review.PLoS"/>
   <result pre="a novel real time tool to predict peak in seasonal" exact="influenza" post="healthcare utilisation. The Scottish experience of the 2017/18 season"/>
   <result pre="of electronic medical records.BMC Fam Pract. 2006;7(1):58. 10.1186/1471-2296-7-5817044914 33ZambonMCStocktonJDClewleyJPFlemingDMContribution of" exact="influenza" post="and respiratory syncytial virus to community cases of influenza-like"/>
   <result pre="34WidmerKZhuYWilliamsJVGriffinMREdwardsKMTalbotHKRates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and" exact="influenza" post="virus in older adults.J Infect Dis. 2012;206(1):56-62. 10.1093/infdis/jis30922529314 35MeijerAOverduinPHommelDvan"/>
   <result pre="Virus Infection.EBioMedicine. 2017;16:124-35. 10.1016/j.ebiom.2017.01.01428111238 41Vega AlonsoTLozano AlonsoJEOrtiz de LejarazuRGutiÃ©rrez PÃ©rezMModelling" exact="influenza" post="epidemicâ€&quot;can we detect the beginning and predict the intensity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6531141\results\search\disease\results.xml">
   <result pre="by non-ON1 strains. ON1 infection is more commonly diagnosed with" exact="bronchiolitis" post="and wheezing is a more common symptoms. However, for"/>
   <result pre="human respiratory syncytial virus genotype ON1 found in infants with" exact="pneumonia" post="in Beijing. China Emerg Microbes Infect2013;2:e22.26038462 [25]LiuJMuYDongWet al.Genetic variation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6534195\results\search\disease\results.xml">
   <result pre="(hazard ratio [HR], 0.24; 95% confidence interval [CI], .14â€&quot;.44) or" exact="influenza" post="virus (HR, 0.52; 95% CI, .38â€&quot;.73) conferred relative protection"/>
   <result pre="be protected against subsequent infection with adenovirus, coronavirus, enterovirus/rhinovirus, and" exact="influenza" post="virus (P = .062â€&quot;.093), while men with influenza virusâ€&quot;positive"/>
   <result pre="enterovirus/rhinovirus, and influenza virus (P = .062â€&quot;.093), while men with" exact="influenza" post="virusâ€&quot;positive FRI episodes tended be protected against subsequent infection"/>
   <result pre="protected against subsequent infection with adenovirus (P = .044) and" exact="influenza" post="virus (P = .081). Conclusion Prior adenovirus or influenza"/>
   <result pre="and influenza virus (P = .081). Conclusion Prior adenovirus or" exact="influenza" post="virus infection conferred cross-protection against subsequent FRI episodes relative"/>
   <result pre="viruses. As previously reported, the rollout of routine trivalent seasonal" exact="influenza" post="vaccination in the Singapore Armed Forces was accompanied by"/>
   <result pre="accompanied by a dramatic decline in the incidence of laboratory-confirmed" exact="influenza" post="virus infections but a much less noticeable decrease in"/>
   <result pre="data, to account for some degree of replacement for the" exact="influenza" post="virus infections averted through vaccination [15]. In this article,"/>
   <result pre="15 December 2009 and 31 December 2014, during which inactivated" exact="influenza" post="vaccine was routinely administered to recruits who did not"/>
   <result pre="did not have any contraindications. This was initially a monovalent" exact="influenza" post="vaccine (MIV) containing only 2009 pandemic influenza A(H1N1) virus"/>
   <result pre="initially a monovalent influenza vaccine (MIV) containing only 2009 pandemic" exact="influenza" post="A(H1N1) virus (A[H1N1]pdm09), for recruits who enlisted between 11"/>
   <result pre="4 October 2010. The MIV was superseded by a trivalent" exact="influenza" post="vaccine (TIV) that included A(H1N1)pdm09, for recruits who enlisted"/>
   <result pre="C, Levels within multilevel analysis. AdV, adenovirus; CoV, coronavirus; FluV," exact="influenza" post="virus; hMPV, human metapneumovirus; NA, not applicable; RSV, respiratory"/>
   <result pre="and other CoVs; enteroviruses and rhinoviruses (ERVs); human metapneumovirus (hMPV);" exact="influenza" post="virus (FluV)â€&quot;influenza A(H3N2) virus, 2009 pandemic influenza A(H1N1) virus"/>
   <result pre="human metapneumovirus (hMPV); influenza virus (FluV)â€&quot;influenza A(H3N2) virus, 2009 pandemic" exact="influenza" post="A(H1N1) virus (A[H1N1]pdm09), influenza A(H1N1) virus, influenza A virusâ€&quot;positive"/>
   <result pre="virus (FluV)â€&quot;influenza A(H3N2) virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09)," exact="influenza" post="A(H1N1) virus, influenza A virusâ€&quot;positive samples for which the"/>
   <result pre="virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09), influenza A(H1N1) virus," exact="influenza" post="A virusâ€&quot;positive samples for which the subtype was undetermined,"/>
   <result pre="A virusâ€&quot;positive samples for which the subtype was undetermined, and" exact="influenza" post="B virus; human parainfluenza virus (hPIV)â€&quot;types 1â€&quot;4; and respiratory"/>
   <result pre="and ethnicity, type of BMT intake, history of smoking and" exact="asthma" post="(including childhood asthma), and receipt of influenza vaccine before"/>
   <result pre="of smoking and asthma (including childhood asthma), and receipt of" exact="influenza" post="vaccine before the FRI episode. Assessment of whether the"/>
   <result pre="years), and 99.9% were male. A total of 83.6% received" exact="influenza" post="vaccine in the past 1 year (with only 113"/>
   <result pre="1.95 (1.18â€&quot;3.25) â€ƒCurrent 1253 120 (9.6) 1.48 (1.19â€&quot;1.85) History of" exact="asthma" post="â€ƒNo 4340 326 (7.5) Reference .812 â€ƒYes 1337 97"/>
   <result pre="â€ƒYes 1337 97 (7.3) .08 (.07â€&quot;.09) Influenza vaccinationc â€ƒNo recent" exact="influenza" post="vaccination 930 97 (10.4) Reference .003 â€ƒMIV for A(H1N1)pdm09"/>
   <result pre="TIV 47 3 (6.4) .59 (.18â€&quot;1.92) Abbreviations: A(H1N1)pdm09, 2009 pandemic" exact="influenza" post="A(H1N1) virus; BMT, basic military training; CI, confidence interval;"/>
   <result pre="virus; BMT, basic military training; CI, confidence interval; MIV, monovalent" exact="influenza" post="vaccine; OR, odds ratio; TIV, trivalent influenza vaccine. aBy"/>
   <result pre="interval; MIV, monovalent influenza vaccine; OR, odds ratio; TIV, trivalent" exact="influenza" post="vaccine. aBy the Fisher exact test, comparing participants with"/>
   <result pre="870 [14.2%], including 138, 137, and 568 positive for A(H1N1)pdm09," exact="influenza" post="A(H3N2) virus, and influenza B virus, respectively), AdV (in"/>
   <result pre="137, and 568 positive for A(H1N1)pdm09, influenza A(H3N2) virus, and" exact="influenza" post="B virus, respectively), AdV (in 677 [11.0%], including 121"/>
   <result pre="0 (0.0)a Abbreviations: AdV, adenovirus; CoV, coronavirus; ERV, enterovirus/rhinovirus; FluV," exact="influenza" post="virus; hMPV, human metapneumovirus; hPIV, human parainfluenza virus; RSV,"/>
   <result pre="a sharp decline following routine administration of TIV. However, considerable" exact="influenza" post="A(H3N2) virus and influenza B virus activity was observed"/>
   <result pre="routine administration of TIV. However, considerable influenza A(H3N2) virus and" exact="influenza" post="B virus activity was observed from April 2013 through"/>
   <result pre="B and D, Distribution of FRI episodes due to any" exact="influenza" post="virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09), influenza A(H3N2)"/>
   <result pre="of FRI episodes due to any influenza virus, 2009 pandemic" exact="influenza" post="A(H1N1) virus (A[H1N1]pdm09), influenza A(H3N2) virus, and influenza B"/>
   <result pre="to any influenza virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09)," exact="influenza" post="A(H3N2) virus, and influenza B virus, by calendar time"/>
   <result pre="2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09), influenza A(H3N2) virus, and" exact="influenza" post="B virus, by calendar time (B) and week after"/>
   <result pre="BMT enlistment (D). Gray shading denotes the period when trivalent" exact="influenza" post="vaccine was routinely administered to incoming recruits. Prior Infection"/>
   <result pre="virus. B, Exposure status for adenovirus. C, Exposure status for" exact="influenza" post="virus. P values were calculated by log-rank tests to"/>
   <result pre="AdV, adenovirus; CI, confidence interval; CoV, coronavirus; ERV, enterovirus/rhinovirus; FluV," exact="influenza" post="virus; HR, hazard ratio; hMPV, human metapneumovirus; hPIV, human"/>
   <result pre="BMT intake, age, ethnicity, smoking history, history of asthma, and" exact="influenza" post="vaccination. cNot adjusted for FRI incidence rate by time"/>
   <result pre="infection. The observation of influenzaâ€™s protection against subsequent episodes of" exact="influenza" post="(mostly due to other types/subtypes in our data, in"/>
   <result pre="interference after accounting for seasonal factors, suggesting that epidemics of" exact="influenza" post="virus and rhinovirus infection tend to shift the timing"/>
   <result pre="inversely associated with the probability of observing adenovirus [12] and" exact="influenza" post="virus infections, with the latter 2 viral infections framed"/>
   <result pre="weak, time-limited protection, with the stronger effects from adenovirus and" exact="influenza" post="virus becoming apparent when aggregating data over the full"/>
   <result pre="to explain the extent of cross-protection observed with adenovirus and" exact="influenza" post="virus infections relative to other FRI episodes. Other proposed"/>
   <result pre="suspected on the basis of time-series analyses, such as how" exact="influenza" post="epidemics potentially delay RSV epidemics [8, 25]. They also"/>
   <result pre="for mechanisms on common factors induced by both adenovirus and" exact="influenza" post="virus. Notably, our previous studies suggest that infections with"/>
   <result pre="relative cross-protection against subsequent FRI episodes conferred by adenovirus and" exact="influenza" post="virus infections. In summary, our study demonstrated broad-based viral"/>
   <result pre="a population of military recruits. Infections from the adenovirus and" exact="influenza" post="virus families conferred significant cross-protective effects against subsequent FRI"/>
   <result pre="Clin1988; 38:280â€&quot;90.2458172 4.ChanKF, CarolanLA, KorenkovD, et al.Investigating viral interference between" exact="influenza" post="a virus and human respiratory syncytial virus in a"/>
   <result pre="5.Costa-HurtadoM, AfonsoCL, MillerPJ, et al.Virus interference between H7N2 low pathogenic" exact="avian influenza" post="virus and lentogenic Newcastle disease virus in experimental co-infections"/>
   <result pre="AfonsoCL, MillerPJ, et al.Virus interference between H7N2 low pathogenic avian" exact="influenza" post="virus and lentogenic Newcastle disease virus in experimental co-infections"/>
   <result pre="infections and viral hierarchy are determinants of viral interference following" exact="influenza" post="virus infection in a ferret model. J Infect Dis2015;"/>
   <result pre="One2015; 10:e0125447.25928217 8.AstenL van, BijkerkP, FanoyE, et al.Early occurrence of" exact="influenza" post="A epidemics coincided with changes in occurrence of other"/>
   <result pre="9.ZhengX, SongZ, LiY, ZhangJ, WangX-LPossible interference between seasonal epidemics of" exact="influenza" post="and other respiratory viruses in Hong Kong, 2014â€&quot;2017. BMC"/>
   <result pre="OttmannM, DuchampMB, et al.Rhinoviruses delayed the circulation of the pandemic" exact="influenza" post="A (H1N1) 2009 virus in France. Clin Microbiol Infect2010;"/>
   <result pre="Microbiol Infect2010; 16:326â€&quot;9.20121829 14.HoHP, ZhaoX, PangJ, et al.Effectiveness of seasonal" exact="influenza" post="vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel"/>
   <result pre="ChenMI-C, et al.Rate of decline of antibody titers to pandemic" exact="influenza" post="A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays"/>
   <result pre="BMC Infect Dis2014; 14:414.25066592 18.YoungB, SadaranganiS, JiangL, Wilder-SmithA, ChenMIDuration of" exact="influenza" post="vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of"/>
   <result pre="19.YoungB, ZhaoX, CookAR, ParryCM, Wilder-SmithA, I-ChengMCDo antibody responses to the" exact="influenza" post="vaccine persist year-round in the elderly? A systematic review"/>
   <result pre="35:212â€&quot;21.27939013 20.GohEH, JiangL, HsuJP, et al.Epidemiology and relative severity of" exact="influenza" post="subtypes in Singapore in the post-pandemic period from 2009"/>
   <result pre="2010. Clin Infect Dis2017; 65:1905â€&quot;13.29028950 21.Schultz-CherrySViral interference: the case of" exact="influenza" post="viruses. J Infect Dis2015; 212:1690â€&quot;1.25943204 22.TakedaK, AkiraSToll-like receptors. Curr"/>
   <result pre="One2016; 11:e0155589.27196110 25.AnestadGInterference between outbreaks of respiratory syncytial virus and" exact="influenza" post="virus infection. Lancet1982; 1:502. 26.LauY-F, KohW-HV, KanC, et al.Epidemiologic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6536658\results\search\disease\results.xml">
   <result pre="We respectively, reviewed the data of patients with KD, influenza," exact="aseptic meningitis," post="exanthem subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute pyelonephritis"/>
   <result pre="reviewed the data of patients with KD, influenza, aseptic meningitis," exact="exanthem" post="subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute pyelonephritis (APN),"/>
   <result pre="influenza, aseptic meningitis, exanthem subitum (ES), Mycoplasma pneumoniae (MP) pneumonia," exact="acute pyelonephritis" post="(APN), Henoch-SchÃ¶nlein purpura (HSP), acute poststreptococcal glomerulonephritis (APSGN), and"/>
   <result pre="aseptic meningitis, exanthem subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute" exact="pyelonephritis" post="(APN), Henoch-SchÃ¶nlein purpura (HSP), acute poststreptococcal glomerulonephritis (APSGN), and"/>
   <result pre="subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute pyelonephritis (APN), Henoch-SchÃ¶nlein" exact="purpura" post="(HSP), acute poststreptococcal glomerulonephritis (APSGN), and childhood asthma. We"/>
   <result pre="(MP) pneumonia, acute pyelonephritis (APN), Henoch-SchÃ¶nlein purpura (HSP), acute poststreptococcal" exact="glomerulonephritis" post="(APSGN), and childhood asthma. We compared and interpreted epidemiological"/>
   <result pre="bell-shape patterns. In annual-case pattern, there were epidemic years in" exact="aseptic meningitis" post="and MP pneumonia, and the fluctuated annual cases were"/>
   <result pre="patterns. In annual-case pattern, there were epidemic years in aseptic" exact="meningitis" post="and MP pneumonia, and the fluctuated annual cases were"/>
   <result pre="of decreasing cases were seen in APSGN, HSP, and childhood" exact="asthma" post="in recent years. In seasonal frequency, influenza or aseptic"/>
   <result pre="HSP, and childhood asthma in recent years. In seasonal frequency," exact="influenza" post="or aseptic meningitis occurred in mainly winter or summer"/>
   <result pre="childhood asthma in recent years. In seasonal frequency, influenza or" exact="aseptic meningitis" post="occurred in mainly winter or summer season, respectively. HSP"/>
   <result pre="asthma in recent years. In seasonal frequency, influenza or aseptic" exact="meningitis" post="occurred in mainly winter or summer season, respectively. HSP"/>
   <result pre="itself or ubiquitously existing human reservoirs. Kawasaki disease etiology epidemiology" exact="acute pyelonephritis" post="exanthem subitum microbiota fig-count: table-count: equation-count: ref-count: page-count: word-count:"/>
   <result pre="or ubiquitously existing human reservoirs. Kawasaki disease etiology epidemiology acute" exact="pyelonephritis" post="exanthem subitum microbiota fig-count: table-count: equation-count: ref-count: page-count: word-count:"/>
   <result pre="ubiquitously existing human reservoirs. Kawasaki disease etiology epidemiology acute pyelonephritis" exact="exanthem" post="subitum microbiota fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction"/>
   <result pre="a nation and neighboring countries, which is contrasting to common" exact="infectious disease" post="epidemics. KD pathogen(s) should satisfy with the epidemiological characteristics"/>
   <result pre="or infection-related immune mediated diseases such as systemic juvenile idiopathic" exact="rheumatoid arthritis" post="or acute rheumatic fever (ARF). However, extensive studies searching"/>
   <result pre="infection-related immune mediated diseases such as systemic juvenile idiopathic rheumatoid" exact="arthritis" post="or acute rheumatic fever (ARF). However, extensive studies searching"/>
   <result pre="diseases such as systemic juvenile idiopathic rheumatoid arthritis or acute" exact="rheumatic fever" post="(ARF). However, extensive studies searching for the etiologic agent(s)"/>
   <result pre="infection-related immune-mediated diseases, including KD, childhood idiopathic thrombocytopenia, and Henoch-SchÃ¶nlein" exact="purpura" post="(HSP) have low prevalence in older children and adults."/>
   <result pre="the epidemiological profiles in KD were similar to those in" exact="acute pyelonephritis" post="(APN) or exanthema subitum (ES). We discussed the implications"/>
   <result pre="epidemiological profiles in KD were similar to those in acute" exact="pyelonephritis" post="(APN) or exanthema subitum (ES). We discussed the implications"/>
   <result pre="KD were similar to those in acute pyelonephritis (APN) or" exact="exanthema subitum" post="(ES). We discussed the implications of these findings in"/>
   <result pre="characteristics of patients diagnosed with Mycoplasma pneumoniae (MP) pneumonia, influenza," exact="aseptic meningitis," post="APN, ES, acute poststreptococcal glomerulonephritis (APSGN), HSP, childhood asthma"/>
   <result pre="pneumoniae (MP) pneumonia, influenza, aseptic meningitis, APN, ES, acute poststreptococcal" exact="glomerulonephritis" post="(APSGN), HSP, childhood asthma (or recurrent wheezing episode), and"/>
   <result pre="aseptic meningitis, APN, ES, acute poststreptococcal glomerulonephritis (APSGN), HSP, childhood" exact="asthma" post="(or recurrent wheezing episode), and KD. As an exception,"/>
   <result pre="episode), and KD. As an exception, the subjects diagnosed with" exact="influenza" post="in this study were selected from outpatients who were"/>
   <result pre="this study were selected from outpatients who were positive for" exact="influenza" post="in rapid diagnostic testing during the winter of influenza"/>
   <result pre="for influenza in rapid diagnostic testing during the winter of" exact="influenza" post="seasons. The diagnosis or selection criteria in each disease"/>
   <result pre="of diseases was over 10 years; for infectious diseases, MP" exact="pneumonia" post="(2003â€&quot;2012, n = 779) (12), influenza (2010â€&quot;2017, n ="/>
   <result pre="for infectious diseases, MP pneumonia (2003â€&quot;2012, n = 779) (12)," exact="influenza" post="(2010â€&quot;2017, n = 2,163) [(13, 14), unpublished observation], aseptic"/>
   <result pre="(12), influenza (2010â€&quot;2017, n = 2,163) [(13, 14), unpublished observation]," exact="aseptic meningitis" post="(1987â€&quot;2003, n = 2,201) (15), APN (2005â€&quot;2015, n ="/>
   <result pre="influenza (2010â€&quot;2017, n = 2,163) [(13, 14), unpublished observation], aseptic" exact="meningitis" post="(1987â€&quot;2003, n = 2,201) (15), APN (2005â€&quot;2015, n ="/>
   <result pre="(17), HSP (1987â€&quot;2015, n = 515) (unpublished observation) and childhood" exact="asthma" post="(or recurrent wheezing episode) (2003â€&quot;2014, n = 384) (18),"/>
   <result pre="disease 1987â€&quot;2016 942 31 1.7:1 2.2 Â± 1.6 1 Mycoplasma" exact="pneumonia" post="2003â€&quot;2012 779 78 1.1:1 5.0 Â± 3.2 4 Influenza"/>
   <result pre="Influenza 2010â€&quot;2018 2,163* 270 1.1:1 5.4 Â± 3.8 3â€&quot;5 Aseptic" exact="meningitis" post="1987â€&quot;1998 2,201 115 2:1 6.0 Â± 3.9 4â€&quot;6 Acute"/>
   <result pre="meningitis 1987â€&quot;1998 2,201 115 2:1 6.0 Â± 3.9 4â€&quot;6 Acute" exact="pyelonephritis" post="2005â€&quot;2015 320 29 1.4:1 1.5 Â± 3.4 0 Exanthem"/>
   <result pre="APSGN 1987â€&quot;2014 99 4 2.3:1 8.3 Â± 2.7 7â€&quot;9 Henoch-ShÃ¶nlein" exact="purpura" post="1987â€&quot;2015 515 18 1.2:1 6.5 Â± 3.0 5 Childhood"/>
   <result pre="purpura 1987â€&quot;2015 515 18 1.2:1 6.5 Â± 3.0 5 Childhood" exact="asthma" post="2003â€&quot;2014 384 32 1.2:1 5.6 Â± 3.5 2â€&quot;4 *Outpatients;"/>
   <result pre="and the lower M:F ratios were seen in ES, MP" exact="pneumonia" post="and influenza (1.1:1, respectively), and KD showed 1.7:1 ratio"/>
   <result pre="lower M:F ratios were seen in ES, MP pneumonia and" exact="influenza" post="(1.1:1, respectively), and KD showed 1.7:1 ratio in this"/>
   <result pre="ages were changed in the epidemic diseases such as MP" exact="pneumonia" post="and influenza over time [(12), unpublished observation]. Figure 1"/>
   <result pre="changed in the epidemic diseases such as MP pneumonia and" exact="influenza" post="over time [(12), unpublished observation]. Figure 1 Age distribution"/>
   <result pre="of pathogens, such as macrolide-resistant strains were noted in MP" exact="pneumonia" post="and in aseptic meningitis caused by mainly enteroviruses; all"/>
   <result pre="as macrolide-resistant strains were noted in MP pneumonia and in" exact="aseptic meningitis" post="caused by mainly enteroviruses; all had similar patterns with"/>
   <result pre="macrolide-resistant strains were noted in MP pneumonia and in aseptic" exact="meningitis" post="caused by mainly enteroviruses; all had similar patterns with"/>
   <result pre="were different in 2009 pandemic and seasonal influenza, across seasonal" exact="influenza" post="after 2009 pandemic [(14), unpublished observation]. Relatively an even,"/>
   <result pre="seen in the fall and winter in MP pneumonia. Aseptic" exact="meningitis" post="was noted mainly during the summer whereas influenza mainly"/>
   <result pre="pneumonia. Aseptic meningitis was noted mainly during the summer whereas" exact="influenza" post="mainly during winter and early spring seasons. There was"/>
   <result pre="Seasonality Kawasaki disease 22.9 27.7 23.1 26.2 No seasonality Mycoplasma" exact="pneumonia" post="11.2 19.1 48.4 21.3 Fall predominance Influenza 45.3 0.2"/>
   <result pre="Fall predominance Influenza 45.3 0.2 0.1 54.4 Spring, winter Aseptic" exact="meningitis" post="22.2 63.5 12.3 1.9 Summer predominance Acute pyelonephritis 26.9"/>
   <result pre="winter Aseptic meningitis 22.2 63.5 12.3 1.9 Summer predominance Acute" exact="pyelonephritis" post="26.9 27.8 23.1 22.2 No seasonality Exanthem subitum 28.4"/>
   <result pre="No seasonality APSGN 21.2 12.1 30.3 36.4 Winter, fall Henoch-ShÃ¶nlein" exact="purpura" post="31.1 13.6 29.1 26.2 Low in summer Childhood asthma"/>
   <result pre="Henoch-ShÃ¶nlein purpura 31.1 13.6 29.1 26.2 Low in summer Childhood" exact="asthma" post="26.8 13.5 43 16.7 Fall, Spring APSGN, acute poststreptococcal"/>
   <result pre="normal flora from initially being an exogenous pathogen. For examples," exact="measles" post="in immune-innocent populations in the past and acquired immunodeficiency"/>
   <result pre="On the other hand, the pathogens causing APN or acute" exact="otitis media," post="such as E. coli or Streptococcus pneumoniae, could be"/>
   <result pre="In the annual-case pattern, cyclic epidemics were noted in MP" exact="pneumonia" post="and aseptic meningitis, and marked fluctuated cases with a"/>
   <result pre="annual-case pattern, cyclic epidemics were noted in MP pneumonia and" exact="aseptic meningitis," post="and marked fluctuated cases with a different peak week"/>
   <result pre="in the host after the initial infection as shown in" exact="herpes zoster," post="herpes labialis, and reactivation of cytomegalovirus and Epstein-Barr virus"/>
   <result pre="has been reported in a variety of diseases, including obesity," exact="autism" post="spectrum disorders, allergic diseases, cancers, and autoimmune diseases such"/>
   <result pre="be less virulent compared to initial external pathogens. For example," exact="scarlet fever" post="caused by Group A beta-hemolytic streptococcus (GAS) was a"/>
   <result pre="severe disease in the past, with two notorious complications: acute" exact="rheumatic fever" post="(ARF) and APSGN. Now, scarlet fever, ARF and APSGN"/>
   <result pre="two notorious complications: acute rheumatic fever (ARF) and APSGN. Now," exact="scarlet fever," post="ARF and APSGN have become rare diseases with a"/>
   <result pre="milder clinical phenotype in the developed countries (17, 45). However," exact="pharyngitis" post="caused by GAS without complications is not uncommon, and"/>
   <result pre="diseases take on milder phenotypes over time, as shown in" exact="scarlet fever," post="pandemic influenza, and AIDS (13, 45, 50). It was"/>
   <result pre="and other symptoms, such as carditis, arthritis, and rarely skin" exact="rash" post="(erythema marginatum), develop (49). The majority of patients with"/>
   <result pre="severely affected patients have long-term complications such as severe rheumatic" exact="heart disease" post="or chronic renal failure, similar to giant coronary artery"/>
   <result pre="group streptococci, other bacteria or viruses are associated with postinfectious" exact="glomerulonephritis" post="or heart tissue inflammation, including myocarditis and possibly heart"/>
   <result pre="are associated with postinfectious glomerulonephritis or heart tissue inflammation, including" exact="myocarditis" post="and possibly heart valve diseases, without evidence of GAS"/>
   <result pre="outbreaks of infectious diseases such as MP pneumonia, influenza, and" exact="aseptic meningitis" post="in our city had occurred concurrently with nationwide epidemics."/>
   <result pre="of infectious diseases such as MP pneumonia, influenza, and aseptic" exact="meningitis" post="in our city had occurred concurrently with nationwide epidemics."/>
   <result pre="Circulation. (2017) 135:e927â€&quot;99. 10.1161/CIR.000000000000048428356445 8.KÃ¼hneT. Diagnosis and management of immune" exact="thrombocytopenia" post="in childhood. Hamostaseologie. (2017) 37:36â€&quot;44. 10.5482/HAMO-16-06-001727699328 9.ChenJYMaoJH. Henoch-SchÃ¶nlein purpura"/>
   <result pre="immune thrombocytopenia in childhood. Hamostaseologie. (2017) 37:36â€&quot;44. 10.5482/HAMO-16-06-001727699328 9.ChenJYMaoJH. Henoch-SchÃ¶nlein" exact="purpura" post="nephritis in children: incidence, pathogenesis and management. World J"/>
   <result pre="thrombocytopenia in childhood. Hamostaseologie. (2017) 37:36â€&quot;44. 10.5482/HAMO-16-06-001727699328 9.ChenJYMaoJH. Henoch-SchÃ¶nlein purpura" exact="nephritis" post="in children: incidence, pathogenesis and management. World J Pediatr."/>
   <result pre="(2007) 69:642â€&quot;51. 10.1016/j.mehy.2006.12.05117337130 12.KimEKYounYSRhimJWShinMSKangJHLeeKY. Epidemiological comparison of three Mycoplasma pneumoniae" exact="pneumonia" post="epidemics in a single hospital over 10 years. Korean"/>
   <result pre="(2011) 11:225. 10.1186/1471-2334-11-22521864391 15.LeeKYBurgnerDLeeHSHongJHLeeMHKangJHet al.. The changing epidemiology of pediatric" exact="aseptic meningitis" post="in Daejeon, Korea from 1987 to 2003. BMC Infect"/>
   <result pre="11:225. 10.1186/1471-2334-11-22521864391 15.LeeKYBurgnerDLeeHSHongJHLeeMHKangJHet al.. The changing epidemiology of pediatric aseptic" exact="meningitis" post="in Daejeon, Korea from 1987 to 2003. BMC Infect"/>
   <result pre="(2005) 5:97. 10.1186/1471-2334-5-9716262909 16.HuhSMParkBKKangHMRhimJWSuhJSLeeKYClinical implications of DMSA scan in childhood" exact="acute pyelonephritis." post="Child Kidney Dis. (2017) 21:107â€&quot;13. 10.3339/jkspn.2017.21.2.107 17.KuemSWHurSMYounYSRhimJWSuhJSLeeKYChanges in acute"/>
   <result pre="Dis. (2015) 19:112â€&quot;7. 10.3339/chikd.2015.19.2.112 18.RhimJWKangHMYangEAKYLee. Epidemiological relationship between Mycoplasma pneumoniae" exact="pneumonia" post="and recurrent wheezing episode in children: an observational study"/>
   <result pre="Clin North Am. (2011) 29:637â€&quot;53. 10.1016/j.emc.2011.04.00421782079 24.LeeKYNew insights for febrile" exact="urinary tract infection" post="(acute pyelonephritis) in children. Child Kidney Dis. (2016) 20:37â€&quot;44."/>
   <result pre="human herpesvirus 6 in different age groups, in children with" exact="exanthema subitum," post="other acute exanthematous childhood diseases, Kawasaki syndrome, and acute"/>
   <result pre="nationwide survey. J Epidemiol. (2015) 25:239â€&quot;45. 10.2188/jea.JE2014008925716368 33.CaniPDDelzenneNM. Interplay between" exact="obesity" post="and associated metabolic disorders: new insights into the gut"/>
   <result pre="34.DoenyasC. Gut microbiota, inflammation, and probiotics on neural development in" exact="autism" post="spectrum disorder. Neuroscience. (2018) 374:271â€&quot;86. 10.1016/j.neuroscience.2018.01.06029427656 35.HÃ¶rmannspergerGClaveTHallerD. Gut matters:"/>
   <result pre="Semin Immunol. (2017) 32:25â€&quot;34. 10.1016/j.smim.2017.08.00128822617 37.ArvonenMBerntsonLPokkaTKarttunenTJVÃ¤hÃ¤saloPStollML. Gut microbiota-host interactions and" exact="juvenile idiopathic arthritis." post="Pediatr Rheumatol Online J. (2016) 14:44. 10.1186/s12969-016-0104-627448997 38.KinumakiASekizukaTHamadaHKatoKYamashitaAKurodaM. Characterization"/>
   <result pre="10.1098/rspb.2014.308526702035 45.QuinnRW. Comprehensive review of morbidity and mortality trends for" exact="rheumatic fever," post="streptococcal disease, and scarlet fever: the decline of rheumatic"/>
   <result pre="rheumatic fever, streptococcal disease, and scarlet fever: the decline of" exact="rheumatic fever." post="Rev Infect Dis. (1989) 11:928â€&quot;53.2690288 46.KaplanELGastanaduyASHuweBB. The role of"/>
   <result pre="Revision of the Jones Criteria for the diagnosis of acute" exact="rheumatic fever" post="in the era of Doppler echocardiography: a scientific statement"/>
   <result pre="of Kawasaki disease. Medicine (Baltimore). (2017) 96:e7583. 10.1097/MD.000000000000758328723797 60.LeeKY. Pneumonia," exact="acute respiratory distress syndrome," post="and early immune-modulator therapy. Int J Mol Sci. (2017)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6541733\results\search\disease\results.xml">
   <result pre="are an important cause of morbidity and mortality associated with" exact="influenza" post="infections. As bacterial disease can be caused by a"/>
   <result pre="cause of morbidity and mortality associated with influenza infections. As" exact="bacterial disease" post="can be caused by a disturbance of the host"/>
   <result pre="disturbance of the host microbiome, we examined the impact of" exact="influenza" post="on the upper respiratory tract microbiome in a human"/>
   <result pre="ecology of the throat microbiome were examined following an experimental" exact="influenza" post="challenge of 52 previously-healthy adult volunteers with influenza A/Wisconsin/67/2005"/>
   <result pre="an experimental influenza challenge of 52 previously-healthy adult volunteers with" exact="influenza" post="A/Wisconsin/67/2005 (H3N2) by intranasal inoculation; 35 healthy control subjects"/>
   <result pre="detected. Results Of the 52 challenged individuals, 43 developed proven" exact="influenza" post="infections, 33 of whom became symptomatic. None of the"/>
   <result pre="influenza, with no significant differences over time between individuals with" exact="influenza" post="and those in the control group. Influenza infection was"/>
   <result pre="or Neisseria meningitidis. Conclusions The throat microbiota is resilient to" exact="influenza" post="infection, indicating the robustness of the upper-airway microbiome. Secondary"/>
   <result pre="the upper-airway microbiome. Secondary bacterial infections cause significant morbidity following" exact="influenza" post="virus infection. We show that influenza A virus infection"/>
   <result pre="cause significant morbidity following influenza virus infection. We show that" exact="influenza" post="A virus infection does not have a major impact"/>
   <result pre="indicating that microbial communities are robust in this site. microbiome" exact="influenza" post="upper respiratory tract Funding Centers for Disease Control and"/>
   <result pre="major cause of the mortality and morbidity associated with the" exact="influenza" post="virus [1]. Bacterial pneumonia caused millions of deaths during"/>
   <result pre="mortality and morbidity associated with the influenza virus [1]. Bacterial" exact="pneumonia" post="caused millions of deaths during influenza epidemics in the"/>
   <result pre="influenza virus [1]. Bacterial pneumonia caused millions of deaths during" exact="influenza" post="epidemics in the 20th century [2]. For example, 94%"/>
   <result pre="of a group of patients who died in the 1918" exact="influenza" post="pandemic had evidence of secondary bacterial pneumonia [3], while"/>
   <result pre="died in the 1918 influenza pandemic had evidence of secondary" exact="bacterial pneumonia" post="[3], while 28% of fatalities in New York associated"/>
   <result pre="in the 1918 influenza pandemic had evidence of secondary bacterial" exact="pneumonia" post="[3], while 28% of fatalities in New York associated"/>
   <result pre="of fatalities in New York associated with the 2009 H1N1" exact="influenza" post="pandemic had bacterial co-infections, with most diagnosed post-mortem [4]."/>
   <result pre="common that it was initially thought to be the cause" exact="influenza" post="[5]. Streptococcus pneumoniae is the commonest influenza-associated infection [6],"/>
   <result pre="is the commonest influenza-associated infection [6], while cavitatory Staphylococcus aureus" exact="pneumonia" post="is a severe influenza complication; secondary pneumonia with methicillin"/>
   <result pre="infection [6], while cavitatory Staphylococcus aureus pneumonia is a severe" exact="influenza" post="complication; secondary pneumonia with methicillin resistant Staphylococcus aureus emerged"/>
   <result pre="cavitatory Staphylococcus aureus pneumonia is a severe influenza complication; secondary" exact="pneumonia" post="with methicillin resistant Staphylococcus aureus emerged in the 2009"/>
   <result pre="the 2009 pandemic [7]. There is also an association between" exact="influenza" post="A and Neisseria meningitidis disease [8]. Multiple mechanisms could"/>
   <result pre="meningitidis disease [8]. Multiple mechanisms could explain the development of" exact="bacterial disease" post="following influenza. The virus is cytolytic and induces epithelial"/>
   <result pre="a more diverse nasopharyngeal microbiome compared with patients suffering from" exact="pneumonia" post="[22], while a highly diverse community is found in"/>
   <result pre="a highly diverse community is found in patients with asthma," exact="cystic fibrosis," post="or Chronic Obstructive Pulmonary Disease [23, 24]. However, little"/>
   <result pre="understand secondary bacterial infections, we investigated the impact of the" exact="influenza" post="virus on the human nasopharyngeal microbiome. Using 454 pyrosequencing,"/>
   <result pre="over a 30-day period in 52 healthy adults challenged with" exact="influenza" post="A H3N2 and in 32 non-challenged individuals. This approach"/>
   <result pre="us to define changes in the human microbiome following an" exact="influenza" post="challenge. Furthermore, we examined whether influenza affected the carriage"/>
   <result pre="human microbiome following an influenza challenge. Furthermore, we examined whether" exact="influenza" post="affected the carriage of pathogens in the upper airways."/>
   <result pre="and 45; were not living with anyone at risk of" exact="influenza" post="complications; and had not had an influenza vaccine in"/>
   <result pre="at risk of influenza complications; and had not had an" exact="influenza" post="vaccine in the last 3 years. Blood samples from"/>
   <result pre="challenge group were inoculated intranasally with 5.5 log10 TCID50/ml/nostril of" exact="influenza" post="strain A/H3N2/Wisconsin/67/2005. The control group members were not subjected"/>
   <result pre="unit on the day before receiving an intranasal challenge of" exact="influenza" post="A (on day 0), then were followed for 28"/>
   <result pre="were analysed by hemagglutination inhibition (HAI) and microneutralization assays. Laboratory-confirmed" exact="influenza" post="was defined as either a 4-fold or greater rise"/>
   <result pre="viral challenge and had an ILI, with evidence of an" exact="influenza" post="infection (n = 19); the Sflu+ group consisted of"/>
   <result pre="the viral challenge and were symptomatic, with evidence of an" exact="influenza" post="infection (n = 14); and the ILI/Sflu+ group consisted"/>
   <result pre="groups (n = 33). Those who were not challenged with" exact="influenza" post="and remained asymptomatic/influenza-negative formed the AC (asymptomatic control) group"/>
   <result pre="After Influenza Challenge Although volunteers were screened for antibodies against" exact="influenza" post="in advance, 3 individuals in the challenge group and"/>
   <result pre="in 43 of the 52 individuals (82%) subjected to the" exact="influenza" post="challenge; 33 subjects developed symptoms, including 19 with ILI"/>
   <result pre="with ILI (ILIflu+). An additional 3 subjects were challenged with" exact="influenza" post="and became symptomatic, but had no evidence of influenza"/>
   <result pre="with influenza and became symptomatic, but had no evidence of" exact="influenza" post="infection. There were 3 other challenged individuals that remained"/>
   <result pre="(white boxes) and asymptomatic control (grey boxes) groups following the" exact="influenza" post="A challenge. The box whisker plots extend from the"/>
   <result pre="structure in the ILI/Sflu+ and asymptomatic control groups during the" exact="influenza" post="challenge. The PCoA was based on the Thetayc index,"/>
   <result pre="The abundance of each phylum remained remarkably constant following the" exact="influenza" post="challenge. There was a significant change in the Bacteroidetes"/>
   <result pre="(P = .8163). Figure 9. Neisseria meningitidis carriage following the" exact="influenza" post="challenge. Meningococcal carriage in (A) the ILI/Sflu+ group and"/>
   <result pre="challenge. The carriage of non-groupable N. meningitidis was unchanged during" exact="influenza" post="infection and ranged between 11.4 and 13.5%, except for"/>
   <result pre="prospective characterization of bacterial communities within the human URT during" exact="influenza" post="infection. Previous studies have examined changes in the microbiota"/>
   <result pre="Furthermore, cross-sectional studies have characterized the microbiomes of patients with" exact="influenza" post="[42]. However we are not aware of a previous"/>
   <result pre="of a previous study that examined individuals during a defined" exact="influenza" post="challenge. We detected slight perturbations in the upper respiratory"/>
   <result pre="perturbations in the upper respiratory microbiota following a challenge with" exact="influenza" post="A. There was a high level of inter-individual variation"/>
   <result pre="with this increase, little is known about its role in" exact="respiratory disease." post="Overall, our study does not provide evidence that influenza"/>
   <result pre="respiratory disease. Overall, our study does not provide evidence that" exact="influenza" post="infection has a marked impact in shaping the pharyngeal"/>
   <result pre="Neisseria. Even though cohort studies have established a relationship between" exact="influenza" post="and the rate of pneumococcal carriage, we did not"/>
   <result pre="we did not find differences in pneumococcal carriage following an" exact="influenza" post="infection. For the meningococcus, we also examined capsule expression,"/>
   <result pre="encapsulated or non-encapsulated N. meningitidis with the advent of an" exact="influenza" post="infection. We did not examine swabs for the presence"/>
   <result pre="presence of S. aureus, as this secondary bacteria pathogen follows" exact="influenza" post="far less frequently than S. pneumoniae and is associated"/>
   <result pre="demonstrate that the upper airway microbiota is not reprogrammed by" exact="influenza" post="infection, with only minor perturbations in bacterial communities, similar"/>
   <result pre="have been disclosed. References References 1.SmithAM, McCullersJASecondary bacterial infections in" exact="influenza" post="virus infection pathogenesis. Curr Top Microbiol Immunol2014; 385:327â€&quot;56.25027822 2.MorensDM,"/>
   <result pre="infection pathogenesis. Curr Top Microbiol Immunol2014; 385:327â€&quot;56.25027822 2.MorensDM, FauciASThe 1918" exact="influenza" post="pandemic: insights for the 21st century. J Infect Dis2007;"/>
   <result pre="series of 68 cases dying before and during the 1918" exact="influenza" post="pandemic peak. Proc Natl Acad Sci USA2011; 108:16416â€&quot;21.21930918 4.LeeEH,"/>
   <result pre="4.LeeEH, WuC, LeeEU, et al.Fatalities associated with the 2009 H1N1" exact="influenza" post="A virus in New York city. Clin Infect Dis2010;"/>
   <result pre="Clin Infect Dis2010; 50:1498â€&quot;504.20420514 5.SmithW, AndrewesCH, LaidlawPPA virus obtained from" exact="influenza" post="patients. Lancet1933; 2:66â€&quot;8. 6.McCullersJAInsights into the interaction between influenza"/>
   <result pre="from influenza patients. Lancet1933; 2:66â€&quot;8. 6.McCullersJAInsights into the interaction between" exact="influenza" post="virus and pneumococcus. Clin Microbiol Rev2006; 19:571â€&quot;82.16847087 7.MurrayRJ, RobinsonJO,"/>
   <result pre="pneumococcus. Clin Microbiol Rev2006; 19:571â€&quot;82.16847087 7.MurrayRJ, RobinsonJO, WhiteJN, et al.Community-acquired" exact="pneumonia" post="due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus"/>
   <result pre="respiratory tract. Pediatr Infect Dis J2009; 28:S121â€&quot;6.19918134 11.McCullersJAThe co-pathogenesis of" exact="influenza" post="viruses with bacteria in the lung. Nat Rev Microbiol2014;"/>
   <result pre="Microbiol2014; 12:252â€&quot;62.24590244 12.PeltolaVT, MurtiKG, McCullersJAInfluenza virus neuraminidase contributes to secondary" exact="bacterial pneumonia." post="J Infect Dis2005; 192:249â€&quot;57.15962219 13.ShakhnovichEA, KingSJ, WeiserJNNeuraminidase expressed by"/>
   <result pre="14.Nita-LazarM, BanerjeeA, FengC, et al.Desialylation of airway epithelial cells during" exact="influenza" post="virus infection enhances pneumococcal adhesion via galectin binding. Mol"/>
   <result pre="WyllieAL, et al.Dysbiosis of upper respiratory tract microbiota in elderly" exact="pneumonia" post="patients. ISME J2016; 10:97â€&quot;108.26151645 23.ZhaoJ, SchlossPD, KalikinLM, et al.Decade-long"/>
   <result pre="10:97â€&quot;108.26151645 23.ZhaoJ, SchlossPD, KalikinLM, et al.Decade-long bacterial community dynamics in" exact="cystic fibrosis" post="airways. Proc Natl Acad Sci USA2012; 109:5809â€&quot;14.22451929 24.HuangYJ, SethiS,"/>
   <result pre="SethiS, MurphyT, NariyaS, BousheyHA, LynchSVAirway microbiome dynamics in exacerbations of" exact="chronic obstructive pulmonary disease." post="J Clin Microbiol2014; 52:2813â€&quot;23.24850358 25.YiH, YongD, LeeK, ChoYJ, ChunJProfiling"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6542110\results\search\disease\results.xml">
   <result pre="Research1746-6148BioMed CentralLondon 1863 doi: 10.1186/s12917-019-1863-3 : Research Article Genotyping bovine" exact="leukemia" post="virus in dairy cattle of Heilongjiang, northeastern China http://orcid.org/0000-0002-9548-7151YuChangqingycq_1926@126.com1WangXuefengwangxuefeng@caas.cn1ZhouYulongzhouyulong1980@163.com2WangYuyuiop6183@163.com1ZhangXianfengzhangxf@hvri.ac.cn1ZhengYonghuizhengyo@msu.edu13[1],"/>
   <result pre="available in this article, unless otherwise stated. Abstract Background Bovine" exact="leukemia" post="virus (BLV) causes enzootic bovine leukosis in cattle and"/>
   <result pre="supplementary material, which is available to authorized users. Keywords Bovine" exact="leukemia" post="virus Genotyping Cattle Enzootic bovine leukosis Funding http://dx.doi.org/10.13039/501100001809National Natural"/>
   <result pre="Funding http://dx.doi.org/10.13039/501100005046Natural Science Foundation of Heilongjiang Province H2016102ZhangXianfeng Background Bovine" exact="leukemia" post="virus (BLV) is closely related to human T-lymphotropic virus,"/>
   <result pre="longevity in dairy cattle [4â€&quot;7]. Recently, a correlation between human" exact="breast cancer" post="and BLV infection was proposed [8â€&quot;11], demonstrating that BLV"/>
   <result pre="in dairy cattle [4â€&quot;7]. Recently, a correlation between human breast" exact="cancer" post="and BLV infection was proposed [8â€&quot;11], demonstrating that BLV"/>
   <result pre="isolates of other genotypes. (PPTX 353 kb) Abbreviations BLV Bovine" exact="leukemia" post="virus env Envelope G Genotype ND Neutralizing domain nt"/>
   <result pre="advances in BLV researchViruses20157116080608810.3390/v711292926610551 2.AidaYMurakamiHTakahashiMTakeshimaSNMechanisms of pathogenesis induced by bovine" exact="leukemia" post="virus as a model for human T-cell leukemia virusFront"/>
   <result pre="by bovine leukemia virus as a model for human T-cell" exact="leukemia" post="virusFront Microbiol2013432810.3389/fmicb.2013.0032824265629 3.RodriguezSMFlorinsAGilletNde BrogniezASanchez-AlcarazMTBoxusMBoulangerFGutierrezGTronoKAlvarezIet al.Preventive and therapeutic strategies for"/>
   <result pre="virusFront Microbiol2013432810.3389/fmicb.2013.0032824265629 3.RodriguezSMFlorinsAGilletNde BrogniezASanchez-AlcarazMTBoxusMBoulangerFGutierrezGTronoKAlvarezIet al.Preventive and therapeutic strategies for bovine" exact="leukemia" post="virus: lessons for HTLVViruses2011371210124810.3390/v307121021994777 4.ErskineRJBartlettPCByremTMRenderCLFebvayCHousemanJTAssociation between bovine leukemia virus,"/>
   <result pre="for bovine leukemia virus: lessons for HTLVViruses2011371210124810.3390/v307121021994777 4.ErskineRJBartlettPCByremTMRenderCLFebvayCHousemanJTAssociation between bovine" exact="leukemia" post="virus, production, and population age in Michigan dairy herdsJ"/>
   <result pre="and population age in Michigan dairy herdsJ Dairy Sci201295272773410.3168/jds.2011-476022281337 5.YangYFanWMaoYYangZLuGZhangRZhangHSzetoCWangCBovine" exact="leukemia" post="virus infection in cattle of China: association with reduced"/>
   <result pre="scoreJ Dairy Sci20169953688369710.3168/jds.2015-1058026923050 6.DaYShanksRDStewartJALewinHAMilk and fat yields decline in bovine" exact="leukemia" post="virus-infected Holstein cattle with persistent lymphocytosisProc Natl Acad Sci"/>
   <result pre="Sci U S A199390146538654110.1073/pnas.90.14.65388341665 7.Della LiberaAMde SouzaFNBatistaCFSantosBPde AzevedoLFSanchezEMDinizSASilvaMXHaddadJPBlagitzMGEffects of bovine" exact="leukemia" post="virus infection on milk neutrophil function and the milk"/>
   <result pre="milk neutrophil function and the milk lymphocyte profileVet Res201546210.1186/s13567-014-0125-425595200 8.BuehringGCShenHMJensenHMChoiKYSunDNuovoGBovine" exact="leukemia" post="virus DNA in human breast tissueEmerg Infect Dis201420577278210.3201/eid2005.13129824750974 9.BuehringGCShenHMJensenHMJinDLHudesMBlockGExposure"/>
   <result pre="DNA in human breast tissueEmerg Infect Dis201420577278210.3201/eid2005.13129824750974 9.BuehringGCShenHMJensenHMJinDLHudesMBlockGExposure to bovine" exact="leukemia" post="virus is associated with breast cancer: a case-control studyPLoS"/>
   <result pre="cancer: a case-control studyPLoS One2015109e013430410.1371/journal.pone.013430426332838 10.ZhangRJiangJSunWZhangJHuangKGuXYangYXuXShiYWangCLack of association between bovine" exact="leukemia" post="virus and breast cancer in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949"/>
   <result pre="studyPLoS One2015109e013430410.1371/journal.pone.013430426332838 10.ZhangRJiangJSunWZhangJHuangKGuXYangYXuXShiYWangCLack of association between bovine leukemia virus and" exact="breast cancer" post="in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked"/>
   <result pre="One2015109e013430410.1371/journal.pone.013430426332838 10.ZhangRJiangJSunWZhangJHuangKGuXYangYXuXShiYWangCLack of association between bovine leukemia virus and breast" exact="cancer" post="in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked"/>
   <result pre="virus and breast cancer in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine" exact="leukemia" post="virus linked to breast cancer but not coinfection with"/>
   <result pre="in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked to" exact="breast cancer" post="but not coinfection with human papillomavirus: case-control study of"/>
   <result pre="Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked to breast" exact="cancer" post="but not coinfection with human papillomavirus: case-control study of"/>
   <result pre="case-control study of women in TexasCancer201812471342134910.1002/cncr.3116929266207 12.LairmoreMDAnimal models of bovine" exact="leukemia" post="virus and human T-lymphotrophic virus type-1: insights in transmission"/>
   <result pre="Sci U S A201311062306231110.1073/pnas.121384211023345446 14.PolatMTakeshimaSNAidaYEpidemiology and genetic diversity of bovine" exact="leukemia" post="virusVirol J201714120910.1186/s12985-017-0876-429096657 15.MamounRZAstierTGuillemainBDuplanJFBovine lymphosarcoma: processing of bovine leukaemia virus-coded"/>
   <result pre="Virol1983642791279510.1099/0022-1317-64-12-27916319563 16.DietzscholdBKaadenORFrenzelBSubunit and fine structure of the glycoprotein of bovine" exact="leukemia" post="virusAnn Rech Vet197894613617224755 17.CoulstonJNaifHBrandonRKumarSKhanSDanielRCLavinMFMolecular cloning and sequencing of an"/>
   <result pre="in argentine dairy cattleArch Virol2005150344345810.1007/s00705-004-0437-115592892 20.AsfawYTsudukuSKonishiMMurakamiKTsuboiTWuDSentsuiHDistribution and superinfection of bovine" exact="leukemia" post="virus genotypes in JapanArch Virol2005150349350510.1007/s00705-004-0433-515592894 21.CamargosMFPeredaAStancekDRochaMAdos ReisJKGreiser-WilkeILeiteRCMolecular characterization of"/>
   <result pre="of the env gene from Brazilian field isolates of bovine" exact="leukemia" post="virusVirus Genes200734334335010.1007/s11262-006-0011-x16917740 22.RodriguezSMGolembaMDCamposRHTronoKJonesLRBovine leukemia virus can be classified into"/>
   <result pre="from Brazilian field isolates of bovine leukemia virusVirus Genes200734334335010.1007/s11262-006-0011-x16917740 22.RodriguezSMGolembaMDCamposRHTronoKJonesLRBovine" exact="leukemia" post="virus can be classified into seven genotypes: evidence for"/>
   <result pre="of two novel cladesJ Gen Virol2009902788279710.1099/vir.0.011791-019587134 23.MoratorioGObalGDubraACorreaABianchiSBuschiazzoACristinaJPritschOPhylogenetic analysis of bovine" exact="leukemia" post="viruses isolated in South America reveals diversification in seven"/>
   <result pre="diversification in seven distinct genotypesArch Virol2010155448148910.1007/s00705-010-0606-320169372 24.MatsumuraKInoueEOsawaYOkazakiKMolecular epidemiology of bovine" exact="leukemia" post="virus associated with enzootic bovine leukosis in JapanVirus Res2011155134334810.1016/j.virusres.2010.11.00521095208"/>
   <result pre="in JapanVirus Res2011155134334810.1016/j.virusres.2010.11.00521095208 25.BalicDLojkicIPeriskicMBedekovicTJungicALemoNRoicBCacZBarbicLMadicJIdentification of a new genotype of bovine" exact="leukemia" post="virusArch Virol201215771281129010.1007/s00705-012-1300-422488472 26.AbabnehMMAl-RukibatRKHananehWMNasarATAl-ZghoulMBDetection and molecular characterization of bovine leukemia"/>
   <result pre="bovine leukemia virusArch Virol201215771281129010.1007/s00705-012-1300-422488472 26.AbabnehMMAl-RukibatRKHananehWMNasarATAl-ZghoulMBDetection and molecular characterization of bovine" exact="leukemia" post="viruses from JordanArch Virol2012157122343234810.1007/s00705-012-1447-z22914962 27.Rola-LuszczakMPlutaAOlechMDonnikIPetropavlovskiyMGerilovychAVinogradovaIChoudhuryBKuzmakJThe molecular characterization of bovine"/>
   <result pre="impact on phylogenyPLoS One201383e5870510.1371/journal.pone.005870523527009 28.PolatMOhnoATakeshimaSNKimJKikuyaMMatsumotoYMingalaCNOnumaMAidaYDetection and molecular characterization of bovine" exact="leukemia" post="virus in Philippine cattleArch Virol2015160128529610.1007/s00705-014-2280-325399399 29.LeeEKimEJJoungHKKimBHSongJYChoISLeeKKShinYKSequencing and phylogenetic analysis"/>
   <result pre="and phylogenetic analysis of the gp51 gene from Korean bovine" exact="leukemia" post="virus isolatesVirol J2015126410.1186/s12985-015-0286-425879943 30.OchirkhuuNKonnaiSOdbilegRNishimoriAOkagawaTMurataSOhashiKDetection of bovine leukemia virus and"/>
   <result pre="from Korean bovine leukemia virus isolatesVirol J2015126410.1186/s12985-015-0286-425879943 30.OchirkhuuNKonnaiSOdbilegRNishimoriAOkagawaTMurataSOhashiKDetection of bovine" exact="leukemia" post="virus and identification of its genotype in Mongolian cattleArch"/>
   <result pre="Virol2016161498599110.1007/s00705-015-2676-826711456 31.PolatMTakeshimaSNHosomichiKKimJMiyasakaTYamadaKAraingaMMurakamiTMatsumotoYde la Barra DiazVet al.A new genotype of bovine" exact="leukemia" post="virus in South America identified by NGS-based whole genome"/>
   <result pre="evolutionary genetic analysisRetrovirology201613410.1186/s12977-016-0239-z26754835 32.LeeEKimEJRatthanophartJVitoonpongRKimBHChoISSongJYLeeKKShinYKMolecular epidemiological and serological studies of bovine" exact="leukemia" post="virus (BLV) infection in Thailand cattleInfect Genet Evol20164124525410.1016/j.meegid.2016.04.01027090024 33.YangYKellyPJBaiJZhangRWangCFirst"/>
   <result pre="in Thailand cattleInfect Genet Evol20164124525410.1016/j.meegid.2016.04.01027090024 33.YangYKellyPJBaiJZhangRWangCFirst molecular characterization of bovine" exact="leukemia" post="virus infections in the CaribbeanPLoS One20161112e016837910.1371/journal.pone.016837927977761 34.PolatMMoeHHShimogiriTMoeKKTakeshimaSNAidaYThe molecular epidemiological"/>
   <result pre="in the CaribbeanPLoS One20161112e016837910.1371/journal.pone.016837927977761 34.PolatMMoeHHShimogiriTMoeKKTakeshimaSNAidaYThe molecular epidemiological study of bovine" exact="leukemia" post="virus infection in Myanmar cattleArch Virol2017162242543710.1007/s00705-016-3118-y27771791 35.GregoryLCarrillo GaetaNAraujoJMatsumiya ThomazelliLHarakawaRIkunoAAHiromi"/>
   <result pre="Paulo, BrazilJ Med Microbiol201766121790179710.1099/jmm.0.00063929120299 36.WangMWangYBalochARPanYXuFTianLZengQMolecular epidemiology and characterization of bovine" exact="leukemia" post="virus in domestic yaks (Bos grunniens) on the Qinghai-Tibet"/>
   <result pre="grunniens) on the Qinghai-Tibet plateau, ChinaArch Virol2018163365967010.1007/s00705-017-3658-929224130 37.JuliarenaMABarriosCNCerianiMCEstebanENHot topic: Bovine" exact="leukemia" post="virus (BLV)-infected cows with low proviral load are not"/>
   <result pre="analysis of envelope glycoproteins from diverse geographical isolates of bovine" exact="leukemia" post="virus identifies highly conserved peptide motifsRetrovirology2018151210.1186/s12977-017-0383-029310678 39.ChackerianBRudenseyLMOverbaughJSpecific N-linked and"/>
   <result pre="single envelope N-Linked glycosylation site enhances the pathogenicity of bovine" exact="leukemia" post="virusJ Virol201589178945895610.1128/JVI.00261-1526085161 42.RizzoGFortiKSerroniACagiolaMBaglivoSScocciaEDe GiuseppeASingle N-glycosylation site of bovine leukemia"/>
   <result pre="bovine leukemia virusJ Virol201589178945895610.1128/JVI.00261-1526085161 42.RizzoGFortiKSerroniACagiolaMBaglivoSScocciaEDe GiuseppeASingle N-glycosylation site of bovine" exact="leukemia" post="virus SU is involved in conformation and viral escapeVet"/>
   <result pre="is involved in conformation and viral escapeVet Microbiol2016197212610.1016/j.vetmic.2016.10.02427938679 43.GatotJSCallebautIVan LintCDemonteDKerkhofsPPortetelleDBurnyAWillemsLKettmannRBovine" exact="leukemia" post="virus SU protein interacts with zinc, and mutations within"/>
   <result pre="and infectivity in vivoJ Virol200276167956796710.1128/JVI.76.16.7956-7967.200212134000 44.ZhaoXBuehringGCNatural genetic variations in bovine" exact="leukemia" post="virus envelope gene: possible effects of selection and escapeVirology2007366115016510.1016/j.virol.2007.03.05817498765"/>
   <result pre="and escapeVirology2007366115016510.1016/j.virol.2007.03.05817498765 45.TakeshimaSNKitamura-MuramatsuYYuanYPolatMSaitoSAidaYBLV-CoCoMo-qPCR-2: improvements to the BLV-CoCoMo-qPCR assay for bovine" exact="leukemia" post="virus by reducing primer degeneracy and constructing an optimal"/>
   <result pre="samples from the same cattleVirus Res201521024825410.1016/j.virusres.2015.08.01326298004 47.JimbaMTakeshimaSNMatobaKEndohDAidaYBLV-CoCoMo-qPCR: Quantitation of bovine" exact="leukemia" post="virus proviral load using the CoCoMo algorithmRetrovirology201079110.1186/1742-4690-7-9121044304"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6542824\results\search\disease\results.xml">
   <result pre="view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract For" exact="dengue fever" post="and other seasonal epidemics we show how the stability"/>
   <result pre="assess Î»*). To test its generality we examined records of" exact="influenza" post="incidence gathered from the World Health Organization database, where"/>
   <result pre="results that are consistent with the results of the country-level" exact="influenza" post="data, and slightly better for New York City. The"/>
   <result pre="in the severity of the diseases with possible under-reporting of" exact="influenza" post="in the inter-disease periods; (2) the fact that the"/>
   <result pre="(4)Â We also note that if novel strains of the" exact="influenza" post="virus are introduced too close to onset of an"/>
   <result pre="Shows the correlations between the eigenvalues âŒ©Î»*âŒª and the subsequent" exact="influenza" post="outbreak magnitudes in the 27 different countries having less"/>
   <result pre="robustness analysis is presented in Supplementary Fig.Â 4. Analysis of" exact="influenza" post="data The influenza analysis used time windows of length"/>
   <result pre="presented in Supplementary Fig.Â 4. Analysis of influenza data The" exact="influenza" post="analysis used time windows of length Tâ€‰=â€‰30 weeks to"/>
   <result pre="capita in the year following the outbreak onsets. Although the" exact="influenza" post="database includes 79 different countries, only about half of"/>
   <result pre="Data of dengue incidence are from http://dengueforecasting.noaa.gov. The data of" exact="influenza" post="incidence are from http://www.pnas.org/content/suppl/2016/10/26/1607747113.DCSupplemental/pnas.1607747113.sd01.txt. Only studies with fewer than"/>
   <result pre="underlying seasonal patternsInt. J. Epidemiol.19821151410.1093/ije/11.1.57085179 15.EllnerSPet al.Noise and nonlinearity in" exact="measles" post="epidemics: combining mechanistic and statistical approaches to population modelingAm."/>
   <result pre="thailand: a longitudinal data analysisPLoS Med.20096e100016810.1371/journal.pmed.100016819918363 18.AxelsenJBYaariRGrenfellBTStoneLMultiannual forecasting of seasonal" exact="influenza" post="dynamics reveals climatic and evolutionary driversProc. Natl. Acad. Sci."/>
   <result pre="R. Soc. B: Biol. Sci.199033023525110.1098/rstb.1990.0195 23.LauerSAet al.Prospective forecasts of annual" exact="dengue hemorrhagic fever" post="incidence in thailand, 2010â€&quot;2014Proc. Natl. Acad. Sci. USA2017115E2175E218210.1073/pnas.1714457115 24.DixonPAMilicichMJSugiharaGEpisodic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6543068\results\search\disease\results.xml">
   <result pre="abstract Abstract Introduction Respiratory syncytial virus (RSV) causes a significant" exact="respiratory disease" post="burden in the under 5 population. The transmission pathway"/>
   <result pre="The quantitative analysis of household outbreaks has been conducted for" exact="influenza" post="(Cauchemez et al., 2009, 2004; House et al., 2012;"/>
   <result pre="vaccine effectiveness (Kwambana-Adams et al., 2017) and a study on" exact="influenza" post="has shown evidence of its controlling effect on other"/>
   <result pre="respiratory syncytial virusPLoS Pathog.52009e1000254 CamachoA.FunkS.fitR: Tool box for fitting dynamic" exact="infectious disease" post="models to time seriesR Package Version 0.12017 CanePaMolecular epidemiology"/>
   <result pre="to household longitudinal dataStat. Med.2320043469348715505892 CauchemezS.DonnellyC.A.ReedC.GhaniA.C.FraserC.KentC.K.FinelliL.FergusonN.M.Household transmission of 2009 pandemic" exact="influenza" post="a (H1N1) virus in the United StatesN. Engl. J."/>
   <result pre="Infectious Diseases2015Oxford University Pressofu118 HouseTa.InglisN.RossJ.V.WilsonF.SulemanS.EdeghereO.SmithG.OlowokureB.KeelingM.J.Estimation of outbreak severity and transmissibility:" exact="influenza" post="A(H1N1)pdm09 in householdsBMC Med.10201211723046520 JacobyP.GlassK.Characterizing the Risk of Respiratory"/>
   <result pre="a low-income country settingPLoS One102015e0138018 KlickB.NishiuraH.NgS.FangV.J.LeungG.M.PeirisJ.S.CowlingB.J.Transmissibility of seasonal and pandemic" exact="influenza" post="in a cohort of households in Hong Kong in"/>
   <result pre="the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecologySci. Rep.7201711128127051 LauM.S.Y.CowlingB.J.CookA.R.RileyS.Inferring" exact="influenza" post="dynamics and control in householdsProc. Natl. Acad. Sci.11220159094909926150502 LeeF.E.WalshE.E.FalseyA.R.BettsR.F.TreanorJ.J.Experimental"/>
   <result pre="and BA9 are prevalent in Thailand, 2012â€&quot;2015PeerJ52017e397029085762 TsangT.K.LauL.L.H.CauchemezS.CowlingB.J.Household transmission of" exact="influenza" post="virusTrends Microbiol.2016 WathuoM.MedleyG.F.NokesD.J.MunywokiP.K.Quantification and determinants of the amount of"/>
   <result pre="Pandemic Using Household-Based Public Health Interventions 32006 YangY.ZhangY.FangL.HalloranM.E.MaM.LiangS.KenahE.BrittonT.ChenE.HuJ.TangF.CaoW.FengZ.LonginiI.M.Household transmissibility of" exact="avian influenza" post="a (H7N9) virus, China, February to May 2013 and"/>
   <result pre="Using Household-Based Public Health Interventions 32006 YangY.ZhangY.FangL.HalloranM.E.MaM.LiangS.KenahE.BrittonT.ChenE.HuJ.TangF.CaoW.FengZ.LonginiI.M.Household transmissibility of avian" exact="influenza" post="a (H7N9) virus, China, February to May 2013 and"/>
   <result pre="2013 to March 2014Eurosurveillance20201511126132766 ZhengX.SongZ.LiY.ZhangJ.WangX.L.Possible interference between seasonal epidemics of" exact="influenza" post="and other respiratory viruses in Hong Kong, 2014-2017BMC Infect."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6544329\results\search\disease\results.xml">
   <result pre="Insects: Mosquitoes El NiÃ±o Southern Oscillation, overseas arrivals and imported" exact="chikungunya" post="cases in Australia: A time series analysis ENSO, overseas"/>
   <result pre="Australia: A time series analysis ENSO, overseas arrivals and imported" exact="chikungunya" post="in Australia HuangXiaodongConceptualizationData curationFormal analysisInvestigationMethodologyVisualizationWriting â€&quot; original draft1HuWenbiaoConceptualizationFormal analysisFunding"/>
   <result pre="Since the National Notifiable Diseases Surveillance System [32] started reporting" exact="chikungunya" post="virus infection in 2008, imported cases to Australia have"/>
   <result pre="the Americas in 2014 [50], along with the first local" exact="chikungunya" post="outbreaks in June 2014 in Florida in the continental"/>
   <result pre="Australia originating in India that year. Bangladesh experienced a significant" exact="chikungunya" post="outbreak in 2017 [54], with Australia observing the largest"/>
   <result pre="MercierA, LepersC, HoyD, DuituturagaS, BenyonE, et al.Concurrent outbreaks of dengue," exact="chikungunya" post="and Zika virus infectionsâ€&quot;an unprecedented epidemic wave of mosquito-borne"/>
   <result pre="10.1056/NEJMp07801317314335 12ParolaP, de LamballerieX, JourdanJ, RoveryC, VaillantV, MinodierP, et al.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islands."/>
   <result pre="2014;63:1137. 14RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliAC, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="Lancet. 2007;370:1840â€&quot;6. 15GouldEA, GallianP, LamballerieXd, NCharrelR. First cases of autochthonous" exact="dengue fever" post="and chikungunya fever in France: from bad dream to"/>
   <result pre="GallianP, LamballerieXd, NCharrelR. First cases of autochthonous dengue fever and" exact="chikungunya" post="fever in France: from bad dream to reality. Clinical"/>
   <result pre="new European invader Aedes (Finlaya) koreicus: a potential vector of" exact="chikungunya" post="virus. Pathog Glob Health. 2018;112(3):107â€&quot;14. 10.1080/20477724.2018.146478029737236 17KraemerMU, SinkaME, DudaKA,"/>
   <result pre="PetersonAT. Climate change influences on global distributions of dengue and" exact="chikungunya" post="virus vectors. Philos Trans R Soc Lond B Biol"/>
   <result pre="10.1007/s00436-010-1767-420155369 26ViennetE, KnopeK, FaddyHM, WilliamsCR, HarleyD. Assessing the threat of" exact="chikungunya" post="virus emergence in Australia. Commun Dis Intell Q Rep."/>
   <result pre="BhimalaKR, KumaraswamyS, KadiriMR, et al.Temperature dependent transmission potential model for" exact="chikungunya" post="in India. Sci Total Environ. 2019;647:66â€&quot;74. 10.1016/j.scitotenv.2018.07.46130077856 38YoshikawaMJ, KusriastutiR."/>
   <result pre="40KnopeKE, KuruczN, DoggettSL, MullerM, JohansenCA, FeldmanR, et al.Arboviral diseases and" exact="malaria" post="in Australia, 2012â€&quot;13: Annual report of the National Arbovirus"/>
   <result pre="JansenS, LÃ¼hkenR, HelmsM, PluskotaB, BeckerN, et al.Experimental risk assessment for" exact="chikungunya" post="virus transmission based on vector competence, distribution and temperature"/>
   <result pre="Branch NCfE, Zoonotic Infectious Diseases CDC. Notes from the field:" exact="chikungunya" post="virus spreads in the Americasâ€&quot;Caribbean and South America, 2013â€&quot;2014."/>
   <result pre="mortality weekly report. 2014;63(22):500â€&quot;1. .24898168 51KendrickK, StanekD, BlackmoreC. Transmission of" exact="chikungunya" post="virus in the continental United States-Florida, 2014. Centers for"/>
   <result pre="Emerging Infectious Diseases. 2013;19(9):1535â€&quot;8. 10.3201/eid1909.130130 PMC3810919. 23965757 65Queensland Goverment. Queensland" exact="chikungunya" post="management plan 2014â€&quot;2019. 2014 [cited 4 March 2019]. Available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6548069\results\search\disease\results.xml">
   <result pre="Zika en Colombia del 2008 al 2018Co-circulaÃ§Ã£o dos vÃ­rus dengue," exact="chikungunya" post="e Zika na ColÃ´mbia, 2008â€&quot;2018 Rico-MendozaAlejandro1AlexandraPorras-RamÃ­rez1ChangAileen2EncinalesLiliana3LynchRebecca4[1], Grupo de Medicina"/>
   <result pre="Colombiaâ€™s Public Health Surveillance System (SIVIGILA). Results. In 2015, when" exact="chikungunya" post="was first detected, it had a higher incidence (1Â"/>
   <result pre="SaÃºde PÃºblica da ColÃ´mbia (SIVIGILA). Resultados. Em 2015, quando o" exact="chikungunya" post="foi detectado pela primeira vez, sua incidÃªncia foi superior"/>
   <result pre="Este achado requer anÃ¡lise adicional. Keywords Zika virus dengue virus" exact="chikungunya" post="virus coinfection Colombia Palabras clave Virus Zika virus del"/>
   <result pre="coinfection Colombia Palabras clave Virus Zika virus del dengue virus" exact="chikungunya" post="coinfecciÃ³n; Colombia Palavras-chave Zika virus vÃ­rus da dengue vÃ­rus"/>
   <result pre="chikungunya coinfecciÃ³n; Colombia Palavras-chave Zika virus vÃ­rus da dengue vÃ­rus" exact="chikungunya" post="coinfecÃ§Ã£o ColÃ´mbia fig-count: table-count: equation-count: ref-count: In Latin America"/>
   <result pre="the Caribbean, the recent epidemics of mosquito-borne arboviruses, including the" exact="chikungunya" post="virus (CHIKV) and Zika virus (ZIKV), combined with the"/>
   <result pre="infection during pregnancy is associated with severe teratogenic effects, including" exact="microcephaly" post="(8-11). Co-circulation not only makes differential diagnoses more complicated"/>
   <result pre="weeks before the onset of symptoms and who presented with" exact="rash" post="and one or more of the following signs: fever"/>
   <result pre="more of the following signs: fever &amp;lt; 38.5 Â°C, nonpurulent" exact="conjunctivitis" post="or conjunctival hyperemia, arthralgia, myalgia, headache, or general discomfort."/>
   <result pre="aimed to describe the geographic distribution of Zika, dengue, and" exact="chikungunya" post="cases in Colombia based on the residence of people"/>
   <result pre="reported. In 2017, SIVIGILA was notified of 1Â 128 potential" exact="chikungunya" post="cases, of which 34 (3.0%; 95% CI: 2.1%â€&quot;4.1%) were"/>
   <result pre="were suspected cases. Also in 2017, the national incidence of" exact="chikungunya" post="in urban populations was 4.0 cases per 100Â 000"/>
   <result pre="del Cauca (Figure 1). TABLE 2 Incidence of dengue (DENV)," exact="chikungunya" post="(CHIKV), and Zika (ZIKV), per 100Â 000 individuals in"/>
   <result pre="of Colombia with co-circulation of dengue (DENV), Zika (ZIKV), and" exact="chikungunya" post="(CHIKV), 2015 to 2018 DISCUSSION DENV, CHIKV, and ZIKV"/>
   <result pre="systematic review. PLOS Negl Trop Dis. 2015;9(3):e0003499. 2MattarSMirandaJPinzonHTiqueVBolanosAAponteJet al. Outbreak of" exact="chikungunya" post="virus in the north Caribbean area of Colombia: clinical"/>
   <result pre="Tique V, Bolanos A, Aponte J, et al.  Outbreak of" exact="chikungunya" post="virus in the north Caribbean area of Colombia: clinical"/>
   <result pre="J Med. 2016 Jun 15. doi: 10.1056/NEJMoa1604037. 4RautCRaoNSinhaDHanumaiahHManjunathaMChikungunya, dengue, and" exact="malaria" post="co-infection after travel to Nigeria, IndiaEmerg Infect Dis201521590794. Raut"/>
   <result pre="N, Sinha D, Hanumaiah H, Manjunatha M. Chikungunya, dengue, and" exact="malaria" post="co-infection after travel to Nigeria, India. Emerg Infect Dis."/>
   <result pre="India. Emerg Infect Dis. 2015;21(5):907â€&quot;9. 5FigueiredoMFigueiredoLEmerging alphaviruses in the Americas:" exact="chikungunya" post="and MayaroRev Soc Bra Med Trop201412476677835. Figueiredo M, Figueiredo"/>
   <result pre="Trop201412476677835. Figueiredo M, Figueiredo L. Emerging alphaviruses in the Americas:" exact="chikungunya" post="and Mayaro. Rev Soc Bra Med Trop. 2014 Dec;47(6):677â€&quot;83."/>
   <result pre="Trop. 2014 Dec;47(6):677â€&quot;83. 6CaronMPaupyCGrardGBecquartPMomboINsoBet al.Recent introduction and rapid dissemination of" exact="chikungunya" post="virus and dengue virus serotype 2 associated with human"/>
   <result pre="Nso B, et al. Recent introduction and rapid dissemination of" exact="chikungunya" post="virus and dengue virus serotype 2 associated with human"/>
   <result pre="Infect. 2017;6(1):1â€&quot;6. 10SuwanmaneeSSurasombatpattanaPSoonthornworasiriNHamelRManeekanPMissÃ©Det al.Monitoring arbovirus in Thailand: surveillance of dengue," exact="chikungunya" post="and zika virus, with a focus on coinfectionsActa Tropica2018188244503024831710."/>
   <result pre="D, et al. Monitoring arbovirus in Thailand: surveillance of dengue," exact="chikungunya" post="and zika virus, with a focus on coinfections. Acta"/>
   <result pre="Dis. 2016;14(3):177â€&quot;9. 13CostaSBrancoMAquino JuniorJRodriguesZQueirozRAraujoAet al.Spatial analysis of probable cases of" exact="dengue fever," post="Â­chikungunya fever, and zika virus infections in Maranhao State,"/>
   <result pre="Araujo A, et al. Spatial analysis of probable cases of" exact="dengue fever," post="Â­chikungunya fever, and zika virus infections in Maranhao State,"/>
   <result pre="2 patients, New Caledonia, 2014. Emerg Infect Dis. 2015;21(2):381â€&quot;2. 15Villamil-GÃ³mezWGonzÃ¡lez-CamargoORodriguez-AyubiJZapata-SerpaDRodriguez-MoralesADengue," exact="chikungunya" post="and Zika co-infection in a patient from ColombiaJ Infect"/>
   <result pre="W, GonzÃ¡lez-Camargo O, Rodriguez-Ayubi J, Zapata-Serpa D, Rodriguez-Morales A. Dengue," exact="chikungunya" post="and Zika co-infection in a patient from Colombia. J"/>
   <result pre="chikunÂ­gunya and dengue viruses. BMC Infect Dis. 2016;16:84. 18Mercado-ReyesMAcosta-ReyesJNavarro-LechugaECorchueloSRicoAParraEet al.Dengue," exact="chikungunya" post="and Zika virus coinfection: results of the national surveillance"/>
   <result pre="E, Corchuelo S, Rico A, Parra E, et al. Dengue," exact="chikungunya" post="and Zika virus coinfection: results of the national surveillance"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6553602\results\search\disease\results.xml">
   <result pre="https://dx.doi.org/10.6084/m9.figshare.c.4444127. One contribution of 15 to a theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="approaches and important themesâ€™. ppub: 2019-6-6epub: 2019-5-5pmc-release: 2019-5-53741775Theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="Nigeria. This article is part of the theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="This issue is linked with the subsequent theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: epidemic forecasting and"/>
   <result pre="as key in light of anticipated emergence of a novel" exact="infectious disease" post="in the futureâ€&quot;the â€˜Disease Xâ€™ as it was recently"/>
   <result pre="similarities with other common diseases seen in the region, i.e." exact="malaria" post="or typhoid fever [12,13]. On average, four out of"/>
   <result pre="other common diseases seen in the region, i.e. malaria or" exact="typhoid fever" post="[12,13]. On average, four out of five cases are"/>
   <result pre="has previously been used to demonstrate the causal link between" exact="influenza" post="transmission risk and humidity or temperature. The LF incidence"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6553608\results\search\disease\results.xml">
   <result pre="samantha.lycett@ed.ac.uk One contribution of 15 to a theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="available online at https://dx.doi.org/10.6084/m9.figshare.c.4441775. ppub: 2019-6-6epub: 2019-5-5pmc-release: 2019-5-53741775Theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="and source are credited.rstb20180257.pdf Abstract In 1918, a strain of" exact="influenza" post="A virus caused a human pandemic resulting in the"/>
   <result pre="know much more about the origins, evolution and epidemiology of" exact="influenza" post="epidemics. Here we review the history of avian influenza"/>
   <result pre="epidemiology of influenza epidemics. Here we review the history of" exact="avian influenza" post="viruses through the lens of their genetic makeup: from"/>
   <result pre="of influenza epidemics. Here we review the history of avian" exact="influenza" post="viruses through the lens of their genetic makeup: from"/>
   <result pre="zoonoses up to 2018. We describe the genesis of novel" exact="influenza" post="A virus strains by reassortment and evolution in wild"/>
   <result pre="migration in their long-range spread. The emergence of highly pathogenic" exact="avian influenza" post="viruses, and the zoonotic incursions of avian H5 and"/>
   <result pre="in their long-range spread. The emergence of highly pathogenic avian" exact="influenza" post="viruses, and the zoonotic incursions of avian H5 and"/>
   <result pre="of decades are also described. The threat of a new" exact="avian influenza" post="virus causing a human pandemic is still present today,"/>
   <result pre="decades are also described. The threat of a new avian" exact="influenza" post="virus causing a human pandemic is still present today,"/>
   <result pre="health. This article is part of the theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="This issue is linked with the subsequent theme issue â€˜Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: epidemic forecasting and"/>
   <result pre="outbreaks in humans, animals and plants: epidemic forecasting and controlâ€™." exact="avian influenza" post="virus epidemiology phylogenetics pandemic zoonotic Funding College of Medicine"/>
   <result pre="in humans, animals and plants: epidemic forecasting and controlâ€™. avian" exact="influenza" post="virus epidemiology phylogenetics pandemic zoonotic Funding College of Medicine"/>
   <result pre="single-stranded RNA viruses with segmented genomes. There are four main" exact="influenza" post="virus species: A, B, C and D. Type A"/>
   <result pre="more restricted host ranges. Influenza A viruses (IAV), including all" exact="avian influenza" post="viruses, possess eight separate genomic segments ranging in size"/>
   <result pre="restricted host ranges. Influenza A viruses (IAV), including all avian" exact="influenza" post="viruses, possess eight separate genomic segments ranging in size"/>
   <result pre="between 890 and 2341 nucleotides [1,2]. Like other RNA viruses," exact="influenza" post="viruses have a fast mutation rate, typically accumulating two"/>
   <result pre="Figure 1. PB2 phylogeny of a stratified sample of all" exact="influenza" post="subtypes. Tips in the circular neighbour-joining tree are coloured"/>
   <result pre="continents, H1N1, H1N2, H3N2 swine influenza, the H1N1 pandemic swine" exact="influenza" post="lineage in humans and swine, and the avianâ€&quot;Americas lineage"/>
   <result pre="swine, and the avianâ€&quot;Americas lineage with many subtypes. (c) Fowl" exact="plague" post="is avian influenza Severe non-bacterial outbreaks with high mortality"/>
   <result pre="the avianâ€&quot;Americas lineage with many subtypes. (c) Fowl plague is" exact="avian influenza" post="Severe non-bacterial outbreaks with high mortality rates in domestic"/>
   <result pre="avianâ€&quot;Americas lineage with many subtypes. (c) Fowl plague is avian" exact="influenza" post="Severe non-bacterial outbreaks with high mortality rates in domestic"/>
   <result pre="it was not until 1955 that Schafer determined that â€˜fowl" exact="plague" post="virusâ€™ (FPV) was indeed a type of IAV, with"/>
   <result pre="of IAV, with similar internal antigens to human and swine" exact="influenza" post="viruses [15]. Sequencing studies performed many years later resulted"/>
   <result pre="years later resulted in the identification of the highly pathogenic" exact="avian influenza" post="(HPAI) virus strains responsible for these outbreaks as H7"/>
   <result pre="later resulted in the identification of the highly pathogenic avian" exact="influenza" post="(HPAI) virus strains responsible for these outbreaks as H7"/>
   <result pre="However, this was reconsidered after the isolation of low pathogenic" exact="avian influenza" post="(LPAI) H5 and H7 strains from ducks in the"/>
   <result pre="this was reconsidered after the isolation of low pathogenic avian" exact="influenza" post="(LPAI) H5 and H7 strains from ducks in the"/>
   <result pre="low and high pathogenicity H5 viruses are shown. (d) Avian" exact="influenza" post="and human pandemics One hundred years ago, in 1918,"/>
   <result pre="in 1918, the â€˜Spanish fluâ€™ pandemic, caused by an H1N1" exact="influenza" post="virus is estimated to have contributed to the deaths"/>
   <result pre="no or little prior immunity. The relationship between fowl plague," exact="avian influenza" post="and human influenza was not apparent before the 1950s,"/>
   <result pre="or little prior immunity. The relationship between fowl plague, avian" exact="influenza" post="and human influenza was not apparent before the 1950s,"/>
   <result pre="immunity. The relationship between fowl plague, avian influenza and human" exact="influenza" post="was not apparent before the 1950s, but by 1967"/>
   <result pre="are considered in more detail later. 2. Global patterns of" exact="avian influenza" post="circulation Water fowl, especially Anseriformes (ducks, geese and swans)"/>
   <result pre="considered in more detail later. 2. Global patterns of avian" exact="influenza" post="circulation Water fowl, especially Anseriformes (ducks, geese and swans)"/>
   <result pre="analyses [67,68], and these techniques are particularly suitable for understanding" exact="avian influenza" post="systems since they make use of the fast-evolving viral"/>
   <result pre="[67,68], and these techniques are particularly suitable for understanding avian" exact="influenza" post="systems since they make use of the fast-evolving viral"/>
   <result pre="and across the Bering straits, which allows occasional transmission of" exact="influenza" post="viruses between North America and Eurasia. Flyways from http://wpe.wetlands.org/Iwhatfly."/>
   <result pre="between wild and domestic animals. 3. Rise of highly pathogenic" exact="avian influenza" post="As noted above (box 1), H5 and H7 avian"/>
   <result pre="wild and domestic animals. 3. Rise of highly pathogenic avian" exact="influenza" post="As noted above (box 1), H5 and H7 avian"/>
   <result pre="been raised about H5N1 as the source of the next" exact="influenza" post="pandemic [134,135], so its spread out of Asia was"/>
   <result pre="seasonal IAV, and now co-circulates alongside seasonal H3N2 IAV and" exact="influenza" post="B viruses in the human population. 5. Emergence of"/>
   <result pre="the industry, this is the most expensive recorded North American" exact="avian influenza" post="epidemic to date [182,183]. The control measures were successful,"/>
   <result pre="industry, this is the most expensive recorded North American avian" exact="influenza" post="epidemic to date [182,183]. The control measures were successful,"/>
   <result pre="brief history of bird flu, we have seen that current" exact="avian influenza" post="virus strains have been circulating and diversifying in wild"/>
   <result pre="history of bird flu, we have seen that current avian" exact="influenza" post="virus strains have been circulating and diversifying in wild"/>
   <result pre="of the disease. In some senses, the dynamics of human" exact="influenza" post="in humans and avian influenza in birds are similarâ€&quot;both"/>
   <result pre="some senses, the dynamics of human influenza in humans and" exact="avian influenza" post="in birds are similarâ€&quot;both can be thought of as"/>
   <result pre="senses, the dynamics of human influenza in humans and avian" exact="influenza" post="in birds are similarâ€&quot;both can be thought of as"/>
   <result pre="to keep outbreaks in these populations to a minimum. Ongoing" exact="avian influenza" post="virus spill-overs into human cases suggest that zoonotic bird"/>
   <result pre="keep outbreaks in these populations to a minimum. Ongoing avian" exact="influenza" post="virus spill-overs into human cases suggest that zoonotic bird"/>
   <result pre="in avian, human and other domestic animal populations, and control" exact="avian influenza" post="in domestic avian populations, then we can surely reduce"/>
   <result pre="avian, human and other domestic animal populations, and control avian" exact="influenza" post="in domestic avian populations, then we can surely reduce"/>
   <result pre="we can surely reduce the risks of a new human" exact="avian influenza" post="pandemic. Supplementary Material Supplementary Text LINK Supplementary Material Data"/>
   <result pre="can surely reduce the risks of a new human avian" exact="influenza" post="pandemic. Supplementary Material Supplementary Text LINK Supplementary Material Data"/>
   <result pre="Elsevier (10.1016/B978-0-12-384684-6.00136-1) 2WebsterRG, BeanWJ, GormanOT, ChambersTM, KawaokaY1992Evolution and ecology of" exact="influenza" post="A viruses. Microbiol. Rev.56, 152â€&quot;179. (10.1111/j.1541-0420.2008.01180.x)1579108 3ChenR, HolmesEC2006Avian influenza"/>
   <result pre="of influenza A viruses. Microbiol. Rev.56, 152â€&quot;179. (10.1111/j.1541-0420.2008.01180.x)1579108 3ChenR, HolmesEC2006Avian" exact="influenza" post="virus exhibits rapid evolutionary dynamics. Mol. Biol. Evol.23, 2336â€&quot;2341."/>
   <result pre="TemkinaOA, EgorovVV, KlotchenkoSA, PlotnikovaMA, KiselevOI2014Molecular mechanisms enhancing the proteome of" exact="influenza" post="A viruses: an overview of recently discovered proteins. Virus"/>
   <result pre="proteins. Virus Res.185, 53â€&quot;63. (10.1016/j.virusres.2014.03.015)24675275 5TongSet al.2012A distinct lineage of" exact="influenza" post="A virus from bats. Proc. Natl Acad. Sci. USA109,"/>
   <result pre="Sci. USA109, 4269â€&quot;4274. (10.1073/pnas.1116200109)22371588 6TongSet al.2013New World bats harbor diverse" exact="influenza" post="A viruses. PLoS Pathog.9, e1003657 (10.1371/journal.ppat.1003657)24130481 7LemeyPet al.2014Unifying viral"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2. PLoS Pathog.10, e1003932 (10.1371/journal.ppat.1003932)24586153 8BaoY, BolotovP, DernovoyD, KiryutinB,"/>
   <result pre="e1003932 (10.1371/journal.ppat.1003932)24586153 8BaoY, BolotovP, DernovoyD, KiryutinB, ZaslavskyL, TatusovaT, OstellJ, LipmanD2008The" exact="influenza" post="virus resource at the National Center for Biotechnology Information."/>
   <result pre="Virol.82, 596â€&quot;601. (10.1128/JVI.02005-07)17942553 9DuganVGet al.2008The evolutionary genetics and emergence of" exact="avian influenza" post="viruses in wild birds. PLoS Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL,"/>
   <result pre="596â€&quot;601. (10.1128/JVI.02005-07)17942553 9DuganVGet al.2008The evolutionary genetics and emergence of avian" exact="influenza" post="viruses in wild birds. PLoS Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL,"/>
   <result pre="PLoS Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL, LycettSJ, Leigh BrownAJ2014Reassortment patterns of" exact="avian influenza" post="virus internal segments among different subtypes. BMC Evol. Biol.14,"/>
   <result pre="Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL, LycettSJ, Leigh BrownAJ2014Reassortment patterns of avian" exact="influenza" post="virus internal segments among different subtypes. BMC Evol. Biol.14,"/>
   <result pre="BMC Evol. Biol.14, 16 (10.1186/1471-2148-14-16)24456010 11BrownIH2000The epidemiology and evolution of" exact="influenza" post="viruses in pigs. Vet. Microbiol.74, 29â€&quot;46. (10.1016/S0378-1135(00)00164-4)10799776 12LycettSJet al.2012Estimating"/>
   <result pre="29â€&quot;46. (10.1016/S0378-1135(00)00164-4)10799776 12LycettSJet al.2012Estimating reassortment rates in co-circulating Eurasian swine" exact="influenza" post="viruses. J. Gen. Virol.93, 2326â€&quot;2336. (10.1099/vir.0.044503-0)22971819 13AlexanderDJ, BrownIH2009History of"/>
   <result pre="J. Gen. Virol.93, 2326â€&quot;2336. (10.1099/vir.0.044503-0)22971819 13AlexanderDJ, BrownIH2009History of highly pathogenic" exact="avian influenza." post="Rev. Sci. Tech.28, 19â€&quot;38. (10.20506/rst.28.1.1856)19618616 14LupianiB, ReddySM2009The history of"/>
   <result pre="influenza. Rev. Sci. Tech.28, 19â€&quot;38. (10.20506/rst.28.1.1856)19618616 14LupianiB, ReddySM2009The history of" exact="avian influenza." post="Comp. Immunol. Microbiol. Infect. Dis.32, 311â€&quot;323. (10.1016/j.cimid.2008.01.004)18533261 15SchaferW1955Vergleichende sero-immunologische"/>
   <result pre="und klassischen GeflÃ¼gelpest [Comparative sero-immunological studies on the viruses of" exact="influenza" post="and classical avian influenza]. Zeitschr. Naturforsch.10, 81â€&quot;91 (in German)."/>
   <result pre="16RÃ¶hmC, HorimotoT, KawaokaY, SÃ¼ssJ, WebsterRG1995Do hemagglutinin genes of highly pathogenic" exact="avian influenza" post="viruses constitute unique phylogenetic lineages?Virology209, 664â€&quot;670. (10.1006/viro.1995.1301)7778300 17PereiraHG, TumovaB,"/>
   <result pre="HorimotoT, KawaokaY, SÃ¼ssJ, WebsterRG1995Do hemagglutinin genes of highly pathogenic avian" exact="influenza" post="viruses constitute unique phylogenetic lineages?Virology209, 664â€&quot;670. (10.1006/viro.1995.1301)7778300 17PereiraHG, TumovaB,"/>
   <result pre="viruses constitute unique phylogenetic lineages?Virology209, 664â€&quot;670. (10.1006/viro.1995.1301)7778300 17PereiraHG, TumovaB, LawVG1965Avian" exact="influenza" post="A viruses. Bull. World Health Org.32, 855â€&quot;860. 18PorterAG, BarberC,"/>
   <result pre="18PorterAG, BarberC, CareyNH, HallewellRA, ThrelfallG, EmtageJS1979Complete nucleotide sequence of an" exact="influenza" post="virus haemagglutinin gene from cloned DNA. Nature282, 471â€&quot;477. (10.1038/282471a0)503226"/>
   <result pre="Nature282, 471â€&quot;477. (10.1038/282471a0)503226 19BeckerWB1966The isolation and classification of tern virus:" exact="influenza" post="virus A/Tern/South Africa/1961. J. Hyg. (Lond).64, 309â€&quot;320. (10.1017/S0022172400040596)5223681 20LangG,"/>
   <result pre="Hyg. (Lond).64, 309â€&quot;320. (10.1017/S0022172400040596)5223681 20LangG, NarayanO, RouseBT, FergusonAE, ConnellMC1968A new" exact="influenza" post="A virus infection in turkeys II. A highly pathogenic"/>
   <result pre="772/66. Can. Vet. J9, 151.5690802 21BeardCW, HelferDH1972Isolation of two turkey" exact="influenza" post="viruses in Oregon. Avian Dis.16, 1133â€&quot;1136. (10.2307/1588841)4629606 22AlexanderDJ2000A review"/>
   <result pre="viruses in Oregon. Avian Dis.16, 1133â€&quot;1136. (10.2307/1588841)4629606 22AlexanderDJ2000A review of" exact="avian influenza" post="in different bird species. Vet. Microbiol.74, 3â€&quot;13. (10.1016/S0378-1135(00)00160-7)10799774 23AlexanderDJ2007An"/>
   <result pre="in Oregon. Avian Dis.16, 1133â€&quot;1136. (10.2307/1588841)4629606 22AlexanderDJ2000A review of avian" exact="influenza" post="in different bird species. Vet. Microbiol.74, 3â€&quot;13. (10.1016/S0378-1135(00)00160-7)10799774 23AlexanderDJ2007An"/>
   <result pre="Vet. Microbiol.74, 3â€&quot;13. (10.1016/S0378-1135(00)00160-7)10799774 23AlexanderDJ2007An overview of the epidemiology of" exact="avian influenza." post="Vaccine25, 5637â€&quot;5644. (10.1016/j.vaccine.2006.10.051)17126960 24KraussSet al.2007Influenza in migratory birds and"/>
   <result pre="Health Code (2018). See http://www.oie.int/index.php?id=169&amp;amp;L=0&amp;amp;htmfile=chapitre_avian_influenza_viruses.htm. 26KlenkHD, RottR1988The molecular biology of" exact="influenza" post="virus pathogenicity. Adv. Virus Res.34, 247â€&quot;281. (10.1016/S0065-3527(08)60520-5)3046255 27VeyM, OrlichM,"/>
   <result pre="(10.1016/S0065-3527(08)60520-5)3046255 27VeyM, OrlichM, AdlerS, KlenkHD, RottR, GartenW1992Hemagglutinin activation of pathogenic" exact="avian influenza" post="viruses of serotype H7 requires the protease recognition motif"/>
   <result pre="27VeyM, OrlichM, AdlerS, KlenkHD, RottR, GartenW1992Hemagglutinin activation of pathogenic avian" exact="influenza" post="viruses of serotype H7 requires the protease recognition motif"/>
   <result pre="recognition motif R-X-K/R-R. Virology188, 408â€&quot;413. (10.1016/0042-6822(92)90775-K)1566583 28RottR1992The pathogenic determinant of" exact="influenza" post="virus. Vet. Microbiol.33, 303â€&quot;310. (10.1016/0378-1135(92)90058-2)1481363 29LuczoJM, StambasJ, DurrPA, MichalskiWP,"/>
   <result pre="30JohnsonNPAS, MuellerJ2002Updating the accounts: global mortality of the 1918â€&quot;1920 â€˜Spanishâ€™" exact="influenza" post="pandemic. Bull. Hist. Med.76, 105â€&quot;115. (10.1353/bhm.2002.0022)11875246 31PereiraHG, TumovaB, WebsterRG1967Antigenic"/>
   <result pre="Bull. Hist. Med.76, 105â€&quot;115. (10.1353/bhm.2002.0022)11875246 31PereiraHG, TumovaB, WebsterRG1967Antigenic relationship between" exact="influenza" post="A viruses of human and avian origins. Nature215, 982â€&quot;983."/>
   <result pre="(10.1038/215982a0)6055434 32FangR, Min JouW, HuylebroeckD, DevosR, FiersW1981Complete structure of A/duck/Ukraine/63" exact="influenza" post="hemagglutinin gene: animal virus as progenitor of human H3"/>
   <result pre="animal virus as progenitor of human H3 Hong Kong 1968" exact="influenza" post="hemagglutinin. Cell25, 315â€&quot;323. (10.1016/0092-8674(81)90049-0)6169439 33SchÃ¤ferJR, KawaokaY, BeanWJ, SÃ¼ssJ, SenneD,"/>
   <result pre="KawaokaY, BeanWJ, SÃ¼ssJ, SenneD, WebsterRG1993Origin of the pandemic 1957 H2" exact="influenza" post="A virus and the persistence of its possible progenitors"/>
   <result pre="reservoir. Virology194, 781â€&quot;788. (10.1006/viro.1993.1319)7684877 34SmithW, AndrewesCH, LaidlawPP1933A virus obtained from" exact="influenza" post="patients. Lancet222, 66â€&quot;68. (10.1016/S0140-6736(00)78541-2) 35TaubenbergerJK, HultinJV, MorensDM2007Discovery and characterization"/>
   <result pre="(10.1016/S0140-6736(00)78541-2) 35TaubenbergerJK, HultinJV, MorensDM2007Discovery and characterization of the 1918 pandemic" exact="influenza" post="virus in historical context. Antivir. Ther.12, 581â€&quot;591.17944266 36FanningTG, SlemonsRD,"/>
   <result pre="context. Antivir. Ther.12, 581â€&quot;591.17944266 36FanningTG, SlemonsRD, ReidAH, JanczewskiTA, DeanJ, TaubenbergerJK20021917" exact="avian influenza" post="virus sequences suggest that the 1918 pandemic virus did"/>
   <result pre="Antivir. Ther.12, 581â€&quot;591.17944266 36FanningTG, SlemonsRD, ReidAH, JanczewskiTA, DeanJ, TaubenbergerJK20021917 avian" exact="influenza" post="virus sequences suggest that the 1918 pandemic virus did"/>
   <result pre="7860â€&quot;7862. (10.1128/JVI.76.15.7860-7862.2002)12097598 37ReidAH, FanningTG, SlemonsRD, JanczewskiTA, DeanJ, TaubenbergerJK2003Relationship of pre-1918" exact="avian influenza" post="HA and NP sequences to subsequent avian influenza strains."/>
   <result pre="(10.1128/JVI.76.15.7860-7862.2002)12097598 37ReidAH, FanningTG, SlemonsRD, JanczewskiTA, DeanJ, TaubenbergerJK2003Relationship of pre-1918 avian" exact="influenza" post="HA and NP sequences to subsequent avian influenza strains."/>
   <result pre="of pre-1918 avian influenza HA and NP sequences to subsequent" exact="avian influenza" post="strains. Avian Dis.47, 921â€&quot;925. (10.1637/0005-2086-47.s3.921)14575087 38ReidAH, TaubenbergerJK2003The origin of"/>
   <result pre="pre-1918 avian influenza HA and NP sequences to subsequent avian" exact="influenza" post="strains. Avian Dis.47, 921â€&quot;925. (10.1637/0005-2086-47.s3.921)14575087 38ReidAH, TaubenbergerJK2003The origin of"/>
   <result pre="Dis.47, 921â€&quot;925. (10.1637/0005-2086-47.s3.921)14575087 38ReidAH, TaubenbergerJK2003The origin of the 1918 pandemic" exact="influenza" post="virus: a continuing enigma. J. Gen. Virol.84, 2285â€&quot;2292. (10.1099/vir.0.19302-0)12917448"/>
   <result pre="(10.1099/vir.0.19302-0)12917448 39TaubenbergerJK, ReidAH, LourensRM, WangR, JinG, FanningTG2005Characterization of the 1918" exact="influenza" post="virus polymerase genes. Nature437, 889â€&quot;893. (10.1038/nature04230)16208372 40WorobeyM, HanGZ, RambautA2014A"/>
   <result pre="RambautA2014A synchronized global sweep of the internal genes of modern" exact="avian influenza" post="virus. Nature508, 254â€&quot;257. (10.1038/nature13016)24531761 41KawaokaY, KraussS, WebsterRG1989Avian-to-human transmission of"/>
   <result pre="synchronized global sweep of the internal genes of modern avian" exact="influenza" post="virus. Nature508, 254â€&quot;257. (10.1038/nature13016)24531761 41KawaokaY, KraussS, WebsterRG1989Avian-to-human transmission of"/>
   <result pre="(10.1038/nature13016)24531761 41KawaokaY, KraussS, WebsterRG1989Avian-to-human transmission of the PB1 gene of" exact="influenza" post="A viruses in the 1957 and 1968 pandemics. J."/>
   <result pre="1968 pandemics. J. Virol.63, 4603â€&quot;4608.2795713 42JosephUet al.2015Adaptation of pandemic H2N2" exact="influenza" post="A viruses in humans. J. Virol.89, 2442â€&quot;2447. (10.1128/JVI.02590-14)25505070 43BeanWJ,"/>
   <result pre="43BeanWJ, SchellM, KatzJ, KawaokaY, NaeveC, GormanO, WebsterRG1992Evolution of the H3" exact="influenza" post="virus hemagglutinin from human and nonhuman hosts. J. Virol.66,"/>
   <result pre="44SmithGJDet al.2009Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemic. Nature459, 1122â€&quot;1125. (10.1038/nature08182)19516283 45BhattSet al..2013The evolutionary dynamics"/>
   <result pre="A epidemic. Nature459, 1122â€&quot;1125. (10.1038/nature08182)19516283 45BhattSet al..2013The evolutionary dynamics of" exact="influenza" post="A virus adaptation to mammalian hosts. Phil. Trans. R."/>
   <result pre="features and rapid viral diagnosis of human disease associated with" exact="avian influenza" post="A H5N1 virus. Lancet351, 467â€&quot;471. (10.1016/S0140-6736(98)01182-9)9482437 47ShiW, ShiY, WuY,"/>
   <result pre="and rapid viral diagnosis of human disease associated with avian" exact="influenza" post="A H5N1 virus. Lancet351, 467â€&quot;471. (10.1016/S0140-6736(98)01182-9)9482437 47ShiW, ShiY, WuY,"/>
   <result pre="WuY, LiuD, GaoGF2013Origin and molecular characterization of the human-infecting H6N1" exact="influenza" post="virus in Taiwan. Protein Cell4, 846â€&quot;853. (10.1007/s13238-013-3083-0)24136722 48ParryJ2013H7N9 avian"/>
   <result pre="49ChenHet al.2014Clinical and epidemiological characteristics of a fatal case of" exact="avian influenza" post="A H10N8 virus infection: a descriptive study. Lancet383, 714â€&quot;721."/>
   <result pre="al.2014Clinical and epidemiological characteristics of a fatal case of avian" exact="influenza" post="A H10N8 virus infection: a descriptive study. Lancet383, 714â€&quot;721."/>
   <result pre="ChughtaiAA, AdamDC, MacIntyreCR2017An overview of the epidemiology and emergence of" exact="influenza" post="A infection in humans over time. Arch. Public Health75,"/>
   <result pre="humans over time. Arch. Public Health75, 15 (10.1186/s13690-017-0182-z)28352464 51FouchierRAMet al.2004Avian" exact="influenza" post="A virus (H7N7) associated with human conjunctivitis and a"/>
   <result pre="(10.1186/s13690-017-0182-z)28352464 51FouchierRAMet al.2004Avian influenza A virus (H7N7) associated with human" exact="conjunctivitis" post="and a fatal case of acute respiratory distress syndrome."/>
   <result pre="(H7N7) associated with human conjunctivitis and a fatal case of" exact="acute respiratory distress syndrome." post="Proc. Natl Acad. Sci. USA101, 1356â€&quot;1361. (10.1073/pnas.0308352100)14745020 52KoopmansMet al.2004Transmission"/>
   <result pre="Natl Acad. Sci. USA101, 1356â€&quot;1361. (10.1073/pnas.0308352100)14745020 52KoopmansMet al.2004Transmission of H7N7" exact="avian influenza" post="A virus to human beings during a large outbreak"/>
   <result pre="Acad. Sci. USA101, 1356â€&quot;1361. (10.1073/pnas.0308352100)14745020 52KoopmansMet al.2004Transmission of H7N7 avian" exact="influenza" post="A virus to human beings during a large outbreak"/>
   <result pre="587â€&quot;593. (10.1016/S0140-6736(04)15589-X)14987882 53OlsenB, MunsterVJ, WallenstenA, WaldenstrÃ¶mJ, OsterhausADME, FouchierRAM2006Global patterns of" exact="influenza" post="A virus in wild birds. Science312, 384â€&quot;388. (10.1126/science.1122438)16627734 54EasterdayBC,"/>
   <result pre="Science312, 384â€&quot;388. (10.1126/science.1122438)16627734 54EasterdayBC, TrainerDO, TÅ¯movÃ¡B, PereiraHG1968Evidence of infection with" exact="influenza" post="viruses in migratory waterfowl. Nature219, 523â€&quot;524. (10.1038/219523a0)4299258 55DownieJC, LaverWG1973Isolation"/>
   <result pre="waterfowl. Nature219, 523â€&quot;524. (10.1038/219523a0)4299258 55DownieJC, LaverWG1973Isolation of a type A" exact="influenza" post="virus from an Australian pelagic bird. Virology51, 259â€&quot;269. (10.1016/0042-6822(73)90426-1)4632652"/>
   <result pre="WebsterRG, SchildGC, DowdleWR, LaverWG1973Characterization and ecology of a type A" exact="influenza" post="virus isolated from a shearwater. Bull. World Health Organ.49,"/>
   <result pre="a shearwater. Bull. World Health Organ.49, 559â€&quot;566.4548383 57KuikenT2013Is low pathogenic" exact="avian influenza" post="virus virulent for wild waterbirds?Proc. R. Soc. B280, 20130990"/>
   <result pre="shearwater. Bull. World Health Organ.49, 559â€&quot;566.4548383 57KuikenT2013Is low pathogenic avian" exact="influenza" post="virus virulent for wild waterbirds?Proc. R. Soc. B280, 20130990"/>
   <result pre="(10.1371/journal.pone.0008935)20126617 59RunstadlerJ, HillN, HusseinITM, PuryearW, KeoghM2013Connecting the study of wild" exact="influenza" post="with the potential for pandemic disease. Infect. Genet. Evol.17,"/>
   <result pre="StallknechtDE, SwayneDE2008Experimental infection of swans and geese with highly pathogenic" exact="avian influenza" post="virus (H5N1) of Asian lineage. Emerg. Infect. Dis.14, 136â€&quot;142."/>
   <result pre="SwayneDE2008Experimental infection of swans and geese with highly pathogenic avian" exact="influenza" post="virus (H5N1) of Asian lineage. Emerg. Infect. Dis.14, 136â€&quot;142."/>
   <result pre="and geographical distance are barriers to the gene flow of" exact="influenza" post="virus among North American birds. Ecol. Lett.15, 24â€&quot;33. (10.1111/j.1461-0248.2011.01703.x)22008513"/>
   <result pre="24â€&quot;33. (10.1111/j.1461-0248.2011.01703.x)22008513 62ScotchM, LamTT-Y, PabiloniaKL, AndersonT, BarochJ, KohlerD, DeLibertoTJ2014Diffusion of" exact="influenza" post="viruses among migratory birds with a focus on the"/>
   <result pre="southwest United States. Infect. Genet. Evol.26, 185â€&quot;193. (10.1016/j.meegid.2014.05.029)24910106 63TianHet al.2015Avian" exact="influenza" post="H5N1 viral and bird migration networks in Asia. Proc."/>
   <result pre="Leigh BrownAJ2014Determining the phylogenetic and phylogeographic origin of highly pathogenic" exact="avian influenza" post="(H7N3) in Mexico. PLoS ONE9, e107330 (10.1371/journal.pone.0107330)25226523 65BahlJ, VijaykrishnaD,"/>
   <result pre="BrownAJ2014Determining the phylogenetic and phylogeographic origin of highly pathogenic avian" exact="influenza" post="(H7N3) in Mexico. PLoS ONE9, e107330 (10.1371/journal.pone.0107330)25226523 65BahlJ, VijaykrishnaD,"/>
   <result pre="65BahlJ, VijaykrishnaD, HolmesEC, SmithGJD, GuanY2009Gene flow and competitive exclusion of" exact="avian influenza" post="A virus in natural reservoir hosts. Virology390, 289â€&quot;297. (10.1016/j.virol.2009.05.002)19501380"/>
   <result pre="VijaykrishnaD, HolmesEC, SmithGJD, GuanY2009Gene flow and competitive exclusion of avian" exact="influenza" post="A virus in natural reservoir hosts. Virology390, 289â€&quot;297. (10.1016/j.virol.2009.05.002)19501380"/>
   <result pre="e1000520 (10.1371/journal.pcbi.1000520)19779555 68PybusOG, RambautA2009Evolutionary analysis of the dynamics of viral" exact="infectious disease." post="Nat. Rev. Genet.10, 540â€&quot;550. (10.1038/nrg2583)19564871 69LycettSJet al.2016Role for migratory"/>
   <result pre="al.2016Role for migratory wild birds in the global spread of" exact="avian influenza" post="H5N8. Science354, 213â€&quot;217. (10.1126/science.aaf8852)27738169 70HillSC, LeeY-J, SongB-M, KangH-M, LeeE-K,"/>
   <result pre="for migratory wild birds in the global spread of avian" exact="influenza" post="H5N8. Science354, 213â€&quot;217. (10.1126/science.aaf8852)27738169 70HillSC, LeeY-J, SongB-M, KangH-M, LeeE-K,"/>
   <result pre="domestic duck density shape the epidemiology of highly pathogenic H5N8" exact="influenza" post="in the Republic of Korea. Infect. Genet. Evol.34, 267â€&quot;277."/>
   <result pre="267â€&quot;277. (10.1016/j.meegid.2015.06.014)26079277 71BahlJet al.2011Temporally structured metapopulation dynamics and persistence of" exact="influenza" post="A H3N2 virus in humans. Proc. Natl Acad. Sci."/>
   <result pre="76LuL, Leigh BrownAJ, LycettSJ2017Quantifying predictors for the spatial diffusion of" exact="avian influenza" post="virus in China. BMC Evol. Biol.17, 16 (10.1186/s12862-016-0845-3)28086751 77FariaNR,"/>
   <result pre="Leigh BrownAJ, LycettSJ2017Quantifying predictors for the spatial diffusion of avian" exact="influenza" post="virus in China. BMC Evol. Biol.17, 16 (10.1186/s12862-016-0845-3)28086751 77FariaNR,"/>
   <result pre="LemeyP2015Bayesian inference reveals host-specific contributions to the epidemic expansion of" exact="influenza" post="A H5N1. Mol. Biol. Evol.32, 3264â€&quot;3275. (10.1093/molbev/msv185)26341298 91BahlJet al.2016Ecosystem"/>
   <result pre="Evol.32, 3264â€&quot;3275. (10.1093/molbev/msv185)26341298 91BahlJet al.2016Ecosystem interactions underlie the spread of" exact="avian influenza" post="A viruses with pandemic potential. PLoS Pathog.12, e1005620 (10.1371/journal.ppat.1005620)27166585"/>
   <result pre="3264â€&quot;3275. (10.1093/molbev/msv185)26341298 91BahlJet al.2016Ecosystem interactions underlie the spread of avian" exact="influenza" post="A viruses with pandemic potential. PLoS Pathog.12, e1005620 (10.1371/journal.ppat.1005620)27166585"/>
   <result pre="92KoehlerAV, PearceJM, FlintPL, FransonJC, IpHS2008Genetic evidence of intercontinental movement of" exact="avian influenza" post="in a migratory bird: the northern pintail (Anas acuta)."/>
   <result pre="PearceJM, FlintPL, FransonJC, IpHS2008Genetic evidence of intercontinental movement of avian" exact="influenza" post="in a migratory bird: the northern pintail (Anas acuta)."/>
   <result pre="6521â€&quot;6524. (10.1128/JVI.00728-15)25855748 94CheonS-Het al.2018Genetic evidence for the intercontinental movement of" exact="avian influenza" post="viruses possessing North American-origin nonstructural gene allele B into"/>
   <result pre="(10.1128/JVI.00728-15)25855748 94CheonS-Het al.2018Genetic evidence for the intercontinental movement of avian" exact="influenza" post="viruses possessing North American-origin nonstructural gene allele B into"/>
   <result pre="Evol.66, 18â€&quot;25. (10.1016/j.meegid.2018.09.001)30196122 95ChenHet al.2006Establishment of multiple sublineages of H5N1" exact="influenza" post="virus in Asia: implications for pandemic control. Proc. Natl"/>
   <result pre="USA103, 2845â€&quot;2850. (10.1073/pnas.0511120103)16473931 96Gauthier-ClercM, LebarbenchonC, ThomasF2007Recent expansion of highly pathogenic" exact="avian influenza" post="H5N1: a critical review. Ibis149, 202â€&quot;214. (10.1111/j.1474-919X.2007.00699.x) 97KilpatrickAM, ChmuraAA,"/>
   <result pre="2845â€&quot;2850. (10.1073/pnas.0511120103)16473931 96Gauthier-ClercM, LebarbenchonC, ThomasF2007Recent expansion of highly pathogenic avian" exact="influenza" post="H5N1: a critical review. Ibis149, 202â€&quot;214. (10.1111/j.1474-919X.2007.00699.x) 97KilpatrickAM, ChmuraAA,"/>
   <result pre="ChmuraAA, GibbonsDW, FleischerRC, MarraPP, DaszakP2006Predicting the global spread of H5N1" exact="avian influenza." post="Proc. Natl Acad. Sci. USA103, 19 368â€&quot;19 373. (10.1073/pnas.0609227103)"/>
   <result pre="USA103, 19 368â€&quot;19 373. (10.1073/pnas.0609227103) 98KraussSet al.2015Long-term surveillance of H7" exact="influenza" post="viruses in American wild aquatic birds: are the H7N3"/>
   <result pre="influenza viruses in American wild aquatic birds: are the H7N3" exact="influenza" post="viruses in wild birds the precursors of highly pathogenic"/>
   <result pre="domestic poultry?Emerg. Microbes Infect.4, e35 (10.1038/emi.2015.35)26954883 99MorrisRS, JacksonR2005Epidemiology of H5N1" exact="avian influenza" post="in Asia and implications for regional control. Rome, Italy:"/>
   <result pre="poultry?Emerg. Microbes Infect.4, e35 (10.1038/emi.2015.35)26954883 99MorrisRS, JacksonR2005Epidemiology of H5N1 avian" exact="influenza" post="in Asia and implications for regional control. Rome, Italy:"/>
   <result pre="regional control. Rome, Italy: FAO. See http://www.fao.org/docs/eims/upload/246974/aj122e00.pdf. 100CappelleJet al.2014Risks of" exact="avian influenza" post="transmission in areas of intensive free-ranging duck production with"/>
   <result pre="control. Rome, Italy: FAO. See http://www.fao.org/docs/eims/upload/246974/aj122e00.pdf. 100CappelleJet al.2014Risks of avian" exact="influenza" post="transmission in areas of intensive free-ranging duck production with"/>
   <result pre="ProsserDJ, GuoF, GilbertM2011Spatial distribution and risk factors of highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 in China. PLoS Pathog.7, e1001308 (10.1371/journal.ppat.1001308)21408202 102GilbertM,"/>
   <result pre="GuoF, GilbertM2011Spatial distribution and risk factors of highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 in China. PLoS Pathog.7, e1001308 (10.1371/journal.ppat.1001308)21408202 102GilbertM,"/>
   <result pre="PfeifferDU2012Risk factor modelling of the spatio-temporal patterns of highly pathogenic" exact="avian influenza" post="(HPAIV) H5N1: a review. Spat. Spatiotemp. Epidemiol.3, 173â€&quot;183. (10.1016/j.sste.2012.01.002)"/>
   <result pre="factor modelling of the spatio-temporal patterns of highly pathogenic avian" exact="influenza" post="(HPAIV) H5N1: a review. Spat. Spatiotemp. Epidemiol.3, 173â€&quot;183. (10.1016/j.sste.2012.01.002)"/>
   <result pre="e49528 (10.1371/journal.pone.0049528)23185352 104LamTT-Yet al.2013The genesis and source of the H7N9" exact="influenza" post="viruses causing human infections in China. Nature502, 241â€&quot;244. (10.1038/nature12515)23965623"/>
   <result pre="China. Nature502, 241â€&quot;244. (10.1038/nature12515)23965623 105MonneIet al.2014Emergence of a highly pathogenic" exact="avian influenza" post="virus from a low-pathogenic progenitor. J. Virol.88, 4375â€&quot;4388. (10.1128/JVI.03181-13)24501401"/>
   <result pre="Nature502, 241â€&quot;244. (10.1038/nature12515)23965623 105MonneIet al.2014Emergence of a highly pathogenic avian" exact="influenza" post="virus from a low-pathogenic progenitor. J. Virol.88, 4375â€&quot;4388. (10.1128/JVI.03181-13)24501401"/>
   <result pre="progenitor. J. Virol.88, 4375â€&quot;4388. (10.1128/JVI.03181-13)24501401 106SeekingsAHet al.2018Direct evidence of H7N7" exact="avian influenza" post="virus mutation from low to high virulence on a"/>
   <result pre="J. Virol.88, 4375â€&quot;4388. (10.1128/JVI.03181-13)24501401 106SeekingsAHet al.2018Direct evidence of H7N7 avian" exact="influenza" post="virus mutation from low to high virulence on a"/>
   <result pre="and historical patterns in the emergences of novel highly pathogenic" exact="avian influenza" post="(HPAI) H5 and H7 viruses in poultry. Front. Vet."/>
   <result pre="historical patterns in the emergences of novel highly pathogenic avian" exact="influenza" post="(HPAI) H5 and H7 viruses in poultry. Front. Vet."/>
   <result pre="108BeanWJ, KawaokaY, WoodJM, PearsonJE, WebsterRG1985Characterization of virulent and avirulent A/chicken/Pennsylvania/83" exact="influenza" post="A viruses: potential role of defective interfering RNAs in"/>
   <result pre="molecular changes associated with emergence of a highly pathogenic H5N2" exact="influenza" post="virus in Mexico. Virology213, 223â€&quot;230. (10.1006/viro.1995.1562)7483266 110CapuaI, MutinelliF, MarangonS,"/>
   <result pre="virus in Mexico. Virology213, 223â€&quot;230. (10.1006/viro.1995.1562)7483266 110CapuaI, MutinelliF, MarangonS, AlexanderDJ2000H7N1" exact="avian influenza" post="in Italy (1999 to 2000) in intensively reared chickens"/>
   <result pre="in Mexico. Virology213, 223â€&quot;230. (10.1006/viro.1995.1562)7483266 110CapuaI, MutinelliF, MarangonS, AlexanderDJ2000H7N1 avian" exact="influenza" post="in Italy (1999 to 2000) in intensively reared chickens"/>
   <result pre="BoumaA, ElbersARW, de JongMCM, NodelijkG, de KlerkF, KochG, van BovenM2004Avian" exact="influenza" post="A virus (H7N7) epidemic in The Netherlands in 2003:"/>
   <result pre="Avian Dis.51, 313â€&quot;316. (10.1637/7627-042706R.1)17494573 113DuanLet al.2007Characterization of low-pathogenic H5 subtype" exact="influenza" post="viruses from Eurasia: implications for the origin of highly"/>
   <result pre="OsterhausAD, van BeekR, De JongJC, RimmelzwaanGF, SenneDA, KraussS, ShortridgeKF, WebsterRG1998Human" exact="influenza" post="A H5N1 virus related to a highly pathogenic avian"/>
   <result pre="WebsterRG1998Human influenza A H5N1 virus related to a highly pathogenic" exact="avian influenza" post="virus. Lancet351, 472â€&quot;477. (10.1016/S0140-6736(97)11212-0)9482438 116ClaasECJ, de JongJC, van BeekR,"/>
   <result pre="influenza A H5N1 virus related to a highly pathogenic avian" exact="influenza" post="virus. Lancet351, 472â€&quot;477. (10.1016/S0140-6736(97)11212-0)9482438 116ClaasECJ, de JongJC, van BeekR,"/>
   <result pre="Lancet351, 472â€&quot;477. (10.1016/S0140-6736(97)11212-0)9482438 116ClaasECJ, de JongJC, van BeekR, RimmelzwaanGF, OsterhausADME1998Human" exact="influenza" post="virus A/HongKong/156/97 (H5N1) infection. Vaccine16, 977â€&quot;978. (10.1016/S0264-410X(98)00005-X)9682346 117SubbaraoKet al.1998Characterization"/>
   <result pre="A/HongKong/156/97 (H5N1) infection. Vaccine16, 977â€&quot;978. (10.1016/S0264-410X(98)00005-X)9682346 117SubbaraoKet al.1998Characterization of an" exact="avian influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="(H5N1) infection. Vaccine16, 977â€&quot;978. (10.1016/S0264-410X(98)00005-X)9682346 117SubbaraoKet al.1998Characterization of an avian" exact="influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="with a fatal respiratory illness. Science279, 393â€&quot;396. (10.1126/science.279.5349.393)9430591 118ChanPKS2002Outbreak of" exact="avian influenza" post="A(H5N1) virus infection in Hong Kong in 1997. Clin."/>
   <result pre="a fatal respiratory illness. Science279, 393â€&quot;396. (10.1126/science.279.5349.393)9430591 118ChanPKS2002Outbreak of avian" exact="influenza" post="A(H5N1) virus infection in Hong Kong in 1997. Clin."/>
   <result pre="Infect. Dis.34(Suppl. 2), S58â€&quot;S64. (10.1086/338820)11938498 119ShortridgeKFet al.1998Characterization of avian H5N1" exact="influenza" post="viruses from poultry in Hong Kong. Virology252, 331â€&quot;342. (10.1006/viro.1998.9488)9878612"/>
   <result pre="poultry in Hong Kong. Virology252, 331â€&quot;342. (10.1006/viro.1998.9488)9878612 120ShortridgeKF1999Poultry and the" exact="influenza" post="H5N1 outbreak in Hong Kong, 1997: abridged chronology and"/>
   <result pre="S26â€&quot;S29. (10.1016/S0264-410X(99)00102-4)10471177 121DuanLet al.2008The development and genetic diversity of H5N1" exact="influenza" post="virus in China, 1996â€&quot;2006. Virology380, 243â€&quot;254. (10.1016/j.virol.2008.07.038)18774155 122GuanY, PeirisJSM,"/>
   <result pre="DyrtingKC, KraussS, ZhangLJ, WebsterRG, ShortridgeKF2002Emergence of multiple genotypes of H5N1" exact="avian influenza" post="viruses in Hong Kong SAR. Proc. Natl Acad. Sci."/>
   <result pre="KraussS, ZhangLJ, WebsterRG, ShortridgeKF2002Emergence of multiple genotypes of H5N1 avian" exact="influenza" post="viruses in Hong Kong SAR. Proc. Natl Acad. Sci."/>
   <result pre="123LiKSet al.2004Genesis of a highly pathogenic and potentially pandemic H5N1" exact="influenza" post="virus in eastern Asia. Nature430, 209â€&quot;213. (10.1038/nature02746)15241415 124collab: World"/>
   <result pre="World Health Organisation. 2018Cumulative number of confirmed human cases for" exact="avian influenza" post="A(H5N1) reported to WHO, 2003â€&quot;2018. Geneva, Switzerland: WHO. See"/>
   <result pre="Health Organisation. 2018Cumulative number of confirmed human cases for avian" exact="influenza" post="A(H5N1) reported to WHO, 2003â€&quot;2018. Geneva, Switzerland: WHO. See"/>
   <result pre="in migratory waterfowl. Nature436, 191â€&quot;192. (10.1038/nature03974)16007072 127LiuJet al.2005Highly pathogenic H5N1" exact="influenza" post="virus infection in migratory birds. Science309, 1206 (10.1126/science.1115273)16000410 128ShinyaK,"/>
   <result pre="replicative efficiency, but not cell tropism, of Hong Kong H5N1" exact="influenza" post="A viruses in mice. Virology320, 258â€&quot;266. (10.1016/j.virol.2003.11.030)15016548 129SalzbergSLet al.2007Genome"/>
   <result pre="258â€&quot;266. (10.1016/j.virol.2003.11.030)15016548 129SalzbergSLet al.2007Genome analysis linking recent European and African" exact="influenza" post="(H5N1) viruses. Emerg. Infect. Dis.13, 713â€&quot;718. (10.3201/eid1305.070013)17553249 130YingstSL, SaadMD,"/>
   <result pre="cats, northern Iraq. Emerg. Infect. Dis.12, 1295â€&quot;1297. (10.3201/eid1208.060264)16972356 131MonneIet al.2008Reassortant" exact="avian influenza" post="virus (H5N1) in poultry, Nigeria, 2007. Emerg. Infect. Dis.14,"/>
   <result pre="northern Iraq. Emerg. Infect. Dis.12, 1295â€&quot;1297. (10.3201/eid1208.060264)16972356 131MonneIet al.2008Reassortant avian" exact="influenza" post="virus (H5N1) in poultry, Nigeria, 2007. Emerg. Infect. Dis.14,"/>
   <result pre="Dis.14, 637â€&quot;640. (10.3201/eid1404.071178)18394282 132HuangKet al.2012Establishment and lineage replacement of H6" exact="influenza" post="viruses in domestic ducks in southern China. J. Virol.86,"/>
   <result pre="and antigenic evolution and geographical spread of H5N1 highly pathogenic" exact="avian influenza" post="viruses in western Africa. J. Gen. Virol.88, 2297â€&quot;2306. (10.1099/vir.0.82939-0)17622635"/>
   <result pre="antigenic evolution and geographical spread of H5N1 highly pathogenic avian" exact="influenza" post="viruses in western Africa. J. Gen. Virol.88, 2297â€&quot;2306. (10.1099/vir.0.82939-0)17622635"/>
   <result pre="and perspective. mBio3, e00045-12 (10.1128/mBio.00045-12)22366820 137UngchusakKet al.2005Probable person-to-person transmission of" exact="avian influenza" post="A (H5N1). N. Engl. J. Med.352, 333â€&quot;340. (10.1056/NEJMoa044021)15668219 138WangHet"/>
   <result pre="perspective. mBio3, e00045-12 (10.1128/mBio.00045-12)22366820 137UngchusakKet al.2005Probable person-to-person transmission of avian" exact="influenza" post="A (H5N1). N. Engl. J. Med.352, 333â€&quot;340. (10.1056/NEJMoa044021)15668219 138WangHet"/>
   <result pre="333â€&quot;340. (10.1056/NEJMoa044021)15668219 138WangHet al.2008Probable limited person-to-person transmission of highly pathogenic" exact="avian influenza" post="A (H5N1) virus in China. Lancet371, 1427â€&quot;1434. (10.1016/S0140-6736(08)60493-6)18400288 139collab:"/>
   <result pre="(10.1056/NEJMoa044021)15668219 138WangHet al.2008Probable limited person-to-person transmission of highly pathogenic avian" exact="influenza" post="A (H5N1) virus in China. Lancet371, 1427â€&quot;1434. (10.1016/S0140-6736(08)60493-6)18400288 139collab:"/>
   <result pre="A (H1N1) Virus Investigation Team. 2009Emergence of a novel swine-origin" exact="influenza" post="A (H1N1) virus in humans. N. Engl. J. Med.360,"/>
   <result pre="Serology Working Group. 2013Estimating age-specific cumulative incidence for the 2009" exact="influenza" post="pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling study. Lancet Infect."/>
   <result pre="Infect. Dis.12, 687â€&quot;695. (10.1016/S1473-3099(12)70121-4)22738893 142LiuDet al.2013Origin and diversity of novel" exact="avian influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="Dis.12, 687â€&quot;695. (10.1016/S1473-3099(12)70121-4)22738893 142LiuDet al.2013Origin and diversity of novel avian" exact="influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="1926â€&quot;1932. (10.1016/S0140-6736(13)60938-1)23643111 143GuanY, ShortridgeKF, KraussS, ChinPS, DyrtingKC, EllisTM, WebsterRG, PeirisM2000H9N2" exact="influenza" post="viruses possessing H5N1-like internal genomes continue to circulate in"/>
   <result pre="WebbyRJ, WebsterRG, PeirisJS, PoonL, ButtC, LeungYHC, GuanY2004Continuing evolution of H9N2" exact="influenza" post="viruses in southeastern China. J. Virol.78, 8609â€&quot;8614. (10.1128/JVI.78.16.8609-8614.2004)15280470 145ShiH,"/>
   <result pre="LuJ, LiuX2010Evaluation of transmission route and replication efficiency of H9N2" exact="avian influenza" post="virus. Avian Dis.54, 22â€&quot;27. (10.1637/8937-052809-Reg.1)20408394 146GaoRet al.2013Human infection with"/>
   <result pre="LiuX2010Evaluation of transmission route and replication efficiency of H9N2 avian" exact="influenza" post="virus. Avian Dis.54, 22â€&quot;27. (10.1637/8937-052809-Reg.1)20408394 146GaoRet al.2013Human infection with"/>
   <result pre="Dis.54, 22â€&quot;27. (10.1637/8937-052809-Reg.1)20408394 146GaoRet al.2013Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virus. N. Engl. J. Med.368, 1888â€&quot;1897. (10.1056/NEJMoa1304459)23577628"/>
   <result pre="J. Med.368, 1888â€&quot;1897. (10.1056/NEJMoa1304459)23577628 147ChenYet al.2013Human infections with the emerging" exact="avian influenza" post="A H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="Med.368, 1888â€&quot;1897. (10.1056/NEJMoa1304459)23577628 147ChenYet al.2013Human infections with the emerging avian" exact="influenza" post="A H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="2018. Rome, Italy: FAO. See http://www.fao.org/ag/againfo/programmes/en/empres/h7n9/situation_update.html. 149MillmanAJet al.2015Detecting spread of" exact="avian influenza" post="A(H7N9) virus beyond China. Emerg. Infect. Dis.21, 741â€&quot;749. (10.3201/eid2105.141756)25897654"/>
   <result pre="Rome, Italy: FAO. See http://www.fao.org/ag/againfo/programmes/en/empres/h7n9/situation_update.html. 149MillmanAJet al.2015Detecting spread of avian" exact="influenza" post="A(H7N9) virus beyond China. Emerg. Infect. Dis.21, 741â€&quot;749. (10.3201/eid2105.141756)25897654"/>
   <result pre="LiuD, CuiJ, GaoGF, ZhouJ, LiuX2017Epidemiology, evolution, and pathogenesis of H7N9" exact="influenza" post="viruses in five epidemic waves since 2013 in China."/>
   <result pre="Costa-HurtadoM, SuarezDL2014Role of poultry in the spread of novel H7N9" exact="influenza" post="virus in China. J. Virol.88, 5381â€&quot;5390. (10.1128/JVI.03689-13)24574407 152JiaoPet al.2018H7N9"/>
   <result pre="influenza virus in China. J. Virol.88, 5381â€&quot;5390. (10.1128/JVI.03689-13)24574407 152JiaoPet al.2018H7N9" exact="avian influenza" post="virus is efficiently transmissible and induces an antibody response"/>
   <result pre="virus in China. J. Virol.88, 5381â€&quot;5390. (10.1128/JVI.03689-13)24574407 152JiaoPet al.2018H7N9 avian" exact="influenza" post="virus is efficiently transmissible and induces an antibody response"/>
   <result pre="in chickens. Front. Immunol.9, 789 (10.3389/fimmu.2018.00789)29706970 153HerfstSet al.2012Airborne transmission of" exact="influenza" post="A/H5N1 virus between ferrets. Science336, 1534â€&quot;1541. (10.1126/science.1213362)22723413 154ImaiMet al.2012Experimental"/>
   <result pre="between ferrets. Science336, 1534â€&quot;1541. (10.1126/science.1213362)22723413 154ImaiMet al.2012Experimental adaptation of an" exact="influenza" post="H5 HA confers respiratory droplet transmission to a reassortant"/>
   <result pre="420â€&quot;428. (10.1038/nature10831)22722205 155ZhuHet al.2013Infectivity, transmission, and pathology of human-isolated H7N9" exact="influenza" post="virus in ferrets and pigs. Science341, 183â€&quot;186. (10.1126/science.1239844)23704376 156KucharskiAJ,"/>
   <result pre="pigs. Science341, 183â€&quot;186. (10.1126/science.1239844)23704376 156KucharskiAJ, MillsHL, DonnellyCA, RileyS2015Transmission potential of" exact="influenza" post="A(H7N9) virus, China, 2013â€&quot;2014. Emerg. Infect. Dis.21, 852â€&quot;855. (10.3201/eid2105.141137)25897624"/>
   <result pre="of closure of live poultry markets on poultry-to-person transmission of" exact="avian influenza" post="A H7N9 virus: an ecological study. Lancet383, 541â€&quot;548. (10.1016/S0140-6736(13)61904-2)24183056"/>
   <result pre="closure of live poultry markets on poultry-to-person transmission of avian" exact="influenza" post="A H7N9 virus: an ecological study. Lancet383, 541â€&quot;548. (10.1016/S0140-6736(13)61904-2)24183056"/>
   <result pre="Lancet383, 541â€&quot;548. (10.1016/S0140-6736(13)61904-2)24183056 158LamTT-Yet al.2015Dissemination, divergence and establishment of H7N9" exact="influenza" post="viruses in China. Nature522, 102â€&quot;105. (10.1038/nature14348)25762140 159ArtoisJet al.2018Changing geographic"/>
   <result pre="102â€&quot;105. (10.1038/nature14348)25762140 159ArtoisJet al.2018Changing geographic patterns and risk factors for" exact="avian influenza" post="A(H7N9) infections in humans, China. Emerg. Infect. Dis.24, 87â€&quot;94."/>
   <result pre="(10.1038/nature14348)25762140 159ArtoisJet al.2018Changing geographic patterns and risk factors for avian" exact="influenza" post="A(H7N9) infections in humans, China. Emerg. Infect. Dis.24, 87â€&quot;94."/>
   <result pre="(10.3201/eid2401.171393)29260681 160ZhouLet al.2017Preliminary epidemiology of human infections with highly pathogenic" exact="avian influenza" post="A(H7N9) virus, China, 2017. Emerg. Infect. Dis.23, 1355â€&quot;1359. (10.3201/eid2308.170640)28580900"/>
   <result pre="160ZhouLet al.2017Preliminary epidemiology of human infections with highly pathogenic avian" exact="influenza" post="A(H7N9) virus, China, 2017. Emerg. Infect. Dis.23, 1355â€&quot;1359. (10.3201/eid2308.170640)28580900"/>
   <result pre="and virological characteristics of the first detected human case of" exact="avian influenza" post="A(H5N6) virus. Infect. Genet. Evol.40, 236â€&quot;242. (10.1016/j.meegid.2016.03.010)26973295 164collab: Ministry"/>
   <result pre="virological characteristics of the first detected human case of avian" exact="influenza" post="A(H5N6) virus. Infect. Genet. Evol.40, 236â€&quot;242. (10.1016/j.meegid.2016.03.010)26973295 164collab: Ministry"/>
   <result pre="a good job of the autumn immunization of highly pathogenic" exact="avian influenza" post="in the whole country. Report no. 07B130303201700282 (in Chinese)."/>
   <result pre="good job of the autumn immunization of highly pathogenic avian" exact="influenza" post="in the whole country. Report no. 07B130303201700282 (in Chinese)."/>
   <result pre="China. See http://www.moa.gov.cn/govpublic/SYJ/201707/t20170711_5744436.htm. 165collab: Food and Agriculture Organisation. 2018Chinese-origin H7N9" exact="avian influenza" post="spread in poultry and human exposure â€&quot; Qualitative risk"/>
   <result pre="See http://www.moa.gov.cn/govpublic/SYJ/201707/t20170711_5744436.htm. 165collab: Food and Agriculture Organisation. 2018Chinese-origin H7N9 avian" exact="influenza" post="spread in poultry and human exposure â€&quot; Qualitative risk"/>
   <result pre="WHO/OIE/FAO H5N1 Evolution Working Group. 2012Continued evolution of highly pathogenic" exact="avian influenza" post="A (H5N1): updated nomenclature. Influenza Other Resp. Viruses6, 1â€&quot;5."/>
   <result pre="H5N1 Evolution Working Group. 2012Continued evolution of highly pathogenic avian" exact="influenza" post="A (H5N1): updated nomenclature. Influenza Other Resp. Viruses6, 1â€&quot;5."/>
   <result pre="1â€&quot;5. (10.1111/j.1750-2659.2011.00298.x) 167SmithGJD, DonisRO2015Nomenclature updates resulting from the evolution of" exact="avian influenza" post="A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013â€&quot;2014."/>
   <result pre="(10.1111/j.1750-2659.2011.00298.x) 167SmithGJD, DonisRO2015Nomenclature updates resulting from the evolution of avian" exact="influenza" post="A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013â€&quot;2014."/>
   <result pre="Other Resp. Viruses9, 271â€&quot;276. (10.1111/irv.12324) 168GuMet al.2011Novel reassortant highly pathogenic" exact="avian influenza" post="(H5N5) viruses in domestic ducks, China. Emerg. Infect. Dis.17,"/>
   <result pre="Resp. Viruses9, 271â€&quot;276. (10.1111/irv.12324) 168GuMet al.2011Novel reassortant highly pathogenic avian" exact="influenza" post="(H5N5) viruses in domestic ducks, China. Emerg. Infect. Dis.17,"/>
   <result pre="Infect. Dis.17, 1060â€&quot;1063. (10.3201/eid/1706.101406)21749770 169ZhaoGet al.2012Novel reassortant highly pathogenic H5N2" exact="avian influenza" post="viruses in poultry in China. PLoS ONE7, e46183 (10.1371/journal.pone.0046183)23049973"/>
   <result pre="Dis.17, 1060â€&quot;1063. (10.3201/eid/1706.101406)21749770 169ZhaoGet al.2012Novel reassortant highly pathogenic H5N2 avian" exact="influenza" post="viruses in poultry in China. PLoS ONE7, e46183 (10.1371/journal.pone.0046183)23049973"/>
   <result pre="170ZhaoKet al.2013Characterization of three H5N5 and one H5N8 highly pathogenic" exact="avian influenza" post="viruses in China. Vet. Microbiol.163, 351â€&quot;357. (10.1016/j.vetmic.2012.12.025)23375651 171ZouW, GuoX,"/>
   <result pre="al.2013Characterization of three H5N5 and one H5N8 highly pathogenic avian" exact="influenza" post="viruses in China. Vet. Microbiol.163, 351â€&quot;357. (10.1016/j.vetmic.2012.12.025)23375651 171ZouW, GuoX,"/>
   <result pre="YangY, JinM2012Complete genome sequence of a novel natural recombinant H5N5" exact="influenza" post="virus from ducks in central China. J. Virol.86, 13878"/>
   <result pre="172LiuCG, LiuM, LiuF, LvR, LiuDF, QuLD, ZhangY2013Emerging multiple reassortant H5N5" exact="avian influenza" post="viruses in ducks, China, 2008. Vet. Microbiol.167, 296â€&quot;306. (10.1016/j.vetmic.2013.09.004)24080350"/>
   <result pre="LiuM, LiuF, LvR, LiuDF, QuLD, ZhangY2013Emerging multiple reassortant H5N5 avian" exact="influenza" post="viruses in ducks, China, 2008. Vet. Microbiol.167, 296â€&quot;306. (10.1016/j.vetmic.2013.09.004)24080350"/>
   <result pre="173WuH, PengX, XuL, JinC, ChengL, LuX, XieT, YaoH, WuN2014Novel reassortant" exact="influenza" post="A(H5N8) viruses in domestic ducks, eastern China. Emerg. Infect."/>
   <result pre="WuD, GaoX, PeiE, WangT, GaoY, XiaX2014A novel highly pathogenic H5N8" exact="avian influenza" post="virus isolated from a wild duck in China. Influenza"/>
   <result pre="GaoX, PeiE, WangT, GaoY, XiaX2014A novel highly pathogenic H5N8 avian" exact="influenza" post="virus isolated from a wild duck in China. Influenza"/>
   <result pre="YeJ, ZhaoZ, WuS, XuC, JiaoP, LiaoM2015New reassortant H5N8 highly pathogenic" exact="avian influenza" post="virus from waterfowl in southern China. Front. Microbiol.6, 1170"/>
   <result pre="ZhaoZ, WuS, XuC, JiaoP, LiaoM2015New reassortant H5N8 highly pathogenic avian" exact="influenza" post="virus from waterfowl in southern China. Front. Microbiol.6, 1170"/>
   <result pre="in southern China. Front. Microbiol.6, 1170 (10.3389/fmicb.2015.01170)26557113 176LeeY-Jet al.2014Novel reassortant" exact="influenza" post="A(H5N8) viruses, South Korea, 2014. Emerg. Infect. Dis.20, 1087â€&quot;1089."/>
   <result pre="Korea, 2014. Emerg. Infect. Dis.20, 1087â€&quot;1089. (10.3201/eid2006.140233)24856098 177JeongJet al.2014Highly pathogenic" exact="avian influenza" post="virus (H5N8) in domestic poultry and its relationship with"/>
   <result pre="2014. Emerg. Infect. Dis.20, 1087â€&quot;1089. (10.3201/eid2006.140233)24856098 177JeongJet al.2014Highly pathogenic avian" exact="influenza" post="virus (H5N8) in domestic poultry and its relationship with"/>
   <result pre="2014. Vet. Microbiol.173, 249â€&quot;257. (10.1016/j.vetmic.2014.08.002)25192767 178IpHSet al.2015Novel Eurasian highly pathogenic" exact="avian influenza" post="A H5 viruses in wild birds, Washington, USA, 2014."/>
   <result pre="Vet. Microbiol.173, 249â€&quot;257. (10.1016/j.vetmic.2014.08.002)25192767 178IpHSet al.2015Novel Eurasian highly pathogenic avian" exact="influenza" post="A H5 viruses in wild birds, Washington, USA, 2014."/>
   <result pre="Dis.21, 886â€&quot;890. (10.3201/eid2105.142020)25898265 179BevinsSNet al.2016Widespread detection of highly pathogenic H5" exact="influenza" post="viruses in wild birds from the Pacific flyway of"/>
   <result pre="(10.1038/srep28980)27381241 180PasickJ, BerhaneY, JosephT, BowesV, HisanagaT, HandelK, AlexandersenS2015Reassortant highly pathogenic" exact="influenza" post="A H5N2 virus containing gene segments related to Eurasian"/>
   <result pre="TorchettiMK, HicksJ, KillianML, BahlJ, Pantin-JackwoodM, SwayneDE2018Transmission dynamics of highly pathogenic" exact="avian influenza" post="virus A(H5Nx) clade 2.3.4.4, North America, 2014â€&quot;2015. Emerg. Infect."/>
   <result pre="HicksJ, KillianML, BahlJ, Pantin-JackwoodM, SwayneDE2018Transmission dynamics of highly pathogenic avian" exact="influenza" post="virus A(H5Nx) clade 2.3.4.4, North America, 2014â€&quot;2015. Emerg. Infect."/>
   <result pre="APHIS. 2016Final report for the 2014â€&quot;2015 outbreak of highly pathogenic" exact="avian influenza" post="(HPAI) in the United States. Washington, DC: United States"/>
   <result pre="2016Final report for the 2014â€&quot;2015 outbreak of highly pathogenic avian" exact="influenza" post="(HPAI) in the United States. Washington, DC: United States"/>
   <result pre="See https://www.aphis.usda.gov/animal_health/emergency_management/downloads/hpai/2015-hpai-final-report.pdf. 183RamosS, MacLachlanM, MeltonA2017Impacts of the 2014â€&quot;2015 highly pathogenic" exact="avian influenza" post="outbreak on the U.S. poultry sector. Livestock Dairy Poultry"/>
   <result pre="https://www.aphis.usda.gov/animal_health/emergency_management/downloads/hpai/2015-hpai-final-report.pdf. 183RamosS, MacLachlanM, MeltonA2017Impacts of the 2014â€&quot;2015 highly pathogenic avian" exact="influenza" post="outbreak on the U.S. poultry sector. Livestock Dairy Poultry"/>
   <result pre="the apparent disappearance of Eurasian highly pathogenic H5 clade 2.3.4.4" exact="influenza" post="A viruses in North American waterfowl. Proc. Natl Acad."/>
   <result pre="A(H5N8) virus similar to strain in Korea causing highly pathogenic" exact="avian influenza" post="in Germany. Emerg. Infect. Dis.21, 860â€&quot;863. (10.3201/eid2105.141897)25897703 186GlobigAet al.2017Epidemiological"/>
   <result pre="virus similar to strain in Korea causing highly pathogenic avian" exact="influenza" post="in Germany. Emerg. Infect. Dis.21, 860â€&quot;863. (10.3201/eid2105.141897)25897703 186GlobigAet al.2017Epidemiological"/>
   <result pre="al.2017Epidemiological and molecular analysis of an outbreak of highly pathogenic" exact="avian influenza" post="H5N8 clade 2.3.4.4 in a German zoo: effective disease"/>
   <result pre="and molecular analysis of an outbreak of highly pathogenic avian" exact="influenza" post="H5N8 clade 2.3.4.4 in a German zoo: effective disease"/>
   <result pre="BouwstraR, VerdonckF, PenttinenP, HarderT2014Comparing introduction to Europe of highly pathogenic" exact="avian influenza" post="viruses A(H5N8) in 2014 and A(H5N1) in 2005. Eurosurveillance19,"/>
   <result pre="VerdonckF, PenttinenP, HarderT2014Comparing introduction to Europe of highly pathogenic avian" exact="influenza" post="viruses A(H5N8) in 2014 and A(H5N1) in 2005. Eurosurveillance19,"/>
   <result pre="(10.2807/1560-7917.es2014.19.50.20996)25597538 188VerhagenJHet al.2015Wild bird surveillance around outbreaks of highly pathogenic" exact="avian influenza" post="A(H5N8) virus in the Netherlands, 2014, within the context"/>
   <result pre="188VerhagenJHet al.2015Wild bird surveillance around outbreaks of highly pathogenic avian" exact="influenza" post="A(H5N8) virus in the Netherlands, 2014, within the context"/>
   <result pre="21â€&quot;32. (10.2807/1560-7917.ES2015.20.12.21069)25719964 189BouwstraR, HeutinkR, BossersA, HardersF, KochG, ElbersA2015Full-genome sequence of" exact="influenza" post="A(H5N8) virus in poultry linked to sequences of strains"/>
   <result pre="HardersF, van der SpekA, ElbersAR, BossersA2015Phylogenetic analysis of highly pathogenic" exact="avian influenza" post="A(H5N8) virus outbreak strains provides evidence for four separate"/>
   <result pre="van der SpekA, ElbersAR, BossersA2015Phylogenetic analysis of highly pathogenic avian" exact="influenza" post="A(H5N8) virus outbreak strains provides evidence for four separate"/>
   <result pre="November 2014. Eurosurveillance20, 21174 (10.2807/1560-7917.es2015.20.26.21174)26159311 191BriandF-Xet al.2017Emerging highly pathogenic H5" exact="avian influenza" post="viruses in France during winter 2015/16: phylogenetic analyses and"/>
   <result pre="2014. Eurosurveillance20, 21174 (10.2807/1560-7917.es2015.20.26.21174)26159311 191BriandF-Xet al.2017Emerging highly pathogenic H5 avian" exact="influenza" post="viruses in France during winter 2015/16: phylogenetic analyses and"/>
   <result pre="(10.2807/1560-7917.ES.2017.22.9.30473)28277218 192BriandFXet al.2018Emergence and multiple reassortments of French2015â€&quot;2016highly pathogenic H5" exact="avian influenza" post="viruses. Infect. Genet. Evol.61, 208â€&quot;214. (10.1016/j.meegid.2018.04.007) 193de VriesE, GuoH,"/>
   <result pre="192BriandFXet al.2018Emergence and multiple reassortments of French2015â€&quot;2016highly pathogenic H5 avian" exact="influenza" post="viruses. Infect. Genet. Evol.61, 208â€&quot;214. (10.1016/j.meegid.2018.04.007) 193de VriesE, GuoH,"/>
   <result pre="DaiM, RottierPJM, van KuppeveldFJM, de HaanCAM2015Rapid emergence of highly pathogenic" exact="avian influenza" post="subtypes from a subtype H5N1 hemagglutinin variant. Emerg. Infect."/>
   <result pre="RottierPJM, van KuppeveldFJM, de HaanCAM2015Rapid emergence of highly pathogenic avian" exact="influenza" post="subtypes from a subtype H5N1 hemagglutinin variant. Emerg. Infect."/>
   <result pre="842â€&quot;846. (10.3201/eid2105.141927)25897518 194YangLet al.2017Genesis and dissemination of highly pathogenic H5N6" exact="avian influenza" post="viruses. J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants"/>
   <result pre="(10.3201/eid2105.141927)25897518 194YangLet al.2017Genesis and dissemination of highly pathogenic H5N6 avian" exact="influenza" post="viruses. J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants"/>
   <result pre="viruses. J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants of" exact="avian influenza" post="A (H5N6) virus in China. J. Gen. Virol.96, 975â€&quot;981."/>
   <result pre="J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants of avian" exact="influenza" post="A (H5N6) virus in China. J. Gen. Virol.96, 975â€&quot;981."/>
   <result pre="Virol.96, 975â€&quot;981. (10.1099/vir.0.000056)25604926 196BiYet al.2016Genesis, evolution and prevalence of H5N6" exact="avian influenza" post="viruses in China. Cell Host Microbe20, 810â€&quot;821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet"/>
   <result pre="975â€&quot;981. (10.1099/vir.0.000056)25604926 196BiYet al.2016Genesis, evolution and prevalence of H5N6 avian" exact="influenza" post="viruses in China. Cell Host Microbe20, 810â€&quot;821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet"/>
   <result pre="Cell Host Microbe20, 810â€&quot;821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet al.2016Diversity and evolution of" exact="avian influenza" post="viruses in live poultry markets, free-range poultry and wild"/>
   <result pre="Host Microbe20, 810â€&quot;821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet al.2016Diversity and evolution of avian" exact="influenza" post="viruses in live poultry markets, free-range poultry and wild"/>
   <result pre="birds in China. J. Gen. Virol.97, 844â€&quot;854. (10.1099/jgv.0.000399)26758561 198BiYet al.2016Novel" exact="avian influenza" post="A (H5N6) viruses isolated in migratory waterfowl before the"/>
   <result pre="in China. J. Gen. Virol.97, 844â€&quot;854. (10.1099/jgv.0.000399)26758561 198BiYet al.2016Novel avian" exact="influenza" post="A (H5N6) viruses isolated in migratory waterfowl before the"/>
   <result pre="29888 (10.1038/srep29888)27431568 199PanMet al.2016Human infection with a novel, highly pathogenic" exact="avian influenza" post="A (H5N6) virus: virological and clinical findings. J. Infect.72,"/>
   <result pre="(10.1038/srep29888)27431568 199PanMet al.2016Human infection with a novel, highly pathogenic avian" exact="influenza" post="A (H5N6) virus: virological and clinical findings. J. Infect.72,"/>
   <result pre="52â€&quot;59. (10.1016/j.jinf.2015.06.009)26143617 200YangZ-F, MokCKP, PeirisJSM, ZhongN-S2015Human infection with a novel" exact="avian influenza" post="A(H5N6) virus. N. Engl. J. Med.373, 487â€&quot;489. (10.1056/NEJMc1502983) 201ZhangYet"/>
   <result pre="(10.1016/j.jinf.2015.06.009)26143617 200YangZ-F, MokCKP, PeirisJSM, ZhongN-S2015Human infection with a novel avian" exact="influenza" post="A(H5N6) virus. N. Engl. J. Med.373, 487â€&quot;489. (10.1056/NEJMc1502983) 201ZhangYet"/>
   <result pre="Med.373, 487â€&quot;489. (10.1056/NEJMc1502983) 201ZhangYet al.2017Human infections with novel reassortant H5N6" exact="avian influenza" post="viruses in China. Emerg. Microbes Infect.6, e50 (10.1038/emi.2017.38)28588293 202NguyenDTet"/>
   <result pre="487â€&quot;489. (10.1056/NEJMc1502983) 201ZhangYet al.2017Human infections with novel reassortant H5N6 avian" exact="influenza" post="viruses in China. Emerg. Microbes Infect.6, e50 (10.1038/emi.2017.38)28588293 202NguyenDTet"/>
   <result pre="distribution, reassortment, and emergence of new subtypes of highly pathogenic" exact="avian influenza" post="A(H5) viruses collected from Vietnamese poultry from 2012 to"/>
   <result pre="reassortment, and emergence of new subtypes of highly pathogenic avian" exact="influenza" post="A(H5) viruses collected from Vietnamese poultry from 2012 to"/>
   <result pre="(10.1128/JVI.01708-16) 203ThanhHD, TranVT, NguyenDT, HungV-K, KimW2018Novel reassortant H5N6 highly pathogenic" exact="influenza" post="A viruses in Vietnamese quail outbreaks. Comp. Immunol. Microbiol."/>
   <result pre="Immunol. Microbiol. Infect. Dis.56, 45â€&quot;57. (10.1016/j.cimid.2018.01.001)29406283 204WongFYKet al.2015Reassortant highly pathogenic" exact="influenza" post="A(H5N6) virus in Laos. Emerg. Infect. Dis.21, 511â€&quot;516. (10.3201/eid2103.141488)25695754"/>
   <result pre="Dis.21, 511â€&quot;516. (10.3201/eid2103.141488)25695754 205SiY-Jet al.2017Genetic characterisation of novel, highly pathogenic" exact="avian influenza" post="(HPAI) H5N6 viruses isolated in birds, South Korea, November"/>
   <result pre="511â€&quot;516. (10.3201/eid2103.141488)25695754 205SiY-Jet al.2017Genetic characterisation of novel, highly pathogenic avian" exact="influenza" post="(HPAI) H5N6 viruses isolated in birds, South Korea, November"/>
   <result pre="206ZhangJet al.2018Genetic diversity and dissemination pathways of highly pathogenic H5N6" exact="avian influenza" post="viruses from birds in southwestern China along the East"/>
   <result pre="al.2018Genetic diversity and dissemination pathways of highly pathogenic H5N6 avian" exact="influenza" post="viruses from birds in southwestern China along the East"/>
   <result pre="flyway. J. Infect.76, 418â€&quot;422. (10.1016/j.jinf.2017.11.009)29246638 207OkamatsuMet al.2017Characterization of highly pathogenic" exact="avian influenza" post="virus A(H5N6), Japan, November 2016. Emerg. Infect. Dis.23, 691â€&quot;695."/>
   <result pre="J. Infect.76, 418â€&quot;422. (10.1016/j.jinf.2017.11.009)29246638 207OkamatsuMet al.2017Characterization of highly pathogenic avian" exact="influenza" post="virus A(H5N6), Japan, November 2016. Emerg. Infect. Dis.23, 691â€&quot;695."/>
   <result pre="691â€&quot;695. (10.3201/eid2304.161957)28322695 208TakemaeNet al..2017Five distinct reassortants of H5N6 highly pathogenic" exact="avian influenza" post="A viruses affected Japan during the winter of 2016â€&quot;2017."/>
   <result pre="(10.3201/eid2304.161957)28322695 208TakemaeNet al..2017Five distinct reassortants of H5N6 highly pathogenic avian" exact="influenza" post="A viruses affected Japan during the winter of 2016â€&quot;2017."/>
   <result pre="8â€&quot;20. (10.1016/j.virol.2017.08.035)28892736 209LeeH, LaoA2018Transmission dynamics and control strategies assessment of" exact="avian influenza" post="A (H5N6) in the Philippines. Infect. Dis. Model.3, 35â€&quot;59."/>
   <result pre="(10.1016/j.virol.2017.08.035)28892736 209LeeH, LaoA2018Transmission dynamics and control strategies assessment of avian" exact="influenza" post="A (H5N6) in the Philippines. Infect. Dis. Model.3, 35â€&quot;59."/>
   <result pre="SwayneDE, KurskayaO, SobolevI, KabilovM, AlekseevA, IrzaV, ShestopalovA2017Novel reassortant clade 2.3.4.4" exact="avian influenza" post="A(H5N8) virus in wild aquatic birds, Russia, 2016. Emerg."/>
   <result pre="KurskayaO, SobolevI, KabilovM, AlekseevA, IrzaV, ShestopalovA2017Novel reassortant clade 2.3.4.4 avian" exact="influenza" post="A(H5N8) virus in wild aquatic birds, Russia, 2016. Emerg."/>
   <result pre="359â€&quot;360. (10.3201/eid2302.161252)27875109 211KleyheegEet al.2017Deaths among wild birds during highly pathogenic" exact="avian influenza" post="A(H5N8) virus outbreak, the Netherlands. Emerg. Infect. Dis.23, 2050â€&quot;2054."/>
   <result pre="(10.3201/eid2302.161252)27875109 211KleyheegEet al.2017Deaths among wild birds during highly pathogenic avian" exact="influenza" post="A(H5N8) virus outbreak, the Netherlands. Emerg. Infect. Dis.23, 2050â€&quot;2054."/>
   <result pre="Emerg. Infect. Dis.23, 2050â€&quot;2054. (10.3201/eid2312.171086)29148372 212GrundCet al.2018A novel European H5N8" exact="influenza" post="A virus has increased virulence in ducks but low"/>
   <result pre="zoonotic potential. Emerg. Microbes Infect.7, 132 (10.1038/s41426-018-0130-1)30026505 213LiMet al.2017Highly pathogenic" exact="avian influenza" post="A(H5N8) virus in wild migratory birds, Qinghai Lake, China."/>
   <result pre="potential. Emerg. Microbes Infect.7, 132 (10.1038/s41426-018-0130-1)30026505 213LiMet al.2017Highly pathogenic avian" exact="influenza" post="A(H5N8) virus in wild migratory birds, Qinghai Lake, China."/>
   <result pre="Lake, China. Emerg. Infect. Dis.23, 637â€&quot;641. (10.3201/eid2304.161866)28169827 214GlobigAet al.2017Highly pathogenic" exact="avian influenza" post="H5N8 clade 2.3.4.4b in Germany in 2016/2017. Front. Vet."/>
   <result pre="China. Emerg. Infect. Dis.23, 637â€&quot;641. (10.3201/eid2304.161866)28169827 214GlobigAet al.2017Highly pathogenic avian" exact="influenza" post="H5N8 clade 2.3.4.4b in Germany in 2016/2017. Front. Vet."/>
   <result pre="240 (10.3389/fvets.2017.00240)29417053 215GhafouriSA, GhalyanchiLangeroudiA, MaghsoudlooH, FarahaniRKH, AbdollahiH, TehraniF, FallahMH2017Clade 2.3.4.4" exact="avian influenza" post="A (H5N8) outbreak in commercial poultry, Iran, 2016: the"/>
   <result pre="(10.3389/fvets.2017.00240)29417053 215GhafouriSA, GhalyanchiLangeroudiA, MaghsoudlooH, FarahaniRKH, AbdollahiH, TehraniF, FallahMH2017Clade 2.3.4.4 avian" exact="influenza" post="A (H5N8) outbreak in commercial poultry, Iran, 2016: the"/>
   <result pre="al.2017Outbreaks among wild birds and domestic poultry caused by reassorted" exact="influenza" post="A(H5N8) clade 2.3.4.4 viruses, Germany, 2016. Emerg. Infect. Dis.23,"/>
   <result pre="633 (10.3201/eid2304.161949)28055819 217PohlmannAet al.2018Swarm incursions of reassortants of highly pathogenic" exact="avian influenza" post="virus strains H5N8 and H5N5, clade 2.3.4.4b, Germany, winter"/>
   <result pre="(10.3201/eid2304.161949)28055819 217PohlmannAet al.2018Swarm incursions of reassortants of highly pathogenic avian" exact="influenza" post="virus strains H5N8 and H5N5, clade 2.3.4.4b, Germany, winter"/>
   <result pre="2016/17. Sci. Rep.8, 15 (10.1038/s41598-017-16936-8)29311555 218NagarajanSet al.2017Novel reassortant highly pathogenic" exact="avian influenza" post="(H5N8) virus in zoos, India. Emerg. Infect. Dis.23, 717â€&quot;719."/>
   <result pre="Sci. Rep.8, 15 (10.1038/s41598-017-16936-8)29311555 218NagarajanSet al.2017Novel reassortant highly pathogenic avian" exact="influenza" post="(H5N8) virus in zoos, India. Emerg. Infect. Dis.23, 717â€&quot;719."/>
   <result pre="219BeerensN, KochG, HeutinkR, HardersF, VriesDPE, HoC, BossersA, ElbersA2018Novel highly pathogenic" exact="avian influenza" post="A(H5N6) virus in the Netherlands, December 2017. Emerg. Infect."/>
   <result pre="KochG, HeutinkR, HardersF, VriesDPE, HoC, BossersA, ElbersA2018Novel highly pathogenic avian" exact="influenza" post="A(H5N6) virus in the Netherlands, December 2017. Emerg. Infect."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6555921\results\search\disease\results.xml">
   <result pre="tree shrew is a promising model for the study of" exact="influenza" post="B virus infection YuanBing506638016@qq.com12YangChunguangyang_cg2140@163.com3XiaXueshanoliverxia2000@aliyun.com4ZaninMarkmark.zanin@gird.cn3WongSook-sansook-san.wong@gird.cn3YangFan64561651@qq.com5ChangJixiangchangjixiang233@163.com5MaiZhitongmzt7513@163.com3ZhaoJinzhaojin34@163.com3ZhangYunhuiyunhuizhang3188@126.com12LiRunfengomega_lee@163.com3ZhongNanshannanshan@vip.163.com3YangZifengjeffyah@163.com36[1], grid.414918.1Department of Respiration, the First"/>
   <result pre="Influenza B virus is a main causative pathogen of annual" exact="influenza" post="epidemics, however, research on influenza B virus in general"/>
   <result pre="main causative pathogen of annual influenza epidemics, however, research on" exact="influenza" post="B virus in general lags behind that on influenza"/>
   <result pre="on influenza B virus in general lags behind that on" exact="influenza" post="A viruses, one of the important reasons is studies"/>
   <result pre="A viruses, one of the important reasons is studies on" exact="influenza" post="B viruses in animal models are limited. Here we"/>
   <result pre="we investigated the tree shrew as a potential model for" exact="influenza" post="B virus studies. Methods Tree shrews and ferrets were"/>
   <result pre="ferrets were inoculated with either a Yamagata or Victoria lineage" exact="influenza" post="B virus. Symptoms including nasal discharge and weight loss"/>
   <result pre="detected at 6DPI in tree shrews. Tree shrews infected with" exact="influenza" post="B virus showed similar seroconversion and respiratory tract pathology"/>
   <result pre="the tree shrew was sensitive to infection and disease by" exact="influenza" post="B virus. Conclusion The tree shrew to be a"/>
   <result pre="Conclusion The tree shrew to be a promising model for" exact="influenza" post="B virus research. Electronic supplementary material The online version"/>
   <result pre="ProvinceD-2017050YuanBing Highlights Ferrets, tree shrews and mice were infected by" exact="influenza" post="B virus strains of Yamagata or Victoria lineage isolated"/>
   <result pre="mortality in BALB/c mice. Viral replication and clinical signs of" exact="influenza" post="were similar between tree shrews and ferrets, although weight"/>
   <result pre="shrews are a useful alternative to ferrets for studies of" exact="influenza" post="B viruses, particularly considering their relatively small size, evolutionary"/>
   <result pre="viruses (IBVs) are one of the main causes of seasonal" exact="influenza" post="cases, accounting for up to 40% of total cases"/>
   <result pre="of total cases [1]. However, during the 2011/2012 and 2015/2016" exact="influenza" post="seasons in China, 53.7 and 52.2% of influenza notifications"/>
   <result pre="and 2015/2016 influenza seasons in China, 53.7 and 52.2% of" exact="influenza" post="notifications were due to IBV infections [2]. There are"/>
   <result pre="(Victoria) and B/Yamagata/16/1988-like (Yamagata). Generally, IBVs cause a less severe" exact="respiratory disease" post="compared to influenza A viruses (IAVs) [3]. However, IBVs"/>
   <result pre="Generally, IBVs cause a less severe respiratory disease compared to" exact="influenza" post="A viruses (IAVs) [3]. However, IBVs cause more complications"/>
   <result pre="to primates compared to ferrets, which are commonly used in" exact="influenza" post="virus research [10, 11]. Tree shrews are also smaller"/>
   <result pre="more cost-effective. Unlike mice, tree shrews display symptoms including fever," exact="rhinitis" post="and mild pneumonia post inoculation with IAVs, and show"/>
   <result pre="mice, tree shrews display symptoms including fever, rhinitis and mild" exact="pneumonia" post="post inoculation with IAVs, and show a distribution of"/>
   <result pre="the tree shrew to two animal models commonly used in" exact="influenza" post="research; ferrets and mice, using two strains of IBVs"/>
   <result pre="Fig. 2 Tree shrews show weight loss post inoculation with" exact="influenza" post="B viruses but ferrets do not. Tree shrews did"/>
   <result pre="up to 10% body weight loss (c) post inoculation with" exact="influenza" post="B viruses. Ferrets inoculated with B/Guangzhou/12/2016 showed a mean"/>
   <result pre="strain B/Guangzhou/0215/2012 (V0215) Fig. 3 Both Yamagata and Victoria lineage" exact="influenza" post="B viruses caused 100% mortality in BALB/c mice. Mice"/>
   <result pre="measured in tree shrews and ferrets 21â€‰days post inoculation with" exact="influenza" post="B viruses Virus Number of animals seroconverted (mean and"/>
   <result pre="V0215 (Fig. 6). Fig. 4 Inoculation of tree shrews with" exact="influenza" post="B viruses causes inflammation in tissues of the respiratory"/>
   <result pre="tissues of the respiratory tracts of tree shrews inoculated with" exact="influenza" post="B virus. Statistically significant differences in fold expression levels"/>
   <result pre="B/Guangzhou/0215/2012 (V0215). **pâ€‰ pâ€‰ Fig. 5 Inoculation of ferrets with" exact="influenza" post="B viruses causes inflammation in tissues of the respiratory"/>
   <result pre="in tissues of the respiratory tracts of ferrets inoculated with" exact="influenza" post="B virus. mRNA expression was detected via real-time PCR"/>
   <result pre="strain B/Guangzhou/0215/2012 (V0215) Fig. 6 Inoculation of BALB/c mice with" exact="influenza" post="B viruses causes inflammation in tissues of the respiratory"/>
   <result pre="in tissues of the respiratory tracts of mice inoculated with" exact="influenza" post="B virus. The Yamagata strain B/Guangzhou/12/2016 elicited greater increases"/>
   <result pre="respiratory tissues obtained from tree shrews inoculated by IBVs revealed" exact="rhinitis" post="and pneumonia in all animals, evident as submucosal hyperemia"/>
   <result pre="obtained from tree shrews inoculated by IBVs revealed rhinitis and" exact="pneumonia" post="in all animals, evident as submucosal hyperemia and focal"/>
   <result pre="inflammatory cells (Figs.Â 7, 8 and 9). Evidence of mild" exact="rhinitis" post="in six of nine tree shrews inoculated with V0215"/>
   <result pre="evident (Fig.Â 7). Two tree shrews showed evidence of moderate" exact="rhinitis" post="and one showed severe rhinitis. Tracheitis, characterized desquamated cilia"/>
   <result pre="mild cases, one moderate case and one severe case of" exact="pneumonia" post="were observed in seven tree shrews inoculated with V0215."/>
   <result pre="V0215. Two mild, three moderate and two severe cases of" exact="pneumonia" post="were observed in nine tree shrews inoculated with Y12."/>
   <result pre="of Ã—â€‰200 Histopathology of respiratory tissues obtained from ferrets revealed" exact="rhinitis" post="and pneumonia in both V0215 and Y12 inoculated ferrets"/>
   <result pre="Histopathology of respiratory tissues obtained from ferrets revealed rhinitis and" exact="pneumonia" post="in both V0215 and Y12 inoculated ferrets at 2,"/>
   <result pre="Y12 inoculated ferrets at 2, 4 and 6DPI. A mild" exact="tracheitis" post="characterized by few desquamated cilia was only evident in"/>
   <result pre="one Y12 inoculated ferret at 2DPI (Fig.Â 8). A moderate" exact="rhinitis" post="characterized by hyperemia and inflammatory cells in the submucosal"/>
   <result pre="in a V0215 inoculated ferret at 2DPI (Fig. 8a). Severe" exact="rhinitis" post="was also observed in a Y12 inoculated ferret at"/>
   <result pre="at 4 and 6DPI (Fig. 8g and m, respectively). Interstitial" exact="pneumonia" post="characterized by pulmonary interstitial thickening filled with inflammatory cells"/>
   <result pre="was observed in both V0215 and Y12 inoculated ferrets. Severe" exact="pneumonia" post="was also observed in a V0215 inoculated ferret at"/>
   <result pre="evidence of inflammation was mild (Fig. 8i and o). Moderate" exact="pneumonia" post="was observed in Y12 inoculated ferrets at 2, 4"/>
   <result pre="inoculated with V0215 or Y12. After inoculation with Y12, interstitial" exact="pneumonia" post="was observed in all but two mice (Fig.Â 9)."/>
   <result pre="five at 4DPI and four at 6DPI. Four mice showed" exact="pneumonia" post="of moderate severity; three at 2DPI and one at"/>
   <result pre="three at 2DPI and one at 6DPI. Two mice showed" exact="pneumonia" post="of mild severity at 2DPI. Of mice inoculated with"/>
   <result pre="in the respiratory tracts of these animals. Ferrets infected with" exact="influenza" post="B virus may have mild respiratory and systemic symptoms,"/>
   <result pre="we observed that the main symptoms in mice infected with" exact="influenza" post="virus include ruffled fur, arched back, shortness of breath"/>
   <result pre="mice infected with influenza virus include ruffled fur, arched back," exact="shortness" post="of breath and malaise. From the analogue comparison of"/>
   <result pre="the main pathogenic mechanism. Previously, it was considered that unadapted" exact="influenza" post="B virus could not be infected or replicated effectively"/>
   <result pre="effectively in laboratory animals such as mice [16, 17], because" exact="influenza" post="B virus exhibit a limited host range and lacked"/>
   <result pre="and mice were susceptible to two lineages of unadapted human" exact="influenza" post="B (V0215 and Y12). The results showed that the"/>
   <result pre="showed that the respiratory tract of these animals infected with" exact="influenza" post="B virus could replicate the virus effectively, which the"/>
   <result pre="period of respiratory viral shedding of tree shrews infected with" exact="influenza" post="B virus were similar to those of ferrets, and"/>
   <result pre="and similar to the respiratory viral shedding symptoms of human" exact="influenza" post="diseases,such as viral shedding time of duration and peak"/>
   <result pre="found differences in susceptibility of three animals to above two" exact="influenza" post="B viruses. There were no significant differences in titers"/>
   <result pre="respiratory tissues obtained from tree shrews inoculated by IBVs revealed" exact="rhinitis" post="and pneumonia in all animals. Because Y12 has longer"/>
   <result pre="obtained from tree shrews inoculated by IBVs revealed rhinitis and" exact="pneumonia" post="in all animals. Because Y12 has longer viral shedding"/>
   <result pre="by pathological examination. The antibody response of hosts infected with" exact="influenza" post="virus is an important immune and epidemic prevention mechanism."/>
   <result pre="is an important immune and epidemic prevention mechanism. Highly virulent" exact="influenza" post="virus strains produce higher antibody titers, which are related"/>
   <result pre="higher antibody titers, which are related to the severity of" exact="influenza" post="infection [24, 25]. A survey of serum antibodies against"/>
   <result pre="influenza infection [24, 25]. A survey of serum antibodies against" exact="influenza" post="viruses in Pennsylvania showed that the titers of antibodies"/>
   <result pre="cytokines and chemokines is the first line of defense against" exact="influenza" post="virus infection and the key factor of the immune"/>
   <result pre="infection and the key factor of the immune pathogenesis of" exact="influenza" post="virus infection in human and animal models [27]. Moderate"/>
   <result pre="[27]. Moderate inflammation can inhibit the replication and transmission of" exact="influenza" post="virus and prevent the development of disease, while excessive"/>
   <result pre="clinical severe pathological injury [28]. Especially in some highly pathogenic" exact="avian influenza" post="patients, excessive inflammation can promote the imbalance of immune"/>
   <result pre="severe pathological injury [28]. Especially in some highly pathogenic avian" exact="influenza" post="patients, excessive inflammation can promote the imbalance of immune"/>
   <result pre="termed a â€œcytokine stormâ€�, leading to multiple organ dysfunction or" exact="acute respiratory distress syndrome" post="[29]. In this study, we detected six cytokines in"/>
   <result pre="suggesting that similar to human infection, tree shrews infected with" exact="influenza" post="can also form a feedback regulation mechanism between pro-inflammatory"/>
   <result pre="B/ Guangzhou/12/2016 We thank Dr. Feng Ye for gift of" exact="influenza" post="B virus B/Guangzhou/12/2016. Funding This work was supported by"/>
   <result pre="published maps and institutional affiliations. References References 1.BurnhamAJBaranovichTGovorkovaEANeuraminidase inhibitors for" exact="influenza" post="B virus infection: efficacy and resistanceAntivir Res2013100252053410.1016/j.antiviral.2013.08.02324013000 2.[Database] World"/>
   <result pre="infection: efficacy and resistanceAntivir Res2013100252053410.1016/j.antiviral.2013.08.02324013000 2.[Database] World Health Organization. Global" exact="influenza" post="surveillance and response system (GISRS). 2018. http://www.who.int/influenza/gisrs_laboratory/en/. 2018. 3.JacksonDElderfieldRABarclayWSMolecular"/>
   <result pre="and response system (GISRS). 2018. http://www.who.int/influenza/gisrs_laboratory/en/. 2018. 3.JacksonDElderfieldRABarclayWSMolecular studies of" exact="influenza" post="B virus in the reverse genetics eraJ Gen Virol20119211710.1099/vir.0.026187-020926635"/>
   <result pre="genetics eraJ Gen Virol20119211710.1099/vir.0.026187-020926635 4.MoonJHNaJYKimJHYumMKOhJWKimCRSeolIJNeurological and muscular manifestations associated with" exact="influenza" post="B infection in childrenPediatr Neurol20134929710110.1016/j.pediatrneurol.2013.04.00423859854 5.FrankH.WittekindC.LiebertU. G.SiekmeyerM.SiekmeyerW.SchusterV.KiessW.Lethal influenza B"/>
   <result pre="associated with influenza B infection in childrenPediatr Neurol20134929710110.1016/j.pediatrneurol.2013.04.00423859854 5.FrankH.WittekindC.LiebertU. G.SiekmeyerM.SiekmeyerW.SchusterV.KiessW.Lethal" exact="influenza" post="B myocarditis in a child and review of the"/>
   <result pre="influenza B infection in childrenPediatr Neurol20134929710110.1016/j.pediatrneurol.2013.04.00423859854 5.FrankH.WittekindC.LiebertU. G.SiekmeyerM.SiekmeyerW.SchusterV.KiessW.Lethal influenza B" exact="myocarditis" post="in a child and review of the literature for"/>
   <result pre="literature for pediatric age groupsInfection201038323123510.1007/s15010-010-0013-420358246 6.HaydenFGJenningsLRobsonRSchiffGJacksonHRanaBMcClellandGIpeDRobertsNWardPOral oseltamivir in human experimental" exact="influenza" post="B infectionAntivir Ther20005320521311075941 7.SatoMSaitoRSatoITanabeNShobugawaYSasakiALiDSuzukiYSakaiTOgumaTTsukadaHGejyoFSuzukiHEffectiveness of oseltamivir treatment among children"/>
   <result pre="B infectionAntivir Ther20005320521311075941 7.SatoMSaitoRSatoITanabeNShobugawaYSasakiALiDSuzukiYSakaiTOgumaTTsukadaHGejyoFSuzukiHEffectiveness of oseltamivir treatment among children with" exact="influenza" post="a or B virus infections during four successive winters"/>
   <result pre="JapanTohoku J Exp Med2008214211312010.1620/tjem.214.11318285668 8.SugayaNMitamuraKYamazakiMTamuraDIchikawaMKimuraKKawakamiCKisoMItoMHatakeyamaSKawaokaYLower clinical effectiveness of oseltamivir against" exact="influenza" post="B contrasted with influenza a infection in childrenClin Infect"/>
   <result pre="8.SugayaNMitamuraKYamazakiMTamuraDIchikawaMKimuraKKawakamiCKisoMItoMHatakeyamaSKawaokaYLower clinical effectiveness of oseltamivir against influenza B contrasted with" exact="influenza" post="a infection in childrenClin Infect Dis200744219720210.1086/50992517173216 9.Tsukiyama-KoharaKKoharaMTupaia belangeri as"/>
   <result pre="shrew provides a useful alternative model for the study of" exact="influenza" post="H1N1 virusVirol J20131011110.1186/1743-422X-10-11123575279 13.YangZFYangCGWangYTPanSHJiangHMLiRFGuanWDStudy on the selection of mouse"/>
   <result pre="13.YangZFYangCGWangYTPanSHJiangHMLiRFGuanWDStudy on the selection of mouse adaptation strain from clinical" exact="influenza" post="B virusJournal of the third military Medical University2014365446449 14.ReedLJMuenchHA"/>
   <result pre="fifty per cent endpointsAm J Epidemiol193827349349710.1093/oxfordjournals.aje.a118408 15.YangZWangYZhongSZhaoSZengXMoZQinSGuanWLiCZhongNIn vitro inhibition of" exact="influenza" post="virus infection by a crude extract from Isatis indigotica"/>
   <result pre="the prevention of viral attachmentMol Med Rep20125379379922179315 16.KimE-HParkS-JKwonH-IKimSMKimY-iSongM-SChoiE-JPascuaPNQChoiY-KMouse adaptation of" exact="influenza" post="B virus increases replication in the upper respiratory tract"/>
   <result pre="in the C-terminal domain of the matrix protein M1 of" exact="influenza" post="B virus confers mouse adaptation and virulenceVirology2005336231832610.1016/j.virol.2005.03.02815892972 18.KitanoMItohYKodamaMIshigakiHNakayamaMNagataTIshidaHTsuchiyaHToriiRBabaKEstablishment of"/>
   <result pre="adaptation and virulenceVirology2005336231832610.1016/j.virol.2005.03.02815892972 18.KitanoMItohYKodamaMIshigakiHNakayamaMNagataTIshidaHTsuchiyaHToriiRBabaKEstablishment of a cynomolgus macaque model of" exact="influenza" post="B virus infectionVirology2010407217818410.1016/j.virol.2010.08.00620822788 19.OsterhausARimmelzwaanGMartinaBBestebroerTFouchierRInfluenza B virus in sealsScience200028854681051105310.1126/science.288.5468.105110807575 20.CarratFVerguEFergusonNMLemaitreMCauchemezSLeachSValleronA-JTime"/>
   <result pre="studiesAm J Epidemiol2008167777578510.1093/aje/kwm37518230677 21.FritzRSHaydenFGCalfeeDPCassLMPengAWAlvordWGStroberWStrausSENasal cytokine and chemokine responses in experimental" exact="influenza" post="a virus infection: results of a placebo-controlled trial of"/>
   <result pre="Infect Dis1999180358659310.1086/31493810438343 22.BodewesRRimmelzwaanGFOsterhausADAnimal models for the preclinical evaluation of candidate" exact="influenza" post="vaccinesExpert Rev Vaccines201091597210.1586/erv.09.14820021306 23.RoweTBannerDFarooquiANgDCKelvinAARubinoSHuangSSHFangYKelvinDJIn vivo ribavirin activity against severe"/>
   <result pre="Rev Vaccines201091597210.1586/erv.09.14820021306 23.RoweTBannerDFarooquiANgDCKelvinAARubinoSHuangSSHFangYKelvinDJIn vivo ribavirin activity against severe pandemic H1N1" exact="influenza" post="a/Mexico/4108/2009J Gen Virol201091122898290610.1099/vir.0.024323-020797971 24.HuangSSBannerDFangYNgDCKanagasabaiTKelvinDJKelvinAAComparative analyses of pandemic H1N1 and"/>
   <result pre="24.HuangSSBannerDFangYNgDCKanagasabaiTKelvinDJKelvinAAComparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and" exact="influenza" post="B infections depict distinct clinical pictures in ferretsPLoS One2011611e2751210.1371/journal.pone.002751222110664"/>
   <result pre="prevention and treatment modalitiesAnn Pharmacother200943122001201110.1345/aph.1M55719920156 26.RossTMHairongLChiaBSHillEWeirbackHZimmerSPrevalence of antibodies against seasonal" exact="influenza" post="a and B viruses during the 2009-2010 and 2010-2011"/>
   <result pre="influenza a and B viruses during the 2009-2010 and 2010-2011" exact="influenza" post="seasons in residents of Pittsburgh, PA, USAPLoS Curr20113RRN126510.1371/currents.RRN126522037352 27.Nagaoka,"/>
   <result pre="and Tsukahara, H. (2017). Local and systemic immune responses to" exact="influenza" post="a virus infection in pneumonia and encephalitis mouse models."/>
   <result pre="and systemic immune responses to influenza a virus infection in" exact="pneumonia" post="and encephalitis mouse models. Dis Markers 2017, 2594231. 28.La"/>
   <result pre="immune responses to influenza a virus infection in pneumonia and" exact="encephalitis" post="mouse models. Dis Markers 2017, 2594231. 28.La GrutaNLKedzierskaKStambasJDohertyPCA question"/>
   <result pre="Markers 2017, 2594231. 28.La GrutaNLKedzierskaKStambasJDohertyPCA question of self-preservation: immunopathology in" exact="influenza" post="virus infectionImmunol Cell Biol2007852859210.1038/sj.icb.710002617213831 29.de JongMDSimmonsCPThanhTTHienVMSmithGJChauTNHoangDMChauNVKhanhTHDongVCQuiPTCamBVHa doQGuanYPeirisJSChinhNTHienTTFarrarJFatal outcome of"/>
   <result pre="virus infectionImmunol Cell Biol2007852859210.1038/sj.icb.710002617213831 29.de JongMDSimmonsCPThanhTTHienVMSmithGJChauTNHoangDMChauNVKhanhTHDongVCQuiPTCamBVHa doQGuanYPeirisJSChinhNTHienTTFarrarJFatal outcome of human" exact="influenza" post="a (H5N1) is associated with high viral load and"/>
   <result pre="response in the respiratory tract of ferrets following infection with" exact="influenza" post="a and B virusesJ Virol20159062838284810.1128/JVI.02797-1526719259 32.Garcia-RamirezRARamirez-VenegasAQuintana-CarrilloRCamarenaAEFalfan-ValenciaRMejia-ArangureJMTNF, IL6, and IL1B"/>
   <result pre="Virol20159062838284810.1128/JVI.02797-1526719259 32.Garcia-RamirezRARamirez-VenegasAQuintana-CarrilloRCamarenaAEFalfan-ValenciaRMejia-ArangureJMTNF, IL6, and IL1B polymorphisms are associated with severe" exact="influenza" post="a (H1N1) virus infection in the Mexican populationPLoS One20151012e014483210.1371/journal.pone.014483226657940"/>
   <result pre="infection in the Mexican populationPLoS One20151012e014483210.1371/journal.pone.014483226657940 33.ZhouJWangDGaoRZhaoBSongJQiXZhangYShiYYangLZhuWBaiTQinKLanYZouSGuoJDongJDongLWeiHLiXLuJLiuLZhaoXHuangWWenLBoHXinLChenYXuCPeiYYangYZhangXWangSFengZHanJYangWGaoGFWuGLiDWangYShuYBiological features of novel" exact="avian influenza" post="a (H7N9) virusNature2013499745950050310.1038/nature1237923823727 34.BlackwellTSChristmanJWSepsis and cytokines: current statusBr J"/>
   <result pre="in the Mexican populationPLoS One20151012e014483210.1371/journal.pone.014483226657940 33.ZhouJWangDGaoRZhaoBSongJQiXZhangYShiYYangLZhuWBaiTQinKLanYZouSGuoJDongJDongLWeiHLiXLuJLiuLZhaoXHuangWWenLBoHXinLChenYXuCPeiYYangYZhangXWangSFengZHanJYangWGaoGFWuGLiDWangYShuYBiological features of novel avian" exact="influenza" post="a (H7N9) virusNature2013499745950050310.1038/nature1237923823727 34.BlackwellTSChristmanJWSepsis and cytokines: current statusBr J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6557625\results\search\disease\results.xml">
   <result pre="ANP32B, or not to be, that is the question for" exact="influenza" post="virus BakerSteven Fhttps://orcid.org/0000-0001-8379-283X*MehleAndrewhttps://orcid.org/0000-0001-6060-4330amehle@wisc.edu*[], Department of Medical Microbiology and ImmunologyUniversity"/>
   <result pre="credited.elife-48084.pdf Abstract The evolutionary history of ANP32 proteins impacts how" exact="influenza" post="virus jumps from birds to mammals. influenza ANP32A ANP32B"/>
   <result pre="proteins impacts how influenza virus jumps from birds to mammals." exact="influenza" post="ANP32A ANP32B polymerase host specificity evolution Research organism Chicken"/>
   <result pre="2019. Species specific differences in use of ANP32 proteins by" exact="influenza" post="A virus. eLife8:e45066. doi: 10.7554/eLife.45066 Every year, the influenza"/>
   <result pre="by influenza A virus. eLife8:e45066. doi: 10.7554/eLife.45066 Every year, the" exact="influenza" post="A virus causes flu epidemics around the world, and"/>
   <result pre="produce new virions to infect more cells. Diverse populations of" exact="influenza" post="A viruses circulate in birds, their natural reservoir, before"/>
   <result pre="replicating, is less well understood. Looking into the ways that" exact="influenza" post="A virus infects new species, and how the hosts"/>
   <result pre="offers a glimpse into complex evolutionary processes in action. The" exact="influenza" post="polymerase is a complex formed of three proteins including"/>
   <result pre="Different species bear different ANP32 proteins. The polymerase of the" exact="influenza" post="A virus adapts to the ANP32 proteins that are"/>
   <result pre="In humans, ANP32A, 32B and 32E are present, and the" exact="influenza" post="virus can use either ANP32A or ANP32B to support"/>
   <result pre="In chicken, ANP32A, 32B and 32E are present, and the" exact="influenza" post="virus relies exclusively on ANP32A (red circle). Open circles"/>
   <result pre="ANP32 proteins and their potential role in the evolution of" exact="influenza" post="viruses. Now, in eLife, Barclay and colleagues at Imperial"/>
   <result pre="ANP32A and ANP32B have a redundant role in helping the" exact="influenza" post="virus to replicate in human cells. The double-knockout of"/>
   <result pre="chicken ANP32A. How ANP32 proteins support the activity of the" exact="influenza" post="polymerase also remains to be elucidated. In addition, it"/>
   <result pre="the current studies would predict to be non-functional for the" exact="influenza" post="virus. Instead, the mouse variant of ANP32B that has"/>
   <result pre="distant from rodents and which has no obvious history with" exact="influenza" post="virus. &quot;For who would bear the whips of scorn"/>
   <result pre="References References AlmondJW1977A single gene determines the host range of" exact="influenza" post="virusNature27061761810.1038/270617a0593388 BakerSFLedwithMPMehleA2018Differential splicing of ANP32A in birds alters its"/>
   <result pre="birds alters its ability to stimulate RNA synthesis by restricted" exact="influenza" post="polymeraseCell Reports242581258810.1016/j.celrep.2018.08.01230184493 DominguesPHaleBG2017Functional insights into ANP32A-dependent influenza A virus"/>
   <result pre="synthesis by restricted influenza polymeraseCell Reports242581258810.1016/j.celrep.2018.08.01230184493 DominguesPHaleBG2017Functional insights into ANP32A-dependent" exact="influenza" post="A virus polymerase host restrictionCell Reports202538254610.1016/j.celrep.2017.08.06128903035 LongJSGiotisESMoncorgÃ©OFriseRMistryBJamesJMorissonMIqbalMVignalASkinnerMABarclayWS2016Species difference in"/>
   <result pre="virus polymerase host restrictionCell Reports202538254610.1016/j.celrep.2017.08.06128903035 LongJSGiotisESMoncorgÃ©OFriseRMistryBJamesJMorissonMIqbalMVignalASkinnerMABarclayWS2016Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restrictionNature52910110410.1038/nature1647426738596 LongJSMistryBHaslamSMBarclayWS2019aHost and viral determinants"/>
   <result pre="A virus polymerase host restrictionNature52910110410.1038/nature1647426738596 LongJSMistryBHaslamSMBarclayWS2019aHost and viral determinants of" exact="influenza" post="A virus species specificityNature Reviews Microbiology17678110.1038/s41579-018-0115-z30487536 LongJSIdoko-AkohAMistryBGoldhillDStallerESchreyerJRossCGoodbournSSheltonHSkinnerMASangHMcGrewMJBarclayW2019bSpecies specific differences"/>
   <result pre="Microbiology17678110.1038/s41579-018-0115-z30487536 LongJSIdoko-AkohAMistryBGoldhillDStallerESchreyerJRossCGoodbournSSheltonHSkinnerMASangHMcGrewMJBarclayW2019bSpecies specific differences in use of ANP32 proteins by" exact="influenza" post="A viruseLife8e4506610.7554/eLife.4506631159925 SubbaraoEKLondonWMurphyBR1993A single amino acid in the PB2"/>
   <result pre="viruseLife8e4506610.7554/eLife.4506631159925 SubbaraoEKLondonWMurphyBR1993A single amino acid in the PB2 gene of" exact="influenza" post="A virus is a determinant of host rangeJournal of"/>
   <result pre="of Virology67176117648445709 SugiyamaKKawaguchiAOkuwakiMNagataK2015pp32 and APRIL are host cell-derived regulators of" exact="influenza" post="virus RNA synthesis from cRNAeLife4e0893910.7554/eLife.0893926512887 Te VelthuisAJFodorE2016Influenza virus RNA"/>
   <result pre="contribution and host range determination of ANP32A and ANP32B in" exact="influenza" post="A virus polymerase activityJournal of VirologyJVI.00174-1910.1128/JVI.00174-1930996088"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6559644\results\search\disease\results.xml">
   <result pre="and Life Sciences : Organisms : Viruses: Arboviruses Circulation of" exact="chikungunya" post="virus East/Central/South African lineage in Rio de Janeiro, Brazil"/>
   <result pre="original author and source are credited.pone.0217871.pdf Abstract The emergence of" exact="chikungunya" post="virus (CHIKV) has raised serious concerns due to the"/>
   <result pre="a later chronic condition, with persistent or relapse symptoms of" exact="arthropathy" post="[7]. As the majority of CHIKV infected patients are"/>
   <result pre="and establishment in the region. Thus, to better understand the" exact="chikungunya" post="outbreak in Rio de Janeiro, we generated 11 near-complete"/>
   <result pre="November 2015 [23, 24]. Fig 3 shows the number of" exact="chikungunya" post="cases weekly notified in the north-eastern region, the south-eastern"/>
   <result pre="the north-eastern and south-eastern regions of Brazil, 2015â€&quot;2018. Number of" exact="chikungunya" post="fever cases by epidemiological week registered in the north-eastern"/>
   <result pre="the northeast region. Fig 3 also shows an increase in" exact="chikungunya" post="number of cases registered in Rio de Janeiro in"/>
   <result pre="Brazil has witnessed since 1928 [30]. By analyzing 64 new" exact="yellow fever" post="virus genomes the virus transmission pattern was revealed to"/>
   <result pre="mosquito-borne viruses. Supporting information S1 Fig Maximum likelihood phylogeny of" exact="chikungunya" post="virus. (TIF) LINK Click here for additional data file."/>
   <result pre="GreigJ, NgV, et al.A scoping review of published literature on" exact="chikungunya" post="virus. PLoS One. 2018;13(11):e020755410.1371/journal.pone.020755430496207 3collab: PAHO/WHO. NÃºmero de casos"/>
   <result pre="PLoS One. 2018;13(11):e020755410.1371/journal.pone.020755430496207 3collab: PAHO/WHO. NÃºmero de casos reportados de" exact="chikungunya" post="en paÃ­ses o territorios de las AmÃ©ricas 2017. Regional"/>
   <result pre="2017. 4Brasil. Boletim EpidemiolÃ³gicoâ€&quot;Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e doenÃ§a aguda pelo vÃ­rus Zika atÃ© a Semana"/>
   <result pre="11SchuffeneckerI, ItemanI, MichaultA, MurriS, FrangeulL, VaneyMC, et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3(7):e26310.1371/journal.pmed.003026316700631"/>
   <result pre="(Maywood). 2011;236(8):909â€&quot;14.21750019 13TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog."/>
   <result pre="10.3201/eid2310.17030728930031 18CunhaMDP, SantosCAD, NetoDFL, SchanoskiAS, PourSZ, PassosSD, et al.Outbreak of" exact="chikungunya" post="virus in a vulnerable population of Sergipe, Brazil-A molecular"/>
   <result pre="22Brasil. Boletim EpidemiolÃ³gico. Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e febre pelo vÃ­rus Zika atÃ© a Semana EpidemiolÃ³gica"/>
   <result pre="2. 23Brasil. Boletim EpidemiolÃ³gico. Monitoramento dos casos dedengue, febre de" exact="chikungunya" post="efebre pelo vÃ­rus Zika atÃ© a SemanaEpidemiolÃ³gica 47, 2015."/>
   <result pre="de JesusJ, AguiarRS, IaniFCM, et al.Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potential. Science. 2018;361(6405):894â€&quot;9. 10.1126/science.aat711530139911 31QuickJ, GrubaughND, PullanST,"/>
   <result pre="43Brasil. Boletim EpidemiolÃ³gico. Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e febre pelo vÃ­rus Zika atÃ© a Semana EpidemiolÃ³gica"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6560071\results\search\disease\results.xml">
   <result pre="vaccine candidates for WNV (Merino-Ramos etÂ al., 2014), tick-borne virus" exact="encephalitis" post="(Heinz etÂ al., 1995), Japanese encephalitis virus (Hunt etÂ"/>
   <result pre="al., 2014), tick-borne virus encephalitis (Heinz etÂ al., 1995), Japanese" exact="encephalitis" post="virus (Hunt etÂ al., 2001), and Murray Valley encephalitis"/>
   <result pre="Japanese encephalitis virus (Hunt etÂ al., 2001), and Murray Valley" exact="encephalitis" post="virus (Kroeger and McMinn, 2002) in the mouse model."/>
   <result pre="in the immediate defense of disseminated infection by West Nile" exact="encephalitis" post="virus. J. Virol.77, 2578â€&quot;2586. 10.1128/JVI.77.4.2578-2586.2003, PMID: 12551996 DochertyD. E.LongR."/>
   <result pre="Recombinant and virion-derived soluble and particulate immunogens for vaccination against" exact="tick-borne encephalitis." post="Vaccine13, 1636â€&quot;1642. 10.1016/0264-410X(95)00133-L, PMID: 8719513 HintonM. G.ReisenW. K.WheelerS. S.TownsendA."/>
   <result pre="R.CroppC. B.ChangG. J. (2001). A recombinant particulate antigen of Japanese" exact="encephalitis" post="virus produced in stably-transformed cells is an effective noninfectious"/>
   <result pre="311â€&quot;322. 10.3201/eid0903.020628, PMID: 12643825 KroegerM. A.McMinnP. C. (2002). Murray Valley" exact="encephalitis" post="virus recombinant subviral particles protect mice from lethal challenge"/>
   <result pre="PMID: 16023273 SwayneD. E.BeckJ. R.SmithC. S.ShiehW. J.ZakiS. R. (2001). Fatal" exact="encephalitis" post="and myocarditis in young domestic geese (Anser anser domesticus)"/>
   <result pre="SwayneD. E.BeckJ. R.SmithC. S.ShiehW. J.ZakiS. R. (2001). Fatal encephalitis and" exact="myocarditis" post="in young domestic geese (Anser anser domesticus) caused by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6560413\results\search\disease\results.xml">
   <result pre="current knowledge for each of them and in comparison to" exact="chikungunya" post="virus. alphaviruses chikungunya virus Mayaro virus Oâ€™nyongâ€™nyong virus Ross"/>
   <result pre="each of them and in comparison to chikungunya virus. alphaviruses" exact="chikungunya" post="virus Mayaro virus Oâ€™nyongâ€™nyong virus Ross River virus 1."/>
   <result pre="rheumatic tropism. The latter, also called arthritogenic alphaviruses, notably include" exact="chikungunya" post="virus (CHIKV), now widely distributed, Oâ€™nyongâ€™nyong virus (ONNV) located"/>
   <result pre="Description and Main Epidemics 2.1. Chikungunya Virus Robinson first described" exact="chikungunya" post="fever in 1955, after an epidemic of dengue-like fever"/>
   <result pre="which bends upâ€� describing this particular clinical manifestation. Three main" exact="chikungunya" post="virus genotypes, named after their original geographical distribution, are"/>
   <result pre="Asian genotypes (that include the Caribbean strains) [8,9]. Before 2000," exact="chikungunya" post="virus had been circulating mainly in Sub-Saharan Africa (Zimbabwe"/>
   <result pre="been reported. Since then, two worldwide epidemics occurred that pushed" exact="chikungunya" post="virus into the spotlight. The first epidemic, caused by"/>
   <result pre="described by Robinson [7]) with possible synovitis, and a delayed" exact="rash" post="that is often pruriginous while rarely bullous [128,163,164]. Less"/>
   <result pre="severe or lethal cases were questioned because of co-circulation with" exact="dengue fever" post="[19,129,165,166], it is now clearly established that CHIKV infection"/>
   <result pre="infection and is mostly located in the cervical region. Skin" exact="rash" post="is associated a few days later and is often"/>
   <result pre="(ranging between three and 21 days [75,169]). Fever polyarthralgia and" exact="rash" post="are, as is the case for the other rheumatic"/>
   <result pre="mentioned in case reports [72,170]. Severe forms of infection include" exact="glomerulonephritis" post="[158] and encephalitis [159,160,161], but to our knowledge, no"/>
   <result pre="reports [72,170]. Severe forms of infection include glomerulonephritis [158] and" exact="encephalitis" post="[159,160,161], but to our knowledge, no lethality has been"/>
   <result pre="it is important to differentiate chronic inflammatory rheumatism causing erosive" exact="arthritis" post="[131] and for which the differential diagnosis is rheumatoid"/>
   <result pre="erosive arthritis [131] and for which the differential diagnosis is" exact="rheumatoid arthritis," post="from musculoskeletal disorder. Indeed, whereas the latter is only"/>
   <result pre="in vitro and in vivo data suggest that post-RRV infection" exact="arthritis" post="may be erosive [182,183]. 5. Laboratory Features 5.1. Standard"/>
   <result pre="live-attenuated vaccines [205,206], recombinant virus vaccines (measles virus [207,208,209], vesicular" exact="stomatitis" post="virus [210,211]), inactivated vaccines [212,213], virus-like particles (VLPs) [214,215,216],"/>
   <result pre="Phase II clinical trials. The first one is a recombinant" exact="measles" post="virus encoding the CHIKV structural proteins. The first results"/>
   <result pre="after two injections (regardless of the individualâ€™s immunological status against" exact="measles" post="virus) and excellent safety and tolerability [209]. The second"/>
   <result pre="to 10 million cases all together during the 21st Century," exact="chikungunya" post="virus is undoubtedly a re-emerged disease threatening both tropical"/>
   <result pre="virus is responsible. Indeed, despite some virus-specific trends such as" exact="lymphadenopathy" post="for ONNV, arthritogenic alphaviruses share very similar clinical manifestations"/>
   <result pre="interest. References References 1.SuhrbierA.Jaffar-BandjeeM.-C.GasqueP.Arthritogenic alphavirusesâ€&quot;An overviewNat. Rev. Rheumatol.2012842042910.1038/nrrheum.2012.6422565316 2.ChretienJ.-P.AnyambaA.BednoS.A.BreimanR.F.SangR.SergonK.PowersA.M.OnyangoC.O.SmallJ.TuckerC.J.et al.Drought-associated" exact="chikungunya" post="emergence along coastal east africaAm. J. Trop. Med. Hyg.20077640540710.4269/ajtmh.2007.76.40517360859"/>
   <result pre="territory, in 1952-1953Trans. R. Soc. Trop. Med. Hyg.195549283210.1016/0035-9203(55)90080-814373834 8.PowersA.M.TeshR.B.BraultA.C.WeaverS.C.Re-emergence of" exact="chikungunya" post="and Oâ€™nyongâ€™nyong viruses: Evidence for distinct geographical lineages and"/>
   <result pre="the Chikungunya virusBull. World Health Organ.19734937404545155 14.FourieE.D.MorrisonJ.G.Rheumatoid arthritic syndrome after" exact="chikungunya" post="feverS. Afr. Med. J.197956130132494034 15.Muyembe-TamfumJ.J.PeyrefitteC.N.YogoleloR.Mathina BasisyaE.KoyangeD.PukutaE.MashakoM.TolouH.DurandJ.P.[Epidemic of Chikungunya virus"/>
   <result pre="of haemorrhagic fever in calcutta: Isolation of three strains of" exact="chikungunya" post="virusIndian J. Med. Res.19645267668314195507 21.MunasingheD.R.AmarasekeraP.J.FernandoC.F.O.An epidemic of dengue-like fever"/>
   <result pre="Trop. Med. Public Health20043540841515691147 27.LarasK.SukriN.C.LarasatiR.P.BangsM.J.KosimR.DjauziWandraT.MasterJ.KosasihH.HartatiS.et al.Tracking the re-emergence of epidemic" exact="chikungunya" post="virus in IndonesiaTrans. R. Soc. Trop. Med. Hyg.20059912814110.1016/j.trstmh.2004.03.01315693148 28.SimonF.TolouH.JeandelP.Chikungunya,"/>
   <result pre="Can DoAvailable online: https://www.nejm.org/doi/10.1056/NEJMp1407698?url_ver=Z39.88-2003&amp;amp;rfr_id=ori%3Arid%3Acrossref.org&amp;amp;rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov(accessed on 14 March 2019) 31.CassadouS.BoucauS.Petit-SinturelM.HucP.Leparc-GoffartI.LedransM.Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin island,"/>
   <result pre="Saint Martin island, October to December 2013Eurosurveillance2014192075210.2807/1560-7917.ES2014.19.13.2075224721536 32.RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA.C.PanningM.CordioliP.FortunaC.BorosS.MaguranoF.et al.Infection with" exact="chikungunya" post="virus in Italy: An outbreak in a temperate regionLancet"/>
   <result pre="regionLancet Lond. Engl.20073701840184610.1016/S0140-6736(07)61779-6 33.ManicaM.GuzzettaG.PolettiP.FilipponiF.SoliminiA.CaputoB.Della TorreA.RosÃ R.MerlerS.Transmission dynamics of the ongoing" exact="chikungunya" post="outbreak in Central Italy: From coastal areas to the"/>
   <result pre="of Rome, summer 2017Eurosurveillance20172217-0068510.2807/1560-7917.ES.2017.22.44.17-00685 34.VenturiG.Di LucaM.FortunaC.RemoliM.E.RiccardoF.SeveriniF.TomaL.Del MansoM.BenedettiE.CaporaliM.G.et al.Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017Eurosurveillance20172210.2807/1560-7917.ES.2017.22.39.17-0064629019306 35.AngeliniR.FinarelliA.C.AngeliniP.PoC.PetropulacosK.SilviG.MaciniP.FortunaC.VenturiG.MaguranoF.et"/>
   <result pre="September to October 2014Eurosurveillance20152010.2807/1560-7917.ES2015.20.17.21108 37.CalbaC.Guerbois-GallaM.FrankeF.JeanninC.Auzet-CaillaudM.GrardG.PigaglioL.DecoppetA.WeicherdingJ.SavaillM.-C.et al.Preliminary report of an autochthonous" exact="chikungunya" post="outbreak in France, July to September 2017Eurosurveillance20172210.2807/1560-7917.ES.2017.22.39.17-00647 38.HaddowA.J.DaviesC.W.WalkerA.J.Oâ€™nyongâ€™nyong fever:"/>
   <result pre="January to March 2002Commun. Dis. Intell.200428261266 71.KnopeK.MullerM.KuruczN.DoggettS.FeldmanR.JohansenC.HobbyM.BennettS.LynchS.SlyA.et al.Arboviral diseases and" exact="malaria" post="in Australia, 2013-14: Annual report of the National Arbovirus"/>
   <result pre="THE COOK ISLANDSAm. J. Trop. Med. Hyg.1981301294130210.4269/ajtmh.1981.30.12947325286 76.HalsteadS.B.UdomsakdiS.Vertebrate hosts of" exact="chikungunya" post="virusBull. World Health Organ.1966358920604287 77.EastwoodG.SangR.C.GuerboisM.TarachaE.L.N.WeaverS.C.Enzootic Circulation of Chikungunya Virus"/>
   <result pre="Non-human Kenyan PrimatesAm. J. Trop. Med. Hyg.2017971399140410.4269/ajtmh.17-012629016323 78.WeinbrenM.HaddowA.WilliamsM.The occurrence of" exact="chikungunya" post="virus in Uganda I. Isolation from mosquitoesTrans. R. Soc."/>
   <result pre="epidemiologyTrans. R. Soc. Trop. Med. Hyg.195549335710.1016/0035-9203(55)90081-X14373835 83.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.-C.LavenirR.PardigonN.ReynesJ.-M.PettinelliF.et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 84.VazeilleM.MoutaillerS.CoudrierD.RousseauxC.KhunH.HuerreM.ThiriaJ.DehecqJ.-S.FontenilleD.SchuffeneckerI.et al.Two"/>
   <result pre="in the mosquito, Aedes albopictusPLoS ONE20072e116810.1371/journal.pone.000116818000540 85.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 86.KadingR.C.BorlandE.M.CranfieldM.PowersA.M.Prevalence"/>
   <result pre="DistrictAm. J. Trop. Med. Hyg.19996115816210.4269/ajtmh.1999.61.15810432073 90.VanlandinghamD.L.HongC.KlinglerK.TsetsarkinK.McElroyK.L.PowersA.M.LehaneM.J.HiggsS.Differential infectivities of Oâ€™nyongâ€™nyong and" exact="chikungunya" post="virus isolates in Anopheles gambiae and Aedes aegypti mosquitoesAm."/>
   <result pre="albopictus from Houston, Texas, for dengue serotypes 1 to 4," exact="yellow fever" post="and Ross River virusesJ. Am. Mosq. Control Assoc.198734604652849638 114.MitchellC.J.GublerD.J.Vector"/>
   <result pre="2005 to 2007Transfusion2008481333134110.1111/j.1537-2995.2008.01646.x18298600 119.SimonF.JavelleE.CabieA.BouquillardE.TroisgrosO.GentileG.Leparc-GoffartI.HoenB.GandjbakhchF.Rene-CorailP.et al.French guidelines for the management of" exact="chikungunya" post="(acute and persistent presentations). November 2014MÃ©decine Mal. Infect.20154524326310.1016/j.medmal.2015.05.007 120.AubryM.TeissierA.HuartM.MerceronS.VanhomwegenJ.MapotoekeM.Mariteragi-HelleT.RocheC.VialA.-L.TeururaiS.et"/>
   <result pre="French Polynesia, 2014â€&quot;2015Emerg. Infect. Dis.20182455856110.3201/eid2403.17114929460745 121.YoonI.-K.AleraM.T.LagoC.B.Tac-AnI.A.VillaD.FernandezS.ThaisomboonsukB.KlungthongC.LevyJ.W.VelascoJ.M.et al.High rate of subclinical" exact="chikungunya" post="virus infection and association of neutralizing antibody with protection"/>
   <result pre="157 Adult PatientsClin. Infect. Dis.2007441401140710.1086/51753717479933 129.ThiruvengadamK.V.KalyanasundaramV.RajgopalJ.Clinical and pathological studies on" exact="chikungunya" post="fever in Madras cityIndian J. Med. Res.1965537297445830407 130.CouturierE.GuilleminF.MuraM.LÃ©onL.VirionJ.-M.LetortM.-J.De ValkH.SimonF.VaillantV.Impaired"/>
   <result pre="cityIndian J. Med. Res.1965537297445830407 130.CouturierE.GuilleminF.MuraM.LÃ©onL.VirionJ.-M.LetortM.-J.De ValkH.SimonF.VaillantV.Impaired quality of life after" exact="chikungunya" post="virus infection: A 2-year follow-up studyRheumatology2012511315132210.1093/rheumatology/kes01522427407 131.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.SudeepA.B.MuruganandamN.ChaitanyaI.K.GuruprasadD.R.Clinical progression of"/>
   <result pre="chikungunya virus infection: A 2-year follow-up studyRheumatology2012511315132210.1093/rheumatology/kes01522427407 131.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.SudeepA.B.MuruganandamN.ChaitanyaI.K.GuruprasadD.R.Clinical progression of" exact="chikungunya" post="fever during acute and chronic arthritic stages and the"/>
   <result pre="in American soldiers in VietnamAnn. Intern. Med.1967661129114310.7326/0003-4819-66-6-11295338939 137.VijayakumarK.P.AnishT.S.N.GeorgeB.LawrenceT.MuthukkuttyS.C.RamachandranR.Clinical profile of" exact="chikungunya" post="patients during the epidemic of 2007 in Kerala, IndiaJ."/>
   <result pre="2007 in Kerala, IndiaJ. Glob. Infect. Dis.2011322121887052 138.ZingmanM.A.PaulinoA.T.PayanoM.P.Clinical manifestations of" exact="chikungunya" post="among university professors and staff in Santo Domingo, the"/>
   <result pre="fever presenting with acute optic neuropathyBMJ Case Rep.20152015bcr201521008110.1136/bcr-2015-210081 154.MaitiC.R.MukherjeeA.K.BoseB.SahaG.L.Myopericarditis following" exact="chikungunya" post="virus infectionJ. Indian Med. Assoc.197870256258712084 155.ObeyesekereI.HermonY.Arbovirus heart disease: Myocarditis"/>
   <result pre="virus infectionJ. Indian Med. Assoc.197870256258712084 155.ObeyesekereI.HermonY.Arbovirus heart disease: Myocarditis and" exact="cardiomyopathy" post="following dengue and chikungunya feverâ€&quot;A follow-up studyAm. Heart J.19738518619410.1016/0002-8703(73)90459-64688831"/>
   <result pre="Assoc.197870256258712084 155.ObeyesekereI.HermonY.Arbovirus heart disease: Myocarditis and cardiomyopathy following dengue and" exact="chikungunya" post="feverâ€&quot;A follow-up studyAm. Heart J.19738518619410.1016/0002-8703(73)90459-64688831 156.DorlÃ©ansF.HoenB.NajioullahF.Herrmann-StorckC.SchepersK.M.AbelS.LamauryI.FagourL.CÃ©saireR.GuyomardS.et al.Outbreak of Chikungunya"/>
   <result pre="Ross River virus disease (epidemic polyarthritis)Clin. Nephrol.1988291491522834127 159.ScrimgeourE.M.AaskovJ.G.MatzL.R.Ross River virus" exact="arthritis" post="in Papua New GuineaTrans. R. Soc. Trop. Med. Hyg.19878183383410.1016/0035-9203(87)90045-92835834"/>
   <result pre="GuineaTrans. R. Soc. Trop. Med. Hyg.19878183383410.1016/0035-9203(87)90045-92835834 160.ScrimgeourE.M.Suspected Ross River virus" exact="encephalitis" post="in Papua New GuineaAust. N. Z. J. Med.19992955910.1111/j.1445-5994.1999.tb00759.x10868536 161.LucasR.E.QiaoM.A"/>
   <result pre="Papua New GuineaAust. N. Z. J. Med.19992955910.1111/j.1445-5994.1999.tb00759.x10868536 161.LucasR.E.QiaoM.A case of" exact="encephalitis" post="in central Australia due to Ross River virus?Aust. N."/>
   <result pre="Pediatr.2010169677210.1007/s00431-009-0986-019401826 164.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of" exact="chikungunya" post="fever: A case seriesPediatr. Dermatol.20183539239610.1111/pde.1345029573443 165.JadhavM.NamboodripadM.CarmanR.H.CareyD.E.MyersR.M.Chikungunya disease in infants"/>
   <result pre="virologically proved casesIndian J. Med. Res.1965537647765830895 166.De RanitzC.M.MyersR.M.VarkeyM.J.IsaacZ.H.CareyD.E.Clinical impressions of" exact="chikungunya" post="in Vellore gained from study of adult patientsIndian J."/>
   <result pre="studyPLoS Negl. Trop. Dis.20137e213710.1371/annotation/850ee20f-2641-46ac-b0c6-ef4ae79b6de623556021 174.BouquillardÃ‰.CombeB.A report of 21 cases of" exact="rheumatoid arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint"/>
   <result pre="Negl. Trop. Dis.20137e213710.1371/annotation/850ee20f-2641-46ac-b0c6-ef4ae79b6de623556021 174.BouquillardÃ‰.CombeB.A report of 21 cases of rheumatoid" exact="arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint"/>
   <result pre="Region, 2006Emerg. Infect. Dis.20081441642210.3201/eid1403.07090618325256 185.AppassakijH.KhuntikijP.KemapunmanusM.WutthanarungsanR.SilpapojakulK.Viremic profiles in asymptomatic and symptomatic" exact="chikungunya" post="fever: A blood transfusion threat?Transfusion2013532567257410.1111/j.1537-2995.2012.03960.x23176378 186.Acosta-AmpudiaY.MonsalveD.M.RodrÃ­guezY.PachecoY.AnayaJ.-M.RamÃ­rez-SantanaC.Mayaro: An emerging viral"/>
   <result pre="Kinetics of Zika and Chikungunya Viruses, BrazilEmerg. Infect. Dis.20192531131510.3201/eid2502.18016630666934 192.MalvyD.EzzedineK.Mamani-MatsudaM.AutranB.TolouH.ReceveurM.-C.PistoneT.RambertJ.MoynetD.MossalayiD.Destructive" exact="arthritis" post="in a patient with chikungunya virus infection with persistent"/>
   <result pre="Viruses, BrazilEmerg. Infect. Dis.20192531131510.3201/eid2502.18016630666934 192.MalvyD.EzzedineK.Mamani-MatsudaM.AutranB.TolouH.ReceveurM.-C.PistoneT.RambertJ.MoynetD.MossalayiD.Destructive arthritis in a patient with" exact="chikungunya" post="virus infection with persistent specific IgM antibodiesBMC Infect. Dis.2009920010.1186/1471-2334-9-20020003320"/>
   <result pre="individual and community mitigation measures for prevention and control of" exact="chikungunya" post="virusPLoS ONE201914e021205410.1371/journal.pone.021205430811438 201.KuruczN.JacupsS.CarterJ.M.Determining Culex annulirostris larval densities and control"/>
   <result pre="Infect. Dis.2016214S488S49610.1093/infdis/jiw27127920179 205.EdelmanR.TacketC.O.WassermanS.S.BodisonS.A.PerryJ.A.PerryJ.G.Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218Am. J. Trop. Med. Hyg.20006268168510.4269/ajtmh.2000.62.68111304054 206.WangE.VolkovaE.AdamsA.P.ForresterN.XiaoS.-Y.FrolovI.WeaverS.C.Chimeric alphavirus"/>
   <result pre="Med. Hyg.20006268168510.4269/ajtmh.2000.62.68111304054 206.WangE.VolkovaE.AdamsA.P.ForresterN.XiaoS.-Y.FrolovI.WeaverS.C.Chimeric alphavirus vaccine candidates for chikungunyaVaccine2008265030503910.1016/j.vaccine.2008.07.05418692107 207.BrandlerS.RuffiÃ©C.CombredetC.BraultJ.-B.NajburgV.PrevostM.-C.HabelA.TauberE.DesprÃ¨sP.TangyF.A recombinant" exact="measles" post="vaccine expressing chikungunya virus-like particles is strongly immunogenic and"/>
   <result pre="alphavirus vaccine candidates for chikungunyaVaccine2008265030503910.1016/j.vaccine.2008.07.05418692107 207.BrandlerS.RuffiÃ©C.CombredetC.BraultJ.-B.NajburgV.PrevostM.-C.HabelA.TauberE.DesprÃ¨sP.TangyF.A recombinant measles vaccine expressing" exact="chikungunya" post="virus-like particles is strongly immunogenic and protects mice from"/>
   <result pre="is strongly immunogenic and protects mice from lethal challenge with" exact="chikungunya" post="virusVaccine2013313718372510.1016/j.vaccine.2013.05.08623742993 208.RamsauerK.SchwameisM.FirbasC.MÃ¼llnerM.PutnakR.J.ThomasS.J.DesprÃ¨sP.TauberE.JilmaB.TangyF.Immunogenicity, safety, and tolerability of a recombinant measles-virus-based"/>
   <result pre="chikungunya virusVaccine2013313718372510.1016/j.vaccine.2013.05.08623742993 208.RamsauerK.SchwameisM.FirbasC.MÃ¼llnerM.PutnakR.J.ThomasS.J.DesprÃ¨sP.TauberE.JilmaB.TangyF.Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: A randomised, double-blind, placebo-controlled, active-comparator, first-in-man trialLancet Infect."/>
   <result pre="trialLancet Infect. Dis.20151551952710.1016/S1473-3099(15)70043-525739878 209.ReisingerE.C.TschismarovR.BeublerE.WiedermannU.FirbasC.LoebermannM.PfeifferA.MuellnerM.TauberE.RamsauerK.Immunogenicity, safety, and tolerability of the measles-vectored" exact="chikungunya" post="virus vaccine MV-CHIK: A double-blind, randomised, placebo-controlled and active-controlled"/>
   <result pre="virus-neutralizing antibodies in miceVirus Res.201216723624610.1016/j.virusres.2012.05.00422610133 221.ChangL.-J.DowdK.A.MendozaF.H.SaundersJ.G.SitarS.PlummerS.H.YamshchikovG.SarwarU.N.HuZ.EnamaM.E.et al.Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: A phase 1"/>
   <result pre="cross-sectional study in a Cambodian rural communityEmerg. Microbes Infect.201871310.1038/s41426-017-0010-029410416 225.PowersA.M.Licensed" exact="chikungunya" post="virus vaccine: A possibility?Lancet20183922660266110.1016/S0140-6736(18)32809-530409444 226.LangsjoenR.M.HallerS.L.RoyC.J.Vinet-OliphantH.BergrenN.A.ErasmusJ.H.LivengoodJ.A.PowellT.D.WeaverS.C.RossiS.L.Chikungunya Virus Strains Show Lineage-Specific"/>
   <result pre="227.PartidosC.D.PaykelJ.WegerJ.BorlandE.M.PowersA.M.SeymourR.WeaverS.C.StinchcombD.T.OsorioJ.E.Cross-protective immunity against Oâ€™nyongâ€™nyong virus afforded by a novel recombinant" exact="chikungunya" post="vaccineVaccine2012304638464310.1016/j.vaccine.2012.04.09922583812 228.RobinsonD.M.ColeF.E.McManusA.T.PedersenC.E.Inactivated Mayaro vaccine produced in human diploid cell"/>
   <result pre="developmentPLoS Negl. Trop. Dis.201913e000691910.1371/journal.pntd.000691930653504 238.SuhrbierA.La LinnM.Clinical and pathologic aspects of" exact="arthritis" post="due to Ross River virus and other alphavirusesCurr. Opin."/>
   <result pre="alphavirusesCurr. Opin. Rheumatol.20041637437910.1097/01.bor.0000130537.76808.2615201600 239.PadmakumarB.JayanJ.B.MenonR.M.KrishnankuttyB.PayippallilR.NishaR.Comparative evaluation of four therapeutic regimes in" exact="chikungunya" post="arthritis: A prospective randomized parallel-group studyIndian J. Rheumatol.200949410110.1016/S0973-3698(10)60189-6 240.WolfS.TaylorA.ZaidA.FreitasJ.HerreroL.J.RaoS.SuhrbierA.ForwoodM.R.BucalaR.MahalingamS.Inhibition"/>
   <result pre="Loss Induced by Chikungunya Virus InfectionJ. Virol.20158958159310.1128/JVI.02034-1425339772 242.RulliN.E.GuglielmottiA.ManganoG.RolphM.S.ApicellaC.ZaidA.SuhrbierA.MahalingamS.Amelioration of alphavirus-induced" exact="arthritis" post="and myositis in a mouse model by treatment with"/>
   <result pre="by Chikungunya Virus InfectionJ. Virol.20158958159310.1128/JVI.02034-1425339772 242.RulliN.E.GuglielmottiA.ManganoG.RolphM.S.ApicellaC.ZaidA.SuhrbierA.MahalingamS.Amelioration of alphavirus-induced arthritis and" exact="myositis" post="in a mouse model by treatment with bindarit, an"/>
   <result pre="the antiviral screening platformsExpert Rev. Anti-Infect. Ther.20191712210.1080/14787210.2019.159559130449226 248.De LamballerieX.BoissonV.ReynierJ.-C.EnaultS.CharrelR.N.FlahaultA.RoquesP.Le GrandR.On" exact="chikungunya" post="acute infection and chloroquine treatmentVector Borne Zoonotic Dis.2008883783910.1089/vbz.2008.004918620511 249.RoquesP.ThibervilleS.-D.Dupuis-MaguiragaL.LumF.-M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de"/>
   <result pre="260.MackenzieJ.S.LindsayM.D.A.SmithD.W.ImrieA.The ecology and epidemiology of Ross River and Murray Valley" exact="encephalitis" post="viruses in Western Australia: Examples of One Health in"/>
   <result pre="&amp;amp; evaluation of biotinylated DNA probe for clinical diagnosis of" exact="chikungunya" post="infection in patientsâ€™ acute phase serum &amp;amp; CSF samplesIndian"/>
   <result pre="CSF samplesIndian J. Med. Res.201313811712424056565 278.TuekprakhonA.PuipromO.SasakiT.MichielsJ.BartholomeeusenK.NakayamaE.E.MenoM.K.PhadungsombatJ.HuitsR.AriÃ«nK.K.et al.Broad-spectrum monoclonal antibodies against" exact="chikungunya" post="virus structural proteins: Promising candidates for antibody-based rapid diagnostic"/>
   <result pre="other general symptoms, and after a few days, a delayed" exact="rash" post="often appears. Lymphadenopathy is particularly frequent in ONNV infection."/>
   <result pre="(with cytolysis and increased creatinine kinase). Polyarthralgia with or without" exact="arthritis" post="and asthenia might be prolonged during the sub-acute phase"/>
   <result pre="as chronic symptoms, sometimes as post-infectious chronic inflammatory rheumatism mimicking" exact="rheumatoid arthritis." post="Indirect diagnosis by serology requires two blood samples separated"/>
   <result pre="since then. microorganisms-07-00133-t001_Table 1Table 1 Arthritogenic alphavirus general characteristics. CHIKV," exact="chikungunya" post="virus; ONNV, Oâ€™nyongâ€™nyong virus; MAYV, Mayaro virus; RRV, Ross"/>
   <result pre="5/626 [125,146,147,148,149] Severe forms Meningo-encephalopathy [150,151], Guillain-BarrÃ© syndrome [152], acute" exact="optic neuropathy" post="[153], Myo-pericarditis [150,154,155], shock [150], neonatal infection [156,157] unknown"/>
   <result pre="[125,146,147,148,149] Severe forms Meningo-encephalopathy [150,151], Guillain-BarrÃ© syndrome [152], acute optic" exact="neuropathy" post="[153], Myo-pericarditis [150,154,155], shock [150], neonatal infection [156,157] unknown"/>
   <result pre="[150,154,155], shock [150], neonatal infection [156,157] unknown unknown Glomerulonephritis [158]," exact="encephalitis" post="[159,160,161]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563376\results\search\disease\results.xml">
   <result pre="available in this article, unless otherwise stated. Abstract Annual seasonal" exact="influenza" post="epidemics of variable severity result in significant morbidity and"/>
   <result pre="(U.S.) and worldwide. In temperate climate countries, including the U.S.," exact="influenza" post="activity peaks during the winter months. Annual influenza vaccination"/>
   <result pre="the U.S., influenza activity peaks during the winter months. Annual" exact="influenza" post="vaccination is recommended for all persons in the U.S."/>
   <result pre="(e.g. young children, elderly). Observational studies have reported effectiveness of" exact="influenza" post="vaccination to reduce the risks of severe disease requiring"/>
   <result pre="hospitalization, intensive care unit admission, and death. A diagnosis of" exact="influenza" post="should be considered in critically ill patients admitted with"/>
   <result pre="such as exacerbation of underlying chronic comorbidities, community-acquired pneumonia, and" exact="respiratory failure" post="during influenza season. Molecular tests are recommended for influenza"/>
   <result pre="of underlying chronic comorbidities, community-acquired pneumonia, and respiratory failure during" exact="influenza" post="season. Molecular tests are recommended for influenza testing of"/>
   <result pre="respiratory failure during influenza season. Molecular tests are recommended for" exact="influenza" post="testing of respiratory specimens in hospitalized patients. Antigen detection"/>
   <result pre="make clinical decisions, and respiratory specimens should be tested for" exact="influenza" post="by molecular assays. Because critically ill patients with lower"/>
   <result pre="ill patients with lower respiratory tract disease may have cleared" exact="influenza" post="virus in the upper respiratory tract, but have prolonged"/>
   <result pre="influenza virus in the upper respiratory tract, but have prolonged" exact="influenza" post="viral replication in the lower respiratory tract, an endotracheal"/>
   <result pre="purposes) should be tested by molecular assay for detection of" exact="influenza" post="viruses. Observational studies have reported that antiviral treatment of"/>
   <result pre="studies have reported that antiviral treatment of critically ill adult" exact="influenza" post="patients with a neuraminidase inhibitor is associated with survival"/>
   <result pre="unless clinically indicated for another reason, such as treatment of" exact="asthma" post="or COPD exacerbation, or septic shock. A number of"/>
   <result pre="Influenza Influenza vaccination Influenza testing Antiviral treatment Background Annual seasonal" exact="influenza" post="epidemics of variable severity result in significant morbidity and"/>
   <result pre="and worldwide [1â€&quot;3]. In temperate climate countries, including the U.S.," exact="influenza" post="activity peaks during the winter months whereas in tropical"/>
   <result pre="activity peaks during the winter months whereas in tropical regions" exact="influenza" post="activity may be more variable [4â€&quot;6]. Most persons with"/>
   <result pre="activity may be more variable [4â€&quot;6]. Most persons with symptomatic" exact="influenza" post="virus infection have self-limited uncomplicated upper respiratory tract illness."/>
   <result pre="during 2010â€&quot;2016, approximately 8.3% of the U.S. population experienced symptomatic" exact="influenza" post="each year [7]. However, complications may result in severe"/>
   <result pre="medical visits, 140,000â€&quot;960,000 hospitalizations, and 12,000â€&quot;79,000 deaths were associated with" exact="influenza" post="each year in the U.S. [8]. Another study estimated"/>
   <result pre="There are an estimated 291,000â€&quot;646,000 respiratory deaths attributed to seasonal" exact="influenza" post="each year worldwide [2]. Here, we review strategies for"/>
   <result pre="Here, we review strategies for prevention, diagnosis, and treatment of" exact="influenza" post="virus infections in the ICU (TableÂ 1). Table 1"/>
   <result pre="1). Table 1 Key points: care of patients with severe" exact="influenza" post="Key Points â€¢ There are an estimated 291,000â€&quot;646,000 seasonal"/>
   <result pre="291,000â€&quot;646,000 seasonal influenza-associated respiratory deaths every year worldwide. â€¢ Annual" exact="influenza" post="vaccination is the primary method of preventing influenza and"/>
   <result pre="â€¢ Annual influenza vaccination is the primary method of preventing" exact="influenza" post="and influenza-related complications, especially in high-risk persons. â€¢ Influenza"/>
   <result pre="patients, and should not be delayed while awaiting results of" exact="influenza" post="diagnostic tests. â€¢ Enterically administered oseltamivir is recommended for"/>
   <result pre="influenza diagnostic tests. â€¢ Enterically administered oseltamivir is recommended for" exact="influenza" post="patients except for those with contraindications (e.g., gastric stasis,"/>
   <result pre="be required to determine therapeutic endpoints in ventilated patients with" exact="influenza" post="â€¢ Corticosteroids are not recommended for the routine treatment"/>
   <result pre="â€¢ Corticosteroids are not recommended for the routine treatment of" exact="influenza" post="except when indicated for treatment of underlying medical conditions"/>
   <result pre="indicated for treatment of underlying medical conditions (e.g., COPD or" exact="asthma" post="exacerbation) or septic shock. Risk factors Influenza vaccination is"/>
   <result pre="Risk factors Influenza vaccination is the primary method for preventing" exact="influenza" post="and reducing the risk of severe outcomes. In the"/>
   <result pre="U.S., the Advisory Committee on Immunization Practices (ACIP) recommends annual" exact="influenza" post="vaccination for all persons aged 6â€‰months and older and"/>
   <result pre="6â€‰months and older and prioritizes those at higher risk for" exact="influenza" post="complications [10]. High-risk groups include adults aged &amp;gt;â€‰65â€‰years [11,"/>
   <result pre="who might be at risk for experiencing Reye syndrome with" exact="influenza" post="virus infection, and those who are extremely obese (BMI"/>
   <result pre="complications [10, 19â€&quot;23]. Table 2 Groups at high risk for" exact="influenza" post="complications* Risk factors for severe influenza outcomes â€¢ Age"/>
   <result pre="at high risk for influenza complications* Risk factors for severe" exact="influenza" post="outcomes â€¢ Age â€¢ Age &amp;gt;â€‰65â€‰years â€¢ Pregnant women"/>
   <result pre="â€¢ Age â€¢ Age &amp;gt;â€‰65â€‰years â€¢ Pregnant women â€¢ Extreme" exact="obesity" post="(BMIÂ &amp;gt;Â 40â€‰kg/m2) â€¢ Native Americans/Alaskan Natives (may also"/>
   <result pre="on Immunization Practices Many studies evaluated risk factors for severe" exact="influenza" post="during the 2009 H1N1 influenza pandemic. Adult ICU patients"/>
   <result pre="evaluated risk factors for severe influenza during the 2009 H1N1" exact="influenza" post="pandemic. Adult ICU patients with influenza A(H1N1)pdm09 virus infection"/>
   <result pre="during the 2009 H1N1 influenza pandemic. Adult ICU patients with" exact="influenza" post="A(H1N1)pdm09 virus infection were primarily non-elderly, were obese [24â€&quot;28],"/>
   <result pre="[24â€&quot;28], and had higher odds of death, invasive mechanical ventilation," exact="acute respiratory distress syndrome" post="(ARDS), septic shock, and multi-lobar pneumonia when compared with"/>
   <result pre="ventilation, acute respiratory distress syndrome (ARDS), septic shock, and multi-lobar" exact="pneumonia" post="when compared with seasonal influenza patients [24, 29]. In"/>
   <result pre="(ARDS), septic shock, and multi-lobar pneumonia when compared with seasonal" exact="influenza" post="patients [24, 29]. In children, independent risk factors for"/>
   <result pre="influenza patients [24, 29]. In children, independent risk factors for" exact="influenza" post="A(H1N1)pdm09-related mortality included chronic neurologic condition or immune compromise,"/>
   <result pre="influenza A(H1N1)pdm09-related mortality included chronic neurologic condition or immune compromise," exact="acute myocarditis" post="or encephalitis, and early presumed MRSA co-infection of the"/>
   <result pre="A(H1N1)pdm09-related mortality included chronic neurologic condition or immune compromise, acute" exact="myocarditis" post="or encephalitis, and early presumed MRSA co-infection of the"/>
   <result pre="Bacterial co-infection was identified in approximately one third of fatal" exact="influenza" post="A(H1N1)pdm09 cases in the largest autopsy case series [31]."/>
   <result pre="in the inter-pandemic period are also common in critically ill" exact="influenza" post="patients [32]. One study identified past or current tobacco"/>
   <result pre="study reported that mortality was higher in immunosuppressed patients with" exact="influenza" post="A(H1N1)pdm09 than in immunocompetent patients [34]. Severity of influenza"/>
   <result pre="with influenza A(H1N1)pdm09 than in immunocompetent patients [34]. Severity of" exact="influenza" post="seasons varies from year-to-year based on the predominant influenza"/>
   <result pre="of influenza seasons varies from year-to-year based on the predominant" exact="influenza" post="viruses, and between seasonal and pandemic influenza [35, 36]."/>
   <result pre="on the predominant influenza viruses, and between seasonal and pandemic" exact="influenza" post="[35, 36]. One study reported that patients with influenza"/>
   <result pre="pandemic influenza [35, 36]. One study reported that patients with" exact="influenza" post="A(H1N1)pdm09 had higher odds of severe disease than patients"/>
   <result pre="had higher odds of severe disease than patients with either" exact="influenza" post="A(H3N2) or influenza B virus infections [37]. However, influenza"/>
   <result pre="of severe disease than patients with either influenza A(H3N2) or" exact="influenza" post="B virus infections [37]. However, influenza B virus infection"/>
   <result pre="either influenza A(H3N2) or influenza B virus infections [37]. However," exact="influenza" post="B virus infection has been shown to increase the"/>
   <result pre="increase the odds of in-hospital mortality in children compared with" exact="influenza" post="A virus infection [38]. Prevention and vaccination Influenza vaccination"/>
   <result pre="&amp;gt;â€‰6â€‰months in the U.S. and should continue as long as" exact="influenza" post="viruses are circulating in the community. Previously unvaccinated children"/>
   <result pre="6â€‰months through 8â€‰years require two doses 1Â month apart. Since" exact="influenza" post="vaccine effectiveness (VE) to prevent medically attended illness varies"/>
   <result pre="and immune function, some vaccinated individuals can become symptomatic with" exact="influenza" post="virus infection. However, several studies have reported influenza vaccine"/>
   <result pre="symptomatic with influenza virus infection. However, several studies have reported" exact="influenza" post="vaccine effectiveness in reducing illness severity, including reducing severe"/>
   <result pre="reduced a half-day in patients aged 50â€&quot;64â€‰years who had received" exact="influenza" post="vaccination compared with unvaccinated patients [41]. A study across"/>
   <result pre="[41]. A study across all age groups in Spain reported" exact="influenza" post="VE of 58% in reducing the risk of severe"/>
   <result pre="influenza VE of 58% in reducing the risk of severe" exact="influenza" post="requiring hospitalization [42]. A Southern Hemisphere study reported influenza"/>
   <result pre="severe influenza requiring hospitalization [42]. A Southern Hemisphere study reported" exact="influenza" post="VE of 82% in reducing influenza-associated ICU admissions among"/>
   <result pre="adults [43] while a study in Spain showed an adjusted" exact="influenza" post="VE of 23% in preventing ICU admission and death"/>
   <result pre="preventing ICU admission and death [44]. Despite the benefits of" exact="influenza" post="vaccination, there continues to be low vaccine coverage among"/>
   <result pre="high prevalence of high-risk comorbidities [45, 46]. In children, low" exact="influenza" post="vaccination coverage has also been reported among those admitted"/>
   <result pre="ICUs, even among those with underlying high-risk conditions [47]. Full" exact="influenza" post="vaccination was shown to result in a 74% reduction"/>
   <result pre="in pediatric ICU admissions compared to unvaccinated or partially vaccinated" exact="influenza" post="patients [47]. Furthermore, one study showed that influenza VE"/>
   <result pre="partially vaccinated influenza patients [47]. Furthermore, one study showed that" exact="influenza" post="VE was 65% in reducing the risk of mortality"/>
   <result pre="the U.S. [48]. These data further emphasize the benefits of" exact="influenza" post="vaccination in reducing severe influenza complications, especially in high-risk"/>
   <result pre="further emphasize the benefits of influenza vaccination in reducing severe" exact="influenza" post="complications, especially in high-risk persons. Diagnosis Persons with uncomplicated"/>
   <result pre="influenza complications, especially in high-risk persons. Diagnosis Persons with uncomplicated" exact="influenza" post="typically experience acute onset of respiratory symptoms (cough, rhinorrhea,"/>
   <result pre="rhinorrhea, congestion), myalgias, and headache with or without fever. During" exact="influenza" post="season, clinicians should alsoÂ consider influenza when there is"/>
   <result pre="or without fever. During influenza season, clinicians should alsoÂ consider" exact="influenza" post="when there is only fever present or in patients"/>
   <result pre="who are afebrile and have respiratory symptoms [49]. Complications of" exact="influenza" post="vary by age, underlying comorbidities or high-risk conditions such"/>
   <result pre="multi-organ failure, exacerbation of an underlying condition such as chronic" exact="lung disease" post="[50, 51], heart failure [52], or other extrapulmonary complications"/>
   <result pre="failure [52], or other extrapulmonary complications including stroke, encephalopathy, or" exact="encephalitis" post="[30, 49, 53]. Influenza testing is recommended for all"/>
   <result pre="with suspected influenza, including those admitted to the ICU during" exact="influenza" post="season with acute respiratory illness and community-acquired pneumonia, without"/>
   <result pre="alternative diagnosis. Furthermore, all individuals requiring critical care outside of" exact="influenza" post="season should be tested for influenza if there is"/>
   <result pre="critical care outside of influenza season should be tested for" exact="influenza" post="if there is a possible epidemiological link to an"/>
   <result pre="individual with recent influenza, such as travel to areas with" exact="influenza" post="activity or exposure to an institutional influenza outbreak. Special"/>
   <result pre="to areas with influenza activity or exposure to an institutional" exact="influenza" post="outbreak. Special consideration should be given to elderly and"/>
   <result pre="consideration should be given to elderly and immunocompromised patients, as" exact="influenza" post="virus infection may not present with typical acute respiratory"/>
   <result pre="of America (IDSA) 2018 Influenza Clinical Practice Guidelines also recommend" exact="influenza" post="testing for patients at high risk of complications such"/>
   <result pre="such as exacerbation of chronic cardiopulmonary disease [49]. Diagnosis of" exact="influenza" post="should be made as soon as possible in critically"/>
   <result pre="have reported an increase in mortality of ICU patients with" exact="influenza" post="A(H1N1)pdm09 virus infection when diagnosis was delayed [54], and"/>
   <result pre="was initiated within 6â€‰h of admission [55]. Several kinds of" exact="influenza" post="diagnostic tests are available in clinical settings with variable"/>
   <result pre="the clinician to properly interpret their results. Most studies of" exact="influenza" post="diagnostic accuracy have been conducted on specimens from patients"/>
   <result pre="with uncomplicated influenza, and few have assessed the performance of" exact="influenza" post="tests in critically ill patients. The IDSA guidelines recommend"/>
   <result pre="tests in critically ill patients. The IDSA guidelines recommend molecular" exact="influenza" post="assays for testing respiratory specimens from all hospitalized patients"/>
   <result pre="for testing respiratory specimens from all hospitalized patients with suspected" exact="influenza" post="because of their high sensitivity, specificity, and time to"/>
   <result pre="results (15â€‰min to several hours) [49]. The use of rapid" exact="influenza" post="molecular diagnostic testing can result in better outcomes for"/>
   <result pre="or throat NP or BAL/mini BAL Nasal or endotracheal Rapid" exact="influenza" post="diagnostic Test (RIDT) Antigen detection 10â€&quot;15â€‰min Low to moderate"/>
   <result pre="Some molecular assays also detect other respiratory pathogens #Patients with" exact="respiratory failure" post="and suspected influenza should have lower respiratory tract specimens"/>
   <result pre="detect other respiratory pathogens #Patients with respiratory failure and suspected" exact="influenza" post="should have lower respiratory tract specimens collected and tested,"/>
   <result pre="tested, including if upper respiratory tract specimens are negative for" exact="influenza" post="because a patient may have cleared influenza virus from"/>
   <result pre="are negative for influenza because a patient may have cleared" exact="influenza" post="virus from the upper respiratory tract and continue to"/>
   <result pre="virus from the upper respiratory tract and continue to have" exact="influenza" post="viral replication in the lower respiratory tract NP nasopharyngeal,"/>
   <result pre="recommended for diagnosis or clinical management of patients with suspected" exact="influenza" post="A recent meta-analysis reported that influenza antigen detection tests"/>
   <result pre="of patients with suspected influenza A recent meta-analysis reported that" exact="influenza" post="antigen detection tests that produce rapid results had very"/>
   <result pre="but sensitivities were highly variable compared with RT-PCR [58]. Rapid" exact="influenza" post="diagnostic tests (RIDTs) without an analyzer device had only"/>
   <result pre="device (digital immunoassays) had moderately high sensitivity (77â€&quot;80%), and rapid" exact="influenza" post="molecular assays (nucleic acid detection) had high sensitivity (92â€&quot;95%)"/>
   <result pre="high sensitivity (92â€&quot;95%) [58]. Low sensitivity of RIDTs for detecting" exact="influenza" post="virus in ICU patients has been reported [59]. Recently,"/>
   <result pre="has been reported [59]. Recently, a systematic analysis of rapid" exact="influenza" post="molecular tests from 29 studies reported pooled sensitivity and"/>
   <result pre="97.4%, respectively [60]. Therefore, antigen detection assays, such as rapid" exact="influenza" post="diagnostic tests and immunofluorescence assays, are not recommended for"/>
   <result pre="immunofluorescence assays, are not recommended for hospitalized patients with suspected" exact="influenza" post="because of their lower sensitivities, unless molecular assays are"/>
   <result pre="unless molecular assays are not available [49]. Negative results for" exact="influenza" post="based on tests with low sensitivity (e.g., RIDTs, immunofluorescence"/>
   <result pre="up with reverse transcription polymerase chain reaction (RT-PCR) or other" exact="influenza" post="molecular assays to confirm results, and antiviral treatment should"/>
   <result pre="should continue until results are available. Preferred respiratory specimens for" exact="influenza" post="testing in hospitalized patients without lower respiratory tract disease"/>
   <result pre="tract specimens should be considered in hospitalized patients with suspected" exact="influenza" post="if upper respiratory tract specimens are negative and a"/>
   <result pre="31]. In hospitalized patients receiving invasive mechanical ventilation in whom" exact="influenza" post="is suspected, but not yet diagnosed, influenza testing should"/>
   <result pre="ventilation in whom influenza is suspected, but not yet diagnosed," exact="influenza" post="testing should be performed on endotracheal aspirate specimens instead"/>
   <result pre="the upper respiratory tract [61]. Molecular testing, including RT-PCR for" exact="influenza" post="viruses can also be performed on bronchoalveolar lavage (BAL)"/>
   <result pre="have very low diagnostic yield and are not recommended for" exact="influenza" post="testing [49]. Diagnostic test results on specimens collected from"/>
   <result pre="making even for patients with extra-pulmonary complications of influenza. Novel" exact="influenza" post="A viruses are typically of animal origin, differ antigenically"/>
   <result pre="animal origin, differ antigenically and genetically from currently circulating seasonal" exact="influenza" post="A viruses (including H1N1pdm09 and H3N2 subtypes) and have"/>
   <result pre="H3N2 subtypes) and have infected at least one person. Novel" exact="influenza" post="A viruses can cause a wide clinical spectrum of"/>
   <result pre="and multi-organ failure [62] and human infection with a novel" exact="influenza" post="A virus is of public health concern. In the"/>
   <result pre="health concern. In the U.S., human infection with a novel" exact="influenza" post="A virus is nationally reportable to the Centers for"/>
   <result pre="Health Organization. A major concern is the risk of novel" exact="influenza" post="A virus transmission among humans; depending upon the prevalence"/>
   <result pre="upon the prevalence of pre-existing immunity in the population, novel" exact="influenza" post="A viruses may have pandemic potential. Patients suspected with"/>
   <result pre="A viruses may have pandemic potential. Patients suspected with novel" exact="influenza" post="A virus infection should be investigated for a possible"/>
   <result pre="close contact to an individual with suspected or confirmed novel" exact="influenza" post="A virus infection. Novel influenza A virus infection cannot"/>
   <result pre="with suspected or confirmed novel influenza A virus infection. Novel" exact="influenza" post="A virus infection cannot be distinguished from seasonal influenza"/>
   <result pre="Novel influenza A virus infection cannot be distinguished from seasonal" exact="influenza" post="A virus infection by clinical findings or testing at"/>
   <result pre="RT-PCR at public health laboratories [63]. Cases of suspected novel" exact="influenza" post="A virus infections should be discussed with appropriate local"/>
   <result pre="to coordinate the testing of appropriate respiratory specimens. Treatment of" exact="influenza" post="Treatment of severe influenza presents multiple challenges. The mainstay"/>
   <result pre="of appropriate respiratory specimens. Treatment of influenza Treatment of severe" exact="influenza" post="presents multiple challenges. The mainstay of therapy for patients"/>
   <result pre="presents multiple challenges. The mainstay of therapy for patients with" exact="influenza" post="is initiation of antiviral medication as soon as possible"/>
   <result pre="rimantadine) (TableÂ 4). NAIs and baloxavir have activity against both" exact="influenza" post="A and B viruses. Adamantanes only have activity against"/>
   <result pre="influenza A and B viruses. Adamantanes only have activity against" exact="influenza" post="A viruses and are not recommended for treatment of"/>
   <result pre="influenza A viruses and are not recommended for treatment of" exact="influenza" post="due to widespread resistance among currently circulating strains of"/>
   <result pre="due to widespread resistance among currently circulating strains of seasonal" exact="influenza" post="A viruses. Notably, FDA-approved antiviral medications for treatment of"/>
   <result pre="influenza A viruses. Notably, FDA-approved antiviral medications for treatment of" exact="influenza" post="are approved for early treatment of uncomplicated influenza in"/>
   <result pre="treatment of influenza are approved for early treatment of uncomplicated" exact="influenza" post="in outpatients based upon randomized placebo-controlled clinical trials conducted"/>
   <result pre="of randomized placebo-controlled clinical trials of early oseltamivir treatment of" exact="influenza" post="in pediatric and adult outpatients have reported clinical benefit"/>
   <result pre="duration of illness and risk for some complications associated with" exact="influenza" post="[65, 66]. Table 4 Antiviral treatment Antiviral agents and"/>
   <result pre="A phase III clinical trial of baloxavir treatment of hospitalized" exact="influenza" post="patients is ongoing: https://clinicaltrials.gov/ct2/show/NCT03684044 No completed randomized, placebo-controlled trials"/>
   <result pre="placebo-controlled trials of antiviral treatment have been conducted in hospitalized" exact="influenza" post="patients to establish the efficacy of oseltamivir or other"/>
   <result pre="( â€‰48â€‰h), and a 69% reduction in mortality risk between" exact="influenza" post="patients receiving early NAI treatment and those who did"/>
   <result pre="underpowered because death is less common in hospitalized children with" exact="influenza" post="than in adults. Although studies have shown the greatest"/>
   <result pre="median duration of ICU hospitalization in severely ill patients with" exact="influenza" post="A(H3N2), but not A(H1N1pdm09) or B virus infection in"/>
   <result pre="reported delays in initiation of oseltamivir treatment prescribed to hospitalized" exact="influenza" post="patients and suggested empiric administration of oseltamivir treatment in"/>
   <result pre="for patients being admitted with lower respiratory tract disease during" exact="influenza" post="season [79]. Overall, based upon available observational data to"/>
   <result pre="of therapy with neuraminidase inhibitors are limited in critically ill" exact="influenza" post="patients. Enterically administered oseltamivir is the preferred treatment for"/>
   <result pre="patients and the risk of bronchospasm in patients with underlying" exact="lung disease." post="Studies indicate that oseltamivir administered orally or via oro/naso-gastric"/>
   <result pre="not provide additional clinical benefit in obese adults, including extreme" exact="obesity" post="(BMI &amp;gt;â€‰40) [93, 94]. Duration of therapy can be"/>
   <result pre="Duration of therapy can be difficult to define, as prolonged" exact="influenza" post="viral replication and shedding from the both upper and"/>
   <result pre="also help reduce the pro-inflammatory dysregulated cytokine response triggered by" exact="influenza" post="virus infection and reduce nosocomial influenza virus transmission to"/>
   <result pre="cytokine response triggered by influenza virus infection and reduce nosocomial" exact="influenza" post="virus transmission to healthcare personnel in the ICU. Consultation"/>
   <result pre="should be considered for ICU patients with evidence of persistent" exact="influenza" post="viral replication after NAI treatment, particularly in severely immunocompromised"/>
   <result pre="enteric oseltamivir [101]. Notably, a randomized trial conducted in three" exact="influenza" post="seasons found similar clinical outcomes between IV peramivir and"/>
   <result pre="outcomes between IV peramivir and enteric oseltamivir in hospitalized adult" exact="influenza" post="patients [102]; a separate trial did not identify significant"/>
   <result pre="clinical benefit between enteric oseltamivir and intravenous peramivir in hospitalized" exact="influenza" post="patients [104]. In 2018, a novel antiviral agent, baloxavir"/>
   <result pre="agent, baloxavir marboxil, was FDA-approved for early treatment of uncomplicated" exact="influenza" post="in outpatients aged â‰¥â€‰12â€‰years old. Baloxavir acts via inhibition"/>
   <result pre="outpatients aged â‰¥â€‰12â€‰years old. Baloxavir acts via inhibition of the" exact="influenza" post="virus cap-dependent endonuclease, a different mechanism than the neuraminidase"/>
   <result pre="different mechanism than the neuraminidase inhibitors, and can treat NAI-resistant" exact="influenza" post="virus infections. Randomized controlled trials of single-dose oral baloxavir"/>
   <result pre="or in combination with an NAI for treatment of hospitalized" exact="influenza" post="patients is unclear. Specifically, optimal dosing, duration of therapy,"/>
   <result pre="have yet to be determined for baloxavir treatment of hospitalized" exact="influenza" post="patients. In the outpatient RCT, patients treated with single-dose"/>
   <result pre="RCT, patients treated with single-dose baloxavir showed significant reduction in" exact="influenza" post="viral levels in the upper respiratory tract at 24â€‰h"/>
   <result pre="oseltamivir [105]. However, it is unknown whether this reduction in" exact="influenza" post="viral shedding correlates with reduced transmissibility. A potential concern"/>
   <result pre="baloxavir in combination with oseltamivir versus oseltamivir monotherapy in hospitalized" exact="influenza" post="patients is currently enrolling participants [107]. There are no"/>
   <result pre="no completed randomized clinical trials of adjunctive corticosteroid treatment in" exact="influenza" post="patients. A trial of corticosteroid therapy was planned during"/>
   <result pre="tripled the risk of developing critical illness or death from" exact="influenza" post="A(H1N1)pdm09 virus infection [109]. A re-analysis of prospectively collected"/>
   <result pre="infection [109]. A re-analysis of prospectively collected data on 1846" exact="influenza" post="patients admitted with primary influenza pneumonia to 148 ICUs"/>
   <result pre="prospectively collected data on 1846 influenza patients admitted with primary" exact="influenza" post="pneumonia to 148 ICUs in Spain during 2009â€&quot;2014 using"/>
   <result pre="collected data on 1846 influenza patients admitted with primary influenza" exact="pneumonia" post="to 148 ICUs in Spain during 2009â€&quot;2014 using propensity"/>
   <result pre="observational studies have concluded that that corticosteroid treatment of hospitalized" exact="influenza" post="patients does not result in better outcomes and may"/>
   <result pre="have also reported potential association between corticosteroid treatment and adverse" exact="influenza" post="outcomes [30, 114, 115]. A recent Cochrane review of"/>
   <result pre="suggested increased mortality when adjunctive corticosteroid therapy is used for" exact="influenza" post="patients; however, the available evidence was of low quality"/>
   <result pre="studies have reported that corticosteroid treatment is associated with prolonged" exact="influenza" post="viral shedding in hospitalized patients [117â€&quot;119], including in sporadic"/>
   <result pre="in hospitalized patients [117â€&quot;119], including in sporadic human infections with" exact="avian influenza" post="A(H7N9) virus in China [120], and increased rates of"/>
   <result pre="hospitalized patients [117â€&quot;119], including in sporadic human infections with avian" exact="influenza" post="A(H7N9) virus in China [120], and increased rates of"/>
   <result pre="not well understood. One observational study of hospitalized patients with" exact="viral pneumonia" post="due to avian influenza A(H7N9) virus infection in China"/>
   <result pre="well understood. One observational study of hospitalized patients with viral" exact="pneumonia" post="due to avian influenza A(H7N9) virus infection in China"/>
   <result pre="observational study of hospitalized patients with viral pneumonia due to" exact="avian influenza" post="A(H7N9) virus infection in China reported that high-dose, but"/>
   <result pre="study of hospitalized patients with viral pneumonia due to avian" exact="influenza" post="A(H7N9) virus infection in China reported that high-dose, but"/>
   <result pre="unless clinically indicated for another reason, such as treatment of" exact="asthma" post="or COPD exacerbation or septic shock [49]. Further studies"/>
   <result pre="benefit or harms associated with corticosteroid treatment of critically ill" exact="influenza" post="patients. Although neuraminidase inhibitors (oseltamivir) are currently recommended for"/>
   <result pre="neuraminidase inhibitors (oseltamivir) are currently recommended for antiviral treatment of" exact="influenza" post="in hospitalized patients based on observational studies, including in"/>
   <result pre="are a number of novel strategies and products for treating" exact="influenza" post="in various stages of development. One approach under investigation"/>
   <result pre="therapy, which combines amantadine, ribavirin, and oseltamivir for treatment of" exact="influenza" post="in critically ill and high-risk patients. Unfortunately, studies to"/>
   <result pre="of monoclonal and polyclonal antibodies, targeted against a variety of" exact="influenza" post="viral proteins, are also in development [130â€&quot;133]. Similarly, convalescent"/>
   <result pre="interest is the modification of the host antiviral response to" exact="influenza" post="virus infection. There are ongoing preclinical and clinical studies"/>
   <result pre="at risk for severe complications of influenza. A diagnosis of" exact="influenza" post="should be considered in critically ill patients admitted with"/>
   <result pre="such as exacerbation of underlying chronic comorbidities, community-acquired pneumonia, and" exact="respiratory failure" post="during influenza season. Influenza molecular assays are recommended for"/>
   <result pre="of underlying chronic comorbidities, community-acquired pneumonia, and respiratory failure during" exact="influenza" post="season. Influenza molecular assays are recommended for testing upper"/>
   <result pre="ill patients with lower respiratory tract disease may have cleared" exact="influenza" post="virus in the upper respiratory tract, but have prolonged"/>
   <result pre="influenza virus in the upper respiratory tract, but have prolonged" exact="influenza" post="viral replication in the lower respiratory tract, an endotracheal"/>
   <result pre="is recommended as soon as possible for patients with suspected" exact="influenza" post="without waiting for testing results. Corticosteroids should not be"/>
   <result pre="results. Corticosteroids should not be routinely administered for treatment of" exact="influenza" post="and should only be given for other indications (e.g.,"/>
   <result pre="should only be given for other indications (e.g., exacerbation of" exact="asthma" post="or chronic obstructive pulmonary disease, or septic shock), because"/>
   <result pre="be given for other indications (e.g., exacerbation of asthma or" exact="chronic obstructive pulmonary disease," post="or septic shock), because of the risk for prolongation"/>
   <result pre="or septic shock), because of the risk for prolongation of" exact="influenza" post="viral shedding and ventilator-associated pneumonia in critically ill influenza"/>
   <result pre="the risk for prolongation of influenza viral shedding and ventilator-associated" exact="pneumonia" post="in critically ill influenza patients with respiratory failure. Future"/>
   <result pre="of influenza viral shedding and ventilator-associated pneumonia in critically ill" exact="influenza" post="patients with respiratory failure. Future directions for treatment of"/>
   <result pre="shedding and ventilator-associated pneumonia in critically ill influenza patients with" exact="respiratory failure." post="Future directions for treatment of influenza in critically ill"/>
   <result pre="influenza patients with respiratory failure. Future directions for treatment of" exact="influenza" post="in critically ill patients include novel antiviral compounds, combination"/>
   <result pre="the U.S. CDCâ€™s Advisory Committee on Immunization Practices recommendations for" exact="influenza" post="vaccination. This may also apply to indigenous people from"/>
   <result pre="and institutional affiliations. References References 1.JacksonMLPhillipsCHBenoitJet al.Burden of medically attended" exact="influenza" post="infection and cases averted by vaccination - United States,"/>
   <result pre="cases averted by vaccination - United States, 2013/14 through 2015/16" exact="influenza" post="seasonsVaccine201836446747210.1016/j.vaccine.2017.12.01429249545 2.IulianoADRoguskiKMChangHHet al.Estimates of global seasonal influenza-associated respiratory mortality:"/>
   <result pre="and subtropics - when to vaccinate?PLoS One2016114e015300310.1371/journal.pone.015300327119988 5.TinocoYOAzziz-BaumgartnerEUyekiTMet al.Burden of" exact="influenza" post="in 4 ecologically distinct regions of Peru: household active"/>
   <result pre="of a community cohort, 2009-2015Clin Infect Dis20176591532154110.1093/cid/cix56529020267 6.YangWCummingsMJBakamutumahoBet al.Dynamics of" exact="influenza" post="in tropical Africa: temperature, humidity, and co-circulating (sub)typesInfluenza Other"/>
   <result pre="and co-circulating (sub)typesInfluenza Other Respir Viruses201812444645610.1111/irv.1255629573157 7.TokarsJIOlsenSJReedCSeasonal incidence of symptomatic" exact="influenza" post="in the United StatesClin Infect Dis201866101511151810.1093/cid/cix106029206909 8.Centers for Disease"/>
   <result pre="Available at: https://www.cdc.gov/flu/about/burden/index.html. Accessed 24 Apr 2019. 9.ReedCChavesSSDaily KirleyPet al.Estimating" exact="influenza" post="disease burden from population-based surveillance data in the United"/>
   <result pre="in the United StatesPLoS One2015103e011836910.1371/journal.pone.011836925738736 10.GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the advisory committee on immunization"/>
   <result pre="recommendations of the advisory committee on immunization practices-United States, 2018-19" exact="influenza" post="seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess pneumonia and influenza associated hospitalization"/>
   <result pre="on immunization practices-United States, 2018-19 influenza seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess" exact="pneumonia" post="and influenza associated hospitalization during influenza epidemics in the"/>
   <result pre="practices-United States, 2018-19 influenza seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess pneumonia and" exact="influenza" post="associated hospitalization during influenza epidemics in the United States,"/>
   <result pre="seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess pneumonia and influenza associated hospitalization during" exact="influenza" post="epidemics in the United States, 1970-78Am J Public Health198676776176510.2105/AJPH.76.7.7613717461"/>
   <result pre="States, 1970-78Am J Public Health198676776176510.2105/AJPH.76.7.7613717461 12.BarkerWHMulloolyJPImpact of epidemic type A" exact="influenza" post="in a defined adult populationAm J Epidemiol1980112679881110.1093/oxfordjournals.aje.a1130527457471 13.PoehlingKAEdwardsKMGriffinMRet al.The"/>
   <result pre="a defined adult populationAm J Epidemiol1980112679881110.1093/oxfordjournals.aje.a1130527457471 13.PoehlingKAEdwardsKMGriffinMRet al.The burden of" exact="influenza" post="in young children, 2004-2009Pediatrics2013131220721610.1542/peds.2012-125523296444 14.PoehlingKAEdwardsKMWeinbergGAet al.The underrecognized burden of"/>
   <result pre="influenza in young children, 2004-2009Pediatrics2013131220721610.1542/peds.2012-125523296444 14.PoehlingKAEdwardsKMWeinbergGAet al.The underrecognized burden of" exact="influenza" post="in young childrenN Engl J Med20063551314010.1056/NEJMoa05486916822994 15.SistonAMRasmussenSAHoneinMAet al.Pandemic 2009"/>
   <result pre="influenza in young childrenN Engl J Med20063551314010.1056/NEJMoa05486916822994 15.SistonAMRasmussenSAHoneinMAet al.Pandemic 2009" exact="influenza" post="A(H1N1) virus illness among pregnant women in the United"/>
   <result pre="StatesJAMA2010303151517152510.1001/jama.2010.47920407061 16.MertzDGeraciJWinkupJGessnerBDOrtizJRLoebMPregnancy as a risk factor for severe outcomes from" exact="influenza" post="virus infection: a systematic review and meta-analysis of observational"/>
   <result pre="and meta-analysis of observational studiesVaccine201735452152810.1016/j.vaccine.2016.12.01228024955 17.LouieJKAcostaMJamiesonDJHoneinMAcollab: Group CPHNWSevere 2009 H1N1" exact="influenza" post="in pregnant and postpartum women in CaliforniaN Engl J"/>
   <result pre="and postpartum women in CaliforniaN Engl J Med20103621273510.1056/NEJMoa091044420032319 18.LouieJKJamiesonDJRasmussenSA2009 Pandemic" exact="influenza" post="a (H1N1) virus infection in postpartum women in CaliforniaAm"/>
   <result pre="among adultsVaccine200725584685510.1016/j.vaccine.2006.09.04117074423 22.MertzDKimTHJohnstoneJet al.Populations at risk for severe or complicated" exact="influenza" post="illness: systematic review and meta-analysisBMJ2013347f506110.1136/bmj.f506123974637 23.Van KerkhoveMDVandemaeleKAShindeVet al.Risk factors"/>
   <result pre="meta-analysisBMJ2013347f506110.1136/bmj.f506123974637 23.Van KerkhoveMDVandemaeleKAShindeVet al.Risk factors for severe outcomes following 2009" exact="influenza" post="A (H1N1) infection: a global pooled analysisPLoS Med201187e100105310.1371/journal.pmed.100105321750667 24.RelloJRodriguezAIbanezPet"/>
   <result pre="pooled analysisPLoS Med201187e100105310.1371/journal.pmed.100105321750667 24.RelloJRodriguezAIbanezPet al.Intensive care adult patients with severe" exact="respiratory failure" post="caused by influenza A (H1N1)v in SpainCrit Care2009135R14810.1186/cc804419747383 25.RiceTWRubinsonLUyekiTMet"/>
   <result pre="al.Intensive care adult patients with severe respiratory failure caused by" exact="influenza" post="A (H1N1)v in SpainCrit Care2009135R14810.1186/cc804419747383 25.RiceTWRubinsonLUyekiTMet al.Critical illness from"/>
   <result pre="(H1N1)v in SpainCrit Care2009135R14810.1186/cc804419747383 25.RiceTWRubinsonLUyekiTMet al.Critical illness from 2009 pandemic" exact="influenza" post="A virus and bacterial coinfection in the United StatesCrit"/>
   <result pre="StatesCrit Care Med20124051487149810.1097/CCM.0b013e3182416f2322511131 26.WebbSAPettilÃ¤VSeppeltIet al.Critical care services and 2009 H1N1" exact="influenza" post="in Australia and New ZealandN Engl J Med2009361201925193410.1056/NEJMoa090848119815860 27.DomÃ­nguez-CheritGLapinskySEMaciasAEet"/>
   <result pre="ZealandN Engl J Med2009361201925193410.1056/NEJMoa090848119815860 27.DomÃ­nguez-CheritGLapinskySEMaciasAEet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) in MexicoJAMA2009302171880188710.1001/jama.2009.153619822626 28.KumarAZarychanskiRPintoRet al.Critically ill patients with 2009"/>
   <result pre="influenza A(H1N1) in MexicoJAMA2009302171880188710.1001/jama.2009.153619822626 28.KumarAZarychanskiRPintoRet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) infection in CanadaJAMA2009302171872187910.1001/jama.2009.149619822627 29.MincholeEFigueredoALOmeÃ±acaMet al.Seasonal influenza a H1N1pdm09"/>
   <result pre="patients with 2009 influenza A(H1N1) infection in CanadaJAMA2009302171872187910.1001/jama.2009.149619822627 29.MincholeEFigueredoALOmeÃ±acaMet al.Seasonal" exact="influenza" post="a H1N1pdm09 virus and severe outcomes: a reason for"/>
   <result pre="People PLoS One20161111e016571110.1371/journal.pone.016571127832114 30.RandolphAGVaughnFSullivanRet al.Critically ill children during the 2009-2010" exact="influenza" post="pandemic in the United StatesPediatrics20111286e1450e145810.1542/peds.2011-077422065262 31.ShiehWJBlauDMDenisonAMet al.2009 pandemic influenza"/>
   <result pre="2009-2010 influenza pandemic in the United StatesPediatrics20111286e1450e145810.1542/peds.2011-077422065262 31.ShiehWJBlauDMDenisonAMet al.2009 pandemic" exact="influenza" post="A (H1N1): pathology and pathogenesis of 100 fatal cases"/>
   <result pre="and treatment-related risk factors for mortality among immunosuppressed patients with" exact="influenza" post="A (H1N1) virus admitted to the intensive care unitJ"/>
   <result pre="al.Complications among adults hospitalized with influenza: a comparison of seasonal" exact="influenza" post="and the 2009 H1N1 pandemicClin Infect Dis201459216617410.1093/cid/ciu28524785230 36.AyscuePMurrayEUyekiTet al.Influenza-associated"/>
   <result pre="2014MMWR Morb Mortal Wkly Rep201463714314724553197 37.ChavesSSAragonDBennettNet al.Patients hospitalized with laboratory-confirmed" exact="influenza" post="during the 2010-2011 influenza season: exploring disease severity by"/>
   <result pre="Rep201463714314724553197 37.ChavesSSAragonDBennettNet al.Patients hospitalized with laboratory-confirmed influenza during the 2010-2011" exact="influenza" post="season: exploring disease severity by virus type and subtypeJ"/>
   <result pre="in children, FluSurv-NET, 2011â€&quot;2017Open Forum Infectious Dis20185suppl_1S748S7S910.1093/ofid/ofy210.2146 39.CasadoIDomÃ­nguezAToledoDet al.Effect of" exact="influenza" post="vaccination on the prognosis of hospitalized influenza patientsExpert Rev"/>
   <result pre="39.CasadoIDomÃ­nguezAToledoDet al.Effect of influenza vaccination on the prognosis of hospitalized" exact="influenza" post="patientsExpert Rev Vaccines201615342543210.1586/14760584.2016.113432826690376 40.ArriolaCGargSAndersonEJet al.Influenza vaccination modifies disease severity"/>
   <result pre="among community-dwelling adults hospitalized with influenzaClin Infect Dis20176581289129710.1093/cid/cix46828525597 41.ArriolaCSAndersonEJBaumbachJet al.Does" exact="influenza" post="vaccination modify influenza severity? Data on older adults hospitalized"/>
   <result pre="hospitalized with influenzaClin Infect Dis20176581289129710.1093/cid/cix46828525597 41.ArriolaCSAndersonEJBaumbachJet al.Does influenza vaccination modify" exact="influenza" post="severity? Data on older adults hospitalized with influenza during"/>
   <result pre="vaccination modify influenza severity? Data on older adults hospitalized with" exact="influenza" post="during the 2012-2013 season in the United StatesJ Infect"/>
   <result pre="Catalonia. Influenza vaccine effectiveness in reducing severe outcomes over six" exact="influenza" post="seasons, a case-case analysis, Spain, 2010/11 to 2015/16. Euro"/>
   <result pre="2018;23(43). 10.2807/1560-7917.ES.2018.23.43.1700732. 45.CataniaJQueLGGovertJAHollingsworthJWWolfeCRHigh intensive care unit admission rate for 2013-2014" exact="influenza" post="is associated with a low rate of vaccinationAm J"/>
   <result pre="vaccinationAm J Respir Crit Care Med2014189448548710.1164/rccm.201401-0066LE24512430 46.TaylorGAbdesselamKPeludeLet al.Epidemiological features of" exact="influenza" post="in Canadian adult intensive care unit patientsEpidemiol Infect2016144474175010.1017/S095026881500211326384310 47.FerdinandsJMOlshoLEAganAAet"/>
   <result pre="Canadian adult intensive care unit patientsEpidemiol Infect2016144474175010.1017/S095026881500211326384310 47.FerdinandsJMOlshoLEAganAAet al.Effectiveness of" exact="influenza" post="vaccine against life-threatening RT-PCR-confirmed influenza illness in US children,"/>
   <result pre="patientsEpidemiol Infect2016144474175010.1017/S095026881500211326384310 47.FerdinandsJMOlshoLEAganAAet al.Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed" exact="influenza" post="illness in US children, 2010-2012J Infect Dis2014210567468310.1093/infdis/jiu18524676207 48.Flannery B,"/>
   <result pre="frequently present as the infecting agent in acute exacerbations of" exact="chronic obstructive pulmonary disease" post="in patients presenting to hospitalIntern Med J201646101160116510.1111/imj.1321327515577 51.SandrockCENorrisAInfection in"/>
   <result pre="in patients presenting to hospitalIntern Med J201646101160116510.1111/imj.1321327515577 51.SandrockCENorrisAInfection in severe" exact="asthma" post="exacerbations and critical asthma syndromeClin Rev Allergy Immunol201548110411310.1007/s12016-014-8435-x24984968 52.Panhwar"/>
   <result pre="hospitalIntern Med J201646101160116510.1111/imj.1321327515577 51.SandrockCENorrisAInfection in severe asthma exacerbations and critical" exact="asthma" post="syndromeClin Rev Allergy Immunol201548110411310.1007/s12016-014-8435-x24984968 52.Panhwar MS, Kalra A, Gupta"/>
   <result pre="Kolte D, Khera S, Bhatt DL, Ginwalla M. Effect of" exact="influenza" post="on outcomes in patients with heart failure. JACC Heart"/>
   <result pre="burden of influenza: a review of the extra-pulmonary complications of" exact="influenza" post="infectionInfluenza Other Respir Viruses201711537239310.1111/irv.1247028745014 54.Alvarez-LermaFMarin-CorralJVilaCet al.Delay in diagnosis of"/>
   <result pre="influenza infectionInfluenza Other Respir Viruses201711537239310.1111/irv.1247028745014 54.Alvarez-LermaFMarin-CorralJVilaCet al.Delay in diagnosis of" exact="influenza" post="A (H1N1)pdm09 virus infection in critically ill patients and"/>
   <result pre="58.MerckxJWaliRSchillerIet al.Diagnostic accuracy of novel and traditional rapid tests for" exact="influenza" post="infection compared with reverse transcriptase polymerase chain reaction: a"/>
   <result pre="review and meta-analysisAnn Intern Med2017167639440910.7326/M17-084828869986 59.BlythCCIredellJRDwyerDERapid-test sensitivity for novel swine-origin" exact="influenza" post="A (H1N1) virus in humansN Engl J Med200936125249310.1056/NEJMc090904919923563 60.Vos"/>
   <result pre="molecular assays, RT-PCR, and other molecular assays for diagnosis of" exact="influenza" post="virus infection. Available at: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm. Accessed 24 Apr 2019."/>
   <result pre="virus infection. Available at: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm. Accessed 24 Apr 2019. 62.UyekiTMKatzJMJerniganDBNovel" exact="influenza" post="A viruses and pandemic threatsLancet2017389100852172217410.1016/S0140-6736(17)31274-628589883 63.UyekiTMInfluenzaAnn Intern Med20171675ITC33ITC4810.7326/AITC20170905028869984 64.Centers"/>
   <result pre="Available at: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm. Accessed 24 Apr 2019. 65.DobsonJWhitleyRJPocockSMontoASOseltamivir treatment for" exact="influenza" post="in adults: a meta-analysis of randomised controlled trialsLancet201538599791729173710.1016/S0140-6736(14)62449-125640810 66.MaloshREMartinETHeikkinenTBrooksWAWhitleyRJMontoASEfficacy"/>
   <result pre="early treatment with oseltamivir in hospitalized patients with documented 2009" exact="influenza" post="A (H1N1): retrospective cohort studyJ Antimicrob Chemother20116651150510.1093/jac/dkr08921393197 68.CoffinSELeckermanKKerenRHallMLocalioRZaoutisTEOseltamivir shortens"/>
   <result pre="treatment on outcomes of public health importance during the 2009-2010" exact="influenza" post="a(H1N1) pandemic: a systematic review and meta-analysis in hospitalized"/>
   <result pre="inhibitors in reducing mortality in patients admitted to hospital with" exact="influenza" post="A H1N1pdm09 virus infection: a meta-analysis of individual participant"/>
   <result pre="al.Effectiveness of antiviral treatment in preventing death in severe hospitalised" exact="influenza" post="cases over six seasonsEpidemiol Infect2018146779980810.1017/S095026881800066329606178 74.RodriguezADiazEMartin-LoechesIet al.Impact of early"/>
   <result pre="treatment on outcome in critically ill patients with 2009 pandemic" exact="influenza" post="AJ Antimicrob Chemother20116651140114910.1093/jac/dkq51121385717 75.DollMKWintersNBoikosCKraicer-MelamedHGoreGQuachCSafety and effectiveness of neuraminidase inhibitors"/>
   <result pre="AJ Antimicrob Chemother20116651140114910.1093/jac/dkq51121385717 75.DollMKWintersNBoikosCKraicer-MelamedHGoreGQuachCSafety and effectiveness of neuraminidase inhibitors for" exact="influenza" post="treatment, prophylaxis, and outbreak control: a systematic review of"/>
   <result pre="77.LouieJKYangSAcostaMet al.Treatment with neuraminidase inhibitors for critically ill patients with" exact="influenza" post="A (H1N1)pdm09Clin Infect Dis20125591198120410.1093/cid/cis63622843781 78.Lytras T, Mouratidou E, Andreopoulou"/>
   <result pre="intervention study on higher-dose oseltamivir treatment in adults hospitalized with" exact="influenza" post="a and B infectionsClin Infect Dis201357111511151910.1093/cid/cit59724046309 89.NoelZRBastinMLTMontgomeryAAFlanneryAHComparison of high-dose"/>
   <result pre="randomized study of standard versus double dose oseltamivir for treating" exact="influenza" post="in the communityAntivir Ther201520768969810.3851/IMP280724912485 93.PaiMPLodiseTPJrOseltamivir and oseltamivir carboxylate pharmacokinetics"/>
   <result pre="is not necessaryAntimicrob Agents Chemother201155125640564510.1128/AAC.00422-1121930881 94.Thorne-HumphreyLMGoralskiKBSlayterKLet al.Oseltamivir pharmacokinetics in morbid" exact="obesity" post="(OPTIMO trial)J Antimicrob Chemother20116692083209110.1093/jac/dkr25721700623 95.collab: To KKHungIFLiIWet al.Delayed clearance"/>
   <result pre="marked cytokine activation in severe cases of pandemic H1N1 2009" exact="influenza" post="virus infectionClin Infect Dis201050685085910.1086/65058120136415 96.LeeNChanPKWongCKet al.Viral clearance and inflammatory"/>
   <result pre="and inflammatory response patterns in adults hospitalized for pandemic 2009" exact="influenza" post="A(H1N1) virus pneumoniaAntivir Ther201116223724710.3851/IMP172221447873 97.IsonMGde JongMDGilliganKJet al.End points for"/>
   <result pre="A(H1N1) virus pneumoniaAntivir Ther201116223724710.3851/IMP172221447873 97.IsonMGde JongMDGilliganKJet al.End points for testing" exact="influenza" post="antiviral treatments for patients at high risk of severe"/>
   <result pre="two placebo-controlled trialsAntivir Ther201520770971910.3851/IMP287425318121 100.IsonMGFraizJHellerBet al.Intravenous peramivir for treatment of" exact="influenza" post="in hospitalized patientsAntivir Ther201419434936110.3851/IMP268023985625 101.LeeJParkJHJwaHKimYHComparison of efficacy of intravenous"/>
   <result pre="peramivir compared with oral oseltamivir for the treatment of seasonal" exact="influenza" post="in hospitalized adultsAntivir Ther201318565166110.3851/IMP244223111657 103.de JongMDIsonMGMontoASet al.Evaluation of intravenous"/>
   <result pre="Ther201318565166110.3851/IMP244223111657 103.de JongMDIsonMGMontoASet al.Evaluation of intravenous peramivir for treatment of" exact="influenza" post="in hospitalized patientsClin Infect Dis20145912e172e18510.1093/cid/ciu63225115871 104.NakamuraSMiyazakiTIzumikawaKet al.Efficacy and safety"/>
   <result pre="intravenous peramivir compared with oseltamivir in high-risk patients infected with" exact="influenza" post="A and B viruses: a multicenter randomized controlled studyOpen"/>
   <result pre="controlled studyOpen Forum Infect Dis201743ofx12910.1093/ofid/ofx12928761899 105.HaydenFGSugayaNHirotsuNet al.Baloxavir marboxil for uncomplicated" exact="influenza" post="in adults and adolescentsN Engl J Med20183791091392310.1056/NEJMoa171619730184455 106.OmotoSSperanziniVHashimotoTet al.Characterization"/>
   <result pre="in adults and adolescentsN Engl J Med20183791091392310.1056/NEJMoa171619730184455 106.OmotoSSperanziniVHashimotoTet al.Characterization of" exact="influenza" post="virus variants induced by treatment with the endonuclease inhibitor"/>
   <result pre="a randomized trial for pandemic critical illness: the 2009 H1N1" exact="influenza" post="pandemicIntensive Care Med2012381293910.1007/s00134-011-2409-822120766 109.HanKMaHAnXet al.Early use of glucocorticoids was"/>
   <result pre="Dis201153432633310.1093/cid/cir39821810744 110.MorenoGRodriguezAReyesLFet al.Corticosteroid treatment in critically ill patients with severe" exact="influenza" post="pneumonia: a propensity score matching studyIntensive Care Med20184491470148210.1007/s00134-018-5332-430074052 111.RodrigoCLeonardi-BeeJNguyen-Van-TamJSLimWSEffect"/>
   <result pre="Dis2015212218319410.1093/infdis/jiu64525406333 112.YangJWFanLCMiaoXYet al.Corticosteroids for the treatment of human infection with" exact="influenza" post="virus: a systematic review and meta-analysisClin Microbiol Infect2015211095696310.1016/j.cmi.2015.06.02226123860 113.NiYNChenGSunJLiangBMLiangZAThe"/>
   <result pre="Infect2015211095696310.1016/j.cmi.2015.06.02226123860 113.NiYNChenGSunJLiangBMLiangZAThe effect of corticosteroids on mortality of patients with" exact="influenza" post="pneumonia: a systematic review and meta-analysisCrit Care20192319910.1186/s13054-019-2395-830917856 114.Brun-BuissonCRichardJCMercatAThiebautACBrochardLcollab: Group"/>
   <result pre="review and meta-analysisCrit Care20192319910.1186/s13054-019-2395-830917856 114.Brun-BuissonCRichardJCMercatAThiebautACBrochardLcollab: Group R-SAHNvREarly corticosteroids in severe" exact="influenza" post="a/H1N1 pneumonia and acute respiratory distress syndromeAm J Respir"/>
   <result pre="meta-analysisCrit Care20192319910.1186/s13054-019-2395-830917856 114.Brun-BuissonCRichardJCMercatAThiebautACBrochardLcollab: Group R-SAHNvREarly corticosteroids in severe influenza a/H1N1" exact="pneumonia" post="and acute respiratory distress syndromeAm J Respir Crit Care"/>
   <result pre="Med201118391200120610.1164/rccm.201101-0135OC21471082 115.KimSHHongSBYunSCet al.Corticosteroid treatment in critically ill patients with pandemic" exact="influenza" post="A/H1N1 2009 infection: analytic strategy using propensity scoresAm J"/>
   <result pre="Database Syst Rev20192CD01040630798570 117.LeeNCockramCSChanPKHuiDSChoiKWSungJJAntiviral treatment for patients hospitalized with severe" exact="influenza" post="infection may affect clinical outcomesClin Infect Dis20084681323132410.1086/53347718444878 118.GiannellaMAlonsoMGarcia de"/>
   <result pre="Infect Dis20084681323132410.1086/53347718444878 118.GiannellaMAlonsoMGarcia de ViedmaDet al.Prolonged viral shedding in pandemic" exact="influenza" post="a(H1N1): clinical significance and viral load analysis in hospitalized"/>
   <result pre="120.WangYGuoQYanZet al.Factors associated with prolonged viral shedding in patients with" exact="avian influenza" post="A(H7N9) virus infectionJ Infect Dis2018217111708171710.1093/infdis/jiy11529648602 121.LeeNLeoYSCaoBet al.Neuraminidase inhibitors, superinfection"/>
   <result pre="al.Factors associated with prolonged viral shedding in patients with avian" exact="influenza" post="A(H7N9) virus infectionJ Infect Dis2018217111708171710.1093/infdis/jiy11529648602 121.LeeNLeoYSCaoBet al.Neuraminidase inhibitors, superinfection"/>
   <result pre="Dis2018217111708171710.1093/infdis/jiy11529648602 121.LeeNLeoYSCaoBet al.Neuraminidase inhibitors, superinfection and corticosteroids affect survival of" exact="influenza" post="patientsEur Respir J20154561642165210.1183/09031936.0016971425573405 122.Martin-LoechesILisboaTRhodesAet al.Use of early corticosteroid therapy"/>
   <result pre="on ICU admission in patients affected by severe pandemic (H1N1)v" exact="influenza" post="A infectionIntensive Care Med201137227228310.1007/s00134-010-2078-z21107529 123.DelaneyJWPintoRLongJet al.The influence of corticosteroid"/>
   <result pre="123.DelaneyJWPintoRLongJet al.The influence of corticosteroid treatment on the outcome of" exact="influenza" post="A(H1N1pdm09)-related critical illnessCrit Care2016207510.1186/s13054-016-1230-827036638 124.CaoBGaoHZhouBet al.Adjuvant corticosteroid treatment in"/>
   <result pre="critical illnessCrit Care2016207510.1186/s13054-016-1230-827036638 124.CaoBGaoHZhouBet al.Adjuvant corticosteroid treatment in adults with" exact="influenza" post="A (H7N9) viral pneumoniaCrit Care Med2016446e318e32810.1097/CCM.000000000000161626934144 125.BeigelJHBaoYBeelerJet al.Oseltamivir, amantadine,"/>
   <result pre="Dis201717121255126510.1016/S1473-3099(17)30476-028958678 126.SeoSEnglundJANguyenJTet al.Combination therapy with amantadine, oseltamivir and ribavirin for" exact="influenza" post="A infection: safety and pharmacokineticsAntivir Ther201318337738610.3851/IMP247523264438 127.KimWYYoung SuhGHuhJWet al.Triple-combination"/>
   <result pre="pharmacokineticsAntivir Ther201318337738610.3851/IMP247523264438 127.KimWYYoung SuhGHuhJWet al.Triple-combination antiviral drug for pandemic H1N1" exact="influenza" post="virus infection in critically ill patients on mechanical ventilationAntimicrob"/>
   <result pre="in combination with Oseltamivir for treatment of acute uncomplicated seasonal" exact="influenza" post="A: TOPAZ trial. J Infect Dis. 2019;219(7):1026â€&quot;34. 129.collab: MDVI"/>
   <result pre="efficacy and safety study of favipiravir for treatment of uncomplicated" exact="influenza" post="in adults - T705US316. ClinicalTrialsgov [Internet]. November 11, 2015"/>
   <result pre="Oseltamivir (TamifluÂ®) compared with Oseltamivir alone in hospitalized adults with" exact="influenza" post="a infection requiring oxygen support. ClinicalTrialsgov [internet]. August 28,"/>
   <result pre="in combination with oseltamivir versus oseltamivir in participants with severe" exact="influenza" post="a infection. ClinicalTrialsgov [internet]. June 18, 2018 ed2018BethesdaNational Library"/>
   <result pre="al.Convalescent plasma treatment reduced mortality in patients with severe pandemic" exact="influenza" post="A (H1N1) 2009 virus infectionClin Infect Dis201152444745610.1093/cid/ciq10621248066 136.HungIFNcollab: To"/>
   <result pre="multicenter double-blind randomized controlled trial for patients with severe 2009" exact="influenza" post="A(H1N1) infectionChest2013144246447310.1378/chest.12-290723450336 137.HungIA randomized controlled trial on the treatment"/>
   <result pre="infectionChest2013144246447310.1378/chest.12-290723450336 137.HungIA randomized controlled trial on the treatment of severe" exact="influenza" post="a infection. ClinicalTrialsgov [internet]. July 25, 2017 ed2017BethesdaNational Library"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563504\results\search\disease\results.xml">
   <result pre="human and animal health worldwide. Understanding the control mechanisms of" exact="influenza" post="infection and dynamics is crucial and could result in"/>
   <result pre="a new approach to understanding the overall structure of twelve" exact="influenza" post="A virus infection models and their relationship to each"/>
   <result pre="helpful in model development and model integration, also beyond the" exact="influenza" post="area. chemical organization theory influenza A virus dynamics modeling"/>
   <result pre="model integration, also beyond the influenza area. chemical organization theory" exact="influenza" post="A virus dynamics modeling complex networks analysis 1. Introduction"/>
   <result pre="modeling complex networks analysis 1. Introduction Influenza is an infectious" exact="respiratory disease," post="annually infecting 5â€&quot;15% of the human population and causing"/>
   <result pre="of epidemics is caused by the continuous alteration of seasonal" exact="influenza" post="viruses, which enables them to efficiently escape the immune"/>
   <result pre="major burden of disease in humans is caused by seasonal" exact="influenza" post="A (IAV) and influenza B viruses, causing symptoms varying"/>
   <result pre="in humans is caused by seasonal influenza A (IAV) and" exact="influenza" post="B viruses, causing symptoms varying from mild respiratory disease"/>
   <result pre="(IAV) and influenza B viruses, causing symptoms varying from mild" exact="respiratory disease" post="characterized by fever, sore throat, headache and muscle pain"/>
   <result pre="and muscle pain to severe and in some cases lethal" exact="pneumonia" post="and secondary bacterial infections [3]. The long-term spread of"/>
   <result pre="pneumonia and secondary bacterial infections [3]. The long-term spread of" exact="influenza" post="viruses in the human population and the acute nature"/>
   <result pre="viruses in the human population and the acute nature of" exact="influenza" post="virus epidemics is driven by the global movement of"/>
   <result pre="movement of these viruses. Differences in seasonal epidemics caused by" exact="influenza" post="viruses are mainly driven by differences in the rates"/>
   <result pre="the rates of virus evolution. The single-stranded RNA segments of" exact="influenza" post="viruses, which are located inside the virus particle (or"/>
   <result pre="have been developed to provide insight into within-host dynamics of" exact="influenza" post="A virus infections (for reviews, see [4,5,6,7,8]). These models"/>
   <result pre="Figure 1. By applying the method to twelve models of" exact="influenza" post="A virus infection, we found different types of model"/>
   <result pre="illustrate our method, we follow a basic ODE model of" exact="influenza" post="dynamics, namely the target cell limited model by Baccam"/>
   <result pre="The organization O 2 B represents an organism without any" exact="influenza" post="A virus infection. Note that there is no organization"/>
   <result pre="present now the full analysis for eleven additional more detailed" exact="influenza" post="models of IAV dynamics, with up to 15 variables"/>
   <result pre="References References 1.StÃ¶hrK.Influenzaâ€&quot;WHO caresLancet Infect. Dis.2002251710.1016/S1473-3099(02)00366-312206966 2.PetrovaV.N.RussellC.A.The evolution of seasonal" exact="influenza" post="virusesNat. Rev. Microbiol.201816476010.1038/nrmicro.2017.11829081496 3.KrammerF.SmithG.J.FouchierR.A.PeirisM.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis. Prim.2018410.1038/s41572-018-0002-y29955068 4.SmithA.M.PerelsonA.S.Influenza"/>
   <result pre="Rev. Syst. Biol. Med.2011342944510.1002/wsbm.12921197654 5.BeaucheminC.A.HandelA.A review of mathematical models of" exact="influenza" post="A infections within a host or cell culture: Lessons"/>
   <result pre="and challenges aheadBMC Public Health201111Suppl. 1S710.1186/1471-2458-11-S1-S721356136 6.DobrovolnyH.M.ReddyM.B.KamalM.A.RaynerC.R.BeaucheminC.A.Assessing mathematical models of" exact="influenza" post="infections using features of the immune responsePLoS ONE20138e5708810.1371/journal.pone.005708823468916 7.BoianelliA.NguyenV.K.EbensenT.SchulzeK.WilkE.SharmaN.Stegemann-KoniszewskiS.BruderD.ToapantaF.R.GuzmanC.A.et"/>
   <result pre="for Influenza ResearchViruses201575274530410.3390/v710287526473911 8.HandelA.LiaoL.E.BeaucheminC.A.Progress and trends in mathematical modelling of" exact="influenza" post="A virus infectionsCurr. Opin. Syst. Biol.201812303610.1016/j.coisb.2018.08.009 9.LeeH.Y.TophamD.J.ParkS.Y.HollenbaughJ.TreanorJ.MosmannT.R.JinX.WardB.M.MiaoH.Holden-WiltseJ.et al.Simulation and"/>
   <result pre="9.LeeH.Y.TophamD.J.ParkS.Y.HollenbaughJ.TreanorJ.MosmannT.R.JinX.WardB.M.MiaoH.Holden-WiltseJ.et al.Simulation and prediction of the adaptive immune response to" exact="influenza" post="A virus infectionJ. Virol.2009837151716510.1128/JVI.00098-0919439465 10.DittrichP.Speroni di FenizioP.Chemical Organization TheoryBull."/>
   <result pre="Limit Sets in Chemical Reaction SystemsAdv. Complex Syst.201114779610.1142/S0219525911002895 13.BaccamP.BeaucheminC.MackenC.A.HaydenF.G.PerelsonA.S.Kinetics of" exact="influenza" post="A virus infection in humansJ. Virol.2006807590759910.1128/JVI.01623-0516840338 14.MiaoH.HollenbaughJ.A.ZandM.S.Holden-WiltseJ.MosmannT.R.PerelsonA.S.WuH.TophamD.J.Quantifying the early"/>
   <result pre="response and adaptive immune response kinetics in mice infected with" exact="influenza" post="A virusJ. Virol.2010846687669810.1128/JVI.00266-1020410284 15.SmithA.M.SmithA.P.A Critical, Nonlinear Threshold Dictates Bacterial"/>
   <result pre="dependence supports biphasic viral decayFront. Microbiol.20189155410.3389/fmicb.2018.0155430042759 23.PawelekK.A.HuynhG.T.QuinlivanM.CullinaneA.RongL.PerelsonA.S.Modeling within-host dynamics of" exact="influenza" post="virus infection including immune responsesPLoS Comput. Biol.20128e100258810.1371/journal.pcbi.100258822761567 24.HandelA.LonginiI.M.Jr.AntiaR.Towards a"/>
   <result pre="Biol.20128e100258810.1371/journal.pcbi.100258822761567 24.HandelA.LonginiI.M.Jr.AntiaR.Towards a quantitative understanding of the within-host dynamics of" exact="influenza" post="A infectionsJ. R. Soc. Interface20097354710.1098/rsif.2009.006719474085 25.HandelA.LonginiI.M.Jr.AntiaR.Neuraminidase inhibitor resistance in"/>
   <result pre="generation and spreadPLoS Comput. Biol.20073e24010.1371/journal.pcbi.003024018069885 26.Hernandez-VargasA.E.Meyer-HermannM.Innate immune system dynamics to" exact="influenza" post="virusIFAC Proc. Vol.20124526026510.3182/20120829-3-HU-2029.00029 27.CaoP.YanA.W.HeffernanJ.M.PetrieS.MossR.G.CarolanL.A.GuarnacciaT.A.KelsoA.BarrI.G.McVernonJ.et al.Innate Immunity and the Inter-exposure"/>
   <result pre="and Explain Observed Viral HierarchiesPLoS Comput. Biol.201511e100433410.1371/journal.pcbi.100433426284917 28.SaenzR.A.QuinlivanM.EltonD.MacraeS.BlundenA.S.MumfordJ.A.DalyJ.M.DigardP.CullinaneA.GrenfellB.T.et al.Dynamics of" exact="influenza" post="virus infection and pathologyJ. Virol.2010843974398310.1128/JVI.02078-0920130053 29.HanciogluB.SwigonD.ClermontG.A dynamical model of"/>
   <result pre="pathologyJ. Virol.2010843974398310.1128/JVI.02078-0920130053 29.HanciogluB.SwigonD.ClermontG.A dynamical model of human immune response to" exact="influenza" post="A virus infectionJ. Theor. Biol.2007246708610.1016/j.jtbi.2006.12.01517266989 30.BocharovG.A.RomanyukhaA.A.Mathematical model of antiviral"/>
   <result pre="Influenza A virus infectionJ. Theor. Biol.199416732336010.1006/jtbi.1994.10747516024 31.CaoP.McCawJ.The mechanisms for within-host" exact="influenza" post="virus control affect model-based assessment and prediction of antiviral"/>
   <result pre="infected cells ( E P * ) and free infectious" exact="influenza" post="viruses ( V ). Figure 4 The Baccam II"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563844\results\search\disease\results.xml">
   <result pre="comply with these terms. Abstract The high genetic variability of" exact="influenza" post="A viruses poses a continual challenge to seasonal and"/>
   <result pre="was observed. In addition to identifying dextromethorphan as a potential" exact="influenza" post="treatment option, our study illustrates the feasibility of a"/>
   <result pre="bioinformatics-driven rational approach for repurposing approved drugs against infectious diseases." exact="influenza" post="A virus drug repurposing antiviral (H1N1 and H3N2) activity"/>
   <result pre="glycoproteins. Based on the antigenic properties of these viral glycoproteins," exact="influenza" post="A viruses are classified into different subtypes. To date,"/>
   <result pre="(3, 4). With the exception of bat-associated subtypes (4), all" exact="influenza" post="A virus subtypes can be found in wild aquatic"/>
   <result pre="without causing severe disease (8). Even though the production of" exact="influenza" post="vaccines is well established, and the regulatory process allows"/>
   <result pre="play an important role in reducing disease severity during seasonal" exact="influenza" post="epidemics. Two classes of approved drugs against influenza A"/>
   <result pre="during seasonal influenza epidemics. Two classes of approved drugs against" exact="influenza" post="A virus infections have been available for years: adamantane-based"/>
   <result pre="of widespread use, and at this time, all circulating human" exact="influenza" post="A viruses are adamantane-resistant (12), and the number of"/>
   <result pre="inhibitor, has been licensed in Japan for the treatment of" exact="influenza" post="virus infections (14), and favipiravir, an inhibitor of the"/>
   <result pre="list of promising candidate proteins and pathways involved in the" exact="influenza" post="virus life cycle (18â€&quot;21). Watanabe et al. previously described"/>
   <result pre="fetal calf serum (FCS), and 1% L-glutamine at 37Â°C. The" exact="influenza" post="A virus strains H1N1 A/Puerto Rico/8/34 (PR8, (23), H3N2"/>
   <result pre="the experiment was repeated including additional drug concentrations and different" exact="influenza" post="A strains. For the calculation of the 50% effective"/>
   <result pre="(mustela putorius furo, bred in-house) without antibodies against circulating seasonal" exact="influenza" post="A virus strains were treated orally every 8 h"/>
   <result pre="Influenza Virus Life Cycle Whole genome siRNA screens using different" exact="influenza" post="A virus strains and cell lines have yielded a"/>
   <result pre="a list of cellular proteins that are required in the" exact="influenza" post="virus life cycle (22). While it is in most"/>
   <result pre="that modulate their expression levels or activity may also inhibit" exact="influenza" post="virus. Therefore, we computationally searched for FDA-approved drugs annotated"/>
   <result pre="updated host factor network generated by a meta-analysis of available" exact="influenza" post="virus siRNA screen data sets (Figure 1). This bioinformatics"/>
   <result pre="(Table 1). Figure 1 Identification of candidate drugs. Network of" exact="influenza" post="host factors with drug targets highlighted. From the network"/>
   <result pre="DrugBank flat file version 3.0 (27). Table 1 Inhibition of" exact="influenza" post="A virus replication by licensed drugs with Drug ID"/>
   <result pre="Compounds Inhibit Influenza A Virus Replication To identify candidates with" exact="influenza" post="virus inhibitory activity, cells were pre-treated with the respective"/>
   <result pre="of the endosome, which may explain its inhibitory effect on" exact="influenza" post="A viruses (32). Naltrexone, a competitive opioid receptor agonist"/>
   <result pre="6-phosphogluconate dehydrogenase (PGD) in vitro (37), which is upregulated in" exact="influenza" post="A virus-infected cells (38). To determine whether the antiviral"/>
   <result pre="potential candidates extended to circulating seasonal H3N2 and pandemic H1N1" exact="influenza" post="strains, A/Victoria/36/2011 (H3N2), and A/Mexico/InDRE4487/2009 (H1N1pdm09) were included in"/>
   <result pre="cells were pretreated for 8 h and infected with the" exact="influenza" post="strains A/Puerto Rico/8/34 (PR8) (A), A/Mexico/InDRE4487/2009 (H1N1pdm09) (B), or"/>
   <result pre="index (SI) of the different compounds against H1N1 and H3N2" exact="influenza" post="A viruses. PR8 pH1N1 H3N2 CC50 (Î¼M) EC50 (Î¼M)"/>
   <result pre="different strains and even different virus families (16, 45). For" exact="influenza" post="virus, several whole genome siRNA screens have been published"/>
   <result pre="years (18â€&quot;21), allowing the cross-matching of host proteins required for" exact="influenza" post="replication with known cellular drug targets. Using this approach,"/>
   <result pre="reduction of clinical signs, supporting its further consideration as an" exact="influenza" post="treatment option. High-throughput siRNA screens have opened a new"/>
   <result pre="for drug repurposing (46). This is of special relevance for" exact="infectious disease" post="targets with lesser market potential, as the development of"/>
   <result pre="subject of ongoing studies. Ferrets closely mimic the course of" exact="influenza" post="disease seen in humans (44, 60). Seasonal and pandemic"/>
   <result pre="disease seen in humans (44, 60). Seasonal and pandemic 2009" exact="influenza" post="viruses thus cause a mild to moderate disease of"/>
   <result pre="drugs are frequently used as over the counter remedies for" exact="influenza" post="and influenza-like respiratory infections, a more detailed evaluation of"/>
   <result pre="century. Emerg Infect Dis. (2006) 12:9â€&quot;14. 10.3201/eid1201.05125416494710 2.OsterhausABrooksABrobergEMacIntyreRCapuaI. Why should" exact="influenza" post="be a public health priority. Vaccine. (2015) 33:7022â€&quot;5. 10.1016/j.vaccine.2015.08.04926319062"/>
   <result pre="PA: Lippincott Williams &amp;amp; Wilkins (2013). p. 1151â€&quot;85. 4.MehleA. Unusual" exact="influenza" post="A viruses in bats. Viruses. (2014) 6:3438â€&quot;49. 10.3390/v609343825256392 5.NeumannGKawaokaYTransmission"/>
   <result pre="A viruses in bats. Viruses. (2014) 6:3438â€&quot;49. 10.3390/v609343825256392 5.NeumannGKawaokaYTransmission of" exact="influenza" post="A viruses. Virology. (2015) 479â€&quot;80:234â€&quot;246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic"/>
   <result pre="influenza A viruses. Virology. (2015) 479â€&quot;80:234â€&quot;246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic" exact="avian influenza" post="as a zoonotic agent. Vet Microbiol. (2010) 140:237â€&quot;45. 10.1016/j.vetmic.2009.08.02219782482"/>
   <result pre="A viruses. Virology. (2015) 479â€&quot;80:234â€&quot;246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic avian" exact="influenza" post="as a zoonotic agent. Vet Microbiol. (2010) 140:237â€&quot;45. 10.1016/j.vetmic.2009.08.02219782482"/>
   <result pre="Vet Microbiol. (2010) 140:237â€&quot;45. 10.1016/j.vetmic.2009.08.02219782482 7.PerdueMLSwayneDE. Public health risk from" exact="avian influenza" post="viruses. Avian Dis. (2005) 49:317â€&quot;27. 10.1637/7390-060305R.116252482 8.WuHWangXXueMXueMWuCLuQet al.. Spatial"/>
   <result pre="Microbiol. (2010) 140:237â€&quot;45. 10.1016/j.vetmic.2009.08.02219782482 7.PerdueMLSwayneDE. Public health risk from avian" exact="influenza" post="viruses. Avian Dis. (2005) 49:317â€&quot;27. 10.1637/7390-060305R.116252482 8.WuHWangXXueMXueMWuCLuQet al.. Spatial"/>
   <result pre="al.. Spatial characteristics and the epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in five waves from 2013 to 2017"/>
   <result pre="Spatial characteristics and the epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in five waves from 2013 to 2017"/>
   <result pre="Zhejiang Province, China. PLoS One. (2017) 12:e0180763. 10.1371/journal.pone.018076328750032 9.NafzigerANPrattDS. Seasonal" exact="influenza" post="vaccination and technologies. J Clin Pharmacol. (2014) 54:719â€&quot;31. 10.1002/jcph.29924691877"/>
   <result pre="6:187â€&quot;98. 10.2147/IDR.S3660124277988 12.DeydeVMXuXBrightRAShawMSmithCBet al.. Surveillance of resistance to adamantanes among" exact="influenza" post="A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis."/>
   <result pre="10.1086/51893617570112 13.GubarevaLVBesselaarTGDanielsRSFryAGregoryVHuangWet al.. Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors, 2015â€&quot;2016. Antiviral Res. (2017) 146:12â€&quot;20."/>
   <result pre="10.1038/nrmicro303623728212 18.BrassALHuangICBenitaYJohnSPKrishnanMNFeeleyEMet al.. The IFITM proteins mediate cellular resistance to" exact="influenza" post="A H1N1 virus, West Nile virus, and dengue virus."/>
   <result pre="al.. Genome-wide RNAi screen identifies human host factors crucial for" exact="influenza" post="virus replication. Nature. (2010) 463:818â€&quot;22. 10.1038/nature0876020081832 20.KÃ¶nigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human"/>
   <result pre="(2010) 463:818â€&quot;22. 10.1038/nature0876020081832 20.KÃ¶nigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human host factors required for" exact="influenza" post="virus replication. Nature. (2010) 463:813â€&quot;7. 10.1038/nature0869920027183 21.ShapiraSDGat-ViksIShumBODricotAde GraceMMWuLet al.."/>
   <result pre="Cell. (2009) 139:1255â€&quot;67. 10.1016/j.cell.2009.12.01820064372 22.WatanabeTWatanabeSKawaokaY. Cellular networks involved in the" exact="influenza" post="virus life cycle. Cell Host Microbe. (2010) 7:427â€&quot;39. 10.1016/j.chom.2010.05.00820542247"/>
   <result pre="Cell Host Microbe. (2010) 7:427â€&quot;39. 10.1016/j.chom.2010.05.00820542247 23.SvitekNRuddPAObojesKPilletSvon MesslingV. Severe seasonal" exact="influenza" post="in ferrets correlates with reduced interferon and increased IL-6"/>
   <result pre="28.SleemanKMishinVPDeydeVMFurutaYKlimovAIGubarevaLV. In vitro antiviral activity of favipiravir (T-705) against drug-resistant" exact="influenza" post="and 2009 A(H1N1) viruses. Antimicrobial Agents Chemother. (2010) 54:2517â€&quot;24."/>
   <result pre="32.YamauchiYBoukariHBanerjeeISbalzariniIFHorvathPHeleniusA. Histone deacetylase 8 is required for centrosome cohesion and" exact="influenza" post="A virus entry. PLoS Pathog. (2011) 7:e1002316. 10.1371/journal.ppat.100231622046129 33.SuTPSuTCNakamuraYTsaiSY."/>
   <result pre="Enzyme Inhib Med Chem. (2010) 25:871â€&quot;5. 10.3109/1475636090348958121054237 38.JankeRGenzelYWetzelMReichlU. Effect of" exact="influenza" post="virus infection on key metabolic enzyme activities in MDCK"/>
   <result pre="al.. Mast cell-induced lung injury in mice infected with H5N1" exact="influenza" post="virus. J Virol. (2012) 86:3347â€&quot;56. 10.1128/JVI.06053-1122238293 40.LiuSL Li YHShiGYTangSHJiangSJHuangCWLiuPYet"/>
   <result pre="40.LiuSL Li YHShiGYTangSHJiangSJHuangCWLiuPYet al.. Dextromethorphan reduces oxidative stress and inhibits" exact="atherosclerosis" post="and neointima formation in mice. Cardiovasc Res. (2009) 82:161â€&quot;9."/>
   <result pre="Effects of double combinations of amantadine, oseltamivir, and ribavirin on" exact="influenza" post="A (H5N1) virus infections in cell culture and in"/>
   <result pre="effects of dextromethorphan. PLoS ONE.9:e89985. 10.1371/journal.pone.008998524587167 43.BouvierNM. Animal models for" exact="influenza" post="virus transmission studies: a historical perspective. Curr Opin Virol."/>
   <result pre="10.1016/j.cell.2007.08.03617981125 58.OchiaiHKurokawaMNiwayamaS. Influence of trifluoperazine on the late stage of" exact="influenza" post="virus infection in MDCK cells. Antiviral Res. (1991) 15:149â€&quot;60."/>
   <result pre="(1991) 15:149â€&quot;60. 10.1016/0166-3542(91)90032-M1859203 59.FujiokaYTsudaMNanboAHattoriTSasakiJSasakiTet al.. A Ca(2+)-dependent signalling circuit regulates" exact="influenza" post="A virus internalization and infection. Nat Commun. (2013) 4:2763."/>
   <result pre="10.1038/ncomms376324434940 60.BelserJAKatzJMTumpeyTM. The ferret as a model organism to study" exact="influenza" post="A virus infection. Dis Model Mech. (2011) 4:575â€&quot;9. 10.1242/dmm.00782321810904"/>
   <result pre="Characterization in vitro and in vivo of pandemic (H1N1) 2009" exact="influenza" post="viruses isolated from patients. J Virol. (2012) 86:9361â€&quot;8. 10.1128/JVI.01214-1222718834"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6564047\results\search\disease\results.xml">
   <result pre=": Gene amplification: RNA amplification Field diagnosis and genotyping of" exact="chikungunya" post="virus using a dried reverse transcription loop-mediated isothermal amplification"/>
   <result pre="amplification (LAMP) assay and MinION sequencing Diagnosis and genotyping of" exact="chikungunya" post="by MinION HayashidaKyokoConceptualizationInvestigationWriting â€&quot; original draftWriting â€&quot; review &amp;amp;"/>
   <result pre="author and source are credited.pntd.0007480.pdf Abstract Detection and sequencing of" exact="chikungunya" post="virus (CHIKV) genome was performed using a combination of"/>
   <result pre="several outbreaks in the world. As the clinical symptoms of" exact="chikungunya" post="is similar to other mosquito-borne febrile diseases, the definitive"/>
   <result pre="the present work, a simple dried format LAMP test for" exact="chikungunya" post="diagnosis was developed which can be directly amplified from"/>
   <result pre="DRA007513. Introduction Chikungunya is a mosquito-borne febrile disease caused by" exact="chikungunya" post="virus (CHIKV), which is a positive strand RNA virus"/>
   <result pre="the genus Alphavirus. In the last decade, serious outbreaks of" exact="chikungunya" post="have been reported. These appeared to have started on"/>
   <result pre="as temperate Mediterranean areas of Europe [5â€&quot;7]. Since late 2013," exact="chikungunya" post="outbreaks have been also reported in the Caribbean, United"/>
   <result pre="mosquito vectors and mammalian hosts. Since the clinical features of" exact="chikungunya" post="are similar to other mosquito-borne febrile diseases, including Dengue"/>
   <result pre="clinical signs is difficult in endemic regions. Definitive diagnosis of" exact="chikungunya" post="is based on serology, virus isolation, or genome detection"/>
   <result pre="equipment is required. Notably as most of the newly emerging" exact="infectious disease" post="outbreaks have been reported in the remote areas with"/>
   <result pre="Laboratory using both RNA and serum samples of patients with" exact="chikungunya" post="collected and kept at the Fiocruz. RNA and serum"/>
   <result pre="1). 10.1371/journal.pntd.0007480.t001Table 1 RT-LAMP results using RNA and serum from" exact="chikungunya" post="patient and endemic healthy control in Rio de Janeiro,"/>
   <result pre="healthy N.D. N.D. N.D. RNA and serum samples from 33" exact="chikungunya" post="patients and 4 endemic healthy control patients were examined"/>
   <result pre="of the qRT-PCR Ct value. N.D.: not detected. Genotyping of" exact="chikungunya" post="virus by CHIKV-CZC-LAMP and MinION The amplified products by"/>
   <result pre="sequence data, demonstrating the proof-of-concept of our analysis. For the" exact="chikungunya" post="patient samples from Rio de Janeiro, the obtained sequences"/>
   <result pre="system will also be useful for diagnosis not only of" exact="chikungunya" post="but also other established and newly emerging infections of"/>
   <result pre="Feira de Santana, respectively [9â€&quot;11]. In 2016, an outbreak of" exact="chikungunya" post="was reported in Rio de Janeiro, and ECSA genotype"/>
   <result pre="our CHIK-CZC-LAMP combined with MinION portable sequencer using samples from" exact="chikungunya" post="patients in Rio de Janeiro, to determine if on-site"/>
   <result pre="resource-limited region was possible. The sequence data obtained from the" exact="chikungunya" post="samples revealed that those were the ECSA genotype, which"/>
   <result pre="pathogen lineages will be required for a better understanding of" exact="chikungunya" post="epidemics. Many lineages from diverse geographical areas have potential"/>
   <result pre="serum samples from 16 CHIKV serology positive patients during recent" exact="chikungunya" post="outbreaks in Rio de Janeiro, Brazil. In combination with"/>
   <result pre="3MavalankarD, ShastriP, BandyopadhyayT, ParmarJ, RamaniKV. Increased mortality rate associated with" exact="chikungunya" post="epidemic, Ahmedabad, India. Emerg Infect Dis. 2008;14:412â€&quot;5. 10.3201/eid1403.07072018325255 4RianthavornP,"/>
   <result pre="2008;14:412â€&quot;5. 10.3201/eid1403.07072018325255 4RianthavornP, PrianantathavornK, WuttirattanakowitN, TheamboonlersA, PoovorawanY. An outbreak of" exact="chikungunya" post="in southern Thailand from 2008 to 2009 caused by"/>
   <result pre="10.3201/eid1705.10187321529410 6RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliA, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="20(17). pii: 21108. 8WahidB, AliA, RafiqueS, IdreesM. Global expansion of" exact="chikungunya" post="virus: mapping the 64-year history. Int J Infect Dis."/>
   <result pre="2015;13:10210.1186/s12916-015-0348-x25976325 12ParolaP, de LamballerieX, JourdanJ, RoveryC, VaillantV, MinodierP, et al.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islands."/>
   <result pre="13SchuffeneckerI, ItemanI, MichaultA, MurriS, FrangeulL, VaneyM-C, et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e26310.1371/journal.pmed.003026316700631"/>
   <result pre="PLoS Med. 2006;3:e26310.1371/journal.pmed.003026316700631 14LanciottiRS, ValadereAM. Transcontinental movement of Asian genotype" exact="chikungunya" post="virus. Emerg Infect Dis.2014;20:1400â€&quot;2. 10.3201/eid2008.14026825076384 15TeixeiraMG, AndradeAMS, Costa M"/>
   <result pre="Costa M daCN, CastroJ-NSM, OliveiraFLS, GoesCSB, et al.East/Central/South African genotype" exact="chikungunya" post="virus, Brazil, 2014. Emerg Infect Dis. 2015;21:906â€&quot;7. 10.3201/eid2105.14172725898939 16SouzaTMA,"/>
   <result pre="SimuunzaM, NdebeJ, ChotaA, et al.Direct detection of falciparum and non-falciparum" exact="malaria" post="DNA from a drop of blood with high sensitivity"/>
   <result pre="WileyMR. et al.First report of naturally infected Aedes aegypti with" exact="chikungunya" post="virus genotype ECSA in the Americas. PLoS Negl Trop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6572267\results\search\disease\results.xml">
   <result pre="has experienced several arbovirus outbreaks in recent years, among which" exact="yellow fever" post="stands out. The state of Minas Gerais faced outbreaks"/>
   <result pre="out. The state of Minas Gerais faced outbreaks of sylvatic" exact="yellow fever" post="in 2017 and 2018, with 1002 confirmed cases and"/>
   <result pre="work presents the results of survey efforts to detect the" exact="yellow fever" post="virus in mosquitoes from two conservation areas in the"/>
   <result pre="was extracted from the mosquitoes for real-time PCR analysis for" exact="yellow fever," post="chikungunya, mayaro, Zika and dengue viruses. The yellow fever"/>
   <result pre="for yellow fever, chikungunya, mayaro, Zika and dengue viruses. The" exact="yellow fever" post="infection rate was 8.2% for Hg. janthinomys (13 mosquitoes),"/>
   <result pre="janthinomys (13 mosquitoes), which is the main vector of sylvatic" exact="yellow fever" post="in Brazil. In addition to surveying the mosquito fauna"/>
   <result pre="monitoring the circulation of viruses near large urban centers. arboviruses" exact="yellow fever" post="mosquitoes 1. Introduction Yellow fever (YF) is a severe"/>
   <result pre="lethality (20â€&quot;50% among symptomatic cases) [1] and is caused by" exact="yellow fever" post="virus (YFV), an arbovirus of the family Flaviviridae. The"/>
   <result pre="(Linnaeus, 1972), however there have been no reports of urban" exact="yellow fever" post="in Brazil since 1942 [5,6]. On the African continent,"/>
   <result pre="2017â€&quot;2018, including Zika, for which there were 3308 confirmed cases," exact="chikungunya" post="with 61,625 confirmed cases and dengue with 145,137 confirmed"/>
   <result pre="Minas Gerais, Brazil, and to evaluate the viral presence of" exact="yellow fever" post="virus (YFV), dengue virus (DENV), chikungunya virus (CHIKV), Zika"/>
   <result pre="viral presence of yellow fever virus (YFV), dengue virus (DENV)," exact="chikungunya" post="virus (CHIKV), Zika virus (ZIKV) and mayaro virus (MAYV)."/>
   <result pre="to block local transmission at that moment of epidemics. Several" exact="yellow fever" post="vaccination campaigns were promoted and an example of this"/>
   <result pre="a previous outbreak in the South region, the trajectory of" exact="yellow fever" post="virus circulation was estimated as 600 km in six"/>
   <result pre="SantosA.A.C.de MelloI.S.SantosM.P.RibeiroI.P.Ferreira-de-BritoA.de MirandaR.M.de CastroM.G.RibeiroM.S.et al.Genomic and structural features of the" exact="yellow fever" post="virus from the 2016-2017 Brazilian outbreakJ. Gen. Virol.20189953654810.1099/jgv.0.00103329469689 11.Monitoramento"/>
   <result pre="outbreakJ. Gen. Virol.20189953654810.1099/jgv.0.00103329469689 11.Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e doenÃ§a aguda pelo vÃ­rus Zika atÃ© a Semana"/>
   <result pre="of an artificial diet for Wolbachia-infected Aedes aegyptiSci. Rep.2017711110.1038/s41598-017-16045-628127051 17.DomingoC.PatelP.YillahJ.WeidmannM.MÃ©ndezJ.A.NakounÃ©E.R.NiedrigM.Advanced" exact="yellow fever" post="virus genome detection in point-of-care facilities and reference laboratoriesJ."/>
   <result pre="Med. Hyg.20118575075710.4269/ajtmh.2011.11-035921976583 23.FigueiredoL.B.CecÃ­lioA.B.FerreiraG.P.DrumondB.P.de OliveiraJ.G.BonjardimC.A.FerreiraP.C.P.KroonE.G.Dengue virus 3 genotype 1 associated with" exact="dengue fever" post="and dengue hemorrhagic fever, BrazilEmerg. Infect. Dis.20081431431610.3201/eid1402.07027818258129 24.NevesD.P.da SilvaJ.E.Aspectos"/>
   <result pre="OliveiraJ.G.BonjardimC.A.FerreiraP.C.P.KroonE.G.Dengue virus 3 genotype 1 associated with dengue fever and" exact="dengue hemorrhagic fever," post="BrazilEmerg. Infect. Dis.20081431431610.3201/eid1402.07027818258129 24.NevesD.P.da SilvaJ.E.Aspectos da biologia dos culicinae"/>
   <result pre="RosaJ.F.S.New entomological and virological data on the vectors of sylvatic" exact="yellow fever" post="in BrazilArthropod-Borne Virus Inf. Exch.19932122 26.GoenagaS.FabbriC.DueÃ±asJ.C.R.GardenalC.N.RossiG.C.CalderonG.MoralesM.A.GarciaJ.B.EnriaD.A.LevisS.Isolation of Yellow Fever"/>
   <result pre="Brazil, 2008Emerg. Infect. Dis.2010161918192421122222 29.de SouzaR.P.PetrellaS.CoimbraT.L.M.MaedaA.Y.RoccoI.M.BisordiI.SilveiraV.R.PereiraL.E.SuzukiA.dos Santos SilvaS.J.et al.Isolation of" exact="yellow fever" post="virus (YFV) from naturally infected Haemagogus (Conopostegus) leucocelaenus (Diptera,"/>
   <result pre="Haemagogus (Haemagogus) janthinomys in Eastern AmazoniaVector-Borne Zoonotic Dis.20022475010.1089/15303660276026077912656130 36.MartinsR.M.MaiaM.D.L.S.FariasR.H.G.CamachoL.A.B.FreireM.S.GallerR.YamamuraA.M.Y.AlmeidaL.F.C.LimaS.M.B.NogueiraR.M.R.et al.17DD" exact="yellow fever" post="vaccine: A double blind, randomized clinical trial of immunogenicity"/>
   <result pre="of monkeys, mosquitoes, and humans in the occurrence of a" exact="yellow fever" post="outbreak in a fragmented landscape in south Brazil: Protecting"/>
   <result pre="studiesAm. J. Trop. Med. Hyg.1950s1-3010.4269/ajtmh.1950.s1-30.301 44.PinheiroF.P.Travassos da RosaA.P.A.MoraesM.A.P.An epidemic of" exact="yellow fever" post="in central Brazil, 1972-1973. II. Ecological studiesAm. J. Trop."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6585104\results\search\disease\results.xml">
   <result pre=": Debate Why all blood donations should be tested for" exact="hepatitis" post="E virus (HEV) http://orcid.org/0000-0003-3244-6085DennerJoachimDennerJ@rki.de1PischkeSvens.pischke@uke.de2SteinmannEikeeike.steinmann@ruhr-uni-bochum.de3BlÃ¼melJohannesJohannes.Bluemel@pei.de4GlebeDieterDieter.Glebe@viro.med.uni-giessen.de5[1], 0000 0001 0940 3744grid.13652.33Robert Koch"/>
   <result pre="article, unless otherwise stated. Abstract Background Hepatitis E is a" exact="liver disease" post="caused by a small RNA virus known as hepatitis"/>
   <result pre="liver disease caused by a small RNA virus known as" exact="hepatitis" post="E virus (HEV). Four major genotypes infect humans, of"/>
   <result pre="against human immunodeficiency virus 1 (HIV-1) and HIV-2, against human" exact="hepatitis" post="C virus (HCV), against human hepatitis B core antigen"/>
   <result pre="and HIV-2, against human hepatitis C virus (HCV), against human" exact="hepatitis" post="B core antigen (HBcAg), as well as for human"/>
   <result pre="hepatitis B core antigen (HBcAg), as well as for human" exact="hepatitis" post="B surface antigen (HBsAg) and for the genomes of"/>
   <result pre="West Nile virus (WNV), human T cell lymphotropic virus (HTLV)," exact="rabies" post="virus as well as of parasites (mainly malaria) and"/>
   <result pre="[41], the rate of HEV-positive donations was 1:4525 [42] and" exact="hepatitis" post="E viraemia was found at a relatively high rate"/>
   <result pre="in rare cases a mild anicteric illness and a moderate" exact="hepatitis" post="were reported. In some cases an acute hepatitis by"/>
   <result pre="a moderate hepatitis were reported. In some cases an acute" exact="hepatitis" post="by red blood cell transfusion was described in immunocompetent"/>
   <result pre="was described in immunocompetent subjects [53]. In a patient with" exact="thrombotic thrombocytopenic purpura" post="(TTP), an acute HEV infection by cryosupernatant plasma triggered"/>
   <result pre="in immunocompetent subjects [53]. In a patient with thrombotic thrombocytopenic" exact="purpura" post="(TTP), an acute HEV infection by cryosupernatant plasma triggered"/>
   <result pre="also observed in an immunocompetent patient with a history of" exact="systemic lupus erythematosus" post="[55]. Neurological manifestations caused by HEV infections have been"/>
   <result pre="observed in an immunocompetent patient with a history of systemic" exact="lupus erythematosus" post="[55]. Neurological manifestations caused by HEV infections have been"/>
   <result pre="are still not well analysed [56]. In patients with underlying" exact="liver disease," post="a severe hepatitis occurs [19]. HEV may be an"/>
   <result pre="analysed [56]. In patients with underlying liver disease, a severe" exact="hepatitis" post="occurs [19]. HEV may be an immunosuppressive virus. There"/>
   <result pre="47]. In one case, HEV transmission was associated with fatal" exact="hepatitis" post="in a Japanese cancer patient [62]. However, it is"/>
   <result pre="HEV transmission was associated with fatal hepatitis in a Japanese" exact="cancer" post="patient [62]. However, it is obvious that the risk"/>
   <result pre="Cancer patients under chemotherapy, HIV infected individuals, and patients with" exact="rheumatoid arthritis" post="and other rheumatic diseases under immunosuppressive treatment should also"/>
   <result pre="patients under chemotherapy, HIV infected individuals, and patients with rheumatoid" exact="arthritis" post="and other rheumatic diseases under immunosuppressive treatment should also"/>
   <result pre="included. The fatal outcome of a transfusion-transmitted infection of a" exact="cancer" post="patient in Japan [62] underlines that the risk-group should"/>
   <result pre="J, Waldvogel S, Wiengand T, ZÃ¼ger M, Gowland P. Current" exact="hepatitis" post="E virus seroprevalence in Swiss blood donors and apparent"/>
   <result pre="Nishiyama T, Primadharsini PP, Okamoto H. Characterization of the quasi-enveloped" exact="hepatitis" post="E virus particles released by the cellular Exosomal pathway."/>
   <result pre="released by the cellular Exosomal pathway. J Virol. 2017;(22):91. 8.WooPCLauSKTengJLCaoKYWerneryUSchountzTChiuTHTsangAKWongPCWongEYYuenKYNew" exact="hepatitis" post="E virus genotype in Bactrian camels, Xinjiang, China, 2013Emerg"/>
   <result pre="Bactrian camels, Xinjiang, China, 2013Emerg Infect Dis201622122219222110.3201/eid2212.16097927869607 9.PavioNDoceulVBagdassarianEJohneRRecent knowledge on" exact="hepatitis" post="E virus in Suidae reservoirs and transmission routes to"/>
   <result pre="and two reference ELISAsJ Virol Methods2013190111610.1016/j.jviromet.2013.03.01023523888 13.LeeGHTanBHTeoECLimSGDanYYWeeAAwPPZhuYHibberdMLTanCKPurdyMATeoCGChronic infection with camelid" exact="hepatitis" post="E virus in a liver transplant recipient who regularly"/>
   <result pre="consumes camel meat and MilkGastroenterology.2016150235535710.1053/j.gastro.2015.10.04826551551 14.YangYShiRSheRMaoJZhaoYDuFLiuCLiuJChengMZhuRLiWWangXSoomroMHFatal disease associated with swine" exact="hepatitis" post="E virus and porcine circovirus 2 co-infection in four"/>
   <result pre="in the context of xenotransplantation: detection and vertical transmission of" exact="hepatitis" post="E virusPLoS One20151010e013989310.1371/journal.pone.013989326466154 16.SchielkeASachsKLierzMAppelBJansenAJohneRDetection of hepatitis E virus in"/>
   <result pre="and vertical transmission of hepatitis E virusPLoS One20151010e013989310.1371/journal.pone.013989326466154 16.SchielkeASachsKLierzMAppelBJansenAJohneRDetection of" exact="hepatitis" post="E virus in wild boars of rural and urban"/>
   <result pre="genome characterization of an endemic strainVirol J200965810.1186/1743-422X-6-5819442307 17.WidÃ©nFSundqvistLMatyi-TothAMetreveliGBelÃ¡kSHallgrenGNorderHMolecular epidemiology of" exact="hepatitis" post="E virus in humans, pigs and wild boars in"/>
   <result pre="humans, pigs and wild boars in SwedenEpidemiol Infect2011139336137110.1017/S095026881000134220546635 18.KrumbholzAMohnULangeJMotzMWenzelJJJilgWWaltherMStraubeEWutzlerPZellRPrevalence of" exact="hepatitis" post="E virus-specific antibodies in humans with occupational exposure to"/>
   <result pre="Hepatitis E: Two Sides of the Same CoinViruses201681129910.3390/v8110299 20.SommerkornFMSchauerBSchreinerTFickenscherHKrumbholzAPerformance of" exact="hepatitis" post="E virus (HEV)-antibody tests: a comparative analysis based on"/>
   <result pre="SauxJCChevÃ©JOllivierJLe PenduJLe GuyaderFSBioaccumulation efficiency, tissue distribution, and environmental occurrence of" exact="hepatitis" post="E virus in bivalve shellfish from FranceAppl Environ Microbiol201480144269427610.1128/AEM.00978-1424795382"/>
   <result pre="from FranceAppl Environ Microbiol201480144269427610.1128/AEM.00978-1424795382 22.O'HaraZCrossanCCraftJScobieLFirst report of the presence of" exact="hepatitis" post="E virus in Scottish-harvested shellfish purchased at retail levelFood"/>
   <result pre="M, Stark K. Case-control study on risk factors for acute" exact="hepatitis" post="E in Germany, 2012 to 2014. Euro Surveill. 2018;23(19)."/>
   <result pre="2018;23(19). 25.WenzelJJPreissJSchemmererMHuberBJilgWTest performance characteristics of anti-HEV IgG assays strongly influence" exact="hepatitis" post="E seroprevalence estimatesJ Infect Dis2013207349750010.1093/infdis/jis68823148290 26.VollmerTDiekmannJJohneREberhardtMKnabbeCDreierJNovel approach for detection"/>
   <result pre="E seroprevalence estimatesJ Infect Dis2013207349750010.1093/infdis/jis68823148290 26.VollmerTDiekmannJJohneREberhardtMKnabbeCDreierJNovel approach for detection of" exact="hepatitis" post="E virus infection in German blood donorsJ Clin Microbiol20125082708271310.1128/JCM.01119-1222675127"/>
   <result pre="in German blood donorsJ Clin Microbiol20125082708271310.1128/JCM.01119-1222675127 27.MansuyJMGallianPDimeglioCSauneKArnaudCPelletierBMorelPLegrandDTiberghienPIzopetJA nationwide survey of" exact="hepatitis" post="E viral infection in French blood donorsHepatology.20166341145115410.1002/hep.2843627008201 28.GallianPLhommeSPiquetYSaunÃ©KAbravanelFAssalATiberghienPIzopetJHepatitis E"/>
   <result pre="virus infections in blood donorsFrance Emerg Infect Dis201420111914191710.3201/eid2011.14051625340881 29.GallianPCouchouronADupontIFabraCPiquetYDjoudiRAssalATiberghienPComparison of" exact="hepatitis" post="E virus nucleic acid test screening platforms and RNA"/>
   <result pre="screening platforms and RNA prevalence in French blood donorsTransfusion.201757122322410.1111/trf.1388928097700 30.SlotEHogemaBRiezebos-BrilmanAKokTMolierMZaaijerHSilent" exact="hepatitis" post="E virus infection in Dutch blood donors, 2011 to"/>
   <result pre="infection in Dutch blood donors, 2011 to 2012Eurosurveillance201318312055010.2807/1560-7917.ES2013.18.31.2055023929229 31.ZaaijerHLNo artefact," exact="hepatitis" post="E is emergingHepatology20156265410.1002/hep.27611 32.BealeMATettmarKSzypulskaRTedderRSIjaz S. is there evidence of"/>
   <result pre="E is emergingHepatology20156265410.1002/hep.27611 32.BealeMATettmarKSzypulskaRTedderRSIjaz S. is there evidence of recent" exact="hepatitis" post="E virus infection in English and north welsh blood"/>
   <result pre="virus in Scottish blood donorsVox Sang2013105428328910.1111/vox.1205623763589 35.HarritshÃ¸jLHHolmDKSaekmoseSGJensenBAHogemaBMFischerTKMidgleySEKrogJSErikstrupCUllumHLow transfusion transmission of" exact="hepatitis" post="E among 25,637 single-donation, nucleic acid-tested blood donorsTransfusion.20165692225223210.1111/trf.1370027385646 36.SauledaSOngEBesMJanssenACoryRBabizkiMShinTLindquistAHoangAVangLPironMCasamitjanaNKoppelmanMDanzigLLinnenJMSeroprevalence"/>
   <result pre="E among 25,637 single-donation, nucleic acid-tested blood donorsTransfusion.20165692225223210.1111/trf.1370027385646 36.SauledaSOngEBesMJanssenACoryRBabizkiMShinTLindquistAHoangAVangLPironMCasamitjanaNKoppelmanMDanzigLLinnenJMSeroprevalence of" exact="hepatitis" post="E virus (HEV) and detection of HEV RNA with"/>
   <result pre="in blood donors, FranceEmerg Infect Dis2011171223091210.3201/eid1712.11037122172156 38.HogemaBMMolierMSlotEZaaijerHLPast and present of" exact="hepatitis" post="E in the NetherlandsTransfusion.201454123092309610.1111/trf.1273324889277 39.ChristensenPBEngleREHjortCHomburgKMVachWGeorgsenJPurcellRHTime trend of the prevalence"/>
   <result pre="E in the NetherlandsTransfusion.201454123092309610.1111/trf.1273324889277 39.ChristensenPBEngleREHjortCHomburgKMVachWGeorgsenJPurcellRHTime trend of the prevalence of" exact="hepatitis" post="E antibodies among farmers and blood donors: a potential"/>
   <result pre="Dis20084781026103110.1086/59197018781880 40.HogemaBMMolierMSjerpsMde WaalMvan SwietenPvan de LaarTMolenaar-de BackerMZaaijerHLIncidence and duration of" exact="hepatitis" post="E virus infection in Dutch blood donorsTransfusion.201656372272810.1111/trf.1340226559806 41.JuhlDBaylisSABlÃ¼melJGÃ¶rgSHennigHSeroprevalence and"/>
   <result pre="virus infection in Dutch blood donorsTransfusion.201656372272810.1111/trf.1340226559806 41.JuhlDBaylisSABlÃ¼melJGÃ¶rgSHennigHSeroprevalence and incidence of" exact="hepatitis" post="E virus infection in German blood donorsTransfusion.2014541495610.1111/trf.1212123441647 42.BaylisSAGÃ¤rtnerTNickSOvemyrJBlÃ¼melJOccurrence of"/>
   <result pre="hepatitis E virus infection in German blood donorsTransfusion.2014541495610.1111/trf.1212123441647 42.BaylisSAGÃ¤rtnerTNickSOvemyrJBlÃ¼melJOccurrence of" exact="hepatitis" post="E virus RNA in plasma donations from Sweden, Germany"/>
   <result pre="systematic review and meta-analysis. Liver Int. 2018 Apr 16. 44.BoxallEHerbornAKochethuGPrattGAdamsDIjazSTeoCGTransfusion-transmitted" exact="hepatitis" post="E in a 'nonhyperendemic' countryTransfus Med2006162798310.1111/j.1365-3148.2006.00652.x16623913 45.WesthÃ¶lterDHillerJDenzerUPolywkaSAyukFRybczynskiMHorvatitsTGundlachSBlÃ¶ckerJSchulze Zur WieschJFischerNAddoMMPeineSGÃ¶keBLohseAWLÃ¼tgehetmannMPischkeSHEV-positive"/>
   <result pre="represent a relevant infection risk for immunosuppressed recipientsJ Hepatol2018691364210.1016/j.jhep.2018.02.03129551705 46.DreierJKnabbeCVollmerTTransfusion-transmitted" exact="hepatitis" post="E: NAT screening of blood donations and infectious doseFront"/>
   <result pre="or blood-that is the questionTransfusion.201757226727210.1111/trf.1397628194857 48.SatakeMMatsubayashiKHoshiYTairaRFuruiYKokudoNAkamatsuNYoshizumiTOhkohchiNOkamotoHMiyoshiMTamuraAFuseKTadokoroKUnique clinical courses of transfusion-transmitted" exact="hepatitis" post="E in patients with immunosuppressionTransfusion.201757228028810.1111/trf.1399428144952 49.SchlosserBSteinANeuhausRPahlSRamezBKrÃ¼gerDHBergTHofmannJLiver transplant from a"/>
   <result pre="transplant from a donor with occult HEV infection induced chronic" exact="hepatitis" post="and cirrhosis in the recipientJ Hepatol201256250050210.1016/j.jhep.2011.06.02121798217 50.PischkeSSuneethaPVBaechleinCBarg-HockHHeimAKamarNSchlueJStrassburgCPLehnerFRaupachRBremerBMagerstedtPCornbergMSeehusenFBaumgaertnerWKlempnauerJIzopetJMannsMPGrummerBWedemeyerHHepatitis E virus"/>
   <result pre="a donor with occult HEV infection induced chronic hepatitis and" exact="cirrhosis" post="in the recipientJ Hepatol201256250050210.1016/j.jhep.2011.06.02121798217 50.PischkeSSuneethaPVBaechleinCBarg-HockHHeimAKamarNSchlueJStrassburgCPLehnerFRaupachRBremerBMagerstedtPCornbergMSeehusenFBaumgaertnerWKlempnauerJIzopetJMannsMPGrummerBWedemeyerHHepatitis E virus infection as"/>
   <result pre="Hepatol201256250050210.1016/j.jhep.2011.06.02121798217 50.PischkeSSuneethaPVBaechleinCBarg-HockHHeimAKamarNSchlueJStrassburgCPLehnerFRaupachRBremerBMagerstedtPCornbergMSeehusenFBaumgaertnerWKlempnauerJIzopetJMannsMPGrummerBWedemeyerHHepatitis E virus infection as a cause of graft" exact="hepatitis" post="in liver transplant recipientsLiver Transpl2010161748210.1002/lt.2195819866448 51.PischkeSGreerMHardtkeSBremerBGisaALehmannPHaverichAWelteTMannsMPWedemeyerHGottliebJHepatitis E study group."/>
   <result pre="Transpl2010161748210.1002/lt.2195819866448 51.PischkeSGreerMHardtkeSBremerBGisaALehmannPHaverichAWelteTMannsMPWedemeyerHGottliebJHepatitis E study group. Course and treatment of chronic" exact="hepatitis" post="E virus infection in lung transplant recipientsTranspl Infect Dis201416233333910.1111/tid.1218324438577"/>
   <result pre="lung transplant recipientsTranspl Infect Dis201416233333910.1111/tid.1218324438577 52.AnkcornMJIjazSPohJElsharkawyAMSmitECrambRRaviSMartinKTedderRNeubergerJToward systematic screening for persistent" exact="hepatitis" post="E virus infections in transplant patientsTransplantation.201810271139114710.1097/TP.000000000000209729953421 53.Riveiro-BarcielaMSauledaSQuerJSalvadorFGregoriJPirÃ³nMRodrÃ­guez-FrÃ­asFButiMRed blood cell"/>
   <result pre="virus infections in transplant patientsTransplantation.201810271139114710.1097/TP.000000000000209729953421 53.Riveiro-BarcielaMSauledaSQuerJSalvadorFGregoriJPirÃ³nMRodrÃ­guez-FrÃ­asFButiMRed blood cell transfusion-transmitted acute" exact="hepatitis" post="E in an immunocompetent subject in Europe: a case"/>
   <result pre="an immunocompetent subject in Europe: a case reportTransfusion.201757224424710.1111/trf.1387627785789 54.Riveiro-BarcielaMBesMQuerJValcarcelDPirizSGregoriJLlorensMSalcedoMTPironMEstebanRButiMSauledaSThrombotic thrombocytopenic" exact="purpura" post="relapse induced by acute hepatitis E transmitted by cryosupernatant"/>
   <result pre="a case reportTransfusion.201757224424710.1111/trf.1387627785789 54.Riveiro-BarcielaMBesMQuerJValcarcelDPirizSGregoriJLlorensMSalcedoMTPironMEstebanRButiMSauledaSThrombotic thrombocytopenic purpura relapse induced by acute" exact="hepatitis" post="E transmitted by cryosupernatant plasma and successfully controlled with"/>
   <result pre="transmitted by cryosupernatant plasma and successfully controlled with ribavirinTransfusion.201858112501250510.1111/trf.1483130284732 55.GrewalPKamiliSMotamedDChronic" exact="hepatitis" post="E in an immunocompetent patient: a case reportHepatology.201459134734810.1002/hep.2663623913727 56.DaltonHRKamarNvan"/>
   <result pre="virus and neurological injuryNat Rev Neurol2016122778510.1038/nrneurol.2015.23426711839 57.CaoDCaoQMSubramaniamSYugoDMHeffronCLRogersAJKenneySPTianDMatzingerSROverendCCatanzaroNLeRoithTWangHPiÃ±eyroPLindstromNClark-DeenerSYuanLMengXJPig model mimicking chronic" exact="hepatitis" post="E virus infection in immunocompromised patients to assess immune"/>
   <result pre="TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant" exact="hepatitis" post="eIntervirology.2009522788510.1159/00021486219401616 59.ZhuFCZhangJZhangXFZhouCWangZZHuangSJWangHYangCLJiangHMCaiJPWangYJAiXHuYMTangQYaoXYanQXianYLWuTLiYMMiaoJNgMHShihJWXiaNSEfficacy and safety of a recombinant hepatitis E"/>
   <result pre="and fulminant hepatitis eIntervirology.2009522788510.1159/00021486219401616 59.ZhuFCZhangJZhangXFZhouCWangZZHuangSJWangHYangCLJiangHMCaiJPWangYJAiXHuYMTangQYaoXYanQXianYLWuTLiYMMiaoJNgMHShihJWXiaNSEfficacy and safety of a recombinant" exact="hepatitis" post="E vaccine in healthy adults: a large-scale, randomised, double-blind"/>
   <result pre="2019. 63.de VosASJanssenMPZaaijerHLHogemaBMCost-effectiveness of the screening of blood donations for" exact="hepatitis" post="E virus in the NetherlandsTransfusion.201757225826610.1111/trf.1397828144956 64.KampCBlÃ¼melJBaylisSABekeredjian-DingIChudyMHeidenMHenselerOKeller-StanislawskiBde VosASFunkMBImpact of hepatitis"/>
   <result pre="for hepatitis E virus in the NetherlandsTransfusion.201757225826610.1111/trf.1397828144956 64.KampCBlÃ¼melJBaylisSABekeredjian-DingIChudyMHeidenMHenselerOKeller-StanislawskiBde VosASFunkMBImpact of" exact="hepatitis" post="E virus testing on the safety of blood components"/>
   <result pre="Platelet Transfusion in an Immunocompetent Trauma PatientEmerging Infectious Diseases201723114614710.3201/eid2301.16092327983485 67.GrewalPKamiliSMotamedDChronic" exact="hepatitis" post="E in an immunocompetent patient: a case reportHepatology, Hepatology201459134734810.1002/hep.2663623913727"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6586808\results\search\disease\results.xml">
   <result pre="infection is often asymptomatic, or associated with mild respiratory or" exact="gastrointestinal disease" post="in children. However some types, in particular human parechovirus"/>
   <result pre="LC133458.1 2014 Case V3 V7140151 Faeces 16/05/2017 399 VIC Irritable," exact="gastroenteritis" post="1 N MK604056 HPeV1 Strain 131170176, Japan LC318432.1 2017"/>
   <result pre="KY556666.1 2015 Case V5 V7169416 CSF 29/08/2017 17 VIC Sepsis-like," exact="meningitis" post="3 Y MK604058 Australian recombinant HPeV3 FEC10 KY556666.1 2015"/>
   <result pre="the 2 HPeV1 cases (W14 and W17) had less severe" exact="gastroenteritis" post="or fever respectively. Phylogenetic analysis Recombination, selection and phylogenetic"/>
   <result pre="a range of clinical presentations including irritability, fever, rash, gastroenteritis," exact="meningitis" post="and sepsis-like syndrome. These samples likely represented the most"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6591850\results\search\disease\results.xml">
   <result pre="and respiratory syncytial virus, BrazilEmerg Infect Dis20099121626162810.3201/eid0912.030522 7.PeirisJSMTangWHChanKHKhongPLGuanYLauYLet al.Children with" exact="respiratory disease" post="associated with metapneumovirus in Hong KongEmerg Infect Dis20039662863310.3201/eid0906.03000912781000 8.Guerrero-PlataACasolaASuarezGYuXSpetchLPeeplesMEet"/>
   <result pre="individualsPLoS One2011611910.1371/journal.pone.0016314 17.HeldLHÃ¶hleMHofmannMA statistical framework for the analysis of multivariate" exact="infectious disease" post="surveillance countsStat Modelling20055318719910.1191/1471082X05st098oa 18.Oâ€™HaraRBKotzeDJDo not log-transform count dataMethods Ecol"/>
   <result pre="a non-linear random effects model for multivariate time series of" exact="infectious disease" post="countsStat Med201130101118113621484849 23.PaulMMeyerSThe function hhh4 in the R -package"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6593267\results\search\disease\results.xml">
   <result pre="significantly advantage for detection of the true etiology of a" exact="respiratory disease." post="Furthermore, knowledge of which virus is the cause of"/>
   <result pre="Furthermore, knowledge of which virus is the cause of a" exact="respiratory disease" post="is not useful from a therapeutic point of view"/>
   <result pre="is not useful from a therapeutic point of view unless" exact="influenza" post="virus or respiratory syncytial virus are the infecting agents"/>
   <result pre="are warranted. multiplex platforms PCR respiratory pathogens respiratory tract infection" exact="influenza" post="respiratory syncytial virus Funding Horizon 202010.13039/501100007601 fig-count: table-count: equation-count:"/>
   <result pre="viruses, mainly respiratory syncytial virus (RSV) (Griffiths et al., 2017)," exact="influenza" post="virus (IV) (Antonova et al., 2012), and rhinovirus (RV)"/>
   <result pre="are the cause, Streptococcus pyogenes is a common cause of" exact="pharyngitis" post="(Paradise, 1992), and Streptococcus pneumoniae is a typical cause"/>
   <result pre="capacity to cause upper and lower RTIs and to trigger" exact="asthma" post="and chronic obstructive pulmonary disease exacerbations (Esposito et al.,"/>
   <result pre="cause upper and lower RTIs and to trigger asthma and" exact="chronic obstructive pulmonary disease" post="exacerbations (Esposito et al., 2012b; Parker et al., 2014;"/>
   <result pre="for those agents that are frequently asymptomatically carried. Although certain" exact="influenza" post="patients can shed the virus up to 8 days,"/>
   <result pre="currently available on these diagnostic platforms. Presently, only drugs against" exact="influenza" post="virus, RSV and atypical bacteria are licensed. Furthermore, it"/>
   <result pre="al., 2018) is not recommended for all the cases of" exact="influenza" post="because influenza is frequently a mild disease, and the"/>
   <result pre="is not recommended for all the cases of influenza because" exact="influenza" post="is frequently a mild disease, and the advantage of"/>
   <result pre="is a drug licensed for the treatment of cytomegalovirus (CMV)" exact="retinitis" post="in HIV-infected patients, has been used to treat ADV"/>
   <result pre="considered as a potential solution to treat mild-to-moderate cases of" exact="respiratory disease" post="in otherwise healthy children (Ganapathi et al., 2016). Can"/>
   <result pre="risk of transmission and potential nosocomial clusters of RSV and" exact="influenza" post="virus on hemato-oncological wards (Baier et al., 2018). On"/>
   <result pre="and untested children was not significant. The knowledge that a" exact="bronchiolitis" post="case was associated with the detection of RSV in"/>
   <result pre="et al. (2003) showed that children with a positive rapid" exact="influenza" post="test were significantly less likely than those with a"/>
   <result pre="Cantais et al. (2018), who showed that the diagnosis of" exact="influenza" post="was followed by a 47.9% reduction in blood puncture,"/>
   <result pre="improve the judgement of clinicians. However, the diagnosis of a" exact="viral disease" post="by a laboratory test can be interpreted as a"/>
   <result pre="References References AntonovaE. N.RycroftC. E.AmbroseC. S.HeikkinenT.PrincipiN. (2012). Burden of paediatric" exact="influenza" post="in Western Europe: a systematic review. BMC Public Health12:968."/>
   <result pre="2019). BlockS. L.HammerschlagM. R.HedrickJ.TylerR.SmithA.RoblinP.et al.. (1997). Chlamydia pneumoniae in acute" exact="otitis media." post="Pediatr. Infect. Dis. J.16, 858â€&quot;862. 10.1097/00006454-199709000-000089306480 BrancheA. R.FalseyA. R."/>
   <result pre="248â€&quot;253. 10.1016/j.pec.2014.01.01024569180 CantaisA.MoryO.PlatA.BourmaudA.GiraudA.CostilleM.et al.. (2018). Impact of bedside diagnosis of" exact="influenza" post="in the paediatric emergency ward. Clin. Microbiol. Infect. 10.1016/j.cmi.2018.11.019"/>
   <result pre="human rhinovirus isolates collected from otherwise healthy children with community-acquired" exact="pneumonia" post="during five successive years. PLoS ONE8:e80614. 10.1371/journal.pone.008061424260436 DoanQ.EnarsonP.KissoonN.KlassenT. P.JohnsonD."/>
   <result pre="Infect. Dis.31, 1637â€&quot;1645. 10.1007/s10096-011-1487-422124536 EspositoS.MarchisioP.MorelliP.CrovariP.PrincipiN. (2003). Effect of a rapid" exact="influenza" post="diagnosis. Arch. Dis. Child.88, 525â€&quot;526. 10.1136/adc.88.6.52512765923 EspositoS.PrincipiN. (2012). Unsolved"/>
   <result pre="Seegene Allplex Respiratory Panel 1 kit for the detection of" exact="influenza" post="virus and human respiratory syncytial virus. J. Clin. Virol.105,"/>
   <result pre="G.SugayaN.HirotsuN.LeeN.de JongM. D.HurtA. C.et al.. (2018). Baloxavir marboxil for uncomplicated" exact="influenza" post="in adults and adolescents. N. Engl. J. Med.379, 913â€&quot;923."/>
   <result pre="(2017). Viral shedding and transmission potential of asymptomatic and paucisymptomatic" exact="influenza" post="virus infections in the community. Clin. Infect. Dis.64, 736â€&quot;742."/>
   <result pre="Front. Microbiol.9:3101. 10.3389/fmicb.2018.0310130619180 ParadiseJ. L. (1992). Etiology and management of" exact="pharyngitis" post="and pharyngotonsillitis in children: a current review. Ann. Otol."/>
   <result pre="PrincipiN.PirallaA.ZampieroA.BianchiniS.UmbrelloG.ScalaA.et al.. (2015a). Bocavirus infection in otherwise healthy children with" exact="respiratory disease." post="PLoS ONE10:e0135640. 10.1371/journal.pone.013564026267139 PrincipiN.ZampieroA.GambinoM.ScalaA.SenatoreL.LeliiM.et al.. (2015b). Prospective evaluation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6594658\results\search\disease\results.xml">
   <result pre="their global reach. Author summary When novel infectious diseases like" exact="chikungunya" post="or Zika emerge and threaten global spread, public health"/>
   <result pre="wide range of possible epidemic outcomes, from terminal importations to" exact="stuttering" post="chains of transmission to full blown epidemics [4, 9â€&quot;11]."/>
   <result pre="S1 File). Results In the face of a novel emerging" exact="infectious disease" post="threat, public health officials must borrow information from related"/>
   <result pre="used to assess disease transmission risk during elimination efforts, including" exact="malaria" post="in non-endemic regions [48]. The key innovation is that,"/>
   <result pre="method for continuously updating transmission risk estimates for populations experiencing" exact="infectious disease" post="importations, with or without secondary transmission. As we demonstrated"/>
   <result pre="of R(0) and transmission heterogeneity from the size distribution of" exact="stuttering" post="chains. PLoS Comput Biol. 2013;9(5):e100299310.1371/journal.pcbi.100299323658504 14BlumbergS, Lloyd-SmithJO. Comparing methods"/>
   <result pre="the impact of temperature on transmission of Zika, dengue and" exact="chikungunya" post="using mechanistic models. PLOS Neglected Tropical Diseases. 2017;11:e000556810.1371/journal.pntd.000556828448507 24TeslaB,"/>
   <result pre="NovotnyJ, NtshalintshaliN, KuneneS, CauchemezS. Public health. Measuring the path toward" exact="malaria" post="elimination. Science. 2014;344(6189):1230â€&quot;1232. 10.1126/science.125144924926005"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6608929\results\search\disease\results.xml">
   <result pre="the foreseeable future. Despite successes such as the eradication of" exact="smallpox" post="and reductions in the prevalence of falciparum malaria, there"/>
   <result pre="often the primary vector of the dengue, chikungunya, Zika, and" exact="yellow fever" post="viruses. Variation in dengue transmission risk, for instance, is"/>
   <result pre="References 1HeesterbeekH, AndersonR, AndreasenV, BansalS, De AngelisD, DyeC, et al.Modeling" exact="infectious disease" post="dynamics in the complex landscape of global health. Science."/>
   <result pre="the impact of temperature on transmission of Zika, dengue, and" exact="chikungunya" post="using mechanistic models. PLoS Negl Trop Dis. 2017;11:e000556810.1371/journal.pntd.000556828448507 4NationsUnited."/>
   <result pre="GalvaniA, MeyersL. Effects of heterogeneous and clustered contact patterns on" exact="infectious disease" post="dynamics. PloS Computational Biology. 2011;7:e100204210.1371/journal.pcbi.100204221673864 13SmithD, DushoffJ, McKenzieF. The"/>
   <result pre="Assessing the role of spatial heterogeneity and human movement in" exact="malaria" post="dynamics and control. Journal of Theoretical Biology. 2012;303:1â€&quot;14. 10.1016/j.jtbi.2012.02.01022525434"/>
   <result pre="LeeJ, LevisP, FeldmanM, JonesJ. A high-resolution human contact network for" exact="infectious disease" post="transmission. Proceedings of the National Academy of Sciences. 2010;107:22020â€&quot;5."/>
   <result pre="Dzul-ManzanillaF, Gomez-DantesH, Pavia-RuzN, HladishT, LenhartA, et al.Spatio-temporal coherence of dengue," exact="chikungunya" post="and ZIka outbreaks in Merida, Mexico. PLoS Negl Trop"/>
   <result pre="OuedraogoA, et al.Mathematical models of human mobility of relevance to" exact="malaria" post="transmission in Africa. Scientific Reports. 2018;8:771310.1038/s41598-018-26023-129769582 46PerkinsT, Paz-SoldanV, StoddardS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6609753\results\search\disease\results.xml">
   <result pre="is properly cited. Abstract Influenza is a very important respiratory" exact="infectious disease" post="that causes seasonal epidemics and pandemics. A well-organized surveillance"/>
   <result pre="the epidemiologic features of influenza. Korea currently operates a national" exact="influenza" post="surveillance system based on the clinical sentinel surveillance system,"/>
   <result pre="related to influenza. This article discusses the general aspects of" exact="influenza" post="surveillance systems and the future direction of the national"/>
   <result pre="influenza surveillance systems and the future direction of the national" exact="influenza" post="surveillance system of Korea. Influenza Human Sentinel surveillance Population"/>
   <result pre="Population surveillance Korea Introduction Influenza is a very important respiratory" exact="infectious disease" post="that causes seasonal epidemics globally and annually among people"/>
   <result pre="but also causes pandemics every 10 to 40 years. Thus," exact="influenza" post="is considered as one of the most important among"/>
   <result pre="surveillance system is necessary to monitor and respond effectively to" exact="influenza" post="epidemics. An influenza surveillance system is useful for identifying"/>
   <result pre="necessary to monitor and respond effectively to influenza epidemics. An" exact="influenza" post="surveillance system is useful for identifying influenza epidemics, the"/>
   <result pre="influenza epidemics. An influenza surveillance system is useful for identifying" exact="influenza" post="epidemics, the nature of the virus, and the burden"/>
   <result pre="of disease, as well as determining the policies aimed at" exact="influenza" post="epidemic control, vaccine selection, and the development of guidelines"/>
   <result pre="development of guidelines for the use of antiviral drugs. An" exact="influenza" post="surveillance system can also be used to monitor influenza"/>
   <result pre="An influenza surveillance system can also be used to monitor" exact="influenza" post="pandemics and new respiratory infectious diseases. Korea currently operates"/>
   <result pre="and new respiratory infectious diseases. Korea currently operates a national" exact="influenza" post="surveillance system based on the clinical sentinel surveillance system,"/>
   <result pre="pieces of information related to influenza. This article reviews the" exact="influenza" post="surveillance system characteristics, foreign surveillance systems, including those of"/>
   <result pre="Health Organization (WHO) and the United States (US), and the" exact="influenza" post="surveillance system of Korea. It further discusses the future"/>
   <result pre="Korea. It further discusses the future direction of the national" exact="influenza" post="surveillance system of Korea. Influenza surveillance systems in general"/>
   <result pre="or passive or active surveillance systems [4]. In countries operating" exact="influenza" post="surveillance systems, the most common form is active sentinel"/>
   <result pre="and laboratory data [5678]. There are two major forms of" exact="influenza" post="surveillance systems: clinical sentinel surveillance and virologic sentinel surveillance"/>
   <result pre="[9]. A clinical sentinel surveillance system is used to identify" exact="influenza" post="outbreaks and epidemics, establish a vaccination plan, initiate antiviral"/>
   <result pre="other indicators can be used that represent the burden of" exact="influenza" post="in the community such as absenteeism, or that show"/>
   <result pre="community such as absenteeism, or that show the severity of" exact="influenza" post="or burden from the healthcare perspective such as emergency"/>
   <result pre="OPD-based surveillance systems are used to determine the occurrence of" exact="influenza" post="epidemics by monitoring the ratio of the number of"/>
   <result pre="distribution and population characteristics among OPD clinics that directly treat" exact="influenza" post="patients. The selected sites report the information of patients"/>
   <result pre="participating sites, virologic surveillance data, geographical and demographic characteristics, and" exact="influenza" post="vaccination rate. The hospitalization-based surveillance system contributes to the"/>
   <result pre="contributes to the understanding of the severity and burden of" exact="influenza" post="by monitoring cases of severe acute respiratory illness (SARI),"/>
   <result pre="progression than other respiratory viruses. The main anticipated effect of" exact="influenza" post="vaccination is to reduce the burden of influenza. Therefore,"/>
   <result pre="determine the appropriateness and evaluate the effectiveness of policies for" exact="influenza" post="control. Data collected through both surveillance systems can be"/>
   <result pre="collected through both surveillance systems can be used to assess" exact="influenza" post="vaccine effectiveness. However, a procedure for increasing the accuracy"/>
   <result pre="vaccine effectiveness. However, a procedure for increasing the accuracy of" exact="influenza" post="vaccination history is required to evaluate the influenza vaccine"/>
   <result pre="accuracy of influenza vaccination history is required to evaluate the" exact="influenza" post="vaccine effectiveness accurately. In addition, a sufficient number of"/>
   <result pre="the vaccine effect by virus type/subtypes and age groups. Foreign" exact="influenza" post="surveillance systems 1. World Health Organization The WHO discussion"/>
   <result pre="Health Organization The WHO discussion on the operation of the" exact="influenza" post="network began in 1951 at a conference held in"/>
   <result pre="Pandemic Influenza Preparedness Framework was adopted, which involved sharing of" exact="influenza" post="virus characteristics and other benefits of vaccines, and its"/>
   <result pre="and Response System (GISRS). The GISRS consists of 144 national" exact="influenza" post="centers, 6 WHO collaborating centers (CCs), 4 essential regulatory"/>
   <result pre="13 H5 reference laboratories (H5RefLabs) as of 2019 [11]. National" exact="influenza" post="centers collect virus specimens, and ship representative clinical specimens"/>
   <result pre="antigenic and genetic analysis. The WHO recommends the composition of" exact="influenza" post="vaccines based on the results of the analysis. WHO"/>
   <result pre="the six WHO CCs is responsible for surveillance, epidemiology, and" exact="influenza" post="prevention. Essential regulatory laboratories have the critical function of"/>
   <result pre="critical function of connecting surveillance and risk assessment activities with" exact="influenza" post="vaccine response. H5RefLabs were established in 2004, in response"/>
   <result pre="2004, in response to the public health needs arising from" exact="avian influenza" post="A/H5N1 infection in humans and influenza pandemic preparedness. H5RefLabs"/>
   <result pre="in response to the public health needs arising from avian" exact="influenza" post="A/H5N1 infection in humans and influenza pandemic preparedness. H5RefLabs"/>
   <result pre="needs arising from avian influenza A/H5N1 infection in humans and" exact="influenza" post="pandemic preparedness. H5RefLabs collect and analyze influenza A/H5N1 or"/>
   <result pre="in humans and influenza pandemic preparedness. H5RefLabs collect and analyze" exact="influenza" post="A/H5N1 or other influenza subtypes that can potentially cause"/>
   <result pre="pandemic preparedness. H5RefLabs collect and analyze influenza A/H5N1 or other" exact="influenza" post="subtypes that can potentially cause human infections. The data"/>
   <result pre="database and presented via FluNet, a global web-based tool for" exact="influenza" post="virologic surveillance first launched in 1997. The virologic data"/>
   <result pre="[12]. Thus, in many countries, data on the burden of" exact="influenza" post="are being prepared [13141516]. 2. United States The US"/>
   <result pre="five categories of information from eight different data sources on" exact="influenza" post="activity year-round: virologic surveillance, outpatient illness surveillance, summary of"/>
   <result pre="weekly total number of specimens tested, the number of positive" exact="influenza" post="test results, and the percentage of positive test results"/>
   <result pre="test results, and the percentage of positive test results by" exact="influenza" post="virus type. Public health laboratories also report other kinds"/>
   <result pre="weekly total number of specimens tested, the number of positive" exact="influenza" post="test results, and the number by influenza virus type,"/>
   <result pre="number of positive influenza test results, and the number by" exact="influenza" post="virus type, subtype, and influenza B lineage. Outpatient illness"/>
   <result pre="results, and the number by influenza virus type, subtype, and" exact="influenza" post="B lineage. Outpatient illness surveillance. Information on outpatient visits"/>
   <result pre="departments report the estimated level of the geographic spread of" exact="influenza" post="activity in their states each week through the State"/>
   <result pre="each week through the State and Territorial Epidemiologists Reports. The" exact="influenza" post="activity is classified at five levels: no activity, sporadic,"/>
   <result pre="Influenza. Each state reports on the weekly geographic spread of" exact="influenza" post="activity through the State and Territorial Epidemiologists Reports. Influenza"/>
   <result pre="Influenza Hospitalization Surveillance Network monitors laboratory-confirmed influenza-associated hospitalization. During the" exact="influenza" post="season, data are collected from cases with laboratory-confirmed influenza."/>
   <result pre="mortality surveillance system. The National Center for Health Statistics collects" exact="pneumonia" post="and influenza mortality data from each state based on"/>
   <result pre="system. The National Center for Health Statistics collects pneumonia and" exact="influenza" post="mortality data from each state based on ICD-10 codes."/>
   <result pre="from each state based on ICD-10 codes. The seasonal baseline" exact="pneumonia" post="and influenza mortality rate is estimated using a periodic"/>
   <result pre="state based on ICD-10 codes. The seasonal baseline pneumonia and" exact="influenza" post="mortality rate is estimated using a periodic regression model."/>
   <result pre="2004, deaths among children younger than 18 years with laboratory-confirmed" exact="influenza" post="have been added as a nationally notifiable condition. In"/>
   <result pre="been operating a vaccine effectiveness surveillance [18]. Surveillance for monitoring" exact="influenza" post="vaccine effectiveness is managed separately by the US Flu"/>
   <result pre="At the participating sites, respiratory specimens are collected for isolating" exact="influenza" post="viruses together with demographic and medical information, including underlying"/>
   <result pre="together with demographic and medical information, including underlying diseases and" exact="influenza" post="vaccination history. The two networks assess and report influenza"/>
   <result pre="and influenza vaccination history. The two networks assess and report" exact="influenza" post="vaccine effectiveness separately during each season [1920]. The US"/>
   <result pre="each season [1920]. The US CDC calculates and reports the" exact="influenza" post="disease burden using the Influenza surveillance data, and the"/>
   <result pre="aim of the EISN is to contribute to reducing the" exact="influenza" post="burden in Europe. The EISN originated in the European"/>
   <result pre="member states in Europe. Each member state has a separate" exact="influenza" post="surveillance system and case definition for the surveillance. The"/>
   <result pre="influenza-positive cases from intensive care units. 4. Japan The national" exact="influenza" post="surveillance system of Japan is affiliated to the National"/>
   <result pre="sentinel surveillance systems for various kinds of infectious diseases including" exact="influenza" post="[23]. The sentinel outpatient surveillance system has been applied"/>
   <result pre="[23]. The sentinel outpatient surveillance system has been applied to" exact="influenza" post="surveillance. Sentinel sites were designated according to the geographic"/>
   <result pre="with ILI every week. Virologic surveillance, consisting of testing for" exact="influenza" post="virus and the analysis of viral antigenicity, is incorporated"/>
   <result pre="for hospitalization surveillance. Japan has monitored the incidence of influenza-associated" exact="encephalopathy" post="since the late 1990s. Japan has a surveillance system"/>
   <result pre="school closures. The law of Japan states that children with" exact="influenza" post="infection should stay home for at least 6 days"/>
   <result pre="the school can be closed to stop the transmission of" exact="influenza" post="depending on the size of influenza outbreaks. In addition"/>
   <result pre="stop the transmission of influenza depending on the size of" exact="influenza" post="outbreaks. In addition to the surveillance system operated by"/>
   <result pre="is organized by volunteer clinicians who report the number of" exact="influenza" post="patients diagnosed at their clinics through the ML-Influenza Database."/>
   <result pre="diagnosed at their clinics through the ML-Influenza Database. The current" exact="influenza" post="surveillance system of Korea The influenza surveillance system of"/>
   <result pre="ML-Influenza Database. The current influenza surveillance system of Korea The" exact="influenza" post="surveillance system of Korea was initiated in October 1997"/>
   <result pre="since 2000 to the Korea Influenza Surveillance Scheme. Currently, the" exact="influenza" post="surveillance system operated by the Korea CDC consists of"/>
   <result pre="surveillance (Korea Influenza and Respiratory Virus Surveillance System [KINRESS]), and" exact="influenza" post="hospitalization and mortality surveillance systems [24]. Clinical sentinel surveillance."/>
   <result pre="of the following year. The data are used to identify" exact="influenza" post="epidemics in Korea. Laboratory sentinel surveillance. KINRESS is operated"/>
   <result pre="reexamination of unidentified specimens. Based on these results, the circulating" exact="influenza" post="viruses in Korea are identified, and the characteristics of"/>
   <result pre="patients diagnosed with influenza. Medical histories are also collected, including" exact="influenza" post="vaccination history, underlying medical condition, travel history, and the"/>
   <result pre="have been used to analyze the clinical course of severe" exact="influenza" post="[2627], influenza disease burden [28], characteristics of influenza viruses"/>
   <result pre="used to analyze the clinical course of severe influenza [2627]," exact="influenza" post="disease burden [28], characteristics of influenza viruses that caused"/>
   <result pre="of severe influenza [2627], influenza disease burden [28], characteristics of" exact="influenza" post="viruses that caused severe clinical course [29], influenza vaccine"/>
   <result pre="characteristics of influenza viruses that caused severe clinical course [29]," exact="influenza" post="vaccine effectiveness, and so on. In addition to surveillance"/>
   <result pre="addition to surveillance for severe influenza, there is surveillance for" exact="avian influenza" post="viruses that can cause human infection such as A/H7N9"/>
   <result pre="to surveillance for severe influenza, there is surveillance for avian" exact="influenza" post="viruses that can cause human infection such as A/H7N9"/>
   <result pre="to be operated at nine hospitals. The future direction of" exact="influenza" post="surveillance systems in Korea Influenza comprises not only a"/>
   <result pre="part of the government budget has been used to target" exact="influenza" post="vaccination. Influenza vaccination among the elderly has been included"/>
   <result pre="immunization program from the 2019â€&quot;2020 season. Considering the impact of" exact="influenza" post="and the continuous change in the characteristics of influenza"/>
   <result pre="of influenza and the continuous change in the characteristics of" exact="influenza" post="viruses, a proper surveillance system is essential in Korea."/>
   <result pre="a proper surveillance system is essential in Korea. The national" exact="influenza" post="surveillance system currently operated by the government has played"/>
   <result pre="by the government has played an important role in identifying" exact="influenza" post="epidemic patterns and virus characteristics in Korea. However, it"/>
   <result pre="KCDC provides a limited understanding of the characteristics of serious" exact="influenza" post="and its disease burden. The hospitalization and mortality surveillance"/>
   <result pre="difficult to identify the characteristics of viruses associated with severe" exact="influenza" post="because specimens are not collected. If it is not"/>
   <result pre="of influenza. In the US, when assessing the burden of" exact="influenza" post="illness, the spectrum of influenza from mild to dead"/>
   <result pre="when assessing the burden of influenza illness, the spectrum of" exact="influenza" post="from mild to dead is estimated based on hospitalized"/>
   <result pre="Another limitation is the difficulty in assessing the effectiveness of" exact="influenza" post="vaccines. Although information regarding influenza vaccination history has been"/>
   <result pre="in assessing the effectiveness of influenza vaccines. Although information regarding" exact="influenza" post="vaccination history has been collected, the reliability of the"/>
   <result pre="outpatients and inpatients. An example is the surveillance system for" exact="influenza" post="vaccine effectiveness in the US. The assessment of the"/>
   <result pre="effectiveness in the US. The assessment of the burden of" exact="influenza" post="and the evaluation of the vaccine effectiveness is very"/>
   <result pre="cannot fulfill every purpose. To meet the unmet need of" exact="influenza" post="surveillance in Korea, therefore, it does not simply suffice"/>
   <result pre="simply suffice to adjust the data collected from the existing" exact="influenza" post="surveillance system. The national influenza surveillance system currently operated"/>
   <result pre="data collected from the existing influenza surveillance system. The national" exact="influenza" post="surveillance system currently operated in Korea is relatively well-organized"/>
   <result pre="However, more needs to be done to better cope with" exact="influenza" post="considering the influenza situation of Korea and foreign surveillance"/>
   <result pre="to be done to better cope with influenza considering the" exact="influenza" post="situation of Korea and foreign surveillance systems. A better"/>
   <result pre="support proper policy making and produce enough scientific evidence regarding" exact="influenza" post="control. Conflict of Interest: No conflicts of interest. References"/>
   <result pre="Economic Area countries, 2009 to 2013Euro Surveill2018231700454 2GrossPAHermogenesAWSacksHSLauJLevandowskiRAThe efficacy of" exact="influenza" post="vaccine in elderly persons. A meta-analysis and review of"/>
   <result pre="literatureAnn Intern Med19951235185277661497 3DollMKWintersNBoikosCKraicer-MelamedHGoreGQuachCSafety and effectiveness of neuraminidase inhibitors for" exact="influenza" post="treatment, prophylaxis, and outbreak control: a systematic review of"/>
   <result pre="Med Public Health20074025926417693727 5SanicasMForleoEPozziGDiopDA review of the surveillance systems of" exact="influenza" post="in selected countries in the tropical regionPan Afr Med"/>
   <result pre="in the tropical regionPan Afr Med J20141912125745529 6ThommesEWKruseMKohliMSharmaRNoorduynSGReview of seasonal" exact="influenza" post="in Canada: Burden of disease and the cost-effectiveness of"/>
   <result pre="Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated" exact="influenza" post="vaccinesHum Vaccin Immunother20171386787627858509 7SambalaEZNdwandweDEImaanLMWiysongeCSEvaluation of influenza surveillance systems in"/>
   <result pre="cost-effectiveness of quadrivalent inactivated influenza vaccinesHum Vaccin Immunother20171386787627858509 7SambalaEZNdwandweDEImaanLMWiysongeCSEvaluation of" exact="influenza" post="surveillance systems in sub-Saharan Africa: a systematic review protocolBMJ"/>
   <result pre="sub-Saharan Africa: a systematic review protocolBMJ Open20199e023335 8YangPDuanWLvMShiWPengXWangXLuYLiangHSealeHPangXWangQReview of an" exact="influenza" post="surveillance system, Beijing, People's Republic of ChinaEmerg Infect Dis2009151603160819861053"/>
   <result pre="9KimWJNohJYParkMSSongJYShinOAhnDHWieSHLeeJSJangJCheongHJChunBCChoiYKChoiWSInfluenzaSeoulTransgovernmental Enterprise for Pandemic Influenza in Korea2016 10ZieglerTMamahitACoxNJ65Â years of" exact="influenza" post="surveillance by a World Health Organization-coordinated global networkInfluenza Other"/>
   <result pre="Organization-coordinated global networkInfluenza Other Respir Viruses201812558565 11collab: World Heaith OrganizationGlobal" exact="influenza" post="surveillance and response system (GISRS)Accessed 22 April 2019Available at:"/>
   <result pre="12ChaiyakunaprukNKotirumSNewallATLambachPHutubessyRCWRationale and opportunities in estimating the economic burden of seasonal" exact="influenza" post="across countries using a standardized WHO tool and manualInfluenza"/>
   <result pre="Viruses201812132129143498 13OlivaJDelgado-SanzCLarrauriAcollab: Spanish Influenza Surveillance SystemEstimating the burden of seasonal" exact="influenza" post="in Spain from surveillance of mild and severe influenza"/>
   <result pre="seasonal influenza in Spain from surveillance of mild and severe" exact="influenza" post="disease, 2010-2016Influenza Other Respir Viruses20181216117028960828 14SchanzerDLSabouiMLeeLNwosuABancejCBurden of influenza, respiratory"/>
   <result pre="respiratory inpatients, Canada, 2003-2014Influenza Other Respir Viruses20181211312129243369 15SimmermanJMUyekiTMThe burden of" exact="influenza" post="in East and South-East Asia: a review of the"/>
   <result pre="Infect Dis2018241173117729912681 17collab: Centers for Disease Control and PreventionOverview of" exact="influenza" post="surveillance in the United StatesAccessed 22 April 2019Available at:"/>
   <result pre="2019Available at: https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm 19TreanorJJTalbotHKOhmitSEColemanLAThompsonMGChengPYPetrieJGLofthusGMeeceJKWilliamsJVBermanLBreese HallCMontoASGriffinMRBelongiaEShayDKcollab: US Flu-VE NetworkEffectiveness of seasonal" exact="influenza" post="vaccines in the United States during a season with"/>
   <result pre="three vaccine strainsClin Infect Dis20125595195922843783 20FerdinandsJMGaglaniMMartinETMiddletonDMontoASMurthyKSilveiraFPTalbotHKZimmermanRAlyanakEStricklandCSpencerSFryAMcollab: HAIVEN Study InvestigatorsPrevention of" exact="influenza" post="hospitalization among adults in the US, 2015-16: Results from"/>
   <result pre="ahead of print 21RolfesMAFoppaIMGargSFlanneryBBrammerLSingletonJABurnsEJerniganDOlsenSJBreseeJReedCAnnual estimates of the burden of seasonal" exact="influenza" post="in the United States: a tool for strengthening influenza"/>
   <result pre="seasonal influenza in the United States: a tool for strengthening" exact="influenza" post="surveillance and preparednessInfluenza Other Respir Viruses20181213213729446233 22collab: European Centre"/>
   <result pre="Respir Viruses20181213213729446233 22collab: European Centre for Disease Prevention and ControlEuropean" exact="influenza" post="surveillance network (EISN)Accessed 2 April 2019Available at: https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/eisn 23ZaraketHSaitoRJapanese"/>
   <result pre="24collab: Korea Centers for Disease Control and Prevention (KCDC)2018-2019 season" exact="influenza" post="management guidelineOsongKCDC2018 25SeoYBSongJYCheongHJChoYDWieSHJeongHWKimWJHospital-based influenza morbidity and mortality surveillance system"/>
   <result pre="Disease Control and Prevention (KCDC)2018-2019 season influenza management guidelineOsongKCDC2018 25SeoYBSongJYCheongHJChoYDWieSHJeongHWKimWJHospital-based" exact="influenza" post="morbidity and mortality surveillance system for influenza-like illnesses: a"/>
   <result pre="mortality surveillance system for influenza-like illnesses: a comparison with national" exact="influenza" post="surveillance systemsInfluenza Other Respir Viruses20148172024020512 26HongKWCheongHJChoiWSLeeJWieSHBaekJHKimHYJeongHWKimWJClinical courses and outcomes"/>
   <result pre="26HongKWCheongHJChoiWSLeeJWieSHBaekJHKimHYJeongHWKimWJClinical courses and outcomes of hospitalized adult patients with seasonal" exact="influenza" post="in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp;amp; Mortality (HIMM)"/>
   <result pre="27KangSHCheongHJSongJYNohJYJeonJHChoiMJLeeJSeoYBLeeJSWieSHJeongHWKimYKParkKHKimSWJeongEJLeeSHChoiWSKimWJAnalysis of risk factors for severe acute respiratory infection and" exact="pneumonia" post="and among adult patients with acute respiratory illness during"/>
   <result pre="and among adult patients with acute respiratory illness during 2011-2014" exact="influenza" post="seasons in KoreaInfect Chemother20164829430127883375 28ChoiWSCowlingBJNohJYSongJYWieSHLeeJSSeoYBLeeJJeongHWKimYKKimSWParkKHLeeSHCheongHJKimWJDisease burden of 2013-2014 seasonal"/>
   <result pre="influenza seasons in KoreaInfect Chemother20164829430127883375 28ChoiWSCowlingBJNohJYSongJYWieSHLeeJSSeoYBLeeJJeongHWKimYKKimSWParkKHLeeSHCheongHJKimWJDisease burden of 2013-2014 seasonal" exact="influenza" post="in adults in KoreaPLoS One201712e017201228278158 29LeeHSNohJYSongJYCheongHJChoiWSJeongHWWieSHKimWJMolecular genetic characteristics of"/>
   <result pre="influenza in adults in KoreaPLoS One201712e017201228278158 29LeeHSNohJYSongJYCheongHJChoiWSJeongHWWieSHKimWJMolecular genetic characteristics of" exact="influenza" post="A virus clinically isolated during 2011-2016 influenza seasons in"/>
   <result pre="genetic characteristics of influenza A virus clinically isolated during 2011-2016" exact="influenza" post="seasons in KoreaInfluenza Other Respir Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based influenza morbidity"/>
   <result pre="during 2011-2016 influenza seasons in KoreaInfluenza Other Respir Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based" exact="influenza" post="morbidity and mortality (HIMM) surveillance for A/H7N9 influenza virus"/>
   <result pre="Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based influenza morbidity and mortality (HIMM) surveillance for A/H7N9" exact="influenza" post="virus infection in returning travelersJ Korean Med Sci201833e4929359537 31collab:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6610691\results\search\disease\results.xml">
   <result pre="nervous system cerebrospinal fluid children dengue virus flavivirus Saint Louis" exact="encephalitis" post="virus Zika virus Introduction Aseptic meningoencephalitis is an important"/>
   <result pre="virus flavivirus Saint Louis encephalitis virus Zika virus Introduction Aseptic" exact="meningoencephalitis" post="is an important cause of mortality and morbidity in"/>
   <result pre="of children in the USA whereas in Asia the Japanese" exact="encephalitis" post="virus is found most often [2], [3]. Japanese encephalitis"/>
   <result pre="Japanese encephalitis virus is found most often [2], [3]. Japanese" exact="encephalitis" post="virus, and some representatives of the Flavivirus genus (family"/>
   <result pre="neurotropic viruses, including West Nile virus (WNV) and Saint Louis" exact="encephalitis" post="virus (SLEV) [4]. However, in recent years, other members"/>
   <result pre="Brazilian Ministry of Health [16] reported 7237 notified cases of" exact="meningitis" post="probably caused by viruses. Our group investigated 299 cases"/>
   <result pre="viruses. Our group investigated 299 cases of children with suspected" exact="meningoencephalitis" post="from 2014 to 2018 in Minas Gerais State, Brazil"/>
   <result pre="DENV RNA was found in CSF samples from children with" exact="meningoencephalitis" post="tested during the 2014/2015 epidemic in Minas Gerais State,"/>
   <result pre="these patients was an 11-year-old girl with a diagnosis of" exact="encephalitis" post="and positive serum IgM [20]. In EspÃ­rito Santo State,"/>
   <result pre="Viral diagnosis CNS manifestation State References Dengue virus 1 serological" exact="encephalitis" post="Rio de Janeiro Soares etÂ al. 2006 [20] 1"/>
   <result pre="Rio de Janeiro Soares etÂ al. 2006 [20] 1 serological" exact="acute disseminated encephalomyelitis" post="RondÃ´nia Miranda de Sousa etÂ al. 2006 [22] 2"/>
   <result pre="Janeiro Soares etÂ al. 2006 [20] 1 serological acute disseminated" exact="encephalomyelitis" post="RondÃ´nia Miranda de Sousa etÂ al. 2006 [22] 2"/>
   <result pre="RondÃ´nia Miranda de Sousa etÂ al. 2006 [22] 2 PCR" exact="encephalitis" post="EspÃ­rito Santo Domingues etÂ al. 2007 [21] 3 serological"/>
   <result pre="encephalitis EspÃ­rito Santo Domingues etÂ al. 2007 [21] 3 serological" exact="meningitis" post="CearÃ¡ Araujo etÂ al. 2012 [19] 7 PCR and"/>
   <result pre="CearÃ¡ Araujo etÂ al. 2012 [19] 7 PCR and serological" exact="meningoencephalitis" post="Minas Gerais Marinho etÂ al. 2017 [17] 5 PCR"/>
   <result pre="Gerais Marinho etÂ al. 2017 [17] 5 PCR and serological" exact="meningitis" post="Minas Gerais De Oliveira etÂ al. 2017 [18] 5"/>
   <result pre="etÂ al. 2017 [18] 5 PCR and serological Encephalitis and" exact="meningitis" post="Amazonas Bastos etÂ al. 2018 [23] Saint Louis encephalitis"/>
   <result pre="and meningitis Amazonas Bastos etÂ al. 2018 [23] Saint Louis" exact="encephalitis" post="virus 3 PCR meningoencephalitis SÃ£o Paulo Mondini etÂ al."/>
   <result pre="etÂ al. 2018 [23] Saint Louis encephalitis virus 3 PCR" exact="meningoencephalitis" post="SÃ£o Paulo Mondini etÂ al. 2007 [32] Zika virus"/>
   <result pre="Paulo Mondini etÂ al. 2007 [32] Zika virus 1 PCR" exact="encephalitis" post="â€&quot; Silva Vieira etÂ al. 2018 [26] A case"/>
   <result pre="Silva Vieira etÂ al. 2018 [26] A case of post-infection" exact="acute disseminated encephalomyelitis" post="was reported in a child by de Miranda de"/>
   <result pre="etÂ al. 2018 [26] A case of post-infection acute disseminated" exact="encephalomyelitis" post="was reported in a child by de Miranda de"/>
   <result pre="anti-dengue IgM antibodies in the serum and CSF, indicating that" exact="neuromyelitis optica" post="may be caused by DENV. Recently a study carried"/>
   <result pre="with meningitis/encephalitis. All children presented cytological CSF characteristic of viral" exact="meningoencephalitis" post="[23]. Zika virus The circulation of ZIKV has been"/>
   <result pre="[4], [6], [25]. In Brazil, only a single case of" exact="encephalitis" post="has been described in an 8-year-old child with ZIKV"/>
   <result pre="(unpublished data), 3% of CSF samples from children with suspected" exact="meningoencephalitis" post="were ZIKV positive by PCR. Although studies have primarily"/>
   <result pre="suggest that the virus is an important causative agent of" exact="meningoencephalitis" post="in paediatric patients. Saint Louis encephalitis virus Saint Louis"/>
   <result pre="important causative agent of meningoencephalitis in paediatric patients. Saint Louis" exact="encephalitis" post="virus Saint Louis encephalitis virus was first isolated in"/>
   <result pre="meningoencephalitis in paediatric patients. Saint Louis encephalitis virus Saint Louis" exact="encephalitis" post="virus was first isolated in 1933 during a major"/>
   <result pre="as the main targets for flavivirus infection such as Japanese" exact="encephalitis" post="virus in CNS in mice model and they described"/>
   <result pre="be similar in both children and adults [11], [23], with" exact="rash" post="observed in approximately 50% of patients, particularly children [11]."/>
   <result pre="children were seizures or tonic-clonic seizures, convulsions [5], [14], [26];" exact="meningitis" post="signs with acute onset of fever, headache, vomiting, nuchal"/>
   <result pre="with acute onset of fever, headache, vomiting, nuchal rigidity [19];" exact="encephalitis" post="signs of cerebral involvement with altered consciousness or cognition"/>
   <result pre="flavivirus. Soares etÂ al.[20] had 57% of the cases of" exact="meningitis" post="caused by DENV with normal chemocytological CSF. Other studies"/>
   <result pre="system infections in hospitalised Cambodian childrenBMC Infect Dis17201780629284418 3HasbunR.WoottonS.H.RosenthalN.Balada-LlasatJ.M.ChungJ.DuffS.Epidemiology of" exact="meningitis" post="and encephalitis in infants and children in the United"/>
   <result pre="in hospitalised Cambodian childrenBMC Infect Dis17201780629284418 3HasbunR.WoottonS.H.RosenthalN.Balada-LlasatJ.M.ChungJ.DuffS.Epidemiology of meningitis and" exact="encephalitis" post="in infants and children in the United States, 2011â€&quot;2014Pediatr"/>
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: a case studyLancet Infect Dis16201665366026897108 13O'LearyD.R.KuhnS.KnissK.L.HinckleyA.F.RasmussenS.A.PapeW.J.Birth outcomes"/>
   <result pre="serotypes in childrenBrazil Emerg Infect Dis23201711511827983492 18de OliveiraD.B.CandianiT.M.Franco-LuizA.P.M.AlmeidaG.M.F.AbrahÃ£oJ.S.RiosM.Etiological agents of" exact="viral meningitis" post="in children from a dengue-endemic area, Southeast region of"/>
   <result pre="in childrenBrazil Emerg Infect Dis23201711511827983492 18de OliveiraD.B.CandianiT.M.Franco-LuizA.P.M.AlmeidaG.M.F.AbrahÃ£oJ.S.RiosM.Etiological agents of viral" exact="meningitis" post="in children from a dengue-endemic area, Southeast region of"/>
   <result pre="in a Brazilian childRev Soc Bras Med Trop51201839039229972576 27RoccoI.M.SantosC.L.BisordiI.PetrellaS.M.PereiraL.E.SouzaR.P.St. Louis" exact="encephalitis" post="virus: first isolation from a human in SÃ£o Paulo"/>
   <result pre="BrazilRev Inst Med Trop Sao Paulo47200528128516302112 28CauseyO.R.ShopeR.E.TheilerM.Isolation of St. Louis" exact="encephalitis" post="virus from arthropods in Para, BrazilAm J Trop Med"/>
   <result pre="of the Pantanal, BrazilPLoS Negl Trop Dis82014e2706 31SilvaJ.R.RomeiroM.F.SouzaW.M.MunhozT.D.BorgesG.P.SoaresO.A.AÂ Saint Louis" exact="encephalitis" post="and Rocio virus serosurvey in Brazilian horsesRev Soc Bras"/>
   <result pre="serosurvey in Brazilian horsesRev Soc Bras Med Trop47201441441725229279 32MondiniA.CardealI.L.LÃ¡zaroE.NunesS.H.MoreiraC.C.RahalP.Saint Louis" exact="encephalitis" post="virus, BrazilEmerg Infect Dis13200717617817370543 33PetersenL.R.BraultA.C.NasciR.S.West Nile virus: review of"/>
   <result pre="nervous system and neuroinflammation precede bloodâ€&quot;brain barrier disruption during Japanese" exact="encephalitis" post="virus infectionJÂ Virol8920155602561425762733 35RamosC.SÃ¡nchezG.PandoR.H.BaqueraJ.HernÃ¡ndezD.MotaJ.Dengue virus in the brain of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6611972\results\search\disease\results.xml">
   <result pre="in FP and whose ability to transmit dengue, zika and" exact="chikungunya" post="viruses is well known. In addition, we discuss the"/>
   <result pre="risk for new emergences. Keywords Aedes aegypti Aedes polynesiensis arboviruses" exact="chikungunya" post="virus Culex annulirostris dengue virus French Polynesia mosquito vectors"/>
   <result pre="mentioned in old written works [1]. Zika virus (ZIKV) and" exact="chikungunya" post="virus (CHIKV) were introduced in 2013 and 2014, respectively,"/>
   <result pre="strains of mosquitoes were developed by manipulating Wolbachia to induce" exact="infertility" post="between a Wolbachia-infected male mosquito and an uninfected female"/>
   <result pre="C.Â annulirostris, C.Â sitiens and C.Â quinquefasciatus may transmit Japanese" exact="encephalitis" post="virus [51] and, with A.Â vexans, West Nile virus"/>
   <result pre="Nile virus [43], [52]. Aedes aegypti is a vector of" exact="yellow fever" post="virus [53]. Consequently, these arboviruses are a risk for"/>
   <result pre="Aedes aegypti and Aedes polynesiensis populations from French Polynesia for" exact="chikungunya" post="virusPLoS Negl Trop Dis102016e0004694 7RichardV.ViallonJ.Cao-LormeauV.M.Use of centrifugal filter devices"/>
   <result pre="strains to oral and parenteral infection with dengue and Japanese" exact="encephalitis" post="virusesAm J Trop Med Hyg3419856036152860816 11CalvezE.MoussonL.VazeilleM.O'ConnorO.Cao-LormeauV.M.Mathieu-DaudeF.Zika virus outbreak in"/>
   <result pre="River virus vectors at Maroochy Shire, AustraliaJÂ Med Entomol37200014615215218919 32MillerB.R.MonathT.P.TabachnickW.J.EzikeV.I.Epidemic" exact="yellow fever" post="caused by an incompetent mosquito vectorTrop Med Parasitol4019893963992623418 33MitchellC.J.GublerD.J.Vector"/>
   <result pre="51OliveiraA.R.S.StratheE.EtcheverryL.CohnstaedtL.W.McVeyD.S.PiaggioJ.Assessment of data on vector and host competence for Japanese" exact="encephalitis" post="virus: a systematic review of the literaturePrev Vet Med1542018718929685447"/>
   <result pre="Res Public Health1020133735375223965926 53KlittingR.GouldE.A.PaupyC.de LamballerieX.What does the future hold for" exact="yellow fever" post="virus? (I)Genes62018"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6612077\results\search\disease\results.xml">
   <result pre="pathogenicity with other family members such as dengue virus (DENV)," exact="yellow fever" post="virus (YFV), West Nile virus (WNV) and Japanese encephalitis"/>
   <result pre="yellow fever virus (YFV), West Nile virus (WNV) and Japanese" exact="encephalitis" post="virus (JEV) [2]. Approximately 80% of Zika infections are"/>
   <result pre="non-specific clinical symptoms such as mild fever, rash, arthralgia, myalgia," exact="conjunctivitis" post="and headache [5]. Nevertheless, sometimes ZIKV infection can lead"/>
   <result pre="complications, such as Guillain-Barre Syndrome in adults [6, 7] and" exact="microcephaly" post="in neonates [8]. ZIKV is transmitted to humans mainly"/>
   <result pre="been a challenging aspect in the control and prevention of" exact="infectious disease," post="for their ability to spread virus and high mobility"/>
   <result pre="Rep201771582910.1038/s41598-017-05013-928724972 5.PetersenLRJamiesonDJPowersAMHoneinMAZika VirusN Engl J Med2016374161552156310.1056/NEJMra160211327028561 6.BritoFMAntunesDBCMoreiraAde MoraisMMHenriques-SouzaAet al.Guillain-Barre syndrome," exact="acute disseminated encephalomyelitis" post="and encephalitis associated with Zika virus infection in Brazil:"/>
   <result pre="VirusN Engl J Med2016374161552156310.1056/NEJMra160211327028561 6.BritoFMAntunesDBCMoreiraAde MoraisMMHenriques-SouzaAet al.Guillain-Barre syndrome, acute disseminated" exact="encephalomyelitis" post="and encephalitis associated with Zika virus infection in Brazil:"/>
   <result pre="J Med2016374161552156310.1056/NEJMra160211327028561 6.BritoFMAntunesDBCMoreiraAde MoraisMMHenriques-SouzaAet al.Guillain-Barre syndrome, acute disseminated encephalomyelitis and" exact="encephalitis" post="associated with Zika virus infection in Brazil: detection of"/>
   <result pre="the Australian blood supply?Aust N Z J Public Health201842110410510.1111/1753-6405.1269728749569 16.KielyPWoodEMGambhirMChengACMcQuiltenZKSeedCREmerging" exact="infectious disease" post="agents and blood safety in Australia: spotlight on Zika"/>
   <result pre="United States in 2002N Engl J Med2003349131236124510.1056/NEJMoa03096914500806 35.Transfusion-related transmission of" exact="yellow fever" post="vaccine virus--California, 2009. MMWR Morb Mortal Wkly Rep, 2010."/>
   <result pre="virus in sera of Brazilian blood donorsTransfusion20125281667167110.1111/j.1537-2995.2012.03729.x22670858 40.GallianPLeparc-GoffartIRichardPMaireFFlusinODjoudiRet al.Epidemiology of" exact="chikungunya" post="virus outbreaks in Guadeloupe and Martinique, 2014: an observational"/>
   <result pre="global epidemiology: to screen or not to screen?Transfusion20125281634163910.1111/j.1537-2995.2012.03747.x22882092 42.StramerSLHollingerFBKatzLMKleinmanSMetzelPSet al.Emerging" exact="infectious disease" post="agents and their potential threat to transfusion safetyTransfusion200949Suppl 21S29S10.1111/j.1537-2995.2009.02279.x19686562"/>
   <result pre="in red blood cells using amustaline and glutathioneTransfusion201757122888289610.1111/trf.1431828921542 50.LaughhunnAHuangYSVanlandinghamDLLanteriMCStassinopoulosAInactivation of" exact="chikungunya" post="virus in blood components treated with amotosalen/ultraviolet a light"/>
   <result pre="Pharmacol Ther201746977377910.1111/apt.1431928892184 53.FordACMarwahaALimAMoayyediPSystematic review and meta-analysis of the prevalence of" exact="irritable bowel syndrome" post="in individuals with dyspepsiaClin Gastroenterol Hepatol20108540140910.1016/j.cgh.2009.07.02019631762"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6624372\results\search\disease\results.xml">
   <result pre="Population density and water balance influence the global occurrence of" exact="hepatitis" post="E epidemics CarratalÃ Annaanna.carratala@epfl.ch1http://orcid.org/0000-0002-1184-7501JoostStÃ©phane2[1], 0000000121839049grid.5333.6Environmental Chemistry Laboratory (LCE), School"/>
   <result pre="visit http://creativecommons.org/licenses/by/4.0/. Abstract In developing countries, the waterborne transmission of" exact="hepatitis" post="E virus (HEV), caused by HEV genotypes 1 (HEV-1)"/>
   <result pre="viruses in the near future. Subject terms Ecological modelling Viral" exact="hepatitis" post="Introduction Hepatitis E virus (HEV) is recognized as one"/>
   <result pre="recognized as one of the most important agents of acute" exact="viral hepatitis" post="worldwide1. According to estimates of the World Health Organization"/>
   <result pre="as one of the most important agents of acute viral" exact="hepatitis" post="worldwide1. According to estimates of the World Health Organization"/>
   <result pre="have instead been identified as causative agents in sporadic acute" exact="hepatitis" post="E cases in the United States, Europe, China and"/>
   <result pre="in Mexico in 198632. Figure 1 Outbreaks caused worldwide by" exact="hepatitis" post="E virus (HEV-1 or HEV-2) due to the consumption"/>
   <result pre="refugee camps. Table 1 General summary of the dataset of" exact="hepatitis" post="E waterborne outbreaks (1980â€&quot;2017) compiled in this study, per"/>
   <result pre="in Asia than in Africa. Models of spatial suitability for" exact="hepatitis" post="E virus outbreaks General model The combination of variables"/>
   <result pre="general model of the ecological suitability for the occurrence of" exact="hepatitis" post="E waterborne outbreaks obtained by the Maxent method. This"/>
   <result pre="environmental variables selected on the basis of current knowledge on" exact="hepatitis" post="E virus. This model predicts a high ecological suitability"/>
   <result pre="from countries with very high suitability for the occurrence of" exact="hepatitis" post="E outbreaks such as India, Indonesia, Pakistan or Bangladesh,"/>
   <result pre="40%39, thus migration fluxes may contribute to the occurrence of" exact="hepatitis" post="E viruses in Saudi Arabia, where some areas are"/>
   <result pre="and environmental suitability for the occurrence of waterborne outbreaks of" exact="hepatitis" post="E virus (genotypes 1 and 2). Specifically, our results"/>
   <result pre="a step forward for anticipating and preventing the occurrence of" exact="hepatitis" post="E epidemics due to the contamination of drinking and"/>
   <result pre="work was compiled using literature records of waterborne outbreaks of" exact="hepatitis" post="E available in the PubMed database and in WHO"/>
   <result pre="use the term â€œwaterborne HEVâ€� to refer to outbreaks of" exact="hepatitis" post="E caused by either genotype 1 and 2. The"/>
   <result pre="density is beneficial for the onset of waterborne outbreaks of" exact="hepatitis" post="E, and that population density has increased in many"/>
   <result pre="population density data, environmental data and our complete dataset of" exact="hepatitis" post="E outbreaks (general model), (ii) a model using environmental"/>
   <result pre="a model using environmental data and our complete dataset of" exact="hepatitis" post="E outbreaks (environmental model), (iii) models using population density"/>
   <result pre="of drinking water on attack and fatality rates in a" exact="hepatitis" post="E epidemic in SomaliaAm J Trop Med Hyg1994514667410.4269/ajtmh.1994.51.4667943574 4.SailajaBet"/>
   <result pre="in SomaliaAm J Trop Med Hyg1994514667410.4269/ajtmh.1994.51.4667943574 4.SailajaBet al.Outbreak of waterborne" exact="hepatitis" post="E in Hyderabad, India, 2005Epidemiol Infect20091372344010.1017/S095026880800095218606027 5.GreenAThe omitted epidemic-hepatitis"/>
   <result pre="the family HepeviridaeJ Gen Virol20149522233210.1099/vir.0.068429-024989172 7.OkamotoHGenetic variability and evolution of" exact="hepatitis" post="E virusVirus Res.20071272162810.1016/j.virusres.2007.02.00217363102 8.Purcell, R. H. &amp;amp; Emerson, S."/>
   <result pre="&amp;amp; Wilkins, Philadelphia, PA, 2001). 9.Gupta, N. et al. Acute" exact="hepatitis" post="E in India appears to be caused exclusively by"/>
   <result pre="in India appears to be caused exclusively by genotype 1" exact="hepatitis" post="E virus (2018). 10.SpinaAet al.A large outbreak of Hepatitis"/>
   <result pre="11.HuangCCet al.Molecular cloning and sequencing of the mexico isolate of" exact="hepatitis" post="E virus (HEV)Virology1992191550810.1016/0042-6822(92)90230-M1448913 12.BuissonYet al.Identification of a novel hepatitis"/>
   <result pre="of hepatitis E virus (HEV)Virology1992191550810.1016/0042-6822(92)90230-M1448913 12.BuissonYet al.Identification of a novel" exact="hepatitis" post="E virus in NigeriaJ Gen Virol200081903910.1099/0022-1317-81-4-90310725415 13.MailaHTBowyerSMSwanepoelRIdentification of a"/>
   <result pre="in NigeriaJ Gen Virol200081903910.1099/0022-1317-81-4-90310725415 13.MailaHTBowyerSMSwanepoelRIdentification of a new strain of" exact="hepatitis" post="E virus from an outbreak in Namibia in 1995J"/>
   <result pre="in Namibia in 1995J Gen Virol200485899510.1099/vir.0.19587-014718623 14.NicandEet al.Genetic heterogeneity of" exact="hepatitis" post="E virus in Darfur, Sudan, and neighboring ChadJ Med"/>
   <result pre="in Darfur, Sudan, and neighboring ChadJ Med Virol2005775192110.1002/jmv.2048716254969 15.IppaguntaSKNaikSSharmaBAggarwalRPresence of" exact="hepatitis" post="E virus in sewage in Northern India: frequency and"/>
   <result pre="viruses in two settlements based in Eastern Chad: Analysis of" exact="hepatitis" post="E virus, hepatitis A virus and human adenovirus in"/>
   <result pre="settlements based in Eastern Chad: Analysis of hepatitis E virus," exact="hepatitis" post="A virus and human adenovirus in water sourcesJ Water"/>
   <result pre="in Mexico, 1986â€&quot;1987JAMA J Am Med Assoc19902633281510.1001/jama.1990.03440240071018 33.NaikSRAggarwalRSalunkePNMehrotraNNA large waterborne" exact="viral hepatitis" post="E epidemic in Kanpur, IndiaIndian J Pediatr19936064364310.1007/BF02821726 34.RabMAet al.Water-borne"/>
   <result pre="Mexico, 1986â€&quot;1987JAMA J Am Med Assoc19902633281510.1001/jama.1990.03440240071018 33.NaikSRAggarwalRSalunkePNMehrotraNNA large waterborne viral" exact="hepatitis" post="E epidemic in Kanpur, IndiaIndian J Pediatr19936064364310.1007/BF02821726 34.RabMAet al.Water-borne"/>
   <result pre="hepatitis E epidemic in Kanpur, IndiaIndian J Pediatr19936064364310.1007/BF02821726 34.RabMAet al.Water-borne" exact="hepatitis" post="E virus epidemic in Islamabad, Pakistan: A common source"/>
   <result pre="syndrome in northern Uganda, 2010â€&quot;2012Am J Trop Med Hyg201592411410.4269/ajtmh.14-019625448237 36.JohargyAKMahomedMFKhanMMKabrahSAnti" exact="hepatitis" post="E virus seropositivity in a group of male blood"/>
   <result pre="in Makkah, Saudi ArabiaJ Pak Med Assoc201363185923894892 37.AbdelaalMet al.Epidemiology of" exact="hepatitis" post="E virus in male blood donors in Jeddah, Saudi"/>
   <result pre="donors in Jeddah, Saudi ArabiaIr J Med Sci199816794610.1007/BF029379469638024 38.ArifMQattanIal-FalehFRamiaSEpidemiology of" exact="hepatitis" post="E virus (HEV) infection in Saudi ArabiaAnn Trop Med"/>
   <result pre="ArabiaAnn Trop Med Parasitol199488163810.1080/00034983.1994.118128548067812 39.ArankalleVAet al.Age-specific prevalence of antibodies to" exact="hepatitis" post="A and E viruses in pune, india, 1982 and"/>
   <result pre="and 1992J Infect Dis19951714475010.1093/infdis/171.2.4477844387 40.CorwinALet al.The unique riverine ecology of" exact="hepatitis" post="E virus transmission in South-East AsiaTrans R Soc Trop"/>
   <result pre="ONE201495e9854610.1371/journal.pone.009854624874010 44.KaurMet al.Hepatitis E virus: A leading cause of waterborne" exact="viral hepatitis" post="in Northwest Districts of Punjab, IndiaJ Lab Physicians20179121410.4103/0974-2727.19963628367028 45.PonsWendyYoungIanTruongJeniferJones-BittonAndriaMcEwenScottPintarKatarinaPapadopoulosAndrewA"/>
   <result pre="44.KaurMet al.Hepatitis E virus: A leading cause of waterborne viral" exact="hepatitis" post="in Northwest Districts of Punjab, IndiaJ Lab Physicians20179121410.4103/0974-2727.19963628367028 45.PonsWendyYoungIanTruongJeniferJones-BittonAndriaMcEwenScottPintarKatarinaPapadopoulosAndrewA"/>
   <result pre="in Canada and the United StatesPLOS ONE20151010e014164610.1371/journal.pone.014164626513152 46.HuangWet al.Cross-protection of" exact="hepatitis" post="E virus genotypes 1 and 4 in rhesus macaquesJ"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6629778\results\search\disease\results.xml">
   <result pre="al., 2001; Mostashari et al., 2001). Mortality due to WNV" exact="encephalitis" post="ranges between 10 and 17% and increases with age"/>
   <result pre="Americas. After its arrival in 2015, an increased incidence of" exact="microcephaly" post="in newborns and Guillain-BarrÃ© syndrome (GBS) in adults infected"/>
   <result pre="other flaviviruses able to cause neurological diseases (such as Japanese" exact="encephalitis" post="and tick-borne encephalitis virus), and due to the size"/>
   <result pre="able to cause neurological diseases (such as Japanese encephalitis and" exact="tick-borne encephalitis" post="virus), and due to the size of the review"/>
   <result pre="to cause neurological diseases (such as Japanese encephalitis and tick-borne" exact="encephalitis" post="virus), and due to the size of the review"/>
   <result pre="continues its steady expansion and constitutes the most common mosquito-borne" exact="viral disease" post="worldwide. WNV is the most widespread flavivirus causing neurological"/>
   <result pre="in the Americas is responsible for thousands of cases of" exact="microcephaly" post="in newborns and Guillain-Barre syndrome in adults. Different strategies"/>
   <result pre="WNV infection can lead to severe neurological problems. These include" exact="aseptic meningitis," post="febrile convulsions in children, encephalitis, and myelitis (Turtle et"/>
   <result pre="These include aseptic meningitis, febrile convulsions in children, encephalitis, and" exact="myelitis" post="(Turtle et al., 2012). Thus, models of the brain"/>
   <result pre="mainly been studied in monolayer cultures of various brain cell-type" exact="cancer" post="cell lines, such as neuro-2a (de Borba et al.,"/>
   <result pre="to be a novel tool for drug screening development for" exact="cancer" post="(Weeber et al., 2017), intestinal diseases (Liu et al.,"/>
   <result pre="screening approach was recently utilized to elucidate that ZIKV-elicited congenital" exact="microcephaly" post="may act through dysregulation of the retinoic acid response"/>
   <result pre="role of both viral and human microRNA in congenital ZIKV" exact="microcephaly" post="(Pylro et al., 2016). In addition to studies focused"/>
   <result pre="infection and pathogenesis. However, in vitro models that rely on" exact="cancer" post="cell lines or monolayer cultures are limited in human"/>
   <result pre="comparative analysis of the relative efficacy of vector-control strategies against" exact="dengue fever." post="Bull. Math. Biol.76, 697â€&quot;717. 10.1007/s11538-014-9939-524619807 AmannaI. J.SlifkaM. K. (2014)."/>
   <result pre="pathologic study of a DENV2 clinical isolate capable of inducing" exact="encephalitis" post="and hematological disturbances in immunocompetent mice. PLoS ONE7:e44984. 10.1371/journal.pone.004498423028722"/>
   <result pre="leucocyte antigen-DR on peripheral blood monocytes during mild and severe" exact="dengue fever." post="Immunology130, 202â€&quot;216. 10.1111/j.1365-2567.2009.03224.x20113369 BalasubramanianA.TeramotoT.KulkarniA. A.BhattacharjeeA. K.PadmanabhanR. (2017). Antiviral activities"/>
   <result pre="GoodfellowF. T.TeslaB.SimchickG.ZhaoQ.HodgeT.BrindleyM. A.et al.. (2016). Zika virus induced mortality and" exact="microcephaly" post="in chicken embryos. Stem Cells Dev.25, 1691â€&quot;1697. 10.1089/scd.2016.023127627457 GrebenyukS.RangaA."/>
   <result pre="Front. Bioeng. Biotechnol.7:39. 10.3389/fbioe.2019.0003930941347 GuirakhooF.KitchenerS.MorrisonD.ForratR.McCarthyK.NicholsR.et al. (2006). Live attenuated chimeric" exact="yellow fever" post="dengue type 2 (ChimeriVaxâ&quot;¢-DEN2) vaccine: Phase I clinical trial"/>
   <result pre="Phase I clinical trial for safety and immunogenicity: effect of" exact="yellow fever" post="pre-immunity in induction of cross neutralizing antibody responses to"/>
   <result pre="First Isolation of West Nile virus from a patient with" exact="encephalitis" post="in the United States. Emerging Infect. Dis.8, 1367â€&quot;1371. 10.3201/eid0812.02053212498649"/>
   <result pre="MarianiJ.CoppolaG.ZhangP.AbyzovA.ProviniL.TomasiniL.et al.. (2015). FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in" exact="autism" post="spectrum disorders. Cell162, 375â€&quot;390. 10.1016/j.cell.2015.06.03426186191 MartinJ. E.PiersonT. C.HubkaS.RuckerS.GordonI. J.EnamaM."/>
   <result pre="S. (2003). Infection and injury of neurons by West Nile" exact="encephalitis" post="virus. J. Virol.77, 13203â€&quot;13213. 10.1128/JVI.77.24.13203-13213.200314645577 SiemannD. N.StrangeD. P.MaharajP. N.ShiP."/>
   <result pre="endpoints of CELADEN: a randomized, placebo-controlled trial of celgosivir in" exact="dengue fever" post="patients. PLoS Negl. Trop. Dis.10:e0004851. 10.1371/journal.pntd.000485127509020 TalaveraD.CastilloA. M.DominguezM. C.GutierrezA."/>
   <result pre="Immunother.13, 1059â€&quot;1072. 10.1080/21645515.2016.126177028281864 TsaiT. F.PopoviciF.CernescuC.CampbellG. L.NedelcuN. I. (1998). West Nile" exact="encephalitis" post="epidemic in southeastern Romania. Lancet352, 767â€&quot;771. 10.1016/S0140-6736(98)03538-79737281 TsaiY. T.ChangS."/>
   <result pre="WeeberF.OoftS. N.DijkstraK. K.VoestE. E. (2017). Tumor organoids as a pre-clinical" exact="cancer" post="model for drug discovery. Cell Chem. Biol.24, 1092â€&quot;1100. 10.1016/j.chembiol.2017.06.01228757181"/>
   <result pre="Modeling the Effects of augmentation strategies on the control of" exact="dengue fever" post="with an impulsive differential equation. Bull. Math. Biol.78, 1968â€&quot;2010."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6630566\results\search\disease\results.xml">
   <result pre="have spread efficiently from person to person to cause an" exact="influenza" post="pandemic. The ability to infect a different species, replicate"/>
   <result pre="avian IAV to infect and spread in humans are discussed." exact="influenza" post="species barrier cross-species infection zoonoses animalâ€&quot;human interface 1. Introduction"/>
   <result pre="interface 1. Introduction Much of what we know about pandemic" exact="influenza" post="viruses is based on analysis of the four influenza"/>
   <result pre="pandemic influenza viruses is based on analysis of the four" exact="influenza" post="A viruses (IAVs) that caused influenza pandemics in the"/>
   <result pre="analysis of the four influenza A viruses (IAVs) that caused" exact="influenza" post="pandemics in the last 100 years: the 1918 H1N1,"/>
   <result pre="infected by relatively few IAV subtypes. For example, classical swine" exact="influenza" post="(which refers to H1N1 virus infection in pigs), H1N1pdm09"/>
   <result pre="viruses infect pigs, H3 and H7 subtypes have caused equine" exact="influenza" post="and sustained epidemics in humans have only been caused"/>
   <result pre="segments of negative-sense, single-stranded RNA. The enormous genetic diversity of" exact="influenza" post="viruses in nature is a result of an error-prone"/>
   <result pre="fatal, multi-system infection in poultry that is called highly pathogenic" exact="avian influenza" post="(HPAI). Avian IAVs that lack the MCBS are referred"/>
   <result pre="multi-system infection in poultry that is called highly pathogenic avian" exact="influenza" post="(HPAI). Avian IAVs that lack the MCBS are referred"/>
   <result pre="that lack the MCBS are referred to as low pathogenicity" exact="avian influenza" post="(LPAI) viruses [14]. Highly pathogenic avian H5N1, H7N7 and,"/>
   <result pre="lack the MCBS are referred to as low pathogenicity avian" exact="influenza" post="(LPAI) viruses [14]. Highly pathogenic avian H5N1, H7N7 and,"/>
   <result pre="Furthermore, erroneous polymerase activity during viral RNA replication of some" exact="influenza" post="viruses can lead to the production of short aberrant"/>
   <result pre="IAVs have infected and become established in pigs [22], so" exact="influenza" post="in swine today is caused by a variety of"/>
   <result pre="Consequence of Interspecies Transmission Influenza pandemics occur when a novel" exact="influenza" post="A virus, to which a significant proportion of the"/>
   <result pre="IAVs in humans is referred to as antigenic shift. Novel" exact="influenza" post="viruses are introduced from an animal reservoir. If the"/>
   <result pre="a pandemic threat. The 1957 H2N2 and 1968 H3N2 pandemic" exact="influenza" post="viruses were genetic reassortants that derived three [HA, NA"/>
   <result pre="or two (HA and PB1) gene segments, respectively, from an" exact="avian influenza" post="virus and the remaining gene segments from the previously"/>
   <result pre="two (HA and PB1) gene segments, respectively, from an avian" exact="influenza" post="virus and the remaining gene segments from the previously"/>
   <result pre="and the remaining gene segments from the previously circulating human" exact="influenza" post="virus [27,28]. The host in which these reassortment events"/>
   <result pre="to infected poultry. Compared to the four viruses that caused" exact="influenza" post="pandemics, with very rare exceptions in close contacts, these"/>
   <result pre="the Species Barrier The molecular determinants of the transmissibility of" exact="influenza" post="viruses are not well understood. Epidemiologically successful IAVs, e.g.,"/>
   <result pre="not well understood. Epidemiologically successful IAVs, e.g., seasonal and pandemic" exact="influenza" post="viruses, transmit efficiently from person to person while those"/>
   <result pre="animal by a mesh (airborne transmission) are assessed. While seasonal" exact="influenza" post="A viruses transmit by contact and airborne transmission, avian"/>
   <result pre="the ferret, a site that was overlooked in all previous" exact="influenza" post="research [42]. We found that the soft palate of"/>
   <result pre="economic consequences of a pandemic and the certainty that another" exact="influenza" post="pandemic will occur are so great that the public"/>
   <result pre="most effective approach to prevent and treat influenza. However, pandemic" exact="influenza" post="vaccines pose several challenges [43,44,45]; currently licensed vaccines take"/>
   <result pre="highly strain-specific immunity. There are active efforts to develop universal" exact="influenza" post="vaccines that will provide protection against a broad range"/>
   <result pre="and spread efficiently from person to person to cause an" exact="influenza" post="pandemic. The global impact of influenza pandemics drives scientific"/>
   <result pre="person to cause an influenza pandemic. The global impact of" exact="influenza" post="pandemics drives scientific efforts to understand the barriers to"/>
   <result pre="declares no conflict of interest. References References 1.MostafaA.AbdelwhabE.M.MettenleiterT.C.PleschkaS.Zoonotic potential of" exact="influenza" post="a viruses: A comprehensive overviewViruses20181049710.3390/v1009049730217093 2.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage"/>
   <result pre="a viruses: A comprehensive overviewViruses20181049710.3390/v1009049730217093 2.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of" exact="influenza" post="a virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 3.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et"/>
   <result pre="Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 3.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats harbor diverse" exact="influenza" post="a virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 4.ZhangY.Z.WuW.C.ShiM.HolmesE.C.The diversity, evolution and origins of"/>
   <result pre="of vertebrate rna virusesCurr. Opin. Virol.20183191610.1016/j.coviro.2018.07.01730114593 5.YoonS.W.WebbyR.J.WebsterR.G.Evolution and ecology of" exact="influenza" post="a virusesCurr. Top. Microbiol. Immunol.201438535937524990620 6.MatrosovichM.N.MatrosovichT.Y.GrayT.RobertsN.A.KlenkH.D.Human and avian influenza"/>
   <result pre="ecology of influenza a virusesCurr. Top. Microbiol. Immunol.201438535937524990620 6.MatrosovichM.N.MatrosovichT.Y.GrayT.RobertsN.A.KlenkH.D.Human and" exact="avian influenza" post="viruses target different cell types in cultures of human"/>
   <result pre="of influenza a virusesCurr. Top. Microbiol. Immunol.201438535937524990620 6.MatrosovichM.N.MatrosovichT.Y.GrayT.RobertsN.A.KlenkH.D.Human and avian" exact="influenza" post="viruses target different cell types in cultures of human"/>
   <result pre="avian h5n1 virus hemagglutininNat. Biotechnol.20082610711310.1038/nbt137518176555 8.RogersG.N.PaulsonJ.C.DanielsR.S.SkehelJ.J.WilsonI.A.WileyD.C.Single amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificityNature1983304767810.1038/304076a06191220 9.ShinyaK.EbinaM.YamadaS.OnoM.KasaiN.KawaokaY.Avian flu: Influenza virus"/>
   <result pre="al.Glycomic analysis of human respiratory tract tissues and correlation with" exact="influenza" post="virus infectionPLoS Pathog.20139e100322310.1371/journal.ppat.100322323516363 12.Stieneke GroberA.VeyM.AnglikerH.ShawE.ThomasG.RobertsC.KlenkH.D.GartenW.Influenza virus hemagglutinin with multibasic"/>
   <result pre="by furin, a subtilisin-like endoproteaseEMBO J.1992112407241410.1002/j.1460-2075.1992.tb05305.x1628614 13.VeyM.OrlichM.AdlerS.KlenkH.D.RottR.GartenW.Hemagglutinin activation of pathogenic" exact="avian influenza" post="viruses of serotype h7 requires the protease recognition motif"/>
   <result pre="furin, a subtilisin-like endoproteaseEMBO J.1992112407241410.1002/j.1460-2075.1992.tb05305.x1628614 13.VeyM.OrlichM.AdlerS.KlenkH.D.RottR.GartenW.Hemagglutinin activation of pathogenic avian" exact="influenza" post="viruses of serotype h7 requires the protease recognition motif"/>
   <result pre="Microbiol.2005359160010.1038/nrmicro120816064053 15.SubbaraoE.K.LondonW.MurphyB.R.A single amino acid in the pb2 gene of" exact="influenza" post="a virus is a determinant of host rangeJ. Virol.199367176117648445709"/>
   <result pre="host rangeJ. Virol.199367176117648445709 16.LiZ.ChenH.JiaoP.DengG.TianG.LiY.HoffmannE.WebsterR.G.MatsuokaY.YuK.Molecular basis of replication of duck h5n1" exact="influenza" post="viruses in a mammalian mouse modelJ. Virol.200579120581206410.1128/JVI.79.18.12058-12064.200516140781 17.MehleA.DoudnaJ.A.Adaptive strategies"/>
   <result pre="in a mammalian mouse modelJ. Virol.200579120581206410.1128/JVI.79.18.12058-12064.200516140781 17.MehleA.DoudnaJ.A.Adaptive strategies of the" exact="influenza" post="virus polymerase for replication in humansProc. Natl. Acad. Sci."/>
   <result pre="humansProc. Natl. Acad. Sci. USA2009106213122131610.1073/pnas.091191510619995968 18.LongJ.S.MistryB.HaslamS.M.BarclayW.S.Host and viral determinants of" exact="influenza" post="a virus species specificityNat. Rev. Microbiol.201917678110.1038/s41579-018-0115-z30487536 19.LongJ.S.GiotisE.S.MoncorgeO.FriseR.MistryB.JamesJ.MorissonM.IqbalM.VignalA.SkinnerM.A.et al.Species difference"/>
   <result pre="species specificityNat. Rev. Microbiol.201917678110.1038/s41579-018-0115-z30487536 19.LongJ.S.GiotisE.S.MoncorgeO.FriseR.MistryB.JamesJ.MorissonM.IqbalM.VignalA.SkinnerM.A.et al.Species difference in anp32a underlies" exact="influenza" post="a virus polymerase host restrictionNature201652910110410.1038/nature1647426738596 20.GabrielG.KlingelK.OtteA.ThieleS.HudjetzB.Arman-KalcekG.SauterM.ShmidtT.RotherF.BaumgarteS.et al.Differential use of"/>
   <result pre="of importin-alpha isoforms governs cell tropism and host adaptation of" exact="influenza" post="virusNat. Commun.2011215610.1038/ncomms115821245837 21.Te VelthuisA.J.W.LongJ.C.BauerD.L.V.FanR.L.Y.YenH.L.SharpsJ.SiegersJ.Y.KillipM.J.FrenchH.Oliva-MartinM.J.et al.Mini viral rnas act as"/>
   <result pre="VelthuisA.J.W.LongJ.C.BauerD.L.V.FanR.L.Y.YenH.L.SharpsJ.SiegersJ.Y.KillipM.J.FrenchH.Oliva-MartinM.J.et al.Mini viral rnas act as innate immune agonists during" exact="influenza" post="virus infectionNat. Microbiol.201831234124210.1038/s41564-018-0240-530224800 22.NelsonM.I.VincentA.L.Reverse zoonosis of influenza to swine:"/>
   <result pre="immune agonists during influenza virus infectionNat. Microbiol.201831234124210.1038/s41564-018-0240-530224800 22.NelsonM.I.VincentA.L.Reverse zoonosis of" exact="influenza" post="to swine: New perspectives on the human-animal interfaceTrends Microbiol.20152314215310.1016/j.tim.2014.12.00225564096"/>
   <result pre="New perspectives on the human-animal interfaceTrends Microbiol.20152314215310.1016/j.tim.2014.12.00225564096 23.VincentA.AwadaL.BrownI.ChenH.ClaesF.DauphinG.DonisR.CulhaneM.HamiltonK.LewisN.et al.Review of" exact="influenza" post="a virus in swine worldwide: A call for increased"/>
   <result pre="researchZoonoses Public Health20146141710.1111/zph.1204923556412 24.ChenY.TrovaoN.S.WangG.ZhaoW.HeP.ZhouH.MoY.WeiZ.OuyangK.HuangW.et al.Emergence and evolution of novel reassortant" exact="influenza" post="a viruses in canines in southern ChinamBio20189e00909e0091810.1128/mBio.00909-1829871917 25.CrawfordP.C.DuboviE.J.CastlemanW.L.StephensonI.GibbsE.P.ChenL.SmithC.HillR.C.FerroP.PompeyJ.et al.Transmission"/>
   <result pre="viruses in canines in southern ChinamBio20189e00909e0091810.1128/mBio.00909-1829871917 25.CrawfordP.C.DuboviE.J.CastlemanW.L.StephensonI.GibbsE.P.ChenL.SmithC.HillR.C.FerroP.PompeyJ.et al.Transmission of equine" exact="influenza" post="virus to dogsScience200531048248510.1126/science.111795016186182 26.SongD.S.LeeJ.Y.OhJ.S.LyooK.S.YoonK.J.ParkY.H.ParkB.K.Isolation of h3n2 swine influenza virus"/>
   <result pre="of equine influenza virus to dogsScience200531048248510.1126/science.111795016186182 26.SongD.S.LeeJ.Y.OhJ.S.LyooK.S.YoonK.J.ParkY.H.ParkB.K.Isolation of h3n2 swine" exact="influenza" post="virus in south koreaJ. Vet. Diagn. Invest.200315303410.1177/10406387030150010712580292 27.KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission"/>
   <result pre="Vet. Diagn. Invest.200315303410.1177/10406387030150010712580292 27.KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission of the pb1 gene of" exact="influenza" post="a viruses in the 1957 and 1968 pandemicsJ. Virol.198963460346082795713"/>
   <result pre="and 1968 pandemicsJ. Virol.198963460346082795713 28.SchaferJ.R.KawaokaY.BeanW.J.SussJ.SenneD.WebsterR.G.Origin of the pandemic 1957 h2" exact="influenza" post="a virus and the persistence of its possible progenitors"/>
   <result pre="its possible progenitors in the avian reservoirVirology199319478178810.1006/viro.1993.13197684877 29.ScholtissekC.Molecular evolution of" exact="influenza" post="virusesVirus Genes19951120921510.1007/BF017286608828147 30.ReidA.H.TaubenbergerJ.K.FanningT.G.Evidence of an absence: The genetic origins"/>
   <result pre="of an absence: The genetic origins of the 1918 pandemic" exact="influenza" post="virusNat. Rev. Microbiol.2004290991410.1038/nrmicro102715494747 31.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic influenza"/>
   <result pre="pandemic influenza virusNat. Rev. Microbiol.2004290991410.1038/nrmicro102715494747 31.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic" exact="influenza" post="virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 32.WorobeyM.HanG.Z.RambautA.A synchronized global sweep"/>
   <result pre="32.WorobeyM.HanG.Z.RambautA.A synchronized global sweep of the internal genes of modern" exact="avian influenza" post="virusNature201450825425710.1038/nature1301624531761 33.HammondA.FitznerJ.CollinsL.OngS.K.VandemaeleK.Human cases of influenza at the human-animal interface,"/>
   <result pre="synchronized global sweep of the internal genes of modern avian" exact="influenza" post="virusNature201450825425710.1038/nature1301624531761 33.HammondA.FitznerJ.CollinsL.OngS.K.VandemaeleK.Human cases of influenza at the human-animal interface,"/>
   <result pre="internal genes of modern avian influenza virusNature201450825425710.1038/nature1301624531761 33.HammondA.FitznerJ.CollinsL.OngS.K.VandemaeleK.Human cases of" exact="influenza" post="at the human-animal interface, January 2015â€&quot;April 2017Wkly. Epidemiol. Rec.201733460475"/>
   <result pre="Rec.201733460475 34.MainesT.R.ChenL.M.MatsuokaY.ChenH.RoweT.OrtinJ.FalconA.NguyenT.H.Mai leQ.SedyaningsihE.R.et al.Lack of transmission of h5n1 avian-human reassortant" exact="influenza" post="viruses in a ferret modelProc. Natl. Acad. Sci. USA2006103121211212610.1073/pnas.060513410316880383"/>
   <result pre="Natl. Acad. Sci. USA2006103121211212610.1073/pnas.060513410316880383 35.WanH.SorrellE.M.SongH.HossainM.J.Ramirez-NietoG.MonneI.StevensJ.CattoliG.CapuaI.ChenL.M.et al.Replication and transmission of h9n2" exact="influenza" post="viruses in ferrets: Evaluation of pandemic potentialPLoS ONE20083e292310.1371/journal.pone.000292318698430 36.Van"/>
   <result pre="ha and polymerase subunit pb2 proteins confer transmission of an" exact="avian influenza" post="virus through the airProc. Natl. Acad. Sci. USA20091063366337110.1073/pnas.081317210619211790 37.LakdawalaS.S.LamirandeE.W.SuguitanA.L.Jr.WangW.SantosC.P.VogelL.MatsuokaY.LindsleyW.G.JinH.SubbaraoK.Eurasian-origin"/>
   <result pre="and polymerase subunit pb2 proteins confer transmission of an avian" exact="influenza" post="virus through the airProc. Natl. Acad. Sci. USA20091063366337110.1073/pnas.081317210619211790 37.LakdawalaS.S.LamirandeE.W.SuguitanA.L.Jr.WangW.SantosC.P.VogelL.MatsuokaY.LindsleyW.G.JinH.SubbaraoK.Eurasian-origin"/>
   <result pre="transmissibility, aerosol release, and morphology of the 2009 pandemic h1n1" exact="influenza" post="virusPLoS Pathog.20117e100244310.1371/journal.ppat.100244322241979 38.YenH.L.LiangC.H.WuC.Y.ForrestH.L.FergusonA.ChoyK.T.JonesJ.WongD.D.CheungP.P.HsuC.H.et al.Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of"/>
   <result pre="38.YenH.L.LiangC.H.WuC.Y.ForrestH.L.FergusonA.ChoyK.T.JonesJ.WongD.D.CheungP.P.HsuC.H.et al.Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic h1n1" exact="influenza" post="virus in ferretsProc. Natl. Acad. Sci. USA2011108142641426910.1073/pnas.111100010821825167 39.ImaiM.WatanabeT.HattaM.DasS.C.OzawaM.ShinyaK.ZhongG.HansonA.KatsuraH.WatanabeS.et al.Experimental"/>
   <result pre="ferretsProc. Natl. Acad. Sci. USA2011108142641426910.1073/pnas.111100010821825167 39.ImaiM.WatanabeT.HattaM.DasS.C.OzawaM.ShinyaK.ZhongG.HansonA.KatsuraH.WatanabeS.et al.Experimental adaptation of an" exact="influenza" post="h5 ha confers respiratory droplet transmission to a reassortant"/>
   <result pre="h5 ha/h1n1 virus in ferretsNature201248642042810.1038/nature1083122722205 40.HerfstS.SchrauwenE.J.LinsterM.ChutinimitkulS.de WitE.MunsterV.J.SorrellE.M.BestebroerT.M.BurkeD.F.SmithD.J.et al.Airborne transmission of" exact="influenza" post="a/h5n1 virus between ferretsScience20123361534154110.1126/science.121336222723413 41.MatrosovichM.TuzikovA.BovinN.GambaryanA.KlimovA.CastrucciM.R.DonatelliI.KawaokaY.Early alterations of the receptor-binding"/>
   <result pre="alterations of the receptor-binding properties of h1, h2, and h3" exact="avian influenza" post="virus hemagglutinins after their introduction into mammalsJ. Virol.2000748502851210.1128/JVI.74.18.8502-8512.200010954551 42.LakdawalaS.S.JayaramanA.HalpinR.A.LamirandeE.W.ShihA.R.StockwellT.B.LinX.SimenauerA.HansonC.T.VogelL.et"/>
   <result pre="of the receptor-binding properties of h1, h2, and h3 avian" exact="influenza" post="virus hemagglutinins after their introduction into mammalsJ. Virol.2000748502851210.1128/JVI.74.18.8502-8512.200010954551 42.LakdawalaS.S.JayaramanA.HalpinR.A.LamirandeE.W.ShihA.R.StockwellT.B.LinX.SimenauerA.HansonC.T.VogelL.et"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="virusesNature201552612212510.1038/nature1537926416728 43.BazM.LukeC.J.ChengX.JinH.SubbaraoK.H5n1 vaccines in humansVirus Res.2013178789810.1016/j.virusres.2013.05.00623726847 44.CzakoR.SubbaraoK.Refining the approach"/>
   <result pre="vaccines in humansVirus Res.2013178789810.1016/j.virusres.2013.05.00623726847 44.CzakoR.SubbaraoK.Refining the approach to vaccines against" exact="influenza" post="a viruses with pandemic potentialFuture Virol.2015101033104710.2217/fvl.15.6926587050 45.SubbaraoK.JosephT.Scientific barriers to"/>
   <result pre="with pandemic potentialFuture Virol.2015101033104710.2217/fvl.15.6926587050 45.SubbaraoK.JosephT.Scientific barriers to developing vaccines against" exact="avian influenza" post="virusesNature Rev.2007726727810.1038/nri205417363960 46.FoxA.QuinnK.M.SubbaraoK.Extending the breadth of influenza vaccines: Status"/>
   <result pre="pandemic potentialFuture Virol.2015101033104710.2217/fvl.15.6926587050 45.SubbaraoK.JosephT.Scientific barriers to developing vaccines against avian" exact="influenza" post="virusesNature Rev.2007726727810.1038/nri205417363960 46.FoxA.QuinnK.M.SubbaraoK.Extending the breadth of influenza vaccines: Status"/>
   <result pre="vaccines against avian influenza virusesNature Rev.2007726727810.1038/nri205417363960 46.FoxA.QuinnK.M.SubbaraoK.Extending the breadth of" exact="influenza" post="vaccines: Status and prospects for a universal vaccineDrugs2018781297130810.1007/s40265-018-0958-730088204"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6630949\results\search\disease\results.xml">
   <result pre="health burden worldwide. Vaccination is the best way to prevent" exact="influenza" post="virus infections. However, conventional vaccines are only effective for"/>
   <result pre="a short period of time due to the propensity of" exact="influenza" post="viruses to undergo antigenic drift and antigenic shift. The"/>
   <result pre="have been discovered that may serve as means to suppress" exact="influenza" post="viral infection and allow the process of natural immunity"/>
   <result pre="approach assumes a robust tool that could aid control of" exact="influenza" post="viruses. In this review, we comment on some improvements"/>
   <result pre="viruses. In this review, we comment on some improvements in" exact="influenza" post="management and promising vaccine development platforms with an emphasis"/>
   <result pre="coupled with the use of antivirals in the management of" exact="influenza" post="infection. Influenza virus vaccines passive immunization immunotherapeutics 1. Introduction"/>
   <result pre="nearly a million morbidities and half-a-million mortalities. Four types of" exact="influenza" post="viruses (i.e., A, B, C, and D) have been"/>
   <result pre="humans) and D (isolated from cattle) are less common; typically," exact="influenza" post="virus C is associated with less severe illness [1,2]."/>
   <result pre="associated with less severe illness [1,2]. On the other hand," exact="influenza" post="viruses A (infecting avian and mammals including human) and"/>
   <result pre="humans and seals) account for the annual global burden of" exact="influenza" post="[3,4]. The persistence of influenza viruses A and B"/>
   <result pre="the annual global burden of influenza [3,4]. The persistence of" exact="influenza" post="viruses A and B has been attributed to their"/>
   <result pre="ability to evolve rapidly. Antigenic variabilities are also common with" exact="influenza" post="viruses A and B, and these are partly as"/>
   <result pre="by Fergusson et al. revealed that antigenic drifts in seasonal" exact="influenza" post="viruses (H3, H1, and B) were estimated at fixation"/>
   <result pre="supports the idea that antigenic drifts occur more frequently in" exact="influenza" post="A viruses than influenza B viruses. In addition, high"/>
   <result pre="antigenic drifts occur more frequently in influenza A viruses than" exact="influenza" post="B viruses. In addition, high mutation rates cause a"/>
   <result pre="rates cause a tremendous impact in efficacy of the seasonal" exact="influenza" post="vaccines which comprise forecasted strains [9]. For instance, gain"/>
   <result pre="the same study, the authors further observed that the 1968" exact="influenza" post="epidemic strain (A/VIC/3/75) that had N63 (known glycosylation site),"/>
   <result pre="in potential cause of vaccine failure. Antigenic shift also allows" exact="influenza" post="viruses to escape pre-existing immunity [11]. This mechanism is"/>
   <result pre="reliant on the ability of the eight genomic fragments of" exact="influenza" post="viruses to reassort with genomes of other influenza viral"/>
   <result pre="fragments of influenza viruses to reassort with genomes of other" exact="influenza" post="viral subtypes. It occurs when two or more of"/>
   <result pre="viral subtypes or strains [11,12]. Thus, antigenic shifts (principally underlying" exact="influenza" post="A virus pandemics) and antigenic drifts (underlying vaccine mismatches"/>
   <result pre="virus pandemics) and antigenic drifts (underlying vaccine mismatches against seasonal" exact="influenza" post="A and B viruses) and a wide host-range (for"/>
   <result pre="influenza A and B viruses) and a wide host-range (for" exact="influenza" post="A viruses) all contribute to the recurring cases of"/>
   <result pre="influenza A viruses) all contribute to the recurring cases of" exact="influenza" post="all year round [13,14]. Furthermore, antigenic drifts and shifts"/>
   <result pre="immediate need for highly efficacious intervention. We review here vital" exact="influenza" post="management strategies, novel vaccine and antiviral development approaches with"/>
   <result pre="prospects. 2. Current Influenza Vaccines Three types of vaccines against" exact="influenza" post="are currently used worldwide including inactivated influenza vaccine (IIV),"/>
   <result pre="of vaccines against influenza are currently used worldwide including inactivated" exact="influenza" post="vaccine (IIV), live-attenuated influenza vaccine (LAIV) and influenza virus"/>
   <result pre="are currently used worldwide including inactivated influenza vaccine (IIV), live-attenuated" exact="influenza" post="vaccine (LAIV) and influenza virus subunit vaccine: each of"/>
   <result pre="including inactivated influenza vaccine (IIV), live-attenuated influenza vaccine (LAIV) and" exact="influenza" post="virus subunit vaccine: each of which has its own"/>
   <result pre="in the nasopharynx elicit immune response that epitomizes a natural" exact="influenza" post="infection. For this reason, LAIV has shown some superiority"/>
   <result pre="about 0.7 Î¼g/ mL [24,25,26]. The development of the subunit" exact="influenza" post="vaccines, which often comprise of influenza virus HA that"/>
   <result pre="development of the subunit influenza vaccines, which often comprise of" exact="influenza" post="virus HA that have been purified following protein expression"/>
   <result pre="Besides, the subunit vaccine also offers desirable protection against seasonal" exact="influenza" post="viruses; but its downside being higher dosage requirement at"/>
   <result pre="both the LAIV and IIV are cocktails of circulating seasonal" exact="influenza" post="viruses. Mainly three viruses, i.e., A (H1N1) pdm09, A"/>
   <result pre="i.e., A (H1N1) pdm09, A (H3N2), and the pre-determined dominant" exact="influenza" post="B lineage (whether Yamagata or Victoria) are the constituents"/>
   <result pre="Yamagata or Victoria) are the constituents of the seasonal trivalent" exact="influenza" post="vaccines (TIV). Subunit vaccines are also formulated as TIV,"/>
   <result pre="[29]. However, it became necessary to feature both lineages of" exact="influenza" post="B viruses based on the current global epidemiology of"/>
   <result pre="influenza B viruses based on the current global epidemiology of" exact="influenza" post="as recommended by Ambrose and Levin in 2012. This"/>
   <result pre="Levin in 2012. This resulted in the advancement of quadrivalent" exact="influenza" post="vaccines (QIV) containing the pre-determined representatives of both Yamagata"/>
   <result pre="(QIV) containing the pre-determined representatives of both Yamagata and Victoria" exact="influenza" post="B virus lineages, in addition to the two pre-determined"/>
   <result pre="virus lineages, in addition to the two pre-determined circulating seasonal" exact="influenza" post="A subtypes [30]. This approach of vaccine preparation thus"/>
   <result pre="a constant reformulation to maintain desirable efficacy limits during an" exact="influenza" post="season [30,31]. 3. Use of the Seasonal Influenza Vaccines"/>
   <result pre="with influenza, the US CDC advocates the use of seasonal" exact="influenza" post="vaccines in all persons &amp;gt;6 months prior to the"/>
   <result pre="other hand, the WHO extends recommendations for the use of" exact="influenza" post="vaccination in the persons categorized as high-risk, which comprises"/>
   <result pre="Africa and Asia, there are either limited or no established" exact="influenza" post="vaccination policies. Thus, restricted availability of influenza vaccines makes"/>
   <result pre="or no established influenza vaccination policies. Thus, restricted availability of" exact="influenza" post="vaccines makes vaccinations quite uncommon to these populations. Perhaps,"/>
   <result pre="acquiring vaccines annually or still, the reduced efficacy of the" exact="influenza" post="vaccines, as have been critically assessed by Xu et"/>
   <result pre="been made for twice-dose vaccination due to frequencies of seasonal" exact="influenza" post="occurrences, all year round [34]. Although poor vaccine coverage"/>
   <result pre="Duque et al., upon investigation on the availability of seasonal" exact="influenza" post="vaccines, there are still no clearly underpinned core reasons"/>
   <result pre="clearly underpinned core reasons [35]. Therefore, the improved efficacy of" exact="influenza" post="vaccines would also contribute to enhanced vaccine coverage in"/>
   <result pre="in Africa and Asia. 4. Novel Influenza Vaccine Platforms Rapid" exact="influenza" post="virus evolution and yearly vaccine reformulations make the stockpiling"/>
   <result pre="but without their complete set of genetic materials. A typical" exact="influenza" post="VLP has the HA, NA, and the matrix protein"/>
   <result pre="a range of viruses including human papilloma virus (HPV) and" exact="hepatitis" post="B virus (HBV) or hepatitis E virus (HEV) as"/>
   <result pre="human papilloma virus (HPV) and hepatitis B virus (HBV) or" exact="hepatitis" post="E virus (HEV) as discussed by Zhao et al."/>
   <result pre="these examples have completely different â€œbiologiesâ€� when compared with the" exact="influenza" post="virus, rapid advances and need for a new vaccine"/>
   <result pre="a new vaccine platform are generating some promising data for" exact="influenza" post="VLPs. For instance, to overcome challenges raised by rapid"/>
   <result pre="influenza VLPs. For instance, to overcome challenges raised by rapid" exact="influenza" post="evolution Gao et al. attempted to generate VLPs with"/>
   <result pre="which increased murine mucosal immunity to both drifted and homologous" exact="influenza" post="A (H3N2) viruses, as well as the longevity of"/>
   <result pre="a platform for improved formulation of multivalent (containing heterologous epitopes)" exact="influenza" post="vaccine. 6. Computationally Optimized Broadly Reactive Antigen Vaccines (COBRA)"/>
   <result pre="was fitter in eggs, is good news for generation of" exact="influenza" post="vaccines in eggs [48]. Alternatively, replication-incompetent viruses can be"/>
   <result pre="trivalent vaccine which revealed protection of vaccinees against the seasonal" exact="influenza" post="viruses [49,50]. This platform has also paved way for"/>
   <result pre="has also paved way for the generation of single-cycle replicating" exact="influenza" post="viruses as vaccine candidates and have shown similar or"/>
   <result pre="protection than the conventional LAIV [51,52,53]. The main reasons synthetic" exact="influenza" post="vaccines remain promising is due to their ability to"/>
   <result pre="children during a pandemic revealed a cross-reactivity pattern to historical" exact="influenza" post="A (H1N1) isolates [57]. A conserved epitope situated on"/>
   <result pre="epitope in a murine challenge against diverse strains of the" exact="influenza" post="A (H1N1) [57]. Another universal vaccine candidate currently undergoing"/>
   <result pre="HA; three, to NP and one, to M1) of several" exact="influenza" post="virus strains, and this vaccine has been shown to"/>
   <result pre="(APCs) to efficiently involve the T-cell arm of immunity to" exact="influenza" post="virus clearance. One of the examples is the work"/>
   <result pre="of Fonteneau and colleagues who showed that after exposure to" exact="influenza" post="virus, dendritic cells (DCs) (both CD11c+ DCs and plasmacytoid"/>
   <result pre="10. Nanoparticle-Based Influenza Vaccines Continued efforts to develop a universal" exact="influenza" post="vaccine has driven the use of self-assembling monomeric ion-carrier"/>
   <result pre="vaccines displaying multivalent HA from 8 diverse strains of H1N1" exact="influenza" post="A viruses, were shown to induce broadly protective antibodies"/>
   <result pre="affording protection of mice challenged with virulent strain of an" exact="influenza" post="virus [63,64]. Intranasal administration of polylactic-co-glycolic acid (PLGA) nanoparticle"/>
   <result pre="[63,64]. Intranasal administration of polylactic-co-glycolic acid (PLGA) nanoparticle conjugated to" exact="influenza" post="A (H1N1) conserved peptides as a vaccine were also"/>
   <result pre="in mice that were immunized prior to challenge with specific" exact="influenza" post="A viruses [67]. Though a promising influenza vaccine platform,"/>
   <result pre="challenge with specific influenza A viruses [67]. Though a promising" exact="influenza" post="vaccine platform, high-throughput nanoparticle-based vaccines approaches that will facilitate"/>
   <result pre="nanoparticle-based vaccines approaches that will facilitate replacement of the seasonal" exact="influenza" post="vaccines are still to be developed [68]. 11. Viral-Vectored"/>
   <result pre="the humoral and cellular immunity [69]. Use of the modified" exact="vaccinia virus" post="Ankara (MVA) as a vector, incorporating influenza NP and"/>
   <result pre="the modified vaccinia virus Ankara (MVA) as a vector, incorporating" exact="influenza" post="NP and M1 proteins, has shown potent induction of"/>
   <result pre="NP and M1 proteins, has shown potent induction of both" exact="influenza" post="virus-specific humoral and cell-mediated responses leading to the phase"/>
   <result pre="to the phase II clinical trial [70,71]. An Adenovirus vectored" exact="influenza" post="vaccine has equally shown a strong induction of influenza"/>
   <result pre="vectored influenza vaccine has equally shown a strong induction of" exact="influenza" post="virus HA-stalk cross-reactive antibodies in mice [72]. Recently, Lingel"/>
   <result pre="mice [72]. Recently, Lingel et al. expressed multivalent adenovirus vectored" exact="influenza" post="virus vaccine (that comprise the consensus sequences of divergent"/>
   <result pre="administration in mice conferred protection of mice in a lethal" exact="influenza" post="virus challenge experiment [73]. This provides an avenue for"/>
   <result pre="baculovirus, Newcastle disease virus, pox virus, parainfluenza virus and vesicular" exact="stomatitis" post="virus, are other vectors that have also been proposed"/>
   <result pre="vaccines [74]. 12. Current Influenza Managing Antivirals Management of ongoing" exact="influenza" post="infection currently requires the use of antiviral drugs. Two"/>
   <result pre="antiviral drugs. Two drug classes approved for the control of" exact="influenza" post="infections include the adamantanes (Amantadines and Rimantadines) and NA"/>
   <result pre="is otherwise responsible for newly generated virion dissemination [75,76,77,78]. However," exact="influenza" post="viruses resistant to both the adamantanes and neuraminidase inhibitors"/>
   <result pre="Additionally, lack of data suggesting antiviral efficacy against highly pathogenic" exact="avian influenza" post="viruses (HPAI), i.e., H5N1 remains an important issue in"/>
   <result pre="lack of data suggesting antiviral efficacy against highly pathogenic avian" exact="influenza" post="viruses (HPAI), i.e., H5N1 remains an important issue in"/>
   <result pre="is imperative to note that there are still NA inhibitor-sensitive" exact="influenza" post="A viruses in circulation, and this drug class can"/>
   <result pre="Management Therapies 13.1. Next-Generation Antivirals Against Influenza The burden of" exact="influenza" post="requires identification of a novel compounds that have the"/>
   <result pre="the airways [89]. This inhibits the initial attachment of the" exact="influenza" post="virus HA that recognizes Neu5Ac in the Î±(2, 3)-"/>
   <result pre="shown to inhibit H1N1pdm09, H3N2, and H5N1 viruses [91,92,93]. Besides" exact="influenza" post="viruses, other sialic acid-dependent viruses such as human metapneumovirus"/>
   <result pre="These metabolites have been shown to inhibit the maturation of" exact="influenza" post="HA by blocking the trafficking and insertion of HA"/>
   <result pre="a licensed anthelminthic drug that has been repurposed to ameliorate" exact="influenza" post="due to its broad range of protection efficiency against"/>
   <result pre="influenza due to its broad range of protection efficiency against" exact="influenza" post="viruses in a phase II b/III clinical trial [95]."/>
   <result pre="b/III clinical trial [95]. The antiviral, JNJ-63623872 (Pimodivir) is non-nucleoside" exact="influenza" post="virus PB2 inhibitor, which binds a conserved domain on"/>
   <result pre="binds a conserved domain on the polymerase subunit, PB2 of" exact="influenza" post="A viruses and thereby inhibiting host cap-snatching (a perquisite"/>
   <result pre="pre-approval trial (of Pimodivir) for the treatment of patients with" exact="influenza" post="virus A (H7N9) infection, has been allowed. In 2002,"/>
   <result pre="was shown to have a selective index over 2000 for" exact="influenza" post="viruses, with no detectable cytotoxicity in vitro [101]. Trials"/>
   <result pre="[101]. Trials of T-705 in mice confirmed both selectivity to" exact="influenza" post="viruses and protection as an anti-influenza virus therapeutic agent."/>
   <result pre="noro- and flavi-viruses [106,107,108,109]. In summary, T-705 is effective against" exact="influenza" post="viruses in group 1 such as H1N1pdm09, H5N1 and"/>
   <result pre="H1N1pdm09 virus strain [111] Efficacy of T-705 for treatment of" exact="influenza" post="has thus warranted its advancement through phase III and"/>
   <result pre="shown to act as a selective cap-dependent endonuclease inhibitor of" exact="influenza" post="virusesâ€™ (both A and B) polymerase subunit PA. The"/>
   <result pre="phase I trial [113]. The overall optimal performance against uncomplicated" exact="influenza" post="among adults and adolescents, was shown during phase II"/>
   <result pre="the US as Xofluxa, for the treatment of acute uncomplicated" exact="influenza" post="among â‰¥12 years [115]. Arbidol (Umifenovir) is another influenza-limiting"/>
   <result pre="originally developed in Russia and was found to potently inhibit" exact="influenza" post="virus fusion with susceptible cell membranes, followed by interferon"/>
   <result pre="interferon induction [118]. Like other broad-spectrum antivirals discussed earlier, besides" exact="influenza" post="viruses, Arbidol has been shown to efficiently suppress other"/>
   <result pre="and the flaviviruses (Zika virus, West Nile virus and Tick-borne" exact="encephalitis" post="virus) [119,120,121]. Currently, phase III trial of the Arbidol"/>
   <result pre="of 2017, Ingavirin has been approved for the treatment of" exact="influenza" post="and other viral causes of acute respiratory illness, in"/>
   <result pre="Management of Influenza The need for new strategies to control" exact="influenza" post="infections has led to the investigations of antibody therapy"/>
   <result pre="virus infections [125,126]. The feasibility of immunotherapy for rapidly evolving" exact="influenza" post="was attained upon the discovery of broadly neutralizing antibody"/>
   <result pre="as well as C179 was later found to neutralize only" exact="influenza" post="A viruses with group 1 HA. Similarly, another potential"/>
   <result pre="anti-H5N1 antibody could protect mice against a lethal challenge of" exact="influenza" post="H5N1 [133]. Such an example shows that use of"/>
   <result pre="Such an example shows that use of passive immunotherapy during" exact="influenza" post="outbreaks could complement the use of available antivirals that"/>
   <result pre="[136]. Wohlbold et al. also realized the importance of the" exact="influenza" post="HA stalk as a good vaccine target when they"/>
   <result pre="immunized with three tandem copies of M2e, fused with the" exact="hepatitis" post="B virus (HBV) core fusion protein) to show Fc-dependent"/>
   <result pre="for RSV with the commercial immunotherapy palivizumab, antibody-based therapies with" exact="influenza" post="antibodies could aid most susceptible populations including infants, which"/>
   <result pre="in mice (who received the construct intramuscularly) during a pathogenic" exact="influenza" post="virus (H1, H2, and H5) challenge [144]. Their experiments"/>
   <result pre="immuno-prophylaxis and -therapeutics have more prospects in effective intermediation of" exact="influenza" post="outbreaks and production of specific influenza vaccines, noting that"/>
   <result pre="in effective intermediation of influenza outbreaks and production of specific" exact="influenza" post="vaccines, noting that the broadly-reacting antibodies have the capacity"/>
   <result pre="antibody-dependent cell lysis (ADCL) are well-studied in the context of" exact="influenza" post="viruses. ADCC, which mainly involves destruction of infected cells"/>
   <result pre="has been observed for murine antibodies weakly interacting with cognate" exact="influenza" post="M2e [147]. Similarly, virus replication in mice was shown"/>
   <result pre="infected mice that either received anti-influenza serum before or after" exact="influenza" post="infection, when neutrophils were retained and not inhibited by"/>
   <result pre="ADCL is another mechanism that could augment the killing of" exact="influenza" post="viruses as observed by Terajima et al., realizing that"/>
   <result pre="emphasize the therapeutic capacity of novel monoclonal antibodies in combating" exact="influenza" post="infection, and speculate that, in addition to the use"/>
   <result pre="to the use of effective antivirals, passive immunotherapy against both" exact="influenza" post="A and B viruses might be the way forward"/>
   <result pre="A and B viruses might be the way forward for" exact="influenza" post="virus management amongst all classes (be it high- or"/>
   <result pre="influenza. Acknowledgments The authors are thankful to The Pirbright Instituteâ€™s" exact="avian influenza" post="research team (Jean-Remy Sadeyen, Pengxiang Chang, Sushant Bhat, Joshua"/>
   <result pre="Acknowledgments The authors are thankful to The Pirbright Instituteâ€™s avian" exact="influenza" post="research team (Jean-Remy Sadeyen, Pengxiang Chang, Sushant Bhat, Joshua"/>
   <result pre="Epidemiology, pathology, evolution and biological characteristicsVirulence201781580159110.1080/21505594.2017.136521628812422 2.KimuraH.AbikoC.PengG.MurakiY.SugawaraK.HongoS.KitameF.MizutaK.NumazakiY.SuzukiH.et al.Interspecies transmission of" exact="influenza" post="C virus between humans and pigsVirus Res.199748717910.1016/S0168-1702(96)01427-X9140195 3.HinshawV.S.WebsterR.G.EasterdayB.C.BeanW.J.Jr.Replication of"/>
   <result pre="influenza C virus between humans and pigsVirus Res.199748717910.1016/S0168-1702(96)01427-X9140195 3.HinshawV.S.WebsterR.G.EasterdayB.C.BeanW.J.Jr.Replication of" exact="avian influenza" post="A viruses in mammalsInfect. Immun.1981343543617309229 4.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in"/>
   <result pre="C virus between humans and pigsVirus Res.199748717910.1016/S0168-1702(96)01427-X9140195 3.HinshawV.S.WebsterR.G.EasterdayB.C.BeanW.J.Jr.Replication of avian" exact="influenza" post="A viruses in mammalsInfect. Immun.1981343543617309229 4.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in"/>
   <result pre="mammalsInfect. Immun.1981343543617309229 4.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 5.GerhardW.WebsterR.G.Antigenic drift in" exact="influenza" post="A viruses. I. Selection and characterization of antigenic variants"/>
   <result pre="I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1)" exact="influenza" post="virus with monoclonal antibodiesJ. Exp. Med.197814838339210.1084/jem.148.2.383359746 6.YewdellJ.W.WebsterR.G.GerhardW.U.Antigenic variation in"/>
   <result pre="Exp. Med.197814838339210.1084/jem.148.2.383359746 6.YewdellJ.W.WebsterR.G.GerhardW.U.Antigenic variation in three distinct determinants of an" exact="influenza" post="type A haemagglutinin moleculeNature197927924624810.1038/279246a086955 7.HensleyS.E.DasS.R.BaileyA.L.SchmidtL.M.HickmanH.D.JayaramanA.ViswanathanK.RamanR.SasisekharanR.BenninkJ.R.et al.Hemagglutinin Receptor Binding Avidity"/>
   <result pre="Influenza A Virus Antigenic DriftScience200932673473610.1126/science.117825819900932 8.FergusonN.M.GalvaniA.P.BushR.M.Ecological and immunological determinants of" exact="influenza" post="evolutionNature200342242843310.1038/nature0150912660783 9.CarratF.FlahaultA.Influenza vaccine: The challenge of antigenic driftVaccine2007256852686210.1016/j.vaccine.2007.07.02717719149 10.SkehelJ.J.StevensD.J.DanielsR.S.DouglasA.R.KnossowM.WilsonI.A.WileyD.C.A"/>
   <result pre="driftVaccine2007256852686210.1016/j.vaccine.2007.07.02717719149 10.SkehelJ.J.StevensD.J.DanielsR.S.DouglasA.R.KnossowM.WilsonI.A.WileyD.C.A carbohydrate side chain on hemagglutinins of Hong Kong" exact="influenza" post="viruses inhibits recognition by a monoclonal antibodyProc. Natl. Acad."/>
   <result pre="and H3 strains elucidates antigenic shift and drift in human" exact="influenza" post="virusNature198028730130610.1038/287301a07421990 13.DonatelliI.CastrucciM.R.De MarcoM.A.DeloguM.WebsterR.G.Humanâ€&quot;Animal Interface: The Case for Influenza Interspecies"/>
   <result pre="and Inactivated Influenza Vaccine in AdultsClin. Vaccine Immunol.201724e00414-1610.1128/CVI.00414-1627847366 17.ShinjohM.SugayaN.YamaguchiY.IibuchiN.KamimakiI.GotoA.KobayashiH.KobayashiY.ShibataM.TamaokaS.et al.Inactivated" exact="influenza" post="vaccine effectiveness and an analysis of repeated vaccination for"/>
   <result pre="for children during the 2016/17 seasonVaccine2018365510551810.1016/j.vaccine.2018.07.06530093289 18.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of" exact="influenza" post="vaccines: A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 19.BeyerW.E.P.PalacheA.M.de"/>
   <result pre="A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 19.BeyerW.E.P.PalacheA.M.de JongJ.C.OsterhausA.D.M.E.Cold-adapted live" exact="influenza" post="vaccine versus inactivated vaccine: Systemic vaccine reactions, local and"/>
   <result pre="al.Comparison of the safety, vaccine virus shedding, and immunogenicity of" exact="influenza" post="virus vaccine, trivalent, types A and B, live cold-adapted,"/>
   <result pre="childrenN. Engl. J. Med.19983381405141210.1056/NEJM1998051433820029580647 22.KeitelW.A.CouchR.B.CateT.R.MaassabH.F.Variability in infectivity of cold-adapted recombinant" exact="influenza" post="virus vaccines in humansJ. Infect. Dis.199416947710.1093/infdis/169.2.4778106789 23.GalazkaA.M.LauerB.A.HendersonR.H.KejaJ.Indications and Contraindications"/>
   <result pre="to vaccines practice parameter 2012 updateJ. Allergy Clin. Immunol.2012130254310.1016/j.jaci.2012.04.00322608573 25.OwensG.MacGinnitieA.Higher-ovalbumin-content" exact="influenza" post="vaccines are well tolerated in children with egg allergyJ."/>
   <result pre="children with egg allergyJ. Allergy Clin. Immunol.201112726426510.1016/j.jaci.2010.10.00521094520 26.LiJ.T.RankM.A.SquillaceD.L.KitaH.Ovalbumin content of" exact="influenza" post="vaccinesJ. Allergy Clin. Immunol.20101251412141310.1016/j.jaci.2010.03.00920451987 27.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.collab: Centers for Disease Control"/>
   <result pre="J. Transplant.20141429062913 28.StephensonI.NicholsonK.G.GluckR.MischlerR.NewmanR.W.PalacheA.M.VerlanderN.Q.WarburtonF.WoodJ.M.ZambonM.C.Safety and antigenicity of whole virus and subunit" exact="influenza" post="A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: Phase I"/>
   <result pre="healthy adults: Phase I randomised trialLancet20033621959196610.1016/S0140-6736(03)15014-314683655 29.GiezemanK.M.NautaJ.de BruijnI.A.PalacheA.M.Trivalent inactivated subunit" exact="influenza" post="vaccine Influvac (R): 25-Year experience of safety and immunogenicityVaccine2009272414241710.1016/j.vaccine.2009.02.00819368782"/>
   <result pre="25-Year experience of safety and immunogenicityVaccine2009272414241710.1016/j.vaccine.2009.02.00819368782 30.AmbroseC.S.LevinM.J.The rationale for quadrivalent" exact="influenza" post="vaccinesHum. Vaccines Immunother.20128818810.4161/hv.8.1.17623 31.KumarA.MeldgaardT.S.BertholetS.Novel Platforms for the Development of"/>
   <result pre="Vaccines Immunother.20128818810.4161/hv.8.1.17623 31.KumarA.MeldgaardT.S.BertholetS.Novel Platforms for the Development of a Universal" exact="influenza" post="vaccineFront. Immunol.2018960010.3389/fimmu.2018.0060029628926 32.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of influenza with"/>
   <result pre="a Universal influenza vaccineFront. Immunol.2018960010.3389/fimmu.2018.0060029628926 32.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of" exact="influenza" post="with vaccines: Recommendations of the Advisory Committee on Immunization"/>
   <result pre="in tropical and subtropical areasLancet Respir. Med.2017592092210.1016/S2213-2600(17)30377-629066091 35.DuqueJ.McMorrowM.L.CohenA.L.Influenza vaccines and" exact="influenza" post="antiviral drugs in Africa: Are they available and do"/>
   <result pre="from three H5N1 clades protects chickens from H5N1 and H5N8" exact="influenza" post="virusesVaccine2016341575158110.1016/j.vaccine.2016.02.01126868083 41.WangB.-Z.QuanF.-S.KangS.-M.BozjaJ.SkountzouI.CompansR.W.Incorporation of membrane-anchored flagellin into influenza virus-like particles"/>
   <result pre="H5N1 and H5N8 influenza virusesVaccine2016341575158110.1016/j.vaccine.2016.02.01126868083 41.WangB.-Z.QuanF.-S.KangS.-M.BozjaJ.SkountzouI.CompansR.W.Incorporation of membrane-anchored flagellin into" exact="influenza" post="virus-like particles enhances the breadth of immune responsesJ. Virol.200882118131182310.1128/JVI.01076-0818786995"/>
   <result pre="the breadth of immune responsesJ. Virol.200882118131182310.1128/JVI.01076-0818786995 42.MohanT.BermanZ.LuoY.WangC.WangS.CompansR.W.WangB.Z.Chimeric virus-like particles containing" exact="influenza" post="HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against"/>
   <result pre="viral challengeJ. Virol.2012861029310230110.1128/JVI.01131-1222787224 50.MosslerC.GroissF.WolztM.WolschekM.SeipeltJ.MusterT.Phase I/II trial of a replication-deficient trivalent" exact="influenza" post="virus vaccine lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 51.BazM.BoonnakK.PaskelM.SantosC.PowellT.TownsendA.SubbaraoK.Nonreplicating influenza A virus vaccines"/>
   <result pre="of a replication-deficient trivalent influenza virus vaccine lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 51.BazM.BoonnakK.PaskelM.SantosC.PowellT.TownsendA.SubbaraoK.Nonreplicating" exact="influenza" post="A virus vaccines confer broad protection against lethal challengeMBio20156e01487-1510.1128/mBio.01487-1526489862"/>
   <result pre="Induced by a Single-Cycle Influenza VaccineJ. Immunol.20182004068407710.4049/jimmunol.180014229703861 53.NachbagauerR.LiuW.C.ChoiA.WohlboldT.J.AtlasT.RajendranM.SolÃ³rzanoA.Berlanda-ScorzaF.GarcÃ­a-SastreA.PaleseP.et al.A universal" exact="influenza" post="virus vaccine candidate confers protection against pandemic H1N1 infection"/>
   <result pre="in preclinical ferret studiesNpj Vaccines201722610.1038/s41541-017-0026-429263881 54.ImpagliazzoA.MilderF.KuipersH.WagnerM.V.ZhuX.Y.HoffmanR.M.B.van MeersbergenR.HuizinghJ.WanningenP.VerspuijJ.et al.A stable trimeric" exact="influenza" post="hemagglutinin stem as a broadly protective immunogenScience20153491301130610.1126/science.aac726326303961 55.CorreiaB.E.BatesJ.T.LoomisR.J.BaneyxG.CarricoC.JardineJ.G.RupertP.CorrentiC.KalyuzhniyO.VittalV.et al.Proof"/>
   <result pre="57.ThompsonC.P.LourencoJ.WaltersA.A.ObolskiU.EdmansM.PalmerD.S.KooblallK.CarnellG.W.Oâ€™ConnorD.BowdenT.A.et al.A naturally protective epitope of limited variability as an" exact="influenza" post="vaccine targetNat. Commun.20189385910.1038/s41467-018-06228-830242149 58.AtsmonJ.Kate-IlovitzE.ShaikevichD.SingerY.VolokhovI.HaimK.Y.Ben-YedidiaT.Safety and immunogenicity of multimeric-001â€&quot;A novel"/>
   <result pre="vaccine targetNat. Commun.20189385910.1038/s41467-018-06228-830242149 58.AtsmonJ.Kate-IlovitzE.ShaikevichD.SingerY.VolokhovI.HaimK.Y.Ben-YedidiaT.Safety and immunogenicity of multimeric-001â€&quot;A novel universal" exact="influenza" post="vaccineJ. Clin. Immunol.20123259560310.1007/s10875-011-9632-522318394 59.FonteneauJ.-F.GillietM.LarssonM.DasilvaI.MÃ¼nzC.LiuY.-J.BhardwajN.Activation of influenza virusâ€&quot;specific CD4+ and"/>
   <result pre="of multimeric-001â€&quot;A novel universal influenza vaccineJ. Clin. Immunol.20123259560310.1007/s10875-011-9632-522318394 59.FonteneauJ.-F.GillietM.LarssonM.DasilvaI.MÃ¼nzC.LiuY.-J.BhardwajN.Activation of" exact="influenza" post="virusâ€&quot;specific CD4+ and CD8+ T cells: A new role"/>
   <result pre="role for plasmacytoid dendritic cells in adaptive immunityBlood20031013520352610.1182/blood-2002-10-306312511409 60.Abdel-MotalU.M.GuayH.M.WigglesworthK.WelshR.M.GaliliU.Immunogenicity of" exact="influenza" post="virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting"/>
   <result pre="APC surface molecules influences the immune response phenotypePLoS ONE20138e8000810.1371/journal.pone.008000824244595 62.KanekiyoM.WeiC.J.YassineH.M.McTamneyP.M.BoyingtonJ.C.WhittleJ.R.RaoS.S.KongW.P.WangL.NabelG.J.Self-assembling" exact="influenza" post="nanoparticle vaccines elicit broadly neutralizing H1N1 antibodiesNature201349910210610.1038/nature1220223698367 63.DengL.ChoK.J.FiersW.SaelensX.M2e-Based Universal"/>
   <result pre="antibodiesNature201349910210610.1038/nature1220223698367 63.DengL.ChoK.J.FiersW.SaelensX.M2e-Based Universal Influenza A VaccinesVaccines2015310513610.3390/vaccines301010526344949 64.TaoW.Q.GillH.S.M2e-immobilized gold nanoparticles as" exact="influenza" post="A vaccine: Role of soluble M2e and longevity of"/>
   <result pre="Sci. USA20161134133414210.1073/pnas.1600299113 67.DengL.MohanT.ChangT.Z.GonzalezG.X.WangY.KwonY.M.KangS.M.CompansR.W.ChampionJ.A.WangB.Z.Double-layered protein nanoparticles induce broad protection against divergent" exact="influenza" post="A virusesNat. Commun.20182435910.1038/s41467-017-02725-429367723 68.HardingA.T.HeatonN.S.Efforts to Improve the Seasonal Influenza"/>
   <result pre="al.Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic" exact="influenza" post="A vaccine, MVA-NP+M1Clin. Infect. Dis.2011521710.1093/cid/ciq01521148512 71.AntrobusR.D.BerthoudT.K.MullarkeyC.E.HoschlerK.CoughlanL.ZambonM.HillA.V.GilbertS.C.Coadministration of seasonal influenza"/>
   <result pre="heterosubtypic influenza A vaccine, MVA-NP+M1Clin. Infect. Dis.2011521710.1093/cid/ciq01521148512 71.AntrobusR.D.BerthoudT.K.MullarkeyC.E.HoschlerK.CoughlanL.ZambonM.HillA.V.GilbertS.C.Coadministration of seasonal" exact="influenza" post="vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated"/>
   <result pre="of an Adenoviral Vectored Multivalent Centralized Influenza VaccineSci. Rep.201771491210.1038/s41598-017-14891-y29097763 74.TrippR.A.TompkinsS.M.Virus-vectored" exact="influenza" post="virus vaccinesViruses201463055307910.3390/v608305525105278 75.GubarevaL.V.KaiserL.HaydenF.G.Influenza virus neuraminidase inhibitorsLancet200035582783510.1016/S0140-6736(99)11433-810711940 76.PintoL.H.DieckmannG.R.GandhiC.S.PapworthC.G.BramanJ.ShaughnessyM.A.LearJ.D.LambR.A.DeGradoW.F.A functionally defined"/>
   <result pre="76.PintoL.H.DieckmannG.R.GandhiC.S.PapworthC.G.BramanJ.ShaughnessyM.A.LearJ.D.LambR.A.DeGradoW.F.A functionally defined model for the M2 proton channel of" exact="influenza" post="A virus suggests a mechanism for its ion selectivityProc."/>
   <result pre="ion channel activityCell19926951752810.1016/0092-8674(92)90452-I1374685 78.MaC.PolishchukA.L.OhigashiY.StoufferA.L.SchÃ¶nA.MagavernE.JingX.LearJ.D.FreireE.LambR.A.Identification of the functional core of the" exact="influenza" post="A virus A/M2 proton-selective ion channelProc. Natl. Acad. Sci."/>
   <result pre="Natl. Acad. Sci. USA2009106122831228810.1073/pnas.090572610619590009 79.Van VorisL.P.BettsR.F.HaydenF.G.ChristmasW.A.DouglasR.G.Jr.Successful treatment of naturally occurring" exact="influenza" post="A/USSR/77 H1N1JAMA19812451128123110.1001/jama.1981.033103600200167007668 80.BeanW.J.ThrelkeldS.C.WebsterR.G.Biologic potential of amantadine-resistant influenza A virus"/>
   <result pre="of naturally occurring influenza A/USSR/77 H1N1JAMA19812451128123110.1001/jama.1981.033103600200167007668 80.BeanW.J.ThrelkeldS.C.WebsterR.G.Biologic potential of amantadine-resistant" exact="influenza" post="A virus in an avian modelJ. Infect. Dis.19891591050105610.1093/infdis/159.6.10502723453 81.DeydeV.M.XuX.Y.BrightR.A.ShawM.SmithC.B.ZhangY.ShuY.GubarevaL.V.CoxN.J.KlimovA.I.Surveillance"/>
   <result pre="avian modelJ. Infect. Dis.19891591050105610.1093/infdis/159.6.10502723453 81.DeydeV.M.XuX.Y.BrightR.A.ShawM.SmithC.B.ZhangY.ShuY.GubarevaL.V.CoxN.J.KlimovA.I.Surveillance of resistance to adamantanes among" exact="influenza" post="A(H3N2) and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 82.HussainM.GalvinH.D.HawT.Y.NutsfordA.N.HusainM.Drug"/>
   <result pre="and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 82.HussainM.GalvinH.D.HawT.Y.NutsfordA.N.HusainM.Drug resistance in" exact="influenza" post="A virus: The epidemiology and managementInfect. Drug Resist.20171012113410.2147/IDR.S10547328458567 83.McKimm-BreschkinJ.L.Neuraminidase"/>
   <result pre="84.Rameix-WeltiM.A.EnoufV.CuvelierF.JeanninP.van der WerfS.Enzymatic properties of the neuraminidase of seasonal H1N1" exact="influenza" post="viruses provide insights for the emergence of natural resistance"/>
   <result pre="Virol.20094425526110.1016/j.jcv.2009.01.01019272835 86.SamsonM.PizzornoA.AbedY.BoivinG.Influenza virus resistance to neuraminidase inhibitorsAntivir. Res.20139817418510.1016/j.antiviral.2013.03.01423523943 87.NoahD.L.NoahJ.W.Adapting global" exact="influenza" post="management strategies to address emerging virusesAm. J. Physiol.-Lung Cell."/>
   <result pre="Physiol.-Lung Cell. Mol. Physiol.201330510811710.1152/ajplung.00105.201323709619 88.NguyenH.T.NguyenT.MishinV.P.SleemanK.BalishA.JonesJ.CreangaA.MarjukiH.UyekiT.M.NguyenD.H.et al.Antiviral susceptibility of highly pathogenic" exact="avian influenza" post="A(H5N1) viruses isolated from poultry, Vietnam, 2009â€&quot;2011Emerg. Infect. Dis.2013191963197110.3201/eid1912.13070524274711"/>
   <result pre="Cell. Mol. Physiol.201330510811710.1152/ajplung.00105.201323709619 88.NguyenH.T.NguyenT.MishinV.P.SleemanK.BalishA.JonesJ.CreangaA.MarjukiH.UyekiT.M.NguyenD.H.et al.Antiviral susceptibility of highly pathogenic avian" exact="influenza" post="A(H5N1) viruses isolated from poultry, Vietnam, 2009â€&quot;2011Emerg. Infect. Dis.2013191963197110.3201/eid1912.13070524274711"/>
   <result pre="89.MalakhovM.P.AschenbrennerL.M.SmeeD.F.WanderseeM.K.SidwellR.W.GubarevaL.V.MishinV.P.HaydenF.G.KimD.H.IngA.et al.Sialidase fusion protein as a novel broad-spectrum inhibitor of" exact="influenza" post="virus infectionAntimicrob. Agents Chemother.2006501470147910.1128/AAC.50.4.1470-1479.200616569867 90.BaumL.G.PaulsonJ.C.Sialyloligosaccharides of the respiratory epithelium"/>
   <result pre="90.BaumL.G.PaulsonJ.C.Sialyloligosaccharides of the respiratory epithelium in the selection of human" exact="influenza" post="virus receptor specificityActa Histochem. Suppl.19904035382091044 91.BelserJ.A.LuX.SzretterK.J.JinX.AschenbrennerL.M.LeeA.HawleyS.KimD.H.MalakhovM.P.YuM.et al.DAS181, a novel"/>
   <result pre="al.DAS181, a novel sialidase fusion protein, protects mice from lethal" exact="avian influenza" post="H5N1 virus infectionJ. Infect. Dis.20071961493149910.1086/52260918008229 92.ChanR.W.ChanM.C.WongA.C.KaramanskaR.DellA.HaslamS.M.SihoeA.D.ChuiW.H.Triana-BaltzerG.LiQ.et al.DAS181 inhibits H5N1"/>
   <result pre="a novel sialidase fusion protein, protects mice from lethal avian" exact="influenza" post="H5N1 virus infectionJ. Infect. Dis.20071961493149910.1086/52260918008229 92.ChanR.W.ChanM.C.WongA.C.KaramanskaR.DellA.HaslamS.M.SihoeA.D.ChuiW.H.Triana-BaltzerG.LiQ.et al.DAS181 inhibits H5N1"/>
   <result pre="influenza H5N1 virus infectionJ. Infect. Dis.20071961493149910.1086/52260918008229 92.ChanR.W.ChanM.C.WongA.C.KaramanskaR.DellA.HaslamS.M.SihoeA.D.ChuiW.H.Triana-BaltzerG.LiQ.et al.DAS181 inhibits H5N1" exact="influenza" post="virus infection of human lung tissuesAntimicrob. Agents Chemother.2009533935394110.1128/AAC.00389-0919596886 93.Triana-BaltzerG.B.BabizkiM.ChanM.C.WongA.C.AschenbrennerL.M.CampbellE.R.LiQ.X.ChanR.W.PeirisJ.S.NichollsJ.M.et"/>
   <result pre="al.DAS181, a sialidase fusion protein, protects human airway epithelium against" exact="influenza" post="virus infection: An in vitro pharmacodynamic analysisJ. Antimicrob. Chemother.20106527528410.1093/jac/dkp42119942616"/>
   <result pre="activity of VX-787, a first-in-class, orally bioavailable inhibitor of the" exact="influenza" post="virus polymerase PB2 subunitAntimicrob. Agents Chemother.2015591569158210.1128/AAC.04623-1425547360 98.SmeeD.F.BarnardD.L.JonesS.M.Activities of JNJ63623872"/>
   <result pre="PB2 subunitAntimicrob. Agents Chemother.2015591569158210.1128/AAC.04623-1425547360 98.SmeeD.F.BarnardD.L.JonesS.M.Activities of JNJ63623872 and oseltamivir against" exact="influenza" post="A H1N1pdm and H3N2 virus infections in miceAntivir. Res.2016136455010.1016/j.antiviral.2016.10.00927771390"/>
   <result pre="H1N1pdm and H3N2 virus infections in miceAntivir. Res.2016136455010.1016/j.antiviral.2016.10.00927771390 99.FuY.GaelingsL.SoderholmS.BelanovS.NandaniaJ.NymanT.A.MatikainenS.AndersS.VelagapudiV.KainovD.E.JNJ872 inhibits" exact="influenza" post="A virus replication without altering cellular antiviral responsesAntivir. Res.2016133233110.1016/j.antiviral.2016.07.00827451344"/>
   <result pre="RNA viral infectionsAntivir. Res.2009829510210.1016/j.antiviral.2009.02.19819428599 102.FurutaY.TakahashiK.Kuno-MaekawaM.SangawaH.UeharaS.KozakiK.NomuraN.EgawaH.ShirakiK.Mechanism of action of T-705 against" exact="influenza" post="virusAntimicrob. Agents Chemother.20054998198610.1128/AAC.49.3.981-986.200515728892 103.BaranovichT.WongS.S.ArmstrongJ.MarjukiH.WebbyR.J.WebsterR.G.GovorkovaE.A.T-705 (favipiravir) induces lethal mutagenesis in"/>
   <result pre="influenza virusAntimicrob. Agents Chemother.20054998198610.1128/AAC.49.3.981-986.200515728892 103.BaranovichT.WongS.S.ArmstrongJ.MarjukiH.WebbyR.J.WebsterR.G.GovorkovaE.A.T-705 (favipiravir) induces lethal mutagenesis in" exact="influenza" post="A H1N1 viruses in vitroJ. Virol.2013873741375110.1128/JVI.02346-1223325689 104.JinZ.SmithL.K.RajwanshiV.K.KimB.DevalJ.The ambiguous base-pairing"/>
   <result pre="and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5â€²-triphosphate towards" exact="influenza" post="A virus polymerasePLoS ONE20138e6834710.1371/journal.pone.006834723874596 105.NaesensL.GuddatL.W.KeoughD.T.van KuilenburgA.B.MeijerJ.Vande VoordeJ.BalzariniJ.Role of human"/>
   <result pre="Adults and AdolescentsN. Engl. J. Med.201837991392310.1056/NEJMoa171619730184455 115.Oâ€™HanlonR.ShawM.L.Baloxavir marboxil: The new" exact="influenza" post="drug on the marketCurr. Opin. Virol.201935141810.1016/j.coviro.2019.01.00630852344 116.GagarinovaV.M.Ignatâ€™evaG.S.SinitskaiaL.V.IvanovaA.M.RodinaM.A.Turâ€™evaA.V.The new chemical"/>
   <result pre="Virol.201935141810.1016/j.coviro.2019.01.00630852344 116.GagarinovaV.M.Ignatâ€™evaG.S.SinitskaiaL.V.IvanovaA.M.RodinaM.A.Turâ€™evaA.V.The new chemical preparation arbidol: Its prophylactic efficacy during" exact="influenza" post="epidemicsZh Mikrobiol. Epidemiol. Immunobiol.199354043 117.BoriskinY.S.LenevaI.A.PecheurE.I.PolyakS.J.Arbidol: A broad-spectrum antiviral compound"/>
   <result pre="FlavivirusesViruses20181018410.3390/v10040184 122.LoginovaS.BorisevichS.V.MaksimovV.A.BondarevV.P.Nebolâ€™sinV.E.Therapeutic efficacy of Ingavirin, a new domestic formulation against" exact="influenza" post="A virus (H3N2)Antibiot Khimioter200853273019227120 123.GalegovG.A.AndronovaV.L.Nebolâ€™sinV.E.Antiviral effect of Ingavirin against"/>
   <result pre="A virus (H3N2)Antibiot Khimioter200853273019227120 123.GalegovG.A.AndronovaV.L.Nebolâ€™sinV.E.Antiviral effect of Ingavirin against seasonal" exact="influenza" post="virus A/H1N1 in MDCK cell cultureAntibiot Khimioter2009541922 124.ZarubaevV.V.BeliaevskaiaS.V.SirotkinA.K.AnfimovP.M.Nebolâ€™sinV.E.KiselevO.I.ReÄ­khartD.V.In vitro"/>
   <result pre="vivo effects of ingavirin on the ultrastructure and infectivity of" exact="influenza" post="virusVopr. Virusol.201156212522171473 125.SimoesE.A.GroothuisJ.R.Carbonell-EstranyX.RiegerC.H.MitchellI.FredrickL.M.KimpenJ.L.collab: Palivizumab Long-Term Respiratory Outcomes Study GroupPalivizumab"/>
   <result pre="broadly neutralizing stem antibody in complex with a pandemic H2" exact="influenza" post="virus hemagglutininJ. Virol.2013877149715410.1128/JVI.02975-1223552413 129.ThrosbyM.van den BrinkE.JongeneelenM.PoonL.L.M.AlardP.CornelissenL.BakkerA.CoxF.van DeventerE.GuanY.et al.Heterosubtypic Neutralizing"/>
   <result pre="Acute Uncomplicated InfluenzaAntimicrob. Agents Chemother.201862e00694-1810.1128/AAC.00694-1830150460 132.PappasL.FoglieriniM.PiccoliL.KallewaardN.L.TurriniF.SilacciC.Fernandez-RoadriguezB.AgaticG.Giacchetto-SasselliI.PellicciottaG.et al.Rapid development of broadly" exact="influenza" post="neutralizing antibodies through redundant mutationsNature201451641842210.1038/nature1376425296253 133.LuJ.GuoZ.PanX.WangG.ZhangD.LiY.TanB.OuyangL.YuX.Passive immunotherapy for influenza"/>
   <result pre="broadly influenza neutralizing antibodies through redundant mutationsNature201451641842210.1038/nature1376425296253 133.LuJ.GuoZ.PanX.WangG.ZhangD.LiY.TanB.OuyangL.YuX.Passive immunotherapy for" exact="influenza" post="A H5N1 virus infection with equine hyperimmune globulin F"/>
   <result pre="neutralizing antibodies are produced by individuals immunized with a seasonal" exact="influenza" post="vaccineJ. Clin. Investig.20101201663167310.1172/JCI4190220389023 136.MargineI.KrammerF.HaiR.HeatonN.TanG.AndrewsS.RunstadlerJ.A.WilsonP.C.AlbrechtR.A.Garcia-SastreA.et al.Hemagglutinin stalk-based universal vaccine constructs"/>
   <result pre="136.MargineI.KrammerF.HaiR.HeatonN.TanG.AndrewsS.RunstadlerJ.A.WilsonP.C.AlbrechtR.A.Garcia-SastreA.et al.Hemagglutinin stalk-based universal vaccine constructs protect against group 2" exact="influenza" post="A virusesJ. Virol.201310.1128/JVI.01715-1323903831 137.NachbagauerR.MillerM.S.HaiR.RyderA.B.RoseJ.K.PaleseP.GarcÃ­a-SastreA.KrammerF.AlbrechtR.A.Hemagglutinin stalk immunity reduces influenza virus"/>
   <result pre="group 2 influenza A virusesJ. Virol.201310.1128/JVI.01715-1323903831 137.NachbagauerR.MillerM.S.HaiR.RyderA.B.RoseJ.K.PaleseP.GarcÃ­a-SastreA.KrammerF.AlbrechtR.A.Hemagglutinin stalk immunity reduces" exact="influenza" post="virus replication and transmission in ferretsJ. Virol.2016903268327310.1128/JVI.02481-15 138.WohlboldT.J.NachbagauerR.MargineI.TanG.S.HirshA.KrammerF.Vaccination with"/>
   <result pre="with soluble headless hemagglutinin protects mice from challenge with divergent" exact="influenza" post="virusesVaccine2015333314332110.1016/j.vaccine.2015.05.03826026378 139.El BakkouriK.DescampsF.De FiletteM.SmetA.FestjensE.BirkettA.Van RooijenN.VerbeekS.FiersW.SaelensX.Universal vaccine based on ectodomain"/>
   <result pre="RooijenN.VerbeekS.FiersW.SaelensX.Universal vaccine based on ectodomain of matrix protein 2 of" exact="influenza" post="A: Fc receptors and alveolar macrophages mediate protectionJ. Immunol.20111861022103110.4049/jimmunol.090214721169548"/>
   <result pre="Fc receptors and alveolar macrophages mediate protectionJ. Immunol.20111861022103110.4049/jimmunol.090214721169548 140.WilsonJ.R.BelserJ.A.DaSilvaJ.GuoZ.SunX.GansebomS.BaiY.StarkT.J.ChangJ.CarneyP.et al.An" exact="influenza" post="A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from"/>
   <result pre="virus disease in nonhuman primates with ZMappNature2014514475310.1038/nature1377725171469 144.BalazsA.B.BloomJ.D.HongC.M.RaoD.S.BaltimoreD.Broad protection against" exact="influenza" post="infection by vectored immunoprophylaxis in miceNat. Biotechnol.20133164765210.1038/nbt.261823728362 145.BerryC.M.PenhaleW.J.SangsterM.Y.Passive broad-spectrum"/>
   <result pre="influenza infection by vectored immunoprophylaxis in miceNat. Biotechnol.20133164765210.1038/nbt.261823728362 145.BerryC.M.PenhaleW.J.SangsterM.Y.Passive broad-spectrum" exact="influenza" post="immunoprophylaxisInfluenza. Res. Treat.2014201426759410.1155/2014/26759425328697 146.ZhouB.ZhongN.GuanY.Treatment with convalescent plasma for influenza"/>
   <result pre="broad-spectrum influenza immunoprophylaxisInfluenza. Res. Treat.2014201426759410.1155/2014/26759425328697 146.ZhouB.ZhongN.GuanY.Treatment with convalescent plasma for" exact="influenza" post="A (H5N1) infectionN. Engl. J. Med.20073571450145110.1056/NEJMc07035917914053 147.JegerlehnerA.SchmitzN.StorniT.BachmannM.F.Influenza A vaccine"/>
   <result pre="in both protection against and recovery from pulmonary infection with" exact="influenza" post="virus in miceJ. Virol.2008822772278310.1128/JVI.01210-0718184718 149.TerajimaM.CoM.D.T.CruzJ.EnnisF.A.High Antibody-Dependent Cellular Cytotoxicity Antibody"/>
   <result pre="150.YuX.TsibaneT.McGrawP.A.HouseF.S.KeeferC.J.HicarM.D.TumpeyT.M.PappasC.PerroneL.A.MartinezO.et al.Neutralizing antibodies derived from the B cells of 1918" exact="influenza" post="pandemic survivorsNature200845553210.1038/nature0723118716625 151.KrammerF.GarcÃ­a-SastreA.PaleseP.Is it possible to develop a â€œuniversalâ€�"/>
   <result pre="influenza pandemic survivorsNature200845553210.1038/nature0723118716625 151.KrammerF.GarcÃ­a-SastreA.PaleseP.Is it possible to develop a â€œuniversalâ€�" exact="influenza" post="virus vaccine? Toward a universal influenza virus vaccine: Potential"/>
   <result pre="to develop a â€œuniversalâ€� influenza virus vaccine? Toward a universal" exact="influenza" post="virus vaccine: Potential target antigens and critical aspects for"/>
   <result pre="antibody-dependent cell lysis (ADCL). vaccines-07-00053-t001_Table 1Table 1 Summary of novel" exact="influenza" post="virus vaccine platforms. Vaccines Design References Virus-like particle vaccines"/>
   <result pre="inhibition III completed USA JNJ-63623872 (Pimodivir) Small molecule inhibitor of" exact="influenza" post="A virus PB2 III recruiting Belgium T705 (Favipiravir) RNA-dependent"/>
   <result pre="from the clinicaltrials.gov. 1 Approved for treatment of acute uncomplicated" exact="influenza" post="among â‰¥12 years vaccines-07-00053-t003_Table 3Table 3 Antibodies undergoing clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631137\results\search\disease\results.xml">
   <result pre="traditional design of effective vaccines for rapidly-evolving pathogens, such as" exact="influenza" post="A virus, has failed to provide broad spectrum and"/>
   <result pre="demonstrated the potential to facilitate the design of a universal" exact="influenza" post="vaccine. However, few studies have integrated computational optimization in"/>
   <result pre="T-cell epitopes. Interactions between virus-host-environment determine the evolvability of the" exact="influenza" post="population. We propose that with the development of novel"/>
   <result pre="will be crucial for the development of a long-lasting universal" exact="influenza" post="vaccine. Taken together, computational approaches are powerful and promising"/>
   <result pre="powerful and promising tools for the development of a universal" exact="influenza" post="vaccine with durable and broad protection. Universal influenza vaccine"/>
   <result pre="a universal influenza vaccine with durable and broad protection. Universal" exact="influenza" post="vaccine computational design interactions of virus-host-environment 1. Introduction In"/>
   <result pre="lasting protection for human populations. This is particularly true for" exact="influenza" post="viruses, a single-stranded, negative sense RNA virus. One of"/>
   <result pre="One of the important weapons being developed to effectively prevent" exact="influenza" post="virus infection is a vaccine that can provide durable"/>
   <result pre="those that may cause potential pandemics, that is, a universal" exact="influenza" post="vaccine [1]. The National Institute of Allergy and Infectious"/>
   <result pre="and Infectious Diseases (NIAID) has defined the criteria for universal" exact="influenza" post="vaccine, which includes (1) being at least 75% effective"/>
   <result pre="which includes (1) being at least 75% effective against symptomatic" exact="influenza" post="infection; (2) protecting against group I and group II"/>
   <result pre="influenza infection; (2) protecting against group I and group II" exact="influenza" post="A viruses (influenza B would be a secondary target);"/>
   <result pre="design novel broadly-reactive vaccine candidates, which have been used for" exact="influenza" post="and other pathogens [2]. These new approaches have revealed"/>
   <result pre="the genomic era can aid in achieving goals of universal" exact="influenza" post="vaccine design. However, it has found limited applications in"/>
   <result pre="briefly summarize the currently applied approaches of seasonal and universal" exact="influenza" post="vaccine design and their disadvantages (part 2), gather information"/>
   <result pre="necessary resources and efforts needed for computational approaches of universal" exact="influenza" post="vaccine candidates (part 4). We will explore the important"/>
   <result pre="computational advances that could help in restructuring the existing seasonal" exact="influenza" post="vaccine design and contribute to the development of universal"/>
   <result pre="influenza vaccine design and contribute to the development of universal" exact="influenza" post="vaccine. 2. Current Approach for Influenza Vaccine Design 2.1."/>
   <result pre="for Seasonal Vaccine Design To prevent infections from circulating seasonal" exact="influenza" post="viruses, the annually administered influenza virus vaccines contain H1N1"/>
   <result pre="prevent infections from circulating seasonal influenza viruses, the annually administered" exact="influenza" post="virus vaccines contain H1N1 (phylogenetic group 1 hemagglutinin), H3N2"/>
   <result pre="group 1 hemagglutinin), H3N2 (phylogenetic group 2 hemagglutinin) and two" exact="influenza" post="B virus components (Victoria-like and Yamagata-like) [7]. The vaccine"/>
   <result pre="components (Victoria-like and Yamagata-like) [7]. The vaccine candidates from natural" exact="influenza" post="virus strains are recommended by the World Health Organization"/>
   <result pre="of vaccine strains to make recommendation on the components of" exact="influenza" post="vaccine [8]. The evaluations are mainly based on viral"/>
   <result pre="at least 6-8 months to produce sufficient global supplies of" exact="influenza" post="vaccine via current vaccine production technologies with egg-based, cell-based"/>
   <result pre="vaccine [9,10]. For a comprehensive review of traditional approaches for" exact="influenza" post="vaccine selection, design, development and challenges refer to this"/>
   <result pre="by Wong and Webby [11]. Influenza vaccines selected from natural" exact="influenza" post="virus strains predominantly elicit specific antibodies against the globular"/>
   <result pre="annual vaccines, demonstrating severely low and unstable immune protection from" exact="influenza" post="infection [18]. Predictive models of viral evolution to forecast"/>
   <result pre="[18]. Predictive models of viral evolution to forecast dominant circulating" exact="influenza" post="viral strains in the upcoming influenza seasons through the"/>
   <result pre="to forecast dominant circulating influenza viral strains in the upcoming" exact="influenza" post="seasons through the analysis of genetic and epidemiological data"/>
   <result pre="seasons through the analysis of genetic and epidemiological data from" exact="influenza" post="surveillance system have been developed to make quantitative predictions"/>
   <result pre="viral evolution and aim to improve the selection of seasonal" exact="influenza" post="vaccine candidates [10,19]. This framework has demonstrated potential to"/>
   <result pre="has demonstrated potential to integrate multiple data sources to improve" exact="influenza" post="vaccine design. 2.2. Universal Influenza Vaccine Design Seasonal vaccines"/>
   <result pre="vaccines offer a little or no protection to emerging zoonotic" exact="influenza" post="viruses with pandemic potential, as many species, especially wild"/>
   <result pre="are recognized as the natural reservoir of all subtypes of" exact="influenza" post="A viruses and have the potential to occur spillover"/>
   <result pre="have the potential to elicit broadly protective antibodies against seasonal" exact="influenza" post="strain. M2-based universal vaccine design focuses on the conserved"/>
   <result pre="domain [25]. While the stalk domain is conserved across multiple" exact="influenza" post="subtypes, it is shielded by the immune-dominant head domain."/>
   <result pre="and protective vaccines for hypervariable and rapidly-evolving viral pathogens, including" exact="influenza" post="viruses [30,31]. The reasons for this failure include inherent"/>
   <result pre="vaccine design often ignores the underlying processes of the global" exact="influenza" post="meta-population which generates diversity that allows the viral populations"/>
   <result pre="fit the needs of universal vaccine design for highly diverse" exact="influenza" post="virus in several promising aspects [38,39]: (1) being able"/>
   <result pre="assessment and prediction. Computational approaches to identify candidates for universal" exact="influenza" post="vaccine design have been used with a variety of"/>
   <result pre="both, to tackle with the high degree of variability in" exact="influenza" post="viruses by boosting the immunity from the conserved or"/>
   <result pre="severity. Particularly, memory CD4+ T-cells can provide substantial protection against" exact="influenza" post="infection through direct effector mechanisms as well as indirect"/>
   <result pre="[72,73,74,75,76,77,78]. Taken together, these studies suggest that an epitope-based universal" exact="influenza" post="vaccine can be developed by selecting the well-conserved and"/>
   <result pre="be developed by selecting the well-conserved and immunodominant epitopes across" exact="influenza" post="subtypes using the immunomics approach. A major challenge in"/>
   <result pre="in Clinical Development There are currently three promising epitope-based universal" exact="influenza" post="vaccines, FP-01.1, Flu-v and Multimeric-001 (M-001) are at different"/>
   <result pre="(PB1 and PB2) and have high level conservancy across H1-H9" exact="influenza" post="A subtypes with wider population coverage. The phase I"/>
   <result pre="epitopes derived from NP, matrix proteins (M1 and M2) from" exact="influenza" post="A and NP from influenza B viruses and are"/>
   <result pre="proteins (M1 and M2) from influenza A and NP from" exact="influenza" post="B viruses and are conserved across most influenza viruses"/>
   <result pre="NP from influenza B viruses and are conserved across most" exact="influenza" post="viruses with high population coverage [81,82]. The phase II"/>
   <result pre="and also induced antibody response [83]. Multimeric-001 (M-001), a universal" exact="influenza" post="epitope-based vaccine, is currently at the pivotal phase III"/>
   <result pre="conserved and common epitopes from NP, M1, and HA of" exact="influenza" post="A and B viruses to activate both humoral and"/>
   <result pre="system to provide multi-strain protection from the seasonal and pandemic" exact="influenza" post="viruses [85]. The predicted population coverage of these selected"/>
   <result pre="approaches to prevent infections from remerging or emerging highly evolving" exact="influenza" post="viruses. 3.2.3. Computational Approaches that Incorporate Host Immunological Factors"/>
   <result pre="[89,94]. These technologies and bioinformatics tools can be applied to" exact="influenza" post="virus vaccine design with creating library of antibody repertoire"/>
   <result pre="generated consensus sequences for NA protein of H1N1 and several" exact="influenza" post="proteins of H5N1, including HA, NA and matrix protein"/>
   <result pre="rounds of consensus generation. Within each phylogenetic subclade of the" exact="influenza" post="virus subtype, the primary consensus with the most common"/>
   <result pre="immune targets. Phylogenetic evolutionary models have been used to infer" exact="influenza" post="viral evolutionary history for decades with molecular data, including"/>
   <result pre="[44] developed an ancestral sequence reconstruction method for highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 surface proteins HA and NA. Based on"/>
   <result pre="developed an ancestral sequence reconstruction method for highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 surface proteins HA and NA. Based on"/>
   <result pre="of these viruses. These ancestral sequences were synthesized into attenuated" exact="influenza" post="viruses that could replicate. Their cross-reactive protection against H5N1"/>
   <result pre="vaccine design, the computational approach is promising. Precise estimation of" exact="influenza" post="virus evolution including protein structural and its functional information"/>
   <result pre="heritable phenotype [123]. The zoonotic nature and complicated ecology of" exact="influenza" post="viruses make evolvability more difficult to quantify and predict."/>
   <result pre="and potentially interact to shape viral phylogeniesâ€� [124,125]. Dynamics of" exact="influenza" post="virus infections and transmissions at individual-level (such as viral"/>
   <result pre="experimental testing can be integrated together to improve prediction on" exact="influenza" post="virus evolvability. For example, experimental studies designed to assess"/>
   <result pre="which can improve the prediction of viral evolvability for natural" exact="influenza" post="virus strains [127]. The potential predictors and consequent mutations"/>
   <result pre="enhance our understanding on viral characteristics, potential immune escape, or" exact="influenza" post="antiviral drug resistance [128]. Challenges for this area are"/>
   <result pre="ameliorate the output from computational modeling [19,129,130]. Compared to other" exact="infectious disease" post="sampling, influenza viruses have already established an excellent global"/>
   <result pre="from computational modeling [19,129,130]. Compared to other infectious disease sampling," exact="influenza" post="viruses have already established an excellent global network of"/>
   <result pre="a large amount of genetic data has been available for" exact="influenza" post="research. However, three main limitations exist in current surveillance:"/>
   <result pre="the unequal sampling in zoonotic hosts is more severe. Human" exact="influenza" post="outbreaks have been well monitored and sampled [129]. However,"/>
   <result pre="can provide an initial rationalization and optimal sample size for" exact="avian influenza" post="virus surveillance [129,133,134]. The affiliated sequence meta-data records have"/>
   <result pre="provide an initial rationalization and optimal sample size for avian" exact="influenza" post="virus surveillance [129,133,134]. The affiliated sequence meta-data records have"/>
   <result pre="access database platforms have facilitated the accessibility and sharing of" exact="influenza" post="sequence data to the science community. Despite the availability"/>
   <result pre="have been using the traditional approaches to design and develop" exact="influenza" post="vaccines. The rapid genetic changes and antigenic drift of"/>
   <result pre="influenza vaccines. The rapid genetic changes and antigenic drift of" exact="influenza" post="virus populations result in short-term protection necessitating continual vaccine"/>
   <result pre="the interactions of host- pathogen-environment that produced important insights into" exact="influenza" post="disease dynamics across biological scales. Integrating these computational and"/>
   <result pre="can facilitate the development of a broadly cross-reactive, evolutionarily-resistant universal" exact="influenza" post="vaccine. Acknowledgments We thank Lambodhar Damodaran and Jiani Chen"/>
   <result pre="DiseasesJ. Infect. Dis.201821834735410.1093/infdis/jiy10329506129 2.RappuoliR.AderemA.A 2020 vision for vaccines against HIV," exact="tuberculosis" post="and malariaNature201147346346910.1038/nature1012421614073 3.MedinaR.A.StertzS.ManicassamyB.ZimmermannP.SunX.AlbrechtR.A.Uusi-KerttulaH.ZagordiO.BelsheR.B.FreyS.E.et al.Glycosylations in the Globular Head of"/>
   <result pre="the Promise of Applied Evolutionary BiologyTrends Microbiol.20182610211810.1016/j.tim.2017.09.00429097090 11.WongS.-S.WebbyR.J.Traditional and new" exact="influenza" post="vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 12.AndersonC.S.OrtegaS.ChavesF.A.ClarkA.M.YangH.TophamD.J.DeDiegoM.L.Natural and directed antigenic drift of"/>
   <result pre="Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 12.AndersonC.S.OrtegaS.ChavesF.A.ClarkA.M.YangH.TophamD.J.DeDiegoM.L.Natural and directed antigenic drift of the H1" exact="influenza" post="virus hemagglutinin stalk domainSci. Rep.201771461410.1038/s41598-017-14931-729097696 13.Berlanda ScorzaF.TsvetnitskyV.DonnellyJ.J.Universal influenza vaccines:"/>
   <result pre="the H1 influenza virus hemagglutinin stalk domainSci. Rep.201771461410.1038/s41598-017-14931-729097696 13.Berlanda ScorzaF.TsvetnitskyV.DonnellyJ.J.Universal" exact="influenza" post="vaccines: Shifting to better vaccinesVaccine2016342926293310.1016/j.vaccine.2016.03.08527038130 14.SkowronskiD.M.JanjuaN.Z.De SerresG.SabaiducS.EshaghiA.DickinsonJ.A.FonsecaK.WinterA.L.GubbayJ.B.KrajdenM.et al.Low 2012â€&quot;13"/>
   <result pre="Not Antigenic Drift in Circulating VirusesPLoS ONE20149e9215310.1371/journal.pone.009215324667168 15.ZostS.J.ParkhouseK.GuminaM.E.KimK.Diaz PerezS.WilsonP.C.TreanorJ.J.SantA.J.CobeyS.HensleyS.E.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="16.WuN.C.ZostS.J.ThompsonA.J.OyenD.NycholatC.M.McBrideR.PaulsonJ.C.HensleyS.E.WilsonI.A.A structural explanation for the low effectiveness of the seasonal" exact="influenza" post="H3N2 vaccinePLoS Pathog.201713e100668210.1371/journal.ppat.100668229059230 17.PaulesC.I.SullivanS.G.SubbaraoK.FauciA.S.Chasing Seasonal Influenzaâ€&quot;The Need for a"/>
   <result pre="Prediction for Human Influenza VirusesTrends Microbiol.20182611913110.1016/j.tim.2017.09.00129032900 20.WebsterR.G.BeanW.J.GormanO.T.ChambersT.M.KawaokaY.Evolution and ecology of" exact="influenza" post="A virusesMicrobiol. Rev.1992561521791579108 21.GuanY.VijaykrishnaD.BahlJ.ZhuH.WangJ.SmithG.J.D.The emergence of pandemic influenza virusesProtein"/>
   <result pre="ecology of influenza A virusesMicrobiol. Rev.1992561521791579108 21.GuanY.VijaykrishnaD.BahlJ.ZhuH.WangJ.SmithG.J.D.The emergence of pandemic" exact="influenza" post="virusesProtein Cell2010191310.1007/s13238-010-0008-z21203993 22.SmithG.J.D.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic influenza virusesProc."/>
   <result pre="of pandemic influenza virusesProtein Cell2010191310.1007/s13238-010-0008-z21203993 22.SmithG.J.D.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic" exact="influenza" post="virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 23.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential"/>
   <result pre="Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 23.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature200945993193910.1038/nature0815719525932 24.ZhangH.WangL.CompansR.W.WangB.-Z.Universal Influenza Vaccines, a Dream to Be Realized"/>
   <result pre="Be Realized SoonViruses20146197410.3390/v605197424784572 25.JangY.H.SeongB.L.Options and obstacles for designing a universal" exact="influenza" post="vaccineViruses201463159318010.3390/v608315925196381 26.KirchenbaumG.A.RossT.M.Eliciting broadly protective antibody responses against influenzaCurr. Opin."/>
   <result pre="protective antibody responses against influenzaCurr. Opin. Immunol.201428717610.1016/j.coi.2014.02.00524632083 27.SauttoG.A.KirchenbaumG.A.RossT.M.Towards a universal" exact="influenza" post="vaccine: Different approaches for one goalVirol. J.2018151710.1186/s12985-017-0918-y29370862 28.CarterD.M.DarbyC.A.LefoleyB.C.CrevarC.J.AlefantisT.OomenR.AndersonS.F.StrugnellT.CortÃ©s-GarciaG.VogelT.U.Design and"/>
   <result pre="Hemagglutinin Vaccine for H1N1 Influenza VirusesJ. Virol.2016904720473410.1128/JVI.03152-1526912624 29.JobE.R.YsenbaertT.SmetA.ChristopoulouI.StrugnellT.OlooE.O.OomenR.P.KleanthousH.VogelT.U.SaelensX.Broadened immunity against" exact="influenza" post="by vaccination with computationally designed influenza virus N1 neuraminidase"/>
   <result pre="Virol.2016904720473410.1128/JVI.03152-1526912624 29.JobE.R.YsenbaertT.SmetA.ChristopoulouI.StrugnellT.OlooE.O.OomenR.P.KleanthousH.VogelT.U.SaelensX.Broadened immunity against influenza by vaccination with computationally designed" exact="influenza" post="virus N1 neuraminidase constructsNPJ Vaccines201835510.1038/s41541-018-0093-130510776 30.HeL.ZhuJ.Computational tools for epitope"/>
   <result pre="particle vaccinesClin. Vaccine Immunol.20121912813910.1128/CVI.05533-1122190399 35.ShuY.McCauleyJ.GISAID: Global initiative on sharing all" exact="influenza" post="dataâ€&quot;â€&quot;From vision to realityEurosurveillance2017223049410.2807/1560-7917.ES.2017.22.13.3049428382917 36.NCBI Influenza virus databaseAvailable online:"/>
   <result pre="databaseAvailable online: https://www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-select.cgi?go=database(accessed on 28 April 2019) 37.collab: WHOFluIDâ€&quot;A global" exact="influenza" post="epidemiological data sharing platformWHO2017Available online: https://www.who.int/influenza/surveillance_monitoring/fluid/en/(accessed on 5 March"/>
   <result pre="40.NabelG.J.FauciA.S.Induction of unnatural immunity: Prospects for a broadly protective universal" exact="influenza" post="vaccineNat. Med.2010161389139110.1038/nm1210-138921135852 41.GilesB.M.RossT.M.A computationally optimized broadly reactive antigen (COBRA)"/>
   <result pre="from H5N1 InfectionJ. Infect. Dis.20122051562157010.1093/infdis/jis23222448011 44.DucatezM.F.BahlJ.GriffinY.Stigger-RosserE.FranksJ.BarmanS.VijaykrishnaD.WebbA.GuanY.WebsterR.G.Feasibility of reconstructed ancestral H5N1" exact="influenza" post="viruses for cross-clade protective vaccine developmentProc. Natl. Acad. Sci."/>
   <result pre="epitope-based diagnostics and vaccinesBMC Bioinformatics2006715310.1186/1471-2105-7-15316545123 65.Molero-AbrahamM.LafuenteE.M.FlowerD.R.RecheP.A.Selection of conserved epitopes from" exact="hepatitis" post="C virus for pan-populational stimulation of T-cell responsesClin. Dev."/>
   <result pre="cross-reactive and virus-specific T-cell populations after immunization with serologically distinct" exact="influenza" post="A virusesJ. Exp. Med.197714555756810.1084/jem.145.3.557233901 70.KreijtzJ.H.BodewesR.van AmerongenG.KuikenT.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Primary influenza A virus"/>
   <result pre="with serologically distinct influenza A virusesJ. Exp. Med.197714555756810.1084/jem.145.3.557233901 70.KreijtzJ.H.BodewesR.van AmerongenG.KuikenT.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Primary" exact="influenza" post="A virus infection induces cross-protective immunity against a lethal"/>
   <result pre="a heterosubtypic virus strain in miceVaccine20072561262010.1016/j.vaccine.2006.08.03617005299 71.ZweerinkH.J.CourtneidgeS.A.SkehelJ.J.CrumptonM.J.AskonasB.A.Cytotoxic T cells kill" exact="influenza" post="virus infected cells but do not distinguish between serologically"/>
   <result pre="cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic" exact="influenza" post="virusesInfluenza Other Respi. Viruses2010424925810.1111/j.1750-2659.2010.00161.x20716156 73.DuvvuriV.R.DuvvuriB.JamnikV.GubbayJ.B.WuJ.WuG.E.T cell memory to evolutionarily"/>
   <result pre="74.De GrootA.S.ArditoM.McClaineE.M.MoiseL.MartinW.D.Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin" exact="influenza" post="A (H1N1) virus with epitopes in 2008â€&quot;2009 conventional influenza"/>
   <result pre="swine-origin influenza A (H1N1) virus with epitopes in 2008â€&quot;2009 conventional" exact="influenza" post="vaccineVaccine2009275740574710.1016/j.vaccine.2009.07.04019660593 75.GeX.TanV.BollykyP.L.StandiferN.E.JamesE.A.KwokW.W.Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell"/>
   <result pre="Influenza A VirusJ. Virol.2010843312331910.1128/JVI.02226-0920071564 76.GreenbaumJ.A.KotturiM.F.KimY.OseroffC.VaughanK.SalimiN.VitaR.PonomarenkoJ.ScheuermannR.H.SetteA.et al.Pre-existing immunity against swine-origin H1N1" exact="influenza" post="viruses in the general human populationProc. Natl. Acad. Sci."/>
   <result pre="al.Preexisting influenza-specific CD4+ T cells correlate with disease protection against" exact="influenza" post="challenge in humansNat. Med.2012187428010.1038/nm.261222286307 79.ClinicalTrials.gov Identifier:NCT01265914 A Study to"/>
   <result pre="safety of different doses and formulations of a broad spectrum" exact="influenza" post="vaccine (FLU-v) developed by SEEK: Study protocol for a"/>
   <result pre="https://clinicaltrials.gov/ct2/show/NCT03450915?term=epitope&amp;amp;cond=Influenza&amp;amp;rank=6(accessed on 20 February 2019) 85.GottliebT.Ben-YedidiaT.Epitope-based approaches to a universal" exact="influenza" post="vaccineJ. Autoimmun.201454152010.1016/j.jaut.2014.07.00525172355 86.AtsmonJ.CaracoY.Ziv-SeferS.ShaikevichD.AbramovE.VolokhovI.BruzilS.HaimaK.Y.GottliebT.Ben-YedidiaT.Priming by a novel universal influenza vaccine"/>
   <result pre="a universal influenza vaccineJ. Autoimmun.201454152010.1016/j.jaut.2014.07.00525172355 86.AtsmonJ.CaracoY.Ziv-SeferS.ShaikevichD.AbramovE.VolokhovI.BruzilS.HaimaK.Y.GottliebT.Ben-YedidiaT.Priming by a novel universal" exact="influenza" post="vaccine (Multimeric-001)â€&quot;A gateway for improving immune response in the"/>
   <result pre="108.BaeleG.SuchardM.A.RambautA.LemeyP.Emerging Concepts of Data Integration in Pathogen PhylodynamicsSyst. Biol.201766e47e6510.1093/sysbio/syw05428173504 109.KirkpatrickE.QiuX.WilsonP.C.BahlJ.KrammerF.The" exact="influenza" post="virus hemagglutinin head evolves faster than the stalk domainSci."/>
   <result pre="evolutionary models improve phylogenetic reconstruction for emerging, seasonal, and pandemic" exact="influenza" post="virusesbioRxiv201710.1101/228692 111.KleinmanC.L.RodrigueN.LartillotN.PhilippeH.Statistical Potentials for Improved Structurally Constrained Evolutionary ModelsMol."/>
   <result pre="VirusPLOS Pathog.201612e100585610.1371/journal.ppat.100585627571422 127.ThyagarajanB.BloomJ.D.The inherent mutational tolerance and antigenic evolvability of" exact="influenza" post="hemagglutininElife2014310.7554/eLife.03300 128.BloomJ.D.GongL.I.BaltimoreD.Permissive Secondary Mutations Enable the Evolution of Influenza"/>
   <result pre="Computational identification of selective sweeps to monitor the adaptation of" exact="influenza" post="A virusesSci. Rep.2018837310.1038/s41598-017-18791-z29321538 131.AmpofoW.K.Azziz-BaumgartnerE.BashirU.CoxN.J.FasceR.GiovanniM.GrohmannG.HuangS.KatzJ.MironenkoA.et al.Strengthening the influenza vaccine virus"/>
   <result pre="the adaptation of influenza A virusesSci. Rep.2018837310.1038/s41598-017-18791-z29321538 131.AmpofoW.K.Azziz-BaumgartnerE.BashirU.CoxN.J.FasceR.GiovanniM.GrohmannG.HuangS.KatzJ.MironenkoA.et al.Strengthening the" exact="influenza" post="vaccine virus selection and development processVaccine2015334368438210.1016/j.vaccine.2015.06.09026148877 132.collab: Institute of"/>
   <result pre="Academies Press (US)Washington, DC, USA2010 133.HoyeB.J.MunsterV.J.NishiuraH.KlaassenM.FouchierR.A.Surveillance of wild birds for" exact="avian influenza" post="virusEmerg. Infect. Dis.2010161827183410.3201/eid1612.10058921122209 134.SquiresR.B.NoronhaJ.HuntV.GarcÃ­a-SastreA.MackenC.BaumgarthN.SuarezD.PickettB.E.ZhangY.LarsenC.N.Influenza research database: An integrated bioinformatics"/>
   <result pre="Press (US)Washington, DC, USA2010 133.HoyeB.J.MunsterV.J.NishiuraH.KlaassenM.FouchierR.A.Surveillance of wild birds for avian" exact="influenza" post="virusEmerg. Infect. Dis.2010161827183410.3201/eid1612.10058921122209 134.SquiresR.B.NoronhaJ.HuntV.GarcÃ­a-SastreA.MackenC.BaumgarthN.SuarezD.PickettB.E.ZhangY.LarsenC.N.Influenza research database: An integrated bioinformatics"/>
   <result pre="Infect. Dis.2010161827183410.3201/eid1612.10058921122209 134.SquiresR.B.NoronhaJ.HuntV.GarcÃ­a-SastreA.MackenC.BaumgarthN.SuarezD.PickettB.E.ZhangY.LarsenC.N.Influenza research database: An integrated bioinformatics resource for" exact="influenza" post="research and surveillanceInfluenza Other Respi. Viruses2012640441610.1111/j.1750-2659.2011.00331.x22260278 135.GunnarssonG.Latorre-MargalefN.HobsonK.A.Van WilgenburgS.L.ElmbergJ.OlsenB.FouchierR.A.M.WaldenstrÃ¶mJ.Disease dynamics"/>
   <result pre="bird migrationâ€&quot;â€&quot;Linking mallards Anas platyrhynchos and subtype diversity of the" exact="influenza" post="A virus in time and spacePLoS ONE20127e3567910.1371/journal.pone.003567922536424 136.ElbeS.Buckland-MerrettG.Data, disease"/>
   <result pre="are modeled to understand the susceptibility and immune response to" exact="influenza" post="viruses by studying the host immunogenetics, for example, the"/>
   <result pre="ecological determinants that affect viral evolution and host immunity to" exact="influenza" post="virus. In order to generate critical components for vaccine"/>
   <result pre="high-quality information and broad-reactive components for a universal vaccine of" exact="influenza" post="viruses. Figure 2 Framework for computational influenza universal vaccine"/>
   <result pre="universal vaccine of influenza viruses. Figure 2 Framework for computational" exact="influenza" post="universal vaccine design. (A) Model-free consensus-based optimized approach. Consensus"/>
   <result pre="domains. Based on the evolutionary relationship among different subtypes of" exact="influenza" post="A virus, common ancestral sequences of head and stalk"/>
   <result pre="sequences of head and stalk domains can be generated within" exact="influenza" post="A virus Group 1 (H1, H2, H5, H6, H7,"/>
   <result pre="approaches should be used for all the gene segments of" exact="influenza" post="viruses to generate a full profile of viral immunogenicity."/>
   <result pre="viral immunogenicity. vaccines-07-00045-t001_Table 1Table 1 Summary and examples of computational" exact="influenza" post="universal vaccine design. Approach Conceptual Design Evidence-Level Advantages Disadvantages"/>
   <result pre="the same subtype;(3) Neutralize the receptor binding sites to prevent" exact="influenza" post="disease with a clear path towards clinical proof of"/>
   <result pre="2B Pre-clinical (1) Induce broad cross-reactive protection within highly diverse" exact="influenza" post="subtype(2) Account for sampling bias and the variability of"/>
   <result pre="Table 2 for details vaccines-07-00045-t002_Table 2Table 2 Promising epitope-based universal" exact="influenza" post="vaccines at clinical trials. Vaccine Company Projects Clinical Phase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631207\results\search\disease\results.xml">
   <result pre="or in vitro against viral replication and and/or ZIKV-induced neurotoxicity." exact="microcephaly" post="arbovirus flavivirus drug development neurodevelopment therapy drug screening pregnancy"/>
   <result pre="neurodevelopment therapy drug screening pregnancy Food and Drug Administration (FDA)" exact="encephalitis" post="1. Introduction Zika virus (ZIKV) has been known since"/>
   <result pre="reported in newborn babies exposed to ZIKV in uterus, being" exact="microcephaly" post="the most severe outcome. Infants who develop ZIKV-induced microcephaly"/>
   <result pre="being microcephaly the most severe outcome. Infants who develop ZIKV-induced" exact="microcephaly" post="show recurrent seizures [3], and severely compromised neuropsychomotor development"/>
   <result pre="Extensive research has focused on unraveling the mechanisms of congenital" exact="microcephaly" post="induced by ZIKV [6,7,8]. However, increasing evidence from clinical"/>
   <result pre="dystonic movement, and impaired fine motor skills [9,10,11]. Post-natal onset" exact="microcephaly" post="was also reported, and studies suggest that 60% of"/>
   <result pre="show that ZIKV infection in adult patients may result in" exact="encephalitis" post="[18,19,20], encephalomyelitis [18,20], acute myelitis [18,19], chronic inflammatory demyelinating"/>
   <result pre="ZIKV infection in adult patients may result in encephalitis [18,19,20]," exact="encephalomyelitis" post="[18,20], acute myelitis [18,19], chronic inflammatory demyelinating polyneuropathy [21],"/>
   <result pre="adult patients may result in encephalitis [18,19,20], encephalomyelitis [18,20], acute" exact="myelitis" post="[18,19], chronic inflammatory demyelinating polyneuropathy [21], and Guillain-Barre syndrome"/>
   <result pre="may result in encephalitis [18,19,20], encephalomyelitis [18,20], acute myelitis [18,19]," exact="chronic inflammatory demyelinating polyneuropathy" post="[21], and Guillain-Barre syndrome [19,22,23] (Figure 1B). Episodes of"/>
   <result pre="encephalitis [18,19,20], encephalomyelitis [18,20], acute myelitis [18,19], chronic inflammatory demyelinating" exact="polyneuropathy" post="[21], and Guillain-Barre syndrome [19,22,23] (Figure 1B). Episodes of"/>
   <result pre="northeast of Brazil, epidemiological studies showed that higher incidence of" exact="microcephaly" post="was observed in districts with lower developmental index, higher"/>
   <result pre="potential of sofosbuvir (SFB), an antiviral prodrug clinically used against" exact="hepatitis" post="C virus (HCV), to inhibit ZIKV replication [100,101]. Later,"/>
   <result pre="American ZIKV strains in different in vitro models: placental and" exact="neuroblastoma" post="cell lines, human fetal-derived neuronal stem cells, induced-pluripotent neural"/>
   <result pre="cause excitotoxicity in the brain and contribute to further aggravate" exact="neurodegeneration" post="[94]. Based on such assumption, Costa and colleagues showed"/>
   <result pre="development (Balasubramanian, 2017). AQ has been used for treatment of" exact="malaria" post="in pediatric settings, but serious adverse effects were shown"/>
   <result pre="function of viral RNA polymerase of several viruses such as" exact="measles" post="and rabies [131]. One specific adenosine analog, NITD008, has"/>
   <result pre="viral RNA polymerase of several viruses such as measles and" exact="rabies" post="[131]. One specific adenosine analog, NITD008, has been proven"/>
   <result pre="action is BCX4430 (Galidesivir), which showed strong antiviral activity against" exact="yellow fever" post="and several others viruses in previous studies, and was"/>
   <result pre="(RIB) is a nucleoside analogue used for the treatment of" exact="hepatitis" post="C. In an early report, RIB was able to"/>
   <result pre="of Zika virus from amniotic fl uid of fetuses with" exact="microcephaly" post="in Brazil: A case studyLancet Infect Dis20161665366010.1016/S1473-3099(16)00095-526897108 36.YuanL.HuangX.-Y.LiuZ.-Y.ZhangF.ZhuX.-L.YuJ.-Y.JiX.XuY.-P.LiG.LiC.et al.A"/>
   <result pre="distributed among human populations?PLoS Biol.201816e200659210.1371/journal.pbio.200659230142150 75.de OliveiraW.K.de FranÃ§aG.V.A.CarmoE.H.DuncanB.B.de Souza KuchenbeckerR.SchmidtM.I.Infection-related" exact="microcephaly" post="after the 2015 and 2016 Zika virus outbreaks in"/>
   <result pre="Prevents Neuronal Death Induced by Zika Virus InfectionMBio20178e00350-1710.1128/mBio.00350-1728442607 95.CairnsD.M.BoorguD.S.S.K.LevinM.KaplanD.L.Niclosamide rescues" exact="microcephaly" post="in a humanized in vitro model of Zika infection"/>
   <result pre="agent, demonstrates antitumor activity by blocking multiple signaling pathways of" exact="cancer" post="stem cellsChin. J. Cancer20123117818410.5732/cjc.011.1029022237038 126.collab: BayerYomesan (Package Insert)BayerLeverkusen, Germany1988"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631456\results\search\disease\results.xml">
   <result pre="4232 doi: 10.1186/s12879-019-4232-8 : Research Article An outbreak of epidemic" exact="keratoconjunctivitis" post="caused by human adenovirus type 8 in primary school,"/>
   <result pre="article, unless otherwise stated. Abstract Background Two outbreaks of epidemic" exact="keratoconjunctivitis" post="(EKC) occurred successively with an interval of 5 days"/>
   <result pre="was constructed by MEGA 7.0. Results A total of 331" exact="acute conjunctivitis" post="cases, including probable cases of EKC, were reported in"/>
   <result pre="constructed by MEGA 7.0. Results A total of 331 acute" exact="conjunctivitis" post="cases, including probable cases of EKC, were reported in"/>
   <result pre="China; therefore, it is necessary to monitor the pathogens causing" exact="acute conjunctivitis" post="in this area. Keywords Human adenovirus 8 Epidemic Keratoconjunctivitis"/>
   <result pre="therefore, it is necessary to monitor the pathogens causing acute" exact="conjunctivitis" post="in this area. Keywords Human adenovirus 8 Epidemic Keratoconjunctivitis"/>
   <result pre="of Yunnan Province Disease Control and Prevention2017ZX10104001-005-002XuWen Background Acute infectious" exact="conjunctivitis" post="is a very common disease that is usually caused"/>
   <result pre="bacteria; it has high incidence rates. Outbreaks of acute infectious" exact="conjunctivitis" post="can occur in schools, military camps and hospitals where"/>
   <result pre="economic and social burdens [1, 2]. In recent years, viral" exact="conjunctivitis" post="has been the most common form, followed by bacterial"/>
   <result pre="viral conjunctivitis has been the most common form, followed by" exact="bacterial conjunctivitis" post="[3, 4]; adenoviruses are one of the main causes"/>
   <result pre="conjunctivitis has been the most common form, followed by bacterial" exact="conjunctivitis" post="[3, 4]; adenoviruses are one of the main causes"/>
   <result pre="42, 48, 53, 54, 56, and 64 are associated with" exact="acute conjunctivitis." post="Of these, HAdV-8, âˆ’â€‰19 andâ€‰âˆ’â€‰37 cause a severe form"/>
   <result pre="these, HAdV-8, âˆ’â€‰19 andâ€‰âˆ’â€‰37 cause a severe form of epidemic" exact="keratoconjunctivitis" post="(EKC) [5, 7â€&quot;9, 13â€&quot;17]. In addition, EKC [18â€&quot;20] is"/>
   <result pre="manifestations of the patients, and the risk factors associated with" exact="acute conjunctivitis" post="transmission within the schools; and provided infection control recommendations."/>
   <result pre="of the patients, and the risk factors associated with acute" exact="conjunctivitis" post="transmission within the schools; and provided infection control recommendations."/>
   <result pre="Autonomous Prefecture. Outbreak information In May 2018, two outbreaks of" exact="acute conjunctivitis" post="occurred in Weixi County Ethnic Primary School and Yongchun"/>
   <result pre="Prefecture. Outbreak information In May 2018, two outbreaks of acute" exact="conjunctivitis" post="occurred in Weixi County Ethnic Primary School and Yongchun"/>
   <result pre="previous studies. These variables included the number of individuals with" exact="acute conjunctivitis" post="in their family, in the same class and in"/>
   <result pre="studies. These variables included the number of individuals with acute" exact="conjunctivitis" post="in their family, in the same class and in"/>
   <result pre="45â€‰days, respectively. A total of 331 cases of acute haemorrhagic" exact="conjunctivitis" post="(AHC) were reported; 171 cases (attack rate 30.59%, 171/559,"/>
   <result pre="and 78 cases were interviewed. Logistic regression analysis showed that" exact="acute conjunctivitis" post="occurrence within the family; contact with a patientâ€™s eyes"/>
   <result pre="78 cases were interviewed. Logistic regression analysis showed that acute" exact="conjunctivitis" post="occurrence within the family; contact with a patientâ€™s eyes"/>
   <result pre="an incubation period (IP) approximately 6â€‰days; these characteristics fit HAdV" exact="conjunctivitis" post="very well. The pathogen causing the outbreaks was determined"/>
   <result pre="have occurred or been reported. Previous studies have shown that" exact="acute conjunctivitis" post="is most common in summer [4]. The clinical manifestations,"/>
   <result pre="occurred or been reported. Previous studies have shown that acute" exact="conjunctivitis" post="is most common in summer [4]. The clinical manifestations,"/>
   <result pre="39â€&quot;41]. Conjunctival hyperaemia and increased secretion are common features of" exact="acute conjunctivitis," post="while watery secretions are more characteristic of viral conjunctivitis"/>
   <result pre="acute conjunctivitis, while watery secretions are more characteristic of viral" exact="conjunctivitis" post="[4]. These characteristics are of great significance for laboratory"/>
   <result pre="of an outbreak. In China, AHC is the only notifiable" exact="acute conjunctivitis" post="disease. Due to the lack of an aetiological diagnosis,"/>
   <result pre="an outbreak. In China, AHC is the only notifiable acute" exact="conjunctivitis" post="disease. Due to the lack of an aetiological diagnosis,"/>
   <result pre="lack of an aetiological diagnosis, clinically suspected cases of viral" exact="conjunctivitis" post="are more likely to be reported as clinically diagnosed"/>
   <result pre="surveillance is necessary in areas with a high incidence of" exact="acute conjunctivitis." post="Abbreviations CDC Center for Disease Control and Prevention EKC"/>
   <result pre="Abbreviations CDC Center for Disease Control and Prevention EKC Epidemic" exact="keratoconjunctivitis" post="HAdV Human adenoviruses HAdv-8 Human adenovirus type 8 NGS"/>
   <result pre="assistance with the collection and transportation of conjunctival swabs from" exact="acute conjunctivitis" post="patients and for clinically diagnosing the patients. Authorsâ€™ contributions"/>
   <result pre="with the collection and transportation of conjunctival swabs from acute" exact="conjunctivitis" post="patients and for clinically diagnosing the patients. Authorsâ€™ contributions"/>
   <result pre="References 1.SmithAFWaycasterCEstimate of the direct and indirect annual cost of" exact="bacterial conjunctivitis" post="in the United StatesBMC Ophthalmol200991310.1186/1471-2415-9-1319939250 2.FilleulLPagesFWanGCBrottetEVilainPCosts of conjunctivitis outbreak,"/>
   <result pre="1.SmithAFWaycasterCEstimate of the direct and indirect annual cost of bacterial" exact="conjunctivitis" post="in the United StatesBMC Ophthalmol200991310.1186/1471-2415-9-1319939250 2.FilleulLPagesFWanGCBrottetEVilainPCosts of conjunctivitis outbreak,"/>
   <result pre="of bacterial conjunctivitis in the United StatesBMC Ophthalmol200991310.1186/1471-2415-9-1319939250 2.FilleulLPagesFWanGCBrottetEVilainPCosts of" exact="conjunctivitis" post="outbreak, Reunion Island, FranceEmerg Infect Dis201824116817010.3201/eid2401.17091629260662 3.FarokhfarAAhmadzadehAAHeidariGMASheikhrezaeeMCommon causes of"/>
   <result pre="4.AzariAABarneyNPConjunctivitis: a systematic review of diagnosis and treatmentJAMA2013310161721172910.1001/jama.2013.28031824150468 5.LiJLuXJiangBDuYYangYQianHLiuBLinCJiaLChenLet al.Adenovirus-associated" exact="acute conjunctivitis" post="in Beijing, China, 2011-2013BMC Infect Dis201818113510.1186/s12879-018-3014-z29558885 6.BalasopoulouAKappaokkinosPPagoulatosDPlotasPMakriOEGeorgakopoulosCDVantarakisAAlpha molecular epidemiological"/>
   <result pre="a systematic review of diagnosis and treatmentJAMA2013310161721172910.1001/jama.2013.28031824150468 5.LiJLuXJiangBDuYYangYQianHLiuBLinCJiaLChenLet al.Adenovirus-associated acute" exact="conjunctivitis" post="in Beijing, China, 2011-2013BMC Infect Dis201818113510.1186/s12879-018-3014-z29558885 6.BalasopoulouAKappaokkinosPPagoulatosDPlotasPMakriOEGeorgakopoulosCDVantarakisAAlpha molecular epidemiological"/>
   <result pre="Infect Dis201818113510.1186/s12879-018-3014-z29558885 6.BalasopoulouAKappaokkinosPPagoulatosDPlotasPMakriOEGeorgakopoulosCDVantarakisAAlpha molecular epidemiological analysis of adenoviruses from excess" exact="conjunctivitis" post="casesBMC Ophthalmol20171715110.1186/s12886-017-0447-x28438142 7.GhebremedhinBHuman adenovirus: viral pathogen with increasing importanceEur"/>
   <result pre="analysis of a novel intertypic recombinant human adenovirus causing epidemic" exact="keratoconjunctivitis" post="in JapanJ Clin Microbiol201149248449010.1128/JCM.01044-1021147954 9.TabbaraKFOmarNHammoudaEAkanumaMOhguchiTArigaTTagawaYKitaichiNIshidaSAokiKet al.Molecular epidemiology of adenoviral"/>
   <result pre="keratoconjunctivitis in JapanJ Clin Microbiol201149248449010.1128/JCM.01044-1021147954 9.TabbaraKFOmarNHammoudaEAkanumaMOhguchiTArigaTTagawaYKitaichiNIshidaSAokiKet al.Molecular epidemiology of adenoviral" exact="keratoconjunctivitis" post="in Saudi ArabiaMol Vis2010162132213621139691 10.PintoRDLiraRPArietaCECastroRSBononSHThe prevalence of adenoviral conjunctivitis"/>
   <result pre="adenoviral keratoconjunctivitis in Saudi ArabiaMol Vis2010162132213621139691 10.PintoRDLiraRPArietaCECastroRSBononSHThe prevalence of adenoviral" exact="conjunctivitis" post="at the clinical Hospital of the State University of"/>
   <result pre="University of Campinas, BrazilClinics (Sao Paulo)2015701174875010.6061/clinics/2015(11)0626602522 11.MaranhaoAGSoaresCCAlbuquerqueMCSantosNMolecular epidemiology of adenovirus" exact="conjunctivitis" post="in Rio de Janeiro, Brazil, between 2004 and 2007Rev"/>
   <result pre="for prevention and treatmentDtsch Arztebl Int20111082747548021814523 15.HuangGYaoWYuWMaoLSunHYaoWTianJWangLBoZZhuZet al.Outbreak of epidemic" exact="keratoconjunctivitis" post="caused by human adenovirus type 56, China, 2012PLoS One2014910e11078110.1371/journal.pone.011078125343525"/>
   <result pre="adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of" exact="keratoconjunctivitis" post="occurred in Pune, Maharashtra, Western IndiaJ Med Virol201688122100210510.1002/jmv.2456527152842 17.RobinsonCMShariatiFZaitshikJGillaspyAFDyerDWChodoshJHuman"/>
   <result pre="17.RobinsonCMShariatiFZaitshikJGillaspyAFDyerDWChodoshJHuman adenovirus type 19: genomic and bioinformatics analysis of a" exact="keratoconjunctivitis" post="isolateVirus Res2009139112212610.1016/j.virusres.2008.10.00119000724 18.UemuraTMigitaHUenoTTsukahara-KawamuraTSaekiYFujimotoTUchioEClinical and virological analysis of epidemic keratoconjunctivitis"/>
   <result pre="a keratoconjunctivitis isolateVirus Res2009139112212610.1016/j.virusres.2008.10.00119000724 18.UemuraTMigitaHUenoTTsukahara-KawamuraTSaekiYFujimotoTUchioEClinical and virological analysis of epidemic" exact="keratoconjunctivitis" post="caused by adenovirus type 54 in a regional ophthalmic"/>
   <result pre="acute hemorrhagic conjunctivitisMed Mal Infect201040421221810.1016/j.medmal.2009.09.00619836177 20.ZhangLZhaoNHuangXJinXGengXChanTCLiuSMolecular epidemiology of acute hemorrhagic" exact="conjunctivitis" post="caused by coxsackie a type 24 variant in China,"/>
   <result pre="a type 24 variant in China, 2004-2014Sci Rep201774520210.1038/srep4520228332617 21.MaitreyiRSDarLMuthukumarAVajpayeeMXessIVajpayeeRBSethPBroorSAcute hemorrhagic" exact="conjunctivitis" post="due to enterovirus 70 in IndiaEmerg Infect Dis19995226726910.3201/eid0502.99021210221880 22.ShulmanLMManorYAzarRHandsherRVonsoverAMendelsonERothmanSHassinDHalmutTAbramovitzBet"/>
   <result pre="outbreak of hemorrhagic conjunctivitisJ Clin Microbiol1997358214521499230400 23.LeiZZhuZWangBMeiHLiHGaDJieGChiMZhangSMaCet al.Outbreaks of epidemic" exact="keratoconjunctivitis" post="caused by human adenovirus type 8 in the Tibet"/>
   <result pre="of China in 2016PLoS One2017129e18504810.1371/journal.pone.0185048 24.BurrSESillahAJoofHBaileyRLHollandMJAn outbreak of acute haemorrhagic" exact="conjunctivitis" post="associated with coxsackievirus A24 variant in the Gambia, West"/>
   <result pre="identified based on phylogenetic analysis during an outbreak of acute" exact="keratoconjunctivitis" post="in ChennaiIndian J Med Res2012136226026422960893 27.ReillySDhillonBJNkanzaKMD'SouzaAMTaylorNHobbsSJFrekeARoomeAPAdenovirus type 8 keratoconjunctivitis--an"/>
   <result pre="(Lond)198696355757510.1017/S00221724000663653016080 28.GreggMBField epidemiology19964459 29.YeZWRuanFZhangXBXiaoSJInvestigation of an outbreak of acute hemorrhagic" exact="conjunctivitis" post="and analysis of risk factors in primary schoolPract Prev"/>
   <result pre="factors in primary schoolPract Prev Med2013201214671468 30.ZhuZZhangYXuSYuPTianXWangLLiuZTangLMaoNJiYet al.Outbreak of acute" exact="respiratory disease" post="in China caused by B2 species of adenovirus type"/>
   <result pre="of adenovirus type 11J Clin Microbiol200947369770310.1128/JCM.01769-0819109466 31.RichmondSBurmanRCrosdaleECropperLLongsonDEnochBEDoddCLA large outbreak of" exact="keratoconjunctivitis" post="due to adenovirus type 8J Hyg (Lond)198493228529110.1017/S00221724000648106094666 32.VineyKAKehoePJDoyleBSheppeardVRoberts-WitteveenARSemirliHMcPhieKADwyerDEMcAnultyJMAn outbreak"/>
   <result pre="to adenovirus type 8J Hyg (Lond)198493228529110.1017/S00221724000648106094666 32.VineyKAKehoePJDoyleBSheppeardVRoberts-WitteveenARSemirliHMcPhieKADwyerDEMcAnultyJMAn outbreak of epidemic" exact="keratoconjunctivitis" post="in a regional ophthalmology clinic in New South WalesEpidemiol"/>
   <result pre="ophthalmology clinic in New South WalesEpidemiol Infect200813691197120610.1017/S095026880700984318047749 33.MelendezCPFlorentinoMMMartinezILLopezHMOutbreak of epidemic" exact="keratoconjunctivitis" post="caused by adenovirus in medical residentsMol Vis20091555756219365589 34.DoyleTJKingDCobbJMillerDJohnsonBAn outbreak"/>
   <result pre="by adenovirus in medical residentsMol Vis20091555756219365589 34.DoyleTJKingDCobbJMillerDJohnsonBAn outbreak of epidemic" exact="keratoconjunctivitis" post="at an outpatient ophthalmology clinicInfect Dis Rep201022e1710.4081/idr.2010.e1724470897 35.AkiyoshiKSugaTFukuiKTaniguchiKOkabeNFujimotoTOutbreak of"/>
   <result pre="at an outpatient ophthalmology clinicInfect Dis Rep201022e1710.4081/idr.2010.e1724470897 35.AkiyoshiKSugaTFukuiKTaniguchiKOkabeNFujimotoTOutbreak of epidemic" exact="keratoconjunctivitis" post="caused by adenovirus type 54 in a nursery school"/>
   <result pre="Kobe City, Japan in 2008Jpn J Infect Dis201164435335521788718 36.KingDJohnsonBMillerDLandonEMDevriesAFullerSAdenovirus-associated epidemic" exact="keratoconjunctivitis" post="outbreaks--four states, 2008-2010MMWR Morb Mortal Wkly Rep2013623263764123945769 37.LeeYCChenNHuangITYangHHHuangCTChenLKSheuMMHuman adenovirus"/>
   <result pre="2008-2010MMWR Morb Mortal Wkly Rep2013623263764123945769 37.LeeYCChenNHuangITYangHHHuangCTChenLKSheuMMHuman adenovirus type 8 epidemic" exact="keratoconjunctivitis" post="with large corneal epithelial full-layer detachment: an endemic outbreak"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631769\results\search\disease\results.xml">
   <result pre="caused by human-to-human or animal-to-human transmissible viral pathogens. Annually, seasonal" exact="influenza" post="epidemics attack human populations leading to 290â€&quot;650 thousand deaths/year"/>
   <result pre="fusion protein of the H1-type haemagglutinin (HA) of the pandemic" exact="influenza" post="A virus (H1N1) strain from 2009 (H1N1pdm09) and the"/>
   <result pre="reliable approach to protect against two different viral infections. OMVs" exact="influenza" post="vaccine MERS-CoV H1N1pdm 1. Introduction Acute respiratory infections are"/>
   <result pre="millions of human deaths worldwide each year [3]. Annually, seasonal" exact="influenza" post="epidemics attack 10â€&quot;20% of the human population leading to"/>
   <result pre="world is confronted every 10â€&quot;40 years with antigenically distinct pandemic" exact="influenza" post="virus strains of wide geographical distribution and considerable human-to-human"/>
   <result pre="recent years, the world has been challenged with newly emerging" exact="influenza" post="A virus (IAV) infections, which have the potential to"/>
   <result pre="the human population within limited epidemics. For instance, highly pathogenic" exact="avian influenza" post="viruses (HPAIV) of the H5N1-subtype and low pathogenic avian"/>
   <result pre="human population within limited epidemics. For instance, highly pathogenic avian" exact="influenza" post="viruses (HPAIV) of the H5N1-subtype and low pathogenic avian"/>
   <result pre="avian influenza viruses (HPAIV) of the H5N1-subtype and low pathogenic" exact="avian influenza" post="viruses (LPAIV) of the H7N9-, H10N8- and H6N1-subtypes [6,7,8,9]"/>
   <result pre="influenza viruses (HPAIV) of the H5N1-subtype and low pathogenic avian" exact="influenza" post="viruses (LPAIV) of the H7N9-, H10N8- and H6N1-subtypes [6,7,8,9]"/>
   <result pre="caused global pandemic outbreaks, such as the 2009 swine-origin H1N1" exact="influenza" post="virus (H1N1pdm09) [10,11]. In 2012, a novel Middle East"/>
   <result pre="viral HA1 protein was achieved using rabbit monoclonal antibodies recognizing" exact="influenza" post="A virus hemagglutinin (Abcam), diluted 1:1000 in blocking buffer."/>
   <result pre="weight (2 Î¼g/g). An infectious dose of 105.5 TCID50 of" exact="influenza" post="virus A/California/04/2009 (H1N1) wild type, was administered intra-nasally to"/>
   <result pre="were performed according to Egyptian regulations for the propagation of" exact="influenza" post="viruses. All experiments involving low pathogenic and highly pathogenic"/>
   <result pre="influenza viruses. All experiments involving low pathogenic and highly pathogenic" exact="avian influenza" post="A viruses were performed in biosafety level 2 and"/>
   <result pre="viruses. All experiments involving low pathogenic and highly pathogenic avian" exact="influenza" post="A viruses were performed in biosafety level 2 and"/>
   <result pre="humoral and cellular neutralizing antibody (nAb) immune responses [26,27,28,29,30,31]. Traditionally," exact="influenza" post="vaccines are produced by generating a natural or recombinant"/>
   <result pre="address additional vaccines needed to combat seasonal H1N1, H3N2 and" exact="influenza" post="B viruses. OMVs had been introduced as a part"/>
   <result pre="responses in animal models from diverse microorganisms such as N." exact="meningitis" post="B, Vibrio cholera, Salmonella Typhimurium, Pseudomonas aeruginosa, Gallibacterium anatis,"/>
   <result pre="Gallibacterium anatis, Acinetobacter baumannii, Chlamydia trachomatis, Shigella spp., and Mycobacterium" exact="tuberculosis" post="[35,36,37,38,39,40,41]. LPS in the outer surface of OMVs acts"/>
   <result pre="the immunogenicity and produce antiviral innate immune responses against various" exact="influenza" post="virus infections via activation of macrophages [42,43,44]. Despite that"/>
   <result pre="OMVs-H1/RBD produced high levels of a neutralizing Abs titer against" exact="influenza" post="H1N1 virus at 8 weeks post immunization. Stimulated neutralizing"/>
   <result pre="stable chimeric fusion protein of H1-type HA of the pandemic" exact="influenza" post="A virus (H1N1) strain and RBD of MERS-CoV induces"/>
   <result pre="flu infects humans for the first timeBMJ2013346f215110.1136/bmj.f215123558347 7.BahgatM.M.KutkatM.A.NasraaM.H.MostafaA.WebbyR.BahgatI.M.AliM.A.Characterization of an" exact="avian influenza" post="virus H5N1 Egyptian isolateJ. Virol. Methods.200915924425010.1016/j.jviromet.2009.04.00819406157 8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and"/>
   <result pre="infects humans for the first timeBMJ2013346f215110.1136/bmj.f215123558347 7.BahgatM.M.KutkatM.A.NasraaM.H.MostafaA.WebbyR.BahgatI.M.AliM.A.Characterization of an avian" exact="influenza" post="virus H5N1 Egyptian isolateJ. Virol. Methods.200915924425010.1016/j.jviromet.2009.04.00819406157 8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and"/>
   <result pre="8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and epidemiological characteristics of a fatal case of" exact="avian influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and"/>
   <result pre="al.Clinical and epidemiological characteristics of a fatal case of avian" exact="influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and"/>
   <result pre="descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and molecular characterization of the human-infecting H6N1" exact="influenza" post="virus in TaiwanProtein Cell2013484685310.1007/s13238-013-3083-024136722 10.LesslerJ.ReichN.G.CummingsD.A.NairH.P.JordanH.T.ThompsonN.Outbreak of 2009 pandemic influenza"/>
   <result pre="H6N1 influenza virus in TaiwanProtein Cell2013484685310.1007/s13238-013-3083-024136722 10.LesslerJ.ReichN.G.CummingsD.A.NairH.P.JordanH.T.ThompsonN.Outbreak of 2009 pandemic" exact="influenza" post="A (H1N1) at a New York City schoolN. Engl."/>
   <result pre="Engl. J. Med.20093612628263610.1056/NEJMoa090608920042754 11.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature200945993193910.1038/nature0815719525932 12.Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Available online: https://www.who.int/emergencies/mers-cov/en/(accessed"/>
   <result pre="ThreatViruses2018109310.3390/v10020093 14.MostafaA.PleschkaS.Influenza H3N2 Vaccines: Recent ChallengesTrends Microbiol.201710.1016/j.tim.2017.12.00329268980 15.ZostS.J.ParkhouseK.GuminaM.E.KimK.Diaz PerezS.WilsonP.C.TreanorJ.J.SantA.J.CobeyS.HensleyS.E.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="16.WuN.C.ZostS.J.ThompsonA.J.OyenD.NycholatC.M.McBrideR.PaulsonJ.C.HensleyS.E.WilsonI.A.A structural explanation for the low effectiveness of the seasonal" exact="influenza" post="H3N2 vaccinePLoS Pathogens201713e100668210.1371/journal.ppat.100668229059230 17.GerritzenM.J.H.MartensD.E.WijffelsR.H.van der PolL.StorkM.Bioengineering bacterial outer membrane"/>
   <result pre="lumenJ. Extracell Vesicles2014310.3402/jev.v3.24015 21.MostafaA.KanraiP.ZiebuhrJ.PleschkaS.Improved dual promotor-driven reverse genetics system for" exact="influenza" post="virusesJ. Virol. Methods201319360361010.1016/j.jviromet.2013.07.02123886561 22.BommakantiG.CitronM.P.HeplerR.W.CallahanC.HeideckerG.J.NajarT.A.LuX.JoyceJ.G.ShiverJ.W.CasimiroD.R.et al.Design of an HA2-based Escherichia"/>
   <result pre="Virol. Methods201319360361010.1016/j.jviromet.2013.07.02123886561 22.BommakantiG.CitronM.P.HeplerR.W.CallahanC.HeideckerG.J.NajarT.A.LuX.JoyceJ.G.ShiverJ.W.CasimiroD.R.et al.Design of an HA2-based Escherichia coli expressed" exact="influenza" post="immunogen that protects mice from pathogenic challengeProc. Natl. Acad."/>
   <result pre="coronavirus: A comprehensive reviewFront. Med.20161012013610.1007/s11684-016-0430-626791756 32.MostafaA.KanraiP.ZiebuhrJ.PleschkaS.The PB1 segment of an" exact="influenza" post="A virus H1N1 2009pdm isolate enhances the replication efficiency"/>
   <result pre="virus H1N1 2009pdm isolate enhances the replication efficiency of specific" exact="influenza" post="vaccine strains in cell culture and embryonated eggsJ. Gen."/>
   <result pre="the conserved hemagglutinin stalk domain and its prospects for universal" exact="influenza" post="vaccine developmentBiomed. Res. Int.201410.1155/2014/546274 34.LynchM.Evolution of the mutation rateTrends"/>
   <result pre="using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria" exact="meningitis" post="BImmunobiology201810.1016/j.imbio.2018.07.02130055864 40.PerssonG.PorsS.E.ThofnerI.C.N.BojesenA.M.Vaccination with outer membrane vesicles and the fimbrial"/>
   <result pre="Immunology20189250110.3389/fimmu.2018.0250130459769 50.RappazzoC.G.WatkinsH.C.GuarinoC.M.ChauA.LopezJ.L.DeLisaM.P.LeiferC.A.WhittakerG.R.PutnamD.Recombinant m2e outer membrane vesicle vaccines protect against lethal" exact="influenza" post="a challenge in balb/c miceVaccine2016341252125810.1016/j.vaccine.2016.01.02826827663 51.WatkinsH.C.RappazzoC.G.HigginsJ.S.SunX.BrockN.ChauA.MisraA.CannizzoJ.P.B.KingM.R.MainesT.R.et al.Safe Recombinant Outer"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6632129\results\search\disease\results.xml">
   <result pre="1392 confirmed cases [3] (https://dass.gouv.nc/votre-sante/documents-rapports-etudes) (Figure 1B). Despite repeated introductions," exact="chikungunya" post="virus (CHIKV) has not caused major outbreaks in NC,"/>
   <result pre="no conflict of interest. References References 1.RothA.MercierA.LepersC.Concurrent outbreaks of dengue," exact="chikungunya" post="and zika virus infectionsâ€&quot;An unprecedented epidemic wave of mosquito-borne"/>
   <result pre="vectorsPLoS Negl. Trop. Dis.201812e000663710.1371/journal.pntd.000663730016372 8.TeurlaiM.MenkesC.E.CavareroV.Socio-economic and climate factors associated with" exact="dengue fever" post="spatial heterogeneity: A worked example in New CaledoniaPLoS Negl."/>
   <result pre="1000 inhabitants per month are indicated for dengue, Zika and" exact="chikungunya" post="(http://www.institutpasteur.nc/wp-content/uploads/2016/12/)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6635310\results\search\disease\results.xml">
   <result pre="viral diseases specially water born infections, such as diarrheal diseases," exact="hepatitis" post="A and E, air-borne infections and vector borne diseases"/>
   <result pre="and E, air-borne infections and vector borne diseases such as" exact="yellow fever," post="west Nile fever (WNF) and dengue fever (5, 6)."/>
   <result pre="diseases such as yellow fever, west Nile fever (WNF) and" exact="dengue fever" post="(5, 6). This review explains the viral infections during"/>
   <result pre="and history of virusesâ€™ circulation. In early spring in Iran," exact="influenza" post="viruses and respiratory syncytial virus circulations were reported in"/>
   <result pre="sewage systems, poor hygiene, overcrowding and unhealthy drinking water, viral" exact="gastroenteritis" post="may occur. After hurricane Katrina, outbreaks of norovirus gastroenteritis"/>
   <result pre="viral gastroenteritis may occur. After hurricane Katrina, outbreaks of norovirus" exact="gastroenteritis" post="were reported (12). There was an outbreak of norovirus"/>
   <result pre="water or food, is the main route for transmission of" exact="hepatitis" post="A and E, as reported in India and Sudan"/>
   <result pre="(16, 17). Shears et al. reported the increased number of" exact="hepatitis" post="A infections after Khartoum floods in 1988 (18). In"/>
   <result pre="Khartoum floods in 1988 (18). In Italy the number of" exact="hepatitis" post="A cases was increased in Liguria, Piemonte and Lombardia"/>
   <result pre="with non-affected counties (20). There was not any report of" exact="gastrointestinal disease" post="outbreak after different floods in Iran, but in general"/>
   <result pre="after different floods in Iran, but in general outbreaks of" exact="hepatitis" post="A and E and enteroviruses might happen in areas"/>
   <result pre="Mosquito borne diseases. After flooding, mosquito borne diseases for example" exact="dengue fever," post="especially in endemic areas, can increase. Standing water after"/>
   <result pre="In the flooding in northern Peru in 2017, outbreaks of" exact="chikungunya" post="and dengue fever with more than 19000 suspected cases"/>
   <result pre="flooding in northern Peru in 2017, outbreaks of chikungunya and" exact="dengue fever" post="with more than 19000 suspected cases of dengue fever"/>
   <result pre="and dengue fever with more than 19000 suspected cases of" exact="dengue fever" post="were reported (21). Outbreaks of WNF after flooding occurred"/>
   <result pre="flood in Punjab/Pakistan in 2010, 21204 people were reported with" exact="dengue fever" post="(23, 24). Again in 2011â€&quot;2013 dengue infections were reported"/>
   <result pre="in Karachi, 700, 858, 630 and 2700 deaths related to" exact="dengue fever" post="were identified in 2010, 2011, 2012 and 2013 respectively"/>
   <result pre="Iran (37). The species A. albopictus is well-known for transmitting" exact="chikungunya" post="and dengue viruses. In another research, Aedes unilineatus was"/>
   <result pre="[Online] Available from: http://www.who.int/hac/crises/pak/sitreps/16august2010/en/index.html 9.JavidNMoradiATabarraeiABazouriMasoudClinical and epidemiological profile of pandemic" exact="influenza" post="a H1N1, H3N2, and type B in the southeast"/>
   <result pre="Iran. Arch Pediatr Infect Dis2013; 1:118â€&quot;121. 11.HajikhezriZMakvndiMSamarbaf-zadehARNeisiNAhmadiK.Relative frequency of seasonal" exact="influenza" post="A and B in Khuzestan province by reverse transcription-polymerase"/>
   <result pre="1998, and 2004. Am J Trop Med Hyg2006; 74:1067â€&quot;1073.16760521 16.McCarthyMCHeJHyamsKCel-TiganiAKhalidIOCarlM.Acute" exact="hepatitis" post="E infection during the 1988 floods in Khartoum, Sudan."/>
   <result pre="Trans R Soc Trop Med Hyg1994; 88:177.8036664 17.PalSJuyalDSharmaMKotianSNegiVSharmaN.An outbreak of" exact="hepatitis" post="A virus among children in a flood rescue camp:"/>
   <result pre="35:677â€&quot;680.16248864 33.SharififardMAlaviSMSalmanzadehSSafdariFKamaliA.Epidemiological survey of crimean-Congo Hemorrhagic fever (CCHF), a fatal" exact="infectious disease" post="in Khuzestan province, southwest Iran, during 1999â€&quot;2015. Jundishapur J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6641468\results\search\disease\results.xml">
   <result pre=": Mathematics : Statistics : Statistical Methods: Forecasting Seasonality of" exact="influenza" post="and its association with meteorological parameters in two cities"/>
   <result pre="two cities of Pakistan: A time series analysis Association of" exact="influenza" post="seasonality with meteorological parameters http://orcid.org/0000-0002-4107-6154NisarNadiaConceptualizationData curationFormal analysisInvestigationMethodologySoftwareValidationVisualizationWriting â€&quot; original"/>
   <result pre="which are yet to be fully ascertained. Temperate zones show" exact="influenza" post="epidemic during the winter months. The tropical and subtropical"/>
   <result pre="winter months. The tropical and subtropical regions show more diverse" exact="influenza" post="outbreak patterns. This study explores the seasonality of influenza"/>
   <result pre="diverse influenza outbreak patterns. This study explores the seasonality of" exact="influenza" post="activity and predicts influenza peak based on historical surveillance"/>
   <result pre="This study explores the seasonality of influenza activity and predicts" exact="influenza" post="peak based on historical surveillance time series data in"/>
   <result pre="Methods This is a descriptive study of routinely collected monthly" exact="influenza" post="sentinel surveillance data and meteorological data from 2012â€&quot;16 in"/>
   <result pre="(North) and Multan (Central). Results Mean number of cases of" exact="influenza" post="and levels of precipitation were higher in Islamabad compared"/>
   <result pre="levels were similar in both the cities. The number of" exact="influenza" post="cases rose with decrease in precipitation and temperature in"/>
   <result pre="be said about humidity. The relationship between meteorological parameters and" exact="influenza" post="incidence was not pronounced in case of Multan. The"/>
   <result pre="a significant peak during the month of January. Conclusion The" exact="influenza" post="surveillance system gave a better understanding of the disease"/>
   <result pre="better understanding of the disease trend and could accurately forecast" exact="influenza" post="activity in Pakistan. Funding http://dx.doi.org/10.13039/100000030Centers for Disease Control and"/>
   <result pre="paper and Supporting Information files. Introduction Influenza is a communicable" exact="respiratory disease" post="caused by the influenza virus. The disease severity may"/>
   <result pre="Introduction Influenza is a communicable respiratory disease caused by the" exact="influenza" post="virus. The disease severity may range from mild to"/>
   <result pre="illness and 290,000â€&quot;650,000 deaths worldwide in 2017 due to seasonal" exact="influenza" post="epidemics [1]. Influenza is known to have a specific"/>
   <result pre="be fully ascertained [2]. Studies report that temperate zones show" exact="influenza" post="epidemic during the winter months of November-March in northern"/>
   <result pre="hemisphere [3,4]. The tropical and subtropical regions show more diverse" exact="influenza" post="outbreak patterns. Annual epidemics occur in the tropical locations"/>
   <result pre="while biannual incidence is the norm in some regions, and" exact="influenza" post="activity occurs throughout the year in other countries [3]."/>
   <result pre="countries [3]. There is limited understanding about the epidemiology of" exact="influenza" post="and the characteristics of seasonal influenza in the tropical"/>
   <result pre="about the epidemiology of influenza and the characteristics of seasonal" exact="influenza" post="in the tropical region where there is influenza activity"/>
   <result pre="of seasonal influenza in the tropical region where there is" exact="influenza" post="activity all throughout the year.[5,6] A number of theories"/>
   <result pre="this [8]. In tropical and subtropical regions the upsurge of" exact="influenza" post="has been coupled with precipitation (rain). Epidemics also occur"/>
   <result pre="sub-tropical and tropical regions no significant relation between rainfall and" exact="influenza" post="activity has been observed [9]. There are three mediating"/>
   <result pre="There are three mediating mechanisms that might help in explaining" exact="influenza" post="activity and epidemics: 1) Contact rate, 2) Viral survival"/>
   <result pre="is possible that the seasonal factors that govern activity of" exact="influenza" post="virus in temperate zones do not impact influenza virus"/>
   <result pre="activity of influenza virus in temperate zones do not impact" exact="influenza" post="virus very strongly in the tropics. [3] Pakistan is"/>
   <result pre="in the southern region. The country had a robust laboratory-based" exact="influenza" post="sentinel surveillance system in eight sites from 2009â€&quot;2016. This"/>
   <result pre="the relationship between meteorological parameters (humidity, precipitation and temperature) and" exact="influenza" post="activity in two major cities of Pakistan, Islamabad and"/>
   <result pre="pandemic period. We also sought to explore the seasonality of" exact="influenza" post="activity and predict influenza peak based on historical surveillance"/>
   <result pre="sought to explore the seasonality of influenza activity and predict" exact="influenza" post="peak based on historical surveillance time series data. Materials"/>
   <result pre="design This is a descriptive study of routinely collected monthly" exact="influenza" post="sentinel surveillance and meteorological data from 2012â€&quot;16 in two"/>
   <result pre="scanty rainfall. Influenza surveillance system In 2008, a sentinel laboratory-based" exact="influenza" post="surveillance network was established in collaboration with the US-Centers"/>
   <result pre="the first sentinel site under the network [16]. Seven more" exact="influenza" post="surveillance sentinel sites in high load tertiary hospitals across"/>
   <result pre="of onset and requiring hospital admission[17]. Study variables Data on" exact="influenza" post="cases and positivity were obtained from the surveillance database"/>
   <result pre="the surveillance database during 2012â€&quot;16. Surveillance data during the pandemic" exact="influenza" post="seasons (2009â€&quot;2011) were excluded to understand the characteristics of"/>
   <result pre="seasons (2009â€&quot;2011) were excluded to understand the characteristics of seasonal" exact="influenza" post="only. Monthly data on three weather parameters namely temperature,"/>
   <result pre="to present the monthly trend in the number of confirmed" exact="influenza" post="cases and its relationship with other meteorological parameters for"/>
   <result pre="the strength and direction of association between meteorological parameters and" exact="influenza" post="cases and test positivity at monthly intervals. Fitting a"/>
   <result pre="smoothing models to describe autocorrelations in the data and forecast" exact="influenza" post="activity for the next 12 months [18]. Expert modeler"/>
   <result pre="of the meteorological parameters (precipitation, humidity and temperature) and the" exact="influenza" post="activity in Islamabad and Multan. The mean number of"/>
   <result pre="in Islamabad and Multan. The mean number of cases of" exact="influenza" post="and levels of precipitation were much higher in Islamabad"/>
   <result pre="1 Meteorological parameters (humidity, precipitation and temperature) and number of" exact="influenza" post="cases in two cities of Pakistan, 2012â€&quot;16. Characteristics Mean"/>
   <result pre="19 24 50 Fig 1 shows that the number of" exact="influenza" post="cases rose with decrease in precipitation and temperature in"/>
   <result pre="be said about humidity. The relationship between meteorological parameters and" exact="influenza" post="incidence was not pronounced in case of Multan (Fig"/>
   <result pre="of Multan (Fig 2). Fig 1 Precipitation, humidity, temperature and" exact="influenza" post="cases in Islamabad during 2012â€&quot;16. Fig 2 Precipitation, humidity,"/>
   <result pre="in Islamabad during 2012â€&quot;16. Fig 2 Precipitation, humidity, temperature and" exact="influenza" post="cases in Multan during 2012â€&quot;16. Overall, temperature (r ="/>
   <result pre="However, no significant correlation was found between meteorological parameters and" exact="influenza" post="cases in Multan. (Table 2). 10.1371/journal.pone.0219376.t002Table 2 Correlation of"/>
   <result pre="Multan. (Table 2). 10.1371/journal.pone.0219376.t002Table 2 Correlation of meteorological parameters with" exact="influenza" post="test positivity and number of cases of influenza in"/>
   <result pre="parameters with influenza test positivity and number of cases of" exact="influenza" post="in two cities of Pakistan, 2012â€&quot;16. Overall (n ="/>
   <result pre="Fig 3 also shows the relationship between meteorological parameters and" exact="influenza" post="cases in each month. An increase in cases of"/>
   <result pre="influenza cases in each month. An increase in cases of" exact="influenza" post="is seen with a fall in temperature and precipitation."/>
   <result pre="3 Association of precipitation, humidity and temperature with number of" exact="influenza" post="cases in Islamabad and Multan during 2012â€&quot;16. Exponential smoothing"/>
   <result pre="of Multan whereas simple seasonal model fitted well with the" exact="influenza" post="surveillance data for Islamabad. The Ljung-Box (modified Box-Pierce) test"/>
   <result pre="outliers in the data.(Table 3). 10.1371/journal.pone.0219376.t003Table 3 Model statistics for" exact="influenza" post="surveillance data in two cities of Pakistan, 2012â€&quot;16. Model"/>
   <result pre="15 0.960 Winterâ€™s additive Fig 4 shows the trend of" exact="influenza" post="cases during the period 2012â€&quot;16 in Islamabad. It shows"/>
   <result pre="peaks during the months of July-September. Fig 4 Forecasting of" exact="influenza" post="in Islamabad using exponential smoothing model. The blue line"/>
   <result pre="smoothing model. The blue line represents the observed values of" exact="influenza" post="incidence from 2012 to 2016, and the red line"/>
   <result pre="curve of 2017. Fig 5 shows the seasonal trend of" exact="influenza" post="cases during 2012â€&quot;16 in Multan showing regular seasonal peaks"/>
   <result pre="seen in both the sequence charts. Fig 5 Forecasting of" exact="influenza" post="in Multan using exponential smoothing model. The blue line"/>
   <result pre="smoothing model. The blue line represents the observed values of" exact="influenza" post="incidence from 2012 to 2016, and the red line"/>
   <result pre="47%). The socio-demographic and clinical details of patients tested for" exact="influenza" post="are given in Table 4. 10.1371/journal.pone.0219376.t004Table 4 Socio-demographic and"/>
   <result pre="10.1371/journal.pone.0219376.t004Table 4 Socio-demographic and clinical characteristics of patients tested for" exact="influenza" post="in two cities of Pakistan, 2012â€&quot;16. Characteristics Islamabad Multan"/>
   <result pre="Severe Acute Respiratory Illness Of those tested, 1101 cases of" exact="influenza" post="were reported from Islamabad (n = 961) and Multan"/>
   <result pre="was the predominant strain (41.9%, n = 403) followed by" exact="influenza" post="A/H3N2 (273, 28%) in Islamabad. Multan also followed the"/>
   <result pre="and reported highest number of A/H1N1pdm09 (60, 44%) followed by" exact="influenza" post="B (28, 20%) (Table 5). 10.1371/journal.pone.0219376.t005Table 5 Socio-demographic and"/>
   <result pre="(Table 5). 10.1371/journal.pone.0219376.t005Table 5 Socio-demographic and clinical characteristics of confirmed" exact="influenza" post="cases in two cities of Pakistan, 2012â€&quot;16. Characteristics Islamabad"/>
   <result pre="Acute Respiratory Illness Fig 6 shows that the cases of" exact="influenza" post="peaked during the months of December, January and February"/>
   <result pre="and October in 2012. Fig 6 Weekly incidence curve of" exact="influenza" post="in two cities of Pakistan, 2012â€&quot;16. Discussion This study"/>
   <result pre="Discussion This study highlights the relationship between meteorological parameters and" exact="influenza" post="activity in two major cities of Pakistan in the"/>
   <result pre="of Pakistan in the post-2011 pandemic period and also predicts" exact="influenza" post="activity based on historical surveillance time series data. Time"/>
   <result pre="system. This study used the exponential smoothing model to forecast" exact="influenza" post="incidence, contributing to an early warning system that can"/>
   <result pre="public awareness, and tackle the situation effectively. The association between" exact="influenza" post="activity and climatic factors was assessed for 78 geographical"/>
   <result pre="for 78 geographical locations around the globe. At high latitudes," exact="influenza" post="peaks coincided with months of lower temperature and lower"/>
   <result pre="with months of lower temperature and lower humidity.In contrast, peak" exact="influenza" post="activity in localities within 10Â° of the equator correlated"/>
   <result pre="of this study[20â€&quot;23]. The study had some interesting findings. First," exact="influenza" post="activity, in terms of number of cases and test"/>
   <result pre="elsewhere, no significant correlation was found between humidity levels and" exact="influenza" post="activity [26]. However, amulti-site influenza study from India reported"/>
   <result pre="found between humidity levels and influenza activity [26]. However, amulti-site" exact="influenza" post="study from India reported a positive correlation between relative"/>
   <result pre="from India reported a positive correlation between relative humidity and" exact="influenza" post="positive cases by multivariate analysis[27]. Another study from Thailand"/>
   <result pre="Thailand showed that only maximum relative humidity correlated with suspected" exact="influenza" post="cases in the southern region, whereas all parameters including"/>
   <result pre="including maximum, minimum, and average relative humidity correlated with suspected" exact="influenza" post="cases in the central region[28]. Third, the study forecasted"/>
   <result pre="effectively. The study has some significant strong points. First, the" exact="influenza" post="surveillance data were part of a US-CDC supported laboratory"/>
   <result pre="the country with high patient influx. Confirmation of diagnosis of" exact="influenza" post="was done using real time RT-PCR which is the"/>
   <result pre="the gold standard test. Second, five-year historical data (2008â€&quot;17) on" exact="influenza" post="surveillance in two major cities of the country allows"/>
   <result pre="study had some limitations as well. First, the cases of" exact="influenza" post="presented in this study were reported from hospital-based sentinel"/>
   <result pre="time. This might be explained by antigenic drift of the" exact="influenza" post="virus and many unknown factors that affect disease transmission."/>
   <result pre="Third, we could only infer associations, but not causality, between" exact="influenza" post="activity and various meteorological parameters. As a result, the"/>
   <result pre="factors not considered in this study. Conclusion In conclusion, the" exact="influenza" post="surveillance system gave a better understanding of the disease"/>
   <result pre="better understanding of the disease trend and could accurately forecast" exact="influenza" post="activity in Pakistan. Exponential smoothing model was the best"/>
   <result pre="smoothing model was the best fit statistical model for predicting" exact="influenza" post="cases. This information will be useful for public health"/>
   <result pre="in effectively implementing preventive and control measures for the seasonal" exact="influenza" post="outbreaks or epidemics. Supporting information S1 File Climate SPSS"/>
   <result pre="Available: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) 2FoxSJ, MillerJC, MeyersLA. Seasonality in risk of pandemic" exact="influenza" post="emergence. 2017; 10.1371/journal.pcbi.1005749 3LowenAC, SteelJ. Roles of Humidity and"/>
   <result pre="2014;88: 7692â€&quot;7695. 10.1128/JVI.03544-1324789791 4TameriusJ, NelsonMI, ZhouSZ, ViboudC, MillerMA, AlonsoWJ. Global" exact="influenza" post="seasonality: Reconciling patterns across temperate and tropical regions. Environ"/>
   <result pre="439â€&quot;445. 10.1289/ehp.100238321097384 5CainiS, El-Guerche SÃ©blainC, CiblakMA, PagetJ. Epidemiology of seasonal" exact="influenza" post="in the Middle East and North Africa regions, 2010â€&quot;2016:"/>
   <result pre="in the Middle East and North Africa regions, 2010â€&quot;2016: Circulating" exact="influenza" post="A and B viruses and spatial timing of epidemics."/>
   <result pre="et al.Decline in temperature and humidity increases the occurrence of" exact="influenza" post="in cold climate. Environ Heal. BioMed Central; 2014;13: 2210.1186/1476-069X-13-2224678699"/>
   <result pre="KatayamaK, SanoK. Absolute humidity as a deterministic factor affecting seasonal" exact="influenza" post="epidemics in Japan. Tohoku J Exp Med. 2011;224: 251â€&quot;6."/>
   <result pre="251â€&quot;6. Available: http://www.ncbi.nlm.nih.gov/pubmed/2170585021705850 21TameriusJ, NelsonMI, ZhouSZ, ViboudC, MillerMA, AlonsoWJ. Global" exact="influenza" post="seasonality: Reconciling patterns across temperate and tropical regions. Environmental"/>
   <result pre="Shaping Influenza Seasonality. 2014;88: 1410.1128/JVI.03544-1324789791 24ShamanJ, KohnM. Absolute humidity modulates" exact="influenza" post="survival, transmission, and seasonality. 2009;106. 25LowenAC, SteelJ, MubarekaS, PaleseP."/>
   <result pre="27JalgaonkarS V., KantL, ChadhaMS, MishraAC, BroorS, AbrahamAM, et al.Multisite virological" exact="influenza" post="surveillance in India: 2004â€&quot;2008. Influenza Other Respi Viruses. 2011;6:"/>
   <result pre="Limited; 2015;2015: 43649510.1155/2015/43649526664492 29ChanPKS, MokHY, LeeTC, ChuIMT, LamW-Y, SungJJY. Seasonal" exact="influenza" post="activity in Hong Kong and its association with meteorological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6642581\results\search\disease\results.xml">
   <result pre="critical extracellular matrix. Approximately 30â€&quot;40% of hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. These patients who develop"/>
   <result pre="influenza are diagnosed with acute pneumonia. These patients who develop" exact="pneumonia" post="are more likely to be â€‰65â€‰years old, Caucasian, and"/>
   <result pre="old, Caucasian, and nursing home residents; have chronic lung or" exact="heart disease" post="and history of smoking, and are immunocompromised. Influenza can"/>
   <result pre="to bacterial sepsis and ARDS. Viral infections presenting concurrently with" exact="bacterial pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial" exact="pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="(ICU) admission. Influenza A is the predominant viral etiology of" exact="acute respiratory distress syndrome" post="(ARDS) in adults. Risk factors independently associated with ARDS"/>
   <result pre="old, pregnancy, and obesity, while protective factors are female sex," exact="influenza" post="vaccination, and infections with Influenza A (H3N2) or Influenza"/>
   <result pre="B viruses. In the ICU, particularly during the winter season," exact="influenza" post="should be suspected not only in patients with typical"/>
   <result pre="Influenza Epidemiology Pneumonia Sepsis ARDS Complications Background The pathophysiology of" exact="influenza" post="virus infection Human influenza virus infection replicates primarily in"/>
   <result pre="ARDS Complications Background The pathophysiology of influenza virus infection Human" exact="influenza" post="virus infection replicates primarily in the respiratory epithelium. Other"/>
   <result pre="The ferret has traditionally been used as a model of" exact="influenza" post="transmission as most human influenza viruses do not need"/>
   <result pre="used as a model of influenza transmission as most human" exact="influenza" post="viruses do not need any adaptation to infect and"/>
   <result pre="have identified the soft palate as a major source of" exact="influenza" post="viruses that are transmitted between individuals. Notably, the soft"/>
   <result pre="preferred by the hemagglutinin proteins currently found in circulating human" exact="influenza" post="viruses [2]. This enrichment also occurs in the soft"/>
   <result pre="the soft palate of humans [3]. The primary mechanism of" exact="influenza" post="pathophysiology is a result of lung inflammation and compromise"/>
   <result pre="respiratory distress [4]. Some associations have also been observed between" exact="influenza" post="virus infection and cardiac sequelae, including increased risk of"/>
   <result pre="including increased risk of myocardial disease in the weeks following" exact="influenza" post="virus infection. The mechanisms of this, beyond a general"/>
   <result pre="Amplification of inflammation and local and systemic cytokine production How" exact="influenza" post="triggers ARDS Influenza virus infects respiratory epithelial cells that"/>
   <result pre="and allowing viral exposure to endothelial cells. Early interactions between" exact="influenza" post="virus, the alveolar macrophages that are resident in the"/>
   <result pre="damage and improved survival in a mouse model of severe" exact="influenza" post="virus infection and in a model of influenza-pneumococcal coinfection"/>
   <result pre="targeting NLRP3 (a key component of inflammasome signaling) downstream of" exact="influenza" post="has had positive effects on recovery in animal models"/>
   <result pre="NET structures have been observed in humans suffering from severe" exact="influenza" post="disease. In one study of severe H7N9 and H1N1pdm09"/>
   <result pre="promote recovery implicates host metabolism in the etiology of severe" exact="influenza" post="disease, given the central role mTOR plays in nutrient"/>
   <result pre="noted in local and systemic analyses of severe cases of" exact="influenza" post="[25] and metabolic interventions have been shown to alter"/>
   <result pre="context. For example, in mouse models of bacterial sepsis or" exact="influenza" post="virus infection, glucose restriction had opposing effects, protecting against"/>
   <result pre="immunity and potentially increased viral pathogenesis. The mechanisms relating to" exact="obesity" post="to susceptibility are likely complex and multi-factorial, including increased"/>
   <result pre="increased inflammation and decreased wound healing in obese individuals. Additionally," exact="obesity" post="dampens some features of adaptive immunity that may delay"/>
   <result pre="increase susceptibility to initial infection [29â€&quot;31]. Influenza clinical progression to" exact="pneumonia" post="and ARDS Approximately 30â€&quot;40% of the hospitalized patients with"/>
   <result pre="and ARDS Approximately 30â€&quot;40% of the hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. These patients who develop"/>
   <result pre="influenza are diagnosed with acute pneumonia. These patients who develop" exact="pneumonia" post="are more likely to be young ( â€‰65â€‰years old),"/>
   <result pre="old), Caucasian, and nursing home residents; have chronic lung or" exact="heart disease" post="and history of smoking; and are more commonly immunocompromised."/>
   <result pre="develop severe Influenza complications [32â€&quot;35]. Nonetheless, unlike seasonal epidemics of" exact="influenza" post="virus infection that display these classic risk factors, pandemics"/>
   <result pre="2009 H1N1 were associated with a higher rate of hospitalized" exact="respiratory failure" post="in previously healthy and young adults [36, 37]. More"/>
   <result pre="risk factors independently associated with ARDS in patients diagnosed with" exact="influenza" post="are age between 36 and 55â€‰years old, pregnancy, and"/>
   <result pre="obesity, while protective factors associated with ARDS were female sex," exact="influenza" post="vaccination, and infections with Influenza A (H3N2) or Influenza"/>
   <result pre="new risk factor for the development of ARDS during the" exact="influenza" post="season is the performance of cardiac surgery [43]. The"/>
   <result pre="the performance of cardiac surgery [43]. The challenge of diagnosing" exact="pneumonia" post="and ARDS in patients with positive laboratory results for"/>
   <result pre="pneumonia and ARDS in patients with positive laboratory results for" exact="influenza" post="relates to the temporality of the clinical events. Influenza"/>
   <result pre="the clinical events. Influenza virus infection alone can cause severe" exact="pneumonia" post="and ARDS, but it can also act in conjunction"/>
   <result pre="with a bacterial infection (discussed below). It can precede a" exact="pneumonia" post="episode caused by a secondary bacterial infection, most commonly"/>
   <result pre="pneumoniae, or can be followed by an episode of nosocomial" exact="pneumonia" post="[44]. Clinicians commonly fail to clinically diagnose influenza in"/>
   <result pre="of nosocomial pneumonia [44]. Clinicians commonly fail to clinically diagnose" exact="influenza" post="in up to two-thirds of patients whom have confirmed"/>
   <result pre="influenza in up to two-thirds of patients whom have confirmed" exact="influenza" post="virus infection [45]. In the case of severe pneumonia"/>
   <result pre="confirmed influenza virus infection [45]. In the case of severe" exact="pneumonia" post="or ARDS, the only reliable clue that influenza is"/>
   <result pre="of severe pneumonia or ARDS, the only reliable clue that" exact="influenza" post="is a possible causal agent is the presentation during"/>
   <result pre="of the epidemic because the symptomatology alone cannot distinguish severe" exact="influenza" post="from other viral or bacterial respiratory infections. Primary influenza"/>
   <result pre="severe influenza from other viral or bacterial respiratory infections. Primary" exact="influenza" post="pneumonia shows persistence and/or subsequent worsening of respiratory symptoms,"/>
   <result pre="influenza from other viral or bacterial respiratory infections. Primary influenza" exact="pneumonia" post="shows persistence and/or subsequent worsening of respiratory symptoms, while"/>
   <result pre="shows persistence and/or subsequent worsening of respiratory symptoms, while secondary" exact="bacterial pneumonia" post="occurs 1â€&quot;3â€‰weeks as a â€œrelapseâ€� after the initial Influenza"/>
   <result pre="persistence and/or subsequent worsening of respiratory symptoms, while secondary bacterial" exact="pneumonia" post="occurs 1â€&quot;3â€‰weeks as a â€œrelapseâ€� after the initial Influenza"/>
   <result pre="etiology [46]. Influenza presenting as sepsis The immune response to" exact="influenza" post="shares many common pathways with the response to bacteria,"/>
   <result pre="to bacteria, thus it should not be surprising that an" exact="influenza" post="virus infection can have a very similar clinical presentation"/>
   <result pre="receptors for Gram-positive and Gram-negative bacteria, are also related to" exact="influenza" post="pathogenicity [49â€&quot;51]. The inflammatory response also varies according to"/>
   <result pre="to tissue edema and organ failure have been observed with" exact="influenza" post="virus infections [55, 56]. Analogous to the influenza virus"/>
   <result pre="observed with influenza virus infections [55, 56]. Analogous to the" exact="influenza" post="virus predisposition to secondary bacterial pneumonia, influenza virus increases"/>
   <result pre="[55, 56]. Analogous to the influenza virus predisposition to secondary" exact="bacterial pneumonia," post="influenza virus increases by 6-fold the progression to secondary"/>
   <result pre="Analogous to the influenza virus predisposition to secondary bacterial pneumonia," exact="influenza" post="virus increases by 6-fold the progression to secondary bacterial"/>
   <result pre="Asia found that 4% of all sepsis were caused by" exact="influenza" post="viruses [61]. In the recent 2017 winter season with"/>
   <result pre="than expected, which the authors attributed in part to the" exact="influenza" post="virus season [38]. Role of viral-bacterial co-infections and their"/>
   <result pre="for over a century, including the period of the 1918" exact="influenza" post="pandemic; however, until just a few years ago, the"/>
   <result pre="these viral-bacterial infections also affect 10â€&quot;20% of patients with hospital-acquired" exact="pneumonia" post="(HAP) [44, 68â€&quot;70]. In a large cohort study with"/>
   <result pre="The mechanism of increased susceptibility to bacterial co-infection after an" exact="influenza" post="virus infection has been a focus of many studies."/>
   <result pre="many studies. The lung immune environment is substantially altered after" exact="influenza" post="virus infection, with early depletion of alveolar macrophages [79]."/>
   <result pre="can allow a window of opportunity for bacteria [80]. Similarly," exact="influenza" post="virus infection induces systemic glucocorticoids that can dampen inflammation"/>
   <result pre="bacterial growth, as was shown in a mouse model of" exact="influenza" post="virus-Listeria co-infection [81]. Blocking the glucocorticoid response actually led"/>
   <result pre="actually led to death from the inflammation associated with the" exact="influenza" post="virus infection, demonstrating the balance between tolerance and pathogen"/>
   <result pre="host [81]. Other less common severe complications of Influenza Acute" exact="myositis" post="accompanied by rhabdomyolysis may rarely happen, most commonly in"/>
   <result pre="elevation of serum creatinine phosphokinase and myoglobinuria [82]. Myocarditis and" exact="pericarditis" post="have also been rarely described in clinical cases, but"/>
   <result pre="autopsy studies [83, 84]. Central nervous system complications associated with" exact="influenza" post="include encephalitis, acute disseminated encephalomyelitis, transverse myelitis, aseptic meningitis,"/>
   <result pre="84]. Central nervous system complications associated with influenza include encephalitis," exact="acute disseminated encephalomyelitis," post="transverse myelitis, aseptic meningitis, and Guillain-Barre syndrome [85â€&quot;87] (TableÂ"/>
   <result pre="associated with influenza include encephalitis, acute disseminated encephalomyelitis, transverse myelitis," exact="aseptic meningitis," post="and Guillain-Barre syndrome [85â€&quot;87] (TableÂ 2). Table 2 Severe"/>
   <result pre="meningitis, and Guillain-Barre syndrome [85â€&quot;87] (TableÂ 2). Table 2 Severe" exact="influenza" post="complications Severe influenza complications Influenza pneumonia Secondary bacterial pneumonia"/>
   <result pre="syndrome [85â€&quot;87] (TableÂ 2). Table 2 Severe influenza complications Severe" exact="influenza" post="complications Influenza pneumonia Secondary bacterial pneumonia ARDS Influenza sepsis"/>
   <result pre="2). Table 2 Severe influenza complications Severe influenza complications Influenza" exact="pneumonia" post="Secondary bacterial pneumonia ARDS Influenza sepsis Secondary bacterial sepsis"/>
   <result pre="2 Severe influenza complications Severe influenza complications Influenza pneumonia Secondary" exact="bacterial pneumonia" post="ARDS Influenza sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis"/>
   <result pre="Severe influenza complications Severe influenza complications Influenza pneumonia Secondary bacterial" exact="pneumonia" post="ARDS Influenza sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis"/>
   <result pre="ARDS Influenza sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis Acute" exact="myocarditis" post="Acute pericarditis Acute encephalitis Acute disseminated encephalomyelitis Transverse myelitis"/>
   <result pre="sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis Acute myocarditis Acute" exact="pericarditis" post="Acute encephalitis Acute disseminated encephalomyelitis Transverse myelitis Aseptic meningitis"/>
   <result pre="bacterial sepsis Myositis and rhabdomyolysis Acute myocarditis Acute pericarditis Acute" exact="encephalitis" post="Acute disseminated encephalomyelitis Transverse myelitis Aseptic meningitis Guillain-Barre syndrome"/>
   <result pre="and rhabdomyolysis Acute myocarditis Acute pericarditis Acute encephalitis Acute disseminated" exact="encephalomyelitis" post="Transverse myelitis Aseptic meningitis Guillain-Barre syndrome Conclusions Influenza virus"/>
   <result pre="Acute myocarditis Acute pericarditis Acute encephalitis Acute disseminated encephalomyelitis Transverse" exact="myelitis" post="Aseptic meningitis Guillain-Barre syndrome Conclusions Influenza virus affects the"/>
   <result pre="Acute pericarditis Acute encephalitis Acute disseminated encephalomyelitis Transverse myelitis Aseptic" exact="meningitis" post="Guillain-Barre syndrome Conclusions Influenza virus affects the respiratory tract"/>
   <result pre="critical extracellular matrix. Approximately 30â€&quot;40% of hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. These patients who develop"/>
   <result pre="influenza are diagnosed with acute pneumonia. These patients who develop" exact="pneumonia" post="are more likely to be â€‰65â€‰years old, Caucasian, and"/>
   <result pre="old, Caucasian, and nursing home residents; have chronic lung or" exact="heart disease" post="and history of smoking; and are immunocompromised. Influenza can"/>
   <result pre="to bacterial sepsis and ARDS. Viral infections presenting concurrently with" exact="bacterial pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial" exact="pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="admission. Influenza A virus is the predominant viral etiology of" exact="acute respiratory distress syndrome" post="(ARDS) in adults. Risk factors independently associated with ARDS"/>
   <result pre="old, pregnancy, and obesity, while protective factors are female sex," exact="influenza" post="vaccination, and infections with Influenza A (H3N2) or Influenza"/>
   <result pre="immune system response. Approximately 30â€&quot;40% of hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. Coinfections with other viruses"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="virusesNature.2015526757112212510.1038/nature1537926416728 3.NichollsJMBourneAJChenHGuanYPeirisJSSialic acid receptor detection in the human respiratory"/>
   <result pre="for widespread distribution of potential binding sites for human and" exact="avian influenza" post="virusesRespir Res200787310.1186/1465-9921-8-7317961210 4.ZangrilloABiondi-ZoccaiGLandoniGFratiGPatronitiNPesentiAet al.Extracorporeal membrane oxygenation (ECMO) in patients"/>
   <result pre="widespread distribution of potential binding sites for human and avian" exact="influenza" post="virusesRespir Res200787310.1186/1465-9921-8-7317961210 4.ZangrilloABiondi-ZoccaiGLandoniGFratiGPatronitiNPesentiAet al.Extracorporeal membrane oxygenation (ECMO) in patients"/>
   <result pre="Res200787310.1186/1465-9921-8-7317961210 4.ZangrilloABiondi-ZoccaiGLandoniGFratiGPatronitiNPesentiAet al.Extracorporeal membrane oxygenation (ECMO) in patients with H1N1" exact="influenza" post="infection: a systematic review and meta-analysis including 8 studies"/>
   <result pre="heart failure prognosis?Heart Fail Rev201722332933610.1007/s10741-017-9614-728508293 6.KwongJCSchwartzKLCampitelliMAAcute myocardial infarction after laboratory-confirmed" exact="influenza" post="infectionN Engl J Med2018378262540254129949484 7.SandersCJVogelPMcClarenJLBajracharyaRDohertyPCThomasPGCompromised respiratory function in lethal"/>
   <result pre="influenza infectionN Engl J Med2018378262540254129949484 7.SandersCJVogelPMcClarenJLBajracharyaRDohertyPCThomasPGCompromised respiratory function in lethal" exact="influenza" post="infection is characterized by the depletion of type I"/>
   <result pre="J Physiol Lung Cell Mol Physiol20133047L481L48810.1152/ajplung.00343.201223355384 8.CardaniABoultonAKimTSBracialeTJAlveolar macrophages prevent lethal" exact="influenza" post="pneumonia by inhibiting infection of type-1 alveolar epithelial cellsPLoS"/>
   <result pre="Physiol Lung Cell Mol Physiol20133047L481L48810.1152/ajplung.00343.201223355384 8.CardaniABoultonAKimTSBracialeTJAlveolar macrophages prevent lethal influenza" exact="pneumonia" post="by inhibiting infection of type-1 alveolar epithelial cellsPLoS Pathog2017131e100614010.1371/journal.ppat.100614028085958"/>
   <result pre="9.TeijaroJRWalshKBCahalanSFremgenDMRobertsEScottFet al.Endothelial cells are central orchestrators of cytokine amplification during" exact="influenza" post="virus infectionCell.2011146698099110.1016/j.cell.2011.08.01521925319 10.BoydDFThomasPGTowards integrating extracellular matrix and immunological pathwaysCytokine.201798798610.1016/j.cyto.2017.03.00428325629"/>
   <result pre="AR, et al. Matrix metalloproteinase-9 deficiency protects mice from severe" exact="influenza" post="A viral infection. JCI Insight. 2018;3(24). 10.1172/jci.insight.99022. 16.AllenICScullMAMooreCBHollEKMcElvania-TeKippeETaxmanDJet al.The"/>
   <result pre="16.AllenICScullMAMooreCBHollEKMcElvania-TeKippeETaxmanDJet al.The NLRP3 inflammasome mediates in vivo innate immunity to" exact="influenza" post="A virus through recognition of viral RNAImmunity.200930455656510.1016/j.immuni.2009.02.00519362020 17.ThomasPGDashPAldridgeJRJrEllebedyAHReynoldsCFunkAJet al.The"/>
   <result pre="intracellular sensor NLRP3 mediates key innate and healing responses to" exact="influenza" post="A virus via the regulation of caspase-1Immunity.200930456657510.1016/j.immuni.2009.02.00619362023 18.RenRWuSCaiJYangYRenXFengYet al.The"/>
   <result pre="A virus via the regulation of caspase-1Immunity.200930456657510.1016/j.immuni.2009.02.00619362023 18.RenRWuSCaiJYangYRenXFengYet al.The H7N9" exact="influenza" post="A virus infection results in lethal inflammation in the"/>
   <result pre="19.TateMDOngJDDowlingJKMcAuleyJLRobertsonABLatzEet al.Reassessing the role of the NLRP3 inflammasome during pathogenic" exact="influenza" post="A virus infection via temporal inhibitionSci Rep201662791210.1038/srep2791227283237 20.TavaresLPGarciaCCMachadoMGQueiroz-JuniorCMBarthelemyATrotteinFet al.CXCR1/2"/>
   <result pre="and neutrophil extracellular traps contribute to acute lung injury of" exact="influenza" post="pneumonitisAm J Pathol2011179119921010.1016/j.ajpath.2011.03.01321703402 22.ZhuLLiuLZhangYPuLLiuJLiXet al.High level of neutrophil extracellular"/>
   <result pre="sirolimus, and steroids improves outcomes in patients with severe H1N1" exact="pneumonia" post="and acute respiratory failureCrit Care Med201442231332110.1097/CCM.0b013e3182a2727d24105455 25.SunXSongLFengSLiLYuHWangQet al.Fatty acid"/>
   <result pre="in bacterial and viral inflammationCell.201616661512152510.1016/j.cell.2016.07.02627610573 27.SmallwoodHSDuanSMorfouaceMRezinciucSShulkinBLShelatAet al.Targeting metabolic reprogramming by" exact="influenza" post="infection for therapeutic interventionCell Rep20171981640165310.1016/j.celrep.2017.04.03928538182 28.ThaiMThakerSKFengJDuYHuHTing WuTet al.MYC-induced reprogramming"/>
   <result pre="optimal virus replicationNat Commun20156887310.1038/ncomms987326561297 29.MaierHELopezRSanchezNNgSGreshLOjedaSet al.Obesity increases the duration of" exact="influenza" post="a virus shedding in adultsJ Infect Dis201821891378138210.1093/infdis/jiy37030085119 30.O'BrienKBVogelPDuanSGovorkovaEAWebbyRJMcCullersJAet al.Impaired"/>
   <result pre="Dis201821891378138210.1093/infdis/jiy37030085119 30.O'BrienKBVogelPDuanSGovorkovaEAWebbyRJMcCullersJAet al.Impaired wound healing predisposes obese mice to severe" exact="influenza" post="virus infectionJ Infect Dis2012205225226110.1093/infdis/jir72922147799 31.PaichHASheridanPAHandyJKarlssonEASchultz-CherrySHudgensMGet al.Overweight and obese adult"/>
   <result pre="humans have a defective cellular immune response to pandemic H1N1" exact="influenza" post="A virusObesity (Silver Spring)201321112377238610.1002/oby.2038323512822 32.CasalinoEAntoniolSFidouhNChoquetCLucetJCDuvalXet al.Influenza virus infections among"/>
   <result pre="cohort studyChest.2016149252653410.1378/chest.14-276826203671 34.GargSJainSDawoodFSJhungMPerezAD'MelloTet al.Pneumonia among adults hospitalized with laboratory-confirmed seasonal" exact="influenza" post="virus infection-United States, 2005-2008BMC Infect Dis20151536910.1186/s12879-015-1004-y26307108 35.UyekiTimothy MBernsteinHenry HBradleyJohn"/>
   <result pre="al.Factors associated with death or hospitalization due to pandemic 2009" exact="influenza" post="A(H1N1) infection in CaliforniaJAMA.2009302171896190210.1001/jama.2009.158319887665 37.collab: Writing Committee of the"/>
   <result pre="Writing Committee of the WHOCoCAoPIBautistaEChotpitayasunondhTGaoZHarperSAShawMet al.Clinical aspects of pandemic 2009" exact="influenza" post="A (H1N1) virus infectionN Engl J Med2010362181708171910.1056/NEJMra100044920445182 38.BurrellAHucksonSPilcherDVcollab: AnzicsICU"/>
   <result pre="infectionN Engl J Med2010362181708171910.1056/NEJMra100044920445182 38.BurrellAHucksonSPilcherDVcollab: AnzicsICU admissions for Sepsis or" exact="pneumonia" post="in Australia and New Zealand in 2017N Engl J"/>
   <result pre="New Zealand in 2017N Engl J Med2018378222138213910.1056/NEJMc171717829847767 39.IkeJDKempkerJAKramerMRMartinGSThe association between" exact="acute respiratory distress syndrome" post="hospital case volume and mortality in a U.S. cohort,"/>
   <result pre="2002-2011Crit Care Med201846576477310.1097/CCM.000000000000301529394181 40.SchoutenLRVeltkampFBosAPvan WoenselJBSerpa NetoASchultzMJet al.Incidence and mortality of" exact="acute respiratory distress syndrome" post="in children: a systematic review and meta-analysisCrit Care Med201644481982926509320"/>
   <result pre="H, Yann LS, Daniel L-B. Intensive care unit surveillance of" exact="influenza" post="infection in France: the 2009/10 pandemic and the three"/>
   <result pre="subsequent seasons. Euro Surveill. 2015;20(46). 42.LiHWengHLanCZhangHWangXPanJet al.Comparison of patients with" exact="avian influenza" post="A (H7N9) and influenza a (H1N1) complicated by acute"/>
   <result pre="seasons. Euro Surveill. 2015;20(46). 42.LiHWengHLanCZhangHWangXPanJet al.Comparison of patients with avian" exact="influenza" post="A (H7N9) and influenza a (H1N1) complicated by acute"/>
   <result pre="42.LiHWengHLanCZhangHWangXPanJet al.Comparison of patients with avian influenza A (H7N9) and" exact="influenza" post="a (H1N1) complicated by acute respiratory distress syndromeMedicine (Baltimore)20189712e019410.1097/MD.000000000001019429561442"/>
   <result pre="Med2018378877277310.1056/NEJMc171272729466160 44.ZhouFLiHGuLLiuMXueCXCaoBet al.Risk factors for nosocomial infection among hospitalised severe" exact="influenza" post="A(H1N1)pdm09 patientsRespir Med2018134869110.1016/j.rmed.2017.11.01729413513 45.DugasAFValsamakisAAtreyaMRThindKAlarcon ManchegoPFaisalAet al.Clinical diagnosis of influenza"/>
   <result pre="severe influenza A(H1N1)pdm09 patientsRespir Med2018134869110.1016/j.rmed.2017.11.01729413513 45.DugasAFValsamakisAAtreyaMRThindKAlarcon ManchegoPFaisalAet al.Clinical diagnosis of" exact="influenza" post="in the EDAm J Emerg Med201533677077510.1016/j.ajem.2015.03.00825827595 46.van AstenLLuna PinzonAde"/>
   <result pre="Emerg Med201533677077510.1016/j.ajem.2015.03.00825827595 46.van AstenLLuna PinzonAde LangeDWde JongeEDijkstraFMarbusSet al.Estimating severity of" exact="influenza" post="epidemics from severe acute respiratory infections (SARI) in intensive"/>
   <result pre="review of mechanisms and methodsAntivir Res201293121510.1016/j.antiviral.2011.10.01922068147 48.FlorescuDFKalilACThe complex link between" exact="influenza" post="and severe sepsisVirulence.20145113714210.4161/viru.2710324253109 49.ImaiYKubaKNeelyGGYaghubian-MalhamiRPerkmannTvan LooGet al.Identification of oxidative stress"/>
   <result pre="Immunol201031293910.1038/mi.2009.12019865078 51.ShireyKALaiWScottAJLipskyMMistryPPletnevaLMet al.The TLR4 antagonist Eritoran protects mice from lethal" exact="influenza" post="infectionNature.2013497745049850210.1038/nature1211823636320 52.FriesenhagenJBoergelingYHrinciusELudwigSRothJViemannDHighly pathogenic avian influenza viruses inhibit effective immune"/>
   <result pre="antagonist Eritoran protects mice from lethal influenza infectionNature.2013497745049850210.1038/nature1211823636320 52.FriesenhagenJBoergelingYHrinciusELudwigSRothJViemannDHighly pathogenic" exact="avian influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJ"/>
   <result pre="Eritoran protects mice from lethal influenza infectionNature.2013497745049850210.1038/nature1211823636320 52.FriesenhagenJBoergelingYHrinciusELudwigSRothJViemannDHighly pathogenic avian" exact="influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJ"/>
   <result pre="Biol2012921112010.1189/jlb.091147922442495 53.CheungCYPoonLLLauASLukWLauYLShortridgeKFet al.Induction of proinflammatory cytokines in human macrophages by" exact="influenza" post="A (H5N1) viruses: a mechanism for the unusual severity"/>
   <result pre="macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009" exact="influenza" post="virusesJ Gen Virol201192Pt 61428143410.1099/vir.0.030346-021367984 55.WangSLeTQKuriharaNChidaJCisseYYanoMet al.Influenza virus-cytokine-protease cycle in"/>
   <result pre="as a therapeutic target in severe influenzaAntivir Res201399211311810.1016/j.antiviral.2013.05.00323685311 57.JainSBenoitSRSkarbinskiJBramleyAMFinelliLPandemic InfluenzaAVHITInfluenza-associated" exact="pneumonia" post="among hospitalized patients with 2009 pandemic influenza A (H1N1)"/>
   <result pre="Res201399211311810.1016/j.antiviral.2013.05.00323685311 57.JainSBenoitSRSkarbinskiJBramleyAMFinelliLPandemic InfluenzaAVHITInfluenza-associated pneumonia among hospitalized patients with 2009 pandemic" exact="influenza" post="A (H1N1) virus--United States, 2009Clin Infect Dis20125491221122910.1093/cid/cis19722437239 58.KumarAZarychanskiRPintoRCookDJMarshallJLacroixJet al.Critically"/>
   <result pre="States, 2009Clin Infect Dis20125491221122910.1093/cid/cis19722437239 58.KumarAZarychanskiRPintoRCookDJMarshallJLacroixJet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) infection in CanadaJAMA.2009302171872187910.1001/jama.2009.149619822627 59.Dominguez-CheritGLapinskySEMaciasAEPintoREspinosa-PerezLde la TorreAet al.Critically ill"/>
   <result pre="in CanadaJAMA.2009302171872187910.1001/jama.2009.149619822627 59.Dominguez-CheritGLapinskySEMaciasAEPintoREspinosa-PerezLde la TorreAet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) in MexicoJAMA.2009302171880188710.1001/jama.2009.153619822626 60.FariasJAFernandezAMonteverdeEVidalNAriasPMontesMJet al.Critically ill infants and children"/>
   <result pre="A(H1N1) in MexicoJAMA.2009302171880188710.1001/jama.2009.153619822626 60.FariasJAFernandezAMonteverdeEVidalNAriasPMontesMJet al.Critically ill infants and children with" exact="influenza" post="A (H1N1) in pediatric intensive care units in ArgentinaIntensive"/>
   <result pre="Forum Infect Dis201632ofw07110.1093/ofid/ofw07127191004 68.LoubetPVoiriotGHouhou-FidouhNNeuvilleMBouadmaLLescureFXet al.Impact of respiratory viruses in hospital-acquired" exact="pneumonia" post="in the intensive care unit: a single-center retrospective studyJ"/>
   <result pre="influenzaIntensive Care Med2017431485810.1007/s00134-016-4578-y27709265 75.RandolphAGVaughnFSullivanRRubinsonLThompsonBTYoonGet al.Critically ill children during the 2009-2010" exact="influenza" post="pandemic in the United StatesPediatrics.20111286e1450e145810.1542/peds.2011-077422065262 76.RiceTWRubinsonLUyekiTMVaughnFLJohnBBMillerRR3rdet al.Critical illness from"/>
   <result pre="in the United StatesPediatrics.20111286e1450e145810.1542/peds.2011-077422065262 76.RiceTWRubinsonLUyekiTMVaughnFLJohnBBMillerRR3rdet al.Critical illness from 2009 pandemic" exact="influenza" post="A virus and bacterial coinfection in the United StatesCrit"/>
   <result pre="in the United StatesCrit Care Med20124051487149810.1097/CCM.0b013e3182416f2322511131 77.RozencwajgSBrechotNSchmidtMHekimianGLebretonGBessetSet al.Co-infection with influenza-associated" exact="acute respiratory distress syndrome" post="requiring extracorporeal membrane oxygenationInt J Antimicrob Agents201851342743310.1016/j.ijantimicag.2017.11.00529174419 78.RandolphAGXuRNovakTNewhamsMMBubeck WardenburgJWeissSLet"/>
   <result pre="influenza-related critical illnessClin Infect Dis201968336537210.1093/cid/ciy49529893805 79.GhoneimHEThomasPGMcCullersJADepletion of alveolar macrophages during" exact="influenza" post="infection facilitates bacterial superinfectionsJ Immunol201319131250125910.4049/jimmunol.130001423804714 80.GouldingJGodleeAVekariaSHiltyMSnelgroveRHussellTLowering the threshold of"/>
   <result pre="Microbe20107210311410.1016/j.chom.2010.01.01020159617 82.DellKMSchulmanSLRhabdomyolysis and acute renal failure in a child with" exact="influenza" post="a infectionPediatr Nephrol199711336336510.1007/s0046700502999203195 83.MamasMAFraserDNeysesLCardiovascular manifestations associated with influenza virus"/>
   <result pre="child with influenza a infectionPediatr Nephrol199711336336510.1007/s0046700502999203195 83.MamasMAFraserDNeysesLCardiovascular manifestations associated with" exact="influenza" post="virus infectionInt J Cardiol2008130330430910.1016/j.ijcard.2008.04.04418625525 84.PaddockCDLiuLDenisonAMBartlettJHHolmanRCDeleon-CarnesMet al.Myocardial injury and bacterial"/>
   <result pre="with influenza virus infectionInt J Cardiol2008130330430910.1016/j.ijcard.2008.04.04418625525 84.PaddockCDLiuLDenisonAMBartlettJHHolmanRCDeleon-CarnesMet al.Myocardial injury and" exact="bacterial pneumonia" post="contribute to the pathogenesis of fatal influenza B virus"/>
   <result pre="influenza virus infectionInt J Cardiol2008130330430910.1016/j.ijcard.2008.04.04418625525 84.PaddockCDLiuLDenisonAMBartlettJHHolmanRCDeleon-CarnesMet al.Myocardial injury and bacterial" exact="pneumonia" post="contribute to the pathogenesis of fatal influenza B virus"/>
   <result pre="injury and bacterial pneumonia contribute to the pathogenesis of fatal" exact="influenza" post="B virus infectionJ Infect Dis2012205689590510.1093/infdis/jir86122291193 85.GoenkaAMichaelBDLedgerEHartIJAbsoudMChowGet al.Neurological manifestations of"/>
   <result pre="influenza B virus infectionJ Infect Dis2012205689590510.1093/infdis/jir86122291193 85.GoenkaAMichaelBDLedgerEHartIJAbsoudMChowGet al.Neurological manifestations of" exact="influenza" post="infection in children and adults: results of a National"/>
   <result pre="Surveillance StudyClin Infect Dis201458677578410.1093/cid/cit92224352349 86.OkunoHYahataYTanaka-TayaKAraiSSatohHMorinoSet al.Characteristics and outcomes of Influenza-associated" exact="encephalopathy" post="cases among children and adults in Japan, 2010-2015Clin Infect"/>
   <result pre="burden of influenza: a review of the extra-pulmonary complications of" exact="influenza" post="infectionInfluenza Other Respir Viruses201711537239310.1111/irv.1247028745014"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6646355\results\search\disease\results.xml">
   <result pre="linked to several neurological disorders, such as Guillain-Barre Syndrome10,11 and" exact="microcephaly" post="in infants born to mothers who were infected with"/>
   <result pre="potential countermeasures, thereby helping to decrease the potentiality of this" exact="infectious disease" post="to become a pandemic. The primary objective of this"/>
   <result pre="suspected cases if they were presented to health practitioners with" exact="rash" post="and/or mild fever and at least two of the"/>
   <result pre="following characteristics: acute onset of generalized macular or papular rash," exact="arthritis" post="or arthralgia, or nonpurulent conjunctivitis. Out of the total"/>
   <result pre="19 (2014). 12.Schuler-FacciniLet al.Possible association between Zika virus infection and" exact="microcephaly" post="- Brazil, 2015MMWR Morb. Mortal. Wkly. Rep.201665596210.15585/mmwr.mm6503e226820244 13.MlakarJet al.Zika"/>
   <result pre="optimal control theory perspectivesJournal of Computational and Applied Mathematics201630714316110.1016/j.cam.2016.02.051 15.MutuaJMWangFBVaidyaNKModeling" exact="malaria" post="and typhoid fever co-infection dynamicsMath. Biosci.201526412814410.1016/j.mbs.2015.03.01425865934 16.Keeling, M. J."/>
   <result pre="theory perspectivesJournal of Computational and Applied Mathematics201630714316110.1016/j.cam.2016.02.051 15.MutuaJMWangFBVaidyaNKModeling malaria and" exact="typhoid fever" post="co-infection dynamicsMath. Biosci.201526412814410.1016/j.mbs.2015.03.01425865934 16.Keeling, M. J. &amp;amp; Rohani, P."/>
   <result pre="Oxford, 1992). 18.VaidyaNKet al.Modelling the epidemic spread of an H1N1" exact="influenza" post="outbreak in a rural university townEpidemiol. Infect.20151431610162010.1017/s095026881400256825323631 19.AkbariSVaidyaNKWahlLMThe time"/>
   <result pre="disease transmissionMath. Biosci.2002180294810.1016/S0025-5564(02)00108-612387915 32.ChitnisNHymanJMCushingJMDetermining important parameters in the spread of" exact="malaria" post="through the sensitivity analysis of a mathematical modelBull. Math."/>
   <result pre="and SIR models for dengue transmissionMath. Biosci.201310.1016/j.mbs.2013.10.00724427785 38.ManoreCAHickmannKSXuSWearingHJHymanJMComparing dengue and" exact="chikungunya" post="emergence and endemic transmission in A. aegypti and A."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6648004\results\search\disease\results.xml">
   <result pre="presents the most recent scientific evidence of kidney involvement in" exact="yellow fever," post="since AKI plays an important role in the mortality"/>
   <result pre="required to provide a better clinical control for patients with" exact="yellow fever." post="Yellow fever Acute kidney injury Epidemics Pathophysiology fig-count: table-count:"/>
   <result pre="virion production7 , 9 . A meticulous study of the" exact="yellow fever" post="virus genome is essential to establish genetic differences between"/>
   <result pre="of the mosquito since 1942. However, the enzootic cycle (sylvatic" exact="yellow fever" post="cycle involving non-human primates) occurs in the Amazon basin"/>
   <result pre="the last two years, there has been a recrudescence of" exact="yellow fever" post="(YF) in some countries in Africa and South America11"/>
   <result pre="rate, ranging from 25% to 50%13 - 15 . The" exact="yellow fever" post="virus is one of the most critical arboviruses. Annually,"/>
   <result pre="renal and myocardial lesions. In more severe cases, internal hemorrhage," exact="kidney failure," post="shock, coma or even death can occur11 . In"/>
   <result pre="this hypothesis. Currently, specific antiviral treatment is not available for" exact="yellow fever" post="(YF). Prevention and vaccination are the key control-factors in"/>
   <result pre="At the beginning of the 21th century, new cases of" exact="yellow fever" post="outside the rainforest environment have become a matter of"/>
   <result pre="have been reported. Since 2015, Brazil has faced significant sylvatic" exact="yellow fever" post="outbreaks in the four States of the Southeast region,"/>
   <result pre="more than 20 years20 . Furthermore, in 2016, an unconnected" exact="yellow fever" post="outbreak took place in Uganda (Africa), and some occasional"/>
   <result pre="on, and, more recently, Nigeria has been facing an active" exact="yellow fever" post="outbreak25 - 27 . Historical aspects and epidemiology There"/>
   <result pre="by an infected vector ( A. aegypti ), as the" exact="yellow fever" post="was very unusual on sailing ships3 , 28 ,"/>
   <result pre="some specific regions. Besides, the epizootic cycle may overlap sporadic" exact="yellow fever" post="outbreaks in non-immunized populations that live in or close"/>
   <result pre="Brazilian Ministry of Health and the WHO32 , 33 ," exact="yellow fever" post="is a seasonal disease that mostly occurs during the"/>
   <result pre="Figure 1 . Figure 1 Distribution of confirmed cases of" exact="yellow fever" post="in Brazil in the seasonal monitoring period. Adapted from"/>
   <result pre="Brazilian Ministry of Health published in February 2018 that 1,080" exact="yellow fever" post="cases were notified between July 2017 and January 2018,"/>
   <result pre="shown in Table 1 . Table 1 Distribution of reported" exact="yellow fever" post="cases in Brazil, from July the 1st 2017 to"/>
   <result pre="SaÃºde32. The Brazilian Amazon basin is an epidemic area for" exact="yellow fever." post="However, sporadic outbreaks may occur outside this region, as"/>
   <result pre="outside this region, as shown in 2016, when thousands of" exact="yellow fever" post="cases in humans were reported (more than 1,900) in"/>
   <result pre="1,900) in Southeastern Brazil10 . According to the revised 2010" exact="yellow fever" post="map, Brazil is one of the 11 South American"/>
   <result pre="can be infected, providing a new endemic area for sylvatic" exact="yellow fever." post="Therefore, the YFV moves forward through the forest areas,"/>
   <result pre="circulation34 , and the displacement of asymptomatic patients infected with" exact="yellow fever" post="virus has implications for the global dissemination of yellow"/>
   <result pre="yellow fever virus has implications for the global dissemination of" exact="yellow fever," post="it is imperative that travelers are vaccinated, due the"/>
   <result pre="imperative that travelers are vaccinated, due the high risk of" exact="yellow fever" post="transmission23 , 25 , 33 . Yellow fever was"/>
   <result pre="from the WHO25 , 33 , 34 reports, show the" exact="yellow fever" post="geographic distribution worldwide ( Figure 2 ). Figure 2"/>
   <result pre="( Figure 2 ). Figure 2 Areas at risk of" exact="yellow fever" post="transmission. Adapted from the World Health Organization34. Pathogenesis and"/>
   <result pre="urban vector. A. aegypti is responsible for the dissemination of" exact="yellow fever" post="in the urban environment. Therefore, the human-human transmission can"/>
   <result pre="clinical disease in humans is broad, and the severity of" exact="yellow fever" post="can cause symptoms ranging from inapparent infection to severe"/>
   <result pre="appear, and, according to Maciel et al .36 , disseminated" exact="mycosis" post="(severe infection in yellow fever patients) can mimic bacterial"/>
   <result pre="Maciel et al .36 , disseminated mycosis (severe infection in" exact="yellow fever" post="patients) can mimic bacterial sepsis. Diagnosis and diagnostic methods"/>
   <result pre="Diagnosis and diagnostic methods One of the greatest challenges in" exact="yellow fever" post="is the diagnosis of disease, because symptoms can be"/>
   <result pre="early stages of YF, the differential diagnosis is imperative, because" exact="yellow fever" post="can be easily mistaken for other hemorrhagic diseases, such"/>
   <result pre="be easily mistaken for other hemorrhagic diseases, such as leptospirosis," exact="dengue fever," post="malaria and viral hepatitis2 . Another important point is"/>
   <result pre="mistaken for other hemorrhagic diseases, such as leptospirosis, dengue fever," exact="malaria" post="and viral hepatitis2 . Another important point is that"/>
   <result pre="areas of other tropical diseases, such as zika, dengue and" exact="chikungunya" post="infections1 , 5 . Additionally, the quick identification of"/>
   <result pre="5 . Additionally, the quick identification of zika, dengue and" exact="chikungunya" post="viruses can indirectly help to control and prevent yellow"/>
   <result pre="and chikungunya viruses can indirectly help to control and prevent" exact="yellow fever," post="since the preventive measures to control the vector of"/>
   <result pre="POC can be a great monitoring and diagnostic tool for" exact="yellow fever" post="as well, because it can help to attain a"/>
   <result pre="outbreaks. Other hemorrhagic diseases that constitute the differential diagnosis of" exact="yellow fever" post="have been studied in search of bioactive molecules and"/>
   <result pre="and appear in inflammatory reactions, they are not specific for" exact="yellow fever." post="Attaining a correct diagnosis is essential, especially if there"/>
   <result pre="diagnosis is essential, especially if there are concomitant infections, because" exact="yellow fever" post="can quickly evolve to the severe forms of the"/>
   <result pre="disease or even death4 , 41 . Kidney injury in" exact="yellow fever" post="One of the targets for viral replication are kidney"/>
   <result pre="cylinders has some similarities with some classic histopathological findings of" exact="yellow fever" post="in humans30 . Maciel et al .36 described in"/>
   <result pre="the autopsy of patients affected by the severe form of" exact="yellow fever" post="virus infection, which was associated to disseminated mycoses. In"/>
   <result pre="according to the study by Maciel et al .36 ," exact="interstitial nephritis" post="was identified, associated with tubular necrosis and interlobular thrombosis"/>
   <result pre="to the study by Maciel et al .36 , interstitial" exact="nephritis" post="was identified, associated with tubular necrosis and interlobular thrombosis"/>
   <result pre="ischemic necrosis of the adrenal gland. The autopsy of another" exact="yellow fever" post="patient showed that there was preservation of the parenchymal"/>
   <result pre="face of the right kidney. The microscopic analysis revealed multiple" exact="interstitial nephritis" post="foci, combined with fibrosis and tubular necrosis. Thrombosis and"/>
   <result pre="of the right kidney. The microscopic analysis revealed multiple interstitial" exact="nephritis" post="foci, combined with fibrosis and tubular necrosis. Thrombosis and"/>
   <result pre="in the kidneys of animals that needed euthanasia. Surprisingly, the" exact="yellow fever" post="virus antigen was not detected in kidney tissues, which"/>
   <result pre="site. As discussed by Engelmann et al .42 , the" exact="yellow fever" post="disease follows the same pattern in monkeys as described"/>
   <result pre="even if the patient is normovolemic, which may evolve to" exact="anuria" post="and acute tubular necrosis (ATN). At this stage, there"/>
   <result pre="the patient is normovolemic, which may evolve to anuria and" exact="acute tubular necrosis" post="(ATN). At this stage, there is a high rate"/>
   <result pre="al .42 , these observations provide new information on the" exact="yellow fever" post="pathogenesis, suggesting that the kidney and the lymphoid tissue"/>
   <result pre="and chromium-EDTA45 , 46 , they are not helpful in" exact="yellow fever," post="because of the appalling disease severity and progression. According"/>
   <result pre="About 20 to 50% of death cases involving liver and" exact="kidney failure" post="due to YFV is a significant high rate that"/>
   <result pre="are not adequately applied and are overlooked. Treatment To date," exact="yellow fever" post="treatment consists of intensive support by providing hydration, blood"/>
   <result pre="antiviral inhibitor of the RNA-directed RNA polymerase (NS5B) enzyme of" exact="hepatitis" post="C virus, which is essential for viral replication. This"/>
   <result pre="for viral replication. This molecule incorporates into the RNA of" exact="hepatitis" post="C virus and inhibits its replication. This drug is"/>
   <result pre="to treat diseases such as dengue and malaria49 . Nanotechnology" exact="aids" post="in drug delivery, using biological organisms or nanoparticles (that"/>
   <result pre="on vector control measures14 , 37 . In 1927, the" exact="yellow fever" post="virus strain Asibi isolated from a patient in Ghana"/>
   <result pre="and since then The Oswald Cruz Foundation has produced the" exact="yellow fever" post="17DD (YF-17D) vaccine. To produce the 17DD vaccine, a"/>
   <result pre="vaccine. To produce the 17DD vaccine, a sample of the" exact="yellow fever" post="virus is inoculated into pathogens-free embryonated chicken eggs, as"/>
   <result pre="vaccination calendar, campaigns and providing vaccination coverage to travelers visiting" exact="yellow fever" post="risk zones. In addition to vaccination, vector control is"/>
   <result pre="and is also classified as a preventive action. Nevertheless, the" exact="yellow fever" post="virus can also be transmitted between humans by the"/>
   <result pre="Aedes mosquito, the urban vector, resulting in urban epidemics. Therefore," exact="yellow fever" post="surveillance that includes humans, animals (other primate hosts) and"/>
   <result pre="20 . Between 2008 and 2009, the transmission of wild" exact="yellow fever" post="occurred in Sao Paulo and Rio Grande do Sul"/>
   <result pre="are very effective against many viruses55 . CONCLUSION As a" exact="viral disease" post="with a huge impact, constituting a global public health"/>
   <result pre="of the disease may occur27 . Other aspects that make" exact="yellow fever" post="a challenging disease are its similarity with other hemorrhagic"/>
   <result pre="and preventive measures3 , 4 , 27 . Even though" exact="yellow fever" post="is a disease that has spread along the years"/>
   <result pre="is a scarcity of studies on the kidney involvement in" exact="yellow fever." post="The kidney is a very complex organ and its"/>
   <result pre="variety of histological findings related to kidney damage, such as" exact="interstitial nephritis," post="tubular necrosis, interlobular thrombosis in kidney vessels, hemorrhage and"/>
   <result pre="necrosis21 , 30 , 36 , 42 . Although the" exact="yellow fever" post="virus cannot be completely eradicated due to the existence"/>
   <result pre="not contain viral genetic material56 . Therefore, the spread of" exact="yellow fever" post="disease can be controlled. However, once the disease is"/>
   <result pre="we suggest that more studies on the kidney involvement in" exact="yellow fever" post="and the early diagnosis of kidney damage should be"/>
   <result pre="of YF sequelae. References REFERENCES 1MansuyJMLhommeSCazabatMPasquierCMartin-BlondelGIzopetJDetection of Zika, dengue and" exact="chikungunya" post="viruses using single-reaction multiplex real-time RT-PCRDiagn Microbiol Infect Dis20189228428730029808"/>
   <result pre="using single-reaction multiplex real-time RT-PCRDiagn Microbiol Infect Dis20189228428730029808 2DomingoCPatelPYillahJWeidmannMMÃ©ndezJANakounÃ©ERet al.Advanced" exact="yellow fever" post="virus genome detection in point-of-care facilities and reference laboratoriesJ"/>
   <result pre="facilities and reference laboratoriesJ Clin Microbiol2012504054406023052311 3HigueraARamÃ­rezJDMolecular epidemiology of dengue," exact="yellow fever," post="Zika and Chikungunya arboviruses: an updateActa Trop20191909911130444971 4StockNKEscadafalCAchaziKCissÃ©MNiedrigMDevelopment and"/>
   <result pre="polymerase chain reaction assay for simultaneous detection of Zika, dengue," exact="yellow fever," post="and chikungunya viruses in a single tubeJ Med Virol2018901681168629979812"/>
   <result pre="assay for simultaneous detection of Zika, dengue, yellow fever, and" exact="chikungunya" post="viruses in a single tubeJ Med Virol2018901681168629979812 6AubryFNougairÃ¨deAGouldEALamballerieXFlavivirus reverse"/>
   <result pre="a historical perspectiveAntiviral Res2015114678525512228 7BozzaccoLYiZAndreoUConklinCRLiMMRiceCMMacDonaldMRChaperone-assisted protein folding is critical for" exact="yellow fever" post="virus NS3/4A cleavage and replicationJ Virol2016903212322826739057 8KlittingRFischerCDrexlerJFGouldEARoizDPaupyCLamballerieXWhat does the"/>
   <result pre="cleavage and replicationJ Virol2016903212322826739057 8KlittingRFischerCDrexlerJFGouldEARoizDPaupyCLamballerieXWhat does the future hold for" exact="yellow fever" post="virus? (II)GenesBasel20189size: E425pages 9Fernandez-GarciaMDMeertensLChazalMHafirassouMLDejarnacOZamborliniAet al.Vaccine and wild-type strains of"/>
   <result pre="fever virus? (II)GenesBasel20189size: E425pages 9Fernandez-GarciaMDMeertensLChazalMHafirassouMLDejarnacOZamborliniAet al.Vaccine and wild-type strains of" exact="yellow fever" post="virus engage distinct entry mechanisms and differentially stimulate antiviral"/>
   <result pre="differentially stimulate antiviral immune responsesMBio20167e01956-1526861019 10RezendeIMSacchettoLMunhoz de MelloEAlvesPAIaniFCAdelinoTEet al.Persistence of" exact="yellow fever" post="virus outside the Amazon Basin, causing epidemics in Southeast"/>
   <result pre="detection, prevention and therapyAntiviral Res2015115487025545072 15PestanaCPLawson-FerreiraRLessa-AquinoCLealMLFreireMSHommaAet al.Sanger-based sequencing technology for" exact="yellow fever" post="vaccine genetic quality controlJ Virol Methods2018260828730009851 16DouamFSoto AlbrechtYEHrebikovaGSadiminEDavidsonCKotenkoSVet al.Type"/>
   <result pre="al.Type III interferon-mediated signaling is critical for controlling live attenuated" exact="yellow fever" post="virus infection in vivoMBio20178e00819-1728811340 17SaavedraMEarly-life disease exposure and occupational"/>
   <result pre="vivoMBio20178e00819-1728811340 17SaavedraMEarly-life disease exposure and occupational status: the impact of" exact="yellow fever" post="during the 19thcenturyExplor Econ Hist2017646281 18MansoPPDias de OliveiraBCCarvalho de"/>
   <result pre="OliveiraBCCarvalho de SequeiraPRodrigues Maia de SouzaYSantos FerroJMSilvaIJet al.Kinetic study of" exact="yellow fever" post="17DD viral infection in Gallus gallus domesticus embryosPLoS One201611e015504127158977"/>
   <result pre="Dis20148size: e2740pages 20ShearerFMLongbottomJBrowneAJPigottDMBradyOJKraemerMUet al.Existing and potential infection risk zones of" exact="yellow fever" post="worldwide: a modelling analysisLancet Glob Health20186e270e27829398634 21CavalcanteKRTauilPLRisk of re-emergence"/>
   <result pre="a modelling analysisLancet Glob Health20186e270e27829398634 21CavalcanteKRTauilPLRisk of re-emergence of urban" exact="yellow fever" post="in BrazilEpidemiol Serv SaÃºde20172661762028977185 22SelemaneIEpidemiological monitoring of the last"/>
   <result pre="BrazilEpidemiol Serv SaÃºde20172661762028977185 22SelemaneIEpidemiological monitoring of the last outbreak of" exact="yellow fever" post="in Brazil: an outlook from PortugalTravel Med Infect Dis201928465130583006"/>
   <result pre="spread and challenges for immunisationMem Inst Oswaldo Cruz2018113e18027830427974 24MirDDelatorreEBonaldoMLourenÃ§o-de-OliveiraRVicenteACBelloGPhylodynamics of" exact="yellow fever" post="virus in the Americas: new insights into the origin"/>
   <result pre="vaccines and biologicals: yellow fevercited 2019 Jun 24https://www.who.int/immunization/diseases/yellow_fever/en/ 26ShearerFMMoyesCLPigottDMBradyOJMarinhoFDeshpandeAet al.Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
   <result pre="to 2016: an adjusted retrospective analysisLancet Infect Dis2017171209121728822780 27IngelbeenBWeregemereNANoelHTshapendaGPMossokoMNsioJet al.Urban" exact="yellow fever" post="outbreak-Democratic Republic of the Congo, 2016: towards more rapid"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virusInfect Genet Evol20131929231123523817 29ChippauxJPChippauxAYellow fever in Africa and the"/>
   <result pre="Venom Anim Toxins Incl Trop Dis201824size: 20pages 30FernandesNCCunhaMSGuerraJMRÃ©ssioRACirqueiraCSIgleziasSDet al.Outbreak of" exact="yellow fever" post="among nonhuman primates, Espirito Santo, Brazil, 2017Emerg Infect Dis2017232038204129148378"/>
   <result pre="Santo, Brazil, 2017Emerg Infect Dis2017232038204129148378 31TretyakovaINickolsBHidajatRJokinenJLukashevichISPushkoPPlasmid DNA initiates replication of" exact="yellow fever" post="vaccine in vitro and elicits virus-specificVirology2014-2835 32collab: Brasilcollab: MinistÃ©rio"/>
   <result pre="2019 Jun 24http://portalms.saude.gov.br/noticias/agencia-saude/42422-ministerio-da-saude-atualiza-casos-de-febre-amarela-30-jan 33collab: World Health OrganizationVaccines and vaccination against" exact="yellow fever." post="WHO Position Paper â€&quot; June 2013Wkly Epidemiol Rec20138826928323909008 34collab:"/>
   <result pre="fever: a current threatcited 2019 Jun 24https://www.who.int/csr/disease/yellowfev/impact1/en/ 35KlittingRRothLReyFALamballerieXMolecular determinants of" exact="yellow fever" post="virus pathogenicity in Syrian golden hamsters: one mutation away"/>
   <result pre="one mutation away from virulenceEmerg Microb Infect20187size: 51pages 36MacielGVTavaresMCPereiraLSSilvaGLOliveiraNRPaulinoEJÃºnioret al.Disseminated" exact="mycosis" post="in a patient with yellow feverAutops Case Rep20188e201803830123781 37EscadafalCFayeOSallAAFayeOWeidmannMStrohmeierOet"/>
   <result pre="Case Rep20188e201803830123781 37EscadafalCFayeOSallAAFayeOWeidmannMStrohmeierOet al.Rapid molecular assays for the detection of" exact="yellow fever" post="virus in low-resource settingsPLoS Negl Trop Dis20148e273024603874 38IbrahimFThioTHFaisalTNeumanMThe application"/>
   <result pre="41PriyaSPSakinahSSharmilahKHamatRASekawiZHiguchiAet al.Leptospirosis: molecular trial path and immunopathogenesis correlated with dengue," exact="malaria" post="and mimetic hemorrhagic infectionsActa Trop201717620622328823908 42EngelmannFJossetLGirkeTParkBBarronADewaneJet al.Pathophysiologic and transcriptomic"/>
   <result pre="hemorrhagic infectionsActa Trop201717620622328823908 42EngelmannFJossetLGirkeTParkBBarronADewaneJet al.Pathophysiologic and transcriptomic analyses of viscerotropic" exact="yellow fever" post="in a rhesus macaque modelPLoS Negl Trop Dis20148size: e3295pages"/>
   <result pre="HoelzLBastosMMet al.Beyond members of the Flaviviridae family, sofosbuvir also inhibits" exact="chikungunya" post="virus replicationAntimicrob Agents Chemother201963e01389-1830455237 49IslanGADurÃ¡nMCacicedoMLNakazatoGKobayashiRKMartinezDSet al.Nanopharmaceuticals as a solution"/>
   <result pre="da febre amarela no BrasilRev Pan-Amaz Saude201121126 51LindseyNPHoriuchiKAFultonCPanellaAJKosoyOIVelezJOet al.Persistence of" exact="yellow fever" post="virus-specific neutralizing antibodies after vaccination among US travellersJ Travel"/>
   <result pre="among US travellersJ Travel Med201825tay108 52LindseyNPSchroederBAMillerERBraunMMHinckleyAFMaranoNet al.Adverse event reports following" exact="yellow fever" post="vaccinationVaccine2008266077608218809449 53DouamFPlossAYellow fever virus: knowledge gaps impeding the fight"/>
   <result pre="gaps impeding the fight against an old foeTrends Microbiol20182691392829933925 54VanniceKWilder-SmithAHombachJFractional-dose" exact="yellow fever" post="vaccination: advancing the evidence baseN Engl J Med201837960360529995585 55DixitRHerzJDaltonRBooyRBenefits"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6653809\results\search\disease\results.xml">
   <result pre="to sylvatic maintenance cycles in South America, as did the" exact="yellow fever" post="virus (YFV) in the past. All these viruses are"/>
   <result pre="an urban cycle as a spill-back from the sylvatic cycle." exact="yellow fever" post="arbovirus sylvatic cycle arbovirus infecting non-human primates arboviruses in"/>
   <result pre="in South America. This group of viruses also includes the" exact="yellow fever" post="virus (YFV), which switched to a sylvatic maintenance cycle"/>
   <result pre="around 10% of the infected individuals, YFV can cause severe" exact="hepatitis" post="and hemorrhagic fever (Vasconcelos, 2003). All 4 DENV are"/>
   <result pre="patients, especially women over 45 years of age, develop an" exact="arthropathy" post="that chronifies with great impact on the quality of"/>
   <result pre="of primates transmitted by Haemagogus mosquitoes that reside in treetops," exact="stroke" post="Manaus, a city with 2 million inhabitants, producing dozens"/>
   <result pre="caused outbreaks of acute febrile illness, including some cases of" exact="meningitis" post="in Manaus city (MourÃ£o et al., 2012). These data"/>
   <result pre="an urban arbovirus that became sylvatic in South America. Today," exact="yellow fever" post="has shown to be a zoonosis of non-human primates"/>
   <result pre="the largest epidemic in the past 60 years. Epizootics of" exact="yellow fever" post="in primates have advanced through gallery forests, mostly along"/>
   <result pre="January 2016 to June 2017, transmitted in a sylvatic cycle," exact="yellow fever" post="caused 3,140 cases with 410 deaths, mostly in the"/>
   <result pre="Ministry of Health, 2018). In 2018â€&quot;2019, this ongoing epizootic of" exact="yellow fever" post="bypassed the SÃ£o Paulo metropolitan area and moved toward"/>
   <result pre="outbreak (Figure 2). Non-human American primates are highly susceptible to" exact="yellow fever," post="and many animals, namely howler monkeys (Alouatta), die as"/>
   <result pre="is estimated that 90% of the howler monkeys died from" exact="yellow fever" post="in 2016â€&quot;2017 (Lopes, 2017). The death of primates is"/>
   <result pre="The death of primates is a precocious detectable sign of" exact="yellow fever" post="epizootics, and the surveillance of primate deaths in Brazil"/>
   <result pre="Brazil became an important tool to prevent cases of human" exact="yellow fever" post="with the rapid vaccination of inhabitants in the target"/>
   <result pre="the mapping of ecological corridors and the progression rate of" exact="yellow fever" post="among primates in SÃ£o Paulo State in 2017â€&quot;2018. Public"/>
   <result pre="before the arrival of the epizootic (Fioravanti, 2018). During the" exact="yellow fever" post="epizootic in southeastern Brazil, and in addition to taking"/>
   <result pre="an effective protector that avoids cases and also re-urbanization of" exact="yellow fever," post="the 17DD vaccine. This vaccine, containing live attenuated virus,"/>
   <result pre="or more of the population to impair urban outbreaks of" exact="yellow fever" post="(Shearer et al., 2017). This sudden outbreak began in"/>
   <result pre="et al., 2017). This sudden outbreak began in 2015 and" exact="stroke" post="a community of the Brazilian Southeast that was poorly"/>
   <result pre="against the issue, approximately 20,000,000 people were quickly vaccinated against" exact="yellow fever" post="in 2017â€&quot;2018. Similar to YFV, sylvatic cycles may occur"/>
   <result pre="T. M.Freitas-JuniorL. H. (2018). Evaluation of broad-spectrum antiviral compounds against" exact="chikungunya" post="infection using a phenotypic screening strategy. F1000Research7:173010.12688/f1000research.16498.1 collab: Brazilian"/>
   <result pre="vivo. PLoS Negl. Trop. Dis.13:e0007072. 10.1371/journal.pntd.000707230699122 FriersonJ. G. (2010). The" exact="yellow fever" post="vaccine: a history. Yale J. Biol. Med. 83, 77â€&quot;85.20589188"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virus. Infect. Genet. Evol.19, 292â€&quot;311. 10.1016/j.meegid.2013.03.00823523817 KunoG.Gwong-JenJ.TsuchiyaC. K. R.KarabatsosN.CroppB."/>
   <result pre="Em. com. br. gerais. LourenÃ§o-de-OliveiraR.FaillouxA. B. (2017). High risk for" exact="chikungunya" post="virus to initiate an enzootic sylvatic cycle in the"/>
   <result pre="(2018). Evidence for multiple sylvatic transmission cycles during the 2016-2017" exact="yellow fever" post="virus outbreak, Brazil. Clin Microbiol Infect.24:1019.e1â€&quot;019.e4. 10.1016/j.cmi.2018.01.02629427798 MourÃ£oM. P."/>
   <result pre="Med.13:102. 10.1186/s12916-015-0348-x25976325 ShearerF. M.MoyesC. L.PigottD. M.BradyO. J.MarinhoF.DeshpandeA.et al. (2017). Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6656825\results\search\disease\results.xml">
   <result pre="10.1186/s13613-019-0559-y : Research Human metapneumovirus as cause of severe community-acquired" exact="pneumonia" post="in adults: insights from a ten-year molecular and epidemiological"/>
   <result pre="human metapneumovirus in critically ill adult patients with severe community-acquired" exact="pneumonia" post="(CAP) and the role of biomarkers identifying bacterial coinfection"/>
   <result pre="metapneumovirus showed group B predominance (60.7%). All patients had acute" exact="respiratory failure." post="Median APACHE II and SOFA score were 13 and"/>
   <result pre="material, which is available to authorized users. Keywords Severe community-acquired" exact="pneumonia" post="Human metapneumovirus Acute respiratory distress syndrome Biomarkers Background Human"/>
   <result pre="in 2â€&quot;4% of adult patients admitted due to a community-acquired" exact="pneumonia" post="(CAP) [8, 9] and has been associated with asthma"/>
   <result pre="community-acquired pneumonia (CAP) [8, 9] and has been associated with" exact="asthma" post="and chronic obstructive pulmonary disease exacerbation [10â€&quot;12]. The same"/>
   <result pre="(CAP) [8, 9] and has been associated with asthma and" exact="chronic obstructive pulmonary disease" post="exacerbation [10â€&quot;12]. The same as with other common respiratory"/>
   <result pre="with non-severe pneumonia, whereas risk factors like immunosuppression, specific comorbiditiesâ€&quot;chronic" exact="lung disease," post="heart disease, blood disordersâ€&quot; elderly and living in long-term"/>
   <result pre="pneumonia, whereas risk factors like immunosuppression, specific comorbiditiesâ€&quot;chronic lung disease," exact="heart disease," post="blood disordersâ€&quot; elderly and living in long-term care facilities"/>
   <result pre="care facilities are associated with a higher risk of severe" exact="viral pneumonia" post="[13, 14]. Nevertheless, recent studies suggest that hMPV infection"/>
   <result pre="facilities are associated with a higher risk of severe viral" exact="pneumonia" post="[13, 14]. Nevertheless, recent studies suggest that hMPV infection"/>
   <result pre="critical illness, also in previously healthy patients [15â€&quot;18]. Severe community-acquired" exact="pneumonia" post="(SCAP) is a known infectious complication of respiratory viruses"/>
   <result pre="describe the clinical and epidemiological characteristics of adults with severe" exact="pneumonia" post="caused by hMPV who required intensive care unit (ICU)"/>
   <result pre="turned the standard of care in the ICU after 2009" exact="influenza" post="pandemic. To be included, cases meet two of the"/>
   <result pre="of the following three criteria upon admission: (a) severe acute" exact="respiratory failure" post="(paO2/FiO2â€‰ 21]. Exclusion criteria: subjects with nosocomial pneumonia or"/>
   <result pre="acute respiratory failure (paO2/FiO2â€‰ 21]. Exclusion criteria: subjects with nosocomial" exact="pneumonia" post="or admitted due to non-respiratory infection (non-severe coincidental infection)"/>
   <result pre="due to non-respiratory infection (non-severe coincidental infection) and patients with" exact="pneumonia" post="during the preceding 2Â months (persistence of viral RNA"/>
   <result pre="16 (57.1%) in Marchâ€&quot;April. HMPV circulated every year later than" exact="influenza" post="virus, being the epidemic peak of both infections separated"/>
   <result pre="infections in patients admitted to ICU occurred out of the" exact="influenza" post="epidemic period (TableÂ 1). Fig.Â 1 Cases of severe"/>
   <result pre="epidemic period (TableÂ 1). Fig.Â 1 Cases of severe community-acquired" exact="pneumonia" post="associated with human metapneumovirus infection, hospitalized in the Intensive"/>
   <result pre="SebastiÃ¡n, North of Spain) TableÂ 1 Annual epidemic peaks of" exact="influenza" post="virus and human metapneumovirus infections, and temporal distribution of"/>
   <result pre="and temporal distribution of isolates in patients with severe community-acquired" exact="pneumonia" post="due to human metapneumovirus infection (Gipuzkoa, Spain, 2008â€&quot;2017) Year"/>
   <result pre="February (nâ€‰=â€‰1) March (nâ€‰=â€‰2) hMPV human metapneumovirus, SCAP severe community-acquired" exact="pneumonia" post="Genotyping of hMPV was performed in 27 cases, being"/>
   <result pre="(67% genotype B). At ICU admission, all patients had acute" exact="respiratory failure" post="and received empiric antibiotic therapy. Median APACHE II score"/>
   <result pre="patients (67.9%) had major comorbidities such as immune compromise (nâ€‰=â€‰7)," exact="asthma" post="(nâ€‰=â€‰3) or chronic respiratory disease (nâ€‰=â€‰3) (TableÂ 2). Seven"/>
   <result pre="comorbidities such as immune compromise (nâ€‰=â€‰7), asthma (nâ€‰=â€‰3) or chronic" exact="respiratory disease" post="(nâ€‰=â€‰3) (TableÂ 2). Seven patients (none died) had coinfection"/>
   <result pre="4 5 Â Lymphopenia/mm3 ( 23 (82.1) 6 17 COPD" exact="chronic obstructive pulmonary disease" post="Predominant radiologic pattern in patients with hMPV infection and"/>
   <result pre="mechanical ventilation (median 5.5Â days [IQR 5â€&quot;14.2]) due to acute" exact="respiratory failure" post="and four were tracheostomized due to prolonged mechanical ventilation."/>
   <result pre="All of them underwent invasive mechanical ventilation due to acute" exact="respiratory failure" post="(one had coinfection with hPIV3). The main clinical and"/>
   <result pre="2: Table S2). The majority of the patients (83.3%) had" exact="lymphocytopenia" post="( 2). Four patients (average age 68.5Â years), three"/>
   <result pre="immunocompromised, died during the ICU stay due to complications of" exact="respiratory failure." post="Among survivors, ICU and hospital median stay were 6.5"/>
   <result pre="study gives new insights on the molecular epidemiology of hMPV" exact="pneumonia" post="admitted to the ICU over 10Â years. HMPV was"/>
   <result pre="65Â years without comorbidities. HMPV CAP often presented as acute" exact="respiratory failure" post="with bilateral opacities and half of ICU subjects underwent"/>
   <result pre="implement hMPV diagnosis tests in subjects with CAP developing acute" exact="respiratory failure." post="Two out of three patients of this study had"/>
   <result pre="patients with hMPV infection acquired in the community and acute" exact="respiratory failure" post="who required ICU admission [15â€&quot;17]. In a large prospective"/>
   <result pre="of this study had major comorbidities at admission, mainly chronic" exact="respiratory failure" post="and immunosuppression, being those patients and the elderly the"/>
   <result pre="with CAP, helping physicians to early discrimination between viral or" exact="bacterial pneumonia" post="and antimicrobial stewardship [29]. Three different genotypes of hMPV"/>
   <result pre="CAP, helping physicians to early discrimination between viral or bacterial" exact="pneumonia" post="and antimicrobial stewardship [29]. Three different genotypes of hMPV"/>
   <result pre="not be investigated for viral etiology. However, from the 2009" exact="influenza" post="pandemics, nasopharyngeal swab samples with respiratory viral detection are"/>
   <result pre="conclusion, our study confirms that hMPV, a respiratory virus causing" exact="bronchiolitis" post="and pneumonia in children, was associated with severe CAP"/>
   <result pre="study confirms that hMPV, a respiratory virus causing bronchiolitis and" exact="pneumonia" post="in children, was associated with severe CAP requiring ICU"/>
   <result pre="specifically hMPV) should be ruled out when complicated with acute" exact="respiratory failure." post="While one out of four patients showed pneumococcal coinfection,"/>
   <result pre="to the Intensive Care Unit due to a severe community-acquired" exact="pneumonia" post="associated with human metapneumovirus infection (Guipuzcoa, Basque Country, Spain,"/>
   <result pre="to the Intensive Care Unit due to a severe community-acquired" exact="pneumonia" post="associated with human metapneumovirus infection (Guipuzcoa, Basque Country, Spain,"/>
   <result pre="human metapneumovirus infection (Guipuzcoa, Basque Country, Spain, 2007â€&quot;2017). Abbreviations ARDS" exact="acute respiratory distress syndrome" post="APACHE II acute physiology and chronic health evaluation II"/>
   <result pre="II acute physiology and chronic health evaluation II CAP community-acquired" exact="pneumonia" post="COPD chronic obstructive pulmonary disease CRP C-reactive protein hMPV"/>
   <result pre="physiology and chronic health evaluation II CAP community-acquired pneumonia COPD" exact="chronic obstructive pulmonary disease" post="CRP C-reactive protein hMPV human metapneumovirus ICU intensive care"/>
   <result pre="SAPS III simplified acute physiology score III SCAP severe community-acquired" exact="pneumonia" post="SOFA sequential organ failure assessment Publisher's Note Springer Nature"/>
   <result pre="review of respiratory viral pathogens identified in adults with community-acquired" exact="pneumonia" post="in EuropeJ Clin Virol201795263510.1016/j.jcv.2017.07.01928837859 9.JainSSelfWHWunderinkRGet al.Community-acquired pneumonia requiring hospitalization"/>
   <result pre="adults with community-acquired pneumonia in EuropeJ Clin Virol201795263510.1016/j.jcv.2017.07.01928837859 9.JainSSelfWHWunderinkRGet al.Community-acquired" exact="pneumonia" post="requiring hospitalization among U.S. adultsN Engl J Med2015373541542710.1056/NEJMoa150024526172429 10.WalshEEPetersonDRFalseyARHuman"/>
   <result pre="11.WilliamsJVCroweJEJrEnriquezRet al.Human metapneumovirus infection plays an etiologic role in acute" exact="asthma" post="exacerbations requiring hospitalization in adultsJ Infect Dis200519271149115310.1086/44439216136455 12.HamelinMECÃ´tÃ©SLaforgeJet al.Human"/>
   <result pre="Infect Dis200519271149115310.1086/44439216136455 12.HamelinMECÃ´tÃ©SLaforgeJet al.Human metapneumovirus infection in adults with community-acquired" exact="pneumonia" post="and exacerbation of chronic obstructive pulmonary diseaseClin Infect Dis200541449850210.1086/43198116028158"/>
   <result pre="and exacerbation of chronic obstructive pulmonary diseaseClin Infect Dis200541449850210.1086/43198116028158 13.GattarelloSRelloJSevere" exact="viral pneumonia" post="in adults: what is important for the ICU physician?Hosp"/>
   <result pre="exacerbation of chronic obstructive pulmonary diseaseClin Infect Dis200541449850210.1086/43198116028158 13.GattarelloSRelloJSevere viral" exact="pneumonia" post="in adults: what is important for the ICU physician?Hosp"/>
   <result pre="casesAnn Intensive Care.2012213010.1186/2110-5820-2-3022812412 17.ChoiSHHongSBKoGBLeeYet al.Viral infection in patients with severe" exact="pneumonia" post="requiring intensive care unit admissionAm J Respir Crit Care"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6658116\results\search\disease\results.xml">
   <result pre="Nile virus (WNV) has been responsible for the largest human" exact="encephalitis" post="epidemics in the continental United States. Avians and Culex"/>
   <result pre="in 1999, West Nile virus (WNV) has caused large human" exact="encephalitis" post="epidemics in the United States resulting in 48,183 reported"/>
   <result pre="is closely related to other human pathogens such as Japanese" exact="encephalitis" post="(JEV), Saint Louis encephalitis and Murray Valley encephalitis viruses"/>
   <result pre="other human pathogens such as Japanese encephalitis (JEV), Saint Louis" exact="encephalitis" post="and Murray Valley encephalitis viruses within the Japanese encephalitis"/>
   <result pre="as Japanese encephalitis (JEV), Saint Louis encephalitis and Murray Valley" exact="encephalitis" post="viruses within the Japanese encephalitis virus (JEV) serocomplex[5, 6]."/>
   <result pre="Louis encephalitis and Murray Valley encephalitis viruses within the Japanese" exact="encephalitis" post="virus (JEV) serocomplex[5, 6]. The natural reservoir/amplification hosts of"/>
   <result pre="been exposed to WNV or another endemic flavivirus, St. Louis" exact="encephalitis" post="virus (SLEV), birds were bled prior to inoculation and"/>
   <result pre="viruses cannot be discounted as in vitro studies with recombinant" exact="rabies" post="virus glycoproteins have shown that differential glycosylation efficiencies of"/>
   <result pre="Other flaviviruses such as Yellow fever virus and St. Louis" exact="encephalitis" post="viruses do not encode a glycosylated E protein[10, 47,"/>
   <result pre="Trop Med. 1940;s1-20(4):471â€&quot;92. 2HubalekZ, HalouzkaJ. West Nile feverâ€&quot;a reemerging mosquito-borne" exact="viral disease" post="in Europe. Emerg Infect Dis. 1999;5(5):643â€&quot;50. 10.3201/eid0505.99050510511520 3MarfinAA, PetersenLR,"/>
   <result pre="of the West Nile virus responsible for an outbreak of" exact="encephalitis" post="in the northeastern United States. Science. 1999;286(5448):2333â€&quot;7. 10.1126/science.286.5448.233310600742 13BinH,"/>
   <result pre="differential oral infection phenotypes of West Nile and St. Louis" exact="encephalitis" post="viruses in Culex spp. mosquitoes. Am J Trop Med"/>
   <result pre="and biological characterization of a non-glycosylated isolate of St Louis" exact="encephalitis" post="virus. J Gen Virol. 1993;74(12):2653â€&quot;60. 10.1099/0022-1317-74-12-26537506301 49FallG, DialloM, LoucoubarC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6659212\results\search\disease\results.xml">
   <result pre="experimentally found to be potential vectors of arboviruses such as" exact="chikungunya" post="virus (CHIKV) [5] and Rift Valley fever phlebovirus (RVFV)"/>
   <result pre="been associated with severe clinical manifestations and congenital malformations including" exact="microcephaly" post="[11] and Guillain-BarrÃ© syndrome [12]. ZIKV was isolated for"/>
   <result pre="transmission rate TE transmission efficiency MEB midgut escape barrier CHIKV" exact="chikungunya" post="virus DENV dengue virus RVFV Rift Valley fever phlebovirus"/>
   <result pre="and February 2014Euro Surveill2014192075110.2807/1560-7917.ES2014.19.13.2075124721538 11.CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013â€&quot;15: a retrospective studyLancet20163872125213210.1016/S0140-6736(16)00651-626993883 12.Cao-LormeauV-MBlakeAMonsSLastÃ¨reSRocheCVanhomwegenJet al.Guillain-BarrÃ©"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6661876\results\search\disease\results.xml">
   <result pre="epidemiological characteristics, detection methods, pathogenesis, treatment and prophylactic measures of" exact="influenza" post="in China. It will be helpful for us to"/>
   <result pre="us to understand the current situation of influenza. Key words" exact="influenza" post="epidemiology H7N9 page-count: Introduction Influenza (Flu) is a kind"/>
   <result pre="(Flu) is a kind of acute respiratory infection caused by" exact="influenza" post="virus (IVs). Influenza A Virus (IAV), Influenza B Virus"/>
   <result pre="the epidemiological characteristics, detection methods, pathogenesis, prevention and treatment of" exact="influenza" post="in China. Epidemiology of common influenza viruses H7N9 In"/>
   <result pre="prevention and treatment of influenza in China. Epidemiology of common" exact="influenza" post="viruses H7N9 In 2013, human cases of new H7N9"/>
   <result pre="influenza viruses H7N9 In 2013, human cases of new H7N9" exact="avian influenza" post="infection were first reported in Shanghai and Anhui.[2] Then"/>
   <result pre="viruses H7N9 In 2013, human cases of new H7N9 avian" exact="influenza" post="infection were first reported in Shanghai and Anhui.[2] Then"/>
   <result pre="with H7N9.[3] Since the first human infection case with H7N9" exact="avian influenza" post="virus (AIVs) was identified in March 2013, five viral"/>
   <result pre="H7N9.[3] Since the first human infection case with H7N9 avian" exact="influenza" post="virus (AIVs) was identified in March 2013, five viral"/>
   <result pre="As of March 2, 2018, the World Health Organization (WHO)" exact="influenza" post="surveillance reported a total of 1567 laboratory confirmed cases"/>
   <result pre="of 1567 laboratory confirmed cases of human infection with H7N9" exact="avian influenza," post="of which 615 died and the cumulative mortality rate"/>
   <result pre="live poultry markets, culling poultry, and establishing the platform for" exact="influenza" post="research and early-warning and standard bioinformatics analyses for monitoring"/>
   <result pre="al.[6] performed large-scale surveillance and evaluated the vaccine to H5/H7" exact="influenza" post="virus in laboratories and farmed poultry in September 2017."/>
   <result pre="showed that this bivalent H5/H7 inactivated vaccine had controlled H7" exact="influenza" post="viruses efficiently. The obvious decreased prevalence of the H7N9"/>
   <result pre="During October 2017 to 2018 winter, H1N1 became the main" exact="influenza" post="virus type in mainland China once again. According to"/>
   <result pre="Center for Disease Control and Prevention (CDC), the number of" exact="influenza" post="epidemics in the Chinese mainland in 2017 was 456,718,"/>
   <result pre="456,718, with an incidence rate of 33.1/100,000. The intensity of" exact="influenza" post="activity caused by H1N1 was higher than recent years."/>
   <result pre="The popular dominant viruses were mainly the Yamagata strain of" exact="influenza" post="B and influenza A (including H3N2 and H1N1). There"/>
   <result pre="viruses were mainly the Yamagata strain of influenza B and" exact="influenza" post="A (including H3N2 and H1N1). There were differences in"/>
   <result pre="30, 2013, the first case of human infection with H10N8" exact="avian influenza" post="virus was discovered in Nanchang City, Chinaâ€™s Jiangxi Province.[8]"/>
   <result pre="2013, the first case of human infection with H10N8 avian" exact="influenza" post="virus was discovered in Nanchang City, Chinaâ€™s Jiangxi Province.[8]"/>
   <result pre="patient was a 73-year-old woman, who was diagnosed with severe" exact="pneumonia" post="accompanied by high blood pressure, heart disease, myasthenia gravis"/>
   <result pre="was diagnosed with severe pneumonia accompanied by high blood pressure," exact="heart disease," post="myasthenia gravis and other underlying diseases, with a low"/>
   <result pre="with severe pneumonia accompanied by high blood pressure, heart disease," exact="myasthenia gravis" post="and other underlying diseases, with a low immunity level."/>
   <result pre="that the risk of human infection and transmission of H10N8" exact="avian influenza" post="virus through personal contact was low. In February 2014,"/>
   <result pre="the risk of human infection and transmission of H10N8 avian" exact="influenza" post="virus through personal contact was low. In February 2014,"/>
   <result pre="from Hunan Province was the first person diagnosed with H5N6" exact="influenza" post="virus infection in China.[9] In the following two years,"/>
   <result pre="China. Influenza virus detection method The main detection methods of" exact="influenza" post="virus mainly include viral nucleic acid detection, viral antigen"/>
   <result pre="isolation culture and serological detection. The most common method is" exact="influenza" post="virus nucleic acid, which is always detected by multiple"/>
   <result pre="Biochip technique Rapid identification of infections with specific subtypes of" exact="influenza" post="virus is critical for treatment and pandemic control. Wang"/>
   <result pre="(human H1N1, human H3N2, avian H5N1 and avian H7N9) of" exact="influenza" post="viruses in circulation in China. PCR products were analyzed"/>
   <result pre="a rapid, reliable and inexpensive detection and differentiation of human-infecting" exact="influenza" post="viruses. Gene Sequencing In recent years, the sequencing of"/>
   <result pre="al[11] used NGS technology in clinical specimens to investigate an" exact="influenza" post="outbreak in hospitals. Nasopharyngeal swabs from patients were collected"/>
   <result pre="factor storms, leading to systemic inflammatory reactions, which can cause" exact="acute respiratory distress syndrome" post="(ARDS), shock and multiple organ failure. During viral replication"/>
   <result pre="that, in patients infected with H1N1, the level of circulating" exact="influenza" post="specific CD4+ but not CD8+T cells is positively correlated"/>
   <result pre="play an important role in the prevention and treatment of" exact="influenza" post="in the future. Treatments Current Antiviral Drugs At present,"/>
   <result pre="sites on the NA molecule to inhibit the release of" exact="influenza" post="virus progeny from the cell surface. Three FDA-approved NAIs"/>
   <result pre="resistance to adamantanes; therefore, they are no longer recommended for" exact="influenza" post="treatment. NAIs are still the main antiviral drugs.[18] Zou"/>
   <result pre="on design and structural characterization of potent peptidic inhibitors against" exact="influenza" post="HA. The peptide design was based on complementarity determining"/>
   <result pre="CR9114. The optimized peptides exhibit nanomolar affinity and neutralization against" exact="influenza" post="A viruses including H1N1 and H5N1. These peptidic compounds"/>
   <result pre="accelerate development of novel small molecule and peptide-based therapeutics against" exact="influenza" post="virus. A small molecule prodrug â€&quot; Baloxavir marboxil In"/>
   <result pre="currently a new drug that can inhibit the proliferation of" exact="influenza" post="virus. Recently, Koshimichi et al.[22] published a phase III"/>
   <result pre="U.S. FDA approved it for the treatment of uncomplicated acute" exact="influenza" post="patients aged 12 years and older, who have been"/>
   <result pre="the past 20 years. Corticosteroids The application of corticosteroids in" exact="influenza" post="virus pneumonia has always been controversial. A multicenter, retrospective"/>
   <result pre="20 years. Corticosteroids The application of corticosteroids in influenza virus" exact="pneumonia" post="has always been controversial. A multicenter, retrospective study about"/>
   <result pre="mortality than late administration. More patients receiving steroids had acquired" exact="pneumonia" post="and a trend to a longer duration of ventilation.[23]"/>
   <result pre="group was more likely to have superinfection such as secondary" exact="bacterial pneumonia" post="or invasive fungal infection, and had more prolonged intensive"/>
   <result pre="was more likely to have superinfection such as secondary bacterial" exact="pneumonia" post="or invasive fungal infection, and had more prolonged intensive"/>
   <result pre="the timing, dosage, and course of corticosteroids in patients with" exact="influenza" post="virus pneumonia are still the focus of controversy. Extracorporeal"/>
   <result pre="dosage, and course of corticosteroids in patients with influenza virus" exact="pneumonia" post="are still the focus of controversy. Extracorporeal membrane oxygenation"/>
   <result pre="of patients. ECMO was the breakthrough treatment for the severe" exact="avian influenza" post="A (H1N1) outbreak of 2009 and reduced mortality from"/>
   <result pre="patients. ECMO was the breakthrough treatment for the severe avian" exact="influenza" post="A (H1N1) outbreak of 2009 and reduced mortality from"/>
   <result pre="is effective at improving oxygenation and ventilation of patients with" exact="avian influenza" post="A (H7N9) induced severe ARDS. Early initiation of ECMO"/>
   <result pre="effective at improving oxygenation and ventilation of patients with avian" exact="influenza" post="A (H7N9) induced severe ARDS. Early initiation of ECMO"/>
   <result pre="Chinese medicine also plays an important role in fighting against" exact="influenza" post="virus. Chinese herbal medicines are commonly used for anti-influenza"/>
   <result pre="and tonic drugs. The main ways of Chinese medicine against" exact="influenza" post="virus are as follows: (1) Banlangen, Honeysuckle, Forsythia, Guanzhong"/>
   <result pre="killing the virus, inhibiting the adsorption, infection and replication of" exact="influenza" post="virus. Among them, baicalin[30] and silybin inhibit the virus"/>
   <result pre="word, combination of traditional Chinese medicine and Western medicine against" exact="influenza" post="virus is a direction worth exploring. Prevention Isolation of"/>
   <result pre="prevent IVA. Wu et al.[33] compared the detection frequency of" exact="avian influenza" post="H7 subtypes at live poultry markets in Guangdong Province,"/>
   <result pre="IVA. Wu et al.[33] compared the detection frequency of avian" exact="influenza" post="H7 subtypes at live poultry markets in Guangdong Province,"/>
   <result pre="centuryEur J Immunol2009392946â€&quot;5419790188 2GaoRCaoBHuYFengZWangDHuWet alHuman infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN Engl J Med20133681888â€&quot;9723577628 3BaoCJCuiLBZhouMHHongLGaoGFWangHLive animal markets"/>
   <result pre="A (H7N9) virusN Engl J Med20133681888â€&quot;9723577628 3BaoCJCuiLBZhouMHHongLGaoGFWangHLive animal markets and" exact="influenza" post="A (H7N9) virus infectionN Engl J Med20133682337â€&quot;923697471 4WangXJiangHWuPUyekiTMFengLLaiSet alEpidemiology"/>
   <result pre="A (H7N9) virus infectionN Engl J Med20133682337â€&quot;923697471 4WangXJiangHWuPUyekiTMFengLLaiSet alEpidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="(H7N9) virus infectionN Engl J Med20133682337â€&quot;923697471 4WangXJiangHWuPUyekiTMFengLLaiSet alEpidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="Infect Dis201717822â€&quot;3228583578 5WeiXCuiJWhy were so few people infected with H7N9" exact="influenza" post="A viruses in China from late 017 to 2018?Sci"/>
   <result pre="7ZhuHLeeACYLiCMakWWNChenYYChanKHet alLow population serum microneutralization antibody titer against the predominating" exact="influenza" post="A(H3N2) N121K virus during the severe influenza summer peak"/>
   <result pre="against the predominating influenza A(H3N2) N121K virus during the severe" exact="influenza" post="summer peak of Hong Kong in 2017Emerg Microbes Infect"/>
   <result pre="2018;723 8WanJZhangJTaoWJiangGZhouWPanJet alA report of first fatal case of H10N8" exact="avian influenza" post="virus pneumonia in the worldZhonghua Wei Zhong Bing Ji"/>
   <result pre="8WanJZhangJTaoWJiangGZhouWPanJet alA report of first fatal case of H10N8 avian" exact="influenza" post="virus pneumonia in the worldZhonghua Wei Zhong Bing Ji"/>
   <result pre="report of first fatal case of H10N8 avian influenza virus" exact="pneumonia" post="in the worldZhonghua Wei Zhong Bing Ji Jiu Yi"/>
   <result pre="and virological characteristics of the first detected human case of" exact="avian influenza" post="A(H5N6) virusInfect Genet Evol201640236â€&quot;4226973295 10WangYQuJBaQDongJZhangLZhangHet alDetection and typing of"/>
   <result pre="virological characteristics of the first detected human case of avian" exact="influenza" post="A(H5N6) virusInfect Genet Evol201640236â€&quot;4226973295 10WangYQuJBaQDongJZhangLZhangHet alDetection and typing of"/>
   <result pre="A(H5N6) virusInfect Genet Evol201640236â€&quot;4226973295 10WangYQuJBaQDongJZhangLZhangHet alDetection and typing of human-infecting" exact="influenza" post="viruses in China by using a multiplex DNA biochip"/>
   <result pre="using a multiplex DNA biochip assayJ Virol Methods2016234178â€&quot;8527150046 11SeongMWChoSIParkHSeoSHLeeSJKimECet alGenotyping" exact="influenza" post="virus by next-generation deep sequencing in clinical specimensAnn Lab"/>
   <result pre="next-generation deep sequencing in clinical specimensAnn Lab Med201636255â€&quot;826915615 12LiHCaoBPandemic and" exact="avian influenza" post="A viruses in humans: epidemiology, virology, clinical characteristics, and"/>
   <result pre="deep sequencing in clinical specimensAnn Lab Med201636255â€&quot;826915615 12LiHCaoBPandemic and avian" exact="influenza" post="A viruses in humans: epidemiology, virology, clinical characteristics, and"/>
   <result pre="alHigh levels of virus-specific CD4+ T cells predict severe pandemic" exact="influenza" post="A virus infectionAm J Respir Crit Care Med20121861292â€&quot;723087026 15XueCWenMBaoLLiHLiFLiuMet"/>
   <result pre="Respir Crit Care Med20121861292â€&quot;723087026 15XueCWenMBaoLLiHLiFLiuMet alVÎ³4+Î³Î´T cells aggravate severe H1N1" exact="influenza" post="virus infection-induced acute pulmonary immunopathological injury via secreting interleukin-17AFront"/>
   <result pre="of therapeutics in clinical development for respiratory syncytial virus and" exact="influenza" post="in childrenClin Ther2018401268â€&quot;8130077340 17WangYGuoQYanZZhouDZhangWZhouSet alFactors associated with prolonged viral"/>
   <result pre="17WangYGuoQYanZZhouDZhangWZhouSet alFactors associated with prolonged viral shedding in patients with" exact="avian influenza" post="A(H7N9) virus infectionJ Infect Dis20182171708â€&quot;1729648602 18GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of"/>
   <result pre="alFactors associated with prolonged viral shedding in patients with avian" exact="influenza" post="A(H7N9) virus infectionJ Infect Dis20182171708â€&quot;1729648602 18GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of"/>
   <result pre="A(H7N9) virus infectionJ Infect Dis20182171708â€&quot;1729648602 18GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the advisory committee on immunization"/>
   <result pre="recommendations of the advisory committee on immunization practices-united states, 2018-19" exact="influenza" post="seasonMMWR Recomm Rep2018671â€&quot;20 19ZouXGuoQZhangWChenHBaiWLuBet alDynamic variation and reversion in"/>
   <result pre="germline-like human monoclonal antibody targets a ph-sensitive epitope on H7N9" exact="influenza" post="hemagglutininCell Host Microbe201722471â€&quot;8328966056 21KadamRUJuraszekJBrandenburgBBuyckCSchepensWBGKesteleynBet alPotent peptidic fusion inhibitors of"/>
   <result pre="influenza hemagglutininCell Host Microbe201722471â€&quot;8328966056 21KadamRUJuraszekJBrandenburgBBuyckCSchepensWBGKesteleynBet alPotent peptidic fusion inhibitors of" exact="influenza" post="virusScience2017358496â€&quot;50228971971 22KoshimichiHIshibashiTKawaguchiNSatoCKawasakiAWajimaTSafety, tolerability, and pharmacokinetics of the novel anti-influenza"/>
   <result pre="study findingsClin Drug Investig2018381189â€&quot;96 23HaydenFGSugayaNHirotsuNLeeNdeJong MDHurtACet alBaloxavir marboxil for uncomplicated" exact="influenza" post="in adults and adolescentsN Engl J Med2018379913â€&quot;2330184455 24Brun-BuissonCRichardJCMercatAThiÃ©bautACBrochardL; REVA-SRLF"/>
   <result pre="J Med2018379913â€&quot;2330184455 24Brun-BuissonCRichardJCMercatAThiÃ©bautACBrochardL; REVA-SRLF A/H1N1v2009Registry Group. Early corticosteroids in severe" exact="influenza" post="A/H1N1 pneumonia and acute respiratory distress syndromeAm J Respir"/>
   <result pre="24Brun-BuissonCRichardJCMercatAThiÃ©bautACBrochardL; REVA-SRLF A/H1N1v2009Registry Group. Early corticosteroids in severe influenza A/H1N1" exact="pneumonia" post="and acute respiratory distress syndromeAm J Respir Crit Care"/>
   <result pre="Med20111831200â€&quot;6 25KimSHHongSBYunSCChoiWIAhnJJLeeYJet alCorticosteroid treatment in critically ill patients with pandemic" exact="influenza" post="A/H1N1 2009 infection: analytic strategy using propensity scoresAm J"/>
   <result pre="therapy on ICU admission in patients affected by severe pandemic(H1N1)v" exact="influenza" post="A infectionIntensive Care Med201137272â€&quot;8321107529 27CaoBGaoHZhouBDengXHuCDengCet alAdjuvant corticosteroid treatment in"/>
   <result pre="infectionIntensive Care Med201137272â€&quot;8321107529 27CaoBGaoHZhouBDengXHuCDengCet alAdjuvant corticosteroid treatment in adults with" exact="influenza" post="A (H7N9) viral pneumoniaCrit Care Med201644e318â€&quot;e32826934144 28LiHYangSGGuLZhangYYanXXLiangZAet alEffect of"/>
   <result pre="low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with" exact="influenza" post="A(H1N1) pdm09 viral pneumoniaInfluenza Other Respir Viruses201711345â€&quot;5428464462 29HuangLZhangWYangYWuWLuWXueHet alApplication"/>
   <result pre="29HuangLZhangWYangYWuWLuWXueHet alApplication of extracorporeal membrane oxygenation in patients with severe" exact="acute respiratory distress syndrome" post="induced by avian influenza A (H7N9) viral pneumonia: national"/>
   <result pre="in patients with severe acute respiratory distress syndrome induced by" exact="avian influenza" post="A (H7N9) viral pneumonia: national data from the Chinese"/>
   <result pre="patients with severe acute respiratory distress syndrome induced by avian" exact="influenza" post="A (H7N9) viral pneumonia: national data from the Chinese"/>
   <result pre="multicentre collaborationBMC Infect Dis2018182329310581 30ZhuHYHanLShiXLWangBLHuangHWangXet alBaicalin inhibits autophagy induced by" exact="influenza" post="A virus H3N2Antiviral Res201511362â€&quot;7025446340 31ZhouZLiXLiuJDongLChenQLiuJet alHoneysuckle-encoded atypical microRNA2911 directly"/>
   <result pre="A virus H3N2Antiviral Res201511362â€&quot;7025446340 31ZhouZLiXLiuJDongLChenQLiuJet alHoneysuckle-encoded atypical microRNA2911 directly targets" exact="influenza" post="A virusesCell Res20152539â€&quot;4925287280 32ChenHWChengJXLiuMTKingKPengJYZhangXQet alInhibitory and combinatorial effect of"/>
   <result pre="alInhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on" exact="influenza" post="virusesAntiviral Res201399371â€&quot;8223820269 33WuJKeCLauEHYSongYChengKLZouLet alInfluenza H5/H7 virus vaccination in poultry"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6663013\results\search\disease\results.xml">
   <result pre="Life Sciences : Genetics: Microbial Genetics Severe cases of seasonal" exact="influenza" post="in Russia in 2017-2018 Severe cases of seasonal influenza"/>
   <result pre="seasonal influenza in Russia in 2017-2018 Severe cases of seasonal" exact="influenza" post="in Russia in 2017-2018 http://orcid.org/0000-0001-8865-8592KolosovaNatalia P.ConceptualizationFormal analysisInvestigationMethodologyValidationVisualizationWriting â€&quot; original"/>
   <result pre="the original author and source are credited.pone.0220401.pdf Abstract The 2017â€&quot;2018" exact="influenza" post="epidemic season in Russia was characterized by a relatively"/>
   <result pre="and mortality. We evaluated herd immunity prior to the 2017â€&quot;2018" exact="influenza" post="season in hemagglutination inhibition assay, and performed characterization of"/>
   <result pre="influenza season in hemagglutination inhibition assay, and performed characterization of" exact="influenza" post="viruses isolated from severe or fatal influenza cases and"/>
   <result pre="performed characterization of influenza viruses isolated from severe or fatal" exact="influenza" post="cases and from influenza cases in people vaccinated in"/>
   <result pre="viruses isolated from severe or fatal influenza cases and from" exact="influenza" post="cases in people vaccinated in the fall of 2017."/>
   <result pre="the fall of 2017. During the 2017â€&quot;2018 epidemic season, 87" exact="influenza" post="A and B viruses were isolated and viruses of"/>
   <result pre="and B viruses were isolated and viruses of the 75" exact="influenza" post="cases, including selected viral isolates and viruses analyzed directly"/>
   <result pre="hemagglutinin gene of A(H1N1)pdm09 for epidemiological surveillance. One strain of" exact="influenza" post="virus A(H1N1)pdm09 was resistant to oseltamivir and had the"/>
   <result pre="the presence of protective antibody titers against vaccine strains of" exact="influenza" post="A and influenza B/Victoria-like, respectively. Mass vaccination of the"/>
   <result pre="protective antibody titers against vaccine strains of influenza A and" exact="influenza" post="B/Victoria-like, respectively. Mass vaccination of the population had evidently"/>
   <result pre="reduced the severity of the flu epidemic during the 2017â€&quot;2018" exact="influenza" post="epidemic season in Russia. Funding This work was supported"/>
   <result pre="and its Supporting Information files. Introduction Influenza is an infectious" exact="respiratory disease" post="caused by influenza viruses type A, B, C and"/>
   <result pre="files. Introduction Influenza is an infectious respiratory disease caused by" exact="influenza" post="viruses type A, B, C and D. The disease"/>
   <result pre="An emergence in the human population of a variant of" exact="influenza" post="A virus with new antigenic properties may cause a"/>
   <result pre="mortality [3]. Thereby, monitoring population immunity and severe cases of" exact="influenza" post="is an essential activity carried out within the framework"/>
   <result pre="studying the population humoral immunity and the epidemic situation of" exact="influenza" post="in Russia since 2009 [4â€&quot;8]. This study continues our"/>
   <result pre="continues our work on annual evaluation of herd immunity to" exact="influenza" post="just before the influenza epidemic seasons in Russia and"/>
   <result pre="annual evaluation of herd immunity to influenza just before the" exact="influenza" post="epidemic seasons in Russia and analyses of circulating influenza"/>
   <result pre="the influenza epidemic seasons in Russia and analyses of circulating" exact="influenza" post="viruses in Russia, with a focus on the influenza"/>
   <result pre="circulating influenza viruses in Russia, with a focus on the" exact="influenza" post="viruses which cause severe illness, including cases with lethal"/>
   <result pre="with lethal outcome. The epidemic rise in the incidence of" exact="influenza" post="in Russia began during the 6th to 7th weeks"/>
   <result pre="In contrast to Western countries, the epidemic rise in the" exact="influenza" post="disease incidence was smooth, and throughout the epidemic, the"/>
   <result pre="2017â€&quot;2018 epidemic season in Russia was characterized by a low" exact="influenza" post="disease incidence in persons vaccinated in the fall of"/>
   <result pre="purpose of this study was to assess population immunity to" exact="influenza" post="viruses before the 2017â€&quot;2018 Russian epidemic season and to"/>
   <result pre="viruses before the 2017â€&quot;2018 Russian epidemic season and to characterize" exact="influenza" post="viruses from clinical material from cases of severe influenza"/>
   <result pre="characterize influenza viruses from clinical material from cases of severe" exact="influenza" post="disease, autopsy material from influenza disease cases with lethal"/>
   <result pre="material from cases of severe influenza disease, autopsy material from" exact="influenza" post="disease cases with lethal outcome, and clinical material from"/>
   <result pre="[6]. The A/Michigan/45/2015 A(H1N1)pdm09, A/HongKong/4801/2014 A(H3N2) and B/Brisbane/60/2008 (Victoria lineage)" exact="influenza" post="viruses were kindly provided by the WHO Collaborating Center"/>
   <result pre="the Russian Federation. PCR-based diagnostics of the original material for" exact="influenza" post="virus RNA was conducted in local laboratories, and then"/>
   <result pre="of cells [12]. Diagnostic real-time PCR for detecting RNA of" exact="influenza" post="A virus and influenza B virus was performed using"/>
   <result pre="real-time PCR for detecting RNA of influenza A virus and" exact="influenza" post="B virus was performed using RNA isolated with the"/>
   <result pre="Rights Protection and Human Wellbeing (Moscow, Russia). Serological analysis of" exact="influenza" post="viruses Serological typing/subtyping of isolated influenza virus strains and"/>
   <result pre="Russia). Serological analysis of influenza viruses Serological typing/subtyping of isolated" exact="influenza" post="virus strains and studying their antigenic features were carried"/>
   <result pre="A/Michigan/45/2015 A(H1N1)pdm09, A/HongKong/4801/2014 A(H3N2), B/Brisbane/60/2008 (Victoria lineage), B/Phuket/3073/2013 (Yamagata lineage)" exact="influenza" post="viruses were used for serological typing of influenza virus"/>
   <result pre="(Yamagata lineage) influenza viruses were used for serological typing of" exact="influenza" post="virus isolates. All reference sera were kindly furnished by"/>
   <result pre="Influenza in Atlanta, US. Sensitivity to anti-neuraminidase drugs Susceptibility of" exact="influenza" post="viruses to neuraminidase inhibitors oseltamivir and zanamivir was tested"/>
   <result pre="the protocol recommended by the WHO [13]. Sequence analysis of" exact="influenza" post="viruses Sequencing was carried out at the FBRI SRC"/>
   <result pre="Results Investigation of herd immunity To assess herd immunity to" exact="influenza" post="A and B viruses, 3728 serum samples collected in"/>
   <result pre="the results obtained in the HI tests with the seasonal" exact="influenza" post="vaccine strains for 2017â€&quot;2018. Fig 1 Seropositivity for influenza"/>
   <result pre="seasonal influenza vaccine strains for 2017â€&quot;2018. Fig 1 Seropositivity for" exact="influenza" post="vaccine viruses in the studied groups of people from"/>
   <result pre="(1:40 and above) in HI tests with vaccine strains of" exact="influenza" post="A virus subtypes A(H1N1)pdm09 and A(H3N2) (Fig 1). The"/>
   <result pre="A(H3N2) (Fig 1). The proportion of seropositive individuals for the" exact="influenza" post="B virus of the Victoria genetic lineage was slightly"/>
   <result pre="seropositive individuals in 2016, versus 33% in 2017) to the" exact="influenza" post="A(H1N1)pdm09 virus, while the proportion of seropositive individuals to"/>
   <result pre="strains in circulation during the 2016â€&quot;2017 season. Characterization of seasonal" exact="influenza" post="viruses In the epidemic season of 2017â€&quot;2018, the SRC"/>
   <result pre="primary samples were received that were positive for RNA of" exact="influenza" post="A and B viruses, including 90 samples of autopsy"/>
   <result pre="with severe disease and 136 samples from patients vaccinated against" exact="influenza" post="in the fall of 2017 (Table 1). 10.1371/journal.pone.0220401.t001Table 1"/>
   <result pre="1). 10.1371/journal.pone.0220401.t001Table 1 Data on patients with cases of severe" exact="influenza" post="disease, cases of influenza disease with fatal outcome, and"/>
   <result pre="on patients with cases of severe influenza disease, cases of" exact="influenza" post="disease with fatal outcome, and patients vaccinated in the"/>
   <result pre="2017. Group Fatal cases (number) Severe cases (number) Vaccinated against" exact="influenza" post="in the fall of 2017 (number of infected) Sex"/>
   <result pre="70 3 Pregnant women 1 146 12 People vaccinated against" exact="influenza" post="in the fall of 2017 4 132 136 Total"/>
   <result pre="136 Total 90 757 136 During the monitoring of seasonal" exact="influenza" post="virus in the territory of the Russian Federation in"/>
   <result pre="Russian Federation in the 2017â€&quot;2018 epidemic season, 87 strains of" exact="influenza" post="A and B viruses were isolated: 47 strains of"/>
   <result pre="strains of A(H1N1)pdm09, 13 strains of A(H3N2), 25 strains of" exact="influenza" post="B virus of the Yamagata lineage and 2 strains"/>
   <result pre="B virus of the Yamagata lineage and 2 strains of" exact="influenza" post="B virus of the Victoria lineage. Influenza viruses from"/>
   <result pre="clinical material (S1, S3 and S5 Tables). Antigenic analysis of" exact="influenza" post="viruses The antigenic properties of all strains of influenza"/>
   <result pre="of influenza viruses The antigenic properties of all strains of" exact="influenza" post="A(H1N1)pdm09 virus (including 17 isolates from lethal cases of"/>
   <result pre="disease) were similar to the A/Michigan/45/2015 vaccine strain, strains of" exact="influenza" post="B/Yamagata-like virus (3 of which were isolated from lethal"/>
   <result pre="similar to the B/Phuket/3073/2013 vaccine strain, and two strains of" exact="influenza" post="B/Victoria-like virus were similar to the B/Brisbane/60/2008 vaccine strain."/>
   <result pre="egg adaptive changes decreased vaccine effectiveness [19]. Genetic analysis of" exact="influenza" post="viruses Influenza viruses from 75 selected cases (original specimen"/>
   <result pre="(S1 Table), 26 viruses of A(H3N2) subtype (S3 Table), 18" exact="influenza" post="B/Yamagata-like viruses and 2 influenza B/Victoria-like viruses (S5 Table)."/>
   <result pre="A(H3N2) subtype (S3 Table), 18 influenza B/Yamagata-like viruses and 2" exact="influenza" post="B/Victoria-like viruses (S5 Table). The complete nucleotide sequences of"/>
   <result pre="complete nucleotide sequences of the hemagglutinin (HA) gene for 70" exact="influenza" post="viruses were determined and were used to perform a"/>
   <result pre="analysis. The results of the phylogenetic analysis showed that the" exact="influenza" post="A(H1N1)pdm09 viruses from 26 cases grouped in clade 6B.1"/>
   <result pre="from 26 cases grouped in clade 6B.1 (S1 Fig), 25" exact="influenza" post="A(H3N2) viruses grouped in clade 3C.2a (of which 11"/>
   <result pre="of complete genomes (or partially sequenced genomes) of 29 selected" exact="influenza" post="viruses A(H1N1)pdm09 showed a close genetic similarity with the"/>
   <result pre="A(H1N1)pdm09 cases comprised 65% of all studied and diagnostically confirmed" exact="influenza" post="lethal cases in Russia, with H3N2 and influenza type"/>
   <result pre="diagnostically confirmed influenza lethal cases in Russia, with H3N2 and" exact="influenza" post="type B being 15% and 20%, respectively, according to"/>
   <result pre="of the HA gene of 29 selected cases of A(H1N1)pdm09" exact="influenza" post="revealed in the major virus variant the presence of"/>
   <result pre="criteria of the WHO expert working group on surveillance of" exact="influenza" post="antiviral susceptibility) [20, 21]. No mutations associated with resistance"/>
   <result pre="antiviral susceptibility) [20, 21]. No mutations associated with resistance of" exact="influenza" post="A(H1N1)pdm09 viruses to the NA inhibitor zanamivir were identified."/>
   <result pre="the NA inhibitor zanamivir were identified. Genetic analysis of A(H3N2)" exact="influenza" post="virus was performed for 26 selected cases, including 2"/>
   <result pre="of amino acid substitutions in the HA of the studied" exact="influenza" post="A(H3N2) viruses in comparison with the A/Hong Kong/4801/2014 vaccine"/>
   <result pre="with the vaccine strain. The majority of the fatal of" exact="influenza" post="B/Yamagata-like viruses were associated with the presence of the"/>
   <result pre="influenza B/Yamagata-like viruses were associated with the presence of the" exact="influenza" post="illness risk group factors established by the WHO (age"/>
   <result pre="genetically similar to the B/Brisbane/60/2008 vaccine strain. No variants of" exact="influenza" post="B/Victoria-like viruses with a deletion in the HA gene"/>
   <result pre="amino acid positions in the protein) were found. Analysis of" exact="influenza" post="cases in vaccinated individuals Of the 136 cases in"/>
   <result pre="those that recovered from influenza, 63 cases were diagnosed with" exact="influenza" post="virus B, 41 with A(H3N2) virus, 25 with A(H1N1)pdm09"/>
   <result pre="with A(H3N2) virus, 25 with A(H1N1)pdm09 virus and 3 with" exact="influenza" post="A virus that was not subtyped. There were only"/>
   <result pre="B/Yamagata-like virus. One of the A(H1N1)pdm09 viruses from a lethal" exact="influenza" post="case in a vaccinated individual, A/Irkutsk/1727/2018, was genetically analyzed."/>
   <result pre="the presence of serious chronic diseases, which are considered as" exact="influenza" post="risk factors by the WHO [26]. The second lethal"/>
   <result pre="risk factors by the WHO [26]. The second lethal A(H1N1)pdm09" exact="influenza" post="case in a vaccinated individual was associated with the"/>
   <result pre="the presence of serious chronic diseases, one of which was" exact="chronic obstructive pulmonary disease" post="(COPD). Analysis of sensitivity to anti-neuraminidase drugs In the"/>
   <result pre="seasonal influenza, sensitivity to oseltamivir and zanamivir of 87 isolated" exact="influenza" post="viruses A and B was analyzed. According to the"/>
   <result pre="the phenotypic study, all isolated isolates of A(H3N2) and B" exact="influenza" post="viruses were sensitive to anti-neuraminidase drugs oseltamivir and zanamivir."/>
   <result pre="Discussion In this study the assessment of population immunity to" exact="influenza" post="viruses before the 2017â€&quot;2018 Russian epidemic season was performed"/>
   <result pre="Russian epidemic season was performed and a representative set of" exact="influenza" post="viruses, which circulated in Russia during the 2017â€&quot;2018 epidemic"/>
   <result pre="Russia during the 2017â€&quot;2018 epidemic season, from cases of severe" exact="influenza" post="disease, including cases with lethal outcome, and clinical material"/>
   <result pre="at the beginning of the epidemic period, one of the" exact="influenza" post="A virus subtypes (A(H1N1)pdm09 and A(H3N2), respectively) prevailed in"/>
   <result pre="(A(H1N1)pdm09 and A(H3N2), respectively) prevailed in the northern hemisphere and" exact="influenza" post="B viruses became prevalent at the end of the"/>
   <result pre="the epidemic season, joint circulation of type A and B" exact="influenza" post="strains was observed [6, 8]. The United States were"/>
   <result pre="The United States were characterized by a significant prevalence of" exact="influenza" post="A viruses (71.2%) over influenza B viruses (28.8%); of"/>
   <result pre="by a significant prevalence of influenza A viruses (71.2%) over" exact="influenza" post="B viruses (28.8%); of the influenza A viruses, 84.9%"/>
   <result pre="A viruses (71.2%) over influenza B viruses (28.8%); of the" exact="influenza" post="A viruses, 84.9% belonged to the A(H3N2) subtype and"/>
   <result pre="A(H3N2) subtype and 15.1% belonged to the A(H1N1)pdm09 subtype. Among" exact="influenza" post="B viruses, viruses of the B/Yamagata genetic lineage prevailed"/>
   <result pre="was observed with occurrences of a slightly higher prevalence of" exact="influenza" post="A virus (Canada, 57%), or influenza B virus (Europe,"/>
   <result pre="slightly higher prevalence of influenza A virus (Canada, 57%), or" exact="influenza" post="B virus (Europe, 56%). Different countries in Europe demonstrated"/>
   <result pre="in Europe demonstrated the predominance of a particular subtype of" exact="influenza" post="A virus (A(H3N2) in the UK, A(H1N1)pdm09 in France,"/>
   <result pre="proportions of both subtypes were approximately equal [9]. In China," exact="influenza" post="viruses of A and B type circulated in approximately"/>
   <result pre="to 4th weeks of 2018), A(H1N1)pdm09 strains significantly prevailed among" exact="influenza" post="A viruses [4TN]. Most of the influenza A(H1N1)pdm09 viruses"/>
   <result pre="significantly prevailed among influenza A viruses [4TN]. Most of the" exact="influenza" post="A(H1N1)pdm09 viruses studied in North America and Europe were"/>
   <result pre="recommendation of the WHO [29]. In Russia, none of the" exact="influenza" post="virus subtypes was dominant in the 2017â€&quot;2018 epidemic season:"/>
   <result pre="27]. Analysis revealed an increase in the proportion of A(H1N1)pdm09" exact="influenza" post="virus detected in lethal influenza cases (65%) compared to"/>
   <result pre="in the proportion of A(H1N1)pdm09 influenza virus detected in lethal" exact="influenza" post="cases (65%) compared to equal proportions of A(H1N1)pdm09, A(H3N2)"/>
   <result pre="cases (65%) compared to equal proportions of A(H1N1)pdm09, A(H3N2) and" exact="influenza" post="B viruses in all influenza cases. A similar increased"/>
   <result pre="proportions of A(H1N1)pdm09, A(H3N2) and influenza B viruses in all" exact="influenza" post="cases. A similar increased proportion of A(H1N1)pdm09 compared with"/>
   <result pre="virus isolates from the 19 studied lethal cases of A(H1N1)pdm09" exact="influenza" post="(Table 2, S1 and S2 Tables). It is known"/>
   <result pre="tract, which can lead to an increased risk of developing" exact="viral pneumonia." post="Some researchers suggest that increased virulence and lethality of"/>
   <result pre="Some researchers suggest that increased virulence and lethality of A(H1N1)pdm09" exact="influenza" post="virus may be caused by the presence of D222G/N"/>
   <result pre="accumulate as a result of selection from a mixture of" exact="influenza" post="virus variants (quasi-species) in the lower parts of the"/>
   <result pre="receptors in allantoic cells [35, 36, 37]. Cultivation of human" exact="influenza" post="viruses on MDCK cells has proved to be a"/>
   <result pre="stability and are used as the standard cell line for" exact="influenza" post="virus propagation [34]. MDCK cells have both 2,6- and"/>
   <result pre="those cell types. In previously reported genetic stability studies of" exact="influenza" post="virus propagation on MDCK cells, it was shown that"/>
   <result pre="evaluate the significance of the observed genetic changes of seasonal" exact="influenza" post="viruses in studies that employ virus isolation using MDCK"/>
   <result pre="epidemiological analysis and prognosis. Among the 87 analyzed isolates of" exact="influenza" post="A and B viruses, only one A(H1N1)pdm09 strain isolated"/>
   <result pre="only one A(H1N1)pdm09 strain isolated from a lethal case of" exact="influenza" post="was resistant to oseltamivir while remaining susceptible to zanamivir;"/>
   <result pre="season of 2017â€&quot;2018, however, no more than 1% of the" exact="influenza" post="viruses analyzed in the Northern Hemisphere were characterized by"/>
   <result pre="decrease in sensitivity to NA inhibitors [27]. This class of" exact="influenza" post="drugs is still highly effective and specific for the"/>
   <result pre="is still highly effective and specific for the treatment of" exact="influenza" post="and is recommended for use at an early stage"/>
   <result pre="the population with protective antibody titers was 24%-47% against the" exact="influenza" post="vaccine strains prior to the 2017â€&quot;2018 epidemic season and"/>
   <result pre="VB â€œVectorâ€�, Rospotrebnadzor received clinical samples from 136 cases of" exact="influenza" post="among individuals vaccinated in the fall of 2017, 60%"/>
   <result pre="the fall of 2017, 60% of which included cases of" exact="influenza" post="disease among children under the age of 18 years"/>
   <result pre="the 2017â€&quot;2018 season. The epidemic rise in the incidence of" exact="influenza" post="began during the 6th to 7th weeks of 2018,"/>
   <result pre="The proportion of patients with severe acute respiratory infection of" exact="influenza" post="etiology placed in the intensive care unit (2.3%) was"/>
   <result pre="trivalent vaccine recommended by the WHO for use in the" exact="influenza" post="season of 2018â€&quot;2019, 2 components were simultaneously replaced: A(H3N2)"/>
   <result pre="instead of B/Brisbane/60/2008 strain) [27]. A new variant of B/Victoria-like" exact="influenza" post="virus, which has a deletion in the HA gene,"/>
   <result pre="prior to the 2017â€&quot;2018 epidemic season. The rise of the" exact="influenza" post="epidemic began during the 6th to 7th weeks of"/>
   <result pre="2017â€&quot;2018 epidemic season in Russia was characterized by a low" exact="influenza" post="disease incidence in persons vaccinated in the fall of"/>
   <result pre="next generation sequencing of the original clinical material and isolated" exact="influenza" post="strains of A(H1N1)pdm09 viruses revealed major or minor viral"/>
   <result pre="the 87 analyzed viral isolates only one strain of A(H1N1)pdm09" exact="influenza" post="virus was resistant to oseltamivir and had the H275Y"/>
   <result pre="inhibitor drugs at the first manifestation of clinical signs of" exact="influenza" post="disease are effective means of population protection against influenza."/>
   <result pre="information S1 Fig The phylogenetic tree for HA of A(H1N1)pdm09" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="file. S2 Fig The phylogenetic tree for HA of A(H3N2)" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="file. S3 Fig The phylogenetic tree for HA of B/Yamagata-like" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="file. S4 Fig The phylogenetic tree for HA of B/Victoria-like" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="Click here for additional data file. S5 Table Type B" exact="influenza" post="virus cases characteristics. (DOC) LINK Click here for additional"/>
   <result pre="additional data file. S6 Table Case characteristics and properties of" exact="influenza" post="viruses isolated and characterized in the 2017â€&quot;2018 epidemic season."/>
   <result pre="10.1016/j.meegid.2011.05.00221600305 5IlyichevaT, SobolevI, SusloparovI, KurskayaO, DurymanovA, SharshovK, et al.Monitoring of" exact="influenza" post="viruses in Western Siberia in 2008â€&quot;2012. Infection, Genetics and"/>
   <result pre="KolosovaN, GoncharovaN, SvyatchenkoS, PetrovaO, BondarA, MikheevV, RyzhikovAFatal cases of seasonal" exact="influenza" post="in Russia in 2015â€&quot;2016. PLoS One2016; 11(10):e016533210.1371/journal.pone.016533227776172 7IlyichevaT, AbdurashitovM,"/>
   <result pre="GoncharovaN, KolosovaN, MikheevV, RyzhikovA. Herd immunity and fatal cases of" exact="influenza" post="among the population exposed to poultry and wild birds"/>
   <result pre="2016; 88(1):35â€&quot;44. 10.1002/jmv.2430126105790 8IlyichevaTN., DurymanovAG., SvyatchenkoSV, et al.Humoral immunity to" exact="influenza" post="in an at-risk population and severe influenza cases in"/>
   <result pre="al.Humoral immunity to influenza in an at-risk population and severe" exact="influenza" post="cases in Russia in 2016â€&quot;2017. Arch Virol. 2018; 163:"/>
   <result pre="from http://www.influenza.spb.ru/en/influenza_surveillance_system_in_russia/who_national_influenza_centre. 11MarchenkoVY, SusloparovIM, KomissarovAB, et al.Reintroduction of highly pathogenic" exact="avian influenza" post="A/H5N8 virus of clade 2.3.4.4. in Russia. Arch.Virol. 2017;162(5):1381â€&quot;1385."/>
   <result pre="http://www.influenza.spb.ru/en/influenza_surveillance_system_in_russia/who_national_influenza_centre. 11MarchenkoVY, SusloparovIM, KomissarovAB, et al.Reintroduction of highly pathogenic avian" exact="influenza" post="A/H5N8 virus of clade 2.3.4.4. in Russia. Arch.Virol. 2017;162(5):1381â€&quot;1385."/>
   <result pre="method for full genome sequencing of multiple subtypes of human" exact="influenza" post="A viruses. J Clin Virol. 2015;68:43â€&quot;48. 10.1016/j.jcv.2015.04.01926071334 16HoffmannE, StechJ,"/>
   <result pre="PerezDR. Universal primer set for the full-length amplification of all" exact="influenza" post="A viruses. Arch. Virol. 2001;146:2275â€&quot;2289. 10.1007/s00705017000211811679 17Li H, 2013."/>
   <result pre="10.1093/molbev/mst19724132122 19BarrIG, DonisRO, KatzJM, McCauleyJW, OdagiriT, TrusheimH, et al.Cell culture-derived" exact="influenza" post="vaccines in the severe 2017â€&quot;2018 epidemic season: a step"/>
   <result pre="in the severe 2017â€&quot;2018 epidemic season: a step towards improved" exact="influenza" post="vaccine effectiveness. NPJ Vaccines. 2018109;3:4410.1038/s41541-018-0079-z30323955 20collab: WHOMeetings of the"/>
   <result pre="20collab: WHOMeetings of the WHO working group on surveillance of" exact="influenza" post="antiviral susceptibilityâ€&quot;Geneva, November 2011 and June 2012. Wkly. Epidemiol."/>
   <result pre="GregoryV, GubarevaLV, et al.Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors and status of novel antivirals,"/>
   <result pre="HsuSZ, KuoCY, HuangHY, HuangTY, WangHC, et al.An epidemic surge of" exact="influenza" post="A(H3N2) virus at the end of the 2016â€&quot;2017 season"/>
   <result pre="24ZostSJ, ParkhouseK, GuminaME, KimK, Diaz PerezS, WilsonPC, et al.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="BarrIG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1)" exact="influenza" post="viruses. Antimicrob Agents Chemother. 2009;53(10):4433â€&quot;4440. 10.1128/AAC.00334-0919651908 26Geneva: World Health"/>
   <result pre="Mortal Wkly Rep. 201868;67(22):634â€&quot;642. 10.15585/mmwr.mm6722a429879098 28BlantonL, AlabiN, MustaquimD, et al.Update:" exact="influenza" post="activity in the United States during the 2016â€&quot;17 season"/>
   <result pre="States during the 2016â€&quot;17 season and composition of the 2017â€&quot;18" exact="influenza" post="vaccine. MMWR Morb Mortal Wkly Rep2017;66:668â€&quot;76. 10.15585/mmwr.mm6625a328662019 29BlumbergEAMMWR: Prevention"/>
   <result pre="Am J Transplant. 201811;18(11):282910.1111/ajt.1514030372600 30SelkovaEP, GrenkovaTA, GudovaNV, OganesyanAS. Results on" exact="influenza" post="and acute respiratory viral infection in the 2017â€&quot;2018 epidemic"/>
   <result pre="SnackenR, MelidouA, IonescuS, PenttinenP. The European Influenza Surveillance Network. Dominant" exact="influenza" post="A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and"/>
   <result pre="GiombiniE, BartoliniB, AbbateI, et al.Detection of haemagglutinin D222 polymorphisms in" exact="influenza" post="A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. Clin Microbiol Infect. 2013;19(7):668â€&quot;73."/>
   <result pre="33BaldantiF, CampaniniG, PirallaA, RovidaF, BraschiA, MojoliF, et al.Severe outcome of" exact="influenza" post="A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin:"/>
   <result pre="LaurieKL. MDCK-SIAT1 cells show improved isolation rates for recent human" exact="influenza" post="viruses compared to conventional MDCK cells. J Clin Microbiol."/>
   <result pre="linkages in the chicken egg amnion and allantois influence human" exact="influenza" post="virus receptor specificity and variant selection. J. Virol. 71:3357â€&quot;3362."/>
   <result pre="JiaLiu, ZiLi, YuelongShu, DayanWang. Mutations associated with egg adaptation of" exact="influenza" post="A(H1N1)pdm09 virus in laboratory based surveillance in China, 2009â€&quot;2016,"/>
   <result pre="MajorD, RobertsonEW, WoodJM. Sequence analysis of the haemagglutinin (HA) of" exact="influenza" post="A (H1N1) viruses present in clinical material and comparison"/>
   <result pre="J Gen Virol. 1991;72:2671â€&quot;77; 10.1099/0022-1317-72-11-2671 .1940864 38ChowellG, MillerMA, ViboudC. Seasonal" exact="influenza" post="in the United States, France, and Australia: transmission and"/>
   <result pre="inhibition antibody titers as a correlate of protection for inactivated" exact="influenza" post="vaccines in children. Pediatr Infect Dis J. 201112;30(12):1081â€&quot;5. 10.1097/INF.0b013e318236766221983214"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6669529\results\search\disease\results.xml">
   <result pre="the genus Morbillivirus within the family Paramyxoviridae, which also includes" exact="measles" post="virus (measles morbillivirusâ€&quot;MeV), phocine distemper virus (phocine morbillivirusâ€&quot;PDV), peste"/>
   <result pre="Domestic Dogs and Wildlife Canine distemper is a worldwide distributed" exact="viral disease" post="that is highly contagious and has high morbidity and"/>
   <result pre="gastroenteritis, hyperkeratosis of the plantar pads and snout, and tooth" exact="enamel hypoplasia" post="in puppies [26] In addition, seizures, myoclonia with hyperesthesia,"/>
   <result pre="in viremia in peripheral blood mononuclear cells and mild transient" exact="leukopenia" post="and lymphopenia, however no clinical signs of disease were"/>
   <result pre="have shown high neuropathogenicity potential in those animals with severe" exact="encephalitis" post="[32,111,112,113]. Thus, the ability of the virus to adapt"/>
   <result pre="was made to establish a possible association between CDV with" exact="multiple sclerosis" post="by finding CDV antibodies in patients with multiple sclerosis"/>
   <result pre="with multiple sclerosis by finding CDV antibodies in patients with" exact="multiple sclerosis" post="[118]. It is well known that experimental MeV vaccination"/>
   <result pre="All of these cases showed evidence of nervous symptomatology and" exact="respiratory disease" post="with fatal outcomes [129]. The mutations association studies of"/>
   <result pre="protein expressionJ. Virol.200882105101051810.1128/JVI.01419-0818753197 6.WolfeN.D.DunavanC.P.DiamondJ.Origins of major human infectious diseasesNature200744727928310.1038/nature0577517507975 7.SchuhmannK.M.PfallerC.K.ConzelmannK.K.The" exact="measles" post="virus V protein binds to p65 (Rela) to suppress"/>
   <result pre="marker PVRL4 (nectin 4) is an epithelial cell receptor for" exact="measles" post="virusPLoS Pathog.20117e100224010.1371/journal.ppat.100224021901103 15.SchultzR.D.ThielB.MukhtarE.SharpP.LarsonL.J.Age and long-term protective immunity in dogs"/>
   <result pre="of canine distemper virusVirol. J.2019163010.1186/s12985-019-1136-630845967 102.LinL.T.RichardsonC.D.The host cell receptors for" exact="measles" post="virus and their interaction with the viral hemagglutinin (h)"/>
   <result pre="cell-to-cell spreadVirology2014454â€&quot;45510911710.1016/j.virol.2014.02.01424725937 108.NoyceR.S.RichardsonC.D.Nectin 4 is the epithelial cell receptor for" exact="measles" post="virusTrends Microbiol.20122042943910.1016/j.tim.2012.05.00622721863 109.PratakpiriyaW.Ping TehA.P.RadtanakatikanonA.PiraratN.Thi LanN.TakedaM.TechangamsuwanS.YamaguchiR.Expression of canine distemper virus"/>
   <result pre="119.De VriesP.UytdehaagF.G.OsterhausA.D.Canine distemper virus (CDV) immune-stimulating complexes (iscoms), but not" exact="measles" post="virus iscoms, protect dogs against CDV infectionJ. Gen. Virol1988692071208310.1099/0022-1317-69-8-20713404123"/>
   <result pre="virus induce incomplete immunity to canine distemperArch. Virol.198482738210.1007/BF013093696497659 121.BakerJ.A.SheffyB.E.RobsonD.S.GilmartinJ.Response to" exact="measles" post="virus by puppies with maternally transferred distemper antibodiesCornell Vet.1966565885946008347"/>
   <result pre="viruses studied with monoclonal antibodiesJ. Gen. Virol.1986671381139210.1099/0022-1317-67-7-13812425047 124.RouxelR.N.SvitekN.von MesslingV.A chimeric" exact="measles" post="virus with canine distemper envelope protects ferrets from lethal"/>
   <result pre="J. Paleopathol.20192426627810.1016/j.ijpp.2018.12.00730743216 142.BeatyS.M.LeeB.Constraints on the genetic and antigenic variability of" exact="measles" post="virusViruses2016810910.3390/v804010927110809 143.YuanC.LiuW.WangY.HouJ.ZhangL.WangG.Homologous recombination is a force in the evolution"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6669691\results\search\disease\results.xml">
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Reporter" exact="influenza" post="A viruses (IAVs) carrying fluorescent or luminescent genes provide"/>
   <result pre="co-circulates with H1N1 among humans causing annual epidemics, a reporter" exact="influenza" post="A subtype H3N2 virus would be highly valuable. In"/>
   <result pre="(Gluc) gene. Using reverse genetics, NY-r19-Gluc, a replication competent reassortant" exact="influenza" post="A subtype H3N2 virus expressing reporter Gluc was successfully"/>
   <result pre="therapeutic antibodies as well as the evaluation of novel vaccines." exact="influenza" post="A virus subtype H3N2 reassortant reporter virus 1. Introduction"/>
   <result pre="A virus subtype H3N2 reassortant reporter virus 1. Introduction The" exact="influenza" post="A virus (IAV) is a major cause of respiratory"/>
   <result pre="Currently, IAV subtypes H1N1 and H3N2 as well as two" exact="influenza" post="B virus strains of Yamagata and Victoria lineages co-circulate"/>
   <result pre="the similarity between different groups is only 40â€&quot;44% [10]. Seasonal" exact="influenza" post="vaccines are prepared in advance according to the recommendations"/>
   <result pre="containing two IAV strains (H1N1 and H3N2) and one (trivalent" exact="influenza" post="vaccine) or two (quadrivalent influenza vaccine) influenza B virus"/>
   <result pre="and H3N2) and one (trivalent influenza vaccine) or two (quadrivalent" exact="influenza" post="vaccine) influenza B virus (IBV) strains. These vaccines usually"/>
   <result pre="and one (trivalent influenza vaccine) or two (quadrivalent influenza vaccine)" exact="influenza" post="B virus (IBV) strains. These vaccines usually become less"/>
   <result pre="match the circulating strain(s), particularly in the context of an" exact="influenza" post="pandemic [12]. Several compounds have been shown to block"/>
   <result pre="Here we report the successful generation of a reporter reassortant" exact="influenza" post="A subtype H3N2 virus carrying the Gaussia luciferase (Gluc)"/>
   <result pre="to NS1 Loses the Reporter Gene Rapidly Previously, a reporter" exact="influenza" post="A subtype H1N1 virus PR8-Gluc was successfully generated by"/>
   <result pre="a similar strategy was initially employed to generate the reporter" exact="influenza" post="A subtype H3N2 virus, NY-Gluc (Figure 1a). However, as"/>
   <result pre="Carrying PR8/NS-Gluc Segment Induces CPE Alteration To generate the reporter" exact="influenza" post="A subtype H3N2 virus, another strategy was explored based"/>
   <result pre="reassortant NY-r19-Gluc virus is a good candidate as a reporter" exact="influenza" post="A subtype H3N2 virus for further characterization and application."/>
   <result pre="cells (Figure 4d). Collectively, these data demonstrate that the reporter" exact="influenza" post="A subtype H3N2 virus NY-r19-Gluc is replication-competent, and viral"/>
   <result pre="open reading frame that was successfully used to construct reporter" exact="influenza" post="A subtype H1N1 viruses [28,45] failed to generate a"/>
   <result pre="A subtype H1N1 viruses [28,45] failed to generate a reporter" exact="influenza" post="A subtype H3N2 virus (Figure 1). This is not"/>
   <result pre="protein was also explored in this study, and a reporter" exact="influenza" post="A subtype H3N2 virus NY-r18-Gluc was successfully rescued. This"/>
   <result pre="tool. Using a third strategy, we successfully generated a reporter" exact="influenza" post="subtype H3N2 virus NY-r19-Gluc, which is a 6:2 genetic"/>
   <result pre="or vaccines against IAVs. In summary, a stable replication-competent reassortant" exact="influenza" post="A subtype H3N2 virus carrying a Gluc gene was"/>
   <result pre="New York, NY, USA) for generously providing the plasmids for" exact="influenza" post="reverse genetics. Author Contributions Conceptualization, L.R. and R.D.; Data"/>
   <result pre="Challenges and solutionsCell Host Microbe20151729530010.1016/j.chom.2015.02.01225766291 4.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of" exact="influenza" post="A virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 5.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et"/>
   <result pre="Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 5.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats harbor diverse" exact="influenza" post="A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 6.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.Prevention and control of seasonal influenza"/>
   <result pre="diverse influenza A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 6.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.Prevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the Advisory Committee on Immunization"/>
   <result pre="Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15" exact="influenza" post="seasonMmwr. Morb. Mortal. Wkly. Rep.20146369169725121712 7.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an"/>
   <result pre="influenza seasonMmwr. Morb. Mortal. Wkly. Rep.20146369169725121712 7.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an" exact="avian influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="seasonMmwr. Morb. Mortal. Wkly. Rep.20146369169725121712 7.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an avian" exact="influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="fatal respiratory illnessScience199827939339610.1126/science.279.5349.3939430591 8.GaoR.CaoB.HuY.FengZ.WangD.HuW.ChenJ.JieZ.QiuH.XuK.et al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusNew Engl. J. Med.20133681888189710.1056/NEJMoa130445923577628 9.YangJ.LiM.ShenX.LiuS.Influenza A virus"/>
   <result pre="Broad Protection against the Influenza A VirusViruses20191140510.3390/v11050405 11.RussellR.J.GamblinS.J.HaireL.F.StevensD.J.XiaoB.HaY.SkehelJ.J.H1 and H7" exact="influenza" post="haemagglutinin structures extend a structural classification of haemagglutinin subtypesVirology200432528729610.1016/j.virol.2004.04.04015246268"/>
   <result pre="structural classification of haemagglutinin subtypesVirology200432528729610.1016/j.virol.2004.04.04015246268 12.VemulaS.V.SayedahmedE.E.SambharaS.MittalS.K.Vaccine approaches conferring cross-protection against" exact="influenza" post="virusesExpert Rev. Vaccines2017161141115410.1080/14760584.2017.137939628925296 13.PlotchS.J.Oâ€™HaraB.MorinJ.PalantO.LaRocqueJ.BloomJ.D.LangS.A.Jr.DiGrandiM.J.BradleyM.NilakantanR.et al.Inhibition of influenza A virus"/>
   <result pre="conferring cross-protection against influenza virusesExpert Rev. Vaccines2017161141115410.1080/14760584.2017.137939628925296 13.PlotchS.J.Oâ€™HaraB.MorinJ.PalantO.LaRocqueJ.BloomJ.D.LangS.A.Jr.DiGrandiM.J.BradleyM.NilakantanR.et al.Inhibition of" exact="influenza" post="A virus replication by compounds interfering with the fusogenic"/>
   <result pre="of stachyflin derivativesJ. Antibiot.20025516517110.7164/antibiotics.55.16512002998 15.LuoG.ColonnoR.KrystalM.Characterization of a hemagglutinin-specific inhibitor of" exact="influenza" post="A virusVirology1996226667610.1006/viro.1996.06288941323 16.LuoG.TorriA.HarteW.E.DanetzS.CianciC.TileyL.DayS.MullaneyD.YuK.L.OuelletC.et al.Molecular mechanism underlying the action of"/>
   <result pre="mechanism underlying the action of a novel fusion inhibitor of" exact="influenza" post="A virusJ. Virol.199771406240709094684 17.StaschkeK.A.HatchS.D.TangJ.C.HornbackW.J.MunroeJ.E.ColacinoJ.M.MuesingM.A.Inhibition of influenza virus hemagglutinin-mediated membrane"/>
   <result pre="novel fusion inhibitor of influenza A virusJ. Virol.199771406240709094684 17.StaschkeK.A.HatchS.D.TangJ.C.HornbackW.J.MunroeJ.E.ColacinoJ.M.MuesingM.A.Inhibition of" exact="influenza" post="virus hemagglutinin-mediated membrane fusion by a compound related to"/>
   <result pre="by a compound related to podocarpic acidVirology199824826427410.1006/viro.1998.92739721235 18.ZhuL.LiY.LiS.LiH.QiuZ.LeeC.LuH.LinX.ZhaoR.ChenL.et al.Inhibition of" exact="influenza" post="A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral"/>
   <result pre="Chemical GeneticsJ. Virol.2015902690270110.1128/JVI.02326-1526676787 21.BodianD.L.YamasakiR.B.BuswellR.L.StearnsJ.F.WhiteJ.M.KuntzI.D.Inhibition of the fusion-inducing conformational change of" exact="influenza" post="hemagglutinin by benzoquinones and hydroquinonesBiochemistry1993322967297810.1021/bi00063a0078457561 22.RussellR.J.KerryP.S.StevensD.J.SteinhauerD.A.MartinS.R.GamblinS.J.SkehelJ.J.Structure of influenza hemagglutinin"/>
   <result pre="change of influenza hemagglutinin by benzoquinones and hydroquinonesBiochemistry1993322967297810.1021/bi00063a0078457561 22.RussellR.J.KerryP.S.StevensD.J.SteinhauerD.A.MartinS.R.GamblinS.J.SkehelJ.J.Structure of" exact="influenza" post="hemagglutinin in complex with an inhibitor of membrane fusionProc."/>
   <result pre="of an inducer of the low-pH conformational change in the" exact="influenza" post="virus hemagglutinin: irreversible inhibition of infectivityJ. Virol.199771880888209343241 24.BoriskinY.S.LenevaI.A.PecheurE.I.PolyakS.J.Arbidol: A"/>
   <result pre="compound that blocks viral fusionCurr. Med. Chem.200815997100510.2174/09298670878404965818393857 25.SuttonT.C.ObadanA.LavigneJ.ChenH.LiW.PerezD.R.Genome rearrangement of" exact="influenza" post="virus for anti-viral drug screeningVirus Res.2014189142310.1016/j.virusres.2014.05.00324833536 26.EckertN.WrenschF.GartnerS.PalanisamyN.GoedeckeU.JagerN.PohlmannS.WinklerM.Influenza A virus"/>
   <result pre="Influenza A Viruses Expressing Reporter GenesViruses2016817910.3390/v8070179 30.FukuyamaS.KatsuraH.ZhaoD.OzawaM.AndoT.ShoemakerJ.E.IshikawaI.YamadaS.NeumannG.WatanabeS.et al.Multi-spectral fluorescent reporter" exact="influenza" post="viruses (Color-flu) as powerful tools for in vivo studiesNat."/>
   <result pre="Vivo ApplicationsPLoS ONE201510e013388810.1371/journal.pone.013388826241861 32.PerezJ.T.Garcia-SastreA.ManicassamyB.Insertion of a GFP reporter gene in" exact="influenza" post="virusCurr. Protoc. Microbiol.201310.1002/9780471729259.mc15g04s2923686828 33.ZhaoX.WangL.CuiQ.LiP.WangY.ZhangY.YangY.RongL.DuR.A Mechanism Underlying Attenuation of Recombinant"/>
   <result pre="genes contribute to the high virulence of the human H5N1" exact="influenza" post="virus isolate A/Vietnam/1203/04J. Exp. Med.200620368969710.1084/jem.2005193816533883 35.FriedeM.MullerS.BriandJ.P.PlaueS.FernandesI.FrischB.SchuberF.Van RegenmortelM.H.Selective induction of"/>
   <result pre="isolate A/Vietnam/1203/04J. Exp. Med.200620368969710.1084/jem.2005193816533883 35.FriedeM.MullerS.BriandJ.P.PlaueS.FernandesI.FrischB.SchuberF.Van RegenmortelM.H.Selective induction of protection against" exact="influenza" post="virus infection in mice by a lipid-peptide conjugate delivered"/>
   <result pre="in mice by a lipid-peptide conjugate delivered in liposomesVaccine19941279179710.1016/0264-410X(94)90287-97975857 36.WraithD.C.VesseyA.E.AskonasB.A.Purified" exact="influenza" post="virus nucleoprotein protects mice from lethal infectionJ. Gen. Virol.198768"/>
   <result pre="synthetic peptides corresponding to B- and T-cell recognition sites of" exact="influenza" post="A hemagglutininVaccine19951392793210.1016/0264-410X(95)00014-R7483766 38.SaelensX.VanlandschootP.MartinetW.MarasM.NeirynckS.ContrerasR.FiersW.JouW.M.Protection of mice against a lethal influenza"/>
   <result pre="of influenza A hemagglutininVaccine19951392793210.1016/0264-410X(95)00014-R7483766 38.SaelensX.VanlandschootP.MartinetW.MarasM.NeirynckS.ContrerasR.FiersW.JouW.M.Protection of mice against a lethal" exact="influenza" post="virus challenge after immunization with yeast-derived secreted influenza virus"/>
   <result pre="a lethal influenza virus challenge after immunization with yeast-derived secreted" exact="influenza" post="virus hemagglutininEur. J. Biochem.199926016617510.1046/j.1432-1327.1999.00150.x10091596 39.StevensonP.G.HawkeS.BanghamC.R.Protection against lethal influenza virus"/>
   <result pre="yeast-derived secreted influenza virus hemagglutininEur. J. Biochem.199926016617510.1046/j.1432-1327.1999.00150.x10091596 39.StevensonP.G.HawkeS.BanghamC.R.Protection against lethal" exact="influenza" post="virus encephalitis by intranasally primed CD8+ memory T cellsJ."/>
   <result pre="influenza virus hemagglutininEur. J. Biochem.199926016617510.1046/j.1432-1327.1999.00150.x10091596 39.StevensonP.G.HawkeS.BanghamC.R.Protection against lethal influenza virus" exact="encephalitis" post="by intranasally primed CD8+ memory T cellsJ. Immunol. (Baltimore,"/>
   <result pre="cellsJ. Immunol. (Baltimore, Md.: 1950)199615730653073 40.MitchellJ.A.GreenT.D.BrightR.A.RossT.M.Induction of heterosubtypic immunity to" exact="influenza" post="A virus using a DNA vaccine expressing hemagglutinin-C3d fusion"/>
   <result pre="using a DNA vaccine expressing hemagglutinin-C3d fusion proteinsVaccine20032190291410.1016/S0264-410X(02)00539-X12547601 41.QuanF.S.SteinhauerD.HuangC.RossT.M.CompansR.W.KangS.M.A bivalent" exact="influenza" post="VLP vaccine confers complete inhibition of virus replication in"/>
   <result pre="capacity of a cyclic peptide corresponding to site A of" exact="influenza" post="virus haemagglutininVaccine1990830831410.1016/0264-410X(90)90086-22396470 43.ThangavelR.R.BouvierN.M.Animal models for influenza virus pathogenesis, transmission,"/>
   <result pre="to site A of influenza virus haemagglutininVaccine1990830831410.1016/0264-410X(90)90086-22396470 43.ThangavelR.R.BouvierN.M.Animal models for" exact="influenza" post="virus pathogenesis, transmission, and immunologyJ. Immunol. Methods2014410607910.1016/j.jim.2014.03.02324709389 44.FalzaranoD.GrosethA.HoenenT.Development and"/>
   <result pre="challenges and perspectivesAntivir. Res.2014103788710.1016/j.antiviral.2014.01.00324462694 45.ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virusProc."/>
   <result pre="a GFP reporter virusProc. Natl. Acad. Sci. USA2010107115311153610.1073/pnas.091499410720534532 46.AntanasijevicA.ChengH.WardropD.J.RongL.CaffreyM.Inhibition of" exact="influenza" post="H7 hemagglutinin-mediated entryPLoS ONE20138e7636310.1371/journal.pone.007636324194835 47.WangY.DingY.YangC.LiR.DuQ.HaoY.LiZ.JiangH.ZhaoJ.ChenQ.et al.Inhibition of the infectivity"/>
   <result pre="ONE20138e7636310.1371/journal.pone.007636324194835 47.WangY.DingY.YangC.LiR.DuQ.HaoY.LiZ.JiangH.ZhaoJ.ChenQ.et al.Inhibition of the infectivity and inflammatory response of" exact="influenza" post="virus by Arbidol hydrochloride in vitro and in vivo"/>
   <result pre="vivo (mice and ferret)Biomed. Pharmacother.20179139340110.1016/j.biopha.2017.04.09128475918 Figure 1 Generation of reporter" exact="influenza" post="A subtype H3N2 virus by fusing Gluc gene to"/>
   <result pre="(a) Engineering of Gluc reporter gene in the genome of" exact="influenza" post="A NY (H3N2) virus. The porcine teschovirusâ€&quot;1 2A (PTV-1"/>
   <result pre="(p.i.) luciferase assays were performed. Figure 2 Generation of reporter" exact="influenza" post="A subtype H3N2 virus by using segment PR8/NS-Gluc, which"/>
   <result pre="syncytia induced by NY-r18-Gluc infection. Figure 3 Generation of reporter" exact="influenza" post="A subtype H3N2 virus encoding the HA and NA"/>
   <result pre="canine kidney (MDCK) cells were infected with A/NY-r19â€&quot;Gluc, A/NY-r19, and" exact="influenza" post="A virus (IAV) NY at a multiplicity of infection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6670050\results\search\disease\results.xml">
   <result pre="applicable. basic reproduction number Bayesian model dengue force of infection" exact="infectious disease" post="seroprevalence vector control Funding National Environment Agency10.13039/501100001358 National Medical"/>
   <result pre="infections avertedâ€� has been widely applied in the evaluation of" exact="malaria" post="disease control efforts in Africa (36) and the dengue"/>
   <result pre="by the request that donors with recent (diagnosed) dengue or" exact="chikungunya" post="virus infection defer their donation for 6 months (48),"/>
   <result pre="Sci Rep. 2016;6:22592.26940650 20HapuarachchiHC, KooC, RajarethinamJ, et al.Epidemic resurgence of" exact="dengue fever" post="in Singapore in 2013â€&quot;2014: a virological and entomological perspective."/>
   <result pre="et al.Reconstructing historical changes in the force of infection of" exact="dengue fever" post="in Singapore: implications for surveillance and control. Bull World"/>
   <result pre="in dengue transmission may act to increase the incidence of" exact="dengue hemorrhagic fever." post="Proc Natl Acad Sci U S A. 2008;105(6):2238â€&quot;2243.18250338 32RodrÃ­guez-BarraquerI,"/>
   <result pre="Trop Dis. 2012;6(6):e1679.22745839 36BhattS, WeissDJ, CameronE, et al.The effect of" exact="malaria" post="control on Plasmodium falciparum in Africa between 2000 and"/>
   <result pre="Surveill Response J. 2011;2(2):24â€&quot;29. 41RoweEK, LeoYS, WongJG, et al.Challenges in" exact="dengue fever" post="in the elderly: atypical presentation and risk of severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6676504\results\search\disease\results.xml">
   <result pre="the crucial components of protective immunity? dengue flavivirus pathogenesis immunity" exact="dengue fever" post="severe dengue vaccines epidemiology Funding The author(s) declared that"/>
   <result pre="the expanding scientific literature. Studies on dengue as an arthropod-borne" exact="viral disease" post="contribute to three areas of research: (a) one on"/>
   <result pre="1 and 3 infections result in high rates of classic" exact="dengue fever" post="but dengue 2 and 4 infections cause milder disease"/>
   <result pre="ways 40â€&quot; 43. The most notable genetic effect is the" exact="suppression" post="of severe disease accompanying a second heterotypic dengue infection"/>
   <result pre="first infecting DENV type. A subset of severe dengue cases," exact="hemophagocytic lymphohistiocytosis" post="(HLH), is increasingly recognized. HLH, a rare and potentially"/>
   <result pre="2008 to 2013. Cases were often infants, who frequently had" exact="influenza" post="co-infections and were satisfactorily treated with steroids 47. There"/>
   <result pre="(21 years old or older) with acute laboratory-confirmed dengue with" exact="thrombocytopenia" post="(not more than 20,000 platelets per microliter) but no"/>
   <result pre="patients who may progress to shock syndrome. A low echocardiographic" exact="stroke" post="volume index and reduced left ventricular function plus high"/>
   <result pre="decline of platelet counts successfully predicted shock 57. Epidemiology During" exact="yellow fever" post="epidemics, it was well understood that multiple cases occurred"/>
   <result pre="is not spread significantly by sick individuals. Those who developed" exact="dengue fever" post="spent more time at home, visited fewer locations, and"/>
   <result pre="Chittagong, where a number of recent outbreaks of dengue and" exact="chikungunya" post="have occurred, had a high prevalence of dengue antibodies,"/>
   <result pre="emergence of epidemic severe dengue throughout India. The reason why" exact="yellow fever" post="continues to be a major health problem in the"/>
   <result pre="fateful event that occurred centuries ago: the stable introduction of" exact="yellow fever" post="virus into a complex zoonotic cycle 71. All four"/>
   <result pre="activate platelets in vitro via Toll-like-receptor 4 (TLR4), and produce" exact="thrombocytopenia" post="in TLR4 knockout and normal mice 90â€&quot; 93. In"/>
   <result pre="chimera of structural genes of the four DENVs with the" exact="yellow fever" post="vaccine non-structural genome. This vaccine was tested for vaccine"/>
   <result pre="II.Am J Trop Med Hyg.1952;1(1):30â€&quot;50. 10.4269/ajtmh.1952.1.3014903434 11NimmannityaSHalsteadSBCohenSNet al.: Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962-1964. I. Observations"/>
   <result pre="virus infections.Front Immunol.2014;5:280. 10.3389/fimmu.2014.0028024966859 13HalsteadSB: Observations related to pathogensis of" exact="dengue hemorrhagic fever." post="VI. Hypotheses and discussion.Yale J Biol Med.1970;42:350â€&quot;62. 5419208 14HalsteadSBLanNTMyintTTet"/>
   <result pre="of third or fourth dengue infections resulting in admissions and" exact="dengue hemorrhagic fever," post="and serotype sequences.Am J Trop Med Hyg.2007;77(5):910â€&quot;3. 10.4269/ajtmh.2007.77.91017984352 F1000"/>
   <result pre="2001â€&quot;2002.Int J Infect Dis.2012;16(3):e198â€&quot;e203. 10.1016/j.ijid.2011.09.02622277259 32HubertBHalsteadSB: Dengue 1 virus and" exact="dengue hemorrhagic fever," post="French Polynesia, 2001.Emerg Infect Dis.2009;15(8):1265â€&quot;70. 10.3201/eid1508.08150019751589 33GambleJBethellDDayNPet al.: Age-related"/>
   <result pre="association test indicate two distinct pathogenic pathways involved in classical" exact="dengue fever" post="and dengue shock syndrome.PLoS Negl Trop Dis.2018;12(2):e0006202. 10.1371/journal.pntd.000620229447178 F1000"/>
   <result pre="Borne Zoonotic Dis.2019. 10.1089/vbz.2018.240830964397 73HalsteadSBNimmannityaSCohenSN: Observations related to pathogenesis of" exact="dengue hemorrhagic fever." post="IV. Relation of disease severity to antibody response and"/>
   <result pre="recovered.Yale J Biol Med.1970;42(5):311â€&quot;28. 5419206 74AyeKSCharngkaewKWinNet al.: Pathologic highlights of" exact="dengue hemorrhagic fever" post="in 13 autopsy cases from Myanmar.Hum Pathol.2014;45(6):1221â€&quot;33. 10.1016/j.humpath.2014.01.02224767772 75HalsteadSB:"/>
   <result pre="Sci.2018;25(1):77. 10.1186/s12929-018-0482-930409217 87SchlesingerJJBrandrissMWWalshEE: Protection of mice against dengue 2 virus" exact="encephalitis" post="by immunization with the dengue 2 virus non-structural glycoprotein"/>
   <result pre="protein 1 activates platelets via Toll-like receptor 4, leading to" exact="thrombocytopenia" post="and hemorrhage.PLoS Pathog.2019;15(4):e1007625. 10.1371/journal.ppat.100762531009511 94ModhiranNWattersonDMullerDAet al.: Dengue virus NS1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6676611\results\search\disease\results.xml">
   <result pre="severe and lead to long term respiratory sequelae, such as" exact="bronchiolitis" post="obliterans or bronchiectasis [3]. HAdVs were an important cause"/>
   <result pre="to long term respiratory sequelae, such as bronchiolitis obliterans or" exact="bronchiectasis" post="[3]. HAdVs were an important cause of acute respiratory"/>
   <result pre="and HAdV7 was related to post-infectious pulmonary sequelae, such as" exact="bronchiolitis" post="obliterans [9â€&quot;11]. Molecular genotyping of HAdV was used to"/>
   <result pre="the demographics, clinical characteristics, and risk factors of hospitalization and" exact="pneumonia" post="in patients between the 2011 and 2014 epidemics. Methods"/>
   <result pre="containing Madin-Darby canine kidney cells, Vero cells, A549 cells or" exact="rhabdomyosarcoma" post="cells within 24â€‰h of collection. Cells were incubated at"/>
   <result pre="However, patients with severe definite bacterial infection, including bacteremia and" exact="urinary tract infection" post="were excluded from this cohort. Fifty-three adult patients were"/>
   <result pre="a significantly higher percentage of hospitalized patients had cough and" exact="diarrhea" post="compared with non-hospitalized patients (both pâ€‰ pâ€‰ pâ€‰=â€‰0.015), and"/>
   <result pre="cough (ORâ€‰=â€‰1.959, pâ€‰=â€‰0.017), and increased CRP values (ORâ€‰=â€‰1.015, pâ€‰pâ€‰=â€‰0.011), bronchiolitis/" exact="bronchopneumonia" post="(ORâ€‰=â€‰2.505, pâ€‰=â€‰0.024), underlying disease (ORâ€‰=â€‰18.187, pâ€‰pâ€‰=â€‰0.037), vomiting (ORâ€‰=â€‰2.413, pâ€‰=â€‰0.003),"/>
   <result pre="Pâ€‰ Comparison of difference between patients with and without HAdV" exact="pneumonia" post="Diagnosis of radiologically-conformed alveolar pneumonia was according to World"/>
   <result pre="patients with and without HAdV pneumonia Diagnosis of radiologically-conformed alveolar" exact="pneumonia" post="was according to World Health Organization (WHO) criteria [20]."/>
   <result pre="such an opacityâ€�. There were 29 patients diagnosed with HAdV" exact="pneumonia" post="in the two epidemics. We compared the demographics and"/>
   <result pre="between these two groups. However, a significantly higher percentage of" exact="pneumonia" post="patients had co-infections compared to non-pneumonia patients (pâ€‰=â€‰0.012). Among"/>
   <result pre="infection (75%) was more predominant than bacterial infection in the" exact="pneumonia" post="group. Pneumonia patients had significantly higher mean WBC counts"/>
   <result pre="patients. There was no significant difference in genotype distribution between" exact="pneumonia" post="patients and non-pneumonia patients. Table 4 Comparison of demographics"/>
   <result pre="Table 4 Comparison of demographics and clinical characteristics between the" exact="pneumonia" post="and non-pneumonia patients in 2011 and 2014 epidemics Variables"/>
   <result pre="the demographics, clinical characteristics, and risk factors of hospitalization and" exact="pneumonia" post="in patients from the 2011 and 2014 adenovirus epidemics"/>
   <result pre="be other important emergent genotypes in immunocompetent adults with severe" exact="pneumonia" post="in China, we did not identify any HAdV55 or"/>
   <result pre="that infection with HAdV7 was more likely to be associated" exact="pneumonia" post="[11, 17]. On the contrary, we found that the"/>
   <result pre="epidemic (21.0% vs. 16.7%), but had a lower rate of" exact="pneumonia" post="(1.6% vs. 3.3%). Also, when we pooled these two"/>
   <result pre="associated with pneumonia. HAdV4 caused an epidemic outbreak of acute" exact="respiratory disease" post="(ARD) in military recruits in United States and may"/>
   <result pre="recruits in United States and may also result in severe" exact="pneumonia" post="[28, 29]. HAdV1 was also reported to cause severe"/>
   <result pre="pneumonia [28, 29]. HAdV1 was also reported to cause severe" exact="pneumonia" post="in immunocompetent patients in French intensive care unit [30]."/>
   <result pre="were not associated with severe lower respiratory tract infection (four" exact="pneumonia" post="cases caused by HAdV1; one pneumonia case caused by"/>
   <result pre="respiratory tract infection (four pneumonia cases caused by HAdV1; one" exact="pneumonia" post="case caused by HAdV4). It is therefore possible that"/>
   <result pre="risk factor for severe HAdV infection. The neurological disease, chronic" exact="lung disease," post="and airway anomalies were reported to be related to"/>
   <result pre="and airway anomalies were reported to be related to HAdV" exact="pneumonia" post="[19, 21]. Neurological disease was particularly associated with severe"/>
   <result pre="pneumonia [19, 21]. Neurological disease was particularly associated with severe" exact="pneumonia" post="caused by HAdV3 and 7 during the 2011 epidemic"/>
   <result pre="leukocytosis (WBC &amp;gt;â€‰15,000/mm3) was more common in HAdV2 infection, whereas" exact="leukopenia" post="(WBCâ€‰ 27]. Leukocytosis seems to occur in the early"/>
   <result pre="seems to occur in the early course of infection, whereas" exact="leukopenia" post="and thrombocytopenia were shown to correlate with progression [17,"/>
   <result pre="occur in the early course of infection, whereas leukopenia and" exact="thrombocytopenia" post="were shown to correlate with progression [17, 32]. This"/>
   <result pre="major laboratory finding in HAdV infection, while other studies reported" exact="leukopenia" post="[17, 19, 21]. In our study, we demonstrated that"/>
   <result pre="values compared to children infected with other genotypes [15]. HAdV" exact="pneumonia" post="is the most common manifestation of severe HAdV infection"/>
   <result pre="less 5% of all HAdV infection [35]. In our analysis," exact="pneumonia" post="patients had higher WBC counts and CRP levels than"/>
   <result pre="[40, 41]. Since 2006, there are the outbreaks and severe" exact="respiratory disease" post="worldwide, which were caused by HAdV14p1 and HAdV55 of"/>
   <result pre="lower respiratory tract infections ANC Absolute neutrophil count ARD Acute" exact="respiratory disease" post="ARIs Acute respiratory infections CRP C-Reactive protein HAdV Human"/>
   <result pre="and transmission characteristics of human adenovirus type 7 caused acute" exact="respiratory disease" post="outbreak in military trainees in East ChinaAm J Transl"/>
   <result pre="One201389e7520810.1371/journal.pone.007520824073254 17.LaiCYLeeCJLuCYLeePIShaoPLWuETet al.Adenovirus serotype 3 and 7 infection with acute" exact="respiratory failure" post="in children in Taiwan, 2010-2011PLoS One201381e5361410.1371/journal.pone.005361423326469 18.LinYCLuPLLinKHChuPYWangCFLinJHet al.Molecular epidemiology"/>
   <result pre="Dis201218111825183210.3201/eid1811.12062923092602 20.Organization WH. Revised WHO classification and treatment of childhood" exact="pneumonia" post="at health facilities. https://apps.who.int/iris/bitstream/handle/10665/137319/9789241507813_eng.pdf;jsessionid=DC643EB627A159361843B225BF79BF8E?sequence=1. 21.ChengJLPengCCChiuNCWengLCChiuYYChangLet al.Risk factor analysis and"/>
   <result pre="24.ZhaoSWanCKeCSetoJDehghanSZouLet al.Re-emergent human adenovirus genome type 7d caused an acute" exact="respiratory disease" post="outbreak in southern China after a twenty-one year absenceSci"/>
   <result pre="China after a twenty-one year absenceSci Rep20144736510.1038/srep0736525482188 25.GuLLiuZLiXQuJGuanWLiuYet al.Severe community-acquired" exact="pneumonia" post="caused by adenovirus type 11 in immunocompetent adults in"/>
   <result pre="in immunocompetent adults in BeijingJ Clin Virol201254429530110.1016/j.jcv.2012.04.01822608839 26.TanDZhuHFuYTongFYaoDWallineJet al.Severe community-acquired" exact="pneumonia" post="caused by human adenovirus in immunocompetent adults: a multicenter"/>
   <result pre="case reportJ Clin Virol201681788110.1016/j.jcv.2016.06.00527354307 30.CassirNHraiechSNougairedeAZandottiCFournierPPapazianLOutbreak of adenovirus type 1 severe" exact="pneumonia" post="in a French intensive care unit, Septemberâ€&quot;October 2012Eurosurveillance201419392091410.2807/1560-7917.ES2014.19.39.2091425306980 31.GrayGCMcCarthyTLebeckMGSchnurrDPRussellKLKajonAEet"/>
   <result pre="adenovirus infectionSwiss Med Wkly200213225â€&quot;2634535012422291 35.ChenSPHuangYCChiuCHWongKSHuangYLHuangCGet al.Clinical features of radiologically confirmed" exact="pneumonia" post="due to adenovirus in childrenJ Clin Virol201356171210.1016/j.jcv.2012.08.02123021965 36.ChenSTianXVaccine development"/>
   <result pre="43.KajonAELuXErdmanDDLouieJSchnurrDGeorgeKSet al.Molecular epidemiology and brief history of emerging adenovirus 14-associated" exact="respiratory disease" post="in the United StatesJ Infect Dis201020219310310.1086/65308320500088 44.LuQBTongYGWoYWangHYLiuEMGrayGCet al.Epidemiology of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6679168\results\search\disease\results.xml">
   <result pre="contagious virus that causes seasonal epidemics and unpredictable pandemics. Four" exact="influenza" post="virus types have been identified to date: A, B,"/>
   <result pre="humans. Influenza A and B viruses are responsible for seasonal" exact="influenza" post="epidemics in humans and are responsible for up to"/>
   <result pre="flu infections annually. The M2 protein is present in all" exact="influenza" post="types and belongs to the class of viroporins, i.e.,"/>
   <result pre="ion channels that increase membrane permeability in virus-infected cells. In" exact="influenza" post="A and B, AM2 and BM2 are predominantly proton"/>
   <result pre="some permeability to monovalent cations. By contrast, M2 proteins in" exact="influenza" post="C and D, CM2 and DM2, appear to be"/>
   <result pre="The present review summarizes the biochemical and structural aspects of" exact="influenza" post="viroporins and discusses the most relevant aspects of function,"/>
   <result pre="relevant aspects of function, inhibition, and interaction with the host." exact="influenza" post="virus matrix protein 2 (M2) viroporins ion channel inhibition"/>
   <result pre="segmented, negative-sense RNA viruses belonging to the Orthomyxoviridae family. Four" exact="influenza" post="virus types have been identified to date, classified based"/>
   <result pre="bovine and canine species [4]. The main reservoir of the" exact="influenza" post="A viruses are aquatic birds [5]. The seasonal flu"/>
   <result pre="viruses are aquatic birds [5]. The seasonal flu caused by" exact="influenza" post="A virus (IAV) in humans is a very contagious"/>
   <result pre="are caused by the sporadic transmission of avian or swan" exact="influenza" post="viruses to humans, as pre-immunity to these new strains"/>
   <result pre="still capable of causing serious outbreaks, is responsible for seasonal" exact="influenza" post="epidemics among humans [9,10], and accounts for half of"/>
   <result pre="epidemics among humans [9,10], and accounts for half of the" exact="influenza" post="diseases in recent years (www.cdc.gov). Types B (IBV) and"/>
   <result pre="to BM2 [60]. 3. CM2 and DM2 3.1. CM2 The" exact="influenza" post="C virus M2 protein (CM2) was first reported by"/>
   <result pre="is encoded by RNA segment 6 (M gene) of the" exact="influenza" post="C virus [20], which produces a p42 protein precursor,"/>
   <result pre="could partially restore the infectious virus production of an M2-deficient" exact="influenza" post="A virus [103], which suggests that CM2 can alter"/>
   <result pre="probably plays a role in the uncoating process of the" exact="influenza" post="C virus. The glycoprotein HEF of the influenza C"/>
   <result pre="of the influenza C virus. The glycoprotein HEF of the" exact="influenza" post="C virus has the ability to cause low pH-dependent"/>
   <result pre="impaired packaging and uncoating in virus-like particles (VLPs) and recombinant" exact="influenza" post="viruses [109]. 3.2. DM2 A new type of influenza"/>
   <result pre="recombinant influenza viruses [109]. 3.2. DM2 A new type of" exact="influenza" post="virus, known as type D, has recently been identified"/>
   <result pre="remains to be elucidated. The main features of viroporins in" exact="influenza" post="are summarized in Table 1. 4. Other Influenza Viroporins"/>
   <result pre="variants of AM2 [131,132,133,134]. Indeed, more than 95% of circulating" exact="influenza" post="A viruses carry the S31N mutation in their M2"/>
   <result pre="Cu(II) inhibition. Therefore, Cu(II) complexes may also be toxic to" exact="influenza" post="B viruses. 6. M2-Mediated Disruption of Ion Homeostasis The"/>
   <result pre="NLRP3 inflammasome in influenza-infected cells [142]. AM2 also contributes to" exact="influenza" post="pathogenesis by downregulating the expression and function of two"/>
   <result pre="channels, the amiloride-sensitive epithelial sodium channels (ENaC) [143] and the" exact="cystic fibrosis" post="transmembrane conductance regulator (CFTR) chloride channels [144]. These are"/>
   <result pre="impairment in their activity is associated with detrimental consequences, including" exact="pulmonary edema" post="and rhinorrhea (see [147]). AM2 has been found to"/>
   <result pre="some of these proteinâ€&quot;protein interactions involving M2, and how the" exact="influenza" post="virus may exploit these host cell factors to its"/>
   <result pre="and have been reported to exhibit inhibitory effects on the" exact="influenza" post="virus [165]. This action of cardiac glycosides on viral"/>
   <result pre="ouabain, digoxin and lanatoside C, which express antiviral activity against" exact="influenza" post="[166,167]. The Î²1 auxiliary subunit of the Na+/K+ ATPase,"/>
   <result pre="and a stable ATP1B1-knockdown cell line was able to suppress" exact="influenza" post="virus A/WSN/33 replication [167]. Using deletion mutations, the authors"/>
   <result pre="identified as binders to M2 in all of four independent" exact="influenza" post="interactome screening campaigns [171,179,180,181]. It would be interesting to"/>
   <result pre="TRAPP complex subunits may cooperate in the modulation of the" exact="influenza" post="life cycle. Finally, the host factor Golgi-specific brefeldin A-resistant"/>
   <result pre="the process. 8. Conclusions In summary, most information available for" exact="influenza" post="viroporins is centered around AM2, followed by BM2. For"/>
   <result pre="authors declare no conflict of interest. References References 1.RitcheyM.B.PaleseP.KilbourneE.D.RNAs of" exact="influenza" post="A, B, and C virusesJ. Virol.197618738744944790 2.HauseB.M.CollinE.A.LiuR.HuangB.ShengZ.LuW.WangD.NelsonE.A.LiF.Characterization of a"/>
   <result pre="A, B, and C virusesJ. Virol.197618738744944790 2.HauseB.M.CollinE.A.LiuR.HuangB.ShengZ.LuW.WangD.NelsonE.A.LiF.Characterization of a novel" exact="influenza" post="virus in cattle and swine: Proposal for a new"/>
   <result pre="in the Orthomyxoviridae familyMBio2014510.1128/mBio.00031-1424595369 3.HauseB.M.DucatezM.CollinE.A.RanZ.LiuR.ShengZ.ArmienA.KaplanB.ChakravartyS.HoppeA.D.et al.Isolation of a novel swine" exact="influenza" post="virus from Oklahoma in 2011 which is distantly related"/>
   <result pre="from Oklahoma in 2011 which is distantly related to human" exact="influenza" post="C virusesPLoS Pathog.20139e100317610.1371/journal.ppat.100317623408893 4.ParrishC.R.MurciaP.R.HolmesE.C.Influenza virus reservoirs and intermediate hosts:"/>
   <result pre="reservoirs and intermediate hosts: Dogs, horses, and new possibilities for" exact="influenza" post="virus exposure of humansJ. Virol.2015892990299410.1128/JVI.03146-1425540375 5.WebsterR.G.BeanW.J.GormanO.T.ChambersT.M.KawaokaY.Evolution and ecology of"/>
   <result pre="influenza virus exposure of humansJ. Virol.2015892990299410.1128/JVI.03146-1425540375 5.WebsterR.G.BeanW.J.GormanO.T.ChambersT.M.KawaokaY.Evolution and ecology of" exact="influenza" post="A virusesMicrobiol. Rev.1992561521791579108 6.HayA.J.GregoryV.DouglasA.R.YiP.L.The evolution of human influenza virusesPhilos."/>
   <result pre="ecology of influenza A virusesMicrobiol. Rev.1992561521791579108 6.HayA.J.GregoryV.DouglasA.R.YiP.L.The evolution of human" exact="influenza" post="virusesPhilos. Trans. R. Soc. B Biol. Sci.20013561861187010.1098/rstb.2001.0999 7.NeumannG.NodaT.KawaokaY.Emergence and"/>
   <result pre="B Biol. Sci.20013561861187010.1098/rstb.2001.0999 7.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature200945993193910.1038/nature0815719525932 8.MolinariN.A.M.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal influenza in the"/>
   <result pre="of swine-origin H1N1 influenza virusNature200945993193910.1038/nature0815719525932 8.MolinariN.A.M.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal" exact="influenza" post="in the US: Measuring disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 9.WebsterR.G.MontoA.S.BracialeT.J.LambR.A.Textbook"/>
   <result pre="Wiley &amp;amp; Sons, Ltd.Hoboken, NJ, USA2013 10.KoutsakosM.NguyenT.H.BarclayW.S.KedzierskaK.Knowns and unknowns of" exact="influenza" post="B virusesFuture Microbiol.20161111913510.2217/fmb.15.12026684590 11.RanZ.ShenH.LangY.KolbE.A.TuranN.ZhuL.MaJ.BawaB.LiuQ.LiuH.et al.Domestic pigs are susceptible to"/>
   <result pre="virusesFuture Microbiol.20161111913510.2217/fmb.15.12026684590 11.RanZ.ShenH.LangY.KolbE.A.TuranN.ZhuL.MaJ.BawaB.LiuQ.LiuH.et al.Domestic pigs are susceptible to infection with" exact="influenza" post="B virusesJ. Virol.2015894818482610.1128/JVI.00059-1525673727 12.OsterhausA.D.M.E.RimmelzwaanG.F.MartinaB.E.E.BestebroerT.M.FouchierR.A.M.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 13.FergusonL.OlivierA.K.GenovaS.EppersonW.B.SmithD.R.SchneiderL.BartonK.McCuanK.WebbyR.J.WanX.F.Pathogenesis"/>
   <result pre="B virusesJ. Virol.2015894818482610.1128/JVI.00059-1525673727 12.OsterhausA.D.M.E.RimmelzwaanG.F.MartinaB.E.E.BestebroerT.M.FouchierR.A.M.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 13.FergusonL.OlivierA.K.GenovaS.EppersonW.B.SmithD.R.SchneiderL.BartonK.McCuanK.WebbyR.J.WanX.F.Pathogenesis of" exact="influenza" post="D virus in cattleJ. Virol.2016905636564210.1128/JVI.03122-1527030270 14.PaleseP.ShawM.L.Orthomyxoviridae: The viruses and"/>
   <result pre="Virol.198862276227722455818 16.SkehelJ.J.WileyD.C.Receptor binding and membrane fusion in virus entry: The" exact="influenza" post="hemagglutininAnnu. Rev. Biochem.20006953156910.1146/annurev.biochem.69.1.53110966468 17.KunduA.AvalosR.T.SandersonC.M.NayakD.P.Transmembrane domain of influenza virus neuraminidase,"/>
   <result pre="virus entry: The influenza hemagglutininAnnu. Rev. Biochem.20006953156910.1146/annurev.biochem.69.1.53110966468 17.KunduA.AvalosR.T.SandersonC.M.NayakD.P.Transmembrane domain of" exact="influenza" post="virus neuraminidase, a type II protein, possesses an apical"/>
   <result pre="MDCK cellsJ. Virol.199670650865158709291 18.SakaguchiT.TuQ.A.PintoL.H.LambR.A.The active oligomeric state of the minimalistic" exact="influenza" post="virus M-2 ion channel is a tetramerProc. Natl. Acad."/>
   <result pre="WilkinsPhiladelphia, PA, USA2013 20.MurakiY.HongoS.The molecular virology and reverse genetics of" exact="influenza" post="C virusJpn. J. Infect. Dis.20106315716520495266 21.Castano-RodriguezC.HonrubiaJ.M.Gutierrez-AlvarezJ.DeDiegoM.L.Nieto-TorresJ.L.Jimenez-GuardenoJ.M.Regla-NavaJ.A.Fernandez-DelgadoR.Verdia-BaguenaC.Queralt-MartinM.et al.Role of Severe"/>
   <result pre="on the infected-cell surfaceCell19854062763310.1016/0092-8674(85)90211-93882238 26.LambR.A.ChoppinP.W.The gene structure and replication of" exact="influenza" post="virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 27.SugrueR.J.HayA.J.Structural characteristics of the M2 protein"/>
   <result pre="virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 27.SugrueR.J.HayA.J.Structural characteristics of the M2 protein of" exact="influenza" post="a viruses: Evidence that it forms a tetrameric channelVirology199118061762410.1016/0042-6822(91)90075-M1989386"/>
   <result pre="channelVirology199118061762410.1016/0042-6822(91)90075-M1989386 28.HullJ.D.GilmoreR.LambR.A.Integration of a small integral membrane protein, M2, of" exact="influenza" post="virus into the endoplasmic reticulum: Analysis of the internal"/>
   <result pre="with an ectoplasmic NH2 terminusJ. Cell Biol.19881061489149810.1083/jcb.106.5.14892836432 29.HeleniusA.Unpacking the incoming" exact="influenza" post="virusCell19926957757810.1016/0092-8674(92)90219-31375129 30.MartinK.HeleniusA.Transport of incoming influenza virus nucleocapsids into the"/>
   <result pre="Cell Biol.19881061489149810.1083/jcb.106.5.14892836432 29.HeleniusA.Unpacking the incoming influenza virusCell19926957757810.1016/0092-8674(92)90219-31375129 30.MartinK.HeleniusA.Transport of incoming" exact="influenza" post="virus nucleocapsids into the nucleusJ. Virol.19916523224410.1016/0962-8924(92)90130-F1985199 31.TakeuchiK.LambR.A.Influenza virus M2"/>
   <result pre="protein ion channel activity stabilizes the native form of fowl" exact="plague" post="virus hemagglutinin during intracellular transportJ. Virol.1994689119197507186 32.CiamporF.BayleyP.M.NermutM.V.HirstE.M.A.SugrueR.J.HayA.J.Evidence that the"/>
   <result pre="intracellular transportJ. Virol.1994689119197507186 32.CiamporF.BayleyP.M.NermutM.V.HirstE.M.A.SugrueR.J.HayA.J.Evidence that the amantadine-induced, M2-mediated conversion of" exact="influenza" post="A virus hemagglutinin to the low pH conformation occurs"/>
   <result pre="conformation occurs in an acidic trans golgi compartmentVirology1992188142410.1016/0042-6822(92)90730-D1566569 33.GrambasS.HayA.J.Maturation of" exact="influenza" post="a virus hemagglutinin-Estimates of the pH encountered during transport"/>
   <result pre="regulation by the M2 proteinVirology1992190111810.1016/0042-6822(92)91187-Y1529523 34.SugrueR.J.BahadurG.ZambonM.C.Hall-SmithM.DouglasA.R.HayA.J.Specific structural alteration of the" exact="influenza" post="haemagglutinin by amantadineEMBO J.199093469347610.1002/j.1460-2075.1990.tb07555.x2209554 35.MaC.PolishchukA.L.OhigashiY.StoufferA.L.SchÃ¶nA.MagavernE.JingX.LearJ.D.FreireE.LambR.A.et al.Identification of the functional"/>
   <result pre="amantadineEMBO J.199093469347610.1002/j.1460-2075.1990.tb07555.x2209554 35.MaC.PolishchukA.L.OhigashiY.StoufferA.L.SchÃ¶nA.MagavernE.JingX.LearJ.D.FreireE.LambR.A.et al.Identification of the functional core of the" exact="influenza" post="A virus A/M2 proton-selective ion channelProc. Natl. Acad. Sci."/>
   <result pre="36.PintoL.H.DieckmannG.R.GandhiC.S.PapworthC.G.BramanJ.ShaughnessyM.A.LearJ.D.LambR.A.DegradoW.F.A functionally defined model for the M2 proton channel of" exact="influenza" post="A virus suggests a mechanism for its ion selectivityProc."/>
   <result pre="ion selectivityProc. Natl. Acad. Sci. USA199794113011130610.1073/pnas.94.21.113019326604 37.TangY.ZaitsevaF.LambR.A.PintoL.H.The gate of the" exact="influenza" post="virus M2 proton channel is formed by a single"/>
   <result pre="single tryptophan residueJ. Biol. Chem.2002277398803988610.1074/jbc.M20658220012183461 38.PintoL.H.LambR.A.The M2 proton channels of" exact="influenza" post="A and B virusesJ. Biol. Chem.20062818997900010.1074/jbc.R50002020016407184 39.HattaM.GotoH.KawaokaY.Influenza B virus"/>
   <result pre="the cell surfaceVirology200330671710.1016/S0042-6822(02)00083-112620792 42.WangJ.PielakR.M.McClintockM.A.ChouJ.J.Solution structure and functional analysis of the" exact="influenza" post="B proton channelNat. Struct. Mol. Biol.2009161267127110.1038/nsmb.170719898475 43.MaC.WangJ.Functional studies reveal"/>
   <result pre="similarities and differences between AM2 and BM2 proton channels from" exact="influenza" post="virusesBiochim. Biophys. Acta Biomembr.2018186027228010.1016/j.bbamem.2017.10.02629106970 44.OdagiriT.HongJ.OharaY.The BM2 protein of influenza"/>
   <result pre="from influenza virusesBiochim. Biophys. Acta Biomembr.2018186027228010.1016/j.bbamem.2017.10.02629106970 44.OdagiriT.HongJ.OharaY.The BM2 protein of" exact="influenza" post="B virus is synthesized in the late phase of"/>
   <result pre="virions as a subviral componentJ. Gen. Virol.1999802573258110.1099/0022-1317-80-10-257310573149 45.SugrueR.J.BelsheR.B.HayA.J.Palmitoylation of the" exact="influenza" post="a virus M2 proteinVirology1990179515610.1016/0042-6822(90)90272-S2219738 46.HolsingerL.J.AlamsR.Influenza virus M2 integral membrane"/>
   <result pre="formation of disulfide bondsVirology1991183324310.1016/0042-6822(91)90115-R2053285 47.ThomasJ.M.StevensM.P.PercyN.BarclayW.S.Phosphorylation of the M2 protein of" exact="influenza" post="A virus is not essential for virus viabilityVirology1998252546410.1006/viro.1998.93849875317 48.HutchinsonE.C.DenhamE.M.ThomasB.TrudgianD.C.HesterS.S.RidlovaG.YorkA.TurrellL.FodorE.Mapping"/>
   <result pre="is not essential for virus viabilityVirology1998252546410.1006/viro.1998.93849875317 48.HutchinsonE.C.DenhamE.M.ThomasB.TrudgianD.C.HesterS.S.RidlovaG.YorkA.TurrellL.FodorE.Mapping the phosphoproteome of" exact="influenza" post="A and B viruses by mass spectrometryPLoS Pathog.20128e100299310.1371/journal.ppat.100299323144613 49.ParkE.K.CastrucciM.R.PortnerA.KawaokaY.The"/>
   <result pre="Pathog.20128e100299310.1371/journal.ppat.100299323144613 49.ParkE.K.CastrucciM.R.PortnerA.KawaokaY.The M2 ectodomain is important for its incorporation into" exact="influenza" post="A virionsJ. Virol.199872244924559499106 50.AcharyaR.CarnevaleV.FiorinG.LevineB.G.PolishchukA.L.BalannikV.SamishI.LambR.A.PintoL.H.DeGradoW.F.et al.Structure and mechanism of proton"/>
   <result pre="transport through the transmembrane tetrameric M2 protein bundle of the" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA2010107150751508010.1073/pnas.100707110720689043 51.ThomastonJ.L.PolizziN.F.KonstantinidiA.WangJ.KolocourisA.DegradoW.F.Inhibitors of the"/>
   <result pre="Soc.2018140152191522610.1021/jacs.8b0674130165017 52.SchnellJ.R.ChouJ.J.Structure and mechanism of the M2 proton channel of" exact="influenza" post="A virusNature200845159159510.1038/nature0653118235503 53.WangJ.WuY.MaC.FiorinG.WangJ.PintoL.H.LambR.A.KleinM.L.DeGradoW.F.Structure and inhibition of the drug-resistant S31N"/>
   <result pre="the drug-resistant S31N mutant of the M2 ion channel of" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA20131101315132010.1073/pnas.121652611023302696 54.HuF.Schmidt-RohrK.HongM.NMR detection of"/>
   <result pre="channelJ. Am. Chem. Soc.20121343703371310.1021/ja208118521974716 55.SharmaM.YiM.DongH.QinH.PetersonE.BusathD.D.ZhouH.X.CrossT.A.Insight into the mechanism of the" exact="influenza" post="A proton channel from a structure in a lipid"/>
   <result pre="a lipid bilayerScience201033050951210.1126/science.119175020966252 56.CadyS.D.Schmidt-RohrK.WangJ.SotoC.S.DegradoW.F.HongM.Structure of the amantadine binding site of" exact="influenza" post="M2 proton channels in lipid bilayersNature201046368969210.1038/nature0872220130653 57.LiangR.LiH.SwansonJ.M.VothG.A.Multiscale simulation reveals"/>
   <result pre="simulation reveals a multifaceted mechanism of proton permeation through the" exact="influenza" post="A M2 proton channelProc. Natl. Acad. Sci. USA20141119396940110.1073/pnas.140199711124979779 58.HuJ.FuR.NishimuraK.ZhangL.ZhouH.X.BusathD.D.VijayvergiyaV.CrossT.A.Histidines,"/>
   <result pre="Sci. USA20141119396940110.1073/pnas.140199711124979779 58.HuJ.FuR.NishimuraK.ZhangL.ZhouH.X.BusathD.D.VijayvergiyaV.CrossT.A.Histidines, heart of the hydrogen ion channel from" exact="influenza" post="A virus: Toward an understanding of conductance and proton"/>
   <result pre="stabilizes the Trp41 gate of the M2 proton channel of" exact="influenza" post="a virusStructure2013212033204110.1016/j.str.2013.08.02924139991 61.PielakR.M.ChouJ.J.Kinetic analysis of the M2 proton conduction"/>
   <result pre="virusStructure2013212033204110.1016/j.str.2013.08.02924139991 61.PielakR.M.ChouJ.J.Kinetic analysis of the M2 proton conduction of the" exact="influenza" post="virusJ. Am. Chem. Soc.2010132176951769710.1021/ja108458u21090748 62.OkadaA.MiuraT.TakeuchiH.Protonation of histidine and histidine-tryptophan"/>
   <result pre="interaction in the activation of the M2 ion channel from" exact="influenza" post="A virusBiochemistry2001406053606010.1021/bi002844111352741 63.ColvinM.T.AndreasL.B.ChouJ.J.GriffinR.G.Proton association constants of his 37 in"/>
   <result pre="65.StoufferA.L.AcharyaR.SalomD.LevineA.S.Di CostanzoL.SotoC.S.TereshkoV.NandaV.StayrookS.DeGradoW.F.Structural basis for the function and inhibition of an" exact="influenza" post="virus proton channelNature200845159659910.1038/nature0652818235504 66.ThomastonJ.L.Alfonso-PrietoM.WoldeyesR.A.FraserJ.S.KleinM.L.FiorinG.DeGradoW.F.High-resolution structures of the M2 channel"/>
   <result pre="virus proton channelNature200845159659910.1038/nature0652818235504 66.ThomastonJ.L.Alfonso-PrietoM.WoldeyesR.A.FraserJ.S.KleinM.L.FiorinG.DeGradoW.F.High-resolution structures of the M2 channel from" exact="influenza" post="A virus reveal dynamic pathways for proton stabilization and"/>
   <result pre="Natl. Acad. Sci. USA2015112142601426510.1073/pnas.151849311226578770 67.ThomastonJ.L.DeGradoW.F.Crystal structure of the drug-resistant S31N" exact="influenza" post="M2 proton channelProtein Sci.20161551155410.1002/pro.293727082171 68.ThomastonJ.L.WoldeyesR.A.NakaneT.YamashitaA.TanakaT.KoiwaiK.BrewsterA.S.BaradB.A.ChenY.LemminT.et al.XFEL structures of the"/>
   <result pre="influenza M2 proton channelProtein Sci.20161551155410.1002/pro.293727082171 68.ThomastonJ.L.WoldeyesR.A.NakaneT.YamashitaA.TanakaT.KoiwaiK.BrewsterA.S.BaradB.A.ChenY.LemminT.et al.XFEL structures of the" exact="influenza" post="M2 proton channel: Room temperature water networks and insights"/>
   <result pre="69.AgmonN.The Grotthuss mechanismChem. Phys. Lett.199524445646210.1016/0009-2614(95)00905-J 70.LiangR.SwansonJ.M.J.MadsenJ.J.HongM.DeGradoW.F.VothG.A.Acid activation mechanism of the" exact="influenza" post="A M2 proton channelProc. Natl. Acad. Sci. USA2016113E6955E696410.1073/pnas.161547111327791184 71.LinT.SchroederC.Definitive"/>
   <result pre="attoampere unitary current to the M2 ion channel protein of" exact="influenza" post="A virusJ. Virol.2001753647365610.1128/JVI.75.8.3647-3656.200111264354 72.ChizhmakovI.V.OgdenD.C.GeraghtyF.M.HayhurstA.SkinnerA.BetakovaT.HayA.J.Differences in conductance of M2 proton"/>
   <result pre="Virol.2001753647365610.1128/JVI.75.8.3647-3656.200111264354 72.ChizhmakovI.V.OgdenD.C.GeraghtyF.M.HayhurstA.SkinnerA.BetakovaT.HayA.J.Differences in conductance of M2 proton channels of two" exact="influenza" post="viruses at low and high pHJ. Physiol.200354642743810.1113/jphysiol.2002.02891012527729 73.MouldJ.A.LiH.C.DudlakC.S.LearJ.D.PekoszA.LambR.A.PintoL.H.Mechanism for"/>
   <result pre="73.MouldJ.A.LiH.C.DudlakC.S.LearJ.D.PekoszA.LambR.A.PintoL.H.Mechanism for proton conduction of the M2 ion channel of" exact="influenza" post="A virusJ. Biol. Chem.20002758592859910.1074/jbc.275.12.859210722698 74.MoffatJ.C.VijayvergiyaV.GaoP.F.CrossT.A.WoodburyD.J.BusathD.D.Proton transport through influenza A"/>
   <result pre="channel of influenza A virusJ. Biol. Chem.20002758592859910.1074/jbc.275.12.859210722698 74.MoffatJ.C.VijayvergiyaV.GaoP.F.CrossT.A.WoodburyD.J.BusathD.D.Proton transport through" exact="influenza" post="A virus M2 protein reconstituted in vesiclesBiophys. J.20089443444510.1529/biophysj.107.10908217827230 75.DecourseyT.E.Voltage-gated"/>
   <result pre="transfer pathwaysPhysiol. Rev.20038347557910.1152/physrev.00028.200212663866 76.HuF.LuoW.HongM.Mechanisms of proton conduction and gating in" exact="influenza" post="M2 proton channels from solid-state NMRScience201033050550810.1126/science.119171420966251 77.WilliamsJ.K.ZhangY.Schmidt-RohrK.HongM.PH-dependent conformation, dynamics,"/>
   <result pre="and aromatic interaction of the gating tryptophan residue of the" exact="influenza" post="M2 proton channel from solid-state NMRBiophys. J.20131041698170810.1016/j.bpj.2013.02.05423601317 78.DiFrancescoM.L.HansenU.P.ThielG.MoroniA.SchroederI.Effect of"/>
   <result pre="reveals structural characteristics of the proton transport cycle in the" exact="influenza" post="A protein M2 in cell-free membrane patches of Xenopus"/>
   <result pre="oocytesPLoS ONE2014910.1371/journal.pone.0107406 79.ZhouH.X.A theory for the proton transport of the" exact="influenza" post="virus M2 protein: Extensive test against conductance dataBiophys. J.201110091292110.1016/j.bpj.2011.01.00221320435"/>
   <result pre="of the hydration status of the tryptophan gate in the" exact="influenza" post="A M2 proton channelPCCP201618289392895010.1039/C6CP03426H27725984 81.LinC.W.MensaB.Barniol-XicotaM.DeGradoW.F.GaiF.Activation pH and Gating Dynamics"/>
   <result pre="characterization of conformational plasticity within the transmembrane domain of the" exact="influenza" post="A M2 proton channelBiochim. Biophys. Acta200717683162317010.1016/j.bbamem.2007.08.02517936720 84.YiM.CrossT.A.ZhouH.X.Conformational heterogeneity of"/>
   <result pre="suggest a conduction mechanism for the M2 proton channel from" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA20091061069107410.1073/pnas.081172010619144924 86.WeiC.PohorilleA.M2 Proton Channel:"/>
   <result pre="the pore-lining residues of the BM2 ion channel protein of" exact="influenza" post="B virusJ. Biol. Chem.2008283159211593110.1074/jbc.M71030220018408016 89.WilliamsJ.K.TietzeD.LeeM.WangJ.HongM.Solid-State NMR Investigation of the"/>
   <result pre="Chem. Soc.20161388143815510.1021/jacs.6b0314227286559 90.WilliamsJ.K.ShcherbakovA.A.WangJ.HongM.Protonation equilibria and pore-opening structure of the dual-histidine" exact="influenza" post="B virus M2 transmembrane proton channel from solid-state NMRJ."/>
   <result pre="NMRJ. Biol. Chem.2017292178761788410.1074/jbc.M117.81399828893910 91.HongoS.SugawaraK.NishimuraH.MurakiY.KitameF.NakamuraK.Identification of a second protein encoded by" exact="influenza" post="C virus RNA segment 6J. Gen. Virol.1994753503351010.1099/0022-1317-75-12-35037996141 92.HongoS.IshiiK.MoriK.TakashitaE.MurakiY.MatsuzakiY.SugawaraK.Detection of"/>
   <result pre="(P42) by signal peptidase cleavageJ. Virol.19997346509847305 95.PekoszA.LambR.A.The CM2 protein of" exact="influenza" post="C virus is an oligomeric integral membrane glycoprotein structurally"/>
   <result pre="virus is an oligomeric integral membrane glycoprotein structurally analogous to" exact="influenza" post="A virus M2 and influenza B virus NB proteinsVirology199723743945110.1006/viro.1997.87889356355"/>
   <result pre="membrane glycoprotein structurally analogous to influenza A virus M2 and" exact="influenza" post="B virus NB proteinsVirology199723743945110.1006/viro.1997.87889356355 96.HongoS.SugawaraK.MurakiY.KitameF.NakamuraK.Characterization of a second protein"/>
   <result pre="a second protein (CM2) encoded by RNA segment 6 of" exact="influenza" post="C virusJ. Virol.199771278627929060633 97.MurakiY.OkuwaT.HimedaT.HongoS.OharaY.Effect of Cysteine Mutations in the"/>
   <result pre="CM2 on the Influenza C Virus ReplicationPLoS ONE2013810.1371/journal.pone.006051023593230 98.TadaY.HongoS.MurakiY.MatsuzakiY.SugawaraK.KitameF.NakamuraK.Phosphorylation of" exact="influenza" post="C virus CM2 proteinVirus Res.199858657210.1016/S0168-1702(98)00103-89879763 99.KukolA.ArkinI.T.Structure of the Influenza"/>
   <result pre="searchingJ. Biol. Chem.20002754225422910.1074/jbc.275.6.422510660588 100.MurakiY.WashiokaH.SugawaraK.MatsuzakiY.TakashitaE.HongoS.Identification of an amino acid residue on" exact="influenza" post="C virus M1 protein responsible for formation of the"/>
   <result pre="transmembrane helix-helix interactionsBiophys. J.2001812681269210.1016/S0006-3495(01)75911-511606281 102.BetakovaT.HayA.J.Evidence that the CM2 protein of" exact="influenza" post="C virus can modify the pH of the exocytic"/>
   <result pre="of the exocytic pathway of transfected cellsJ. Gen. Virol.2007882291229610.1099/vir.0.82785-017622634 103.StewartS.M.PekoszA.The" exact="influenza" post="C virus CM2 protein can alter intracellular pH, and:"/>
   <result pre="and: Its transmembrane domain can substitute for that of the" exact="influenza" post="a virus M2 protein and support infectious virus productionJ."/>
   <result pre="virus productionJ. Virol.2012861277128110.1128/JVI.05681-1121917958 104.OhuchiM.OhuchiR.MifuneK.Demonstration of hemolytic and fusion activities of" exact="influenza" post="C virusJ. Virol.198242107610797097857 105.ChizhmakovI.V.GeraghtyF.M.OgdenD.C.HayhurstA.AntoniouM.HayA.J.Selective proton permeability and pH regulation"/>
   <result pre="virusJ. Virol.198242107610797097857 105.ChizhmakovI.V.GeraghtyF.M.OgdenD.C.HayhurstA.AntoniouM.HayA.J.Selective proton permeability and pH regulation of the" exact="influenza" post="virus M2 channel expressed in mouse erythroleukaemia cellsJ. Physiol.199649432933610.1113/jphysiol.1996.sp0214958841994"/>
   <result pre="Physiol.199649432933610.1113/jphysiol.1996.sp0214958841994 106.MouldJ.A.DruryJ.E.FringS.M.KauppU.B.PekoszA.LambR.A.PintoL.H.Permeation and activation of the M2 ion channel of" exact="influenza" post="A virusJ. Biol. Chem.2000275310383105010.1074/jbc.M00366320010913133 107.BetÃ¡kovÃ¡T.KollerovÃ¡E.pH modulating activity of ion"/>
   <result pre="virusJ. Biol. Chem.2000275310383105010.1074/jbc.M00366320010913133 107.BetÃ¡kovÃ¡T.KollerovÃ¡E.pH modulating activity of ion channels of" exact="influenza" post="A, B, and C virusesActa Virol.20065018719317131938 108.ZhirnovO.P.GrigorievV.B.Disassembly of influenza"/>
   <result pre="of influenza A, B, and C virusesActa Virol.20065018719317131938 108.ZhirnovO.P.GrigorievV.B.Disassembly of" exact="influenza" post="C viruses, distinct from that of influenza A and"/>
   <result pre="Virol.20065018719317131938 108.ZhirnovO.P.GrigorievV.B.Disassembly of influenza C viruses, distinct from that of" exact="influenza" post="A and B viruses requires neutral-alkaline pHVirology199420028429110.1006/viro.1994.11888128628 109.FurukawaT.MurakiY.NodaT.TakashitaE.ShoR.SugawaraK.MatsuzakiY.ShimotaiY.HongoS.Role of"/>
   <result pre="requires neutral-alkaline pHVirology199420028429110.1006/viro.1994.11888128628 109.FurukawaT.MurakiY.NodaT.TakashitaE.ShoR.SugawaraK.MatsuzakiY.ShimotaiY.HongoS.Role of the CM2 protein in the" exact="influenza" post="C virus replication cycleJ. Virol.2011851322132910.1128/JVI.01367-1021106743 110.KesingerE.LiuJ.JensenA.ChiaC.P.DemersA.MoriyamaH.Influenza D virus M2"/>
   <result pre="ion channel activity in Xenopus laevis oocytesPLoS ONE201813e019922710.1371/journal.pone.019922729927982 111.HenkelM.MitznerD.HenkleinP.Meyer-AlmesF.J.MoroniA.DiFrancescoM.L.HenkesL.M.KreimM.KastS.M.SchubertU.et al.Proapoptotic" exact="influenza" post="A virus protein PB1-F2 forms a nonselective ion channelPLoS"/>
   <result pre="PB1-F2 forms a nonselective ion channelPLoS ONE2010510.1371/journal.pone.0011112 112.ChenW.CalvoP.A.MalideD.GibbsJ.SchubertU.BacikI.BastaS.Oâ€™NeillR.SchickliJ.PaleseP.et al.A novel" exact="influenza" post="A virus mitochondrial protein that induces cell deathNat. Med.200171306131210.1038/nm1201-130611726970"/>
   <result pre="and deletions in a bicistronic mRNA on the synthesis of" exact="influenza" post="B virus NB and NA glycoproteinsJ. Virol.19896328352908923 117.DemersA.RanZ.DengQ.WangD.EdmanB.LuW.LiF.Palmitoylation is"/>
   <result pre="NA glycoproteinsJ. Virol.19896328352908923 117.DemersA.RanZ.DengQ.WangD.EdmanB.LuW.LiF.Palmitoylation is required for intracellular trafficking of" exact="influenza" post="B virus NB protein and efficient influenza B virus"/>
   <result pre="intracellular trafficking of influenza B virus NB protein and efficient" exact="influenza" post="B virus growth in vitroJ. Gen. Virol.2014951211122010.1099/vir.0.063511-024671751 118.SunstromN.A.PremkumarL.S.PremkumarA.EwartG.CoxG.B.GageP.W.Ion channels"/>
   <result pre="in vitroJ. Gen. Virol.2014951211122010.1099/vir.0.063511-024671751 118.SunstromN.A.PremkumarL.S.PremkumarA.EwartG.CoxG.B.GageP.W.Ion channels formed by NB, an" exact="influenza" post="B virus proteinJ. Membr. Biol.199615012713210.1007/s0023299000378661776 119.PremkumarA.EwartG.D.CoxG.B.GageP.W.An amino-acid substitution in"/>
   <result pre="protein affects ion-channel gatingJ. Membr. Biol.200419713514310.1007/s00232-004-0648-015042345 120.HattaM.KawaokaY.The NB protein of" exact="influenza" post="B virus is not necessary for virus replication in"/>
   <result pre="Virus EntryMed. Res. Rev.20143430133910.1002/med.2128923801557 126.DeydeV.M.XuX.BrightR.A.ShawM.SmithC.B.ZhangY.ShuY.GubarevaL.V.CoxN.J.KlimovA.I.Surveillance of resistance to adamantanes among" exact="influenza" post="A(H3N2) and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 127.BrightR.A.ShayD.K.ShuB.CoxN.J.KlimovA.I.Adamantane"/>
   <result pre="and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 127.BrightR.A.ShayD.K.ShuB.CoxN.J.KlimovA.I.Adamantane resistance among" exact="influenza" post="A viruses isolated early during the 2005-2006 influenza season"/>
   <result pre="resistance among influenza A viruses isolated early during the 2005-2006" exact="influenza" post="season in the United StatesJAMA200629589189410.1001/jama.295.8.joc6002016456087 128.BrightR.A.MedinaM.J.XuX.Perez-OronozG.WallisT.R.DavisX.M.PovinelliL.CoxN.J.KlimovA.I.Incidence of adamantane resistance"/>
   <result pre="season in the United StatesJAMA200629589189410.1001/jama.295.8.joc6002016456087 128.BrightR.A.MedinaM.J.XuX.Perez-OronozG.WallisT.R.DavisX.M.PovinelliL.CoxN.J.KlimovA.I.Incidence of adamantane resistance among" exact="influenza" post="A (H3N2) viruses isolated worldwide from 1994 to 2005:"/>
   <result pre="from 1994 to 2005: A cause for concernLancet20053661175118110.1016/S0140-6736(05)67338-216198766 129.HaydenF.G.De JongM.D.Emerging" exact="influenza" post="antiviral resistance threatsJ. Infect. Dis.201120361010.1093/infdis/jiq01221148489 130.FioreA.E.FryA.ShayD.GubarevaL.BreseeJ.S.UyekiT.M.collab: Centers for Disease"/>
   <result pre="vitro and in vivo antiviral activities against amantadine-sensitive and -resistant" exact="influenza" post="A virusesAntivir. Res.2017140455410.1016/j.antiviral.2017.01.00628087313 135.DongG.PengC.LuoJ.WangC.HanL.WuB.JiG.HeH.Adamantane-resistant influenza a viruses in the"/>
   <result pre="activities against amantadine-sensitive and -resistant influenza A virusesAntivir. Res.2017140455410.1016/j.antiviral.2017.01.00628087313 135.DongG.PengC.LuoJ.WangC.HanL.WuB.JiG.HeH.Adamantane-resistant" exact="influenza" post="a viruses in the world (1902-2013): Frequency and distribution"/>
   <result pre="Today2012171111112010.1016/j.drudis.2012.06.00222704956 137.GuR.X.LiuL.A.WeiD.Q.Structural and energetic analysis of drug inhibition of the" exact="influenza" post="A M2 proton channelTrends Pharmacol. Sci.20133457158010.1016/j.tips.2013.08.00324011996 138.ToJ.SuryaW.TorresJ.Targeting the Channel"/>
   <result pre="Biol.2016104307355 139.GandhiC.S.ShuckK.LearJ.D.DieckmannG.R.DeGradoW.F.LambR.A.PintoL.H.Cu(II) inhibition of the proton translocation machinery of the" exact="influenza" post="A virus M 2 proteinJ. Biol. Chem.19992745474548210.1074/jbc.274.9.547410026160 140.SuY.HuF.HongM.Paramagnetic Cu(II)"/>
   <result pre="probing membrane protein structure and function: Inhibition mechanism of the" exact="influenza" post="M2 proton channelJ. Am. Chem. Soc.20121348693870210.1021/ja302632822519936 141.GordonN.A.McGuireK.L.WallentineS.K.MohlG.A.LynchJ.D.HarrisonR.G.BusathD.D.Divalent copper complexes"/>
   <result pre="M2 proton channelJ. Am. Chem. Soc.20121348693870210.1021/ja302632822519936 141.GordonN.A.McGuireK.L.WallentineS.K.MohlG.A.LynchJ.D.HarrisonR.G.BusathD.D.Divalent copper complexes as" exact="influenza" post="A M2 inhibitorsAntivir. Res.201714710010610.1016/j.antiviral.2017.10.00929032206 142.IchinoheT.PangI.K.IwasakiA.Influenza virus activates inflammasomes via"/>
   <result pre="Host Microbe2009636738010.1016/j.chom.2009.09.00519837376 150.BourmakinaS.V.GarcÃ­a-SastreA.Reverse genetics studies on the filamentous morphology of" exact="influenza" post="a virusJ. Gen. Virol.20038451752710.1099/vir.0.18803-012604801 151.BealeR.WiseH.StuartA.RavenhillB.J.DigardP.RandowF.A LC3-interacting motif in the"/>
   <result pre="influenza a virusJ. Gen. Virol.20038451752710.1099/vir.0.18803-012604801 151.BealeR.WiseH.StuartA.RavenhillB.J.DigardP.RandowF.A LC3-interacting motif in the" exact="influenza" post="A virus M2 protein is required to subvert autophagy"/>
   <result pre="Hsp40 to inhibit PKR activationPLoS ONE2011610.1371/journal.pone.002021521698289 155.GuanZ.LiuD.MiS.ZhangJ.YeQ.WangM.GaoG.F.YanJ.Interaction of Hsp40 with" exact="influenza" post="virus M2 protein: Implications for PKR signaling pathwayProtein Cell2010194495510.1007/s13238-010-0115-x21204021"/>
   <result pre="the viral M2 proteinBiochem. J.201747471573010.1042/BCJ2016086128087685 158.MaH.KienF.ManiÃ¨reM.ZhangY.LagardeN.TseK.S.PoonL.L.M.NalB.Human annexin A6 interacts with" exact="influenza" post="a virus protein M2 and negatively modulates infectionJ. Virol.2012861789180110.1128/JVI.06003-1122114333"/>
   <result pre="Chem.20172925070508810.1074/jbc.M117.77611228130444 160.RudickM.AndersonR.G.W.Multiple functions of caveolin-1J. Biol. Chem.2002277412954129812189159 161.SunL.HemgÃ¥rdG.V.SusantoS.A.WirthM.Caveolin-1 influences human" exact="influenza" post="A virus (H1N1) multiplication in cell cultureVirol. J.2010710.1186/1743-422X-7-108 162.CouetJ.LiS.OkamotoT.IkezuT.LisantiM.P.Identification"/>
   <result pre="minireviewInt. J. Mol. Sci.201819215410.3390/ijms1908215430042322 164.ChanM.C.W.KuokD.I.T.LeungC.Y.H.HuiK.P.Y.ValkenburgS.A.LauE.H.Y.NichollsJ.M.FangX.GuanY.LeeJ.W.et al.Human mesenchymal stromal cells reduce" exact="influenza" post="A H5N1-associated acute lung injury in vitro and in"/>
   <result pre="vitro and in vivoProc. Natl. Acad. Sci. USA20161133621362610.1073/pnas.160191111326976597 165.HoffmannH.H.PaleseP.ShawM.L.Modulation of" exact="influenza" post="virus replication by alteration of sodium ion transport and"/>
   <result pre="ebola virusViruses2016827710.3390/v811027727801778 167.MiS.F.LiY.YanJ.H.GaoG.F.Na+/K+-ATPase Î²1 subunit interacts with M2 proteins of" exact="influenza" post="A and B viruses and affects the virus replicationSci."/>
   <result pre="168.DomsR.W.LambR.A.RoseJ.K.HeleniusA.Folding and assembly of viral membrane proteinsVirology199319354556210.1006/viro.1993.11648460475 169.HugheyP.G.CompansR.W.ZebedeeS.L.LambR.A.Expression of the" exact="influenza" post="A virus M2 protein Is restricted to apical surfaces"/>
   <result pre="Virus BuddingCell Host Microbe20151872373510.1016/j.chom.2015.11.00226651948 172.BruceE.A.DigardP.StuartA.D.The Rab11 pathway is required for" exact="influenza" post="A virus budding and filament formationJ. Virol.2010845848585910.1128/JVI.00307-1020357086 173.ChenW.FengY.ChenD.Wandinger-NessA.Rab11 is"/>
   <result pre="ESCRT-Independent Membrane ScissionCell201014290291310.1016/j.cell.2010.08.02920850012 177.ZhuP.LiangL.ShaoX.LuoW.JiangS.ZhaoQ.SunN.ZhaoY.LiJ.WangJ.et al.Host cellular protein TRAPPC6AÎ&quot; interacts with" exact="influenza" post="A virus M2 protein and regulates viral propagation by"/>
   <result pre="Proteostasis Limits Influenza Virus, HIV, and Dengue Virus InfectionImmunity201644465810.1016/j.immuni.2015.12.01726789921 180.WangL.FuB.LiW.PatilG.LiuL.DorfM.E.LiS.Comparative" exact="influenza" post="protein interactomes identify the role of plakophilin 2 in"/>
   <result pre="viroporins in influenza. Influenza A M2 (AM2; strain A/Udorn/1972 H3N2)," exact="influenza" post="B M2 (BM2; strain B/Taiwan/70061/2006), influenza C M2 (CM2;"/>
   <result pre="(AM2; strain A/Udorn/1972 H3N2), influenza B M2 (BM2; strain B/Taiwan/70061/2006)," exact="influenza" post="C M2 (CM2; strain C/Ann Arbor/1/1950) and influenza D"/>
   <result pre="strain B/Taiwan/70061/2006), influenza C M2 (CM2; strain C/Ann Arbor/1/1950) and" exact="influenza" post="D M2 (DM2; strain D/swine/Oklahoma/1334/2011). The predicted transmembrane regions"/>
   <result pre="conformation. Scheme adapted from [70]. cells-08-00654-t001_Table 1Table 1 Properties of" exact="influenza" post="viroporins. PB1-F2 and NB are much less studied compared"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6681032\results\search\disease\results.xml">
   <result pre="5â€²-monophosphate analog called EdAP (5). EdAP exhibited potent inhibition against" exact="influenza" post="virus multiplication in Madinâ€&quot;Darby canine kidney (MDCK) cells transfected"/>
   <result pre="this DNA-type nucleic acid analog (5) inhibited the multiplication of" exact="influenza" post="A virus, although influenza virus is an RNA virus"/>
   <result pre="analog (5) inhibited the multiplication of influenza A virus, although" exact="influenza" post="virus is an RNA virus that does not generate"/>
   <result pre="an RNA virus that does not generate DNA. 4â€²-ethynyl-2â€²-deoxyadenosine 5â€²-monophosphate" exact="influenza" post="anti-influenza activity 1. Introduction Influenza caused by influenza A"/>
   <result pre="4â€²-ethynyl-2â€²-deoxyadenosine 5â€²-monophosphate influenza anti-influenza activity 1. Introduction Influenza caused by" exact="influenza" post="A virus is an infectious respiratory disease, which is"/>
   <result pre="Introduction Influenza caused by influenza A virus is an infectious" exact="respiratory disease," post="which is responsible for seasonal epidemics and periodic global"/>
   <result pre="medicine has been frequently reported to limit treatment efficiency. The" exact="influenza" post="A virus is a negative-sense single-strand RNA virus with"/>
   <result pre="antiviral compound. The inhibitors should work against several subtypes of" exact="influenza" post="A viruses and be tolerated by a drug-resistant mutant"/>
   <result pre="a drug-resistant mutant because it is highly conserved in all" exact="influenza" post="subtypes and is essential to the viral life cycle."/>
   <result pre="5â€²-monophosphate analog called EdAP (5) as a potent inhibitor of" exact="influenza" post="A virus. Interestingly, this DNA-type nucleic acid analog inhibited"/>
   <result pre="Interestingly, this DNA-type nucleic acid analog inhibited the multiplication of" exact="influenza" post="A virus, although influenza A virus is an RNA"/>
   <result pre="acid analog inhibited the multiplication of influenza A virus, although" exact="influenza" post="A virus is an RNA virus that does not"/>
   <result pre="on our hypothesis that EFdA analogs may work against the" exact="influenza" post="virus [25]. The adenosine derivatives of compounds 1â€&quot;3 were"/>
   <result pre="3). Consequently, compound 5 significantly inhibited the growth of the" exact="influenza" post="virus, with an IC50 of 3.8 Î¼M, whereas no"/>
   <result pre="inhibition level of 5 was around a 79% decrease of" exact="influenza" post="virus-produced NPs. This level is comparable to that of"/>
   <result pre="MD. 3.2.2. Virus As described previously [38], the number of" exact="influenza" post="A/Narita/1/09 H1N1pdm viruses were increased in MDCKâ€&quot;SIAT1 cells containing"/>
   <result pre="inhibitor-containing MEM medium on the cells was replaced with the" exact="influenza" post="virus-inhibitor mixture. After incubation at 37 Â°C in a"/>
   <result pre="(4E6) and secondary Î²-galactosidase-conjugated antimouse IgG antibody. The number of" exact="influenza" post="virus-produced nucleoproteins (NPs) in the permeabilized cells in each"/>
   <result pre="only the virus was used to express the number of" exact="influenza" post="virus-produced NPs in each well. Then, a graph was"/>
   <result pre="was generated by plotting the percentage of relative numbers of" exact="influenza" post="virus-produced NPs against the logarithm of the inhibitor concentrations."/>
   <result pre="50% in comparison to the control (IC50) was obtained. The" exact="influenza" post="virus-produced NPs in the permeabilized cells in each well"/>
   <result pre="developed EdAP, a new 4â€²-ethynyl-2â€²-deoxyadenosine 5â€²-monophosphate analog, as a potent" exact="influenza" post="A inhibitor with an IC50 of 3.8 Î¼M. EdAP"/>
   <result pre="References References 1.Global Influenza Strategy 2019â€&quot;2030World Health OrganizationGeneva, Switzerland2019 2.StevaertA.NaesensL.The" exact="influenza" post="virus polymerase complex: An update on its structure, functions,"/>
   <result pre="23.StoddartC.A.GalkinaS.A.JoshiP.KosikovaG.MorenoM.E.RiveraJ.M.SloanB.ReeveA.B.SarafianosS.G.Murphey-CorbM.et al.Oral administration of the nucleoside EFdA (4â€²-ethynyl-2-fluoro-2â€²-deoxyadenosine) provides rapid" exact="suppression" post="of HIV viremia in humanized mice and favorable pharmacokinetic"/>
   <result pre="Chem.2000434516452510.1021/jm000209n11087576 26.SriwilaijaroenN.WilairatP.HiramatsuH.TakahashiT.SuzukiT.ItoM.ItoY.TashiroM.SuzukiY.Mechanisms of the action of povidone-iodine against human and" exact="avian influenza" post="A viruses: Its effects on hemagglutination and sialidase activitiesVirol."/>
   <result pre="26.SriwilaijaroenN.WilairatP.HiramatsuH.TakahashiT.SuzukiT.ItoM.ItoY.TashiroM.SuzukiY.Mechanisms of the action of povidone-iodine against human and avian" exact="influenza" post="A viruses: Its effects on hemagglutination and sialidase activitiesVirol."/>
   <result pre="apricot fruit juice concentrate show multiple inhibitory effects on pandemic" exact="influenza" post="A (H1N1) virusFood Chem.20111271910.1016/j.foodchem.2010.12.031 39.SriwilaijaroenN.MageshS.ImamuraA.AndoH.IshidaH.SakaiM.IshitsuboE.HoriT.MoriyaS.IshikawaT.et al.A novel potent and"/>
   <result pre="Chem.20111271910.1016/j.foodchem.2010.12.031 39.SriwilaijaroenN.MageshS.ImamuraA.AndoH.IshidaH.SakaiM.IshitsuboE.HoriT.MoriyaS.IshikawaT.et al.A novel potent and highly specific inhibitor against" exact="influenza" post="viral N1-N9 neuraminidases: Insight into neuraminidase-inhibitor interactionsJ. Med. Chem.2016594563457710.1021/acs.jmedchem.5b0186327095056"/>
   <result pre="neuraminidase-inhibitor interactionsJ. Med. Chem.2016594563457710.1021/acs.jmedchem.5b0186327095056 40.SriwilaijaroenN.SuzukiK.TakashitaE.HiramatsuH.KanieO.SuzukiY.6SLN-lipo PGA specifically catches (coats) human" exact="influenza" post="virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic"/>
   <result pre="(coats) human influenza virus and synergizes neuraminidase-targeting drugs for human" exact="influenza" post="therapeutic potentialJ. Antimicrob. Chemother.2015702797280910.1093/jac/dkv19326169554 Figures, Scheme and Table Figure"/>
   <result pre="1 Synthesis of EdAP (5). Figure 3 Inhibition of the" exact="influenza" post="virus growth in the MDCKâ€&quot;SIAT1 cells by EdAP (5)."/>
   <result pre="MDCKâ€&quot;SIAT1 cells by EdAP (5). Upper panel: The number of" exact="influenza" post="virus-produced nucleoproteins (NPs) in cells decreased with an increase"/>
   <result pre="indicated. Lower panel: The reduction in the relative numbers of" exact="influenza" post="virus-produced NPs in cells was a function of EdAP"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6687121\results\search\disease\results.xml">
   <result pre="author and source are credited.pone.0220391.pdf Abstract Background The number of" exact="dengue fever" post="(DF) cases and the number of dengue outbreaks have"/>
   <result pre="and its Supporting Information files. Introduction Dengue is an arthropod-borne" exact="viral disease" post="that results in a broad spectrum of clinical symptoms"/>
   <result pre="broad spectrum of clinical symptoms ranging from mild fever to" exact="dengue hemorrhagic fever" post="(DHF), which can lead to dengue shock syndrome (DSS)"/>
   <result pre="[6]. Despite being considered an imported disease in mainland China," exact="dengue fever" post="(DF) cases and the number of dengue outbreaks have"/>
   <result pre="the effectiveness of control measures for many infectious diseases, including" exact="chikungunya" post="fever[12], Ebola[13], hemorrhagic conjunctivitis[14], shigellosis[15], influenza[16] and norovirus[17]. For"/>
   <result pre="to 5%. Despite the fact that dengue is a mosquito-borne" exact="viral disease" post="and the inapparent infection can also transmit it, we"/>
   <result pre="studies and may provide more accurate simulations. Finally, owing to" exact="hypersensitivity" post="to the number of cases for one parameter, the"/>
   <result pre="References 1PangXJ, ZhangRD, ChengG. Progress towards understanding the pathogenesis of" exact="dengue hemorrhagic fever." post="VIROLOGICA SINICA. 2016;32,110.1007/s12250-016-3855-9 .27853992 2Maria GGuzman,EvaHarris. Dengue. Lancet. 2015;385,453â€&quot;65."/>
   <result pre="A model for evaluation of key measures for control of" exact="chikungunya" post="fever outbreak in China. Chin J Epidemiol. 2015;36,1253â€&quot;1257.(in Chinese)"/>
   <result pre="Dynamic modelling of strategies for the control of acute haemorrhagic" exact="conjunctivitis" post="outbreaks in schools in Changsha,China (2004â€&quot;2015). Epidemiol. Infect.2017;145, 368â€&quot;378."/>
   <result pre="10.1016/j.mbs.2009.10.005 .19861133 25NewtonE, ReiterP. A model of the transmission of" exact="dengue fever" post="with an evaluation of the impact of ultra-low volume"/>
   <result pre="XieZ, HuGQ. Evaluating the effects of common control measures for" exact="influenza" post="A (H1N1) outbreak at school in China: A modeling"/>
   <result pre="2017;12,e018452710.1371/journal.pone.0184527 .28886143 36ManoreCA, HickmannKS, XuS, WearingHJ, HymanJM. Comparing dengue and" exact="chikungunya" post="emergence and endemic transmission in A. aegypti and A."/>
   <result pre="LiuRC, ZhangXX, XieZ, ChenSL. Simulation of key interventions for seasonal" exact="influenza" post="outbreak control at school in Changsha, China. Journal of"/>
   <result pre="ZhuYS, XiaY, ZhangYT, HuangXD, HuangJW,et al.Dynamic spatiotemporal analysis of indigenous" exact="dengue fever" post="at street-level in Guangzhou city, China. PLoS Negl Trop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6688121\results\search\disease\results.xml">
   <result pre="need to be obtained within days. visualization phylogenetics phylogenomics phylodynamics" exact="infectious disease" post="epidemiology evolution fig-count: table-count: equation-count: ref-count: page-count: word-count: 1."/>
   <result pre="and continuously updated pipelines that accommodate increasing data flow during" exact="infectious disease" post="outbreaks (19) (see further sections for more information and"/>
   <result pre="in nature, driven by the intrinsic objective to better understand" exact="viral disease" post="epidemiology. Due to the increasing complexity and interactivity of"/>
   <result pre="Finally, visualization and accompanying interpretation are a critical component of" exact="infectious disease" post="epidemiological and evolutionary analyses. Indeed, many researchers use visualization"/>
   <result pre="or more phylogenetic trees, for example when inferred from different" exact="influenza" post="proteins (PB1, PB2, PA, HA, NP, NA, M1, and"/>
   <result pre="on the output of a Bayesian phylodynamic analysis of a" exact="rabies" post="virus (RABV) data set consisting of time-stamped genetic data"/>
   <result pre="of spatio-temporal histories have become broadly and increasingly applied in" exact="viral disease" post="investigations. The incorporation of geographical and phylogenetic uncertainty into"/>
   <result pre="time by integrating viral phenotypic information into phylogenetic trees of" exact="influenza" post="viruses, thereby providing additional insights into the rate of"/>
   <result pre="evolutionary phenomena such as recombination (e.g., HIV-1) and hybridization (e.g.," exact="influenza" post="virus) events (30, 32, 87). Tanglegrams and related visualization"/>
   <result pre="the selection of the virus strain composition of the seasonal" exact="influenza" post="vaccine is informed by analyses and visualizations of circulating"/>
   <result pre="has substantially grown as an elementary discipline for investigations of" exact="infectious disease" post="epidemiology and evolution. An extensive array of software and"/>
   <result pre="References References 1.RifeBDMavianCChenXCiccozziMSalemiMMinJet al.. Phylodynamic applications in 21st century global" exact="infectious disease" post="research. Glob Health Res Policy. (2017) 2:13. 10.1186/s41256-017-0034-y29202081 2.DellicourSBaeleGDudasGFariaNRPybusOGSuchardMAet"/>
   <result pre="10.1126/science.125673925278604 4.FariaNRKraemerMUGHillSCGoes de JesusJAguiarRSIaniFCMet al.. Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potential. Science. (2018) 361:894â€&quot;9. 10.1126/science.aat711530139911 5.DudasGCarvalhoLMBedfordTTatemAJBaeleGFariaNRet al.."/>
   <result pre="epidemic. Nature. (2017) 544:309â€&quot;15. 10.1038/nature2204028405027 6.RussellCAKassonPMDonisRORileySDunbarJRambautAet al.Science Forum: improving pandemic" exact="influenza" post="risk assessment. eLife. (2014) 3:e0388310.7554/eLife.0388325321142 7.GermanDGrabowskiMKBeyrerC. Enhanced use of"/>
   <result pre="Genom. (2016) 2:e000093. 10.1099/mgen.0.00009328348833 47.NeherRABedfordT. nextflu: real-time tracking of seasonal" exact="influenza" post="virus evolution in humans. Bioinformatics. (2015) 31:3546â€&quot;8. 10.1093/bioinformatics/btv38126115986 48.YuGLamTTZhuHGuanY."/>
   <result pre="10.1093/ve/vey01629942656 52.StreickerDTurmelleAVonhofMKuzminIMcCrackenGFRupprechtC. Host phylogeny constrains cross-species emergence and establishment of" exact="rabies" post="virus in bats. Science. (2010) 329:676â€&quot;9. 10.1126/science.118883620689015 53.LemeyPRambautADrummondAJSuchardMA. Bayesian"/>
   <result pre="plot reveals temporal changes of epidemic spread in HIV and" exact="hepatitis" post="C virus (HCV). Proc Natl Acad Sci USA. (2013)"/>
   <result pre="70.NeherRABedfordTDanielsRSRussellCAShraimanBI. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal" exact="influenza" post="viruses. Proc Natl Acad Sci USA. (2016) 113:E1701â€&quot;1709. 10.1073/pnas.152557811326951657"/>
   <result pre="71.SmithDJLapedesASde JongJCBestebroerTMRimmelzwaanGFOsterhausADet al.. Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. Science. (2004) 305:371â€&quot;6. 10.1126/science.109721115218094 72.KatzelnickLCFonvilleJMGromowskiGDBustos ArriagaJGreenAJamesSLet al.Dengue viruses"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2. PLoS Pathog. (2014) 10:e1003932. 10.1371/journal.ppat.100393224586153 74.MininVNSuchardMA. Counting labeled"/>
   <result pre="75.BedfordTCobeySBeerliPPascualM. Global migration dynamics underlie evolution and persistence of human" exact="influenza" post="A (H3N2). PLoS Pathog. (2010) 6:e1000918. 10.1371/journal.ppat.100091820523898 76.SuYCBahlJJosephUButtKMPeckHAKoayESet al.."/>
   <result pre="PLoS Pathog. (2010) 6:e1000918. 10.1371/journal.ppat.100091820523898 76.SuYCBahlJJosephUButtKMPeckHAKoayESet al.. Phylodynamics of H1N1/2009" exact="influenza" post="reveals the transition from host adaptation to immune-driven selection."/>
   <result pre="10.1371/journal.pcbi.100461326717515 81.YpmaRJvan BallegooijenWMWallingaJ. Relating phylogenetic trees to transmission trees of" exact="infectious disease" post="outbreaks. Genetics. (2013) 195:1055â€&quot;62. 10.1534/genetics.113.15485624037268 82.MollentzeNNelLHTownsendSle RouxKHampsonKHaydonDTet al.. A"/>
   <result pre="10.1098/rspb.2013.325124619442 83.KlinkenbergDBackerJADidelotXColijnCWallingaJ. Simultaneous inference of phylogenetic and transmission trees in" exact="infectious disease" post="outbreaks. PLoS Comput Biol. (2017) 13:e1005495. 10.1371/journal.pcbi.100549528545083 84.DudasGBedfordTLycettSRambautA. Reassortment"/>
   <result pre="outbreaks. PLoS Comput Biol. (2017) 13:e1005495. 10.1371/journal.pcbi.100549528545083 84.DudasGBedfordTLycettSRambautA. Reassortment between" exact="influenza" post="B lineages and the emergence of a coadapted PB1-PB2-HA"/>
   <result pre="variants in the non-structural proteins 5A and 5B of the" exact="hepatitis" post="C virus. Virus Evol. (2018) 4:vex041. 10.1093/ve/vex04129362671 97.MagiorkinisGMagiorkinisEParaskevisDHoSYShapiroBPybusOGet al.."/>
   <result pre="Evol. (2018) 4:vex041. 10.1093/ve/vex04129362671 97.MagiorkinisGMagiorkinisEParaskevisDHoSYShapiroBPybusOGet al.. The global spread of" exact="hepatitis" post="C virus 1a and 1b: a phylodynamic and phylogeographic"/>
   <result pre="10.1089/aid.2015.009526651266 100.NelsonMISimonsenLViboudCMillerMAHolmesEC. Phylogenetic analysis reveals the global migration of seasonal" exact="influenza" post="A viruses. PLoS Pathog. (2007) 3:1220â€&quot;28. 10.1371/journal.ppat.003013117941707 101.FourmentMDarlingAEHolmesEC. The"/>
   <result pre="101.FourmentMDarlingAEHolmesEC. The impact of migratory flyways on the spread of" exact="avian influenza" post="virus in North America. BMC Evol Biol. (2017) 17:118."/>
   <result pre="The impact of migratory flyways on the spread of avian" exact="influenza" post="virus in North America. BMC Evol Biol. (2017) 17:118."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6689504\results\search\disease\results.xml">
   <result pre=": Original Article Transient expression of hemagglutinin antigen from canine" exact="influenza" post="virus H3N2 in Nicotiana benthamiana and Lactuca sativa https://orcid.org/0000-0001-9241-0100MaharjanPuna"/>
   <result pre="provided the original work is properly cited. Abstract Purpose Canine" exact="influenza" post="virus (CIV), H3N2, carries potentiality for zoonotic transmission and"/>
   <result pre="DNA sequences of the HA gene from Korean CIV strain" exact="influenza" post="A/canine/Korea/S3001/2015 (H3N2) for cloning into a geminiviral expression vectors"/>
   <result pre="as an instant host system for the transient expression of" exact="influenza" post="antigen at the time of emergency. The geminiviral vector"/>
   <result pre="of complex-glycosylated and basal-glycosylated rHA in lettuce and tobacco. Canine" exact="influenza" post="H3N2 Lactuca sativa Nicotiana benthamiana Plant-made vaccine Viral vector"/>
   <result pre="Canine influenza, a dog flu, is caused by two different" exact="influenza" post="A viruses; equine-originated canine influenza virus (CIV) H3N8 and"/>
   <result pre="is caused by two different influenza A viruses; equine-originated canine" exact="influenza" post="virus (CIV) H3N8 and the avian-originated CIV H3N2 virus"/>
   <result pre="and fact of the quick and constant mutation in the" exact="influenza" post="virus genome, CIV H3N2 may possibly lead to human"/>
   <result pre="cold chain distribution. The advancement of the transgenic lettuce produced" exact="hepatitis" post="B surface antigen vaccine into a clinical trial (phase"/>
   <result pre="phases of a clinical trial. For example, Nicotiana benthamiana-produced human" exact="influenza" post="virus-like particles (VLP) quadrivalent (phase III), human influenza H1N1"/>
   <result pre="benthamiana-produced human influenza virus-like particles (VLP) quadrivalent (phase III), human" exact="influenza" post="H1N1 (phase I), tobacco produced Ebola vaccine (phase II),"/>
   <result pre="the various strain and subtype of human (H1N1, H3N2) and" exact="avian influenza" post="(H5N1) have been expressed transiently in N. benthamiana and"/>
   <result pre="various strain and subtype of human (H1N1, H3N2) and avian" exact="influenza" post="(H5N1) have been expressed transiently in N. benthamiana and"/>
   <result pre="trial [15161718]. However, there is no report on the canine" exact="influenza" post="vaccine antigen expressed in plant. In this study, we"/>
   <result pre="In this study, we investigated whether HA from Korean canine" exact="influenza" post="strain A/canine/Korea/S3001/2015H3N2 can be expressed in N. benthamiana and"/>
   <result pre="buffer (https://advansta.com). The membrane was probed with a rabbit polyclonal" exact="influenza" post="A H3N2-HA antibody (PA5-34930, Thermo Fisher, Waltham, MA, USA)"/>
   <result pre="cloning, we optimized the viral specific codon of HA from" exact="influenza" post="A/canine/Korea/S3001/2015 (H3N2) towards the usage of preferred codon in"/>
   <result pre="to express the vaccine candidate protein against the human infectious" exact="viral disease" post="in the lettuce, there is only a few report"/>
   <result pre="there is only a few report on transient expression of" exact="influenza" post="vaccine candidate in lettuce [22232425]. Geminiviral vector system has"/>
   <result pre="studies suggest the importance of considering the glycosylation aspect for" exact="influenza" post="vaccine design. During 2016â€&quot;2017 influenza season, human H3N2 vaccine"/>
   <result pre="considering the glycosylation aspect for influenza vaccine design. During 2016â€&quot;2017" exact="influenza" post="season, human H3N2 vaccine used at that time was"/>
   <result pre="of this study is to accomplish the transient expression of" exact="influenza" post="HA antigen from A/canine/Korea/S3001/2015/H3N2 strain in the plant that"/>
   <result pre="that commercially available lettuce head can be used to produce" exact="influenza" post="antigen when geminiviral vector system was employed (Figs. 1,"/>
   <result pre="carries a great value for the quick response to the" exact="influenza" post="outbreak and pandemic owing to the rapid production of"/>
   <result pre="influenza outbreak and pandemic owing to the rapid production of" exact="influenza" post="vaccine reducing the time required for the preparation of"/>
   <result pre="be the relevant system to cope with seasonal and pandemic" exact="influenza" post="since influenza HA vaccine with variable glycosylation pattern could"/>
   <result pre="relevant system to cope with seasonal and pandemic influenza since" exact="influenza" post="HA vaccine with variable glycosylation pattern could be produced"/>
   <result pre="embrace a great value for the prompt response to novel" exact="influenza" post="strain outbreak [3435]. In conclusion, we successfully produced complex-glycosylated"/>
   <result pre="that may help alleviate the situation at the time of" exact="influenza" post="epidemic. We would like to thank Hugh S. Mason"/>
   <result pre="to this article was reported. References 1CrawfordPCDuboviEJCastlemanWLet al.Transmission of equine" exact="influenza" post="virus to dogsScience200531048248516186182 2SongDKangBLeeCet al.Transmission of avian influenza virus"/>
   <result pre="al.Transmission of equine influenza virus to dogsScience200531048248516186182 2SongDKangBLeeCet al.Transmission of" exact="avian influenza" post="virus (H3N2) to dogsEmerg Infect Dis20081474174618439355 3collab: Center for"/>
   <result pre="of equine influenza virus to dogsScience200531048248516186182 2SongDKangBLeeCet al.Transmission of avian" exact="influenza" post="virus (H3N2) to dogsEmerg Infect Dis20081474174618439355 3collab: Center for"/>
   <result pre="3collab: Center for Disease Control and PreventionKey facts about canine" exact="influenza" post="(dog flu)Atlanta, GACenter for Disease Control and Prevention2019 4SongDSAnDJMoonHJet"/>
   <result pre="Disease Control and Prevention2019 4SongDSAnDJMoonHJet al.Interspecies transmission of the canine" exact="influenza" post="H3N2 virus to domestic cats in South Korea, 2010J"/>
   <result pre="Gen Virol201192Pt 102350235521715595 5KimHSongDMoonHet al.Inter- and intraspecies transmission of canine" exact="influenza" post="virus (H3N2) in dogs, cats, and ferretsInfluenza Other Respir"/>
   <result pre="al.Comparative analysis of virulence of a novel, avian-origin H3N2 canine" exact="influenza" post="virus in various host speciesVirus Res201519513514025218482 7SohrabSSSuhailMKamalMAHusenAAzharEIRecent development and"/>
   <result pre="vaccinesCurr Drug Metab20171883184128699508 8PilletSAubinETrepanierSet al.A plant-derived quadrivalent virus like particle" exact="influenza" post="vaccine induces cross-reactive antibody and T cell response in"/>
   <result pre="Biopharmaceautical2019 12SkehelJJWileyDCReceptor binding and membrane fusion in virus entry: the" exact="influenza" post="hemagglutininAnnu Rev Biochem20006953156910966468 13GrgacicEVAndersonDAVirus-like particles: passport to immune recognitionMethods200640606516997714"/>
   <result pre="15CummingsJFGuerreroMLMoonJEet al.Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based" exact="influenza" post="vaccine derived from influenza A (H1N1)pdm09 virus: a Phase"/>
   <result pre="of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from" exact="influenza" post="A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in"/>
   <result pre="adultsVaccine2014322251225924126211 16ChichesterJAJonesRMGreenBJet al.Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based" exact="influenza" post="vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a"/>
   <result pre="plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1)" exact="influenza" post="virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study"/>
   <result pre="healthy adultsViruses201243227324423202523 17ShojiYFarranceCEBautistaJet al.A plant-based system for rapid production of" exact="influenza" post="vaccine antigensInfluenza Other Respir Viruses2012620421021974811 18LandryNPilletSFavreDet al.Influenza virus-like particle"/>
   <result pre="benthamiana elicit durable, poly-functional and cross-reactive T cell responses to" exact="influenza" post="HA antigensClin Immunol201415416417725128897 19DiamosAGRosenthalSHMasonHS5â€² and 3â€² untranslated regions strongly"/>
   <result pre="DNA replicon systemBiotechnol Bioeng201010691720047189 22KapustaJModelskaAFiglerowiczMet al.A plant-derived edible vaccine against" exact="hepatitis" post="B virusFASEB J1999131796179910506582 23PniewskiTKapustaJBociagPet al.Low-dose oral immunization with lyophilized"/>
   <result pre="al.Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing" exact="hepatitis" post="B surface antigen for prototype plant-derived vaccine tablet formulationJ"/>
   <result pre="system generating orally immunogenic Norwalk virus-like particlesVaccine2008261846185418325641 27ZostSJParkhouseKGuminaMEet al.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="strainsProc Natl Acad Sci U S A2017114125781258329109276 28AnYParsonsLMJankowskaEMelnykDJoshiMCipolloJFN-glycosylation of seasonal" exact="influenza" post="vaccine hemagglutinins: implication for potency testing and immune processingJ"/>
   <result pre="al.Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic" exact="avian influenza" post="virus H5N1 challenge infectionJ Virol201084120021201020810729 31PhoolcharoenWDyeJMKilbourneJet al.A nonreplicating subunit"/>
   <result pre="with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian" exact="influenza" post="virus H5N1 challenge infectionJ Virol201084120021201020810729 31PhoolcharoenWDyeJMKilbourneJet al.A nonreplicating subunit"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6689664\results\search\disease\results.xml">
   <result pre="prevalence and distribution of the main viral causes of equine" exact="encephalitis" post="and discusses their impact and potential approaches to limit"/>
   <result pre="vector vaccination mathematical modeling fig-count: table-count: ref-count: page-count: Introduction Viral" exact="encephalitis" post="is one of the most common infections of the"/>
   <result pre="This review focuses on the main neurotropic viruses that cause" exact="encephalitis" post="in equids and not viruses that can cause other"/>
   <result pre="diseases such as equine herpes myeloencephalopathy. Other viruses that cause" exact="encephalitis" post="in horses less frequently or affecting a smaller region"/>
   <result pre="Kunjin Australia Birds Equids Human Y Y 92 St. Louis" exact="encephalitis" post="North America Birds Equids Human Y Y 93 Usutu"/>
   <result pre="Lagomorphs Rodents Skunks DogsBirds Equids Human Y Y 95 Tick-borne" exact="encephalitis" post="AsiaEurope FinlandRussia Small rodents Equids HumanPrimatesDogsRuminants Y Y 96â€&quot;98"/>
   <result pre="continent.3 The most common equine encephalitic viruses are Eastern equine" exact="encephalitis" post="(EEE), Western equine encephalitis (WEE), and Venezuelan equine encephalitis"/>
   <result pre="equine encephalitic viruses are Eastern equine encephalitis (EEE), Western equine" exact="encephalitis" post="(WEE), and Venezuelan equine encephalitis (VEE). Collectively known as"/>
   <result pre="equine encephalitis (EEE), Western equine encephalitis (WEE), and Venezuelan equine" exact="encephalitis" post="(VEE). Collectively known as the equine encephalitides, they are"/>
   <result pre="a fatal human case in 2009 associated with WEE virus" exact="encephalitis" post="in a child led to a seroprevalence survey in"/>
   <result pre="the epizootic strains 1-AB and 1-AC of VEE virus produce" exact="encephalomyelitis" post="in horses, with a fatality rate close to 90%.19,20"/>
   <result pre="contains the largest number of viral species that may cause" exact="encephalitis" post="in horses. All are zoonotic and transmitted by mosquitoes"/>
   <result pre="The most significant are West Nile virus (WNV) and Japanese" exact="encephalitis" post="virus (JEV).1 West Nile virus West Nile virus is"/>
   <result pre="endemic in northern Australia but has caused recent outbreaks of" exact="encephalitis" post="in horses in the southeast probably because of enhanced"/>
   <result pre="PRNT, plaque reduction neutralization test; VNT, virus neutralization test. Japanese" exact="encephalitis" post="virus Japanese encephalitis virus most commonly circulates amongst birds"/>
   <result pre="neutralization test; VNT, virus neutralization test. Japanese encephalitis virus Japanese" exact="encephalitis" post="virus most commonly circulates amongst birds and mosquitoes.30 Pigs"/>
   <result pre="order (Rhabdoviridae, Orthobornaviridae, and Paramyxoviridae) include viruses that can produce" exact="encephalitis" post="in animals and humans.36 Rabies virus Rabies virus, a"/>
   <result pre="in 2017.39 Nevertheless, in some African countries, large numbers of" exact="rabies" post="cases occur in equids, including donkeys, and there may"/>
   <result pre="pathogen in the genus Orthobornavirus (family Bornaviridae) that causes mononuclear" exact="encephalomyelitis" post="in horses.41 This disease is endemic in certain areas"/>
   <result pre="reports of confirmed human BoDV-1 infection including a recent fatal" exact="encephalitis" post="case,54 but it is unclear whether these represent interspecies"/>
   <result pre="domestic pigs and people but can occasionally affect horses producing" exact="encephalitis" post="and meningitis.59 Prevention and control The majority of equine"/>
   <result pre="detection of pathogens.64 Early identification of the virus causing equine" exact="encephalitis" post="will improve the effectiveness of many disease control measures."/>
   <result pre="currently available for many of the viruses that cause equine" exact="encephalitis" post="(Table 3). An equine vaccine for JEV is notably"/>
   <result pre="for use in horses to protect against viruses that cause" exact="encephalitis" post="Virus Vaccine type Eastern equine encephalitis Inactivated whole virus"/>
   <result pre="against viruses that cause encephalitis Virus Vaccine type Eastern equine" exact="encephalitis" post="Inactivated whole virus Western equine encephalitis Inactivated whole virus"/>
   <result pre="Vaccine type Eastern equine encephalitis Inactivated whole virus Western equine" exact="encephalitis" post="Inactivated whole virus Venezuelan equine encephalitis (VEE) Inactivated whole"/>
   <result pre="whole virus Western equine encephalitis Inactivated whole virus Venezuelan equine" exact="encephalitis" post="(VEE) Inactivated whole virusA conditionally available modified live virus"/>
   <result pre="theoretical idea.66 Vaccination has led to the global eradication of" exact="smallpox" post="and rinderpest virus. However, herd immunity and disease eradication"/>
   <result pre="example, where poisoning of bats has been used to control" exact="rabies" post="in South America. At the equine premises level, exposure"/>
   <result pre="vector of equine encephalitic viruses, ticks (eg, Powassan virus74 and" exact="louping ill" post="virus) and midges (eg, African horse sickness viruses) can"/>
   <result pre="this work. References References 1.LongMT. West nile virus and equine" exact="encephalitis" post="viruses. Vet Clin North Am Equine Pract. 2014;30:523â€&quot;542. doi:10.1016/j.cveq.2014.08.00125441112"/>
   <result pre="PowersAM, Villarreal ChavezCL, et al. Genetic and antigenic diversity among" exact="eastern equine encephalitis" post="viruses from North, Central, and South America. Am J"/>
   <result pre="ChavezCL, et al. Genetic and antigenic diversity among eastern equine" exact="encephalitis" post="viruses from North, Central, and South America. Am J"/>
   <result pre="LedermannJP, Saxton-ShawKD, et al. The first outbreak of Eastern equine" exact="encephalitis" post="in Vermont: outbreak description and phylogenetic relationships of the"/>
   <result pre="LindsayLR, DrebotM, MichelP. Characterizing areas of potential human exposure to" exact="eastern equine encephalitis" post="virus using serological and clinical data from horses. Epidemiol"/>
   <result pre="MichelP. Characterizing areas of potential human exposure to eastern equine" exact="encephalitis" post="virus using serological and clinical data from horses. Epidemiol"/>
   <result pre="Infect. 2017;145:667â€&quot;677. doi:10.1017/S095026881700066827903326 8.RocheleauJ-P, ArsenaultJ, LindsayLR, et al. Eastern equine" exact="encephalitis" post="virus: high seroprevalence in horses from Southern Quebec, Canada,"/>
   <result pre="Emerg Dis. 2015;64:990â€&quot;993. doi:10.1111/tbed.1238226608567 10.AguilarPV, RobichRM, TurellMJ, et al. Endemic" exact="eastern equine encephalitis" post="in the Amazon region of Peru. Am J Trop"/>
   <result pre="2015;64:990â€&quot;993. doi:10.1111/tbed.1238226608567 10.AguilarPV, RobichRM, TurellMJ, et al. Endemic eastern equine" exact="encephalitis" post="in the Amazon region of Peru. Am J Trop"/>
   <result pre="Hyg. 2007;76:293â€&quot;298. doi:10.4269/ajtmh.2007.76.29317297038 11.CarreraJ-P, ForresterN, WangE, et al. Eastern equine" exact="encephalitis" post="in Latin America. New Engl J Med. 2013;369:732â€&quot;744. doi:10.1056/NEJMoa121262823964935"/>
   <result pre="doi:10.1056/NEJMoa121262823964935 12.de Novaes OliveiraR, IamamotoK, SilvaMLCR, et al. Eastern equine" exact="encephalitis" post="cases among horses in Brazil between 2005 and 2009."/>
   <result pre="Virol. 2014;159:2615â€&quot;2620. doi:10.1007/s00705-014-2121-424862186 13.SilvaMLCR, GalizaGJN, DantasAFM, et al. Outbreaks of" exact="eastern equine encephalitis" post="in northeastern Brazil. J Vet Diagn Invest. 2011;23:570â€&quot;575. doi:10.1177/104063871140341421908293"/>
   <result pre="doi:10.1007/s00705-014-2121-424862186 13.SilvaMLCR, GalizaGJN, DantasAFM, et al. Outbreaks of eastern equine" exact="encephalitis" post="in northeastern Brazil. J Vet Diagn Invest. 2011;23:570â€&quot;575. doi:10.1177/104063871140341421908293"/>
   <result pre="2015;110:125â€&quot;133. doi:10.1590/0074-0276014038325742272 15.NegiSS, BraunWA, AugusteAJ, BergrenNA, ForresterNL, WeaverSC. Western equine" exact="encephalitis" post="virus: evolutionary analysis of a declining alphavirus based on"/>
   <result pre="al. Continued evidence of decline in the enzootic activity of" exact="western equine encephalitis" post="virus in Colorado. J Med Entomol. 2018;1987:1â€&quot;5. 19.Estrada-FrancoJG, CarraraA-S,"/>
   <result pre="evidence of decline in the enzootic activity of western equine" exact="encephalitis" post="virus in Colorado. J Med Entomol. 2018;1987:1â€&quot;5. 19.Estrada-FrancoJG, CarraraA-S,"/>
   <result pre="AronsonJF, WeaverSC, GonzalezD. Equine amplification and virulence of subtype IE" exact="venezuelan equine encephalitis" post="viruses isolated during the 1993 and 1996 Mexican Epizootics."/>
   <result pre="GonzalezD. Equine amplification and virulence of subtype IE venezuelan equine" exact="encephalitis" post="viruses isolated during the 1993 and 1996 Mexican Epizootics."/>
   <result pre="WertheimJO, DuganVG, et al. Evolution and spread of Venezuelan equine" exact="encephalitis" post="complex alphavirus in the Americas. PLoS Negl Trop Dis."/>
   <result pre="Dis. 2017;11:1â€&quot;19. doi:10.1371/journal.pntd.0005693 21.Navarro-LopezR, ClementsT, FreierJE, et al. Venezuelan equine" exact="encephalitis" post="virus, Southern Mexico. Emerg Infect Dis. 2012;10:2113â€&quot;2121. 22.AdamsAP, Navarro-LopezR,"/>
   <result pre="Infect Dis. 2012;10:2113â€&quot;2121. 22.AdamsAP, Navarro-LopezR, Ramirez-AguilarFJ, et al. Venezuelan equine" exact="encephalitis" post="virus activity in the Gulf Coast region of Mexico,"/>
   <result pre="ArshadSS, SelvarajahGT, et al. Prevalence and risk factors of Japanese" exact="encephalitis" post="virus (JEV) in livestock and companion animal in high-risk"/>
   <result pre="Health Prod. 2018;50:741â€&quot;752. doi:10.1007/s11250-017-1490-629243139 31.RicklinME, Garcia-NicolasO, BrechbuhlD, et al. Japanese" exact="encephalitis" post="virus tropism in experimentally infected pigs. Vet Res. 2016;47:34."/>
   <result pre="Vet Res. 2016;47:34. doi:10.1186/s13567-016-0319-z26911997 32.MansfieldKL, Hernandez-TrianaLM, BanyardAC, FooksAR, JohnsonN. Japanese" exact="encephalitis" post="virus infection, diagnosis and control in domestic animals. Vet"/>
   <result pre="SinghBK, VirmaniN, KumarS, SinghRK. Isolation and genetic characterization of Japanese" exact="encephalitis" post="virus from equines in India. J Vet Sci. 2012;13:111â€&quot;118."/>
   <result pre="Med Assoc. 2018;253:1555â€&quot;1568. doi:10.2460/javma.253.8.98030668262 40.JemberuWT, MollaW, AlmawG, AlemuS. Incidence of" exact="rabies" post="in humans and domestic animals and peopleâ€™s awareness in"/>
   <result pre="Vet Res. 2002;33:127â€&quot;138. doi:10.1051/vetres:200200211944803 54.KornK, CorasR, BobingerT, et al. Fatal" exact="encephalitis" post="associated with Borna disease virus 1. New Engl J"/>
   <result pre="et al. Vaccination of dogs in an African city interrupts" exact="rabies" post="transmission and reduces human exposure. Sci Transl Med. 2017;9:eaaf6984."/>
   <result pre="exposure. Sci Transl Med. 2017;9:eaaf6984. doi:10.1126/scitranslmed.aaf698429263230 68.CurtisC. Insecticide-treated nets against" exact="malaria" post="vectors and polystyrene beads against Culex larvae. Trends Parasitol."/>
   <result pre="applications. Proc Biol Sci. 2004;271:501â€&quot;507. doi:10.1098/rspb.2003.260815129960 74.KeaneDP, LittlePB. Equine viral" exact="encephalomyelitis" post="in Canada: a review of known and potential causes."/>
   <result pre="80.KelenPV, DownsJA, UnnaschT, StarkL. A risk index model for predicting" exact="eastern equine encephalitis" post="virus transmission to horses in Florida. Appl Geog. 2014;48:79â€&quot;86."/>
   <result pre="UnnaschT, StarkL. A risk index model for predicting eastern equine" exact="encephalitis" post="virus transmission to horses in Florida. Appl Geog. 2014;48:79â€&quot;86."/>
   <result pre="of geographic information technology in determining risk of eastern equine" exact="encephalomyelitis" post="virus transmission. AMCA. 2000;16:28â€&quot;35. 82.ZouL, MillerSN, SchmidtmannET. A GIS"/>
   <result pre="to experimental infection with Murray Valley encephalitis, Kunjin and Japanese" exact="encephalitis" post="viruses. Austr J Exp Biol Med Sci. 1983;61:655â€&quot;664. doi:10.1038/icb.1983.62"/>
   <result pre="doi:10.1038/icb.1983.62 93.WhiteGS, SymmesK, SunP, et al. Reemergence of St. Louis" exact="encephalitis" post="virus, California, 2015. Emerg Infect Dis. 2016;22:2185â€&quot;2188. doi:10.3201/eid2212.16080527869600 94.HydeJ,"/>
   <result pre="PÃ©terO, VoordouwMJ. Goats as sentinel hosts for the detection of" exact="tick-borne encephalitis" post="risk areas in the Canton of Valais, Switzerland. BMC"/>
   <result pre="VoordouwMJ. Goats as sentinel hosts for the detection of tick-borne" exact="encephalitis" post="risk areas in the Canton of Valais, Switzerland. BMC"/>
   <result pre="Res. 2017;13:1â€&quot;13. doi:10.1186/s12917-016-0931-128049469 97.RushtonJO, LecollinetS, HubÃ¡lekZ, SvobodovÃ¡P, LussyH, NowotnyN. Tick-borne" exact="encephalitis" post="virus in horses, Austria, 2011. Emerg Infect Dis. 2013;19:635â€&quot;637."/>
   <result pre="Infect Dis. 2013;19:635â€&quot;637. doi:10.3201/eid1904.12145023631894 98.YoshiiK, SongJY, ParkSB, YangJ, SchmittHJ. Tick-borne" exact="encephalitis" post="in Japan, Republic of Korea and China. Emerg Microbes"/>
   <result pre="2005;157:711â€&quot;713. doi:10.1136/vr.157.22.71116311385 110.BouzalasIG, DiakakisN, ChaintoutisSC, et al. Emergence of equine" exact="west nile encephalitis" post="in central Macedonia, Greece, 2010. Transbound Emerg Dis. 2016;63:e219â€&quot;e227."/>
   <result pre="110.BouzalasIG, DiakakisN, ChaintoutisSC, et al. Emergence of equine west nile" exact="encephalitis" post="in central Macedonia, Greece, 2010. Transbound Emerg Dis. 2016;63:e219â€&quot;e227."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6690514\results\search\disease\results.xml">
   <result pre="Analysis Techniques: Amino Acid Analysis Evolutionary dynamics of the H7N9" exact="avian influenza" post="virus based on large-scale sequence analysis Evolutionary dynamics of"/>
   <result pre="Techniques: Amino Acid Analysis Evolutionary dynamics of the H7N9 avian" exact="influenza" post="virus based on large-scale sequence analysis Evolutionary dynamics of"/>
   <result pre="are credited.pone.0220249.pdf Abstract Since 2013, epidemics caused by novel H7N9" exact="avian influenza" post="A viruses (AIVs) have become a considerable public health"/>
   <result pre="credited.pone.0220249.pdf Abstract Since 2013, epidemics caused by novel H7N9 avian" exact="influenza" post="A viruses (AIVs) have become a considerable public health"/>
   <result pre="of the virus can circulate in avian species [2]. Occasionally," exact="avian influenza" post="A viruses (AIVs) can be transmitted from avian species"/>
   <result pre="the virus can circulate in avian species [2]. Occasionally, avian" exact="influenza" post="A viruses (AIVs) can be transmitted from avian species"/>
   <result pre="severe human infections and deaths [5]. Subsequent outbreaks of H7N9" exact="influenza" post="in humans have occurred in the winter and spring"/>
   <result pre="AIV as a triple-reassortant virus of H7, N9, and H9N2" exact="influenza" post="viruses. Phylogenetic characteristics, variations involving key amino acids, virulence,"/>
   <result pre="for the efficient growth of IAVs. NA also contributes to" exact="influenza" post="virus species specificity and determines the virulence and drug"/>
   <result pre="early warning signs of an H7N9 epidemic. We used relevant" exact="influenza" post="virus bioinformatics databases to investigate the evolutionary dynamics of"/>
   <result pre="H7N9 AIVs are much higher than any previous H7 subtype" exact="influenza" post="[15,16]. Compared with early H7, the HA of the"/>
   <result pre="H7N9 vaccines have been widely used to prevent and control" exact="avian influenza" post="in poultry farms [8,36], the immune pressure among poultry"/>
   <result pre="vaccines have been widely used to prevent and control avian" exact="influenza" post="in poultry farms [8,36], the immune pressure among poultry"/>
   <result pre="manuscript. References References 1SchrauwenEJ, FouchierRA. Host adaptation and transmission of" exact="influenza" post="A viruses in mammals. Emerg Microbes Infect. 2014; 3(2):e910.1038/emi.2014.9"/>
   <result pre="LiY, ShiM, ZhangJ, BourgeoisM, et al.New world bats harbor diverse" exact="influenza" post="A viruses. PLoS Pathog. 2013; 9(10): e100365710.1371/journal.ppat.1003657 .24130481 3MaW,"/>
   <result pre="RichtJA. The role of swine in the generation of novel" exact="influenza" post="viruses. Zoonoses Public Health. 2009; 56(6â€&quot;7): 326â€&quot;37. 10.1111/j.1863-2378.2008.01217.x .19486316"/>
   <result pre=".19486316 4WebsterRG, BeanWJ, GormanOT, ChambersTM, KawaokaY. Evolution and ecology of" exact="influenza" post="A viruses. Microbiol Rev. 1992; 56(1): 152â€&quot;79. .1579108 5GaoR,"/>
   <result pre="FengZ, WangD, HuW, et al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virus. N Engl J Med. 2013; 368(20):"/>
   <result pre=".28734617 7WangX, JiangH, WuP, UyekiTM, FengL, LaiS, et al.Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="7WangX, JiangH, WuP, UyekiTM, FengL, LaiS, et al.Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="GuM, LiR, et al.Recombinant baculovirus vaccine expressing hemagglutinin of H7N9" exact="avian influenza" post="virus confers full protection against lethal highly pathogenic H7N9"/>
   <result pre="LiR, et al.Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian" exact="influenza" post="virus confers full protection against lethal highly pathogenic H7N9"/>
   <result pre="ShiY, WangD, XiaoH, LiW, et al.Origin and diversity of novel" exact="avian influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="WangD, XiaoH, LiW, et al.Origin and diversity of novel avian" exact="influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="GarcÃ­a-SastreA, TumpeyTM, et al.A single amino acid substitution in 1918" exact="influenza" post="virus hemagglutinin changes receptor binding specificity. J Virol. 2005;"/>
   <result pre="10.1128/JVI.79.17.11533-11536.2005 .16103207 13OshanskyCM, PickensJA, BradleyKC, JonesLP, Saavedra-EbnerGM, BarberJP, et al.Avian" exact="influenza" post="viruses infect primary human bronchial epithelial cells unconstrained by"/>
   <result pre="KawaokaY. Host range restriction and pathogenicity in the context of" exact="influenza" post="pandemic. Emerg Infect Dis. 2006; 12(6): 881â€&quot;6. 10.3201/eid1206.051336 .16707041"/>
   <result pre="10.3201/eid1206.051336 .16707041 15WebbyRJ, YangZ. The changing landscape of A H7N9" exact="influenza" post="virus infections in China. Lancet Infect Dis. 2017; 17(8):"/>
   <result pre="acid substitutions involved in the adaption of three avian-origin H7N9" exact="influenza" post="viruses in mice. Virol J. 2019; 16(1): 310.1186/s12985-018-1109-1 .30621708"/>
   <result pre="KraussS, YenHL, GuanY, PeirisM, et al.Lethality to ferrets of H5N1" exact="influenza" post="viruses isolated from humans and poultry in 2004. J"/>
   <result pre="JiangS. Genomic signature and protein sequence analysis of a novel" exact="influenza" post="A (H7N9) virus that causes an outbreak in humans"/>
   <result pre="monoclonal neutralizing antibody that targets a unique conserved epitope on" exact="influenza" post="HA. Nat Commun. 2018; 9(1): 266910.1038/s41467-018-04704-9 .29991715 20XuH, ZhangW,"/>
   <result pre="sites screening on HA sequence that affect the virulence of" exact="influenza" post="A H5N1 for mammalian species. Fudan Univ J Med"/>
   <result pre="et al.A carbohydrate side chain on hemagglutinins of Hong Kong" exact="influenza" post="viruses inhibits recognition by a monoclonal antibody. Proc Natl"/>
   <result pre="the hemagglutinin (HA) cleavage site sequence of H5 and H7" exact="avian influenza" post="viruses: amino acid sequence at the HA cleavage site"/>
   <result pre="hemagglutinin (HA) cleavage site sequence of H5 and H7 avian" exact="influenza" post="viruses: amino acid sequence at the HA cleavage site"/>
   <result pre="PaulsonJC, DanielsRS, SkehelJJ, WilsonIA, WileyDC. Single amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificity. Nature. 1983; 304(5921): 76â€&quot;8."/>
   <result pre="sequences and receptor-binding properties among 13 serotypes of hemagglutinins of" exact="influenza" post="A viruses. Virology. 1991; 182(2): 475â€&quot;85. 10.1016/0042-6822(91)90588-3 .2024485 25ObenauerJC,"/>
   <result pre="DensonJ, MehtaPK, SuX, MukatiraS, FinkelsteinDB, et al.Large-scale sequence analysis of" exact="avian influenza" post="isolates. Science. 2006; 311(5767): 1576â€&quot;80. 10.1126/science.1121586 .16439620 26ZhangWT, JiangQW."/>
   <result pre="MehtaPK, SuX, MukatiraS, FinkelsteinDB, et al.Large-scale sequence analysis of avian" exact="influenza" post="isolates. Science. 2006; 311(5767): 1576â€&quot;80. 10.1126/science.1121586 .16439620 26ZhangWT, JiangQW."/>
   <result pre="26ZhangWT, JiangQW. Phylogenetic analysis for H3A1 strain of all human" exact="influenza" post="A virus. Zhonghua Liu Xing Bing Xue Za Zhi."/>
   <result pre="HA gene of pandemic (2009) and seasonal human and swine" exact="influenza" post="A H1 subtype viruses. Virology. 2010; 405(2): 314â€&quot;21. 10.1016/j.virol.2010.06.018"/>
   <result pre="LiX, ZhangY, GuoJ, LiM, et al.Selection pressure analysis of H3N2" exact="influenza" post="virus from China between 1992 and 2012. Zhonghua Shi"/>
   <result pre="XieD. Evolution and adaptation of hemagglutinin gene of human H5N1" exact="influenza" post="virus. Virus Genes. 2012; 44(3): 450â€&quot;8. 10.1007/s11262-012-0717-x .22286608 30SchrauwenEJ,"/>
   <result pre="de GraafM, HerfstS, RimmelzwaanGF, OsterhausAD, FouchierRA. Determinants of virulence of" exact="influenza" post="A virus. Eur J Clin Microbiol Infect Dis. 2014;"/>
   <result pre="32FangS, WangX, DongF, JinT, LiuG, LuX, et al.Genomic characterization of" exact="influenza" post="A (H7N9) viruses isolated in Shenzhen, Southern China, during"/>
   <result pre="SchimanskiL, DongT, et al.Structure-function analysis of neutralizing antibodies to H7N9" exact="influenza" post="from naturally infected humans. Nat Microbiol. 2019; 4(2): 306â€&quot;15."/>
   <result pre="CuiLB, TangFY, et al.Probable person to person transmission of novel" exact="avian influenza" post="A (H7N9) virus in Eastern China, 2013: epidemiological investigation."/>
   <result pre="TangFY, et al.Probable person to person transmission of novel avian" exact="influenza" post="A (H7N9) virus in Eastern China, 2013: epidemiological investigation."/>
   <result pre="PengH, TaoQ, ZhaoX, TangH, TangZ, et al.Serologic assay for avian-origin" exact="influenza" post="A (H7N9) virus in adults of Shanghai, Guangzhou and"/>
   <result pre="SkehelJJ. Structural identification of the antibody-binding sites of Hong Kong" exact="influenza" post="haemagglutinin and their involvement in antigenic variation. Nature. 1981;"/>
   <result pre="activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of" exact="influenza" post="virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother. 2001;"/>
   <result pre="2001; 45(12): 3403â€&quot;8. 10.1128/AAC.45.12.3403-3408.2001 .11709315 39MuÃ±ozET, DeemMW. Epitope analysis for" exact="influenza" post="vaccine design. Vaccine. 2005; 23(9): 1144â€&quot;8. 10.1016/j.vaccine.2004.08.028 .15629357 40YangH,"/>
   <result pre="receptor complexes of the hemagglutinin from a highly pathogenic H7N7" exact="influenza" post="virus. J Virol. 2012; 86(16): 8645â€&quot;52. 10.1128/JVI.00281-12 .22674977 41WuY,"/>
   <result pre="et al.Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9" exact="influenza" post="viruses. Cell Res. 2013; 23(12): 1347â€&quot;55. 10.1038/cr.2013.144 .24165891 42BertoniM,"/>
   <result pre="CoxNJ. Positive selection on the H3 hemagglutinin gene of human" exact="influenza" post="virus A. Mol Biol Evol. 1999; 16(11): 1457â€&quot;65. 10.1093/oxfordjournals.molbev.a026057"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6694824\results\search\disease\results.xml">
   <result pre="Long JS, Barclay WS. 2019. ANP32 proteins are essential for" exact="influenza" post="virus replication in human cells. J Virol 93:e00217-19. https://doi.org/10.1128/JVI.00217-19."/>
   <result pre="is the etiological agent behind some of the most devastating" exact="infectious disease" post="pandemics to date, and influenza outbreaks still pose a"/>
   <result pre="of the most devastating infectious disease pandemics to date, and" exact="influenza" post="outbreaks still pose a major threat to public health."/>
   <result pre="against viral proteins, including the polymerase, but RNA viruses like" exact="influenza" post="tend to become resistant to such drugs very rapidly."/>
   <result pre="that the human proteins ANP32A and ANP32B are essential for" exact="influenza" post="A and B virus replication, such that in their"/>
   <result pre="intervention. Abstract ABSTRACT ANP32 proteins have been implicated in supporting" exact="influenza" post="virus replication, but most of the work to date"/>
   <result pre="the ability of avian Anp32 proteins to overcome restriction of" exact="avian influenza" post="polymerases in human cells. Using a CRISPR approach, we"/>
   <result pre="ability of avian Anp32 proteins to overcome restriction of avian" exact="influenza" post="polymerases in human cells. Using a CRISPR approach, we"/>
   <result pre="ANP32B are functionally redundant but essential host factors for mammalian-adapted" exact="influenza" post="A virus (IAV) and influenza B virus (IBV) replication"/>
   <result pre="essential host factors for mammalian-adapted influenza A virus (IAV) and" exact="influenza" post="B virus (IBV) replication in human cells. When both"/>
   <result pre="human cells. When both proteins are absent from human cells," exact="influenza" post="polymerases are unable to replicate the viral genome, and"/>
   <result pre="approach has identified a pair of essential host factors for" exact="influenza" post="virus replication and can be harnessed to inform future"/>
   <result pre="is the etiological agent behind some of the most devastating" exact="infectious disease" post="pandemics to date, and influenza outbreaks still pose a"/>
   <result pre="of the most devastating infectious disease pandemics to date, and" exact="influenza" post="outbreaks still pose a major threat to public health."/>
   <result pre="against viral proteins, including the polymerase, but RNA viruses like" exact="influenza" post="tend to become resistant to such drugs very rapidly."/>
   <result pre="that the human proteins ANP32A and ANP32B are essential for" exact="influenza" post="A and B virus replication, such that in their"/>
   <result pre="inform future intervention. KEYWORDS ANP32 ANP32A ANP32B CRISPR host factor" exact="influenza" post="polymerase replication virus Funding Imperial College President's Scholarship StallerEcco"/>
   <result pre="emergence of pandemic viruses from birds, the natural reservoir of" exact="influenza" post="viruses. The most notorious of these events, in 1918,"/>
   <result pre="(2). In order to mitigate the impact of the next" exact="influenza" post="pandemic and reduce the seasonal burden, new approaches to"/>
   <result pre="pandemic and reduce the seasonal burden, new approaches to thwart" exact="influenza" post="virus are required. A first step toward novel treatment"/>
   <result pre="replication of its genome and production of new virions. The" exact="influenza" post="genome is made up of eight segments of single-stranded"/>
   <result pre="at the C terminus. ANP32 proteins have been associated with" exact="influenza" post="A polymerase function. A nuclear fraction containing ANP32A and"/>
   <result pre="has been suggested to account for host range restriction of" exact="avian influenza" post="strains in mammalian cells, and much of the work"/>
   <result pre="been suggested to account for host range restriction of avian" exact="influenza" post="strains in mammalian cells, and much of the work"/>
   <result pre="experimental platform in which to investigate the interplay between different" exact="influenza" post="virus polymerases and mammalian ANP32 proteins. We find that"/>
   <result pre="and ANP32B proteins are thus functionally redundant but essential for" exact="influenza" post="virus replication. We further show that this redundancy is"/>
   <result pre="of the host proteins as key for the support of" exact="influenza" post="polymerase activity and a target for future interventions. RESULTS"/>
   <result pre="1 Human cells lacking ANP32A and ANP32B do not support" exact="influenza" post="virus polymerase activity. (a) Schematic showing location of CRISPR"/>
   <result pre="and double ANP32-knockout cells with reconstituted polymerases from three different" exact="influenza" post="A virusesâ€&quot;a seasonal H3N2 virus (A/Victoria/3/75), an avian H5N1"/>
   <result pre="and a 2009 pandemic H1N1 virus (A/England/195/2009)â€&quot;as well as an" exact="influenza" post="B virus (B/Florida/04/2006). Surprisingly, absence of ANP32A in human"/>
   <result pre="ANP32A in human cells did not result in loss of" exact="influenza" post="polymerase activity; in fact, activity increased for some polymerase"/>
   <result pre="suggest functionally redundant roles for ANP32A and ANP32B in supporting" exact="influenza" post="virus polymerase activity in human cells. In order to"/>
   <result pre="PB1, PB2-627K, PA-green fluorescent protein (GFP), and NP, with an" exact="influenza" post="minigenome encoding blue fluorescent protein (BFP) as a reporter."/>
   <result pre="that ANP32A and ANP32B proteins are essential but redundant for" exact="influenza" post="A and B polymerase activity in human cells. Intriguingly,"/>
   <result pre="that lack expression of ANP32 proteins, we preexpressed an inactive" exact="influenza" post="polymerase complex (to stabilize any cRNA generated) for 20â€‰h"/>
   <result pre="to ask whether Anp32 proteins from nonhuman species relevant to" exact="influenza" post="virology were capable of supporting polymerase function. We carried"/>
   <result pre="factor for some polymerase constellations, we hypothesized that in mice," exact="influenza" post="virus might rely solely on MusB to support its"/>
   <result pre="ANP32A and ANP32B are functionally redundant in their support for" exact="influenza" post="virus polymerase in human cells and that the RdRp"/>
   <result pre="of ANP32A might liberate the preferred ANP32B for recruitment by" exact="influenza" post="virus RdRp. Alternatively, ANP32A and ANP32B, being very similar"/>
   <result pre="ANP32B being functionally superior in humans to ANP32A for supporting" exact="influenza" post="polymerase. However, these differences were not so readily apparent"/>
   <result pre="MusA, but IBV polymerase can, albeit inefficiently. The ability of" exact="influenza" post="A virus to replicate in mice is explained by"/>
   <result pre="cells, it is the Anp32A orthologue that is utilized by" exact="avian influenza" post="polymerase, whereas chAnp32B does not support replication; this difference"/>
   <result pre="it is the Anp32A orthologue that is utilized by avian" exact="influenza" post="polymerase, whereas chAnp32B does not support replication; this difference"/>
   <result pre="recurring issue with such drugs is the ease with which" exact="influenza" post="virus evolves resistance to them, be it in a"/>
   <result pre="on the host protein without compromising its cellular functions. As" exact="influenza" post="virus replication is completely abrogated in their absence, ANP32"/>
   <result pre="at least 3 repeats. Minigenome assay. In order to measure" exact="influenza" post="virus polymerase activity, pCAGGS expression plasmids encoding PB1 (0.04â€‰Î¼g),"/>
   <result pre="encodes a minigenome containing a firefly reporter flanked by either" exact="influenza" post="A or B promoter sequences, or, in Fig. 2e,"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling study. Lancet Infect"/>
   <result pre="Infect Dis12:687â€&quot;695. doi:10.1016/S1473-3099(12)70121-4.22738893 3.HsuMT, ParvinJD, GuptaS, KrystalM, PaleseP1987Genomic RNAs of" exact="influenza" post="viruses are held in a circular conformation in virions"/>
   <result pre="S A84:8140â€&quot;8144. doi:10.1073/pnas.84.22.8140.2446318 4.MoellerA, KirchdoerferRN, PotterCS, CarragherB, WilsonIA2012Organization of the" exact="influenza" post="virus replication machinery. Science338:1631â€&quot;1634. doi:10.1126/science.1227270.23180774 5.ArranzR, ColomaR, ChichonFJ, ConesaJJ,"/>
   <result pre="ColomaR, ChichonFJ, ConesaJJ, CarrascosaJL, ValpuestaJM, OrtinJ, Martin-BenitoJ2012The structure of native" exact="influenza" post="virion ribonucleoproteins. Science338:1634â€&quot;1637. doi:10.1126/science.1228172.23180776 6.PflugA, GuilligayD, ReichS, CusackS2014Structure of"/>
   <result pre="influenza virion ribonucleoproteins. Science338:1634â€&quot;1637. doi:10.1126/science.1228172.23180776 6.PflugA, GuilligayD, ReichS, CusackS2014Structure of" exact="influenza" post="A polymerase bound to the viral RNA promoter. Nature516:355â€&quot;360."/>
   <result pre="LukarskaM, Resa-InfanteP, ReichS, CusackS2017Structural insights into RNA synthesis by the" exact="influenza" post="virus transcription-replication machine. Virus Res234:103â€&quot;117. doi:10.1016/j.virusres.2017.01.013.28115197 9.ReillyPT, YuY, HamicheA,"/>
   <result pre="KornbluthS2006Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in" exact="breast cancer" post="cells. Cancer Res66:2210â€&quot;2218. doi:10.1158/0008-5472.CAN-05-3923.16489023 14.MunemasaY, SuzukiT, AizawaK, MiyamotoS, ImaiY,"/>
   <result pre="sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast" exact="cancer" post="cells. Cancer Res66:2210â€&quot;2218. doi:10.1158/0008-5472.CAN-05-3923.16489023 14.MunemasaY, SuzukiT, AizawaK, MiyamotoS, ImaiY,"/>
   <result pre="KawaguchiA, OkuwakiM, NagataK2015Pp32 and APRIL are host cell-derived regulators of" exact="influenza" post="virus RNA synthesis from cRNA. Elife4:e08939. doi:10.7554/eLife.08939.26512887 18.LongJS, GiotisES,"/>
   <result pre="JamesJ, MorissonM, IqbalM, VignalA, SkinnerMA, BarclayWS2016Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature529:101â€&quot;104. doi:10.1038/nature16474.26738596 19.BakerSF, LedwithMP,"/>
   <result pre="birds alters its ability to stimulate RNA synthesis by restricted" exact="influenza" post="polymerase. Cell Rep24:2581â€&quot;2588.e4. doi:10.1016/j.celrep.2018.08.012.30184493 20.DominguesP, HaleBG2017Functional insights into ANP32A-dependent"/>
   <result pre="influenza polymerase. Cell Rep24:2581â€&quot;2588.e4. doi:10.1016/j.celrep.2018.08.012.30184493 20.DominguesP, HaleBG2017Functional insights into ANP32A-dependent" exact="influenza" post="A virus polymerase host restriction. Cell Rep20:2538â€&quot;2546. doi:10.1016/j.celrep.2017.08.061.28903035 21.WatanabeT,"/>
   <result pre="22.Bradel-TrethewayBG, MattiacioJL, KrasnoselskyA, StevensonC, PurdyD, DewhurstS, KatzeMG2011Comprehensive proteomic analysis of" exact="influenza" post="virus polymerase complex reveals a novel association with mitochondrial"/>
   <result pre="Virol85:8569â€&quot;8581. doi:10.1128/JVI.00496-11.21715506 23.LongJS, MistryB, HaslamSM, BarclayWS2019Host and viral determinants of" exact="influenza" post="A virus species specificity. Nat Rev Microbiol17:67â€&quot;81. doi:10.1038/s41579-018-0115-z.30487536 24.EssletzbichlerP,"/>
   <result pre="doi:10.1038/nbt.3437.26780180 29.JorbaN, ColomaR, OrtinJ2009Genetic trans-complementation establishes a new model for" exact="influenza" post="virus RNA transcription and replication. PloS Pathog5:e1000462. doi:10.1371/journal.ppat.1000462.19478885 30.YorkA,"/>
   <result pre="contribution and host range determination of ANP32A and ANP32B in" exact="influenza" post="A virus polymerase activity. J Virol93 doi:10.1128/jvi.00174-19:JVI.00174-19. 32.KarlasA, MachuyN,"/>
   <result pre="RudelT, MeyerTF2010Genome-wide RNAi screen identifies human host factors crucial for" exact="influenza" post="virus replication. Nature463:818â€&quot;822. doi:10.1038/nature08760.20081832 33.HanJ, PerezJT, ChenC, LiY, BenitezA,"/>
   <result pre="AndradeJ, tenOeverB, ManicassamyB2018Genome-wide CRISPR/Cas9 screen identifies host factors essential for" exact="influenza" post="virus replication. Cell Rep23:596â€&quot;607. doi:10.1016/j.celrep.2018.03.045.29642015 34.LongJS, Idoko-AkohA, MistryB, GoldhillD,"/>
   <result pre="McGrewMJ, BarclayW2019Species specific differences in use of ANP32 proteins by" exact="influenza" post="A virus. Elife8:e45066. doi:10.7554/eLife.45066.31159925 35.BloomJD, GongLI, BaltimoreD2010Permissive secondary mutations"/>
   <result pre="doi:10.7554/eLife.45066.31159925 35.BloomJD, GongLI, BaltimoreD2010Permissive secondary mutations enable the evolution of" exact="influenza" post="oseltamivir resistance. Science328:1272â€&quot;1275. doi:10.1126/science.1187816.20522774 36.BrightRA, ShayDK, ShuB, CoxNJ, KlimovAI2006Adamantane"/>
   <result pre="resistance. Science328:1272â€&quot;1275. doi:10.1126/science.1187816.20522774 36.BrightRA, ShayDK, ShuB, CoxNJ, KlimovAI2006Adamantane resistance among" exact="influenza" post="A viruses isolated early during the 2005â€&quot;2006 influenza season"/>
   <result pre="resistance among influenza A viruses isolated early during the 2005â€&quot;2006" exact="influenza" post="season in the United States. Jama295:891â€&quot;894. doi:10.1001/jama.295.8.joc60020.16456087 37.TakashitaE, MoritaH,"/>
   <result pre="MoritaH, OgawaR, NakamuraK, FujisakiS, ShirakuraM, KuwaharaT, KishidaN, WatanabeS, OdagiriT2018Susceptibility of" exact="influenza" post="viruses to the novel cap-dependent endonuclease inhibitor baloxavir marboxil."/>
   <result pre="effect of the PB2 mutation 627K on highly pathogenic H5N1" exact="avian influenza" post="virus is dependent on the virus lineage. J Virol87:9983â€&quot;9996."/>
   <result pre="of the PB2 mutation 627K on highly pathogenic H5N1 avian" exact="influenza" post="virus is dependent on the virus lineage. J Virol87:9983â€&quot;9996."/>
   <result pre="J Virol87:9983â€&quot;9996. doi:10.1128/JVI.01399-13.23843645 39.MoncorgeO, LongJS, CauldwellAV, ZhouH, LycettSJ, BarclayWS2013Investigation of" exact="influenza" post="virus polymerase activity in pig cells. J Virol87:384â€&quot;394. doi:10.1128/JVI.01633-12.23077313"/>
   <result pre="CadmanA, ZurcherT, BarclayWS2002A reverse genetics approach for recovery of recombinant" exact="influenza" post="B viruses entirely from cDNA. J Virol76:11744â€&quot;11747. doi:10.1128/jvi.76.22.11744-11747.2002.12388735 41.BystrykhLV2012Generalized"/>
   <result pre="WatanabeT, FujiiK, GotoH, WatanabeS, NodaT, KawaokaY2011Strand-specific real-time RT-PCR for distinguishing" exact="influenza" post="vRNA, cRNA, and mRNA. J Virol Methods173:1â€&quot;6. doi:10.1016/j.jviromet.2010.12.014.21185869 44.KnyazC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6695095\results\search\disease\results.xml">
   <result pre="Gene Expression Dysregulation of M segment gene expression contributes to" exact="influenza" post="A virus host restriction Regulation of influenza A virus"/>
   <result pre="expression contributes to influenza A virus host restriction Regulation of" exact="influenza" post="A virus gene expression as a host range determinant"/>
   <result pre="are credited.ppat.1007892.pdf Abstract The M segment of the 2009 pandemic" exact="influenza" post="A virus (IAV) has been implicated in its emergence"/>
   <result pre="cells with avian IAVs, and which is overcome in human-adapted" exact="influenza" post="A lineages. Critically, the mechanism leading to this host-restricted"/>
   <result pre="changes in the M segment of pH1N1 and H3N2 human" exact="influenza" post="A lineages. Fig 2 pH1N1 M segment confers higher"/>
   <result pre="kinetics than the PR8 NL09 M virus. Fig 3 pH1N1" exact="influenza" post="A virus M segment confers efficient replication and transmission"/>
   <result pre="cells have been previously reported for the avian IAV, fowl" exact="plague" post="virus [20,21]. We therefore hypothesized that the high expression"/>
   <result pre="segment mRNAs and gene products. (A) The M segment of" exact="influenza" post="virus is template for synthesis of mRNA7 (encoding M1),"/>
   <result pre="peptide from a short open reading frame). (B) Pandemic H1N1" exact="influenza" post="virus M1 and M2 proteins differ from the avian"/>
   <result pre="differ by 8.3% at the nucleotide level. (C) Seasonal H3N2" exact="influenza" post="virus strain A/Panama/2007/99 M1 and M2 proteins differ from"/>
   <result pre="differ by 9% at the nucleotide level. (D) Seasonal H3N2" exact="influenza" post="virus strain A/Bethesda/55/15 M1 and M2 proteins differ from"/>
   <result pre="LINK Click here for additional data file. S3 Fig pH1N1" exact="influenza" post="virus M segment increases kinetics of replication of PR8-based"/>
   <result pre="Fig Schematic depicting chimeric M Segment RNAs. (A) Pandemic H1N1" exact="influenza" post="virus M1 and M2 proteins differ from the avian"/>
   <result pre="1PattersonKD, PyleGF (1991) The geography and mortality of the 1918" exact="influenza" post="pandemic. Bull Hist Med65: 4â€&quot;21. 2021692 2ViboudC, SimonsenL, FuentesR,"/>
   <result pre="et al. (2005) Multinational impact of the 1968 Hong Kong" exact="influenza" post="pandemic: evidence for a smoldering pandemic. J Infect Dis192:"/>
   <result pre="ThompsonWW, WortleyPM, et al. (2007) The annual impact of seasonal" exact="influenza" post="in the US: measuring disease burden and costs. Vaccine25:"/>
   <result pre="5086â€&quot;5096. 10.1016/j.vaccine.2007.03.04617544181 5ReperantLA, KuikenT, OsterhausAD (2012) Adaptive pathways of zoonotic" exact="influenza" post="viruses: from exposure to establishment in humans. Vaccine30: 4419â€&quot;4434."/>
   <result pre="Vol. 4:105â€&quot;121. 10.1146/annurev-virology-101416-04172628548881 7SteelJ, LowenAC, MubarekaS, PaleseP (2009) Transmission of" exact="influenza" post="virus in a mammalian host is increased by PB2"/>
   <result pre="(1993) A single amino acid in the PB2 gene of" exact="influenza" post="A virus is a determinant of host range. J"/>
   <result pre="FriseR, MistryB, et al. (2016) Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature529: 101â€&quot;104. 10.1038/nature1647426738596 11RogersGN,"/>
   <result pre="10.1038/nature1647426738596 11RogersGN, PaulsonJC (1983) Receptor determinants of human and animal" exact="influenza" post="virus isolates: differences in receptor specificity of the H3"/>
   <result pre="361â€&quot;373. 6868370 12TannerWD, TothDJ, GundlapalliAV (2015) The pandemic potential of" exact="avian influenza" post="A(H7N9) virus: a review. Epidemiol Infect143: 3359â€&quot;3374. 10.1017/S095026881500157026205078 13CapuaI,"/>
   <result pre="6868370 12TannerWD, TothDJ, GundlapalliAV (2015) The pandemic potential of avian" exact="influenza" post="A(H7N9) virus: a review. Epidemiol Infect143: 3359â€&quot;3374. 10.1017/S095026881500157026205078 13CapuaI,"/>
   <result pre="review. Epidemiol Infect143: 3359â€&quot;3374. 10.1017/S095026881500157026205078 13CapuaI, MunozO (2013) Emergence of" exact="influenza" post="viruses with zoonotic potential: open issues which need to"/>
   <result pre="7â€&quot;12. 10.1016/j.vetmic.2013.01.04423567150 14CauldwellAV, LongJS, MoncorgeO, BarclayWS (2014) Viral determinants of" exact="influenza" post="A host range. J Gen Virol. 95: 1193â€&quot;1210. 10.1099/vir.0.062836-024584475"/>
   <result pre="RNA and protein synthesis in a permissive and an abortive" exact="influenza" post="virus infection In: MahyBWJ, BarryRD, editors. Negative Strand Viruses"/>
   <result pre="(1978) Macromolecular syntheses during abortive infection of KB cells by" exact="influenza" post="virus In: MahyBWJ, BarryRD, editors. Negative Strand Viruses and"/>
   <result pre="Press pp. 475â€&quot;482. 17LohmeyerJ, TalensLT, KlenkHD (1979) Biosynthesis of the" exact="influenza" post="virus envelope in abortive infection. J Gen Virol42: 73â€&quot;88."/>
   <result pre="Sequences of mRNAs derived from genome RNA segment 7 of" exact="influenza" post="virus: colinear and interrupted mRNAs code for overlapping proteins."/>
   <result pre="a second protein (M2) encoded by RNA segment 7 of" exact="influenza" post="virus. Virology112: 729â€&quot;737. 7257188 20InglisSC, BrownCM (1984) Differences in"/>
   <result pre="of virus mRNA splicing during permissive or abortive infection with" exact="influenza" post="A (fowl plague) virus. J Gen Virol65 (Pt 1):"/>
   <result pre="21LauSC, ScholtissekC (1995) Abortive infection of Vero cells by an" exact="influenza" post="A virus (FPV). Virology212: 225â€&quot;231. 10.1006/viro.1995.14737676635 22BogdanowB, EichelbaumK, SadewasserA,"/>
   <result pre="SadewasserA, WangX, HusicI, et al. (2018) The dynamic proteome of" exact="influenza" post="A virus infection identifies M segment splicing as a"/>
   <result pre="(2018) Adaptive evolution during the establishment of European avian-like H1N1" exact="influenza" post="A virus in swine. Evol Appl11: 534â€&quot;546. 10.1111/eva.1253629636804 24CampbellPJ,"/>
   <result pre="et al. (2014) The M segment of the 2009 pandemic" exact="influenza" post="virus confers increased NA activity, filamentous morphology and efficient"/>
   <result pre="et al. (2014) Residue 41 of the Eurasian avian-like swine" exact="influenza" post="a virus matrix protein modulates virion filament length and"/>
   <result pre="(2011) The M segment of the 2009 new pandemic H1N1" exact="influenza" post="virus is critical for its high transmission efficiency in"/>
   <result pre="transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1" exact="influenza" post="virus. PLoS Pathog7: e100244310.1371/journal.ppat.1002443 29RossmanJS, LambRA (2011) Influenza virus"/>
   <result pre="Garcia-SastreA (2003) Reverse genetics studies on the filamentous morphology of" exact="influenza" post="A virus. J Gen Virol84: 517â€&quot;527. 10.1099/vir.0.18803-012604801 32EllemanCJ, BarclayWS"/>
   <result pre="(2004) The M1 matrix protein controls the filamentous phenotype of" exact="influenza" post="A virus. Virology321: 144â€&quot;153. 10.1016/j.virol.2003.12.00915033573 33StaufferS, FengY, NebiogluF, HeiligR,"/>
   <result pre="a high K+ concentration is required for efficient uncoating of" exact="influenza" post="A virus cores after penetration. J Virol88: 13029â€&quot;13046. 10.1128/JVI.01430-1425165113"/>
   <result pre="penetration. J Virol88: 13029â€&quot;13046. 10.1128/JVI.01430-1425165113 34O'NeillRE, TalonJ, PaleseP (1998) The" exact="influenza" post="virus NEP (NS2 protein) mediates the nuclear export of"/>
   <result pre="(2003) Crystal structure of the M1 protein-binding domain of the" exact="influenza" post="A virus nuclear export protein (NEP/NS2). EMBO J22: 4646â€&quot;4655."/>
   <result pre="VreedeF, et al. (2014) The nuclear export protein of H5N1" exact="influenza" post="A viruses recruits Matrix 1 (M1) protein to the"/>
   <result pre="10.1074/jbc.M114.56917824891509 37WatanabeK, HandaH, MizumotoK, NagataK (1996) Mechanism for inhibition of" exact="influenza" post="virus RNA polymerase activity by matrix protein. J Virol70:"/>
   <result pre="39AliA, AvalosRT, PonimaskinE, NayakDP (2000) Influenza virus assembly: effect of" exact="influenza" post="virus glycoproteins on the membrane association of M1 protein."/>
   <result pre="of transmembrane domain and cytoplasmic tail amino acid sequences of" exact="influenza" post="a virus neuraminidase in raft association and virus budding."/>
   <result pre="Ion selectivity and activation of the M2 ion channel of" exact="influenza" post="virus. Biophys J70: 1335â€&quot;1346. 10.1016/S0006-3495(96)79690-X8785289 42GrambasS, HayAJ (1992) Maturation"/>
   <result pre="virus. Biophys J70: 1335â€&quot;1346. 10.1016/S0006-3495(96)79690-X8785289 42GrambasS, HayAJ (1992) Maturation of" exact="influenza" post="A virus hemagglutininâ€&quot;estimates of the pH encountered during transport"/>
   <result pre="HayAJ (1992) Regulation of pH by the M2 protein of" exact="influenza" post="A viruses. Virus Res22: 247â€&quot;258. 1626420 44TakeuchiK, LambRA (1994)"/>
   <result pre="protein ion channel activity stabilizes the native form of fowl" exact="plague" post="virus hemagglutinin during intracellular transport. J Virol68: 911â€&quot;919. 7507186"/>
   <result pre="RavenhillBJ, DigardP, et al. (2014) A LC3-interacting motif in the" exact="influenza" post="A virus M2 protein is required to subvert autophagy"/>
   <result pre="AlbrechtR, DengjelJ, TorossiT, et al. (2009) Matrix protein 2 of" exact="influenza" post="A virus blocks autophagosome fusion with lysosomes. Cell Host"/>
   <result pre="WhelanSP, WertzGW (1997) cis-Acting signals involved in termination of vesicular" exact="stomatitis" post="virus mRNA synthesis include the conserved AUAC and the"/>
   <result pre="WhelanSP, WertzGW (1997) Role of the intergenic dinucleotide in vesicular" exact="stomatitis" post="virus RNA transcription. J Virol71: 1794â€&quot;1801. 9032308 52PaganI, HolmesEC,"/>
   <result pre="53AbrahamG, BanerjeeAK (1976) Sequential transcription of the genes of vesicular" exact="stomatitis" post="virus. Proc Natl Acad Sci U S A73: 1504â€&quot;1508."/>
   <result pre="(2006) The guinea pig as a transmission model for human" exact="influenza" post="viruses. Proc Natl Acad Sci U S A103: 9988â€&quot;9992."/>
   <result pre="and unspliced RNAs encoded by virion RNA segment 7 of" exact="influenza" post="virus. Nucleic Acids Res9: 2727â€&quot;2740. 10.1093/nar/9.12.27276169001 57FujitaN, ItohT, OmoriH,"/>
   <result pre="61SkehelJJ, HayAJ, ArmstrongJA (1978) On the mechanism of inhibition of" exact="influenza" post="virus replication by amantadine hydrochloride. J Gen Virol38: 97â€&quot;110."/>
   <result pre="M-gene segment can substantially increase replication efficiency of NS1 deletion" exact="influenza" post="A virus in MDCK cells. J Virol86: 12341â€&quot;12350. 10.1128/JVI.01725-1222951840"/>
   <result pre="of a conserved hairpin in the M gene segment of" exact="influenza" post="A virus shows its role in virus replication. RNA"/>
   <result pre="64ShihSR, KrugRM (1996) Novel exploitation of a nuclear function by" exact="influenza" post="virus: the cellular SF2/ASF splicing factor controls the amount"/>
   <result pre="al. (2018) Co-regulatory activity of hnRNP K and NS1-BP in" exact="influenza" post="and human mRNA splicing. Nat Commun9: 240710.1038/s41467-018-04779-429921878 66RenY, LiC,"/>
   <result pre="(1998) Selective perturbation of apical membrane traffic by expression of" exact="influenza" post="M2, an acid-activated ion channel, in polarized madin-darby canine"/>
   <result pre="network pH but not lysosome pH by dose-dependent expression of" exact="influenza" post="M2 protein. J Biol Chem274: 9854â€&quot;9860. 10.1074/jbc.274.14.985410092677 74BurleighLM, CalderLJ,"/>
   <result pre="75RobertsPC, LambRA, CompansRW (1998) The M1 and M2 proteins of" exact="influenza" post="A virus are important determinants in filamentous particle formation."/>
   <result pre="76FodorE, DevenishL, EngelhardtOG, PaleseP, BrownleeGG, et al. (1999) Rescue of" exact="influenza" post="A virus from recombinant DNA. J Virol73: 9679â€&quot;9682. 10516084"/>
   <result pre="ZamarinD, Garcia-SastreA, CullinaneA, ChambersT, et al. (2005) Attenuation of equine" exact="influenza" post="viruses through truncations of the NS1 protein. J Virol79:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6696070\results\search\disease\results.xml">
   <result pre="their habitats due to favorable warm water environments, such as" exact="cercarial dermatitis," post="jellyfish envenomation and melioidosis [21,22]. Furthermore, extreme weather events"/>
   <result pre="warm water environments, such as cercarial dermatitis, jellyfish envenomation and" exact="melioidosis" post="[21,22]. Furthermore, extreme weather events can also motivate the"/>
   <result pre="of pathogenic diseases, vectors, and favorable conditions for transmission and" exact="infectious disease" post="outbreaks post weather events. Moreover, as the discussion is"/>
   <result pre="the MeSH hierarchy. For instance, terms such as malaria, dengue," exact="yellow fever," post="lyme, encephalitis and zoonoses are all included in â€œinfectious"/>
   <result pre="For instance, terms such as malaria, dengue, yellow fever, lyme," exact="encephalitis" post="and zoonoses are all included in â€œinfectious diseasesâ€�, a"/>
   <result pre="revealed that in Peru, Ecuador and Bolivia, the outburst of" exact="malaria" post="was due to heavy rainfall caused by an El"/>
   <result pre="no link between hospital admission and climate change based on" exact="malaria" post="in East Africa under the El Nino event [31,32]."/>
   <result pre="Nino event [31,32]. Another study found a sudden downfall in" exact="malaria" post="cases in regions of the Usambara Mountains, Tanzania after"/>
   <result pre="that humidity with higher temperatures resulted in an increment of" exact="asthma" post="patientsâ€™ visits to hospitals [43,44]. Numerous model projects based"/>
   <result pre="the association between higher temperature and myocardial infarction along with" exact="congestive heart failure" post="due to excessive heat [48,49]. A detailed understanding of"/>
   <result pre="the growth of parasites such as Plasmodium spp. associated with" exact="malaria" post="minimizes when temperatures surmount 38â€&quot;39 Â°C [69]. Global warming"/>
   <result pre="Global warming might also induce genetic modifications in pathogens like" exact="chikungunya" post="viruses, which might make them more resilient and reproduce"/>
   <result pre="humidity also play a key role in the transmission of" exact="influenza" post="A virus (H1N1) [77]. It has been identified that"/>
   <result pre="virus (H1N1) [77]. It has been identified that transmission of" exact="influenza" post="virus occurred more in cold and relatively less humid"/>
   <result pre="to find the impact of Asian dust storms (ADS) on" exact="influenza" post="virus concentration. The results highlighted that during ADS periods,"/>
   <result pre="results highlighted that during ADS periods, the concentration of H1N1" exact="influenza" post="virus was substantially higher compared to other days [80]."/>
   <result pre="vectors and related diseases. Vector-borne diseases such as lyme, malaria," exact="yellow fever," post="dengue, and plague are some of the examples with"/>
   <result pre="Vector-borne diseases such as lyme, malaria, yellow fever, dengue, and" exact="plague" post="are some of the examples with wide geographical expansion"/>
   <result pre="O. hupensis increased its range with widespread distribution, thereby spreading" exact="schistosomiasis" post="over northern China [12]. Another detailed study in Nepal"/>
   <result pre="found in terms of spatiotemporal distribution of vector-borne diseases. Firstly," exact="malaria" post="which was confined to the forest and nearby areas"/>
   <result pre="also observed for dengue [89,90,91]. One more vector-borne disease, Japanese" exact="encephalitis" post="transmitted by mosquito species Culex tritaeniorhynchushas, rose northwards in"/>
   <result pre="Initially reported in 24 districts of the lowland Terai, Japanese" exact="encephalitis" post="was transmitted to other mountain regions including Kathmandu [14,15]."/>
   <result pre="was transmitted to other mountain regions including Kathmandu [14,15]. Lastly," exact="visceral leishmaniasis" post="and lymphatic filariasis were other vector-borne diseases whose spatiotemporal"/>
   <result pre="transmitted to other mountain regions including Kathmandu [14,15]. Lastly, visceral" exact="leishmaniasis" post="and lymphatic filariasis were other vector-borne diseases whose spatiotemporal"/>
   <result pre="mountain regions including Kathmandu [14,15]. Lastly, visceral leishmaniasis and lymphatic" exact="filariasis" post="were other vector-borne diseases whose spatiotemporal distribution were reported"/>
   <result pre="the distribution of disease vectors. For instance, viruses responsible for" exact="yellow fever" post="and dengue are carried and transmitted by the Aedes"/>
   <result pre="above 16 Â°C, thereby on dropping the temperature below it" exact="aids" post="control measures over malaria epidemics [104]. Precipitation can play"/>
   <result pre="on dropping the temperature below it aids control measures over" exact="malaria" post="epidemics [104]. Precipitation can play a dual role in"/>
   <result pre="(ADS) were involved in a widespread transmission of the H1N1" exact="influenza" post="virus [80]. Some studies even concluded that ADS can"/>
   <result pre="[80]. Some studies even concluded that ADS can carry those" exact="influenza" post="viruses from Asia to the Americas during winters through"/>
   <result pre="conditions can be detrimental for sand flies. Campylobacteriosis, a bacterial" exact="gastrointestinal disease" post="is stimulated by thermophilic Campylobacter spp. bacteria. Researchers found"/>
   <result pre="climate change. The country has seen a dramatic increase in" exact="malaria" post="and dengue cases in the past decades. [133,134]. Likewise,"/>
   <result pre="of anti-malaria spraying that caused more than 75,000 cases of" exact="malaria" post="after a hurricane incidence in 1963 in Haiti [136]."/>
   <result pre="tragedy occurred in Guatemala, Honduras and Nicaragua where dengue and" exact="malaria" post="morbidity rates rapidly increased after Hurricane Mitch in 1998"/>
   <result pre="a group of infectious diseases such as hepatitis, measles, typhoid," exact="malaria" post="and paratyphoid fever were found after five months of"/>
   <result pre="of infectious diseases such as hepatitis, measles, typhoid, malaria and" exact="paratyphoid fever" post="were found after five months of hurricane calamity in"/>
   <result pre="where a successful forecast was made regarding the outbreak of" exact="malaria" post="[143]. However, these forecasts are not always reliable, considering"/>
   <result pre="In addition, Hurricane Mitch of 1998 caused high dengue and" exact="malaria" post="morbidity rates due to lack of awareness and substandard"/>
   <result pre="hupensis and the implications of global climate changeMolluscan Res.201030102108 13.HendersonA.LeakeC.J.BurkeD.S.Japanese" exact="encephalitis" post="in NepalLancet198321359136010.1016/S0140-6736(83)91110-8 14.BistaM.B.ShresthaJ.M.Epidemiological situation of Japanese encephalitis in NepalJ."/>
   <result pre="changeMolluscan Res.201030102108 13.HendersonA.LeakeC.J.BurkeD.S.Japanese encephalitis in NepalLancet198321359136010.1016/S0140-6736(83)91110-8 14.BistaM.B.ShresthaJ.M.Epidemiological situation of Japanese" exact="encephalitis" post="in NepalJ. Nepal. Med. Assoc.200544515610.31729/jnma.397 15.ImpoinvilD.E.SolomonT.SchluterW.W.RayamajhiA.BichhaR.P.ShakyaG.CaminadeC.BaylisM.The spatial heterogeneity between"/>
   <result pre="in NepalJ. Nepal. Med. Assoc.200544515610.31729/jnma.397 15.ImpoinvilD.E.SolomonT.SchluterW.W.RayamajhiA.BichhaR.P.ShakyaG.CaminadeC.BaylisM.The spatial heterogeneity between Japanese" exact="encephalitis" post="incidence distribution and environmental variables in NepalPLoS ONE20116e2219210.1371/journal.pone.002219221811573 16.JoshiD.D.SharmaM.BhandariS.Visceral"/>
   <result pre="encephalitis incidence distribution and environmental variables in NepalPLoS ONE20116e2219210.1371/journal.pone.002219221811573 16.JoshiD.D.SharmaM.BhandariS.Visceral" exact="leishmaniasis" post="in Nepal during 1980â€&quot;2006J. Commun. Dis.20063813914817370676 17.PunS.B.SatoT.PandeyK.PandeyB.D.Changing trends in"/>
   <result pre="Nepal2014Available online: http://dohs.gov.np/wp-content/uploads/2014/04/Annual_Report_2069_70.pdf(accessed on 2 August 2018) 19.AdhikariR.K.BhusalK.P.Surveillance of lymphatic" exact="filariasis" post="in selected districts of NepalJ. Inst. Med.2008303540 20.SlaperH.VeldersG.J.M.MatthijsenJ.Ozone depletion"/>
   <result pre="in selected districts of NepalJ. Inst. Med.2008303540 20.SlaperH.VeldersG.J.M.MatthijsenJ.Ozone depletion and" exact="skin cancer" post="incidence: A source risk approachJ. Hazard Mater.199861778410.1016/S0304-3894(98)00110-1 21.VerbruggeL.M.RaineyJ.J.ReiminkR.L.BlankespoorH.D.Swimmerâ€™s itch:"/>
   <result pre="selected districts of NepalJ. Inst. Med.2008303540 20.SlaperH.VeldersG.J.M.MatthijsenJ.Ozone depletion and skin" exact="cancer" post="incidence: A source risk approachJ. Hazard Mater.199861778410.1016/S0304-3894(98)00110-1 21.VerbruggeL.M.RaineyJ.J.ReiminkR.L.BlankespoorH.D.Swimmerâ€™s itch:"/>
   <result pre="Oscillation and vector-borne diseaseLancet19933421284128510.1016/0140-6736(93)92368-47901589 31.HayS.I.CoxJ.RogersD.J.RandolphS.E.SternD.I.ShanksG.D.MyersM.F.SnowR.W.Climate change and the resurgence of" exact="malaria" post="in the East African highlandsNature200241590590910.1038/415905a11859368 32.ShanksG.D.HayS.I.SternD.I.BiomndoK.SnowR.W.Meteorologic influences on Plasmodium"/>
   <result pre="in the East African highlandsNature200241590590910.1038/415905a11859368 32.ShanksG.D.HayS.I.SternD.I.BiomndoK.SnowR.W.Meteorologic influences on Plasmodium falciparum" exact="malaria" post="in the highland tea estates of Kericho, western KenyaEmerg."/>
   <result pre="case-only analysisEnviron. Health Perspect.20061141331133610.1289/ehp.907416966084 42.AbrignaniM.G.CorraoS.BiondoG.B.RendaN.BraschiA.NovoG.Di GirolamoA.BraschiG.B.NovoS.Influence of climatic variables on" exact="acute myocardial infarction" post="hospital admissionsInt. J. Cardiol.200913712312910.1016/j.ijcard.2008.06.03618694607 43.MirekuN.WangY.AgerJ.ReddyR.C.BaptistA.P.Changes in weather and the"/>
   <result pre="J. Cardiol.200913712312910.1016/j.ijcard.2008.06.03618694607 43.MirekuN.WangY.AgerJ.ReddyR.C.BaptistA.P.Changes in weather and the effects on pediatric" exact="asthma" post="exacerbationsAnn. Allergy Asthma Immunol.200910322022410.1016/S1081-1206(10)60185-819788019 44.LinS.LuoM.WalkerR.J.LiuX.HwangS.A.ChineryR.Extreme high temperatures and hospital"/>
   <result pre="50.ChenH.X.The influence of flood and drought on the epidemic of" exact="hemorrhagic fever with renal syndrome" post="and prevention measuresChin. J. Public Health199915665 51.PanH.M.ChengD.M.ShiY.N.The influence of"/>
   <result pre="J. Public Health199915665 51.PanH.M.ChengD.M.ShiY.N.The influence of flood disasters to the" exact="leptospirosis" post="epidemicChin. J. Nat. Med.200357375 52.SandersE.J.Rigau-PerezJ.G.SmitsH.L.DesedaC.C.VorndamV.A.AyeT.SpiegelR.A.WeyantR.S.BraggS.L.Increase of leptospirosis in dengue-negative"/>
   <result pre="disasters to the leptospirosis epidemicChin. J. Nat. Med.200357375 52.SandersE.J.Rigau-PerezJ.G.SmitsH.L.DesedaC.C.VorndamV.A.AyeT.SpiegelR.A.WeyantR.S.BraggS.L.Increase of" exact="leptospirosis" post="in dengue-negative patients after a hurricane in Puerto Rico"/>
   <result pre="normal weather periods and El Nino events with hospitalization for" exact="viral pneumonia" post="in females: California, 1983â€&quot;1998Am. J. Public Health2001911200120810.2105/AJPH.91.8.120011499104 57.ChretienJ.P.AnyambaA.BednoS.A.BreimanR.F.SangR.SergonK.PowersA.M.OnyangoC.O.SmallJ.TuckerC.J.Drought-associated Chikungunya"/>
   <result pre="weather periods and El Nino events with hospitalization for viral" exact="pneumonia" post="in females: California, 1983â€&quot;1998Am. J. Public Health2001911200120810.2105/AJPH.91.8.120011499104 57.ChretienJ.P.AnyambaA.BednoS.A.BreimanR.F.SangR.SergonK.PowersA.M.OnyangoC.O.SmallJ.TuckerC.J.Drought-associated Chikungunya"/>
   <result pre="and emerging infectious diseasesJ. Am. Med. Assoc.199627521722310.1001/jama.1996.03530270057032 70.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.C.LavenirR.PardigonN.ReynesJ.M.PettinelliF.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 71.FrankC.LittmanM.AlpersK.HallauerJ.Vibrio vulnificus"/>
   <result pre="agenda for the Environmental Agency of England and WalesWeather20056020621110.1256/wea.29.05 76.JofreJ.BlanchA.R.LucenaF.SabaterS.Water-borne" exact="infectious disease" post="outbreaks associated with water scarcity and rainfall eventsWater Scarcity"/>
   <result pre="Germany2010Volume 8147159978-3-642-03971-3 77.XuB.JinZ.Y.JiangZ.B.GuoJ.P.TimberlakeM.MaX.L.WengQ.Climatological and geographical impacts on global pandemic of" exact="influenza" post="A (H1N1)Global Urban Monitoring and Assessment through Earth Observation1st"/>
   <result pre="Aedes aegypti mosquitosSoutheast Asian J. Trop. Med. Public Health1998292802849886113 80.ChenP.S.TsaiF.T.LinC.K.YangC.Y.ChanC.C.YoungC.Y.LeeC.H.Ambient" exact="influenza" post="and avian influenza virus during dust storm days and"/>
   <result pre="mosquitosSoutheast Asian J. Trop. Med. Public Health1998292802849886113 80.ChenP.S.TsaiF.T.LinC.K.YangC.Y.ChanC.C.YoungC.Y.LeeC.H.Ambient influenza and" exact="avian influenza" post="virus during dust storm days and background daysEnviron. Health"/>
   <result pre="Asian J. Trop. Med. Public Health1998292802849886113 80.ChenP.S.TsaiF.T.LinC.K.YangC.Y.ChanC.C.YoungC.Y.LeeC.H.Ambient influenza and avian" exact="influenza" post="virus during dust storm days and background daysEnviron. Health"/>
   <result pre="in NepalTrop. Med. Health20134110311110.2149/tmh.2012-1724155651 91.DhimalM.GautamI.KressA.MullerR.KuchU.Spatio-temporal distribution of dengue and lymphatic" exact="filariasis" post="vectors along an altitudinal transect in Central NepalPLoS Negl."/>
   <result pre="Biol. Sci.201537010.1098/rstb.2013.0551 99.BayohM.N.LindsayS.W.Temperature-related duration of aquatic stages of the Afrotropical" exact="malaria" post="vector mosquito Anopheles gambiae in the laboratoryMed. Vet. Entomol.20041817417910.1111/j.0269-283X.2004.00495.x15189243"/>
   <result pre="s.sParasites Vectors2014748910.1186/s13071-014-0489-325367091 101.PaaijmansK.P.ImbahaleS.S.ThomasM.B.TakkenW.Relevant microclimate for determining the development rate of" exact="malaria" post="mosquitoes and possible implications of climate changeMalar. J.2010919610.1186/1475-2875-9-19620618930 102.EisenL.MonaghanA.J.Lozano-FuentesS.SteinhoffD.F.HaydenM.H.BieringerP.E.The"/>
   <result pre="the cool geographic range marginsJ. Med. Entomol.20145149651610.1603/ME1321424897844 103.BriscoeM.S.Aedes aegypti the" exact="yellow fever" post="mosquito, its life history, bionomics and structureJ. Natl. Med."/>
   <result pre="the Potential for Malaria TransmissionPLoS ONE20138e7927610.1371/journal.pone.007927624244467 105.HoshenM.B.MorseA.P.A weather-driven model of" exact="malaria" post="transmissionMalar. J.200433210.1186/1475-2875-3-3215350206 106.ZellR.Global climate change and the emergence/re-emergence of"/>
   <result pre="Res.201615111512310.1016/j.envres.2016.07.02627475051 123.ChienL.C.YuH.L.Impact of meteorological factors on the spatiotemporal patterns of" exact="dengue fever" post="incidencesEnviron. Int.201473465610.1016/j.envint.2014.06.01825084561 124.BarrettA.D.T.HiggsS.Yellow fever: A disease that has yet"/>
   <result pre="health decision-making in QuebecInt. J. Health Geogr.200764010.1186/1476-072X-6-4017883862 126.TianH.Y.ZhouS.DongL.Van BoeckelT.P.CuiY.J.WuY.R.CazellesB.HuangS.Q.YangR.F.GrenfellB.T.et al.Avian" exact="influenza" post="H5N1 viral and bird migration networks in AsiaProc. Natl."/>
   <result pre="Infect. Dis.2009936537510.1016/S1473-3099(09)70104-519467476 129.LiR.JiangZ.B.XuB.Global spatiotemporal and genetic footprint of the H5N1" exact="avian influenza" post="virusInt. J. Health Geogr.2014131410.1186/1476-072X-13-1424885233 130.WangY.JiangZ.B.JinZ.Y.TanH.Y.XuB.Risk factors for infectious diseases"/>
   <result pre="Dis.2009936537510.1016/S1473-3099(09)70104-519467476 129.LiR.JiangZ.B.XuB.Global spatiotemporal and genetic footprint of the H5N1 avian" exact="influenza" post="virusInt. J. Health Geogr.2014131410.1186/1476-072X-13-1424885233 130.WangY.JiangZ.B.JinZ.Y.TanH.Y.XuB.Risk factors for infectious diseases"/>
   <result pre="three Tibetan countiesSci. Total Environ.2014485414810.1016/j.scitotenv.2014.02.09424704955 132.JiangQ.ZhouJ.JiangZ.B.XuB.Identifying risk factors of avian" exact="infectious disease" post="at household level in Poyang Lake region, ChinaPrev. Vet."/>
   <result pre="Trop. Pediatr.20045030130510.1093/tropej/50.5.30115510763 135.LloydS.J.KovatsR.S.ArmstrongB.G.Global diarrhoea morbidity, weather and climateClim. Res.20073411912710.3354/cr034119 136.BissellR.A.Delayed-impact" exact="infectious disease" post="after a natural disasterJ. Emerg. Med.19831596610.1016/0736-4679(83)90010-06436364 137.collab: Pan American"/>
   <result pre="Disasters: Prevention and Control MeasuresExpert Rev. Anti-Infect. Ther.2012109510410.1586/eri.11.15522149618 139.AbdelwhabE.SelimA.ArafaA.GalalS.KilanyW.HassanM.AlyM.HafezM.Circulation of" exact="avian influenza" post="H5N1 in live bird markets in EgyptAvian Dis.20105491191410.1637/9099-100809-RESNOTE.120608538 140.RowlingM.Africa"/>
   <result pre="Prevention and Control MeasuresExpert Rev. Anti-Infect. Ther.2012109510410.1586/eri.11.15522149618 139.AbdelwhabE.SelimA.ArafaA.GalalS.KilanyW.HassanM.AlyM.HafezM.Circulation of avian" exact="influenza" post="H5N1 in live bird markets in EgyptAvian Dis.20105491191410.1637/9099-100809-RESNOTE.120608538 140.RowlingM.Africa"/>
   <result pre="decrease of 5 Â°C in minimum average temperature due to" exact="influenza" post="epidemics. However, 25â€&quot;40% hospitalizations were observed in Sacramento with"/>
   <result pre="[30][56] La Nina La Nina events cause outbreaks of Japanese" exact="encephalitis" post="and West Nile Virus.Occurrence of drought due to the"/>
   <result pre="due to the La Nina event was linked to the" exact="chikungunya" post="fever epidemic [30][57] Quasi-Biennial Oscillation (OBQ) OBQ was confirmed"/>
   <result pre="on the direct relationship between heatwaves and myocardial infarction with" exact="congestive heart failure." post="[42][47][48,49] Flood A direct association was observed between gastroenteritis"/>
   <result pre="heart failure. [42][47][48,49] Flood A direct association was observed between" exact="gastroenteritis" post="and intensity of flood at Lewes in Southern England."/>
   <result pre="Lewes in Southern England. [60] Hurricane Honduras and Venezuela evidenced" exact="malaria" post="and dengue outbreak post a hurricane event. [6] Cyclone"/>
   <result pre="post a hurricane event. [6] Cyclone Cyclone events remarkably increase" exact="leptospirosis" post="and cholera incidences. [52,53] ijerph-16-02799-t002_Table 2Table 2 Collection of"/>
   <result pre="Diseases Main Outcomes References Pathogens Japanese Encephalitis Virus (JEV) Japanese" exact="encephalitis" post="viral disease A temperature range of 25â€&quot;26 Â°C is"/>
   <result pre="Main Outcomes References Pathogens Japanese Encephalitis Virus (JEV) Japanese encephalitis" exact="viral disease" post="A temperature range of 25â€&quot;26 Â°C is best for"/>
   <result pre="Campylobacter spp. [121] Influenza Virus H5N1 Bird flu/Avian Influenza H1N1" exact="influenza" post="virus concentration was found to be significantly higher during"/>
   <result pre="H1N1 Influenza (flu) Temperature and humidity enhance the transmission of" exact="influenza" post="A virus (H1N1). [77] Dengue virus Dengue The impact"/>
   <result pre="has expanded to further 68 districts. [86,87,88] Culex tritaeniorhynchushas Japanese" exact="encephalitis" post="Rising rate in warming forces Culex to find refuge"/>
   <result pre="encourages the growth of mosquito species, resulting in outbreaks of" exact="yellow fever" post="in Africa and South America. [124] Culex spp.(Mosquito) West"/>
   <result pre="with humidity, rainfall and temperature changes. [125] Ixodes Ricinus(Tick) Tick-borne" exact="encephalitis" post="Faster development and increased activity with rise in humidity"/>
   <result pre="winter temperature, O. hupensis widens its distribution range, thereby spreading" exact="schistosomiasis" post="in northern China. [12] Transmission Influenza Virus H5N1 Bird"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6701881\results\search\disease\results.xml">
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil a case studyLancet Infect Dis201616665366026897108 4RussoFBBeltrÃ£o-BragaPCBThe impact"/>
   <result pre="125 amino acidsBiochim Biophys Acta20151848123150315726403837 28ElazarMLiuPRiceCMGlennJSAn N-terminal amphipathic helix in" exact="hepatitis" post="C virus (HCV) NS4B mediates membrane association, correct localization"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6702286\results\search\disease\results.xml">
   <result pre="these terms. Abstract Rift Valley Fever is an important zoonotic" exact="viral disease" post="of livestock occurring across much of Africa causing acute"/>
   <result pre="word-count: Introduction Rift Valley Fever (RVF) is a mosquito-borne zoonotic" exact="viral disease" post="of ruminants, caused by a Phlebovirus in the Bunyaviridae"/>
   <result pre="This survey was part of a larger study of bovine" exact="tuberculosis" post="and liver fluke and the sample size was based"/>
   <result pre="The smaller chloropeth maps show the mean estimated prevalence of" exact="rift valley fever" post="seroprevalence for each site by Division (NWR) or sub-Division"/>
   <result pre="age group as one would expect for a vector borne" exact="infectious disease" post="(Figures 5 and 6). Figure 5 Bayesian mean and"/>
   <result pre="screening of febriles illnesses should be considered by hospitals where" exact="malaria" post="has been ruled out. Data Availability The datasets generated"/>
   <result pre="(2009) 234:883â€&quot;93. 10.2460/javma.234.7.88319335238 11.ChevalierVRakotondrafaraTJourdanMHeraudJMAndriamanivoHRDurandBet al.. An unexpected recurrent transmission of" exact="rift valley fever" post="virus in cattle in a temperate and mountainous area"/>
   <result pre="online at: https://www.wto.org/english/tratop_e/tpr_e/s285-00_e.pdf (accessed January 10, 2019). 17.BronsvoortBMDTanyaVNKitchingRPNfonCHammanSMMorganKL. Foot and" exact="mouth disease" post="and livestock husbandry practices in the Adamawa Province of"/>
   <result pre="Health Prod. (2003) 35:491â€&quot;507. 10.1023/A:102730252530114690088 18.NfonCKMarszalPZhangSWeingartlHM. Innate immune response to" exact="rift valley fever" post="virus in goats. PLoS Negl Trop Dis. (2012) 6:e1623."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6706471\results\search\disease\results.xml">
   <result pre="Myerburg MM, Marr LC, Lakdawala SS. 2019. Environmental persistence of" exact="influenza" post="viruses is dependent upon virus type and host origin."/>
   <result pre="Creative Commons Attribution 4.0 International license.mSphere.00552-19.pdf The rapid spread of" exact="influenza" post="viruses (IV) from person to person during seasonal epidemics"/>
   <result pre="spread of IV in our environment. Abstract ABSTRACT Highly transmissible" exact="influenza" post="viruses (IV) must remain stable and infectious under a"/>
   <result pre="stationary droplets under a range of RH conditions. H3N2 and" exact="influenza" post="B virus (IBV) isolates are resistant to RH-dependent decay"/>
   <result pre="longevities of H1N1, H3N2, and IBV in droplets. Surprisingly, low-pathogenicity" exact="avian influenza" post="H6N1 and H9N2 viruses, which cause sporadic infections in"/>
   <result pre="of H1N1, H3N2, and IBV in droplets. Surprisingly, low-pathogenicity avian" exact="influenza" post="H6N1 and H9N2 viruses, which cause sporadic infections in"/>
   <result pre="virus type and host origin. IMPORTANCE The rapid spread of" exact="influenza" post="viruses (IV) from person to person during seasonal epidemics"/>
   <result pre="and spread of IV in our environment. KEYWORDS aerosols droplets" exact="influenza" post="virus persistence relative humidity Funding Tsinghua Education Foundation of"/>
   <result pre="(NIH)https://doi.org/10.13039/100000002 UL1-TR-001857 fig-count: table-count: equation-count: ref-count: page-count: word-count: INTRODUCTION Seasonal" exact="influenza" post="viruses (IV) cause yearly infection cycles that tend to"/>
   <result pre="the risk of transmission under different environmental conditions during an" exact="influenza" post="epidemic. Recurring epidemics are driven by cocirculation of human-pathogenic"/>
   <result pre="driven by cocirculation of human-pathogenic seasonal H1N1 and H3N2 subtype" exact="influenza" post="A viruses (IAV) and influenza B viruses (IBV), which"/>
   <result pre="seasonal H1N1 and H3N2 subtype influenza A viruses (IAV) and" exact="influenza" post="B viruses (IBV), which persist in the population despite"/>
   <result pre="(22). The impact of the environment on the seasonality of" exact="influenza" post="viruses in temperate climates is still poorly understood. One"/>
   <result pre="IV that are poorly transmissible in the human population. Low-pathogenicity" exact="avian influenza" post="(LPAI) viruses, including H6N1 and H9N2, have caused sporadic"/>
   <result pre="that are poorly transmissible in the human population. Low-pathogenicity avian" exact="influenza" post="(LPAI) viruses, including H6N1 and H9N2, have caused sporadic"/>
   <result pre="IBV is sensitive to RH-mediated decay in stationary droplets. Seasonal" exact="influenza" post="infections are caused by IAV subtypes H1N1 and H3N2"/>
   <result pre="we tested the stability of MDCK cell-propagated and HBE cell-propagated" exact="avian influenza" post="virus H6N1 (avH6N1) and avH9N2 strains in large droplets"/>
   <result pre="tested the stability of MDCK cell-propagated and HBE cell-propagated avian" exact="influenza" post="virus H6N1 (avH6N1) and avH9N2 strains in large droplets"/>
   <result pre="type (wt) (item number FR-458) and A/Brisbane/59/2007 (H1N1) FR-1 and" exact="influenza" post="B virus B/Texas/02/2013 (Victoria lineage, cell-derived, FR-1302) were obtained"/>
   <result pre="and Research, Food and Drug Administration (Silver Spring, MD). LPAI" exact="influenza" post="A viruses A/shorebird/DE Bay/230/2009 (H6N1) NR-45155 and A/shorebird/DE/127/2003 (H9N2)"/>
   <result pre="number UL1-TR-001857. References REFERENCES 1.TameriusJ, NelsonMI, ZhouSZ, ViboudC, MillerMA, AlonsoWJ2011Global" exact="influenza" post="seasonality: reconciling patterns across temperate and tropical regions. Environ"/>
   <result pre="doi:10.1073/pnas.1607747113.27799563 4.HemmesJH, KoolSM, WinklerKC1962Virus survival as a seasonal factor in" exact="influenza" post="and poliomyelitis. Antonie Van Leeuwenhoek28:221. doi:10.1007/BF02538737.13953681 5.MarrLC, TangJW, Van"/>
   <result pre="MullekomJ, LakdawalaSS2019Mechanistic insights into the effect of humidity on airborne" exact="influenza" post="virus survival, transmission and incidence. J R Soc Interface16:20180298."/>
   <result pre="TumpeyTM, MainesTR2015Environmental conditions affect exhalation of H3N2 seasonal and variant" exact="influenza" post="viruses and respiratory droplet transmission in ferrets. PLoS One10:e0125874."/>
   <result pre="tests with four viruses. J Hyg (Lond)59:479â€&quot;486. doi:10.1017/s0022172400039176.13904777 10.HoodAM1963Infectivity of" exact="influenza" post="virus aerosols. J Hyg (Lond)61:331. doi:10.1017/s0022172400039619.14066589 11.NotiJD, BlachereFM, McMillenCM,"/>
   <result pre="LindsleyWG, KashonML, SlaughterDR, BeezholdDH2013High humidity leads to loss of infectious" exact="influenza" post="virus from simulated coughs. PLoS One8:e57485. doi:10.1371/journal.pone.0057485.23460865 12.SchafferFL, SoergelME,"/>
   <result pre="simulated coughs. PLoS One8:e57485. doi:10.1371/journal.pone.0057485.23460865 12.SchafferFL, SoergelME, StraubeDC1976Survival of airborne" exact="influenza" post="virus: effects of propagating host, relative humidity, and composition"/>
   <result pre="infections. III. Certain aspects of the behavior of type A" exact="influenza" post="virus as an air-borne cloud. J Infect Dis87:128â€&quot;132. doi:10.1093/infdis/87.2.128.14774528"/>
   <result pre="J Infect Dis87:128â€&quot;132. doi:10.1093/infdis/87.2.128.14774528 14.YangW, ElankumaranS, MarrLC2012Relationship between humidity and" exact="influenza" post="A viability in droplets and implications for influenzaâ€™s seasonality."/>
   <result pre="17.NturibiE, BhagwatAR, CoburnS, MyerburgMM, LakdawalaSS1292017, posting date. Intracellular colocalization of" exact="influenza" post="viral RNA and Rab11A is dependent upon microtubule filaments."/>
   <result pre="microtubule filaments. J Virol doi:10.1128/JVI.01179-17. 18.PetrovaVN, RussellCA2018The evolution of seasonal" exact="influenza" post="viruses. Nat Rev Microbiol16:60. doi:10.1038/nrmicro.2017.146.29109554 19.BarrIG, McCauleyJ, CoxN, DanielsR,"/>
   <result pre="Composition for 2009-2010. 2010Epidemiological, antigenic and genetic characteristics of seasonal" exact="influenza" post="A(H1N1), A(H3N2) and B influenza viruses: basis for the"/>
   <result pre="and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B" exact="influenza" post="viruses: basis for the WHO recommendation on the composition"/>
   <result pre="viruses: basis for the WHO recommendation on the composition of" exact="influenza" post="vaccines for use in the 2009â€&quot;2010 Northern Hemisphere season."/>
   <result pre="ViboudC, KoelleK, FerrariMJ, BhartiN, GrenfellBT2007Global patterns in seasonal activity of" exact="influenza" post="A/H3N2, A/H1N1, and B from 1997 to 2005: viral"/>
   <result pre="doi:10.1371/journal.pone.0001296.18074020 21.GoldsteinE, CobeyS, TakahashiS, MillerJC, LipsitchM2011Predicting the epidemic sizes of" exact="influenza" post="A/H1N1, A/H3N2, and B: a statistical method. PLoS Med8:e1001051."/>
   <result pre="LevyJ, UyekiTM, LeungGM, PeirisJS, ChotpitayasunondhT, NishiuraH, SimmermanJM2014Modes of transmission of" exact="influenza" post="B virus in households. PLoS One9:e108850. doi:10.1371/journal.pone.0108850.25268241 23.YuanRY, LiangLJ,"/>
   <result pre="WuJ, KangYF, SongYC, ZouLR, ZhangX, NiHZ, KeCW2017Human infection with an" exact="avian influenza" post="A/H9N2 virus in Guangdong in 2016. J Infect74:422â€&quot;425. doi:10.1016/j.jinf.2017.01.003.28109675"/>
   <result pre="KangYF, SongYC, ZouLR, ZhangX, NiHZ, KeCW2017Human infection with an avian" exact="influenza" post="A/H9N2 virus in Guangdong in 2016. J Infect74:422â€&quot;425. doi:10.1016/j.jinf.2017.01.003.28109675"/>
   <result pre="HuSX, ZhouSY, TangYL, XiangXY, LiFC, LiWC, GaoLD2015Human infection with an" exact="avian influenza" post="A (H9N2) virus in the middle region of China."/>
   <result pre="ZhouSY, TangYL, XiangXY, LiFC, LiWC, GaoLD2015Human infection with an avian" exact="influenza" post="A (H9N2) virus in the middle region of China."/>
   <result pre="LimW, WebsterRG, YuenKY, PeirisJSM, GuanY2005Human infection with an avian H9N2" exact="influenza" post="A virus in Hong Kong in 2003. J Clin"/>
   <result pre="LinMC, ChungWC, LiaoCH, LeeMS, HuangWT, ChenPJ, LiuMT, ChangFY2013Human infection with" exact="avian influenza" post="A H6N1 virus: an epidemiological analysis. Lancet Respir Med1:771â€&quot;778."/>
   <result pre="ChungWC, LiaoCH, LeeMS, HuangWT, ChenPJ, LiuMT, ChangFY2013Human infection with avian" exact="influenza" post="A H6N1 virus: an epidemiological analysis. Lancet Respir Med1:771â€&quot;778."/>
   <result pre="HerfstS, MurciaPR, RocheB, WilkeCO, RussellCA11112016, posting date. Viral factors in" exact="influenza" post="pandemic risk assessment. Elife doi:10.7554/eLife.18491. 28.DriskellEA, PickensJA, Humberd-SmithJ, GordyJT,"/>
   <result pre="PickensJA, Humberd-SmithJ, GordyJT, BradleyKC, SteinhauerDA, BerghausRD, StallknechtDE, HowerthEW, TompkinsSM2012Low pathogenic" exact="avian influenza" post="isolates from wild birds replicate and transmit via contact"/>
   <result pre="Humberd-SmithJ, GordyJT, BradleyKC, SteinhauerDA, BerghausRD, StallknechtDE, HowerthEW, TompkinsSM2012Low pathogenic avian" exact="influenza" post="isolates from wild birds replicate and transmit via contact"/>
   <result pre="PaulsonJC, BrockwellC, WebbyR, BlancoJ, Al-NatourMQ, PerezDR2008Replication and transmission of H9N2" exact="influenza" post="viruses in ferrets: evaluation of pandemic potential. PLoS One3:e2923."/>
   <result pre="PLoS One3:e2923. doi:10.1371/journal.pone.0002923.18698430 30.KimbleJB, SorrellE, ShaoH, MartinPL, PerezDR2011Compatibility of H9N2" exact="avian influenza" post="surface genes and 2009 pandemic H1N1 internal genes for"/>
   <result pre="One3:e2923. doi:10.1371/journal.pone.0002923.18698430 30.KimbleJB, SorrellE, ShaoH, MartinPL, PerezDR2011Compatibility of H9N2 avian" exact="influenza" post="surface genes and 2009 pandemic H1N1 internal genes for"/>
   <result pre="the 20th century. Emerg Infect Dis12:9â€&quot;14. doi:10.3201/eid1201.051254.16494710 32.NeumannG, KawaokaY2015Transmission of" exact="influenza" post="A viruses. Virology479â€&quot;480:234â€&quot;246. doi:10.1016/j.virol.2015.03.009. 33.FlemingDM, DurnallH, WarburtonF, EllisJS, ZambonMC2016Is"/>
   <result pre="Virology479â€&quot;480:234â€&quot;246. doi:10.1016/j.virol.2015.03.009. 33.FlemingDM, DurnallH, WarburtonF, EllisJS, ZambonMC2016Is the onset of" exact="influenza" post="in the community age-related?Epidemiol Infect144:2295â€&quot;2305. doi:10.1017/S0950268816000510.27350234 34.RogersGN, PaulsonJC1983Receptor determinants"/>
   <result pre="age-related?Epidemiol Infect144:2295â€&quot;2305. doi:10.1017/S0950268816000510.27350234 34.RogersGN, PaulsonJC1983Receptor determinants of human and animal" exact="influenza" post="virus isolates: differences in receptor specificity of the H3"/>
   <result pre="35.RogersGN, PaulsonJC, DanielsRS, SkehelJJ, WilsonIA, WileyDC1983Single amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificity. Nature304:76â€&quot;78. doi:10.1038/304076a0.6191220 36.LakdawalaSS, JayaramanA,"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="viruses. Nature526:122. doi:10.1038/nature15379.26416728 37.BeanB, MooreBM, SternerB, PetersonLR, GerdingDN, BalfourHHJr.1982Survival"/>
   <result pre="viruses. Nature526:122. doi:10.1038/nature15379.26416728 37.BeanB, MooreBM, SternerB, PetersonLR, GerdingDN, BalfourHHJr.1982Survival of" exact="influenza" post="viruses on environmental surfaces. J Infect Dis146:47â€&quot;51. doi:10.1093/infdis/146.1.47.6282993 38.ThomasY,"/>
   <result pre="doi:10.1093/infdis/146.1.47.6282993 38.ThomasY, VogelG, WunderliW, SuterP, WitschiM, KochD, TapparelC, KaiserL2008Survival of" exact="influenza" post="virus on banknotes. Appl Environ Microbiol74:3002â€&quot;3007. doi:10.1128/AEM.00076-08.18359825 39.Pulit-PenalozaJA, BelserJA,"/>
   <result pre="banknotes. Appl Environ Microbiol74:3002â€&quot;3007. doi:10.1128/AEM.00076-08.18359825 39.Pulit-PenalozaJA, BelserJA, TumpeyTM, MainesTR2019Swine-origin H1" exact="influenza" post="viruses isolated from humans exhibit sustained infectivity in an"/>
   <result pre="transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1" exact="influenza" post="virus. PLoS Pathog7:e1002443. doi:10.1371/journal.ppat.1002443.22241979 42.Oâ€™DonnellCD, VogelL, MatsuokaY, JinH, SubbaraoK2014The"/>
   <result pre="and thermal stability of the hemagglutinin of pandemic live attenuated" exact="influenza" post="virus vaccines. J Virol88:12374â€&quot;12384. doi:10.1128/JVI.01107-14.25122789 43.RussierM, YangG, RehgJE, WongSS,"/>
   <result pre="FabrizioTP, BarmanS, KraussS, WebsterRG, WebbyRJ, RussellCJ2016Molecular requirements for a pandemic" exact="influenza" post="virus: an acid-stable hemagglutinin protein. Proc Natl Acad Sci"/>
   <result pre="WebbyRJ, PeirisM2011Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1" exact="influenza" post="virus in ferrets. Proc Natl Acad Sci U S"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6708098\results\search\disease\results.xml">
   <result pre="viruses were rhinovirus (7.2%), respiratory syncytial virus A (7.2%) and" exact="influenza" post="B virus (6%). Conclusion: This study was an important"/>
   <result pre="Our results indicated that rhinovirus, respiratory syncytial virus A and" exact="influenza" post="B virus are important viral pathogens causing respiratory infection"/>
   <result pre="knownâ€� in this topic: Some previous studies reported that adenoviruses," exact="influenza" post="viruses, human rhinoviruses, and coronaviruses are the predominant viruses"/>
   <result pre="Human rhinovirus (7.2%), human respiratory syncytial virus A (7.2%), and" exact="influenza" post="B virus (6%) were the most frequently detected respiratory"/>
   <result pre="detected respiratory viruses in our study, followed by bocavirus (3%)," exact="influenza" post="A H1N1 (2.2%), influenza A H3N2 (1.5%), human respiratory"/>
   <result pre="our study, followed by bocavirus (3%), influenza A H1N1 (2.2%)," exact="influenza" post="A H3N2 (1.5%), human respiratory syncytial virus B (1.5%),"/>
   <result pre="viral transmission to newer cohorts (3). The higher vulnerability to" exact="respiratory disease" post="epidemics observed in military trainees has been attributed to"/>
   <result pre="and insomnia (4, 5). Numerous previous studies reported that adenoviruses," exact="influenza" post="A and B, human rhinoviruses, and coronaviruses are the"/>
   <result pre="predominant viruses detected in the military population. Outbreaks of adenovirus-associated" exact="respiratory disease" post="have been reported globally in the military environments (3,"/>
   <result pre="days prior to the onset of illness (8). Outbreaks of" exact="influenza" post="viruses A and B have also been associated with"/>
   <result pre="have also been associated with much morbidity and mortality, especially" exact="influenza" post="A (H1N1) pdm09 virus infection (9-13). It has been"/>
   <result pre="40 years) are amongst the major risk factors for acquiring" exact="influenza" post="infections (14). Human rhinoviruses are the most important causative"/>
   <result pre="Human rhinoviruses are the most important causative agents of the" exact="common cold" post="and associated with more complicated upper respiratory tract infections"/>
   <result pre="this study. Exclusion criteria were a prior history of chronic" exact="respiratory disease" post="such as asthma and chronic obstructive pulmonary disease (COPD),"/>
   <result pre="were a prior history of chronic respiratory disease such as" exact="asthma" post="and chronic obstructive pulmonary disease (COPD), recent antiviral therapy,"/>
   <result pre="prior history of chronic respiratory disease such as asthma and" exact="chronic obstructive pulmonary disease" post="(COPD), recent antiviral therapy, and military personnel. Those trainees"/>
   <result pre="(n=29; 7.2%), human respiratory syncytial virus A (n=29; 7.2%), and" exact="influenza" post="B virus (n=24; 6%) were the most frequently detected"/>
   <result pre="respiratory viruses in our study, followed by bocavirus (n=12; 3%)," exact="influenza" post="A H1N1 (n=9; 2.2%), influenza A H3N2 (n=6; 1.5%),"/>
   <result pre="followed by bocavirus (n=12; 3%), influenza A H1N1 (n=9; 2.2%)," exact="influenza" post="A H3N2 (n=6; 1.5%), human respiratory syncytial virus B"/>
   <result pre="1.5%), and human coronavirus 229E (n=3; 0.7%). Other viruses including" exact="influenza" post="C virus, human parainfluenza viruses, metapneumovirus, and echovirus have"/>
   <result pre="patients with respiratory syncytial viruses A and B, followed by" exact="influenza" post="B (n=2; 25%) and coronavirus 229E (n=1; 12.5%). Sore"/>
   <result pre="rhinovirus infection. The most cases of myalgia were seen in" exact="influenza" post="B (n=5; 62.5%) and influenza A H1N1 (n=3; 37.5%)"/>
   <result pre="of myalgia were seen in influenza B (n=5; 62.5%) and" exact="influenza" post="A H1N1 (n=3; 37.5%) infections, respectively (Table 1). Fig."/>
   <result pre="According to our results, rhinovirus, respiratory syncytial virus A, and" exact="influenza" post="B virus have been responsible for ~66% of viral"/>
   <result pre="infections among military trainees. Previous studies have shown that adenoviruses," exact="influenza" post="A and B viruses, human coronaviruses, rhinoviruses, and at"/>
   <result pre="British military recruits receiving basic training with respiratory symptoms, adenovirus," exact="influenza" post="viruses and respiratory syncytial virus were found in 35%,"/>
   <result pre="19% and 14%, respectively (33). It is notable that among" exact="influenza" post="viruses, influenza B was more associated with symptomatic infections,"/>
   <result pre="14%, respectively (33). It is notable that among influenza viruses," exact="influenza" post="B was more associated with symptomatic infections, which was"/>
   <result pre="and the most commonly detected viruses among FRI cases were" exact="influenza" post="A H1N1(13%), influenza B (13%), and coxsackievirus (9%). The"/>
   <result pre="commonly detected viruses among FRI cases were influenza A H1N1(13%)," exact="influenza" post="B (13%), and coxsackievirus (9%). The low prevalence of"/>
   <result pre="in compared with other viral infections. Our study revealed that" exact="influenza" post="viruses (particularly influenza B) also have an important role"/>
   <result pre="other viral infections. Our study revealed that influenza viruses (particularly" exact="influenza" post="B) also have an important role in causing respiratory"/>
   <result pre="military trainees. It may be explained by the fact that" exact="influenza" post="infection tends to occur in the winter, while adenovirus"/>
   <result pre="a military recruit settingJ Infect Dis200619478778516960774 8TateJEBunningMLLottLLuXSuJMetzgarDet al.Outbreak of severe" exact="respiratory disease" post="associated with emergent human adenovirus serotype 14 at a"/>
   <result pre="training facility in 2007J Infect Dis20091991014192619351260 9DuronSMayetALienhardFHaus-CheymolRVerretCVÃ©dySet al.The French Military" exact="influenza" post="surveillance system (MISS): overview of epidemiological and virological results"/>
   <result pre="system (MISS): overview of epidemiological and virological results during four" exact="influenza" post="seasons--2008-2012Swiss Med Wkly2013143w1384824089257 10MayetADuronSNivoixPHaus-CheymolRLigierCGacheKet al.Novel influenza A (H1N1) outbreak"/>
   <result pre="virological results during four influenza seasons--2008-2012Swiss Med Wkly2013143w1384824089257 10MayetADuronSNivoixPHaus-CheymolRLigierCGacheKet al.Novel" exact="influenza" post="A (H1N1) outbreak among French armed forces in 2009:"/>
   <result pre="2009: results of Military Influenza Surveillance SystemPublic health2011125849450021767855 11LiuPYWangLCLinYHTsaiCAShiZYOutbreak of" exact="influenza" post="A and B among military recruits: evidence from viral"/>
   <result pre="chain reactionJ Microbiol Immunol Infect20094221142119597642 12YapJTanCHCookARLohJPTambyahPATanBHet al.Differing clinical characteristics between" exact="influenza" post="strains among young healthy adults in the tropicsBMC Infect"/>
   <result pre="clinical characteristicsBMC Infect Dis201414120424735158 14TarabboMLapaDCastillettiCTommaselliPGuarducciRLucÃ Get al.Retrospective investigation of an" exact="influenza" post="A/H1N1pdm outbreak in an Italian military ship cruising in"/>
   <result pre="Acute Respiratory Disease During 2010-2012 in Shiraz, IranArch Pediatr201422e15930 38BaratiMNoorbakhshSTabatabaeiATajFETalebi-TaherMAdenovirus," exact="influenza" post="virus A, B and respiratory syncitial virus infection in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6708702\results\search\disease\results.xml">
   <result pre="doi: 10.1097/CM9.0000000000000376 : Correspondence First outbreak of human infection with" exact="avian influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017 WangJing1JiangLi-Na1NingChuan-Yi2YangYi-Ping3ChenMin1ZhangChao1HeWei-Tao1TanYi1"/>
   <result pre="10.1097/CM9.0000000000000376 : Correspondence First outbreak of human infection with avian" exact="influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017 WangJing1JiangLi-Na1NingChuan-Yi2YangYi-Ping3ChenMin1ZhangChao1HeWei-Tao1TanYi1"/>
   <result pre="Content is available in the text To the Editor: Since" exact="avian influenza" post="A(H7N9) was first identified in Shanghai, China, in March"/>
   <result pre="is available in the text To the Editor: Since avian" exact="influenza" post="A(H7N9) was first identified in Shanghai, China, in March"/>
   <result pre="4.09% of cases (31/758) were infected with the highly pathogenic" exact="avian influenza" post="(HPAI) A(H7N9). This indicated that the pathotype of the"/>
   <result pre="of cases (31/758) were infected with the highly pathogenic avian" exact="influenza" post="(HPAI) A(H7N9). This indicated that the pathotype of the"/>
   <result pre="the pathotype of the A(H7N9) had switched from low pathogenic" exact="avian influenza" post="(LPAI) to HPAI. Guangxi is located in southwest China,"/>
   <result pre="pathotype of the A(H7N9) had switched from low pathogenic avian" exact="influenza" post="(LPAI) to HPAI. Guangxi is located in southwest China,"/>
   <result pre="of cases is also explored. The collection of data from" exact="influenza" post="A(H7N9) cases was decided to be a part of"/>
   <result pre="in the laboratory to test for A(H7N9). Active surveillance on" exact="avian influenza" post="was increased from February 2017 until the outbreak was"/>
   <result pre="the laboratory to test for A(H7N9). Active surveillance on avian" exact="influenza" post="was increased from February 2017 until the outbreak was"/>
   <result pre="and drinking water of poultry, were collected and tested for" exact="avian influenza" post="virus by the local CDC. Fisher exact test was"/>
   <result pre="drinking water of poultry, were collected and tested for avian" exact="influenza" post="virus by the local CDC. Fisher exact test was"/>
   <result pre="1]. We found a steep increase in the number of" exact="avian influenza" post="A(H7N9) cases between February 10 and March 21, 2017."/>
   <result pre="We found a steep increase in the number of avian" exact="influenza" post="A(H7N9) cases between February 10 and March 21, 2017."/>
   <result pre="this study, we described the prevalence of human infection with" exact="influenza" post="A(H7N9) in Guangxi during 2016 to 2017 season and"/>
   <result pre="which could lead to an increase in the risk of" exact="avian influenza" post="infection. This difference was mainly due to the fact"/>
   <result pre="could lead to an increase in the risk of avian" exact="influenza" post="infection. This difference was mainly due to the fact"/>
   <result pre="active environmental surveillance are critical in preventing and controlling future" exact="influenza" post="A(H7N9) epidemics. Underlying chronic conditions and delayed treatment accelerate"/>
   <result pre="He WT, Tan Y. First outbreak of human infection with" exact="avian influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017. Chin"/>
   <result pre="WT, Tan Y. First outbreak of human infection with avian" exact="influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017. Chin"/>
   <result pre="Organization, 2017Available from: https://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf?ua=1Accessed June 3, 2019. 2.WangXJiangHWuPUyekiTMFengLLaiSet al.Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="2017Available from: https://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf?ua=1Accessed June 3, 2019. 2.WangXJiangHWuPUyekiTMFengLLaiSet al.Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="doi: 10.1016/S1473-3099(17)30323-7.28583578 3.KangMLauEHYGuanWYangYSongTCowlingBJet al.Epidemiology of human infections with highly pathogenic" exact="avian influenza" post="A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill2017;"/>
   <result pre="10.1016/S1473-3099(17)30323-7.28583578 3.KangMLauEHYGuanWYangYSongTCowlingBJet al.Epidemiology of human infections with highly pathogenic avian" exact="influenza" post="A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill2017;"/>
   <result pre="Euro Surveill2017; 22:30568doi: 10.2807/1560-7917.ES.2017.22.27.30568. 4.SunXBelserJAPappasCPulit-PenalozaJABrockNZengHet al.Risk assessment of fifth-wave H7N9" exact="influenza" post="A viruses in mammalian models. J Virol2018; 93:e01740â€&quot;e1818. doi:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6710328\results\search\disease\results.xml">
   <result pre="pillars in the development of virology, comprising poliovirus, rhinovirus, and" exact="hepatitis" post="A virus. Picornavirus infectious particles use the fecalâ€&quot;oral or"/>
   <result pre="the fecalâ€&quot;oral route (Yin-Murphy and Almond, 1996). RVs cause the" exact="common cold," post="the most prevalent infectious disease worldwide, resulting in uncountable"/>
   <result pre="Almond, 1996). RVs cause the common cold, the most prevalent" exact="infectious disease" post="worldwide, resulting in uncountable lost days from school and"/>
   <result pre="also have been proposed to be decoy particles for the" exact="hepatitis" post="B virus (Rydell et al., 2017). Several picornavirus procapsids"/>
   <result pre="receptor engagement in the evolution of a pandemic acute hemorrhagic" exact="conjunctivitis" post="virus. Proc. Natl. Acad. Sci. U.S.A.115, 397â€&quot;402. 10.1073/pnas.171328411529284752 BaltimoreD."/>
   <result pre="Sci. U.S.A.114, 8017â€&quot;8022. 10.1073/pnas.170736911428696310 DrysdaleS. B.MejiasA.RamiloO. (2017). Rhinovirusâ€&quot;not just the" exact="common cold." post="J. Infect.74(Suppl. 1), S41â€&quot;S46. 10.1016/S0163-4453(17)30190-128646961 EggersH. J. (1999). Milestones"/>
   <result pre="Infect.74(Suppl. 1), S41â€&quot;S46. 10.1016/S0163-4453(17)30190-128646961 EggersH. J. (1999). Milestones in early" exact="poliomyelitis" post="research (1840 to 1949). J. Virol.73, 4533â€&quot;4535. 10233910 EggersH."/>
   <result pre="F.WellerT. H.RobbinsF. C. (1949). Cultivation of the Lansing strain of" exact="poliomyelitis" post="virus in cultures of various human embryonic tissues. Science109,"/>
   <result pre="Allergy Clin. Immunol.126, 120â€&quot;126. 10.1016/j.jaci.2010.04.01620541246 KirkegaardK. (2017). Unconventional secretion of" exact="hepatitis" post="A virus. Proc. Natl. Acad. Sci. U. S.A. 114,"/>
   <result pre="J. Virol.86, 13062â€&quot;13069. 10.1128/JVI.01033-1223015694 LiJ.WangJ.XuC.YinQ.HuM.SunZ.et al.. (2017). Hand, foot, and" exact="mouth disease" post="in Mainland China before it was listed as category"/>
   <result pre="Chem.291, 13999â€&quot;14011. 10.1074/jbc.M116.72659627137934 McKinneyR. E.KatzS. L.WilfertC. M. (1987). Chronic enteroviral" exact="meningoencephalitis" post="in agammaglobulinemic patients. Clin. Infect. Dis.9, 334â€&quot;356. 10.1093/clinids/9.2.3343296100 McLeishN."/>
   <result pre="G.ArnoldE.EricksonJ. W.FrankenbergerE. A.GriffithJ. P.HechtH.-J.et al.. (1985). Structure of a human" exact="common cold" post="virus and functional relationship to other picornaviruses. Nature317, 145â€&quot;153."/>
   <result pre="subviral particles reduces the neutralizing effect of anti-HBs antibodies on" exact="hepatitis" post="B viral particles in vitro. Virology509, 67â€&quot;70. 10.1016/j.virol.2017.05.01728605637 SabinA."/>
   <result pre="of monoclonal antibodies to identify four neutralization immunogens on a" exact="common cold" post="picornavirus, human rhinovirus 14. J. Virol.57, 246â€&quot;257. 2416951 ShinglerK."/>
   <result pre="canyon. Nature383, 350â€&quot;354. 10.1038/383350a08848050 StapletonJ. T. (1992). Passive immunization against" exact="hepatitis" post="A. Vaccine10, S45â€&quot;S47. 10.1016/0264-410X(92)90541-Q1335658 StapletonJ. T.LemonS. M. (1987). Neutralization"/>
   <result pre="Neutralization escape mutants define a dominant immunogenic neutralization site on" exact="hepatitis" post="A virus. J. Virol.61, 491â€&quot;498. 2433464 StauntonD. E.MerluzziV. J.RothleinR.BartonR.MarlinS."/>
   <result pre="population. Nature439, 344â€&quot;348. 10.1038/nature0438816327776 WangX.ZhuL.DangM.HuZ.GaoQ.YuanS.et al.. (2017). Potent neutralization of" exact="hepatitis" post="A virus reveals a receptor mimic mechanism and the"/>
   <result pre="al.. (2015). Phylogenetic analysis of the major causative agents of" exact="hand, foot and mouth disease" post="in Suzhou city, Jiangsu province, China, in 2012â€&quot;2013. Emerg."/>
   <result pre="analysis of the major causative agents of hand, foot and" exact="mouth disease" post="in Suzhou city, Jiangsu province, China, in 2012â€&quot;2013. Emerg."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711296\results\search\disease\results.xml">
   <result pre="that serve as endemic hosts, resistant hosts or hosts supporting" exact="stuttering" post="chains of transmission [13,14]. Bats may also be critical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711302\results\search\disease\results.xml">
   <result pre="recent epidemics (e.g. Ebola virus [5]) and pandemics (e.g. H1N1" exact="influenza" post="virus [6]); however, we emphasize the general methods and"/>
   <result pre="spatial and temporal resolution. The authors use case studies of" exact="brucellosis" post="in the Greater Yellowstone Ecosystem [13] and of avian"/>
   <result pre="of brucellosis in the Greater Yellowstone Ecosystem [13] and of" exact="avian influenza" post="virus in China and North America [14] to emphasize"/>
   <result pre="brucellosis in the Greater Yellowstone Ecosystem [13] and of avian" exact="influenza" post="virus in China and North America [14] to emphasize"/>
   <result pre="cross-species transmission [9]. The authors focus their case study on" exact="yellow fever," post="a mosquito-borne viral disease of historical importance in South"/>
   <result pre="authors focus their case study on yellow fever, a mosquito-borne" exact="viral disease" post="of historical importance in South America that persists in"/>
   <result pre="and immunological data from Brazil across 16 years to predict" exact="yellow fever" post="spillover in humans. The authors show that a mechanistic"/>
   <result pre="at some spatial and temporal resolution (e.g., spatio-temporal counts of" exact="yellow fever" post="spillovers [15]). The authors show how modelling cross-species transmission"/>
   <result pre="the host in the environment [9]. For pathogens such as" exact="avian influenza" post="virus, persistence in the environment (e.g. ponds) can also"/>
   <result pre="host in the environment [9]. For pathogens such as avian" exact="influenza" post="virus, persistence in the environment (e.g. ponds) can also"/>
   <result pre="reservoirs. Although no gold standard for capturing, isolating and identifying" exact="avian influenza" post="virus diversity from the environment exists, environmental metagenomics and"/>
   <result pre="Although no gold standard for capturing, isolating and identifying avian" exact="influenza" post="virus diversity from the environment exists, environmental metagenomics and"/>
   <result pre="to highlight challenges and opportunities arising at the intersection of" exact="infectious disease" post="ecology, microbial risk assessment and virology. Lunn et al."/>
   <result pre="to cause epidemics or pandemics in the new host species:" exact="influenza" post="A viruses [43], human immunodeficiency virus [44] and canine"/>
   <result pre="at the human-wildlife-environment interface. In The connections between ecology and" exact="infectious disease" post="(ed. HurstCJ), pp. 267â€&quot;298. Cham, Switzerland: Springer International Publishing."/>
   <result pre="(10.3201/eid2206.160021)27070842 6NeumannG, NodaT, KawaokaY2009Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virus. Nature459, 931â€&quot;939. (10.1038/nature08157)19525932 7CassirerEFet al.2018Pneumonia in bighorn sheep:"/>
   <result pre="MerkleJA, GudeJA, CrossPC2019Modeling elk-to-livestock transmission risk to predict hotspots of" exact="brucellosis" post="spillover. J. Wildl. Manage.83, 817â€&quot;829. (10.1002/jwmg.21645) 9PlowrightRK, ParrishCR, McCallumH,"/>
   <result pre="DobsonAP, EdwardsWH, HamlinKL, LuikartG, MiddletonAD, ScurlockBM, WhitePJ2010Probable causes of increasing" exact="brucellosis" post="in free-ranging elk of the Greater Yellowstone Ecosystem. Ecol."/>
   <result pre="Yellowstone Ecosystem. Ecol. Appl.20, 278â€&quot;288. (10.1890/08-2062.1)20349847 14LiuJet al.2005Highly pathogenic H5N1" exact="influenza" post="virus infection in migratory birds. Science309, 1206 (10.1126/science.1115273)16000410 15ChildsML,"/>
   <result pre="NovaN, ColvinJ, MordecaiEA2019Mosquito and primate ecology predict human risk of" exact="yellow fever" post="virus spillover in Brazil. Phil. Trans. R. Soc. B374,"/>
   <result pre="Soc. B374, 20180335 (10.1098/rstb.2018.0335)31401964 16FariaNRet al.2018Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potential. Science361, 894â€&quot;899. (10.1126/science.aat7115)30139911 17WashburneAD, CrowleyDE, BeckerDJ,"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virus. Infect. Genet. Evol.19, 292â€&quot;311. (10.1016/j.meegid.2013.03.008)23523817 21PlowrightRK, PeelAJ, StreickerDG,"/>
   <result pre="26BrebanR, DrakeJM, StallknechtDE, RohaniP2009The role of environmental transmission in recurrent" exact="avian influenza" post="epidemics. PLoS Comput. Biol.5, e1000346 (10.1371/journal.pcbi.1000346)19360126 27RocheB, DrakeJM, BrownJ,"/>
   <result pre="DrakeJM, StallknechtDE, RohaniP2009The role of environmental transmission in recurrent avian" exact="influenza" post="epidemics. PLoS Comput. Biol.5, e1000346 (10.1371/journal.pcbi.1000346)19360126 27RocheB, DrakeJM, BrownJ,"/>
   <result pre="RohaniP2014Adaptive evolution and environmental durability jointly structure phylodynamic patterns in" exact="avian influenza" post="viruses. PLoS Biol.12, e1001931 (10.1371/journal.pbio.1001931)25116957 28PepinKM, HopkenMW, ShrinerSA, SpackmanE,"/>
   <result pre="evolution and environmental durability jointly structure phylodynamic patterns in avian" exact="influenza" post="viruses. PLoS Biol.12, e1001931 (10.1371/journal.pbio.1001931)25116957 28PepinKM, HopkenMW, ShrinerSA, SpackmanE,"/>
   <result pre="RileyS, Lloyd-SmithJO, PiaggioAJ2019Improving risk assessment of the emergence of novel" exact="influenza" post="A viruses by incorporating environmental surveillance. Phil. Trans. R."/>
   <result pre="20180346 (10.1098/rstb.2018.0346)31401963 29KellerMWet al.2018Direct RNA sequencing of the coding complete" exact="influenza" post="A virus genome. Sci. Rep.8, 14408 (10.1038/s41598-018-32615-8)30258076 30RosarioK, NilssonC,"/>
   <result pre="20190017 (10.1098/rstb.2019.0017)31401954 43LongJS, MistryB, HaslamSM, BarclayWS2019Host and viral determinants of" exact="influenza" post="A virus species specificity. Nat. Rev. Microbiol.17, 67â€&quot;81. (10.1038/s41579-018-0115-z)30487536"/>
   <result pre="R. Soc. B374, 20180342 (10.1098/rstb.2018.0342)31401951 61SokolowSHet al.2015Reduced transmission of human" exact="schistosomiasis" post="after restoration of a native river prawn that preys"/>
   <result pre="CoxJ, DrakeleyCJ, FergusonHM, KaoRR2019Predictive analysis across spatial scales links zoonotic" exact="malaria" post="to deforestation. Proc. R. Soc. B286, 20182351 (10.1098/rspb.2018.2351)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711314\results\search\disease\results.xml">
   <result pre="of viruses that have gained efficient onward transmission after spillover:" exact="influenza" post="A viruses that are respiratory transmitted, HIV, a retrovirus,"/>
   <result pre="integrative approaches to understanding pathogen spilloverâ€™. epidemic emergence virus HIV" exact="influenza" post="parvovirus host range Funding U.S. Department of Defensehttp://dx.doi.org/10.13039/100000005 National"/>
   <result pre="East Respiratory Syndrome (MERS) coronaviruses, Nipah virus, Hendra virus and" exact="avian influenza" post="A viruses (IAV). In addition to emergence in humans,"/>
   <result pre="Respiratory Syndrome (MERS) coronaviruses, Nipah virus, Hendra virus and avian" exact="influenza" post="A viruses (IAV). In addition to emergence in humans,"/>
   <result pre="transmissible virus of mammals. Across these known examples of animal" exact="influenza" post="viruses overcoming host-specific differences to cause epidemics in humans,"/>
   <result pre="host adaptation [40]. (e) Particle release and host-to-host transmission of" exact="influenza" post="A virus Many IAVs cause severe infections of new"/>
   <result pre="disaggregate and release efficiently. The processes underlying the transmission of" exact="influenza" post="viruses are still not well understood, but likely require"/>
   <result pre="all regions of the world, with some dogs developing severe" exact="gastroenteritis" post="with profuse bloody diarrhoea, while neonatal puppies developed a"/>
   <result pre="challenge. Emerg. Infect. Dis.8, 1468â€&quot;1473. (10.3201/eid0812.010317)12498665 8NelsonMI, VincentAL2015Reverse zoonosis of" exact="influenza" post="to swine: new perspectives on the humanâ€&quot;animal interface. Trends"/>
   <result pre="Infect. Dis.17, 711â€&quot;713. (10.3201/eid1704.100883)21470468 10MenaIet al.2016Origins of the 2009 H1N1" exact="influenza" post="pandemic in swine in Mexico. Elife5, e16777 (10.7554/eLife.16777)27350259 11LongJS,"/>
   <result pre="e16777 (10.7554/eLife.16777)27350259 11LongJS, MistryB, HaslamSM, BarclayWS2018Host and viral determinants of" exact="influenza" post="A virus species specificity. Nat. Rev. Microbiol.17, 67â€&quot;81. (10.1038/s41579-018-0115-z)"/>
   <result pre="evolution of Zika virus. Nat. Ecol. Evol.3, 561â€&quot;569. (10.1038/s41559-019-0836-z)30886369 19HumphreysM2018The" exact="influenza" post="of 1918: evolutionary perspectives in a historical context. Evol."/>
   <result pre="context. Evol. Med. Public Health2018, 219â€&quot;229. (10.1093/emph/eoy024)30410762 20BarclayW, OpenshawP2018The 1918" exact="influenza" post="pandemic: one hundred years of progress, but where now?Lancet"/>
   <result pre="Respir. Med.6, 588â€&quot;589. (10.1016/S2213-2600(18)30272-8)29941354 21YoonS-W, WebbyRJ, WebsterRG2014Evolution and ecology of" exact="influenza" post="A viruses. Curr. Top. Microbiol. Immunol.385, 359â€&quot;375. (10.1007/82_2014_396)24990620 22VincentAet"/>
   <result pre="viruses. Curr. Top. Microbiol. Immunol.385, 359â€&quot;375. (10.1007/82_2014_396)24990620 22VincentAet al.2014Review of" exact="influenza" post="A virus in swine worldwide: a call for increased"/>
   <result pre="4â€&quot;17. (10.1111/zph.12049)23556412 23HaywardJJ, DuboviEJ, ScarlettJM, JaneczkoS, HolmesEC, ParrishCR2010Microevolution of canine" exact="influenza" post="virus in shelters and its molecular epidemiology in the"/>
   <result pre="States. J. Virol.84, 12 636â€&quot;12 645. (10.1128/JVI.01350-10) 24PuryearWBet al.2016Prevalence of" exact="influenza" post="A virus in live-captured North Atlantic gray seals: a"/>
   <result pre="Infect.5, e81 (10.1038/emi.2016.77)27485496 25HeWet al.2018Emergence and adaptation of H3N2 canine" exact="influenza" post="virus from avian influenza virus: an overlooked role of"/>
   <result pre="25HeWet al.2018Emergence and adaptation of H3N2 canine influenza virus from" exact="avian influenza" post="virus: an overlooked role of dogs in interspecies transmission."/>
   <result pre="al.2018Emergence and adaptation of H3N2 canine influenza virus from avian" exact="influenza" post="virus: an overlooked role of dogs in interspecies transmission."/>
   <result pre="Dis.66, 842â€&quot;851. (10.1111/tbed.13093) 26CiminskiK, ThamamongoodT, ZimmerG, SchwemmleM2017Novel insights into bat" exact="influenza" post="A viruses. J. Gen. Virol.98, 2393â€&quot;2400. (10.1099/jgv.0.000927)28906230 27ParrishCR, KawaokaY2005The"/>
   <result pre="the acquisition of new host ranges by canine parvovirus and" exact="influenza" post="A viruses. Annu. Rev. Microbiol.59, 553â€&quot;586. (10.1146/annurev.micro.59.030804.121059)16153179 28ChristmanMC, KedwaiiA,"/>
   <result pre="retrospective. Infect. Genet. Evol.11, 803â€&quot;811. (10.1016/j.meegid.2011.02.021)21382522 29LipsitchMet al.2016Viral factors in" exact="influenza" post="pandemic risk assessment. Elife5, e18491 (10.7554/eLife.18491)27834632 30WilksS, de GraafM,"/>
   <result pre="Elife5, e18491 (10.7554/eLife.18491)27834632 30WilksS, de GraafM, SmithDJ, BurkeDF.2012A review of" exact="influenza" post="haemagglutinin receptor binding as it relates to pandemic properties."/>
   <result pre="4369â€&quot;4376. (10.1016/j.vaccine.2012.02.076)22682293 31de GraafM, FouchierRAM2014Role of receptor binding specificity in" exact="influenza" post="A virus transmission and pathogenesis. EMBO J.33, 823â€&quot;841. (10.1002/embj.201387442)24668228"/>
   <result pre="K193T mutation. J. Virol.92, e02016-17 (10.1128/JVI.02016-17)29491160 34BoivinS, HartDJ2011Interaction of the" exact="influenza" post="A virus polymerase PB2 C-terminal region with importin alpha"/>
   <result pre="10 439â€&quot;10 448. (10.1074/jbc.M110.182964) 35LongJSet al.2016Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature529, 101â€&quot;104. (10.1038/nature16474)26738596 36LakdawalaSS,"/>
   <result pre="(10.1038/nature16474)26738596 36LakdawalaSS, FodorE, SubbaraoK2016Moving on out: transport and packaging of" exact="influenza" post="viral RNA into virions. Annu. Rev. Virol.3, 411â€&quot;427. (10.1146/annurev-virology-110615-042345)27741407"/>
   <result pre="38NogalesA, Martinez-SobridoL, TophamDJ, DeDiegoML2018Modulation of innate immune responses by the" exact="influenza" post="A NS1 and PA-X proteins. Viruses10, 708 (10.3390/v10120708) 39PepinKM,"/>
   <result pre="Nat. Rev. Microbiol.8, 802â€&quot;813. (10.1038/nrmicro2440)20938453 40ChauchÃ©Cet al.2018Mammalian adaptation of an" exact="avian influenza" post="A virus involves stepwise changes in NS1. J. Virol.92,"/>
   <result pre="Rev. Microbiol.8, 802â€&quot;813. (10.1038/nrmicro2440)20938453 40ChauchÃ©Cet al.2018Mammalian adaptation of an avian" exact="influenza" post="A virus involves stepwise changes in NS1. J. Virol.92,"/>
   <result pre="in hemagglutinin subunits HA1 and HA2 affecting hemagglutinin stability and" exact="influenza" post="virus infectivity. J. Virol.89, 10 602â€&quot;10 611. (10.1128/JVI.00939-15) 43HolmesKK,"/>
   <result pre="BiY, GaoGF2015MERS, SARS, and Ebola: the role of super-spreaders in" exact="infectious disease." post="Cell Host Microbe18, 398â€&quot;401. (10.1016/j.chom.2015.09.013)26468744 68PeckKM, LauringAS2018Complexities of viral"/>
   <result pre="rates. J. Virol.92, e01031-17 (10.1128/JVI.01031-17)29720522 69LyonsDM, LauringAS2018Mutation and epistasis in" exact="influenza" post="virus evolution. Viruses10, 407 (10.3390/v10080407) 70PoirierEZ, VignuzziM2017Virus population dynamics"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711507\results\search\disease\results.xml">
   <result pre="other individuals in the community. As a best case, the" exact="infectious disease" post="may even be eliminated if the number of infected"/>
   <result pre="a partly vaccinated population can prevent the spread of an" exact="infectious disease," post="and thereby protect unvaccinated persons. In addition, the possibility"/>
   <result pre="we will illustrate methodological issues in disease transmission modeling using" exact="dengue fever" post="as an exemplary infectious disease. Dengue is a mosquito-borne"/>
   <result pre="in disease transmission modeling using dengue fever as an exemplary" exact="infectious disease." post="Dengue is a mosquito-borne tropical infectious disease caused by"/>
   <result pre="as an exemplary infectious disease. Dengue is a mosquito-borne tropical" exact="infectious disease" post="caused by the dengue virus. The dengue virus is"/>
   <result pre="focus on infectious diseases and the case example of a" exact="dengue fever" post="epidemic. Dynamic (compared to static) In transmission models, the"/>
   <result pre="incubation period. The symptoms range from an asymptomatic disease to" exact="dengue fever" post="(DF), severe hemorrhagic fever (DHF), and to life-threatening septic"/>
   <result pre="period (mosquitoes) 8â€&quot;12 days (random) McBride et al. [30] DF:" exact="dengue fever," post="DHF: hemorrhagic fever, DSS: septic shock The provided datasets"/>
   <result pre="PoungsombatS, et al.Temporal patterns and a disease forecasting model of" exact="dengue hemorrhagic fever" post="in Jakarta based on 10 years of surveillance data."/>
   <result pre="World Health Organization. 1972;46(2):211â€&quot;26. Epub 1972/01/01. .4537483 50GublerDJ. Dengue and" exact="dengue hemorrhagic fever." post="Clinical microbiology reviews. 1998;11:480â€&quot;96. 9665979 51EddyDM, HollingworthW, CaroJJ, TsevatJ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6714416\results\search\disease\results.xml">
   <result pre="exist till date. Recent ZIKV outbreaks and increase association of" exact="microcephaly" post="with congenital ZIKV and neurological complications (Guillain-BarrÃ© syndrome) has"/>
   <result pre="diagnosis, preventive aspects, and management protocol. K EYWORDS: Guillain-BarrÃ© syndrome" exact="microcephaly" post="pregnancy public health menace zika virus I NTRODUCTION Zika"/>
   <result pre="of ZIKV from a surveillant macaque in the course of" exact="yellow fever" post="surveillance in Uganda's Zika forests, thus, deriving the name"/>
   <result pre="geographic regions[35]Adaptable to both urban and sylvatic habitats[36]Alleged linkage for" exact="yellow fever" post="virus in Brazil[37] N ONMOSQUITO T RANSMISSION Although mosquitoes"/>
   <result pre="has attracted significant attention due to an alarming increase in" exact="microcephaly" post="cases in congenital ZIKV-infected newborns. Isolation of ZIKV RNA"/>
   <result pre="febrile sentinel monkey acquired this virus during the surveillance of" exact="yellow fever" post="virus in Zika forests of Uganda.[54344] The first human"/>
   <result pre="confirmed ZIKV infected patients presented maculo-papular exanthema (rash), bilateral nonpurulent" exact="conjunctivitis" post="and arthralgia over the 13 weeks duration of the"/>
   <result pre="the third reported epidemic of ZIKV.[4849] The first incidence of" exact="microcephaly" post="with ZIKV was documented in October 2015 in Brazil."/>
   <result pre="the WHO in February 2016 due to alleged linkage with" exact="microcephaly" post="and varied neurologic complications.[50] Data till February 2, 2017,"/>
   <result pre="South America &amp;gt;1.5 million cases October 2015 First incidence of" exact="microcephaly" post="with ZIKV February 2016 WHO declared ZIKV a public"/>
   <result pre="macular or maculopapular exanthema (seen in 90% of cases). The" exact="rash" post="has a characteristic centrifugal pattern (extends from the trunk"/>
   <result pre="and persist for a period of 4â€&quot;5 days.[315657] The typical" exact="rash" post="of ZIKV is usually seen within the 1st or"/>
   <result pre="the symptoms sets in. This is in contrast to the" exact="rash" post="in dengue and Chikungunya, which usually appears after 4"/>
   <result pre="and joint pain as compared to severe intense myalgia of" exact="chikungunya" post="infection.[31] Localized or generalized lymphadenopathy may also be seen"/>
   <result pre="to severe intense myalgia of chikungunya infection.[31] Localized or generalized" exact="lymphadenopathy" post="may also be seen in a few cases of"/>
   <result pre="to two or more of the following features: Fever Nonpurulent" exact="conjunctivitis" post="and pruritus Arthralgia of multiple joints (polyarthralgia) Periarticular edema."/>
   <result pre="Unusual Blood dyscrasias (shock and thrombocytopenia) +++ +/_ +/_ Non-purulent" exact="conjunctivitis" post="+ +++ ++ Peripheral edema _ + _ lymphadenopathy"/>
   <result pre="Non-purulent conjunctivitis + +++ ++ Peripheral edema _ + _" exact="lymphadenopathy" post="++ + ++ Neurological complications Encephalitis Guillain-BarrÃ© syndrome and"/>
   <result pre="lymphadenopathy ++ + ++ Neurological complications Encephalitis Guillain-BarrÃ© syndrome and" exact="encephalitis" post="Guillain-BarrÃ© syndrome and encephalitis (especially in neonates) Course of"/>
   <result pre="Neurological complications Encephalitis Guillain-BarrÃ© syndrome and encephalitis Guillain-BarrÃ© syndrome and" exact="encephalitis" post="(especially in neonates) Course of disease Mostly, dengue infection"/>
   <result pre="other causes of chronic rheumatism predispose patients to chronicity of" exact="chikungunya" post="infection Hospitalization Secondary dengue infection often requires hospitalization and"/>
   <result pre="cases are managed on an outpatient basis Patients with severe" exact="chikungunya" post="fever requiring hospitalization tend to be older and have"/>
   <result pre="probable association. Thereafter, a total of 2366 confirmed cases of" exact="microcephaly" post="associated with ZIKV infection have been noted in Brazil.[68]"/>
   <result pre="the infectious symptoms in the mother. Various proposed mechanisms for" exact="microcephaly" post="in ZIKV infection are: (1) Increased occurrence of microcephaly"/>
   <result pre="for microcephaly in ZIKV infection are: (1) Increased occurrence of" exact="microcephaly" post="cases associated with ZIKV epidemics (2) 2 Documented cases"/>
   <result pre="amniotic fluid.[70] N EUROLOGICAL C OMPLICATIONS GBS refers to a" exact="polyneuropathy" post="of acute onset. More than two-thirds of the reported"/>
   <result pre="ZIKV evaluation is suggested in following cases: (1) infants with" exact="microcephaly" post="or intracranial calcifications born to women who traveled to"/>
   <result pre="ZIKV should be immediately referred to an expert gynecologist or" exact="infectious disease" post="specialist. Review of fetal ultrasounds to monitor fetal growth"/>
   <result pre="HIV-infected patient in Rio De Janeiro, BrazilJ Clin Virol2016741326615388 19GautretPSimonFDengue," exact="chikungunya" post="and Zika and mass gatherings: What happened in Brazil,"/>
   <result pre="Trop Med Hyg19691841154976739 28Akoua-KoffiCDiarrassoubaSBÃ©niÃ©VBNgbichiJMBozouaTBossonAet al.Investigation surrounding a fatal case of" exact="yellow fever" post="in CÃ´te D'ivoire in 1999Bull Soc Pathol Exot2001942273011681215 29FagbamiAZika"/>
   <result pre="of Communicable DiseasesSurveillance protocol and response to the occurrence of" exact="microcephaly" post="related to Zika virus infection2015BrasÃ­liaMinistry of Health55 46HancockWTMarfelMBelMZika virus,"/>
   <result pre="2007Emerg Infect Dis2008141232918680646 54MardekianSKRobertsALDiagnostic options and challenges for dengue and" exact="chikungunya" post="virusesBiomed Res Int2015201583437126509163 55LopesNNozawaCLinharesRECGeneral features and epidemiology of emerging"/>
   <result pre="literaturePLoS One201611e015637627244249 60De OliveiraWKCortez-EscalanteJDe OliveiraWTCarmoGMHenriqueCMCoelhoGEet al.Increase in reported prevalence of" exact="microcephaly" post="in infants born to women living in areas with"/>
   <result pre="Health Organization201722 69De CarvalhoNSDe CarvalhoBFFugaÃ§aCADÃ³risBBiscaiaESZika virus infection during pregnancy and" exact="microcephaly" post="occurrence: A review of literature and Brazilian dataBraz J"/>
   <result pre="Immunol20177713 81SatoHNakadaHYamaguchiRImotoSMiyanoSKamiMet al.When should we intervene to control the 2009" exact="influenza" post="A (H1N1) pandemic?Euro Surveill201015pii: 19455 82Scalia TombaGWallingaJA simple explanation"/>
   <result pre="clinical trialsLancet20183915526229217376 87MillerBRMitchellCJGenetic selection of a flavivirus-refractory strain of the" exact="yellow fever" post="mosquito Aedes aegyptiAm J Trop Med Hyg1991453994071659238 88MeghaniZBoÃ«teCGenetically engineered"/>
   <result pre="outbreak â€&quot; United states, 2016MMWR Morb Mortal Wkly Rep20166530326796813 94JamiesonDJRasmussenSAUyekiTMWeinbaumCPandemic" exact="influenza" post="and pregnancy revisited: Lessons learned from 2009 pandemic influenza"/>
   <result pre="94JamiesonDJRasmussenSAUyekiTMWeinbaumCPandemic influenza and pregnancy revisited: Lessons learned from 2009 pandemic" exact="influenza" post="A (H1N1)Am J Obstet Gynecol2011204S1321640228 95LiRDingJDingGFanXHeYWangXet al.Zika virus infections,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6716807\results\search\disease\results.xml">
   <result pre="and patterns of subgroup persistence identified through surveillance of pediatric" exact="pneumonia" post="hospital admissions in coastal Kenya, 2007â€&quot;2016 http://orcid.org/0000-0002-8020-0787OketchJohn W.+254 715"/>
   <result pre="on HMPV in Africa, which bears a high burden of" exact="pneumonia" post="morbidity and mortality [26, 27]. In this study, we"/>
   <result pre="surface F and G gene nucleotide sequences collected through paediatric" exact="pneumonia" post="surveillance at the Kilifi County Hospital in rural coastal"/>
   <result pre="aimed at understanding the epidemiology and disease burden of RSV-associated" exact="pneumonia" post="cases [29]. KCH, located in coastal Kenya, is a"/>
   <result pre="presented with modified WHO defined syndromic severe or very severe" exact="pneumonia" post="as previously described [29]. During the period between 2007"/>
   <result pre="and cases positives per year from 2007 to 16 amongst" exact="pneumonia" post="paediatric admissions to Kilifi County Hospital, Kenya Year Admissionsa"/>
   <result pre="5â€‰years of age; b. Cases of severe or very severe" exact="pneumonia" post="amongst the admissions [29]; c. Samples eligible for testing"/>
   <result pre="the admissions [29]; c. Samples eligible for testing from the" exact="pneumonia" post="admissions included only residents from within the Kilifi Health"/>
   <result pre="cases identified monthly from surveillance of severe and very severe" exact="pneumonia" post="cases aged under 5â€‰years admitted to Kilifi County Hospital,"/>
   <result pre="under 5â€‰years admitted to Kilifi County Hospital, Kenya 2007â€&quot;2016. Number" exact="pneumonia" post="cases and number tested are shown on the secondary"/>
   <result pre="the primary Y axis. Samples eligible for testing from the" exact="pneumonia" post="admissions included only residents from within the Kilifi Health"/>
   <result pre="not observe a statistically significant association between HMPV subgroup and" exact="pneumonia" post="severity ( p-valueâ€‰=â€‰0.264) (Table 3). Table 3 Association between"/>
   <result pre="current dataset. There is also some evidence that reduction in" exact="bacterial pneumonia" post="(e.g. S. pneumoniae), as has been seen in this"/>
   <result pre="dataset. There is also some evidence that reduction in bacterial" exact="pneumonia" post="(e.g. S. pneumoniae), as has been seen in this"/>
   <result pre="over this study period [52], results in a reduction in" exact="viral pneumonia" post="[53, 54]. Future investigations will be necessary to give"/>
   <result pre="this study period [52], results in a reduction in viral" exact="pneumonia" post="[53, 54]. Future investigations will be necessary to give"/>
   <result pre="change over time. In addition, the proportion of very severe" exact="pneumonia" post="cases was high among sampled eligibles compared to unsampled"/>
   <result pre="Stockholm, Sweden, 2002-2006J Med Virol2008809161168 26.Green RJ, Kolberg JM. Neonatal" exact="pneumonia" post="in sub-Saharan Africa. Pneumonia . 2016;0â€&quot;1. 27.LiuLJohnsonHLCousensSPerinJScottSLawnJEet al.Global, regional,"/>
   <result pre="Infect Dis201616130127316548 29.NokesDJNgamaMBettAAbwaoJMunywokiPEnglishMet al.Incidence and severity of respiratory syncytial virus" exact="pneumonia" post="in rural Kenyan children identified through hospital surveillanceClin Infect"/>
   <result pre="Journal of Epidemiology 2012;(April): 41(3):650â€&quot;7. 31.BerkleyJAMunywokiPNgamaMAbwaoJBettALassauniÃ©reRet al.Viral etiology of severe" exact="pneumonia" post="among Kenyan young infants and childrenJama.2010303202051205720501927 32.HammittLLKazunguSWelchSBettAOnyangoCOGunsonRNet al.Added value"/>
   <result pre="of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed" exact="pneumonia" post="and clinically-defined pneumonia in Kenyan children : an interrupted"/>
   <result pre="conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined" exact="pneumonia" post="in Kenyan children : an interrupted time-series analysisLancet Global"/>
   <result pre="54.FathimaPBlythCCLehmannDLimFJAbdallaTDe KlerkNet al.The impact of pneumococcal vaccination on bacterial and" exact="viral pneumonia" post="in Western Australian children: record linkage cohort study of"/>
   <result pre="KlerkNet al.The impact of pneumococcal vaccination on bacterial and viral" exact="pneumonia" post="in Western Australian children: record linkage cohort study of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6720359\results\search\disease\results.xml">
   <result pre="provided the original work is properly cited. Abstract Background Yearly" exact="influenza" post="epidemics have considerable effects on public health worldwide. The"/>
   <result pre="epidemics have considerable effects on public health worldwide. The 2017-2018" exact="influenza" post="season in Italy was of greater severity than previous"/>
   <result pre="The aim of this study was to describe the 2017-2018" exact="influenza" post="season in Southern Italy and the molecular characteristics of"/>
   <result pre="from week 46/2017 to week 17/2018 were tested to identify" exact="influenza" post="A viruses (IAV) and influenza B viruses (IBV). Sequencing"/>
   <result pre="17/2018 were tested to identify influenza A viruses (IAV) and" exact="influenza" post="B viruses (IBV). Sequencing and phylogenetic analysis of haemagglutinin"/>
   <result pre="Intensive-care unit (ICU) admission was required in 50 cases of" exact="acute respiratory distress syndrome" post="(ARDS). Among the &amp;gt;64-year age group, 18 out of"/>
   <result pre="14 of these (77.8%) were B/Yamagata lineage. Conclusions The 2017-2018" exact="influenza" post="season was one of the most severe in a"/>
   <result pre="suggests that further data on the effectiveness of the available" exact="influenza" post="vaccines are needed to determine the best way to"/>
   <result pre="protect the elderly against both IBV lineages. 1. Introduction Yearly" exact="influenza" post="epidemics have severe effects on public health worldwide. Influenza"/>
   <result pre="in children [2]. Every year, 3â€&quot;5 million cases of severe" exact="influenza" post="and around 290,000â€&quot;650,000 influenza-related deaths occur [3]. Vaccination is"/>
   <result pre="occur [3]. Vaccination is the most effective way to prevent" exact="influenza" post="virus infection and its complications. However, because of antigenic"/>
   <result pre="and its complications. However, because of antigenic drift in seasonal" exact="influenza" post="viruses, the composition of the vaccines must be changed"/>
   <result pre="In Italy, the recommendations for the use of the available" exact="influenza" post="vaccines are reported yearly in a document of the"/>
   <result pre="a document of the Ministry of Health. For the 2017-2018" exact="influenza" post="season, for the northern hemisphere, the recommended vaccine formulation"/>
   <result pre="acute respiratory infections (ARIs) to the national focal point for" exact="influenza" post="surveillance [6]. From week 40 of one year to"/>
   <result pre="(epidemiological surveillance) and collect respiratory specimens to identify the circulating" exact="influenza" post="strains (virological surveillance) [7]. In Italy, the estimated incidence"/>
   <result pre="strains (virological surveillance) [7]. In Italy, the estimated incidence of" exact="influenza" post="in the 2017-2018 season was &amp;gt;8.5 million [8], which"/>
   <result pre="in the week 02/2018 [8]. Some 60% of all laboratory-confirmed" exact="influenza" post="cases were caused by influenza B virus (IBV) [9]."/>
   <result pre="Some 60% of all laboratory-confirmed influenza cases were caused by" exact="influenza" post="B virus (IBV) [9]. No recent data are available"/>
   <result pre="[9]. No recent data are available on the epidemiology of" exact="influenza" post="and on the circulation of influenza viruses during recent"/>
   <result pre="on the epidemiology of influenza and on the circulation of" exact="influenza" post="viruses during recent seasons in Southern Italy. The aim"/>
   <result pre="The aim of this study was to describe the 2017-2018" exact="influenza" post="season in the Apulia region (Southern Italy), along with"/>
   <result pre="&amp;gt;4 million people. According to the national protocol, the regional" exact="influenza" post="surveillance system surveys about 2% of the general population"/>
   <result pre="least one of three respiratory symptoms (cough, sore throat, and" exact="shortness" post="of breath) [10]. For epidemiological purposes, the number of"/>
   <result pre="sign or symptom of acute respiratory illness (cough, sore throat," exact="shortness" post="of breath, and coryza) [10], and from patients admitted"/>
   <result pre="admitted to all intensive-care units (ICUs) of the region with" exact="acute respiratory distress syndrome" post="(ARDS), during the influenza season. All the samples were"/>
   <result pre="the region with acute respiratory distress syndrome (ARDS), during the" exact="influenza" post="season. All the samples were analysed at the Laboratory"/>
   <result pre="(Anyplex RV16 Detection; Seegene, Seoul, Republic of Korea). Subtyping of" exact="influenza" post="A virus (IAV) was performed with a commercial real-time"/>
   <result pre="from patients with SARI, and 14 from ICU-ARDS), 36 were" exact="influenza" post="A/H1N1pdm09 (five from individuals with ILIs, 10 from patients"/>
   <result pre="patients with SARI, and 21 from ICU-ARDS), and two were" exact="influenza" post="A/H3N2 (one from a patient with SARI and one"/>
   <result pre="that already deposited. 3. Results In Apulia, during the 2017-2018" exact="influenza" post="season, the first two sporadic cases were identified in"/>
   <result pre="week 9/2018. A total of 2,175 patients was tested for" exact="influenza" post="viruses, and 565 (26.0%) were positive. IBV strains were"/>
   <result pre="50 individuals, 8 of whom were vaccinated for the 2017-2018" exact="influenza" post="season, and all but 3 of whom had comorbidities."/>
   <result pre="age group, in which 12 of the 50 individuals with" exact="influenza" post="(24.0%) had ICU-ARDS, whereas no children &amp;lt;15 years old"/>
   <result pre="3 shows the distribution of the number of cases of" exact="influenza" post="by age group and type of virus identified for"/>
   <result pre="the 15â€&quot;49-year and 50â€&quot;64-year age groups was mostly associated with" exact="influenza" post="A/H1N1pdm09 infection, whereas among the 65â€&quot;74-year and &amp;gt;74-year age"/>
   <result pre="IBV infection was significantly more frequent in patients with severe" exact="influenza" post="(ICU-ARDS and SARI cases) compared to sentinel patients (ILI"/>
   <result pre="more frequent in ILI cases compared to patients with severe" exact="influenza" post="(p&amp;lt;0.0001), whereas no significant difference was found for the"/>
   <result pre="genes of the 35 IBV strains characterised during the 2017-2018" exact="influenza" post="season (Figure 4) showed that all of the B/Yamagata"/>
   <result pre="season in the northern hemisphere). 4. Discussion The monitoring of" exact="influenza" post="epidemiology and disease and the characterisation of circulating strain"/>
   <result pre="provide data to public-health authorities to facilitate the management of" exact="influenza" post="epidemics and the planning of control measures. In Apulia,"/>
   <result pre="In Apulia, as in the rest of Italy, the 2017-2018" exact="influenza" post="season had one of the greatest impacts on public"/>
   <result pre="fell, and infection with A/H1N1pdm09 became predominant. The proportion of" exact="influenza" post="infections resulting from IBV was higher in Apulia than"/>
   <result pre="Italy as a whole (71.0% versus 60.0%) [9]. The 2017-2018" exact="influenza" post="season was characterised by an IBV lineage mismatch with"/>
   <result pre="the lineage mismatch contributed to the severe impact of the" exact="influenza" post="epidemic. Notably, all of the characterised B/Yamagata strains belonged"/>
   <result pre="the impact of IBV in the elderly in the 2017-2018" exact="influenza" post="season, the Italian Ministry of Health has also recommended,"/>
   <result pre="at low risk (without multiple comorbidities) [24]. The use of" exact="influenza" post="vaccines in those &amp;gt;64 years old is under debate"/>
   <result pre="[30â€&quot;34]. Further evidence of the relative effectiveness of the different" exact="influenza" post="vaccines in the elderly is needed for definitive recommendations"/>
   <result pre="In conclusion, our data provide information on the most recent" exact="influenza" post="season and on the molecular epidemiology of the circulating"/>
   <result pre="influenza season and on the molecular epidemiology of the circulating" exact="influenza" post="viruses in Apulia, a densely populated region of Italy."/>
   <result pre="virological surveillance remain an essential tool for monitoring of the" exact="influenza" post="season and the characteristics of circulating viruses, to identify"/>
   <result pre="and Jolanda Prisco for invaluable help in collecting data on" exact="influenza" post="cases and on ICU-ARDS. Abbreviations ARDS: Acute respiratory distress"/>
   <result pre="respiratory distress syndrome ARI: Acute respiratory infection aTIV: Adjuvanted trivalent" exact="influenza" post="vaccine IAV: Influenza A virus IBV: Influenza B virus"/>
   <result pre="IBV: Influenza B virus ILI: Influenza-like illness ICU-ARDS: Case of" exact="influenza" post="infection with ARDS requiring admission to an intensive-care unit"/>
   <result pre="with ARDS requiring admission to an intensive-care unit QIV: Quadrivalent" exact="influenza" post="vaccine SARI: Severe acute respiratory infection TIV: Trivalent influenza"/>
   <result pre="Quadrivalent influenza vaccine SARI: Severe acute respiratory infection TIV: Trivalent" exact="influenza" post="vaccine. Data Availability The data that support the findings"/>
   <result pre="Fact Sheets Influenza (Seasonal). http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) 4Ministry of Health. Recommendations for" exact="influenza" post="prevention and control, 2017-2018 season, Italy. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2017&amp;amp;codLeg=60180&amp;amp;parte=1%20&amp;amp;serie=null 5World Health"/>
   <result pre="â€&quot; Operating protocol for epidemiological and virological surveillance - 2017-2018" exact="influenza" post="season. http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&amp;amp;id=2649 8InfluNet - Epidemiological report, week 17/2018. http://www.salute.gov.it/portale/temi/documenti/epidemiologica/Influnet_2018_17.pdf"/>
   <result pre="Health Organization (WHO). WHO information for the molecular detection of" exact="influenza" post="viruses. July 2017. https://www.who.int/influenza/gisrs_laboratory/WHO_information_for_the_molecular_detection_of_influenza_viruses_20171023_Final.pdf?ua=1 12VegaT.LozanoJ. E.MeerhoffT.et al.Influenza surveillance in"/>
   <result pre="HemagglutininJournal of Virology20088263011302010.1128/JVI.02477-0718184701 15World Health Organization (WHO). Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017- 2018 northern"/>
   <result pre="virus vaccines for use in the 2017- 2018 northern hemisphere" exact="influenza" post="season. March 2017. https://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 16RondyM.KisslingE.EmborgH.et al.Interim 2017/18 influenza seasonal"/>
   <result pre="northern hemisphere influenza season. March 2017. https://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 16RondyM.KisslingE.EmborgH.et al.Interim 2017/18" exact="influenza" post="seasonal vaccine effectiveness: combined results from five European studiesEurosurveillance201823910.2807/1560-7917.ES.2018.23.9.18-00086"/>
   <result pre="of D222G amino acid substitution in the haemagglutinin of pandemic" exact="influenza" post="A (H1N1) 2009 viruses. Wkly Epidemiol Rec. 2010 Jan"/>
   <result pre="Epidemiol Rec. 2010 Jan 22;85(4):21-2 19RykkvinR.KilanderA.DudmanS. G.HungnesO.Within-patient emergence of the" exact="influenza" post="A(H1N1)pdm09 HA1 222G variant and clear association with severe"/>
   <result pre="virus receptors in the human airwayNature2006440708343543610.1038/440435a16554799 22Flu News Italy. Integrated" exact="influenza" post="surveillance report, 2017/2018 influenza season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health."/>
   <result pre="human airwayNature2006440708343543610.1038/440435a16554799 22Flu News Italy. Integrated influenza surveillance report, 2017/2018" exact="influenza" post="season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health. Recommendations for influenza prevention"/>
   <result pre="report, 2017/2018 influenza season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health. Recommendations for" exact="influenza" post="prevention and control, 2018-2019 season, Italy. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2018&amp;amp;codLeg=64381&amp;amp;parte=1%20&amp;amp;serie=null 24Apulia region."/>
   <result pre="region. Nota n. 4571, 16.10.2017. â€œMinistry of Health, Recommendations for" exact="influenza" post="prevention and control, 2017-2018 season, Italy. Notification.â€� https://www.sanita.puglia.it/documents/36044/41587901/Circolare+regionale/62a1ca12-38de-4dde-9944-e97f04a84dea 25BarbieriM.CapriS.WaureC."/>
   <result pre="D. E.BoccaliniS.PanattoD.Age- and risk-related appropriateness of the use of available" exact="influenza" post="vaccines in the Italian elderly population is advantageous: Results"/>
   <result pre="Hygiene2017584E279E28729707658 26MenniniF. S.BiniC.MarcellusiA.RinaldiA.FrancoE.Cost-effectiveness of switching from trivalent to quadrivalent inactivated" exact="influenza" post="vaccines for the at-risk population in ItalyHuman Vaccines &amp;amp;"/>
   <result pre="&amp;amp; Immunotherapeutics20181481867187310.1080/21645515.2018.146936829708843 27MontomoliE.TorelliA.ManiniI.GianchecchiE.Immunogenicity and safety of the new inactivated quadrivalent" exact="influenza" post="vaccine vaxigrip tetra: Preliminary results in children â‰¥6 months"/>
   <result pre="months and older adultsVaccines201861 28CapriS.BarbieriM.de WaureC.BoccaliniS.PanattoD.Cost-effectiveness analysis of different seasonal" exact="influenza" post="vaccines in the elderly Italian populationHuman Vaccines &amp;amp; Immunotherapeutics20181461331134110.1080/21645515.2018.143879229425079"/>
   <result pre="the elderly Italian populationHuman Vaccines &amp;amp; Immunotherapeutics20181461331134110.1080/21645515.2018.143879229425079 29de WaureC.BoccaliniS.BonanniP.et al.Adjuvanted" exact="influenza" post="vaccine for the Italian elderly in the 2018/19 season:"/>
   <result pre="during 2016â€&quot;2017 seasonClinical Infectious Diseases2018 31CastillaJ.NavascuÃ©sA.CasadoI.et al.Interim effectiveness of trivalent" exact="influenza" post="vaccine in a season dominated by lineage mismatched influenza"/>
   <result pre="trivalent influenza vaccine in a season dominated by lineage mismatched" exact="influenza" post="B, northern Spain, 2017/18Eurosurveillance201823710.2807/1560-7917.ES.2018.23.7.18-00057 32CamilloniB.NeriM.LepriE.IorioA. M.Cross-reactive antibodies in middle-aged"/>
   <result pre="antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent" exact="influenza" post="vaccine against B viruses of the B/Victoria or B/Yamagata"/>
   <result pre="33RayR.Dos SantosG.BuckP. O.et al.A review of the value of quadrivalent" exact="influenza" post="vaccines and their potential contribution to influenza controlHuman Vaccines"/>
   <result pre="value of quadrivalent influenza vaccines and their potential contribution to" exact="influenza" post="controlHuman Vaccines &amp;amp; Immunotherapeutics20171371640165210.1080/21645515.2017.131337528532276 34SkowronskiD. M.ChambersC.De SerresG.et al.Vaccine effectiveness"/>
   <result pre="34SkowronskiD. M.ChambersC.De SerresG.et al.Vaccine effectiveness against lineage matched and mismatched" exact="influenza" post="B viruses across 8 seasons in Canada, 2010-11 to"/>
   <result pre="1 Distribution of samples according to type or subtype of" exact="influenza" post="virus identified and incidence of influenza-like illness (ILI) in"/>
   <result pre="in each week of surveillance in Apulia in the 2017-2018" exact="influenza" post="season. Figure 2 Distribution of influenza-positive cases by age"/>
   <result pre="and type of virus identified, in Apulia in the 2017-2018" exact="influenza" post="season. Figure 3 Distribution of the number of cases"/>
   <result pre="season. Figure 3 Distribution of the number of cases of" exact="influenza" post="infection with ARDS requiring admission to an intensive-care unit"/>
   <result pre="and type of virus identified, in Apulia in the 2017-2018" exact="influenza" post="season. Figure 4 Phylogenetic analysis of the haemagglutinin (HA)"/>
   <result pre="influenza-like illness; SARI, severe acute respiratory illness; ICU-ARDS, cases with" exact="acute respiratory distress syndrome" post="requiring admission to an intensive-care unit) and, if vaccinated,"/>
   <result pre="influenza-like illness; SARI, severe acute respiratory illness; ICU-ARDS, cases with" exact="acute respiratory distress syndrome" post="requiring admission to an intensive-care unit) and, if vaccinated,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6720821\results\search\disease\results.xml">
   <result pre="recent use of mathematical epidemiological SIR or SEIR models in" exact="plague" post="research. This use of S(E)IR models is highly problematic,"/>
   <result pre="in that such models are used to â€œproveâ€� that historical" exact="plague" post="was a (1) Filoviridae disease and (2) a bacterial"/>
   <result pre="historical plague was a (1) Filoviridae disease and (2) a" exact="bacterial disease" post="caused by Yersinia pestis which was transmitted by human"/>
   <result pre="fleas). They purportedly consistently disprove (4) the conventional view that" exact="plague" post="is/was a rat-and-rat-flea-borne disease. For these reasons, the focus"/>
   <result pre="historical epidemiological data. An important or predominant vectorial role in" exact="plague" post="epidemics for human fleas and lice requires that several"/>
   <result pre="not considered by advocates of the human ectoparasite hypothesis of" exact="plague" post="transmission: (1) the prevalence and levels of human plague"/>
   <result pre="of plague transmission: (1) the prevalence and levels of human" exact="plague" post="bacteraemia (human plague cases as sources of infection of"/>
   <result pre="(1) the prevalence and levels of human plague bacteraemia (human" exact="plague" post="cases as sources of infection of feeding human ectoparasites);"/>
   <result pre="human fleas and lice; (3) the consequent number of ingested" exact="plague" post="bacteria; (4) the lethal dose of bacteria for 50%"/>
   <result pre="human ectoparasite hypothesis. The view of the standard works on" exact="plague" post="has been corroborated, that bubonic plague, historical and modern,"/>
   <result pre="of the standard works on plague has been corroborated, that" exact="bubonic plague," post="historical and modern, is/was a rat-and-rat-flea-borne disease caused by"/>
   <result pre="as a mechanism of transmission of LDs to humans in" exact="plague" post="epidemics and removed this solution to the problem of"/>
   <result pre="the erroneous use of them, in this case on historical" exact="plague" post="epidemics. The S(E)IR models are good for their intended"/>
   <result pre="of tenability). This has clearly been the case in historical" exact="plague" post="research with significance also for the understanding of modern"/>
   <result pre="plague research with significance also for the understanding of modern" exact="bubonic plague." post="However, models are in methodological principle analogues and can,"/>
   <result pre="epidemic spread. Relating to the theory of early-phase transmission of" exact="plague" post="by fleas, B. J. Hinnebusch (Chief of the Plague"/>
   <result pre="high flea burden and not in the case of human" exact="plague" post="[3, 4]. Epidemiological mathematical models produce the outcome of"/>
   <result pre="identity and epidemiological dynamics of the Black Death and historical" exact="plague" post="epidemics. 2. Basic Structures of the Reedâ€&quot;Frost Mathematical Epidemiological"/>
   <result pre="the Black Death and the subsequent epidemics of the second" exact="plague" post="pandemic. The model's name refers to two scholars at"/>
   <result pre="lasting immunity on survivors. This is also the case with" exact="bubonic plague," post="and survivors generally acquire only weak and brief immunity"/>
   <result pre="This is reflected in the numerous cases of survivors of" exact="plague" post="disease who fall ill by plague again and also"/>
   <result pre="cases of survivors of plague disease who fall ill by" exact="plague" post="again and also three times in the same epidemic"/>
   <result pre="sources [12]. This was also noted in connection with modern" exact="bubonic plague" post="in India, China, and Vietnam, [13, 14]; Langen and"/>
   <result pre="[12]. This was also noted in connection with modern bubonic" exact="plague" post="in India, China, and Vietnam, [13, 14]; Langen and"/>
   <result pre="[13, 14]; Langen and Liechtenstein state on the experience with" exact="plague" post="epidemics in Java: â€œreinfection with plague may occur within"/>
   <result pre="on the experience with plague epidemics in Java: â€œreinfection with" exact="plague" post="may occur within a few months; surviving an attack"/>
   <result pre="a very limited immunityâ€� [15]. This shows, for starters, that" exact="bubonic plague" post="cannot be modelled by SIR models including the Reedâ€&quot;Frost"/>
   <result pre="very limited immunityâ€� [15]. This shows, for starters, that bubonic" exact="plague" post="cannot be modelled by SIR models including the Reedâ€&quot;Frost"/>
   <result pre="the Reedâ€&quot;Frost version of the model because it is a" exact="bacterial disease" post="and because it does not confer lasting immunity. The"/>
   <result pre="only to simple situations as illustrated by an outbreak of" exact="measles" post="in a closed groupâ€� [16], and the latter is"/>
   <result pre="applied on epidemics that were or were suspected of being" exact="bubonic plague," post="which are by wide consensus transmitted and disseminated by"/>
   <result pre="and/or (4) have animal reservoirs, as in the case of" exact="bubonic plague." post="Furthermore, (5) people in historical society did not, by"/>
   <result pre="level of exposure to infection. The social scenes of historical" exact="plague" post="epidemics were never â€œsimple situationsâ€� as all historians know."/>
   <result pre="and Duncan used the Reedâ€&quot;Frost model to analyse various historical" exact="plague" post="epidemics, and it consistently confirmed the revolutionary theory that"/>
   <result pre="epidemics, and it consistently confirmed the revolutionary theory that historical" exact="plague" post="had to be a Filoviridae disease, (a variant of)"/>
   <result pre="or Marburg disease [5]. According to the Reedâ€&quot;Frost model, historical" exact="plague" post="epidemics allegedly exhibited a pattern of spread formed by"/>
   <result pre="the second pandemic or in the countries where the third" exact="plague" post="pandemic spread. Scott and Duncan performed these analyses without"/>
   <result pre="let it suffice to point out that (1) epidemics of" exact="bubonic plague" post="in general do not conform to the pattern of"/>
   <result pre="it suffice to point out that (1) epidemics of bubonic" exact="plague" post="in general do not conform to the pattern of"/>
   <result pre="case with bubo(es), a defining feature of modern and historical" exact="plague" post="[11] (although rare cases of enlarged lymph nodes have"/>
   <result pre="expected) [29]. In a treatise designed to show that historical" exact="plague" post="cannot have been bubonic plague but was a Filoviridae"/>
   <result pre="treatise designed to show that historical plague cannot have been" exact="bubonic plague" post="but was a Filoviridae disease, Scott and Duncan tacitly"/>
   <result pre="designed to show that historical plague cannot have been bubonic" exact="plague" post="but was a Filoviridae disease, Scott and Duncan tacitly"/>
   <result pre="due to bacterial infection or transmitted by insects, such as" exact="bubonic plague." post="As such the whole treatise is based on a"/>
   <result pre="Reedâ€&quot;Frost model cannot be used to â€œrepresent,â€� i.e., to model" exact="bubonic plague" post="for several sufficient conditions, because it is a bacterial"/>
   <result pre="model cannot be used to â€œrepresent,â€� i.e., to model bubonic" exact="plague" post="for several sufficient conditions, because it is a bacterial"/>
   <result pre="bubonic plague for several sufficient conditions, because it is a" exact="bacterial disease" post="with an animal reservoir and transmitted by insects, means"/>
   <result pre="used when a central issue is whether or not historical" exact="plague" post="was bubonic plague, a crucial condition also ignored by"/>
   <result pre="a central issue is whether or not historical plague was" exact="bubonic plague," post="a crucial condition also ignored by Scott and Duncan."/>
   <result pre="1992 doctoral thesis on the Black Death and subsequent late-medieval" exact="plague" post="epidemics in the Scandinavian countries (and to my 2004"/>
   <result pre="of the Black Death conformed to the conventional view of" exact="bubonic plague" post="as rat-and-rat-flea-borne [28], as presented in all standard works"/>
   <result pre="the Black Death conformed to the conventional view of bubonic" exact="plague" post="as rat-and-rat-flea-borne [28], as presented in all standard works"/>
   <result pre="assert repeatedly that, according to evidence produced in India, modern" exact="bubonic plague" post="was â€œa rural disease hitting harder in the small"/>
   <result pre="repeatedly that, according to evidence produced in India, modern bubonic" exact="plague" post="was â€œa rural disease hitting harder in the small"/>
   <result pre="Death was a different disease from the modern epidemics of" exact="bubonic plague" post="in India. This is at variance with the central"/>
   <result pre="was a different disease from the modern epidemics of bubonic" exact="plague" post="in India. This is at variance with the central"/>
   <result pre="important pioneering observation of a unique and defining feature of" exact="bubonic plague" post="that modern bubonic plague in India and the Black"/>
   <result pre="pioneering observation of a unique and defining feature of bubonic" exact="plague" post="that modern bubonic plague in India and the Black"/>
   <result pre="a unique and defining feature of bubonic plague that modern" exact="bubonic plague" post="in India and the Black Death in Europe had"/>
   <result pre="unique and defining feature of bubonic plague that modern bubonic" exact="plague" post="in India and the Black Death in Europe had"/>
   <result pre="that the Black Death had similar epidemiological properties as modern" exact="plague" post="in India and was bubonic plague. Hankin was not"/>
   <result pre="similar epidemiological properties as modern plague in India and was" exact="bubonic plague." post="Hankin was not alone in making these peculiar observations."/>
   <result pre="the Black Death in England and found a similar corroboration:" exact="bubonic plague" post="in India in the early 1900s and the Black"/>
   <result pre="Black Death in England and found a similar corroboration: bubonic" exact="plague" post="in India in the early 1900s and the Black"/>
   <result pre="cities, and this was a unique and defining feature of" exact="bubonic plague" post="[38]. In their book and collateral articles, G. Christakos"/>
   <result pre="and this was a unique and defining feature of bubonic" exact="plague" post="[38]. In their book and collateral articles, G. Christakos"/>
   <result pre="the Black Death. In this book, this defining feature of" exact="bubonic plague" post="is presented in a chapter containing both modern and"/>
   <result pre="Black Death. In this book, this defining feature of bubonic" exact="plague" post="is presented in a chapter containing both modern and"/>
   <result pre="directly from person to person, such as, for instance, rat-and-rat-flea-based" exact="bubonic plague," post="can exhibit a different pattern. In the case of"/>
   <result pre="provides a basic explanation for why, in the case of" exact="bubonic plague," post="the severity of impact on human populations declines with"/>
   <result pre="lived in the countryside. Christakos et al.'s focus on urban" exact="plague" post="is misplaced. One point remains to be explained: the"/>
   <result pre="underpinned unique pattern of mortality according to settlement size for" exact="bubonic plague," post="namely, the inverse correlation according to population density, it"/>
   <result pre="population density, it also constitutes evidence that modern and historical" exact="plague" post="at least predominantly were the same disease, namely, rat-and-rat-flea-borne"/>
   <result pre="plague at least predominantly were the same disease, namely, rat-and-rat-flea-borne" exact="bubonic plague." post="On p. 206, in Chapter V(D, f) on â€œSome"/>
   <result pre="showing the main features of the â€œPropagation of the modern" exact="bubonic plague" post="in India (adapted from Plague Research Commission, 1912).â€� In"/>
   <result pre="the main features of the â€œPropagation of the modern bubonic" exact="plague" post="in India (adapted from Plague Research Commission, 1912).â€� In"/>
   <result pre="report LI, which do not relate to the spread of" exact="plague" post="in India. This is not a misprint or scribe's"/>
   <result pre="Hankin and Greenwood compared their studies of the spread of" exact="plague" post="in India with the spread of the Black Death"/>
   <result pre="England and concluded that the pattern of spread of these" exact="plague" post="epidemics was similar. This apparently spurious map and reference"/>
   <result pre="need for construed support. All assertions to the effect that" exact="plague" post="in India or China spread according to a different"/>
   <result pre="on epidemiological studies by IPRC [12] or on the Chinese" exact="plague" post="research team based in Shanghai [41] or on the"/>
   <result pre="based in Shanghai [41] or on the standard works on" exact="plague" post="synthesizing (also) this plague research [11, 12, 23â€&quot;25]. 5.1."/>
   <result pre="or on the standard works on plague synthesizing (also) this" exact="plague" post="research [11, 12, 23â€&quot;25]. 5.1. The Burial Register of"/>
   <result pre="of Plague Epidemics Another defining feature of modern and historical" exact="bubonic plague" post="formed by the rat-and-rat-flea-borne epidemiology can be demonstrated also"/>
   <result pre="Plague Epidemics Another defining feature of modern and historical bubonic" exact="plague" post="formed by the rat-and-rat-flea-borne epidemiology can be demonstrated also"/>
   <result pre="cases. Instead, it is concordant with another defining feature of" exact="bubonic plague," post="the latency period, the â€œsilentâ€� period between the first"/>
   <result pre="continuity by day in early August. In the case of" exact="bubonic plague," post="the first deaths would reflect the arrival of one"/>
   <result pre="and time of incubation, indicating 25 June as the day" exact="plague" post="contagion arrived. If this infective flea or another flea"/>
   <result pre="period, is a characteristic feature and defining feature of rat-based-rat-flea-borne" exact="bubonic plague" post="[12]. In this case, the latency period is followed"/>
   <result pre="is a characteristic feature and defining feature of rat-based-rat-flea-borne bubonic" exact="plague" post="[12]. In this case, the latency period is followed"/>
   <result pre="the slow and â€œsputteringâ€� development of the endemic phase of" exact="bubonic plague," post="reflecting the early epizootic phase in the rat colonies"/>
   <result pre="instance, whether the form of the epidemic could conform to" exact="bubonic plague," post="which could not be performed by model, only by"/>
   <result pre="epidemiological evidence supporting the notion that the disease was ordinary" exact="bubonic plague." post="The slowly developing early epidemic phase in August with"/>
   <result pre="lice. Without alternative empirical-based explanation, this usual epidemic pattern of" exact="bubonic plague" post="invalidates their model-based hypothesis (see below). The inverse correlation"/>
   <result pre="Without alternative empirical-based explanation, this usual epidemic pattern of bubonic" exact="plague" post="invalidates their model-based hypothesis (see below). The inverse correlation"/>
   <result pre="and the latency period are two defining features of rat-and-rat-flea-borne" exact="bubonic plague" post="that can be identified by the individualized study of"/>
   <result pre="the latency period are two defining features of rat-and-rat-flea-borne bubonic" exact="plague" post="that can be identified by the individualized study of"/>
   <result pre="J. G. Dijkstra, which reveals the specific pattern of rat-and-rat-flea-borne" exact="bubonic plague" post="[47, 48]. 5.2. Clinical Features as Evidence The Filoviridae"/>
   <result pre="G. Dijkstra, which reveals the specific pattern of rat-and-rat-flea-borne bubonic" exact="plague" post="[47, 48]. 5.2. Clinical Features as Evidence The Filoviridae"/>
   <result pre="refer to any known case. In contrast, human cases of" exact="bubonic plague" post="normally exhibit buboes both in modern and historical plague,"/>
   <result pre="to any known case. In contrast, human cases of bubonic" exact="plague" post="normally exhibit buboes both in modern and historical plague,"/>
   <result pre="system. Buboes are described as a normal clinical feature of" exact="plague" post="in connection with the siege of Kaffa from where"/>
   <result pre="arriving with goods from Genoa. Recently, a paleobiological study of" exact="plague" post="graves from the Black Death near Genoa identified Y."/>
   <result pre="bodily locations, beginning with Guy de Chauliac's clinical description of" exact="plague" post="cases in Avignon [50]. From Avignon, the spread of"/>
   <result pre="Death which identified persons who had been miraculously healed from" exact="plague" post="disease by intercessory prayer to St. Remi, the city's"/>
   <result pre="on normalcy and locations of buboes is consistent with modern" exact="bubonic plague," post="only with bubonic plague and is, thus, a defining"/>
   <result pre="of buboes is consistent with modern bubonic plague, only with" exact="bubonic plague" post="and is, thus, a defining feature of bubonic plague"/>
   <result pre="buboes is consistent with modern bubonic plague, only with bubonic" exact="plague" post="and is, thus, a defining feature of bubonic plague"/>
   <result pre="with bubonic plague and is, thus, a defining feature of" exact="bubonic plague" post="[12, 52]. Dubois sums up the two central aspects"/>
   <result pre="bubonic plague and is, thus, a defining feature of bubonic" exact="plague" post="[12, 52]. Dubois sums up the two central aspects"/>
   <result pre="It is characterized by two features: (1) â€œalmost everywhere, the" exact="plague" post="has shown the bubonic form with secondary manifestationsâ€�; (2)"/>
   <result pre="the springâ€� [52]. These features are defining features of rat-and-rat-flea-borne" exact="bubonic plague" post="[12]. There are other clinical features which could be"/>
   <result pre="springâ€� [52]. These features are defining features of rat-and-rat-flea-borne bubonic" exact="plague" post="[12]. There are other clinical features which could be"/>
   <result pre="that they had proved with the Reedâ€&quot;Frost model that historical" exact="plague" post="had a very long incubation period of 32â€&quot;34â€‰days with"/>
   <result pre="during the 5â€‰days of illness. In all, historical cases of" exact="plague" post="disease purportedly lasted 37â€&quot;39â€‰days of which the diseased were"/>
   <result pre="that Black Death was a different kind of epidemic than" exact="bubonic plague." post="No damaging hard evidence has been found against the"/>
   <result pre="(SIR) model, and apparent scholarly distance to modern research on" exact="bubonic plague" post="and Filoviridae disease. They are incompatible with a full-scale"/>
   <result pre="model, and apparent scholarly distance to modern research on bubonic" exact="plague" post="and Filoviridae disease. They are incompatible with a full-scale"/>
   <result pre="containing, inter alia, 12 studies of biological material obtained in" exact="plague" post="graves or pits which with probability or certainty related"/>
   <result pre="of 45 biomolecular studies of skeletal material obtained in putative" exact="plague" post="graves or burial pits in 40 different localities and"/>
   <result pre="allegedly produced strong evidence that the Black Death and historical" exact="plague" post="was not bubonic plague caused by transmission of the"/>
   <result pre="evidence that the Black Death and historical plague was not" exact="bubonic plague" post="caused by transmission of the bacterium Y. pestis by"/>
   <result pre="that the Black Death and historical plague was not bubonic" exact="plague" post="caused by transmission of the bacterium Y. pestis by"/>
   <result pre="synthesis of the paleobiological studies of biological material from historical" exact="plague" post="graves was presented and in 2016 an updated version"/>
   <result pre="an updated version [12, 54]. These syntheses showed that paleobiological" exact="plague" post="studies had become so numerous, covered such a wide"/>
   <result pre="were so consistent in their identification of Yersinia pestis, the" exact="plague" post="bacterium, that alternative microbiological theories were excluded. The new"/>
   <result pre="scientific discipline had definitely confirmed the results of conventional historical" exact="plague" post="studies [28, 54â€&quot;56]. Nonetheless, a few years later, it"/>
   <result pre="adapted for their use and used to prove that historical" exact="plague" post="was a Filoviridae disease, had become an alternative by"/>
   <result pre="thesis for the degree of Master of Science called Modelling" exact="plague" post="transmission in Medieval European cities [7] at CEES of"/>
   <result pre="Christakos found between pre-plague city size and the duration of" exact="plague" post="epidemics during the Black Death [30] formed the basis"/>
   <result pre="model, according to Christakos et al., allegedly invalidated that historical" exact="plague" post="could have been bubonic plague. Instead, it allegedly proved"/>
   <result pre="et al., allegedly invalidated that historical plague could have been" exact="bubonic plague." post="Instead, it allegedly proved that the Black Death and"/>
   <result pre="Instead, it allegedly proved that the Black Death and later" exact="plague" post="epidemics of the second pandemic were an entirely different"/>
   <result pre="entirely different conclusion, namely, that the Black Death and later" exact="plague" post="epidemics of the second pandemic were not a Filoviridae"/>
   <result pre="by direct infection of contaminated living cells but was indeed" exact="bubonic plague," post="caused by the bacterium Y. pestis and (purportedly) transmitted"/>
   <result pre="instance, in her statement that it contains a dataset of" exact="plague" post="outbreaks in 53 cities that purportedly, without (superfluous) support"/>
   <result pre="examples of SIR models with presentations of mortality data from" exact="plague" post="epidemics based on purported correct historical information. However, these"/>
   <result pre="includes also the reuse of Christakos et al.'s model of" exact="plague" post="deaths in Givry by month, purportedly with an entirely"/>
   <result pre="to the number of deaths per week for the 1905-06" exact="plague" post="epidemic in Bombay.â€� However, Dean uses Christakos et al.'s"/>
   <result pre="with the human ectoparasite theory but easily compatible with rat-based-flea-borne" exact="bubonic plague" post="and as such a defining feature of this modality"/>
   <result pre="the human ectoparasite theory but easily compatible with rat-based-flea-borne bubonic" exact="plague" post="and as such a defining feature of this modality"/>
   <result pre="that, in Mumbai, â€œplague in man is a reflection of" exact="plague" post="in ratsâ€� and insert this crucial condition together with"/>
   <result pre="a substantial number of studies, in relation to, e.g., the" exact="plague" post="epidemics in the East Devon town of Colyton in"/>
   <result pre="1665-66, in studies of five streets in Bristol in the" exact="plague" post="epidemics of 1575 and 1603, and in the district"/>
   <result pre="In the latter study, the patterns of spread of the" exact="plague" post="epidemics of 1617 and 1624, according to individualized burials"/>
   <result pre="pattern of local distribution of deaths caused by the (â€œSpanishâ€�)" exact="influenza" post="epidemic in the same and quite unchanged district in"/>
   <result pre="the disparate and highly distinct patterns of spread of rat-and-rat-flea-borne" exact="plague" post="and spread of flu by interhuman cross infection with"/>
   <result pre="this very best approach produced conclusive epidemiological evidence that the" exact="plague" post="epidemics were rat-and-rat-flea-borne bubonic plague. The presumption or hypothesis"/>
   <result pre="produced conclusive epidemiological evidence that the plague epidemics were rat-and-rat-flea-borne" exact="bubonic plague." post="The presumption or hypothesis that infectious or contagious diseases"/>
   <result pre="Whittles and Didelot published a new study of the 1665-66" exact="plague" post="epidemic in the village/township of Eyam using a SEIR"/>
   <result pre="by Christakos et al. and supported their finding that historical" exact="plague" post="was a Filoviridae Ebola or Marburg disease (see above)."/>
   <result pre="problems and the fallacious implications for the epidemiological study of" exact="plague" post="epidemics when it is clear, among other things, that"/>
   <result pre="plague epidemics when it is clear, among other things, that" exact="plague" post="is a bacterial disease transmitted by hematophagous insects as"/>
   <result pre="it is clear, among other things, that plague is a" exact="bacterial disease" post="transmitted by hematophagous insects as intermediary agents and with"/>
   <result pre="enough new susceptible people.â€� As pointed out earlier, survival of" exact="bubonic plague" post="confers only a brief and weak immunity, as is"/>
   <result pre="new susceptible people.â€� As pointed out earlier, survival of bubonic" exact="plague" post="confers only a brief and weak immunity, as is"/>
   <result pre="that historical sources record many cases where a person contracts" exact="plague" post="twice and also three times in the same epidemic"/>
   <result pre="which seemingly eliminates immunity as an issue. However, in historical" exact="plague" post="epidemics as well as in modern plague in early"/>
   <result pre="However, in historical plague epidemics as well as in modern" exact="plague" post="in early developing countries roughly around a hundred years"/>
   <result pre="the huge amount of accumulated medical and historical data on" exact="bubonic plague" post="which is needed for adequate empirical testing of the"/>
   <result pre="huge amount of accumulated medical and historical data on bubonic" exact="plague" post="which is needed for adequate empirical testing of the"/>
   <result pre="not consult any of the outstanding medical standard works on" exact="bubonic plague" post="for empirical data, in this case on the duration"/>
   <result pre="consult any of the outstanding medical standard works on bubonic" exact="plague" post="for empirical data, in this case on the duration"/>
   <result pre="cf. 59] is unwarranted and shows unfamiliarity with primary empirical" exact="plague" post="research [11]. As other recent users of S(E)IR models"/>
   <result pre="have had to consider the results of paleobiological studies of" exact="plague" post="victims of the past, Whittle and Didelot accept that"/>
   <result pre="the past, Whittle and Didelot accept that the epidemic is" exact="bubonic plague" post="but also conclude emphatically that their model engenders â€œconclusive"/>
   <result pre="past, Whittle and Didelot accept that the epidemic is bubonic" exact="plague" post="but also conclude emphatically that their model engenders â€œconclusive"/>
   <result pre="that interhuman transmission played a predominant role also in the" exact="plague" post="epidemic at Eyam. This should according to methodological principles"/>
   <result pre="should include the prevalence and levels of bacteraemia in human" exact="plague" post="cases which would determine the possible prevalence and level"/>
   <result pre="Didelot do not really relate to the question of human" exact="plague" post="bacteraemia. As for the necessary condition of a viable"/>
   <result pre="As mentioned above, this hypothesis has been invalidated for human" exact="plague" post="and may be significant only in highly susceptible rodent"/>
   <result pre="demographic epidemiological analysis in the article. Previous studies of the" exact="plague" post="epidemic in Eyam are entered in References, but Whittles"/>
   <result pre="not mention that, over a generation ago, Bradley studied the" exact="plague" post="epidemic in Eyam on the basis of a professional"/>
   <result pre="that the epidemiological analysis shows the characteristic features of rat-based-rat-flea-borne" exact="bubonic plague" post="[64]. 10.3. Demographic Analysis of the Epidemic in Eyam"/>
   <result pre="the epidemiological analysis shows the characteristic features of rat-based-rat-flea-borne bubonic" exact="plague" post="[64]. 10.3. Demographic Analysis of the Epidemic in Eyam"/>
   <result pre="information in the burial register in temporal perspective. The first" exact="plague" post="victim was interred on 7 September after 3â€‰days of"/>
   <result pre="have been infected on about 30 August, and the second" exact="plague" post="burial occurred on 22 September, 15â€‰days later. This period"/>
   <result pre="assumption. Instead, the period of delay fits nicely with rat-and-rat-flea-borne" exact="plague" post="where the flea causing the first infection or another"/>
   <result pre="Death epidemic in Givry, the 23â€‰days elapsing between the first" exact="plague" post="case and the second represent proof of the initial"/>
   <result pre="proof of the initial phase of an epidemic of rat-and-rat-flea-borne" exact="bubonic plague." post="The Indian Plague Research Commission (IPRC) early established that"/>
   <result pre="spring months are incompatible with notions of interhuman transmission of" exact="plague" post="because it includes too long intervals without spread of"/>
   <result pre="spread of infection and new victims. There is, e.g., no" exact="plague" post="burial between 1 and 15 and 28 of January"/>
   <result pre="disappearance of the epidemic are also not compatible with louse-borne" exact="plague" post="which Whittles and Didelot, like Dean and Dean et"/>
   <result pre="Dean and Dean et al., include as important agents of" exact="plague" post="transmission [8]. Wintry weather should strengthen human-to-human cross infection"/>
   <result pre="the main reasons louse-borne rickettsial epidemic diseases, such as exanthematic" exact="typhus" post="and quintan fever (trench fever), display strong powers of"/>
   <result pre="tenable, which they evidently are not. The steep fall in" exact="plague" post="cases with the advent of cold weather should acutely"/>
   <result pre="cold weather should acutely raise the questions of whether human" exact="plague" post="cases actually functioned as sources of potential lethal doses"/>
   <result pre="and fleas. All advocates of the human ectoparasite theory of" exact="plague" post="transmission have in common that they avoid raising this"/>
   <result pre="It is not correct that this seasonal pattern of a" exact="plague" post="epidemic, the sharp decline with cold weather followed by"/>
   <result pre="a unique case [8]. This is the typical feature of" exact="plague" post="epidemics that break out in the autumn and do"/>
   <result pre="[12]. This argument is evidence of deficient knowledge of historical" exact="plague" post="epidemics. As fur fleas, rat fleas enjoy a comfortable"/>
   <result pre="Whittles and Didelot, but that the prevalence and levels of" exact="plague" post="bacteraemia in rats sharply decline when temperatures fall below"/>
   <result pre="about 10Â°C. For this reason, the rates and levels of" exact="plague" post="infection acquired by feeding rat fleas fall steeply, and"/>
   <result pre="extinguished) [26, 68, 69]. For this reason, the transseasonality of" exact="bubonic plague" post="is also a unique and defining feature of rat-based-rat-flea-borne"/>
   <result pre="[26, 68, 69]. For this reason, the transseasonality of bubonic" exact="plague" post="is also a unique and defining feature of rat-based-rat-flea-borne"/>
   <result pre="plague is also a unique and defining feature of rat-based-rat-flea-borne" exact="bubonic plague" post="[12]. 11. The Functions of Human Plague Cases as"/>
   <result pre="is also a unique and defining feature of rat-based-rat-flea-borne bubonic" exact="plague" post="[12]. 11. The Functions of Human Plague Cases as"/>
   <result pre="human fleas and lice were the predominant vectors of the" exact="plague" post="epidemics of the past, for instance, Dean, Whittles and"/>
   <result pre="and human fleas have been found to be infected by" exact="plague" post="bacteria after having fed on human plague patients with"/>
   <result pre="be infected by plague bacteria after having fed on human" exact="plague" post="patients with bacteraemia, i.e., with plague bacteria in the"/>
   <result pre="having fed on human plague patients with bacteraemia, i.e., with" exact="plague" post="bacteria in the blood stream. Evidently, this does not"/>
   <result pre="[71], a former leader of the French research effort on" exact="plague" post="in Madagascar in the capacity of director of the"/>
   <result pre="ants, beetles, and cockroaches which have ingested bloody cough from" exact="pneumonic plague" post="patients or other plague material become infected but no"/>
   <result pre="beetles, and cockroaches which have ingested bloody cough from pneumonic" exact="plague" post="patients or other plague material become infected but no"/>
   <result pre="have ingested bloody cough from pneumonic plague patients or other" exact="plague" post="material become infected but no one has argued that"/>
   <result pre="one has argued that they function as (significant) vectors of" exact="plague" post="contagion [11, 40]. The fact that insects feeding on"/>
   <result pre="and cannot serve as evidence of a vectorial capacity for" exact="plague" post="disease or transmission of lethal doses. 11.2. Are Human"/>
   <result pre="relation to LD A significant or central vectorial role in" exact="plague" post="epidemics for human fleas and lice are dependent on"/>
   <result pre="are not considered by proponents of human ectoparasite hypotheses of" exact="plague" post="transmission: (1) the prevalence and levels of human plague"/>
   <result pre="of plague transmission: (1) the prevalence and levels of human" exact="plague" post="bacteraemia; (2) the general size of blood meals ingested"/>
   <result pre="human fleas and lice; (3) the consequent number of ingested" exact="plague" post="bacteria; (4) the lethal dose (LD) of plague bacteria"/>
   <result pre="of ingested plague bacteria; (4) the lethal dose (LD) of" exact="plague" post="bacteria for human beings, normally expressed as the number"/>
   <result pre="on these matters in the discussion. Mass studies of human" exact="plague" post="bacteraemia were performed on patients in Mumbai's plague hospitals"/>
   <result pre="of human plague bacteraemia were performed on patients in Mumbai's" exact="plague" post="hospitals around 1900 and several quite large studies by"/>
   <result pre="physicians during the Vietnam War when there were quite big" exact="plague" post="epidemics with 4,500â€&quot;5,600 recorded cases in the three peak"/>
   <result pre="that, respectively, not more than 45% and 30% of human" exact="plague" post="cases developed plague bacteraemia, or conversely that 70â€&quot;55% did"/>
   <result pre="more than 45% and 30% of human plague cases developed" exact="plague" post="bacteraemia, or conversely that 70â€&quot;55% did not and could"/>
   <result pre="272. These studies showed that the huge majority of bacteraemic" exact="plague" post="patients developed only slight levels of bacteraemia and that"/>
   <result pre="must ingest blood containing on the average âˆ¼2440 or âˆ¼5560" exact="plague" post="bacteria/mL, respectively, in order to become infected by 1"/>
   <result pre="plague bacteria/mL, respectively, in order to become infected by 1" exact="plague" post="bacterium, which represents the infection-level divisors or gauges. According"/>
   <result pre="individual measurements of human septicaemia, at least 90% of all" exact="plague" post="patients will not infect a feeding female flea, which"/>
   <result pre="takes by far the largest blood meals, with a single" exact="plague" post="bacterium during the course of plague disease [54]. When"/>
   <result pre="meals, with a single plague bacterium during the course of" exact="plague" post="disease [54]. When fleas ingest sufficiently contaminated blood, bacteria"/>
   <result pre="least 97% of feeding fleas which have fed on human" exact="plague" post="diseased will for all practical purposes be infection free"/>
   <result pre="line of reasoning can be developed further. Among the 272" exact="plague" post="patients who were individually examined for (level of) bacteraemia,"/>
   <result pre="of bacteraemia. By very far, the highest level of human" exact="plague" post="bacteraemia on record is a unique or extreme outlier"/>
   <result pre="statistical outliers, who constitute 2.9% of all individually examined human" exact="plague" post="cases for (level of) bacteraemia, probably represent the normal"/>
   <result pre="implies that 99.6% of all fleas which feed on human" exact="plague" post="cases for all practical purposes will be infection free"/>
   <result pre="meal. This is concordant with the fact that transmission of" exact="plague" post="by human fleas is not observed in large-scale laboratory"/>
   <result pre="laboratory experiments [81]. IPRC noted that Pulex irritans could transmit" exact="plague" post="to healthy guinea pigs if fed on extremely bacteraemic"/>
   <result pre="not known, the mechanism of transmission of lethal doses of" exact="plague" post="bacteria to the guinea pigs was not observed and"/>
   <result pre="remain uncertain [82]. Guinea pigs are, however, exceptionally susceptible to" exact="plague" post="infection, studies show that infection by 1 plague bacterium"/>
   <result pre="susceptible to plague infection, studies show that infection by 1" exact="plague" post="bacterium killed two-thirds of guinea pigs, i.e., LD63â€‰=â€‰1 [10]."/>
   <result pre="[10]. This means that the transmission of lethal doses of" exact="plague" post="infection to these guinea pigs probably occurred by the"/>
   <result pre="parts still soiled with blood containing one or a few" exact="plague" post="bacteria, which would be without significance for human beings."/>
   <result pre="This observation is concordant with the fact that transmission of" exact="bubonic plague" post="by human ectoparasites never has been observed during bubonic"/>
   <result pre="observation is concordant with the fact that transmission of bubonic" exact="plague" post="by human ectoparasites never has been observed during bubonic"/>
   <result pre="bubonic plague by human ectoparasites never has been observed during" exact="bubonic plague" post="epidemics. Plague experiments cannot be performed on human beings"/>
   <result pre="plague by human ectoparasites never has been observed during bubonic" exact="plague" post="epidemics. Plague experiments cannot be performed on human beings"/>
   <result pre="case. 90% of black rats survived primary inoculation with 5,550" exact="plague" post="bacteria, corresponding to LD10, LD50 must be significantly higher."/>
   <result pre="of a species of highly susceptible ground squirrels was 6,070" exact="plague" post="bacteria [54], which arguably could be usable as a"/>
   <result pre="at least 2.7â€‰Ã—â€‰106 or 7.2â€‰Ã—â€‰107â€‰bacteria/mL to ingest this number of" exact="plague" post="bacteria. By a huge margin, this requirement is met"/>
   <result pre="of bacteraemia of 4â€‰Ã—â€‰106 or 0.4% of all 272 human" exact="plague" post="cases individually examined for level of plague bacteraemia. This"/>
   <result pre="all 272 human plague cases individually examined for level of" exact="plague" post="bacteraemia. This evidence also explains that no concrete case"/>
   <result pre="explains that no concrete case of interhuman cross infection of" exact="bubonic plague" post="was observed in the big plague epidemics in India,"/>
   <result pre="that no concrete case of interhuman cross infection of bubonic" exact="plague" post="was observed in the big plague epidemics in India,"/>
   <result pre="cross infection of bubonic plague was observed in the big" exact="plague" post="epidemics in India, China, Java, and Madagascar or in"/>
   <result pre="in Egypt and Vietnam, according to the huge syntheses of" exact="plague" post="studies given in the standard works on plague. This"/>
   <result pre="to advocate an important vectorial role for this ectoparasite in" exact="plague" post="epidemics. Dean and Dean et al. refer for evidence"/>
   <result pre="human lice have also been found to be infected by" exact="plague" post="bacteria after having fed on human plague patients with"/>
   <result pre="be infected by plague bacteria after having fed on human" exact="plague" post="patients with bacteraemia. However, as pointed out, this does"/>
   <result pre="this does not constitute evidence of ingestion of LDs of" exact="plague" post="bacteria or of subsequent development of LDs in the"/>
   <result pre="that each Î¼L of blood contains on the average 1" exact="plague" post="bacterium. This implies that a batch of lice with"/>
   <result pre="in the past 24â€‰hours would altogether be infected by 23" exact="plague" post="bacteria when feeding on a person with a level"/>
   <result pre="level measured only in one of 271 individually studied human" exact="plague" post="cases, albeit with large margins. Also as an approximate"/>
   <result pre="which, in the light of the presented data on human" exact="plague" post="bacteraemia, puts in perspective claims that lice can play"/>
   <result pre="lice can play an important part in the transmission of" exact="bubonic plague," post="a negligible part would be more accurate, as maintained"/>
   <result pre="Blanc and Baltazard neglected to examine the group of 90" exact="plague" post="cases constituting their research material with respect to prevalence"/>
   <result pre="it seems, they withdrew blood from 2 of the 90" exact="plague" post="cases (nos. 4 and 24), who were examined by"/>
   <result pre="the basic and crucial premises of their hypothesis that human" exact="plague" post="cases quite generally develop bacteraemia and at sufficient levels"/>
   <result pre="and âˆ¼15,200 Y. pestis/mL in order to take in 1" exact="plague" post="bacterium, which is the infection gauge or infection-level divisor"/>
   <result pre="lice, respectively. This means that 3 of the 272 human" exact="plague" post="cases examined for level of bacteraemia would infect feeding"/>
   <result pre="inaccurate measurements would infect the feeding female lice with 0â€&quot;&amp;gt;âˆ¼160" exact="plague" post="bacteria, 7 cases with âˆ¼160â€&quot;240 bacteria, and only the"/>
   <result pre="for all practical purposes, will not ingest lethal doses of" exact="plague" post="by feeding on human plague cases and by vast"/>
   <result pre="not ingest lethal doses of plague by feeding on human" exact="plague" post="cases and by vast margins. Because lice feed 3"/>
   <result pre="to preserve virulence during the passage through the hindgut. Defecated" exact="plague" post="bacteria have strongly reduced virulence. Also, â€œthe faeces do"/>
   <result pre="or highly restricted results with respect to possible transmission of" exact="plague" post="bacteria by rubbing faeces into bite wounds or scarified"/>
   <result pre="scarified skin on guinea pigs which are extremely susceptible to" exact="plague" post="infection, according to the lice-typhus model [80, 85, 87],"/>
   <result pre="the very high and stable virulence and also size of" exact="plague" post="bacteria [33]. This stands out in contrast to Rickettsia"/>
   <result pre="through tiny bite wounds has only one-sixth the size of" exact="plague" post="bacteria [54]. This is the reason that human plague"/>
   <result pre="of plague bacteria [54]. This is the reason that human" exact="plague" post="cases normally develop buboes because the contagion is deposited"/>
   <result pre="drained to lymph nodes which swell upon infection. Only human" exact="plague" post="cases who develop secondary bacteraemic plague by leakage of"/>
   <result pre="upon infection. Only human plague cases who develop secondary bacteraemic" exact="plague" post="by leakage of bacteria into the blood stream from"/>
   <result pre="by toxins also display petechia. In contrast, cases of exanthematic" exact="typhus" post="rarely develop buboes while petechia are a regular feature,"/>
   <result pre="Baltazard's poster with considerations on experience with a few rural" exact="plague" post="cases in Morocco in 1941 is mentioned in the"/>
   <result pre="the discussion of the possible role of human lice in" exact="plague" post="transmission. The negative results of fine studies on the"/>
   <result pre="90]. In addition, advocates of an important vectorial role in" exact="plague" post="epidemics for human lice also refer to a more"/>
   <result pre="were fed on rabbits inoculated with 109â€‰cfu (colony-forming units) of" exact="plague" post="bacteria without relating to the questions whether transmission of"/>
   <result pre="the questions whether transmission of such a huge load of" exact="plague" post="bacteria occurs in nature, the usual size of infections"/>
   <result pre="rabbits, and the relative incidence of possible consequent transmission of" exact="plague" post="by lice. Another matter is the relevance of the"/>
   <result pre="without a real consideration of the experiments' relationship with human" exact="plague" post="bacteraemia which would be the source of infection in"/>
   <result pre="plague bacteraemia which would be the source of infection in" exact="plague" post="epidemics, only in a highly selective and unrepresentative manner."/>
   <result pre="the fact that the LD63 of guinea pigs is 1" exact="plague" post="bacterium; when fleas were introduced, the epizootic, once started,"/>
   <result pre="[92]. The IPRC also studied the prevalence and level of" exact="plague" post="bacteraemia in black rats [93], data which also could"/>
   <result pre="epidemic plague. Houhamdi et al. used bacterial strains of the" exact="plague" post="â€œbiovar Orientalisâ€� [91], which has been shown not be"/>
   <result pre="for invalidation of the paper. The prevalence and levels of" exact="plague" post="bacteraemia among black rats are hugely different from human"/>
   <result pre="plague bacteraemia among black rats are hugely different from human" exact="plague" post="bacteraemia: rats (and guinea pigs) generally develop nearly 1000"/>
   <result pre="bacteraemia and are comparable, which only a minority of human" exact="plague" post="cases does. In reality, therefore, the real difference is"/>
   <result pre="infection of feeding fleas and lice in comparison with human" exact="plague" post="cases. A large proportion of plague-diseased rats will infect"/>
   <result pre="of plague-diseased rats will infect feeding fleas with numbers of" exact="plague" post="bacteria conducive to formation of blockage/biofilm [93], which is"/>
   <result pre="role for human fleas and/or lice in the transmission of" exact="bubonic plague," post="also for a tiny role. There are also other"/>
   <result pre="role for human fleas or lice in the epidemiology of" exact="plague" post="[54]. This explains that not any of the authors"/>
   <result pre="who also have in common a life-long combat of big" exact="plague" post="epidemics in various early developing countries, in the field"/>
   <result pre="do not attempt to explain how hypothesized lethal doses of" exact="plague" post="bacteria from a preceding feed should be transmitted against"/>
   <result pre="early-phase transmission has been invalidated as a significant factor in" exact="plague" post="epidemics. Taken together, this leaves them without substantiating evidence"/>
   <result pre="leaves them without substantiating evidence on the presumption on human" exact="plague" post="bacteraemia as sufficient source of lethal bacterial doses and"/>
   <result pre="bacterial doses and without a functional means of transmission of" exact="plague" post="infection. This means not only that the analysed use"/>
   <result pre="that human ectoparasites could play an important role in the" exact="plague" post="epidemics of the past. Dean states, e.g., that â€œWith"/>
   <result pre="that â€œMathematical modelling can provide strong insight into mechanisms of" exact="plague" post="transmission for past epidemics,â€� which indicates a clear empirical"/>
   <result pre="demographers, to test the epidemiological and microbiological character of the" exact="plague" post="epidemic in Colyton (Devon, England) in 1645-46 on the"/>
   <result pre="convincing grounds that it displayed the characteristic features of rat-based-rat-flea-borne" exact="bubonic plague" post="[54, 58]. 13. Conclusions: The Uses and Limits of"/>
   <result pre="grounds that it displayed the characteristic features of rat-based-rat-flea-borne bubonic" exact="plague" post="[54, 58]. 13. Conclusions: The Uses and Limits of"/>
   <result pre="the dynamics of spread of the Black Death and subsequent" exact="plague" post="epidemics of the Second Plague Pandemic (1346-c. 1690). Using"/>
   <result pre="identified two entirely different diseases, also different from the rat-and-rat-flea-borne" exact="bubonic plague" post="presented in the standard works on plague: historical plague"/>
   <result pre="two entirely different diseases, also different from the rat-and-rat-flea-borne bubonic" exact="plague" post="presented in the standard works on plague: historical plague"/>
   <result pre="bubonic plague presented in the standard works on plague: historical" exact="plague" post="(1) was a Filoviridae disease (e.g., Ebola disease); (2)"/>
   <result pre="(1) was a Filoviridae disease (e.g., Ebola disease); (2) a" exact="bacterial disease" post="caused by the bacterium Yersinia pestis transmitted by inter-human"/>
   <result pre="to â€œproveâ€� or corroborate incompatible theories, in casu that historical" exact="plague" post="was two entirely different diseases, something must be fundamentally"/>
   <result pre="means that these models will malfunction if the studied historical" exact="plague" post="epidemics were bacterial, e.g., caused by Y. pestis, and/or"/>
   <result pre="of the use of these models with respect to historical" exact="plague" post="epidemics can be empirically tested: (1) Paleobiological studies consistently"/>
   <result pre="be empirically tested: (1) Paleobiological studies consistently show that historical" exact="plague" post="was caused by the conventional plague bacterium Y. pestis"/>
   <result pre="consistently show that historical plague was caused by the conventional" exact="plague" post="bacterium Y. pestis [54, Ch. 1.5; 12, Ch. 10]."/>
   <result pre="Studies of the prevalence and levels of bacteraemia in human" exact="plague" post="cases show that they cannot serve as sources of"/>
   <result pre="ectoparasites that can enable them to transmit lethal doses of" exact="plague" post="except in exceedingly rare cases, irrespective of the hypothesis"/>
   <result pre="show that human fleas normally hardly have vector capacity for" exact="plague" post="infection and potentially can transmit plague only exceedingly rarely."/>
   <result pre="have vector capacity for plague infection and potentially can transmit" exact="plague" post="only exceedingly rarely. (4) The proposed role of ETP"/>
   <result pre="evidence which can explain that all scholarly studies of historical" exact="plague" post="epidemics by use of mathematical epidemiological S(E)IR models have"/>
   <result pre="to identify the microbial agent and epidemiological dynamics of the" exact="plague" post="epidemics of the past and indicate completely different diseases"/>
   <result pre="that plague-infected black rats have a prevalence and levels of" exact="plague" post="bacteraemia that make them extremely good sources for heavy"/>
   <result pre="fleas that can enable them to transmit lethal doses of" exact="plague" post="bacteria. (6) Laboratory studies show that the black-rat flea"/>
   <result pre="of lethal doses of plague. (7) The historical study of" exact="plague" post="epidemics, for instance, the complete history of the Black"/>
   <result pre="display the characteristic patterns of seasonality and spread of rat-and-rat-flea-borne" exact="plague" post="of Y. pestis [12, 28, 54]. This is in"/>
   <result pre="This is in complete concordance with the standard works on" exact="plague" post="and also the historical views provided by diachronic historical"/>
   <result pre="models in this article shows why they malfunction in historical" exact="plague" post="studies and confirmed the limitations in the range of"/>
   <result pre="use of mathematical S(E)IR models in the study of historical" exact="plague" post="epidemics is also analysed on the basis of the"/>
   <result pre="Epidemic Modelling: The Case of Black Death2005Berlin, GermanySpringer 7DeanK. R.Modeling" exact="plague" post="transmission in medieval European cities2015Oslo, NorwayCEES, University of OsloM.S."/>
   <result pre="University of OsloM.S. thesis 8WhittlesL. K.DidelotX.Epidemiological analysis of the Eyam" exact="plague" post="outbreak of 1665-1666Proceedings of the Royal Society B: Biological"/>
   <result pre="Biological Sciences201628318301910.1098/rspb.2016.0618 9DeanK. R.KrauerF.WallÃ¸eL.et al.Human ectoparasites and the spread of" exact="plague" post="in Europe during the second pandemicProceedings of the National"/>
   <result pre="the spatiotemporal modelling and comparative analysis of Black Death and" exact="bubonic plague" post="epidemicsPublic Health2007121970072010.1016/j.puhe.2006.12.01117544041 35https://dictionary.cambridge.org/dictionary/english/village,town,city,metropolis,urban 36BurnetF. M.WhiteD. O.Natural History of Infectious"/>
   <result pre="spatiotemporal modelling and comparative analysis of Black Death and bubonic" exact="plague" post="epidemicsPublic Health2007121970072010.1016/j.puhe.2006.12.01117544041 35https://dictionary.cambridge.org/dictionary/english/village,town,city,metropolis,urban 36BurnetF. M.WhiteD. O.Natural History of Infectious"/>
   <result pre="Research CommissionReports on Plague Investigations in India XLVGreenwoodM.Statistical investigation of" exact="plague" post="in the Punjab, third report: on some of the"/>
   <result pre="the prevalence of plagueJournal of Hygiene1911116215620474479 39BenedictowO. J.Morbidity in historical" exact="plague" post="epidemicsPopulation Studies198741340143110.1080/003247203100014297611612345 40PollitzerR.MeyerK. F.MayJ. M.The ecology of plagueStudies in"/>
   <result pre="Journal of Medicine20153721404710.1056/NEJMoa141124925372658 45collab: Indian Plague Research Commission Reports on" exact="plague" post="investigations in India, XXIIThe epidemiological observations made by the"/>
   <result pre="spread of the Black Death in Italy: first evidence of" exact="plague" post="victims from 14th-century Liguria (Northern Italy)Anthropological Science20171251152410.1537/ase.161011 50JoubertL.Chirurgia Magna"/>
   <result pre="famous of all English plagues: a detailed analysis of the" exact="plague" post="at Eyam 1665-6The Plague Reconsidered1977Derbyshire, UKLocal Population Studies, Matlock6394"/>
   <result pre="17 Jahrhundert, insbesondere in der Stadt Uelzen1954Uelzen, GermanyBecker Verlag 61The" exact="plague" post="reconsidered: a new look at its origins and effects"/>
   <result pre="case of Nonantola (Northern Italy) in 1630Population Studies201873110111810.1080/00324728.2018.145779429770727 64ColemanM. P.A" exact="plague" post="epidemic in voluntary quarantineInternational Journal of Epidemiology198615337938510.1093/ije/15.3.3793533810 65ShrewsburyJ. F."/>
   <result pre="on Plague Investigations in India, XXOn the seasonal prevalence of" exact="plague" post="in IndiaJournal of Hygiene19088226630110.1017/s002217240000331420474359 69SealS. C.Epidemiological studies of plague"/>
   <result pre="of plague in IndiaJournal of Hygiene19088226630110.1017/s002217240000331420474359 69SealS. C.Epidemiological studies of" exact="plague" post="in IndiaBulletin of the World Health Organization1969232-3283292 70BlancG.BaltazardM.RÃ´le de"/>
   <result pre="and inoculation tests for infectionPublic Health Reports (1896â€&quot;1970)193954321467148110.2307/4582984 81BurroughsA. L.Sylvatic" exact="plague" post="studies: the vector efficiency of nine species of fleas"/>
   <result pre="Plague Investigations in India, XVFurther observations on the transmission of" exact="plague" post="by fleas, with special reference to the fate of"/>
   <result pre="by fleas, with special reference to the fate of the" exact="plague" post="bacillus in the body of the rat flea (P."/>
   <result pre="LXIIBacotA. W.MartinC. J.Observations on the mechanism of the transmission of" exact="plague" post="by fleasJournal of Hygiene, Plague Supplement III191414423439 87HinnebuschB. J.ChouikhaI.SunY.-C.Ecological"/>
   <result pre="Yersinia pestis hemin storage (hms) locus in the transmission of" exact="plague" post="by fleasScience1996273527336737010.1126/science.273.5273.3678662526 89LorangeE. A.RaceB. L.SebbaneF.Joseph HinnebuschB.Poor vector competence of"/>
   <result pre="Investigations in India, I Part threeExperiments upon the transmission of" exact="plague" post="by fleasJournal of Hygiene1906645046720474277 93collab: Indian Plague Research Commission,"/>
   <result pre="Reports on Plague Investigations in India, VIIIOn the number of" exact="plague" post="bacilli in the blood, urine, and faeces respectively of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6721381\results\search\disease\results.xml">
   <result pre="Hemorrhagic fever with renal syndrome (HFRS) is an emerging zoonotic" exact="infectious disease" post="caused by hantaviruses which circulate worldwide. So far, it"/>
   <result pre="Hemorrhagic fever with renal syndrome (HFRS) is an emerging zoonotic" exact="infectious disease" post="caused by hantaviruses which circulate worldwide posing the ongoing"/>
   <result pre="Thus, more attention need to be paid cause this zoonotic" exact="infectious disease" post="has killed too many people and made severe adverse"/>
   <result pre="Virol20088061033104110.1002/jmv.2114918428127 13.LiQCaiYWeiYHanXHanZZhangYQiSXuYGenovariation study of hantavirus in main endemic areas of" exact="hemorrhagic fever with renal syndrome" post="in Hebei Province, ChinaPLoS One2016117e015973110.1371/journal.pone.015973127442527 14.YangWLiZLanYWangJMaJJinLSunQLvWLaiSLiaoYet al.A nationwide web-based"/>
   <result pre="datasetsMol Biol Evol20163371870187410.1093/molbev/msw05427004904 23.LiQZhaoWWeiYHanXHanZZhangYQiSXuYAnalysis of incidence and related factors of" exact="hemorrhagic fever with renal syndrome" post="in Hebei Province, ChinaPLoS One201497e10134810.1371/journal.pone.010134825000390 24.KrugerDHSchonrichGKlempaBHuman pathogenic hantaviruses and"/>
   <result pre="pathogenic hantaviruses and prevention of infectionHum Vaccin20117668569310.4161/hv.7.6.1519721508676 25.ChenHXQiuFXDongBJJiSZLiYTWangYWangHMZuoGFTaoXXGaoSYEpidemiological studies on" exact="hemorrhagic fever with renal syndrome" post="in ChinaJ Infect Dis1986154339439810.1093/infdis/154.3.3942874178 26.ChenHXQiuFXEpidemiologic surveillance on the hemorrhagic"/>
   <result pre="renal syndrome in ChinaJ Infect Dis1986154339439810.1093/infdis/154.3.3942874178 26.ChenHXQiuFXEpidemiologic surveillance on the" exact="hemorrhagic fever with renal syndrome" post="in ChinaChin Med J1993106118578637908258 27.TianHYuPCazellesBXuLTanHYangJHuangSXuBCaiJMaCet al.Interannual cycles of Hantaan"/>
   <result pre="citiesProc Natl Acad Sci U S A2018115184707471210.1073/pnas.171276711529666240 32.HanSSKimSChoiYKimSKimYSAir pollution and" exact="hemorrhagic fever with renal syndrome" post="in South Korea: an ecological correlation studyBMC Public Health20131334710.1186/1471-2458-13-34723587219"/>
   <result pre="studyBMC Public Health20131334710.1186/1471-2458-13-34723587219 33.JiangFWangLWangSZhuLDongLZhangZHaoBYangFLiuWDengYet al.Meteorological factors affect the epidemiology of" exact="hemorrhagic fever with renal syndrome" post="via altering the breeding and hantavirus-carrying states of rodents"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6722215\results\search\disease\results.xml">
   <result pre="which does not comply with these terms. distemper evolution morbillivirus" exact="measles" post="zoonotic disease Funding Departamento Administrativo de Ciencia, TecnologÃ­a e"/>
   <result pre="had become common in Europe (Walker et al., 2015). Multiple" exact="measles" post="epidemics, therefore, devastated the indigenous American populations (Walker et"/>
   <result pre="maternal immunity, and the vaccine has been useful against clinical" exact="measles" post="disease in non-human primates (Christe et al., 2019). Hence,"/>
   <result pre="J. Virol.92:e01248â€&quot;18. 10.1128/JVI.01248-1830232185 BakerJ. A.SheffyB. E.RobsonD. S.GilmartinJ. (1966). Response to" exact="measles" post="virus by puppies with maternally transferred distemper antibodies. Cornell"/>
   <result pre="Med. Vet.29, 35âˆ’41. 15376360 BrownA. L.MccarthyR. E. (1974). Relationship between" exact="measles" post="and canine distemper viruses determined by delayed type hypersensitivity"/>
   <result pre="between measles and canine distemper viruses determined by delayed type" exact="hypersensitivity" post="reactions in dogs. Nature248, 344â€&quot;345. 10.1038/248344a04819642 BrownA. L.VitamvasJ. A.MerryD."/>
   <result pre="from related veterinary viruses and need for continued vaccination post" exact="measles" post="eradication. Hum. Vaccin. Immunother.14, 229â€&quot;233. 10.1080/21645515.2017.140367729173050 De VriesR. D.DuprexW."/>
   <result pre="virus. Mem. Inst. Oswaldo Cruz113:e170385. 10.1590/0074-0276017038529768530 FuruseY.SuzukiA.OshitaniH. (2010). Origin of" exact="measles" post="virus: divergence from rinderpest virus between the 11th and"/>
   <result pre="and 12th centuries. Virol. J.7:52. 10.1186/1743-422X-7-5220202190 GoniN.IriarteA.ComasV.SonoraM.MorenoP.MoratorioG.et al.. (2012). Pandemic" exact="influenza" post="A virus codon usage revisited: biases, adaptation and implications"/>
   <result pre="B.OvsyannikovaI. G.WhitakerJ. A.PolandG. A. (2015). Variability in humoral immunity to" exact="measles" post="vaccine: new developments. Trends Mol. Med.21, 789â€&quot;801. 10.1016/j.molmed.2015.10.00526602762 HolzmannH.HengelH.TenbuschM.DoerrH."/>
   <result pre="marker PVRL4 (nectin 4) is an epithelial cell receptor for" exact="measles" post="virus. PLoS Pathog.7:e1002240. 10.1371/journal.ppat.100224021901103 OhishiK.SuzukiR.MaedaT.TsudaM.AbeE.YoshidaT.et al.. (2014). Recent host"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6723535\results\search\disease\results.xml">
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Aseptic" exact="meningitis" post="is a common viral infection associated with human enteroviruses."/>
   <result pre="characterize the enteroviruses associated with outbreaks and sporadic cases of" exact="aseptic meningitis" post="that occurred in different regions of Brazil between 2013"/>
   <result pre="the enteroviruses associated with outbreaks and sporadic cases of aseptic" exact="meningitis" post="that occurred in different regions of Brazil between 2013"/>
   <result pre="children â‰¤ 15 years old. The temporal distribution of all" exact="aseptic meningitis" post="and EV-positive cases showed an obvious seasonal pattern during"/>
   <result pre="â‰¤ 15 years old. The temporal distribution of all aseptic" exact="meningitis" post="and EV-positive cases showed an obvious seasonal pattern during"/>
   <result pre="have provided valuable information about the enteroviral etiology of the" exact="aseptic meningitis" post="cases in Brazil pointing to the importance of enterovirus"/>
   <result pre="provided valuable information about the enteroviral etiology of the aseptic" exact="meningitis" post="cases in Brazil pointing to the importance of enterovirus"/>
   <result pre="pointing to the importance of enterovirus surveillance in neurological diseases." exact="aseptic meningitis" post="enterovirus echovirus-30 echovirus-6 1. Introduction Human enteroviruses (EV) are"/>
   <result pre="to the importance of enterovirus surveillance in neurological diseases. aseptic" exact="meningitis" post="enterovirus echovirus-30 echovirus-6 1. Introduction Human enteroviruses (EV) are"/>
   <result pre="associated with a broad spectrum of clinical presentations such as" exact="hand, foot, and mouth disease," post="acute myalgia, herpangina, conjunctivitis, upper and lower respiratory disease"/>
   <result pre="broad spectrum of clinical presentations such as hand, foot, and" exact="mouth disease," post="acute myalgia, herpangina, conjunctivitis, upper and lower respiratory disease"/>
   <result pre="and mouth disease, acute myalgia, herpangina, conjunctivitis, upper and lower" exact="respiratory disease" post="and severe syndromes of the central nervous system (CNS)"/>
   <result pre="CNS, it is worth mentioning encephalitis, acute flaccid paralysis, paralytic" exact="myelitis" post="and aseptic meningitis [1]. Aseptic meningitis is defined as"/>
   <result pre="is worth mentioning encephalitis, acute flaccid paralysis, paralytic myelitis and" exact="aseptic meningitis" post="[1]. Aseptic meningitis is defined as a non-bacterial acute"/>
   <result pre="worth mentioning encephalitis, acute flaccid paralysis, paralytic myelitis and aseptic" exact="meningitis" post="[1]. Aseptic meningitis is defined as a non-bacterial acute"/>
   <result pre="acute flaccid paralysis, paralytic myelitis and aseptic meningitis [1]. Aseptic" exact="meningitis" post="is defined as a non-bacterial acute infectious disease of"/>
   <result pre="meningitis [1]. Aseptic meningitis is defined as a non-bacterial acute" exact="infectious disease" post="of the tissue that covers the brain and spinal"/>
   <result pre="most common viral infection of the CNS. The majority of" exact="aseptic meningitis" post="cases are caused by non-polio enteroviruses, although other infectious"/>
   <result pre="common viral infection of the CNS. The majority of aseptic" exact="meningitis" post="cases are caused by non-polio enteroviruses, although other infectious"/>
   <result pre="of the meninges [3]. The common symptoms in patients with" exact="viral meningitis" post="can vary with age and underlying immune state, but"/>
   <result pre="the meninges [3]. The common symptoms in patients with viral" exact="meningitis" post="can vary with age and underlying immune state, but"/>
   <result pre="limited number of investigations on EV that are associated with" exact="aseptic meningitis" post="outbreaks have been reported, such as those related to"/>
   <result pre="number of investigations on EV that are associated with aseptic" exact="meningitis" post="outbreaks have been reported, such as those related to"/>
   <result pre="be necessary to understand the distribution of EV serotypes causing" exact="aseptic meningitis" post="besides their clinical features. The present work aimed to"/>
   <result pre="necessary to understand the distribution of EV serotypes causing aseptic" exact="meningitis" post="besides their clinical features. The present work aimed to"/>
   <result pre="work aimed to identify and characterize the EV associated with" exact="aseptic meningitis" post="outbreaks or sporadic cases in different geographic areas of"/>
   <result pre="aimed to identify and characterize the EV associated with aseptic" exact="meningitis" post="outbreaks or sporadic cases in different geographic areas of"/>
   <result pre="and all laboratorial data obtained from the analysis of 2659" exact="aseptic meningitis" post="suspected cases during this period were included in the"/>
   <result pre="all laboratorial data obtained from the analysis of 2659 aseptic" exact="meningitis" post="suspected cases during this period were included in the"/>
   <result pre="specimens (2532/2659) with sufficient volume were used to inoculate human" exact="rhabdomyosarcoma" post="(RD) and human cervix carcinoma (Hep2C) cell lines as"/>
   <result pre="(RT-PCR) for EV. To identify the EV serotypes associated with" exact="aseptic meningitis," post="viral RNA was extracted from 140 Î¼L of the"/>
   <result pre="Results 3.1. Epidemiological Analysis A total of 2659 cases of" exact="aseptic meningitis" post="were reported from 2013 to 2017 in four geographic"/>
   <result pre="3.1. Epidemiological Analysis A total of 2659 cases of aseptic" exact="meningitis" post="were reported from 2013 to 2017 in four geographic"/>
   <result pre="gender ratio (male/female) was 1.4:1, indicating a higher prevalence of" exact="aseptic meningitis" post="in male children (Table 1). Regarding the EV-positive patients,"/>
   <result pre="ratio (male/female) was 1.4:1, indicating a higher prevalence of aseptic" exact="meningitis" post="in male children (Table 1). Regarding the EV-positive patients,"/>
   <result pre="to 2.2) (Table 1). In general, the age distribution of" exact="aseptic meningitis" post="cases ranged from 1 month to 92 years old"/>
   <result pre="2.2) (Table 1). In general, the age distribution of aseptic" exact="meningitis" post="cases ranged from 1 month to 92 years old"/>
   <result pre="the specimens sent for enterovirus investigation. The monthly distributions of" exact="aseptic meningitis" post="cases are illustrated in Figure 1. Although the number"/>
   <result pre="specimens sent for enterovirus investigation. The monthly distributions of aseptic" exact="meningitis" post="cases are illustrated in Figure 1. Although the number"/>
   <result pre="acids identities and similarity, respectively. 4. Discussion Numerous studies about" exact="aseptic meningitis" post="have been conducted over the last few years and"/>
   <result pre="identities and similarity, respectively. 4. Discussion Numerous studies about aseptic" exact="meningitis" post="have been conducted over the last few years and"/>
   <result pre="this study, we evaluated the epidemiological and virological features of" exact="aseptic meningitis" post="outbreaks/sporadic cases caused by EV from 2013 to 2017"/>
   <result pre="study, we evaluated the epidemiological and virological features of aseptic" exact="meningitis" post="outbreaks/sporadic cases caused by EV from 2013 to 2017"/>
   <result pre="to studies performed in other countries [19,20]. A predominance of" exact="aseptic meningitis" post="among males was observed in this work with an"/>
   <result pre="studies performed in other countries [19,20]. A predominance of aseptic" exact="meningitis" post="among males was observed in this work with an"/>
   <result pre="age of six years old [21,22,23]. Regarding the distribution of" exact="aseptic meningitis" post="cases reported in different geographic areas of Brazil, we"/>
   <result pre="of six years old [21,22,23]. Regarding the distribution of aseptic" exact="meningitis" post="cases reported in different geographic areas of Brazil, we"/>
   <result pre="for more than 80% (2174/2659) of these cases. However, although" exact="aseptic meningitis" post="is a notifiable disease in Brazil many regions do"/>
   <result pre="more than 80% (2174/2659) of these cases. However, although aseptic" exact="meningitis" post="is a notifiable disease in Brazil many regions do"/>
   <result pre="of cases per region. Regarding the seasonal distribution of the" exact="aseptic meningitis" post="cases, some studies in temperate climates have shown that"/>
   <result pre="cases per region. Regarding the seasonal distribution of the aseptic" exact="meningitis" post="cases, some studies in temperate climates have shown that"/>
   <result pre="also occurred in other seasons. Conversely, other studies reported that" exact="aseptic meningitis" post="cases in the southern hemisphere countries occurred more frequently"/>
   <result pre="occurred in other seasons. Conversely, other studies reported that aseptic" exact="meningitis" post="cases in the southern hemisphere countries occurred more frequently"/>
   <result pre="E-6 were considered the major enteroviruses causing epidemics/sporadic cases of" exact="aseptic meningitis" post="around of the world as well as a high"/>
   <result pre="were considered the major enteroviruses causing epidemics/sporadic cases of aseptic" exact="meningitis" post="around of the world as well as a high"/>
   <result pre="we found that E-30 was the main pathogen associated with" exact="aseptic meningitis" post="(102/295; 34.6% of the EV-positive patients) followed by E-6"/>
   <result pre="found that E-30 was the main pathogen associated with aseptic" exact="meningitis" post="(102/295; 34.6% of the EV-positive patients) followed by E-6"/>
   <result pre="shown, these two enteroviruses were commonly observed in co-circulation in" exact="aseptic meningitis" post="cases, enabling the occurrence of the co-infection, which may"/>
   <result pre="these two enteroviruses were commonly observed in co-circulation in aseptic" exact="meningitis" post="cases, enabling the occurrence of the co-infection, which may"/>
   <result pre="of Brazil, E-30 was first described to be involved with" exact="aseptic meningitis" post="outbreaks in Southern Brazil between 1998 and 2003 [27]."/>
   <result pre="Brazil, E-30 was first described to be involved with aseptic" exact="meningitis" post="outbreaks in Southern Brazil between 1998 and 2003 [27]."/>
   <result pre="with E-30 strains from Argentina and USA. Information about E-6-causing" exact="aseptic meningitis" post="in Brazil is scarce. Dos Santos et al. reported"/>
   <result pre="E-30 strains from Argentina and USA. Information about E-6-causing aseptic" exact="meningitis" post="in Brazil is scarce. Dos Santos et al. reported"/>
   <result pre="Santos et al. reported a low incidence of E-6 in" exact="aseptic meningitis" post="outbreaks/sporadic cases in Brazil between 1998 and 2003 [27]."/>
   <result pre="et al. reported a low incidence of E-6 in aseptic" exact="meningitis" post="outbreaks/sporadic cases in Brazil between 1998 and 2003 [27]."/>
   <result pre="a previous study demonstrated the involvement of E-6 in an" exact="aseptic meningitis" post="outbreak that occurred in the SÃ£o Paulo state in"/>
   <result pre="previous study demonstrated the involvement of E-6 in an aseptic" exact="meningitis" post="outbreak that occurred in the SÃ£o Paulo state in"/>
   <result pre="In fact, we identified the increasing occurrence of E-6 in" exact="aseptic meningitis" post="cases in Brazil. In the last years, the number"/>
   <result pre="fact, we identified the increasing occurrence of E-6 in aseptic" exact="meningitis" post="cases in Brazil. In the last years, the number"/>
   <result pre="detection rate. Furthermore, E-6 was the main EV involved in" exact="aseptic meningitis" post="cases identified across 2015 and 2016. Phylogenetic analysis revealed"/>
   <result pre="rate. Furthermore, E-6 was the main EV involved in aseptic" exact="meningitis" post="cases identified across 2015 and 2016. Phylogenetic analysis revealed"/>
   <result pre="agents. Overall, the enteroviral etiology and epidemiologic characteristics involved in" exact="aseptic meningitis" post="in Brazil is similar to that observed around the"/>
   <result pre="Overall, the enteroviral etiology and epidemiologic characteristics involved in aseptic" exact="meningitis" post="in Brazil is similar to that observed around the"/>
   <result pre="the world. E-30 and E-6 are predominant serotypes involved in" exact="aseptic meningitis" post="cases. The Brazilian vast territory associated with recurrent E-6/E-30"/>
   <result pre="world. E-30 and E-6 are predominant serotypes involved in aseptic" exact="meningitis" post="cases. The Brazilian vast territory associated with recurrent E-6/E-30"/>
   <result pre="these viruses showed the importance of enterovirus surveillance in the" exact="aseptic meningitis" post="context. Acknowledgments We would like to acknowledge the collaboration"/>
   <result pre="viruses showed the importance of enterovirus surveillance in the aseptic" exact="meningitis" post="context. Acknowledgments We would like to acknowledge the collaboration"/>
   <result pre="SantosG.P.da CostaE.V.TavaresF.N.da CostaL.J.da SilvaE.E.Genetic diversity of Echovirus 30 involved in" exact="aseptic meningitis" post="cases in Brazil (1998â€&quot;2008)J. Med. Virol.2011832164217110.1002/jmv.2223522012725 5.KmetzschC.I.BalkieE.M.MonteiroA.CostaE.V.dos SantosG.P.da SilvaE.E.Echovirus"/>
   <result pre="CostaE.V.TavaresF.N.da CostaL.J.da SilvaE.E.Genetic diversity of Echovirus 30 involved in aseptic" exact="meningitis" post="cases in Brazil (1998â€&quot;2008)J. Med. Virol.2011832164217110.1002/jmv.2223522012725 5.KmetzschC.I.BalkieE.M.MonteiroA.CostaE.V.dos SantosG.P.da SilvaE.E.Echovirus"/>
   <result pre="cases in Brazil (1998â€&quot;2008)J. Med. Virol.2011832164217110.1002/jmv.2223522012725 5.KmetzschC.I.BalkieE.M.MonteiroA.CostaE.V.dos SantosG.P.da SilvaE.E.Echovirus 13" exact="aseptic meningitis," post="BrazilEmerg. Infect. Dis.2006121289129010.3201/eid1708.05131716977690 6.SousaI.P.Jr.BurlandyF.M.OliveiraS.S.NunesA.M.SousaC.da SilvaE.M.SouzaJ.G.A.de PaulaV.A.OliveiraI.C.M.TavaresF.N.et al.Acute flaccid paralysis"/>
   <result pre="Encephalitis in the United States, 2011â€&quot;2014Clin. Infect. Dis.20176535936310.1093/cid/cix31928419350 19.KimH.J.KangB.HwangS.HongJ.KimK.CheonD.S.Epidemics of" exact="viral meningitis" post="caused by echovirus 6 and 30 in Korea in"/>
   <result pre="in the United States, 2011â€&quot;2014Clin. Infect. Dis.20176535936310.1093/cid/cix31928419350 19.KimH.J.KangB.HwangS.HongJ.KimK.CheonD.S.Epidemics of viral" exact="meningitis" post="caused by echovirus 6 and 30 in Korea in"/>
   <result pre="J.201293810.1186/1743-422X-9-3822336050 20.ChenP.LinbX.LiubG.WangbS.SongbL.TaoZ.XuaA.Analysis of enterovirus types in patients with symptoms of" exact="aseptic meningitis" post="in 2014 in Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human"/>
   <result pre="20.ChenP.LinbX.LiubG.WangbS.SongbL.TaoZ.XuaA.Analysis of enterovirus types in patients with symptoms of aseptic" exact="meningitis" post="in 2014 in Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human"/>
   <result pre="in Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human enteroviruses associated with" exact="aseptic meningitis" post="in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of"/>
   <result pre="Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human enteroviruses associated with aseptic" exact="meningitis" post="in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of"/>
   <result pre="meningitis in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of" exact="aseptic meningitis" post="caused by a distinct lineage of coxsackievirus B5 in"/>
   <result pre="in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of aseptic" exact="meningitis" post="caused by a distinct lineage of coxsackievirus B5 in"/>
   <result pre="2007â€&quot;2013J. Med. Virol.2014861609161310.1002/jmv.2388524474149 26.SmutsH.CronjeS.ThomasJ.BrinkD.KorsmanS.HardieD.Molecular characterization of an outbreak of enterovirus-associated" exact="meningitis" post="in Mossel Bay, South Africa, December 2015â€&quot;January 2016BMC Infect."/>
   <result pre="1998â€&quot;2003J. Med. Virol.2006789810410.1002/jmv.2050916299728 28.Pinto JuniorV.L.RebeloM.C.CostaE.V.SilvaE.E.BÃ³iaM.N.Description of a widespread outbreak of" exact="aseptic meningitis" post="due to echovirus 30 in Rio de Janeiro state,"/>
   <result pre="Med. Virol.2006789810410.1002/jmv.2050916299728 28.Pinto JuniorV.L.RebeloM.C.CostaE.V.SilvaE.E.BÃ³iaM.N.Description of a widespread outbreak of aseptic" exact="meningitis" post="due to echovirus 30 in Rio de Janeiro state,"/>
   <result pre="Janeiro state, BrazilBraz. J. Infect. Dis.20091336737010.1590/S1413-8670200900050001120428638 29.LuchsA.RussoD.H.CilliA.CostaF.F.MorilloS.G.MachadoB.C.PelliniA.C.CarmonaR.C.C.TimenetskyM.C.Echovirus 6 associated to" exact="aseptic meningitis" post="outbreak, in SÃ£o Joaquim da Barra, SÃ£o Paulo, BrazilBraz."/>
   <result pre="state, BrazilBraz. J. Infect. Dis.20091336737010.1590/S1413-8670200900050001120428638 29.LuchsA.RussoD.H.CilliA.CostaF.F.MorilloS.G.MachadoB.C.PelliniA.C.CarmonaR.C.C.TimenetskyM.C.Echovirus 6 associated to aseptic" exact="meningitis" post="outbreak, in SÃ£o Joaquim da Barra, SÃ£o Paulo, BrazilBraz."/>
   <result pre="Enterovirus and EV71-Specific PrimersJ. Clin. Microbiol.2002402823282710.1128/JCM.40.8.2823-2827.200212149336 33.SousaI.P.Jr.BurlandyF.M.CostaE.V.TavaresF.N.da SilvaE.E.Enteroviruses associated with" exact="hand, foot, and mouth disease" post="in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of aseptic"/>
   <result pre="PrimersJ. Clin. Microbiol.2002402823282710.1128/JCM.40.8.2823-2827.200212149336 33.SousaI.P.Jr.BurlandyF.M.CostaE.V.TavaresF.N.da SilvaE.E.Enteroviruses associated with hand, foot, and" exact="mouth disease" post="in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of aseptic"/>
   <result pre="mouth disease in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of" exact="aseptic meningitis" post="cases in Brazil from 2013 to 2017 for all"/>
   <result pre="disease in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of aseptic" exact="meningitis" post="cases in Brazil from 2013 to 2017 for all"/>
   <result pre="Proportion of enterovirus detection based on cell culture isolation in" exact="aseptic meningitis" post="patients. Figure 3 Enterovirus serotypes detected between 2013 and"/>
   <result pre="of enterovirus detection based on cell culture isolation in aseptic" exact="meningitis" post="patients. Figure 3 Enterovirus serotypes detected between 2013 and"/>
   <result pre="Figure 3 Enterovirus serotypes detected between 2013 and 2017 from" exact="aseptic meningitis" post="patients. (A). Enterovirus serotypes identified per year (2013â€&quot;2017). (B)."/>
   <result pre="3 Enterovirus serotypes detected between 2013 and 2017 from aseptic" exact="meningitis" post="patients. (A). Enterovirus serotypes identified per year (2013â€&quot;2017). (B)."/>
   <result pre="and 867 bp in length, respectively) of Brazilian isolates causing" exact="meningitis" post="and other sequences available at the GenBank database. (A)"/>
   <result pre="as a color scale. viruses-11-00690-t001_Table 1Table 1 Demographic features of" exact="aseptic meningitis" post="patients in Brazil, 2013â€&quot;2017. Variable Year (All Patients/EV-Positive) Year"/>
   <result pre="a color scale. viruses-11-00690-t001_Table 1Table 1 Demographic features of aseptic" exact="meningitis" post="patients in Brazil, 2013â€&quot;2017. Variable Year (All Patients/EV-Positive) Year"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6724274\results\search\disease\results.xml">
   <result pre="tract infections are common during early childhood. How they impact" exact="cystic fibrosis" post="lung disease history in young children is poorly known."/>
   <result pre="are common during early childhood. How they impact cystic fibrosis" exact="lung disease" post="history in young children is poorly known. The principal"/>
   <result pre="study was to determinate respiratory tract infections frequency in this" exact="cystic fibrosis" post="young population. Secondary outcomes were nature of viral agents"/>
   <result pre="conducted a prospective cohort study of 25 children affected by" exact="cystic fibrosis" post="and aged less than 2â€‰years. Nasal samplings were taken"/>
   <result pre="tested by a combination of five duplex RT-PCRs or PCRs:" exact="influenza" post="A and B, respiratory syncytial virus (RSV), metapneumovirus (MPV),"/>
   <result pre="mild severity. Conclusions Respiratory tract infections in young children with" exact="cystic fibrosis" post="were of mild severity, rarely requiring hospitalization. Unsurprisingly, RV/EV"/>
   <result pre="improvement in patient care over the last few years, CF-related" exact="lung disease" post="remains the main cause of morbidity-mortality in these patients."/>
   <result pre="tested by a combination of five duplex RT-PCRs or PCRs:" exact="influenza" post="A and B, respiratory syncytial virus (RSV), metapneumovirus (MPV),"/>
   <result pre="None received palivizumab and 22 patients (88%) were vaccinated against" exact="influenza" post="virus. Sixty percent had commensal flora at inclusion. Table"/>
   <result pre="were RV/EV (27/44; 61%), RSV (6/44; 14%), adenovirus (6/44; 14%)," exact="influenza" post="(4/44; 9%), bocavirus (3/44; 7%), parainfluenzae (2/44; 5%) and"/>
   <result pre="with adenovirus (nâ€‰=â€‰2), RSV (nâ€‰=â€‰1), bocavirus (nâ€‰=â€‰1); bocavirus associated with" exact="influenza" post="(nâ€‰=â€‰1), adenovirus (nâ€‰=â€‰1) and adenovirus associated with RSV (nâ€‰=â€‰3)"/>
   <result pre="(nâ€‰=â€‰2), bocavirus (nâ€‰=â€‰2), coronavirus (nâ€‰=â€‰1); bocavirus associated with adenovirus (nâ€‰=â€‰1)," exact="influenza" post="(nâ€‰=â€‰1), cytomegalovirus (nâ€‰=â€‰1) For the six patients presenting a"/>
   <result pre="adenoviruses and metapneumovirus. However, a smaller proportion of RSV and" exact="influenza" post="but a higher proportion of bocavirus and coronavirus were"/>
   <result pre="EwijkBEWilbrinkBet al.Frequency and duration of rhinovirus infections in children with" exact="cystic fibrosis" post="and healthy controls: a longitudinal cohort studyPediatr Infect Dis"/>
   <result pre="10.EtheringtonCNaseerRConwaySPet al.The role of respiratory viruses in adult patients with" exact="cystic fibrosis" post="receiving intravenous antibiotics for a pulmonary exacerbationJ Cyst Fibros2014131495510.1016/j.jcf.2013.06.00423891398"/>
   <result pre="14.HoekRAPaatsMSPasSDet al.Incidence of viral respiratory pathogens causing exacerbations in adult" exact="cystic fibrosis" post="patientsScand J Infect Dis2013451656910.3109/00365548.2012.70894222992129 15.WarkPAToozeMCheeseLWhiteheadBet al.Viral infections trigger exacerbations"/>
   <result pre="patientsScand J Infect Dis2013451656910.3109/00365548.2012.70894222992129 15.WarkPAToozeMCheeseLWhiteheadBet al.Viral infections trigger exacerbations of" exact="cystic fibrosis" post="in adults and childrenEur Respir J201240251051210.1183/09031936.0020231122855475 16.AbmanSHOgleJWButler-SimonNet al.Role of"/>
   <result pre="fibrosisPediatr Infect Dis J201736654554810.1097/INF.000000000000150128005688 22.BuchsCDalphinMLSanchezSet al.Palivizumab prophylaxis in infants with" exact="cystic fibrosis" post="does not delay first isolation of Pseudomonas aeruginosa or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6724460\results\search\disease\results.xml">
   <result pre="por Aedes aegyptiRev Bras Malariol DoenÃ§as Trop196921(4)7293110.5123/S1679-497420070002000065397213 6TauilPL[Critical aspects of" exact="yellow fever" post="control in Brazil]. Rev Saude Publica. 2010;44(3):555-8. Apud Franco"/>
   <result pre="12collab: Secretaria da SaÃºde do Estado do CearÃ¡Boletim epidemiolÃ³gico dengue," exact="chikungunya" post="e zika. Coordenadoria de PromoÃ§Ã£o e ProteÃ§Ã£o Ã¨ SaÃºde"/>
   <result pre="Hyg201593(1)182310.4269/ajtmh.13-066326013373 17SacramentoRHde Melo BragaDNSacramentoFFde Carvalho AraÃºjoFMLimaAAde Lima PompeuMMet al.Death by" exact="dengue fever" post="in a Brazilian child: a case reportBMC Res Notes2014785510.1186/1756-0500-7-85525428248"/>
   <result pre="forecastsLancet Infect Dis201414(7)6192610.1016/S1473-3099(14)70781-924841859 20VasconcelosPFde MenezesDBMeloLPPessoETRodriguesSGda RosaESet al.A large epidemic of" exact="dengue fever" post="with dengue hemorrhagic cases in CearÃ¡ State, Brazil, 1994Rev"/>
   <result pre="JÃºniorGBDiÃ³genesSSSilvaHFDengue and aplastic anemia-a rare associationTravel Med Infect Dis20097(2)1182010.1016/j.tmaid.2009.01.00119237145 25AragÃ£oREBarreiraIMLimaLNRabeloLPPereiraFB[Bilateral" exact="optic neuritis" post="after dengue viral infection: case report]Arq Bras Oftalmol201073(2)175810.1590/S0004-2749201000020001520549049 26PonteHJPucciFHMoreira"/>
   <result pre="manifestations in patients admitted to a reference hospital with presumptive" exact="dengue fever" post="diagnosisRev Dor201112(2)104710.1590/S1806-00132011000200005 27LimaDMSabino-Santos JuniorGOliveiraACFontesRMColaresJKAraÃºjoFMet al.Hantavirus infection in suspected dengue"/>
   <result pre="nervous system manifestations, BrazilEmerg Infect Dis201218(4)677910.3201/eid1804.11152222469335 31MacedoRNRochaFARolimDBVilarDCAraÃºjoFMVieiraNNet al.Severe coinfection of" exact="melioidosis" post="and dengue fever in Northeastern Brazil: first case reportRev"/>
   <result pre="manifestations, BrazilEmerg Infect Dis201218(4)677910.3201/eid1804.11152222469335 31MacedoRNRochaFARolimDBVilarDCAraÃºjoFMVieiraNNet al.Severe coinfection of melioidosis and" exact="dengue fever" post="in Northeastern Brazil: first case reportRev Soc Bras Med"/>
   <result pre="first case reportRev Soc Bras Med Trop201245(1)132310.1590/S0037-8682201200010002822370846 32TorresAFBragaDNMunizFMendonÃ§aCOliveiraDNde SouzaETet al.Lymphocytic" exact="myocarditis" post="at autopsy in patients with dengue feverBraz J Infect"/>
   <result pre="BrazilMem Inst Oswaldo Cruz2014109(1)93810.1590/0074-027614038424626308 34TeixeiraMGPaixÃ£oESCosta MdaCCunhaRVPamplonaLDiasJPet al.Arterial hypertension and skin" exact="allergy" post="are risk factors for progression from dengue to dengue"/>
   <result pre="Soc Bras Med Trop201548(6)783510.1590/0037-8682-0205-201526676509 38de Melo BezerraLFFontesRMGomesAMda SilvaDAColaresJKLimaDMSerological evidence of" exact="leptospirosis" post="in patients with a clinical suspicion of dengue in"/>
   <result pre="Publica200925Suppl 1S1253610.1590/S0102-311X200900130001219287857 63HeukelbachJde OliveiraFAKerr-PontesLRFeldmeierHRisk factors associated with an outbreak of" exact="dengue fever" post="in a favela in Fortaleza, north-east BrazilTrop Med Int"/>
   <result pre="Results Reference 1995 Descriptive To evaluate the cases of hemorrhagic" exact="dengue fever" post="in the city of Fortaleza in 1994. Of the"/>
   <result pre="was documented. 23 2009 Descriptive To report a case of" exact="aplastic anemia" post="induced by dengue virus infection. Dengue can induce aplastic"/>
   <result pre="documented. 23 2009 Descriptive To report a case of aplastic" exact="anemia" post="induced by dengue virus infection. Dengue can induce aplastic"/>
   <result pre="aplastic anemia induced by dengue virus infection. Dengue can induce" exact="aplastic anemia" post="by directly invading the bone marrow. This rare complication"/>
   <result pre="anemia induced by dengue virus infection. Dengue can induce aplastic" exact="anemia" post="by directly invading the bone marrow. This rare complication"/>
   <result pre="induce complete remission. 24 2010 Descriptive To report cases of" exact="optic neuritis" post="after dengue virus infection. Two cases of bilateral neuritis"/>
   <result pre="2012 Retrospective To correlate laboratory tests during the progression of" exact="dengue fever" post="with symptoms to predict the severity of the disease."/>
   <result pre="predict the severity of the disease. In patients with CD," exact="thrombocytopenia" post="and elevated transaminase levels were observed; in those with"/>
   <result pre="elevated transaminase levels were observed; in those with DHF, the" exact="thrombocytopenia" post="and elevated transaminase levels were similar to those in"/>
   <result pre="To evaluate the prevalence of dengue in patients with suspected" exact="viral meningitis." post="Dengue should be suspected in patients in endemic areas"/>
   <result pre="diagnoses in endemic disease areas. 31 2013 Retrospective To report" exact="myocarditis" post="due to dengue, which is rarely diagnosed. Myocarditis caused"/>
   <result pre="dengue who may benefit from therapy to prevent death from" exact="heart disease." post="32 2013 Retrospective To describe the clinical spectrum of"/>
   <result pre="obvious. 15 2014 Descriptive To report the first case of" exact="dengue fever" post="in an indigenous child who died. With positive immunohistochemical"/>
   <result pre="none died. 35 2015 Descriptive To diagnose possible cases of" exact="leptospirosis" post="in dengue-negative patients in samples from 2008, 2010, and"/>
   <result pre="that 20% of dengue cases may actually be cases of" exact="leptospirosis" post="in endemic disease areas. 36 2015 Descriptive To identify"/>
   <result pre="transplantation in endemic disease areas. 37 2015 Descriptive To investigate" exact="leptospirosis" post="in patients with clinical suspicion of dengue. Of the"/>
   <result pre="thus prevent death. 39 Notes: DENV: dengue virus, CD: classic" exact="dengue fever," post="SD: severe dengue, DHF: dengue hemorrhagic fever, CSF: cerebrospinal"/>
   <result pre="dengue virus, CD: classic dengue fever, SD: severe dengue, DHF:" exact="dengue hemorrhagic fever," post="CSF: cerebrospinal fluid, CNS: central nervous system, IgM: immunoglobulin"/>
   <result pre="A. aegypti and A. albopictus To compare the incidence of" exact="dengue fever" post="in relation to the rainfall in the city of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6727498\results\search\disease\results.xml">
   <result pre="spectrum, with the exception of a lower incidence of Kaposiâ€™s" exact="sarcoma" post="in HIV-2 infected individuals [13, 14]. Interestingly, studies have"/>
   <result pre="HIV-2-specific T-cells from LTNPs in the French cohort showed potent" exact="suppression" post="of viral replication, in many cases exceeding the suppressive"/>
   <result pre="cureâ€™ has emerged, or lately â€˜relapse-free remissionâ€™ to define sustained" exact="suppression" post="of virus without the need for ART. This means"/>
   <result pre="prospective open cohort studyLancet HIV20186e25e3110.1016/S2352-3018(18)30254-6 13.AriyoshiKSchim van der LoeffMCookPWhitbyDCorrahTJaffarSet al.Kaposiâ€™s" exact="sarcoma" post="in the Gambia, West Africa is less frequent in"/>
   <result pre="dually infected patientsJ Acquir Immune Defic Syndr201672325425810.1097/QAI.000000000000093926825178 129.WejseCFurtadoACamaraCLuneborg-NielsenMSodemannMGerstoftJet al.Impact of" exact="tuberculosis" post="treatment on CD4 cell count, HIV RNA, and p24"/>
   <result pre="with sub-subtype A3J Infect Dis2014209572172810.1093/infdis/jit41623935204 142.LindmanJLManssonFBiagueADa SilvaZJAnderssonSNorrgrenHDeclining prevalence rates of" exact="syphilis" post="among police officers in Guinea-Bissau, West Africa, 1990â€&quot;2010Sex Transm"/>
   <result pre="Guinea-BissauEnviron Int201036767568210.1016/j.envint.2010.04.02020537392 145.NorrgrenHBambaSDa SilvaZJKoivulaTAnderssonSHigher mortality in HIV-2/HTLV-1 co-infected patients with" exact="pulmonary tuberculosis" post="in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patientsInt"/>
   <result pre="Int201036767568210.1016/j.envint.2010.04.02020537392 145.NorrgrenHBambaSDa SilvaZJKoivulaTAnderssonSHigher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary" exact="tuberculosis" post="in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patientsInt"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6728053\results\search\disease\results.xml">
   <result pre="coastal Mombasa compared to Kisumu. Author summary Dengue is a" exact="viral disease" post="of global public health significance owing to rapid spread"/>
   <result pre="insecticide-treated cows, as has been suggested for Anopheles mosquitoes in" exact="malaria" post="control [43]. As a limitation, data on the density"/>
   <result pre="10AghaSB, TchouassiDP, BastosADS, SangR. Assessment of risk of dengue and" exact="yellow fever" post="virus transmission in three major Kenyan cities based on"/>
   <result pre="Negl Trop Dis. 2017;11(8):e000585810.1371/journal.pntd.000585828817563 11AghaSB, TchouassiDP, BastosADS, SangR. Dengue and" exact="yellow fever" post="virus vectors: seasonal abundance, diversity and resting preferences in"/>
   <result pre="Dis. 2015;9(4):e000373310.1371/journal.pntd.000373325923210 19JohnsonBK, OchengD, GichogoA, OkiroM, LibondoD, KinyanjuiP, et al.Epidemic" exact="dengue fever" post="caused by dengue type 2 virus in Kenya: preliminary"/>
   <result pre="of Aedes aegypti from three distinct cities in Kenya for" exact="chikungunya" post="virus. PLoS Negl Trop Dis. 2017;11(8):e000586010.1371/journal.pntd.000586028820881 26PaupyC, Le GoffG,"/>
   <result pre="imperial, and San Joaquin Valleys of California for St. Louis" exact="encephalitis" post="virus. Am J Trop Med Hyg. 1983;32(2):305â€&quot;11. 10.4269/ajtmh.1983.32.3056301301 32TurellMJ."/>
   <result pre="et al.Seroprevalence of infections with dengue, Rift Valley fever and" exact="chikungunya" post="viruses in Kenya, 2007. PLoS One. 2015;10(7):e013264510.1371/journal.pone.013264526177451 36CarringtonLB, SeifertSN,"/>
   <result pre="ValeGA, TorrSJ, FillingerU. Exploring the potential of using cattle for" exact="malaria" post="vector surveillance and control: a pilot study in western"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6729038\results\search\disease\results.xml">
   <result pre="threats to Europe, such as West Nile virus, Toscana virus," exact="measles" post="and enteroviruses [1, 2]. The epidemiology of community-acquired CNS"/>
   <result pre="the burden of the two most common etiological agents for" exact="bacterial meningitis" post="in adults and older children, Streptococcus pneumoniae and Neisseria"/>
   <result pre="burden of the two most common etiological agents for bacterial" exact="meningitis" post="in adults and older children, Streptococcus pneumoniae and Neisseria"/>
   <result pre="type B (Hib) is also becoming a rare cause of" exact="meningitis" post="in Europe [5]. However, reports of serotype replacement and"/>
   <result pre="to be tailored to regions and travel [3, 5]. Neonatal" exact="meningitis" post="is associated with high morbidity and higher incidence compared"/>
   <result pre="virus (VZV) and arthropod-borne viruses (arboviruses) [11]. The epidemiology of" exact="encephalitis" post="is constantly evolving [11], and emerging infectious diseases may"/>
   <result pre="the emergence of Toscana virus as a leading cause of" exact="aseptic meningitis" post="in regions in southern Europe during the summer [13,"/>
   <result pre="emergence of Toscana virus as a leading cause of aseptic" exact="meningitis" post="in regions in southern Europe during the summer [13,"/>
   <result pre="of systematic reviews (ID: CRD42014014212). The protocol was informed by" exact="infectious disease" post="specialists and systematic reviewers. Search strategy One reviewer conducted"/>
   <result pre="22 June 2017. Search terms: (â€œCentral Nervous System Infectionsâ€�[Mesh]) OR" exact="meningitis" post="[Title/Abstract]) OR meningoencephalitis [Title/Abstract]) OR encephalitis [Title/Abstract])) AND (guideline"/>
   <result pre="Search terms: (â€œCentral Nervous System Infectionsâ€�[Mesh]) OR meningitis [Title/Abstract]) OR" exact="meningoencephalitis" post="[Title/Abstract]) OR encephalitis [Title/Abstract])) AND (guideline [Title]) OR guidelines"/>
   <result pre="Nervous System Infectionsâ€�[Mesh]) OR meningitis [Title/Abstract]) OR meningoencephalitis [Title/Abstract]) OR" exact="encephalitis" post="[Title/Abstract])) AND (guideline [Title]) OR guidelines [Title]) OR guidance"/>
   <result pre="(nâ€‰=â€‰1) (Fig.Â 2). Ten focused on viral encephalitis/meningoencephalitis, 14 on" exact="bacterial meningitis" post="and two on both (AdditionalÂ fileÂ 2). Fig. 1"/>
   <result pre="(Fig.Â 2). Ten focused on viral encephalitis/meningoencephalitis, 14 on bacterial" exact="meningitis" post="and two on both (AdditionalÂ fileÂ 2). Fig. 1"/>
   <result pre="changes to personality or behaviour as signs and symptoms of" exact="encephalitis" post="in both children and adults. It was noted that"/>
   <result pre="ALOC altered level of consciousness, AMS altered mental status Bacterial" exact="meningitis" post="Nine CMGs covering bacterial CNS meningitis presented symptoms at"/>
   <result pre="altered mental status Bacterial meningitis Nine CMGs covering bacterial CNS" exact="meningitis" post="presented symptoms at presentation in adults [2, 5, 23,"/>
   <result pre="feeding were most commonly described, followed by bulging fontanelle, petechial" exact="rash" post="and lethargy. It was also highlighted by several CMGs"/>
   <result pre="[5]. It was also highlighted that the classic signs of" exact="meningitis" post="are not always present in adults either [23]. Therefore,"/>
   <result pre="meningitis are not always present in adults either [23]. Therefore," exact="bacterial meningitis" post="cannot be ruled out based on the absence of"/>
   <result pre="are not always present in adults either [23]. Therefore, bacterial" exact="meningitis" post="cannot be ruled out based on the absence of"/>
   <result pre="bacterial aetiologies. CT should not delay antibiotic treatment for suspected" exact="bacterial meningitis" post="Abbreviations: IEC International Encephalitis Consortium, EFNS European Federation of"/>
   <result pre="aetiologies. CT should not delay antibiotic treatment for suspected bacterial" exact="meningitis" post="Abbreviations: IEC International Encephalitis Consortium, EFNS European Federation of"/>
   <result pre="seizures or consciousness disorder ^^If LP contraindicated Viral encephalitis/meningoencephalitis, Bacterial" exact="meningitis" post="Bacterial meningitis All CMGs covering bacterial CNS infections recommended"/>
   <result pre="consciousness disorder ^^If LP contraindicated Viral encephalitis/meningoencephalitis, Bacterial meningitis Bacterial" exact="meningitis" post="All CMGs covering bacterial CNS infections recommended urgent LP"/>
   <result pre="(TableÂ 3), since a positive CSF culture is confirmative of" exact="bacterial meningitis" post="and enables in vitro testing of antimicrobial susceptibility to"/>
   <result pre="3), since a positive CSF culture is confirmative of bacterial" exact="meningitis" post="and enables in vitro testing of antimicrobial susceptibility to"/>
   <result pre="depending on season or exposure, arboviruses. Testing for influenza, mumps," exact="measles" post="and rubella were also recommended, especially during an on-going"/>
   <result pre="season or exposure, arboviruses. Testing for influenza, mumps, measles and" exact="rubella" post="were also recommended, especially during an on-going epidemic [30]."/>
   <result pre="CMV, EBV, JCV, Dengue virus, respiratory viruses, RSV, HIV, adenovirus," exact="influenza" post="A and B, rotavirus, Coxsackie B5, non-typed enterovirus, Parainfluenza"/>
   <result pre="on epidemiological and clinical features. IDSA* Neonates: HSV 2, CMV," exact="rubella" post="virus, L. monocytogenes, T. pallidum, Toxoplasma gondii Infants and"/>
   <result pre="monocytogenes, T. pallidum, Toxoplasma gondii Infants and Children: Eastern equine" exact="encephalitis" post="virus, Japanese encephalitis virus, Murray Valley encephalitis virus, influenza"/>
   <result pre="Toxoplasma gondii Infants and Children: Eastern equine encephalitis virus, Japanese" exact="encephalitis" post="virus, Murray Valley encephalitis virus, influenza virus, La Crosse"/>
   <result pre="Children: Eastern equine encephalitis virus, Japanese encephalitis virus, Murray Valley" exact="encephalitis" post="virus, influenza virus, La Crosse virus Unspecified: HSV, WNV,"/>
   <result pre="equine encephalitis virus, Japanese encephalitis virus, Murray Valley encephalitis virus," exact="influenza" post="virus, La Crosse virus Unspecified: HSV, WNV, TBEV, A."/>
   <result pre="Unspecified: HSV, WNV, TBEV, A. phagocytophilum, B.burgdorferi Elderly: Eastern equine" exact="encephalitis" post="virus, St. Louis encephalitis virus, WNV, sporadic Creutzfeldt-Jakob Disease,"/>
   <result pre="A. phagocytophilum, B.burgdorferi Elderly: Eastern equine encephalitis virus, St. Louis" exact="encephalitis" post="virus, WNV, sporadic Creutzfeldt-Jakob Disease, L. monocytogenes Person-to-person transmission:"/>
   <result pre="sporadic Creutzfeldt-Jakob Disease, L. monocytogenes Person-to-person transmission: VZV, Venezuelan equine" exact="encephalitis" post="virus (rare), poliovirus, non-polio enteroviruses, measles virus, mumps virus,"/>
   <result pre="transmission: VZV, Venezuelan equine encephalitis virus (rare), poliovirus, non-polio enteroviruses," exact="measles" post="virus, mumps virus, rubella virus, EBV, HHV 6, B"/>
   <result pre="Venezuelan equine encephalitis virus (rare), poliovirus, non-polio enteroviruses, measles virus," exact="mumps" post="virus, rubella virus, EBV, HHV 6, B virus, WNV"/>
   <result pre="encephalitis virus (rare), poliovirus, non-polio enteroviruses, measles virus, mumps virus," exact="rubella" post="virus, EBV, HHV 6, B virus, WNV (transfusion transplantation,"/>
   <result pre="B virus, WNV (transfusion transplantation, breast feeding), HIV, Nipah virus," exact="rabies" post="virus (transplantation), influenza virus, M. pneumoniae, Mycobacterium tuberculosis, T."/>
   <result pre="(transfusion transplantation, breast feeding), HIV, Nipah virus, rabies virus (transplantation)," exact="influenza" post="virus, M. pneumoniae, Mycobacterium tuberculosis, T. pallidum. Others based"/>
   <result pre="and risk factors BIA/ABN Adults: HSV-1, HSV-2, VZV, enteroviruses, parechovirus," exact="measles" post="virus, mumps virus, TBEV (eastern Europe), WNV (southern Europe),"/>
   <result pre="factors BIA/ABN Adults: HSV-1, HSV-2, VZV, enteroviruses, parechovirus, measles virus," exact="mumps" post="virus, TBEV (eastern Europe), WNV (southern Europe), HIV, EBV"/>
   <result pre="(eastern Europe), WNV (southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised)" exact="influenza" post="virus (rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis"/>
   <result pre="(rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis virus (rare)," exact="rubella" post="virus (rare) Others based on epidemiological and clinical features."/>
   <result pre="features. BIA/ABN/BPAIIG Children: HSV-1, HSV-2, VZV, enteroviruses, parechovirus, HHV 6/7," exact="measles" post="virus, mumps virus, rotavirus, HIV, TBEV (eastern Europe), WNV"/>
   <result pre="Children: HSV-1, HSV-2, VZV, enteroviruses, parechovirus, HHV 6/7, measles virus," exact="mumps" post="virus, rotavirus, HIV, TBEV (eastern Europe), WNV (southern Europe),"/>
   <result pre="(eastern Europe), WNV (southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised)" exact="influenza" post="virus (rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis"/>
   <result pre="(rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis virus (rare)," exact="rubella" post="virus (rare) Others based on epidemiological and clinical features."/>
   <result pre="epidemiological and clinical features. AEPED* Congenital: Lymphocytic Choriomeningitis virus, CMV," exact="measles" post="virus, T. gondii, T. pallidum, Neonates ( Citrobacter spp.,"/>
   <result pre="HSV, VZV, HIV, enterovirus, L. monocytogenes (higher riskâ€‰&amp;gt;â€‰65Â years), M." exact="tuberculosis" post="(higher riskâ€‰&amp;gt;â€‰75Â years) NNF* Unspecified: HSV-1, HSV-2, VZV, EBV,"/>
   <result pre="A, measles, mumps, rubella, HIV, Hepatitis E, Japanese B, WNV," exact="rabies" post="virus, TBE, Eastern equine encephalitis, S. pneumoniae, B. burgdorferi,"/>
   <result pre="B. burgdorferi, M. pneumoniae, Chlamydia trachomatis, L. monocytogenes, M. tuberculosis," exact="cerebral malaria," post="Cystericosis. Others based on immune status. PHE: ME* Unspecified:"/>
   <result pre="CMV Cytomegalovirus, EBV Epstein-Barr virus, RSV respiratory syncytial virus, TBEV" exact="tick-borne encephalitis" post="virus, WNV West Nile virus, JEV Japanese encephalitis virus,"/>
   <result pre="Cytomegalovirus, EBV Epstein-Barr virus, RSV respiratory syncytial virus, TBEV tick-borne" exact="encephalitis" post="virus, WNV West Nile virus, JEV Japanese encephalitis virus,"/>
   <result pre="TBEV tick-borne encephalitis virus, WNV West Nile virus, JEV Japanese" exact="encephalitis" post="virus, IEC International Encephalitis Consortium, EFNS European Federation of"/>
   <result pre="differential diagnostic recommendations ^Differential diagnostic recommendations not clearly defined Bacterial" exact="meningitis" post="There was consensus on the initial differential diagnostics for"/>
   <result pre="for adults and older children presenting with syndromes suggestive of" exact="bacterial meningitis" post="(TableÂ 5). Besides two CMGs which only focused on"/>
   <result pre="adults and older children presenting with syndromes suggestive of bacterial" exact="meningitis" post="(TableÂ 5). Besides two CMGs which only focused on"/>
   <result pre="25, 36, 39]. Table 5 Differential diagnostic recommendations for suspected" exact="bacterial meningitis" post="Pathogen Age group EFNSEurope ESCMIDEurope DSIDenmark SPILFFrance DGN: BM^Germany"/>
   <result pre="36, 39]. Table 5 Differential diagnostic recommendations for suspected bacterial" exact="meningitis" post="Pathogen Age group EFNSEurope ESCMIDEurope DSIDenmark SPILFFrance DGN: BM^Germany"/>
   <result pre="not presented in the table The different epidemiology for neonatal" exact="meningitis" post="was reflected in the eight CMGs providing recommendations for"/>
   <result pre="diagnostic results. Table 6 Empirical treatment recommendations for suspected viral" exact="encephalitis" post="and meningoencephalitis The table shows the CMGs that included"/>
   <result pre="Table 6 Empirical treatment recommendations for suspected viral encephalitis and" exact="meningoencephalitis" post="The table shows the CMGs that included recommendations for"/>
   <result pre="empirical treatment recommendations should be reviewed pending diagnostic results Bacterial" exact="meningitis" post="All 15 CMGs covering treatment recommended urgent administration of"/>
   <result pre="treatment recommended urgent administration of antibiotics on clinical suspicion of" exact="bacterial meningitis" post="(TableÂ 7). Thirty-three percent (nâ€‰=â€‰5/15) specified a time-frame for"/>
   <result pre="recommended urgent administration of antibiotics on clinical suspicion of bacterial" exact="meningitis" post="(TableÂ 7). Thirty-three percent (nâ€‰=â€‰5/15) specified a time-frame for"/>
   <result pre="timing of antimicrobial administration to clinical outcome in patients with" exact="bacterial meningitis," post="but since it is a neurologic emergency, appropriate therapy"/>
   <result pre="all age-groups [38]. Table 7 Empirical treatment recommendations for suspected" exact="bacterial meningitis" post="Initial treatment recommendations* â€ƒCMG 3rd-generation cephalosporin (ceftriaxone^ or cefotaxime)"/>
   <result pre="age-groups [38]. Table 7 Empirical treatment recommendations for suspected bacterial" exact="meningitis" post="Initial treatment recommendations* â€ƒCMG 3rd-generation cephalosporin (ceftriaxone^ or cefotaxime)"/>
   <result pre="corticosteroids in infants is controversial and only recommended for Hib" exact="meningitis" post="[44]. It was highlighted that corticosteroids can reduce inflammation"/>
   <result pre="infections and antimicrobial resistance. The most recent Europe-wide CMG on" exact="bacterial meningitis" post="was published in 2016 [5], whilst the most recent"/>
   <result pre="and antimicrobial resistance. The most recent Europe-wide CMG on bacterial" exact="meningitis" post="was published in 2016 [5], whilst the most recent"/>
   <result pre="a general consensus on diagnostic methods, but wider variations in" exact="infectious disease" post="differential diagnostics recommendations, especially for paediatric and elderly populations."/>
   <result pre="the need for urgent I.V. antibiotics on clinical suspicion of" exact="bacterial meningitis." post="However, only about half recommended pre-hospital antibiotics when presenting"/>
   <result pre="of America IEC International Encephalitis Consortium I.V. Intravenous JEV Japanese" exact="encephalitis" post="virus LP Lumbar puncture MeSH Medical subject headings MHSSE"/>
   <result pre="SPILF SociÃ©tÃ© de Pathologie Infectieuse de Langue FranÃ§aise TBEV Tick-borne" exact="encephalitis" post="virus TRIP Turning research into practice UK United Kingdom"/>
   <result pre="specialist societies guideline on the diagnosis and management of acute" exact="meningitis" post="and meningococcal sepsis in immunocompetent adultsJ Infect201672440543810.1016/j.jinf.2016.01.00726845731 3.van EttekovenCNvan"/>
   <result pre="and challengesClin Microbiol Infect201723960160610.1016/j.cmi.2017.04.01928478238 4.McIntyrePBO'BrienKLGreenwoodBvan de BeekDEffect of vaccines on" exact="bacterial meningitis" post="worldwideLancet201238098541703171110.1016/S0140-6736(12)61187-823141619 5.van de BeekD.CabellosC.DzupovaO.EspositoS.KleinM.KloekA.T.LeibS.L.MourvillierB.OstergaardC.PaglianoP.PfisterH.W.ReadR.C.SipahiO. ResatBrouwerM.C.ESCMID guideline: diagnosis and treatment"/>
   <result pre="challengesClin Microbiol Infect201723960160610.1016/j.cmi.2017.04.01928478238 4.McIntyrePBO'BrienKLGreenwoodBvan de BeekDEffect of vaccines on bacterial" exact="meningitis" post="worldwideLancet201238098541703171110.1016/S0140-6736(12)61187-823141619 5.van de BeekD.CabellosC.DzupovaO.EspositoS.KleinM.KloekA.T.LeibS.L.MourvillierB.OstergaardC.PaglianoP.PfisterH.W.ReadR.C.SipahiO. ResatBrouwerM.C.ESCMID guideline: diagnosis and treatment"/>
   <result pre="and treatment of acute bacterial meningitisClinical Microbiology and Infection201622S37S6210.1016/j.cmi.2016.01.00727062097 6.KuLCBoggessKACohen-WolkowiezMBacterial" exact="meningitis" post="in the infantClin Perinatol2015421294510.1016/j.clp.2014.10.00425677995 7.TunkelARGlaserCABlochKCSejvarJJMarraCMRoosKLet al.The management of encephalitis:"/>
   <result pre="Diseases Society of AmericaClin Infect Dis20084730332710.1086/58974718582201 8.GlaserCAGilliamSSchnurrDForghaniBHonarmandSKhetsurianiNet al.In search of" exact="encephalitis" post="etiologies: diagnostic challenges in the California encephalitis project, 1998-2000Clin"/>
   <result pre="al.In search of encephalitis etiologies: diagnostic challenges in the California" exact="encephalitis" post="project, 1998-2000Clin Infect Dis200336673174210.1086/36784112627357 9.GranerodJAmbroseHEDaviesNWClewleyJPWalshALMorganDet al.Causes of encephalitis and"/>
   <result pre="the California encephalitis project, 1998-2000Clin Infect Dis200336673174210.1086/36784112627357 9.GranerodJAmbroseHEDaviesNWClewleyJPWalshALMorganDet al.Causes of" exact="encephalitis" post="and differences in their clinical presentations in England: a"/>
   <result pre="algorithms, and priorities in encephalitis: consensus statement of the international" exact="encephalitis" post="consortiumClin Infect Dis2013571114112810.1093/cid/cit45823861361 11.BoucherAHerrmannJLMorandPBuzeleRCrabolYStahlJPet al.Epidemiology of infectious encephalitis causes"/>
   <result pre="the international encephalitis consortiumClin Infect Dis2013571114112810.1093/cid/cit45823861361 11.BoucherAHerrmannJLMorandPBuzeleRCrabolYStahlJPet al.Epidemiology of infectious" exact="encephalitis" post="causes in 2016Med Mal Infect201747322123510.1016/j.medmal.2017.02.00328341533 12.MaillesAStahlJPBlochKCUpdate and new insights"/>
   <result pre="disease 2013 [cited 2018 March]. 22.SolomonTMichaelBDSmithPESandersonFDaviesNWSHartIJet al.Management of suspected viral" exact="encephalitis" post="in adults - Association of British Neurologists and British"/>
   <result pre="UK2015 [cited 2019 Feb]. 25.PHE. UK standards for microbiology investigations:" exact="meningoencephalitis" post="UK: PHE; 2014. Available from: www.gov.uk/government/uploads/system/uploads/attachment_data/file/344105/S_5i1.pdf. [cited 2018 March]"/>
   <result pre="[cited 2018 March] 26.StahlJ.P.AzouviP.BruneelF.De BrouckerT.DuvalX.FantinB.GirardN.HerrmannJ.L.HonnoratJ.LecuitM.MaillesA.Martinez-AlmoynaL.MorandP.PirothL.TattevinP.Guidelines on the management of infectious" exact="encephalitis" post="in adultsMÃ©decine et Maladies Infectieuses201747317919410.1016/j.medmal.2017.01.00528412044 27.Navarro GÃ³mez M, GonzÃ¡lez"/>
   <result pre="AEPED; 2011 [cited 2018 March]. 28.KneenRMichaelBDMensonEMehtaBEastonAHemingwayCet al.Management of suspected viral" exact="encephalitis" post="in children - Association of British Neurologists and British"/>
   <result pre="al.Guidelines for the early clinical and public health management of" exact="bacterial meningitis" post="(including meningococcal disease)2015 36.ChaudhuriAMartinPMKennedyPGEAndrew SeatonRPortegiesPBojarMet al.EFNS guideline on the"/>
   <result pre="for the early clinical and public health management of bacterial" exact="meningitis" post="(including meningococcal disease)2015 36.ChaudhuriAMartinPMKennedyPGEAndrew SeatonRPortegiesPBojarMet al.EFNS guideline on the"/>
   <result pre="bacterial meningitis: report of an EFNS task force on acute" exact="bacterial meningitis" post="in older children and adultsEur J Neurol20081564965910.1111/j.1468-1331.2008.02193.x18582342 37.PfisterHAmbulant erworbene"/>
   <result pre="meningitis: report of an EFNS task force on acute bacterial" exact="meningitis" post="in older children and adultsEur J Neurol20081564965910.1111/j.1468-1331.2008.02193.x18582342 37.PfisterHAmbulant erworbene"/>
   <result pre="manual2016175179 39.LebechAHansenBBrandtCvon LÃ¼ttichauHBodilsenJWieseLet al.Rekommandationer for initial behandling af akut bakteriel" exact="meningitis" post="hos voksne2018DenmarkDansk Selskab for Infektionsmedicin 40.ArtigaoFLopezRCastillo Martin delFMeningitis bacteriana2011SpainProtocolos"/>
   <result pre="of diagnostic accuracyJ Infect20177411910.1016/j.jinf.2016.09.00727746160 42.McGillFGriffithsMJBonnettLJGerettiAMMichaelBDBeechingNJet al.Incidence, aetiology, and sequelae of" exact="viral meningitis" post="in UK adults: a multicentre prospective observational cohort studyLancet"/>
   <result pre="diagnostic accuracyJ Infect20177411910.1016/j.jinf.2016.09.00727746160 42.McGillFGriffithsMJBonnettLJGerettiAMMichaelBDBeechingNJet al.Incidence, aetiology, and sequelae of viral" exact="meningitis" post="in UK adults: a multicentre prospective observational cohort studyLancet"/>
   <result pre="multicentre prospective observational cohort studyLancet Infect Dis2018189992100310.1016/S1473-3099(18)30245-730153934 43.BrouwerMCvan de BeekDViral" exact="meningitis" post="in the UK: time to speed upLancet Infect Dis201818993093110.1016/S1473-3099(18)30287-130153931"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6731212\results\search\disease\results.xml">
   <result pre="Article Epidemiological and clinical characteristics of children hospitalized due to" exact="influenza" post="A and B in the south of Europe, 2010â€&quot;2016"/>
   <result pre="epidemiological and clinical characteristics of children hospitalized due to confirmed" exact="influenza" post="in influenza surveillance sentinel hospitals in Catalonia. Retrospective descriptive"/>
   <result pre="clinical characteristics of children hospitalized due to confirmed influenza in" exact="influenza" post="surveillance sentinel hospitals in Catalonia. Retrospective descriptive study conducted"/>
   <result pre="sentinel hospitals in Catalonia. Retrospective descriptive study conducted in six" exact="influenza" post="seasons (2010â€&quot;2011 to 2015â€&quot;2016) in persons aged 0â€&quot;17 years"/>
   <result pre="to 2015â€&quot;2016) in persons aged 0â€&quot;17 years diagnosed with laboratory-confirmed" exact="influenza" post="requiring hospitalization. 291 cases were notified to the health"/>
   <result pre="notified to the health authorities: 79.4% were due to the" exact="influenza" post="A virus and 20.6% to the B virus. The"/>
   <result pre="were aged &amp;lt;1 year. 62.2% of cases had pneumonia, 26.8%" exact="acute respiratory distress syndrome" post="and 11.7% bacterial pneumonia. 5.8% of cases were vaccinated"/>
   <result pre="cases had pneumonia, 26.8% acute respiratory distress syndrome and 11.7%" exact="bacterial pneumonia." post="5.8% of cases were vaccinated and 21.3% required intensive"/>
   <result pre="were aged &amp;lt;2 years. There were 3 deaths, all with" exact="influenza" post="A infection. Influenza A cases were younger than influenza"/>
   <result pre="with influenza A infection. Influenza A cases were younger than" exact="influenza" post="B cases (OR 3.22; 95% CI: 1.73â€&quot;6.00). Conclusion: Children"/>
   <result pre="Grant number 2017 SGR 1342). Introduction Influenza, an acute viral" exact="infectious disease" post="that primarily affects the upper respiratory tract, is caused"/>
   <result pre="primarily affects the upper respiratory tract, is caused by the" exact="influenza" post="virus, which belongs to the Orthomyxoviridae family. There are"/>
   <result pre="belongs to the Orthomyxoviridae family. There are three types of" exact="influenza" post="viruses, which commonly infect humans: A, B and C."/>
   <result pre="first two are responsible for annual seasonal epidemics. Type A" exact="influenza" post="viruses are divided into subtypes depending on the composition"/>
   <result pre="proteins on the virus surface. There are several subtypes of" exact="influenza" post="A but, currently, the viruses that circulate and affect"/>
   <result pre="(H1N1) pdm09 was first identified in 2009, in the first" exact="influenza" post="pandemic of the 21st century, and since then has"/>
   <result pre="estimated that between 3 and 5 million people have serious" exact="influenza" post="with complications and hospital admission annually and approximately 250,000â€&quot;500,000"/>
   <result pre="reports suggest that children may more easily introduce and transmit" exact="influenza" post="in the community1,5,6. A surveillance program of influenza and"/>
   <result pre="and transmit influenza in the community1,5,6. A surveillance program of" exact="influenza" post="and other acute respiratory infections (PIDIRAC) was initiated in"/>
   <result pre="2005â€&quot;2006 season, the PIDIRAC has formed part of the Spanish" exact="influenza" post="surveillance sentinel system, coordinated by the National Center for"/>
   <result pre="European Center for Disease Control (ECDC) which is responsible for" exact="influenza" post="surveillance in Europe. As a result of the 2009"/>
   <result pre="2010â€&quot;2011 season, the surveillance of severe hospitalized cases of confirmed" exact="influenza" post="was introduced, using a sentinel hospital system that at"/>
   <result pre="geographically distributed throughout all Catalan health care regions. In Catalonia" exact="influenza" post="vaccination is not recommended in childhood except if they"/>
   <result pre="of complications. The aim is to determine the activity of" exact="influenza" post="viruses and the severity of hospitalized cases9. Various studies"/>
   <result pre="of hospitalized cases9. Various studies have analysed the distribution of" exact="influenza" post="in the general population, vaccine effectiveness and hygienic preventive"/>
   <result pre="epidemiological and clinical characteristics of children hospitalized due to confirmed" exact="influenza" post="A or B virus infection in the sentinel hospitals"/>
   <result pre="Methods We carried out a retrospective descriptive study in six" exact="influenza" post="seasons (2010â€&quot;2011 to 2015â€&quot;2016) in children and adolescents aged"/>
   <result pre="and adolescents aged 0â€&quot;17 years hospitalized due to severe acute" exact="influenza" post="virus infection. The surveillance system of severe hospitalized influenza"/>
   <result pre="acute influenza virus infection. The surveillance system of severe hospitalized" exact="influenza" post="in Catalonia, a region in the northeast of Spain"/>
   <result pre="on who was a case. A hospitalized case of severe" exact="influenza" post="was defined as a case of laboratory-confirmed influenza virus"/>
   <result pre="of severe influenza was defined as a case of laboratory-confirmed" exact="influenza" post="virus infection that required hospitalization due to pneumonia, acute"/>
   <result pre="laboratory-confirmed influenza virus infection that required hospitalization due to pneumonia," exact="acute respiratory distress syndrome," post="septic shock, multiorgan failure or any other serious condition,"/>
   <result pre="variables studied were: sex, age, pre-existing chronic disease (asthma, chronic" exact="respiratory disease," post="obesity, diabetes, kidney disease, immunodeficiency, cardiovascular disease, liver disease),"/>
   <result pre="disease (asthma, chronic respiratory disease, obesity, diabetes, kidney disease, immunodeficiency," exact="cardiovascular disease," post="liver disease), date of symptom onset and date of"/>
   <result pre="onset and date of hospital admission, ICU admission, complications (pneumonia," exact="acute respiratory distress syndrome," post="multiorgan failure and septic shock), antiviral treatment received, seasonal"/>
   <result pre="syndrome, multiorgan failure and septic shock), antiviral treatment received, seasonal" exact="influenza" post="vaccination status and viral type/subtype (A H1N1 pdm09, A"/>
   <result pre="was performed to identify factors associated with the type of" exact="influenza" post="virus (A or B). Associations between clinical and epidemiological"/>
   <result pre="(A or B). Associations between clinical and epidemiological characteristics and" exact="influenza" post="type were determined by calculating the odds ratio (OR)"/>
   <result pre="adjusting by the population of each season. The differences between" exact="influenza" post="A subtypes and influenza B were assessed using the"/>
   <result pre="of each season. The differences between influenza A subtypes and" exact="influenza" post="B were assessed using the Chi-square test. The statistical"/>
   <result pre="receive, treat and temporarily store personal data on cases of" exact="infectious disease." post="Therefore, all study activities formed part of public surveillance"/>
   <result pre="by any of the authors. Results During the six seasonal" exact="influenza" post="seasons between 2010â€&quot;2011 and 2015â€&quot;2016, 291 confirmed cases of"/>
   <result pre="influenza seasons between 2010â€&quot;2011 and 2015â€&quot;2016, 291 confirmed cases of" exact="influenza" post="requiring hospitalization were reported to the General Subdirectorate of"/>
   <result pre="hospitalized in the six seasons. There was a predominance of" exact="influenza" post="A(H1N1)pdm09 subtype in cases hospitalized in the 2010â€&quot;2011 and"/>
   <result pre="December, January and February. In seasons with a predominance of" exact="influenza" post="B viruses (season 2012â€&quot;13 and 2015â€&quot;16), there was co-circulation"/>
   <result pre="B viruses (season 2012â€&quot;13 and 2015â€&quot;16), there was co-circulation with" exact="influenza" post="A(H1N1) pdm09 subtype. Figure 1 Weekly hospitalizations due to"/>
   <result pre="influenza A(H1N1) pdm09 subtype. Figure 1 Weekly hospitalizations due to" exact="influenza" post="in children aged &amp;lt;18 years according to season and"/>
   <result pre="2015â€&quot;2016. Of the 291 hospitalized cases, 79% tested positive for" exact="influenza" post="A virus and 21% for influenza B. The most"/>
   <result pre="79% tested positive for influenza A virus and 21% for" exact="influenza" post="B. The most frequent subtypes were H1N1Â pdm09 (57.8%)"/>
   <result pre="was 3.3 years (Â±SD 4), 16.8% had chronic disease, including" exact="asthma" post="(28.6%), cardiovascular disease (26.5%), immunosuppressive disease (20.4%) and chronic"/>
   <result pre="years (Â±SD 4), 16.8% had chronic disease, including asthma (28.6%)," exact="cardiovascular disease" post="(26.5%), immunosuppressive disease (20.4%) and chronic respiratory disease (14.3%)."/>
   <result pre="asthma (28.6%), cardiovascular disease (26.5%), immunosuppressive disease (20.4%) and chronic" exact="respiratory disease" post="(14.3%). The mean length of hospital stay was 9.2"/>
   <result pre="was 5.2 days (Â±SD 4.2). The most frequent complications were" exact="pneumonia" post="(62.2%), acute respiratory distress syndrome (26.8%) and bacterial pneumonia"/>
   <result pre="days (Â±SD 4.2). The most frequent complications were pneumonia (62.2%)," exact="acute respiratory distress syndrome" post="(26.8%) and bacterial pneumonia (11.7%). ICU admission was required"/>
   <result pre="complications were pneumonia (62.2%), acute respiratory distress syndrome (26.8%) and" exact="bacterial pneumonia" post="(11.7%). ICU admission was required in 21.3% of cases"/>
   <result pre="were pneumonia (62.2%), acute respiratory distress syndrome (26.8%) and bacterial" exact="pneumonia" post="(11.7%). ICU admission was required in 21.3% of cases"/>
   <result pre="ICU admission was required in 21.3% of cases (21.7% of" exact="influenza" post="A cases and 19.7% of influenza B cases), with"/>
   <result pre="of cases (21.7% of influenza A cases and 19.7% of" exact="influenza" post="B cases), with a mean length of stay of"/>
   <result pre="The clinical and epidemiological differences of cases hospitalized due to" exact="influenza" post="type A and B are shown in TableÂ 1."/>
   <result pre="A and B are shown in TableÂ 1. Cases of" exact="influenza" post="A were significantly younger (OR 3.22; 95% CI: 1.73â€&quot;6.00):"/>
   <result pre="younger (OR 3.22; 95% CI: 1.73â€&quot;6.00): 62.6% of cases of" exact="influenza" post="A were aged &amp;lt;2 years, while 63.9% of cases"/>
   <result pre="A were aged &amp;lt;2 years, while 63.9% of cases of" exact="influenza" post="B were aged 3â€&quot;17 years. No differences were found"/>
   <result pre="0.57â€&quot;1.92). Differences in the mean hospital stay were not significant:" exact="influenza" post="A 9.89 days (Â±SD18.37) vs. influenza B 8.49 days"/>
   <result pre="stay were not significant: influenza A 9.89 days (Â±SD18.37) vs." exact="influenza" post="B 8.49 days (Â±SD9.08). There were no significant differences"/>
   <result pre="epidemiological characteristics of children aged &amp;lt;18 years hospitalized due to" exact="influenza" post="type A or B virus. Catalonia, seasons 2010â€&quot;2011 to"/>
   <result pre="shown only as a descriptive variable. â&quot;¦: In clinical conditions," exact="asthma" post="and other risk factors, the denominator data is written"/>
   <result pre="questionnaires. TableÂ 2 shows cases requiring ICU admission: 80.6% had" exact="influenza" post="A virus infection (60% due to subtype A (H1N1)"/>
   <result pre="(60% due to subtype A (H1N1) pdm09) and 19.4% had" exact="influenza" post="B virus infection. In children with pre-existing chronic disease,"/>
   <result pre="virus infection. In children with pre-existing chronic disease, 16% had" exact="influenza" post="A infection and 33.3% influenza B: 30.6% were aged"/>
   <result pre="pre-existing chronic disease, 16% had influenza A infection and 33.3%" exact="influenza" post="B: 30.6% were aged &amp;lt;1 year. Table 2 Characteristics"/>
   <result pre="years with ICU admission according to type and subtype of" exact="influenza" post="virus. Catalonia, seasons 2010â€&quot;2011 to 2015â€&quot;2016. Influenza A Influenza"/>
   <result pre="to the ICU, 61.3%, 41.9%, 17.7% and 6.4% had pneumonia," exact="acute respiratory distress syndrome," post="bacterial coinfection or multiorgan failure, respectively: 81.6% of cases"/>
   <result pre="multiorgan failure, respectively: 81.6% of cases of pneumonia, 90.9% of" exact="bacterial pneumonia" post="and 84.6% of acute respiratory distress syndrome occurred in"/>
   <result pre="failure, respectively: 81.6% of cases of pneumonia, 90.9% of bacterial" exact="pneumonia" post="and 84.6% of acute respiratory distress syndrome occurred in"/>
   <result pre="cases of pneumonia, 90.9% of bacterial pneumonia and 84.6% of" exact="acute respiratory distress syndrome" post="occurred in influenza A cases. In more than half"/>
   <result pre="pneumonia and 84.6% of acute respiratory distress syndrome occurred in" exact="influenza" post="A cases. In more than half of all influenza"/>
   <result pre="in influenza A cases. In more than half of all" exact="influenza" post="A cases, the cause was the H1N1 subtype. All"/>
   <result pre="was the H1N1 subtype. All cases presenting multiorgan failure had" exact="influenza" post="A and, of these, 75% were due to subtype"/>
   <result pre="to subtype A (H1N1) pdm09. The mean ICU stay for" exact="influenza" post="A (H1N1) pdm09 and B were longer (12.3 days"/>
   <result pre="(Â±SD 9.7) and 15.1 days (Â±SD 15.6), respectively) than for" exact="influenza" post="A (H3N2) (8.3 daysâ€‰Â±â€‰SD 2.4), although the differences were"/>
   <result pre="year, 1 year and 8 years, respectively), all infected by" exact="influenza" post="type A (two H1N1 pdm09Â and one A without"/>
   <result pre="One death occurred without presenting complications; another occurred after presenting" exact="pneumonia" post="with acute respiratory distress syndrome, bacterial pneumonia and multiorgan"/>
   <result pre="occurred without presenting complications; another occurred after presenting pneumonia with" exact="acute respiratory distress syndrome," post="bacterial pneumonia and multiorgan failure; the third death presented"/>
   <result pre="another occurred after presenting pneumonia with acute respiratory distress syndrome," exact="bacterial pneumonia" post="and multiorgan failure; the third death presented bacterial pneumonia."/>
   <result pre="occurred after presenting pneumonia with acute respiratory distress syndrome, bacterial" exact="pneumonia" post="and multiorgan failure; the third death presented bacterial pneumonia."/>
   <result pre="syndrome, bacterial pneumonia and multiorgan failure; the third death presented" exact="bacterial pneumonia." post="None had received the influenza vaccine. Discussion Our results"/>
   <result pre="the third death presented bacterial pneumonia. None had received the" exact="influenza" post="vaccine. Discussion Our results show the clinical and epidemiological"/>
   <result pre="persons aged 0â€&quot;17 years hospitalized with severe conditions due to" exact="influenza" post="A and B in the post-pandemic seasons between 2010â€&quot;2011"/>
   <result pre="and 2015â€&quot;2016 in Catalonia. Four-fifths of cases were infected by" exact="influenza" post="A and 20% by influenza B. Although not significant,"/>
   <result pre="of cases were infected by influenza A and 20% by" exact="influenza" post="B. Although not significant, hospitalization due to influenza was"/>
   <result pre="20% by influenza B. Although not significant, hospitalization due to" exact="influenza" post="was more frequent in males than in females, as"/>
   <result pre="that differences in sex and morbidity and mortality due to" exact="influenza" post="may be related to endocrine-immunological interactions and behavioural and"/>
   <result pre="a significant differential factor when we analysed virus subtypes. The" exact="influenza" post="A (H1N1) pdm09 subtype was more frequent and aggressive"/>
   <result pre="frequent and aggressive in children aged &amp;lt;2 years (63.1%), while" exact="influenza" post="B was more frequent in children aged 3â€&quot;11 years"/>
   <result pre="had chronic disease. Although not significant, 24.6% of cases of" exact="influenza" post="B had pre-existing chronic disease compared with 14.8% of"/>
   <result pre="had pre-existing chronic disease compared with 14.8% of cases of" exact="influenza" post="A. This is in line with other studies, such"/>
   <result pre="that by Mancinelli et al.1 who found that children with" exact="cancer" post="were more susceptible to influenza B, and the study"/>
   <result pre="who found that children with cancer were more susceptible to" exact="influenza" post="B, and the study by Acar et al.21 which"/>
   <result pre="B, and the study by Acar et al.21 which found" exact="influenza" post="B infection is more frequent in children with pulmonary,"/>
   <result pre="admission. Of these, more than three-quarters were infected with the" exact="influenza" post="A virus, with the H1N1 pdm09Â subtype being found"/>
   <result pre="other published studies1,21â€&quot;23. This suggests disease severity is associated with" exact="influenza" post="A infection, as in our study, in which the"/>
   <result pre="our study, in which the three deaths were caused by" exact="influenza" post="A, and two by subtype H1N1 pdm09. The percentage"/>
   <result pre="The percentage of cases requiring ICU admission were similar in" exact="influenza" post="A and influenza B cases (21.7% and 19.7%, respectively)."/>
   <result pre="cases requiring ICU admission were similar in influenza A and" exact="influenza" post="B cases (21.7% and 19.7%, respectively). The study by"/>
   <result pre="The study by Tran et al.24 obtained similar percentages between" exact="influenza" post="A and influenza B cases (12.7% and 12.6%, respectively);"/>
   <result pre="Tran et al.24 obtained similar percentages between influenza A and" exact="influenza" post="B cases (12.7% and 12.6%, respectively); however, these percentages"/>
   <result pre="in our study severe hospitalized children were included. Pneumonia and" exact="acute respiratory distress syndrome" post="were the most frequent complications, as observed in other"/>
   <result pre="A small percentage of hospitalized cases were vaccinated against seasonal" exact="influenza" post="and only one in four children with pre-existing chronic"/>
   <result pre="et al. described a vaccination coverage of &amp;lt;50%26, even though" exact="influenza" post="vaccination is included in the routine vaccination schedule: before"/>
   <result pre="was &amp;lt;6% in children. Children have a higher incidence of" exact="influenza" post="and a higher hospitalization rate than adults27 and are"/>
   <result pre="such as Austria, Finland, Latvia and Slovakia have introduced routine" exact="influenza" post="vaccination for all children from 6â€&quot;7 months, while in"/>
   <result pre="influenza29â€&quot;31. The United States, Canada and Japan have also included" exact="influenza" post="vaccination from 6 months of age32â€&quot;34. Sugaya et al."/>
   <result pre="months of age32â€&quot;34. Sugaya et al. evaluated the inclusion of" exact="influenza" post="vaccination in the 2013â€&quot;2016 seasons in children aged 6"/>
   <result pre="a vaccine effectiveness (VE) in disease prevention of 51% for" exact="influenza" post="A and 32% for influenza B; the VE in"/>
   <result pre="disease prevention of 51% for influenza A and 32% for" exact="influenza" post="B; the VE in preventing hospitalizations was 52% for"/>
   <result pre="influenza B; the VE in preventing hospitalizations was 52% for" exact="influenza" post="A and 28% for influenza B35. Currently, vaccination of"/>
   <result pre="preventing hospitalizations was 52% for influenza A and 28% for" exact="influenza" post="B35. Currently, vaccination of people aged &amp;lt;60 years with"/>
   <result pre="aged &amp;lt;60 years with a high risk of complications from" exact="influenza" post="is recommended in Catalonia36, but this does not include"/>
   <result pre="there seem to be no studies supporting the administration of" exact="influenza" post="vaccine or antiviral treatment in children aged &amp;lt;6 months,"/>
   <result pre="the clinical and epidemiological characteristics of children hospitalized due to" exact="influenza" post="in Catalonia, and the differences observed according to the"/>
   <result pre="interests. References References 1.MancinelliLet al.Clinical features of children hospitalized with" exact="influenza" post="A and B infections during the 2012â€&quot;2013 influenza season"/>
   <result pre="hospitalized with influenza A and B infections during the 2012â€&quot;2013" exact="influenza" post="season in ItalyBMC Infect. Dis.201616610.1186/s12879-015-1333-x26743673 2.IulianoADet al.Estimates of global"/>
   <result pre="influenza-associated respiratory mortality: a modelling studyLancet.20183911285130010.1016/S0140-6736(17)33293-229248255 3.HongKWet al.Clinical manifestations of" exact="influenza" post="A and B in children and adults at a"/>
   <result pre="in Hong KongVaccine.2012301895190010.1016/j.vaccine.2011.12.02722222872 6.MoolasartVManosuthiWRisk factors for hospitalization among children with" exact="influenza" post="B infectionSoutheast Asian J. Trop. Med. Public Health.20144562262924974646 7.Departament"/>
   <result pre="la grip. Available from: http://canalsalut.gencat.cat/ca/salut-a-z/g/grip/recursos-per-a-professionals/ (2018). 10.AntÃ³nAet al.Virological surveillance of" exact="influenza" post="and other respiratory viruses during six consecutive seasons from"/>
   <result pre="al.Effectiveness of hand hygiene and provision of information in preventing" exact="influenza" post="cases requiring hospitalizationPrev. Med.20125443443910.1016/j.ypmed.2012.04.00922548868 13.DomÃ­nguezAGodoyPTornerNThe effectiveness of influenza vaccination"/>
   <result pre="in preventing influenza cases requiring hospitalizationPrev. Med.20125443443910.1016/j.ypmed.2012.04.00922548868 13.DomÃ­nguezAGodoyPTornerNThe effectiveness of" exact="influenza" post="vaccination in different groupsExpert Rev. Vac.20161575176410.1586/14760584.2016.1142878 14.Observatori del Sistema"/>
   <result pre="Catalunya. Available from: http://observatorisalut.gencat.cat/web/.content/minisite/observatorisalut/ossc_central_resultats/informes/fitxers_estatics/Central_resultats_hospitals_dades_2016.pdf (2017). 15.QuachCPichÃ©-WalkerLPlattRMooreDRisk factors associated with severe" exact="influenza" post="infections in childhood: implication for vaccine strategyPediatrics.2003112e197e20110.1542/peds.112.3.e19712949312 16.World Health"/>
   <result pre="influenza-associated hospitalizations in Hong KongAm. J. Epidemiol.201518233534410.1093/aje/kwv06826219977 18.ChoiWIRhoBHLeeMYMale predominance of" exact="pneumonia" post="and hospitalization in pandemic influenza A (H1N1) 2009 infectionBMC"/>
   <result pre="J. Epidemiol.201518233534410.1093/aje/kwv06826219977 18.ChoiWIRhoBHLeeMYMale predominance of pneumonia and hospitalization in pandemic" exact="influenza" post="A (H1N1) 2009 infectionBMC Res. Notes.2011435110.1186/1756-0500-4-35121906395 19.KleinSLHodgsonARobisonDPMechanisms of sex"/>
   <result pre="(H1N1) 2009 infectionBMC Res. Notes.2011435110.1186/1756-0500-4-35121906395 19.KleinSLHodgsonARobisonDPMechanisms of sex disparities in" exact="influenza" post="pathogenesisJ. Leukoc. Biol.201292677310.1189/jlb.081142722131346 20.KareagaNAet al.CaracterÃ­sticas clÃ­nicas de los niÃ±os"/>
   <result pre="infecciÃ³n por virus InfluenzaAn. Pediatr. (Barc).20056251210.1157/1307017415642235 21.AcarMet al.Clinical differences of" exact="influenza" post="subspecies among hospitalized childrenTurk. Arch. Pediatr.201752152210.5152/TurkPediatriArs.2017.4695 22.KusznierzGet al.Impact of"/>
   <result pre="influenza subspecies among hospitalized childrenTurk. Arch. Pediatr.201752152210.5152/TurkPediatriArs.2017.4695 22.KusznierzGet al.Impact of" exact="influenza" post="in the post-pandemic phase: Clinical features in hospitalized patients"/>
   <result pre="in the post-pandemic phase: Clinical features in hospitalized patients with" exact="influenza" post="A (H1N1) pdm09 and H3N2 viruses, during 2013 in"/>
   <result pre="ArgentinaJ. Med. Virol.2017891186119110.1002/jmv.2475828004402 23.StrengAPrifertCWeissbrichBLieseJGContinued high incidence of children with severe" exact="influenza" post="A(H1N1)pdm09 admitted to paediatric intensive care units in Germany"/>
   <result pre="intensive care units in Germany during the first three post-pandemic" exact="influenza" post="seasons, 2010/11-2012/13BMC Infect Dis.20151857310.1186/s12879-015-1293-1 24.TranDet al.Hospitalization for influenza A"/>
   <result pre="three post-pandemic influenza seasons, 2010/11-2012/13BMC Infect Dis.20151857310.1186/s12879-015-1293-1 24.TranDet al.Hospitalization for" exact="influenza" post="A versus BPediatrics.2016138e2015464310.1542/peds.2015-464327535144 25.MachablishviliATsereteliDZkhashviliKKarseladzeIImnadzePClinical and epidemiological characterization of influenza"/>
   <result pre="for influenza A versus BPediatrics.2016138e2015464310.1542/peds.2015-464327535144 25.MachablishviliATsereteliDZkhashviliKKarseladzeIImnadzePClinical and epidemiological characterization of" exact="influenza" post="A/H1N1pdm and b among hospitalized children, Georgia, season 2010â€&quot;2011Georgian"/>
   <result pre="pediatrÃ­a, Â¿sÃ­ o no?An. Pediatr. (Barc).201379261e1261e1110.1016/j.anpedi.2013.03.00523623850 28.LimJKet al.The association between" exact="influenza" post="treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed"/>
   <result pre="primary school-age children against influenza: experiences of a live attenuated" exact="influenza" post="vaccine programme, England, 2015/16. Euro Surveill. 23 (2018). 31.ECDC."/>
   <result pre="2015/16. Euro Surveill. 23 (2018). 31.ECDC. Vaccine schedules for seasonal" exact="influenza" post="in all countries of the European Union Available from:"/>
   <result pre="Available from: https://ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccination-schedule. 32.CDC. Influenza vaccines â€&quot; United States, 2017â€&quot;18" exact="influenza" post="season. Available from: https://www.cdc.gov/flu/protect/vaccine/vaccines.htm. 33.Public Health Agency of Canada."/>
   <result pre="2015-2016. Available from: https://static1.squarespace.com/static/5111f3d0e4b0e580c19f5405/t/57e9b1b1be6594b5b5cd6243/1474933169756/FluFlyerEng16-17.pdf (2015). 35.SugayaNet al.Three-season effectiveness of inactivated" exact="influenza" post="vaccine in preventing influenza illness and hospitalization in children"/>
   <result pre="(2015). 35.SugayaNet al.Three-season effectiveness of inactivated influenza vaccine in preventing" exact="influenza" post="illness and hospitalization in children in Japan, 2013-2016Vaccine.2018361063107110.1016/j.vaccine.2018.01.02429361343 36.AgÃ¨ncia"/>
   <result pre="for Disease Prevention and Control. ECDC scientific advice on seasonal" exact="influenza" post="vaccination of children and pregnant women. Stockholm: ECDC. Available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6731519\results\search\disease\results.xml">
   <result pre=": italic;} EpidemicsEpidemicsEpidemics1755-43651878-0067Elsevier S1755-4365(18)30105-1 doi: 10.1016/j.epidem.2019.100346100346 : Article Phylogeography of" exact="rubella" post="virus in Asia: Vaccination and demography shape synchronous outbreaks"/>
   <result pre="the CC BY license (http://creativecommons.org/licenses/by/4.0/). Highlights â€¢Metapopulation dynamics contribute to" exact="rubella" post="persistence in East/Southeast Asia. â€¢Circulation patterns differ between rubella"/>
   <result pre="to rubella persistence in East/Southeast Asia. â€¢Circulation patterns differ between" exact="rubella" post="viral genotypes 1E and 2B. â€¢China serves as a"/>
   <result pre="Asia. â€¢Taiwan may act as an important sentinel for regional" exact="rubella" post="activity. Abstract Rubella virus causes mild disease in children"/>
   <result pre="early stages of pregnancy, it can cause spontaneous abortion, congenital" exact="rubella" post="syndrome (CRS) and associated birth defects. Despite the availability"/>
   <result pre="associated birth defects. Despite the availability of an effective vaccine," exact="rubella" post="virus continues to circulate endemically in several regions of"/>
   <result pre="is therefore important to understand how the regional persistence of" exact="rubella" post="is affected both by dynamics occurring across countries and"/>
   <result pre="from countries in E/SE Asia to explore the phylogeography of" exact="rubella" post="virus in this region. Our results underline that metapopulation"/>
   <result pre="region. Our results underline that metapopulation dynamics are key for" exact="rubella" post="persistence and highlight the source-sink population structure of the"/>
   <result pre="still estimates that over 100,000 babies/year are born with congenital" exact="rubella" post="syndrome worldwide (Vynnycky et al., 2016; World Health Organization,"/>
   <result pre="knowledge, just a single study has addressed global diffusion of" exact="rubella" post="(Cloete, 2014); findings indicated that infection tends to flow"/>
   <result pre="of vaccination coverage. While countries such as Japan introduced the" exact="rubella" post="vaccine to adolescent school girls as early as 1977"/>
   <result pre="outbreak, suggesting a degree of regional synchronization. Our understanding of" exact="rubella" post="persistence will be strengthened by characterizing the extent to"/>
   <result pre="with waning immunity, or complex cross-immunity (e.g. influenza), but as" exact="rubella" post="infection and vaccination are completely immunizing, estimation of the"/>
   <result pre="birth cohorts. Characterizing susceptible dynamics will improve our understanding of" exact="rubella" post="persistence and may contribute to optimizing public health intervention"/>
   <result pre="one serotype exists, the CDC has identified two groups of" exact="rubella" post="viruses consisting of ten and three genotypes, respectively (World"/>
   <result pre="we aimed to assess the importance of metapopulation dynamics to" exact="rubella" post="persistence in E/SE Asia. We used publicly available genetic"/>
   <result pre="additionally estimated country-specific susceptibility profiles to link temporal trends in" exact="rubella" post="incidence and susceptible population size with the timing of"/>
   <result pre="that did not map to the 739bp window used for" exact="rubella" post="genotype identification (World Health Organization, 2005) were discarded. For"/>
   <result pre="dependent fashion (BjÃ¸rnstad et al., 2002). Estimated coverage achieved in" exact="rubella" post="vaccination programs, timing and age range of supplementary immunization"/>
   <result pre="that occur at intervals of 2â€&quot;4 years), and time-series of" exact="rubella" post="incidence are publicly available from the World Health Organization"/>
   <result pre="to 2015 (supplementary Fig. 7). Fig. 2 Circulation patterns of" exact="rubella" post="virus in Asia. Circulation maps of a) genotype 1E"/>
   <result pre="this period; according to the World Health Organization, reporting of" exact="rubella" post="cases in many countries did not start until 2005"/>
   <result pre="a vaccination coverage threshold of 80% (1-1/R0 for R0Ëœ5). That" exact="rubella" post="continues to circulate in many of these countries suggests"/>
   <result pre="the importance of metapopulation processes in the epidemic dynamics of" exact="rubella" post="in this region. Demographic reconstruction of the viral effective"/>
   <result pre="coincides with the period in which several Asian countries experienced" exact="rubella" post="epidemics (supplementary Fig. 1a). Broad concordance between peaks in"/>
   <result pre="To understand whether metapopulation dynamics contribute to the persistence of" exact="rubella" post="across neighboring countries that vary in their level of"/>
   <result pre="evidence. Our analysis indicates that circulation patterns may differ between" exact="rubella" post="virus genotypes 1E and 2B. As no evidence of"/>
   <result pre="1E, Taiwan likely acts as an important indicator for regional" exact="rubella" post="activity across East and Southeast Asia. In line with"/>
   <result pre="to E/SE Asia. While other studies have looked at global" exact="rubella" post="circulation, our study focuses on regional spread in an"/>
   <result pre="a poor measure for the connections that are relevant to" exact="rubella" post="spread. Our finding that viral persistence is maintained through"/>
   <result pre="the limited relevance of imports from India for re-introduction of" exact="rubella" post="in E/SE Asia will become increasingly important as the"/>
   <result pre="E/SE Asia will become increasingly important as the region approaches" exact="rubella" post="elimination. Given the introduction of rubella-containing vaccine to all"/>
   <result pre="metric indicating successful control. It remains to be seen how" exact="rubella" post="dynamics throughout the region will affect Japan as it"/>
   <result pre="by its large population size, relatively recent introduction of routine" exact="rubella" post="vaccination, and prevalence of travel connections, our finding of"/>
   <result pre="and characterization, there are multiple factors that predispose Taiwan to" exact="rubella" post="importations. Past serological studies show that seronegativity is higher"/>
   <result pre="2007) and until 2002, Taiwan did not require proof of" exact="rubella" post="vaccination upon immigration (Lin et al., 2010; Taiwan Centers"/>
   <result pre="immigrants now come from nations in Southeast Asia, where endemic" exact="rubella" post="transmission is still widespread and vaccination has only recently"/>
   <result pre="its strong geopolitical ties to China, a clear source of" exact="rubella" post="infection, makes Taiwan an ideal sentinel for the identification"/>
   <result pre="effective population size of both genotypes is striking given that" exact="rubella" post="virus immunity is completely cross-protective. Previous work has shown"/>
   <result pre="two consecutive years of viral population growth during any single" exact="rubella" post="epidemic in a given location, closely synchronized outbreaks across"/>
   <result pre="major pulse driver, akin to that of London for pre-vaccination" exact="measles" post="epidemics in the United Kingdom (Grenfell et al., 2001)."/>
   <result pre="cities are above the critical community size for maintaining persistent" exact="rubella" post="circulation (Metcalf et al., 2013) and that high international"/>
   <result pre="exceeds that from countries in Southeast and South Asia, where" exact="rubella" post="is often not a notifiable disease. Further, even in"/>
   <result pre="lack access to vaccination, will further refine our understanding of" exact="rubella" post="circulation and persistence. Literature on the historical genotypic characterization"/>
   <result pre="and persistence. Literature on the historical genotypic characterization of global" exact="rubella" post="viruses indicates that many subtypes and lineages have gone"/>
   <result pre="in countries with minimal available data. Our results suggest that" exact="rubella" post="lineages are not confined to specific countries and therefore"/>
   <result pre="BAB; OPP1094793). References References AbernathyE.S.Status of global virologic surveillance for" exact="rubella" post="virusesJ. Infect. Dis.2042011S524S53221666209 AndersonR.M.MayR.M.Infectious Diseases of Humans: Dynamics and"/>
   <result pre="using a time series SIR modelEcol. Monogr.722002169184 ChengW.-Y.WangH.-C.LiuM.-T.WuH.-S.Molecular surveillance of" exact="rubella" post="viruses in Taiwan from 2005 to 2011J. Med. Virol.85201374575323417619"/>
   <result pre="Population Ages, Japan Quietly Turns to Immigration2017https://www.migrationpolicy.org/article/its-population-ages-japan-quietly-turns-immigration DewanP.GuptaP.Burden of congenital" exact="rubella" post="syndrome (CRS) in India: a systematic reviewIndian Pediatr.49201237739922700664 DrummondA.J.SuchardM.A.XieD.RambautA.Bayesian"/>
   <result pre="in continuous-time Markov chainsCan. J. Stat.362008355368 FigueiredoC.A.OliveiraM.I.CurtiS.P.AfonsoA.M.S.Yu ALFrugiGualbertoF.DurigonE.L.Phylogenetic analysis of" exact="rubella" post="virus strains during an outbreak in SÃ£o Paulo, 2007-2008J."/>
   <result pre="26 October 2017). GongL.I.SuchardM.A.BloomJ.D.Stability-mediated epistasis constrains the evolution of an" exact="influenza" post="proteinElife22013e00631 GrenfellB.T.BjÃ¸rnstadO.N.KappeyJ.Travelling waves and spatial hierarchies in measles epidemicsNature414200171672311742391"/>
   <result pre="of an influenza proteinElife22013e00631 GrenfellB.T.BjÃ¸rnstadO.N.KappeyJ.Travelling waves and spatial hierarchies in" exact="measles" post="epidemicsNature414200171672311742391 GrenfellB.T.PybusO.G.GogJ.R.WoodJ.L.N.DalyJ.M.MumfordJ.A.HolmesE.C.Unifying the epidemiological and evolutionary dynamics of pathogensScience3032004327"/>
   <result pre="molecular clock of mitochondrial DNAJ. Mol. Evol.2219851601743934395 IcenogleJ.P.FreyT.K.AbernathyE.ReefS.E.SchnurrD.StewartJ.A.Genetic analysis of" exact="rubella" post="viruses found in the United States between 1966 and"/>
   <result pre="the United States between 1966 and 2004: evidence that indigenous" exact="rubella" post="viruses have been eliminatedClin. Infect. Dis.432006S133S14016998772 KearseM.Geneious2012 KinoshitaR.NishiuraH.Assessing herd"/>
   <result pre="have been eliminatedClin. Infect. Dis.432006S133S14016998772 KearseM.Geneious2012 KinoshitaR.NishiuraH.Assessing herd immunity against" exact="rubella" post="in Japan: a retrospective seroepidemiological analysis of age-dependent transmission"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2PLoS Pathog.102014e1003932 LesslerJ.MetcalfC.J.E.Balancing evidence and uncertainty when considering rubella"/>
   <result pre="human influenza H3N2PLoS Pathog.102014e1003932 LesslerJ.MetcalfC.J.E.Balancing evidence and uncertainty when considering" exact="rubella" post="vaccine introductionPLoS One82013 LesslerJ.MetcalfC.J.E.GraisR.F.LuqueroF.J.CummingsD.A.T.GrenfellB.T.Measuring the performance of vaccination programs"/>
   <result pre="in AsiaAm. J. Trop. Med. Hyg.822010404420064993 MartÃ­nez-TorresA.O.MosqueraM.M.De OryF.GonzÃ¡lez-PraetoriusA.EchevarrÃ­aJ.E.Genetic characterization of" exact="rubella" post="virus strains detected in Spain, 1998-2014PLoS One112016e0162403 MetcalfC.J.E.BjÃ¸rnstadO.N.FerrariM.J.KlepacP.BhartiN.Lopez-GatellH.GrenfellB.T.The epidemiology"/>
   <result pre="virus strains detected in Spain, 1998-2014PLoS One112016e0162403 MetcalfC.J.E.BjÃ¸rnstadO.N.FerrariM.J.KlepacP.BhartiN.Lopez-GatellH.GrenfellB.T.The epidemiology of" exact="rubella" post="in Mexico: seasonality, stochasticity and regional variationEpidemiol. Infect.13920111029103820843389 MetcalfC.J.E.MunaycoC.V.ChowellG.GrenfellB.T.BjÃ¸rnstadO.N.Rubella"/>
   <result pre="and importance of spatial coupling to the risk of congenital" exact="rubella" post="syndrome in PeruJ. R. Soc. Interface8201136937620659931 MetcalfC.J.E.Implications of spatially"/>
   <result pre="of spatially heterogeneous vaccination coverage for the risk of congenital" exact="rubella" post="syndrome in South AfricaJ. R. Soc. Interface10201320120756 MininV.N.SuchardM.A.Counting labeled"/>
   <result pre="coalescent-based inference of population dynamicsMol. Biol. Evol.2520081459147118408232 MiramboM.M.MajigoM.AboudS.GroÃŸU.MshanaS.E.Serological makers of" exact="rubella" post="infection in Africa in the pre vaccination era: a"/>
   <result pre="the pre vaccination era: a systematic reviewBMC Res. Notes8201571626602892 MuldersM.N.Global" exact="measles" post="and rubella laboratory network support for elimination goals, 2010â€&quot;2015MMWR"/>
   <result pre="vaccination era: a systematic reviewBMC Res. Notes8201571626602892 MuldersM.N.Global measles and" exact="rubella" post="laboratory network support for elimination goals, 2010â€&quot;2015MMWR Morb. Mortal."/>
   <result pre="Inf. Source2009118 PhamV.H.VanNguyen T.NguyenT.T.T.DangL.D.HoangN.H.VanNguyen T.AbeK.Rubella epidemic in Vietnam: Characteristic of" exact="rubella" post="virus genes from pregnant women and their fetuses/newborns with"/>
   <result pre="virus genes from pregnant women and their fetuses/newborns with congenital" exact="rubella" post="syndromeJ. Clin. Virol.57201315215623481444 PlotkinS.A.The history of rubella and rubella"/>
   <result pre="fetuses/newborns with congenital rubella syndromeJ. Clin. Virol.57201315215623481444 PlotkinS.A.The history of" exact="rubella" post="and rubella vaccination leading to eliminationClin. Infect. Dis.432006S164S16816998777 Pons-salortM.ParkerE.Pk.GrasslyN.C.The"/>
   <result pre="congenital rubella syndromeJ. Clin. Virol.57201315215623481444 PlotkinS.A.The history of rubella and" exact="rubella" post="vaccination leading to eliminationClin. Infect. Dis.432006S164S16816998777 Pons-salortM.ParkerE.Pk.GrasslyN.C.The epidemiology of"/>
   <result pre="outstanding questionsCurr. Opin. Infect. Dis.28201547948726203854 RivaillerP.AbernathyE.IcenogleJ.Genetic diversity of currently circulating" exact="rubella" post="viruses: a need to define more precise viral groupsJ."/>
   <result pre="precise viral groupsJ. Gen. Virol.2017 RussellC.A.The global circulation of seasonal" exact="influenza" post="A (H3N2) virusesScience (80-.)3202008340346 ShihC.T.ChangY.C.WangH.L.LinC.C.Comparing the rubella seronegativity in"/>
   <result pre="circulation of seasonal influenza A (H3N2) virusesScience (80-.)3202008340346 ShihC.T.ChangY.C.WangH.L.LinC.C.Comparing the" exact="rubella" post="seronegativity in pregnant women who received one dose of"/>
   <result pre="rubella seronegativity in pregnant women who received one dose of" exact="rubella" post="vaccine at different ages in TaiwanVaccine3420164787479127544587 SugishitaY.ShimataniN.KatowS.TakahashiT.HoriN.Epidemiological characteristics of"/>
   <result pre="rubella vaccine at different ages in TaiwanVaccine3420164787479127544587 SugishitaY.ShimataniN.KatowS.TakahashiT.HoriN.Epidemiological characteristics of" exact="rubella" post="and congenital rubella syndrome in the 2012-2013 epidemics in"/>
   <result pre="different ages in TaiwanVaccine3420164787479127544587 SugishitaY.ShimataniN.KatowS.TakahashiT.HoriN.Epidemiological characteristics of rubella and congenital" exact="rubella" post="syndrome in the 2012-2013 epidemics in Tokyo, JapanJpn. J."/>
   <result pre="on 25 October 2017). TakahashiS.MetcalfC.J.E.FerrariM.J.MossW.J.TrueloveS.A.TatemA.J.GrenfellB.T.LesslerJ.Reduced vaccination and the risk of" exact="measles" post="and other childhood infections post-EbolaScience34720151240124225766232 TakahashiS.MetcalfC.J.E.FerrariM.J.TatemA.J.LesslerJ.The geography of measles"/>
   <result pre="of measles and other childhood infections post-EbolaScience34720151240124225766232 TakahashiS.MetcalfC.J.E.FerrariM.J.TatemA.J.LesslerJ.The geography of" exact="measles" post="vaccination in the African Great Lakes regionNat. Commun.820171558528541287 Tanaka-TayaKeikoSatohHiroshiAraiSatoruYamagishiTakuyaYahataYuichiroNakashimaKazutoshiSugawaraTamieOhkusaYasushiMatsuiTamanoSaitoTakehitoKanouKazuhikoShimadaTomoeKinoshitaHitomiYamashitaKazuyoYasuiYoshinoriYukiK.O.Nationwide"/>
   <result pre="measles vaccination in the African Great Lakes regionNat. Commun.820171558528541287 Tanaka-TayaKeikoSatohHiroshiAraiSatoruYamagishiTakuyaYahataYuichiroNakashimaKazutoshiSugawaraTamieOhkusaYasushiMatsuiTamanoSaitoTakehitoKanouKazuhikoShimadaTomoeKinoshitaHitomiYamashitaKazuyoYasuiYoshinoriYukiK.O.Nationwide" exact="rubella" post="epidemic - Japan, 2013MMWR Morb. Mortal. Wkly. Rep.62201345746223760185 TeradaK.Rubella"/>
   <result pre="- Japan, 2013MMWR Morb. Mortal. Wkly. Rep.62201345746223760185 TeradaK.Rubella and congenital" exact="rubella" post="syndrome in Japan: epidemiological problemsJpn. J. Infect. Dis.562003818712944671 ThaoN.T.T.Evolution"/>
   <result pre="ASEAN Stud.320156892 United NationsInternational Migration Report 2015(doi:ST/ESA/SER.A/384)2016 Vauloup-FellousC.HÃ¼bschenJ.M.AbernathyE.S.IcenogleJ.GaidotN.DubreuilP.Parent-du-ChÃ¢teletI.Grangeot-KerosL.MullerC.P.Phylogenetic analysis of" exact="rubella" post="viruses involved in congenital rubella infections in France between"/>
   <result pre="Report 2015(doi:ST/ESA/SER.A/384)2016 Vauloup-FellousC.HÃ¼bschenJ.M.AbernathyE.S.IcenogleJ.GaidotN.DubreuilP.Parent-du-ChÃ¢teletI.Grangeot-KerosL.MullerC.P.Phylogenetic analysis of rubella viruses involved in congenital" exact="rubella" post="infections in France between 1995 and 2009J. Clin. Microbiol.4820102530253520463161"/>
   <result pre="immunisation coverage data to estimate the global burden of congenital" exact="rubella" post="syndrome, 1996-2010 : a systematic reviewPLoS One112016e0149160 WangI.J.HuangL.M.ChenH.H.HwangK.C.ChenC.J.Seroprevalence of"/>
   <result pre="rubella syndrome, 1996-2010 : a systematic reviewPLoS One112016e0149160 WangI.J.HuangL.M.ChenH.H.HwangK.C.ChenC.J.Seroprevalence of" exact="rubella" post="infection after national immunization program in Taiwan: vaccination status"/>
   <result pre="Interface13201620151101- WesolowskiA.Multinational patterns of seasonal asymmetry in human movement influence" exact="infectious disease" post="dynamicsNat. Commun.82017206929234011 WinterA.K.PramanikS.LesslerJ.FerrariM.GrenfellB.T.MetcalfC.J.E.Rubella Vaccination in India: Identifying broad consequences"/>
   <result pre="Health OrganizationStandardization of the nomenclature for genetic characteristics of wild-type" exact="rubella" post="virusesWkly. Epidemiol. Rec.80200512613215850226 World Health OrganizationRubella vaccines: WHO position"/>
   <result pre="methodsJ. Mol. Evol.3919943063147932792 ZhuZ.Emergence and continuous evolution of genotype 1E" exact="rubella" post="viruses in ChinaJ. Clin. Microbiol.50201235336322162559 ZhuZ.Evolutionary analysis of rubella"/>
   <result pre="1E rubella viruses in ChinaJ. Clin. Microbiol.50201235336322162559 ZhuZ.Evolutionary analysis of" exact="rubella" post="viruses in mainland China during 2010â€&quot;2012: endemic circulation of"/>
   <result pre="of genotype 2BSci. Rep.52015799925613734 ZhuZ.Analysis of complete genomes of the" exact="rubella" post="virus genotypes 1E and 2B which circulated in China,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6731520\results\search\disease\results.xml">
   <result pre="of the British salmonid aquaculture industry from the perspective of" exact="infectious disease" post="control. We combine for the first time live fish"/>
   <result pre="an estimated one third of salmon mortality was attributed to" exact="infectious disease" post="(Kilburn et al., 2012). Finfish diseases can have severe"/>
   <result pre="diseases can be maintained in wild populations with examples in" exact="parasitic disease" post="or sustained via vertical transmission. However, most evidence points"/>
   <result pre="excluded here, although this background risk could be incorporated in" exact="infectious disease" post="simulation models and this would be relevant for the"/>
   <result pre="a detailed multi-layer network mapping of the potential routes of" exact="infectious disease" post="transmission. These layers are live fish movement, transmission along"/>
   <result pre="position in connecting sub-components of the network. More generally in" exact="infectious disease" post="transmission, â€œsuper-spreadersâ€� are often identified (Woolhouse et al., 1997),"/>
   <result pre="the potential effectiveness of control measures requires dynamic simulation of" exact="infectious disease" post="transmission on this network. In conclusion, the contact structure"/>
   <result pre="infectionJ. Aquat. Anim. Health1632004109115 DentJ.E.The potential spread of highly pathogenic" exact="avian influenza" post="virus via dynamic contacts between poultry premises in Great"/>
   <result pre="Aquat. Anim. Health1632004109115 DentJ.E.The potential spread of highly pathogenic avian" exact="influenza" post="virus via dynamic contacts between poultry premises in Great"/>
   <result pre="Western ScotlandAquaculture36836920128994 KivelÃ¤M.Multilayer networksJ. Complex Netw.232014203271 LÃ¸vdalT.EngerÃ˜.Detection of infectious salmon" exact="anemia" post="virus in sea water by nested RT-PCRDis. Aquat. Org.49200212312812078980"/>
   <result pre="Health.2016 MardonesF.O.Farm-level reproduction number during an epidemic of infectious salmon" exact="anemia" post="virus in southern Chile in 2007-2009Prev. Vet. Med.1023201117518421840073 MardonesF.O.The"/>
   <result pre="role of fish movements and the spread of infectious salmon" exact="anemia" post="virus (ISAV) in Chile, 2007â€&quot;2009Prev. Vet. Med.11412014374624485704 MunroL.A.GregoryA.Application of"/>
   <result pre="20162017The Scottish GovernmentEdinburgh MurrayA.G.SmithR.J.StaggR.M.Shipping and the spread of infectious salmon" exact="anemia" post="in Scottish aquacultureEmerg. Infect. Dis.8120021511749740 MurrayA.G.Epidemiology of Renibacterium salmoninarum"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6734352\results\search\disease\results.xml">
   <result pre="Science1021-77701423-0127BioMed CentralLondon 563 doi: 10.1186/s12929-019-0563-4 : Research Inhibition of H1N1" exact="influenza" post="virus infection by zinc oxide nanoparticles: another emerging application"/>
   <result pre="oxide nanoparticles (ZnO-NPs) and PEGylated zinc oxide nanoparticles against H1N1" exact="influenza" post="virus. Methods The nanoparticles were characterized using the inductively"/>
   <result pre="an indirect immunofluorescence assay was also performed. Results Post-exposure of" exact="influenza" post="virus with PEGylated ZnO-NPs and bare ZnO-NPs at the"/>
   <result pre="be a novel, effective, and promising antiviral agent against H1N1" exact="influenza" post="virus infection, and future studies can be designed to"/>
   <result pre="of these nanoparticles. Keywords Antiviral activity Zinc oxide nanoparticle H1N1" exact="influenza" post="Polyethylene glycol Funding iran university of medical sciences9321540003MonavariSeyed Hamidreza"/>
   <result pre="recent estimates reported by the World Health Organization (WHO), seasonal" exact="influenza" post="epidemics lead to about 3â€&quot;5 million cases of severe"/>
   <result pre="the viral nucleoprotein and major matrix protein, of which only" exact="influenza" post="A and B viruses are the major culprit in"/>
   <result pre="there are only two classes of drugs available against different" exact="influenza" post="A strains and subtypes licensed by the U.S. Food"/>
   <result pre="effects of ZnO-NPs and ZnO-PEG-NPs on the replication of H1N1" exact="influenza" post="virus, which are amongst the most challenging viruses that"/>
   <result pre="dissolved in DMEM and used as a standard drug against" exact="influenza" post="at different concentrations. Polyethylene glycol (PEG) 6000 was also"/>
   <result pre="evaluate direct effects of ZnO and ZnO-PEG nanoparticles on H1N1" exact="influenza" post="particles, equal volumes of the viral suspensions (100 TCID50/ml)"/>
   <result pre="of total progeny virus. Quantitative Real-Time PCR assay To determine" exact="influenza" post="viral load, a quantitative system using Real-Time PCR assay"/>
   <result pre="kit contains primers and probe designed for detection of all" exact="influenza" post="A subtypes. The assay was performed using the Rotor-Gene"/>
   <result pre="ZnO-PEG-NPs did not lead to any reduction of the H1N1" exact="influenza" post="virus titer. Meanwhile, virucidal activity was not observed at"/>
   <result pre="nanoparticles, suggesting that nanoparticles could not act directly against the" exact="influenza" post="virus particle resulting in viral inactivation. The striking finding"/>
   <result pre="in a significant decrease in viral titer. Post-exposure of H1N1" exact="influenza" post="virus with PEGylated ZnO-NPs at the concentrations of 75,"/>
   <result pre="ZnO-PEG-NPs, polyethylene glycol, and oseltamivir on the titer of H1N1" exact="influenza" post="virus by TCID50 assay. * Statistically significant (pâ€‰ nâ€‰=â€‰3)"/>
   <result pre="level The antiviral activities of ZnO-NPs and ZnO-PEG-NPs against H1N1" exact="influenza" post="virus were further confirmed by quantitative Real-Time PCR. It"/>
   <result pre="94.6%, respectively. The inhibition rates were calculated based on the" exact="influenza" post="viral loads. It is obvious that the anti-influenza activity"/>
   <result pre="52.2% (Fig.Â 6). It is notable that the production of" exact="influenza" post="virus was completely inhibited by oseltamivir at the concentration"/>
   <result pre="6 The inhibitory rates of the four compounds against H1N1" exact="influenza" post="virus determined byÂ Real-Time PCR assay regarding to the"/>
   <result pre="study the inhibitory impact of nanoparticles on the expression of" exact="influenza" post="virus antigens on the MDCK-SIAT1 cells surface, an indirect"/>
   <result pre="of 75â€‰Î¼g/mL. Fig. 7 Immunofluorescence staining for detection of H1N1" exact="influenza" post="virus antigens in the MDCK-SIAT1 cells. (a) CellÂ control,"/>
   <result pre="(d) 200â€‰Î¼g/ml ZnO-PEG-NPs at 24â€‰h post infection Discussion The H1N1" exact="influenza" post="virus is a significant global public health threat with"/>
   <result pre="cause worldwide epidemics and pandemics. The current antiviral drugs against" exact="influenza" post="are weakened due to their significant adverse effects and"/>
   <result pre="a key role in enhancement of antiviral activity against H1N1" exact="influenza" post="virus and reduction of cell cytotoxicity on MDCK-SIAT1 cells."/>
   <result pre="that PEGylated ZnO-NP was associated with higher antiviral activity against" exact="herpes simplex" post="virus type 1 (HSV-1) and lower cytotoxicity on Vero"/>
   <result pre="for assessment of cytotoxicity of ZnO-NPs and ZnO-PEG-NPs on MCF-7" exact="breast cancer" post="cells, and they demonstrated the higher cytotoxicity for bare"/>
   <result pre="assessment of cytotoxicity of ZnO-NPs and ZnO-PEG-NPs on MCF-7 breast" exact="cancer" post="cells, and they demonstrated the higher cytotoxicity for bare"/>
   <result pre="the nanoparticles have inhibitory activities to suppress the proliferation of" exact="influenza" post="virus when added 1â€‰h after infection. As shown in"/>
   <result pre="not result in any decrease in the titer of H1N1" exact="influenza" post="virus. These findings indicate that the nanoparticles do not"/>
   <result pre="not occupied specific receptors involved in attachment and entry of" exact="influenza" post="particles into the host cells. These experimental results show"/>
   <result pre="with the some stages in the life cycle of the" exact="influenza" post="virus which occur after viral adsorption and internalization by"/>
   <result pre="revealed that inhibitory potential of ZnO-NPs and ZnO-PEG-NPs against H1N1" exact="influenza" post="virus was only documented in post-exposure antiviral assay, antiviral"/>
   <result pre="cellular uptake of nanoparticles [22, 23]. On the other hand," exact="influenza" post="viruses carry out their transcription and replication entirely inside"/>
   <result pre="its maximal non-cytotoxic concentration (200â€‰Î¼g/ml) had slightly antiviral activity on" exact="influenza" post="virus (with inhibition rate of 13.5%). As an explanation,"/>
   <result pre="conducted to investigate the inhibitory effects of various nanostructures on" exact="influenza" post="virus infection. In the most recent work, Kumar et"/>
   <result pre="against PR8-H1N1strain, and they proposed the IO-NPs as the potent" exact="influenza" post="virus inhibitor with 8 fold decrease in viral RNA"/>
   <result pre="nanoparticles (SeNPs) and zanamivir modified selenium nanoparticles (Se@ZNV) against H1N1" exact="influenza" post="virus investigated, and their results indicated that Se@ZNV has"/>
   <result pre="capabilities of SeNPs and oseltamivir surface-modified SeNPs (Se@OTV) against H1N1" exact="influenza" post="virus [28]. Their findings showed that Se@OTV is associated"/>
   <result pre="with higher antiviral activity and has less toxicity. Interference with" exact="influenza" post="virus life cycle by inhibition of hemagglutinin and neuraminidase"/>
   <result pre="as a possible mechanism. During the last stage of the" exact="influenza" post="virus replication cycle, newly assembled viral particles should be"/>
   <result pre="this cleavage step, and interfere with the release of progeny" exact="influenza" post="virus from infected host cells and subsequently, prevent the"/>
   <result pre="research which examined the inhibitory effects of ZnO-NPs on H1N1" exact="influenza" post="virus. The results showed that PEGylated ZnO-NPs have a"/>
   <result pre="can be effective in enhancement of antiviral activity against H1N1" exact="influenza" post="virus and reduction of cell cytotoxicity on MDCK-SIAT1 cells."/>
   <result pre="experiments also demonstrated that the nanoparticles have inhibitory properties against" exact="influenza" post="virus only after viral entry into the host cells."/>
   <result pre="microscope (TEM), as well as to examine the pattern of" exact="influenza" post="virus gene expression in the presence of the nanoparticles."/>
   <result pre="test with hemagglutination inhibition test to evaluate neutralizing antibody against" exact="influenza" post="virus (H1N1)Iran J Public Health20174612169029259944 2.World Health Organization. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)."/>
   <result pre="Organization. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 6 Nov 2018. 3.KeshavarzMTavakoliAMozaffari NejadASMokhtari-AzadTRezaeiFA review of" exact="influenza" post="vaccination among different population groups in IranJ Clin Diagn"/>
   <result pre="population groups in IranJ Clin Diagn Res2018126 4.MoghoofeiMMonavariSHMostafaeiSHadifarSGhasemiABabaeiFet al.Prevalence of" exact="influenza" post="a infection in the M iddle-E ast: a systematic"/>
   <result pre="systematic review and meta-analysisClin Respir J20181251787180110.1111/crj.1275829316311 5.ChaisriUChaicumpaWEvolution of therapeutic antibodies," exact="influenza" post="virus biology, influenza, and influenza immunotherapyBiomed Res Int20182018974754910.1155/2018/974754929998138 6.EsghaeiMMonavariSHRTavassoti-KheiriMShamsi-ShahrabadiMHeydarchiBFarahmandBet"/>
   <result pre="J20181251787180110.1111/crj.1275829316311 5.ChaisriUChaicumpaWEvolution of therapeutic antibodies, influenza virus biology, influenza, and" exact="influenza" post="immunotherapyBiomed Res Int20182018974754910.1155/2018/974754929998138 6.EsghaeiMMonavariSHRTavassoti-KheiriMShamsi-ShahrabadiMHeydarchiBFarahmandBet al.Expression of the influenza M2"/>
   <result pre="influenza, and influenza immunotherapyBiomed Res Int20182018974754910.1155/2018/974754929998138 6.EsghaeiMMonavariSHRTavassoti-KheiriMShamsi-ShahrabadiMHeydarchiBFarahmandBet al.Expression of the" exact="influenza" post="M2 protein in three different eukaryotic cell linesJ Virol"/>
   <result pre="different eukaryotic cell linesJ Virol Methods2012179116116510.1016/j.jviromet.2011.10.01622079618 7.Toledo-RuedaWRosas-MurrietaNHMuÃ±oz-MedinaJEGonzÃ¡lez-BonillaCRReyes-LeyvaJSantos-LÃ³pezGAntiviral resistance markers in" exact="influenza" post="virus sequences in Mexico, 2000â€&quot;2017Infect Drug Resist201811175110.2147/IDR.S15315430349332 8.DingYCaoZCaoLDingGWangZXiaoWAntiviral activity"/>
   <result pre="Mexico, 2000â€&quot;2017Infect Drug Resist201811175110.2147/IDR.S15315430349332 8.DingYCaoZCaoLDingGWangZXiaoWAntiviral activity of chlorogenic acid against" exact="influenza" post="a (H1N1/H3N2) virus and its inhibition of neuraminidaseSci Rep201774572310.1038/srep4572328393840"/>
   <result pre="amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant" exact="influenza" post="a virusesPLoS One201271e3100610.1371/journal.pone.003100622292088 10.Tavakoli A, Hashemzadeh MS. Inhibition of"/>
   <result pre="influenza a virusesPLoS One201271e3100610.1371/journal.pone.003100622292088 10.Tavakoli A, Hashemzadeh MS. Inhibition of" exact="herpes simplex" post="virus type 1 by copper oxide nanoparticles. J Virol"/>
   <result pre="12.MukherjeeSPatraCRBiologically synthesized metal nanoparticles: recent advancement and future perspectives in" exact="cancer" post="theranosticsFuture Sci OA201733FSO20310.4155/fsoa-2017-003528884002 13.JainNBhargavaARathiMDilipRVPanwarJRemoval of protein capping enhances the"/>
   <result pre="glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against" exact="herpes simplex" post="virus type 1Nanomedicine.201813212675269010.2217/nnm-2018-008930346253 17.ReedLJMuenchHA simple method of estimating fifty"/>
   <result pre="activity of peanut (Arachis hypogaea L.) skin extract against human" exact="influenza" post="virusesJ Med Food201821877778410.1089/jmf.2017.412129847745 21.MonavariSHThe inhibitory effect of acyclovir loaded"/>
   <result pre="Med Food201821877778410.1089/jmf.2017.412129847745 21.MonavariSHThe inhibitory effect of acyclovir loaded nano-niosomes against" exact="herpes simplex" post="virus type-1 in cell cultureMed J Islam Repub Iran2014289925664300"/>
   <result pre="deliveryPharm Res201532103248326010.1007/s11095-015-1701-726002743 24.AkarsuHIwatsuki-HorimotoKNodaTKawakamiEKatsuraHBaudinFet al.Structure-based design of NS2 mutants for attenuated" exact="influenza" post="a virus vaccinesVirus Res2011155124024810.1016/j.virusres.2010.10.01420970464 25.RosaSConnollyCSchettinoGButterworthKTPriseKMBiological mechanisms of gold nanoparticle"/>
   <result pre="Nanotechnol201781210.1186/s12645-017-0026-028217176 26.KumarRNayakMSahooGCPandeyKSarkarMCAnsariYet al.Iron oxide nanoparticles based antiviral activity of H1N1" exact="influenza" post="a virusJ Infect Chemother201925532532910.1016/j.jiac.2018.12.00630770182 27.LinZLiYGuoMXiaoMWangCZhaoMet al.Inhibition of H1N1 influenza"/>
   <result pre="H1N1 influenza a virusJ Infect Chemother201925532532910.1016/j.jiac.2018.12.00630770182 27.LinZLiYGuoMXiaoMWangCZhaoMet al.Inhibition of H1N1" exact="influenza" post="virus by selenium nanoparticles loaded with zanamivir through p38"/>
   <result pre="al.Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1" exact="influenza" post="virusInt J Nanomedicine201712573310.2147/IJN.S14093928848350 29.MittalNMedhiBThe bird flu: a new emerging"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6739551\results\search\disease\results.xml">
   <result pre="et al.17), Dengue virus (according to Drosten et al.18) and" exact="yellow fever" post="virus (using in-house primers) were amplified in discrete RT-PCRs"/>
   <result pre="in Table 1. Separate reaction mixtures for Lassa, Dengue and" exact="yellow fever" post="viruses were prepared and cycled as described in the"/>
   <result pre="Goettingen, Germany). TABLE 1 Primers used for Lassa, Dengue and" exact="yellow fever" post="investigation, Lagos, Nigeria, March 2018. Virus Primer name Primer"/>
   <result pre="chain reaction amplification and Agarose gel analysis of the Lassa," exact="yellow fever" post="and Dengue viruses Among the 70 samples, 5 (7.1%)"/>
   <result pre="band sizes (~405 bp) and (~75 bp) were detected for" exact="yellow fever" post="or Dengue18 viruses (Figures 2 and 3). FIGURE 1"/>
   <result pre="FIGURE 3 Reverse transcription polymerase chain reaction detection of the" exact="yellow fever" post="virus, Lagos, Nigeria, March 2018. The gel lanes represent"/>
   <result pre="(-VE CTRL) while a tissue culture inactivated sample of 17D" exact="yellow fever" post="strain from the Virology Unit Laboratory of the Bernhard"/>
   <result pre="hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and" exact="yellow fever" post="virus by real-time reverse transcription-PCR. J Clin Microbiol. 2002;40(7):2323â€&quot;2330."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6742212\results\search\disease\results.xml">
   <result pre="of severe cases or chikungunya-related deaths [5, 6]. Particularly, the" exact="chikungunya" post="outbreak in Reunion Island revealed unknown characteristics of the"/>
   <result pre="in Ahmedabad, India [8], and Mauritius [9] during the 2005â€&quot;2006" exact="chikungunya" post="epidemics. These findings were published at least 4 years"/>
   <result pre="region, and the Pan American Health Organization (PAHO) reported 631" exact="chikungunya" post="deaths among 2.5 million cases [10]. This number of"/>
   <result pre="Martinique), an excess mortality of more than 14,000 deaths during" exact="chikungunya" post="epidemics has been estimated for the years 2014 to"/>
   <result pre="[12]. In addition, some aspects of the clinical course of" exact="chikungunya" post="contribute to death underreporting, such as (i) the fatal"/>
   <result pre="to death underreporting, such as (i) the fatal association of" exact="chikungunya" post="with the decompensation of comorbidities leads to death certificates"/>
   <result pre="city in Brazil (capital of CearÃ¡ state) that had a" exact="chikungunya" post="epidemic in 2016â€&quot;2017 (80,000 cases), recording the highest number"/>
   <result pre="by one of the studies that investigated excess mortality during" exact="chikungunya" post="epidemics [12]. It also reported a median time between"/>
   <result pre="be related to different pathophysiological processes. On the one hand," exact="chikungunya" post="deaths caused primarily by acute CHIKV infection with direct"/>
   <result pre="eventually culminate in nosocomial infections [5, 16]. Fig 1 Confirmed" exact="chikungunya" post="cases (N = 80,153), case fatality rates (per 1,000"/>
   <result pre="= 80,153), case fatality rates (per 1,000 cases), and confirmed" exact="chikungunya" post="deaths (N = 169) by age groups and interval"/>
   <result pre="to emerging threats. In 2008, a Death Investigation Committee (including" exact="infectious disease" post="specialists, virologists, and pathologists) was created by the state"/>
   <result pre="of patients in a timeline format between the onset of" exact="chikungunya" post="symptoms and the death in order to try to"/>
   <result pre="the underreporting of deaths due to dengue, Zika virus, and" exact="chikungunya" post="in Fortaleza [17]. Unfortunately, very few municipalities/localities in Brazil"/>
   <result pre="to elucidate arboviruses deaths. What should be done to prevent" exact="chikungunya" post="fatality? Despite the need for further studies to establish"/>
   <result pre="causal link between CHIKV and mortality, current evidence suggest that" exact="chikungunya" post="may be the vector-borne disease associated with the highest"/>
   <result pre="lethality of the disease. Currently, most clinical protocols to manage" exact="chikungunya" post="cases are focused on acute or chronic joint pain"/>
   <result pre="imperative that international agencies formally recognize the high lethality of" exact="chikungunya" post="in specific groups in order to reorient disease surveillance."/>
   <result pre="order to reorient disease surveillance. Although usually a benign disease," exact="chikungunya" post="does not always have a self-limited clinical course. CHIKV"/>
   <result pre="of preexisting medical conditions leading to a fatal outcome. Current" exact="chikungunya" post="clinical protocols should be reviewed with the ultimate aim"/>
   <result pre="and in Brazil [3, 18]. However, contrary to dengue protocols," exact="chikungunya" post="management guidelines are not yet targeted to avoid fatal"/>
   <result pre="scant histopathological data and knowledge gaps in the pathophysiology of" exact="chikungunya" post="limit the comprehensiveness of the risk classification, available knowledge"/>
   <result pre="of new epidemics, it is critical that new protocols of" exact="chikungunya" post="management be devised, with a particular attention to mortality"/>
   <result pre="BouquillardE, TroisgrosO, GentileG, et al.French guidelines for the management of" exact="chikungunya" post="(acute and persistent presentations). November 2014. MÃ©decine et Maladies"/>
   <result pre="10.1016/j.medmal.2015.05.00726119684 4QueyriauxB, SimonF, GrandadamM, MichelR, TolouH, BoutinJP. Clinical burden of" exact="chikungunya" post="virus infection. The Lancet Infectious diseases. 2008;8(1):2â€&quot;3. Epub 2007/12/25."/>
   <result pre="SoletJL, SissokoD, BalleydierE, LarrieuS, FilleulL, et al.A major epidemic of" exact="chikungunya" post="virus infection on Reunion Island, France, 2005â€&quot;2006. The American"/>
   <result pre="8MavalankarD, ShastriP, BandyopadhyayT, ParmarJ, RamaniKV. Increased mortality rate associated with" exact="chikungunya" post="epidemic, Ahmedabad, India. Emerging infectious diseases. 2008;14(3):412â€&quot;5. Epub 2008/03/08."/>
   <result pre="and Martinique, islands of the French West Indies, during the" exact="chikungunya" post="epidemic of 2014. Epidemiology and infection. 2018;146(16):2059â€&quot;65. Epub 2018/08/29."/>
   <result pre="Alarcon-ElbalPM, Paulino-RamirezR, DonalisioMR. Excess mortality profile during the Asian genotype" exact="chikungunya" post="epidemic in the Dominican Republic, 2014. Transactions of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6742362\results\search\disease\results.xml">
   <result pre="Biology : Population Metrics: Age Distribution The epidemiological signature of" exact="influenza" post="B virus and its B/Victoria and B/Yamagata lineages in"/>
   <result pre="B/Victoria and B/Yamagata lineages in the 21st century Epidemiology of" exact="influenza" post="B virus and its lineages http://orcid.org/0000-0002-2262-1102CainiSaverioConceptualizationData curationFormal analysisInvestigationMethodologyVisualizationWriting â€&quot;"/>
   <result pre="the epidemiological characteristics, pattern of circulation, and geographical distribution of" exact="influenza" post="B viruses and its lineages using data from the"/>
   <result pre="the Global Influenza B Study. We included over 1.8 million" exact="influenza" post="cases occurred in thirty-one countries during 2000â€&quot;2018. We calculated"/>
   <result pre="during 2000â€&quot;2018. We calculated the proportion of cases caused by" exact="influenza" post="B and its lineages; determined the timing of influenza"/>
   <result pre="by influenza B and its lineages; determined the timing of" exact="influenza" post="A and B epidemics; compared the age distribution of"/>
   <result pre="lineage-level mismatch for the trivalent vaccine. The median proportion of" exact="influenza" post="cases caused by influenza B virus was 23.4%, with"/>
   <result pre="trivalent vaccine. The median proportion of influenza cases caused by" exact="influenza" post="B virus was 23.4%, with a tendency (borderline statistical"/>
   <result pre="type in about one every seven seasons. In temperate countries," exact="influenza" post="B epidemics occurred on average three weeks later than"/>
   <result pre="influenza B epidemics occurred on average three weeks later than" exact="influenza" post="A epidemics; no consistent pattern emerged in the tropics."/>
   <result pre="tropics. The two B lineages caused a comparable proportion of" exact="influenza" post="B cases globally, however the B/Yamagata was more frequent"/>
   <result pre="tropics. The type B virus caused a substantial proportion of" exact="influenza" post="infections globally in the 21st century, and its two"/>
   <result pre="on populations globally [1]. The impact of seasonal and pandemic" exact="influenza" post="on population health in high-income countries has been described"/>
   <result pre="in high-income countries has been described extensively [2]. In Europe," exact="influenza" post="ranks first among infectious diseases in terms of burden,"/>
   <result pre="has been accumulating that the burden of disease associated with" exact="influenza" post="is high in low- and middle-income countries as well"/>
   <result pre="middle-income countries as well [4]. Type A viruses cause most" exact="influenza" post="cases and are responsible for pandemics, but influenza B"/>
   <result pre="cause most influenza cases and are responsible for pandemics, but" exact="influenza" post="B is an important cause of morbidity and mortality"/>
   <result pre="co-circulated globally in the 21st century [8â€&quot;9]. The mainstay of" exact="influenza" post="prevention is vaccination, aimed primarily at individuals who are"/>
   <result pre="ensure adequate immunity against influenza; thus, investigating the timing of" exact="influenza" post="epidemics and the patterns of circulation of the different"/>
   <result pre="influenza epidemics and the patterns of circulation of the different" exact="influenza" post="virus types, subtypes and lineages is of great importance"/>
   <result pre="importance from a public health perspective [11]. Until 2012, trivalent" exact="influenza" post="vaccines (TIV) were available that contained only one type"/>
   <result pre="vaccines (TIV) were available that contained only one type B" exact="influenza" post="virus, belonging to either the B/Victoria or B/Yamagata lineage."/>
   <result pre="the mismatched lineage [12], and substantial health impact [13]. Quadrivalent" exact="influenza" post="vaccine (QIV), containing one B/Victoria and one B/Yamagata virus"/>
   <result pre="describe the epidemiology, clinical characteristics and burden of disease of" exact="influenza" post="B in more depth, and to compare the cost-effectiveness"/>
   <result pre="settings and populations. Despite significant advances in our understanding of" exact="influenza" post="B [14], important knowledge gaps persist, in particular concerning"/>
   <result pre="for instance in order to evaluate the cost-effectiveness of alternative" exact="influenza" post="prevention strategies and thus enable more appropriate public health"/>
   <result pre="Here, we conducted a global analysis of the epidemiology of" exact="influenza" post="B virus and its lineages using the database of"/>
   <result pre="detail elsewhere [14,23â€&quot;24]. The GIBS database encompasses epidemiological and virological" exact="influenza" post="surveillance data from thirty-one countries around the world (Fig"/>
   <result pre="population centre [25]. Participating countries were required to make available" exact="influenza" post="surveillance data for as many consecutive years as possible"/>
   <result pre="(from 2000 onwards). Data include the weekly number of laboratory-confirmed" exact="influenza" post="cases broken down by virus type (A, B), type"/>
   <result pre="age groups) was also available. In most participating countries, the" exact="influenza" post="surveillance system covers the whole national territory, and a"/>
   <result pre="system covers the whole national territory, and a sample of" exact="influenza" post="virus positive specimens or virus isolates is routinely sent"/>
   <result pre="The GIBS database was initially assembled in 2013â€&quot;14 by merging" exact="influenza" post="surveillance data up to as late as December 2013"/>
   <result pre="20 weeks of reported data and at least 100 laboratory-confirmed" exact="influenza" post="cases. In each season, we calculated the percentage of"/>
   <result pre="influenza cases. In each season, we calculated the percentage of" exact="influenza" post="cases that were due to influenza B. We then"/>
   <result pre="calculated the percentage of influenza cases that were due to" exact="influenza" post="B. We then determined the percentage of cases that"/>
   <result pre="country) the subset of seasons with 50 or more characterized" exact="influenza" post="B viruses. The non-parametric Kruskal-Wallis test was applied to"/>
   <result pre="Kruskal-Wallis test was applied to compare the median proportion of" exact="influenza" post="A and B cases (over all influenza cases) and"/>
   <result pre="median proportion of influenza A and B cases (over all" exact="influenza" post="cases) and B/Victoria and B/Yamagata cases (over all cases"/>
   <result pre="and B/Victoria and B/Yamagata cases (over all cases with characterized" exact="influenza" post="B viruses) between countries based on their latitude (Northern"/>
   <result pre="[25]. We compared the timing of the primary peak of" exact="influenza" post="A and B epidemics in each country using the"/>
   <result pre="hemisphere countries) because of the markedly atypical timing of the" exact="influenza" post="A(H1N1)pdm09 pandemics. Time series were first standardized by dividing"/>
   <result pre="series were first standardized by dividing the weekly number of" exact="influenza" post="cases by the maximum weekly number (per country by"/>
   <result pre="in each country. We aimed to evaluated the frequency of" exact="influenza" post="B lineage-level vaccine mismatch, which was defined as a"/>
   <result pre="mismatch between the lineage that caused the majority (&amp;gt;50%) of" exact="influenza" post="B cases in a given season and country, and"/>
   <result pre="and the lineage included in the trivalent vaccine. Information on" exact="influenza" post="vaccine formulation was retrieved from the WHO website [27]."/>
   <result pre="belt. While the WHO issues recommendations on the composition of" exact="influenza" post="vaccines to be used in tropical countries [28], these"/>
   <result pre="the resulting increase in the number of cases with characterized" exact="influenza" post="B viruses made it possible to compare the age"/>
   <result pre="viruses made it possible to compare the age distribution of" exact="influenza" post="B/Victoria and B/Yamagata cases in a similar way to"/>
   <result pre="a similar way to what had been done previously for" exact="influenza" post="B vs. A (and its subtypes) [14,24]. This analysis"/>
   <result pre="for at least 50 B/Victoria and at least 50 B/Yamagata" exact="influenza" post="cases over all seasons available. The virus-lineage-specific age distribution"/>
   <result pre="cases over all seasons available. The virus-lineage-specific age distribution of" exact="influenza" post="B cases was visualized, separately in each country, using"/>
   <result pre="Wilcoxon rank sum test to compare the median age of" exact="influenza" post="B cases by virus lineage. Statistical analyses were conducted"/>
   <result pre="the Global Influenza B Study encompassed a total of 1.820.301" exact="influenza" post="cases between 2000 and 2018, of which 419,167 (23.0%)"/>
   <result pre="with USA and Australia contributing 54.1% and 25.3% of all" exact="influenza" post="cases to the database, respectively. Information on age was"/>
   <result pre="remaining countries, information on age was available for most (95.0%)" exact="influenza" post="cases. After applying our exclusion criteria, 299 seasons with"/>
   <result pre="our exclusion criteria, 299 seasons with 100 or more reported" exact="influenza" post="cases overall were included in the analysis, of which"/>
   <result pre="to eighteen (for New Zealand). The number of overall and" exact="influenza" post="B cases in each country and season included in"/>
   <result pre="country and season included in the analysis, the proportion of" exact="influenza" post="B cases of which the virus was characterized, and"/>
   <result pre="and B/Yamagata lineages, are provided in S1 Table. Frequency of" exact="influenza" post="B Influenza B virus caused a median 23.4% (interquartile"/>
   <result pre="caused a median 23.4% (interquartile range [IQR] 9.3â€&quot;38.9%) of reported" exact="influenza" post="cases in a season. More specifically, the proportion of"/>
   <result pre="influenza cases in a season. More specifically, the proportion of" exact="influenza" post="cases caused by the B virus type was &amp;lt;20%"/>
   <result pre="and above 50% in 45 seasons (15.1%). The proportion of" exact="influenza" post="B cases over all influenza cases reported in the"/>
   <result pre="seasons (15.1%). The proportion of influenza B cases over all" exact="influenza" post="cases reported in the season varied geographically (Fig 2):"/>
   <result pre="(22.2%, IQR 9.1â€&quot;34.5%) hemispheres. The proportion of seasons in which" exact="influenza" post="B cases constituted between 20 and 50% or more"/>
   <result pre="20 and 50% or more than 50% of all reported" exact="influenza" post="cases did not significantly differ (p = 0.275) between"/>
   <result pre="two hemispheres (39.9% and 14.3%, respectively). Fig 2 Distribution of" exact="influenza" post="seasons by proportion of influenza B cases and geographical"/>
   <result pre="respectively). Fig 2 Distribution of influenza seasons by proportion of" exact="influenza" post="B cases and geographical area (Inter-tropical belt, Northern hemisphere,"/>
   <result pre="75th percentiles. The Global Influenza B Study, 2000â€&quot;2018. Timing of" exact="influenza" post="A and B epidemics In countries of the Southern"/>
   <result pre="A and B epidemics In countries of the Southern hemisphere," exact="influenza" post="A epidemics typically peaked in July-September, on average 1.1"/>
   <result pre="typically peaked in July-September, on average 1.1 month earlier than" exact="influenza" post="B (August-September) (Table 1). Influenza epidemics also peaked in"/>
   <result pre="in the winter months of Northern hemisphere countries, earlier for" exact="influenza" post="A (January-February, except Ukraine, in March) than for influenza"/>
   <result pre="for influenza A (January-February, except Ukraine, in March) than for" exact="influenza" post="B (February-March, except England, in January), with an average"/>
   <result pre="countries among those situated in the Northern hemisphere), where both" exact="influenza" post="A and B epidemics typically peaked in August. There"/>
   <result pre="(0.3 months earlier on average) for the primary peak of" exact="influenza" post="A and B epidemics. 10.1371/journal.pone.0222381.t001Table 1 Typical timing of"/>
   <result pre="B epidemics. 10.1371/journal.pone.0222381.t001Table 1 Typical timing of the peak of" exact="influenza" post="A and B epidemics according to countriesâ€™ latitude. The"/>
   <result pre="Global Influenza B Study, 2000â€&quot;2018. Country Latitude Typical timing of" exact="influenza" post="peak A B Southern hemisphere New Zealand 41.8 S"/>
   <result pre="where the virus lineage was determined for 50 or more" exact="influenza" post="B cases (out of a total 299 seasons, 28.1%)"/>
   <result pre="B/Yamagata lineage viruses caused a similar range of proportions of" exact="influenza" post="B cases. More precisely, the median proportion of influenza"/>
   <result pre="of influenza B cases. More precisely, the median proportion of" exact="influenza" post="B cases reported in a season that were caused"/>
   <result pre="5.3â€&quot;89.6%). The range of the proportion of B/Victoria over all" exact="influenza" post="B cases was 0%-100%, meaning that there were seasons"/>
   <result pre="was 0%-100%, meaning that there were seasons in which all" exact="influenza" post="B cases were caused by either virus lineage. Co-circulation"/>
   <result pre="84 seasons, both lineages accounted for at least 20% of" exact="influenza" post="B cases, while the B/Victoria and B/Yamagata lineages caused"/>
   <result pre="the B/Victoria and B/Yamagata lineages caused over 80% of all" exact="influenza" post="B cases in 27 (32.1%) and 30 (35.8%) seasons,"/>
   <result pre="(35.8%) seasons, respectively. The proportion of either lineage over all" exact="influenza" post="B cases varied according to the age structure of"/>
   <result pre="the countriesâ€™ latitude as well (Fig 3). The proportion of" exact="influenza" post="B cases caused by the B/Victoria lineage in a"/>
   <result pre="a median age below 30 years (median proportion over all" exact="influenza" post="B cases = 67.0%) compared to countries with a"/>
   <result pre="(36.2%). Likewise, the median proportion of B/Victoria over all characterized" exact="influenza" post="B cases in a season was higher in countries"/>
   <result pre="Southern hemisphere (43.8%) (p-value = 0.048). Fig 3 Proportion of" exact="influenza" post="B cases in a season that were caused by"/>
   <result pre="Influenza B Study, 2000â€&quot;2018. Age distribution of B/Victoria and B/Yamagata" exact="influenza" post="cases In Table 2, we compared the median age"/>
   <result pre="cases In Table 2, we compared the median age of" exact="influenza" post="B cases according to virus lineage. In Australia, B/Victoria"/>
   <result pre="and in Ukraine (p-value 0.082). 10.1371/journal.pone.0222381.t002Table 2 Age distribution of" exact="influenza" post="B/Victoria and B/Yamagata patients by country (sorted by median"/>
   <result pre="B Study, 2000â€&quot;2018. Country (a) Median age general population No." exact="influenza" post="B cases Median age (IQR) Victoria Yamagata Victoria Yamagata"/>
   <result pre="was available for â‰¥50 B Victoria and â‰¥50 B Yamagata" exact="influenza" post="cases. (b) Wilcoxon rank-sum test for comparison of medians"/>
   <result pre="of B/Victoria and B/Yamagata cases (S1 File). In most countries," exact="influenza" post="B/Victoria cases tended to be distributed according to their"/>
   <result pre="peaking at above 50 years of age. Frequency of lineage-level" exact="influenza" post="B trivalent vaccine mismatches The proportion of influenza B"/>
   <result pre="of lineage-level influenza B trivalent vaccine mismatches The proportion of" exact="influenza" post="B lineage-level vaccine mismatch was 54.2% in countries in"/>
   <result pre="composition for the Southern hemisphere. Discussion Our analysis found that" exact="influenza" post="B virus was responsible for nearly one fourth of"/>
   <result pre="B virus was responsible for nearly one fourth of all" exact="influenza" post="cases in an average season between 2000 and 2018."/>
   <result pre="in an average season between 2000 and 2018. More specifically," exact="influenza" post="B virus accounted for over 20% of all influenza"/>
   <result pre="specifically, influenza B virus accounted for over 20% of all" exact="influenza" post="cases in more than half of the seasons, and"/>
   <result pre="seven seasons. This proportion varied geographically, as the proportion of" exact="influenza" post="B over all influenza cases tended to be higher"/>
   <result pre="varied geographically, as the proportion of influenza B over all" exact="influenza" post="cases tended to be higher on average in tropical"/>
   <result pre="epidemics tended to peak on average three weeks later than" exact="influenza" post="A epidemics during the winter period in temperate countries"/>
   <result pre="is consistent with previous country reports [21,30,32â€&quot;34]. The timing of" exact="influenza" post="A and B epidemics was different in tropical countries"/>
   <result pre="weather conditions that are most favourable to the occurrence of" exact="influenza" post="epidemics (e.g. cold-dry) last for only a limited number"/>
   <result pre="area (i.e. anywhere around the world seasons occurred where all" exact="influenza" post="B cases were caused by either the B/Victoria or"/>
   <result pre="faced when trying to predict which lineage will cause most" exact="influenza" post="B cases next season. This helps explain the very"/>
   <result pre="that whilst the two lineages caused a comparable proportion of" exact="influenza" post="B cases globally during the study period, their distribution"/>
   <result pre="â€œcold-dryâ€� and â€œhumid-rainyâ€� environmental conditions that drive the occurrence of" exact="influenza" post="epidemics in temperate and tropical countries, respectively [38]. This"/>
   <result pre="be supported by the available evidence, which suggests instead that" exact="influenza" post="viruses of different types and subtypes (e.g. A(H3N2), A(H1N1)pdm09,"/>
   <result pre="that differ greatly under many aspects, including the type of" exact="influenza" post="surveillance system) that B/Yamagata cases are on average older"/>
   <result pre="patients. Importantly, our findings support earlier work showing that each" exact="influenza" post="A subtype (H3N2, pre-2009-pandemic H1N1, and H1N1pdm09) tends to"/>
   <result pre="viruses [41]. Finally, antigenic original sin (i.e. preferential response to" exact="influenza" post="B viruses encountered in the past [42]) may also"/>
   <result pre="These findings have important implications for assessing the impact of" exact="influenza" post="B viruses in a population each season. Knowing early"/>
   <result pre="season. Knowing early in the season (through surveillance activities) which" exact="influenza" post="B lineage virus is circulating will allow one to"/>
   <result pre="was a lineage-level vaccine mismatch) and a high burden of" exact="influenza" post="B was observed in many European countries [43]. We"/>
   <result pre="B was observed in many European countries [43]. We analyzed" exact="influenza" post="surveillance data from around the world to determine the"/>
   <result pre="data from around the world to determine the epidemiology of" exact="influenza" post="B virus and its lineages in the 21st century."/>
   <result pre="lineages, thus achieving a better understanding of the epidemiology of" exact="influenza" post="B globally. The most important limitation of our study"/>
   <result pre="included, number of years with data and average number of" exact="influenza" post="cases reported per year, proportion of influenza B viruses"/>
   <result pre="average number of influenza cases reported per year, proportion of" exact="influenza" post="B viruses that were characterized availability of information on"/>
   <result pre="intensity of surveillance activities, and the coverage of each countryâ€™s" exact="influenza" post="surveillance system. Throughout this paper, we have used statistical"/>
   <result pre="of analysis for the comparison of the frequency of B" exact="influenza" post="across countries, the standardization offered by the EPIPOI software"/>
   <result pre="the EPIPOI software in the analysis of temporal patterns of" exact="influenza" post="epidemics, and the use of medians to compare the"/>
   <result pre="the use of medians to compare the age distribution of" exact="influenza" post="cases between countries. However, we acknowledge that these sources"/>
   <result pre="quantify precisely, and a further improvement in the harmonization of" exact="influenza" post="surveillance data remains desirable as it would allow researchers"/>
   <result pre="study provides important new information that describes the epidemiology of" exact="influenza" post="B viruses and its lineages during the start of"/>
   <result pre="during the start of the 21st century. We showed that" exact="influenza" post="B virus caused nearly one fourth (on average) of"/>
   <result pre="B virus caused nearly one fourth (on average) of all" exact="influenza" post="cases occurring annually in the world during 2000â€&quot;2018, and"/>
   <result pre="both lineages accounted each for a comparable proportion of all" exact="influenza" post="B cases globally. We also observed that cases infected"/>
   <result pre="our knowledge of the epidemiology and pattern of circulation of" exact="influenza" post="B virus, these findings will help inform health policy"/>
   <result pre="policy decisions aiming to reduce disease burden associated with seasonal" exact="influenza" post="locally, regionally and globally. Supporting information S1 Table Laboratory-confirmed"/>
   <result pre="influenza locally, regionally and globally. Supporting information S1 Table Laboratory-confirmed" exact="influenza" post="cases reported in each country and season, and proportion"/>
   <result pre="country and season, and proportion of those caused by the" exact="influenza" post="B virus type (overall and by lineage). The Global"/>
   <result pre="year for other countries. (b) Seasons with fewer than 100" exact="influenza" post="cases were not included. (c) Number of influenza B"/>
   <result pre="than 100 influenza cases were not included. (c) Number of" exact="influenza" post="B cases in each season, and proportion of influenza"/>
   <result pre="of influenza B cases in each season, and proportion of" exact="influenza" post="B over all influenza cases in the same season."/>
   <result pre="in each season, and proportion of influenza B over all" exact="influenza" post="cases in the same season. (d) Number of influenza"/>
   <result pre="all influenza cases in the same season. (d) Number of" exact="influenza" post="B cases for which the virus lineage was characterized,"/>
   <result pre="which the virus lineage was characterized, and proportion over all" exact="influenza" post="B cases in the same season. (e) Number of"/>
   <result pre="influenza B cases in the same season. (e) Number of" exact="influenza" post="B cases caused by viruses belonging to the Victoria"/>
   <result pre="the Victoria and Yamagata lineages, and proportion over all characterized" exact="influenza" post="B viruses in the same season. Not reported in"/>
   <result pre="season. Not reported in seasons with fewer than 50 characterized" exact="influenza" post="B cases. (DOCX) LINK Click here for additional data"/>
   <result pre="for additional data file. S1 File Age distribution of laboratory-confirmed" exact="influenza" post="patients infected with type B viruses belonging to the"/>
   <result pre="exact age for â‰¥50 B Victoria and â‰¥50 B Yamagata" exact="influenza" post="for the whole study period cases were included. Countries"/>
   <result pre="FlanneryB, BrammerL, SingletonJAet al.Annual estimates of the burden of seasonal" exact="influenza" post="in the United States: A tool for strengthening influenza"/>
   <result pre="seasonal influenza in the United States: A tool for strengthening" exact="influenza" post="surveillance and preparedness. Influenza Other Respir Viruses. 2018;12(1):132â€&quot;137. 10.1111/irv.1248629446233"/>
   <result pre="4LeeVJ, HoZJM, GohEH, CampbellH, CohenC, CozzaV, et al.Advances in measuring" exact="influenza" post="burden of disease. Influenza Other Respir Viruses. 2018;12(1):3â€&quot;9. 10.1111/irv.1253329460425"/>
   <result pre="10.1111/irv.1253329460425 5Paul GlezenW, SchmierJK, KuehnCM, RyanKJ, OxfordJ. The burden of" exact="influenza" post="B: a structured literature review. Am J Public Health."/>
   <result pre="RotaJS, KendalAP, NeromeK. Cocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983. Virology. 1990;175(1):59â€&quot;68. 10.1016/0042-6822(90)90186-u2309452 8PaivaTM,"/>
   <result pre="BenegaMA, SilvaDB, SantosKC, CruzAS, HortenciMF, et al.Evolutionary pattern of reemerging" exact="influenza" post="B/Victoria lineage viruses in SÃ£o Paulo, Brazil, 1996â€&quot;2012: Implications"/>
   <result pre="LeePI, KimWJ, BuchyP, et al.Literature review of the epidemiology of" exact="influenza" post="B disease in 15 countries in the Asia-Pacific region."/>
   <result pre="ScienceM, KusterSP, et al.Populations at risk for severe or complicated" exact="influenza" post="illness: systematic review and meta-analysis. BMJ. 2013;347:f506110.1136/bmj.f506123974637 11CainiS, SchellevisF,"/>
   <result pre="SchellevisF, El-Guerche SÃ©blainC, PagetJ. Important changes in the timing of" exact="influenza" post="epidemics in the WHO European Region over the past"/>
   <result pre="Surveill. 2018;23(1). 12TriccoAC, ChitA, SoobiahC, HallettD, MeierG, ChenMH, et al.Comparing" exact="influenza" post="vaccine efficacy against mismatched and matched strains: a systematic"/>
   <result pre="and meta-analysis. BMC Med. 2013;11:15310.1186/1741-7015-11-15323800265 13HeikkinenT, IkonenN, ZieglerT. Impact of" exact="influenza" post="B lineage-level mismatch between trivalent seasonal influenza vaccines and"/>
   <result pre="ZieglerT. Impact of influenza B lineage-level mismatch between trivalent seasonal" exact="influenza" post="vaccines and circulating viruses, 1999â€&quot;2012. Clin Infect Dis. 2014;59(11):1519â€&quot;24."/>
   <result pre="CiblakMA, KusznierzG, OwenR, WangchukS, et al.Epidemiological and virological characteristics of" exact="influenza" post="B: results of the Global Influenza B Study. Influenza"/>
   <result pre="al.A systematic review of the health economic consequences of quadrivalent" exact="influenza" post="vaccination. Expert Rev Pharmacoecon Outcomes Res. 2017;17(3):249â€&quot;265. 10.1080/14737167.2017.134314528613092 16SoÄ�anM,"/>
   <result pre="A comparison of the demographic and clinical characteristics of laboratory-confirmed" exact="influenza" post="B Yamagata and Victoria lineage infection. J Clin Virol."/>
   <result pre="17LeTT, PhamTH, PhamTH, Nguyen leKH, NguyenCT, HoangVM, et al.Circulation of" exact="influenza" post="B lineages in northern Viet Nam, 2007â€&quot;2014. Western Pac"/>
   <result pre="18XuC, ChanKH, TsangTK, FangVJ, FungRO, IpDK, et al.Comparative epidemiology of" exact="influenza" post="B Yamagata- and Victoria-lineage viruses in households. Am J"/>
   <result pre="Epidemiol. 2015;182(8):705â€&quot;13. 10.1093/aje/kwv11026400854 19BarrIG, VijaykrishnaD, SullivanSG. Differential age susceptibility to" exact="influenza" post="B/Victoria lineage viruses in the 2015 Australian influenza season."/>
   <result pre="susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian" exact="influenza" post="season. Euro Surveill. 2016;21(4). 20SelekaM, TreurnichtFK, TempiaS, HellfersceeO, MtshaliS,"/>
   <result pre="2016;21(4). 20SelekaM, TreurnichtFK, TempiaS, HellfersceeO, MtshaliS, CohenAL, et al.Epidemiology of" exact="influenza" post="B/Yamagata and B/Victoria lineages in South Africa, 2005â€&quot;2014. PLoS"/>
   <result pre="2005â€&quot;2014. PLoS One. 2017;12(5):e017765510.1371/journal.pone.017765528542324 21MoaAM, MuscatelloDJ, TurnerRM, MacIntyreCR. Epidemiology of" exact="influenza" post="B in Australia: 2001â€&quot;2014 influenza seasons. Influenza Other Respir"/>
   <result pre="MuscatelloDJ, TurnerRM, MacIntyreCR. Epidemiology of influenza B in Australia: 2001â€&quot;2014" exact="influenza" post="seasons. Influenza Other Respir Viruses. 2017;11(2):102â€&quot;109. 10.1111/irv.1243227650482 22LapinsckiB, PereiraLA,"/>
   <result pre="22LapinsckiB, PereiraLA, NogueiraMB, VidalLR, RiedigerI, DeburMC, et al.Molecular epidemiology of" exact="influenza" post="B virus and implications in immunization strategy, Southern Brazil."/>
   <result pre="23CainiS, AndradeW, BadurS, BalmasedaA, BarakatA, BellaA, et al.Temporal patterns of" exact="influenza" post="A and B in tropical and temperate countries: what"/>
   <result pre="in tropical and temperate countries: what are the lessons for" exact="influenza" post="vaccination?PLoS One. 2016;11(3):e015231010.1371/journal.pone.015231027031105 24CainiS, SpreeuwenbergP, KusznierzGF, RudiJM, OwenR, PenningtonK,"/>
   <result pre="2016;11(3):e015231010.1371/journal.pone.015231027031105 24CainiS, SpreeuwenbergP, KusznierzGF, RudiJM, OwenR, PenningtonK, et al.Distribution of" exact="influenza" post="virus types by age using case-based global surveillance data"/>
   <result pre="Health. 2012;12(1):982.23153033 27World Health Organization. Recommendations on the composition of" exact="influenza" post="virus vaccines. http://www.who.int/influenza/vaccines/virus/recommendations/en/ Cited 18 June 2018 28World Health"/>
   <result pre="18 June 2018 29HirveS, LambachP, PagetJ, VandemaeleK, FitznerJ, ZhangW. Seasonal" exact="influenza" post="vaccine policy, use and effectiveness in the tropics and"/>
   <result pre="2016;10(4):254â€&quot;67. 10.1111/irv.1237426842617 30MosnierA, CainiS, DaviaudI, BensoussanJL, Stoll-KellerF, BuiTT, et al.Ten" exact="influenza" post="seasons in France: distribution and timing of influenza A"/>
   <result pre="et al.Ten influenza seasons in France: distribution and timing of" exact="influenza" post="A and B circulation, 2003â€&quot;2013. BMC Infect Dis. 2015;15:35710.1186/s12879-015-1056-z26289794"/>
   <result pre="Infect Dis. 2015;15:35710.1186/s12879-015-1056-z26289794 31BarrosEN, CintraO, RossettoE, FreitasL, ColindresR. Patterns of" exact="influenza" post="B circulation in Brazil and its relevance to seasonal"/>
   <result pre="YangP, QianH, ShiW, WuS, et al.Epidemiological and phylogenetic characteristics of" exact="influenza" post="B infection in severe acute respiratory infection cases in"/>
   <result pre="van GinkelA, SuijkerbuijkA, van der HoekW, et al.Early occurrence of" exact="influenza" post="A epidemics coincided with changes in occurrence of other"/>
   <result pre="10.1111/irv.1234826369646 34CainiS, AlonsoWJ, SÃ©blainCE, SchellevisF, PagetJ. The spatiotemporal characteristics of" exact="influenza" post="A and B in the WHO European Region: can"/>
   <result pre="and B in the WHO European Region: can one define" exact="influenza" post="transmission zones in Europe?Euro Surveill. 2017;22(35). 35LaurieKL, GuarnacciaTA, CarolanLA,"/>
   <result pre="infections and viral hierarchy are determinants of viral interference following" exact="influenza" post="virus infection in a ferret model. J Infect Dis."/>
   <result pre="10.1093/infdis/jiv26025943206 36BelsheRB, CoelinghK, AmbroseCS, WooJC, WuX. Efficacy of live attenuated" exact="influenza" post="vaccine in children against influenza B viruses by lineage"/>
   <result pre="WuX. Efficacy of live attenuated influenza vaccine in children against" exact="influenza" post="B viruses by lineage and antigenic similarity. Vaccine. 2010;28(9):2149â€&quot;56."/>
   <result pre="NguyenTP, MoyesJ, CohenC, et al.The cost-effectiveness of trivalent and quadrivalent" exact="influenza" post="vaccination in communities in South Africa, Vietnam and Australia."/>
   <result pre="ShamanJ, AlonsoWJ, Bloom-FeshbachK, UejioCK, ComrieA, et al.Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climates. PLoS Pathog. 2013;9(3):e100319410.1371/journal.ppat.100319423505366"/>
   <result pre="2013;9(3):e100319410.1371/journal.ppat.100319423505366 39LowenAC, SteelJ. Roles of humidity and temperature in shaping" exact="influenza" post="seasonality. J Virol. 2014;88(14):7692â€&quot;5. 10.1128/JVI.03544-1324789791 40VijaykrishnaD, HolmesEC, JosephU, FourmentM,"/>
   <result pre="JosephU, FourmentM, SuYC, HalpinR, et al.The contrasting phylodynamics of human" exact="influenza" post="B viruses. Elife. 2015;4:e0505510.7554/eLife.0505525594904 41NyirendaM, OmoriR, TessmerHL, ArimuraH, ItoK."/>
   <result pre="OmoriR, TessmerHL, ArimuraH, ItoK. Estimating the lineage dynamics of human" exact="influenza" post="B viruses. PLoS One. 2016;11(11):e016610710.1371/journal.pone.016610727829058 42SkowronskiDM, HottesTS, De SerresG,"/>
   <result pre="MelidouA, IonescuS, Penttinen; collab: The European Influenza Surveillance Network. Dominant" exact="influenza" post="A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6743175\results\search\disease\results.xml">
   <result pre="typing of human rhinovirus of adults hospitalized for exacerbation of" exact="asthma" post="and chronic obstructive pulmonary disease KoFanny Wai-san1ChanPaul Kay-sheung2ChanRenee W."/>
   <result pre="human rhinovirus of adults hospitalized for exacerbation of asthma and" exact="chronic obstructive pulmonary disease" post="KoFanny Wai-san1ChanPaul Kay-sheung2ChanRenee W. Y.3ChanKa-Pang1IpApril1KwokAngela2NgaiJenny Chun-li1NgSo-Shan1OnChan Tat1http://orcid.org/0000-0003-4382-2445HuiDavid Shu-cheongdschui@cuhk.edu.hk1[1], 0000"/>
   <result pre="this article, unless otherwise stated. Abstract Background Acute exacerbations of" exact="chronic obstructive pulmonary disease" post="(AECOPD) and asthma are associated with a variety of"/>
   <result pre="Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and" exact="asthma" post="are associated with a variety of precipitating factors including"/>
   <result pre="multiplex polymerase chain reaction of patients hospitalized with AECOPD and" exact="asthma" post="exacerbations. In addition, infective etiologies were assessed for association"/>
   <result pre="outcome of the patients. Methods Adults admitted with AECOPD and" exact="asthma" post="exacerbations between August 2016 and July 2017 were recruited."/>
   <result pre="Results Altogether 402 patients with AECOPD, 80 stable COPD, 100" exact="asthma" post="exacerbation and 21 stable asthma subjects were recruited. Among"/>
   <result pre="AECOPD, 80 stable COPD, 100 asthma exacerbation and 21 stable" exact="asthma" post="subjects were recruited. Among those admitted for AECOPD and"/>
   <result pre="asthma subjects were recruited. Among those admitted for AECOPD and" exact="asthma" post="exacerbations, 141(35.1%) and 45(45.0%) respectively had pathogens identified in"/>
   <result pre="identified in the NPA specimens. The commonest virus identified was" exact="influenza" post="A followed by HRV. HRV typing identified HRV-A and"/>
   <result pre="readmission rates and mortality except that identification of pathogens in" exact="asthma" post="exacerbation was associated with a lower rate of readmissions"/>
   <result pre="60â€‰days. Conclusions Many respiratory viruses were associated with AECOPD and" exact="asthma" post="exacerbation. HRV-A and HRV-C were the more common HRV"/>
   <result pre="of pathogens in NPA was associated with less readmissions for" exact="asthma" post="patients at 30 and 60â€‰days. Trial registration ClinicalTrials.gov NCT02866357."/>
   <result pre="Health Bureau, HKSAR Government 13140671 Summary at a glance For" exact="asthma" post="and COPD exacerbations, identification of pathogens in nasopharyngeal aspirate"/>
   <result pre="not affect clinical outcomes except that identification of pathogens in" exact="asthma" post="exacerbation was associated with a lower rate of readmissions"/>
   <result pre="between 22 and 60% in patients with AECOPD [6]. For" exact="asthma" post="exacerbation, a previous study from the United Kingdom found"/>
   <result pre="that upper respiratory viral infections were associated with 80â€&quot;85% of" exact="asthma" post="exacerbations in children aged 9â€&quot;11â€‰years [7]. There are limited"/>
   <result pre="9â€&quot;11â€‰years [7]. There are limited data on viral aetiologies for" exact="asthma" post="exacerbation in adults. A recent study in Australia found"/>
   <result pre="aetiologies were identified in 32, 5 and 7% respectively of" exact="asthma" post="exacerbations with hospital admissions [8]. HRVs are a major"/>
   <result pre="admissions [8]. HRVs are a major trigger of AECOPD and" exact="asthma" post="exacerbations and may pose a significant problem for disease"/>
   <result pre="respiratory viruses, HRV infection preceded as many as 50% of" exact="asthma" post="exacerbations in children [11]. Over 100 types of HRVs"/>
   <result pre="the subtypes of HRV that is related to adults with" exact="asthma" post="exacerbations [14]. Furthermore it is unknown that if certain"/>
   <result pre="the typing of HRV) in relation to acute exacerbations of" exact="asthma" post="and COPD. The secondary aim was to assess if"/>
   <result pre="hospitalization, 30 and 60-day readmissions and mortality. Methods Subjects with" exact="asthma" post="exacerbation or AECOPD who were admitted to the Prince"/>
   <result pre="for at least two consecutive days [16, 17]. Patients with" exact="asthma" post="exacerbations were subjects aged â‰¥18â€‰years, who had background asthma"/>
   <result pre="with asthma exacerbations were subjects aged â‰¥18â€‰years, who had background" exact="asthma" post="(with a consistent history, prior documented evidence of variable"/>
   <result pre="wheeze or cough for at least 2 consecutive days. Control" exact="asthma" post="and COPD subjects were recruited from the respiratory clinic"/>
   <result pre="of lung resection or other significant pulmonary diseases such as" exact="pulmonary fibrosis," post="active infection such as pulmonary tuberculosis and having short"/>
   <result pre="pulmonary diseases such as pulmonary fibrosis, active infection such as" exact="pulmonary tuberculosis" post="and having short life expectancies including subjects with terminal"/>
   <result pre="diseases such as pulmonary fibrosis, active infection such as pulmonary" exact="tuberculosis" post="and having short life expectancies including subjects with terminal"/>
   <result pre="from the patients within 1â€&quot;2â€‰days of hospitalization for exacerbation of" exact="asthma" post="and COPD. This study was approved by the Joint"/>
   <result pre="22 respiratory pathogens (coronavirus 229E, HKU1, NL63, OC43, human metapneumovirus," exact="influenza" post="A (including H1 and H3), influenza A H1N1pdm09, influenza"/>
   <result pre="NL63, OC43, human metapneumovirus, influenza A (including H1 and H3)," exact="influenza" post="A H1N1pdm09, influenza B, parainfluenza 1, 2, 3 &amp;amp;"/>
   <result pre="metapneumovirus, influenza A (including H1 and H3), influenza A H1N1pdm09," exact="influenza" post="B, parainfluenza 1, 2, 3 &amp;amp; 4, rhinovirus/enterovirus, RSV-A"/>
   <result pre="baseline assessment for up to 2â€‰months. For control COPD and" exact="asthma" post="patients, we identified patients from the out-patient clinic and"/>
   <result pre="aimed at recruiting 400 episodes of AECOPD, 100 episodes of" exact="asthma" post="exacerbation and 1/5 the number of exacerbation of subjects"/>
   <result pre="to the prevalence of different viruses found in AECOPD and" exact="asthma" post="patients and comparisons with the control subjects were done"/>
   <result pre="recruited 402 patients with AECOPD, 80 stable COPD, 100 with" exact="asthma" post="exacerbation, and 21 with stable asthma subjects for this"/>
   <result pre="stable COPD, 100 with asthma exacerbation, and 21 with stable" exact="asthma" post="subjects for this study. The characteristics of the COPD"/>
   <result pre="subjects for this study. The characteristics of the COPD and" exact="asthma" post="subjects are shown in TableÂ 1. The exacerbation and"/>
   <result pre="and inhaler therapies. Table 1 Characteristics of the COPD and" exact="asthma" post="patients Subjects with acute exacerbation of COPD (nÂ =â€‰402)"/>
   <result pre="(nÂ =â€‰80) p-value(compared acute exacerbation and stable COPD) Subjects with" exact="asthma" post="exacerbation of (nÂ =â€‰100) Control asthma (nÂ =â€‰21) p-value(compared"/>
   <result pre="stable COPD) Subjects with asthma exacerbation of (nÂ =â€‰100) Control" exact="asthma" post="(nÂ =â€‰21) p-value(compared acute and stable asthma) Gender (Male)"/>
   <result pre="(49.5%) 75 (93.8%) 30 (30.0%) 4 (19.0%) 0.23 Comorbidities â€ƒOld" exact="tuberculosis" post="67 (16.6%) 9 (11.3%) 0.22 4 (4.0%) 0 (0.0%)"/>
   <result pre="(8.9%) 4 (5.0%) 0.24 9 (9.0%) 0 (0.0%) 0.35 â€ƒIschaemic" exact="heart disease" post="38 (9.4%) 5 (6.2%) 0.35 7 (7.0%) 1 (4.7%)"/>
   <result pre="AdditionalÂ fileÂ 1: Figure S1. Only the AECOPD group and" exact="asthma" post="exacerbation group (not control subjects), had influenza A identified"/>
   <result pre="AECOPD group and asthma exacerbation group (not control subjects), had" exact="influenza" post="A identified by RTPCR in the NPA. For those"/>
   <result pre="by RTPCR in the NPA. For those with AECOPD and" exact="asthma" post="exacerbation subjects, 5 out of the 50 (10.0%) and"/>
   <result pre="had the H1N1pdm09 strain identified respectively. The rest of the" exact="influenza" post="A belonged to the H3N2 strain. Fig. 1 NPA"/>
   <result pre="with those without isolation of pathogens. Among 100 subjects with" exact="asthma" post="exacerbation, 45(45.0%) had pathogens detected. 5(5.0%) subjects had co-infections"/>
   <result pre="co-infections with more than 1 pathogen studied. Among the 21" exact="asthma" post="control subjects, only 1(4.8%) subject had parainfluenza virus detected."/>
   <result pre="had parainfluenza virus detected. The prevalence of microorganisms identified in" exact="asthma" post="(exacerbated asthma and stable) patients is shown in Fig.Â"/>
   <result pre="virus detected. The prevalence of microorganisms identified in asthma (exacerbated" exact="asthma" post="and stable) patients is shown in Fig.Â 2. The"/>
   <result pre="file 1: Figure S2. Fig. 2 NPA results of the" exact="asthma" post="cases. a: Patients with acute exacerbation of asthma and"/>
   <result pre="of the asthma cases. a: Patients with acute exacerbation of" exact="asthma" post="and stable asthma with or without microorganisms detected in"/>
   <result pre="cases. a: Patients with acute exacerbation of asthma and stable" exact="asthma" post="with or without microorganisms detected in the NPA. b:"/>
   <result pre="M pneumoniaeâ€‰=â€‰Mycoplasma pneumoniae; HRVsâ€‰=â€‰Human rhinovirus; RSVâ€‰=â€‰Respiratory syncytial virus Subjects with" exact="asthma" post="exacerbations with detection of pathogens in the NPA had"/>
   <result pre="in the NPA vs those without microorganisms identified for both" exact="asthma" post="and COPD exacerbations. Results are shown in TableÂ 2."/>
   <result pre="unit, NIV non-invasive ventilation Comparison of subjects with and without" exact="influenza" post="vaccination found that the rate of influenza-related exacerbations appeared"/>
   <result pre="of influenza-related exacerbations appeared to be higher in those with" exact="influenza" post="vaccination but that did not reach statistical significance. Results"/>
   <result pre="shown in TableÂ 3. Table 3 Subjects with and without" exact="influenza" post="vaccination and rate of admission for exacerbations with influenza"/>
   <result pre="without influenza vaccination and rate of admission for exacerbations with" exact="influenza" post="A or B isolated in the NPA among subjects"/>
   <result pre="B isolated in the NPA among subjects with COPD and" exact="asthma" post="AECOPD (nÂ =â€‰402) Asthma exacerbation (nÂ =â€‰100) With flu"/>
   <result pre="B identified in NPA among the subjects with or without" exact="influenza" post="vaccination in the COPD* and asthma# acute exacerbation subjects:*pÂ"/>
   <result pre="detected in 26, 11 and 1 subjects respectively with AECOPD," exact="asthma" post="exacerbations and stable COPD. No subject in stable asthma"/>
   <result pre="AECOPD, asthma exacerbations and stable COPD. No subject in stable" exact="asthma" post="group had HRV identified in the NPA. The subtypes"/>
   <result pre="identified in the subjects AECOPD Stable COPD Asthma exacerbation Stable" exact="asthma" post="HRV_A HRV_A1 HRV_A7 HRV_A21 HRV_A33 HRV_A33 HRV_A36 HRV_A36 HRV_A43"/>
   <result pre="between the various types of HRV in both AECOPD and" exact="asthma" post="exacerbations with hospital LOS, readmission and mortality. The results"/>
   <result pre="relationships of HRV types and clinical outcomes of AECOPD and" exact="asthma" post="exacerbation are shown in Additional file 1: Tables S1"/>
   <result pre="detection of respiratory pathogens of adults hospitalized for AECOPD and" exact="asthma" post="exacerbations, this study has found that the rates of"/>
   <result pre="rates were much lower among the corresponding control COPD and" exact="asthma" post="subjects, which were 11.2 and 4.8% respectively. HRV typing"/>
   <result pre="the more common HRV that were associated with AECOPD and" exact="asthma" post="exacerbations with a wide variety of genotypes. Detection of"/>
   <result pre="the hospital LOS, readmissions and mortality except that patients with" exact="asthma" post="exacerbation, identification of pathogens was associated with a lower"/>
   <result pre="our previous study 10â€‰years ago (35.1 vs 22%) [1], and" exact="influenza" post="A viruses remained the most common pathogen identified. Most"/>
   <result pre="commonest virus identified [6]. In contrast, relatively few studies reported" exact="influenza" post="A as the most frequently found virus [20, 21]."/>
   <result pre="as the most frequently found virus [20, 21]. Among the" exact="asthma" post="subjects, 45.0% had pathogens detected in this study. Most"/>
   <result pre="of the previous studies on detection of respiratory pathogens in" exact="asthma" post="exacerbations were conducted in children [22]. A Korean study"/>
   <result pre="in children [22]. A Korean study found that in adult" exact="asthma" post="subjects with acute exacerbation, 26.3% had viruses identified in"/>
   <result pre="HRV being the commonest organisms identified [24]. Adult subjects with" exact="asthma" post="exacerbation thus appeared to have a lower rate of"/>
   <result pre="identified in the NPA were observed in this study with" exact="influenza" post="viruses reaching the peak in November to February and"/>
   <result pre="July for AECOPD. A similar pattern was observed for adult" exact="asthma" post="exacerbation with influenza virus detection which peaked in November"/>
   <result pre="A similar pattern was observed for adult asthma exacerbation with" exact="influenza" post="virus detection which peaked in November and June to"/>
   <result pre="June to July. This pattern was in phase with the" exact="influenza" post="seasonal patterns in Hong Kong [25]. A study of"/>
   <result pre="of airway diseases in the UK were related to childhood" exact="asthma" post="with a seasonal increase of HRV infections in September"/>
   <result pre="Spring [26]. Similar patterns were noted for adult COPD and" exact="asthma" post="exacerbation patients in this study. For children, HRV-A and"/>
   <result pre="For children, HRV-A and HRV-C are more frequently associated with" exact="asthma" post="exacerbations. A cross-sectional study of subjects aged 13]. Similar"/>
   <result pre="A cross-sectional study of subjects aged 13]. Similar observation for" exact="asthma" post="children in other parts of the world was observed"/>
   <result pre="those requiring hospitalization [30, 31]. In contrast, our adults with" exact="asthma" post="exacerbation had HRV-A being isolated from the NPA more"/>
   <result pre="that HRV-A or HRV-C had a potential role in precipitating" exact="asthma" post="attacks among Japanese adult patients, with a broad genetic"/>
   <result pre="generally have not typed the HRV. Those with history of" exact="influenza" post="vaccination appeared to have a higher rate of identification"/>
   <result pre="vaccination appeared to have a higher rate of identification of" exact="influenza" post="viruses in the NPA than those without vaccination for"/>
   <result pre="the NPA than those without vaccination for both AECOPD and" exact="asthma" post="exacerbation though this did not reach statistical significance. A"/>
   <result pre="suggested that protective serum antibody titres in COPD patients after" exact="influenza" post="vaccination was lower than control subjects [32]. Overall the"/>
   <result pre="lower than control subjects [32]. Overall the mortality benefit of" exact="influenza" post="vaccine in COPD is suggested by some studies but"/>
   <result pre="Another systemic review indicated a favorable benefit-risk ratio for seasonal" exact="influenza" post="vaccination in patients with COPD [34]. For persons with"/>
   <result pre="For persons with asthma, a recent systematic review observed that" exact="influenza" post="vaccination might be effective in both reducing influenza infection"/>
   <result pre="observed that influenza vaccination might be effective in both reducing" exact="influenza" post="infection and asthma attacks [35]. However, another Cochrane review"/>
   <result pre="vaccination might be effective in both reducing influenza infection and" exact="asthma" post="attacks [35]. However, another Cochrane review has expressed uncertainty"/>
   <result pre="review has expressed uncertainty of the degree of protection that" exact="influenza" post="vaccination might confer against asthma exacerbations that are related"/>
   <result pre="the degree of protection that influenza vaccination might confer against" exact="asthma" post="exacerbations that are related to influenza infection [36]. During"/>
   <result pre="vaccination might confer against asthma exacerbations that are related to" exact="influenza" post="infection [36]. During the study period from August 2016"/>
   <result pre="During the study period from August 2016 to July 2017," exact="influenza" post="A(H3N2) was the main circulating strain causing the Summer"/>
   <result pre="sites and distances in addition to egg adaptation especially for" exact="influenza" post="A(H3N2) virus [38]. A previous systematic review found substantial"/>
   <result pre="virus [38]. A previous systematic review found substantial variations in" exact="influenza" post="vaccine effectiveness across types and subtypes of influenza with"/>
   <result pre="variations in influenza vaccine effectiveness across types and subtypes of" exact="influenza" post="with substantially lower protection against H3N2 [39]. Examination of"/>
   <result pre="influenza with substantially lower protection against H3N2 [39]. Examination of" exact="influenza" post="vaccine effectiveness by serology is beyond the scope of"/>
   <result pre="due to current or previous infection or vaccination by measuring" exact="influenza" post="antibody based on haemagglutinin inhibition. While identification of pathogens"/>
   <result pre="lower rate of readmissions for asthma, exacerbations of COPD and" exact="asthma" post="might also be due to other acute and transient"/>
   <result pre="were other factors that might be associated with AECOPD and" exact="asthma" post="exacerbations, e.g. air pollution, weather changes, allergic sensitization, etc."/>
   <result pre="viral and atypical pathogens that were associated with AECOPD and" exact="asthma" post="exacerbations in hospitalized patients. HRV typing suggested that HRV-A"/>
   <result pre="more common HRV subtypes that were associated with AECOPD and" exact="asthma" post="exacerbations with a wide variety of genotypes. Presence of"/>
   <result pre="mortality except that patients who had infective aetiology identified during" exact="asthma" post="exacerbation had lower rates of readmissions at 30 and"/>
   <result pre="cases in different months. Figure S2. NPA results of the" exact="asthma" post="exacerbation cases in different months. (DOCX 145 kb) Abbreviations"/>
   <result pre="competing interests. References References 1.KoFWIpMChanPKChanMCChanMCToKWNgSSChauSSTangJWHuiDSViral etiology of acute exacerbations of" exact="chronic obstructive pulmonary disease" post="in Hong KongChest200713290090810.1378/chest.07-053017573516 2.KoFWIpMChanPKFokJPChanMCNgaiJCChanDPHuiDSA 1-year prospective study of the"/>
   <result pre="2018). 4.KoFWTamWWongTWChanDPTungAHLaiCKHuiDSTemporal relationship between air pollutants and hospital admissions for" exact="chronic obstructive pulmonary disease" post="in Hong KongThorax20076278078510.1136/thx.2006.07616617311838 5.KoFWTamWWongTWLaiCKWongGWLeungTFNgSSHuiDSEffects of air pollution on asthma"/>
   <result pre="pulmonary disease in Hong KongThorax20076278078510.1136/thx.2006.07616617311838 5.KoFWTamWWongTWLaiCKWongGWLeungTFNgSSHuiDSEffects of air pollution on" exact="asthma" post="hospitalization rates in different age groups in Hong KongClin"/>
   <result pre="al.Community study of role of viral infections in exacerbations of" exact="asthma" post="in 9-11 year old childrenBMJ19953101225122910.1136/bmj.310.6989.12257767192 8.WarkPAToozeMPowellHParsonsKViral and bacterial infection"/>
   <result pre="9-11 year old childrenBMJ19953101225122910.1136/bmj.310.6989.12257767192 8.WarkPAToozeMPowellHParsonsKViral and bacterial infection in acute" exact="asthma" post="and chronic obstructive pulmonary disease increases the risk of"/>
   <result pre="old childrenBMJ19953101225122910.1136/bmj.310.6989.12257767192 8.WarkPAToozeMPowellHParsonsKViral and bacterial infection in acute asthma and" exact="chronic obstructive pulmonary disease" post="increases the risk of readmissionRespirology201318996100210.1111/resp.1209923600594 9.JohnstonNWJohnstonSLDuncanJMGreeneJMKebadzeTKeithPKRoyMWasermanSSearsMRThe September epidemic of"/>
   <result pre="disease increases the risk of readmissionRespirology201318996100210.1111/resp.1209923600594 9.JohnstonNWJohnstonSLDuncanJMGreeneJMKebadzeTKeithPKRoyMWasermanSSearsMRThe September epidemic of" exact="asthma" post="exacerbations in children: a search for etiologyJ Allergy Clin"/>
   <result pre="J20001667768310.1034/j.1399-3003.2000.16d19.x11106212 11.ThumerelleCDeschildreABouquillonCSantosCSardetAScalbertMDelbecqueLDebrayPDewildeATurckDLeclercFRole of viruses and atypical bacteria in exacerbations of" exact="asthma" post="in hospitalized children: a prospective study in the Nord-pas"/>
   <result pre="in the development of therapeutic agents for viral exacerbations of" exact="asthma" post="and chronic obstructive pulmonary diseasePulm Pharmacol Ther201430C3243 13.MakRKTseLYLamWYWongGWChanPKLeungTFClinical spectrum"/>
   <result pre="14.JarttiTGernJERole of viral infections in the development and exacerbation of" exact="asthma" post="in childrenJ Allergy Clin Immunol201714089590610.1016/j.jaci.2017.08.00328987219 15.Global Initiative for Chronic"/>
   <result pre="Strategy for the diagnosis, management, and prevention of chronic obstructive" exact="lung disease." post="Updated 2018. 2018:http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf (last assessed date 20 Feb 2018)."/>
   <result pre="To MYYeungACWongYSWongGWChanPKMultiplex molecular detection of respiratory pathogens in children with" exact="asthma" post="exacerbationChest201013734835410.1378/chest.09-125019749009 25.Center for Health Protection. Department of Health. The"/>
   <result pre="Erbas B. The role of human rhinovirus (HRV) species on" exact="asthma" post="exacerbation severity in children and adolescents. The Journal of"/>
   <result pre="asthma exacerbation severity in children and adolescents. The Journal of" exact="asthma" post=": official journal of the Association for the Care"/>
   <result pre="SpainPediatr Infect Dis J20102971772010.1097/INF.0b013e3181d7a70820305581 29.KhetsurianiNLuXTeagueWGKazerouniNAndersonLJErdmanDDNovel human rhinoviruses and exacerbation of" exact="asthma" post="in childrenEmerg Infect Dis2008141793179610.3201/eid1411.08038618976575 30.CoxDWBizzintinoJFerrariGKhooSKZhangGWhelanSLeeWMBochkovYAGeelhoedGCGoldblattJGernJELaingIALe SouefPNHuman rhinovirus species C"/>
   <result pre="on viral replication and cytokine productionJ Allergy Clin Immunol201413433234110.1016/j.jaci.2014.01.02924636084 32.EaganTMHardieJAJul-LarsenAGrydelandTBBakkePSCoxRJSelf-reported" exact="influenza" post="vaccination and protective serum antibody titers in a cohort"/>
   <result pre="understanding immunogenicity, efficacy and effectivenessTher Adv Respir Dis20161034936710.1177/175346581664605027193567 34.Bekkat-BerkaniRWilkinsonTBuchyPDos SantosGStefanidisDDevasterJMMeyerNSeasonal" exact="influenza" post="vaccination in patients with COPD: a systematic literature reviewBMC"/>
   <result pre="a systematic literature reviewBMC pulmonary medicine2017177910.1186/s12890-017-0420-828468650 35.VasileiouESheikhAButlerCEl FerkhKvon WissmannBMcMenaminJRitchieLSchwarzeJPapadopoulosNGJohnstonSLTianLSimpsonCREffectiveness of" exact="influenza" post="vaccines in asthma: a systematic review and meta-analysisClinical infectious"/>
   <result pre="Society of America2017651388139510.1093/cid/cix52428591866 36.Cates CJ, Rowe BH. Vaccines for preventing" exact="influenza" post="in people with asthma. The Cochrane database of systematic"/>
   <result pre="(Last access date 24 Aug 2018). 2018;15:1â€&quot;7. 38.ZostSJParkhouseKGuminaMEKimKDiaz PerezSWilsonPCTreanorJJSantAJCobeySHensleySEContemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="egg-adapted vaccine strainsProc Natl Acad Sci U S A2017114125781258310.1073/pnas.171237711429109276 39.BelongiaEASimpsonMDKingJPSundaramMEKelleyNSOsterholmMTMcLeanHQVariable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6743794\results\search\disease\results.xml">
   <result pre="months. Although the immune response against other arboviruses, such as" exact="chikungunya" post="virus (CHIKV), dengue virus (DENV) and Zika virus (ZIKV),"/>
   <result pre="from the media because the epidemics caused by Zika and" exact="chikungunya" post="virus rapidly spread to new areas and infected a"/>
   <result pre="activates the NLRP3 inflammasome, which is important to regulate this" exact="viral disease." post="Our study provides molecular targets for a future treatment"/>
   <result pre="increasing awareness of emerging infections worldwide. After the spread of" exact="chikungunya" post="virus (CHIKV) to new areas of the globe and"/>
   <result pre="River virus (RRV), Eastern (EEEV), Western (WEEV), and Venezuelan equine" exact="encephalitis" post="(VEEV) viruses [8]. Haemagogus mosquitoes have been documented as"/>
   <result pre="involved in a wide variety of diseases, such as autoimmunity," exact="cancer" post="and neurodegenerative and infectious diseases [12,23,25]. Arboviral infections, including"/>
   <result pre="were treated with mock or infected with Zika virus (ZIKV)," exact="chikungunya" post="virus (CHIKV) or Mayaro virus (MAYV) at a MOI"/>
   <result pre="WT mice (Fig 5E). Of note, Nlrp3â€&quot;/â€&quot;mice showed reduced pain" exact="hypersensitivity" post="at earlier time points upon infection but developed pain"/>
   <result pre="hypersensitivity at earlier time points upon infection but developed pain" exact="hypersensitivity" post="similar to WT mice after 5 days of infection"/>
   <result pre="ZaidA, TengTS, HerreroLJ, WolfS, et al.Specific inhibition of NLRP3 in" exact="chikungunya" post="disease reveals a role for inflammasomes in alphavirus-induced inflammation."/>
   <result pre="10.1038/nm.322123749230 38HaeseNN, BroeckelRM, HawmanDW, HeiseMT, MorrisonTE, StreblowDN. Animal models of" exact="chikungunya" post="virus infection and disease. J Infect Dis. 2016;214: S482â€&quot;S487."/>
   <result pre="ZaidA, TengT-S, HerreroLJ, WolfS, et al.Specific inhibition of NLRP3 in" exact="chikungunya" post="disease reveals a role for inflammasomes in alphavirus-induced inflammation."/>
   <result pre="of NK and NKT-like populations during the early stages of" exact="chikungunya" post="infection. Front Microbiol. 2015;6: 1â€&quot;11. 10.3389/fmicb.2015.0089525653648 53LeroyEM, DebrÃ©P, PetitdemangeC,"/>
   <result pre="et al.Reassessing the role of the NLRP3 inflammasome during pathogenic" exact="influenza" post="A virus infection via temporal inhibition. Sci Rep. 2016;6:"/>
   <result pre="1â€&quot;8. 10.1038/srep2791228442746 56IchinoheT, LeeHK, OguraY, FlavellR, IwasakiA. Inflammasome recognition of" exact="influenza" post="virus is essential for adaptive immune responses. J Exp"/>
   <result pre="OkoL, MontgomerySA, WhitmoreAC, LotsteinAR, GunnBM, et al.A mouse model of" exact="chikungunya" post="virus-induced musculoskeletal inflammatory disease: Evidence of arthritis, tenosynovitis, myositis,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6745427\results\search\disease\results.xml">
   <result pre="competence and the public health threat of dengue, MERS-CoV, and" exact="influenza" post="outbreaks. Sustained investment and ample financial allocation are needed"/>
   <result pre="and Zika virus.1 A total of 2926 confirmed cases of" exact="dengue fever" post="were documented in 2016 in Saudi Arabia alone,2 and"/>
   <result pre="vector (Aedes mosquito species). Saudi Arabia recorded 6000 cases of" exact="dengue fever" post="in 2015, and six infected patients died.2Aedes aegypti and"/>
   <result pre="other mosquito-borne flaviviruses within the Flaviviridae family such as Zika," exact="yellow fever," post="West Nile, and Japanese encephalitis.1,3-5 In 2006, a total"/>
   <result pre="indica green-synthesized silver nanoparticles: A sustainable control tool against the" exact="malaria" post="vector Anopheles stephensi?Res Vet Sci2015 Oct;102(102):127-135. 10.1016/j.rvsc.2015.08.00126412532 9AzizATAl-ShamiSAMahyoubJAHatabbiMAhmadAHMd RawiCSPromoting"/>
   <result pre="community opinion survey.PLoS Curr2016 May;8:8. 10.1371/currents.outbreaks.1c39ec05a743d41ee39391ed0f2ed8d327366585 15MainsJWBrelsfoardCLRoseRIDobsonSLFemale adult Aedes albopictus" exact="suppression" post="by wolbachia-infected male mosquitoes.Sci Rep2016 Sep;6:33846. 10.1038/srep3384627659038 16MuruganKPriyankaVDineshDMadhiyazhaganPPanneerselvamCSubramaniamJet al.Predation"/>
   <result pre="using Hugonia mystax: larvicidal potential against Zika virus, dengue, and" exact="malaria" post="vector mosquitoes.Artif Cells Nanomed Biotechnol2017 Nov;45(7):1317-1325. 10.1080/21691401.2016.122866427611658 19TamboEChenJHZhouXNKhaterEIOutwitting dengue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6750865\results\search\disease\results.xml">
   <result pre="of neuronal and glial cells development and microcephaly. Keywords ZIKV" exact="microcephaly" post="neuroinflammatory response cell death fig-count: ref-count: page-count: Perspectives Zika"/>
   <result pre="to the outbreak and exponential growth of reported cases of" exact="microcephaly" post="and other congenital defects.1,2 ZIKV exhibits extreme versatility and"/>
   <result pre="infection. These studies suggest that there is a link between" exact="microcephaly" post="and cell death resulting from the neuroinflammatory response, whereby"/>
   <result pre="and ZIKV-induced microcephaly. Apoptosis, Necrosis, And Necroptosis The development of" exact="microcephaly" post="presents a great challenge owing to the lack of"/>
   <result pre="various mechanisms to maintain homeostasis, without causing major damage; in" exact="microcephaly" post="cases, apoptosis induces the uncontrolled death of neurons and"/>
   <result pre="extremely harmful to neurons and glial cells, i.e., pyroptosis in" exact="microcephaly" post="cases ZIKV-induced.17â€&quot;20 Interestingly, pyroptosis differs from apoptosis and necrosis"/>
   <result pre="the viral pathogenesis. Conclusion And Future Direction Many questions about" exact="microcephaly" post="induced by ZIKV remain. However, investigations of several mechanisms"/>
   <result pre="of ZIKV infection suggest that there is a link between" exact="microcephaly" post="and cell death in which the neuroinflammatory response in"/>
   <result pre="Possible integrated mechanism of cell injury and its relationship with" exact="microcephaly" post="ZIKV-induced and cell death. Cell injury is determined by"/>
   <result pre="paraptosis, and autophagy can directly impact on the development of" exact="microcephaly" post="during ZIKV congenital infection or in the death of"/>
   <result pre="neurons and glial cells by necrosis induced by ZIKV in" exact="microcephaly" post="cases. Another type of cell death associated with microcephaly,"/>
   <result pre="of cell damage in central nervous system of fatal cases" exact="microcephaly" post="by Zika virus. Sci Rep. 2018;1:1. doi:10.1038/s41598-017-17765-5 8.SolomonIH, MilnerDA,"/>
   <result pre="apoptosis and in situ immune response in fatal cases of" exact="microcephaly" post="caused by Zika virus. Am J Pathol. 2018;9440:30153â€&quot;30156. 13.Ghosh"/>
   <result pre="damage to the central nervous system in fatal Zika virus" exact="microcephaly" post="cases. Cytokine. 2018;111:255â€&quot;264. doi:10.1016/j.cyto.2018.08.00830199767 21.ZhengY, LiuQ, WuY, et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6751066\results\search\disease\results.xml">
   <result pre="of the Creative Commons Attribution 4.0 International license.mBio.02180-19.pdf Current seasonal" exact="influenza" post="vaccines are suboptimal and low in immunogenicity and do"/>
   <result pre="and do not provide long-lasting immunity and cross protection against" exact="influenza" post="virus strains that have antigenically drifted. More-effective influenza vaccines"/>
   <result pre="protection against influenza virus strains that have antigenically drifted. More-effective" exact="influenza" post="vaccines which can induce both humoral immunity and T"/>
   <result pre="and T cell immunity are needed. The NS1 protein of" exact="influenza" post="virus is a virulence element and the critical factor"/>
   <result pre="vaccines in humans. We have generated a panel of both" exact="influenza" post="A and influenza B DelNS1 LAIVs which are able"/>
   <result pre="We have generated a panel of both influenza A and" exact="influenza" post="B DelNS1 LAIVs which are able to grow in"/>
   <result pre="and emerging influenza. Abstract ABSTRACT Nonstructural protein 1 (NS1) of" exact="influenza" post="virus is a key virulence element with multifunctional roles"/>
   <result pre="would create a safer and more extensively immunogenic live attenuated" exact="influenza" post="virus (LAIV) vaccine. However, DelNS1 viruses are very difficult"/>
   <result pre="developed two master backbones of deleted-NS1 (DelNS1) viral genomes from" exact="influenza" post="A or B viruses which contain novel adaptive mutations"/>
   <result pre="nonpathogenic in mice but replicate well in vaccine-producing cells. Both" exact="influenza" post="A and influenza B DelNS1 LAIVs grow better at"/>
   <result pre="but replicate well in vaccine-producing cells. Both influenza A and" exact="influenza" post="B DelNS1 LAIVs grow better at 33Â°C than at"/>
   <result pre="strong long-lasting cross protection against heterosubtypic or antigenically distantly related" exact="influenza" post="viruses in mice. Mechanistic investigations revealed that DelNS1-LAIVs induce"/>
   <result pre="against seasonal and emerging influenza. KEYWORDS live attenuated vaccine NS1" exact="influenza" post="vaccines Funding Research Grant Council of Hong Kong SAR"/>
   <result pre="to alleviate the disease burden and mortality associated with seasonal" exact="influenza" post="and is also the method of choice to curb"/>
   <result pre="circulating strains makes it difficult to predict the evolution of" exact="influenza" post="viruses (IVs). An inability to induce long-lasting immunity and"/>
   <result pre="inability to induce long-lasting immunity and the effects of historical" exact="influenza" post="virus infections on vaccine-induced immune responses further complicate the"/>
   <result pre="responses further complicate the current vaccine strategy. Mismatch of seasonal" exact="influenza" post="vaccines and circulating strains occurs regularly, resulting in severe"/>
   <result pre="influenza vaccines and circulating strains occurs regularly, resulting in severe" exact="influenza" post="seasons (1). It is also recognized that HA-based influenza"/>
   <result pre="severe influenza seasons (1). It is also recognized that HA-based" exact="influenza" post="vaccine technology cannot respond swiftly to emerging pandemic viruses,"/>
   <result pre="the 2009 H1N1 pandemic. Therefore, it is imperative to develop" exact="influenza" post="vaccines with the ability to induce enduring broadly protective"/>
   <result pre="induce enduring broadly protective immunity against matched and mismatched seasonal" exact="influenza" post="virus strains and that can be produced rapidly in"/>
   <result pre="In recent years, new strategies for the development of novel" exact="influenza" post="vaccines conferring superior length and breadth of protection have"/>
   <result pre="antibodies targeting the more highly conserved stem region of the" exact="influenza" post="virus HA protein (7, 8). Attention has also recently"/>
   <result pre="Attention has also recently been focused on immunity elicited by" exact="influenza" post="virus neuraminidase (NA), which is less variable than HA,"/>
   <result pre="based on the conserved ectodomain of matrix protein 2 of" exact="influenza" post="virus have been evaluated previously in multiple reports (11,"/>
   <result pre="evaluated previously in multiple reports (11, 12). Another strategy in" exact="influenza" post="vaccine research focuses on using live attenuated influenza viruses"/>
   <result pre="strategy in influenza vaccine research focuses on using live attenuated" exact="influenza" post="viruses (LAIVs) to mimic natural infection and induce both"/>
   <result pre="natural infection and induce both humoral and cellular immunity to" exact="influenza" post="virus. A cold-adapted LAIV (Influenza Mist) has been licensed"/>
   <result pre="aim to induce HA-specific neutralizing or stem-targeting antibodies to block" exact="influenza" post="virus, LAIVs elicit multifaceted immune responses through limited virus"/>
   <result pre="able to induce broader cross protective immunity than current inactivated" exact="influenza" post="vaccines. It has long been questioned why natural infections"/>
   <result pre="vaccines. It has long been questioned why natural infections with" exact="influenza" post="virus fail to induce broad and long-lasting immunity against"/>
   <result pre="immunity and interference with the induction of adaptive immunity during" exact="influenza" post="virus infection (19, 20). A role for NS1 in"/>
   <result pre="considered a desirable strategy for making safer and more immunogenic" exact="influenza" post="vaccines (22). An NS1-truncated vaccine induces strong immune responses"/>
   <result pre="of H3N2 or H1N1 viruses also cross protect against swine" exact="influenza" post="viruses in pigs (25â€&quot;27), further highlighting the potential of"/>
   <result pre="preventing influenza. Furthermore, two clinical trials using deleted-NS1-trivalent LAIVs containing" exact="influenza" post="virus H1N1, H3N2, and B strains demonstrated induction of"/>
   <result pre="strain-specific and cross-neutralizing antibodies in vaccinated humans (28, 29). However," exact="influenza" post="viruses with truncated or deleted NS1 grow at relatively"/>
   <result pre="has hampered the commercial development of deleted-NS1 (DelNS1) live attenuated" exact="influenza" post="virus vaccine strains. Previous studies published by ourselves and"/>
   <result pre="acquisition of adaptive mutations that restore NS1-regulated M splicing during" exact="influenza" post="virus infection would increase virus replication ability in interferon-deficient"/>
   <result pre="sufficient quantities of DelNS1 viruses for use as live attenuated" exact="influenza" post="vaccines. It will also be important to evaluate if"/>
   <result pre="(31), we have established a panel of DelNS1 versions of" exact="influenza" post="A (2009 H1N1, H3N2, and H7N9) and B virus"/>
   <result pre="master donor strains derived from the 2009 H1N1 and HK2011" exact="influenza" post="B virus strains, respectively. We found that different strains"/>
   <result pre="B virus strains, respectively. We found that different strains of" exact="influenza" post="viruses utilize different adaptive strategies to support replication of"/>
   <result pre="of whether they originated from seasonal, pandemic, or highly pathogenic" exact="avian influenza" post="viruses, and are naturally cold-adapted. Importantly, immunization of mice"/>
   <result pre="whether they originated from seasonal, pandemic, or highly pathogenic avian" exact="influenza" post="viruses, and are naturally cold-adapted. Importantly, immunization of mice"/>
   <result pre="H5N1 or H7N9 viruses. Broad protection against antigenically distantly related" exact="influenza" post="viruses was also observed for DelNS1-H3N2 and DelNS1 B"/>
   <result pre="and for expressing additional antigens to enhance specific immunity against" exact="influenza" post="viruses. DelNS1 LAIVs with adaptive mutations enabling growth in"/>
   <result pre="more-effective and broadly protective vaccines for seasonal and emerging pandemic" exact="influenza" post="viruses. RESULTS Generation of 2009 H1N1 DelNS1 virus with"/>
   <result pre="humans and has become one of the two prevalent seasonal" exact="influenza" post="A viruses. We consider this to be an ideal"/>
   <result pre="an ideal virus from which to make a backbone for" exact="influenza" post="A DelNS1 LAIV. Using technology similar to that previously"/>
   <result pre="spontaneous and is a desirable feature in a live attenuated" exact="influenza" post="virus vaccine. To further verify the contribution of the"/>
   <result pre="attenuates the pathogenic properties of both seasonal and highly pathogenic" exact="avian influenza" post="viruses. FIGÂ 2 Avirulence of CA4-DelNS1 virus. (A) A549"/>
   <result pre="the pathogenic properties of both seasonal and highly pathogenic avian" exact="influenza" post="viruses. FIGÂ 2 Avirulence of CA4-DelNS1 virus. (A) A549"/>
   <result pre="challenge. To assess the protective ability of DelNS1 virus in" exact="influenza" post="virus infection, we immunized mice once with CA4-DelNS1 virus,"/>
   <result pre="vaccinated mice at day 3 postchallenge (Fig.Â 3B). Highly pathogenic" exact="avian influenza" post="H5N1 virus infection is fatal in approximately 60% of"/>
   <result pre="mice at day 3 postchallenge (Fig.Â 3B). Highly pathogenic avian" exact="influenza" post="H5N1 virus infection is fatal in approximately 60% of"/>
   <result pre="(Fig.Â S3A to C). Cross protective immunity against antigenically distinct" exact="influenza" post="A strains was also induced by CA4-DelNS1 (H1N1) and"/>
   <result pre="H1N1 strain, no significant DI genomes were detected from either" exact="influenza" post="A or influenza B DelNS1 LAIV (Fig.Â S2E). These"/>
   <result pre="significant DI genomes were detected from either influenza A or" exact="influenza" post="B DelNS1 LAIV (Fig.Â S2E). These results show that"/>
   <result pre="LAIV (Fig.Â S2E). These results show that DelNS1 live attenuated" exact="influenza" post="virus induces sustained and highly protective immunity against lethal"/>
   <result pre="that deletion of NS1 from CA4 created a live attenuated" exact="influenza" post="vaccine that seems to be more cross protective than"/>
   <result pre="LAIVs can elicit immunity that is sufficiently broad to overcome" exact="influenza" post="vaccine mismatches caused by antigenic drift of seasonal influenza"/>
   <result pre="overcome influenza vaccine mismatches caused by antigenic drift of seasonal" exact="influenza" post="viruses. 10.1128/mBio.02180-19.4FIGÂ S4Viral titers in lungs of mice infected"/>
   <result pre="terms of the Creative Commons Attribution 4.0 International license. DelNS1" exact="influenza" post="B virus cross protects against different genetic lineages. To"/>
   <result pre="further evaluate the potential of DelNS1 LAIVs for use in" exact="influenza" post="vaccine applications, we generated a DelNS1 influenza B virus"/>
   <result pre="for use in influenza vaccine applications, we generated a DelNS1" exact="influenza" post="B virus using a master donor backbone from a"/>
   <result pre="virus using a master donor backbone from a Victoria lineage" exact="influenza" post="B virus, B/Hong Kong/8038/2011. The NS1 coding region was"/>
   <result pre="NS segment of B/Hong Kong/8038/2011, and a NS1-deleted version of" exact="influenza" post="B virus was rescued using a reverse genetics protocol"/>
   <result pre="5A) as described above. A NS1-deleted version of B/Hong Kong/8038/2011" exact="influenza" post="B virus adapted to replicate in MDCK cells and"/>
   <result pre="assay (Fig.Â S5A). Analysis of growth properties found that DelNS1-B8038" exact="influenza" post="B virus replicates at 33Â°C in MDCK cells but"/>
   <result pre="reduced replication efficiency at 37Â°C (Fig.Â 5C), similarly to CA4-DelNS1" exact="influenza" post="A viruses. DelNS1-B8038 LAIV cannot replicate in interferon-competent A549"/>
   <result pre="cells (Fig.Â 5C). There are two genetically distinct lineages of" exact="influenza" post="B viruses, namely, Victoria and Yamagata, cocirculating in humans."/>
   <result pre="cocirculating in humans. To assess if DelNS1-B8038, a Victoria lineage" exact="influenza" post="B virus, provides protection from infection with both lineages"/>
   <result pre="B virus, provides protection from infection with both lineages of" exact="influenza" post="B virus, mice were immunized once through the nasal"/>
   <result pre="route and were then (after 3 weeks) challenged with mouse-adapted" exact="influenza" post="B virus of either the Yamagata (B/Florida/4/2006) or Victoria"/>
   <result pre="is able to induce cross protective activity against antigenically distinct" exact="influenza" post="B virus strains. FIGÂ 5 Generation and characterization of"/>
   <result pre="and characterization of DelNS1 B LAIV. (A) Generation of DelNS1-B8038" exact="influenza" post="B virus by reverse genetics. pHW2000 plasmids containing an"/>
   <result pre="the virus titer stabilized. (B) Adaptive mutations in growth-adapted DelNS1-B8038" exact="influenza" post="B virus. Mutations in PA (T210C), NA (T1429C), NP"/>
   <result pre="M (G88C plus A280G) were identified. (C) Growth of DelNS1-B8038" exact="influenza" post="B virus in cell culture. MDCK or A549 cells"/>
   <result pre="mice were challenged with mouse-adapted B/Brisbane/60/2008 (Victoria) or B/Florida/4/2006 (Yamagata)" exact="influenza" post="B virus at 10 MLD50. Body weight and survival"/>
   <result pre="10.1128/mBio.02180-19.5FIGÂ S5Viral titers in lungs of mice infected with mouse-adapted" exact="influenza" post="B viruses. Download FIGÂ S5, PDF file, 0.1 MB."/>
   <result pre="ca-LAIV-immunized mice. CD4+ and CD8+ T cells specific for conserved" exact="influenza" post="virus (NP) epitopes were analyzed using intracellular cytokine staining"/>
   <result pre="of the two for mediating cross protective cell immunity against" exact="influenza" post="virus infection. However, when CA4-DelNS1 LAIV-immunized mice were depleted"/>
   <result pre="immunities and that cross protective immunity was mainly mediated by" exact="influenza" post="virus-specific T cells. FIGÂ 6 DelNS1 LAIV induces cross"/>
   <result pre="6 DelNS1 LAIV induces cross protective T cell responses against" exact="influenza" post="viruses. (A) Induction of antigen-specific CD8+ and CD4+ T"/>
   <result pre="protective immunity against challenge with H7N9, H5N1, and HK68 (H3N2)" exact="influenza" post="A viruses (Fig.Â 3; see also Fig.Â S2 and"/>
   <result pre="S3), no protection was observed when mice were challenged with" exact="influenza" post="B virus (Fig.Â 7B). This indicates that the cross"/>
   <result pre="the cross protective immunity induced by CA4-DelNS1 (H1N1) LAIV is" exact="influenza" post="A specific and does not extend to other types"/>
   <result pre="A specific and does not extend to other types of" exact="influenza" post="virus or to other viruses. Since NS1 is deleted"/>
   <result pre="in its place. We tested this possibility by expressing the" exact="influenza" post="B HA1 domain in the NS1 site of the"/>
   <result pre="BHA1 from the CA4-DelNS1 (H1N1) backbone (Fig.Â 7A). Expression of" exact="influenza" post="B virus HA1 was confirmed by Western blot analysis,"/>
   <result pre="7 mice in the group immunized with vaccine expressing the" exact="influenza" post="B HA1 antigen survived, while all mice immunized with"/>
   <result pre="These data highlight a novel strategy to improve the current" exact="influenza" post="vaccine regime by using DelNS1 LAIV to express additional"/>
   <result pre="viral antigens and thereby broaden and enhance specific immunity to" exact="influenza" post="viruses. FIGÂ 7 DelNS1 LAIV expression of B-HA1 antigen"/>
   <result pre="expression of B-HA1 antigen protected against lethal challenge with both" exact="influenza" post="A and B viruses in mice. (A) Illustration of"/>
   <result pre="CA4-DelNS1 and then challenged 3 weeks later with mouse-adapted H1N1" exact="influenza" post="A virus (A/California/04/2009, 10 MLD50) or influenza B virus"/>
   <result pre="with mouse-adapted H1N1 influenza A virus (A/California/04/2009, 10 MLD50) or" exact="influenza" post="B virus (B/Brisbane/60/2008, 10 MLD50) and monitored for 14â€‰days."/>
   <result pre="CA4-DelNS1 virus or CA4-DelNS1-BHA1, which contains the HA1 gene of" exact="influenza" post="B virus (B/Brisbane/60/2008) at the site in the NS"/>
   <result pre="7 (D) mice. 10.1128/mBio.02180-19.7FIGÂ S7Construction of CA4-DelNS1 (H1N1) LAIV expressing" exact="influenza" post="B virus HA1. Download FIGÂ S7, PDF file, 0.2"/>
   <result pre="Creative Commons Attribution 4.0 International license. DISCUSSION Currently available inactivated" exact="influenza" post="vaccines are suboptimal, particularly in the groups that are"/>
   <result pre="development of more highly effective and cross protective and long-lasting" exact="influenza" post="vaccines must be pursued. Influenza viruses in which the"/>
   <result pre="more immunogenic, due to the absence of the immune response" exact="suppression" post="usually mediated by the NS1 protein. With this assumption,"/>
   <result pre="this assumption, we established a panel of DelNS1 live attenuated" exact="influenza" post="viruses (LAIVs) bearing adaptive mutations that support their replication"/>
   <result pre="virus assistance. Master donor backbone viruses were established for both" exact="influenza" post="A virus and influenza B virus and were verified"/>
   <result pre="backbone viruses were established for both influenza A virus and" exact="influenza" post="B virus and were verified in in vitro and"/>
   <result pre="the lower temperature of 33Â°C. Given the rapid evolution of" exact="influenza" post="viruses and the uncertainty regarding the emergence of novel"/>
   <result pre="and the uncertainty regarding the emergence of novel strains, future" exact="influenza" post="vaccines should ideally provide cross protection against antigenically drifted"/>
   <result pre="against antigenically drifted viral strains and novel subtypes of zoonotic" exact="influenza" post="viruses. Our data strongly support the use of a"/>
   <result pre="more-effective and broader immunity for protection against seasonal and pandemic" exact="influenza" post="virus strains. We have shown DelNS1 H1N1, H3N2, and"/>
   <result pre="the capacity to express extra viral antigens will make better" exact="influenza" post="vaccines, addressing some critical pitfalls of existing products. One"/>
   <result pre="the advantages of LAIV vaccines over inactivated split or subunit" exact="influenza" post="virus vaccines is the ability to induce both humoral"/>
   <result pre="is one of the key criteria for seasonal and pandemic" exact="influenza" post="vaccines. The superior ability of LAIVs to induce potent"/>
   <result pre="are seronegative or who have not experienced previous infection with" exact="influenza" post="viruses, being shed at a comparatively high titer for"/>
   <result pre="below 2â€‰years old, who are commonly naive with respect to" exact="influenza" post="virus infection. On the other hand, preexisting immunity from"/>
   <result pre="use of premature termination codons to attenuate or completely block" exact="influenza" post="virus replication in normal cells (6, 14â€&quot;16). Those studies"/>
   <result pre="if such strategies can be applied in other subtypes of" exact="influenza" post="A or influenza B viruses, given that strain-specific adaptive"/>
   <result pre="can be applied in other subtypes of influenza A or" exact="influenza" post="B viruses, given that strain-specific adaptive mechanisms are relatively"/>
   <result pre="viruses, given that strain-specific adaptive mechanisms are relatively common in" exact="influenza" post="viruses. There is also concern regarding the stability of"/>
   <result pre="strains being regained during infection with LAIV vaccines. Live attenuated" exact="influenza" post="vaccines with modified NS1 or lacking the entire NS1"/>
   <result pre="or of individuals who had not previously been infected with" exact="influenza" post="virus. The safety features inherent with the removal of"/>
   <result pre="the LAIV vaccine for use against both seasonal and pandemic" exact="influenza" post="virus strains. Influenza virus is unique in its ability"/>
   <result pre="to induce high-level protective humoral and T cell responses to" exact="influenza" post="viruses. Our data show that cross protective immunity elicited"/>
   <result pre="rapidly, with more H3N2 epidemics being recorded than H1N1 or" exact="influenza" post="B virus epidemics in the years since H3N2 emerged"/>
   <result pre="challenge with HK68-MA virus. One strategy to improve the current" exact="influenza" post="vaccine regime is to induce immunities to multiple viral"/>
   <result pre="strain; we have demonstrated that expressing the HA1 domain of" exact="influenza" post="B virus in the CA4-DelNS1 system protects immunized mice"/>
   <result pre="vectors to express extra antigens to enhance specific immunity against" exact="influenza" post="or to serve as vaccines for other respiratory viruses."/>
   <result pre="and H3N2 LAIVs together with LAIVs representing either of the" exact="influenza" post="B virus lineages to optimize cross protection against wild-type"/>
   <result pre="H1N1 virus A/California/04/2009, H5N1 virus A/Vietnam/1194/2004, H7N9 virus A/Zhejiang/DTID-ZJU01/2013, and" exact="influenza" post="B virus B/HK/8038/2011 were rescued by reverse genetics (49,"/>
   <result pre="viruses were as described previously (35â€&quot;37, 51). Cold-adapted live attenuated" exact="influenza" post="vaccine (ca-LAIV-H1N1) was purified from the Influenza Mist LAIV"/>
   <result pre="from the Influenza Mist LAIV vaccine available in the 2012" exact="influenza" post="season. Construction of plasmids. NS1 deletion plasmid pHW2000-DelNS1 was"/>
   <result pre="inverse PCR were 5â€²-GACATACTTATGAGGATGTC-3â€² (CA4-DelNS1-F) and 5â€²-CTGAAAGCTTGACATGGTGTTG-3â€² (CA4-DelNS1-R). Primers for" exact="influenza" post="B DelNS1 inverse PCR were 5â€²-CTCAATTTGTGTTGTGGTCATGTTGTCCGCC-3â€² (Influenza b-DelNS1-F) and"/>
   <result pre="pHW2000 plasmids containing the DelNS1 segment and the other 7" exact="influenza" post="virus genomic segments, together with an NS1 expression plasmid,"/>
   <result pre="or A/Hong Kong/1/1968 virus were used for virus rescue. For" exact="influenza" post="B DelNS1 virus DelNS1-B8038, rescued virus was passaged 10"/>
   <result pre="(34). For comparisons, passaged CA4-DelNS1, commercial coadapted Flumist live attenuated" exact="influenza" post="vaccine (2014â€&quot;2015 season), plaque-purified cold-adapted H1N1 CA7 from Flumist,"/>
   <result pre="100 PFU; for H7N9, 10 MLD50, 2â€‰Ã—â€‰105 PFU; for mouse-adapted" exact="influenza" post="B/Florida/4/2006 virus, 10 MLD50, 5â€‰Ã—â€‰105 PFU; for mouse-adapted influenza"/>
   <result pre="mouse-adapted influenza B/Florida/4/2006 virus, 10 MLD50, 5â€‰Ã—â€‰105 PFU; for mouse-adapted" exact="influenza" post="B/Brisbane/60/2008 virus, 10 MLD50, 5â€‰Ã—â€‰106 PFU; for mouse-adapted H3N2"/>
   <result pre="Xia N, Yuen K-Y, Chen H. 2019. Generation of DelNS1" exact="influenza" post="viruses: a strategy for optimizing live attenuated influenza vaccines."/>
   <result pre="of DelNS1 influenza viruses: a strategy for optimizing live attenuated" exact="influenza" post="vaccines. mBio 10:e02180-19. https://doi.org/10.1128/mBio.02180-19. ACKNOWLEDGMENTS We thank Robert Webster"/>
   <result pre="Ortega-SanchezIR, MessonnierML, ThompsonWW, WortleyPM, WeintraubE, BridgesCB2007The annual impact of seasonal" exact="influenza" post="in the US: measuring disease burden and costs. Vaccine25:5086â€&quot;5096."/>
   <result pre="Immunol53:102â€&quot;110. doi:10.1016/j.coi.2018.04.015.29734023 3.NachbagauerR, PaleseP2018Development of next generation hemagglutinin-based broadly protective" exact="influenza" post="virus vaccines. Curr Opin Immunol53:51â€&quot;57. doi:10.1016/j.coi.2018.04.001.29680576 4.PetschB, SchneeM, VogelAB,"/>
   <result pre="KrampsT2012Protective efficacy of in vitro synthesized, specific mRNA vaccines against" exact="influenza" post="A virus infection. Nat Biotechnol30:1210â€&quot;1216. doi:10.1038/nbt.2436.23159882 5.LiebowitzD, LindbloomJD, BrandlJR,"/>
   <result pre="doi:10.1038/nbt.2436.23159882 5.LiebowitzD, LindbloomJD, BrandlJR, GargSJ, TuckerSN2015High titre neutralising antibodies to" exact="influenza" post="after oral tablet immunisation: a phase 1, randomised, placebo-controlled"/>
   <result pre="Infect Dis15:1041â€&quot;1048. doi:10.1016/S1473-3099(15)00266-2.26333337 6.BazM, BoonnakK, PaskelM, SantosC, PowellT, TownsendA, SubbaraoK2015Nonreplicating" exact="influenza" post="A virus vaccines confer broad protection against lethal challenge."/>
   <result pre="MeertenS, YuW, KoudstaalW, GoudsmitJ, WardAB, MeijbergW, WilsonIA, RadoÅ¡eviÄ‡K2015A stable trimeric" exact="influenza" post="hemagglutinin stem as a broadly protective immunogen. Science349:1301â€&quot;1306. doi:10.1126/science.aac7263.26303961"/>
   <result pre="tenOeverBR, TanGS, SubramaniamS, PaleseP, KrammerF2017Broadly protective murine monoclonal antibodies against" exact="influenza" post="B virus target highly conserved neuraminidase epitopes. Nat Microbiol2:1415â€&quot;1424."/>
   <result pre="SaelensX2011Universal vaccine based on ectodomain of matrix protein 2 of" exact="influenza" post="A: Fc receptors and alveolar macrophages mediate protection. J"/>
   <result pre="macrophages mediate protection. J Immunol186:1022â€&quot;1031. doi:10.4049/jimmunol.0902147.21169548 12.KolpeA, SchepensB, FiersW, SaelensX2017M2-based" exact="influenza" post="vaccines: recent advances and clinical potential. Expert Rev Vaccines16:123â€&quot;136."/>
   <result pre="BaiH, WuTT, WangJ, ShuY, SunR2018Genome-wide identification of interferon-sensitive mutations enables" exact="influenza" post="vaccine design. Science359:290â€&quot;296. doi:10.1126/science.aan8806.29348231 15.SiL, XuH, ZhouX, ZhangZ, TianZ,"/>
   <result pre="WuY, ZhangB, NiuZ, ZhangC, FuG, XiaoS, XiaQ, ZhangL, ZhouD2016Generation of" exact="influenza" post="A viruses as live but replication-incompetent virus vaccines. Science354:1170â€&quot;1173."/>
   <result pre="BloomBR, LiQ, DengJC, ZhouP, QinFX, ChengG2017Generation of a live attenuated" exact="influenza" post="vaccine that elicits broad protection in mice and ferrets."/>
   <result pre="mice and ferrets. Cell Host Microbe21:334â€&quot;343. doi:10.1016/j.chom.2017.02.007.28279345 17.KrugRM2015Functions of the" exact="influenza" post="A virus NS1 protein in antiviral defense. Curr Opin"/>
   <result pre="WangX, BaslerCF, TaubenbergerJK, BumgarnerRE, PaleseP, KatzeMG, Garcia-SastreA2002Cellular transcriptional profiling in" exact="influenza" post="A virus-infected lung epithelial cells: the role of the"/>
   <result pre="KraussS, WebbyRJ, WebsterRG2017Molecular basis of mammalian transmissibility of avian H1N1" exact="influenza" post="viruses and their pandemic potential. Proc Natl Acad Sci"/>
   <result pre="Proc Natl Acad Sci U S A114:11217â€&quot;11222. doi:10.1073/pnas.1713974114.28874549 22.RichtJA, Garcia-SastreA2009Attenuated" exact="influenza" post="virus vaccines with modified NS1 proteins. Curr Top Microbiol"/>
   <result pre="Immunol333:177â€&quot;195. doi:10.1007/978-3-540-92165-3_9.19768406 23.MuellerSN, LangleyWA, CarneroE, Garcia-SastreA, AhmedR2010Immunization with live attenuated" exact="influenza" post="viruses that express altered NS1 proteins results in potent"/>
   <result pre="JankeBH, WuWH, YoonKJ, WebbyRJ, SolorzanoA, Garcia-SastreA2006Vaccination of pigs against swine" exact="influenza" post="viruses by using an NS1-truncated modified live-virus vaccine. J"/>
   <result pre="HenningsonJN, LorussoA, VincentAL, LovingCL, RothJA, KehrliMEJr.2012Vaccination with NS1-truncated H3N2 swine" exact="influenza" post="virus primes T cells and confers cross-protection against an"/>
   <result pre="MaW, LagerKM, RichtJA, JankeBH, SandbulteMR, GaugerPC, LovingCL, WebbyRJ, Garcia-SastreA2012Live attenuated" exact="influenza" post="vaccine provides superior protection from heterologous infection in pigs"/>
   <result pre="infection in pigs with maternal antibodies without inducing vaccine-associated enhanced" exact="respiratory disease." post="J Virol86:10597â€&quot;10605. doi:10.1128/JVI.01439-12.22811541 28.MosslerC, GroissF, WolztM, WolschekM, SeipeltJ, MusterT2013Phase"/>
   <result pre="WolztM, WolschekM, SeipeltJ, MusterT2013Phase I/II trial of a replication-deficient trivalent" exact="influenza" post="virus vaccine lacking NS1. Vaccine31:6194â€&quot;6200. doi:10.1016/j.vaccine.2013.10.061.24183981 29.WacheckV, EgorovA, GroissF,"/>
   <result pre="RoethlE, MorokuttiA, WolschekM, FerkoB, SeipeltJ, Dick-GudenusR, MusterT2010A novel type of" exact="influenza" post="vaccine: safety and immunogenicity of replication-deficient influenza virus created"/>
   <result pre="novel type of influenza vaccine: safety and immunogenicity of replication-deficient" exact="influenza" post="virus created by deletion of the interferon antagonist NS1."/>
   <result pre="30.EgorovA, BrandtS, SereinigS, RomanovaJ, FerkoB, KatingerD, GrassauerA, AlexandrovaG, KatingerH, MusterT1998Transfectant" exact="influenza" post="A viruses with long deletions in the NS1 protein"/>
   <result pre="of the M segment of viral RNA supports replication of" exact="influenza" post="virus with an NS1 deletion by modulating alternative splicing"/>
   <result pre="ReiterM, NakowitschS, HumerJ, MorokuttiA, MusterT, EgorovA, KittelC2009Development of a live-attenuated" exact="influenza" post="B DeltaNS1 intranasal vaccine candidate. Vaccine27:2851â€&quot;2857. doi:10.1016/j.vaccine.2009.02.087.19366569 33.van WielinkR,"/>
   <result pre="M-gene segment can substantially increase replication efficiency of NS1 deletion" exact="influenza" post="A virus in MDCK cells. J Virol86:12341â€&quot;12350. doi:10.1128/JVI.01725-12.22951840 34.GouldPS,"/>
   <result pre="in MDCK cells. J Virol86:12341â€&quot;12350. doi:10.1128/JVI.01725-12.22951840 34.GouldPS, EastonAJ, DimmockNJ2017Live attenuated" exact="influenza" post="vaccine contains substantial and unexpected amounts of defective viral"/>
   <result pre="LiuH, KitLC, BairdS, NesrallahM2001Pattern of mutation in the genome of" exact="influenza" post="A virus on adaptation to increased virulence in the"/>
   <result pre="NichollsJM, GuanY, WaldmannTA, PeirisJS, PereraLP, PoonLL2014IL-15 adjuvanted multivalent vaccinia-based universal" exact="influenza" post="vaccine requires CD4+ T cells for heterosubtypic protection. Proc"/>
   <result pre="multimechanistic antibody targeting the receptor binding site potently cross-protects against" exact="influenza" post="B viruses. Sci Transl Med doi:10.1126/scitranslmed.aam5752. 38.BelongiaEA, SimpsonMD, KingJP,"/>
   <result pre="Transl Med doi:10.1126/scitranslmed.aam5752. 38.BelongiaEA, SimpsonMD, KingJP, SundaramME, KelleyNS, OsterholmMT, McLeanHQ2016Variable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
   <result pre="challenges and solutions. Cell Host Microbe17:295â€&quot;300. doi:10.1016/j.chom.2015.02.012.25766291 40.JinH, SubbaraoK2015Live attenuated" exact="influenza" post="vaccine. Curr Top Microbiol Immunol386:181â€&quot;204. doi:10.1007/82_2014_410.25059893 41.MurphyBR, CoelinghK2002Principles underlying"/>
   <result pre="CoelinghK2002Principles underlying the development and use of live attenuated cold-adapted" exact="influenza" post="A and B virus vaccines. Viral Immunol15:295â€&quot;323. doi:10.1089/08828240260066242.12081014 42.CoelinghKL,"/>
   <result pre="Viral Immunol15:295â€&quot;323. doi:10.1089/08828240260066242.12081014 42.CoelinghKL, LukeCJ, JinH, TalaatKR2014Development of live attenuated" exact="influenza" post="vaccines against pandemic influenza strains. Expert Rev Vaccines13:855â€&quot;871. doi:10.1586/14760584.2014.922417.24867587"/>
   <result pre="LukeCJ, JinH, TalaatKR2014Development of live attenuated influenza vaccines against pandemic" exact="influenza" post="strains. Expert Rev Vaccines13:855â€&quot;871. doi:10.1586/14760584.2014.922417.24867587 43.HeatonNS, SachsD, ChenCJ, HaiR,"/>
   <result pre="Rev Vaccines13:855â€&quot;871. doi:10.1586/14760584.2014.922417.24867587 43.HeatonNS, SachsD, ChenCJ, HaiR, PaleseP2013Genome-wide mutagenesis of" exact="influenza" post="virus reveals unique plasticity of the hemagglutinin and NS1"/>
   <result pre="U S A110:20248â€&quot;20253. doi:10.1073/pnas.1320524110.24277853 44.CarrilloB, ChoiJM, BornholdtZA, SankaranB, RiceAP, PrasadBV2014The" exact="influenza" post="A virus protein NS1 displays structural polymorphism. J Virol88:4113â€&quot;4122."/>
   <result pre="LiuH, ChenY, SongW, YuenKY, ChenH2017An NS-segment exonic splicing enhancer regulates" exact="influenza" post="A virus replication in mammalian cells. Nat Commun8:14751. doi:10.1038/ncomms14751.28323816"/>
   <result pre="NguyenTH, WertheimHFL, HurtAC, OsterhausA, BarrIG, FouchierRAM, HorbyPW, SmithDJ2014Antibody landscapes after" exact="influenza" post="virus infection or vaccination. Science346:996â€&quot;1000. doi:10.1126/science.1256427.25414313 47.SmithDJ, LapedesAS, de"/>
   <result pre="BestebroerTM, RimmelzwaanGF, OsterhausAD, FouchierRA2004Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. Science305:371â€&quot;376. doi:10.1126/science.1097211.15218094 48.BedfordT, RileyS, BarrIG, BroorS, ChadhaM, CoxNJ,"/>
   <result pre="SuchardMA, TashiroM, WangD, XuX, LemeyP, RussellCA2015Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic drift. Nature523:217â€&quot;220. doi:10.1038/nature14460.26053121 49.HoffmannE, NeumannG,"/>
   <result pre="NeumannG, KawaokaY, HobomG, WebsterRG2000A DNA transfection system for generation of" exact="influenza" post="A virus from eight plasmids. Proc Natl Acad Sci"/>
   <result pre="in viral protein PB2 enhances the effects of E627K on" exact="influenza" post="virus replication. Nat Commun5:5509. doi:10.1038/ncomms6509.25409547 51.ZhengB, ChanKH, ZhangAJ, ZhouJ,"/>
   <result pre="WooPC, ChanJF, ToKK, ChenH, YuenKY2010D225G mutation in hemagglutinin of pandemic" exact="influenza" post="H1N1 (2009) virus enhances virulence in mice. Exp Biol"/>
   <result pre="LambertK, TakimotoT, TophamDJ2011T cell-mediated protection against lethal 2009 pandemic H1N1" exact="influenza" post="virus infection in a mouse model. J Virol85:448â€&quot;455. doi:10.1128/JVI.01812-10.20980523"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6751421\results\search\disease\results.xml">
   <result pre="America. In the eastern part of India epidemics of acute" exact="hepatitis" post="E are well reported. Hepatitis E commonly presents as"/>
   <result pre="are well reported. Hepatitis E commonly presents as self-limiting acute" exact="viral hepatitis" post="among young adults, except for some critical clinical complications"/>
   <result pre="well reported. Hepatitis E commonly presents as self-limiting acute viral" exact="hepatitis" post="among young adults, except for some critical clinical complications"/>
   <result pre="critical clinical complications during pregnancy. In epidemiological research, subclinical acute" exact="hepatitis" post="E infection is also reported from different parts of"/>
   <result pre="literature there are reports of rare extrahepatic manifestation of acute" exact="hepatitis" post="E. Here we present an elderly lady with acute"/>
   <result pre="hepatitis E. Here we present an elderly lady with acute" exact="hepatitis" post="E who primarily presented with acute myocarditis. Keywords Hepatitis"/>
   <result pre="elderly lady with acute hepatitis E who primarily presented with" exact="acute myocarditis." post="Keywords Hepatitis E Myocarditis Dilated cardiomyopathy Elderly woman fig-count:"/>
   <result pre="primarily presented with acute myocarditis. Keywords Hepatitis E Myocarditis Dilated" exact="cardiomyopathy" post="Elderly woman fig-count: table-count: ref-count: page-count: Introduction India is"/>
   <result pre="table-count: ref-count: page-count: Introduction India is an endemic zone of" exact="hepatitis" post="E virus (HEV), which is associated with both sporadic"/>
   <result pre="IgG antibody was found in 41.8% of patients with acute" exact="viral hepatitis" post="and in 23% of healthy individuals, indicating a high"/>
   <result pre="antibody was found in 41.8% of patients with acute viral" exact="hepatitis" post="and in 23% of healthy individuals, indicating a high"/>
   <result pre="Hepatitis E is a self-limiting disease and most people with" exact="hepatitis" post="E recover completely, except for antenatal HEV infection which"/>
   <result pre="third trimester (15â€&quot;25% of cases) [2]. Apart from hepatic manifestation," exact="hepatitis" post="E causes florid extrahepatic manifestations including acute pancreatitis, Guillain-BarrÃ©"/>
   <result pre="from hepatic manifestation, hepatitis E causes florid extrahepatic manifestations including" exact="acute pancreatitis," post="Guillain-BarrÃ© syndrome, neuralgic amyotrophy, haemolytic anaemia, thrombocytopenia, glomerulonephritis, and"/>
   <result pre="and mixed cryoglobulinaemia. Viral infection is an important cause of" exact="acute myocarditis," post="and the spectrum of viruses known to cause myocarditis"/>
   <result pre="acute myocarditis, and the spectrum of viruses known to cause" exact="myocarditis" post="has changed in the past two decades. Myocarditis occurs"/>
   <result pre="response between host-pathogen interaction that affects mainly younger adults. Acute" exact="myocarditis" post="is uncommon in hepatitis E infection and has been"/>
   <result pre="that affects mainly younger adults. Acute myocarditis is uncommon in" exact="hepatitis" post="E infection and has been reported in young adults"/>
   <result pre="up to date, there is no reported case of HEV-induced" exact="myocarditis" post="especially in the elderly. To the best of our"/>
   <result pre="best of our knowledge, this is the first case of" exact="hepatitis" post="E-induced acute myocarditis, observed in an elderly woman from"/>
   <result pre="our knowledge, this is the first case of hepatitis E-induced" exact="acute myocarditis," post="observed in an elderly woman from West Bengal, India."/>
   <result pre="housewife presented to our hospital with exertional dyspnoea, gradually increasing" exact="shortness" post="of breath, chest pain, palpitation, and decreased urine output"/>
   <result pre="days. She denied any history of diabetes, hypertension, any pre-existing" exact="liver disease," post="abdominal discomfort, or passage of blood or mucus in"/>
   <result pre="or mucus in stool. She was known to have intermittent" exact="shortness" post="of breath especially in the winter season, but she"/>
   <result pre="physician. She had never required hospital admission for exacerbation of" exact="chronic obstructive pulmonary disease." post="This time there was no history of fever, cough"/>
   <result pre="lost her usual appetite. She did not have any skin" exact="rash" post="or arthralgia. Clinical observation at the emergency room revealed"/>
   <result pre="with a very high titre. Other viral screens such as" exact="hepatitis" post="A, hepatitis B, hepatitis C, HIV, and dengue all"/>
   <result pre="very high titre. Other viral screens such as hepatitis A," exact="hepatitis" post="B, hepatitis C, HIV, and dengue all came negative,"/>
   <result pre="titre. Other viral screens such as hepatitis A, hepatitis B," exact="hepatitis" post="C, HIV, and dengue all came negative, and IgM"/>
   <result pre="for Leptospira was also negative. Her peripheral blood smear for" exact="malaria" post="parasite and rapid malarial antigen tests were negative. Her"/>
   <result pre="and dyspnoeic. Repeat arterial blood gas analysis revealed type 1" exact="respiratory failure" post="with hypoxemia, and ECG showed sinus tachycardia, elevation of"/>
   <result pre="enlarged, and the ejection fraction was 25%, suggestive of dilated" exact="cardiomyopathy" post="(Fig. 1, 2, 3). NT pro-BNP was markedly high"/>
   <result pre="(239.1 mg/dL, 17.42% of total CK). This was suggestive of" exact="myocarditis" post="with acutely decompensated heart failure, and a low-dose cardioselective"/>
   <result pre="exposure such as alcohol, heavy metal poisoning, nutrient deficiency). Acute" exact="myocarditis" post="often presents with acute life-threatening decompensated heart failure and"/>
   <result pre="myocarditis, including parvoviruses, adenovirus, H1N1 flu infection, Epstein-Barr virus infection," exact="rubella" post="(German measles), varicella (chickenpox), mumps, measles, yellow fever, dengue,"/>
   <result pre="Epstein-Barr virus infection, rubella (German measles), varicella (chickenpox), mumps, measles," exact="yellow fever," post="dengue, polio, rabies, hepatitis A and C, HIV, and"/>
   <result pre="measles), varicella (chickenpox), mumps, measles, yellow fever, dengue, polio, rabies," exact="hepatitis" post="A and C, HIV, and Zika infection, and parvovirus"/>
   <result pre="infection, and parvovirus B19 [3, 4, 5, 6, 7]. Viral" exact="myocarditis" post="usually progresses on two stages although the exact pathophysiology"/>
   <result pre="10]. Myocarditis is one of the rarest extrahepatic complications of" exact="hepatitis" post="E infection. Up to date, hepatitis E-mediated intense myocarditis"/>
   <result pre="rarest extrahepatic complications of hepatitis E infection. Up to date," exact="hepatitis" post="E-mediated intense myocarditis has been accounted for in three"/>
   <result pre="of hepatitis E infection. Up to date, hepatitis E-mediated intense" exact="myocarditis" post="has been accounted for in three peer-reviewed journals, of"/>
   <result pre="were young adults aged &amp;lt;40 years. The pathophysiology of postinfective" exact="myocarditis" post="being immunogenic and depending on the host immune response,"/>
   <result pre="mostly young adults are affected. However, the non-infective aetiology of" exact="myocarditis" post="has no age bar. Postinfective myocarditis in the elderly"/>
   <result pre="the non-infective aetiology of myocarditis has no age bar. Postinfective" exact="myocarditis" post="in the elderly is rare. Viral myocarditis presents with"/>
   <result pre="age bar. Postinfective myocarditis in the elderly is rare. Viral" exact="myocarditis" post="presents with various symptoms, ranging from negligibly symptomatic cases"/>
   <result pre="to fatal arrhythmia and cardiogenic shock, and may create chronic" exact="myocarditis" post="and enlarged cardiomyopathy in a few patients [11, 12]."/>
   <result pre="and cardiogenic shock, and may create chronic myocarditis and enlarged" exact="cardiomyopathy" post="in a few patients [11, 12]. A combination of"/>
   <result pre="endomyocardial biopsy findings remain the standard of care for diagnosing" exact="myocarditis" post="[14]. Cardiac MRI might be helpful for diagnosing myocarditis"/>
   <result pre="diagnosing myocarditis [14]. Cardiac MRI might be helpful for diagnosing" exact="myocarditis" post="by documenting muscle oedema, hyperaemia, or fibrosis [15]. The"/>
   <result pre="muscle oedema, hyperaemia, or fibrosis [15]. The clinical diagnosis of" exact="myocarditis" post="was established based on the clinical setting and finding"/>
   <result pre="the inherent risk of the procedure at this age. HEV-induced" exact="acute myocarditis" post="was the only apparent cause for this acutely decompensated"/>
   <result pre="inherent risk of the procedure at this age. HEV-induced acute" exact="myocarditis" post="was the only apparent cause for this acutely decompensated"/>
   <result pre="dyspnoea, and she required no oxygen. Conclusion The concomitant acute" exact="viral hepatitis" post="E and acute myocarditis in this case and the"/>
   <result pre="and she required no oxygen. Conclusion The concomitant acute viral" exact="hepatitis" post="E and acute myocarditis in this case and the"/>
   <result pre="no oxygen. Conclusion The concomitant acute viral hepatitis E and" exact="acute myocarditis" post="in this case and the subsequent resolution of cardiac"/>
   <result pre="oxygen. Conclusion The concomitant acute viral hepatitis E and acute" exact="myocarditis" post="in this case and the subsequent resolution of cardiac"/>
   <result pre="subsequent resolution of cardiac symptoms with a resolution of acute" exact="hepatitis" post="indicated an aetiological link between hepatitis and myocarditis. We"/>
   <result pre="a resolution of acute hepatitis indicated an aetiological link between" exact="hepatitis" post="and myocarditis. We feel that it is pertinent to"/>
   <result pre="that it is pertinent to report that benign self-limiting acute" exact="hepatitis" post="E can sometimes be complicated by life-threatening acute myocarditis"/>
   <result pre="self-limiting acute hepatitis E can sometimes be complicated by life-threatening" exact="acute myocarditis" post="leading to decompensated heart failure. In spite of the"/>
   <result pre="acute hepatitis E can sometimes be complicated by life-threatening acute" exact="myocarditis" post="leading to decompensated heart failure. In spite of the"/>
   <result pre="spite of the fact that there were repeated outbreaks of" exact="viral hepatitis" post="E in West Bengal, there had to date been"/>
   <result pre="of the fact that there were repeated outbreaks of viral" exact="hepatitis" post="E in West Bengal, there had to date been"/>
   <result pre="there had to date been no reported case of HEV-induced" exact="acute myocarditis." post="To our knowledge, this is so far the first"/>
   <result pre="ever reported case from West Bengal, and we feel that" exact="hepatitis" post="E should also be kept in mind as a"/>
   <result pre="be kept in mind as a possible viral aetiology of" exact="acute myocarditis," post="irrespective of age. Statement of Ethics This article does"/>
   <result pre="conflict of interest exists. References References 1BazerbachiFHaffarSGargSKLakeJRExtra-hepatic manifestations associated with" exact="hepatitis" post="E virus infection: a comprehensive review of the literatureGastroenterology2015Reportspp."/>
   <result pre="Physician2015761(7)607826175368 3FairweatherDStaffordKASungYKUpdate on coxsackievirus B3 myocarditisCurr Opin Rheumatol2012724(4)401722488075 4SpartalisMTzatzakiESpartalisEDamaskosCMavrogeniSVoudrisVParvovirus B19" exact="myocarditis" post="of fulminant evolutionCardiol Res201788(4)172528868104 5LoboMLTaguchiÃ‚GasparHAFerrantiJFde CarvalhoWBDelgadoAFFulminant myocarditis associated with"/>
   <result pre="Rheumatol2012724(4)401722488075 4SpartalisMTzatzakiESpartalisEDamaskosCMavrogeniSVoudrisVParvovirus B19 myocarditis of fulminant evolutionCardiol Res201788(4)172528868104 5LoboMLTaguchiÃ‚GasparHAFerrantiJFde CarvalhoWBDelgadoAFFulminant" exact="myocarditis" post="associated with the H1N1 influenza virus: case report and"/>
   <result pre="fulminant evolutionCardiol Res201788(4)172528868104 5LoboMLTaguchiÃ‚GasparHAFerrantiJFde CarvalhoWBDelgadoAFFulminant myocarditis associated with the H1N1" exact="influenza" post="virus: case report and literature reviewRev Bras Ter Intensiva2014Jul-Sep26(3)321625295829"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6754462\results\search\disease\results.xml">
   <result pre="help to implement efficient strategies to curb the burden of" exact="dengue fever." post="We conducted this systematic review and meta-analysis to determine"/>
   <result pre="terms Dengue virus Viral infection Epidemiology Introduction The incidence of" exact="dengue fever" post="has grown in the last decade worldwide. According to"/>
   <result pre="be presented as a flu-like illness including headache, myalgia, and" exact="rash" post="like other endemic fever diseases in Africa (example: malaria"/>
   <result pre="and rash like other endemic fever diseases in Africa (example:" exact="malaria" post="and chikungunya fever)2,4. Currently, there is no treatment for"/>
   <result pre="like other endemic fever diseases in Africa (example: malaria and" exact="chikungunya" post="fever)2,4. Currently, there is no treatment for dengue infection."/>
   <result pre="the most seriously affected regions7. In Africa, the first reported" exact="dengue fever" post="outbreaks occurred in Zanzibar in 1823 and 1870. Several"/>
   <result pre="Burkina-Faso, Egypt, South Africa and Senegal, reported unconfirmed outbreaks of" exact="dengue fever" post="in early 1900s. Although many outbreaks arenâ€™t ever officially"/>
   <result pre="continent and build effective interventions to curb the burden of" exact="dengue fever" post="in the continent. Methods Design The Preferred Reporting Items"/>
   <result pre="methodology as in already published meta-analysis of prevalence studies for" exact="chikungunya" post="fever10. Criteria for considering studies for the review We"/>
   <result pre="to curb the burden DENV infection in Africa since severe" exact="dengue fever" post="can rapidly lead to serious illness and death, especially"/>
   <result pre="vaccine and antiretroviral treatment to rapidly curb the burden of" exact="dengue fever" post="in Africa. Another approach for curbing the burden of"/>
   <result pre="fever in Africa. Another approach for curbing the burden of" exact="dengue fever" post="is vector control. For curbing the burden of vector-borne"/>
   <result pre="DENV infection is high in the African continent although this" exact="infectious disease" post="is considered as neglected tropical disease. It is therefore"/>
   <result pre="considered as neglected tropical disease. It is therefore necessary that" exact="dengue fever" post="deserves more attention from healthcare workers, researchers, and health"/>
   <result pre="In the absence to date of effective antiviral treatment for" exact="dengue fever," post="strategies to curb its burden should therefore focus on"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virusInfection, Genetics and Evolution20131929231110.1016/j.meegid.2013.03.00823523817 36.WeetmanDavidKamgangBasileBadoloAthanaseMoyesCatherineShearerFreyaCoulibalyMamadouPintoJoÃ£oLambrechtsLouisMcCallPhilipAedes Mosquitoes and Aedes-Borne Arboviruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6757286\results\search\disease\results.xml">
   <result pre="to humans and animals, with the potential to cause severe" exact="pneumonia" post="and death. Annual vaccination strategies are a mainstay to"/>
   <result pre="related to influenza. However, protection from the emerging subtypes of" exact="influenza" post="A viruses (IAV) even in vaccinated individuals is challenging."/>
   <result pre="runny nose) in any age group [5]. Still others like" exact="influenza" post="A virus (IAV) can cause severe infections in patients"/>
   <result pre="for public health concern. Although generally milder than pandemics, seasonal" exact="influenza" post="epidemics can cause around 650,000 deaths globally each year"/>
   <result pre="year [7]. Despite mainstay vaccination strategies to minimize IAV infections," exact="influenza" post="pandemics have occurred once every 10-30 years, primarily due"/>
   <result pre="subtypes of IAV (H1N1 and H3N2) and two lineages of" exact="influenza" post="B viruses (Victoria and Yamagata) cause annual epidemics in"/>
   <result pre="IAVs dominate, inducing more severe morbidity and mortality compared to" exact="influenza" post="B viruses, therefore, will be the focus of this"/>
   <result pre="and cause severe, lethal disease. In fact, H5N1 highly pathogenic" exact="avian influenza" post="(HPAI) and the H7N9 low pathogenic avian influenza viruses"/>
   <result pre="cause severe, lethal disease. In fact, H5N1 highly pathogenic avian" exact="influenza" post="(HPAI) and the H7N9 low pathogenic avian influenza viruses"/>
   <result pre="highly pathogenic avian influenza (HPAI) and the H7N9 low pathogenic" exact="avian influenza" post="viruses pose a serious public health concern due to"/>
   <result pre="pathogenic avian influenza (HPAI) and the H7N9 low pathogenic avian" exact="influenza" post="viruses pose a serious public health concern due to"/>
   <result pre="rates of 52.79% and 39.42% [17]. The most severe H1N1" exact="influenza" post="pandemic occurred in 1918 claiming over 50 million lives"/>
   <result pre="during HPAI H5N1 virus infection [32â€&quot;34] often leading to severe" exact="pneumonia" post="and death. Secondly, phagocytosis of infected cells by antigen-presenting"/>
   <result pre="first to respond to any noxious stimuli, their role during" exact="influenza" post="is complex and accumulation in the lungs is impacted"/>
   <result pre="the pulmonary endothelia and epithelia [56, 57] leading to severe" exact="pneumonia" post="suggesting that uncontrolled NET production may contribute to disease"/>
   <result pre="CD8+ T cell activation and recruitment into the lungs during" exact="influenza" post="emphasizing the reliance of adaptive immune cells on those"/>
   <result pre="by impaired clearance of surfactant proteins, cellular debris, dead cells," exact="pulmonary edema," post="and inflammation [102, 103]. Moreover, transgenic mice selectively depleted"/>
   <result pre="103]. Moreover, transgenic mice selectively depleted of AMs exhibit severe" exact="influenza" post="[104, 105] suggesting a critical role for AMs in"/>
   <result pre="CXCL10, is greater for highly pathogenic H5N1 virus than seasonal" exact="influenza" post="viruses [116, 117] suggesting that these inflammatory mediators may"/>
   <result pre="observations suggest that pulmonary dysfunction observed in fatal cases of" exact="influenza" post="depends on how macrophages respond to the invading virus."/>
   <result pre="mediators [131], a possible role in recruiting other leukocytes during" exact="influenza" post="needs to be more fully explored. Compared to other"/>
   <result pre="likely to suffer from IAV-induced morbidity and mortality [151â€&quot;153]. Pediatric" exact="influenza" post="patients who developed acute pneumonia demonstrated a rise in"/>
   <result pre="morbidity and mortality [151â€&quot;153]. Pediatric influenza patients who developed acute" exact="pneumonia" post="demonstrated a rise in the serum IL-5 levels and"/>
   <result pre="demonstrated a rise in the serum IL-5 levels and peripheral" exact="eosinophilia" post="[154], suggesting that eosinophil recruitment may be necessary for"/>
   <result pre="recruitment may be necessary for late-stage anti-influenza host defense. Pulmonary" exact="eosinophilia" post="has also been documented in IAV-infected mice [155â€&quot;158] suggesting"/>
   <result pre="Based on known functions of eosinophils during parasite infections and" exact="allergy" post="[159], it may be likely that their influx into"/>
   <result pre="virus in situ (Figure 3). Additionally, mice suffering from acute" exact="allergy" post="are protected from IAV-induced airway damage [157] suggesting that"/>
   <result pre="CD8+ T cells [160] forecast multifaceted functions for eosinophils during" exact="influenza" post="pathogenesis [163]. 7. Natural Killer Cells: On-Site Killing As"/>
   <result pre="cell receptor, termed NKT cells, have gained more attention from" exact="influenza" post="virologists in recent years. These cells provide immunoprotection during"/>
   <result pre="potent producers of IL-5, ILC2s may regulate eosinophil infiltration during" exact="influenza" post="[155, 188]. Within the lungs, ILC2s increase expression of"/>
   <result pre="cytolysis of IAV-infected cells [179â€&quot;182]. However, IFNÎ³ can also enhance" exact="influenza" post="disease severity possibly through suppression of ILC2 function [189]."/>
   <result pre="However, IFNÎ³ can also enhance influenza disease severity possibly through" exact="suppression" post="of ILC2 function [189]. 9. Î³Î´ T Cells: Holding"/>
   <result pre="AECs to produce IL-33 (Figure 4), protecting neonates from severe" exact="influenza" post="[199]. Since Î³Î´ T cell-mediated IL-33 production serves as"/>
   <result pre="York Academy of Sciences20141323111513910.1111/nyas.1246224891213 10TongS.ZhuX.LiY.et al.New world bats harbor diverse" exact="influenza" post="A virusesPLoS Pathogens2013910, article e100365710.1371/journal.ppat.1003657 11CainiS.KronemanM.WiegersT.el Guerche-SÃ©blainC.PagetJ.Clinical characteristics and"/>
   <result pre="virusesPLoS Pathogens2013910, article e100365710.1371/journal.ppat.1003657 11CainiS.KronemanM.WiegersT.el Guerche-SÃ©blainC.PagetJ.Clinical characteristics and severity of" exact="influenza" post="infections by virus type, subtype, and lineage: a systematic"/>
   <result pre="and mortality in Hong Kong, 1998-2013Scientific Reports201771p. 92910.1038/s41598-017-01021-x28428558 13DaleyA.NallusamyR.IsaacsD.Comparison of" exact="influenza" post="A and influenza B virus infection in hospitalized childrenJournal"/>
   <result pre="Hong Kong, 1998-2013Scientific Reports201771p. 92910.1038/s41598-017-01021-x28428558 13DaleyA.NallusamyR.IsaacsD.Comparison of influenza A and" exact="influenza" post="B virus infection in hospitalized childrenJournal of Paediatrics and"/>
   <result pre="of influenza: past and presentAnnual Review of Medicine200051140742110.1146/annurev.med.51.1.407 15KalthoffD.GlobigA.BeerM.(Highly pathogenic)" exact="avian influenza" post="as a zoonotic agentVeterinary Microbiology20101403-423724510.1016/j.vetmic.2009.08.02219782482 16WongS. S. Y.YuenK.Avian influenza"/>
   <result pre="influenza: past and presentAnnual Review of Medicine200051140742110.1146/annurev.med.51.1.407 15KalthoffD.GlobigA.BeerM.(Highly pathogenic) avian" exact="influenza" post="as a zoonotic agentVeterinary Microbiology20101403-423724510.1016/j.vetmic.2009.08.02219782482 16WongS. S. Y.YuenK.Avian influenza"/>
   <result pre="avian influenza as a zoonotic agentVeterinary Microbiology20101403-423724510.1016/j.vetmic.2009.08.02219782482 16WongS. S. Y.YuenK.Avian" exact="influenza" post="virus infections in humansChest2006129115616810.1378/chest.129.1.15616424427 17collab: World Health OrganizationInfluenza at"/>
   <result pre="pandemicsEmerging Infectious Diseases2006121152210.3201/eid1209.05-097916494711 19SimonsenL.SpreeuwenbergP.LustigR.et al.Global mortality estimates for the 2009" exact="influenza" post="pandemic from the GLaMOR project: a modeling studyPLoS Medicine20131011,"/>
   <result pre="e100155810.1371/journal.pmed.100155824302890 20KreijtzJ. H. C. M.FouchierR. A. M.RimmelzwaanG. F.Immune responses to" exact="influenza" post="virus infectionVirus Research20111621-2193010.1016/j.virusres.2011.09.02221963677 21LeMessurierK. S.LinY.McCullersJ. A.SamarasingheA. E.Antimicrobial peptides alter"/>
   <result pre="21LeMessurierK. S.LinY.McCullersJ. A.SamarasingheA. E.Antimicrobial peptides alter early immune response to" exact="influenza" post="A virus infection in C57BL/6 miceAntiviral Research201613320821710.1016/j.antiviral.2016.08.01327531368 22PanW.DongZ.LiF.et al.Visualizing"/>
   <result pre="influenza A virus infection in C57BL/6 miceAntiviral Research201613320821710.1016/j.antiviral.2016.08.01327531368 22PanW.DongZ.LiF.et al.Visualizing" exact="influenza" post="virus infection in living miceNature Communications201341, article 236910.1038/ncomms3369 23ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis"/>
   <result pre="miceNature Communications201341, article 236910.1038/ncomms3369 23ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virusProceedings"/>
   <result pre="W.WenX.et al.Clinical and virological factors associated with viremia in pandemic" exact="influenza" post="A/H1N1/2009 virus infectionPLoS One201169, article e2253410.1371/journal.pone.0022534 25TaubenbergerJ. K.MorensD. M.The"/>
   <result pre="virus infectionPLoS One201169, article e2253410.1371/journal.pone.0022534 25TaubenbergerJ. K.MorensD. M.The pathology of" exact="influenza" post="virus infectionsAnnual Review of Pathology20083149952210.1146/annurev.pathmechdis.3.121806.15431618039138 26HaleB. G.RandallR. E.OrtinJ.JacksonD.The multifunctional"/>
   <result pre="Review of Pathology20083149952210.1146/annurev.pathmechdis.3.121806.15431618039138 26HaleB. G.RandallR. E.OrtinJ.JacksonD.The multifunctional NS1 protein of" exact="influenza" post="A virusesThe Journal of General Virology200889102359237610.1099/vir.0.2008/004606-018796704 27KochsG.Garcia-SastreA.Martinez-SobridoL.Multiple anti-interferon actions"/>
   <result pre="virusesThe Journal of General Virology200889102359237610.1099/vir.0.2008/004606-018796704 27KochsG.Garcia-SastreA.Martinez-SobridoL.Multiple anti-interferon actions of the" exact="influenza" post="A virus NS1 proteinJournal of Virology200781137011702110.1128/JVI.02581-0617442719 28ChenX.LiuS.GorayaM. U.MaaroufM.HuangS.ChenJ. L.Host"/>
   <result pre="NS1 proteinJournal of Virology200781137011702110.1128/JVI.02581-0617442719 28ChenX.LiuS.GorayaM. U.MaaroufM.HuangS.ChenJ. L.Host immune response to" exact="influenza" post="A virus infectionFrontiers in Immunology20189p. 32010.3389/fimmu.2018.00320 29HallerO.KochsG.Human MxA protein:"/>
   <result pre="30MatsukuraS.KokubuF.KuboH.et al.Expression of RANTES by normal airway epithelial cells after" exact="influenza" post="virus A infectionAmerican Journal of Respiratory Cell and Molecular"/>
   <result pre="e2944310.1371/journal.pone.002944322238612 32de JongM. D.SimmonsC. P.ThanhT. T.et al.Fatal outcome of human" exact="influenza" post="A (H5N1) is associated with high viral load and"/>
   <result pre="Medicine200612101203120710.1038/nm1477 33PeirisJ. S. M.YuW. C.LeungC. W.et al.Re-emergence of fatal human" exact="influenza" post="A subtype H5N1 diseaseThe Lancet2004363940961761910.1016/S0140-6736(04)15595-5 34ToK. F.ChanP. K. S.ChanK."/>
   <result pre="K. S.ChanK. F.et al.Pathology of fatal human infection associated with" exact="avian influenza" post="A H5N1 virusJournal of Medical Virology200163324224610.1002/1096-9071(200103)63:3&amp;lt;242::AID-JMV1007&amp;gt;3.0.CO;2-N11170064 35TateM. D.IoannidisL. J.CrokerB.BrownL."/>
   <result pre="S.ChanK. F.et al.Pathology of fatal human infection associated with avian" exact="influenza" post="A H5N1 virusJournal of Medical Virology200163324224610.1002/1096-9071(200103)63:3&amp;lt;242::AID-JMV1007&amp;gt;3.0.CO;2-N11170064 35TateM. D.IoannidisL. J.CrokerB.BrownL."/>
   <result pre="E.BrooksA. G.ReadingP. C.The role of neutrophils during mild and severe" exact="influenza" post="virus infections of micePLoS One201163, article e1761810.1371/journal.pone.001761821423798 36TateM. D.BrooksA."/>
   <result pre="of neutrophils in the upper and lower respiratory tract during" exact="influenza" post="virus infection of miceRespiratory Research200891p. 5710.1186/1465-9921-9-57 37BradleyL. M.DouglassM. F.ChatterjeeD.AkiraS.BaatenB."/>
   <result pre="9 mediates neutrophil migration into the airways in response to" exact="influenza" post="virus-induced toll-like receptor signalingPLoS Pathogens201284, article e100264110.1371/journal.ppat.1002641 38HaydenF. G.FritzR.LoboM."/>
   <result pre="G.FritzR.LoboM. C.AlvordW.StroberW.StrausS. E.Local and systemic cytokine responses during experimental human" exact="influenza" post="A virus infection. Relation to symptom formation and host"/>
   <result pre="R.CXCR2 is required for neutrophil recruitment to the lung during" exact="influenza" post="virus infection, but is not essential for viral clearanceViral"/>
   <result pre="in both protection against and recovery from pulmonary infection with" exact="influenza" post="virus in miceJournal of Virology20088262772278310.1128/JVI.01210-0718184718 41BarlowP. G.SvobodaP.MackellarA.et al.Antiviral activity"/>
   <result pre="Virology20088262772278310.1128/JVI.01210-0718184718 41BarlowP. G.SvobodaP.MackellarA.et al.Antiviral activity and increased host defense against" exact="influenza" post="infection elicited by the human cathelicidin LL-37PLoS One2011610, article"/>
   <result pre="ameliorate lung injury and the development of severe disease during" exact="influenza" post="infectionJournal of Immunology2009183117441745010.4049/jimmunol.090249719917678 44PerroneL. A.PlowdenJ. K.GarcÃ­a-SastreA.KatzJ. M.TumpeyT. M.H5N1 and"/>
   <result pre="of Immunology2009183117441745010.4049/jimmunol.090249719917678 44PerroneL. A.PlowdenJ. K.GarcÃ­a-SastreA.KatzJ. M.TumpeyT. M.H5N1 and 1918 pandemic" exact="influenza" post="virus infection results in early and excessive infiltration of"/>
   <result pre="e100011510.1371/journal.ppat.1000115 45MalachowaN.FreedmanB.SturdevantD. E.et al.Differential ability of pandemic and seasonal H1N1" exact="influenza" post="A viruses to alter the function of human neutrophilsmSphere20183110.1128/mSphereDirect.00567-1729299535"/>
   <result pre="neutrophilsmSphere20183110.1128/mSphereDirect.00567-1729299535 46IvanF. X.TanK. S.PhoonM. C.et al.Neutrophils infected with highly virulent" exact="influenza" post="H3N2 virus exhibit augmented early cell death and rapid"/>
   <result pre="influenzaClinical Infectious Diseases200847121575157810.1086/59319618990065 48ZhangZ.HuangT.YuF.et al.Infectious progeny of 2009 A (H1N1)" exact="influenza" post="virus replicated in and released from human neutrophilsScientific Reports201551,"/>
   <result pre="S.AbramsonJ. S.Synthesis of viral proteins in polymorphonuclear leukocytes infected with" exact="influenza" post="A virusJournal of Clinical Microbiology1988267126712703045149 50YippB. G.KubesP.NETosis: how vital"/>
   <result pre="neutrophil extracellular trap formation is not required for immunity against" exact="influenza" post="infectionPLoS One201167, article e2204310.1371/journal.pone.002204321779371 54TripathiS.VermaA.KimE. J.WhiteM. R.HartshornK. L.LL-37 modulates"/>
   <result pre="e2204310.1371/journal.pone.002204321779371 54TripathiS.VermaA.KimE. J.WhiteM. R.HartshornK. L.LL-37 modulates human neutrophil responses to" exact="influenza" post="A virusJournal of Leukocyte Biology201496593193810.1189/jlb.4A1113-604RR25082153 55HoeksemaM.TripathiS.WhiteM.et al.Arginine-rich histones have"/>
   <result pre="Leukocyte Biology201496593193810.1189/jlb.4A1113-604RR25082153 55HoeksemaM.TripathiS.WhiteM.et al.Arginine-rich histones have strong antiviral activity for" exact="influenza" post="A virusesInnate Immunity201521773674510.1177/175342591559379426138524 56ZhuL.LiuL.ZhangY.et al.High level of neutrophil extracellular"/>
   <result pre="of neutrophil extracellular traps correlates with poor prognosis of severe" exact="influenza" post="A infectionThe Journal of Infectious Diseases2018217342843710.1093/infdis/jix47529325098 57NarasarajuT.YangE.SamyR. P.et al.Excessive"/>
   <result pre="and neutrophil extracellular traps contribute to acute lung injury of" exact="influenza" post="pneumonitisThe American Journal of Pathology2011179119921010.1016/j.ajpath.2011.03.01321703402 58HuffordM. M.RichardsonG.ZhouH.et al.Influenza-infected neutrophils"/>
   <result pre="in the airwaysScience20153496252, article aaa435210.1126/science.aaa4352 60TumpeyT. M.Garcia-SastreA.TaubenbergerJ. K.et al.Pathogenicity of" exact="influenza" post="viruses with genes from the 1918 pandemic virus: functional"/>
   <result pre="in miceJournal of Virology20057923149331494410.1128/JVI.79.23.14933-14944.200516282492 61YatmazS.SeowH. J.GualanoR. C.et al.Glutathione peroxidase-1 reduces" exact="influenza" post="A virus-induced lung inflammationAmerican Journal of Respiratory Cell and"/>
   <result pre="Biology2013481172610.1165/rcmb.2011-0345OC23002098 62VlahosR.StambasJ.BozinovskiS.BroughtonB. R. S.DrummondG. R.SelemidisS.Inhibition of Nox2 oxidase activity ameliorates" exact="influenza" post="A virus-induced lung inflammationPLoS Pathogens201172, article e100127110.1371/journal.ppat.100127121304882 63ThomasG. D.HamersA."/>
   <result pre="69HeroldS.von WulffenW.SteinmuellerM.et al.Alveolar epithelial cells direct monocyte transepithelial migration upon" exact="influenza" post="virus infection: impact of chemokines and adhesion moleculesJournal of"/>
   <result pre="leukocyte attracting chemokine production after stimulation with active and inactivated" exact="influenza" post="A virusCellular Immunology199818611710.1006/cimm.1998.12959637759 71SprengerH.MeyerR. G.KaufmannA.BussfeldD.RischkowskyE.GemsaD.Selective induction of monocyte and"/>
   <result pre="71SprengerH.MeyerR. G.KaufmannA.BussfeldD.RischkowskyE.GemsaD.Selective induction of monocyte and not neutrophil-attracting chemokines after" exact="influenza" post="A virus infectionJournal of Experimental Medicine199618431191119610.1084/jem.184.3.11919064338 72ZenK.ParkosC. A.Leukocyte-epithelial interactionsCurrent"/>
   <result pre="tropismVirus201829454855210.1007/s13337-018-0499-430539061 80LamichhaneP. P.BoonnakK.ChangsomD.et al.H5N1 NS genomic segment distinctly governs the" exact="influenza" post="virus infectivity and cytokine induction in monocytic cellsAsian Pacific"/>
   <result pre="of Allergy and Immunology2018361586828802028 81LeeA. C. Y.ToK. K. W.ZhuH.et al.Avian" exact="influenza" post="virus A H7N9 infects multiple mononuclear cell types in"/>
   <result pre="activated U937 cells with recombinant vaccinia viruses inserted 2004 H5N1" exact="influenza" post="HA genes and NS genesAsian Pacific Journal of Allergy"/>
   <result pre="D.LeMessurierK. S.SchofieldA. K.WoolardS. N.SamarasingheA. E.Macrophage CD14 impacts immune defenses against" exact="influenza" post="virus in allergic hostsMicrobial Pathogenesis201912721221910.1016/j.micpath.2018.12.00830529429 85ClineT. D.BeckD.BianchiniE.Influenza virus replication"/>
   <result pre="of General Virology201798102401241210.1099/jgv.0.00092228884667 86NicolM. Q.DutiaB. M.The role of macrophages in" exact="influenza" post="A virus infectionFuture Virology20149984786210.2217/fvl.14.65 87LinS. J.LoM.KuoR. L.et al.The pathological"/>
   <result pre="amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic" exact="influenza" post="infectionJournal of Biomedical Science2014211p. 9910.1186/s12929-014-0099-6 88LinK. L.SuzukiY.NakanoH.RamsburgE.GunnM. D.CCR2+ monocyte-derived"/>
   <result pre="CCR5 and CCR2 deficiency in the pulmonary inflammatory response to" exact="influenza" post="A virusThe American Journal of Pathology200015661951195910.1016/S0002-9440(10)65068-710854218 90ZaynagetdinovR.SherrillT. P.KendallP. L.et"/>
   <result pre="for CD200 in lung immune homeostasis and the severity of" exact="influenza" post="infectionNature Immunology2008991074108310.1038/ni.163718660812 102KimH. M.LeeY. W.LeeK. J.et al.Alveolar macrophages are"/>
   <result pre="102KimH. M.LeeY. W.LeeK. J.et al.Alveolar macrophages are indispensable for controlling" exact="influenza" post="viruses in lungs of pigsJournal of Virology20088294265427410.1128/JVI.02602-0718287245 103TateM. D.PickettD."/>
   <result pre="C.Critical role of airway macrophages in modulating disease severity during" exact="influenza" post="virus infection of miceJournal of Virology201084157569758010.1128/JVI.00291-1020504924 104CardaniA.BoultonA.KimT. S.BracialeT. J.Alveolar"/>
   <result pre="of miceJournal of Virology201084157569758010.1128/JVI.00291-1020504924 104CardaniA.BoultonA.KimT. S.BracialeT. J.Alveolar macrophages prevent lethal" exact="influenza" post="pneumonia by inhibiting infection of type-1 alveolar epithelial cellsPLoS"/>
   <result pre="miceJournal of Virology201084157569758010.1128/JVI.00291-1020504924 104CardaniA.BoultonA.KimT. S.BracialeT. J.Alveolar macrophages prevent lethal influenza" exact="pneumonia" post="by inhibiting infection of type-1 alveolar epithelial cellsPLoS Pathogens2017131,"/>
   <result pre="105SchneiderC.NobsS. P.HeerA. K.et al.Alveolar macrophages are essential for protection from" exact="respiratory failure" post="and associated morbidity following influenza virus infectionPLoS Pathogens2014104, article"/>
   <result pre="essential for protection from respiratory failure and associated morbidity following" exact="influenza" post="virus infectionPLoS Pathogens2014104, article e100405310.1371/journal.ppat.100405324699679 106WangJ.NikradM. P.TravantyE. A.et al.Innate"/>
   <result pre="P.TravantyE. A.et al.Innate immune response of human alveolar macrophages during" exact="influenza" post="A infectionPLoS One201273, article e2987910.1371/journal.pone.002987922396727 107YuW. C. L.ChanR. W."/>
   <result pre="primary human alveolar epithelial cells and alveolar macrophages infected with" exact="influenza" post="H5N1 and H1N1 virusesJournal of Virology201185146844685510.1128/JVI.02200-1021543489 108EttensohnD. B.FramptonM. W.NicholsJ."/>
   <result pre="may not be susceptible to direct infection by a human" exact="influenza" post="virusThe Journal of Infectious Diseases2016214111658166510.1093/infdis/jiw41327601618 109LondriganS. L.ShortK. R.MaJ.et al.Infection"/>
   <result pre="Diseases2016214111658166510.1093/infdis/jiw41327601618 109LondriganS. L.ShortK. R.MaJ.et al.Infection of mouse macrophages by seasonal" exact="influenza" post="viruses can be restricted at the level of virus"/>
   <result pre="proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal" exact="influenza" post="virus challenge in miceInfluenza and Other Respiratory Viruses20104530731110.1111/j.1750-2659.2010.00155.x20716159 115HuangS.ZhuB.CheonI."/>
   <result pre="receptors in adult and neonatal macrophages infected with human or" exact="avian influenza" post="virusesThe Journal of Infectious Diseases20061941617010.1086/50469016741883 117CheungC. Y.PoonL. L. M.LauA."/>
   <result pre="in adult and neonatal macrophages infected with human or avian" exact="influenza" post="virusesThe Journal of Infectious Diseases20061941617010.1086/50469016741883 117CheungC. Y.PoonL. L. M.LauA."/>
   <result pre="M.LauA. S.et al.Induction of proinflammatory cytokines in human macrophages by" exact="influenza" post="A (H5N1) viruses: a mechanism for the unusual severity"/>
   <result pre="for the unusual severity of human disease?The Lancet200236093481831183710.1016/S0140-6736(02)11772-7 118FriesenhagenJ.BoergelingY.HrinciusE.LudwigS.RothJ.ViemannD.Highly pathogenic" exact="avian influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJournal"/>
   <result pre="the unusual severity of human disease?The Lancet200236093481831183710.1016/S0140-6736(02)11772-7 118FriesenhagenJ.BoergelingY.HrinciusE.LudwigS.RothJ.ViemannD.Highly pathogenic avian" exact="influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJournal"/>
   <result pre="human blood-derived macrophagesJournal of Leukocyte Biology2012921112010.1189/jlb.091147922442495 119WaithmanJ.MinternJ. D.Dendritic cells and" exact="influenza" post="A virus infectionVirulence20123760360810.4161/viru.2186423076333 120HeathW. R.CarboneF. R.Dendritic cell subsets in"/>
   <result pre="miceImmunological Reviews20102341557510.1111/j.0105-2896.2009.00885.x20193012 127GeurtsvanKesselC. H.WillartM. A. M.van RijtL. S.et al.Clearance of" exact="influenza" post="virus from the lung depends on migratory langerin+CD11bâˆ’ but"/>
   <result pre="cells and monocytes to respiratory mucosal sites in children with" exact="influenza" post="virus or respiratory syncytial virus infectionThe Journal of Infectious"/>
   <result pre="131HoA. W. S.PrabhuN.BettsR. J.et al.Lung CD103+ dendritic cells efficiently transport" exact="influenza" post="virus to the lymph node and load viral antigen"/>
   <result pre="of Immunology2011187116011602110.4049/jimmunol.110098722043017 132HelftJ.ManicassamyB.GuermonprezP.et al.Cross-presenting CD103+ dendritic cells are protected from" exact="influenza" post="virus infectionJournal of Clinical Investigation2012122114037404710.1172/JCI6065923041628 133del RioM.-L.Rodriguez-BarbosaJ. I.KremmerE.FÃ¶rsterR.CD103âˆ’ and"/>
   <result pre="determine the functional fate of migratory lung dendritic cells during" exact="influenza" post="virus infectionPLoS Pathogens2011711, article e100234510.1371/journal.ppat.100234522072965 135KimT. S.BracialeT. J.Respiratory dendritic"/>
   <result pre="al.Two distinct activation states of plasmacytoid dendritic cells induced by" exact="influenza" post="virus and CpG 1826 oligonucleotideJournal of Leukocyte Biology200883361062010.1189/jlb.080751118029397 138WolfA."/>
   <result pre="138WolfA. I.BuehlerD.HensleyS. E.et al.Plasmacytoid dendritic cells are dispensable during primary" exact="influenza" post="virus infectionJournal of Immunology2009182287187910.4049/jimmunol.182.2.87119124730 139ThitithanyanontA.EngeringA.EkchariyawatP.et al.High susceptibility of human"/>
   <result pre="of Immunology2009182287187910.4049/jimmunol.182.2.87119124730 139ThitithanyanontA.EngeringA.EkchariyawatP.et al.High susceptibility of human dendritic cells to" exact="avian influenza" post="H5N1 virus infection and protection by IFN-Î± and TLR"/>
   <result pre="Immunology2009182287187910.4049/jimmunol.182.2.87119124730 139ThitithanyanontA.EngeringA.EkchariyawatP.et al.High susceptibility of human dendritic cells to avian" exact="influenza" post="H5N1 virus infection and protection by IFN-Î± and TLR"/>
   <result pre="expression profiles but exhibit differential type I IFN responses to" exact="influenza" post="A virus infectionJournal of Immunology201920272069208110.4049/jimmunol.180119130760619 141LuiG.ManchesO.AngelJ.MolensJ. P.ChaperotL.PlumasJ.Plasmacytoid dendritic cells"/>
   <result pre="interleukin 6Immunity200319222523410.1016/S1074-7613(03)00208-512932356 143DoorleyL. A.LeMessurierK. S.IversonA. R.PalipaneM.SamarasingheA. E.Humoral immune responses during" exact="asthma" post="and influenza co-morbidity in miceImmunobiology2017222121064107310.1016/j.imbio.2017.08.00228889999 144SandbulteM. R.BoonA. C. M.WebbyR."/>
   <result pre="143DoorleyL. A.LeMessurierK. S.IversonA. R.PalipaneM.SamarasingheA. E.Humoral immune responses during asthma and" exact="influenza" post="co-morbidity in miceImmunobiology2017222121064107310.1016/j.imbio.2017.08.00228889999 144SandbulteM. R.BoonA. C. M.WebbyR. J.RiberdyJ. M.Analysis"/>
   <result pre="from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity" exact="influenza" post="virusesVirology20083811222810.1016/j.virol.2008.08.01818801551 145FonteneauJ.-F.GillietM.LarssonM.et al.Activation of influenza virus-specific CD4+ and CD8+"/>
   <result pre="infected with H5N1 or low-pathogenicity influenza virusesVirology20083811222810.1016/j.virol.2008.08.01818801551 145FonteneauJ.-F.GillietM.LarssonM.et al.Activation of" exact="influenza" post="virus-specific CD4+ and CD8+ T cells: a new role"/>
   <result pre="adaptive immunityBlood200310193520352610.1182/blood-2002-10-306312511409 146DavidsonS.CrottaS.McCabeT. M.WackA.Pathogenic potential of interferon Î±Î² in acute" exact="influenza" post="infectionNature Communications20145110.1038/ncomms4864 147BoonnakK.VogelL.FeldmannF.FeldmannH.LeggeK. L.SubbaraoK.Lymphopenia associated with highly virulent H5N1"/>
   <result pre="Immunology2014192125906591210.4049/jimmunol.130299224829418 148LangloisR. A.LeggeK. L.Plasmacytoid dendritic cells enhance mortality during lethal" exact="influenza" post="infections by eliminating virus-specific CD8 T cellsJournal of Immunology201018484440444610.4049/jimmunol.090298420220091"/>
   <result pre="enhanced mononuclear phagocyte response in lungs of mice with lethal" exact="influenza" post="virus infectionComparative Immunology, Microbiology and Infectious Diseases201235430931710.1016/j.cimid.2012.01.01222421538 151BramleyA. M.DasguptaS.SkarbinskiJ.et"/>
   <result pre="Diseases201235430931710.1016/j.cimid.2012.01.01222421538 151BramleyA. M.DasguptaS.SkarbinskiJ.et al.Intensive care unit patients with 2009 pandemic" exact="influenza" post="A (H1N1pdm09) virus infection - United States, 2009Influenza and"/>
   <result pre="al.Factors associated with death or hospitalization due to pandemic 2009" exact="influenza" post="A (H1N1) infection in CaliforniaJAMA2009302171896190210.1001/jama.2009.158319887665 153VaillantL.la RucheG.TarantolaA.BarbozaP.epidemic intelligence teamEpidemiology"/>
   <result pre="RucheG.TarantolaA.BarbozaP.epidemic intelligence teamEpidemiology of fatal cases associated with pandemic H1N1" exact="influenza" post="2009Euro Surveillance2009143310.2807/ese.14.33.19309-en 154TeraiM.HondaT.YamamotoS.et al.Early induction of interleukin-5 and peripheral"/>
   <result pre="influenza 2009Euro Surveillance2009143310.2807/ese.14.33.19309-en 154TeraiM.HondaT.YamamotoS.et al.Early induction of interleukin-5 and peripheral" exact="eosinophilia" post="in acute pneumonia in Japanese children infected by pandemic"/>
   <result pre="154TeraiM.HondaT.YamamotoS.et al.Early induction of interleukin-5 and peripheral eosinophilia in acute" exact="pneumonia" post="in Japanese children infected by pandemic 2009 influenza A"/>
   <result pre="in acute pneumonia in Japanese children infected by pandemic 2009" exact="influenza" post="A in the Tokyo areaMicrobiology and Immunology201155534134610.1111/j.1348-0421.2011.00320.x21323726 155GorskiS. A.HahnY."/>
   <result pre="cell production of IL-5 is regulated by NKT cells during" exact="influenza" post="virus infectionPLoS Pathogens201399, article e100361510.1371/journal.ppat.100361524068930 156DiPiazzaA.NogalesA.PoultonN.WilsonP. C.MartÃ­nez-SobridoL.SantA. J.Pandemic 2009"/>
   <result pre="virus infectionPLoS Pathogens201399, article e100361510.1371/journal.ppat.100361524068930 156DiPiazzaA.NogalesA.PoultonN.WilsonP. C.MartÃ­nez-SobridoL.SantA. J.Pandemic 2009 H1N1" exact="influenza" post="Venus reporter virus reveals broad diversity of MHC class"/>
   <result pre="N.BoydK. L.HoseltonS. A.SchuhJ. M.McCullersJ. A.The immune profile associated with acute" exact="allergic asthma" post="accelerates clearance of influenza virusImmunology and Cell Biology201492544945910.1038/icb.2013.11324469764 158FurzeR."/>
   <result pre="L.HoseltonS. A.SchuhJ. M.McCullersJ. A.The immune profile associated with acute allergic" exact="asthma" post="accelerates clearance of influenza virusImmunology and Cell Biology201492544945910.1038/icb.2013.11324469764 158FurzeR."/>
   <result pre="immune profile associated with acute allergic asthma accelerates clearance of" exact="influenza" post="virusImmunology and Cell Biology201492544945910.1038/icb.2013.11324469764 158FurzeR. C.HussellT.SelkirkM. E.Amelioration of influenza-induced"/>
   <result pre="C. N.DuanS.et al.Eosinophils promote antiviral immunity in mice infected with" exact="influenza" post="A virusThe Journal of Immunology201719883214322610.4049/jimmunol.160078728283567 161SpencerL. A.SzelaC. T.PerezS. A."/>
   <result pre="distinct population of NK cells and mediates their migration during" exact="influenza" post="virus infection in micePLoS One2012712, article e5202710.1371/journal.pone.005202723272202 165KumarP.ThakarM. S.OuyangW.MalarkannanS.IL-22"/>
   <result pre="conventional NK cells is epithelial regenerative and inflammation protective during" exact="influenza" post="infectionMucosal Immunology201361698210.1038/mi.2012.4922739232 166GazitR.GrudaR.ElboimM.et al.Lethal influenza infection in the absence"/>
   <result pre="regenerative and inflammation protective during influenza infectionMucosal Immunology201361698210.1038/mi.2012.4922739232 166GazitR.GrudaR.ElboimM.et al.Lethal" exact="influenza" post="infection in the absence of the natural killer cell"/>
   <result pre="R.HeuselJ. W.LeggeK. L.Natural killer cell recruitment to the lung during" exact="influenza" post="A virus infection is dependent on CXCR3, CCR5, and"/>
   <result pre="killer cells in pigs experimentally infected with 2009 pandemic H1N1" exact="influenza" post="A virusPLoS One201496, article e10061910.1371/journal.pone.0100619 169GrÃ©goireC.ChassonL.LuciC.et al.The trafficking of"/>
   <result pre="human NK cellsNature200140968231055106010.1038/3505911011234016 174DuN.ZhouJ.LinX.et al.Differential activation of NK cells by" exact="influenza" post="A pseudotype H5N1 and 1918 and 2009 pandemic H1N1"/>
   <result pre="inflammatory monocytes in the lungs and decrease immune-pathology during severe" exact="influenza" post="A virus infectionJournal of Leukocyte Biology201291335736810.1189/jlb.041118422003207 177De SantoC.SalioM.MasriS. H.et"/>
   <result pre="SantoC.SalioM.MasriS. H.et al.Invariant NKT cells reduce the immunosuppressive activity of" exact="influenza" post="A virus-induced myeloid-derived suppressor cells in mice and humansThe"/>
   <result pre="al.Interleukin-22 is produced by invariant natural killer T lymphocytes during" exact="influenza" post="A virus infection: potential role in protection against lung"/>
   <result pre="innate lymphoid cellsTrends in Immunology201233838939610.1016/j.it.2012.04.00522609147 186Le GofficR.ArshadM. I.RauchM.et al.Infection with" exact="influenza" post="virus induces IL-33 in murine lungsAmerican Journal of Respiratory"/>
   <result pre="C.et al.Innate lymphoid cells promote lung-tissue homeostasis after infection with" exact="influenza" post="virusNature Immunology201112111045105410.1038/ni.213121946417 189CalifanoD.FuruyaY.RobertsS.AvramD.McKenzieA. N. J.MetzgerD. W.IFN-Î³ increases susceptibility to"/>
   <result pre="influenza virusNature Immunology201112111045105410.1038/ni.213121946417 189CalifanoD.FuruyaY.RobertsS.AvramD.McKenzieA. N. J.MetzgerD. W.IFN-Î³ increases susceptibility to" exact="influenza" post="A infection through suppression of group II innate lymphoid"/>
   <result pre="N. J.MetzgerD. W.IFN-Î³ increases susceptibility to influenza A infection through" exact="suppression" post="of group II innate lymphoid cellsMucosal Immunology201811120921910.1038/mi.2017.4128513592 190ChienY. H.MeyerC.BonnevilleM.Î³Î´"/>
   <result pre="and beyondAnnual Review of Immunology201432112115510.1146/annurev-immunol-032713-120216 191TuW.ZhengJ.LiuY.et al.The aminobisphosphonate pamidronate controls" exact="influenza" post="pathogenesis by expanding a Î³Î´ T cell population in"/>
   <result pre="192QinG.LiuY.ZhengJ.et al.Type 1 responses of human VÎ³9VÎ´2 T cells to" exact="influenza" post="A virusesJournal of Virology20118519101091011610.1128/JVI.05341-1121752902 193GlatzelA.WeschD.SchiemannF.BrandtE.JanssenO.KabelitzD.Patterns of chemokine receptor expression"/>
   <result pre="cellsThe Journal of Immunology2002168104920492910.4049/jimmunol.168.10.492011994442 194LiH.XiangZ.FengT.et al.Human VÎ³9VÎ´2-T cells efficiently kill" exact="influenza" post="virus-infected lung alveolar epithelial cellsCellular &amp;amp; Molecular Immunology201310215916410.1038/cmi.2012.7023353835 195QinG.MaoH.ZhengJ.et"/>
   <result pre="display potent cytotoxicity against monocyte-derived macrophages infected with human and" exact="avian influenza" post="virusesThe Journal of Infectious Diseases2009200685886510.1086/60541319656068 196JamesonJ. M.CruzJ.CostanzoA.TerajimaM.EnnisF. A.A role"/>
   <result pre="potent cytotoxicity against monocyte-derived macrophages infected with human and avian" exact="influenza" post="virusesThe Journal of Infectious Diseases2009200685886510.1086/60541319656068 196JamesonJ. M.CruzJ.CostanzoA.TerajimaM.EnnisF. A.A role"/>
   <result pre="mevalonate pathway in the induction of subtype cross-reactive immunity to" exact="influenza" post="A virus by human Î³Î´ T lymphocytesCellular Immunology20102641717710.1016/j.cellimm.2010.04.01320483407 197DongP.JuX.YanY.et"/>
   <result pre="T cells provide protective function in highly pathogenic avian H5N1" exact="influenza" post="A virus infectionFrontiers in Immunology20189p. 281210.3389/fimmu.2018.02812 198LuY.LiZ.MaC.et al.The interaction"/>
   <result pre="A virus infectionFrontiers in Immunology20189p. 281210.3389/fimmu.2018.02812 198LuY.LiZ.MaC.et al.The interaction of" exact="influenza" post="H5N1 viral hemagglutinin with sialic acid receptors leads to"/>
   <result pre="C.et al.Lung Î³Î´ T cells mediate protective responses during neonatal" exact="influenza" post="infection that are associated with type 2 immunityImmunity2018493531544.e610.1016/j.immuni.2018.07.01130170813 Figure"/>
   <result pre="Figure 1 Schematic representation of neutrophil-mediated host defense mechanisms during" exact="influenza" post="virus infection. Influenza A virus- (IAV)-infected airway epithelium releases"/>
   <result pre="macrophage-, and dendritic cell- (DC-) controlled immunoprotection and immunopathology during" exact="influenza" post="virus infection. Influenza A virus- (IAV-) infected airway epithelium"/>
   <result pre="IFNÎ³ released by NK cell destroy IAV-infected cells while IL-22" exact="aids" post="in the regeneration of damaged epithelium. Figure 4 Innate"/>
   <result pre="and Î³Î´ T cells are important during early stages of" exact="influenza" post="virus infection. Schematic representation of immunoprotection and immunopathology mediated"/>
   <result pre="5 Yin and Yang of innate immune cell functions during" exact="influenza" post="virus infection. At steady state, innate immune cells corporate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6759257\results\search\disease\results.xml">
   <result pre="of the Togaviridae family. Other viruses in this genus include" exact="chikungunya" post="virus (CHIKV), Barmah Forest virus (BFV), Sindbis virus, and"/>
   <result pre="Forest virus (BFV), Sindbis virus, and Eastern and Western equine" exact="encephalitis" post="viruses. The prototype strain of RRV (T48) was isolated"/>
   <result pre="EPA occur after infection with BFV, CHIKV, Epstein-Barr virus (22)," exact="rubella" post="virus (23), and parvovirus B19 (24). BFV co-circulates with"/>
   <result pre="75%), stiff neck (38% and 71%), fever (33% and 47%)," exact="rash" post="(9.5% and 65%), headache (28% and 41%), and sore"/>
   <result pre="potential of the virus. The recent experience with Zika and" exact="chikungunya" post="viruses underscores the serious threat posed to global health"/>
   <result pre="Med Hyg. 1984;33:1228â€&quot;31. 10.4269/ajtmh.1984.33.12286095694 9. ScrimgeourEM. Suspected Ross River virus" exact="encephalitis" post="in Papua New Guinea.Aust N Z J Med. 1999;29:559."/>
   <result pre="Med. 1999;29:559. 10.1111/j.1445-5994.1999.tb00759.x10868536 10. ScrimgeourEM, AaskovJG, MatzLR. Ross River virus" exact="arthritis" post="in Papua New Guinea.Trans R Soc Trop Med Hyg."/>
   <result pre="The ecology and epidemiology of Ross River and Murray Valley" exact="encephalitis" post="viruses in Western Australia: examples of One Health in"/>
   <result pre="PykeAT, McMahonJ, WarrilowD. Complete coding sequence of a case of" exact="chikungunya" post="virus imported into Australia.Genome Announc. 2017;5:e00310â€&quot;7. 10.1128/genomeA.00310-1728495775 26. JansenCC,"/>
   <result pre="usual suspects: comparison of the relative roles of potential urban" exact="chikungunya" post="virus vectors in Australia.PLoS One. 2015;10:e0134975. 10.1371/journal.pone.013497526247366 27. HuestonL,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6760898\results\search\disease\results.xml">
   <result pre="Analysis Methods : Molecular Biology Techniques: Genotyping Molecular characterization of" exact="measles" post="virus strains circulating in Cameroon during the 2013-2016 epidemics"/>
   <result pre="circulating in Cameroon during the 2013-2016 epidemics Molecular characterization of" exact="measles" post="virus strains circulating in Cameroon Obam MekandaFranck-MartinData curationFormal analysisInvestigationWriting"/>
   <result pre="and source are credited.pone.0222428.pdf Abstract The first genotyping data on" exact="measles" post="virus (MeV) strains in Cameroon dates from 1994, while"/>
   <result pre="genotypes circulating in Cameroon. Ninety throat swabs collected during recent" exact="measles" post="outbreaks were analyzed by MeV genotyping RT-PCR using the"/>
   <result pre="viral infection of the child and young adult caused by" exact="measles" post="virus (MeV): a 15.9 kb enveloped, non-segmented, negative-stranded RNA"/>
   <result pre="[2]. Clinically a person is declared a suspect case of" exact="measles" post="when he has a generalized maculopapular rash and fever,"/>
   <result pre="suspect case of measles when he has a generalized maculopapular" exact="rash" post="and fever, with cough and/or coryza, and/or conjunctivitis [3]."/>
   <result pre="generalized maculopapular rash and fever, with cough and/or coryza, and/or" exact="conjunctivitis" post="[3]. Once the disease progresses, the immunosuppression caused by"/>
   <result pre="conjunctivitis [3]. Once the disease progresses, the immunosuppression caused by" exact="measles" post="virus (MeV) exposes the patient to bacterial super infections"/>
   <result pre="virus (MeV) exposes the patient to bacterial super infections causing" exact="otitis media," post="pneumonia, or gastrointestinal infections. The main cause of measles-related"/>
   <result pre="malnutrition and vitamin A deficiency [4]. Before the introduction of" exact="measles" post="immunization in the 1960s, almost everyone contracted measles usually"/>
   <result pre="introduction of measles immunization in the 1960s, almost everyone contracted" exact="measles" post="usually during childhood with an estimated annual incidence of"/>
   <result pre="year. Since the introduction of the vaccine, the incidence of" exact="measles" post="as well as the associated early mortality rate decreased."/>
   <result pre="in Africa and Asia [5]. To date, some countries where" exact="measles" post="has been declared eliminated have confirmed new cases in"/>
   <result pre="The WHO European Region which was already close to eliminating" exact="measles" post="confirmed a total of 21,315 cases between 2016 and"/>
   <result pre="B3.2, and B3.3) [9]. As part of strategic plan for" exact="measles" post="control and elimination, the World Health Organization (WHO) has"/>
   <result pre="of strains is a key tool in the study of" exact="measles" post="transmission pathways, evaluation of endemic measles eradication and indirect"/>
   <result pre="in the study of measles transmission pathways, evaluation of endemic" exact="measles" post="eradication and indirect evaluation of the vaccination system in"/>
   <result pre="defined geographic area for â‰¥12 months of period of time," exact="measles" post="can be decleared eliminated in this area or region"/>
   <result pre="Ethics statement This study was carried out as part of" exact="measles" post="surveillance in Cameroon at Centre Pasteur of Cameroon (CPC),"/>
   <result pre="Pasteur of Cameroon (CPC), the National Reference Laboratory (NRL) for" exact="measles" post="since 2011. There was thus no need for an"/>
   <result pre="throat swabs collected during the 2013, 2014, 2015 and 2016" exact="measles" post="outbreaks were collected by the surveillance team of the"/>
   <result pre="nucleotides of the N gene according to WHO recommendations for" exact="measles" post="virus strains genotyping [17]. All consensus sequences obtained from"/>
   <result pre="shown next to the main tree branches. Discussion Cameroon integrated" exact="measles" post="surveillance in 1974 through sentinel sites in the city"/>
   <result pre="with extremes of 7 months and 20 years, suggesting that," exact="measles" post="remains a disease of children and young adults regardless"/>
   <result pre="the patient in whom the MeV strains were detected presented" exact="rash" post="at varying periods between 1 month and 12 years"/>
   <result pre="better follow-up of the recommendations for control and elimination of" exact="measles" post="as proposed by WHO. The study provided recent data"/>
   <result pre="proposed by WHO. The study provided recent data on circulating" exact="measles" post="viral strains throughout the country as the incidence of"/>
   <result pre="measles viral strains throughout the country as the incidence of" exact="measles" post="has increased worldwide. The limits of this work were"/>
   <result pre="1551â€&quot;1585. https://jhu.pure.elsevier.com/en/publications/measles-virus 2AllaA, Waku-KouomouD, BenjouadA, ElaouadR, WildTF. Rapid diversification of" exact="measles" post="virus genotypes circulating in Morocco during 2004â€&quot;2005 epidemics. J"/>
   <result pre="4MahamudA, BurtonA, HassanM, AhmedJA, WagachaJB, SpiegelP, et al.Risk factors for" exact="measles" post="mortality among hospitalized Somali refugees displaced by famine, Kenya,"/>
   <result pre="1148â€&quot;1153. 6EomH, ParkY, KimJ, YangJ-S, KangH, KimK, et al.Occurrence of" exact="measles" post="in a country with elimination status: Amplifying measles infection"/>
   <result pre="al.Occurrence of measles in a country with elimination status: Amplifying" exact="measles" post="infection in hospitalized children due to imported virus. PLoS"/>
   <result pre="Media C, et al. Europe observes a 4-fold increase in" exact="measles" post="cases in 2017 compared to previous year. 2018; 2017â€&quot;2019."/>
   <result pre="Ben YahiaA, AbudherA, SlimA, et al.Genetic characterization of clade B" exact="measles" post="viruses isolated in Tunisia and Libya 2002â€&quot;2009 and a"/>
   <result pre="Update on the global distribution of genotypes of wild type" exact="measles" post="viruses. J Infect Dis. 2003;187Suppl: S270-610.1086/36804212721925 13PatelMK, Gacic-doboM, StrebelPM,"/>
   <result pre="16DemanouM, RatsitoharanaR, YongaM, DossehA, AnyaB, KobelaM, et al.Molecular characterization of" exact="measles" post="viruses that circulated in Cameroon between 2010 and 2011."/>
   <result pre="IkusikaO, AduF, OyefoluAO, et al.Molecular epidemiology of Nigerian and Ghanaian" exact="measles" post="virus isolates reveals a genotype circulating widely in western"/>
   <result pre="MubarakHSVan De BildtMWG, MustafaOAVosHW, MukhtarMMIbrahimSA, et al.Genetic characterization of wild-type" exact="measles" post="viruses circulating in suburban Khartoum, 1997â€&quot;2000. J Gen Virol."/>
   <result pre="R, Acho A, Ebua J, et al. Molecular characterisation of" exact="measles" post="virus strains among refugees from Central African Republic in"/>
   <result pre="in Cameroon in 2014. 2018; 24GateffC. Evaluation of a mass" exact="measles" post="immunization campaign in yaoundÃ©, cameroun. Trans R Soc Trop"/>
   <result pre="[Internet]. [cited 9 May 2019]. https://www.cdc.gov/vaccines/vpd/mmr/public/index.html 26Secondary failure rates of" exact="measles" post="vaccines: a metaanalysis â€¦â€¯: The Pediatric Infectious Disease Journal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6763598\results\search\disease\results.xml">
   <result pre="were sequentially imported to Brazil and South America. Cases of" exact="yellow fever," post="caused by YFV, were first reported in Brazil in"/>
   <result pre="YFV, were first reported in Brazil in 1685. Thousands of" exact="yellow fever" post="cases were noticed until the beginning of the twentieth"/>
   <result pre="disease. Vector eradication together with vaccination contributed to elimination of" exact="yellow fever" post="from Brazilian urban areas (2). In 1981, the first"/>
   <result pre="with mild infections in Africa and Asia, was associated to" exact="microcephaly" post="and Guillain-BarrÃ© syndrome in the Americas (6). The first"/>
   <result pre="virus was very quickly spreaded and 141 suspected cases of" exact="microcephaly" post="were reported in Northeastern states, in addition to many"/>
   <result pre="many cases of spontaneous abortions and stillbirths (6â€&quot;9). In 2016" exact="yellow fever" post="cases were reported again in Brazil, with a total"/>
   <result pre="are highly pathogenic. Examples are West Nile virus (WNV), Japanese" exact="encephalitis" post="virus (JEV), Saint Louis encephalitis virus (SLEV) and Rocio"/>
   <result pre="West Nile virus (WNV), Japanese encephalitis virus (JEV), Saint Louis" exact="encephalitis" post="virus (SLEV) and Rocio virus (ROCV) (11). Such pathogens"/>
   <result pre="(ZIKV), Yellow fever virus (YFV), West Nile virus (WNV), Japanese" exact="encephalitis" post="virus (JEV), Saint Louis encephalitis virus (SLEV), Rocio virus"/>
   <result pre="West Nile virus (WNV), Japanese encephalitis virus (JEV), Saint Louis" exact="encephalitis" post="virus (SLEV), Rocio virus (ROCV), Cacipocore virus (CPCV), IlhÃ©us"/>
   <result pre="virus, Zika virus, Yellow Fever virus, West Nile virus, Japanese" exact="encephalitis" post="virus, Saint Louis encephalitis virus, Rocio virus, Cacipocore virus,"/>
   <result pre="Fever virus, West Nile virus, Japanese encephalitis virus, Saint Louis" exact="encephalitis" post="virus, Rocio virus, Cacipocore virus, Ilheus virus, and Iguape"/>
   <result pre="field; any MHC restriction at the MHC restriction field and" exact="infectious disease" post="at the disease field. Conservancy Analysis of Selected Epitopes"/>
   <result pre="protective immune response against dengue virus elicited in a mouse" exact="encephalitis" post="model. Virology. (2016) 487:41â€&quot;9. 10.1016/j.virol.2015.10.00626496698 31.RivinoLKumaranEAPJovanovicVNaduaKTeoEWPangSWet al.. Differential targeting"/>
   <result pre="187:4268â€&quot;79. 10.4049/jimmunol.1101970 40.de MeloABNascimentoEJMBraga-NetoUDhaliaRSilvaAMOelkeMet al.. T-cell memory responses elicited by" exact="yellow fever" post="vaccine are targeted to overlapping epitopes containing multiple HLA-I"/>
   <result pre="196:5â€&quot;12. 10.1016/j.virusres.2014.10.02225449574 43.TurtleLBaliTBuxtonGChibSChanSSoniMet al.. Human T cell responses to Japanese" exact="encephalitis" post="virus in health and disease. J Exp Med. (2016)"/>
   <result pre="Bull World Health Organ. (2011) 89:766â€&quot;74. 10.2471/BLT.10.085233 48.KonishiEKitaiYTabeiYNishimuraKHaradaS. Natural Japanese" exact="encephalitis" post="virus infection among humans in west and east Japan"/>
   <result pre="program. Vaccine. (2010) 28:2664â€&quot;70. 10.1016/j.vaccine.2010.01.00820080072 49.JentesESPoumerolGGershmanMDHillDRLemarchandJLewisRFet al.. The revised global" exact="yellow fever" post="risk map and recommendations for vaccination, 2010: consensus of"/>
   <result pre="Dis. (2011) 11:622â€&quot;32. 10.1016/S1473-3099(11)70147-521798462 50.AmarillaAAFumagalliMJFigueiredoMLLima-JuniorDSSantos-JuniorNNAlfonsoHLet al.. Ilheus and Saint Louis" exact="encephalitis" post="viruses elicit cross-protection against a lethal Rocio virus challenge"/>
   <result pre="Med. (2014) 372:141103114505002. 10.1056/NEJMoa141103725365753 54.LiJGaoNFanDChenHShengZFuSet al.. Cross-protection induced by Japanese" exact="encephalitis" post="vaccines against different genotypes of Dengue viruses in mice."/>
   <result pre="mice immunized with recombinant E protein domain III of Japanese" exact="encephalitis" post="virus. Immunol Lett. (2011) 138:156â€&quot;60. 10.1016/j.imlet.2011.04.00321515306 65.ChowdhuryPKhanSAChowdhuryPBorahJDuttaPCross-protective immunity against"/>
   <result pre="Immunol Lett. (2011) 138:156â€&quot;60. 10.1016/j.imlet.2011.04.00321515306 65.ChowdhuryPKhanSAChowdhuryPBorahJDuttaPCross-protective immunity against circulating Japanese" exact="encephalitis" post="virus and West Nile Virus by live attenuated Japanese"/>
   <result pre="encephalitis virus and West Nile Virus by live attenuated Japanese" exact="encephalitis" post="vaccine SA 14-14-2. Int J Infect Dis. (2016) 45:43410.1016/j.ijid.2016.02.922"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6766991\results\search\disease\results.xml">
   <result pre="on 9 December 2018)10.1186/s13567-016-0405-227912792 23.CastrucciM.R.DonatelliI.Genetic reassortment between avian and human" exact="influenza" post="A viruses in Italian pigsVirology1993193503506Available online: https://www.ncbi.nlm.nih.gov/pubmed/8438586(accessed on 9"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6769590\results\search\disease\results.xml">
   <result pre="the formal identification of viral selenoproteins in the genome of" exact="molluscum contagiosum" post="and fowlpox viruses demonstrated the importance of selenoproteins in"/>
   <result pre="in viral cycle. reactive oxygen species glutathione peroxidases thioredoxin reductases" exact="influenza" post="virus hepatitis C virus coxsackie virus human immunodeficiency virus"/>
   <result pre="cycle. reactive oxygen species glutathione peroxidases thioredoxin reductases influenza virus" exact="hepatitis" post="C virus coxsackie virus human immunodeficiency virus molluscum contagiosum"/>
   <result pre="influenza virus hepatitis C virus coxsackie virus human immunodeficiency virus" exact="molluscum contagiosum" post="virus viral selenoproteins immunity 1. Introduction Selenium is an"/>
   <result pre="viruses associated with ROS production are human immunodeficiency virus (HIV)," exact="hepatitis" post="B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus"/>
   <result pre="production are human immunodeficiency virus (HIV), hepatitis B virus (HBV)," exact="hepatitis" post="C virus (HCV), Epstein-Barr virus (EBV), herpes simplex virus"/>
   <result pre="B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus (EBV)," exact="herpes simplex" post="virus type 1 (HSV-1), vesicular stomatitis virus (VSV), respiratory"/>
   <result pre="Epstein-Barr virus (EBV), herpes simplex virus type 1 (HSV-1), vesicular" exact="stomatitis" post="virus (VSV), respiratory syncytial virus (RSV), human T cell"/>
   <result pre="(RSV), human T cell leukaemia virus type 1 (HTLV-1) and" exact="influenza" post="viruses [34]. The mechanisms of ROS generation by the"/>
   <result pre="has been implicated in many pathological conditions including carcinogenesis [36]," exact="neurodegeneration" post="[37,38], atherosclerosis, diabetes [39], and aging [40]. The production"/>
   <result pre="the antioxidant enzyme manganese superoxide dismutase MnSOD [64]. In chronic" exact="hepatitis" post="C, direct interaction of core protein with mitochondria is"/>
   <result pre="stress. This phenomenon has been reported in animal models for" exact="influenza" post="and coxsackie viruses [95,98,99], but the molecular mechanism remains"/>
   <result pre="pancreas, and liver [100]. In the early 1930s an endemic" exact="cardiomyopathy" post="termed Keshan disease was first described in Heilongjiang province,"/>
   <result pre="in childbearing age [66]. It is characterized by cardiac enlargement," exact="congestive heart failure," post="pulmonary edema and death. Keshan disease spread in another"/>
   <result pre="[66]. It is characterized by cardiac enlargement, congestive heart failure," exact="pulmonary edema" post="and death. Keshan disease spread in another 12 provinces"/>
   <result pre="this family: A, B, C and Thogotovirus, but only three" exact="influenza" post="viruses are infectious for humans (A, B and C)"/>
   <result pre="genome consists of eight segmented single-stranded RNA segments (seven for" exact="influenza" post="C virus) encoding between 9 to 12 proteins, including"/>
   <result pre="M1 and M2 [113]. Various subtypes of the most common" exact="influenza" post="A viruses are classified based on the diversity in"/>
   <result pre="NA combinations. Influenza A and B viruses cause epidemics, whereas" exact="influenza" post="C virus tends to cause infections with less severe"/>
   <result pre="revaccinate people at risk every year. The patients infected with" exact="influenza" post="virus display a marked increase in DNA, lipid and"/>
   <result pre="urine [41,114,115,116]. Models of mice and cell lines infected with" exact="influenza" post="viruses also show an enhanced production of ROS together"/>
   <result pre="to study the changes in redox homeostasis induced by the" exact="influenza" post="virus. The work from Beckâ€™s laboratory extended this novel"/>
   <result pre="virus in selenium deficient host has been also reported for" exact="influenza" post="virus similarly to what was found for coxsackie virus."/>
   <result pre="either deficient or adequate in selenium for 4 weeks. Then," exact="influenza" post="A/Bangkok/1/79 (H3N2), a strain that induces mild pneumonitis in"/>
   <result pre="for coxsackie and influenza. 4.4. Hepatitis C Virus (HCV) The" exact="hepatitis" post="C virus (HCV) is an enveloped, linear, positive-sense single-stranded"/>
   <result pre="in immune cells. In 80% of the patients with acute" exact="hepatitis" post="C, the disease evolves to chronic hepatitis, with 2%"/>
   <result pre="the disease evolves to chronic hepatitis, with 2% developing liver" exact="cirrhosis" post="and 1â€&quot;5% developing liver cancer [143,144]. Many characteristics of"/>
   <result pre="chronic hepatitis, with 2% developing liver cirrhosis and 1â€&quot;5% developing" exact="liver cancer" post="[143,144]. Many characteristics of oxidative stress have been reported"/>
   <result pre="hepatitis, with 2% developing liver cirrhosis and 1â€&quot;5% developing liver" exact="cancer" post="[143,144]. Many characteristics of oxidative stress have been reported"/>
   <result pre="Many characteristics of oxidative stress have been reported during chronic" exact="hepatitis" post="C, including a decrease in GSH, increase in MDA,"/>
   <result pre="mechanisms, SELENOM, has been reported to be upregulated in human" exact="hepatocellular carcinoma" post="(HCC) cell lines and liver biopsies of patients with"/>
   <result pre="(HCC) cell lines and liver biopsies of patients with HCV-related" exact="cirrhosis" post="[155]. Whether this is true for other endoplasmic reticulum"/>
   <result pre="HBV includes several viruses that infect liver cells and cause" exact="hepatitis" post="in humans and animals. In the viral genome, the"/>
   <result pre="develop a chronic infection which can further lead to a" exact="cirrhosis" post="(in 20% of the cases) [156,157]. Several studies showed"/>
   <result pre="linked to hepatocellular damage. In intervention studies, selenium supplementation decreased" exact="cancer" post="incidence in HBV infected patients [162], but when the"/>
   <result pre="affects the skin and is caused by the dermatotropic poxvirus" exact="molluscum contagiosum" post="virus (MCV) [237,238]. Unlike smallpox and human monkeypox diseases,"/>
   <result pre="by the dermatotropic poxvirus molluscum contagiosum virus (MCV) [237,238]. Unlike" exact="smallpox" post="and human monkeypox diseases, MCV is nonlethal, mostly common"/>
   <result pre="poxvirus molluscum contagiosum virus (MCV) [237,238]. Unlike smallpox and human" exact="monkeypox" post="diseases, MCV is nonlethal, mostly common in children and"/>
   <result pre="from eukaryotic genomes in the viral genomes of fowlpox and" exact="molluscum contagiosum" post="viruses lead to the careful investigation for further examples"/>
   <result pre="the genomes of HIV-1, HIV-2, HCV, coxsackie virus B3 and" exact="measles" post="viruses [183]. Despite these in silico data that GPX-related"/>
   <result pre="the -1 reading frame of the NS4 region of Japanese" exact="encephalitis" post="virus (JEV). JEV belongs to the Flaviviridae family, which"/>
   <result pre="(JEV). JEV belongs to the Flaviviridae family, which also includes" exact="dengue fever" post="virus (DENV), yellow fever virus (YFV) and West Nile"/>
   <result pre="the Flaviviridae family, which also includes dengue fever virus (DENV)," exact="yellow fever" post="virus (YFV) and West Nile virus (WNV). The gene"/>
   <result pre="(ROS) homeostasis and redox regulation in cellular signalingCell. Signal.20122498199010.1016/j.cellsig.2012.01.00822286106 36.TrachoothamD.AlexandreJ.HuangP.Targeting" exact="cancer" post="cells by ROS-mediated mechanisms: A radical therapeutic approach?Nat. Rev."/>
   <result pre="FrancescoP.FavalliC.RotilioG.GaraciE.Evidence for antiviral activity of glutathione: In vitro inhibition of" exact="herpes simplex" post="virus type 1 replicationAntivir. Res.19952723725310.1016/0166-3542(95)00008-A8540746 64.FloresS.C.MareckiJ.C.HarperK.P.BoseS.K.NelsonS.K.McCordJ.M.Tat protein of human"/>
   <result pre="translational recoding of UGA as selenocysteineNucleic Acids Res.2009375868588010.1093/nar/gkp63519651878 73.LinH.C.HoS.C.ChenY.Y.KhooK.H.HsuP.H.YenH.C.SELENOPROTEINS. CRL2" exact="aids" post="elimination of truncated selenoproteins produced by failed UGA/Sec decodingScience2015349919510.1126/science.aab051526138980"/>
   <result pre="in transgenic miceJ. Nutr.19981281070107610.1093/jn/128.7.10709649587 90.MullerM.F.FlorianS.PommerS.OsterhoffM.EsworthyR.S.ChuF.F.Brigelius-FloheR.KippA.P.Deletion of glutathione peroxidase-2 inhibits azoxymethane-induced" exact="colon cancer" post="developmentPLoS ONE20138e7205510.1371/journal.pone.007205523977205 91.RheeS.G.Overview on PeroxiredoxinMol. Cells2016391510.14348/molcells.2016.236826831451 92.LuJ.HolmgrenA.The thioredoxin antioxidant"/>
   <result pre="transgenic miceJ. Nutr.19981281070107610.1093/jn/128.7.10709649587 90.MullerM.F.FlorianS.PommerS.OsterhoffM.EsworthyR.S.ChuF.F.Brigelius-FloheR.KippA.P.Deletion of glutathione peroxidase-2 inhibits azoxymethane-induced colon" exact="cancer" post="developmentPLoS ONE20138e7205510.1371/journal.pone.007205523977205 91.RheeS.G.Overview on PeroxiredoxinMol. Cells2016391510.14348/molcells.2016.236826831451 92.LuJ.HolmgrenA.The thioredoxin antioxidant"/>
   <result pre="Biol. Med.2003341263127010.1016/S0891-5849(03)00101-112726914 95.BeckM.A.NelsonH.K.ShiQ.Van DaelP.SchiffrinE.J.BlumS.BarclayD.LevanderO.A.Selenium deficiency increases the pathology of an" exact="influenza" post="virus infectionFASEB J.2001151481148310.1096/fj.00-0721fje11387264 96.BeckM.A.MatthewsC.C.Micronutrients and host resistance to viral"/>
   <result pre="of enteroviral genomic sequences in myocardium from cases of endemic" exact="cardiomyopathy" post="(Keshan disease) in ChinaHeart20008369670110.1136/heart.83.6.69610814633 106.LiuY.ChibaM.InabaY.KondoM.Keshan diseaseâ€&quot;A review from the"/>
   <result pre="in the pathogenesis of viral cardiomyopathyCongest Heart Fail20071319319910.1111/j.1527-5299.2007.06410.x17673870 113.PleschkaS.Overview of" exact="influenza" post="virusesCurr. Top. Microbiol. Immunol.201337012010.1007/82_2012_27223124938 114.LimJ.Y.OhE.KimY.JungW.W.KimH.S.LeeJ.SulD.Enhanced oxidative damage to DNA,"/>
   <result pre="enzymes, cytokines, and heat shock proteins in patients infected with" exact="influenza" post="H1N1 virusActa Virol.20145825326010.4149/av_2014_03_25325283860 115.NgM.P.LeeJ.C.LokeW.M.YeoL.L.QuekA.M.LimE.C.HalliwellB.SeetR.C.Does influenza A infection increase oxidative"/>
   <result pre="proteins in patients infected with influenza H1N1 virusActa Virol.20145825326010.4149/av_2014_03_25325283860 115.NgM.P.LeeJ.C.LokeW.M.YeoL.L.QuekA.M.LimE.C.HalliwellB.SeetR.C.Does" exact="influenza" post="A infection increase oxidative damage?Antioxid. Redox Signal.2014211025103110.1089/ars.2014.590724673169 116.ErkekogluP.AsciA.CeyhanM.KizilgunM.SchweizerU.AtasC.KaraA.Kocer GirayB.Selenium"/>
   <result pre="J. Pediatr.20135527128224217073 117.BuffintonG.D.ChristenS.PeterhansE.StockerR.Oxidative stress in lungs of mice infected with" exact="influenza" post="A virusFree Radic. Res. Commun.1992169911010.3109/107157692090491631321077 118.HennetT.PeterhansE.StockerR.Alterations in antioxidant defences"/>
   <result pre="antioxidant defences in lung and liver of mice infected with" exact="influenza" post="A virusJ. Gen. Virol.199273 Pt 1394610.1099/0022-1317-73-1-391530963 119.AmatoreD.SgarbantiR.AquilanoK.BaldelliS.LimongiD.CivitelliL.NencioniL.GaraciE.CirioloM.R.PalamaraA.T.Influenza virus replication"/>
   <result pre="120.YeS.LowtherS.StambasJ.Inhibition of reactive oxygen species production ameliorates inflammation induced by" exact="influenza" post="A viruses via upregulation of SOCS1 and SOCS3J. Virol.2015892672268310.1128/JVI.03529-1425520513"/>
   <result pre="121.NelsonH.K.ShiQ.Van DaelP.SchiffrinE.J.BlumS.BarclayD.LevanderO.A.BeckM.A.Host nutritional selenium status as a driving force for" exact="influenza" post="virus mutationsFASEB J.2001151846184810.1096/fj.01-0115fje11481250 122.JaspersI.ZhangW.BrightonL.E.CarsonJ.L.StybloM.BeckM.A.Selenium deficiency alters epithelial cell morphology"/>
   <result pre="Biol. Med.2007421826183710.1016/j.freeradbiomed.2007.03.01717512462 123.SheridanP.A.ZhongN.CarlsonB.A.PerellaC.M.HatfieldD.L.BeckM.A.Decreased selenoprotein expression alters the immune response during" exact="influenza" post="virus infection in miceJ. Nutr.20071371466147110.1093/jn/137.6.146617513408 124.StÃ½bloM.WaltonF.S.HarmonA.W.SheridanP.A.BeckM.A.Activation of superoxide dismutase"/>
   <result pre="Nutr.20071371466147110.1093/jn/137.6.146617513408 124.StÃ½bloM.WaltonF.S.HarmonA.W.SheridanP.A.BeckM.A.Activation of superoxide dismutase in selenium-deficient mice infected with" exact="influenza" post="virusJ. Trace Elem. Med. Biol.200721526210.1016/j.jtemb.2006.11.00117317526 125.LiW.BeckM.A.Selenium deficiency induced an"/>
   <result pre="deficiency induced an altered immune response and increased survival following" exact="influenza" post="A/Puerto Rico/8/34 infectionExp. Biol. Med.2007232412419 126.FergusonM.R.RojoD.R.von LindernJ.J.Oâ€™BrienW.A.HIV-1 replication cycleClin."/>
   <result pre="139.KamwesigaJ.MutabaziV.KayumbaJ.TayariJ.C.UwimbabaziJ.C.BatanageG.UweraG.BaziruwihaM.NtizimiraC.MurebwayireA.et al.Effect of selenium supplementation on CD4+ T-cell recovery, viral" exact="suppression" post="and morbidity of HIV-infected patients in Rwanda: A randomized"/>
   <result pre="selenium compounds increaseProc. Natl. Acad. Sci. USA19999683583910.1073/pnas.96.3.8359927654 143.DavisG.L.Treatment of chronic" exact="hepatitis" post="CBMJ20013231141114210.1136/bmj.323.7322.114111711386 144.IvanovA.V.BartoschB.SmirnovaO.A.IsaguliantsM.G.KochetkovS.N.HCV and oxidative stress in the liverViruses2013543946910.3390/v502043923358390 145.BoyaP.de"/>
   <result pre="metabolism in peripheral blood mononuclear cells from patients with chronic" exact="hepatitis" post="CJ. Hepatol.19993180881410.1016/S0168-8278(99)80281-510580577 146.De MariaN.ColantoniA.FagiuoliS.LiuG.J.RogersB.K.FarinatiF.Van ThielD.H.FloydR.A.Association between reactive oxygen species"/>
   <result pre="ThielD.H.FloydR.A.Association between reactive oxygen species and disease activity in chronic" exact="hepatitis" post="CFree Radic. Biol. Med.19962129129510.1016/0891-5849(96)00044-58855439 147.BianchiG.MarchesiniG.BriziM.RossiB.ForlaniG.BoniP.MelchiondaN.ThomasethK.PaciniG.Nutritional effects of oral zinc"/>
   <result pre="DNA repair enzyme NEIL1J. Gastroenterol. Hepatol.20102562763410.1111/j.1440-1746.2009.06128.x20074151 150.BureauC.BernadJ.ChaoucheN.OrfilaC.BeraudM.GonindardC.AlricL.VinelJ.P.PipyB.Nonstructural 3 protein of" exact="hepatitis" post="C virus triggers an oxidative burst in human monocytes"/>
   <result pre="via activation of NADPH oxidaseJ. Biol. Chem.2001276230772308310.1074/jbc.M10069820011304537 151.Garcia-MediavillaM.V.Sanchez-CamposS.Gonzalez-PerezP.Gomez-GonzaloM.MajanoP.L.Lopez-CabreraM.ClementeG.Garcia-MonzonC.Gonzalez-GallegoJ.Differential contribution of" exact="hepatitis" post="C virus NS5A and core proteins to the induction"/>
   <result pre="micronutrient, oxidative stress, and viral load in patients with chronic" exact="hepatitis" post="CWorld J. Gastroenterol.2005114697470210.3748/wjg.v11.i30.469716094713 153.LookM.P.RockstrohJ.K.RaoG.S.KreuzerK.A.BartonS.LemochH.SudhopT.HochJ.StockingerK.SpenglerU.et al.Serum selenium, plasma glutathione (GSH)"/>
   <result pre="Rep.201662248710.1038/srep2248726927933 155.GuerrieroE.AccardoM.CaponeF.ColonnaG.CastelloG.CostantiniS.Assessment of the Selenoprotein M (SELM) over-expression on human" exact="hepatocellular carcinoma" post="tissues by immunohistochemistryEur. J. Histochem.201458243310.4081/ejh.2014.243325578973 156.TsaiK.N.KuoC.F.OuJ.J.Mechanisms of Hepatitis B"/>
   <result pre="have an implication on interferon treatment of children with chronic" exact="hepatitis" post="B infectionBiol. Trace Elem. Res.201013515316110.1007/s12011-009-8507-619727570 159.AbediankenariS.GhasemiM.NasehiM.M.AbediS.HosseiniV.Determination of trace elements"/>
   <result pre="Elem. Res.201013515316110.1007/s12011-009-8507-619727570 159.AbediankenariS.GhasemiM.NasehiM.M.AbediS.HosseiniV.Determination of trace elements in patients with chronic" exact="hepatitis" post="BActa Med. Iran.20114966766922071642 160.KhanM.S.DilawarS.AliI.RaufN.The possible role of selenium concentration"/>
   <result pre="BActa Med. Iran.20114966766922071642 160.KhanM.S.DilawarS.AliI.RaufN.The possible role of selenium concentration in" exact="hepatitis" post="B and C patientsSaudi J. Gastroenterol. Off. J. Saudi"/>
   <result pre="J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc.20121810611010.4103/1319-3767.9381122421715 161.ChengZ.ZhiX.SunG.GuoW.HuangY.SunW.TianX.ZhaoF.HuK.Sodium selenite suppresses" exact="hepatitis" post="B virus transcription and replication in human hepatoma cell"/>
   <result pre="hepatoma cell linesJ. Med. Virol.20168865366310.1002/jmv.2436626331371 162.YuS.Y.ZhuY.J.LiW.G.Protective role of selenium against" exact="hepatitis" post="B virus and primary liver cancer in QidongBiol. Trace"/>
   <result pre="162.YuS.Y.ZhuY.J.LiW.G.Protective role of selenium against hepatitis B virus and primary" exact="liver cancer" post="in QidongBiol. Trace Elem. Res.19975611712410.1007/BF027789879152515 163.FinsterbuschT.MankertzA.Porcine circovirusesâ€&quot;Small but powerfulVirus"/>
   <result pre="role of selenium against hepatitis B virus and primary liver" exact="cancer" post="in QidongBiol. Trace Elem. Res.19975611712410.1007/BF027789879152515 163.FinsterbuschT.MankertzA.Porcine circovirusesâ€&quot;Small but powerfulVirus"/>
   <result pre="activating the AKT/mTOR signaling pathwayVet. Res.2018491510.1186/s13567-018-0508-z29439710 169.SumbaP.O.KabiruE.W.NamuyengaE.FioreN.OtienoR.O.MoormannA.M.OragoA.S.RosenbaumP.F.RochfordR.Microgeographic variations in Burkittâ€™s" exact="lymphoma" post="incidence correlate with differences in malnutrition, malaria and Epstein-Barr"/>
   <result pre="variations in Burkittâ€™s lymphoma incidence correlate with differences in malnutrition," exact="malaria" post="and Epstein-Barr virusBr. J. Cancer20101031736174110.1038/sj.bjc.660594721102592 170.JianS.-W.MeiC.-E.LiangY.-N.LiD.ChenQ.-L.LuoH.-L.LiY.-Q.CaiT.-Y.Influence of selenium-rich rice"/>
   <result pre="experimental viral myocarditisBiol. Trace Elem. Res.200180233110.1385/BTER:80:1:2311393307 180.SepÃºlvedaR.T.ZhangJ.WatsonR.R.Selenium supplementation decreases coxsackievirus" exact="heart disease" post="during murine AIDSCardiovasc. Toxicol.20022536110.1385/CT:2:1:5312189280 181.MolinY.FriskP.IlbÃ¤ckN.-G.Viral RNA kinetics is associated"/>
   <result pre="virus B3 infectionMicrobes Infect.20091149349910.1016/j.micinf.2009.02.00219233309 182.JunE.J.YeJ.S.HwangI.S.KimY.K.LeeH.Selenium deficiency contributes to the chronic" exact="myocarditis" post="in coxsackievirus-infected miceActa Virol.201155232910.4149/av_2011_01_2321434702 183.ZhangW.RamanathanC.S.NadimpalliR.G.BhatA.A.CoxA.G.TaylorE.W.Selenium-dependent glutathione peroxidase modules encoded"/>
   <result pre="Aires, ArgentinaPublic Health Nutr.20121553854510.1017/S136898001100136421740621 188.GroenbaekK.FriisH.HansenM.Ring-LarsenH.KrarupH.B.The effect of antioxidant supplementation on" exact="hepatitis" post="C viral load, transaminases and oxidative status: A randomized"/>
   <result pre="load, transaminases and oxidative status: A randomized trial among chronic" exact="hepatitis" post="C virus-infected patientsEur. J. Gastroenterol. Hepatol.20061898598910.1097/01.meg.0000231746.76136.4a16894312 189.ZhangW.CoxA.G.TaylorE.W.Hepatitis C virus"/>
   <result pre="191.ZhongH.TaylorE.W.Structure and dynamics of a predicted ferredoxin-like selenoprotein in Japanese" exact="encephalitis" post="virusJ. Mol. Graph. Model.20042322323110.1016/j.jmgm.2004.07.00215530818 192.FangL.-Q.GoeijenbierM.ZuoS.-Q.WangL.-P.LiangS.KleinS.L.LiX.-L.LiuK.LiangL.GongP.et al.The association between hantavirus"/>
   <result pre="of AH1N1 patients in Mexico CitySci. Rep.20133128410.1038/srep0128423422930 197.YuL.SunL.NanY.ZhuL.-Y.Protection from H1N1" exact="influenza" post="virus infections in mice by supplementation with selenium: A"/>
   <result pre="supplementation enhances antiviral immunity in chickens challenged with low pathogenic" exact="avian influenza" post="virus subtype H9N2Vet. Immunol. Immunopathol.2019207626810.1016/j.vetimm.2018.12.00230593352 199.DeryabinP.G.LvovD.K.BotikovA.G.IvanovV.KalinovskyT.NiedzwieckiA.RathM.Effects of a nutrient"/>
   <result pre="enhances antiviral immunity in chickens challenged with low pathogenic avian" exact="influenza" post="virus subtype H9N2Vet. Immunol. Immunopathol.2019207626810.1016/j.vetimm.2018.12.00230593352 199.DeryabinP.G.LvovD.K.BotikovA.G.IvanovV.KalinovskyT.NiedzwieckiA.RathM.Effects of a nutrient"/>
   <result pre="mixture on infectious properties of the highly pathogenic strain of" exact="avian influenza" post="virus A/H5N1BioFactors (Oxford)200833859710.1002/biof.5520330201 200.ReffettJ.K.SpearsJ.W.BrownT.T.Effect of dietary selenium and vitamin"/>
   <result pre="on infectious properties of the highly pathogenic strain of avian" exact="influenza" post="virus A/H5N1BioFactors (Oxford)200833859710.1002/biof.5520330201 200.ReffettJ.K.SpearsJ.W.BrownT.T.Effect of dietary selenium and vitamin"/>
   <result pre="viruses for which an oxidative stress has been reported are" exact="herpes simplex" post="virus type 1 (HSV-1), influenza viruses, vesicular stomatitis virus"/>
   <result pre="has been reported are herpes simplex virus type 1 (HSV-1)," exact="influenza" post="viruses, vesicular stomatitis virus (VSV), Epstein-Barr virus (EBV), human"/>
   <result pre="are herpes simplex virus type 1 (HSV-1), influenza viruses, vesicular" exact="stomatitis" post="virus (VSV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV),"/>
   <result pre="virus (HIV), human T cell leukaemia virus type 1 (HTLV-1)," exact="hepatitis" post="B virus (HBV), respiratory syncytial virus (RSV) and hepatitis"/>
   <result pre="(HTLV-1), hepatitis B virus (HBV), respiratory syncytial virus (RSV) and" exact="hepatitis" post="C virus (HCV) [34]. Figure 2 Enzymatic activities of"/>
   <result pre="as CVB3/0, and shown in blue) does not lead to" exact="myocarditis" post="in this animal model, although replicating in the mice"/>
   <result pre="the cardio-virulence of the virus, which can now induce severe" exact="myocarditis" post="even in selenium adequate mice. To investigate whether the"/>
   <result pre="[108]. These mice, infected with the benign strain CVB3/0, developed" exact="myocarditis" post="and nucleotide mutations of the viral genome isolated from"/>
   <result pre="selenium deficient mice. Figure 4 Evolution of the pathogenicity of" exact="influenza" post="virus as a function of dietary selenium intake in"/>
   <result pre="number of immune cells, the nucleotide mutations of the isolated" exact="influenza" post="viruses, the oxidation status of glutathione (reduced/oxidized), the GPX"/>
   <result pre="the observations made with coxsackie virus, the mutations of the" exact="influenza" post="viral genome increased the pathogenicity of the virus, which"/>
   <result pre="sequences of the selenoproteins present in the viral genomes of" exact="molluscum contagiosum" post="virus subtype 1 (MCV1) (A,B) and of fowlpox virus"/>
   <result pre="selenomethionineSelenite â†&quot; viral replication via thiol interaction [184] Live attenuated" exact="poliomyelitis" post="vaccine SS = Sodium seleniteâ†‘ GPX activity after infection"/>
   <result pre="effects but has no impacts on viral production [190] Japanese" exact="encephalitis" post="virus (JEV) [191] Bunyaviridae Hantaan virus (HTNV) or Seoul"/>
   <result pre="of TNFalpha and IFNgammaNo change in viral load [197] Avian" exact="influenza" post="(H9N2) SS sodium enriched yeast or sodium seleniteâ†&quot; viral"/>
   <result pre="2011 #4334} SS = selenized table salt or selenized yeastLower" exact="cancer" post="induced by HBV incidence [162] CT = HepG2 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6770471\results\search\disease\results.xml">
   <result pre="mainly affects children. However, PV infections can lead to paralytic" exact="poliomyelitis" post="which can result in death. Following the WHO 1988"/>
   <result pre="Following the WHO 1988 polio eradication program, the number of" exact="poliomyelitis" post="has been reduced by 99% worldwide but a small"/>
   <result pre="[25] and is one of the main etiological agents of" exact="hand, foot and mouth disease" post="(HFMD) [26]. Some cases of EV-A71 infections have been"/>
   <result pre="one of the main etiological agents of hand, foot and" exact="mouth disease" post="(HFMD) [26]. Some cases of EV-A71 infections have been"/>
   <result pre="EV-A71 infections have been associated with neurological complications such as" exact="aseptic meningitis," post="brainstem encephalitis and acute flaccid paralysis [27]. In China,"/>
   <result pre="been associated with neurological complications such as aseptic meningitis, brainstem" exact="encephalitis" post="and acute flaccid paralysis [27]. In China, enteroviruses such"/>
   <result pre="headache, pain in various parts of the body, prostration, rash," exact="lymphadenopathy" post="and leukopenia that affects young children and adults [36]."/>
   <result pre="in various parts of the body, prostration, rash, lymphadenopathy and" exact="leukopenia" post="that affects young children and adults [36]. However, dengue"/>
   <result pre="and adults [36]. However, dengue infection can progress to severe" exact="dengue hemorrhagic fever" post="(DHF) and dengue shock syndrome (DSS). Severe dengue affects"/>
   <result pre="illness with high fever, severe joint pain, polyarthralgia, myalgia, maculopapular" exact="rash" post="and edema. While the fever and rash are self-limiting"/>
   <result pre="polyarthralgia, myalgia, maculopapular rash and edema. While the fever and" exact="rash" post="are self-limiting and are able to resolve within a"/>
   <result pre="the first time in 2012 in Saudi Arabia. The viral" exact="respiratory disease" post="was caused by a novel coronavirus. The causative coronaviruses"/>
   <result pre="are similar to the common flu but in some patients," exact="pneumonia" post="and gastrointestinal symptoms including diarrhea and organ failure were"/>
   <result pre="flu but in some patients, pneumonia and gastrointestinal symptoms including" exact="diarrhea" post="and organ failure were reported [100]. Since September 2012"/>
   <result pre="divided amongst 14 genera [109]. Diseases associated with Paramyxoviridae included" exact="measles" post="(MeV), mumps and Newcastle disease (NDV). Paramyxoviridae virions are"/>
   <result pre="14 genera [109]. Diseases associated with Paramyxoviridae included measles (MeV)," exact="mumps" post="and Newcastle disease (NDV). Paramyxoviridae virions are enveloped and"/>
   <result pre="in the lymphoid tissue, liver, lungs, conjunctiva and skin. The" exact="measles" post="virus (MeV) may persist in the brain, causing fatal"/>
   <result pre="neurodegenerative diseases. This virus can only infect humans and causes" exact="subacute sclerosing panencephalitis" post="and encephalitis [112,113,114]. Measles often lead to fatality in"/>
   <result pre="can only infect humans and causes subacute sclerosing panencephalitis and" exact="encephalitis" post="[112,113,114]. Measles often lead to fatality in young children"/>
   <result pre="respiratory tract infections like pneumonia, brain swelling or encephalitis, dehydration," exact="diarrhea" post="and ear infections [115]. The MeV is a negative"/>
   <result pre="muscle aches, weakness, fatigue and loss of appetite. Complications of" exact="mumps" post="are rare but they can be potentially serious involving"/>
   <result pre="hearing loss, heart problems and miscarriage. In the United States," exact="mumps" post="was one of common disease prior to vaccination became"/>
   <result pre="dramatic decrease was observed in the number of infections. However," exact="mumps" post="outbreaks still occur in the United States and there"/>
   <result pre="at high risk. There is currently no specific treatment for" exact="mumps" post="[122]. The strain Urabe AM9 is one of the"/>
   <result pre="mumps [122]. The strain Urabe AM9 is one of the" exact="mumps" post="virus strains that was widely used in vaccines but"/>
   <result pre="widely used in vaccines but this strain was associated with" exact="meningitis" post="and was withdrawn from the market. Sauder et al."/>
   <result pre="identify the attenuation markers [123]. Passaging of the Urabe AM9" exact="mumps" post="virus in Vero or chicken embryo fibroblast (CEF) cell"/>
   <result pre="avian pathogen that can be transmitted to humans and cause" exact="conjunctivitis" post="and an influenza like disease [124]. Clinical diseases affecting"/>
   <result pre="can be transmitted to humans and cause conjunctivitis and an" exact="influenza" post="like disease [124]. Clinical diseases affecting the neurological, gastrointestinal,"/>
   <result pre="bovine respiratory syncytial virus (BRSV) is a common source of" exact="pneumonia" post="in calves. Clinical infections stem from yearly outbreaks of"/>
   <result pre="that can damage the bronchioles, leading to severe onset of" exact="bronchiolitis" post="in caws [135]. Palivizumab (PZ) is the sole humanized"/>
   <result pre="Palivizumab (PZ) is the sole humanized monoclonal antibody against an" exact="infectious disease" post="that recognizes the fusion protein of respiratory syncytial virus"/>
   <result pre="can be filamentous, 80â€&quot;120 nm in diameter (Figure 9A). The" exact="influenza" post="virus genome is 12â€&quot;15 kb and contains 8 segments"/>
   <result pre="(Figure 9B). Influenza viruses are pathogenic and they can cause" exact="influenza" post="in vertebrates, including birds, humans and other mammals [139]."/>
   <result pre="and the poly(A) tail is added by the viral polymerase" exact="stuttering" post="on the poly U sequence. Alternative splicing of the"/>
   <result pre="protein (M1 or M) [140]. Influenza Virus (IV) The annual" exact="influenza" post="epidemics caused about 3 to 5 million cases of"/>
   <result pre="severe illness with 290,000 to 680,000 deaths worldwide [141]. Current" exact="influenza" post="vaccines have sub-optimal efficacy, as there was a lack"/>
   <result pre="antigenic proximity between the vaccine candidate and the circulating seasonal" exact="influenza" post="virus strains. During the 2016â€&quot;2017 influenza epidemic, the influenza"/>
   <result pre="and the circulating seasonal influenza virus strains. During the 2016â€&quot;2017" exact="influenza" post="epidemic, the influenza A (H3N2) viruses from the clade"/>
   <result pre="seasonal influenza virus strains. During the 2016â€&quot;2017 influenza epidemic, the" exact="influenza" post="A (H3N2) viruses from the clade 3c.2a were dominant"/>
   <result pre="reassortment in order to understand the molecular evolution of the" exact="influenza" post="A (H3N2) isolated directly from clinical samples. Of the"/>
   <result pre="different clade 3c.3a. Many distinct substitutions spanning across the whole" exact="influenza" post="proteome, HA, NA and non-structural protein 1 were found"/>
   <result pre="The epidemiology and molecular characterization of low and highly pathogenic" exact="avian influenza" post="virus strains (LPAIV &amp;amp; HPAIV, respectively) isolated from Germany"/>
   <result pre="epidemiology and molecular characterization of low and highly pathogenic avian" exact="influenza" post="virus strains (LPAIV &amp;amp; HPAIV, respectively) isolated from Germany"/>
   <result pre="[144]. However, studies focusing on the diversity of quasispecies of" exact="avian influenza" post="in the human host are few. Watanabe et al."/>
   <result pre="However, studies focusing on the diversity of quasispecies of avian" exact="influenza" post="in the human host are few. Watanabe et al."/>
   <result pre="against mutants with lower thermostability [145]. The quasispecies population of" exact="influenza" post="A virus was also reported to be in a"/>
   <result pre="into 8 genotypes. More than one billion people have contracted" exact="hepatitis" post="B virus (HBV) and more than 200 million patients"/>
   <result pre="and more than 200 million patients are chronically infected with" exact="hepatitis" post="B (CHB) [153]. CHB infections result in the development"/>
   <result pre="B (CHB) [153]. CHB infections result in the development of" exact="hepatocellular carcinoma" post="and chronic liver failure [151] and every year CHB"/>
   <result pre="Implications for pathogenesisProc. Natl. Acad. Sci. USA1998953152315610.1073/pnas.95.6.31529501231 18.DonohueR.C.PfallerC.K.CattaneoR.Cyclical adaptation of" exact="measles" post="virus quasispecies to epithelial and lymphocytic cells: To V"/>
   <result pre="disease of the central nervous systemJ. Infect. Dis.197412930430910.1093/infdis/129.3.3044361245 26.IshimaruY.NakanoS.YamaokaK.TakamiS.Outbreaks of" exact="hand, foot and mouth disease" post="by enterovirus 71. High incidence of complication disorders of"/>
   <result pre="central nervous systemJ. Infect. Dis.197412930430910.1093/infdis/129.3.3044361245 26.IshimaruY.NakanoS.YamaokaK.TakamiS.Outbreaks of hand, foot and" exact="mouth disease" post="by enterovirus 71. High incidence of complication disorders of"/>
   <result pre="and neurologic diseaseâ€&quot;United States, 1977â€&quot;1991J. Infect. Dis.199416990590810.1093/infdis/169.4.9058133108 28.XingW.LiaoQ.ViboudC.ZhangJ.SunJ.WuJ.T.ChangZ.LiuF.FangV.J.ZhengY.Hand, foot and" exact="mouth disease" post="in China, 2008â€&quot;12: An epidemiological studyLancet Infect. Dis.20141430831810.1016/S1473-3099(13)70342-624485991 29.MandaryM.PohC.Changes"/>
   <result pre="58.ThiboutotM.M.KannanS.KawalekarO.U.ShedlockD.J.KhanA.S.SaranganG.SrikanthP.WeinerD.B.MuthumaniK.Chikungunya: A potentially emerging epidemic?PLoS Negl. Trop. Dis.20104e62310.1371/journal.pntd.000062320436958 59.LemantJ.BoissonV.WinerA.ThibaultL.AndrÃ©H.TixierF.LemercierM.AntokE.CrestaM.P.GrivardP.Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the Reunion Island"/>
   <result pre="112.BiesbroeckL.SidburyR.Viral exanthems: an updateDermatol. Ther.20132643343810.1111/dth.1210724552405 113.LudlowM.McQuaidS.MilnerD.de SwartR.L.DuprexW.P.Pathological consequences of systemic" exact="measles" post="virus infectionJ. Pathol.201523525326510.1002/path.445725294240 114.WatanabeS.ShiroganeY.SatoY.HashiguchiT.YanagiY.New Insights into Measles Virus Brain"/>
   <result pre="into Measles Virus Brain InfectionsTrends Microbiol.20192716417510.1016/j.tim.2018.08.01030220445 115.HuimingY.ChaominW.MengM.Vitamin A for treating" exact="measles" post="in childrenCochrane Database Syst. Rev.20054CD001479 116.PfallerC.K.CattaneoR.SchnellM.J.Reverse genetics of Mononegavirales:"/>
   <result pre="genetics of Mononegavirales: How they work, new vaccines and new" exact="cancer" post="therapeuticsVirology2015479â€&quot;48033134410.1016/j.virol.2015.01.029 117.PalosaariH.ParisienJ.-P.RodriguezJ.J.UlaneC.M.HorvathC.M.STAT protein interference and suppression of cytokine signal"/>
   <result pre="new vaccines and new cancer therapeuticsVirology2015479â€&quot;48033134410.1016/j.virol.2015.01.029 117.PalosaariH.ParisienJ.-P.RodriguezJ.J.UlaneC.M.HorvathC.M.STAT protein interference and" exact="suppression" post="of cytokine signal transduction by measles virus V proteinJ."/>
   <result pre="117.PalosaariH.ParisienJ.-P.RodriguezJ.J.UlaneC.M.HorvathC.M.STAT protein interference and suppression of cytokine signal transduction by" exact="measles" post="virus V proteinJ. Virol.2003777635764410.1128/JVI.77.13.7635-7644.200312805463 118.DevauxP.HodgeG.McChesneyM.B.CattaneoR.Attenuation of V- or C-defective"/>
   <result pre="measles virus V proteinJ. Virol.2003777635764410.1128/JVI.77.13.7635-7644.200312805463 118.DevauxP.HodgeG.McChesneyM.B.CattaneoR.Attenuation of V- or C-defective" exact="measles" post="viruses: Infection control by the inflammatory and interferon responses"/>
   <result pre="and V proteinsJ. Virol.2008828296830610.1128/JVI.00108-0818562542 120.RamachandranA.ParisienJ.-P.HorvathC.M.STAT2 is a primary target for" exact="measles" post="virus V protein-mediated alpha/beta interferon signaling inhibitionJ. Virol.2008828330833810.1128/JVI.00831-0818579593 121.CattaneoR.SchmidA.EschleD.BaczkoK.ter"/>
   <result pre="Virol.2008828330833810.1128/JVI.00831-0818579593 121.CattaneoR.SchmidA.EschleD.BaczkoK.ter MeulenV.BilleterM.A.Biased hypermutation and other genetic changes in defective" exact="measles" post="viruses in human brain infectionsCell19885525526510.1016/0092-8674(88)90048-73167982 122.PaddockM.What to Know About"/>
   <result pre="MumpsUniversity of Illinois-Chicago, School of MedicineChicago, IL, USA2017 123.SauderC.J.VandenburghK.M.IskowR.C.MalikT.CarboneK.M.RubinS.A.Changes in" exact="mumps" post="virus neurovirulence phenotype associated with quasispecies heterogeneityVirology2006350485710.1016/j.virol.2006.01.03516494912 124.GanarK.DasM.SinhaS.KumarS.Newcastle disease"/>
   <result pre="airway cellsJ. Virol.201892e02004-1710.1128/JVI.02004-1729563293 146.BarbezangeC.JonesL.BlancH.IsakovO.CelnikerG.EnoufV.ShomronN.VignuzziM.van der WerfS.Seasonal genetic drift of human" exact="influenza" post="A virus quasispecies revealed by deep sequencingFront. Microbiol.20189259610.3389/fmicb.2018.0259630429836 147.ManchandaH.SeidelN.BlaessM.F.ClausR.A.LindeJ.SlevogtH.SauerbreiA.GuthkeR.SchmidtkeM.Differential"/>
   <result pre="modulate host responses. Figure 9 (A) The schematic illustration of" exact="influenza" post="A virion with the two major glycoproteins displayed on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6771106\results\search\disease\results.xml">
   <result pre="further understanding of intraocular viral persistence and the pathogenesis of" exact="uveitis" post="in EVD survivors. Keywords Ebola Filovirus microRNA Retina Retinal"/>
   <result pre="indicate involvement of the retinal pigment epithelium are associated with" exact="uveitis" post="[3]. Zaire ebolavirus may persist at immune-privileged sites, such"/>
   <result pre="number of interactions for each molecule Discussion Zaire ebolavirus causes" exact="uveitis" post="in EVD survivors [26, 27]. We have identified miRNAs"/>
   <result pre="One other interacting miRNAâ€&quot;miR-101â€&quot;prevents cell death in the context of" exact="herpes simplex" post="virus type 1 infection [30], pointing to a common"/>
   <result pre="cell populations, through the action of viral proteinsâ€&quot;VP24 and VP35â€&quot;and" exact="suppression" post="of RIG-I signaling [32]. Our prior work has demonstrated"/>
   <result pre="infected with cytomegalovirus [33]. MicroRNA-29b is also activated in Japanese" exact="encephalitis" post="virus infection, particularly in persons with neurological sequelae, and"/>
   <result pre="in the ocular fluid of EBOV survivors, particularly those with" exact="uveitis" post="and present biomarkers for ocular involvement. Other investigators have"/>
   <result pre="[45]. Molecular mimicry of miR-155 is also seen in Kaposi" exact="sarcoma" post="herpesvirus infection of B-cells, enabling the virus to drive"/>
   <result pre="their involvement in the intraocular persistence of EBOV and EBOV-associated" exact="uveitis" post="in EVD survivors. Limitations We studied EBOV infection in"/>
   <result pre="tissues and fluids (EVICT) study: reverse transcription-polymerase chain reaction and" exact="cataract" post="surgery outcomes of Ebola survivors in Sierra LeoneEBioMedicine20183021722410.1016/j.ebiom.2018.03.02029622497 27.ForresterJVEbola"/>
   <result pre="Immunol200116741900190810.4049/jimmunol.167.4.190011489969 34.BaluniMGhildiyalSSinghDReddyDHKumarRDholeTNIncreased serum microRNA-29b expression and bad recovery in Japanese" exact="encephalitis" post="virus infected patients; a new component to improve the"/>
   <result pre="Eye Res20092828711610.1016/j.preteyeres.2008.11.00319071227 49.McArdleAJTurkovaACunningtonAJWhen do co-infections matter?Curr Opin Infect Dis201831320921510.1097/QCO.000000000000044729698255 50.GuptaASwaminathanGMartin-GarciaJNavas-MartinSMicroRNAs," exact="hepatitis" post="C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6771534\results\search\disease\results.xml">
   <result pre="and Sons Inc.Hoboken doi: 10.1002/rmv.2054RMV2054RMV-2019-004.R2 : Review: Reviews Characteristics of" exact="herpes simplex" post="virus infection and pathogenesis suggest a strategy for vaccine"/>
   <result pre="(HSV) can cause oral or genital ulcerative lesions and even" exact="encephalitis" post="in various age groups with high infection rates. More"/>
   <result pre="Medicine2016â€�I2Mâ€�1â€�019 fig-count: table-count: page-count: word-count: XuX, ZhangY, LiQ. Characteristics of" exact="herpes simplex" post="virus infection and pathogenesis suggest a strategy for vaccine"/>
   <result pre="2 HCFâ€�1 host cell factor 1 HS heparin sulfate HSV" exact="herpes simplex" post="virus HVEM herpes virus entry mediator ICAMâ€�1 intercellular adhesion"/>
   <result pre="ocular herpes can lead to blindness, and neonatal herpes or" exact="encephalitis" post="can result in higher death rates.2, 3, 4 In"/>
   <result pre="infection are reported annually.8 It is not surprising that a" exact="viral disease" post="with such severe clinical outcomes and such a strong"/>
   <result pre="for HSV vaccine development. Table 1 Development and status of" exact="herpes simplex" post="virus (HSV) vaccine candidates Candidate Type Name Description Preclinical"/>
   <result pre="for the stimulation of adaptive immunity. Figure 1 Interactions of" exact="herpes simplex" post="virus (HSV) surface glycoproteins and tegument proteins with cellular"/>
   <result pre="could be generated with molecular techniques. Figure 3 Tactics for" exact="herpes simplex" post="virus (HSV) vaccine development. The design of HSV vaccine"/>
   <result pre="Med. 2016;375(7):666â€�674.27532832 5McQuillanG, Kruszonâ€�MoranD, ElaineW, FlaggEW, Ryne Pauloseâ€�RamR. Prevalence of" exact="herpes simplex" post="virus type 1 and type 2 in persons aged"/>
   <result pre="NCHS Data Brief. 2018;304:1â€�8. 6BradleyH, MarkowitzLE, GibsonT, McQuillanGM. Seroprevalence of" exact="herpes simplex" post="virus types 1 and 2â€&quot;United States, 1999â€�2010. J Infect"/>
   <result pre="et al. Global and regional estimates of prevalent and incident" exact="herpes simplex" post="virus type 1 infections in 2012. PLoS ONE. 2015;10(10):e0140765.26510007"/>
   <result pre="WaldA. Status of vaccine research and development of vaccines for" exact="herpes simplex" post="virus. Vaccine. 2016;34(26):2948â€�2952.26973067 10AwasthiS, FriedmanHM. Status of prophylactic and"/>
   <result pre="BernsteinDI, et al. Efficacy results of a trial of a" exact="herpes simplex" post="vaccine. N Engl J Med. 2012;366(1):34â€�43.22216840 13SicurellaM, NicoliF, GalleraniE,"/>
   <result pre="J Med. 2012;366(1):34â€�43.22216840 13SicurellaM, NicoliF, GalleraniE, et al. An attenuated" exact="herpes simplex" post="virus type 1 (HSV1) encoding the HIVâ€�1 Tat protein"/>
   <result pre="JackmanWT, et al. Evaluation of AD472, a live attenuated recombinant" exact="herpes simplex" post="virus type 2 vaccine in guinea pigs. Vaccine. 2005;23(46â€�47):5424â€�5431.15950327"/>
   <result pre="19SrivastavaR, KhanAA, SpencerD, et al. HLAâ€�A02:01â€�restricted epitopes identified from the" exact="herpes simplex" post="virus tegument protein VP11/12 preferentially recall polyfunctional effector memory"/>
   <result pre="PLoS ONE. 2015;10(4):e0121518.25837802 21BrehmM, SamaniegoLA, BonneauRH, DeLucaNA, TevethiaSS. Immunogenicity of" exact="herpes simplex" post="virus type 1 mutants containing deletions in one or"/>
   <result pre="activity improves the immunogenicity and protective capacity of a replicationâ€�incompetent" exact="herpes simplex" post="virus type 1 vaccine strain. J Virol. 2000;74:11137â€�11144.11070010 23HuK,"/>
   <result pre="containing DNA vaccine pRSCâ€�gDâ€�ILâ€�21 confers protection against mucosal challenge with" exact="herpes simplex" post="virus type 1 in mice. Vaccine. 2011;29(7):1455â€�1462.21185849 24DuttonJL, LiB,"/>
   <result pre="A novel DNA vaccine technology conveying protection against a lethal" exact="herpes simplex" post="viral challenge in mice. PLoS ONE. 2013;8(10):e76407.24098493 25VeselenakRL, ShlapoberskyM,"/>
   <result pre="by HSVâ€�1, an update. Virol J. 2016;13(1):38.26952111 29WeirJP. Regulation of" exact="herpes simplex" post="virus gene expression. Gene. 2011;271:117â€�130. 30MillerCSDR, JacobRJ. Molecular aspects"/>
   <result pre="virus gene expression. Gene. 2011;271:117â€�130. 30MillerCSDR, JacobRJ. Molecular aspects of" exact="herpes simplex" post="virus I latency, reactivation, and recurrence. Crit Rev Oral"/>
   <result pre="Oral Biol Med. 1998;9(4):541â€�562.9825226 31Alâ€�DujailiLJ, ClerkinPP, ClementC, et al. Ocular" exact="herpes simplex" post="virus: how are latency, reactivation, recurrent disease and therapy"/>
   <result pre="36MelchjorsenJ, SirenJ, JulkunenI, PaludanSR, MatikainenS. Induction of cytokine expression by" exact="herpes simplex" post="virus in human monocyteâ€�derived macrophages and dendritic cells is"/>
   <result pre="2006;87(5):1099â€�1108.16603509 37ChewT, TaylorKE, MossmanKL. Innate and adaptive immune responses to" exact="herpes simplex" post="virus. Viruses. 2009;1(3):979â€�1002.21994578 38LucindaN, FigueiredoMM, PessoaNL, et al. Dendritic"/>
   <result pre="2009;5(5):e1000392.19478997 41DolanA, JamiesonFE, CunninghamC, BarnettBC, McGeochDJ. The genome sequence of" exact="herpes simplex" post="virus type 2. J Virol. 1998;72:2010â€�2021.9499055 42WellerSK, CoenDM. Herpes"/>
   <result pre="J Virol. 2015;89(16):8206â€�8218.26018161 44LoretS, GuayG, LippeR. Comprehensive characterization of extracellular" exact="herpes simplex" post="virus type 1 virions. J Virol. 2008;82(17):8605â€�8618.18596102 45AkhtarJ, ShuklaD."/>
   <result pre="45AkhtarJ, ShuklaD. Viral entry mechanisms: cellular and viral mediators of" exact="herpes simplex" post="virus entry. FEBS J. 2009;276(24):7228â€�7236.19878306 46ChiangHS, LiuHM. The molecular"/>
   <result pre="Front Immunol. 2019;9:3086.30671058 47Kurtâ€�JonesEA, OrzalliMH, KnipeDM. Innate immune mechanisms and" exact="herpes simplex" post="virus infection and disease. Adv Anat Embryol Cell Biol."/>
   <result pre="Microbiol. 2004;6(5):401â€�410.15056211 51SatohT, AriiJ, SuenagaT, et al. PILRalpha is a" exact="herpes simplex" post="virusâ€�1 entry coreceptor that associates with glycoprotein B. Cell."/>
   <result pre="ArgnaniR, AndersonDB, ZucchiniS, ManservigiR, GloriosoJC. Heparan sulfate proteoglycan binding by" exact="herpes simplex" post="virus type 1 glycoproteins B and C, which differ"/>
   <result pre="(gC), H (gH) and L (gL) are associated with enhanced" exact="herpes simplex" post="virus typeâ€�1 (McKrae) entry via the paired immunoglobulinâ€�like typeâ€�2"/>
   <result pre="et al. Soluble V domain of nectinâ€�1/HveC enables entry of" exact="herpes simplex" post="virus type 1 (HSVâ€�1) into HSVâ€�resistant cells by binding"/>
   <result pre="et al. A novel role for 3â€�Oâ€�sulfated heparan sulfate in" exact="herpes simplex" post="virus 1 entry. Cell. 1999;99(1):13â€�22.10520990 56HeldweinEE. gH/gL supercomplexes at"/>
   <result pre="tuned fusion machine. Viruses. 2015;7(12):6552â€�6569.26690469 58RogalinHB, HeldweinEE. Interplay between the" exact="herpes simplex" post="virus 1 gB cytodomain and the gH cytotail during"/>
   <result pre="Virol. 2015;89(24):12262â€�12272.26401042 59AltgÃ¤rdeN, ErikssonC, PeerboomN, et al. Mucinâ€�like region of" exact="herpes simplex" post="virus type 1 attachment protein glycoprotein C (gC) modulates"/>
   <result pre="Sci U S A. 2015;112(29):E3901â€�E3910.26157134 61KalamvokiM, DeschampsT. Extracellular vesicles during" exact="herpes simplex" post="virus type 1 infection: an inquire. Virol J. 2016;13(1):63.27048572"/>
   <result pre="HVEM expressions in circulating CD4(+) and CD8(+) T cells in" exact="hepatocellular carcinoma" post="patients. J Immunol Res. 2018;2018: 4561571. 10.1155/2018/4561571 65DesaiP, AbboudG,"/>
   <result pre="mucosal immunity. J Immunol. 2017;199(8):2968â€�2975.28864473 66DaiX, ZhouZH. Structure of the" exact="herpes simplex" post="virus 1 capsid with associated tegument protein complexes. Science."/>
   <result pre="of herpesviruses. Virus Res. 2015;210:308â€�317.26365681 68SpearPG, RoizmanB. Proteins specified by" exact="herpes simplex" post="virus. V. Purification and structural proteins of the herpes"/>
   <result pre="J Virol. 1972;9(1):143â€�159.4110104 69HeineJW, HonessRW, CassaiE, RoizmanB. Proteins specified by" exact="herpes simplex" post="virus. XII. The virion polypeptides of type 1 strains."/>
   <result pre="of the capsid vertexâ€�specific component at the capsidâ€�tegument interface of" exact="herpes simplex" post="virus 1. J Virol. 2015;89(3):1502â€�1511.25410861 75CardoneG, NewcombWW, ChengN, et"/>
   <result pre="75CardoneG, NewcombWW, ChengN, et al. The UL36 tegument protein of" exact="herpes simplex" post="virus 1 has a composite binding site at the"/>
   <result pre="Virol. 2012;86(8):4058â€�4064.22345483 76WangS, MottKR, WawrowskyK, KousoulasKG, LuscherB, GhiasiH. Binding of" exact="herpes simplex" post="virus 1 UL20 to GODZ (DHHC3) affects its palmitoylation"/>
   <result pre="DouglasMW, CunninghamAL, DiefenbachRJ. Determination of interactions between tegument proteins of" exact="herpes simplex" post="virus type 1. J Virol. 2005;79(15):9566â€�9571.16014918 79MbongEF, WoodleyL, DunkerleyE,"/>
   <result pre="2005;79(15):9566â€�9571.16014918 79MbongEF, WoodleyL, DunkerleyE, SchrimpfJE, MorrisonLA, DuffyC. Deletion of the" exact="herpes simplex" post="virus 1 UL49 gene results in mRNA and protein"/>
   <result pre="J Virol. 2012;86(22):12351â€�12361.22951838 80MossmanK, SherburneR, LaveryC, DuncanJ, SmileyJR. Evidence that" exact="herpes simplex" post="virus VP16 is required for viral egress downstream of"/>
   <result pre="81SvobodovaS, BellS, CrumpCM. Analysis of the interaction between the essential" exact="herpes simplex" post="virus 1 tegument proteins VP16 and VP1/2. J Virol."/>
   <result pre="Cell Biol. 1997;17(12):7108â€�71018.9372942 85DauberB, PoonD, dos SantosT, et al. The" exact="herpes simplex" post="virus virion host shutoff protein enhances translation of viral"/>
   <result pre="its mRNA. Virol J. 2015;12(1):203.26625984 87RollerRJ, HaugoAC, YangK, BainesJD. The" exact="herpes simplex" post="virus 1 UL51 gene product has cell typeâ€�specific functions"/>
   <result pre="al. Dual function of the pUL7â€�pUL51 tegument protein complex in" exact="herpes simplex" post="virus 1 infection. J Virol. 2017;91(2):e02196â€�e02116.27852850 89RollerRJ, FettersR. The"/>
   <result pre="simplex virus 1 infection. J Virol. 2017;91(2):e02196â€�e02116.27852850 89RollerRJ, FettersR. The" exact="herpes simplex" post="virus 1 UL51 protein interacts with the UL7 protein"/>
   <result pre="al. The mutated tegument protein UL7 attenuates the virulence of" exact="herpes simplex" post="virus 1 by reducing the modulation of alphaâ€�4 gene"/>
   <result pre="GuoY, FanS, et al. Attenuated phenotypes and analysis of a" exact="herpes simplex" post="virus 1 strain with partial deletion of the UL7,"/>
   <result pre="genes. Virol Sin. 2017;32(5):404â€�414.28971351 92StrunkU, SaffranHA, WuFW, SmileyJR. Role of" exact="herpes simplex" post="virus VP11/12 tyrosineâ€�based motifs in binding and activation of"/>
   <result pre="2013;87(20):11276â€�11286.23946459 93ChadhaP, SarfoA, ZhangD, et al. Domain interaction studies of" exact="herpes simplex" post="virus 1 tegument protein UL16 reveal its interaction with"/>
   <result pre="IbanezFJ, Retamalâ€�DiazAR, et al. Evasion of early antiviral responses by" exact="herpes simplex" post="viruses. Mediators Inflamm. 2015;2015:593757.25918478 98KoyanagiN, ImaiT, ShindoK, et al."/>
   <result pre="2017;127(10):3784â€�3795.28891812 99YangY, WuS, WangY, et al. The Us3 protein of" exact="herpes simplex" post="virus 1 inhibits T cell signaling by confining linker"/>
   <result pre="interferon (IFNâ€�Î±Â Î²) signaling in astrocytes mediates protection against viral" exact="encephalomyelitis" post="and regulates IFNâ€�Î³â€�dependent responses. J Virol. 2018;92:e01901â€�e01917.29491163 101ChengL, YuH,"/>
   <result pre="102RasmussenSB, SorensenLN, MalmgaardL, et al. Type I interferon production during" exact="herpes simplex" post="virus infection is controlled by cellâ€�typeâ€�specific viral recognition through"/>
   <result pre="RIGâ€�I and MDAâ€�5. J Virol. 2012;86(7):3528â€�3540.22301138 105MaY, HeB. Recognition of" exact="herpes simplex" post="viruses: tollâ€�like receptors and beyond. J Mol Biol. 2014;426(6):1133â€�1147.24262390"/>
   <result pre="the antiviral effector tetherin. Mucosal Immunol. 2016;9(4):1065â€�1075.26627457 107FatahzadehM, SchwartzRA. Human" exact="herpes simplex" post="virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J"/>
   <result pre="The immediateâ€�early protein, ICP0, is essential for the resistance of" exact="herpes simplex" post="virus to interferonâ€�alpha/beta. Virology. 2002;293(2):295â€�304.11886249 109ZhangJ, WangK, WangS, ZhengC."/>
   <result pre="CBP. J Virol. 2013;87(17):9788â€�9801.23824799 116ManivanhR, MehrbachJ, KnipeDM, LeibDA. Role of" exact="herpes simplex" post="virus 1 Î³34.5 in the regulation of IRF3 signaling."/>
   <result pre="beta play a critical role in the resistance against lethal" exact="herpes simplex" post="virus encephalitis. J Infect Dis. 2007;196(6):853â€�860.17703415 120SchmitzJ, OwyangA, OldhamE,"/>
   <result pre="the rules of programmed cell death to improve therapy of" exact="cancer" post="and other diseases. EMBO J. 2011;30(18):3667â€�3683.21863020 124MartineA, JenniferO, JohnAB."/>
   <result pre="Induction and prevention of apoptosis in human HEpâ€�2 cells by" exact="herpes simplex" post="virus type 1. J Virol. 1999;73(12):10359â€�10370.10559354 125JiangX, WangX. Cytochrome"/>
   <result pre="Harb Perspect Biol. 2013;5:a008722.23378584 129YuX, HeS. The interplay between human" exact="herpes simplex" post="virus infection and the apoptosis and necroptosis cell death"/>
   <result pre="Virol J. 2016;13(1):77.27154074 130MediciMA, SciortinoMT, PerriD, et al. Protection by" exact="herpes simplex" post="virus glycoprotein D against Fasâ€�mediated apoptosis. J Biol Chem."/>
   <result pre="XIAP and Bax involved in apoptosis in cells infected with" exact="herpes simplex" post="virus 1 and effect of pavine alkaloid (â€�)â€�thalimonine on"/>
   <result pre="virus 1 and effect of pavine alkaloid (â€�)â€�thalimonine on virusâ€�induced" exact="suppression" post="of apoptosis. Acta Virol. 2004;48:193â€�196.15595215 133MoriI, GoshimaF, WatanabeD, et"/>
   <result pre="136MoriaI, GoshimaF, KoshizukaT, et al. The US3 protein kinase of" exact="herpes simplex" post="virus attenuates the activation of the câ€�Jun Nâ€�terminal protein"/>
   <result pre="apoptosis in HeLa cells. J Virol. 2009;83(4):1767â€�1777.19073744 140AubertM, BlahoJA. The" exact="herpes simplex" post="virus type 1 regulatory protein ICP27 is required for"/>
   <result pre="TurzaNM, KobeltDJ, et al. Infection of mature dendritic cells with" exact="herpes simplex" post="virus type 1 dramatically reduces lymphoid chemokineâ€�mediated migration. J"/>
   <result pre="BosnjakL, CunninghamAL. Immature monocyteâ€�derived dendritic cells are productively infected with" exact="herpes simplex" post="virus type 1. J Virol. 2001;75(13):5958â€�5964.11390597 145WuB, GengS, BiY,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6773679\results\search\disease\results.xml">
   <result pre="syncytial virus infection, ranging from mild respiratory illnesses to severe" exact="bronchiolitis" post="and pneumonia4,7. Children under five years, aged adults, and"/>
   <result pre="cough (69, 90.8%), sore throat (38, 50.0%), expectoration (16, 90.8%)," exact="shortness" post="of breath (10, 13.2%) and nasal discharge (6, 7.9%)."/>
   <result pre="epidemic control and potential vaccine design. Viruses like H3N2 seasonal" exact="influenza" post="virus are highly transmissible, and a new adaptive variant"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2PLoS Pathog.201410e100393210.1371/journal.ppat.100393224586153 36.RegevLet al.Characterization of Human Metapneumovirus Infections in"/>
   <result pre="Influenza A (H3N2) VirusesScience200832034034610.1126/science.115413718420927 39.BedfordTet al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 40.RambautAet al.The genomic and"/>
   <result pre="antigenic driftNature201552321722010.1038/nature1446026053121 40.RambautAet al.The genomic and epidemiological dynamics of human" exact="influenza" post="A virusNature200845361561910.1038/nature0694518418375 41.ThaoNTTet al.Evolution and Spatiotemporal Dynamics of Enterovirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7331570\results\search\disease\results.xml">
   <result pre="infection of secondary infectious classes. One example of this is" exact="dengue hemorrhagic fever" post="and dengue shock syndrome, which comprises the following four"/>
   <result pre="as influenza, smallpox, SARS (severe acute respiratory syndrome), pneumonia, and" exact="dengue fever," post="among others. Precisely, if we are concerned more to"/>
   <result pre="second serotype. This is particularly risky for people suffering from" exact="dengue fever" post="and its related conditions, because infections in this case"/>
   <result pre="the secondary infected is more likely to be associated with" exact="dengue hemorrhagic fever." post="(For interpretation of the references to color in this"/>
   <result pre="to the web version of this article.) Among multi-serotypes epidemics," exact="dengue fever," post="one of the most devastating mosquito-borne viral infections to"/>
   <result pre="several promising vaccines, one vaccine is currently commercially available for" exact="dengue fever" post="(WHO, 2018, Thisyakorn, 2014). The worldâ€™s first dengue vaccine"/>
   <result pre="as effective. Regarding current vaccination and serotype processes linked to" exact="dengue fever," post="the sequence of infection to which an individual is"/>
   <result pre="whether first and/or second infections occur. In the case of" exact="dengue fever," post="the most efficient protective measure is vaccination. In this"/>
   <result pre="secondary vaccine efficiency Î· s . In the case of" exact="dengue fever," post="a portion of secondary infected individuals will be exposed"/>
   <result pre="will be able to minimize death casualties by, among others," exact="dengue fever." post="Contrastingly, if a highly efficient secondary vaccination is less"/>
   <result pre="in 11 countries. Reuters. 2017. Susie, E., 2016. World's first" exact="dengue fever" post="vaccine launched in the Philippines, CNN Zachri, E., Planasari,"/>
   <result pre="multi-agent simulations and mean-field modelingJ. Theor. Biol.469201910712630807759 FukudaE.KokuboS.TanimotoJ.WangZ.HagishimaA.IkegayaN.Risk assessment for" exact="infectious disease" post="and its impact on voluntary vaccination behavior in social"/>
   <result pre="treatment, PRE 100, 062402. KabirK.M.A.TanimotoJ.Dynamical behaviors for vaccination can suppress" exact="infectious disease" post="â€&quot; a game theoretical approachCha. Sol. Frac.1232019229239 Bauch, C.T.,"/>
   <result pre="K.M.A., Tanimoto, J., 2019. Interplay between cost and effectiveness in" exact="influenza" post="vaccine uptake: a vaccination game approach. Proc. R. Soc."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7331681\results\search\disease\results.xml">
   <result pre="J. Med.20053521749175910.1056/NEJMoa04395115858184 3.NokesDJet al.Incidence and severity of respiratory syncytial virus" exact="pneumonia" post="in rural Kenyan children identified through hospital surveillanceClin. Infect."/>
   <result pre="surveillanceClin. Infect. Dis.2009491341134910.1086/60605519788358 4.ThongpanIet al.Respiratory syncytial virus, human metapneumovirus, and" exact="influenza" post="virus infection in Bangkok, 2016â€&quot;2017PeerJ.20197e674810.7717/peerj.674830997293 5.YusufSet al.The relationship of"/>
   <result pre="Infect.20071351077109010.1017/S095026880600776X17346359 6.Chadha, M. et al. Human respiratory syncytial virus and" exact="influenza" post="seasonality patterns-Early findings from the WHO global respiratory syncytial"/>
   <result pre="of viral and bacterial infections among children hospitalized with community-acquired" exact="pneumonia" post="in a tropical regionScand J. Infect. Dis.20104283984410.3109/00365548.2010.49802020608763 10.AlonsoWJet al.Comparative"/>
   <result pre="J. Exp. Pathol.19644564765514245166 18.LiYet al.Global patterns in monthly activity of" exact="influenza" post="virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7332071\results\search\disease\results.xml">
   <result pre="are credited.pntd.0007870.pdf Abstract Emerging mosquito-borne viruses like Zika, dengue, and" exact="chikungunya" post="pose a major threat to public health, especially in"/>
   <result pre="have long-term social and economic consequences due to Zika-induced congenital" exact="microcephaly" post="and other complications. Larval control of the container-inhabiting mosquitoes"/>
   <result pre="of mosquito control efforts influences the size of a mosquito-borne" exact="infectious disease" post="outbreak under the realistic assumption that coordination has costs."/>
   <result pre="Introduction Recent outbreaks of mosquito-borne viruses such as Zika [1]," exact="chikungunya" post="[2], and dengue [3] are a major public health"/>
   <result pre="likely have long-term public health consequences due to Zika-induced congenital" exact="microcephaly" post="in fetuses and Guillain-BarrÃ© syndrome in adults [5â€&quot;8]. As"/>
   <result pre="Lancet Infect Dis. 2016;16: 712â€&quot;723. 10.1016/S1473-3099(16)00026-826874619 5PaixÃ£oES, TeixeiraMG, RodriguesLC. Zika," exact="chikungunya" post="and dengue: the causes and threats of new and"/>
   <result pre="the impact of temperature on transmission of Zika, dengue, and" exact="chikungunya" post="using mechanistic models.PLoS Negl Trop Dis. 2017;11: e000556810.1371/journal.pntd.000556828448507 11ManoreCA,"/>
   <result pre="OrdoÃ±ezT, AyalaEB, et al.A social-ecological analysis of community perceptions of" exact="dengue fever" post="and Aedes aegypti in Machala, Ecuador.BMC Public Health. 2014;14:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7332961\results\search\disease\results.xml">
   <result pre="infected individual presenting disabling joint pains, severe fever, and eventually" exact="rash" post="(Lumsden, 1955; Ross, 1956). The bite of infected female"/>
   <result pre="atypical cases, such as neurological disorders, cardio-respiratory failure, acute hepatitis," exact="acute pancreatitis," post="renal disorders, and muscular impairment. Only two deaths associated"/>
   <result pre="glycoprotein E3 is translated right after the capsid protein; it" exact="aids" post="with cellular chaperones in the proper folding of E2"/>
   <result pre="inhibition also increases SINV infection, but had no effect on" exact="influenza" post="A infection (a member of the Orthomyxoviridae family), suggesting"/>
   <result pre="CHIKV-infected Vero and an adult WT mouse model of CHIKV" exact="arthritis" post="only partially induced by XBP1. Furthermore, the authors demonstrated"/>
   <result pre="inflammation and pathogenesis of several viral, bacterial, autoimmune diseases, and" exact="cancer" post="(Davis et al., 2011; McAuley et al., 2013; Negash"/>
   <result pre="pinnae, mimicking erysipelasâ€™ Milian ear sign; multiple aphthae, erosions, and" exact="cheilitis" post="were also observed in oral mucosa, but they were"/>
   <result pre="majora in women. The infection can also flare-up of pre-existing" exact="psoriasis" post="and lichen planus manifestations. Other usual manifestations Pain in"/>
   <result pre="women. The infection can also flare-up of pre-existing psoriasis and" exact="lichen planus" post="manifestations. Other usual manifestations Pain in the ligaments, headache,"/>
   <result pre="gastrointestinal bleeding, nausea or abdominal pain), red eyes, conjunctivitis, and" exact="lymphadenopathy" post="have also been described, only during the acute phase"/>
   <result pre="to the age of the patient, the incidence of CHIKV-associated" exact="encephalitis" post="shows that individuals younger than 3 years old or"/>
   <result pre="patients with acute infection during La RÃ©union (island) outbreak of" exact="chikungunya" post="fever, in 2005â€&quot;2006 (Robin et al., 2008), but approximately"/>
   <result pre="tachypnea, blood pressure instability, chest pain, electrocardiograph (ECG) abnormalities, and" exact="acute myocardial infarction" post="(Spodick, 1986; Dec et al., 1992; Touret et al.,"/>
   <result pre="were reported, such as pneumonia, diabetes, bullous dermatosis, toxic hepatitis," exact="encephalitis" post="or meningoencephalitis, myocarditis, and cardio-respiratory failure (Economopoulou et al.,"/>
   <result pre="be accounted, but there are reports of atypical cases of" exact="meningoencephalitis" post="and other neurological complications in CHIKV-infected patients in Brazil."/>
   <result pre="aegypti.Virology49759â€&quot;68. 10.1016/j.virol.2016.06.02527423270 AkhrymukI.LukashT.FrolovI.FrolovaE. I. (2019). Novel mutations in nsP2 abolish" exact="chikungunya" post="virus-induced transcriptional shutoff and make the virus less cytopathic"/>
   <result pre="the unfolded protein response.PLoS Biol.4:e42310.1371/journal.pbio.0040423 BernardE.SolignatM.GayB.ChazalN.HiggsS.DevauxC.et al. (2010). Endocytosis of" exact="chikungunya" post="virus into mammalian cells: role of clathrin and early"/>
   <result pre="One5:e1147910.1371/journal.pone.0011479 BerryI. M.RutvisuttinuntW.SippyR.Beltran-AyalaE.FigueroaK.RyanS.et al. (2020). The origins of dengue and" exact="chikungunya" post="viruses in Ecuador following increased migration from Venezuela and"/>
   <result pre="Evol. Biol.20:3110.1186/s12862-020-1596-1598 BonifayT.PrinceC.NeyraC.DemarM.RoussetD.KallelH.et al. (2018). Atypical and severe manifestations of" exact="chikungunya" post="virus infection in French Guiana: a hospital-based study.PLoS One13:e020740610.1371/journal.pone.0207406"/>
   <result pre="Venezuela during 2014.Acta Trop.17488â€&quot;90. 10.1016/j.actatropica.2017.06.02628690146 CarbajoA. E.VezzaniD. (2015). Waiting for" exact="chikungunya" post="fever in Argentina: spatio-temporal risk maps.Mem. Inst. Oswaldo. Cruz.110259â€&quot;262."/>
   <result pre="monocyte chemotactic protein synthesis, protects against bone loss induced by" exact="chikungunya" post="virus infection.J. Virol.89581â€&quot;593. 10.1128/JVI.02034-1425339772 ChenW.FooS. S.ZaidA.TengT. S.HerreroL. J.WolfS.et al."/>
   <result pre="S.ZaidA.TengT. S.HerreroL. J.WolfS.et al. (2017). Specific inhibition of NLRP3 in" exact="chikungunya" post="disease reveals a role for inflammasomes in alphavirus-induced inflammation.Nat."/>
   <result pre="things to come?Virol. J.5:3310.1186/1743-422X-5-33 DecG. W.Jr.WaldmanH.SouthernJ.FallonJ. T.HutterA. M.Jr.PalaciosI. (1992). Viral" exact="myocarditis" post="mimicking acute myocardial infarction.J. Am. Coll. Cardiol.2085â€&quot;89. 10.1016/0735-1097(92)90141-91607543 DelisleE.RousseauC.BrocheB.Leparc-GoffartI.Lâ€™ambertG.CochetA.et"/>
   <result pre="pathway in viral infection.EMBO J.174585â€&quot;4593. 10.1093/emboj/17.16.45859707418 DialloM.ThonnonJ.Traore-LamizanaM.FontenilleD. (1999). Vectors of" exact="chikungunya" post="virus in Senegal: current data and transmission cycles.Am. J."/>
   <result pre="al. (2018). Human CD8 T-cell activation in acute and chronic" exact="chikungunya" post="infection.Immunology155499â€&quot;504. 10.1111/imm.1299230099739 Djavaheri-MergnyM.AmelottiM.MathieuJ.BesanÃ§onF.BauvyC.CodognoP. (2007). Regulation of autophagy by NFkappaB"/>
   <result pre="10.1099/vir.0.071845-025395592 GardnerC. L.HritzJ.SunC.VanlandinghamD. L.SongT. Y.GhedinE.et al. (2014). Deliberate attenuation of" exact="chikungunya" post="virus by adaptation to heparan sulfate-dependent infectivity: a model"/>
   <result pre="Infect.71413â€&quot;421. 10.1016/j.jinf.2015.06.00626092350 GÃ©rardinP.BarauG.MichaultA.BintnerM.RandrianaivoH.ChokerG.et al. (2008). Multidisciplinary prospective study of mother-to-child" exact="chikungunya" post="virus infections on the island of La Reunion.PLoS Med.5:6010.1371/journal.pone.000060"/>
   <result pre="responses.J. Mol. Biol.4261148â€&quot;1160. 10.1016/j.jmb.2013.11.02324316047 HalsteadS. B.UdomsakdiS.ScanlonJ. E.RohitayodhinS. (1969). Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962-1964. V. Epidemiologic"/>
   <result pre="C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.et al. (2010). Persistent chronic inflammation and infection by" exact="chikungunya" post="arthritogenic alphavirus in spite of a robust host immune"/>
   <result pre="phosphorylation.Front. Immunol.9:8410.3389/fimmu.2018.00084 InamadarA. C.PalitA.SampagaviV. V.RaghunathS.DeshmukhN. S. (2008). Cutaneous manifestations of" exact="chikungunya" post="fever: observations made during a recent outbreak in south"/>
   <result pre="(2017). Disruption of the opal stop codon attenuates Chikungunya Virus-induced" exact="arthritis" post="and pathology.mBio8:e001456-1710.1128/mBio.01456-17 JoubertP. E.StaplefordK.Guivel-BenhassineF.VignuzziM.SchwartzO.AlbertM. L. (2015). Inhibition of mTORC1"/>
   <result pre="E.StaplefordK.Guivel-BenhassineF.VignuzziM.SchwartzO.AlbertM. L. (2015). Inhibition of mTORC1 enhances the translation of" exact="chikungunya" post="proteins via the activation of the MnK/eIF4E pathway.PLoS Pathog.11:e100509110.1371/journal.ppat.1005091"/>
   <result pre="GrandR.TolouH.MeritsA.et al. (2014). Unique epitopes recognized by antibodies induced in" exact="chikungunya" post="virus-infected non-human primates: implications for the study of immunopathology"/>
   <result pre="in the induction of ER stress and downstream events in" exact="chikungunya" post="virus infection.Microb. Pathog.101104â€&quot;118. 10.1016/j.micpath.201627863885 KielianM.Chanel-VosC.LiaoM. (2010). Alphavirus entry and"/>
   <result pre="J.8:43210.1186/1743-422X-8-432 KumarR.SharmaM. K.JainS. K.YadavS. K.SinghalA. K. (2017). Cutaneous manifestations of" exact="chikungunya" post="fever: observations from an outbreak at a tertiary care"/>
   <result pre="10.1172/JCI4010420179353 LanciottiR. S.ValadereA. M. (2014). Transcontinental movement of Asian genotype" exact="chikungunya" post="virus.Emerg. Infect. Dis.201400â€&quot;1402. 10.3201/eid2008.14026825076384 LeeC. H. R.Mohamed HussainK.ChuJ. J."/>
   <result pre="muscle cells.PLoS Negl. Trop. Dis.13:e000761010.1371/journal.pntd.0007610 LemantJ.BoissonV.WinerA.ThibaultL.AndrÃ©H.TixierF.et al. (2008). Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the Reunion Island"/>
   <result pre="K.JiangH. H.GordonG.GoldmanJ. E.BerryG.et al. (1998). Protection against fatal Sindbis virus" exact="encephalitis" post="by beclin, a novel Bcl-2-interacting protein.J. Virol.728586â€&quot;8596. 10.1128/jvi.72.11.8586-8596.19989765397 LitzbaN.SchuffeneckerI.ZellerH.DrostenC.EmmerichP.CharrelR.et"/>
   <result pre="Virol.728586â€&quot;8596. 10.1128/jvi.72.11.8586-8596.19989765397 LitzbaN.SchuffeneckerI.ZellerH.DrostenC.EmmerichP.CharrelR.et al. (2008). Evaluation of the first commercial" exact="chikungunya" post="virus indirect immunofluorescence test.J. Virol. Methods149175â€&quot;179. 10.1016/j.jviromet.2008.01.00418294706 LiuC. Y.KaufmanR."/>
   <result pre="M.et al. (2019). FHL1 is a major host factor for" exact="chikungunya" post="virus infection.Nature574259â€&quot;263. 10.1038/s41586-019-1578-431554973 MehtaR.GerardinP.de BritoC. A. A.SoaresC. N.FerreiraM. L."/>
   <result pre="A. A.SoaresC. N.FerreiraM. L. B.SolomonT. (2018). The neurological complications of" exact="chikungunya" post="virus: a systematic review.Rev. Med. Virol.28:e197810.1002/rmv.1978 MeltonJ. V.EwartG. D.WeirR."/>
   <result pre="Anopheles gambiae infectivity.J. Virol.804992â€&quot;4997. 10.1128/JVI.80.10.4992-4997.200616641290 NasciR. S. (2014). Movement of" exact="chikungunya" post="virus into the Western hemisphere.Emerg. Infect. Dis.201394â€&quot;1395. 10.3201/eid2008.14033325061832 NavecaF."/>
   <result pre="IL-1Î² production through the NLRP3 inflammasome by hepatic macrophages links" exact="hepatitis" post="C virus infection with liver inflammation and disease.PLoS Pathog.9:e100333010.1371/journal.ppat.1003330"/>
   <result pre="R.Sobreira-NetoM. A.CastroJ. D. V.et al. (2017). Encephalitis associated with the" exact="chikungunya" post="epidemic outbreak in Brazil: report of 2 cases with"/>
   <result pre="M.et al. (2011). Unconventional repertoire profile is imprinted during acute" exact="chikungunya" post="infection for natural killer cells polarization toward cytotoxicity.PLoS Pathog.7:e100226810.1371/journal.ppat"/>
   <result pre="Immunol.5375â€&quot;386. 10.1038/nri160415864272 PowersA. M.BraultA. C.TeshR. B.WeaverS. C. (2000). Re-emergence of" exact="chikungunya" post="and oâ€™nyong-nyong viruses: evidence for distinct geographical lineages and"/>
   <result pre="2), 471â€&quot;479. 10.1099/0022-1317-81-2-47110644846 PowersA. M.LogueC. H. (2007). Changing patterns of" exact="chikungunya" post="virus: re-emergence of a zoonotic arbovirus.J. Gen. Virol.8(Pt 9),"/>
   <result pre="S.BasheeruddinD. D.ChowdharyT. N.MadhuB. (2009). Cutaneous manifestations in patients suspected of" exact="chikungunya" post="disease.Indian J. Dermatol.54128â€&quot;131. 10.4103/0019-5154.5318620101307 QueyriauxB.SimonF.GrandadamM.MichelR.TolouH.BoutinJ. P. (2008). Clinical burden"/>
   <result pre="disease.Indian J. Dermatol.54128â€&quot;131. 10.4103/0019-5154.5318620101307 QueyriauxB.SimonF.GrandadamM.MichelR.TolouH.BoutinJ. P. (2008). Clinical burden of" exact="chikungunya" post="virus infection.Lancet Infect. Dis.82â€&quot;3. 10.1016/S1473-3099(07)70294-318156079 RadoshitzkyS. R.PegoraroG.ChÃ®X. O. D.NgL.ChiangC."/>
   <result pre="phosphorylation.Virol. J.10:3610.1186/1743-422X-10-36 RenaultP.SoletJ. L.SissokoD.BalleydierE.LarrieuS.FilleulL.et al. (2007). A major epidemic of" exact="chikungunya" post="virus infection on Reunion Island, France, 2005-2006.Am. J. Trop."/>
   <result pre="Trop. Med. Hyg.77727â€&quot;731. 10.4269/ajtmh.2007.77.72717978079 RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA. C.PanningM.et al. (2007). Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region.Lancet3701840â€&quot;1846."/>
   <result pre="PÃºb.43:7710.26633/RPSP.2019.77 RobinS.RamfulD.Le SeachF.Jaffar-BandjeeM. C.RigouG.AlessandriJ. L. (2008). Neurologic manifestations of pediatric" exact="chikungunya" post="infection.J. Child Neurol.231028â€&quot;1035. 10.1177/088307380831415118287573 RossR. W. (1956). The Newala"/>
   <result pre="characteristics.BMC Res. Notes11:17510.1186/s13104-018-3290-0 SchilteC.CoudercT.ChretienF.SourisseauM.GangneuxN.Guivel-BenhassineF.et al. (2010). Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cells.J. Exp. Med.207429â€&quot;442."/>
   <result pre="Exp. Med.207429â€&quot;442. 10.1084/jem.2009085120123960 SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM. C.et al. (2006). Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak.PLoS Med.3:e26310.1371/journal.pmed.0030263 SergonK.NjugunaC.KalaniR.OfulaV.OnyangoC.KonongoiL. S.et"/>
   <result pre="(2018). Vector competence of Italian Aedes albopictus populations for the" exact="chikungunya" post="virus (E1-226V).PLoS Negl. Trop. Dis.12:e000643510.1371/journal.pntd.0006435 SharpT. M.RothN. M.TorresJ.RyffK. R.PÃ©rez"/>
   <result pre="a re-emerging arbovirus.Virology393183â€&quot;197. 10.1016/j.virol.2009.07.02419732931 SourisseauM.SchilteC.CasartelliN.TrouilletC.Guivel-BenhassineF.RudnickaD.et al. (2007). Characterization of reemerging" exact="chikungunya" post="virus.PLoS Pathog.3:e8910.1371/journal.ppat.0030089 SouzaT. M.AzeredoE. L.Badolato-CorrÃªaJ.DamascoP. V.SantosC.Petitinga-PaivaF.et al. (2017). First"/>
   <result pre="10.1086/60549619663604 SuhanaO.NazniW. A.ApandiY.FarahH.LeeH. L.Sofian-AzirunM. (2019). Insight into the origin of" exact="chikungunya" post="virus in Malaysian non-human primates via sequence analysis.Heliyon5:e0268210.1016/j.heliyon.2019.e02682 SuhrbierA.Jaffar-BandjeeM."/>
   <result pre="cell functionality and increased TNF-Î± production as biomarkers of chronic" exact="chikungunya" post="arthritis and rheumatoid arthritis.Hum. Immunol.78370â€&quot;374. 10.1016/j.humimm.2017.02.00628213049 ThibervilleS. D.MoyenN.Dupuis-MaguiragaL.NougairedeA.GouldE. A.RoquesP.et"/>
   <result pre="functionality and increased TNF-Î± production as biomarkers of chronic chikungunya" exact="arthritis" post="and rheumatoid arthritis.Hum. Immunol.78370â€&quot;374. 10.1016/j.humimm.2017.02.00628213049 ThibervilleS. D.MoyenN.Dupuis-MaguiragaL.NougairedeA.GouldE. A.RoquesP.et al."/>
   <result pre="R.Falleiros-ArlantL. H.DueÃ±asL.Pleitez-NavarreteJ.SalgadoD. M.Brea-Del CastilloJ. (2016). Congenital and perinatal complications of" exact="chikungunya" post="fever: a Latin American experience.Int. J. Infect. Dis.5185â€&quot;88. 10.1016/j.ijid.2016.09.00927619845"/>
   <result pre="U.S.A.1087872â€&quot;7877. 10.1073/pnas.101834410821518887 TsetsarkinK. A.ChenR.YunR.RossiS. L. (2014). Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="(2009). Epistatic roles of E2 glycoprotein mutations in adaption of" exact="chikungunya" post="virus to Aedes albopictus and Ae. aegypti mosquitoes.PLoS One31:e683510.1371/journal.pone.0006835"/>
   <result pre="One31:e683510.1371/journal.pone.0006835 TsetsarkinK. A.VanlandinghamD. L.McGeeC. E.HiggsS. (2007). A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential.PLoS Pathog.3:e20110.1371/journal.ppat.0030201 TsetsarkinK."/>
   <result pre="algorithms, and priorities in encephalitis: consensus statement of the international" exact="encephalitis" post="consortium.Clin. Infect. Dis.571114â€&quot;1128. 10.1093/cid/cit45823861361 VijayakumarK. P.Nair AnishT. S.GeorgeB.LawrenceT.MuthukkuttyS. C.RamachandranR."/>
   <result pre="A.AdamsA. P.GarciaT. I.SallA. A.et al. (2010). Genome-scale phylogenetic analyses of" exact="chikungunya" post="virus reveal independent emergences of recent epidemics and various"/>
   <result pre="comparison of the nucleotide sequences of eastern and western equine" exact="encephalomyelitis" post="viruses with those of other alphaviruses and related RNA"/>
   <result pre="al. (2014). Comprehensive proteomic analysis of white blood cells from" exact="chikungunya" post="fever patients of different severities.J. Transl. Med.12:9610.1186/1479-5876-12-96 WintachaiP.WikanN.KuadkitkanA.JaimipukT.UbolS.PulmanausahakulR.et al."/>
   <result pre="receptor protein.J. Med. Virol.841757â€&quot;1770. 10.1002/jmv.2340322997079 XavierJ.GiovanettiM.FonsecaV.ThÃ©zÃ©J.GrÃ¤fT.FabriA.et al. (2019). Circulation of" exact="chikungunya" post="virus East/Central/South African lineage in Rio de Janeiro, Brazil.PLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7333570\results\search\disease\results.xml">
   <result pre="Abstract ABSTRACT Enterovirus A71 (EV-A71) is the major pathogen of" exact="hand, foot, and mouth disease" post="(HFMD); in some severe cases, it could develop into"/>
   <result pre="A71 (EV-A71) is the major pathogen of hand, foot, and" exact="mouth disease" post="(HFMD); in some severe cases, it could develop into"/>
   <result pre="could develop into central nervous system (CNS) disease such as" exact="aseptic meningitis," post="encephalitis, and neurogenic pulmonary edema in children under 5â€‰years."/>
   <result pre="system (CNS) disease such as aseptic meningitis, encephalitis, and neurogenic" exact="pulmonary edema" post="in children under 5â€‰years. The EV-A71 pathogenesis which is"/>
   <result pre="and Enterovirus genus. This virus is the main pathogen for" exact="hand, foot, and mouth disease," post="which is associated with severe neurological manifestations, and it"/>
   <result pre="This virus is the main pathogen for hand, foot, and" exact="mouth disease," post="which is associated with severe neurological manifestations, and it"/>
   <result pre="viral proteins and viral genomes (6), such as poliovirus (7)," exact="hepatitis" post="A virus (8), and coxsackievirus B (9), and so"/>
   <result pre="NgL2017Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with" exact="hand, foot and mouth disease." post="Front Microbiol8:2249. doi:10.3389/fmicb.2017.02249.29238324 2.WangY-F, ChouC-T, LeiH-Y, LiuC-C, WangS-M, YanJ-J,"/>
   <result pre="interactions of enterovirus 71 in patients with hand, foot and" exact="mouth disease." post="Front Microbiol8:2249. doi:10.3389/fmicb.2017.02249.29238324 2.WangY-F, ChouC-T, LeiH-Y, LiuC-C, WangS-M, YanJ-J,"/>
   <result pre="Acad Sci U S A107:6328â€&quot;6333. doi:10.1073/pnas.0914843107.20304794 6.AndersonMR, KashanchiF, JacobsonS2016Exosomes in" exact="viral disease." post="Neurotherapeutics13:535â€&quot;546. doi:10.1007/s13311-016-0450-6.27324390 7.JacksonWT, GiddingsTHJr, TaylorMP, MulinyaweS, RabinovitchM, KopitoRR, KirkegaardK2005Subversion"/>
   <result pre="71 transmission by exosomes establishes a productive infection in human" exact="neuroblastoma" post="cells. Virus Genes52:189â€&quot;194. doi:10.1007/s11262-016-1292-3.26837894 19.MurgociAN, DuhamelM, Raffo-RomeroA, MallahK, AboulouardS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7334892\results\search\disease\results.xml">
   <result pre="species involved in arbovirus transmission are Aedes aegypti (L.), the" exact="yellow fever" post="mosquito, and Culex quinquefasciatus (Say), the southern house mosquito."/>
   <result pre="the principal vector of dengue (DENV) (Harrington et al. 2014)," exact="chikungunya" post="(CHIKV) (Macpherson et al. 2016), yellow fever (Christ et"/>
   <result pre="(Harrington et al. 2014), chikungunya (CHIKV) (Macpherson et al. 2016)," exact="yellow fever" post="(Christ et al. 2017), and Zika viruses (ZIKV) (Weaver"/>
   <result pre="of West Nile virus and other arthropod-borne viruses, including Japanese" exact="encephalitis" post="virus, Saint Louis encephalitis virus and Rift Valley fever"/>
   <result pre="and other arthropod-borne viruses, including Japanese encephalitis virus, Saint Louis" exact="encephalitis" post="virus and Rift Valley fever (Vinogradova 2000). As early"/>
   <result pre="in the antennal lobes affect odor-mediated host seeking in the" exact="yellow fever" post="mosquito, Aedes aegypti. PLoS One12: e0188243.29166650 ChungW. M., BusemanC."/>
   <result pre="FombyT. B., LubyJ. P., and HaleyR. W.2013The 2012 West Nile" exact="encephalitis" post="epidemic in Dallas, TexasJama310: 297â€&quot;307.23860988 CosteroA., EdmanJ. D., ClarkG."/>
   <result pre="C.. 2011Natural plant sugar sources of Anopheles mosquitoes strongly impact" exact="malaria" post="transmission potential. PLoS One6: e15996.21283732 Hall-MendelinS., RitchieS. A., JohansenC."/>
   <result pre="C., HassanaliA., and KnolsB. G.. 2004Feeding and survival of the" exact="malaria" post="vector Anopheles gambiae on plants growing in Kenya. Med."/>
   <result pre="surveillance near the Mexico-U.S. border: isolation and sequence analysis of" exact="chikungunya" post="virus from patients with dengue-like symptoms in Reynosa, Tamaulipas."/>
   <result pre="BidaiseeS., et al.2016Clinical and serological insights from the Asian lineage" exact="chikungunya" post="outbreak in Grenada, 2014: an observational study. Am. J."/>
   <result pre="VasilakisN., WalkerC., TurnerC., KhuwajaS., ArafatR., WeaverS. C., et al.2013Identification of" exact="dengue fever" post="cases in Houston, Texas, with evidence of autochthonous transmission"/>
   <result pre="CoffeyL. L.. 2018Scented sugar baits enhance detection of St. Louis" exact="encephalitis" post="and West Nile viruses in mosquitoes in suburban California."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7336307\results\search\disease\results.xml">
   <result pre="Ebola vaccine candidates chimpanzee adenovirus serotype 3 (ChAd3) and modified" exact="vaccinia virus" post="Ankara (MVA), both expressing Zaire Ebola glycoprotein (EBO-Z; Venkatraman"/>
   <result pre="CMV has also been associated with an increased risk of" exact="tuberculosis" post="disease in infants (MÃ¼ller et al., 2019). In particular,"/>
   <result pre="Wherry, 2012). All participants were negative for acute or chronic" exact="hepatitis" post="B, hepatitis C, HIV, and Plasmodium spp. infections at"/>
   <result pre="All participants were negative for acute or chronic hepatitis B," exact="hepatitis" post="C, HIV, and Plasmodium spp. infections at enrollment. Serostatus"/>
   <result pre="Serostatus of each individual for 19 different pathogens. CMV and" exact="malaria" post="serostatus determined by ELISA. Serostatus for all other pathogens"/>
   <result pre="shown and error bars indicate IQRs. BKV, BK virus; HBV," exact="hepatitis" post="B virus; HCV, hepatitis C virus; HHV-6, human herpesvirus"/>
   <result pre="indicate IQRs. BKV, BK virus; HBV, hepatitis B virus; HCV," exact="hepatitis" post="C virus; HHV-6, human herpesvirus 6; HHV-7, human herpesvirus"/>
   <result pre="helminths have been associated with reduced vaccine responses or immune" exact="suppression" post="and could play a role in the reduced immunogenicity"/>
   <result pre="et al., 2005, 2006). Serum antibodies against human herpesviruses 1â€&quot;8," exact="hepatitis" post="B and C viruses, H. pylori, Chlamydia trachomatis, Toxoplasma"/>
   <result pre="GÃ¤rtnerB., SchnitzlerP., HillA., et al.2019Validation of Multiplex Serology for human" exact="hepatitis" post="viruses B and C, human T-lymphotropic virus 1 and"/>
   <result pre="GriffinG.E., and NutmanT.B.2001Human infection with Ascaris lumbricoides is associated with" exact="suppression" post="of the interleukin-2 response to recombinant cholera toxin B"/>
   <result pre="VossenA.C., CoolsH.J., WestendorpR.G., KroesA.C., and GusseklooJ.2011Cytomegalovirus infection and responsiveness to" exact="influenza" post="vaccination in elderly residents of long-term care facilities. Vaccine."/>
   <result pre="of late-differentiated CD4 T-cells correlates with poor humoral response to" exact="influenza" post="vaccination. Vaccine. 31:685â€&quot;690. 10.1016/j.vaccine.2012.11.04123196209 DerhovanessianE., MaierA.B., HÃ¤hnelK., McElhaneyJ.E., SlagboomE.P.,"/>
   <result pre="with cytomegalovirus is associated with poor memory CD4 responses to" exact="influenza" post="A core proteins in the elderly. J. Immunol. 193:3624â€&quot;3631."/>
   <result pre="and BlombergB.B.2015Cytomegalovirus (CMV) seropositivity decreases B cell responses to the" exact="influenza" post="vaccine. Vaccine. 33:1433â€&quot;1439. 10.1016/j.vaccine.2015.01.07125659271 FurmanD., JojicV., SharmaS., Shen-OrrS.S., AngelC.J.L.,"/>
   <result pre="Oâ€™FallonW.M., and WeyandC.M.2001Value of immunological markers in predicting responsiveness to" exact="influenza" post="vaccination in elderly individuals. J. Virol. 75:12182â€&quot;12187. 10.1128/JVI.75.24.12182-12187.200111711609 HadrupS.R.,"/>
   <result pre="LoweB., BillingsleyP.F., et al.2015Lessons learnt from the first controlled human" exact="malaria" post="infection study conducted in Nairobi, Kenya. Malar. J. 14:18210.1186/s12936-015-0671-x25927522"/>
   <result pre="et al.2007Absence of SV40 antibodies or DNA fragments in prediagnostic" exact="mesothelioma" post="serum samples. Int. J. Cancer. 120:2459â€&quot;2465. 10.1002/ijc.2259217315193 KlenermanP.2018The (gradual)"/>
   <result pre="StockdaleL., MarsayL., et al.2019Cytomegalovirus infection is a risk factor for" exact="tuberculosis" post="disease in infants. JCI Insight. 413009010.1172/jci.insight.13009031697647 Oâ€™ConnorD., TrÃ¼ckJ., LazarusR.,"/>
   <result pre="J. Virol. 79:9527â€&quot;9539. 10.1128/JVI.79.15.9527-9539.200516014915 SabinE.A., AraujoM.I., CarvalhoE.M., and PearceE.J.1996Impairment of" exact="tetanus" post="toxoid-specific Th1-like immune responses in humans infected with Schistosoma"/>
   <result pre="Host Microbe. 12:458â€&quot;469. 10.1016/j.chom.2012.10.00123084915 StoweR.P., PeekM.K., CutchinM.P., and GoodwinJ.S.2012Reactivation of" exact="herpes simplex" post="virus type 1 is associated with cytomegalovirus and age."/>
   <result pre="cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1" exact="influenza" post="vaccine in healthy adults. J. Med. Virol. 85:1557â€&quot;1560. 10.1002/jmv.2364223852679"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7338124\results\search\disease\results.xml">
   <result pre="pmcid: 73381241375 doi: 10.1186/s12985-020-01375-1 : Research Characterization of neuraminidase inhibitor-resistant" exact="influenza" post="virus isolates from immunocompromised patients in the Republic of"/>
   <result pre="credit line to the data. Abstract Background The emergence of" exact="influenza" post="viruses resistant to anti-influenza drugs is a threat to"/>
   <result pre="and Respiratory Viruses Surveillance System (KINRESS) to monitor epidemics of" exact="influenza" post="and Severe Acute Respiratory Infection (SARI) to identify mutated"/>
   <result pre="influenza and Severe Acute Respiratory Infection (SARI) to identify mutated" exact="influenza" post="viruses affecting drug resistance, pathogenesis, and transmission. Methods Oropharyngeal"/>
   <result pre="KINRESS and SARI during the 2018â€&quot;2019 season. The specimens confirmed" exact="influenza" post="virus using real-time RT-PCR on inoculated MDCK cells. HA"/>
   <result pre="on inoculated MDCK cells. HA and NA sequences of the" exact="influenza" post="viruses were analyzed for phylogeny and mutations. Neuraminidase inhibition"/>
   <result pre="identical, their antigenicity was similar to that of the 2018â€&quot;19" exact="influenza" post="vaccine virus. Conclusions Our data indicate the utility of"/>
   <result pre="risk assessment for future epidemics and pandemics caused by drug-resistant" exact="influenza" post="viruses. Keywords Influenza virus Drug resistance H275Y Immunocompromised patients"/>
   <result pre="(NAIs) are globally utilized for the treatment and prevention of" exact="influenza" post="types A and B infection [1], which are stockpiled"/>
   <result pre="following Japan [3]. However, since most recently detected type A" exact="influenza" post="viruses harbor the resistance variation S31N in the matrix"/>
   <result pre="Respiratory Viruses Surveillance System (KINRESS) to monitor epidemic features of" exact="influenza" post="viruses and analyze virus characteristics, including drug resistance, since"/>
   <result pre="resistance, since 2000. The KCDC carries out diagnostic testing for" exact="influenza" post="viruses in respiratory specimens requested by general hospitals as"/>
   <result pre="phenotyping [8]. NAI-resistant viruses were identified in cases in which" exact="influenza" post="virus was continuously detected following NAI treatment of hospitalized,"/>
   <result pre="were detected via the KINRESS in patients with acute hematologic" exact="cancer" post="not exhibiting recovery despite oseltamivir and peramivir administration; these"/>
   <result pre="Biosystems). Table 1 Primer and probe sequence information to detect" exact="influenza" post="virus type (A/B) and subtype (H1/H3) Type/Subtype Primer/probe Sequence"/>
   <result pre="(Applied Biosystems), according to the manufacturerâ€™s instructions. The susceptibility of" exact="influenza" post="viruses to NAI was characterized using oseltamivir, zanamivir, and"/>
   <result pre="(IC50) as described previously [14]. As defined by the WHO," exact="influenza" post="A viruses with normal, reduced, and highly reduced NA"/>
   <result pre="was detected in oropharyngeal swab samples collected from patients with" exact="lymphoblastic leukemia" post="(Patient A: female, 37â€‰years old) and relapsed lymphoma (Patient"/>
   <result pre="detected in oropharyngeal swab samples collected from patients with lymphoblastic" exact="leukemia" post="(Patient A: female, 37â€‰years old) and relapsed lymphoma (Patient"/>
   <result pre="with lymphoblastic leukemia (Patient A: female, 37â€‰years old) and relapsed" exact="lymphoma" post="(Patient B: female, 38â€‰years old), with real-time RT-PCR Ct"/>
   <result pre="from ferrets immunized with A/Michigan/45/2015 and A/Brisbane/02/2018, which are northern-hemisphere" exact="influenza" post="A(H1N1)pdm09 isolates collected in 2018â€&quot;2019 and 2019â€&quot;2020, respectively, with"/>
   <result pre="in 18, 19]. Notably, such immunocompromised patients, when infected with" exact="influenza" post="virus, could shed virus over a prolonged period, likely"/>
   <result pre="transmissibility, these patients may constitute a source for spreading drug-resistant" exact="influenza" post="in the community [18]. Although NAI-resistant virus has been"/>
   <result pre="A(H1N1)pdm09 viruses harboring the H275Y NA variation in patients with" exact="acute lymphoblastic leukemia" post="and relapsed lymphoma hospitalized in the same general hospital,"/>
   <result pre="viruses harboring the H275Y NA variation in patients with acute" exact="lymphoblastic leukemia" post="and relapsed lymphoma hospitalized in the same general hospital,"/>
   <result pre="harboring the H275Y NA variation in patients with acute lymphoblastic" exact="leukemia" post="and relapsed lymphoma hospitalized in the same general hospital,"/>
   <result pre="NA variation in patients with acute lymphoblastic leukemia and relapsed" exact="lymphoma" post="hospitalized in the same general hospital, with both exhibiting"/>
   <result pre="the HA N158D substitution increases the binding affinity of H5N1" exact="avian influenza" post="virus and human receptor (Î±2â€&quot;6-linked sialoside) [21], the function"/>
   <result pre="HA N158D substitution increases the binding affinity of H5N1 avian" exact="influenza" post="virus and human receptor (Î±2â€&quot;6-linked sialoside) [21], the function"/>
   <result pre="Alternatively, NA and HA had different mutation spectra in swine" exact="influenza" post="viruses collected from April to June 2019 in the"/>
   <result pre="States. The antigenic drift in immunocompromised patients may allow swine" exact="influenza" post="virus insertion to occur without pig to human transmission,"/>
   <result pre="without pig to human transmission, ultimately reducing the efficacy of" exact="influenza" post="vaccine escape. Nevertheless, antisera from ferrets immunized with the"/>
   <result pre="influenza vaccine escape. Nevertheless, antisera from ferrets immunized with the" exact="influenza" post="vaccine exhibited good inhibition of A/Korea/S0002/2019 and A/Korea/S0003/2019 infection."/>
   <result pre="in published maps and institutional affiliations. We thank the national" exact="influenza" post="surveillance participating institutes. Authorsâ€™ contributions Conception and design: Chun"/>
   <result pre="References 1.CooperNJSuttonAJAbramsKRWailooATurnerDNicholsonKGEffectiveness of neuraminidase inhibitors in treatment and prevention of" exact="influenza" post="a and B: systematic review and meta-analyses of randomized"/>
   <result pre="global approvalDrugs.20187869369710.1007/s40265-018-0899-129623652 4.MoasserEMoasserAZaraketHIncidence of antiviral drug resistance markers among human" exact="influenza" post="a viruses in the eastern Mediterranean region, 2005-2016Infect Genet"/>
   <result pre="Evol201967606610.1016/j.meegid.2018.10.02330389548 5.Redlberger-FritzMAberleSWStrassiRPopow-KrauppTRapid identification of neuraminidase inhibitor resistance mutations in seasonal" exact="influenza" post="virus a (H1N1), a (H1N1) 2009, and a (H3N2)"/>
   <result pre="neuraminidase inhibitors (NAI)Laboratory methodologies for testing the antiviral susceptibility of" exact="influenza" post="viruses: Neuraminidase inhibitors (NAI)2018 7.A*STAR Bioinformatics Institute. FluSurver. http://flusurver.bii.a-star.edu.sg/"/>
   <result pre="FluSurver. http://flusurver.bii.a-star.edu.sg/ Accessed 14 Mar 2016. 8.NguyenHTFryAMGubarevaLVNeuraminidase inhibitor resistance in" exact="influenza" post="viruses and laboratory testing methodsAntivi Ther20121715917310.3851/IMP2067 9.WeinstockDMGubarevaLVZuccottiGProlonged shedding of"/>
   <result pre="viruses and laboratory testing methodsAntivi Ther20121715917310.3851/IMP2067 9.WeinstockDMGubarevaLVZuccottiGProlonged shedding of multidrug-resistant" exact="influenza" post="a virus in an immunocompromised patientNew Engl J Med200334886786810.1056/NEJM20030227348092312606750"/>
   <result pre="real-time RT-PCR assays for seasonal, pandemic a/H1pdm09 and avian a/H5" exact="influenza" post="viruses detectionJ Microbiol20135125225710.1007/s12275-013-2452-y23625229 11.LiuSSJiaoXYWangSSuWZJiangLZZhangXet al.Susceptibility of influenza a (H1N1)/pdm2009,"/>
   <result pre="and avian a/H5 influenza viruses detectionJ Microbiol20135125225710.1007/s12275-013-2452-y23625229 11.LiuSSJiaoXYWangSSuWZJiangLZZhangXet al.Susceptibility of" exact="influenza" post="a (H1N1)/pdm2009, seasonal a (H3N2) and B viruses to"/>
   <result pre="Rep20177848810.1038/s41598-017-08282-628814737 12.HoffmannEStechJGuanYWebsterRGPerezDRUniversal primer set for the full-length amplification of all" exact="influenza" post="a virusesArch Virol20011462275228910.1007/s00705017000211811679 13.collab: European Centre for Disease Prevention"/>
   <result pre="May 20192019 14.LackenbyABesselaarTGDanielsRSFryAGregoryVGubarevaLVet al.Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors and status of novel antivirals,"/>
   <result pre="surveillance of influenza2011 17.Okomo-AdhiamboMSleemanKBallengerKNguyenHTMishinVPSheuTGet al.Neuraminidase inhibitor susceptibility testing in human" exact="influenza" post="viruses: a laboratory surveillance perspectiveViruses.201022269228910.3390/v210226921994620 18.MemoliMJAthotaRReedSCzajkowskiLBristolTProudfootKet al.The natural history"/>
   <result pre="viruses: a laboratory surveillance perspectiveViruses.201022269228910.3390/v210226921994620 18.MemoliMJAthotaRReedSCzajkowskiLBristolTProudfootKet al.The natural history of" exact="influenza" post="infection in the severely immunocompromised vs nonimmunocompromised hostsClin Infect"/>
   <result pre="hostsClin Infect Dis20135821422410.1093/cid/cit72524186906 19.TrebbienRPedersenSSVorborgKFranckKTFischerTKDevelopment of oseltamivir and zanamivir resistance in" exact="influenza" post="a (H1N1) pdm09 virus, Denmark, 2014Euro Surveill2017223044510.2807/1560-7917.ES.2017.22.3.3044528128091 20.van der"/>
   <result pre="Denmark, 2014Euro Surveill2017223044510.2807/1560-7917.ES.2017.22.3.3044528128091 20.van der VriesEStittelaarKJvan AmerongenGVeldhuis KroezeEJde WaalLFraaijPLet al.Prolonged" exact="influenza" post="virus shedding and emergence of antiviral resistance in immunocompromised"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7338446\results\search\disease\results.xml">
   <result pre="10.1038/s41541-020-0205-6 : Perspective Review of data and knowledge gaps regarding" exact="yellow fever" post="vaccine-induced immunity and duration of protection http://orcid.org/0000-0002-1446-4071StaplesJ. Erinestaples@cdc.gov1BarrettAlan D."/>
   <result pre="detection of antibodies is used to denote protective immunity following" exact="measles" post="vaccination, it also has been documented that individuals lacking"/>
   <result pre="can develop secondary immune response with revaccination or exposure to" exact="measles" post="virus suggesting that alternative types of immunity exist42. Currently,"/>
   <result pre="additional doses of YF vaccine31. Table 1 Seropositivity following full-dose" exact="yellow fever" post="(YF) vaccination in adults. Study vaccine Population Type Test"/>
   <result pre="post-vaccination lacked detectable neutralizing antibodies. Table 2 Seropositivity following full-dose" exact="yellow fever" post="(YF) vaccination in children. Study Vaccine Population Type Test"/>
   <result pre="29â€&quot;94% (median: 68%) in Africa67. The current large outbreaks of" exact="measles" post="throughout the world, including in YF endemic areas where"/>
   <result pre="Vaccines. References References 1.JohanssonMAVasconcelosPFStaplesJEThe whole iceberg: estimating the incidence of" exact="yellow fever" post="virus infection from the number of severe casesTrans. R."/>
   <result pre="Soc. Trop. Med. Hyg.201410848248724980556 2.Ho, Y. L. et al. Severe" exact="yellow fever" post="in Brazil: clinical characteristics and management. J. Travel Med.26,"/>
   <result pre="salud publ. = Pan Am. J. Public Health201943e29 6.ShearerFMet al.Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
   <result pre="(Elsevier Inc., 2018). 9.CaseyRMet al.Immunogenicity of fractional-dose vaccine during a" exact="yellow fever" post="outbreakâ€&quot;final reportN. Engl. J. Med.201938144445429443626 10.Advisory Committee on Immunization"/>
   <result pre="inoculatedTrans. R. Soc. Trop. Med. Hyg.194438231234 14.CourtoisG[Duration of immunity after" exact="yellow fever" post="vaccination]Ann. Soc. Belg. Med. trop.195434912 15.DickGWGeeFLImmunity to yellow fever"/>
   <result pre="after yellow fever vaccination]Ann. Soc. Belg. Med. trop.195434912 15.DickGWGeeFLImmunity to" exact="yellow fever" post="nine years after vaccination with 17D vaccineTrans. R. Soc."/>
   <result pre="R. Soc. Trop. Med. Hyg.19524644945814958824 16.GrootHRiberiroRBNeutralizing and haemagglutination-inhibiting antibodies to" exact="yellow fever" post="17 years after vaccination with 17D vaccineBull. World Health"/>
   <result pre="17.RosenzweigECBabioneRWWissemanCLJr.Immunological studies with group B arthropod-borne viruses. IV. Persistence of" exact="yellow fever" post="antibodies following vaccination with 17D strain yellow fever vaccineAm."/>
   <result pre="Persistence of yellow fever antibodies following vaccination with 17D strain" exact="yellow fever" post="vaccineAm. J. Trop. Med. Hyg.19631223023513975014 18.GotuzzoEYactayoSCordovaEEfficacy and duration of"/>
   <result pre="J. Trop. Med. Hyg.19631223023513975014 18.GotuzzoEYactayoSCordovaEEfficacy and duration of immunity after" exact="yellow fever" post="vaccination: systematic review on the need for a booster"/>
   <result pre="Vaccines.http://www.who.int/entity/immunization/sage/meetings/2013/april /1_Background_Paper_Yellow_Fever_Vaccines.pdf?ua=1 (2013). 20.World Health Organization. Vaccines and vaccination against" exact="yellow fever." post="WHO position paperâ€&quot;June 2013. Wkly. Epidemiol. Rec.88, 269â€&quot;283 (2013)."/>
   <result pre="decision too feverish?Clin. Microbiol. Infect.20131988588623927031 24.Plotkin, S. A. Ten yearly" exact="yellow fever" post="booster vaccinations may still be justified. J. Travel Med.25,"/>
   <result pre="26.AmannaIJSlifkaMKQuestions regarding the safety and duration of immunity following live" exact="yellow fever" post="vaccinationExpert Rev. Vaccines2016151519153327267203 27.KarekoBWet al.Persistence of neutralizing antibody responses"/>
   <result pre="vaccinationExpert Rev. Vaccines2016151519153327267203 27.KarekoBWet al.Persistence of neutralizing antibody responses among" exact="yellow fever" post="virus 17D vaccinees living in a nonendemic settingJ. Infect."/>
   <result pre="group for studies on yellow fever.Duration of post-vaccination immunity against" exact="yellow fever" post="in adultsVaccine2014324977498425090646 29.collab: Collaborative group for studies on yellow"/>
   <result pre="fever.Duration of immunity in recipients of two doses of 17DD" exact="yellow fever" post="vaccineVaccine2019375129513531171393 30.Campi-AzevedoACet al.17DD yellow fever revaccination and heightened long-term"/>
   <result pre="of two doses of 17DD yellow fever vaccineVaccine2019375129513531171393 30.Campi-AzevedoACet al.17DD" exact="yellow fever" post="revaccination and heightened long-term immunity in populations of disease-endemic"/>
   <result pre="disease-endemic areas, BrazilEmerg. Infect. Dis.2019251511152131298654 31.MiyajiKTet al.Prevalence and titers of" exact="yellow fever" post="virus neutralizing antibodies in previously vaccinated adultsRev. Inst. Med."/>
   <result pre="Sao Paulo201759e228380113 32.de Menezes MartinsRet al.Duration of post-vaccination immunity to" exact="yellow fever" post="in volunteers eight years after a dose-response studyVaccine2018364112411729784469 33.de"/>
   <result pre="dose-response studyVaccine2018364112411729784469 33.de NoronhaTGet al.Duration of post-vaccination humoral immunity against" exact="yellow fever" post="in childrenVaccine2019377147715431590934 34.DomingoCet al.Long-term immunity against yellow fever in"/>
   <result pre="immunity against yellow fever in childrenVaccine2019377147715431590934 34.DomingoCet al.Long-term immunity against" exact="yellow fever" post="in children vaccinated during infancy: a longitudinal cohort studyLancet"/>
   <result pre="WHO consultation on immunological endpoints for evaluation of new Japanese" exact="encephalitis" post="vaccines, WHO, Geneva, 2â€&quot;3 September, 2004Vaccine2005235205521116055233 38.RoehrigJTHombachJBarrettADGuidelines for plaque-reduction"/>
   <result pre="Veit, O. &amp;amp; Chen, L. H. Waning immunity after single-dose" exact="yellow fever" post="vaccination: who needs a second shot? J. Travel Med.26,"/>
   <result pre="M.) 1001â€&quot;1030 (Elsevier Inc., 2018). 42.ErdmanDDHeathJLWatsonJCMarkowitzLEBelliniWJImmunoglobulin M antibody response to" exact="measles" post="virus following primary and secondary vaccination and natural virus"/>
   <result pre="43.HepburnMJet al.Neutralizing antibody response to booster vaccination with the 17d" exact="yellow fever" post="vaccineVaccine2006242843284916494976 44.Brasil Ministerio da Saude. [Yellow Fever Seasonal Monitoring"/>
   <result pre="Fever Seasonal Monitoring Brasilâ€&quot;2017/2018]https://portalarquivos2.saude.gov.br/images/pdf/2018/outubro/08/Informe-FA.pdf (2018). 45.CamaraFPde CarvalhoLMGomesALDemographic profile of sylvatic" exact="yellow fever" post="in Brazil from 1973 to 2008Trans. R. Soc. Trop."/>
   <result pre="Yellow Fever].http://www.saude.mg.gov.br/fornecimento-de-medicamentos/story/10284-informe-epidemiologico-da-febre-amarela-27-02 (2018). 48.TuboiSHCostaZGda Costa VasconcelosPFHatchDClinical and epidemiological characteristics of" exact="yellow fever" post="in Brazil: analysis of reported cases 1998â€&quot;2002Trans. R. Soc."/>
   <result pre="Trop. Med. Hyg.200710116917516814821 49.FilippisAMet al.Isolation and characterization of wild type" exact="yellow fever" post="virus in cases temporally associated with 17DD vaccination during"/>
   <result pre="cases temporally associated with 17DD vaccination during an outbreak of" exact="yellow fever" post="in BrazilVaccine2004221073107815003633 50.SaraivaMet al.Historical analysis of the records of"/>
   <result pre="in BrazilVaccine2004221073107815003633 50.SaraivaMet al.Historical analysis of the records of sylvan" exact="yellow fever" post="in the State of Amazonas, Brazil, from 1996 to"/>
   <result pre="anti-yellow fever virus immunoglobulin m antibodies at 3â€&quot;4 years following" exact="yellow fever" post="vaccinationAm. J. Trop. Med. Hyg.2012871112111523109371 53.FergusonMCollaborative study to assess"/>
   <result pre="to assess the suitability of a candidate International Standard for" exact="yellow fever" post="vaccineBiologicals20043219520515572101 54.WietenRWet al.A single 17D yellow fever vaccination provides"/>
   <result pre="International Standard for yellow fever vaccineBiologicals20043219520515572101 54.WietenRWet al.A single 17D" exact="yellow fever" post="vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody"/>
   <result pre="T-cell responses after vaccinationPLoS ONE201611e014987126977808 55.Campi-AzevedoACet al.Short-lived immunity after 17DD" exact="yellow fever" post="single dose indicates that booster vaccination may be required"/>
   <result pre="in childFront. Immunol.201910219231616412 56.Lindsey, N. P. et al. Persistence of" exact="yellow fever" post="virus-specific neutralizing antibodies after vaccination among US travellers. J."/>
   <result pre="Travel Med.25, 10.1093/jtm/tay108 (2018). 57.RoukensAHEvan HalemKde VisserAWVisserLGLong-term protection after fractional-dose" exact="yellow fever" post="vaccination: follow-up study of a randomized, controlled, noninferiority trialAnn."/>
   <result pre="controlled, noninferiority trialAnn. Intern. Med.201816976176530476963 58.LopezPet al.Immunogenicity and safety of" exact="yellow fever" post="vaccine (stamaril) when administered concomitantly with a tetravalent dengue"/>
   <result pre="a randomized trialPediatr. Infect. Dis. J.2016351140114727254034 59.Roy ChowdhuryPet al.Immunogenicity of" exact="yellow fever" post="vaccine coadministered with MenAfriVac in healthy infants in Ghana"/>
   <result pre="in Ghana and MaliClin. Infect. Dis.201561S58659326553692 60.IdokoOTet al.Antibody responses to" exact="yellow fever" post="vaccine in 9 to 11-month-old Malian and Ghanaian childrenExpert"/>
   <result pre="Vaccines20191886787531269829 61.MuyanjaEet al.Immune activation alters cellular and humoral responses to" exact="yellow fever" post="17D vaccineJ. Clin. Investig.20141243147315824911151 62.AlbrechtPEnnisFASaltzmanEJKrugmanSPersistence of maternal antibody in"/>
   <result pre="of maternal antibody in infants beyond 12 months: mechanism of" exact="measles" post="vaccine failureJ. Pediatr.197791715718909009 63.VasconcelosPFCBarrettADTAre booster doses of yellow fever"/>
   <result pre="mechanism of measles vaccine failureJ. Pediatr.197791715718909009 63.VasconcelosPFCBarrettADTAre booster doses of" exact="yellow fever" post="vaccine needed?Lancet Infect. Dis.2019191275127631543248 64.DomingoCNiedrigMSafety of 17D derived yellow"/>
   <result pre="yellow fever vaccine needed?Lancet Infect. Dis.2019191275127631543248 64.DomingoCNiedrigMSafety of 17D derived" exact="yellow fever" post="vaccinesExpert Opin. Drug Saf.2009821122119309249 65.KongsgaardMet al.Adaptive immune responses to"/>
   <result pre="Drug Saf.2009821122119309249 65.KongsgaardMet al.Adaptive immune responses to booster vaccination against" exact="yellow fever" post="virus are much reduced compared to those after primary"/>
   <result pre="Rep.2017766228386132 66.BerkleySHealth securityâ€™s blind spotScience2018359107529590015 67.AdrienNet al.Differences between coverage of" exact="yellow fever" post="vaccine and the first dose of measles-containing vaccine: a"/>
   <result pre="vaccine: a desk review of global data sourcesVaccine2019374511451731266670 68.WietenRWet al.17D" exact="yellow fever" post="vaccine elicits comparable long-term immune responses in healthy individuals"/>
   <result pre="responses in healthy individuals and immune-compromised patientsJ. Infect.20167271372227017899 69.MartinsRMet al.17DD" exact="yellow fever" post="vaccine: a double blind, randomized clinical trial of immunogenicity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7339094\results\search\disease\results.xml">
   <result pre="are among the most important complications in subjects affected by" exact="cancer" post="and/or in recipients of hematopoietic stem cell transplantation (HSCT)"/>
   <result pre="the onset of respiratory diseases in hematological patients such as" exact="influenza" post="(Flu) and parainfluenza virus (PiV), respiratory syncytial virus (RSV),"/>
   <result pre="herpes viruses [cytomegalovirus (CMV), Epstein-Barr virus (EBV), varicella-zoster virus (VZV)," exact="herpes simplex" post="1 and 2 (HSV1-2) and herpesvirus-6] frequently cause serious"/>
   <result pre="the epithelial cells of the upper airways [5]. The human" exact="influenza" post="virus belongs to the Orthomyxoviridae family, and its genome"/>
   <result pre="allow for the identification of different subtypes [2, 5]. Three" exact="influenza" post="virus genera are identified (A, B, C); influenza A"/>
   <result pre="5]. Three influenza virus genera are identified (A, B, C);" exact="influenza" post="A virus is divided into different subtypes on the"/>
   <result pre="period, and systemic use of corticosteroids [8]. The progression of" exact="influenza" post="virus to LRTI implies lymphopenia, the use of steroids"/>
   <result pre="an initial involvement of the upper respiratory tract: cough, rhinorrhea," exact="otitis media," post="wheezing, and sore throat with or without fever [4,"/>
   <result pre="without fever [4, 12]. Other less frequently observed symptoms are" exact="diarrhea" post="or gastrointestinal symptoms and conjunctivitis [9]. In other cases,"/>
   <result pre="less frequently observed symptoms are diarrhea or gastrointestinal symptoms and" exact="conjunctivitis" post="[9]. In other cases, as in influenza virus infection,"/>
   <result pre="gastrointestinal symptoms and conjunctivitis [9]. In other cases, as in" exact="influenza" post="virus infection, the typical manifestations may be absent [2]."/>
   <result pre="the most common community-acquired virus (47%) followed by PiV (14.1%)," exact="influenza" post="(11.2%), RSV (11.8%) and hMPV (8.8%) [8]. Viruses that"/>
   <result pre="only adults [20]Â (Table 2). Although the mortality rate for" exact="pneumonia" post="in healthy children and adults is low (0.5%), this"/>
   <result pre="D Pavilizumab Ribavirin aerosol Influenza 1.3â€&quot;40 8â€&quot;28 S, D Seasonal" exact="influenza" post="immunization Post-exposure prophylaxis with oseltamivir Oseltamivir Rhinovirus 2â€&quot;34 S,"/>
   <result pre="[22] â€&quot; HM hematological malignancy not otherwise specified, ALL acute" exact="lymphoid leukemia," post="AML acute myeloid leukemia The impact of RSV on"/>
   <result pre="hematological malignancy not otherwise specified, ALL acute lymphoid leukemia, AML" exact="acute myeloid leukemia" post="The impact of RSV on immunocompromised patients with myeloma"/>
   <result pre="malignancy not otherwise specified, ALL acute lymphoid leukemia, AML acute" exact="myeloid leukemia" post="The impact of RSV on immunocompromised patients with myeloma"/>
   <result pre="not otherwise specified, ALL acute lymphoid leukemia, AML acute myeloid" exact="leukemia" post="The impact of RSV on immunocompromised patients with myeloma"/>
   <result pre="respiratory tract [13, 21]. Mortality can reach 30% after developing" exact="pneumonia" post="[13]. Morbidity and mortality from this infection increase in"/>
   <result pre="infection increase in premature babies, and in children with underlying" exact="heart disease" post="or severe immunosuppression [16]. A single-center study [22] found"/>
   <result pre="of all episodes of respiratory viral infections in children with" exact="acute lymphoblastic leukemia" post="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients"/>
   <result pre="all episodes of respiratory viral infections in children with acute" exact="lymphoblastic leukemia" post="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients"/>
   <result pre="episodes of respiratory viral infections in children with acute lymphoblastic" exact="leukemia" post="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients"/>
   <result pre="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients with" exact="acute myeloid leukemia," post="14% of children with ALL [22] and 8.7% of"/>
   <result pre="RSV infections occur in 0.3â€&quot;2.2% of pediatric patients with acute" exact="myeloid leukemia," post="14% of children with ALL [22] and 8.7% of"/>
   <result pre="and 1% of lymphoma, respectively [1]. Influenza Virus (FLU) The" exact="influenza" post="virus is probably the most studied and known of"/>
   <result pre="carried out seroprevalence studies on their population with regard to" exact="influenza" post="A and B viruses: a prevalence of antibody levels"/>
   <result pre="for hematological patients [2]. A retrospective study, performed in two" exact="cancer" post="centers in the USA and Mexico on hematological patients"/>
   <result pre="in the USA and Mexico on hematological patients hospitalized for" exact="influenza" post="symptoms between 2009 and 2014 (during the AH1N1 pandemic"/>
   <result pre="(range 1â€&quot;88)Â years and that the majority of patients had" exact="leukemia" post="(54%). Besides, 42% of hospitalized patients developed LRTI and"/>
   <result pre="in HSCT patients to be 6.3% [2]. The incidence of" exact="influenza" post="in hematological and/or transplant patients varies, according to the"/>
   <result pre="about 36% [22] and 38% [5] of respiratory infections. Notaby," exact="influenza" post="is highly variable in terms of both genome (antigenic"/>
   <result pre="risk of complications and death [28]. In patients with myeloma," exact="influenza" post="is the respiratory virus associated with the greatest morbidity"/>
   <result pre="the greatest morbidity and mortality, and their risk of developing" exact="influenza" post="is approximately six times higher than in controls [10]."/>
   <result pre="patients affected by a respiratory virus had a diagnosis of" exact="leukemia" post="or lymphoma (LL). hRV was the most detected virus"/>
   <result pre="by a respiratory virus had a diagnosis of leukemia or" exact="lymphoma" post="(LL). hRV was the most detected virus in all"/>
   <result pre="(hematological, with solid tumor or post-HSCT). In patients affected by" exact="leukemia" post="or lymphoma and by a viral infection, hRV was"/>
   <result pre="solid tumor or post-HSCT). In patients affected by leukemia or" exact="lymphoma" post="and by a viral infection, hRV was detected in"/>
   <result pre="isolated pathogen (33% of cases) in respiratory infections in pediatric" exact="cancer" post="patients [33.9% in acute lymphoblastic leukemia (ALL) and acute"/>
   <result pre="cases) in respiratory infections in pediatric cancer patients [33.9% in" exact="acute lymphoblastic leukemia" post="(ALL) and acute myeloid leukemia (AML) and 31.8% in"/>
   <result pre="in respiratory infections in pediatric cancer patients [33.9% in acute" exact="lymphoblastic leukemia" post="(ALL) and acute myeloid leukemia (AML) and 31.8% in"/>
   <result pre="respiratory infections in pediatric cancer patients [33.9% in acute lymphoblastic" exact="leukemia" post="(ALL) and acute myeloid leukemia (AML) and 31.8% in"/>
   <result pre="pediatric cancer patients [33.9% in acute lymphoblastic leukemia (ALL) and" exact="acute myeloid leukemia" post="(AML) and 31.8% in solid tumors] [12]. A study"/>
   <result pre="cancer patients [33.9% in acute lymphoblastic leukemia (ALL) and acute" exact="myeloid leukemia" post="(AML) and 31.8% in solid tumors] [12]. A study"/>
   <result pre="patients [33.9% in acute lymphoblastic leukemia (ALL) and acute myeloid" exact="leukemia" post="(AML) and 31.8% in solid tumors] [12]. A study"/>
   <result pre="total patients with hRV (110) were affected by ALL or" exact="myelodysplastic syndrome" post="(MDS), 19% by chronic leukemia, and 49% by lymphoma,"/>
   <result pre="syndrome (MDS), 19% by chronic leukemia, and 49% by lymphoma," exact="multiple myeloma" post="(MM) or other. In addition, 45% of these patients"/>
   <result pre="was identified as the second most frequent cause of idiopathic" exact="pneumonia" post="(12% of the detected pathogens) [2]. Fisher et al."/>
   <result pre="around 40% of HSCT patients with documented hRV infection developed" exact="pneumonia" post="and 60% of them had co-infections [35]. Viruses belonging"/>
   <result pre="more recent review highlighted that 7% of all children with" exact="cancer" post="who developed a respiratory infection were positive for hMPV."/>
   <result pre="[39]; according to a 2016 review, ALL is the hematological" exact="neoplasm" post="most frequently associated with this virus. For adults this"/>
   <result pre="and 50% [6] and can reach 17% in patients with" exact="pneumonia" post="[2]. However, no statistically significant differences between HSCT and"/>
   <result pre="RSV infection. Of the 18 CMV/RSV co-infections, 11 developed severe" exact="pneumonia" post="(68% of cases), while the same happened in only"/>
   <result pre="RSV infection. Five HSTC patients (approximately 7%) died of severe" exact="pneumonia" post="[17]. Seropositivity for CMV or reactivation of the same"/>
   <result pre="[6]. A prospective study carried out on children diagnosed with" exact="cancer" post="showed that hBoV was present in 8% of viral"/>
   <result pre="[2]. In contrast to the low incidence of bronchitis and" exact="pneumonia" post="in healthy children, severe clinical pictures have been mainly"/>
   <result pre="an observational retrospective study conducted in immunocompromised patients with viral" exact="lung disease" post="showed that the results of PCR tests performed on"/>
   <result pre="In patients with myeloma, oseltamivir reduces the risk of developing" exact="pneumonia" post="as well as relapses [13], while a delay in"/>
   <result pre="not recommended [13]. Ribavirin therapy is recommended in patients with" exact="leukemia" post="and patients with HSCT at high risk of complications"/>
   <result pre="the 2013 Infectious Diseases Society of America Guidelines, an intramuscular" exact="influenza" post="vaccine is recommended for all immunocompromised patients and HSCT"/>
   <result pre="in contact with the patient [43]. Even in patients with" exact="multiple myeloma," post="an effective preventive strategy to reduce the risk of"/>
   <result pre="myeloma, an effective preventive strategy to reduce the risk of" exact="influenza" post="is represented by the seasonal influenza immunization. Although patients"/>
   <result pre="reduce the risk of influenza is represented by the seasonal" exact="influenza" post="immunization. Although patients with multiple myeloma are known to"/>
   <result pre="is represented by the seasonal influenza immunization. Although patients with" exact="multiple myeloma" post="are known to not have high levels of specific"/>
   <result pre="such as DAS 181 on mortality or on progression to" exact="pneumonia" post="has yet to be determined [5]. Lastly, immunotherapy for"/>
   <result pre="yet to be determined [5]. Lastly, immunotherapy for RSV and" exact="influenza" post="has so far given promising results [5]. As previously"/>
   <result pre="given promising results [5]. As previously stated, infections caused by" exact="influenza" post="virus have been successfully treated with neuramidase inhibitors (oseltamivir);"/>
   <result pre="successfully treated with neuramidase inhibitors (oseltamivir); however, its efficacy for" exact="influenza" post="pneumonia has not been established, and antiviral resistance frequently"/>
   <result pre="treated with neuramidase inhibitors (oseltamivir); however, its efficacy for influenza" exact="pneumonia" post="has not been established, and antiviral resistance frequently occurs"/>
   <result pre="J Hematol Infect Dis2019111e201900610.4084/mjhid.2019.00630671212 5.HijanoDRMaronGHaydenRTRespiratory viral infections in patients with" exact="cancer" post="or undergoing hematopoietic cell transplantFront Microbiol201810.3389/fmicb.2018.0309730619176 6.FontanaLStrasfeldLRespiratory virus infections"/>
   <result pre="epidemiology of acute respiratory viral infections in pediatric patients with" exact="cancer" post="undergoing chemotherapyJ. Pediatr. Hematol. Oncol.2019414e242e24610.1097/MPH.000000000000141830688827 13.TehBWSlavinMAHarrisonSJWorthLJPrevention of viral infections"/>
   <result pre="patientsPediatr Transplant20151919410010.1111/petr.1238325377237 17.YueCet al.Virus infection facilitates the development of severe" exact="pneumonia" post="in transplant patients with hematologic malignanciesOncotarget2016733539305394010.18632/oncotarget.1018227340772 18.HatanakaMet al.Respiratory syncytial"/>
   <result pre="parainfluenza virus type 3 in adults receiving treatment for either" exact="acute leukemia" post="or severe aplastic anemia: a retrospective single center studyAnn"/>
   <result pre="virus type 3 in adults receiving treatment for either acute" exact="leukemia" post="or severe aplastic anemia: a retrospective single center studyAnn"/>
   <result pre="acute lymphoblastic leukemiaCancer2016122579880510.1002/cncr.2983326700662 23.BenitesECAet al.Acute respiratory viral infections in pediatric" exact="cancer" post="patients undergoing chemotherapyJ. Pediatr.201490437037610.1016/j.jped.2014.01.006 24.SauerbreiAet al.Prevalence of antibodies against"/>
   <result pre="cancer patients undergoing chemotherapyJ. Pediatr.201490437037610.1016/j.jped.2014.01.006 24.SauerbreiAet al.Prevalence of antibodies against" exact="influenza" post="A and B viruses in children in Germany, 2008â€&quot;2010Eurosurveillance2008195201410.2807/1560-7917.ES2014.19.5.20687"/>
   <result pre="and B viruses in children in Germany, 2008â€&quot;2010Eurosurveillance2008195201410.2807/1560-7917.ES2014.19.5.20687 25.AlsuwaidiARAl-MekainiLAKamalSMNarchiHSouidAKSeroprevalence of" exact="influenza" post="A and B viruses among unvaccinated children in the"/>
   <result pre="al.Influenza in patients with hematological malignancies: experience at two comprehensive" exact="cancer" post="centersJ Med Virol2018901506010.1002/jmv.2493028851056 27.NicholsWGGuthrieKACoreyLBoeckhMInfluenza infections after hematopoietic stem cell"/>
   <result pre="a systematic reviewCancer Lett2016370235836410.1016/j.canlet.2015.11.01426582658 41.ChoiS-MBoudreaultAAXieHEnglundJACoreyLBoeckhMDifferences in clinical outcomes after 2009" exact="influenza" post="A/H1N1 and seasonal influenza among hematopoietic cell transplant recipientsBlood2011117195050505610.1182/blood-2010-11-31918621372154"/>
   <result pre="41.ChoiS-MBoudreaultAAXieHEnglundJACoreyLBoeckhMDifferences in clinical outcomes after 2009 influenza A/H1N1 and seasonal" exact="influenza" post="among hematopoietic cell transplant recipientsBlood2011117195050505610.1182/blood-2010-11-31918621372154 42.HicksKLChemalyRFKontoyiannisDPCommon community respiratory viruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7340289\results\search\disease\results.xml">
   <result pre="Clinical fluid accumulation 2 (4%) Severe dengue Fluid accumulation with" exact="respiratory failure" post="2 (4%) Organ failure 0 Shock 0 Bleeding 0"/>
   <result pre="address role of genotype in dengue virus disease dynamics including" exact="dengue hemorrhagic fever." post="The results also show impact of global circulation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7340301\results\search\disease\results.xml">
   <result pre="Systems Strengthening : Engineering and Technology: Equipment Zika epidemic and" exact="microcephaly" post="in Brazil: Challenges for access to health care and"/>
   <result pre="is an exploratory cross-sectional study which analyses recorded cases of" exact="microcephaly" post="at the municipal level between 2015 and 2017. Most"/>
   <result pre="Grande do Norte and Paraiba had the highest incidence of" exact="microcephaly" post="in the study period. The states of Bahia, Paraiba"/>
   <result pre="Grande do Norte were selected for their high incidence of" exact="microcephaly" post="due to the Zika Virus. Socio-territorial vulnerability was stratified"/>
   <result pre="the Zika Virus. Socio-territorial vulnerability was stratified using access to" exact="microcephaly" post="diagnosis and treatment indicators. The specialized care network was"/>
   <result pre="study is the first to address accessibility of children with" exact="microcephaly" post="to specialised health care services and points to the"/>
   <result pre="infection became a public health problem after its relationship with" exact="microcephaly" post="cases [2,3,4], Guillain-BarrÃ© Syndrome and encephalitis had been confirmed"/>
   <result pre="after its relationship with microcephaly cases [2,3,4], Guillain-BarrÃ© Syndrome and" exact="encephalitis" post="had been confirmed [5]. The first suspected cases of"/>
   <result pre="of Rio Grande do Norte as an outbreak of a" exact="rash" post="of unknown origin [6]. In 2015 and 2016 Zika"/>
   <result pre="families seeking specialized healthcare and rehabilitation for children born with" exact="microcephaly" post="and other diseases related to Zika. Between January and"/>
   <result pre="early detection of suspected cases of diseases such as dengue," exact="chikungunya" post="and Zika, the main urban arboviruses in the country,"/>
   <result pre="prenatal visits during pregnancy, but since the causal link between" exact="microcephaly" post="and ZIKV infection has been established, prenatal consultation procedures"/>
   <result pre="diagnosis of ZIKV infections and other diseases that may cause" exact="microcephaly" post="(syphilis, toxoplasmosis, among others), complementary laboratory tests, epidemiological investigation"/>
   <result pre="for mothers and relatives [7]. In Brazil, since October 2015," exact="microcephaly" post="attributed to ZIKV infections has been reported in obstetric"/>
   <result pre="three States that presented a high number of cases of" exact="microcephaly" post="in the Zika epidemic from 2015 to 2017. Firstly,"/>
   <result pre="2015 to 2017. Firstly, to know the spatial distribution of" exact="microcephaly" post="by Zika in Brazil, we demanded official access to"/>
   <result pre="This data was collected and classified in confirmed cases of" exact="microcephaly" post="by ZIKV in the years of 2015, 2016 and"/>
   <result pre="municipalities. To maintain personal residential data confidentiality the cases of" exact="microcephaly" post="were plotted in the respective municipalityâ€™s centroids, which is"/>
   <result pre="the middle of the municipality equidistant to its territorial limitsA" exact="microcephaly" post="case is a confirmed case of microcephaly and or"/>
   <result pre="its territorial limitsA microcephaly case is a confirmed case of" exact="microcephaly" post="and or Central Nervous System alteration in new-borns (less"/>
   <result pre="by Zika) and have a significant number of cases of" exact="microcephaly" post="in epidemic period of 2015 to 2017. Three States"/>
   <result pre="childbearing age, pregnant women and puerperal women and new-borns with" exact="microcephaly" post="related to ZIKV infection. The data of specialized health"/>
   <result pre="diagnosis and monitoring of pregnant women with foetuses diagnosed with" exact="microcephaly" post="and new-borns with microcephaly 2015 (RN, PB) and 2016"/>
   <result pre="pregnant women with foetuses diagnosed with microcephaly and new-borns with" exact="microcephaly" post="2015 (RN, PB) and 2016 (BA) Distribution of care"/>
   <result pre="and new-borns affected by virus Zika Protocols for response to" exact="microcephaly" post="related to ZIKA infection of State Health Offices (RN,"/>
   <result pre="Ministry of Health (2018) Brazil accumulated 2639 confirmed cases of" exact="microcephaly" post="of Zika between 2015 to 2017 (327 probable cases"/>
   <result pre="possible to note that the highest concentration of cases of" exact="microcephaly" post="associated with ZIKV infection were in the Northeast of"/>
   <result pre="the epidemic was in 2016, with 1,469 confirmed cases of" exact="microcephaly" post="in Brazil, of which 61.1% (897) occurred in the"/>
   <result pre="a sharp 88.3% drop (Table 2). Comparing spatial distribution of" exact="microcephaly" post="cases by the mother's place of residence from 2015"/>
   <result pre="in 2017 the epidemic decreased. Fig 1 Confirmed cases of" exact="microcephaly" post="by ZIKA, by Brazil, by motherâ€™s place of residence,"/>
   <result pre="in the state of Bahia, with 425 confirmed cases of" exact="microcephaly" post="in the period analysed (2015 to 2017), followed by"/>
   <result pre="100 cases. Like other Brazilian states, the highest concentration of" exact="microcephaly" post="cases occurred in the respective capitals. The capital Salvadorâ€&quot;BA"/>
   <result pre="33.0% of the municipalities recorded at least one case of" exact="microcephaly" post="by ZIKV, as well as 25.1% of the municipalities"/>
   <result pre="municipalities in Bahia (Fig 2). Fig 2 Confirmed cases of" exact="microcephaly" post="by ZIKV, in the states of Rio Grande do"/>
   <result pre="Ministry of Health. In addition, by analysing the prevalence of" exact="microcephaly" post="cases by 1,000 live births between 2015 and 2017,"/>
   <result pre="ParaÃ­ba, on average, for every thousand live births 1.0 had" exact="microcephaly" post="due to ZIKV. In the states of Bahia and"/>
   <result pre="were similar, as for every thousand live births 0.7 had" exact="microcephaly" post="due to ZIKV. Among these State capitals the worst"/>
   <result pre="in Salvadorâ€&quot;BA, which for every thousand live births 2.0 had" exact="microcephaly" post="and JoÃ£o Pessoaâ€&quot;PB, where for every thousand live births"/>
   <result pre="Fig 3 Municipal headquarters located within 100 km of the" exact="microcephaly" post="care units in the states of Rio Grande do"/>
   <result pre="children with ZCS. States Municipalities Care units for children with" exact="microcephaly" post="Services Rio Grande do Norte AÃ§u 1 â€&quot;Integrated Rehabilitation"/>
   <result pre="1 â€&quot;Integrated Rehabilitation Center Monitoring and development of children with" exact="microcephaly" post="by a multiprofessional team AreiaBranca 2 â€&quot;Rehabilitation Center of"/>
   <result pre="and monitoring of growth and development of new-borns diagnosed with" exact="microcephaly" post="JoÃ£o Pessoa 2 â€&quot;Father DamiÃ£o Maternity JoÃ£o Pessoa 3"/>
   <result pre="the rehabilitation and early stimulation processes of children diagnosed with" exact="microcephaly" post="by ZIKV are expected to be found. However, the"/>
   <result pre="Zika epidemic since the detection of the first cases of" exact="microcephaly" post="in Pernambuco, demonstrated the importance of health surveillance and"/>
   <result pre="why the Northeast Region had such a high number of" exact="microcephaly" post="cases, as ZIKV spread with great speed throughout the"/>
   <result pre="during pregnancy. On the other hand, we have found that" exact="microcephaly" post="cases were highly concentrated in the State capitals which"/>
   <result pre="children [22]. These mothers understand that their children born with" exact="microcephaly" post="are also responsibility of the State, because of its"/>
   <result pre="as a proxy for the study. Conclusions The Zika and" exact="microcephaly" post="epidemics in Brazil pose important challenges for health services"/>
   <result pre="search of specialized attention and rehabilitation for children born with" exact="microcephaly" post="and other health problems. The distances between the mothers'"/>
   <result pre="BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al.Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013â€&quot;2015: a retrospective study. Lancet. 21"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7343303\results\search\disease\results.xml">
   <result pre="viruses, which account for the continuously increasing ecological burden and" exact="infectious disease" post="outbreaks. Uncovering the hidden diversity of viruses in insects"/>
   <result pre="emergence of epidemic Zika virus and reemergence of dengue (DENV)," exact="chikungunya" post="(CHIKV), yellow fever (YFV), and other infectious diseases (22,"/>
   <result pre="epidemic Zika virus and reemergence of dengue (DENV), chikungunya (CHIKV)," exact="yellow fever" post="(YFV), and other infectious diseases (22, 23). These viruses"/>
   <result pre="honeybees driven by Varroa mites. Science351:594â€&quot;597. doi:10.1126/science.aac9976.26912700 17.ManleyR, BootsM, WilfertL2015Emerging" exact="viral disease" post="risk to pollinating insects: ecological, evolutionary and anthropogenic factors."/>
   <result pre="persistently transmitted viruses. Annu Rev Phytopathol46:327â€&quot;359. doi:10.1146/annurev.phyto.022508.092135.18680428 22.PaixaoES, TeixeiraMG, RodriguesLC2018Zika," exact="chikungunya" post="and dengue: the causes and threats of new and"/>
   <result pre="KimS, SharakhovIV, VernickKD2019De novo profiling of RNA viruses in Anopheles" exact="malaria" post="vector mosquitoes from forest ecological zones in Senegal and"/>
   <result pre="emergence of arthropod-borne viral diseases: a global prospective on dengue," exact="chikungunya" post="and zika fevers. Acta Trop166:155â€&quot;163. doi:10.1016/j.actatropica.2016.11.020.27876643 57.DaszakP, CunninghamAA, HyattAD2001Anthropogenic"/>
   <result pre="in mammalian and insect hosts after continuous replication of vesicular" exact="stomatitis" post="virus in sandfly cells. J Virol69:6805â€&quot;6809. doi:10.1128/JVI.69.11.6805-6809.1995.7474092 62.LongdonB, BrockhurstMA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7343349\results\search\disease\results.xml">
   <result pre="Abnormal clinical chemistry and hematology results were detected and acute" exact="lymphadenopathy" post="was observed in some AGMs. Infection dynamics in all"/>
   <result pre="physical examinations. Clinical observations Physical examinations Presence or absence of" exact="rash" post="Presence or absence of rash Ocular evaluation Ocular evaluation"/>
   <result pre="examinations Presence or absence of rash Presence or absence of" exact="rash" post="Ocular evaluation Ocular evaluation Appearance of joints Joint evaluation"/>
   <result pre="or absence of blood and source Presence or absence of" exact="lymphadenopathy" post="Presence or absence of cough Lymph node size Food"/>
   <result pre="loss (S1, S2, S3, S4 and S5 Figs). However, acute" exact="lymphadenopathy" post="was observed in several AGMs (Table 4 and S6"/>
   <result pre="had seroconverted (Table 5). Clinical observations and laboratory results Acute" exact="lymphadenopathy" post="involving the left and right axillary lymph nodes was"/>
   <result pre="15 DPI (Table 5). Clinical observations and laboratory results Acute" exact="lymphadenopathy" post="was observed in viremic AGMs at various times during"/>
   <result pre="DPI, 75% of the AGMs (AGM5, AGM6 and AGM7) displayed" exact="lymphadenopathy" post="involving the inguinal lymph nodes. This was a transient"/>
   <result pre="AGM7 lasting a single day. However, AGM6 continued to display" exact="lymphadenopathy" post="involving the axillary or inguinal lymph nodes at multiple"/>
   <result pre="of liver involvement among ZIKV patients maybe uncommon, patients with" exact="liver disease" post="or those with comorbidities that impact liver function should"/>
   <result pre="While ZIKV-infected AGMs did not display overt signs of disease," exact="lymphadenopathy" post="was observed in some AGMs during physical examinations. We"/>
   <result pre="lymphadenopathy. Although we did not observe acute axillary or inguinal" exact="lymphadenopathy" post="in AGMs infected via the intrarectal route, we speculate"/>
   <result pre="may require the use of ultrasound imaging. To our knowledge" exact="lymphadenopathy" post="has not been previously reported in ZIKV-experimentally infected NHPs,"/>
   <result pre="Though we were able to detect acute axial and inguinal" exact="lymphadenopathy" post="in the majority of viremic AGMs (SC and IVAG),"/>
   <result pre="and IVAG), manual abdominal examination may have failed to reveal" exact="lymphadenopathy" post="in the abdomen of AGMs. Therefore, future studies should"/>
   <result pre="of ZIKV infection in AGMs that recapitulates infection dynamics and" exact="lymphadenopathy" post="reported in human casesâ€&quot;providing a single, easily-sourced NHP species"/>
   <result pre="MontarroyosUR, de MeloAP, et al.Association between Zika virus infection and" exact="microcephaly" post="in Brazil, January to May, 2016: preliminary report of"/>
   <result pre="1956;50(3):238â€&quot;42. 10.1016/0035-9203(56)90029-3 .13337908 58HendersonBE, CheshirePP, KiryaGB, LuleM. Immunologic studies with" exact="yellow fever" post="and selected African group B arboviruses in rhesus and"/>
   <result pre="KawakitaY. Studies on SV40 in tissue culture: preliminary step for" exact="cancer" post="reserach in vitro. Nihon Rinsho. 1963;21:1201â€&quot;15. 85ChoF, HiyaokaA, SuzukiMT,"/>
   <result pre="Tropical Medicine and Hygiene. 1982;76(4):552â€&quot;62. 10.1016/0035-9203(82)90161-4 .6304948 103KiryaBG, OkiaNO. A" exact="yellow fever" post="epizootic in Zika Forest, Uganda, during 1972: Part 2:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7343990\results\search\disease\results.xml">
   <result pre="A virus (IAV) causes annual epidemics and sporadic pandemics of" exact="respiratory disease." post="Secondary bacterial coinfection by organisms such as Staphylococcus aureus"/>
   <result pre="finding that could be applied to address global shortages of" exact="influenza" post="vaccines. Abstract ABSTRACT Influenza A virus (IAV) causes annual"/>
   <result pre="Abstract ABSTRACT Influenza A virus (IAV) causes annual epidemics of" exact="respiratory disease" post="in humans, often complicated by secondary coinfection with bacterial"/>
   <result pre="this activity may be harnessed to address global shortages of" exact="influenza" post="vaccines. KEYWORDS Staphylococcus aureus influenza influenza vaccines lipase pathogenesis"/>
   <result pre="to address global shortages of influenza vaccines. KEYWORDS Staphylococcus aureus" exact="influenza" post="influenza vaccines lipase pathogenesis Funding Wellcome Trust (Wellcome)https://doi.org/10.13039/100004440 201531/Z/16/ZFitzgeraldJ."/>
   <result pre="address global shortages of influenza vaccines. KEYWORDS Staphylococcus aureus influenza" exact="influenza" post="vaccines lipase pathogenesis Funding Wellcome Trust (Wellcome)https://doi.org/10.13039/100004440 201531/Z/16/ZFitzgeraldJ. Ross"/>
   <result pre="perform this role in human seasonal IAV infections or low-pathogenicity" exact="avian influenza" post="virus infections (4). Virus replication is entirely dependent on"/>
   <result pre="this role in human seasonal IAV infections or low-pathogenicity avian" exact="influenza" post="virus infections (4). Virus replication is entirely dependent on"/>
   <result pre="skin and soft tissue infections to life-threatening conditions, such as" exact="endocarditis" post="and necrotizing pneumonia (11). Of note, the emergence of"/>
   <result pre="tissue infections to life-threatening conditions, such as endocarditis and necrotizing" exact="pneumonia" post="(11). Of note, the emergence of highly virulent clones"/>
   <result pre="resulted in S. aureus becoming the leading cause of nosocomial" exact="pneumonia" post="in the United States (12). The role of immune"/>
   <result pre="causes for the increased susceptibility to bacterial coinfection following primary" exact="influenza" post="(8). The contribution of individual S. aureus factors is"/>
   <result pre="To investigate further the role of S. aureus proteases during" exact="influenza" post="coinfection, we repeated the protocol employed by Tashiro et"/>
   <result pre="a major limitation of standard methods for the production of" exact="influenza" post="vaccines. FIGÂ 6 Lipase 1 enhances IAV replication in"/>
   <result pre="Accordingly, we suggest that S. aureus superinfection of humans with" exact="influenza" post="may lead to a lipase 1-mediated enhancement of virus"/>
   <result pre="aureus during coinfection. Although it is well established that secondary" exact="bacterial pneumonia" post="is a major cause of mortality during IAV epidemics,"/>
   <result pre="during coinfection. Although it is well established that secondary bacterial" exact="pneumonia" post="is a major cause of mortality during IAV epidemics,"/>
   <result pre="some murine models have demonstrated increased severity of S. aureus" exact="respiratory disease" post="when preceded by IAV infection (52), in a cynomolgus"/>
   <result pre="could be a considerable advantage in the event of an" exact="influenza" post="pandemic caused by a strain bearing an avian strain-derived"/>
   <result pre="an avian strain-derived HA (56). The threat of another global" exact="influenza" post="pandemic is ongoing, and bacterial coinfection is a frequent"/>
   <result pre="Digard P, Fitzgerald JR. 2020. Staphylococcus aureus lipase 1 enhances" exact="influenza" post="A virus replication. mBio 11:e00975-20. https://doi.org/10.1128/mBio.00975-20. ACKNOWLEDGMENTS The study"/>
   <result pre="REFERENCES 1.JosephU, SuYCF, VijaykrishnaD, SmithG2017The ecology and adaptive evolution of" exact="influenza" post="A interspecies transmission. Influenza Other Respir Viruses11:74â€&quot;84. doi:10.1111/irv.12412.27426214 2.TongS,"/>
   <result pre="PaulsonJC, StevensJ, RupprechtCE, HolmesEC, WilsonIA, DonisRO2013New World bats harbor diverse" exact="influenza" post="A viruses. PLoS Pathog9:e1003657. doi:10.1371/journal.ppat.1003657.24130481 3.SkehelJJ, WileyDC2000Receptor binding and"/>
   <result pre="3.SkehelJJ, WileyDC2000Receptor binding and membrane fusion in virus entry: the" exact="influenza" post="hemagglutinin. Annu Rev Biochem69:531â€&quot;569. doi:10.1146/annurev.biochem.69.1.531.10966468 4.LaporteM, NaesensL2017Airway proteases: an"/>
   <result pre="Biochem69:531â€&quot;569. doi:10.1146/annurev.biochem.69.1.531.10966468 4.LaporteM, NaesensL2017Airway proteases: an emerging drug target for" exact="influenza" post="and other respiratory virus infections. Curr Opin Virol24:16â€&quot;24. doi:10.1016/j.coviro.2017.03.018.28414992"/>
   <result pre="of all pandemics. Emerg Infect Dis12:15â€&quot;22. doi:10.3201/eid1201.050979.16494711 8.McCullersJA2014The co-pathogenesis of" exact="influenza" post="viruses with bacteria in the lung. Nat Rev Microbiol12:252â€&quot;262."/>
   <result pre="JostH, MetcalfeM, GoldsmithCS, HumphreyC, SchmitzA, DrewC, PaddockC, UyekiTM, ZakiSR20102009 pandemic" exact="influenza" post="A (H1N1). Am J Pathol177:166â€&quot;175. doi:10.2353/ajpath.2010.100115.20508031 10.MauadT, HajjarLA, CallegariGD,"/>
   <result pre="GutierrezPS, CaldiniE, PasqualucciCA, DolhnikoffM, SaldivaP2010Lung pathology in fatal novel human" exact="influenza" post="A (H1N1) infection. Am J Respir Crit Care Med181:72â€&quot;79."/>
   <result pre="and management. Clin Microbiol Rev28:603â€&quot;661. doi:10.1128/CMR.00134-14.26016486 12.JonesRN2010Microbial etiologies of hospital-acquired" exact="bacterial pneumonia" post="and ventilator-associated bacterial pneumonia. Clin Infect Dis51(Suppl 1):S81â€&quot;S87. doi:10.1086/653053.20597676"/>
   <result pre="management. Clin Microbiol Rev28:603â€&quot;661. doi:10.1128/CMR.00134-14.26016486 12.JonesRN2010Microbial etiologies of hospital-acquired bacterial" exact="pneumonia" post="and ventilator-associated bacterial pneumonia. Clin Infect Dis51(Suppl 1):S81â€&quot;S87. doi:10.1086/653053.20597676"/>
   <result pre="Rev28:603â€&quot;661. doi:10.1128/CMR.00134-14.26016486 12.JonesRN2010Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated" exact="bacterial pneumonia." post="Clin Infect Dis51(Suppl 1):S81â€&quot;S87. doi:10.1086/653053.20597676 13.BorgognaTR, HiseyB, HeitmannE, ObarJJ,"/>
   <result pre="Infect Dis51(Suppl 1):S81â€&quot;S87. doi:10.1086/653053.20597676 13.BorgognaTR, HiseyB, HeitmannE, ObarJJ, MeissnerN, VoyichJM2018Secondary" exact="bacterial pneumonia" post="by Staphylococcus aureus following influenza A infection is SaeR/S"/>
   <result pre="Dis51(Suppl 1):S81â€&quot;S87. doi:10.1086/653053.20597676 13.BorgognaTR, HiseyB, HeitmannE, ObarJJ, MeissnerN, VoyichJM2018Secondary bacterial" exact="pneumonia" post="by Staphylococcus aureus following influenza A infection is SaeR/S"/>
   <result pre="HeitmannE, ObarJJ, MeissnerN, VoyichJM2018Secondary bacterial pneumonia by Staphylococcus aureus following" exact="influenza" post="A infection is SaeR/S dependent. J Infect Dis218:809â€&quot;813. doi:10.1093/infdis/jiy210.29668950"/>
   <result pre="HartmayerC, HertleinT, KlingelK, KretschmerD, PlanzO, PeschelA2017Phenol-soluble modulin peptides contribute to" exact="influenza" post="A virus-associated Staphylococcus aureus pneumonia. Infect Immun85:e00620-17. doi:10.1128/IAI.00620-17. 15.RoweHM,"/>
   <result pre="Immun85:e00620-17. doi:10.1128/IAI.00620-17. 15.RoweHM, MeliopoulosVA, IversonA, BommeP, Schultz-CherryS, RoschJW2019Direct interactions with" exact="influenza" post="promote bacterial adherence during respiratory infections. Nat Microbiol4:1328â€&quot;1336. doi:10.1038/s41564-019-0447-0.31110359"/>
   <result pre="KlenkH-D, RottR1987Synergistic role of staphylococcal proteases in the induction of" exact="influenza" post="virus pathogenicity. Virology157:421â€&quot;430. doi:10.1016/0042-6822(87)90284-4.3029981 17.TashiroM, CiborowskiP, KlenkH-D, PulvererG, RottR1987Role"/>
   <result pre="KlenkH-D, PulvererG, RottR1987Role of Staphylococcus protease in the development of" exact="influenza" post="pneumonia. Nature325:536â€&quot;537. doi:10.1038/325536a0.3543690 18.CadieuxB, VijayakumaranV, BernardsMA, McGavinMJ, HeinrichsDE2014Role of"/>
   <result pre="and molecular characterization. Biochimie82:1005â€&quot;1014. doi:10.1016/s0300-9084(00)01180-9.11099797 23.ZhirnovOP, OvcharenkoAV, BukrinskayaAG1982Proteolytic activation of" exact="influenza" post="WSN virus in cultured cells is performed by homologous"/>
   <result pre="WellsK, TakadaA, KawaokaY2001Plasminogen-binding activity of neuraminidase determines the pathogenicity of" exact="influenza" post="A virus. J Virol75:9297â€&quot;9301. doi:10.1128/JVI.75.19.9297-9301.2001.11533192 25.DadonaiteB, VijayakrishnanS, FodorE, BhellaD,"/>
   <result pre="A virus. J Virol75:9297â€&quot;9301. doi:10.1128/JVI.75.19.9297-9301.2001.11533192 25.DadonaiteB, VijayakrishnanS, FodorE, BhellaD, HutchinsonEC2016Filamentous" exact="influenza" post="viruses. J Gen Virol97:1755â€&quot;1764. doi:10.1099/jgv.0.000535.27365089 26.Simpson-HolleyM, EllisD, FisherD, EltonD,"/>
   <result pre="the actin cytoskeleton and lipid rafts during budding of filamentous" exact="influenza" post="virions. Virology301:212â€&quot;225. doi:10.1006/viro.2002.1595.12359424 27.BruceEA, DigardP, StuartAD2010The Rab11 pathway is"/>
   <result pre="Virology301:212â€&quot;225. doi:10.1006/viro.2002.1595.12359424 27.BruceEA, DigardP, StuartAD2010The Rab11 pathway is required for" exact="influenza" post="A virus budding and filament formation. J Virol84:5848â€&quot;5859. doi:10.1128/JVI.00307-10.20357086"/>
   <result pre="TurnbullML, WiseHM, JaggerBW, BeardPM, KovacikovaK, TaubenbergerJK, VerveldeL, EngelhardtOG, DigardP2018Mutation of" exact="influenza" post="A virus PA-X decreases pathogenicity in chicken embryos and"/>
   <result pre="U S A116:3764â€&quot;3773. doi:10.1073/pnas.1817248116.30755523 36.PohlMO, LanzC, StertzS2016Late stages of the" exact="influenza" post="A virus replication cycleâ€&quot;a tight interplay between virus and"/>
   <result pre="and host. J Gen Virol97:2058â€&quot;2072. doi:10.1099/jgv.0.000562.27449792 37.ScheiffeleP, RothMG, SimonsK1997Interaction of" exact="influenza" post="virus haemagglutinin with sphingolipidâ€&quot;cholesterol membrane domains via its transmembrane"/>
   <result pre="LingwoodCA, ShevchenkoA, SchroederC, SimonsK2012Quantitative analysis of the lipidomes of the" exact="influenza" post="virus envelope and MDCK cell apical membrane. J Cell"/>
   <result pre="apical membrane. J Cell Biol196:213â€&quot;221. doi:10.1083/jcb.201108175.22249292 39.SchroederC, HeiderH, MÃ¶ncke-BuchnerE, LinT-I2005The" exact="influenza" post="virus ion channel and maturation cofactor M2 is a"/>
   <result pre="Cell142:902â€&quot;913. doi:10.1016/j.cell.2010.08.029.20850012 41.BarmanS, NayakDP2007Lipid raft disruption by cholesterol depletion enhances" exact="influenza" post="A virus budding from MDCK cells. J Virol81:12169â€&quot;12178. doi:10.1128/JVI.00835-07.17855515"/>
   <result pre="of lung pericytes and resident fibroblasts in the pathogenesis of" exact="pulmonary fibrosis." post="Am J Respir Crit Care Med188:820â€&quot;830. doi:10.1164/rccm.201212-2297OC.23924232 45.BarronL, GharibSA,"/>
   <result pre="47.IversonAR, BoydKL, McAuleyJL, PlanoLR, HartME, McCullersJA2011Influenza virus primes mice for" exact="pneumonia" post="from Staphylococcus aureus. J Infect Dis203:880â€&quot;888. doi:10.1093/infdis/jiq113.21278211 48.LeemanKT, FillmoreCM,"/>
   <result pre="Biol107:207â€&quot;233. doi:10.1016/B978-0-12-416022-4.00008-1.24439808 49.McCullersJA, BartmessKC2003Role of neuraminidase in lethal synergism between" exact="influenza" post="virus and Streptococcus pneumoniae. J Infect Dis187:1000â€&quot;1009. doi:10.1086/368163.12660947 50.SiegelSJ,"/>
   <result pre="GardnerDJ, OttoM, BriningDL, KreiswirthBN, TaubenbergerJK, ParnellMJ, FeldmannH, MusserJM, DeLeoFR2013Seasonal H3N2" exact="influenza" post="A virus fails to enhance Staphylococcus aureus co-infection in"/>
   <result pre="HayAJ, DanielsRS, McCauleyJW2012Evolution of the receptor binding properties of the" exact="influenza" post="A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A109:21474â€&quot;21479."/>
   <result pre="KloppC, BouchezO, TileyL, GuÃ©rinJ-L2013Whole-genome, deep pyrosequencing analysis of a duck" exact="influenza" post="A virus evolution in swine cells. Infect Genet Evol18:31â€&quot;41."/>
   <result pre="swine cells. Infect Genet Evol18:31â€&quot;41. doi:10.1016/j.meegid.2013.04.034.23660486 59.ChenBJ, LeserGP, JacksonD, LambRA2008The" exact="influenza" post="virus M2 protein cytoplasmic tail interacts with the M1"/>
   <result pre="WitE, SpronkenMIJ, BestebroerTM, RimmelzwaanGF, OsterhausADME, FouchierRAM2004Efficient generation and growth of" exact="influenza" post="virus A/PR/8/34 from eight cDNA fragments. Virus Res103:155â€&quot;161. doi:10.1016/j.virusres.2004.02.028.15163504"/>
   <result pre="WiseHM, RollasonR, GalaoRP, BantingG, NeilSJ, DigardP2012Release of filamentous and spherical" exact="influenza" post="A virus is not restricted by tetherin. J Gen"/>
   <result pre="doi:10.1099/vir.0.038778-0.22258861 62.HaymanA, ComelyS, LackenbyA, HartgrovesLCS, GoodbournS, McCauleyJW, BarclayWS2007NS1 proteins of" exact="avian influenza" post="A viruses can act as antagonists of the human"/>
   <result pre="62.HaymanA, ComelyS, LackenbyA, HartgrovesLCS, GoodbournS, McCauleyJW, BarclayWS2007NS1 proteins of avian" exact="influenza" post="A viruses can act as antagonists of the human"/>
   <result pre="DutiaBM, NashAA2012A novel family of peptides with potent activity against" exact="influenza" post="A viruses. J Gen Virol93:980â€&quot;986. doi:10.1099/vir.0.038679-0.22258859 64.CorriganRM, FosterTJ2009An improved"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7344733\results\search\disease\results.xml">
   <result pre="(CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Background: Currently, the immunogenicity of" exact="influenza" post="vaccines is assessed by detecting an increase of hemagglutination"/>
   <result pre="As neuraminidase (NA)-based immunity may be significant in protecting against" exact="influenza" post="infection, detection of neuraminidase inhibiting (NI) antibodies may improve"/>
   <result pre="(NI) antibodies may improve the assessment of the immunogenicity of" exact="influenza" post="vaccines. Methods: We investigated the immune response to NA"/>
   <result pre="immune response to NA in people after immunization with live" exact="influenza" post="vaccines (LAIVs). A number of A/H7NX or A/H6NX viruses"/>
   <result pre="can provide a more complete assessment of LAIV immunogenicity. live" exact="influenza" post="vaccine immunogenicity neuraminidase inhibiting antibody 1. Introduction The determination"/>
   <result pre="The determination of antibodies that inhibit neuraminidase (NA) in the" exact="influenza" post="virus (the genus Influenzavirus, the family Orthomyxoviridae) is of"/>
   <result pre="used when examining the levels of collective immunity to new" exact="influenza" post="viruses, and for assessing the immunogenicity of influenza vaccines"/>
   <result pre="to new influenza viruses, and for assessing the immunogenicity of" exact="influenza" post="vaccines [1]. Currently, the immunogenicity of influenza vaccines is"/>
   <result pre="the immunogenicity of influenza vaccines [1]. Currently, the immunogenicity of" exact="influenza" post="vaccines is assessed by detecting an increase of hemagglutination"/>
   <result pre="significant in protection against a new antigenic variant of an" exact="influenza" post="virus, detection of neuraminidase inhibiting (NI) antibodies may improve"/>
   <result pre="may improve the study of the immunogenicity of newly developed" exact="influenza" post="vaccines. In the present study, we investigated the formation"/>
   <result pre="formation of NI antibodies in people after immunization with live" exact="influenza" post="vaccines (LAIVs) of pandemic and potentially pandemic subtypes. The"/>
   <result pre="antibodies and, therefore, to develop criteria for the immunogenicity of" exact="influenza" post="vaccine assessment based on the evaluation of NI antibodies."/>
   <result pre="based on the evaluation of NI antibodies. To obtain reassortant" exact="influenza" post="A vaccine viruses, a cold-adapted â€œmaster donor strainâ€� (MDS)"/>
   <result pre="genes of surface glycosylated proteinsâ€&quot; hemagglutitin (HA) and NAâ€&quot;from epidemic" exact="influenza" post="viruses. LAIVs have been used in Russia since the"/>
   <result pre="years of age, and 40% in adults [5,6]. As seasonal" exact="influenza" post="vaccines cannot protect against infection with avian influenza viruses,"/>
   <result pre="[5,6]. As seasonal influenza vaccines cannot protect against infection with" exact="avian influenza" post="viruses, the World Health Organization (WHO) carries out monitoring"/>
   <result pre="As seasonal influenza vaccines cannot protect against infection with avian" exact="influenza" post="viruses, the World Health Organization (WHO) carries out monitoring"/>
   <result pre="(WHO) carries out monitoring and analysis of potentially pandemic zoonotic" exact="influenza" post="viruses in the development of appropriate vaccines [7]. In"/>
   <result pre="formation of antibodies to NA of pandemic and potentially pandemic" exact="influenza" post="viruses after LAIV immunization. 2. Materials and Methods 2.1."/>
   <result pre="before and 21 days after vaccination with seasonal trivalent live" exact="influenza" post="vaccine (LAIV) 2005â€&quot;2006. The trivalent vaccine was manufactured by"/>
   <result pre="Center collected in the 2016, and the paired sera from" exact="influenza" post="convalescents provided by the Institute of Influenza. The patients"/>
   <result pre="A/17/mallard/Netherlands/00/95 (H7N3) vaccine strain, we used the A/tern/South Africa/61 (H5N3)" exact="influenza" post="virus. All viruses were cultured in the allantoic cavity"/>
   <result pre="Results Table 3 presents antibody levels (GMTs) against both main" exact="influenza" post="glycoproteinsâ€&quot;HA and NAâ€&quot;detected before vaccination and after revaccination with"/>
   <result pre="after revaccination with LAIVs developed against pandemic and potentially pandemic" exact="influenza" post="viruses. According to the HI test and ELLA, the"/>
   <result pre="the presence of NI antibodies, including the N1 of the" exact="avian influenza" post="virus A/Vietnam/1203/04 (H5N1) and the drift variant of the"/>
   <result pre="presence of NI antibodies, including the N1 of the avian" exact="influenza" post="virus A/Vietnam/1203/04 (H5N1) and the drift variant of the"/>
   <result pre="drift variant of the pandemic virus A(H1N1)pdm09â€&quot;the A/South Africa/3626/2013 (H1N1)pdm09" exact="influenza" post="virus (Table 4). The lowest preexisting NI antibody levels"/>
   <result pre="NI antibody levels were revealed against A/Anhui/1/13(H7N9) and A/South Africa/3626/13(H1N1)pdm09" exact="influenza" post="viruses (0% and 7% of persons with NI antibody"/>
   <result pre="against A/H1N1pdm09, but also for the NA of the A/Vietnam/1203/04(H5N1)" exact="avian influenza" post="virus. In 2011, 46% of the examined volunteers had"/>
   <result pre="A/H1N1pdm09, but also for the NA of the A/Vietnam/1203/04(H5N1) avian" exact="influenza" post="virus. In 2011, 46% of the examined volunteers had"/>
   <result pre="A/H1N1pdm09 had been recommended for inclusion in the composition of" exact="influenza" post="vaccines in the 2016â€&quot;2017 influenza season (https://www.who.int/influenza/vaccines/virus/recommendations/summary_a_h1n1pdm09_cvv_nh1617.pdf). From 2009,"/>
   <result pre="inclusion in the composition of influenza vaccines in the 2016â€&quot;2017" exact="influenza" post="season (https://www.who.int/influenza/vaccines/virus/recommendations/summary_a_h1n1pdm09_cvv_nh1617.pdf). From 2009, A/California/7/09(H1N1)pdm09-like viruses circulated, which, from"/>
   <result pre="to NA, which may be associated with first contacts with" exact="influenza" post="viruses [24]. Figure 1 demonstrates the NI and HI/MN"/>
   <result pre="previously obtained data on NI antibodies as independent indicators of" exact="influenza" post="immunity, other than hemagglutination inhibiting antibodies [25]. In the"/>
   <result pre="increase in NI antibodies, not only to homologous seasonal A/H1N1" exact="influenza" post="virus, but also to the antigenically distinct variants A/California/7/09"/>
   <result pre="(H1N1)pdm09 and A/Vietnam/1203/04(H5N1). Antibody levels to the A/New Caledonia/20/99 (H1N1)" exact="influenza" post="virus to some extent correlated with titers of the"/>
   <result pre="0.60; n = 56; p &amp;lt; 0.001) and avian A/H5N1" exact="influenza" post="virus (rs = 0.46; n = 56; p &amp;lt;"/>
   <result pre="acid sequences of avian A/H5N1 and epidemic and pandemic A/H1N1pdm09" exact="influenza" post="strains demonstrated the higher homology between amino acid sequences"/>
   <result pre="volunteers examined in 2011; that is, after the pandemic A/H1N1pdm09" exact="influenza" post="virus entered circulation. The mean NI anti-H5N1/2004 antibody titer"/>
   <result pre="we analyzed the NI antibody content in patients with confirmed" exact="influenza" post="A infection, and recipients of A/17/California/09/38 (H1N1)pdm09 LAIV with"/>
   <result pre="statistically significant (p &amp;lt; 0.0001). 4. Discussion LAIVs against seasonal" exact="influenza" post="are harmless and cause persistent homologous responses to wild-type"/>
   <result pre="influenza are harmless and cause persistent homologous responses to wild-type" exact="influenza" post="viruses [4]. Owing to the high variability of influenza"/>
   <result pre="wild-type influenza viruses [4]. Owing to the high variability of" exact="influenza" post="HA, each vaccine formulation should be updated almost annually."/>
   <result pre="each vaccine formulation should be updated almost annually. Although licensed" exact="influenza" post="vaccines are primarily designed to provide homotypic protection, studies"/>
   <result pre="designed to provide homotypic protection, studies show that immunization with" exact="influenza" post="vaccines or natural infections with seasonal influenza A strains"/>
   <result pre="that immunization with influenza vaccines or natural infections with seasonal" exact="influenza" post="A strains induce serum cross-reactive antibodies to antigenically different"/>
   <result pre="of viruses [26,27]. Traditionally, the assessment of the immunogenicity of" exact="influenza" post="vaccines is carried out by assessing the level of"/>
   <result pre="of the virus, the HA. The study of antibodies to" exact="influenza" post="NA is useful when influenza viruses with new HAs"/>
   <result pre="The study of antibodies to influenza NA is useful when" exact="influenza" post="viruses with new HAs appear in circulation, and the"/>
   <result pre="determining NA-inhibiting antibodies. To avoid non-specific reactions with antibodies to" exact="influenza" post="A, viruses of subtype H7 and H6 are used"/>
   <result pre="The protective role of serum antibodies to the NA of" exact="influenza" post="viruses was discovered in the 1970s. During the outbreak"/>
   <result pre="discovered in the 1970s. During the outbreak of Hong Kong" exact="influenza" post="in 1968, the frequency of infection with the A/H3N2"/>
   <result pre="it was found that NA antibodies reduce the severity of" exact="influenza" post="infection in humans [30]. In animal experiments, it was"/>
   <result pre="In 2009, the WHO announced the emergence of a new" exact="influenza" post="pandemic caused by the influenza A/H1N1pdm09 virus, which had"/>
   <result pre="the emergence of a new influenza pandemic caused by the" exact="influenza" post="A/H1N1pdm09 virus, which had not previously been isolated from"/>
   <result pre="announcement of the pandemic, studies of the immune status against" exact="influenza" post="viruses in various populations began [33]. It was revealed"/>
   <result pre="that some people have cross-reacting antibodies to the NA of" exact="influenza" post="viruses with new HA subtypes, resulting from contacts with"/>
   <result pre="a titer of â‰¥1:40 significantly reduced the duration of seasonal" exact="influenza" post="A virus shedding in adults [35]. Age-related differences in"/>
   <result pre="N1 subtype [24]. Despite the fact that the NA of" exact="influenza" post="A/H1N1 and A/H5N1 strains differs in antigenic properties and"/>
   <result pre="the spatial structure of the NA of several subtypes of" exact="influenza" post="A virus and the only subtype of influenza B"/>
   <result pre="subtypes of influenza A virus and the only subtype of" exact="influenza" post="B virus is known, and the mechanisms of the"/>
   <result pre="by amino acids that are conserved in animal and human" exact="influenza" post="A viruses of various subtypes, as well as influenza"/>
   <result pre="human influenza A viruses of various subtypes, as well as" exact="influenza" post="B viruses. NA has often been seen as a"/>
   <result pre="seronegative population. The HI and NI antibody titers to A/California/7/09(H1N1)pdm09" exact="influenza" post="virus after natural infection were higher compared with LAIV"/>
   <result pre="with an increased level of NI antibodies to the H1N1/2009pdm09" exact="influenza" post="virus, but also when vaccinated with a seasonal LAIV."/>
   <result pre="[30]. Higher proportions of pre-existing NI antibodies against distant A/H2N2" exact="influenza" post="viruses among elderly volunteers compared with younger people suggests"/>
   <result pre="for priority vaccination. The absence of antibodies to the A/H7N9" exact="influenza" post="virus among people aged 18â€&quot;49 indicates their susceptibility to"/>
   <result pre="coincidence of the serum immune response to the two surface" exact="influenza" post="antigens indicates the need to use ELLA to more"/>
   <result pre="to use ELLA to more fully characterize the immunogenicity of" exact="influenza" post="vaccines. 5. Conclusions A number of LAIVs developed against"/>
   <result pre="A number of LAIVs developed against pandemic and potentially pandemic" exact="influenza" post="viruses have effectively elicited an immune response in the"/>
   <result pre="increase in inhibition of the hemagglutinating and neuraminidase activity of" exact="influenza" post="viruses, as assessed by post-vaccination sera, was revealed. Combining"/>
   <result pre="antigenically distant strains. Low preexisting NI antibodies against newly emerged" exact="influenza" post="viruses may indicate a high-risk population for priority vaccination."/>
   <result pre="of Influenza, Saint Petersburg, Russia, for providing the sera from" exact="influenza" post="convalescents. Author Contributions Conceptualization, Y.D. and T.S.; methodology, T.S."/>
   <result pre="References References 1.KrammerF.FouchierR.A.EichelbergerM.C.WebbyR.J.Shaw-SalibaK.WanH.WilsonP.C.CompansR.W.SkountzouI.MontoA.S.NAction! How can neuraminidase-based immunity contribute to better" exact="influenza" post="virus vaccines?MBio20189e02332-1710.1128/mBio.02332-17 2.AlexandrovaG.I.BudilovskyG.N.KovalT.A.PolezhaevF.I.GarmashovaL.M.GhendonY.Z.RomanovaY.R.SmorodintsevA.A.Study of live recombinant cold-adapted influenza bivalent"/>
   <result pre="to better influenza virus vaccines?MBio20189e02332-1710.1128/mBio.02332-17 2.AlexandrovaG.I.BudilovskyG.N.KovalT.A.PolezhaevF.I.GarmashovaL.M.GhendonY.Z.RomanovaY.R.SmorodintsevA.A.Study of live recombinant cold-adapted" exact="influenza" post="bivalent vaccine of type A for use in children:"/>
   <result pre="in children: An epidemiological control trialVaccine1986411411810.1016/0264-410X(86)90049-63524050 3.AlexandrovaG.I.MaassabH.F.KendalA.P.MedvedevaT.E.EgorovA.Y.KlimovA.I.CoxN.J.Laboratory properties of cold-adapted" exact="influenza" post="B live vaccine strains developed in the US and"/>
   <result pre="Immunization Practicesâ€™ controversial recommendation against the use of live attenuated" exact="influenza" post="vaccine is based on a biased study design that"/>
   <result pre="VecchiaC.Influenza vaccine in healthy children: A meta-analysisVaccine2005232851286110.1016/j.vaccine.2004.11.05315780733 6.KendalA.P.Cold-adapted live attenuated" exact="influenza" post="vaccines developed in Russia: Can they contribute to meeting"/>
   <result pre="in Russia: Can they contribute to meeting the needs for" exact="influenza" post="control in other countries?Eur. J. Epidemiol.19971359160910.1023/A:10073275058629258574 7.WHO Technical Report."/>
   <result pre="mice induced by live-attenuated or inactivated vaccines against highly pathogenic" exact="influenza" post="A (H5N1) virusesVaccine2006246588659310.1016/j.vaccine.2006.05.03917030078 9.RudenkoL.DeshevaJ.KorovkinS.MironovA.RekstinA.GrigorievaE.DoninaS.GambaryanA.KatlinskyA.Safety and immunogenicity of live attenuated"/>
   <result pre="influenza A (H5N1) virusesVaccine2006246588659310.1016/j.vaccine.2006.05.03917030078 9.RudenkoL.DeshevaJ.KorovkinS.MironovA.RekstinA.GrigorievaE.DoninaS.GambaryanA.KatlinskyA.Safety and immunogenicity of live attenuated" exact="influenza" post="reassortant H5 vaccine (phase I-II clinical trials)Influenza Other Respir."/>
   <result pre="clinical trials)Influenza Other Respir. Viruses2008220320910.1111/j.1750-2659.2008.00064.x19453396 10.RudenkoL.Van Den BoschH.KiselevaI.MironovA.NaikhinA.LarionovaN.BushmenkovD.Live attenuated pandemic" exact="influenza" post="vaccine: Clinical studies on A/17/California/ 2009/38 (H1N1) and licensing"/>
   <result pre="and licensing of the Russian-developed technology to WHO for pandemic" exact="influenza" post="preparedness in developing countriesVaccine201129A40A4410.1016/j.vaccine.2011.04.12221684428 11.DeshevaY.SmolonoginaT.RudenkoL.Detection of anti-neuraminidase antibody in"/>
   <result pre="of anti-neuraminidase antibody in preclinical and clinical studies of live" exact="influenza" post="vaccineInfluenza Other Respir. Viruses20115370 12.DeshevaJ.RudenkoL.RekstinA.SwayneD.E.CoxN.J.KlimovA.I.Development of candidate H7N3 live"/>
   <result pre="Other Respir. Viruses20115370 12.DeshevaJ.RudenkoL.RekstinA.SwayneD.E.CoxN.J.KlimovA.I.Development of candidate H7N3 live attenuated coldâ€&quot;adapted" exact="influenza" post="vaccineProceedings of the International Conference on Options for the"/>
   <result pre="June 2007 13.RudenkoL.KiselevaI.NaykhinA.N.ErofeevaM.StukovaM.DoninaS.PetukhovaG.PisarevaM.KrivitskayaV.GrudininM.et al.Assessment of human immune responses to H7" exact="avian influenza" post="virus of pandemic potential: Results from a placebo-controlled, randomized"/>
   <result pre="2007 13.RudenkoL.KiselevaI.NaykhinA.N.ErofeevaM.StukovaM.DoninaS.PetukhovaG.PisarevaM.KrivitskayaV.GrudininM.et al.Assessment of human immune responses to H7 avian" exact="influenza" post="virus of pandemic potential: Results from a placebo-controlled, randomized"/>
   <result pre="placebo-controlled, randomized double-blind phase I study of live attenuated H7N3" exact="influenza" post="vaccinePLoS ONE20149e8796210.1371/journal.pone.008796224533064 14.Isakova-SivakI.StukovaM.ErofeevaM.NaykhinA.DoninaS.PetukhovaG.KuznetsovaV.KiselevaI.SmolonoginaT.DubrovinaI.et al.H2N2 live attenuated influenza vaccine is"/>
   <result pre="live attenuated H7N3 influenza vaccinePLoS ONE20149e8796210.1371/journal.pone.008796224533064 14.Isakova-SivakI.StukovaM.ErofeevaM.NaykhinA.DoninaS.PetukhovaG.KuznetsovaV.KiselevaI.SmolonoginaT.DubrovinaI.et al.H2N2 live attenuated" exact="influenza" post="vaccine is safe and immunogenic for healthy adult volunteersHum."/>
   <result pre="adult volunteersHum. Vaccin. Immunother.20151197098210.1080/21645515.2015.101085925831405 15.De JongeJ.Isakova-SivakI.Van DijkenH.SpijkersS.MouthaanJ.De JongR.SmolonoginaT.RohollP.RudenkoL.H7N9 live attenuated" exact="influenza" post="vaccine is highly immunogenic, prevents virus replication, and protects"/>
   <result pre="is highly immunogenic, prevents virus replication, and protects against severe" exact="bronchopneumonia" post="in ferretsMol. Ther.201624991100210.1038/mt.2016.2326796670 16.RudenkoL.Isakova-SivakI.NaykhinA.KiselevaI.StukovaM.ErofeevaM.KorenkovD.MatyushenkoV.SparrowE.KienyM.P.H7N9 live attenuated influenza vaccine in"/>
   <result pre="protects against severe bronchopneumonia in ferretsMol. Ther.201624991100210.1038/mt.2016.2326796670 16.RudenkoL.Isakova-SivakI.NaykhinA.KiselevaI.StukovaM.ErofeevaM.KorenkovD.MatyushenkoV.SparrowE.KienyM.P.H7N9 live attenuated" exact="influenza" post="vaccine in healthy adults: A randomised, double-blind, placebo-controlled, phase"/>
   <result pre="OrganizationGeneva, Switzerland2002 20.LindstromS.E.CoxN.J.KlimovA.Genetic analysis of human H2N2 and early H3N2" exact="influenza" post="viruses, 1957â€&quot;1972: Evidence for genetic divergence and multiple reassortment"/>
   <result pre="present in unexposed humansPLoS Med.20074e5910.1371/journal.pmed.004005917298168 23.DeshevaY.SychevI.SmolonoginaT.RekstinA.IlyushinaN.LugovtsevV.GoA.LernerA.Anti-neuraminidase antibodies against pandemic A/H1N1" exact="influenza" post="viruses in healthy and influenza-infected individualsPLoS ONE201813e019677110.1371/journal.pone.019677129742168 24.DeshevaY.A.SmolonoginaT.A.DoninaS.A.RudenkoL.G.Serum strain-specific"/>
   <result pre="strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic A/California/07/2009 (H1N1)" exact="influenza" post="in healthy volunteersBMC Res. Notes2015813610.1186/s13104-015-1086-z25889924 25.MontoA.S.PetrieJ.G.CrossR.T.JohnsonE.LiuM.ZhongW.LevineM.KatzJ.M.OhmitS.E.Antibody to influenza virus"/>
   <result pre="A/California/07/2009 (H1N1) influenza in healthy volunteersBMC Res. Notes2015813610.1186/s13104-015-1086-z25889924 25.MontoA.S.PetrieJ.G.CrossR.T.JohnsonE.LiuM.ZhongW.LevineM.KatzJ.M.OhmitS.E.Antibody to" exact="influenza" post="virus neuraminidase: An independent correlate of protectionJ. Infect. Dis.20152121191119910.1093/infdis/jiv19525858957"/>
   <result pre="of antibody production against neuraminidase to the protection afforded by" exact="influenza" post="vaccinesRev. Med. Virol.20122226727910.1002/rmv.171322438243 27.BodewesR.KreijtzJ.H.BaasC.Geelhoed-MierasM.M.de MutsertG.Van AmerongenG.Van den BrandJ.M.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Vaccination against"/>
   <result pre="vaccinesRev. Med. Virol.20122226727910.1002/rmv.171322438243 27.BodewesR.KreijtzJ.H.BaasC.Geelhoed-MierasM.M.de MutsertG.Van AmerongenG.Van den BrandJ.M.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Vaccination against human" exact="influenza" post="A/H3N2 virus prevents the induction of heterosubtypic immunity against"/>
   <result pre="prevents the induction of heterosubtypic immunity against lethal infection with" exact="avian influenza" post="A/H5N1 virusPLoS ONE20094e553810.1371/journal.pone.000553819440239 28.LaiJ.C.C.KarunarathnaH.M.WongH.H.PeirisJ.S.NichollsJ.M.Neuraminidase activity and specificity of influenza"/>
   <result pre="the induction of heterosubtypic immunity against lethal infection with avian" exact="influenza" post="A/H5N1 virusPLoS ONE20094e553810.1371/journal.pone.000553819440239 28.LaiJ.C.C.KarunarathnaH.M.WongH.H.PeirisJ.S.NichollsJ.M.Neuraminidase activity and specificity of influenza"/>
   <result pre="avian influenza A/H5N1 virusPLoS ONE20094e553810.1371/journal.pone.000553819440239 28.LaiJ.C.C.KarunarathnaH.M.WongH.H.PeirisJ.S.NichollsJ.M.Neuraminidase activity and specificity of" exact="influenza" post="A virus are influenced by haemagglutinin-receptor bindingEmerg. Microbes Infect.2019832733810.1080/22221751.2019.158103430866786"/>
   <result pre="antihemagglutinin and antineuraminidase antibodies as correlates of protection in an" exact="influenza" post="A/H1N1 virus healthy human challenge modelMBio20167e00417-1610.1128/mBio.00417-1627094330 31.KilbourneE.D.PokornyB.A.JohanssonB.BrettI.MilevY.MatthewsJ.T.Protection of mice"/>
   <result pre="virus healthy human challenge modelMBio20167e00417-1610.1128/mBio.00417-1627094330 31.KilbourneE.D.PokornyB.A.JohanssonB.BrettI.MilevY.MatthewsJ.T.Protection of mice with recombinant" exact="influenza" post="virus neuraminidaseJ. Infect. Dis.200418945946110.1086/38112314745703 32.GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.SessionsM.XuX.SkepnerE.DeydeV.et al.Antigenic and genetic characteristics"/>
   <result pre="32.GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.SessionsM.XuX.SkepnerE.DeydeV.et al.Antigenic and genetic characteristics of swine-origin 2009 A (H1N1)" exact="influenza" post="viruses circulating in humansScience200932519720110.1126/science.117622519465683 33.RizzoC.RotaM.C.BellaA.AlfonsiV.DeclichS.CaporaliM.G.RanghiasciA.LapiniG.PiccirellaS.SalmasoS.et al.Cross-reactive antibody responses to"/>
   <result pre="in humansScience200932519720110.1126/science.117622519465683 33.RizzoC.RotaM.C.BellaA.AlfonsiV.DeclichS.CaporaliM.G.RanghiasciA.LapiniG.PiccirellaS.SalmasoS.et al.Cross-reactive antibody responses to the 2009 A/H1N1v" exact="influenza" post="virus in the Italian population in the pre-pandemic periodVaccine2010283558356210.1016/j.vaccine.2010.03.00620307592"/>
   <result pre="in Naturally Infected AdultsClin. Infect. Dis.201910.1093/cid/ciz63931300819 36.BentonD.J.WhartonS.A.MartinS.R.McCauleyJ.W.Role of neuraminidase in" exact="influenza" post="A (H7N9) virus receptor bindingJ. Virol.201791e02293-1610.1128/JVI.02293-1628356530 Figure 1 The"/>
   <result pre="hemagglutination/microneutralization (HI/MN) antibody seroconversions in the paired sera of live" exact="influenza" post="vaccine (LAIV)-vaccinated subjects (â‰¥twofold increase in NI titers; â‰¥fourfold"/>
   <result pre="flu season). (b) Phylogenetic tree of the N1 neuraminidase of" exact="influenza" post="virus isolates belonging to different HA subtypes. (c) NI"/>
   <result pre="in the paired sera collected from convalescents with laboratory confirmed" exact="influenza" post="A (n = 8). antibodies-09-00020-t001_Table 1Table 1 The list"/>
   <result pre="antibodies-09-00020-t001_Table 1Table 1 The list of clinical trials of live" exact="influenza" post="vaccines for use against pandemic and potentially pandemic influenza"/>
   <result pre="live influenza vaccines for use against pandemic and potentially pandemic" exact="influenza" post="viruses. Year Subtype Vaccine Strain â€œWildâ€� Type Virus Genome"/>
   <result pre="[15,16] antibodies-09-00020-t002_Table 2Table 2 The surface antigen compositions of diagnostic" exact="influenza" post="viruses. Subtype HA NA H7N1 A/horse/Prague/1/56 (H7N7) A/New Caledonia/20/99(H1N1)"/>
   <result pre="4Table 4 Pre-existing NI antibodies against pandemic or potentially pandemic" exact="influenza" post="in the sera of non-vaccinated persons. Year NA Subtype"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7344800\results\search\disease\results.xml">
   <result pre="rhesus macaque in the Zika forest of Uganda through a" exact="yellow fever" post="surveillance network in the area [1]. The following year,"/>
   <result pre="donors from Europe (N = 532), and blood donors from" exact="tick-borne encephalitis" post="(TBE) endemic regions with high TBE vaccination coverage (N"/>
   <result pre="from Europe (N = 532), and blood donors from tick-borne" exact="encephalitis" post="(TBE) endemic regions with high TBE vaccination coverage (N"/>
   <result pre="infection in the EU/EEA, June 2015 to January 2017Eurosurveillance201722170025410.2807/1560-7917.ES.2017.22.41.17-0025429043960 6.PaixÄƒoE.S.TeixeiraM.G.RodriguesL.C.Zika," exact="chikungunya" post="and dengue: The causes and threats of new and"/>
   <result pre="Pathol. Lab. Med.2017141606710.5858/arpa.2016-0406-SA27763787 23.FritzellC.RoussetD.AddeA.KazanjiM.Van KerkhoveM.D.FlamandC.Current challenges and implications for dengue," exact="chikungunya" post="and Zika seroprevalence studies worldwide: A scoping reviewPLoS Negl."/>
   <result pre="20 20 0 Yellow fever virus 15 15 0 Japanese" exact="encephalitis" post="virus 3 3 0 Antinuclear antibodies 12 12 0"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7345099\results\search\disease\results.xml">
   <result pre="protein Pichia pastoris diagnosis 1. Introduction Dengue is a systemic" exact="infectious disease," post="globally distributed by establishing cycles of endemic and epidemic"/>
   <result pre="manifestations, from low fever to dengue shock syndrome (DSS) and" exact="dengue hemorrhagic fever" post="(DHF), which can be fatal [4]. This virus has"/>
   <result pre="low-cost diagnosis is essential to confirm suspicions of cases of" exact="dengue fever," post="favoring disease prevention in regions of infection and treatment"/>
   <result pre="urban contextsTrop. Med. Int. Health2008131180118710.1111/j.1365-3156.2008.02124.x18840157 25.PorterK.R.BeckettC.G.KosasihH.TanR.I.AlisjahbanaB.RudimanP.I.WidjajaS.ListiyaningsihE.Maâ€™roefC.N.McArdleJ.L.et al.Epidemiology of dengue and" exact="dengue hemorrhagic fever" post="in a cohort of adults living in Bandung, West"/>
   <result pre="Pichia pastorisJundishapur J. Microbiol.20158e1715710.5812/jjm.8(4)2015.1715726034544 62.KoperaE.DwornykA.KossonP.FlorysK.SaczynskaV.DebskiJ.Cecuda-AdamczewskaV.SzewczykB.ZagÃ³rski-OstojaW.GrzelakK.Expression, purification and characterization of glycosylated" exact="influenza" post="H5N1 hemagglutinin produced in Pichia pastorisActa Biochim. Pol.20146159760210.18388/abp.2014_188225210934 63.WangM.JiangS.WangY.Recent"/>
   <result pre="recombinant subunit vaccines in Pichia pastorisBioengineered2016715516510.1080/21655979.2016.119170727246656 64.Ben AzounS.BelhajA.E.GongrichR.GasserB.KallelH.Molecular optimization of" exact="rabies" post="virus glycoprotein expression in Pichia pastorisMicrob. Biotechnol.2016935536810.1111/1751-7915.1235026880068 65.Ben AzounS.Ben"/>
   <result pre="glycoprotein expression in Pichia pastorisMicrob. Biotechnol.2016935536810.1111/1751-7915.1235026880068 65.Ben AzounS.Ben ZakourM.SghaierS.KallelH.Expression of" exact="rabies" post="virus glycoprotein in the methylotrophic yeast Pichia pastorisBiotechnol. Appl."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7345197\results\search\disease\results.xml">
   <result pre="in Sinop city. We sequenced the complete genomes of one" exact="chikungunya" post="virus (CHIKV)-positive and one out of the 33 Mayaro"/>
   <result pre="eventual spillover to the human population, such as Saint Louis" exact="encephalitis" post="virus (SLEV) [4,5], West Nile virus (WNV) [6,7] and"/>
   <result pre="human and animal populations [11,12], such as the mosquito-borne alphaviruses" exact="chikungunya" post="virus (CHIKV), Oâ€™nyongâ€™nyong virus (ONNV), Ross River virus (RRV)"/>
   <result pre="we sought patients presenting clinical diagnoses of dengue, Zika or" exact="chikungunya" post="infection, who reported arbovirus-like symptoms, such as fever, myalgia,"/>
   <result pre="can be identified such as hemorrhagic fever, Guillainâ€&quot;Barre syndrome and" exact="encephalitis" post="[52]. Among a dozen arboviruses that currently circulate in"/>
   <result pre="over the years, such as MAYV [8,9], Zika virus (ZIKV)," exact="yellow fever" post="virus (YFV) and CHIKV, causing outbreaks with hundreds of"/>
   <result pre="for other arboviruses [55] (Supplementary Table S6). The confirmation of" exact="chikungunya" post="diagnosis by Mato Grosso State Department of Health has"/>
   <result pre="dengueAvailable online: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue(accessed on 30 April 2020) 4.RoccoI.M.SantosC.L.S.BisordiI.PetrellaS.M.C.N.PereiraL.E.SouzaR.P.CoimbraT.L.M.BessaT.A.F.OshiroF.M.LimaL.B.Q.et al.St. Louis" exact="encephalitis" post="virus: First isolation from a human in SÃ£o Paulo"/>
   <result pre="of Chikungunya virus in BrazilBMC Med.20151310210.1186/s12916-015-0348-x25976325 22.TeixeiraM.G.AndradeA.M.S.Da CostaM.C.N.CastroJ.S.M.OliveiraF.L.S.GoesC.S.B.MaiaM.SantanaE.B.NunesB.T.D.VasconcelosP.F.C.East/central/South African genotype" exact="chikungunya" post="virus, Brazil, 2014Emerg. Infect. Dis.20152190690810.3201/eid2105.14172725898939 23.MinistÃ©rio da SaÃºde MinistÃ©rio"/>
   <result pre="Monitoramento dos casos de arboviroses urbanas transmitidas pelo Aedes (dengue," exact="chikungunya" post="e Zika), Semanas EpidemiolÃ³gicas 01 a 52Available online: https://www.saude.gov.br/images/pdf/2020/marco/06/Boletim-epidemiologico-SVS-10.pdf(accessed"/>
   <result pre="emergence of arthropod-borne viral diseases: A global prospective on dengue," exact="chikungunya" post="and zika feversActa Trop.201716615516310.1016/j.actatropica.2016.11.02027876643 25.IzurietaR.O.DeLacureD.A.IzurietaA.HoareI.A.Reina OrtizM.Mayaro virus: The jungle"/>
   <result pre="Infect. Dis.20071376476710.3201/eid1305.07001517553261 37.MachadoL.C.de Morais-SobralM.C.CamposT.d.L.PereiraM.R.de AlbuquerqueM.d.F.P.M.GilbertC.FrancaR.F.O.WallauG.L.Genome sequencing reveals coinfection by multiple" exact="chikungunya" post="virus genotypes in a recent outbreak in BrazilPLoS Negl."/>
   <result pre="de SaÃºde de Mato Grosso Boletim EpidemiolÃ³gico: Dengue, febre de" exact="chikungunya" post="e febre pelo vÃ­rus ZikaAvailable online: http://www.saude.mt.gov.br/dengue/arquivos/526/documentos(accessed on 8"/>
   <result pre="on 8 May 2020) 56.MoraesM.M.KubiszeskiJ.R.VieiraC.J.d.S.P.GusmaoA.F.PratisT.S.ColomboT.E.ThiesS.F.AraujoF.d.C.ZanelliC.F.MilhimB.H.G.d.A.et al.Concomitant detection of Saint Louis" exact="encephalitis" post="virus in two Brazilian StatesMem. Inst. Oswaldo Cruz(under review)"/>
   <result pre="Trop. Med. Hyg.20067546146910.4269/ajtmh.2006.75.46116968922 65.SantosF.M.DiasR.S.de OliveiraM.D.CostaI.C.T.A.FernandesL.d.S.PessoaC.R.da MattaS.L.P.CostaV.V.SouzaD.G.da SilvaC.C.et al.Animal model of" exact="arthritis" post="and myositis induced by the Mayaro virusPLoS Negl. Trop."/>
   <result pre="Hyg.20067546146910.4269/ajtmh.2006.75.46116968922 65.SantosF.M.DiasR.S.de OliveiraM.D.CostaI.C.T.A.FernandesL.d.S.PessoaC.R.da MattaS.L.P.CostaV.V.SouzaD.G.da SilvaC.C.et al.Animal model of arthritis and" exact="myositis" post="induced by the Mayaro virusPLoS Negl. Trop. Dis.201913e000737510.1371/journal.pntd.000737531050676 66.HarshaP.K.ReddyV.RaoD.PattabiramanC.ManiR.S.Continual"/>
   <result pre="75.FischerC.de LamballerieX.DrexlerJ.F.Enhanced Molecular Surveillance of Chikungunya VirusmSphere20194e00295-1910.1128/mSphere.00295-1931270168 76.FigueiredoL.T.M.Large outbreaks of" exact="chikungunya" post="virus in Brazil reveal uncommon clinical features and fatalitiesRev."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7345743\results\search\disease\results.xml">
   <result pre="has revolutionized the field of immunovirology with its application in" exact="viral disease" post="diagnostics and antiviral therapy. This robust and versatile technology"/>
   <result pre="be highly specific to viral antigens, opening new horizons in" exact="viral disease" post="diagnosis and therapeutics. In the last few decades, the"/>
   <result pre="of antibody phage display, murine scFv capable of recognizing the" exact="avian influenza" post="virus (AIV) was isolated and evaluated through ELISA. It"/>
   <result pre="antibody phage display, murine scFv capable of recognizing the avian" exact="influenza" post="virus (AIV) was isolated and evaluated through ELISA. It"/>
   <result pre="of the biggest challenges faced by this industry is duck" exact="viral hepatitis" post="(DVH) caused by duck hepatitis A virus (DHAV). It"/>
   <result pre="the biggest challenges faced by this industry is duck viral" exact="hepatitis" post="(DVH) caused by duck hepatitis A virus (DHAV). It"/>
   <result pre="this industry is duck viral hepatitis (DVH) caused by duck" exact="hepatitis" post="A virus (DHAV). It is characterized into three serotypes,"/>
   <result pre="ELISA [41]. In the dairy and beef industry, foot and" exact="mouth disease" post="(FMD) is considered the most devastating viral disease caused"/>
   <result pre="foot and mouth disease (FMD) is considered the most devastating" exact="viral disease" post="caused by foot and mouth disease virus (FMDV), inflicting"/>
   <result pre="considered the most devastating viral disease caused by foot and" exact="mouth disease" post="virus (FMDV), inflicting huge economic losses. There are seven"/>
   <result pre="as a promising experimental tool in imaging of porcine epidemic" exact="diarrhea" post="virus (PEDV) [48]. In addition to this, a highly"/>
   <result pre="while retaining in vitro neutralizing ability [49]. Recently, the swine" exact="influenza" post="virus (SIV) and PEDV have gained a lot of"/>
   <result pre="repertoire for certain applications in canine medicine. In horses, the" exact="western equine encephalitis" post="virus (WEEV) and the Venezuelan equine encephalitis virus (VEEV)"/>
   <result pre="certain applications in canine medicine. In horses, the western equine" exact="encephalitis" post="virus (WEEV) and the Venezuelan equine encephalitis virus (VEEV)"/>
   <result pre="the western equine encephalitis virus (WEEV) and the Venezuelan equine" exact="encephalitis" post="virus (VEEV) are zoonotic viruses, constantly posing a threat"/>
   <result pre="for its expansion by finding new clones capable of targeting" exact="viral disease." post="Mostly in the poultry sector, the therapeutic application of"/>
   <result pre="of rAbs is considered economically impractical. A prevention strategy against" exact="influenza" post="viral infection has been tested by using recombinant adenovirus"/>
   <result pre="protein. The scFv has shown promising therapeutic effects against duck" exact="viral hepatitis," post="a highly infectious disease of ducks with a mortality"/>
   <result pre="shown promising therapeutic effects against duck viral hepatitis, a highly" exact="infectious disease" post="of ducks with a mortality rate of up to"/>
   <result pre="a mortality rate of up to 100% [60]. Bovine viral" exact="diarrhea" post="virus (BVDV) is a significant cattle pathogen, inflicting huge"/>
   <result pre="in controlling BVDV infection worldwide [62]. In pig farming, transmissible" exact="gastroenteritis" post="virus (TGEV) is considered a highly dangerous infectious agent"/>
   <result pre="novel binder is promising in the control of porcine viral" exact="gastroenteritis" post="[63]. Similarly, high-affinity nanobodies targeting Nsp4 and Nsp9 protein"/>
   <result pre="a naÃ¯ve llama antibody repertoire resulted in the screening of" exact="rabies" post="virus glycoprotein specific VHH, which later led to the"/>
   <result pre="dogs, the therapeutic application of rAbs is mainly restricted to" exact="cancer" post="and inflammatory disturbances [72]. In horses, equine herpesvirus-1 (EHV-1)"/>
   <result pre="al.Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human" exact="endometrial cancer" post="cell linesClin. Cancer Res.2008147367737710.1158/1078-0432.CCR-08-101619010852 13.AzzazyH.M.E.HighsmithW.E.Phage display technology: Clinical applications"/>
   <result pre="targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial" exact="cancer" post="cell linesClin. Cancer Res.2008147367737710.1158/1078-0432.CCR-08-101619010852 13.AzzazyH.M.E.HighsmithW.E.Phage display technology: Clinical applications"/>
   <result pre="28.ThraneS.JanitzekC.M.AgerbÃ¦kM.DitlevS.B.ResendeM.NielsenM.A.TheanderT.G.SalantiA.SanderA.F.A novel virus-like particle based vaccine platform displaying the placental" exact="malaria" post="antigen VAR2CSAPLoS ONE201510e014307110.1371/journal.pone.014307126599509 29.GlanvilleJ.Dâ€™AngeloS.KhanT.A.ReddyS.T.NaranjoL.FerraraF.BradburyA.R.M.Deep sequencing in library selection projects:"/>
   <result pre="35.SenguptaD.ShaikhA.BhatiaS.PateriyaA.K.KhandiaR.SoodR.PrakashA.PattnaikB.PradhanH.K.Development of single-chain Fv against the nucleoprotein of type A" exact="influenza" post="virus and its use in ELISAJ. Virol. Methods201420812913710.1016/j.jviromet.2014.08.00925152529 36.NielsenK.YuW.L.LinM.DavisS.A.N.ElmgrenC.MacKenzieR.TanhaJ.LiS.DubucG.BrownE.G.et"/>
   <result pre="36.NielsenK.YuW.L.LinM.DavisS.A.N.ElmgrenC.MacKenzieR.TanhaJ.LiS.DubucG.BrownE.G.et al.Prototype single step lateral flow technology for detection of" exact="avian influenza" post="virus and chicken antibody to avian influenza virusJ. Immunoass."/>
   <result pre="al.Prototype single step lateral flow technology for detection of avian" exact="influenza" post="virus and chicken antibody to avian influenza virusJ. Immunoass."/>
   <result pre="for detection of avian influenza virus and chicken antibody to" exact="avian influenza" post="virusJ. Immunoass. Immunochem.20072830731810.1080/15321810701603443 37.LiY.CollinsM.S.WhitelamG.C.AlexanderD.J.Rapid pathotyping of Newcastle disease virus"/>
   <result pre="detection of avian influenza virus and chicken antibody to avian" exact="influenza" post="virusJ. Immunoass. Immunochem.20072830731810.1080/15321810701603443 37.LiY.CollinsM.S.WhitelamG.C.AlexanderD.J.Rapid pathotyping of Newcastle disease virus"/>
   <result pre="Pathol.20053444945510.1080/0307945050036776516537158 41.XueW.ZhaoQ.LiP.ZhangR.LanJ.WangJ.YangX.XieZ.JiangS.Identification and characterization of a novel nanobody against duck" exact="hepatitis" post="A virus type 1Virology201952810110910.1016/j.virol.2018.12.01330590261 42.ShengFengC.PingL.TaoS.XinW.GuoFengW.Construction, expression, purification, refold and"/>
   <result pre="activity assay of a specific scFv fragment against foot and" exact="mouth disease" post="virusVet. Res. Commun.20032724325610.1023/A:102330082543812777098 43.SharmaG.K.MahajanS.MaturaR.SubramaniamS.MohapatraJ.K.PattnaikB.Production and characterization of single-chain antibody"/>
   <result pre="promising experimental tools in imaging and isolation of porcine epidemic" exact="diarrhea" post="virusAppl. Microbiol. Biotechnol.20181028931894210.1007/s00253-018-9324-730143837 49.ChenS.LiS.SunH.LiY.JiS.SongK.ZhangL.LuoY.SunY.MaJ.et al.Expression and characterization of a"/>
   <result pre="single-domain antibody-based blocking ELISA for detection of antibodies against swine" exact="influenza" post="virusInt. J. Nanomed.201914933710.2147/IJN.S218458 51.BaoF.WangL.ZhaoX.LuT.NaA.M.WangX.CaoJ.DuY.Preparation and characterization of a single-domain"/>
   <result pre="characterization of a single-domain antibody specific for the porcine epidemic" exact="diarrhea" post="virus spike proteinAMB Express2019910410.1186/s13568-019-0834-131300902 52.MaZ.WangT.LiZ.GuoX.TianY.LiY.XiaoS.A novel biotinylated nanobody-based blocking"/>
   <result pre="for the rapid and sensitive clinical detection of porcine epidemic" exact="diarrhea" post="virusJ. Nanobiotechnol.2019179610.1186/s12951-019-0531-x 53.BraganzaA.WallaceK.PellL.ParrishC.R.SiegelD.L.MasonN.J.Generation and validation of canine single chain"/>
   <result pre="a novel recombinant single-chain variable fragment antibody against Western equine" exact="encephalitis" post="virusHybridoma2000191310.1089/02724570031574310768836 55.DugganJ.M.CoatesD.M.UlaetoD.O.Isolation of single-chain antibody fragments against Venezuelan equine"/>
   <result pre="encephalitis virusHybridoma2000191310.1089/02724570031574310768836 55.DugganJ.M.CoatesD.M.UlaetoD.O.Isolation of single-chain antibody fragments against Venezuelan equine" exact="encephalomyelitis" post="virus from two different immune sourcesViral Immunol.20011426327310.1089/08828240175326677411572636 56.CelerV.BlaÅ¾ekD.NavrÃ¡tilovÃ¡I.SklÃ¡dalP.BlacklawsB.BujdosoR.Recombinant single-chain"/>
   <result pre="expressing an HA (H5)-specific single-domain antibody protects mice from lethal" exact="influenza" post="infectionAntivir. Res.20139731832810.1016/j.antiviral.2012.12.02123274786 59.PitaksajjakulP.LekcharoensukP.UpragarinN.BarbasC.F.IbrahimM.S.IkutaK.RamasootaP.Fab MAbs specific to HA of influenza"/>
   <result pre="lethal influenza infectionAntivir. Res.20139731832810.1016/j.antiviral.2012.12.02123274786 59.PitaksajjakulP.LekcharoensukP.UpragarinN.BarbasC.F.IbrahimM.S.IkutaK.RamasootaP.Fab MAbs specific to HA of" exact="influenza" post="virus with H5N1 neutralizing activity selected from immunized chicken"/>
   <result pre="Commun.201039549650110.1016/j.bbrc.2010.04.04020382115 60.WangY.CuiP.ZhuS.MengT.HaoF.ZhuG.ZuoW.Preparation of single-chain antibody against VP3 protein of duck" exact="hepatitis" post="virus type 1 by phage display technologyJ. Virol. Methods2018257737810.1016/j.jviromet.2018.04.01029727718"/>
   <result pre="Methods2018257737810.1016/j.jviromet.2018.04.01029727718 61.DuanH.MaZ.XuL.ZhangA.LiZ.XiaoS.A novel intracellularly expressed NS5B-specific nanobody suppresses bovine viral" exact="diarrhea" post="virus replicationVet. Microbiol.201924010844910.1016/j.vetmic.2019.10844931836380 62.LiT.HuangM.XiaoH.ZhangG.DingJ.WuP.ZhangH.ShengJ.ChenC.Selection and characterization of specific nanobody"/>
   <result pre="Microbiol.201924010844910.1016/j.vetmic.2019.10844931836380 62.LiT.HuangM.XiaoH.ZhangG.DingJ.WuP.ZhangH.ShengJ.ChenC.Selection and characterization of specific nanobody against bovine virus" exact="diarrhea" post="virus (BVDV) E2 proteinPLoS ONE201712e017846910.1371/journal.pone.017846928582444 63.ZhangF.ChenY.YangL.ZhuJ.Construction and characterization of"/>
   <result pre="characterization of porcine single-chain fragment variable antibodies that neutralize transmissible" exact="gastroenteritis" post="virus in vitroArch. Virol.201916498399410.1007/s00705-019-04156-630729994 64.LiuH.LiangC.DuanH.ZhangX.WangX.XiaoS.ZhouE.M.Intracellularly expressed nanobodies against non-structural"/>
   <result pre="variable (scFv) antibodies targeting the spike protein of porcine epidemic" exact="diarrhea" post="virus provide protection against viral infection in pigletsViruses2019115810.3390/v11010058 71.GriffithsA.D.WilliamsS.C.HartleyO.TomlinsonI.M.WaterhouseP.CrosbyW.L.KontermannR.E.JonesP.T.LowN.M.AllisonT.J.Isolation"/>
   <result pre="Species Target Reference Diagnosis scFv Mouse Recombinant NP protein of" exact="avian influenza" post="virus in poultry [35] VHH Camelid NP protein of"/>
   <result pre="Target Reference Diagnosis scFv Mouse Recombinant NP protein of avian" exact="influenza" post="virus in poultry [35] VHH Camelid NP protein of"/>
   <result pre="virus in poultry [39,40] VHH Camelid VP1 protein of duck" exact="hepatitis" post="A virus-1 in ducks [41] scFv Mouse Foot and"/>
   <result pre="hepatitis A virus-1 in ducks [41] scFv Mouse Foot and" exact="mouth disease" post="virus type O in cows [42] scFv Chicken 3ABC"/>
   <result pre="in cows [42] scFv Chicken 3ABC protein of foot and" exact="mouth disease" post="virus in cows [43,44] scFv Mouse VP2 of protein"/>
   <result pre="cows [43,44] scFv Mouse VP2 of protein of foot and" exact="mouth disease" post="virus in cows [45] scFv Mouse Capsid protein of"/>
   <result pre="in pigs [47] VHH Camelid Membrane proteins of porcine epidemic" exact="diarrhea" post="virus in pigs [48] scFv Mouse E2 protein of"/>
   <result pre="virus in pigs [49] VHH Camelid P protein of, swine" exact="influenza" post="virus in pigs [50] VHH Camelid N protein and"/>
   <result pre="VHH Camelid N protein and spike protein of porcine epidemic" exact="diarrhea" post="virus [51,52] scFv Dog Capsid protein of canine parvovirus"/>
   <result pre="canine parvovirus in dogs [53] scFv Mouse Whole Western equine" exact="encephalitis" post="virus [54] scFv Mouse Whole Venezuelan equine encephalitis virus"/>
   <result pre="Western equine encephalitis virus [54] scFv Mouse Whole Venezuelan equine" exact="encephalitis" post="virus [55] scFv Human * transmembrane envelope glycoprotein gp46"/>
   <result pre="of H5N1 in poultry [59] scFv Mouse VP3 protein duck" exact="hepatitis" post="A virus-1 in ducks [60] VHH Camelid NS5B protein"/>
   <result pre="in ducks [60] VHH Camelid NS5B protein of bovine viral" exact="diarrhea" post="virus in cows [61] VHH Camelid E2 protein bovine"/>
   <result pre="virus in cows [61] VHH Camelid E2 protein bovine viral" exact="diarrhea" post="virus in cows [62] scFv Pig Whole transmissible gastroenteritis"/>
   <result pre="viral diarrhea virus in cows [62] scFv Pig Whole transmissible" exact="gastroenteritis" post="virus in pigs [63] VHH Camelid non-structural protein 4"/>
   <result pre="and respiratory syndrome virus in pigs [65] VHH Camelid Whole" exact="rabies" post="virus in dogs [66] scFv Human * gD protein"/>
   <result pre="cows pigs [69] scFv Pig Spike protein of porcine epidemic" exact="diarrhea" post="virus in pigs [70] * Synthetic human Griffin.1 [71]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7345902\results\search\disease\results.xml">
   <result pre="BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract With the growing success of controlling" exact="malaria" post="in Sub-Saharan Africa, the incidence of fever due to"/>
   <result pre="malaria in Sub-Saharan Africa, the incidence of fever due to" exact="malaria" post="is in decline, whereas the proportion of patients with"/>
   <result pre="expanded to five arboviruses: dengue virus (DENV), zika virus (ZIKV)," exact="yellow fever" post="virus (YFV), chikungunya virus (CHIKV), and rift valley fever"/>
   <result pre="dengue virus (DENV), zika virus (ZIKV), yellow fever virus (YFV)," exact="chikungunya" post="virus (CHIKV), and rift valley fever virus (RVFV). One"/>
   <result pre="virus (ZIKV), yellow fever virus (YFV), chikungunya virus (CHIKV), and" exact="rift valley fever" post="virus (RVFV). One hundred and four children aged between"/>
   <result pre="long served as an entry point for the treatment of" exact="malaria" post="[3]. With encouraging gains in malaria control in Sub-Saharan"/>
   <result pre="for the treatment of malaria [3]. With encouraging gains in" exact="malaria" post="control in Sub-Saharan African countries, the incidence of this"/>
   <result pre="of febrile illness attributable to malaria. Between 2000 and 2013," exact="malaria" post="mortality rates decreased by 47% globally, and by 54%"/>
   <result pre="following criteria: acute fever (â‰¥37.5 Â°C axillary temperature), negative for" exact="malaria" post="rapid diagnostic tests (RDTs) and living in the same"/>
   <result pre="1 for DENV1-3 and set 2 for DENV- 4 [10]);" exact="yellow fever" post="virus (YFV) [12]; chikungunya virus (CHIKV) [13]; rift valley"/>
   <result pre="2 for DENV- 4 [10]); yellow fever virus (YFV) [12];" exact="chikungunya" post="virus (CHIKV) [13]; rift valley fever virus (RVFV) [14];"/>
   <result pre="[10]); yellow fever virus (YFV) [12]; chikungunya virus (CHIKV) [13];" exact="rift valley fever" post="virus (RVFV) [14]; and zika virus (ZIKV) [15], with"/>
   <result pre="the six month survey of arboviral infections in febrile non" exact="malaria" post="patients, three cases of dengue infection were detected in"/>
   <result pre="individual arboviruses was recently supported by the detection of Japanese" exact="encephalitis" post="virus (JEV), during a yellow fever outbreak in Lunda"/>
   <result pre="by the detection of Japanese encephalitis virus (JEV), during a" exact="yellow fever" post="outbreak in Lunda (Angola), in 2016 [33]. This virus"/>
   <result pre="also contribute to the underestimation of the real incidence of" exact="dengue fever" post="in Africa [31]. Since other studies report the expansion"/>
   <result pre="in Africa [31]. Since other studies report the expansion of" exact="dengue fever" post="among NMFI [36], our study and the cited studies"/>
   <result pre="probe-based assay for the detection of African and South American" exact="yellow fever" post="virus strainsJ. Clin. Virol.20104818719210.1016/j.jcv.2010.04.01320556888 20.FayeO.FayeO.DialloD.DialloD.WeidmannM.SallA.A.Quantitative real-time PCR detection of"/>
   <result pre="J.20131031110.1186/1743-422X-10-31124148652 21.BaF.LoucoubarC.FayeO.FallG.MbayeR.N.P.N.SembeneM.DialloM.BaldeA.T.SallA.A.FayeO.Retrospective analysis of febrile patients reveals unnoticed epidemic of" exact="zika fever" post="in Dielmo, Senegal, 2000Clin. Microbiol. Infect. Dis.2018310.15761/CMID.1000129 22.DigoutteJ.Calvo-WilsonM.MondoM.Traore-LamizanaM.AdamF.Continuous cell"/>
   <result pre="with Yellow Fever Coinfection in AfricaN. Engl. J. Med.20173761483148510.1056/NEJMc170160028402771 34.MansfieldK.HernÃ¡ndez-TrianaL.BanyardA.Japanese" exact="encephalitis" post="virus infection, diagnosis and control in domestic animals|Elsevier Enhanced"/>
   <result pre="the gamma distributed (K2+G+I) nucleotide substitution model was used. The" exact="yellow fever" post="17D (FJ654700.1) was used as the outgroup. diagnostics-10-00408-t001_Table 1Table"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7346961\results\search\disease\results.xml">
   <result pre="in Burail, Chandigarh an unexpected rise in number of acute" exact="viral hepatitis" post="(AVH) was reported during December 2016. Aims: An outbreak"/>
   <result pre="Burail, Chandigarh an unexpected rise in number of acute viral" exact="hepatitis" post="(AVH) was reported during December 2016. Aims: An outbreak"/>
   <result pre="was used to identify cases. Suspected cases were tested for" exact="hepatitis" post="A virus (HAV) and E virus (HEV) using enzyme-linked"/>
   <result pre="symptoms. Conclusion: This study described the epidemiological features of dual" exact="hepatitis" post="outbreak due to HAV and HEV from Chandigarh, Union"/>
   <result pre="HEV from Chandigarh, Union Territory, north India. Attack rate jaundice" exact="hepatitis" post="A hepatitis E outbreak investigation Introduction Globally, acute viral"/>
   <result pre="Chandigarh, Union Territory, north India. Attack rate jaundice hepatitis A" exact="hepatitis" post="E outbreak investigation Introduction Globally, acute viral hepatitis (AVH)"/>
   <result pre="jaundice hepatitis A hepatitis E outbreak investigation Introduction Globally, acute" exact="viral hepatitis" post="(AVH) endures a major public health problem and it"/>
   <result pre="hepatitis A hepatitis E outbreak investigation Introduction Globally, acute viral" exact="hepatitis" post="(AVH) endures a major public health problem and it"/>
   <result pre="1.4 million deaths, where 47% deaths are caused due to" exact="hepatitis" post="B virus (HBV), 48% due to hepatitis C virus"/>
   <result pre="caused due to hepatitis B virus (HBV), 48% due to" exact="hepatitis" post="C virus (HCV), and the rest are caused by"/>
   <result pre="C virus (HCV), and the rest are caused by both" exact="hepatitis" post="A (HAV) and E (HEV) viruses.[2] HAV mainly attacks"/>
   <result pre="and social impact in the community.[34] The impact of these" exact="viral disease" post="in respect of public health dimensions is poorly understood"/>
   <result pre="Strategy on Viral Hepatitis, 2016â€&quot;2021, with a vision of eliminating" exact="viral hepatitis" post="as a public health problem with global targets of"/>
   <result pre="on Viral Hepatitis, 2016â€&quot;2021, with a vision of eliminating viral" exact="hepatitis" post="as a public health problem with global targets of"/>
   <result pre="a public health problem with global targets of reducing new" exact="viral hepatitis" post="infections by 90% and reducing deaths due to viral"/>
   <result pre="public health problem with global targets of reducing new viral" exact="hepatitis" post="infections by 90% and reducing deaths due to viral"/>
   <result pre="viral hepatitis infections by 90% and reducing deaths due to" exact="viral hepatitis" post="by 65% by 2030.[2] In achieving sustainable development goals"/>
   <result pre="hepatitis infections by 90% and reducing deaths due to viral" exact="hepatitis" post="by 65% by 2030.[2] In achieving sustainable development goals"/>
   <result pre="Hepatitis Control Program is launched in India aiming to end" exact="viral hepatitis" post="by 2030.[9] During December 2016 to March 2017, 32"/>
   <result pre="Control Program is launched in India aiming to end viral" exact="hepatitis" post="by 2030.[9] During December 2016 to March 2017, 32"/>
   <result pre="March 2017, 32 cases of jaundice with features of acute" exact="hepatitis" post="were reported in the catchment area of Civil Hospital,"/>
   <result pre="aminotransferase. A case positive for IgM anti-HAV was labeled as" exact="hepatitis" post="A, and positive for IgM anti-HEV labeled as hepatitis"/>
   <result pre="as hepatitis A, and positive for IgM anti-HEV labeled as" exact="hepatitis" post="E. The suspected case was defined as a case"/>
   <result pre="was defined as a suspected case that is laboratory-confirmed for" exact="hepatitis" post="A and E. Active surveillance The house to house"/>
   <result pre="as per time, person, and place. Attack rates of acute" exact="hepatitis" post="by age and gender was calculated. Hypothesis was generated"/>
   <result pre="serum glutamic pyruvate transaminase (SGPT) were calculated. The cutoff for" exact="hepatitis" post="was taken as total bilirubin &amp;gt;1.2 mg/dL, SGOT and"/>
   <result pre="identified. Out of these, 141 cases were confirmed serologically for" exact="hepatitis" post="A and E. Hence, a mixed outbreak of hepatitis"/>
   <result pre="for hepatitis A and E. Hence, a mixed outbreak of" exact="hepatitis" post="A and E was declared in Burail. Line list"/>
   <result pre="passive surveillance continued.[Figure 1]. Figure 1 Epidemic curve of acute" exact="viral hepatitis" post="(A and E) cases during December 2016 to November"/>
   <result pre="surveillance continued.[Figure 1]. Figure 1 Epidemic curve of acute viral" exact="hepatitis" post="(A and E) cases during December 2016 to November"/>
   <result pre="the jaundice was the most commonly reported symptom (78%) and" exact="diarrhea" post="was the least (27%) reported symptom. The average duration"/>
   <result pre="= 133). None of the population surveyed was immunized against" exact="hepatitis" post="A vaccine. Place analysis The spot map was drawn"/>
   <result pre="is documented to be major cause of outbreaks of acute" exact="hepatitis" post="in developing countries like India.[1314] These outbreaks are reported"/>
   <result pre="of an outbreak and described the epidemiological features of dual" exact="hepatitis" post="outbreak from northern India. The quality of the water"/>
   <result pre="consider vaccinating the susceptible population, local food vendors with licensed" exact="hepatitis" post="A vaccine. The residents have to be informed about"/>
   <result pre="be informed about the possible contamination of outside food with" exact="hepatitis" post="virus so that they avoid eating out especially in"/>
   <result pre="when last dose receivedâ€¦. Remarks: References 1LocarniniSChenDSShibuyaKNo more excuses: Viral" exact="hepatitis" post="can be eliminatedLancet20163871703427116263 2collab: World Health OrganizationGlobal Health Sector"/>
   <result pre="2019 Jan 29Available from: https://wwwwhoint/news-room/fact-sheets/detail/hepatitis-e 5MirazoSRamosNMainardiVGeronaSArbizaJTransmission, diagnosis, and management of" exact="hepatitis" post="E: An updateHepat Med20146455924966702 6NegiSSBardePVPathakRGaikwadUDasPBhargavAAn outbreak of hepatitis E"/>
   <result pre="management of hepatitis E: An updateHepat Med20146455924966702 6NegiSSBardePVPathakRGaikwadUDasPBhargavAAn outbreak of" exact="hepatitis" post="E virus in Raipur, Chhattisgarh, India in 2014: A"/>
   <result pre="hepatitis: Know it, confront itIndian J Med Res201313881024056549 8KumarTShrivastavaAKumarALasersonKFNarainJPVenkateshSet al.Viral" exact="hepatitis" post="surveillance--India, 2011-2013MMWR Morb Mortal Wkly Rep2015647586226203629 9collab: National Viral"/>
   <result pre="NYMcGraw-Hill EducationAvailable from: http://accessmedicine.mhmedical.com/content.aspx?aid=1155690725 13HakimMSWangWBramerWMGengJHuangFde ManRAet al.The global burden of" exact="hepatitis" post="E outbreaks: A systematic reviewLiver Int2017371931 14GuptaEAgarwalaPHepatitis E virus"/>
   <result pre="a new story!Indian J Med Microbiol2018363172330429382 15DasPAdhikaryKKGuptaPKAn outbreak investigation of" exact="viral hepatitis" post="E in south Dumdum municipality of KolkataIndian J Community"/>
   <result pre="new story!Indian J Med Microbiol2018363172330429382 15DasPAdhikaryKKGuptaPKAn outbreak investigation of viral" exact="hepatitis" post="E in south Dumdum municipality of KolkataIndian J Community"/>
   <result pre="Girdharnagar, Ahmedabad, Gujarat, India, 2008Indian J Community Med2010352949720922110 17AroraDJindalNShuklaRKBansalRWater borne" exact="hepatitis" post="A and hepatitis E in Malwa Region of Punjab,"/>
   <result pre="India, 2008Indian J Community Med2010352949720922110 17AroraDJindalNShuklaRKBansalRWater borne hepatitis A and" exact="hepatitis" post="E in Malwa Region of Punjab, IndiaJ Clin Diagnostic"/>
   <result pre="Diagnostic Res20137216366 18KaurMSidhuSSinghKDeviPKaurMSinghNHepatitis E virus: A leading cause of waterborne" exact="viral hepatitis" post="in Northwest Districts of Punjab, IndiaJ Lab Physicians201791212428367028 19BardePVShuklaMKPathakRKoriBKBhartiPKCirculation"/>
   <result pre="Res20137216366 18KaurMSidhuSSinghKDeviPKaurMSinghNHepatitis E virus: A leading cause of waterborne viral" exact="hepatitis" post="in Northwest Districts of Punjab, IndiaJ Lab Physicians201791212428367028 19BardePVShuklaMKPathakRKoriBKBhartiPKCirculation"/>
   <result pre="in Northwest Districts of Punjab, IndiaJ Lab Physicians201791212428367028 19BardePVShuklaMKPathakRKoriBKBhartiPKCirculation of" exact="hepatitis" post="A genotype IIIA virus in paediatric patients in central"/>
   <result pre="patients in central IndiaIndian J Med Res2014139940425109730 20MathurPAroraNKEpidemiological transition of" exact="hepatitis" post="A in India: Issues for vaccination in developing countriesIndian"/>
   <result pre="J Med Res200812869970419246792 21RakeshPSMainuTTCRRajABabuDRajivMMohandasKSet al.Investigating a community wide outbreak of" exact="hepatitis" post="A in Kerala, IndiaJ Family Med Prim Care2018715374130613555 22VivekRNihalLIlliayarajaJReddyPKSarkarREapenCEet"/>
   <result pre="in south IndiaTrop Med Int Heal20101513339 23VermaPBThakorNGoswamiMAn epidemic investigation of" exact="hepatitis" post="E in Juna Sachivalay area of Gandhinagar city, Gujarat,"/>
   <result pre="city, Gujarat, IndiaInt J Community Med Public Health2016326014 24ChandraNSSharmaARaiRRMalhotraBContribution of" exact="hepatitis" post="E virus in acute sporadic hepatitis in north western"/>
   <result pre="Public Health2016326014 24ChandraNSSharmaARaiRRMalhotraBContribution of hepatitis E virus in acute sporadic" exact="hepatitis" post="in north western IndiaIndian J Med Res20121364778223041743 25KadriSMRehmanSURehanaKBenetouDRAhmadDFAbdullahAet al.Hepatitis"/>
   <result pre="the water to blame?J Epidemiol Glob Health20188203730864764 26GautamNGanjuSGanjuSAWaliaSKumarAKFoetomaternal outcomes of" exact="hepatitis" post="E infection outbreak in North IndiaIndian J Med Microbiol201836121329735841"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7347216\results\search\disease\results.xml">
   <result pre="model for the optimal design of pedestrian queues to mitigate" exact="infectious disease" post="spread Model for infectious disease spread in pedestrian queues"/>
   <result pre="of pedestrian queues to mitigate infectious disease spread Model for" exact="infectious disease" post="spread in pedestrian queues DerjanyPierrotInvestigationMethodologySoftwareVisualizationWriting â€&quot; original draft1http://orcid.org/0000-0003-1487-9573NamilaeSirishConceptualizationFunding acquisitionInvestigationMethodologyProject"/>
   <result pre="people congregated in limited space often elevates the risk of" exact="infectious disease" post="spread due to the increased contacts between susceptible and"/>
   <result pre="deal with the spread of diseases like influenza, SARS, and" exact="measles" post="during air travel [3â€&quot;5]. Examples of epidemics in entertainment"/>
   <result pre="travel [3â€&quot;5]. Examples of epidemics in entertainment venues include the" exact="influenza" post="outbreak in 2002 during the winter Olympiad [6] and"/>
   <result pre="outbreak in 2002 during the winter Olympiad [6] and the" exact="measles" post="outbreak in Disney World in 2016 resulting in 125"/>
   <result pre="for several directly transmitted diseases like Ebola, SARS, and H1N1" exact="influenza" post="by varying the input parameters related to infection probabilities"/>
   <result pre="contact for such diseases. Other infectious diseases like SARS and" exact="influenza" post="are known to be transmitted by both shorter and"/>
   <result pre="inhalation probability (Pa) common in infections such as SARS and" exact="influenza" post="[38, 39], (b) Coarse pathogen droplet inoculation (Pd) common"/>
   <result pre="generated based on [45] and [46] for SARS and H1N1" exact="influenza" post="respectively. Fig 1 Viral shedding probability distributions (Pc). (A)"/>
   <result pre="contact is then combined with the infection model to estimate" exact="infectious disease" post="spread. We consider the situation of a single infective"/>
   <result pre="provides a unique approach to combine pedestrian movement models and" exact="infectious disease" post="spread models. By tracing the trajectory of each pedestrian"/>
   <result pre="of high pedestrian density locations which are often associated with" exact="infectious disease" post="spread [2â€&quot;13]. We demonstrate the approach for layout design"/>
   <result pre="aleatory uncertainty is further compounded by the combination with the" exact="infectious disease" post="spread model, which introduces variables like transmission probability and"/>
   <result pre="density environments affect the number of contacts and thereby impact" exact="infectious disease" post="spread. The mixing of susceptible and infectious individuals in"/>
   <result pre="is applied to a ubiquitous problem of contact evolution and" exact="infectious disease" post="spread in pedestrian waiting queues. We evaluate the effect"/>
   <result pre="paper, the general principles can be used for analysis of" exact="infectious disease" post="spread in any high pedestrian density location. Supporting information"/>
   <result pre="10.1016/j.ijid.2016.03.00726987476 3collab: Centers for Disease Control (CDC. Interstate importation of" exact="measles" post="following transmission in an airportâ€&quot;California, Washington, 1982. MMWR. Morbidity"/>
   <result pre="4OlsenSJ, ChangHL, CheungTY, TangAF, FiskTL, OoiSP, et al.Transmission of the" exact="severe acute respiratory syndrome" post="on aircraft. New England Journal of Medicine. 20031218;349(25):2416â€&quot;22. 10.1056/NEJMoa03134914681507"/>
   <result pre="2015123;350. 8PfaffG, LohrD, SantibanezS, MankertzA, TreeckUV, SchÃ¶nbergerK, et al.Spotlight on" exact="measles" post="2010: Measles outbreak among travellers returning from a mass"/>
   <result pre="RatnamohanM, FennellM, et al.Laboratory test performance in young adults during" exact="influenza" post="outbreaks at World Youth Day 2008. Journal of Clinical"/>
   <result pre="MeldrumR, LaneW, GardnerD, RibeiroCD, GallimoreCI, et al.An outbreak of viral" exact="gastroenteritis" post="following environmental contamination at a concert hall. Epidemiology &amp;amp;"/>
   <result pre="MaratheMV. EpiSimdemics: an efficient algorithm for simulating the spread of" exact="infectious disease" post="over large realistic social networks InSC'08: Proceedings of the"/>
   <result pre="1â€&quot;12). IEEE. 17GermannTC, KadauK, LonginiIM, MackenCA. Mitigation strategies for pandemic" exact="influenza" post="in the United States. Proceedings of the National Academy"/>
   <result pre="CooperB, RobinsJM, MaS, JamesL, et al.Transmission dynamics and control of" exact="severe acute respiratory syndrome." post="Science. 2003620;300(5627):1966â€&quot;70. 10.1126/science.108661612766207 33RiversCM, LofgrenET, MaratheM, EubankS, LewisBL. Modeling"/>
   <result pre="the Royal Society Interface. 2009108;6(suppl_6):S767â€&quot;82. 39YuenKY, WongSS. Human infection by" exact="avian influenza" post="A H5N1. Hong Kong Medical Journal. 2005. 40BourouibaL, DehandschoewerckerE,"/>
   <result pre="Royal Society Interface. 2009108;6(suppl_6):S767â€&quot;82. 39YuenKY, WongSS. Human infection by avian" exact="influenza" post="A H5N1. Hong Kong Medical Journal. 2005. 40BourouibaL, DehandschoewerckerE,"/>
   <result pre="and viral RNA shedding in patients with mild pandemic 2009" exact="influenza" post="A H1N1: opportunistic retrospective study of medical charts in"/>
   <result pre="control.Macmillan; 1961. 49TeunisPF, BrienenN, KretzschmarME. High infectivity and pathogenicity of" exact="influenza" post="A virus via aerosol and droplet transmission. Epidemics. 2010121;2(4):215â€&quot;22."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7347616\results\search\disease\results.xml">
   <result pre="likely actual numbers3,4. Dengue virus (DENV), the pathogen that causes" exact="dengue fever" post="and other manifestations, is classified as part of the"/>
   <result pre="complicated scenario, in which affected countries must frequently cope with" exact="yellow fever," post="dengue and epidemics caused by other arboviruses. This is"/>
   <result pre="individuals that were seropositive for other flaviviruses, including Saint Louis" exact="encephalitis" post="virus (SLEV) and YFV. In almost all cases, we"/>
   <result pre="incubated with human flavivirus-negative serum (blue lines), human Saint Louis" exact="encephalitis" post="virus-positive serum (SLEV, red lines), or human Yellow Fever"/>
   <result pre="a high priority in countries affected by annual epidemics of" exact="dengue fever." post="The correct diagnostic is essential for patient managing and"/>
   <result pre="antibody coverage of gold nanorod for ultra-sensitive detection of a" exact="cancer" post="biomarkerLab Chip201212110222298159 49.MeiZWangYTangLGold Nanorod Array Biochip for Label-Free, Multiplexed"/>
   <result pre="69.MenRet al.Immunization of rhesus monkeys with a recombinant of modified" exact="vaccinia virus" post="Ankara expressing a truncated envelope glycoprotein of dengue type"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7348886\results\search\disease\results.xml">
   <result pre="addition, vertical (mother-to-fetus) transmission of the virus may result in" exact="microcephaly" post="and other birth defects [2]. There is currently no"/>
   <result pre="higher viremia in humans, leading to enhanced cross-placental infection and" exact="microcephaly" post="neurological disease and weight loss [26]. Then, Asian strains,"/>
   <result pre="and licensingOccup. Med. (Lond.)20075755255610.1093/occmed/kqm11018045976 16.KangG.ChenH.MaF.YangY.WangZ.GuoS.SongJ.Comparison of the effect of increased" exact="hepatitis" post="b vaccine dosage on immunogenicity in healthy children and"/>
   <result pre="mug should replace the doses of 5 mug in newborn" exact="hepatitis" post="b vaccination in china: A cost-effectiveness analysisVaccine2015333731373810.1016/j.vaccine.2015.05.08226057138 18.FuS.XuJ.LiX.XieY.QiuY.DuX.YuS.BaiY.ChenY.WangT.et al.Immunization"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7349063\results\search\disease\results.xml">
   <result pre="(CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza, an acute, highly contagious" exact="respiratory disease," post="remains a significant threat to public health. More effective"/>
   <result pre="strategies aimed at inducing broad cross-protection not only against seasonal" exact="influenza" post="variants, but also zoonotic and emerging pandemic influenza strains"/>
   <result pre="against seasonal influenza variants, but also zoonotic and emerging pandemic" exact="influenza" post="strains are urgently needed. A number of conserved protein"/>
   <result pre="the immunogenicity and efficacy of a panel of broadly protective" exact="influenza" post="vaccine prototypes based on both influenza tri-stalk and triple"/>
   <result pre="panel of broadly protective influenza vaccine prototypes based on both" exact="influenza" post="tri-stalk and triple M2e (3M2e) antigens integrated into phage"/>
   <result pre="virus challenge in mice, only the combination of both conserved" exact="influenza" post="antigens into a single VLP fully protected mice from"/>
   <result pre="single VLP fully protected mice from a high-dose homologous H1N1" exact="influenza" post="infection. We propose that a combination of genetic fusion"/>
   <result pre="fusion and chemical coupling techniques to expose two different foreign" exact="influenza" post="antigens on a single particle is a perspective approach"/>
   <result pre="broadly-effective vaccine candidate that could protect against the constantly emerging" exact="influenza" post="virus strains. influenza conserved antigens hemagglutinin stalk M2e protein"/>
   <result pre="that could protect against the constantly emerging influenza virus strains." exact="influenza" post="conserved antigens hemagglutinin stalk M2e protein virus-like particles protection"/>
   <result pre="particles protection vaccines 1. Introduction Influenza, an acute, highly contagious" exact="respiratory disease," post="remains a significant threat to public health. The co-circulating"/>
   <result pre="disease, remains a significant threat to public health. The co-circulating" exact="influenza" post="A (subtypes H1N1 and H3N2) and B (lineages Victoria"/>
   <result pre="and up to 645,832 influenza-associated deaths annually [1,2]. Consequently, seasonal" exact="influenza" post="viruses are responsible for a significant economic burden on"/>
   <result pre="burden on the health care systems and society [3,4]. Although" exact="influenza" post="is considered to be a vaccine-preventable disease, the effectiveness"/>
   <result pre="considered to be a vaccine-preventable disease, the effectiveness of seasonal" exact="influenza" post="vaccines varies greatly across the risk groups and seasons,"/>
   <result pre="effectiveness is significantly compromised by the persistent antigenic changes of" exact="influenza" post="viruses [7,8]. Continuous antibody-mediated immune pressure and the lack"/>
   <result pre="mutant variants affecting immune recognition. This process, characteristic to both" exact="influenza" post="A and B viruses, is known as antigenic drift"/>
   <result pre="outbreaks and seasonal epidemics [7,8,9,10]. Moreover, sporadic reassortment of segmented" exact="influenza" post="A virus genomes in a double-infected host cell can"/>
   <result pre="immunologically naive human population is particularly susceptible. Interspecies transmissions of" exact="influenza" post="A viruses from animal reservoirs have resulted in four"/>
   <result pre="pandemics since the beginning of the 20th century; the Spanish" exact="influenza" post="pandemic in 1918 is considered to be the most"/>
   <result pre="the vaccine effectiveness [5,6,7,8,13]. Furthermore, the components of commercially available" exact="influenza" post="vaccines are mainly obtained by propagating viruses in embryonated"/>
   <result pre="time-consuming, and expensive process with limitations for highly pathogenic avian-borne" exact="influenza" post="virus vaccine preparations [14,15]. The capability to manufacture large"/>
   <result pre="of strain-specific vaccine doses in the event of a sudden" exact="influenza" post="pandemic is limited, which means that during the months"/>
   <result pre="virus strain [11,14,15]. The persistent threat of highly pathogenic poultry" exact="influenza" post="viruses (H5Nx) and other zoonotic influenza strains (H6N1, H7N9,"/>
   <result pre="of highly pathogenic poultry influenza viruses (H5Nx) and other zoonotic" exact="influenza" post="strains (H6N1, H7N9, H10N8) overcoming the species barrier and"/>
   <result pre="[16,17,18,19]. Currently, numerous strategies to improve the effectiveness of seasonal" exact="influenza" post="vaccines, like the use of new adjuvants, increased doses,"/>
   <result pre="these approaches could not provide broad and durable protection from" exact="influenza" post="virus drift and shift variants. All these challenges indicate"/>
   <result pre="strategies aimed at inducing broad cross-protection not only against seasonal" exact="influenza" post="variants but also zoonotic and emerging pandemic influenza strains."/>
   <result pre="against seasonal influenza variants but also zoonotic and emerging pandemic" exact="influenza" post="strains. A number of conserved protein targets to elicit"/>
   <result pre="the viral envelope, these conserved antigens are immunosubdominant and natural" exact="influenza" post="infections and current vaccination regimens elicit little or no"/>
   <result pre="the highly conserved nature, vaccines based solely on one conserved" exact="influenza" post="antigen most often cannot provide complete protection against highly"/>
   <result pre="several conserved epitopes might confer broader and longer-lasting protection against" exact="influenza" post="virus infections. In the present study, we investigated the"/>
   <result pre="the immunogenicity and efficacy of a panel of broadly protective" exact="influenza" post="vaccine prototypes based on influenza HA stalk and M2e"/>
   <result pre="a panel of broadly protective influenza vaccine prototypes based on" exact="influenza" post="HA stalk and M2e antigens integrated into bacteriophage AP205"/>
   <result pre="fusion and chemical coupling techniques to expose two different foreign" exact="influenza" post="antigens on a single particle without compromising the trimeric"/>
   <result pre="broadly-effective vaccine candidate that could protect against the constantly emerging" exact="influenza" post="virus strains. Similar VLP vaccine candidates have employed a"/>
   <result pre="and M2 proteins are expressed abundantly on the surface of" exact="influenza" post="virus infected cells [37]. MDCK cell monolayers, seeded in"/>
   <result pre="In this study, to generate and test different broadly protective" exact="influenza" post="vaccine candidates, HA tri-stalk and a triple M2e protein"/>
   <result pre="platform, alone or in combination, creating five different broadly protective" exact="influenza" post="vaccine prototypes (Figure 2). Since aa 10â€&quot;24 of M2e"/>
   <result pre="(Figure 2). Since aa 10â€&quot;24 of M2e peptide vary between" exact="influenza" post="virus subtypes, combining the M2e from different subtypes can"/>
   <result pre="H1N1 and H11N9 subtypes to cover a wider range of" exact="influenza" post="viruses. Noteworthy, two of the M2e fragments comprising the"/>
   <result pre="monomeric LAH is highly immunogenic in mice when incorporated into" exact="hepatitis" post="B virus core particles [29,33]. Moreover, post-fusion LAH-specific antibodies"/>
   <result pre="bled and sera were analyzed for their reactivity to different" exact="influenza" post="antigens by ELISA. All vaccine prototypes induced high levels"/>
   <result pre="immunogens, were challenged with lethal doses of heterologous and heterosubtypic" exact="influenza" post="viruses (Figure 7). The antibody responses induced by AP-M2e"/>
   <result pre="targeted antibodies are critical for the protection against a homologous" exact="influenza" post="virus infection, and the antibodies targeted to M2e play"/>
   <result pre="group of immunized mice (Figure 12A). 4. Discussion Evolutionarily conserved" exact="influenza" post="antigens could potentially provide broad-spectrum protection against highly variable"/>
   <result pre="influenza antigens could potentially provide broad-spectrum protection against highly variable" exact="influenza" post="virus subtypes, while significantly reducing the time and costs"/>
   <result pre="vaccine production. Furthermore, recombinant vaccines help to avoid potentially harmful" exact="influenza" post="viruses grown in embryonated eggs or cell cultures and"/>
   <result pre="Here we evaluated the antigenicity and protective potential of recombinant" exact="influenza" post="vaccine prototypes, generated by combining the methods of genetic"/>
   <result pre="HA stalk as a prospective component for a broadly protective" exact="influenza" post="vaccine. However, with a few exceptions [41,42,43], a great"/>
   <result pre="and could efficiently recognize HA proteins from heterologous group 1" exact="influenza" post="viruses; notably, cross-reactivity with group 2 antigens was also"/>
   <result pre="stalk-reactive antibodies afford little cross-protection between group 1 and 2" exact="influenza" post="viruses. Importantly, H3N2 viruses show the highest degree of"/>
   <result pre="highest degree of antigenic drift when compared to other seasonal" exact="influenza" post="viruses, posing the greatest risk of unmatched seasonal vaccine"/>
   <result pre="2 viruses to achieve a complete cross-protection against type A" exact="influenza" post="[22,23,24], here we bypass the issue of insufficient cross-protective"/>
   <result pre="have been shown to result in significant protection against divergent" exact="influenza" post="viruses, probably because the high level of IgG1 antibodies"/>
   <result pre="high-yield antigen production, an important hallmark for a broadly protective" exact="influenza" post="vaccine, accessible to the general public. Even though in"/>
   <result pre="virus-neutralizing antibody. Although some anti-stalk antibodies can directly neutralize the" exact="influenza" post="virus [41,42,43], antibodies against M2e do not possess virus-neutralizing"/>
   <result pre="Additional challenge experiment with a high dose of homologous H1N1" exact="influenza" post="virus emphasized the important role of tri-stalk targeted antibody"/>
   <result pre="responses and monitoring weight loss and survival upon a lethal" exact="influenza" post="virus challenge. Assessment of virus replication in the mouse"/>
   <result pre="particulate properties [63]. 5. Conclusions The combination of multiple conserved" exact="influenza" post="antigens into a multivalent single-component AP-M2e/tri-stalk vaccine protected mice"/>
   <result pre="multivalent single-component AP-M2e/tri-stalk vaccine protected mice from high dose homologous" exact="influenza" post="challenge and induced robust heterosubtypic immunity. Since persistent vaccine-induced"/>
   <result pre="immunity is a highly desirable feature of a broadly protective" exact="influenza" post="vaccine, it should be noted that both the post-fusion"/>
   <result pre="vaccine prototype might provide broad protection against seasonal and emergent" exact="influenza" post="strains, thus replacing the current vaccination strategies. Supplementary Materials"/>
   <result pre="acid sequences of N-terminally extended long alfa-helix fragment of various" exact="influenza" post="A HA proteins used in this study, Table S3:"/>
   <result pre="between the vaccination antigens and the corresponding protein fragments of" exact="influenza" post="A challenge viruses used in this study. LINK Click"/>
   <result pre="influenza-associated respiratory mortality: A modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 3.PutriW.C.W.S.MuscatelloD.J.StockwellM.S.NewallA.T.Economic burden of seasonal" exact="influenza" post="in the United StatesVaccine2018363960396610.1016/j.vaccine.2018.05.05729801998 4.PreaudE.DurandL.MacabeoB.FarkasN.SloesenB.PalacheA.ShupoF.SamsonS.I.collab: Vaccines Europe Influenza Working"/>
   <result pre="Influenza Working GroupAnnual public health and economic benefits of seasonal" exact="influenza" post="vaccination: A European estimateBMC Public Health20141481310.1186/1471-2458-14-81325103091 5.collab: CDCCDC Seasonal"/>
   <result pre="ECDCInfluenza Vaccine EffectivenessAvailable online: https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccine-effectiveness(accessed on 6 March 2020) 7.BelongiaE.A.SimpsonM.D.KingJ.P.SundaramM.E.KelleyN.S.OsterholmM.T.McLeanH.Q.Variable" exact="influenza" post="vaccine effectiveness by subtype: A systematic review and meta-analysis"/>
   <result pre="design studiesLancet Infect. Dis.20161694295110.1016/S1473-3099(16)00129-827061888 8.BedfordT.RileyS.BarrI.G.BroorS.ChadhaM.CoxN.J.DanielsR.S.GunasekaranC.P.HurtA.C.KelsoA.et al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 9.HeatonN.S.SachsD.ChenC.-J.HaiR.PaleseP.Genome-wide mutagenesis of influenza"/>
   <result pre="seasonal influenza viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 9.HeatonN.S.SachsD.ChenC.-J.HaiR.PaleseP.Genome-wide mutagenesis of" exact="influenza" post="virus reveals unique plasticity of the hemagglutinin and NS1"/>
   <result pre="hemagglutinin and NS1 proteinsProc. Natl. Acad. Sci. USA2013110202482025310.1073/pnas.132052411024277853 10.WongK.K.Y.RockmanS.OngC.BullR.Stelzer-BraidS.RawlinsonW.Comparison of" exact="influenza" post="virus replication fidelity in vitro using selection pressure with"/>
   <result pre="Memory Toward Unpredictable Influenza VirusesFront. Immunol.201910140010.3389/fimmu.2019.0140031312199 12.TscherneD.M.GarcÃ­a-SastreA.Virulence determinants of pandemic" exact="influenza" post="virusesJ. Clin. Investig.201112161310.1172/JCI4494721206092 13.LukszaM.LÃ¤ssigM.A predictive fitness model for influenzaNature2014507576110.1038/nature1308724572367"/>
   <result pre="13.LukszaM.LÃ¤ssigM.A predictive fitness model for influenzaNature2014507576110.1038/nature1308724572367 14.HannounC.The evolving history of" exact="influenza" post="viruses and influenza vaccinesExpert Rev. Vaccines2013121085109410.1586/14760584.2013.82470924024871 15.BazM.LukeC.J.ChengX.JinH.SubbaraoK.H5N1 vaccines in"/>
   <result pre="model for influenzaNature2014507576110.1038/nature1308724572367 14.HannounC.The evolving history of influenza viruses and" exact="influenza" post="vaccinesExpert Rev. Vaccines2013121085109410.1586/14760584.2013.82470924024871 15.BazM.LukeC.J.ChengX.JinH.SubbaraoK.H5N1 vaccines in humansVirus Res.2013178789810.1016/j.virusres.2013.05.00623726847 16.NuÃ±ezI.A.RossT.M.A"/>
   <result pre="Vaccines2013121085109410.1586/14760584.2013.82470924024871 15.BazM.LukeC.J.ChengX.JinH.SubbaraoK.H5N1 vaccines in humansVirus Res.2013178789810.1016/j.virusres.2013.05.00623726847 16.NuÃ±ezI.A.RossT.M.A review of H5Nx" exact="avian influenza" post="virusesTher. Adv. Vaccines Immunother.20197251513551882162510.1177/251513551882162530834359 17.WeiS.-H.YangJ.-R.WuH.-S.ChangM.-C.LinJ.-S.LinC.-Y.LiuY.-L.LoY.-C.YangC.-H.ChuangJ.-H.et al.Human infection with avian"/>
   <result pre="15.BazM.LukeC.J.ChengX.JinH.SubbaraoK.H5N1 vaccines in humansVirus Res.2013178789810.1016/j.virusres.2013.05.00623726847 16.NuÃ±ezI.A.RossT.M.A review of H5Nx avian" exact="influenza" post="virusesTher. Adv. Vaccines Immunother.20197251513551882162510.1177/251513551882162530834359 17.WeiS.-H.YangJ.-R.WuH.-S.ChangM.-C.LinJ.-S.LinC.-Y.LiuY.-L.LoY.-C.YangC.-H.ChuangJ.-H.et al.Human infection with avian"/>
   <result pre="avian influenza virusesTher. Adv. Vaccines Immunother.20197251513551882162510.1177/251513551882162530834359 17.WeiS.-H.YangJ.-R.WuH.-S.ChangM.-C.LinJ.-S.LinC.-Y.LiuY.-L.LoY.-C.YangC.-H.ChuangJ.-H.et al.Human infection with" exact="avian influenza" post="A H6N1 virus: An epidemiological analysisLancet Respir. Med.2013177177810.1016/S2213-2600(13)70221-224461756 18.GaoR.CaoB.HuY.FengZ.WangD.HuW.ChenJ.JieZ.QiuH.XuK.et"/>
   <result pre="influenza virusesTher. Adv. Vaccines Immunother.20197251513551882162510.1177/251513551882162530834359 17.WeiS.-H.YangJ.-R.WuH.-S.ChangM.-C.LinJ.-S.LinC.-Y.LiuY.-L.LoY.-C.YangC.-H.ChuangJ.-H.et al.Human infection with avian" exact="influenza" post="A H6N1 virus: An epidemiological analysisLancet Respir. Med.2013177177810.1016/S2213-2600(13)70221-224461756 18.GaoR.CaoB.HuY.FengZ.WangD.HuW.ChenJ.JieZ.QiuH.XuK.et"/>
   <result pre="analysisLancet Respir. Med.2013177177810.1016/S2213-2600(13)70221-224461756 18.GaoR.CaoB.HuY.FengZ.WangD.HuW.ChenJ.JieZ.QiuH.XuK.et al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN. Engl. J. Med.20133681888189710.1056/NEJMoa130445923577628 19.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and"/>
   <result pre="19.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and epidemiological characteristics of a fatal case of" exact="avian influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 20.NachbagauerR.KrammerF.Universal influenza"/>
   <result pre="al.Clinical and epidemiological characteristics of a fatal case of avian" exact="influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 20.NachbagauerR.KrammerF.Universal influenza"/>
   <result pre="avian influenza A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 20.NachbagauerR.KrammerF.Universal" exact="influenza" post="virus vaccines and therapeutic antibodiesClin. Microbiol. Infect.20172322222810.1016/j.cmi.2017.02.00928216325 21.ValkenburgS.A.MallajosyulaV.V.A.LiO.T.W.ChinA.W.H.CarnellG.TempertonN.VaradarajanR.PoonL.L.M.Stalking influenza"/>
   <result pre="20.NachbagauerR.KrammerF.Universal influenza virus vaccines and therapeutic antibodiesClin. Microbiol. Infect.20172322222810.1016/j.cmi.2017.02.00928216325 21.ValkenburgS.A.MallajosyulaV.V.A.LiO.T.W.ChinA.W.H.CarnellG.TempertonN.VaradarajanR.PoonL.L.M.Stalking" exact="influenza" post="by vaccination with pre-fusion headless HA mini-stemSci. Rep.201662266610.1038/srep2266626947245 22.KrammerF.PicaN.HaiR.MargineI.PaleseP.Chimeric"/>
   <result pre="by vaccination with pre-fusion headless HA mini-stemSci. Rep.201662266610.1038/srep2266626947245 22.KrammerF.PicaN.HaiR.MargineI.PaleseP.Chimeric hemagglutinin" exact="influenza" post="virus vaccine constructs elicit broadly protective stalk-specific antibodiesJ. Virol.2013876542655010.1128/JVI.00641-1323576508"/>
   <result pre="particle vaccine with adjuvant protects mice against homologous and heterologous" exact="influenza" post="virusesVaccine2016346464647110.1016/j.vaccine.2016.11.02627866773 24.ChenS.ZhengD.LiC.ZhangW.XuW.LiuX.FangF.ChenZ.Protection against multiple subtypes of influenza viruses by"/>
   <result pre="homologous and heterologous influenza virusesVaccine2016346464647110.1016/j.vaccine.2016.11.02627866773 24.ChenS.ZhengD.LiC.ZhangW.XuW.LiuX.FangF.ChenZ.Protection against multiple subtypes of" exact="influenza" post="viruses by virus-like particle vaccines based on a hemagglutinin"/>
   <result pre="vaccines based on a hemagglutinin conserved epitopeBioMed Res. Int.2015201590181710.1155/2015/90181725767809 25.KolpeA.SchepensB.FiersW.SaelensX.M2-based" exact="influenza" post="vaccines: Recent advances and clinical potentialExpert Rev. Vaccines20171612313610.1080/14760584.2017.124004127653543 26.De"/>
   <result pre="Recent advances and clinical potentialExpert Rev. Vaccines20171612313610.1080/14760584.2017.124004127653543 26.De FiletteM.Min JouW.BirkettA.LyonsK.SchultzB.TonkyroA.ReschS.FiersW.Universal" exact="influenza" post="A vaccine: Optimization of M2-based constructsVirology200533714916110.1016/j.virol.2005.04.00415914228 27.SuiZ.ChenQ.WuR.ZhangH.ZhengM.WangH.ChenZ.Cross-protection against influenza"/>
   <result pre="JouW.BirkettA.LyonsK.SchultzB.TonkyroA.ReschS.FiersW.Universal influenza A vaccine: Optimization of M2-based constructsVirology200533714916110.1016/j.virol.2005.04.00415914228 27.SuiZ.ChenQ.WuR.ZhangH.ZhengM.WangH.ChenZ.Cross-protection against" exact="influenza" post="virus infection by intranasal administration of M2-based vaccine with"/>
   <result pre="induces humoral and cellular immune responses conferring cross-protection against heterosubtypic" exact="influenza" post="virusesPLoS ONE201813e019086810.1371/journal.pone.019086829324805 29.RamirezA.MorrisS.MaucourantS.Dâ€™AscanioI.CrescenteV.LuI.-N.FarinelleS.MullerC.P.WhelanM.RosenbergW.A virus-like particle vaccine candidate for influenza"/>
   <result pre="heterosubtypic influenza virusesPLoS ONE201813e019086810.1371/journal.pone.019086829324805 29.RamirezA.MorrisS.MaucourantS.Dâ€™AscanioI.CrescenteV.LuI.-N.FarinelleS.MullerC.P.WhelanM.RosenbergW.A virus-like particle vaccine candidate for" exact="influenza" post="A virus based on multiple conserved antigens presented on"/>
   <result pre="influenza A virus based on multiple conserved antigens presented on" exact="hepatitis" post="B tandem core particlesVaccine20183687388010.1016/j.vaccine.2017.12.05329306508 30.EllebedyA.H.AhmedR.Re-engaging cross-reactive memory B cells:"/>
   <result pre="B tandem core particlesVaccine20183687388010.1016/j.vaccine.2017.12.05329306508 30.EllebedyA.H.AhmedR.Re-engaging cross-reactive memory B cells: The" exact="influenza" post="puzzleFront. Immunol.201235310.3389/fimmu.2012.0005322566934 31.PushkoP.PumpensP.GrensE.Development of virus-like particle technology from small"/>
   <result pre="ObanosM.P.KrimerA.et al.Production and purification of chimeric HBc virus-like particles carrying" exact="influenza" post="virus LAH domain as vaccine candidatesBMC Biotechnol.2017177910.1186/s12896-017-0396-829126399 34.AdachiY.TonouchiK.NithichanonA.KuraokaM.WatanabeA.ShinnakasuR.AsanumaH.AinaiA.OhmiY.YamamotoT.et al.Exposure"/>
   <result pre="occluded hemagglutinin epitope drives selection of a class of cross-protective" exact="influenza" post="antibodiesNat. Commun.201910388310.1038/s41467-019-11821-631462639 35.LuI.-N.KirsteinaA.FarinelleS.WilliemeS.TarsK.MullerC.P.KazaksA.Structure and applications of novel influenza HA"/>
   <result pre="of cross-protective influenza antibodiesNat. Commun.201910388310.1038/s41467-019-11821-631462639 35.LuI.-N.KirsteinaA.FarinelleS.WilliemeS.TarsK.MullerC.P.KazaksA.Structure and applications of novel" exact="influenza" post="HA tri-stalk protein for evaluation of HA stem-specific immunityPLoS"/>
   <result pre="antibodies but plays a critical role in conferring protection after" exact="influenza" post="M2 vaccinationImmunology201414330030910.1111/imm.1231024773389 37.LeserG.P.LambR.A.Influenza virus assembly and budding in raft-derived"/>
   <result pre="39.JegaskandaS.WeinfurterJ.T.FriedrichT.C.KentS.J.Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1" exact="influenza" post="virus infection of macaquesJ. Virol.2013875512552210.1128/JVI.03030-1223468501 40.KrystalM.ElliottR.M.BenzE.W.YoungJ.F.PaleseP.Evolution of influenza A"/>
   <result pre="pandemic H1N1 influenza virus infection of macaquesJ. Virol.2013875512552210.1128/JVI.03030-1223468501 40.KrystalM.ElliottR.M.BenzE.W.YoungJ.F.PaleseP.Evolution of" exact="influenza" post="A and B viruses: Conservation of structural features in"/>
   <result pre="plasma cells that binds to group 1 and group 2" exact="influenza" post="A hemagglutininsScience201133385085610.1126/science.120566921798894 42.NakamuraG.ChaiN.ParkS.ChiangN.LinZ.ChiuH.FongR.YanD.KimJ.ZhangJ.et al.An in vivo human-plasmablast enrichment technique"/>
   <result pre="in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic" exact="influenza" post="A antibodiesCell Host Microbe2013149310310.1016/j.chom.2013.06.00423870317 43.DreyfusC.LaursenN.S.KwaksT.ZuijdgeestD.KhayatR.EkiertD.C.LeeJ.H.MetlagelZ.BujnyM.V.JongeneelenM.et al.Highly conserved protective epitopes"/>
   <result pre="A antibodiesCell Host Microbe2013149310310.1016/j.chom.2013.06.00423870317 43.DreyfusC.LaursenN.S.KwaksT.ZuijdgeestD.KhayatR.EkiertD.C.LeeJ.H.MetlagelZ.BujnyM.V.JongeneelenM.et al.Highly conserved protective epitopes on" exact="influenza" post="B virusesScience20123371343134810.1126/science.122290822878502 44.ThrosbyM.van den BrinkE.JongeneelenM.PoonL.L.M.AlardP.CornelissenL.BakkerA.CoxF.van DeventerE.GuanY.et al.Heterosubtypic neutralizing monoclonal"/>
   <result pre="Microbe20161980081310.1016/j.chom.2016.05.01427281570 47.EkiertD.C.FriesenR.H.E.BhabhaG.KwaksT.JongeneelenM.YuW.OphorstC.CoxF.KorseH.J.W.M.BrandenburgB.et al.A highly conserved neutralizing epitope on group 2" exact="influenza" post="A virusesScience201133384385010.1126/science.120483921737702 48.DiLilloD.J.TanG.S.PaleseP.RavetchJ.V.Broadly neutralizing hemagglutinin stalk-specific antibodies require FcÎ³R"/>
   <result pre="neutralizing hemagglutinin stalk-specific antibodies require FcÎ³R interactions for protection against" exact="influenza" post="virus in vivoNat. Med.20142014315110.1038/nm.344324412922 49.NimmerjahnF.RavetchJ.V.Divergent immunoglobulin g subclass activity"/>
   <result pre="receptors: Old friends and new family membersImmunity200624192810.1016/j.immuni.2005.11.01016413920 51.SchmitzN.BeerliR.R.BauerM.JegerlehnerA.DietmeierK.MaudrichM.PumpensP.SaudanP.BachmannM.F.Universal vaccine against" exact="influenza" post="virus: Linking TLR signaling to anti-viral protectionEur. J. Immunol.20124286386910.1002/eji.20104122522531913"/>
   <result pre="signaling to anti-viral protectionEur. J. Immunol.20124286386910.1002/eji.20104122522531913 52.StepanovaL.A.KotlyarovR.Y.KovalevaA.A.PotapchukM.V.KorotkovA.V.SergeevaM.V.KasianenkoM.A.KuprianovV.V.RavinN.V.TsybalovaL.M.et al.Protection against multiple" exact="influenza" post="A virus strains induced by candidate recombinant vaccine based"/>
   <result pre="bacteriophage-like particles for the packaging of nanomaterialsMol. Biotechnol.20145610211010.1007/s12033-013-9686-023852987 55.MezhenskayaD.Isakova-SivakI.RudenkoL.M2e-based universal" exact="influenza" post="vaccines: A historical overview and new approaches to developmentJ."/>
   <result pre="BakkouriK.YsenbaertT.DengL.et al.M2e-tetramer-specific memory CD4 T cells are broadly protective against" exact="influenza" post="infectionMucosal Immunol.20181127328910.1038/mi.2017.1428295019 58.BrownD.M.DilzerA.M.MeentsD.L.SwainS.L.CD4 T cell-mediated protection from lethal influenza:"/>
   <result pre="Perforin and antibody-mediated mechanisms give a one-two punchJ. Immunol.20061772888289810.4049/jimmunol.177.5.288816920924 59.SchotsaertM.IbaÃ±ezL.I.FiersW.SaelensX.Controlling" exact="influenza" post="by cytotoxic T-cells: Calling for help from destroyersJ. Biomed."/>
   <result pre="viruses on immunogenicity and protection induced by a candidate universal" exact="influenza" post="vaccine in micePLoS ONE201914e021532110.1371/journal.pone.021532130986224 61.Herrera-RodriguezJ.MeijerhofT.NiestersH.G.StjernholmG.HovdenA.-O.SÃ¸rensenB.Ã–kvistM.SommerfeltM.A.HuckriedeA.A novel peptide-based vaccine candidate"/>
   <result pre="ONE201914e021532110.1371/journal.pone.021532130986224 61.Herrera-RodriguezJ.MeijerhofT.NiestersH.G.StjernholmG.HovdenA.-O.SÃ¸rensenB.Ã–kvistM.SommerfeltM.A.HuckriedeA.A novel peptide-based vaccine candidate with protective efficacy against" exact="influenza" post="A in a mouse modelVirology2018515212810.1016/j.virol.2017.11.01829223787 62.Asthagiri ArunkumarG.McMahonM.PavotV.AramouniM.IoannouA.LambeT.GilbertS.KrammerF.Vaccination with viral"/>
   <result pre="expressing NP, M1 and chimeric hemagglutinin induces broad protection against" exact="influenza" post="virus challenge in miceVaccine2019375567557710.1016/j.vaccine.2019.07.09531399277 63.KangS.-M.KimM.-C.CompansR.W.Virus-like particles as universal influenza"/>
   <result pre="against influenza virus challenge in miceVaccine2019375567557710.1016/j.vaccine.2019.07.09531399277 63.KangS.-M.KimM.-C.CompansR.W.Virus-like particles as universal" exact="influenza" post="vaccinesExpert Rev. Vaccines201211995100710.1586/erv.12.7023002980 64.SchwartzmanL.M.CathcartA.L.PujanauskiL.M.QiL.KashJ.C.TaubenbergerJ.K.An Intranasal Virus-Like Particle Vaccine Broadly"/>
   <result pre="0.0001). Figure 9 Immune protection conferred against lethal H1N1 A/California/7/2009" exact="influenza" post="virus challenge. (A) BALB/c mice were vaccinated with Alum-adjuvanted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7349089\results\search\disease\results.xml">
   <result pre="of Kenya, for example identifying vectors of dengue virus or" exact="malaria" post="viruses, little work has been carried out to determine"/>
   <result pre="protozoa of Plasmodium spp., spread by mosquitoes, continue to cause" exact="malaria" post="in certain regions [2]; East coast fever, caused by"/>
   <result pre="the urban transmission exist. For example in Senegal, the alphavirus" exact="chikungunya" post="[CHIKV] circulates between arboreal Aedes (Stegomyia) spp. mosquitoes and"/>
   <result pre="animal and wildlife pathogens, can lead to the emergence of" exact="infectious disease" post="in any of these groups [17]. Kenya itself is"/>
   <result pre="often appears to create ideal habitat along forest edges for" exact="malaria" post="mosquito vectors to breed, and deforestation is associated with"/>
   <result pre="transmission settings of ICEMR Projects will require local and regional" exact="malaria" post="elimination strategiesAm. J. Trop. Med. Hyg.201593284110.4269/ajtmh.15-000926259942 3.GachohiJ.SkiltonR.A.HansenF.NgumiP.KitalaP.M.Epidemiology of East"/>
   <result pre="Past, present and the futureParasites Vectors2012519410.1186/1756-3305-5-19422958352 4.MwandawiroC.S.FujimakiY.MitsuiY.KatsivoM.Mosquito vectors of bancroftian" exact="filariasis" post="in Kwale District, KenyaEast. Afr. Med. J.1997742882939337005 5.HimeidanY.E.S.KwekaE.J.MahgoubM.M.El RayahE.A.OumaJ.O.Recent"/>
   <result pre="River and Garissa Counties, KenyaBMC Infect. Dis.20161669610.1186/s12879-016-2019-827881079 7.KwagonzaL.MasiiraB.Kyobe-BosaH.KadoberaD.AtuheireE.B.LubwamaB.KagiritaA.KatushabeE.KayiwaJ.LutwamaJ.J.et al.Outbreak of" exact="yellow fever" post="in central and southwestern Uganda, February 2016BMC Infect. Dis.20181854810.1186/s12879-018-3440-y30390621"/>
   <result pre="2016BMC Infect. Dis.20181854810.1186/s12879-018-3440-y30390621 8.LaBeaudA.D.BandaT.BrichardJ.MuchiriE.M.MungaiP.L.MutukuF.M.BorlandE.GildengorinG.PfeilS.TengC.Y.et al.High rates of oâ€™nyong nyong and" exact="chikungunya" post="virus transmission in Coastal KenyaPLoS Negl. Trop. Dis.20159e000343610.1371/journal.pntd.000343625658762 9.PowersA.M.BraultA.C.TeshR.B.WeaverS.C.Re-emergence"/>
   <result pre="virus transmission in Coastal KenyaPLoS Negl. Trop. Dis.20159e000343610.1371/journal.pntd.000343625658762 9.PowersA.M.BraultA.C.TeshR.B.WeaverS.C.Re-emergence of" exact="chikungunya" post="and oâ€™nyong-nyong viruses: Evidence for distinct geographical lineages and"/>
   <result pre="epidemic period of 2014PLoS Negl. Trop. Dis.201610e000431310.1371/journal.pntd.000431326812489 14.EastwoodG.TarachaE.L.N.WeaverS.C.SangR.C.GuerboisM.Enzootic circulation of" exact="chikungunya" post="Virus in East Africa: Serological evidence in non-human Kenyan"/>
   <result pre="of controlAnn. Trop. Med. Parasitol.19847859760410.1080/00034983.1984.118118706532329 20.ReiterP.CordellierR.OumaJ.O.CroppC.B.SavageH.M.SandersE.J.MarfinA.A.TukeiP.M.AgataN.N.GitauL.G.et al.First recorded outbreak of" exact="yellow fever" post="in Kenya, 1992â€&quot;1993. II. Entomologic investigationsAm. J. Trop. Med."/>
   <result pre="and their potential implication in pathogen transmissionParasitol. Res.2011110617110.1007/s00436-011-2449-621626425 26.AghaS.B.TchouassiD.P.BastosA.D.S.SangR.Dengue and" exact="yellow fever" post="virus vectors: Seasonal abundance, diversity and resting preferences in"/>
   <result pre="Kenyaâ€™s lakes Victoria and BaringoJ. Med. Ãˆntomol.2016531348136310.1093/jme/tjw10227402888 28.SergonK.OnyangoC.BreimanR.F.OfulaV.BednoS.KonongoiL.S.BurkeH.KondeJ.SangR.DumillaA.M.et al.Seroprevalence of" exact="chikungunya" post="virus (CHIKV) infection on Lamu Island, Kenya, October 2004Am."/>
   <result pre="October 2004Am. J. Trop. Med. Hyg.20087833333710.4269/ajtmh.2008.78.33318256441 29.TsetsarkinK.A.VanLandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 30.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et"/>
   <result pre="specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 30.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="of mosquitoes in southeastern Senegal, epidemiological implication in arbovirus and" exact="malaria" post="transmissionJ. Med. Ãˆntomol.20185645346310.1093/jme/tjy20430428055 49.TorresR.SamudioR.CarreraJ.P.YoungJ.MarquezR.HurtadoL.WeaverS.ChavesL.F.TeshR.CarreraL.C.Enzootic mosquito vector species at equine"/>
   <result pre="malaria transmissionJ. Med. Ãˆntomol.20185645346310.1093/jme/tjy20430428055 49.TorresR.SamudioR.CarreraJ.P.YoungJ.MarquezR.HurtadoL.WeaverS.ChavesL.F.TeshR.CarreraL.C.Enzootic mosquito vector species at equine" exact="encephalitis" post="transmission foci in the RepÃºblica de PanamÃ¡PLoS ONE201712e018549110.1371/journal.pone.018549128937995 50.McMillanJ.R.ArmstrongP.M.AndreadisT.G.Patterns"/>
   <result pre="tropical rainforest of central PanamaSci. Rep.20177724810.1038/s41598-017-07476-228775261 55.VittorA.Y.PanW.GilmanR.H.TielschJ.GlassG.ShieldsT.SÃ¡nchez-LozanoW.PinedoV.V.Salas-CobosE.FloresS.et al.Linking deforestation to" exact="malaria" post="in the Amazon: Characterization of the breeding habitat of"/>
   <result pre="the Amazon: Characterization of the breeding habitat of the principal" exact="malaria" post="vector, Anopheles darlingiAm. J. Trop. Med. Hyg.20098151219556558 56.MacdonaldA.J.MordecaiE.A.Amazon deforestation"/>
   <result pre="vector, Anopheles darlingiAm. J. Trop. Med. Hyg.20098151219556558 56.MacdonaldA.J.MordecaiE.A.Amazon deforestation drives" exact="malaria" post="transmission, and malaria burden reduces forest clearingProc. Natl. Acad."/>
   <result pre="J. Trop. Med. Hyg.20098151219556558 56.MacdonaldA.J.MordecaiE.A.Amazon deforestation drives malaria transmission, and" exact="malaria" post="burden reduces forest clearingProc. Natl. Acad. Sci. USA2019116222122221810.1073/pnas.190531511631611369 57.AfraneY.A.GithekoA.K.YanG.The"/>
   <result pre="deforestation in East African highlandsAnn. N. Y. Acad. Sci.2012124920421010.1111/j.1749-6632.2011.06432.x22320421 58.KovalevS.MukhachevaT.A.Tick-borne" exact="encephalitis" post="virus subtypes emerged through rapid vector switches rather than"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7349415\results\search\disease\results.xml">
   <result pre="aspects, the â€œeasiestâ€� situation would correspond to a confirmed acute" exact="dengue fever," post="only requiring knowing when the patient should come back"/>
   <result pre="benefit. One specificity of CYD-TDV is that it possesses a" exact="yellow fever" post="17D (YF17D) backbone, and thus expresses NS antigens of"/>
   <result pre="fever 17D (YF17D) backbone, and thus expresses NS antigens of" exact="yellow fever" post="virus. Accordingly, while CYD-TDV is able to induce cellular"/>
   <result pre="range of cross-reactive antibody titers from a prior inactivated Japanese" exact="encephalitis" post="(JE) vaccination and then developing enhanced Yellow Fever (YF)"/>
   <result pre="to dengue viruses, such as Yellow fever (YF) or Japanese" exact="encephalitis" post="(JE) viruses. Information in this regard is more limited,"/>
   <result pre="interval of time by the YF17D vaccine on a Japanese" exact="encephalitis" post="chimeric vaccine (JE-CV, using as CYD-TDV a YF17D backbone),"/>
   <result pre="dengue riskNature201855771972310.1038/s41586-018-0157-429795354 40.NasveldP.E.MarjasonJ.BennettS.AaskovJ.ElliottS.McCarthyK.Kanesa-ThasanN.FeroldiE.ReidM.Concomitant or sequential administration of live attenuated Japanese" exact="encephalitis" post="chimeric virus vaccine and yellow fever 17D vaccine: Randomized"/>
   <result pre="administration of live attenuated Japanese encephalitis chimeric virus vaccine and" exact="yellow fever" post="17D vaccine: Randomized double-blind phase II evaluation of safety"/>
   <result pre="of safety and immunogenicityHum. Vaccines2010690691410.4161/hv.6.11.12854 41.LÃ³pezP.LanataC.F.ZambranoB.CortÃ©sM.AndradeT.AmemiyaI.TerronesC.GilA.I.VerasteguiH.MarquezV.et al.Immunogenicity and safety of" exact="yellow fever" post="vaccine (stamaril) when administered concomitantly with a tetravalent dengue"/>
   <result pre="adultsBMC Infect. Dis.20181847510.1186/s12879-018-3389-x30241510 43.GlassA.PolhemusM.WangD.JarmanR.G.ThomasS.J.FribergH.CurrierJ.R.BonaparteM.De La BarraR.PrinciottaM.F.et al.The effects of Japanese" exact="encephalitis" post="vaccine and accelerated dosing scheduling on the immunogenicity of"/>
   <result pre="and accelerated dosing scheduling on the immunogenicity of the chimeric" exact="yellow fever" post="derived tetravalent dengue vaccine: A phase II, randomized, open-label,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7350001\results\search\disease\results.xml">
   <result pre="neurotropic Alphaviruses, Eastern (EEEV), Venezuelan (VEEV), and Western (WEEV) equine" exact="encephalitis" post="viruses, are pathogens of interest for animal health, public"/>
   <result pre="EEEV, VEEV, and WEEV. Alphavirus antigens DNA vaccine Eastern equine" exact="encephalitis" post="virus (EEEV) vaccine Venezuelan equine encephalitis virus (VEEV) Western"/>
   <result pre="DNA vaccine Eastern equine encephalitis virus (EEEV) vaccine Venezuelan equine" exact="encephalitis" post="virus (VEEV) Western equine encephalitis virus (WEEV) 1. Introduction"/>
   <result pre="virus (EEEV) vaccine Venezuelan equine encephalitis virus (VEEV) Western equine" exact="encephalitis" post="virus (WEEV) 1. Introduction Vaccinations provide an effective means"/>
   <result pre="New-World Alphaviruses, Eastern (EEEV), Venezuelan (VEEV), and Western (WEEV) equine" exact="encephalitis" post="viruses circulate between rodents or birds and mosquito vectors"/>
   <result pre="of variable severity, ranging from mild febrile illness to life-threatening" exact="encephalitis" post="[11]. Patients who survive infection may suffer long-term reduced"/>
   <result pre="EEEV results in a self-limiting illness, it can cause severe" exact="encephalitis" post="with 30â€&quot;75% mortality in humans, depending on age, and"/>
   <result pre="disease can occur, beginning with flu-like symptoms and progressing to" exact="encephalitis" post="with high mortality. Overall, 1â€&quot;4% of VEEV patients develop"/>
   <result pre="infected pregnant women. WEEV was discovered in 1930 during an" exact="encephalitis" post="outbreak of thousands of horses and mules in California,"/>
   <result pre="licensed for human use. Early research on vaccines against equine" exact="encephalitis" post="viruses focused on the development of inactivated viruses through"/>
   <result pre="serological nonresponse [31] and (worryingly) has the potential to cause" exact="pancreatic disease" post="[36] and teratogenic effects [37]. C-84, though associated with"/>
   <result pre="Animal Models The usefulness of animal models to study any" exact="infectious disease" post="relies on the ability of the model to reproduce"/>
   <result pre="directed to an in-depth review describing animal models of Alphavirus" exact="encephalitis" post="[43]. Briefly, horses are natural hosts and highly susceptible"/>
   <result pre="subcutaneous infection with VEEV, some hamsters succumb to infection before" exact="central nervous system disease" post="develops [44]. Mouse models have been studied extensively and"/>
   <result pre="infection with VEEV, some hamsters succumb to infection before central" exact="nervous system disease" post="develops [44]. Mouse models have been studied extensively and"/>
   <result pre="induce strong antigen-specific immune responses. A Vaccinia virus expressing a" exact="hepatitis" post="B antigen was the first viral vector developed [64];"/>
   <result pre="to deliver antigens and is approved for use in a" exact="smallpox" post="vaccine licensed in Canada and Europe [91], demonstrating the"/>
   <result pre="against encephalitic Alphaviruses. 4.7. Vesicular Stomatitis Virus Vector The Vesicular" exact="stomatitis" post="virus can induce strong cellular and humoral immune responses"/>
   <result pre="same study that tested ISFV as a vector used vesicular" exact="stomatitis" post="virus serotype Indiana (VSIV) as a vector to deliver"/>
   <result pre="Natl. Acad. Sci. USA20171144055405910.1073/pnas.170141011428396438 10.ForresterN.L.WertheimJ.O.DuganV.G.AugusteA.J.LinD.AdamsA.P.ChenR.GorchakovR.LealG.Estrada-FrancoJ.G.Evolution and spread of Venezuelan equine" exact="encephalitis" post="complex Alphavirus in the AmericasPLoS Negl. Trop. Dis.201711e000569310.1371/journal.pntd.000569328771475 11.RoncaS.E.DineleyK.T.PaesslerS.Neurological"/>
   <result pre="Med. Hyg.19955281310.4269/ajtmh.1995.52.87856830 13.BroeckG.T.MerrellM.H.A serological difference between eastern and western equine" exact="encephalomyelitis" post="virusProc. Soc. Exp. Biol. Med.19333121722010.3181/00379727-31-7066C 14.CarreraJ.P.ForresterN.WangE.VittorA.Y.HaddowA.D.Lopez-VergesS.AbadiaI.CastanoE.SosaN.BaezC.et al.Eastern equine encephalitis"/>
   <result pre="equine encephalomyelitis virusProc. Soc. Exp. Biol. Med.19333121722010.3181/00379727-31-7066C 14.CarreraJ.P.ForresterN.WangE.VittorA.Y.HaddowA.D.Lopez-VergesS.AbadiaI.CastanoE.SosaN.BaezC.et al.Eastern equine" exact="encephalitis" post="in Latin AmericaN. Engl. J. Med.201336973274410.1056/NEJMoa121262823964935 15.KubesV.RiosF.A.The causative agent"/>
   <result pre="AmericaN. Engl. J. Med.201336973274410.1056/NEJMoa121262823964935 15.KubesV.RiosF.A.The causative agent of infectious equine" exact="encephalomyelitis" post="in VenezuelaScience193990202110.1126/science.90.2323.2017818578 16.SuarezO.M.BergoldG.H.Investigations of an outbreak of Venezuelan equine"/>
   <result pre="encephalomyelitis in VenezuelaScience193990202110.1126/science.90.2323.2017818578 16.SuarezO.M.BergoldG.H.Investigations of an outbreak of Venezuelan equine" exact="encephalitis" post="in towns of eastern VenezuelaAm. J. Trop. Med. Hyg.19681787588010.4269/ajtmh.1968.17.8754387218"/>
   <result pre="J. Trop. Med. Hyg.19681787588010.4269/ajtmh.1968.17.8754387218 17.BowenG.S.FashinellT.R.DeanP.B.GreggM.B.Clinical aspects of human Venezuelan equine" exact="encephalitis" post="in TexasBull. Pan Am. Health Organ.1976104657949558 18.RossiA.L.Rural epidemic encephalitis"/>
   <result pre="equine encephalitis in TexasBull. Pan Am. Health Organ.1976104657949558 18.RossiA.L.Rural epidemic" exact="encephalitis" post="in Venezuela caused by a group A arbovirus (VEE)Prog."/>
   <result pre="Virol.196791762034383416 19.WeaverS.C.FerroC.BarreraR.BoshellJ.NavarroJ.C.Venezuelan equine encephalitisAnnu. Rev. Entomol.20044914117410.1146/annurev.ento.49.061802.12342214651460 20.MeyerK.F.HaringC.M.HowittB.The etiology of epizootic" exact="encephalomyelitis" post="of horses in the San Joaquin Valley, 1930Science19317422722810.1126/science.74.1913.22717834966 21.Arechiga-CeballosN.Aguilar-SetienA.Alphaviral"/>
   <result pre="of horses in the San Joaquin Valley, 1930Science19317422722810.1126/science.74.1913.22717834966 21.Arechiga-CeballosN.Aguilar-SetienA.Alphaviral equine" exact="encephalomyelitis" post="(Eastern, Western and Venezuelan)Rev. Sci. Tech. Off. Int. Epiz.20153449150110.20506/rst.34.2.237426601451"/>
   <result pre="useAm. J. Trop. Med. Hyg.20149144245010.4269/ajtmh.14-005524842880 24.ArrigoN.C.AdamsA.P.WeaverS.C.Evolutionary patterns of Eastern equine" exact="encephalitis" post="virus in North versus South America suggest ecological differences"/>
   <result pre="we wish we knewViruses2018108910.3390/v10020089 27.OliviaL.W.ObandaV.BuchtG.MosomtaiG.OtienoV.AhlmC.EvanderM.Global emergence of Alphaviruses that cause" exact="arthritis" post="in humansInfect. Ecol. Epidemiol.201552985310.3402/iee.v5.2985326689654 28.WeaverS.C.PaesslerS.Chapter 21â€&quot;Alphaviral encephalitidesVaccines for Biodefense"/>
   <result pre="and Neglected DiseasesBarrettA.D.T.StanberryL.R.Academic PressAmsterdam, The Netherlands2009339359 29.CoxH.R.OlitskyP.K.Prevention of experimental equine" exact="encephalomyelitis" post="in guinea pigs by means of virus adsorbed on"/>
   <result pre="means of virus adsorbed on aluminum hydroxideScience19347945910.1126/science.79.2055.459 30.BeardJ.FinkelsteinH.SealyW.WyckoffR.Immunization against equine" exact="encephalomyelitis" post="with chick embryo vaccinesScience19388749010.1126/science.87.2265.490 31.PittmanP.R.MakuchR.S.MangiaficoJ.A.CannonT.L.GibbsP.H.PetersC.J.Long-term duration of detectable neutralizing"/>
   <result pre="potential biological warfare agentsClin. Infect. Dis.20003084385010.1086/31381210880299 33.BergeT.O.BanksI.S.TigerttW.Attenuation of Venezuelan equine" exact="encephalomyelitis" post="virus by ire vitro cultivation in guinea-pig heart cellsAm."/>
   <result pre="sequences of the virulent Trinidad donkey strain of Venezuelan equine" exact="encephalitis" post="virus and its attenuated vaccine derivative, strain TC-83Virology1989170193010.1016/0042-6822(89)90347-42524126 35.KinneyR.M.ChangG.TsuchiyaK.R.SneiderJ.M.RoehrigJ.WoodwardT.TrentD.Attenuation"/>
   <result pre="its attenuated vaccine derivative, strain TC-83Virology1989170193010.1016/0042-6822(89)90347-42524126 35.KinneyR.M.ChangG.TsuchiyaK.R.SneiderJ.M.RoehrigJ.WoodwardT.TrentD.Attenuation of Venezuelan equine" exact="encephalitis" post="virus strain TC-83 is encoded by the 5â€™-noncoding region"/>
   <result pre="envelope glycoproteinJ. Virol.1993671269127710.1128/JVI.67.3.1269-1277.19937679745 36.RayfieldE.GorelkinL.CumowR.JahrlingP.Virus-induced pancreatid disease induced by Venezuelan equine" exact="encephalitis" post="virus. Alterations in glucose tolerance and insulin releaseJ. Am."/>
   <result pre="tolerance and insulin releaseJ. Am. Diab. Assoc.197625621623 37.CasamassimaA.C.HessL.W.MartyA.TC-83 Venezuelan equine" exact="encephalitis" post="vaccine exposure during pregnancyTeratology19873628728910.1002/tera.14203603033424216 38.JahrlingP.B.StephensonE.H.Protective efficacies of live attenuated"/>
   <result pre="pregnancyTeratology19873628728910.1002/tera.14203603033424216 38.JahrlingP.B.StephensonE.H.Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine" exact="encephalitis" post="virus vaccines against aerosol challenge in hamstersJ. Clin. Microbiol.19841942943110.1128/JCM.19.3.429-431.19846715512"/>
   <result pre="in humans of a new, inactivated vaccine for Venezuelan equine" exact="encephalitis" post="virus (C-84)J. Infect. Dis.197914070871510.1093/infdis/140.5.708528788 40.KinneyR.M.TsuchiyaK.R.SneiderJ.M.TrentD.W.Molecular evidence for the origin"/>
   <result pre="40.KinneyR.M.TsuchiyaK.R.SneiderJ.M.TrentD.W.Molecular evidence for the origin of the widespread Venezuelan equine" exact="encephalitis" post="epizootic of 1969 to 1972J. Gen. Virol.1992733301330510.1099/0022-1317-73-12-33011469368 41.ReislerR.B.GibbsP.H.DannerD.K.BoudreauE.F.Immune interference"/>
   <result pre="animal models of Alphavirus encephalitisVet. Pathol.20104779080510.1177/030098581037250820551475 44.JacksonA.C.SenGuptaS.K.SmithJ.F.Pathogenesis of Venezuelan equine" exact="encephalitis" post="virus infection in mice and hamstersVet. Pathol.19912841041810.1177/0300985891028005091750167 45.DudleyD.M.NewmanC.M.LalliJ.StewartL.M.KoenigM.R.WeilerA.M.SemlerM.R.BarryG.L.ZarbockK.R.MohnsM.S.Infection via"/>
   <result pre="selection and the propagation of viral stocks for Venezuelan equine" exact="encephalitis" post="virus vaccine efficacy testing under the animal ruleViruses20191180710.3390/v1109080731480472 47.HÃ¶perD.FreulingC.M.MÃ¼llerT.HankeD.von"/>
   <result pre="controlVaccine2015335829583710.1016/j.vaccine.2015.08.09126387431 48.SharmaA.Knollmann-RitschelB.Current understanding of the molecular basis of Venezuelan equine" exact="encephalitis" post="virus pathogenesis and vaccine developmentViruses20191116410.3390/v11020164 49.TurellM.J.LudwigG.V.KondigJ.SmithJ.F.Limited potential for mosquito"/>
   <result pre="potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine" exact="encephalitis" post="virus vaccine candidatesAm. J. Trop. Med. Hyg.1999601041104410.4269/ajtmh.1999.60.104110403340 50.PedersenC.E.Jr.RobinsonD.M.ColeF.E.Jr.Isolation of"/>
   <result pre="Med. Hyg.1999601041104410.4269/ajtmh.1999.60.104110403340 50.PedersenC.E.Jr.RobinsonD.M.ColeF.E.Jr.Isolation of the vaccine strain of Venezuelan equine" exact="encephalomyelitis" post="virus from mosquitoes in LouisianaAm. J. Epidemiol.19729549049610.1093/oxfordjournals.aje.a1214164401801 51.MuellerS.PapamichailD.ColemanJ.R.SkienaS.WimmerE.Reduction of"/>
   <result pre="infectivityJ. Virol.2006809687969610.1128/JVI.00738-0616973573 52.YangC.SkienaS.FutcherB.MuellerS.WimmerE.Deliberate reduction of hemagglutinin and neuraminidase expression of" exact="influenza" post="virus leads to an ultraprotective live vaccine in miceProc."/>
   <result pre="genetic stability in mice of a novel DNA-launched Venezuelan equine" exact="encephalitis" post="virus vaccine with rearranged structural genesVaccines2020811410.3390/vaccines8010114 59.TretyakovaI.TibbensA.JokinenJ.D.JohnsonD.M.LukashevichI.S.PushkoP.Novel DNA-launched Venezuelan"/>
   <result pre="virus vaccine with rearranged structural genesVaccines2020811410.3390/vaccines8010114 59.TretyakovaI.TibbensA.JokinenJ.D.JohnsonD.M.LukashevichI.S.PushkoP.Novel DNA-launched Venezuelan equine" exact="encephalitis" post="virus vaccine with rearranged genomeVaccine2019373317332510.1016/j.vaccine.2019.04.07231072736 60.PhillpottsR.J.Venezuelan equine encephalitis virus"/>
   <result pre="Venezuelan equine encephalitis virus vaccine with rearranged genomeVaccine2019373317332510.1016/j.vaccine.2019.04.07231072736 60.PhillpottsR.J.Venezuelan equine" exact="encephalitis" post="virus complex-specific monoclonal antibody provides broad protection, in murine"/>
   <result pre="to the E3 glycoprotein protects mice against lethal Venezuelan equine" exact="encephalitis" post="virus infectionJ. Virol.201084126831269010.1128/JVI.01345-1020926570 62.ReedD.S.GlassP.J.BakkenR.R.BarthJ.F.LindC.M.da SilvaL.HartM.K.RaynerJ.AltersonK.CusterM.et al.Combined Alphavirus replicon particle"/>
   <result pre="particle vaccine induces durable and cross-protective immune responses against equine" exact="encephalitis" post="virusesJ. Virol.201488120771208610.1128/JVI.01406-1425122801 63.SaxenaM.VanT.T.H.BairdF.J.ColoeP.J.SmookerP.M.Pre-existing immunity against vaccine vectorsâ€&quot;friend or foe?Microbiology201315911110.1099/mic.0.049601-023175507"/>
   <result pre="virusesJ. Virol.201488120771208610.1128/JVI.01406-1425122801 63.SaxenaM.VanT.T.H.BairdF.J.ColoeP.J.SmookerP.M.Pre-existing immunity against vaccine vectorsâ€&quot;friend or foe?Microbiology201315911110.1099/mic.0.049601-023175507 64.SmithG.L.MackettM.MossB.Infectious" exact="vaccinia virus" post="recombinants that express hepatitis B virus surface antigenNature198330249010.1038/302490a06835382 65.DraperS.J.HeeneyJ.L.Viruses"/>
   <result pre="vaccine vectorsâ€&quot;friend or foe?Microbiology201315911110.1099/mic.0.049601-023175507 64.SmithG.L.MackettM.MossB.Infectious vaccinia virus recombinants that express" exact="hepatitis" post="B virus surface antigenNature198330249010.1038/302490a06835382 65.DraperS.J.HeeneyJ.L.Viruses as vaccine vectors for"/>
   <result pre="cancerNat. Rev. Microbiol.201086210.1038/nrmicro224019966816 66.PriceG.E.SoboleskiM.R.LoC.-Y.MisplonJ.A.QuirionM.R.HouserK.V.PearceM.B.PappasC.TumpeyT.M.EpsteinS.L.Single-dose mucosal immunization with a candidate universal" exact="influenza" post="vaccine provides rapid protection from virulent H5N1, H3N2 and"/>
   <result pre="immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine" exact="encephalitis" post="virus E2 glycoprotein protects against airborne challenge with virulent"/>
   <result pre="68.PerkinsS.D.WilliamsA.J.Oâ€™BrienL.M.LawsT.R.PhillpottsR.J.CpG used as an adjuvant for an adenovirus-based Venezuelan equine" exact="encephalitis" post="virus vaccine increases the immune response to the vector,"/>
   <result pre="efficacy of a gene optimised adenovirus-based vaccine for Venezuelan equine" exact="encephalitis" post="virusVirol. J.2009611810.1186/1743-422X-6-11819646224 70.WuJ.Q.BarabÃ©N.D.ChauD.WongC.RaynerG.R.HuW.-G.NagataL.P.Complete protection of mice against a lethal"/>
   <result pre="of mice against a lethal dose challenge of Western equine" exact="encephalitis" post="virus after immunization with an adenovirus-vectored vaccineVaccine2007254368437510.1016/j.vaccine.2007.03.04217467858 71.BarabÃ©N.D.RaynerG.A.ChristopherM.E.NagataL.P.WuJ.Q.Single-dose, fast-acting"/>
   <result pre="an adenovirus-vectored vaccineVaccine2007254368437510.1016/j.vaccine.2007.03.04217467858 71.BarabÃ©N.D.RaynerG.A.ChristopherM.E.NagataL.P.WuJ.Q.Single-dose, fast-acting vaccine candidate against Western equine" exact="encephalitis" post="virus completely protects mice from intranasal challenge with different"/>
   <result pre="virusVaccine2007256271627610.1016/j.vaccine.2007.05.05417630056 72.SwayzeR.D.BhogalH.S.BarabÃ©N.D.McLawsL.J.WuJ.Q.Envelope protein E1 as vaccine target for Western equine" exact="encephalitis" post="virusVaccine20112981382010.1016/j.vaccine.2010.11.00921084062 73.ErasmusJ.H.SeymourR.L.KaelberJ.T.KimD.Y.LealG.ShermanM.B.FrolovI.ChiuW.WeaverS.C.NasarF.Novel insect-specific Eilat virus-based chimeric vaccine candidates provide"/>
   <result pre="equine herpesvirus type 1â€&quot;based experimental vaccine against lethal Venezuelan equine" exact="encephalitis" post="virus infection in the absence of neutralizing antibodiesAm. J."/>
   <result pre="antibodiesAm. J. Trop. Med. Hyg.200878839210.4269/ajtmh.2008.78.8318187789 75.NasarF.MatassovD.SeymourR.L.LathamT.GorchakovR.V.NowakR.M.LealG.HammS.EldridgeJ.H.TeshR.B.Recombinant Isfahan virus and vesicular" exact="stomatitis" post="virus vaccine vectors provide durable, multivalent, single dose protection"/>
   <result pre="dose protection against lethal Alphavirus challengeJ. Virol.201791e01729-1610.1128/JVI.01729-1628148802 76.WangE.PetrakovaO.AdamsA.P.AguilarP.V.KangW.PaesslerS.VolkS.M.FrolovI.WeaverS.C.Chimeric Sindbis/Eastern equine" exact="encephalitis" post="vaccine candidates are highly attenuated and immunogenic in miceVaccine2007257573758110.1016/j.vaccine.2007.07.06117904699"/>
   <result pre="cynomolgus macaques against a lethal aerosol challenge of Eastern equine" exact="encephalitis" post="virusVaccine2013311464147010.1016/j.vaccine.2013.01.01423333212 78.PaesslerS.FayzulinR.Z.AnishchenkoM.GreeneI.P.WeaverS.C.FrolovI.Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated"/>
   <result pre="aerosol challenge of Eastern equine encephalitis virusVaccine2013311464147010.1016/j.vaccine.2013.01.01423333212 78.PaesslerS.FayzulinR.Z.AnishchenkoM.GreeneI.P.WeaverS.C.FrolovI.Recombinant Sindbis/Venezuelan equine" exact="encephalitis" post="virus is highly attenuated and immunogenicJ. Virol.2003779278928610.1128/JVI.77.17.9278-9286.200312915543 79.PaesslerS.NiH.PetrakovaO.FayzulinR.Z.YunN.AnishchenkoM.WeaverS.C.FrolovI.Replication and"/>
   <result pre="attenuated and immunogenicJ. Virol.2003779278928610.1128/JVI.77.17.9278-9286.200312915543 79.PaesslerS.NiH.PetrakovaO.FayzulinR.Z.YunN.AnishchenkoM.WeaverS.C.FrolovI.Replication and clearance of Venezuelan equine" exact="encephalitis" post="virus from the brains of animals vaccinated with chimeric"/>
   <result pre="vaccine candidates protect mice from intranasal challenge with Western equine" exact="encephalitis" post="virusVaccine2009274309431910.1016/j.vaccine.2009.05.01119446595 81.HuW.-G.SteigerwaldR.KallaM.VolkmannA.NollD.NagataL.P.Protective efficacy of monovalent and trivalent recombinant MVA-based"/>
   <result pre="MVA-based vaccines against three encephalitic alphavirusesVaccine2018365194520310.1016/j.vaccine.2018.06.06430037666 82.ZhangC.ZhouD.Adenoviral vector-based strategies against" exact="infectious disease" post="and cancerHum. Vaccines Immunother.2016122064207410.1080/21645515.2016.116590827105067 83.LundstromK.Alphavirus-based vaccinesViruses201462392241510.3390/v606239224937089 84.NasarF.PalaciosG.GorchakovR.V.GuzmanH.Da RosaA.P.T.SavjiN.PopovV.L.ShermanM.B.LipkinW.I.TeshR.B.Eilat virus,"/>
   <result pre="safety of three consecutive production lots of the non replicating" exact="smallpox" post="vaccine MVA: A randomised, double blind, placebo controlled phase"/>
   <result pre="boosts the immune response upon repeated applicationsJ. Virol.2014884897490710.1128/JVI.03276-1324554655 93.GeisbertT.W.FeldmannH.Recombinant vesicular" exact="stomatitis" post="virusâ€&quot;based vaccines against Ebola and Marburg virus infectionsJ. Infect."/>
   <result pre="transgene silencing from plasmid-based vectorsMol. Ther.2012202111211910.1038/mt.2012.6522565847 97.NelsonJ.RodriguezS.FinlaysonN.WilliamsJ.CarnesA.Antibiotic-free production of a" exact="herpes simplex" post="virus 2 DNA vaccine in a high yield cGMP"/>
   <result pre="enhances the immunogenicity of a DNA vaccine against Eastern equine" exact="encephalitis" post="virus in miceInt. Immunopharmacol.201419748010.1016/j.intimp.2014.01.00224440303 104.BoleyP.A.AlhamoM.A.LossieG.YadavK.K.Vasquez-LeeM.SaifL.J.KenneyS.P.Porcine deltacoronavirus infection and transmission"/>
   <result pre="for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine" exact="encephalitis" post="virusVaccine2003214071408010.1016/S0264-410X(03)00362-112922144 106.PerkinsS.D.Oâ€™BrienL.M.PhillpottsR.J.Boosting with an adenovirus-based vaccine improves protective efficacy"/>
   <result pre="with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine" exact="encephalitis" post="virus following DNA vaccinationVaccine2006243440344510.1016/j.vaccine.2006.02.02016527377 107.DupuyL.C.LocherC.P.PaidhungatM.RichardsM.J.LindC.M.BakkenR.ParkerM.D.WhalenR.G.SchmaljohnC.S.Directed molecular evolution improves the"/>
   <result pre="improves the immunogenicity and protective efficacy of a Venezuelan equine" exact="encephalitis" post="virus DNA vaccineVaccine2009274152416010.1016/j.vaccine.2009.04.04919406186 108.DupuyL.C.RichardsM.J.ReedD.S.SchmaljohnC.S.Immunogenicity and protective efficacy of a"/>
   <result pre="and protective efficacy of a DNA vaccine against Venezuelan equine" exact="encephalitis" post="virus aerosol challenge in nonhuman primatesVaccine2010287345735010.1016/j.vaccine.2010.09.00520851089 109.DupuyL.C.RichardsM.J.EllefsenB.ChauL.LuxembourgA.HannamanD.LivingstonB.D.SchmaljohnC.S.A DNA vaccine"/>
   <result pre="challenge in nonhuman primatesVaccine2010287345735010.1016/j.vaccine.2010.09.00520851089 109.DupuyL.C.RichardsM.J.EllefsenB.ChauL.LuxembourgA.HannamanD.LivingstonB.D.SchmaljohnC.S.A DNA vaccine for Venezuelan equine" exact="encephalitis" post="virus delivered by intramuscular electroporation elicits high levels of"/>
   <result pre="the protective efficacy of a DNA vaccine for Venezuelan equine" exact="encephalitis" post="virus delivered by intramuscular injection in miceAntivir. Res.201815911312110.1016/j.antiviral.2018.09.01430268913 111.HannamanD.DupuyL.C.EllefsenB.SchmaljohnC.S.A"/>
   <result pre="1 clinical trial of a DNA vaccine for Venezuelan equine" exact="encephalitis" post="delivered by intramuscular or intradermal electroporationVaccine2016343607361210.1016/j.vaccine.2016.04.07727206386 112.TretyakovaI.LukashevichI.S.GlassP.WangE.WeaverS.PushkoP.Novel vaccine against"/>
   <result pre="by intramuscular or intradermal electroporationVaccine2016343607361210.1016/j.vaccine.2016.04.07727206386 112.TretyakovaI.LukashevichI.S.GlassP.WangE.WeaverS.PushkoP.Novel vaccine against Venezuelan equine" exact="encephalitis" post="combines advantages of DNA immunization and a live attenuated"/>
   <result pre="cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine" exact="encephalitis" post="virus is immunogenic in HLA transgenic miceHum. Vaccines Immunother.2017132824283610.1080/21645515.2017.1329788"/>
   <result pre="miceHum. Vaccines Immunother.2017132824283610.1080/21645515.2017.1329788 114.NagataL.P.HuW.-G.MasriS.A.RaynerG.A.SchmaltzF.L.DasD.WuJ.LongM.C.ChanC.ProllD.Efficacy of DNA vaccination against Western equine" exact="encephalitis" post="virus infectionVaccine2005232280228310.1016/j.vaccine.2005.01.03215755611 115.GauciP.J.WuJ.Q.RaynerG.A.BarabÃ©N.D.NagataL.P.ProllD.F.Identification of Western equine encephalitis virus structural"/>
   <result pre="against Western equine encephalitis virus infectionVaccine2005232280228310.1016/j.vaccine.2005.01.03215755611 115.GauciP.J.WuJ.Q.RaynerG.A.BarabÃ©N.D.NagataL.P.ProllD.F.Identification of Western equine" exact="encephalitis" post="virus structural proteins that confer protection after DNA vaccinationClin."/>
   <result pre="completely protects mice against lethal Venezuelan, Western, and Eastern equine" exact="encephalitis" post="virus aerosol challengesJ. Immunol. Res.20182018852106010.1155/2018/852106029967804 117.LundbergL.CareyB.Kehn-HallK.Venezuelan equine encephalitis virus"/>
   <result pre="Eastern equine encephalitis virus aerosol challengesJ. Immunol. Res.20182018852106010.1155/2018/852106029967804 117.LundbergL.CareyB.Kehn-HallK.Venezuelan equine" exact="encephalitis" post="virus capsid-the clever caperViruses2017927910.3390/v9100279 118.WolffJ.A.MaloneR.W.WilliamsP.ChongW.AcsadiG.JaniA.FelgnerP.L.Direct gene transfer into mouse"/>
   <result pre="Natl. Acad. Sci. USA2012109146041460910.1073/pnas.120936710922908294 125.SamsaM.M.DupuyL.C.BeardC.W.SixC.M.SchmaljohnC.S.MasonP.W.GeallA.J.UlmerJ.B.YuD.Self-amplifying RNA vaccines for Venezuelan equine" exact="encephalitis" post="virus induce robust protective immunogenicity in miceMol. Ther.20192785086510.1016/j.ymthe.2018.12.01330770173 126.FlowerD.R.MacdonaldI.K.RamakrishnanK.DaviesM.N.DoytchinovaI.A.Computer"/>
   <result pre="antibodies for HIV-1 preventionAnnu. Rev. Immunol.20203867370310.1146/annurev-immunol-080219-02362932340576 136.YusimK.FischerW.YoonH.ThurmondJ.FenimoreP.W.LauerG.KorberB.KuikenC.Genotype 1 and global" exact="hepatitis" post="C T-cell vaccines designed to optimize coverage of genetic"/>
   <result pre="Alphavirus structural, protein-based, viral-vectored, and plasmid DNA vaccines. Venezuelan equine" exact="encephalitis" post="virus (VEEV) vaccines are indicated in purple, Western (WEEV)"/>
   <result pre="recombinant vector vaccine candidates for Eastern, Venezuelan, and Western equine" exact="encephalitis" post="viruses. Target Vaccine Genes Animal Model Doses, Route Induced"/>
   <result pre="plasmid DNA vaccine candidates for Eastern, Venezuelan, and Western equine" exact="encephalitis" post="viruses. Target Vaccine Genes Animal Model Immunization Doses, Route"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7350214\results\search\disease\results.xml">
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Emerging" exact="influenza" post="viruses pose an extreme global risk to human health,"/>
   <result pre="health, resulting in an urgent need for effective vaccination against" exact="influenza" post="infection. Adjuvants are vital components that can improve vaccine"/>
   <result pre="named EcML, in enhancing the immunogenicity and efficacy of an" exact="influenza" post="vaccine. Similar to MPL, EcML activated dendritic cells and"/>
   <result pre="that EcML might be a promising vaccine adjuvant for preventing" exact="influenza" post="virus infection. adjuvant vaccine efficacy influenza virus monophosphoryl lipid"/>
   <result pre="vaccine adjuvant for preventing influenza virus infection. adjuvant vaccine efficacy" exact="influenza" post="virus monophosphoryl lipid A antibody production cytotoxic T lymphocyte"/>
   <result pre="lipid A antibody production cytotoxic T lymphocyte 1. Introduction The" exact="influenza" post="virus poses a serious global threat to human health"/>
   <result pre="can cause pandemics associated with high mortality worldwide [1]. While" exact="influenza" post="vaccines have been used in many countries, the seasonal"/>
   <result pre="influenza vaccines have been used in many countries, the seasonal" exact="influenza" post="epidemics have not been well controlled. In addition, the"/>
   <result pre="well controlled. In addition, the outbreak of the swine-origin H1N1" exact="influenza" post="in 2009 resulted in an estimated 300,000 deaths [2,3],"/>
   <result pre="in an estimated 300,000 deaths [2,3], explicitly demonstrating how the" exact="influenza" post="vaccination was insufficient for controlling a potential pandemic. Consequently,"/>
   <result pre="control influenza. One approach to improve the effectiveness of the" exact="influenza" post="vaccine is to include adjuvants. While adjuvants have been"/>
   <result pre="alum, MF59, and AS03, which are included in currently licensed" exact="influenza" post="vaccines [4]. Despite the fact that alum induces humoral"/>
   <result pre="including pain at injection sites and the induction of inflammatory" exact="arthritis" post="[6]. Moreover, cases of rare sleeping disorders and narcolepsy"/>
   <result pre="inflammatory arthritis [6]. Moreover, cases of rare sleeping disorders and" exact="narcolepsy" post="after vaccination with AS03-adjuvanted vaccines were reported [7,8]. Therefore,"/>
   <result pre="used in licensed vaccines for human papillomavirus [15] and the" exact="hepatitis" post="B virus [16]. Thus, developing TLR4 ligands as adjuvants"/>
   <result pre="adjuvants could be beneficial to improving antiviral vaccines such as" exact="influenza" post="vaccine. Monophosphoryl lipid A (MPL) is a detoxified derivative"/>
   <result pre="adjuvanticity of EcML in enhancing the pandemic H1N1 (pH1N1, A/California/04/09)" exact="influenza" post="vaccine efficacy. EcML improved the protective efficacy of the"/>
   <result pre="suggest that EcML might be a promising adjuvant candidate for" exact="influenza" post="vaccines. 2. Materials and Methods 2.1. Mice and Cells"/>
   <result pre="obtained from InvivoGen. 2.3. Preparation of Influenza Virus The pH1N1" exact="influenza" post="virus was grown in 9- to 10-day-old SPF embryonated"/>
   <result pre="collected on day 14 after the last immunization. In the" exact="influenza" post="experiment, the mice were i.m. immunized with pH1N1 split"/>
   <result pre="challenged with a lethal dose (50 LD50) of the pH1N1" exact="influenza" post="virus. The body weight and survival of the challenged"/>
   <result pre="were sacrificed. 2.8. HI Assay HI titers against the pH1N1" exact="influenza" post="virus were determined using sera from the vaccinated mice,"/>
   <result pre="500 median tissue culture infectious dose (TCID50)/well of UV-inactivated pH1N1" exact="influenza" post="virus for 3 days at 37 Â°C. The spot-forming"/>
   <result pre="of Influenza Vaccine Antigen To evaluate whether EcML improves the" exact="influenza" post="vaccine efficacy, we examined the effects of EcML on"/>
   <result pre="challenged with a lethal dose (50 LD50) of the pH1N1" exact="influenza" post="virus. As shown in Figure 6A, mice vaccinated with"/>
   <result pre="adjuvant effects of EcML on the protection against the pH1N1" exact="influenza" post="virus challenge, we examined the influenza-specific humoral and cellular"/>
   <result pre="splenocytes of the vaccinated mice. Our results showed that the" exact="influenza" post="vaccine antigen-specific IgG, IgG1, and IgG2b titers were higher"/>
   <result pre="Moreover, the ELISPOT assay showed that the number of pH1N1" exact="influenza" post="virus-specific IFN-Î³ secreting cells was significantly higher in the"/>
   <result pre="suggest that EcML improves the protective efficacy of the pH1N1" exact="influenza" post="vaccine antigen by enhancing influenza-specific humoral and cellular immune"/>
   <result pre="immune responses. 4. Discussion Despite the availability of annual vaccinations," exact="influenza" post="remains a significant cause of human infectious disease and,"/>
   <result pre="of annual vaccinations, influenza remains a significant cause of human" exact="infectious disease" post="and, thus, there is a push to improve vaccine"/>
   <result pre="vaccine immunogenicity without compromising safety would be beneficial to improving" exact="influenza" post="vaccines. However, the main influenza vaccine adjuvants, including alum,"/>
   <result pre="would be beneficial to improving influenza vaccines. However, the main" exact="influenza" post="vaccine adjuvants, including alum, MF59, and AS03, have limitations"/>
   <result pre="adjuvant in several human vaccines [19] and has reported increasing" exact="influenza" post="vaccine efficacy [28]. However, its disadvantages, including the difficult"/>
   <result pre="Ultimately, EcML effectively improved the protective immunity of the pH1N1" exact="influenza" post="vaccine antigen. DCs play a major role in innate"/>
   <result pre="Previous studies have reported that children vaccinated with the MF59-adjuvanted" exact="influenza" post="vaccine showed adverse reactions, including redness and swelling at"/>
   <result pre="to MPL. Currently, alum and MF59 are mainly used in" exact="influenza" post="vaccines [4], but these adjuvants primarily induce responses toward"/>
   <result pre="and may not be sufficiently effective in the protection against" exact="influenza" post="virus infections. We then evaluated the efficacy of EcML"/>
   <result pre="evaluated the efficacy of EcML as an adjuvant for the" exact="influenza" post="vaccine, in comparison to alum. We found that EcML"/>
   <result pre="alum only partially protected mice (20% survival rate) against pH1N1" exact="influenza" post="virus infection. MPL has been reported to enhance the"/>
   <result pre="has been reported to enhance the protective efficacy of the" exact="influenza" post="vaccine [28]. We observed that EcML provided similarly protective"/>
   <result pre="the pH1N1 vaccine is beneficial for the protection against different" exact="influenza" post="virus subtypes. We observed that the EcML-vaccine group had"/>
   <result pre="has been used in licensed vaccines for human papillomavirus and" exact="hepatitis" post="B virus [43,44]. Thus, the combination of EcML with"/>
   <result pre="drastically increased the protective efficacy of the pH1N1 vaccine against" exact="influenza" post="virus infection by enhancing Ab production, HI titers, CTL"/>
   <result pre="promising adjuvant that may be capable of providing protection from" exact="influenza" post="virus infections. Supplementary Materials The following are available online"/>
   <result pre="conflict of interest. References References 1.Bar-OnY.GlasnerA.MeningherT.AchdoutH.GurC.LankryD.VitenshteinA.MeyersA.F.MandelboimM.MandelboimO.Neuraminidase-mediated, nkp46-dependent immune-evasion mechanism of" exact="influenza" post="virusesCell Rep.201331044105010.1016/j.celrep.2013.03.03423602571 2.GlezenW.P.Emerging infections: Pandemic influenzaEpidemiol. Rev.199618647610.1093/oxfordjournals.epirev.a0179178877331 3.DawoodF.S.IulianoA.D.ReedC.MeltzerM.I.ShayD.K.ChengP.Y.BandaranayakeD.BreimanR.F.BrooksW.A.BuchyP.et al.Estimated"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="a h1n1 virus circulation: A modelling studyLancet Infect. Dis.20121268769510.1016/S1473-3099(12)70121-422738893"/>
   <result pre="a h1n1 virus circulation: A modelling studyLancet Infect. Dis.20121268769510.1016/S1473-3099(12)70121-422738893 4.TregoningJ.S.RussellR.F.KinnearE.Adjuvanted" exact="influenza" post="vaccinesHum. Vaccines Immunother.20181455056410.1080/21645515.2017.1415684 5.MarrackP.McKeeA.S.MunksM.W.Towards an understanding of the adjuvant"/>
   <result pre="and prospects on controlled release adjuvancitySaudi. Pharm. J.20111919720610.1016/j.jsps.2011.06.00323960760 7.MillerE.AndrewsN.StellitanoL.StoweJ.WinstoneA.M.ShneersonJ.VerityC.Risk of" exact="narcolepsy" post="in children and young people receiving as03 adjuvanted pandemic"/>
   <result pre="children and young people receiving as03 adjuvanted pandemic a/h1n1 2009" exact="influenza" post="vaccine: Retrospective analysisBMJ2013346f79410.1136/bmj.f79423444425 8.NohynekH.JokinenJ.PartinenM.VaaralaO.KirjavainenT.SundmanJ.HimanenS.L.HublinC.JulkunenI.OlsenP.et al.As03 adjuvanted ah1n1 vaccine associated"/>
   <result pre="associated with an abrupt increase in the incidence of childhood" exact="narcolepsy" post="in finlandPLoS ONE20127e3353610.1371/journal.pone.003353622470453 9.KumarH.KawaiT.AkiraS.Toll-like receptors and innate immunityBiochem. Biophys."/>
   <result pre="greatly enhances the efficacy and heterosubtypic cross-reactivity of h1n1 pandemic" exact="influenza" post="vaccineSci. Rep.201774483910.1038/srep4483928322289 13.NguyenQ.T.KwakC.LeeW.S.KimJ.JeongJ.SungM.H.YangJ.PooH.Poly-gamma-glutamic acid complexed with alum induces cross-protective"/>
   <result pre="analysis of a phase iii double-blind, randomised controlled trialLancet20073692161217010.1016/S0140-6736(07)60946-517602732 16.KundiM.New" exact="hepatitis" post="b vaccine formulated with an improved adjuvant systemExpert Rev."/>
   <result pre="combination adjuvants on modulating innate and adaptive immune responses to" exact="influenza" post="vaccinationImmune Netw.20171732634210.4110/in.2017.17.5.32629093654 29.SteinmanR.M.Linking innate to adaptive immunity through dendritic"/>
   <result pre="after dendritic-cell vaccinationNat. Med.20051174875610.1038/nm125715951824 35.BlackS.Della CioppaG.MalfrootA.NacciP.NicolayU.PellegriniM.SokalE.VertruyenA.Safety of mf59-adjuvanted versus non-adjuvanted" exact="influenza" post="vaccines in children and adolescents: An integrated analysisVaccine2010287331733610.1016/j.vaccine.2010.08.07520813217 36.StassijnsJ.BollaertsK.BaayM.VerstraetenT.A"/>
   <result pre="much of a good thingPLoS Pathog.201814e100739010.1371/journal.ppat.100739030571771 39.SimonW.L.SalkH.M.OvsyannikovaI.G.KennedyR.B.PolandG.A.Cytokine production associated with" exact="smallpox" post="vaccine responsesImmunotherapy201461097111210.2217/imt.14.7225428648 40.ChristianL.M.PorterK.KarlssonE.Schultz-CherryS.Proinflammatory cytokine responses correspond with subjective side"/>
   <result pre="responsesImmunotherapy201461097111210.2217/imt.14.7225428648 40.ChristianL.M.PorterK.KarlssonE.Schultz-CherryS.Proinflammatory cytokine responses correspond with subjective side effects after" exact="influenza" post="virus vaccinationVaccine2015333360336610.1016/j.vaccine.2015.05.00826027906 41.AmannaI.J.SlifkaM.K.Contributions of humoral and cellular immunity to"/>
   <result pre="experiments. Figure 6 EcML enhances the protective efficacy of the" exact="influenza" post="vaccine antigen. C57BL/6 mice (n = 6 per group)"/>
   <result pre="vaccination, the mice were i.n. challenged with 50 LD50 pH1N1" exact="influenza" post="virus. Body weight changes and survival rates were monitored"/>
   <result pre="after the final administration, and the endpoint titers of the" exact="influenza" post="vaccine antigen-specific Abs are expressed as the means Â±"/>
   <result pre="Splenocytes from the immunized mice were stimulated with UV-inactivated pH1N1" exact="influenza" post="(500 median tissue culture infectious dose (TCID50)/well) for 3"/>
   <result pre="infectious dose (TCID50)/well) for 3 days, and the numbers of" exact="influenza" post="virus-specific IFN-Î³ SFUs were then determined using ELISPOT assay."/>
   <result pre="Splenocytes from the immunized mice were stimulated with UV-inactivated pH1N1" exact="influenza" post="virus (500 TCID50/well) for 5 days. The levels of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7350216\results\search\disease\results.xml">
   <result pre="Lumpy skin disease (LSD) is an economically important, arthropod borne" exact="viral disease" post="of cattle. Vaccination by the live attenuated homologous Neethling"/>
   <result pre="of specific diseases. Lumpy skin disease (LSD) is a vector-borne" exact="viral disease," post="which primarily affects cattle. It is caused by the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7350260\results\search\disease\results.xml">
   <result pre="of infected hematophagous arthropods [1]. These viruses, including dengue (DENV)," exact="yellow fever" post="(YFV), and West Nile (WNV) among others, are the"/>
   <result pre="produced a vaccine based on ZIKV E-DIII fused with the" exact="hepatitis" post="B core antigen (HbcAg-zDIII) to form VLPs in Nicotiana"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7350330\results\search\disease\results.xml">
   <result pre="important mosquito transmitted flaviviruses are the dengue (DENV), Zika (ZIKV)," exact="yellow fever" post="(YFV), West Nile (WNV) and Japanese encephalitis (JEV) viruses."/>
   <result pre="Zika (ZIKV), yellow fever (YFV), West Nile (WNV) and Japanese" exact="encephalitis" post="(JEV) viruses. Among them, DENV, ZIKV and JEV circulate"/>
   <result pre="asymptomatic to symptoms of fever, headache, myalgia, arthralgia and maculopapular" exact="rash" post="at the initial stage of illnesses [2,6]. DENV infections"/>
   <result pre="stage of illnesses [2,6]. DENV infections can be classified as" exact="dengue fever" post="(DF), dengue hemorrhagic fever (DHF) or dengue shock syndrome"/>
   <result pre="[2,6]. DENV infections can be classified as dengue fever (DF)," exact="dengue hemorrhagic fever" post="(DHF) or dengue shock syndrome (DSS) according to the"/>
   <result pre="and a drastic increase in the number of infants with" exact="microcephaly" post="born to mothers with the ZIKV infection meningoencephalitis, causing"/>
   <result pre="de OliveiraW.Cortez-EscalanteJ.De OliveiraW.T.do CarmoG.M.HenriquesC.M.CoelhoG.E.AraÃºjo de FranÃ§aG.V.Increase in reported prevalence of" exact="microcephaly" post="in infants born to women living in areas with"/>
   <result pre="and clinical analysisLancet. Infect. Dis.20171781382110.1016/S1473-3099(17)30249-928527892 24.MoiM.L.NguyenT.T.T.NguyenC.T.VuT.B.H.TunM.M.N.PhamT.D.PhamN.T.TranT.MoritaK.LeT.Q.M.et al.Zika virus infection and" exact="microcephaly" post="in VietnamLancet. Infect. Dis.20171780580610.1016/S1473-3099(17)30412-728741545 25.FonsecaK.MeatherallB.ZarraD.DrebotM.MacDonaldJ.PabbarajuK.WongS.WebsterP.LindsayR.TellierR.First case of Zika virus"/>
   <result pre="field-caught mosquitoes in various regions of ThailandPathogens201983010.3390/pathogens8010030 30.WongsurawatT.AthipanyasilpN.JenjaroenpunP.JunS.R.KaewnapanB.WassenaarT.M.LeelahakornN.AngkasekwinaiN.KantakamalakulW.UsseryD.W.et al.Case of" exact="microcephaly" post="after congenital infection with Asian lineage Zika virus, ThailandEmerg."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7350584\results\search\disease\results.xml">
   <result pre="in adults worldwide. PVB19 is the etiologic agent of the" exact="fifth disease," post="is a cause of aplastic anemia, and can be"/>
   <result pre="etiologic agent of the fifth disease, is a cause of" exact="aplastic anemia," post="and can be associated with kidney injury. We aimed"/>
   <result pre="4 patients with PVB19 infection-associated kidney disease displayed: one lupus-like" exact="glomerulonephritis" post="(GN) without lupus auto-antibodies, one minimal change disease with"/>
   <result pre="small ssDNA virus, known as the etiologic agent of the" exact="fifth disease." post="Most adults worldwide show evidence of past infection (between"/>
   <result pre="concern mainly in kidney transplant recipients, as a cause of" exact="aplastic anemia" post="and pure red cell aplasia. The incidence of PVB19"/>
   <result pre="mainly in kidney transplant recipients, as a cause of aplastic" exact="anemia" post="and pure red cell aplasia. The incidence of PVB19"/>
   <result pre="kidney transplant recipients, as a cause of aplastic anemia and" exact="pure red cell aplasia." post="The incidence of PVB19 infection after kidney transplantation either"/>
   <result pre="as a possible cause of kidney injury. Several cases of" exact="glomerulonephritis" post="(GN) occurring after a PVB19 primo-infection have been reported"/>
   <result pre="to establish. Renal presentation was mostly post-infectious GN, but collapsing" exact="focal segmental glomerulosclerosis" post="(FSGS), membrano-proliferative GN, and thrombotic microangiopathy have also been"/>
   <result pre="Renal presentation was mostly post-infectious GN, but collapsing focal segmental" exact="glomerulosclerosis" post="(FSGS), membrano-proliferative GN, and thrombotic microangiopathy have also been"/>
   <result pre="cases of PVB19-associated kidney diseases Case report nÂ°1 (2018): lupus-like" exact="glomerulonephritis" post="(Fig.Â 1a) A 42-year-old women was admitted to the"/>
   <result pre="pressure (120/60â€‰mmHg), lower limb edema, and bilateral pleural effusion. A" exact="nephrotic syndrome" post="was diagnosed (serum albumin 2.5â€‰g/dL, proteinuria 9.6â€‰g/24â€‰h), with a"/>
   <result pre="pleural effusion. A nephrotic syndrome was diagnosed (serum albumin 2.5â€‰g/dL," exact="proteinuria" post="9.6â€‰g/24â€‰h), with a rise in serum creatinine (1.17â€‰mg/dL), active"/>
   <result pre="cells (RBC) 27/mm3, white blood cells (WBC) 60/mm3), and non-regenerative" exact="anemia" post="(hemoglobin 10.7â€‰g/dL, reticulocytes 35â€‰G/L). The complement C3 was low"/>
   <result pre="(Jones silver staining, Ã—â€‰1000) A kidney biopsy revealed a membrano-proliferative" exact="glomerulonephritis" post="(MPGN), with a â€œfull-houseâ€� pattern of endo-membranous deposits comprising"/>
   <result pre="immuno-competent, no intravenous immunoglobulin was administered. A remission of the" exact="nephrotic syndrome" post="was observed after 4â€‰weeks, with a decrease in serum"/>
   <result pre="has normalized (estimated glomerular filtration rate (eGFR) 86â€‰ml/min/1,73â€‰m2) without residual" exact="proteinuria" post="(0.09â€‰g/24â€‰h). Case report nÂ°2 (2015): minimal change disease (MCD)"/>
   <result pre="(0.09â€‰g/24â€‰h). Case report nÂ°2 (2015): minimal change disease (MCD) and" exact="acute tubular necrosis" post="(Fig. 1b) A 42-year-old women was admitted to the"/>
   <result pre="an acute nephritic syndrome. She reported a fever and 3-day" exact="rash" post="of the arms and legs 1 month earlier, with"/>
   <result pre="hematuria. Serum creatinine was elevated (1.33â€‰mg/dL increasing to 2.24â€‰mg/dl), with" exact="proteinuria" post="(1â€‰g/24â€‰h rising to 4â€‰g/24â€‰h) and hematuria (&amp;gt;â€‰106/mm3). She displayed"/>
   <result pre="(1â€‰g/24â€‰h rising to 4â€‰g/24â€‰h) and hematuria (&amp;gt;â€‰106/mm3). She displayed non-regenerative" exact="anemia" post="(hemoglobin 11â€‰g/dL, which lowered to 7â€‰g/dL before the kidney"/>
   <result pre="the kidney biopsy, without schizocytes, and a normal haptoglobin level)," exact="leukopenia" post="(3.5â€‰G/L), thrombocytopenia (121â€‰G/L), and polyclonal hypergammaglobulinemia. C3 and CH50"/>
   <result pre="biopsy, without schizocytes, and a normal haptoglobin level), leukopenia (3.5â€‰G/L)," exact="thrombocytopenia" post="(121â€‰G/L), and polyclonal hypergammaglobulinemia. C3 and CH50 levels were"/>
   <result pre="and a normal haptoglobin level), leukopenia (3.5â€‰G/L), thrombocytopenia (121â€‰G/L), and" exact="polyclonal hypergammaglobulinemia." post="C3 and CH50 levels were low, with a normal"/>
   <result pre="no abnormality. The kidney biopsy showed minimal change disease and" exact="acute tubular necrosis," post="without immune deposits or glomerular proliferation. Viral and bacterial"/>
   <result pre="quickly recovered a normal renal function (eGFR 86â€‰mL/min/1.73m2), without residual" exact="proteinuria" post="( Case report nÂ°3 (2012): hemolytic and uremic syndrome"/>
   <result pre="blood tests revealed acute renal failure (serum creatinine 6.14â€‰mg/dl), microangiopathic" exact="hemolytic anemia" post="(Hemoglobin 11.9â€‰g/dL, undetectable serum haptoglobin, positive schizocytes 1.5%, elevated"/>
   <result pre="tests revealed acute renal failure (serum creatinine 6.14â€‰mg/dl), microangiopathic hemolytic" exact="anemia" post="(Hemoglobin 11.9â€‰g/dL, undetectable serum haptoglobin, positive schizocytes 1.5%, elevated"/>
   <result pre="deshydrogenase 2000 UI/L), without regeneration (reticulocytes 4.2â€‰G/L) associated with a" exact="thrombocytopenia" post="(platelets 16â€‰G/L). Urinary tests showed proteinuria (0.8â€‰g/L) and leukocyturia"/>
   <result pre="4.2â€‰G/L) associated with a thrombocytopenia (platelets 16â€‰G/L). Urinary tests showed" exact="proteinuria" post="(0.8â€‰g/L) and leukocyturia (350/mm3) without hematuria. Complement fractions were"/>
   <result pre="stool was negative. Because of the low reticulocyte count, despite" exact="hemolytic anemia," post="a PVB19 infection was suspected and confirmed, with elevated"/>
   <result pre="1â€‰month. No relapse occurred subsequently. Case report nÂ°4 (2002): membrano-proliferative" exact="glomerulonephritis" post="(MPGN) (Fig. 1c and d) A 19-year-old woman with"/>
   <result pre="admitted, in 2002, to the Nephrology department to investigate a" exact="nephrotic syndrome." post="One year earlier, she had presented a PVB19 primary"/>
   <result pre="an aplastic crisis. Shortly after, she had developed a moderate" exact="proteinuria" post="(1â€‰g/day) which had not been explored. Upon admission, physical"/>
   <result pre="and a grade 2/6 systolic murmur. Laboratory tests revealed a" exact="nephrotic syndrome" post="(serum albumin 2.4â€‰g/dL, proteinuria 3.5â€‰g/24) with preserved renal function"/>
   <result pre="murmur. Laboratory tests revealed a nephrotic syndrome (serum albumin 2.4â€‰g/dL," exact="proteinuria" post="3.5â€‰g/24) with preserved renal function (serum creatinine 1â€‰mg/dL), without"/>
   <result pre="(serum creatinine 1â€‰mg/dL), without hematuria or leukocyturia, and poorly regenerative" exact="anemia" post="(hemoglobin 6.3â€‰g/dL, reticulocytes 136â€‰G/L, platelets 882â€‰G/L) without vitamin deficiency."/>
   <result pre="The patient received ACE inhibitors, with a remission of the" exact="nephrotic syndrome," post="but with a progressive deterioration of renal function leading"/>
   <result pre="examination Diffuse edema and pleural effusion Acute nephritic syndrome, fever," exact="rash" post="Fever, diarrhea, pallor Edema, pallor Serum creatinine (mg/dL) 1.17"/>
   <result pre="Kidney Biopsy Membrano-proliferative GN, full-house pattern Minimal change disease and" exact="acute tubular necrosis" post="NA Membrano-proliferative GN, C3 deposits Elevated titers of anti-PVB19"/>
   <result pre="in 2, minimal change disease in 1, class III lupus" exact="nephritis" post="in 1, MPGN with a â€œfull-houseâ€� pattern of endo-membranous"/>
   <result pre="GN without lupus auto-antibodies), pauci-immune crescentic GN in 1, hypertensive" exact="nephropathy" post="in 1, acute interstitial nephritis with lymphocytic infiltration in"/>
   <result pre="pauci-immune crescentic GN in 1, hypertensive nephropathy in 1, acute" exact="interstitial nephritis" post="with lymphocytic infiltration in 1. Table 2 Characteristics of"/>
   <result pre="crescentic GN in 1, hypertensive nephropathy in 1, acute interstitial" exact="nephritis" post="with lymphocytic infiltration in 1. Table 2 Characteristics of"/>
   <result pre="Glomerulonephritides â€ƒâ€ƒLupus Nephritis 18 1 13 0 4 â€ƒâ€ƒPauci-immune crescentic" exact="glomerulonephritis" post="8 1 6 0 1 Other Kidney Diseases â€ƒâ€ƒHypertensive"/>
   <result pre="viremia was negative. She had been admitted for arthralgia, and" exact="nephrotic syndrome" post="with acute kidney injury (serum creatinine 1.23â€‰mg/dl). Laboratory tests"/>
   <result pre="injury (serum creatinine 1.23â€‰mg/dl). Laboratory tests had revealed a non-regenerative" exact="anemia" post="(hemoglobin 9,6â€‰g/dl, reticulocytes 26â€‰G/L). Renal pathological examination showed a"/>
   <result pre="(hemoglobin 9,6â€‰g/dl, reticulocytes 26â€‰G/L). Renal pathological examination showed a membranous" exact="nephropathy" post="(Fig. 1d). Serum anti-PLA2R antibodies were negative, but there"/>
   <result pre="ANCA, anti-MBG or PLA2R antibodies), and 6 had a mixed" exact="cryoglobulinemia" post="(all with a negative hepatitis C virus serology). Discussion"/>
   <result pre="and 6 had a mixed cryoglobulinemia (all with a negative" exact="hepatitis" post="C virus serology). Discussion We confirm in this work"/>
   <result pre="was suspected, in all cases, upon the observation of an" exact="anemia" post="that was either non-regenerative or poorly regenerative, sometimes associated"/>
   <result pre="are possible [19]. Autoimmune antibodies, such as a rheumatoid factor," exact="cryoglobulinemia" post="or antinuclear antibodies, can cross-react with PVB19 serology and"/>
   <result pre="role of PVB19 in the development of infectious cryoglobulinemia. Although" exact="hepatitis" post="C virus (HCV) infection is the most frequent cause"/>
   <result pre="virus (HCV) infection is the most frequent cause of infectious" exact="cryoglobulinemia" post="(70â€&quot;90%) [21], several case reports of PVB19-related cryoglobulinemic vasculitis"/>
   <result pre="infectious cryoglobulinemia (70â€&quot;90%) [21], several case reports of PVB19-related cryoglobulinemic" exact="vasculitis" post="have been reported [22, 23]. In the French nationwide"/>
   <result pre="higher seroprevalence of PVB19 was also documented among patients with" exact="cryoglobulinemia" post="compared to a control group (64.9% versus 50%, NS)"/>
   <result pre="parvovirus B19 in the German populationEpidemiol Infect2008136111564157510.1017/S095026880700995818198003 2.WeirEParvovirus B19 infection:" exact="fifth disease" post="and moreCMAJ Can Med Assoc J J Assoc Medicale"/>
   <result pre="7.MagroCMCrowsonANDawoodMNuovoGJParvoviral infection of endothelial cells and its possible role in" exact="vasculitis" post="and autoimmune diseasesJ Rheumatol20022961227123512064841 8.NakazawaTTomosugiNSakamotoKAsakaMYuriTIshikawaIet al.Acute glomerulonephritis after human"/>
   <result pre="possible role in vasculitis and autoimmune diseasesJ Rheumatol20022961227123512064841 8.NakazawaTTomosugiNSakamotoKAsakaMYuriTIshikawaIet al.Acute" exact="glomerulonephritis" post="after human parvovirus B19 infectionAm J Kidney Dis2000356e31.1e31.810.1016/S0272-6386(00)70070-910845847 9.HeegaardEDBrownKEHuman"/>
   <result pre="with erythema infectiosumJ Med Virol199135211011510.1002/jmv.18903502071765775 17.CrabolYTerrierBRozenbergFPestreVLegendreCHermineOet al.Intravenous immunoglobulin therapy for" exact="pure red cell aplasia" post="related to human parvovirus b19 infection: a retrospective study"/>
   <result pre="Dis Off Publ Infect Dis Soc Am.20105071074107510.1086/651164 23.LazzeriniPECusiMGSelviECapecchiMMoscadelliVMigliacciNet al.Non-HCV-related cryoglobulinemic" exact="vasculitis" post="and parvovirus-B19 infectionJt Bone Spine Rev Rhum201885112913010.1016/j.jbspin.2016.12.013 24.TerrierBMarieILacrazABelenottiPBonnetFChicheLet al.Non"/>
   <result pre="parvovirus-B19 infectionJt Bone Spine Rev Rhum201885112913010.1016/j.jbspin.2016.12.013 24.TerrierBMarieILacrazABelenottiPBonnetFChicheLet al.Non HCV-related infectious" exact="cryoglobulinemia" post="vasculitis: results from the French nationwide CryoVas survey and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC7351801\results\search\disease\results.xml">
   <result pre="of Zika virus and of other mosquito-borne viruses such as" exact="chikungunya" post="virus and dengue virus in the last decades. Using"/>
   <result pre="(DENV) in multiple communities [1â€&quot;4]. In 2015, local transmission of" exact="chikungunya" post="virus (CHIKV) occurred in Brownsville, TX, and 10 cases"/>
   <result pre="Contract DE-AC52-07NA27344. References References 1.RamosMMMohammedHZielinski-GutierrezEHaydenMHLopezJLFournierMTrujilloARBurtonRBrunkardJMAnaya-LopezLBanickiAAMoralesPKSmithBMunozJLWaterman SH (2008) Epidemic dengue and" exact="dengue hemorrhagic fever" post="at the Texas-Mexico border: results of a household-based seroepidemiologic"/>
   <result pre="a household-based seroepidemiologic surveyAm J Trop Med Hyg2005783364369 2.ClarkGGDengue and" exact="dengue hemorrhagic fever" post="in northern Mexico and south Texas: do they really"/>
   <result pre="transmission of dengue virusEmerg Infect Dis200391868912533286 5.DSHS announces first Texas-acquired" exact="chikungunya" post="case (2016). Texas Department of State Health Services 6.MartinEMedeirosMCICarbajalEValdezEJuarezJGGarcia-LunaSSalazarAQuallsWAHinojosaSBoruckiMKManleyHABadillo-VargasIEFrankMHamerGLSurveillance"/>
   <result pre="in Northern ItalyParasit Vectors2012522323043958 30.KrockelURoseAEirasAEGeierMNew tools for surveillance of adult" exact="yellow fever" post="mosquitoes: comparison of trap catches with human landing rates"/>
   <result pre="feedingInsect Mol Biol19965125298630532 43.KokozaVAhmedAChoWLJasinskieneNJamesAARaikhelAEngineering blood meal-activated systemic immunity in the" exact="yellow fever" post="mosquito, Aedes aegyptiProc Natl Acad Sci USA200097169144914910908672 44.SaiyasombatRBollingBGBraultACBartholomayLCBlitvichBJEvidence of"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
